PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Takeda, Y; Wakui, N; Asai, Y; Dan, N; Yamauchi, Y; Ueki, N; Otsuka, T; Oba, N; Nishinakagawa, S; Minagawa, M; Takeda, Y; Shiono, S; Kojima, T				Takeda, Yuki; Wakui, Noritaka; Asai, Yasutsugu; Dan, Nobuhiro; Yamauchi, Yoshiya; Ueki, Nobuo; Otsuka, Takafumi; Oba, Nobuyuki; Nishinakagawa, Shuta; Minagawa, Masami; Takeda, Yasushi; Shiono, Saori; Kojima, Tatsuya			Spontaneous complete necrosis of hepatocellular carcinoma: A case report and review of the literature	ONCOLOGY LETTERS			English	Article						hepatocellular carcinoma; spontaneous necrosis; regression; fibrous capsule; arterio-portal shunt; thrombi	SPONTANEOUS REGRESSION	The present study reports the case of a 68-year-old male patient who presented to Tokyo Rosai Hospital for the treatment of alcoholic liver disease. A high density was observed in liver segment S2, while a tumor, 30 mm in size, exhibiting a low density was observed in the delayed phase upon contrast-enhanced computed tomography (CT), which was performed prior to admission. The tumor appeared slightly poorly defined upon abdominal ultrasound and was observed as a 30 mm low-echoic nodule that was internally heterogeneous. A 5-mm thick contrast enhancement effect was observed in the tumor border in the vascular phase on Sonazoid contrast-enhanced ultrasonography, while a defect in the entire tumor was observed in the post-vascular phase. Dysphagia had commenced three months prior to presentation and a weight loss of 3 kg was observed. Therefore, the patient was admitted to Tokyo Rosai Hospital due to the presence of a hepatic tumor, and to undergo a close inspection of the cause of the tumor. Upon close inspection, it was determined that the weight loss and aphagia were caused by progressive bulbar paralysis. A contrast-enhanced CT was performed on post-admission day 29 as a follow-up regarding the hepatic tumor. As a result, although no change in the tumor size was observed, the contrast enhancement in the tumor borderline had disappeared. Necrosis of the tumor was considered. However, as viable persistence of the malignant tumor could not be excluded, a hepatic left lobe excision was performed. The patient was diagnosed with hepatocellular carcinoma (HCC) based on the morphology of the cellular necrosis. In addition, occlusion due to thrombus was observed within the blood vessels passing inside the fibrous capsule. It was hypothesized that the formation of a thick fibrous capsule and occlusion due to thrombus in the feeding vessel were possibly involved as the cause of complete spontaneous necrosis. Written informed consent was obtained from the patient.	[Takeda, Yuki; Wakui, Noritaka; Asai, Yasutsugu; Dan, Nobuhiro; Yamauchi, Yoshiya; Ueki, Nobuo; Otsuka, Takafumi; Oba, Nobuyuki; Nishinakagawa, Shuta; Kojima, Tatsuya] Tokyo Rosai Occupat Dis & Injuries Hosp, Dept Internal Gastroenterol & Hepatol, Tokyo 1430013, Japan; [Minagawa, Masami; Takeda, Yasushi] Tokyo Rosai Occupat Dis & Injuries Hosp, Dept Surg, Tokyo 1430013, Japan; [Shiono, Saori] Tokyo Rosai Occupat Dis & Injuries Hosp, Dept Pathol, Tokyo 1430013, Japan	Wakui, N (reprint author), Tokyo Rosai Occupat Dis & Injuries Hosp, Dept Internal Gastroenterol, 4-13-21 Omori Minami, Tokyo 1430013, Japan.	noriwakui@yahoo.co.jp					ANDREOLA S, 1987, TUMORI, V73, P203; COLE WH, 1981, J SURG ONCOL, V17, P201, DOI 10.1002/jso.2930170302; Ohba K, 1998, GUT, V43, P575; Markovic S, 1996, AM J GASTROENTEROL, V91, P392; Bruix J, 2009, LANCET, V373, P614, DOI 10.1016/S0140-6736(09)60381-0; Arakawa Y, 2008, HEPATO-GASTROENTEROL, V55, P1770; Cheng HM, 2004, AM J CHINESE MED, V32, P579, DOI 10.1142/S0192415X04002211; GAFFEY MJ, 1990, CANCER, V65, P2779, DOI 10.1002/1097-0142(19900615)65:12<2779::AID-CNCR2820651228>3.0.CO;2-T; Iiai T, 2003, HEPATO-GASTROENTEROL, V50, P1628; Izuishi K, 2000, HEPATO-GASTROENTEROL, V47, P1122; Kojiro M, 2005, SEMIN LIVER DIS, V25, P133, DOI 10.1055/s-2005-871193; Lee HS, 2000, J GASTROENTEROL, V35, P552, DOI 10.1007/s005350070080; Li Ai-Jun, 2003, Hepatobiliary Pancreat Dis Int, V2, P152; Maejima Ryuhei, 2011, Nihon Shokakibyo Gakkai Zasshi, V108, P1902; Morimoto Y, 2002, DIGEST SURG, V19, P413, DOI 10.1159/000065822; Ohta H, 2005, ABDOM IMAGING, V30, P734, DOI 10.1007/s00261-005-0313-9; Ozeki Y, 1996, AM J GASTROENTEROL, V91, P391; Storey RE, 2011, MED ONCOL, V28, P948, DOI 10.1007/s12032-010-9562-8; TAKAYASU K, 1986, AM J GASTROENTEROL, V81, P979; TOCCI G, 1990, BRIT MED J, V300, P641; Yamamoto M, 1991, GAN NO RINSHO, V37, p[491, 496]; Yokoyama T, 2012, J NIPPON MED SCH, V79, P213	22	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	APR	2015	9	4					1520	1526		10.3892/ol.2015.2937		7	Oncology	Oncology	CE2GF	WOS:000351631900005		
J	Matsumoto, T; Otsuka, K; Funayama, Y; Imai, Y; Tomii, K				Matsumoto, Takeshi; Otsuka, Kojiro; Funayama, Yuki; Imai, Yukihiro; Tomii, Keisuke			Primary pulmonary lymphoma mimicking a refractory lung abscess: A case report	ONCOLOGY LETTERS			English	Article						primary pulmonary lymphoma; lung abscess; refractory	NON-HODGKINS-LYMPHOMA; PROGNOSIS; FEATURES; DISEASE	The current study presents a case of primary pulmonary lymphoma (PPL) mimicking refractory lung abscess that was diagnosed at autopsy. An 80-year-old male with clinically inapparent aspiration presented with a large cavitated mass and pleural effusion. A lung abscess and empyema was diagnosed, therefore, antibiotics were administered and the pleural effusion was drained. Various examinations, including a biopsy, yielded no specific diagnosis. The lesion was considered inoperable due to the poor general condition of the patient. Subsequently, the mass that had been diagnosed as a refractory lung abscess became enlarged and a repeat biopsy resulted in a diagnosis of diffuse large B-cell lymphoma. The patient succumbed to sudden respiratory failure, and the final diagnosis of PPL was confirmed at autopsy. PPL is a rare disease that accounts for 0.45% of all pulmonary malignant tumors and is difficult to diagnose in inoperable cases. Therefore, patients with PPL who do not undergo surgery can be misdiagnosed and consequently treated inappropriately. PPL should therefore be considered in the differential diagnosis of a refractory lung abscess.	[Matsumoto, Takeshi; Otsuka, Kojiro; Tomii, Keisuke] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo 6500047, Japan; [Funayama, Yuki] Kobe City Med Ctr Gen Hosp, Dept Hematol, Kobe, Hyogo 6500047, Japan; [Imai, Yukihiro] Kobe City Med Ctr Gen Hosp, Dept Pathol, Kobe, Hyogo 6500047, Japan	Matsumoto, T (reprint author), Kobe City Med Ctr Gen Hosp, Dept Resp Med, Chuo Ku, 2-1-1 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	fu_rinkazan0202@yahoo.co.jp					CORDIER JF, 1993, CHEST, V103, P201, DOI 10.1378/chest.103.1.201; Graham BB, 2005, ANN THORAC SURG, V80, P1248, DOI 10.1016/j.athoracsur.2005.04.014; Cadranel J, 2002, EUR RESPIR J, V20, P750, DOI 10.1183/09031936.02.00404102; Nakatsuka S, 2002, J CLIN ONCOL, V20, P4255, DOI 10.1200/JCO.2002.09.021; Ferraro P, 2000, ANN THORAC SURG, V69, P993, DOI 10.1016/S0003-4975(99)01535-0; FREEMAN C, 1972, CANCER, V29, P252, DOI 10.1002/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#; SALTZSTEIN SL, 1963, CANCER, V16, P928, DOI 10.1002/1097-0142(196307)16:7<928::AID-CNCR2820160709>3.0.CO;2-H; LHOSTE RJ, 1984, CANCER, V54, P1397; DRENT M, 1994, CHEST, V105, P514, DOI 10.1378/chest.105.2.514; FICHE M, 1995, HISTOPATHOLOGY, V26, P529, DOI 10.1111/j.1365-2559.1995.tb00271.x; LI G, 1990, HISTOPATHOLOGY, V16, P519, DOI 10.1111/j.1365-2559.1990.tb01157.x; Miyahara N, 2001, INTERNAL MED, V40, P786, DOI 10.2169/internalmedicine.40.786; Ooi GC, 1999, CLIN RADIOL, V54, P438, DOI 10.1016/S0009-9260(99)90828-0; PAPAIOAN.AN, 1965, J THORAC CARDIOV SUR, V49, P373; RADIN AI, 1990, CANCER, V65, P550, DOI 10.1002/1097-0142(19900201)65:3<550::AID-CNCR2820650328>3.0.CO;2-W; Tao Hiroyuki, 2002, Jpn J Thorac Cardiovasc Surg, V50, P533	16	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	APR	2015	9	4					1575	1578		10.3892/ol.2015.2929		4	Oncology	Oncology	CE2GF	WOS:000351631900015		
J	Einama, T; Kamachi, H; Nishihara, H; Homma, S; Kanno, H; Ishikawa, M; Kawamata, F; Konishi, Y; Sato, M; Tahara, M; Okada, K; Muraoka, S; Kamiyama, T; Taketomi, A; Matsuno, Y; Furukawa, H; Todo, S				Einama, Takahiro; Kamachi, Hirofumi; Nishihara, Hiroshi; Homma, Shigenori; Kanno, Hiromi; Ishikawa, Marin; Kawamata, Futoshi; Konishi, Yuji; Sato, Masanori; Tahara, Munenori; Okada, Kuniaki; Muraoka, Shunji; Kamiyama, Toshiya; Taketomi, Akinobu; Matsuno, Yoshihiro; Furukawa, Hiroyuki; Todo, Satoru			Importance of luminal membrane mesothelin expression in intraductal papillary mucinous neoplasms	ONCOLOGY LETTERS			English	Article						mesothelin; intraductal papillary mucinous neoplasms; luminal membrane expression	PANCREATIC-CANCER; MONOCLONAL-ANTIBODY; OVARIAN CANCERS; ADENOCARCINOMA; LOCALIZATION; DIAGNOSIS; TARGET	The present study demonstrated that luminal membrane mesothelin expression is a reliable prognostic factor in gastric cancer. Intraductal papillary mucinous neoplasms (IPMNs) often exhibit a spectrum of dysplasia, ranging between adenoma and carcinoma. Therefore, an immunohistochemical analysis of mesothelin expression in IPMN was performed in the present study, focusing on the localization of mesothelin. IPMNs were classified into two groups, IPMNs associated with invasive carcinoma and low-high (L-H) grade dysplasias. The tumors were classified as mesothelin-positive or -negative and in the mesothelin-positive cases, the localization of mesothelin was evaluated as luminal membrane- or cytoplasmic-positive. Among the 37 IPMNs, mesothelin expression was observed in 21 samples (56.8%), including 46.2% (12 out of 26) of the L-H dysplasia and 81.8% (9 out of 11) of the invasive carcinoma samples (P=0.071). Luminal membrane localization was observed in 10 samples (27%), including 15.4% (4/26) of the L-H dysplasia samples and 54.5% (6 out of 11) of the invasive carcinoma samples (P=0.022). Six patients experienced post-operative recurrence, with five of the recurrent tumors exhibiting mesothelin expression and all six exhibiting luminal membrane localization. It was concluded that immunohistochemical examinations for mesothelin expression and localization are clinically useful for prognostic assessments and decision making regarding further treatment subsequent to surgical procedures in patients with IPMN.	[Einama, Takahiro; Kamachi, Hirofumi; Homma, Shigenori; Kawamata, Futoshi; Konishi, Yuji; Sato, Masanori; Tahara, Munenori; Kamiyama, Toshiya; Taketomi, Akinobu; Todo, Satoru] Hokkaido Univ, Grad Sch Med, Dept Gen Surg, Sapporo, Hokkaido 0608638, Japan; [Einama, Takahiro] Hokkaido Social Work Assoc Obihiro Hosp, Dept Surg, Obihiro, Hokkaido 0800805, Japan; [Einama, Takahiro; Furukawa, Hiroyuki] Asahikawa Med Univ, Div Gastroenterol & Gen Surg, Asahikawa, Hokkaido 0788510, Japan; [Nishihara, Hiroshi] Hokkaido Univ, Dept Translat Pathol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Kanno, Hiromi; Ishikawa, Marin] Hokkaido Univ, Dept Pathol, Canc Res Lab, Sch Med, Sapporo, Hokkaido 0608638, Japan; [Okada, Kuniaki] JA Sapporo Kosei Hosp, Dept Surg, Sapporo, Hokkaido 0600033, Japan; [Muraoka, Shunji] JA Sapporo Kosei Hosp, Dept Pathol, Sapporo, Hokkaido 0600033, Japan; [Matsuno, Yoshihiro] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido 0608638, Japan	Einama, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Gen Surg, Kita Ku, Kita 14,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	titiuehahaue@hotmail.com					Sugiyama M, 2003, BRIT J SURG, V90, P1244, DOI 10.1002/bjs.4265; Nara S, 2009, PANCREAS, V38, P8, DOI 10.1097/MPA.0b013e318181b90d; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Einama T, 2012, BRIT J CANCER, V107, P137, DOI 10.1038/bjc.2012.235; CHANG K, 1992, INT J CANCER, V50, P373, DOI 10.1002/ijc.2910500308; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1418; Kawamata F, 2012, INT J ONCOL, V41, P2109, DOI 10.3892/ijo.2012.1662; Schmidt CM, 2007, ANN SURG, V246, P644, DOI 10.1097/SLA.0b013e318155a7b6; Hassan R, 2005, APPL IMMUNOHISTO M M, V13, P243, DOI 10.1097/01.pai.00000141545.36485.d6; Argani P, 2001, CLIN CANCER RES, V7, P3862; Bharadwaj U, 2011, CARCINOGENESIS, V32, P1013, DOI 10.1093/carcin/bgr075; Bharadwaj U, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-106; Bosman FT, 2010, WHO CLASSIFICATION T, P304; Cheng WF, 2009, BRIT J CANCER, V100, P1144, DOI 10.1038/sj.bjc.6604964; Einama T, 2011, PANCREAS, V40, P1276, DOI 10.1097/MPA.0b013e318221bed8; Inami K, 2010, CANCER SCI, V101, P969, DOI 10.1111/j.1349-7006.2009.01463.x; Kawamata F, 2014, J GASTROENTEROL, V49, P81, DOI 10.1007/s00535-013-0773-6; Li M, 2008, MOL CANCER THER, V7, P286, DOI 10.1158/1535-7163.MCT-07-0483; Ordonez NG, 2003, MODERN PATHOL, V16, P192, DOI 10.1097/01.MP.0000056981.16578.C3	20	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	APR	2015	9	4					1583	1589		10.3892/ol.2015.2969		7	Oncology	Oncology	CE2GF	WOS:000351631900017		
J	Cartwright, IM; Bell, JJ; Maeda, J; Genet, MD; Romero, A; Fujii, Y; Fujimori, A; Kitamuta, H; Kamada, T; Chen, DJ; Kato, TA				Cartwright, Ian M.; Bell, Justin J.; Maeda, Junko; Genet, Matthew D.; Romero, Ashley; Fujii, Yoshihiro; Fujimori, Akira; Kitamuta, Hisashi; Kamada, Tadashi; Chen, David J.; Kato, Takamitsu A.			Effects of targeted phosphorylation site mutations in the DNA-PKcs phosphorylation domain on low and high LET radiation sensitivity	ONCOLOGY LETTERS			English	Article						high linear energy transfer radiation; heavy ions; protons; DNA-protein kinase catalytic subunit	DEPENDENT PROTEIN-KINASE; DOUBLE-STRAND-BREAK; INDUCED CELL-DEATH; CATALYTIC SUBUNIT; REPAIR; DAMAGE; AUTOPHOSPHORYLATION; IRRADIATION; APOPTOSIS; INDUCTION	The present study investigated the effect of targeted mutations in the DNA-dependent protein kinase catalytic subunit and phosphorylation domains on the survival of cells in response to different qualities of ionizing radiation. Mutated Chinese hamster ovary V3 cells were exposed to 500 MeV/nucleon initial energy and 200 keV/m monoenergetic Fe ions; 290 MeV/nucleon initial energy and average 50 keV/m spread-out Bragg peak C ions; 70 MeV/nucleon initial energy and 1 keV/m monoenergetic protons; and 0.663 MeV initial energy and 0.3 keV/m Cs-137 radiation. The results demonstrated that sensitivity to high linear energy transfer radiation is increased when both S2056 and T2609 clusters each contain a point mutation or multiple mutations are present in either cluster, whereas the phosphoinositide 3 kinase cluster only requires a single mutation to induce the sensitized phenotype of V3 cells. Additionally, the present study demonstrated that sensitivity to DNA cross-linking damage by cisplatin only requires a single mutation in one of the three clusters and that additional point mutations do not increase cell sensitivity.	[Cartwright, Ian M.; Bell, Justin J.; Maeda, Junko; Genet, Matthew D.; Romero, Ashley; Kato, Takamitsu A.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Fujii, Yoshihiro] Ibaraki Prefectural Univ Hlth Sci, Dept Radiol Sci, Inashiki, Ibaraki 3000394, Japan; [Fujimori, Akira; Kamada, Tadashi] Natl Inst Radiol Sci, Int Open Lab, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 2638555, Japan; [Kitamuta, Hisashi] Natl Inst Radiol Sci, Res Dev & Support Ctr, Inage Ku, Chiba 2638555, Japan; [Chen, David J.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75235 USA	Kato, TA (reprint author), Colorado State Univ, Dept Environm & Radiol Hlth Sci, 1618 Campus Delivery, Ft Collins, CO 80523 USA.	takamitsu.kato@colostate.edu	Kato, Takamitsu/D-7969-2015		Technology Fee Stipend Student Experimental Learning Fund of the College of Veterinary Medicine and Biosciences (Colorado State University, Fort Collins, CO, USA); Cyclotron, Heavy Ion Medical Accelerator in Chiba (Chiba, Japan); International Open Laboratory of the National Institute of Radiological Sciences (Chiba, Japan)	The authors would like to thank Dr Akiko M. Ueno (Ueno Radiation Biology Research Fund), Dr John H. Benable (Venable Memorial Scholarship), the Technology Fee Stipend Student Experimental Learning Fund of the College of Veterinary Medicine and Biosciences (Colorado State University, Fort Collins, CO, USA), the Cyclotron, Heavy Ion Medical Accelerator in Chiba (Chiba, Japan) and the International Open Laboratory of the National Institute of Radiological Sciences (Chiba, Japan) for supporting the present study.	Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706.5715.2003; Gonzalez VM, 2001, MOL PHARMACOL, V59, P657; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; Sutherland BM, 2001, PHYS MEDICA, V17, P202; GOODHEAD DT, 1994, INT J RADIAT BIOL, V65, P7, DOI 10.1080/09553009414550021; Kurimasa A, 1999, MOL CELL BIOL, V19, P3877; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; FINNIE NJ, 1995, P NATL ACAD SCI USA, V92, P320, DOI 10.1073/pnas.92.1.320; Leatherbarrow EL, 2006, INT J RADIAT BIOL, V82, P111, DOI 10.1080/09553000600599783; Hada M, 2008, J RADIAT RES, V49, P203, DOI 10.1269/jrr.07123; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Basu A., 2010, J NUCL ACIDS, V2010, P1, DOI [DOI 10.4061/2010/201367, 10.4061/2010/201367]; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Nagasawa H, 2011, RADIAT RES, V175, P83, DOI 10.1667/RR2092.1; PETERSON SR, 1995, P NATL ACAD SCI USA, V92, P3171, DOI 10.1073/pnas.92.8.3171; Schmid TE, 2010, INT J RADIAT BIOL, V86, P682, DOI 10.3109/09553001003734543; Sutherland BM, 2001, ENVIRON MOL MUTAGEN, V38, P159, DOI 10.1002/em.1067	21	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	APR	2015	9	4					1621	1627		10.3892/ol.2015.2974		7	Oncology	Oncology	CE2GF	WOS:000351631900023		
J	Yamaguchi, T; Seki, T; Miyasaka, C; Inokuchi, R; Kawamura, R; Sakaguchi, Y; Murata, M; Matsuzaki, K; Nakano, Y; Uemura, Y; Okazaki, K				Yamaguchi, Takashi; Seki, Toshihito; Miyasaka, Chika; Inokuchi, Ryosuke; Kawamura, Rinako; Sakaguchi, Yuutaku; Murata, Miki; Matsuzaki, Koichi; Nakano, Yorika; Uemura, Yoshiko; Okazaki, Kazuichi			Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report	ONCOLOGY LETTERS			English	Article						diffuse alveolar damage; hepatocellular carcinoma; drug-induced interstitial pneumonia; molecular-targeted agent; sorafenib		Sorafenib is a multikinase inhibitor currently approved in Japan for the treatment of unresectable hepatocellular carcinoma. Interstitial pneumonia induced by sorafenib may have a fatal outcome, and therefore, has recently been the focus of many studies. The current report presents an autopsy case of diffuse alveolar damage (DAD) that occurred in a 59-year-old male, who had been treated with sorafenib. The patient had been given sorafenib for six months and had exhibited no respiratory symptoms during this time. However, 19 days after sorafenib treatment was resumed, acute interstitial pneumonia developed. In previously reported cases, the first symptoms of pulmonary toxicity appeared following a limited treatment duration with sorafenib; this was in contrast to the patient in the current study, who developed the first symptoms after eight months. We therefore conclude that physicians must be aware of interstitial pneumonia as a potential pulmonary toxicity associated with sorafenib treatment when treatment with sorafenib is resumed, even after prolonged use. In addition, to best of our knowledge, this is the first case of a postmortem examination reported in patient with interstitial pneumonia induced by sorafenib treatment.	[Yamaguchi, Takashi; Seki, Toshihito; Inokuchi, Ryosuke; Kawamura, Rinako; Sakaguchi, Yuutaku; Murata, Miki; Matsuzaki, Koichi; Okazaki, Kazuichi] Kansai Med Univ, Dept Gastroenterol & Hepatol, Osaka 5708507, Japan; [Yamaguchi, Takashi; Seki, Toshihito; Inokuchi, Ryosuke; Kawamura, Rinako; Sakaguchi, Yuutaku; Murata, Miki; Matsuzaki, Koichi] Kansai Med Univ, Liver Dis Ctr, Takii Hosp, Osaka 5708507, Japan; [Miyasaka, Chika; Nakano, Yorika; Uemura, Yoshiko] Kansai Med Univ, Dept Diagnost Pathol, Osaka 5708507, Japan	Seki, T (reprint author), Kansai Med Univ, Dept Gastroenterol & Hepatol, 10-15 Fumizonocho, Moriguchi, Osaka 5708507, Japan.	sekit@takii.kmu.ac.jp					Barber NA, 2011, TARGET ONCOL, V6, P235, DOI 10.1007/s11523-011-0199-0; Ide S, 2010, LUNG CANCER, V67, P248, DOI 10.1016/j.lungcan.2009.10.007; Esteban A, 2004, ANN INTERN MED, V141, P440; Vasakova M, 2009, SCAND J IMMUNOL, V69, P268, DOI 10.1111/j.1365-3083.2008.02222.x; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Abadie Y, 2005, EUR RESPIR J, V25, P139, DOI 10.1183/09031936.04.00065504; EDMONDSON HA, 1954, CANCER, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Zambon M, 2008, CHEST, V133, P1120, DOI 10.1378/chest.07-2134; Muller NL, 2004, BRIT J CANCER, V91, pS24, DOI 10.1038/sj.bjc.6602064; Myers JL, 2009, HISTOPATHOLOGY, V54, P90, DOI 10.1111/j.1365-2559.2008.03173.x; Myung HJ, 2010, GUT LIVER, V4, P543, DOI 10.5009/gnl.2010.4.4.543; Roberts JR, 2007, CRIT CARE MED, V35, P2164, DOI 10.1097/01.CCM.0000281451.73202.F6; Schwaiblmair Martin, 2012, Open Respir Med J, V6, P63, DOI 10.2174/1874306401206010063; Takeda Haruhiko, 2012, Clin J Gastroenterol, V5, P407, DOI 10.1007/s12328-012-0339-9	15	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	APR	2015	9	4					1633	1636		10.3892/ol.2015.2934		4	Oncology	Oncology	CE2GF	WOS:000351631900025		
J	Mohamed, ER; Noguchi, M; Hamed, AR; Eldahshoury, MZ; Hammady, AR; Salem, EE; Itoh, K				Mohamed, Elnisr Rashed; Noguchi, Masanori; Hamed, Ahmed Roshdi; Eldahshoury, Mohamed Zaki; Hammady, Ahmed Rashed; Salem, Esam Elden; Itoh, Kyogo			Reduced expression of erythropoietin-producing hepatocyte B6 receptor tyrosine kinase in prostate cancer	ONCOLOGY LETTERS			English	Article						erythropoietin-producing hepatocyte B6 expression; prostate cancer; cancer volume; receptor tyrosine kinase; biochemical progression-free survival	BREAST-CARCINOMA CELLS; EPH RECEPTORS; EPHRINS; LIGANDS; NEUROBLASTOMA	Loss of erythropoietin-producing hepatocyte (Eph) B6 gene expression is associated with poor prognosis in neuroblastoma, melanoma and other tumors. The present study evaluated the expression of EphB6 receptor tyrosine kinase in normal and prostate cancer tissue using immunohistochemistry. The association between EphB6 expression, clinicopathological findings, proliferating-cell nuclear antigen (PCNA; another prognostic marker) and progression of prostate cancer was analyzed. Tissue microarray samples of normal prostatic tissue and prostate cancer tissue from 46 patients treated with radical prostatectomy for prostate cancer were included in this study. Polyclonal anti-EphB6 and monoclonal anti-PCNA antibodies were used to assess EphB6 and PCNA expression by immunohistochemistry. EphB6 was expressed in normal and prostate cancer tissue; however, its expression was significantly reduced in prostate cancer tissue compared with normal prostatic tissue (P<0.0001), in high volume (4 cm(3)) cancer compared with low volume (<4 cm(3); P=0.015), and in pT3 stage compared with pT2 stage of the disease (P=0.0007). No correlation was observed between the expression of EphB6 and PCNA. Short biochemical progression-free survival was associated with low EphB6 protein expression (P=0.157). This study revealed that EphB6 may have a tumor suppressor effect in prostate cancer, at least during early stages of this disease. This provides new insight into the potential utility of EphB6 receptor as a diagnostic/prognostic marker for prostate cancer.	[Mohamed, Elnisr Rashed; Eldahshoury, Mohamed Zaki; Hammady, Ahmed Rashed; Salem, Esam Elden] Sohag Univ Hosp, Dept Urol, Sohag 82425, Egypt; [Hamed, Ahmed Roshdi] Sohag Univ Hosp, Dept Pathol, Sohag 82425, Egypt; [Noguchi, Masanori] Kurume Univ, Sch Med, Div Clin Res, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 8300011, Japan; [Itoh, Kyogo] Kurume Univ, Sch Med, Canc Vaccine Ctr, Kurume, Fukuoka 8300011, Japan	Noguchi, M (reprint author), Kurume Univ, Sch Med, Div Clin Res, Res Ctr Innovat Canc Therapy, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	noguchi@med.kurume-u.ac.jp			Ministry of Health, Labor and Welfare of Japan [22591782]	This study was supported by a grant from the Ministry of Health, Labor and Welfare of Japan (grant no. 22591782 to Professor Masanori Noguchi).	Holmberg J, 2000, NATURE, V408, P203; Nakamoto M, 2000, INT J BIOCHEM CELL B, V32, P7, DOI 10.1016/S1357-2725(99)00096-5; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Tang XX, 2004, CLIN CANCER RES, V10, P5837, DOI 10.1158/1078-0432.CCR-04-0395; Noguchi M, 2007, PROSTATE, V67, P933, DOI 10.1002/pros.20572; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Fox BP, 2006, BIOCHEM BIOPH RES CO, V342, P1263, DOI 10.1016/j.bbrc.2006.02.099; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Brantley-Sieders Dana M., 2004, Angiogenesis, V7, P17, DOI 10.1023/B:AGEN.0000037340.33788.87; Fox BP, 2006, BIOCHEM BIOPH RES CO, V340, P268, DOI 10.1016/j.bbrc.2005.11.174; Fox BP, 2004, BIOCHEM BIOPH RES CO, V318, P882, DOI 10.1016/j.bbrc.2004.04.102; Gleason DF, 1977, HISTOLOGIC GRADING C, P171; Hafner C, 2003, INT J ONCOL, V23, P1553; Himanen JP, 2003, INT J BIOCHEM CELL B, V35, P130, DOI 10.1016/S1357-2725(02)00096-1; Noguchi M, 2000, CANCER, V89, P1056, DOI 10.1002/1097-0142(20000901)89:5<1056::AID-CNCR15>3.0.CO;2-U; Taftachi R, 2005, BJU INT, V95, P650, DOI 10.1111/j.1464-410X.2005.05356.x; Tang XX, 2000, P NATL ACAD SCI USA, V97, P10936, DOI 10.1073/pnas.190123297; Xu QL, 1997, J MOL MED-JMM, V75, P576, DOI 10.1007/s001090050142	19	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	APR	2015	9	4					1672	1676		10.3892/ol.2015.2925		5	Oncology	Oncology	CE2GF	WOS:000351631900033		
J	Tajima, H; Takamura, H; Kitagawa, H; Nakayama, A; Shoji, M; Watanabe, T; Tsukada, T; Nakanuma, S; Okamoto, K; Sakai, S; Kinoshita, J; Makino, I; Nakamura, K; Hayashi, H; Oyama, K; Inokuchi, M; Nakagawara, H; Miyashita, T; Ninomiya, I; Fushida, S; Fujimura, T; Wakayama, T; Iseki, S; Ikeda, H; Ohta, T				Tajima, Hidehiro; Takamura, Hiroyuki; Kitagawa, Hirohisa; Nakayama, Akira; Shoji, Masatoshi; Watanabe, Toshifumi; Tsukada, Tomoya; Nakanuma, Shinichi; Okamoto, Koichi; Sakai, Seisho; Kinoshita, Jun; Makino, Isamu; Nakamura, Keishi; Hayashi, Hironori; Oyama, Katsunobu; Inokuchi, Masafumi; Nakagawara, Hisatoshi; Miyashita, Tomoharu; Ninomiya, Itasu; Fushida, Sachio; Fujimura, Takashi; Wakayama, Tomohiko; Iseki, Shoichi; Ikeda, Hiroko; Ohta, Tetsuo			Multiple liver metastases of pancreatic solid pseudopapillary tumor treated with resection following chemotherapy and transcatheter arterial embolization: A case report	ONCOLOGY LETTERS			English	Article						solid pseudopapillary tumor; liver metastasis; resection; hepatic arterial infusion; transarterial tumor embolization; chemotherapy	RADIOFREQUENCY ABLATION; HEPATOCELLULAR-CARCINOMA; PAPILLARY; 5-FLUOROURACIL; GEMCITABINE; EXPERIENCE; NEOPLASMS; BEHAVIOR	A 33-year-old female was diagnosed with a solid pseudopapillary tumor (SPT) of the pancreas and multiple liver metastases at the Department of Gastroenterological Surgery, Ishikawa Prefectural Central Hospital (Kanazawa, Japan). Distal pancreatectomy and postoperative systemic chemotherapy with gemcitabine (GEM) and S-1, an oral fluoropyrimidine derivative, was administered, however, liver metastases became enlarged and local recurrence occurred. Therefore, the patient was referred to the Department of Gastroenterologic Surgery at the Graduate School of Medicine (Kanazawa, Japan) for hepatic arterial infusion (HAI) chemotherapy. Oral S-1 (80 mg/m(2)) was administered as well as HAI chemotherapy with GEM (1,000 mg/standard liver volume). Following 18 cycles, tumor sizes were reduced and 18-fluorodeoxyglucose positron emission tomography ((18)FDG-PET) examination revealed obvious reduction of tumor FDG uptake. Transarterial tumor embolization (TAE) was performed for the previously unresectable right subphrenic liver tumor, and the other tumors were surgically resected. The resected tumors were diagnosed as liver metastases and a local recurrence of SPT in the postoperative pathological examination, which revealed that the resected tumors were composed of sheets of bland cells, which were positive for CD10, CD56, vimentin, neuron-specific enolase and -antitrypsin. The postoperative course was uneventful, and the patient is currently under observation at an outpatient clinic; postoperative adjuvant chemotherapy with oral S-1 has continued, and additional TAE is planned. In the future, if the middle segment of the liver becomes enlarged, surgery for the residual right lobe tumor may be possible. This case demonstrates one method of SPT treatment: Preoperative HAI chemotherapy with GEM, plus oral S-1 and TAE. If complete resection can be achieved, the majority of patients with SPT have a favorable prognosis. In patients with unresectable metastases from SPT, it is crucial to conduct systematic multimodal treatment to maximize treatment success.	[Tajima, Hidehiro; Takamura, Hiroyuki; Kitagawa, Hirohisa; Nakayama, Akira; Shoji, Masatoshi; Watanabe, Toshifumi; Tsukada, Tomoya; Nakanuma, Shinichi; Okamoto, Koichi; Sakai, Seisho; Kinoshita, Jun; Makino, Isamu; Nakamura, Keishi; Hayashi, Hironori; Oyama, Katsunobu; Inokuchi, Masafumi; Nakagawara, Hisatoshi; Miyashita, Tomoharu; Ninomiya, Itasu; Fushida, Sachio; Fujimura, Takashi; Ohta, Tetsuo] Kanazawa Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kanazawa, Ishikawa 9208641, Japan; [Wakayama, Tomohiko; Iseki, Shoichi] Kanazawa Univ, Grad Sch Med Sci, Dept Histol & Embryol, Kanazawa, Ishikawa 9208641, Japan; [Ikeda, Hiroko] Kanazawa Univ, Grad Sch Med Sci, Div Pathol, Kanazawa, Ishikawa 9208641, Japan	Tajima, H (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.	hidetaji@staff.kanazawa-u.ac.jp					Kang CM, 2006, PANCREAS, V32, P276, DOI 10.1097/01.mpa.0000202956.41106.8a; Coleman KM, 2003, RADIOGRAPHICS, V23, P1644, DOI 10.1148/rg.236035006; Salvia R, 2007, J SURG ONCOL, V95, P304, DOI 10.1002/jso.20685; Tang LH, 2005, AM J SURG PATHOL, V29, P512, DOI 10.1097/01.pas.0000155159.28530.88; Martin RCG, 2002, ANN SURG ONCOL, V9, P35, DOI 10.1245/aso.2002.9.1.35; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Sperti C, 2008, WORLD J GASTROENTERO, V14, P960, DOI 10.3748/wjg.14.960; Li JX, 2012, CHINESE MED J-PEKING, V125, P1661, DOI 10.3760/cma.j.issn.0366-6999.2012.09.026; Cantisani KM, 2003, AM J ROENTGENOL, V181-395, P395, DOI [10.2214/ajr.181.2.1810395, DOI 10.2214/AJR.181.2.1810395]; Das G, 2004, INDIAN J GASTROENTER, V23, P188; Franz VK, 1959, TUMORS PANCREAS ATLA, P32; FRIED P, 1985, CANCER, V56, P2783, DOI 10.1002/1097-0142(19851215)56:12<2783::AID-CNCR2820561211>3.0.CO;2-Q; Goh BKP, 2007, J SURG ONCOL, V95, P640, DOI 10.1002/jso.20735; Huang HL, 2005, WORLD J GASTROENTERO, V11, P1403; Kanter J, 2009, J PEDIATR SURG, V44, pE23, DOI 10.1016/j.jpedsurg.2009.07.026; Kloppel G, 1996, WHO INT HISTOLOGICAL, P15; Levy P, 1997, GASTROEN CLIN BIOL, V21, P789; Maffuz A, 2005, LANCET ONCOL, V6, P185, DOI 10.1016/S1470-2045(05)01770-5; MAO CY, 1995, SURGERY, V118, P821, DOI 10.1016/S0039-6060(05)80271-5; MATSUDA Y, 1987, Gastroenterologia Japonica, V22, P379; MATSUNOU H, 1990, CANCER, V65, P283, DOI 10.1002/1097-0142(19900115)65:2<283::AID-CNCR2820650217>3.0.CO;2-X; Nguyen QN, 2011, J GASTROEN HEPATOL, V26, P267, DOI [10.1111/j.1440-1746.2010.06466.x21261715, DOI 10.1111/J.1440-1746.2010.06466.X]; PETTINATO G, 1992, AM J CLIN PATHOL, V98, P478; Shimizu M, 1999, PATHOL INT, V49, P231, DOI 10.1046/j.1440-1827.1999.00852.x; STRAUSS JF, 1993, MED PEDIATR ONCOL, V21, P365, DOI 10.1002/mpo.2950210511; Tajima H, 2011, EXP THER MED, V2, P265, DOI 10.3892/etm.2011.190; Tajima H, 2010, EXP THER MED, V1, P347, DOI 10.3892/etm_00000054; Tajima H, 2010, ONCOL LETT, V1, P91, DOI 10.3892/ol_00000016; UEDA N, 1991, GASTROENTEROL JPN, V26, P497; Vargas-Serrano B, 2006, EUR J RADIOL, V58, P132, DOI 10.1016/j.ejrad.2005.11.014; Zauls JA, 2006, AM J CLIN ONCOL-CANC, V29, P639, DOI 10.1097/01.coc.0000190457.43060.fd	31	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	APR	2015	9	4					1733	1738		10.3892/ol.2015.2967		6	Oncology	Oncology	CE2GF	WOS:000351631900044		
J	Yamashita, M; Yamashita, H; Shibata, S; Okuma, K; Nakagawa, K				Yamashita, Mami; Yamashita, Hideomi; Shibata, Shino; Okuma, Kae; Nakagawa, Keiichi			Symptom relief effect of palliative high dose rate intracavitary radiotherapy for advanced esophageal cancer with dysphagia	ONCOLOGY LETTERS			English	Article						palliative effect; esophageal cancer; high dose rate intracavitary irradiation; dysphagia	RATE BRACHYTHERAPY; STENT PLACEMENT; METAL STENT; CARCINOMA; TRIAL; MANAGEMENT	Intracavitary radiotherapy (ICRT) for the palliative treatment of advanced esophageal cancer with dysphagia is currently performed at the University of Tokyo Hospital (Tokyo, Japan). In the present study, 24 patients exhibiting advanced esophageal cancer with dysphagia received palliative ICRT. ICRT, which was delivered 5 mm below the esophageal mucous membrane, with the exception of one case, was administered at a dose of 6 Gy/fraction. Specific patients additionally underwent definitive or palliative external beam radiation therapy for esophageal cancer a minimum of three months prior to ICRT. The effect of treatment on symptom alleviation was examined by comparing the dysphagia score prior to and following ICRT, with the patients' medical records and a questionnaire used to calculate a dysphagia score ranging from zero (no dysphagia) to four (total dysphagia). In consideration of the individual efficacy of the treatment, the maximum number of repeated ICRT fractions was four (median, 1.7 times). A trend in the improvement of the symptom of dysphagia was observed in response to esophageal ICRT, with the average dysphagia score markedly decreasing from 2.54 to 1.65, however, the difference was not significant (P=0.083). Furthermore, pain was the most frequent side-effect of the esophageal ICRT and no patients exhibited severe complications. Thus, esophageal ICRT at a dose of 6 Gy/fraction may present an effective strategy for relieving the symptom of dysphagia in cases of advanced esophageal cancer.	[Yamashita, Mami; Yamashita, Hideomi; Shibata, Shino] Tokyo Univ Hosp, Dept Radiol, Tokyo 1138655, Japan; [Okuma, Kae; Nakagawa, Keiichi] Tokyo Univ Hosp, Dept Palliat Med, Tokyo 1138655, Japan	Yamashita, H (reprint author), Tokyo Univ Hosp, Dept Radiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yamachan07291973@yahoo.co.jp					Allum WH, 2002, GUT, V50, P1; Amdal CD, 2013, RADIOTHER ONCOL, V107, P428, DOI 10.1016/j.radonc.2013.04.008; KNYRIM K, 1993, NEW ENGL J MED, V329, P1302, DOI 10.1056/NEJM199310283291803; Homs MYV, 2003, RADIOTHER ONCOL, V66, P327, DOI 10.1016/S0167-8140(02)00410-3; Siersema PD, 2001, GASTROINTEST ENDOSC, V54, P145, DOI 10.1067/mge.2001.116879; Spencer GM, 2002, GUT, V50, P224, DOI 10.1136/gut.50.2.224; Homs MYV, 2004, LANCET, V364, P1497, DOI 10.1016/S0140-6736(04)17272-3; Bayraktar O, 2013, SURG LAPARO ENDO PER, V23, pE41, DOI 10.1097/SLE.0b013e318275b35f; Eldeeb H, 2012, J BUON, V17, P508; Friendlander Arthur H, 2009, Spec Care Dentist, V29, P147, DOI 10.1111/j.1754-4505.2009.00088.x; HARVEY JC, 1993, J SURG ONCOL, V52, P101, DOI 10.1002/jso.2930520209; Kulhavy M, 1995, ENDOCURIETHER HYPERT, V11, P235; Leung J T, 1995, Australas Radiol, V39, P375, DOI 10.1111/j.1440-1673.1995.tb00315.x; Schraube P, 1997, RADIOTHER ONCOL, V44, P45, DOI 10.1016/S0167-8140(97)00083-2	14	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	APR	2015	9	4					1747	1752		10.3892/ol.2015.2947		6	Oncology	Oncology	CE2GF	WOS:000351631900047		
J	Suzuki, K; Yasuda, T; Nagao, K; Hori, T; Watanabe, K; Kanamori, M; Kimura, T				Suzuki, Kayo; Yasuda, Taketoshi; Nagao, Kaoru; Hori, Takeshi; Watanabe, Kenta; Kanamori, Masahiko; Kimura, Tomoatsu			Bone metastasis of a gastrointestinal stromal tumor: A report of two cases	ONCOLOGY LETTERS			English	Article						gastrointestinal stromal tumor; bone metastasis; surgery; imatinib	FEATURES; DIAGNOSIS	Gastrointestinal stromal tumors (GISTs) are the most frequently diagnosed mesenchymal tumors of the GI tract. GISTs usually arise from the stomach, followed by the small intestine, rectum and other locations in the GI tract. The most common metastatic sites are the liver and peritoneum, whereas GISTs rarely metastasize to the bone. Although a small number of previous studies have described bone metastases originating from GISTs, the true prevalence is yet to be elucidated. The present study describes two cases of bone metastasis in patients with GISTs and reviews the relevant literature. Case one was of a 78-year-old male who presented with bone metastasis to the femoral neck five years after the resection of a GIST. The metastasis was completely resected and the patient remains alive nine years after the initial diagnosis of the GIST. Case 2 was of a 41-year-old male who presented with bone metastases to the ribs following resection of GISTs seven and 17 years earlier. The metastases were completely resected and the patient remains alive 17 years after the initial diagnosis. In total, only 10 cases of GISTs with metastases to the bone have been reported in the English literature. The possibility of bone metastases originating from a GIST should be considered during clinical follow-up, particularly in the presence of liver metastases. If feasible, bone metastases should be completely surgically excised.	[Suzuki, Kayo; Yasuda, Taketoshi; Watanabe, Kenta; Kimura, Tomoatsu] Toyama Univ, Dept Orthoped Surg, Toyama, Toyama 9300194, Japan; [Nagao, Kaoru; Hori, Takeshi] Iiyama Red Cross Hosp, Dept Orthoped Surg, Nagano 3892295, Japan; [Kanamori, Masahiko] Toyama Univ, Dept Human Sci, Toyama, Toyama 9300194, Japan	Yasuda, T (reprint author), Toyama Univ, Fac Med, Dept Orthoped Surg, 2630 Sugitani, Toyama, Toyama 9300194, Japan.	yasuda@med.u-toyama.ac.jp			KAKENHI [24592227]	This study was supported in part by a Grant-in-Aid for Scientific Research (C) 24592227 (KAKENHI). The authors would like to thank Dr Ayumu Hosokawa, Third Department of Internal Medicine, Toyama University Hospital (Toyama, Toyama, Japan) for providing support during the clinical follow-up.	Abuzakhm Sonia M, 2011, J Gastrointest Oncol, V2, P45, DOI 10.3978/j.issn.2078-6891.2011.006; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; Miettinen M, 2001, VIRCHOWS ARCH, V438, P1, DOI 10.1007/s004280000338; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Burkill GJC, 2003, RADIOLOGY, V226, P527, DOI 10.1148/radiol.2262011880; Miettinen M, 2002, HUM PATHOL, V33, P478, DOI 10.1053/hupa.2002.124123; Blanke CD, 2008, J CLIN ONCOL, V26, P620, DOI 10.1200/JCO.2007.13.4403; Barriere J, 2009, ONKOLOGIE, V32, P345, DOI 10.1159/000215712; Di Scioscio Valerio, 2011, Rare Tumors, V3, pe17, DOI 10.4081/rt.2011.e17; Feki J, 2012, CASE REP ONCOL MED; Hamada S, 2010, INTERNAL MED, V49, P781, DOI 10.2169/internalmedicine.49.3124; Jati A, 2012, DIAGN INTERV RADIOL, V18, P391, DOI 10.4261/1305-3825.DIR.5179-11.1; Joensuu H, 2004, ACTA ORTHOP SCAND, V75, P62; Kroep JR, 2009, J CUTAN PATHOL, V36, P565, DOI 10.1111/j.1600-0560.2008.01067.x; Nannini M, 2011, ONCOL REP, V25, P113, DOI 10.3892/or_00001049; Ozan E, 2010, DIAGN INTERV RADIOL, V16, P217, DOI [10.4261/1305-3825.DIR.1861-08.2, 10.4261/1305-3825.D1R.1861-08.2]; Rammohan Ashwin, 2013, World J Gastrointest Oncol, V5, P102, DOI 10.4251/wjgo.v5.i6.102; Selcukbiricik Fatih, 2012, J Med Case Rep, V6, P145, DOI 10.1186/1752-1947-6-145; Stamatakos M, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-61; Tezcan Y, 2011, MED ONCOL, V28, pS204, DOI 10.1007/s12032-010-9697-7	20	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	APR	2015	9	4					1814	1818		10.3892/ol.2015.2976		5	Oncology	Oncology	CE2GF	WOS:000351631900060		
J	Takashima, S; Kiyoto, S; Takahashi, M; Hara, F; Aogi, K; Ohsumi, S; Mukai, R; Fujita, Y				Takashima, Seiki; Kiyoto, Sachiko; Takahashi, Mina; Hara, Fumikata; Aogi, Kenjiro; Ohsumi, Shozo; Mukai, Ryoko; Fujita, Yoriko			Clinical experience with nanoparticle albumin-bound paclitaxel, a novel taxane anticancer agent, and management of adverse events in females with breast cancer	ONCOLOGY LETTERS			English	Article						nab-paclitaxel; breast cancer; management of adverse events	RANDOMIZED PHASE-II; OVARIAN-CANCER; DOUBLE-BLIND; AMIFOSTINE; TRIAL; CHEMOTHERAPY; MULTICENTER; NEUROPATHY; TAXOL	Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) is currently approved in Japan for treatment of breast cancer. However, apart from phase I clinical trials, data regarding Japanese patients are scant. In the present study, the efficacy and safety of nab-paclitaxel therapy were retrospectively analyzed in 22 patients with advanced or metastatic breast cancer who were treated at the National Hospital Organization Shikoku Cancer Center between November 2010 and June 2012. The nab-paclitaxel was administered once every three weeks. The median age of the patients was 59 years. The tumors were estrogen-receptor positive and/or progesterone-receptor positive in 63.6% patients. None of the patients had HER2-positive breast cancer. The median number of treatment cycles was six (range, two to 12). Six patients exhibited a partial response; the response rate was 27.3% and the clinical benefit rate was 31.8%. The response rate and clinical benefit rate were higher in patients who received nab-paclitaxel as first- or second-line treatment. The median time to treatment failure was 127 days (range, 27-257). Major adverse events were peripheral neuropathy (59%; Grade 3, 9%), myalgia (59%), rash (45%), and nausea and vomiting (50%). The results suggest that nab-paclitaxel is a well-tolerated and clinically useful anticancer preparation.	[Takashima, Seiki; Kiyoto, Sachiko; Takahashi, Mina; Hara, Fumikata; Aogi, Kenjiro; Ohsumi, Shozo] Natl Hosp Org Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime 7910280, Japan; [Mukai, Ryoko] Natl Hosp Org Shikoku Canc Ctr, Dept Nursing, Matsuyama, Ehime 7910280, Japan; [Fujita, Yoriko] Natl Hosp Org Shikoku Canc Ctr, Dept Pharm, Matsuyama, Ehime 7910280, Japan	Takashima, S (reprint author), Natl Hosp Org Shikoku Canc Ctr, Dept Breast Oncol, 160 Kou,Minami Umemoto Machi, Matsuyama, Ehime 7910280, Japan.	hms1251@ybb.ne.jp					Seidman AD, 2008, J CLIN ONCOL, V26, P1642, DOI 10.1200/JCO.2007.11.6699; Hilpert F, 2005, SUPPORT CARE CANCER, V13, P797, DOI 10.1007/s00520-005-0782-y; De Vos FYFL, 2005, GYNECOL ONCOL, V97, P60, DOI 10.1016/j.ygyno.2004.11.052; Mielke S, 2006, EUR J CANCER, V42, P24, DOI 10.1016/j.ejca.2005.06.030; [Anonymous], 2007, TAX PACL INJ PACK IN; [Anonymous], 2013, ABR INJ SUSP NAB PAC; Jones SE, 2005, J CLIN ONCOL, V23, P5542, DOI 10.1200/JCO.2005.02.027; Lorusso D, 2003, ANN ONCOL, V14, P1086, DOI 10.1093/annonc/mdg301; Albain KS, 2008, J CLIN ONCOL, V26, P3950, DOI 10.1200/JCO.2007.11.9362; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; WEISS RB, 1990, J CLIN ONCOL, V8, P1263; [Anonymous], 2014, COMM TERM CRIT ADV E; Argyriou AA, 2005, NEUROLOGY, V64, P26; Center for Cancer Control and Information Services, NAT EST CANC INC BAS; Gelmon K, 1999, J CLIN ONCOL, V17, P3038; Gradishar JW, 2005, J CLIN ONCOL, V23, P7794; Harris LN, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1622; Ibrahim NK, 2002, P AN M AM SOC CLIN, V21, P209; Jacobson Stacy D, 2003, J Support Oncol, V1, P274; Leong SS, 2003, J CLIN ONCOL, V21, P1767, DOI 10.1200/JCO.2003.11.005; Nabholtz JM, 1996, J CLIN ONCOL, V14, P1858; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004; Sevelda P, 2004, J CLIN ONCOL, V22, p454S; Swain Sandra M, 2008, Clin Adv Hematol Oncol, V6, P455	24	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	APR	2015	9	4					1822	1826		10.3892/ol.2015.2954		5	Oncology	Oncology	CE2GF	WOS:000351631900062		
J	Okita, Y; Nonaka, M; Umehara, T; Kanemura, Y; Kodama, Y; Mano, M; Nakajima, S				Okita, Yoshiko; Nonaka, Masahiro; Umehara, Toru; Kanemura, Yonehiro; Kodama, Yoshinori; Mano, Masayuki; Nakajima, Shin			Efficacy of temozolomide and bevacizumab for the treatment of leptomeningeal dissemination of recurrent glioblastoma: A case report	ONCOLOGY LETTERS			English	Article						leptomeningeal dissemination; recurrent glioblastoma; bevacizumab	METASTATIC COLORECTAL-CANCER; OF-THE-LITERATURE; BREAST-CANCER; MALIGNANT GLIOMAS; CLINICAL-TRIALS; THERAPY; FLUOROURACIL; RADIOTHERAPY; LEUCOVORIN; PACLITAXEL	The prognosis of leptomeningeal dissemination of recurrent glioblastoma is poor, and chemotherapy results in minimal palliative efficacy. Temozolomide (TMZ) is an established therapy for patients with malignant glioma and the standard of care in parenchymal gliomas; however, few reports have been published with regard to its use for the treatment of leptomeningeal dissemination. Only one report has indicated the radiographic response of leptomeningeal dissemination to a TMZ rechallenge, suggesting a potential causative effect. While bevacizumab is an effective therapy for recurrent glioblastoma, its effect on leptomeningeal dissemination of recurrent glioblastoma remains unclear. The present study reports a case of leptomeningeal dissemination of recurrent glioblastoma in which transient neurological and radiological improvement was observed following chemotherapy with TMZ and bevacizumab. However, five months after the diagnosis of leptomeningeal dissemination the patient succumbed to the disease.	[Okita, Yoshiko; Nonaka, Masahiro; Umehara, Toru; Kanemura, Yonehiro; Nakajima, Shin] Natl Hosp Org, Osaka Natl Hosp, Dept Neurosurg, Osaka 5400006, Japan; [Kanemura, Yonehiro] Natl Hosp Org, Osaka Natl Hosp, Div Regenerat Med, Inst Clin Res, Osaka 5400006, Japan; [Kodama, Yoshinori; Mano, Masayuki] Natl Hosp Org, Osaka Natl Hosp, Dept Cent Lab & Surg Pathol, Osaka 5400006, Japan	Nonaka, M (reprint author), Natl Hosp Org, Osaka Natl Hosp, Dept Neurosurg, 2-1-14 Hoenzaka, Osaka 5400006, Japan.	nonakamasa65@gmail.com			Ministry of Education, Science and Culture of Japan [24791520]	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (grant no. 24791520 to Dr Yoshiko Okita).	Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Ku GY, 2007, J CLIN ONCOL, V25, pE14, DOI 10.1200/JCO.2006.10.3317; Mohan A, 2013, INDIAN J PHARM SCI, V75, P251, DOI 10.4103/0250-474X.117396; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Lamborn KR, 2008, NEURO-ONCOLOGY, V10, P162, DOI 10.1215/15228517-2007-062; ONDA K, 1989, NEUROSURGERY, V25, P533; Narita Y, 2013, JPN J CLIN ONCOL, V43, P587, DOI 10.1093/jjco/hyt051; AWAD I, 1986, NEUROSURGERY, V19, P247; Wong ET, 1999, J CLIN ONCOL, V17, P2572; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; ARITA N, 1994, ACTA NEUROCHIR, V126, P84, DOI 10.1007/BF01476415; Fiorentino A, 2012, INT J NEUROSCI, V122, P691, DOI 10.3109/00207454.2012.704456; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; VERTOSICK FT, 1990, NEUROSURGERY, V27, P516; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Hubner F, 2001, ACTA NEUROCHIR, V143, P25, DOI 10.1007/s007010170134; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Chamberlain MC, 2010, J NEURO-ONCOL, V96, P259, DOI 10.1007/s11060-009-9957-6; Wong ET, 2011, J NATL COMPR CANC NE, V9, P403; Chamberlain MC, 2003, NEUROSURGERY, V52, P324, DOI 10.1227/01.NEU.0000043929.31608.62; De Braganca Kevin C, 2010, J Neurooncol, V100, P443, DOI 10.1007/s11060-010-0200-2; DELATTRE JY, 1989, ACTA NEUROL SCAND, V79, P133; Foubert F, 2014, DIGEST LIVER DIS, V46, P105, DOI 10.1016/j.dld.2013.07.002; Groves MD, 2011, NEURO-ONCOLOGY, V13, P85; Le Rhun Emilie, 2013, Surg Neurol Int, V4, pS265, DOI 10.4103/2152-7806.111304; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Nandipati S, 2011, J NEURO-ONCOL, V105, P663, DOI 10.1007/s11060-011-0611-8; Vincent A, 2013, J BREAST CANCER, V16, P122, DOI 10.4048/jbc.2013.16.1.122; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491	30	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	APR	2015	9	4					1885	1888		10.3892/ol.2015.2940		4	Oncology	Oncology	CE2GF	WOS:000351631900073		
J	Nakajima, Y; Inagaki, Y; Kido, J; Nagata, T				Nakajima, Y.; Inagaki, Y.; Kido, J.; Nagata, T.			Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells	ORAL DISEASES			English	Article						advanced glycation end products; dental pulp; diabetes; S100A8; S100A9; RAGE-MAPK signaling	ACTIVATED PROTEIN-KINASES; FACTOR-KAPPA-B; DIABETES-MELLITUS; PATHWAYS; INDUCE; ATHEROSCLEROSIS; CALCIFICATION; INFLAMMATION; NEPHROPATHY; APOPTOSIS	ObjectiveAdvanced glycation end products (AGE) are involved in the progression of diabetic complications. Although our previous reports show that AGE increased dental pulp calcification, AGE accumulation is also associated with inflammation. This study examined AGE effect on the expression of inflammation factors using rat dental pulp tissues and cell cultures. Materials and MethodsReceptor for AGE (RAGE), S100A8, S100A9, and interleukin (IL)-1 were selected as inflammation parameters. Rat dental pulp cells were cultured and treated with AGE, and the effects were determined by real-time PCR. An anti-RAGE antibody or MAPK pathway inhibitors (PD98059, SB203580, and SP60012) were used to investigate AGE signaling pathway. ResultsThe mRNA levels of RAGE, S100A8, S100A9, and IL-1 were higher in diabetic pulp tissues. AGE increased mRNA expressions of S100A8, S100A9, and IL-1 in cultured dental pulp cells. In the presence of anti-RAGE antibody, AGE did not increase in S100A8 or S100A9 expressions. The AGE-induced increases in S100A8 and S100A9 were inhibited by PD98059 and SB203580, respectively. ConclusionsAdvanced glycation end products increased mRNA expression of S100A8, S100A9, and IL-1 under diabetic pulp conditions, and AGE-induced increases in S100A8 and S100A9 expressions may be associated with the RAGE-MAPK signaling pathway.	[Nakajima, Y.; Inagaki, Y.; Kido, J.; Nagata, T.] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Periodontol & Endodontol, Tokushima 7708504, Japan	Nagata, T (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Periodontol & Endodontol, 3-18-15 Kuramoto, Tokushima 7708504, Japan.	nagata@dent.tokushima-u.ac.jp			Japan Society for the Promotion of Science (JSPS), Tokyo, Japan [24592869]	This study was supported by a Grant-in-Aid for Scientific Research (No. 24592869) from the Japan Society for the Promotion of Science (JSPS), Tokyo, Japan.	Dukic-Stefanovic S, 2003, J NEUROCHEM, V87, P44, DOI 10.1046/j.1471-4159.2003.01988.x; Kajitani N, 2010, DIABETES RES CLIN PR, V88, P171, DOI 10.1016/j.diabres.2010.01.012; Banerjee M, 2012, CLIN CHIM ACTA, V413, P1163, DOI 10.1016/j.cca.2012.03.021; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Alikhani M, 2007, BONE, V40, P345, DOI 10.1016/j.bone.2006.09.011; Takeuchi M, 2000, MOL MED, V6, P114; Inagaki Y, 2010, J ENDODONT, V36, P1014, DOI 10.1016/j.joen.2010.03.018; Striz I, 2004, PHYSIOL RES, V53, P245; Tanikawa T, 2009, J VASC RES, V46, P572, DOI 10.1159/000226225; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Nakajima Y, 2013, J ENDODONT, V39, P873, DOI 10.1016/j.joen.2012.11.027; Leite MF, 2008, J ENDODONT, V34, P1211, DOI 10.1016/j.joen.2008.07.010; Menini S, 2013, CARDIOVASC RES, V100, P472, DOI 10.1093/cvr/cvt206; Mose M, 2013, EXP DERMATOL, V22, P476, DOI 10.1111/exd.12187; Mercer N, 2007, MOL CELL BIOCHEM, V306, P87, DOI 10.1007/s11010-007-9557-8; Nedic O, 2013, FREE RADICAL RES, V47, P28, DOI 10.3109/10715762.2013.806798; Franke S, 2011, CLIN EXP RHEUMATOL, V29, P650; Garber SE, 2009, J ENDODONT, V35, P60, DOI 10.1016/j.joen.2008.09.010; Rasheed Z, 2011, RHEUMATOLOGY, V50, P838, DOI 10.1093/rheumatology/keq380; Bender IB, 2003, J ENDODONT, V29, P383, DOI 10.1097/00004770-200306000-00001; Lopez-Lopez J, 2011, J ENDODONT, V37, P598, DOI 10.1016/j.joen.2011.01.002; Liu JH, 2009, FEBS J, V276, P4598, DOI 10.1111/j.1742-4658.2009.07165.x; Bando M, 2013, BBA-GENE REGUL MECH, V1829, P954, DOI 10.1016/j.bbagrm.2013.03.010; Burkhardt K, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-10; Delaleu N, 2004, PERIODONTOL 2000, V35, P42, DOI 10.1111/j.0906-6713.2004.003569.x; Eggers K, 2011, EXP CLIN ENDOCR DIAB, V119, P353, DOI 10.1055/s-0030-1268426; Ehlermann P, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-6; Hirata A, 2012, DIABETES RES CLIN PR, V97, P82, DOI 10.1016/j.diabres.2012.01.026; Kalousova M, 2005, MUTAT RES-FUND MOL M, V579, P37, DOI 10.1016/j.mrfmmm.2005.03.024; KASUGAI S, 1993, ARCH ORAL BIOL, V38, P769, DOI 10.1016/0003-9969(93)90073-U; Lima SMF, 2013, INT ENDOD J, V46, P700, DOI 10.1111/iej.12072; Liu YY, 2010, ATHEROSCLEROSIS, V208, P34, DOI 10.1016/j.atherosclerosis.2009.06.007; Marotta PS, 2012, J ENDODONT, V38, P297, DOI 10.1016/j.joen.2011.11.001; Rahimi F, 2005, FEBS J, V272, P2811, DOI 10.1111/j.1742-4658.2005.04703.x; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Yamagishi Sho-ichi, 2005, Curr Diabetes Rev, V1, P93, DOI 10.2174/1573399052952631; Yang K, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-66	37	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	APR	2015	21	3					328	334		10.1111/odi.12280		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE2HH	WOS:000351635600008		
J	Yamada, S; Uchida, K; Iwamoto, Y; Sugino, N; Yoshinari, N; Kagami, H; Taguchi, A				Yamada, S.; Uchida, K.; Iwamoto, Y.; Sugino, N.; Yoshinari, N.; Kagami, H.; Taguchi, A.			Panoramic radiography measurements, osteoporosis diagnoses and fractures in Japanese men and women	ORAL DISEASES			English	Article						mandible; cortex; panoramic radiography; osteoporosis; fracture	BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; RISK; PERFORMANCE	ObjectivesThe purpose of this study was to investigate the association of the shape of the mandibular cortex on panoramic radiographs with the risk of an osteoporosis diagnosis without prevalent fractures and with the risk of osteoporotic fractures in Japanese men and women. Subjects and MethodsOne thousand and twenty-one subjects aged 40-89years, who visited our university hospital and underwent panoramic radiography between 2007 and 2013, participated in this study. Eighty-eight patients received a diagnosis of osteoporosis without prevalent fractures, and 55 were diagnosed with osteoporotic fractures. Blinded to the groupings, we classified the shape of the mandibular cortex on panoramic radiographs as normal, moderately eroded or severely eroded. ResultsAfter adjustment for confounding factors, the odds ratios for an osteoporosis diagnosis associated with moderately eroded and severely eroded mandibular cortices were 1.4 (95% CI, 0.8-2.6) and 2.6 (95% CI, 1.4-5.0), respectively. The odds ratios for an osteoporotic fracture associated with moderately eroded and severely eroded cortices were 0.8 (95% CI, 0.4-1.7) and 1.1 (95% CI, 0.5-2.5), respectively. ConclusionsSubjects in Japan with eroded mandibular cortices tended to be at increased risk of osteoporosis diagnoses but not of fractures.	[Yamada, S.; Uchida, K.; Iwamoto, Y.; Taguchi, A.] Matsumoto Dent Univ, Grad Sch Oral Med, Dept Hard Tissue Res, Hirooka, Shiojiri 3990781, Japan; [Uchida, K.; Sugino, N.; Taguchi, A.] Matsumoto Dent Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Hirooka, Shiojiri 3990781, Japan; [Yoshinari, N.] Matsumoto Dent Univ, Sch Dent, Dept Periodontol, Hirooka, Shiojiri 3990781, Japan; [Kagami, H.] Matsumoto Dent Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Hirooka, Shiojiri 3990781, Japan	Taguchi, A (reprint author), Matsumoto Dent Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, 1780 Gobara, Hirooka, Shiojiri 3990781, Japan.	akiro@po.mdu.ac.jp			Japan Society for the Promotion of Science [23593074, 24592849]	This work was supported in part by Grants-in-Aid from the Japan Society for the Promotion of Science (nos. 23593074 and 24592849).	Antonopoulou M, 2013, MATURITAS, V76, P253, DOI 10.1016/j.maturitas.2013.04.004; Ballane G, 2014, J BONE MINER RES, V29, P1745, DOI 10.1002/jbmr.2218; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178; Kanis JA, 2009, BONE, V44, P734, DOI 10.1016/j.bone.2009.01.373; Bollen AM, 2000, ORAL SURG ORAL MED O, V90, P518, DOI 10.1067/moe.2000.107802; Yamamoto M, 2009, DIABETES CARE, V32, P2263, DOI 10.2337/dc09-0901; Taguchi A, 2006, OSTEOPOROSIS INT, V17, P387, DOI 10.1007/s00198-005-2029-7; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Soen S, 2013, J BONE MINER METAB, V31, P247, DOI 10.1007/s00774-013-0447-8; Leslie WD, 2013, J CLIN ENDOCR METAB, V98, P602, DOI 10.1210/jc.2012-3118; Kitahara H, 2013, OSTEOPOROSIS INT, V24, P907, DOI 10.1007/s00198-012-2038-2; Blake Glen M, 2002, Semin Musculoskelet Radiol, V6, P207, DOI 10.1055/s-2002-36718; Bow CH, 2012, OSTEOPOROSIS INT, V23, P879, DOI 10.1007/s00198-011-1627-9; Iki Masayuki, 2014, Clin Calcium, V24, P657, DOI CliCa1405657664; Jonasson G, 2013, CLIN ORAL INVEST, V17, P565, DOI 10.1007/s00784-012-0745-x; Lee YK, 2014, J CLIN ENDOCR METAB, V99, P97, DOI 10.1210/jc.2013-2352; Leite AF, 2011, ORAL SURG ORAL MED O, V112, P648, DOI 10.1016/j.tripleo.2011.06.014; Nakamoto T, 2003, OSTEOPOROSIS INT, V14, P659, DOI 10.1007/s00198-003-1419-y; Nojiri S, 2013, J BONE MINER METAB, V31, P367, DOI 10.1007/s00774-013-0444-y; Okabe S, 2008, ORAL SURG ORAL MED O, V106, P433, DOI 10.1016/j.tripleo.2007.09.013; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Taguchi A, 2010, ORAL DIS, V16, P316, DOI 10.1111/j.1601-0825.2009.01615.x; Taguchi A, 2008, BONE, V43, P209, DOI 10.1016/j.bone.2008.03.014; Taguchi A, 2004, AM J ROENTGENOL, V183, P1755; Taguchi A, 2005, J JPN DENT ASS, V57, P1149	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	APR	2015	21	3					335	341		10.1111/odi.12282		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE2HH	WOS:000351635600009		
J	Matsumura, S; Higa, K; Igarashi, T; Takaichi, S; Tonogi, M; Shinozaki, N; Shimazaki, J; Yamane, GY				Matsumura, S.; Higa, K.; Igarashi, T.; Takaichi, S.; Tonogi, M.; Shinozaki, N.; Shimazaki, J.; Yamane, G-Y			Characterization of mesenchymal progenitor cell populations from non-epithelial oral mucosa	ORAL DISEASES			English	Article						oral mucosa; mesenchymal stem cells; differentiation; neural crest; regeneration; corneal stroma	EMBRYONIC STEM-CELLS; NEURAL CREST CELLS; HUMAN PERIODONTAL-LIGAMENT; BONE-MARROW; IN-VITRO; MULTILINEAGE DIFFERENTIATION; FUNCTIONAL-PROPERTIES; BRANCHIAL ARCH; LAMINA PROPRIA; STROMAL CELLS	ObjectivesThe characteristics of cell populations extracted from oral mucosal non-epithelial tissues and their ability to differentiate were evaluated in vitro as a potential source of cells for mandibular and corneal regeneration. Materials and methodsOral mucosal non-epithelial cells (OMNECs) were extracted from tissue samples and were studied by flow cytometry and RT-PCR. Cells differentiating into osteoblasts, adipocytes, chondrocytes, neurocytes, or keratocytes were characterized by RT-PCR and cell staining. ResultsOMNECs expressed CD44, CD90, CD105, CD166, and STRO-1 antigens, which are markers for mesenchymal stem cells. In addition, Oct3/4, c-Myc, Nanog, KLF4, and Rex, which are expressed by embryonic or pluripotent stem cells, were detected by RT-PCR. Expression of CD49d, CD56, and PDGFR, proteins closely associated with the neural crest, was observed in OMNECs, as was expression of Twist1, Sox9, Snail1 and Snail2, which are early neural crest and neural markers. Specific differentiation markers were expressed in OMNECs after differentiation into osteoblasts, adipocytes, chondrocytes, or keratocytes. ConclusionsPopulations of OMNECs may contain both mesenchymal stem cells and neural crest origin cells and are a potential cell source for autologous regeneration of mandibular or corneal stroma.	[Matsumura, S.; Igarashi, T.; Takaichi, S.; Tonogi, M.; Yamane, G-Y] Tokyo Dent Coll, Dept Oral Med Oral & Maxillofacial Surg, Ichikawa, Chiba 2728513, Japan; [Higa, K.; Shimazaki, J.] Tokyo Dent Coll, Dept Ophthalmol, Ichikawa, Chiba 2728513, Japan; [Higa, K.; Shinozaki, N.; Shimazaki, J.] Tokyo Dent Coll, Cornea Ctr, Ichikawa, Chiba 2728513, Japan	Matsumura, S (reprint author), Tokyo Dent Coll, Dept Oral Med Oral & Maxillofacial Surg, 5-11-13 Sugano, Ichikawa, Chiba 2728513, Japan.	matsumurashintarou@tdc.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was partly supported by Assistance for Joint Research with Community Program in Life Sciences from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors are grateful to Ms. Mifuyu Ishiwata, Ms. Sae Yamaguchi, and Ms. Kimie Kato for their technical assistance and the staff of the Cornea Center Eye Bank for administrative support. The authors would also like to thank Associate Professors Jeremy Williams and Murat Dogru, Tokyo Dental College, for their assistance with English language editing of the manuscript.	Marynka-Kalmani K, 2010, STEM CELLS, V28, P984, DOI 10.1002/stem.425; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; Zhou Y, 2008, J PERIODONTOL, V79, P525, DOI 10.1902/jop.2008.070373 ; Hong CS, 2005, SEMIN CELL DEV BIOL, V16, P694, DOI 10.1016/j.semcdb.2005.06.005; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Pierantozzi E, 2011, STEM CELLS DEV, V20, P915, DOI 10.1089/scd.2010.0353; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Schugar RC, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/789526; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Stephens P, 2001, BRIT J DERMATOL, V144, P229, DOI 10.1046/j.1365-2133.2001.04006.x; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Heo JS, 2013, NEUROSCIENCE, V238, P305, DOI 10.1016/j.neuroscience.2013.02.011; Feng G, 2010, J BONE JOINT SURG AM, V92A, P675, DOI 10.2106/JBJS.H.01672; Pomp O, 2005, STEM CELLS, V23, P923, DOI 10.1634/stemcells.2005-0038; Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456; Davies LC, 2010, STEM CELLS DEV, V19, P819, DOI 10.1089/scd.2009.0089; Espana EM, 2003, INVEST OPHTH VIS SCI, V44, P5136, DOI 10.1167/iovs.03-0484; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Guerriero E, 2007, INVEST OPHTH VIS SCI, V48, P627, DOI 10.1167/iovs.06-0635; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Wang N, 2013, GENE, V523, P178, DOI 10.1016/j.gene.2013.03.043; Yamada Y, 2004, TISSUE ENG, V10, P955, DOI 10.1089/1076327041348284; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Gay IC, 2007, ORTHOD CRANIOFAC RES, V10, P149, DOI 10.1111/j.1601-6343.2007.00399.x; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Widera D, 2009, STEM CELLS, V27, P1899, DOI 10.1002/stem.104; Degistirici O, 2008, TISSUE ENG PT A, V14, P317, DOI 10.1089/tea.2007.0221; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156; Sorrentino A, 2008, EXP HEMATOL, V36, P1035, DOI 10.1016/j.exphem.2008.03.004; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Charite J, 2001, GENE DEV, V15, P3039, DOI 10.1101/gad.931701; Deflorian G, 2004, DEVELOPMENT, V131, P613, DOI 10.1242/dev.00948; Deng MJ, 2004, TISSUE ENG, V10, P1597, DOI 10.1089/1076327042500409; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; IRWIN CR, 1994, J CELL SCI, V107, P1333; Ishii M, 2003, DEVELOPMENT, V130, P6131, DOI 10.1242/dev.00793; Kil SH, 1998, DEV BIOL, V202, P29, DOI 10.1006/dbio.1998.8985; Lin CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007839; Pinco KA, 2001, MECH DEVELOP, V100, P99, DOI 10.1016/S0925-4773(00)00503-7; Sasaki T, 2006, DEVELOPMENT, V133, P371, DOI 10.1242/dev.02200; Satake Y, 2008, ARCH OPHTHALMOL-CHIC, V126, P23, DOI 10.1001/archopht.126.1.23; Schor S L, 1996, Oral Dis, V2, P155; Stephens P, 2007, ORAL DIS, V13, P1, DOI 10.1111/j.1601-0825.2006.01314.x; Szpaderska AM, 2003, J DENT RES, V82, P621; Takahashi K, 2001, DEV DYNAM, V222, P252, DOI 10.1002/dvdy.1185; Wislet-Gendebien S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046425	59	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1354-523X	1601-0825		ORAL DIS	Oral Dis.	APR	2015	21	3					361	372		10.1111/odi.12288		12	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CE2HH	WOS:000351635600013		
J	Tamamura, S; Ueno, A; Aramaki, N; Matsumoto, H; Uchida, K; Igarashi, T; Kaneko, K				Tamamura, Shuji; Ueno, Akio; Aramaki, Noritaka; Matsumoto, Hiroyuki; Uchida, Kagemi; Igarashi, Toshifumi; Kaneko, Katsuhiko			Effects of oxidative weathering on the composition of organic matter in coal and sedimentary rock	ORGANIC GEOCHEMISTRY			English	Article						Weathering; Sedimentary organic matter; Coal; Humic substance; Humic acid; Fulvic acid; Humin	LOW-TEMPERATURE OXIDATION; GROUNDWATER HUMIC SUBSTANCES; TOTAL LUMINESCENCE SPECTRA; RESISTANT OUTER WALLS; SELECTIVE PRESERVATION; AIR OXIDATION; FULVIC-ACIDS; BLACK SHALE; STRUCTURAL-CHANGES; KEROGEN FORMATION	The effect of oxidative weathering on the composition of sedimentary organic matter (SOM) of lignite, subbituminous coal, quartzose arenite, siliceous mudstone, siliceous shale and diatomaceous shale was investigated in Hokkaido, Japan, in a subarctic humid climate. For 15 samples in total, a humic substance extraction method was applied to divide SOM into lipid-C, humin-C and alkali soluble-C. The alkali soluble-C was further divided into fulvic acid (FA)-C, humic acid (HA)-C and a smaller molecular size fraction (SMSF)-C, which comprised organic molecules able to pass through a dialysis membrane (< 1000 Da) during the HA and FA purification processes. The alkali soluble-C (8-750 g/kg) increased with the degree of sample weathering in compensation for lowering of humin-C. For the alkali soluble-C, HA-C (undetectable to 698 g/kg) became dominant with sample weathering, in contrast to FA-C and SMSF-C. These observations imply that oxidative weathering converts humin-C into alkali soluble-C (mainly HA-C). The C-13 nuclear magnetic resonance (NMR) analysis (precision +/- 2.4%) revealed higher aromatic-C content of HA (average 40%) as compared to bulk humin (average 33%), suggesting that the re-generated HA was derived from condensed products (aromatic-C rich) in the humin, rather than from recalcitrant biomolecules (alkyl-C rich) in that fraction. The longer emission wavelength of the HA and FA from weathered samples in the excitation-emission matrix (EEM) spectra (precision +/- 1.0%) is ascribed to the abundance of oxidized aromatic moieties, with the higher O/C atomic ratio of HA and FA from the weathered samples. (C) 2015 Elsevier Ltd. All rights reserved.	[Tamamura, Shuji; Ueno, Akio; Aramaki, Noritaka; Kaneko, Katsuhiko] Northern Adv Ctr Sci & Technol, Horonobe Res Inst Subsurface Environm, Horonobe, Hokkaido 0983221, Japan; [Matsumoto, Hiroyuki; Uchida, Kagemi] Kushiro Coal Mine CO LTD, Kushiro, Hokkaido 0850811, Japan; [Igarashi, Toshifumi] Hokkaido Univ, Fac Engn, Div Sustainable Resources Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Tamamura, S (reprint author), Northern Adv Ctr Sci & Technol, Horonobe Res Inst Subsurface Environm, 5-3 Sakae Machi, Horonobe, Hokkaido 0983221, Japan.	shuji-tamamura@h-rise.jp			Coal Division of Agency for Natural Resources and Energy	The lignite was sampled in the Teshio Experimental Forest with the permission of Hokkaido University. The core sampling of the Cretaceous quartzose arenite at the Kushiro coal-mining pit was funded by the Coal Division of Agency for Natural Resources and Energy. The collection of the Cretaceous sedimentary rocks at Monomanai was kindly guided by T. Taninaka of the Hokkaido Regional Development Bureau. The unweathered siliceous and diatomaceous shale were kindly offered by JAEA. Dr. Y. Suzuki, from the National Institute of Advanced Industrial Science and Technology, and Dr. T. Tonozaki, from the RaaX Co., Ltd., are acknowledged for lectures on coal geology/analysis. Dr. S. Shimizu in our laboratory is acknowledged for valuable comments to improve this paper. We appreciate T. Endo, R. Endo, M. Akatsuka, H. Tada, M. Takahashi, K. Nishizawa, and M. Muramoto for technical assistance in our laboratory. Professor Myrna J. Simpson (Dept. of Physical and Environmental Sciences, University of Toronto), as associate editor, and three anonymous reviewers are acknowledged for their time and effort for giving valuable comments to improve the quality of this paper. This study was directed by the research project of the Horonobe Research Institute for the Subsurface Environment, prepared in 2011 by Dr. Y. Ishijima, and fixed in 2012 by Y. Ohmi.	Ahmed M, 2001, ORG GEOCHEM, V32, P809, DOI 10.1016/S0146-6380(01)00033-X; Mobed JJ, 1996, ENVIRON SCI TECHNOL, V30, P3061, DOI 10.1021/es960132l; Petsch ST, 2005, PALAEOGEOGR PALAEOCL, V219, P157, DOI 10.1016/j.palaeo.2004.10.019; TEGELAAR EW, 1989, GEOCHIM COSMOCHIM AC, V53, P3103, DOI 10.1016/0016-7037(89)90191-9; Wang H, 2003, COMBUST FLAME, V134, P107, DOI 10.1016/S0010-2180(03)00086-5; Artinger R, 2000, APPL GEOCHEM, V15, P97, DOI 10.1016/S0883-2927(99)00021-9; FENGLER G, 1994, MAR POLLUT BULL, V28, P143, DOI 10.1016/0025-326X(94)90389-1; Boyle ES, 2009, ENVIRON SCI TECHNOL, V43, P2262, DOI 10.1021/es803264g; Formolo M, 2008, INT J COAL GEOL, V76, P86, DOI 10.1016/j.coal.2008.03.005; Pietrzak R, 2003, FUEL, V82, P705, DOI 10.1016/S0016-2361(02)00364-2; Petsch ST, 2001, SCIENCE, V292, P1127, DOI 10.1126/science.1058332; Machnikowska H, 2002, FUEL PROCESS TECHNOL, V77, P17, DOI 10.1016/S0378-3820(02)00064-4; GOTH K, 1988, NATURE, V336, P759, DOI 10.1038/336759a0; Marynowski L, 2011, CHEM GEOL, V285, P144, DOI 10.1016/j.chemgeo.2011.04.001; WU MM, 1988, ENERG FUEL, V2, P150, DOI 10.1021/ef00008a009; Marynowski L, 2011, ORG GEOCHEM, V42, P1076, DOI 10.1016/j.orggeochem.2011.06.017; LITTKE R, 1991, GEOCHIM COSMOCHIM AC, V55, P3369, DOI 10.1016/0016-7037(91)90494-P; DERENNE S, 1991, GEOCHIM COSMOCHIM AC, V55, P1041, DOI 10.1016/0016-7037(91)90162-X; Fimmen RL, 2007, GEOCHIM COSMOCHIM AC, V71, P3003, DOI 10.1016/j.gca.2007.04.009; Alberts JJ, 2004, ORG GEOCHEM, V35, P243, DOI 10.1016/j.orggeochem.2003.11.007; WILSON BW, 1987, ENERG FUEL, V1, P80, DOI 10.1021/ef00001a015; [Anonymous], 2003, 146891 ISO; CHOPPIN GR, 1988, RADIOCHIM ACTA, V44-5, P23; ARAVENA R, 1993, APPL GEOCHEM, V8, P483, DOI 10.1016/0883-2927(93)90077-T; VERHEYEN TV, 1981, GEOCHIM COSMOCHIM AC, V45, P1899, DOI 10.1016/0016-7037(81)90020-X; Hayashi J, 1997, ENERG FUEL, V11, P227, DOI 10.1021/ef960104o; DERENNE S, 1992, ORG GEOCHEM, V19, P345, DOI 10.1016/0146-6380(92)90004-H; Kurkova M, 2004, CHEMOSPHERE, V54, P1237, DOI 10.1016/j.chemosphere.2003.10.020; Petsch ST, 2000, ORG GEOCHEM, V31, P475, DOI 10.1016/S0146-6380(00)00014-0; SCOTT CD, 1986, BIOTECHNOL PROGR, V2, P131, DOI 10.1002/btpr.5420020307; JONES RE, 1949, J SOC CHEM IND-L, V68, P197, DOI 10.1002/jctb.5000680701; JONES RE, 1945, NATURE, V155, P424, DOI 10.1038/155424b0; Xia WC, 2014, APPL SURF SCI, V293, P293, DOI 10.1016/j.apsusc.2013.12.151; MOULIN V, 1992, RADIOCHIM ACTA, V58-9, P179; SCOTT AR, 1994, AAPG BULL, V78, P1186; Moses C, 2014, EARTH-SCI REV, V135, P141, DOI 10.1016/j.earscirev.2014.04.006; Strapoc D, 2011, ANNU REV EARTH PL SC, V39, P617, DOI 10.1146/annurev-earth-040610-133343; Martini AM, 1996, NATURE, V383, P155, DOI 10.1038/383155a0; Ariese F, 2004, AQUAT SCI, V66, P86, DOI 10.1007/s00027-003-0647-8; Berkowitz N., 1979, INTRO COAL TECHNOLOG, P95; Buckau G, 2000, APPL GEOCHEM, V15, P819, DOI 10.1016/S0883-2927(99)00078-5; CALEMMA V, 1994, FUEL, V73, P700, DOI 10.1016/0016-2361(94)90012-4; Chang S, 1998, ENVIRON SCI TECHNOL, V32, P2883, DOI 10.1021/es9802504; CLEMENS AH, 1991, FUEL, V70, P215, DOI 10.1016/0016-2361(91)90155-4; COHEN MS, 1982, APPL ENVIRON MICROB, V44, P23; Durand B., 1980, KEROGEN INSOLUBLE OR, P13; ESTEVEZ M, 1990, FUEL, V69, P157, DOI 10.1016/0016-2361(90)90166-N; FAKOUSSA R M, 1988, Resources Conservation and Recycling, V1, P251, DOI 10.1016/0921-3449(88)90020-1; Faure P, 1999, FUEL, V78, P1515, DOI 10.1016/S0016-2361(99)00086-1; Fischer C, 2005, GEOCHIM COSMOCHIM AC, V69, P1213, DOI 10.1016/j.gca.2004.09.021; Fischer C, 2007, J SEDIMENT RES, V77, P355, DOI 10.2110/jsr.2007.041; FLAVIANO C, 1994, ORG GEOCHEM, V22, P759, DOI 10.1016/0146-6380(94)90137-6; FUKUSHIMA K, 1988, ORG GEOCHEM, V12, P509, DOI 10.1016/0146-6380(88)90143-X; Gong B, 1998, FUEL, V77, P1081, DOI 10.1016/S0016-2361(98)00002-7; Gron C, 1996, ENVIRON INT, V22, P519, DOI 10.1016/0160-4120(96)00056-6; Grzybek T, 2006, FUEL, V85, P1016, DOI 10.1016/j.fuel.2005.09.017; Hofrichter M., 2001, BIOPOLYMERS LIGNIN H, P393; Hu XF, 2014, SEDIMENT GEOL, V303, P15, DOI 10.1016/j.sedgeo.2014.01.006; HUC AY, 1977, FUEL, V56, P73, DOI 10.1016/0016-2361(77)90046-1; HUFFMAN GP, 1985, FUEL, V64, P849, DOI 10.1016/0016-2361(85)90022-5; IBARRA JV, 1985, FUEL, V64, P650, DOI 10.1016/0016-2361(85)90050-X; IIJIMA A, 1981, SEDIMENTOLOGY, V28, P185, DOI 10.1111/j.1365-3091.1981.tb01676.x; ISHIWATARI R, 1977, GEOCHIM COSMOCHIM AC, V41, P815, DOI 10.1016/0016-7037(77)90052-7; Israelachvili J., 1991, INTERMOLECULAR SURFA, P122; BARTON N, 1978, INT J ROCK MECH MIN, V15, P319; Killops S., 2005, INTRO ORGANIC GEOCHE, P117; Kim JI, 1996, RADIOCHIM ACTA, V73, P5; KLIKA Z, 1993, INT J COAL GEOL, V22, P217, DOI 10.1016/0166-5162(93)90027-8; Kononova M.M., 1966, SOIL ORGANIC MATTER, P13; LEYTHAEU.D, 1973, GEOCHIM COSMOCHIM AC, V37, P113, DOI 10.1016/0016-7037(73)90249-4; LIOTTA R, 1983, FUEL, V62, P781, DOI 10.1016/0016-2361(83)90028-5; LYNCH BM, 1987, FUEL, V66, P979, DOI 10.1016/0016-2361(87)90339-5; MARTINEZ M, 1995, ORG GEOCHEM, V23, P253, DOI 10.1016/0146-6380(94)00115-H; MOSS TD, 1988, FUEL, V67, P1382, DOI 10.1016/0016-2361(88)90124-X; NIP M, 1989, GEOCHIM COSMOCHIM AC, V53, P671, DOI 10.1016/0016-7037(89)90010-0; Petsch S.T., 2014, ORGANIC GEOCHEMISTRY, V12, P217; Petsch ST, 2001, GEOCHIM COSMOCHIM AC, V65, P1867, DOI 10.1016/S0016-7037(01)00572-5; PISUPATI SV, 1993, FUEL, V72, P531, DOI 10.1016/0016-2361(93)90113-G; PYNE JW, 1987, APPL ENVIRON MICROB, V53, P2844; RHOADS CA, 1983, FUEL, V62, P1387, DOI 10.1016/0016-2361(83)90104-7; Schafer T, 2005, ORG GEOCHEM, V36, P567, DOI 10.1016/j.orggeochem.2004.10.011; Schwertmann U., 1991, IRON OXIDES LAB PREP, P5; Stevenson F.J., 1994, HUMUS CHEM GENESIS C, V12, p[24, 285]; SUZUKI N, 1984, GEOCHIM COSMOCHIM AC, V48, P243, DOI 10.1016/0016-7037(84)90248-5; Tipping E., 2002, CATION BINDING HUMIC, V9, p[4, 171]; Vecchio R.D., 2004, ENVIRON SCI TECHNOL, V38, P3885; Velde B., 2008, ORIGIN CLAY MINERALS, P75, DOI 10.1007/978-3-540-75634-7_3; VERHEYEN TV, 1985, ORG GEOCHEM, V8, P375, DOI 10.1016/0146-6380(85)90016-6; Wade Jr L.G., 1995, ORGANIC CHEM, V18, p[336, 753]; WASSENAAR L, 1990, ORG GEOCHEM, V15, P383, DOI 10.1016/0146-6380(90)90165-V	90	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0146-6380			ORG GEOCHEM	Org. Geochem.	APR	2015	81						8	19		10.1016/j.orggeochem.2015.01.006		12	Geochemistry & Geophysics	Geochemistry & Geophysics	CD3PI	WOS:000350990500002		
J	Chou, CH; Lee, MTM; Song, IW; Lu, LS; Shen, HC; Lee, CH; Wu, JY; Chen, YT; Kraus, VB; Wu, CC				Chou, C. -H.; Lee, M. T. M.; Song, I. -W.; Lu, L. -S.; Shen, H. -C.; Lee, C. -H.; Wu, J. -Y.; Chen, Y. -T.; Kraus, V. B.; Wu, C. -C.			Insights into osteoarthritis progression revealed by analyses of both knee tibiofemoral compartments	OSTEOARTHRITIS AND CARTILAGE			English	Article						Osteoarthritis progression; Cartilage; Microarray; Lateral knee compartment	HUMAN ARTICULAR-CARTILAGE; GENE-EXPRESSION; SUBCHONDRAL BONE; CHONDROCYTES; HOMEOSTASIS; METABOLISM; PROTEIN; MODEL; JOINT; MICE	Objective: To identify disease relevant genes and pathways associated with knee Osteoarthritis (OA) progression in human subjects using medial and lateral compartment dominant OA knee tissue. Design: Gene expression of knee cartilage was comprehensively assessed for three regions of interest from human medial dominant OA (n = 10) and non-OA (n = 6) specimens. Histology and gene expression were compared for the regions with minimal degeneration, moderate degeneration and significant degeneration. Agilent whole-genome microarray was performed and data were analyzed using Agilent GeneSpring GX11.5. Significant differentially regulated genes were further investigated by Ingenuity Pathway Analysis (IPA) to identify functional categories. To confirm their association with disease severity as opposed to site within the knee, 30 differentially expressed genes, identified by microarray, were analyzed by quantitative reverse-transcription polymerase chain reaction on additional medial (n = 16) and lateral (n = 10) compartment dominant knee OA samples. Results: A total of 767 genes were differentially expressed >= two-fold (P <= 0.05) in lesion compared to relatively intact regions. Analysis of these data by IPA predicted biological functions related to an imbalance of anabolism and catabolism of cartilage matrix components. Up-regulated expression of IL11, POSTN, TNFAIP6, and down-regulated expression of CHRDL2, MATN4, SPOCK3, VIT, PDE3B were significantly associated with OA progression and validated in both medial and lateral compartment dominant OA samples. Conclusions: Our study provides a strategy for identifying targets whose modification may have the potential to ameliorate pathological alternations and progression of disease in cartilage and to serve as biomarkers for identifying individuals susceptible to progression. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.	[Chou, C. -H.; Lee, M. T. M.; Song, I. -W.; Lu, L. -S.; Wu, J. -Y.; Chen, Y. -T.] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chou, C. -H.; Lee, M. T. M.; Song, I. -W.; Lu, L. -S.; Wu, J. -Y.] Acad Sinica, Natl Ctr Genome Med, Taipei 115, Taiwan; [Wu, J. -Y.] Acad Sinica, Translat Resource Ctr Genom Med, Taipei 115, Taiwan; [Song, I. -W.] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Shen, H. -C.; Wu, C. -C.] Natl Def Med Ctr, Triserv Gen Hosp, Dept Orthopaed Surg, Taipei, Taiwan; [Lee, C. -H.] Taipei Med Univ, Coll Med, Sch Med, Dept Orthoped, Taipei, Taiwan; [Lee, C. -H.] Taipei Med Univ Hosp, Dept Orthoped, Taipei, Taiwan; [Kraus, V. B.] Duke Univ, Sch Med, Dept Med, Duke Mol Physiol Inst, Durham, NC 27706 USA; [Chou, C. -H.; Kraus, V. B.] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27706 USA; [Chen, Y. -T.] Duke Univ, Sch Med, Dept Pediat, Durham, NC USA; [Lee, M. T. M.] China Med Univ, Grad Inst Chinese Med Sci, Taichung, Taiwan; [Lee, M. T. M.] RIKEN Ctr Genom Med, Lab Int Alliance, Yokohama, Kanagawa, Japan	Wu, CC (reprint author), Triserv Gen Hosp, Dept Orthopaed Surg, 325,Sec 2,Cheng Gung Rd, Taipei 11472, Taiwan.	cc380@duke.edu; mikelee@src.riken.jp; iwsong16@yahoo.com.tw; liangsuei@gmail.com; doc20231@gmail.com; chianherlee@yahoo.com.tw; jywu@ibms.sinica.edu.tw; chen0010@ibms.sinica.edu.tw; vbk@duke.edu; doc20281@gmail.com			Translational Resource Center for Genomic Medicine (TRC) of National Research Program for Biopharmaceuticals (NRPB)	The authors would like to thank Translational Resource Center for Genomic Medicine (TRC) of National Research Program for Biopharmaceuticals (NRPB), for the support in project management.	Lee JH, 2005, ARTHRITIS RHEUM, V52, P2386, DOI 10.1002/art.21215; Mann HH, 2004, J BIOL CHEM, V279, P25294, DOI 10.1074/jbc.M403778200; Degerman E, 2011, CURR OPIN PHARMACOL, V11, P676, DOI 10.1016/j.coph.2011.09.015; Lynn SK, 2007, KNEE, V14, P22, DOI 10.1016/j.knee.2006.09.002; Aigner T, 2006, ARTHRITIS RHEUM, V54, P3533, DOI 10.1002/art.22174; Chou CH, 2013, OSTEOARTHR CARTILAGE, V21, P450, DOI 10.1016/j.joca.2012.11.016; Wisniewski HG, 2014, OSTEOARTHR CARTILAGE, V22, P235, DOI 10.1016/j.joca.2013.12.004; Appleyard RC, 2003, OSTEOARTHR CARTILAGE, V11, P65, DOI 10.1053/joca.2002.0867; Roemhildt ML, 2013, OSTEOARTHR CARTILAGE, V21, P346, DOI 10.1016/j.joca.2012.10.014; ANDRIACCHI TP, 1994, ORTHOP CLIN N AM, V25, P395; Finnson KW, 2008, J BONE MINER RES, V23, P896, DOI [10.1359/jbmr.080209, 10.1359/JBMR.080209]; Evans CH, 2014, NAT REV RHEUMATOL, V10, P11, DOI 10.1038/nrrheum.2013.159; Manabe RI, 2008, P NATL ACAD SCI USA, V105, P12849, DOI 10.1073/pnas.0803640105; Bateman JF, 2013, ARTHRITIS RHEUM-US, V65, P1547, DOI 10.1002/art.37900; Sharma L, 2013, ANN RHEUM DIS, V72, P235, DOI 10.1136/annrheumdis-2011-201070; Guilak F, 2011, BEST PRACT RES CL RH, V25, P815, DOI 10.1016/j.berh.2011.11.013; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Appleton CTG, 2007, ARTHRITIS RHEUM, V56, P1854, DOI 10.1002/art.22711; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Leijten JCH, 2012, ARTHRITIS RHEUM-US, V64, P3302, DOI 10.1002/art.34535; Wei T, 2010, OSTEOARTHR CARTILAGE, V18, P992, DOI 10.1016/j.joca.2010.04.012; Bay-Jensen AC, 2010, RHEUMATOL INT, V30, P435, DOI 10.1007/s00296-009-1183-1; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143; [Anonymous], 2004, CLIN ORTHOP S, DOI 10.1097/01.blo.0000144970.05107.7e; Bader D. L., 2011, ARTHRITIS, V2011; Chou CH, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4380; Chowdhury TT, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3009; Hartmann U, 2013, J NEUROCHEM, V125, P399, DOI 10.1111/jnc.12212; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P705, DOI 10.1002/art.33388; Nakayama N, 2004, DEVELOPMENT, V131, P229, DOI 10.1242/dev.00901; Nam J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024320; Peffers MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4278; Poulet B, 2012, ARTHRITIS RHEUM-US, V64, P3256, DOI 10.1002/art.34572; Scott CEH, 2013, BONE JOINT J, V95B, P436, DOI 10.1302/0301-620X.95B4.30536; Yan DY, 2013, J BIOL CHEM, V288, P31655, DOI 10.1074/jbc.M112.440420; Young AA, 2005, ARTHRITIS RES THER, V7, pR852, DOI 10.1186/ar1756	36	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	APR	2015	23	4					571	580		10.1016/j.joca.2014.12.020		10	Orthopedics; Rheumatology	Orthopedics; Rheumatology	CD6VJ	WOS:000351227700011		
J	Niimi, R; Kono, T; Nishihara, A; Hasegawa, M; Matsumine, A; Kono, T; Sudo, A				Niimi, R.; Kono, T.; Nishihara, A.; Hasegawa, M.; Matsumine, A.; Kono, T.; Sudo, A.			Analysis of daily teriparatide treatment for osteoporosis in men	OSTEOPOROSIS INTERNATIONAL			English	Article						Anabolic window; Bone mineral density; Men; Osteoporosis; Postmenopausal women; Teriparatide	BONE-MINERAL DENSITY; PARATHYROID-HORMONE; POSTMENOPAUSAL WOMEN; FRACTURE; ALENDRONATE; TURNOVER; THERAPY; MARKERS; RISK	The percent and absolute lumbar spine and femoral neck bone mineral densities and absolute procollagen type I N-terminal propeptide (PINP) increases following a 20-mu g/day teriparatide treatment for 12 months were similar in men and women regardless of sex differences. Introduction Several placebo-controlled studies have measured the effects of daily teriparatide in men and postmenopausal women with osteoporosis but none have directly compared the effects between these groups. We retrospectively compared the effects of daily teriparatide therapy in men and postmenopausal women with osteoporosis and investigated biochemical markers of bone turnover to detect possible sex differences. Methods Patients (563; 75 men and 488 women) with osteoporosis were retrospectively investigated. All patients were administered with teriparatide at 20 mu g/day for 12 months. The primary efficacy measure was changed in lumbar spine (LS) and femoral neck (FN) bone mineral density (BMD) after 12 months of treatment. The change in serum levels of procollagen type I N-terminal propeptide (PINP) and urinary N-telopeptide (uNTX) excretion after 4, 8 and 12 months of treatment were also measured. Results In men, the percent LS BMD significantly increased by 11.3 +/- 9.9 % (mean +/- standard deviation (SD)) and the FN BMD increased by 0.4 +/- 6.4 % without a significant difference at 12 months. In postmenopausal women, the percent LS BMD significantly increased by 9.6 +/- 8.1 % and the FN BMD significantly increased by 2.4 +/- 7.8 % at 12 months. The percent and absolute BMD increases in LS and FN between men and women were similar. The absolute increases in PINP were similar in both groups at 4, 8 and 12 months. However, the absolute increases in uNTX were significantly lower in men than in women at 8 and 12 months. Conclusion Daily teriparatide treatment was as effective in men as in postmenopausal women regardless of sex differences.	[Niimi, R.; Kono, T.; Nishihara, A.; Kono, T.] Tomidahama Hosp, Dept Orthopaed Surg, Yokaichi, Mie 5108008, Japan; [Hasegawa, M.; Matsumine, A.; Sudo, A.] Mie Univ, Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie 514, Japan	Niimi, R (reprint author), Tomidahama Hosp, Dept Orthopaed Surg, 26-14 Tomidahamacho, Yokaichi, Mie 5108008, Japan.	furikakefuri@hotmail.co.jp					Marcus R, 2003, J BONE MINER RES, V18, P18, DOI 10.1359/jbmr.2003.18.1.18; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Miyauchi A, 2010, BONE, V47, P493, DOI 10.1016/j.bone.2010.05.022; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Kurland ES, 2000, J CLIN ENDOCR METAB, V85, P3069, DOI 10.1210/jc.85.9.3069; Orwoll E, 2003, J BONE MINER RES, V18, P9, DOI 10.1359/jbmr.2003.18.1.9; Langdahl BL, 2009, OSTEOPOROSIS INT, V20, P2095, DOI 10.1007/s00198-009-0917-y; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Mullender MG, 2005, CALCIFIED TISSUE INT, V77, P291, DOI 10.1007/s00223-005-0043-6; Watts NB, 2012, J CLIN ENDOCR METAB, V97, P1802, DOI 10.1210/jc.2011-3045; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Gluer CC, 2013, J BONE MINER RES, V28, P1355, DOI 10.1002/jbmr.1870; Finkelstein JS, 2006, J CLIN ENDOCR METAB, V91, P2882, DOI 10.1210/jc.2006-0190; Niimi R, 2015, J BONE MINER RES, V30, P225, DOI 10.1002/jbmr.2345; Niimi R, 2014, BONE, V66, P26, DOI 10.1016/j.bone.2014.05.017; Niimi R, 2014, OSTEOPOROSIS INT, V25, P337; Olszynski WP, 2008, EXPERT OPIN PHARMACO, V9, P491, DOI 10.1517/14656566.9.3.491 	17	2	2	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	APR	2015	26	4					1303	1309		10.1007/s00198-014-3001-1		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CD6PD	WOS:000351210500008		
J	Sumida, K; Ubara, Y; Hoshino, J; Hayami, N; Suwabe, T; Hiramatsu, R; Hasegawa, E; Yamanouchi, M; Sawa, N; Fujii, T; Takaichi, K				Sumida, K.; Ubara, Y.; Hoshino, J.; Hayami, N.; Suwabe, T.; Hiramatsu, R.; Hasegawa, E.; Yamanouchi, M.; Sawa, N.; Fujii, T.; Takaichi, K.			Bone histomorphometry in a long-term hemodialysis patient with hypoparathyroidism and sarcoidosis	OSTEOPOROSIS INTERNATIONAL			English	Article						1,25-Dihydroxyvitamin D; Hemodialysis; Hypoparathyroidism; Remodeling; Sarcoidosis	STAGE RENAL-DISEASE; VITAMIN-D; TUMORAL CALCINOSIS; DIALYSIS PATIENT; ADYNAMIC BONE; HYPERCALCEMIA; FAILURE; CALCIFICATIONS; MORTALITY; TURNOVER	A bone biopsy specimen in a long-term hemodialysis patient with sarcoidosis coexisting with severe hypoparathyroidism has demonstrated that a persistent near physiological level of 1,25-dihydroxyvitamin D-3 contributes to the preservation of bone remodeling and has the potential to retard the development of vascular calcification and atherosclerosis. Sarcoidosis-related hypercalcemia and hypoparathyroidism, which is characterized by 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) overproduction, is rarely seen in hemodialysis patients. Herein, we describe a 60-year-old Japanese woman on hemodialysis for 35 years who presented with malaise and hypercalcemia. Severe hypoparathyroidism without parathyroidectomy and a preserved 1,25(OH)(2)D-3 level were detected. Computed tomography showed bilateral axillary lymphadenopathy and minimal aortic and soft tissue calcification. The axillary node biopsy led to a definite diagnosis of sarcoidosis. A bone biopsy specimen obtained from the right iliac crest showed remodeling of normal lamellar bone with scalloped cement lines and clear double labeling by tetracycline on fluorescence microscopy. Histomorphometric analysis revealed that the bone formation rate was preserved (30.0 %/year), together with a decrease of osteoid volume (5.75 %) and fibrous volume (0 %), indicating that the patient did not have adynamic bone disease and only showed mild disease. This is the first documented case of sarcoidosis-related hypercalcemia associated with severe hypoparathyroidism in a long-term hemodialysis patient who underwent bone histomorphometry. Our findings suggest that, in hemodialysis patients with sarcoidosis coexisting with severe hypoparathyroidism, a persistent near physiological level of 1,25(OH)(2)D-3 contributes to the preservation of bone remodeling and has the potential to retard the development of vascular calcification and atherosclerosis.	[Sumida, K.; Ubara, Y.; Hoshino, J.; Hayami, N.; Suwabe, T.; Hiramatsu, R.; Hasegawa, E.; Yamanouchi, M.; Sawa, N.; Takaichi, K.] Toranomon Gen Hosp, Nephrol Ctr, Minato Ku, Tokyo 1058470, Japan; [Fujii, T.] Toranomon Gen Hosp, Dept Pathol, Minato Ku, Tokyo 1058470, Japan	Sumida, K (reprint author), Toranomon Gen Hosp, Nephrol Ctr, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	k-sumida@toranomon.gr.jp			Okinaka Memorial Institute for Medical Research	This study was partially supported by the Okinaka Memorial Institute for Medical Research. We wish to acknowledge Akemi Ito (Ito Bone Histomorphometry Institute) for performing the bone histomorphometric analysis.	Kitahara T, 2005, AM J KIDNEY DIS, V46, P688, DOI 10.1053/j.ajkd.2005.06.016; BAKER LRI, 1989, KIDNEY INT, V35, P661, DOI 10.1038/ki.1989.36; MILLINER DS, 1990, KIDNEY INT, V38, P931, DOI 10.1038/ki.1990.293; London GM, 2008, J AM SOC NEPHROL, V19, P1827, DOI 10.1681/ASN.2007050622; Naves-Diaz M, 2008, KIDNEY INT, V74, P1070, DOI 10.1038/ki.2008.343; Kobayashi S, 2003, BONE, V32, P163, DOI 10.1016/S8756-3282(02)00947-X; Sutton ALM, 2005, MOL ENDOCRINOL, V19, P2234, DOI 10.1210/me.2005-0081; Ubara Y, 2005, KIDNEY INT, V68, P833, DOI 10.1111/j.1523-1755.2005.00464.x; Goldsmith DJA, 1997, NEPHRON, V77, P37; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Nishizawa Y, 2003, AM J KIDNEY DIS, V41, pS76, DOI [10.1053/ajkd.2003.50090, 10.1016/S0272-6386(03)00411-6]; GALLIENI M, 1995, AM J PHYSIOL-RENAL, V268, pF746; London GM, 2004, J AM SOC NEPHROL, V15, P1943, DOI 10.1097/01.asn.0000129337.50739.48; Levin A, 2005, KIDNEY INT, V68, P1973, DOI 10.1111/j.1523-1755.2005.00651.x; PARFITT AM, 1987, J BONE MINER RES, V2, P595; van Leeuwen JPTM, 2001, CRIT REV EUKAR GENE, V11, P199; Arai Y, 2013, INTERNAL MED, V52, P2639, DOI 10.2169/internalmedicine.52.1075; BARBOUR GL, 1981, NEW ENGL J MED, V305, P440, DOI 10.1056/NEJM198108203050807; Barnard S, 2002, NEPHROL DIAL TRANSPL, V17, P175, DOI 10.1093/ndt/17.1.175; BRANDI L, 1989, NEPHRON, V53, P194; Couttenye M M, 1999, Kidney Int Suppl, V73, pS70; Gerakis A, 1996, NEPHROL DIAL TRANSPL, V11, P2430; Horikoshi R, 2011, CLIN EXP NEPHROL, V15, P154, DOI 10.1007/s10157-010-0362-4; Hrrero JC, 1998, NEPHROL DIAL TRANSPL, V13, P3280; Huart A, 2006, CLIN NEPHROL, V65, P449; KALANTARZADEH K, 1994, NEPHROL DIAL TRANSPL, V9, P829; Kwon A, 2013, BMJ CASE REP, DOI [10.1136/bcr-2013-010017, DOI 10.1136/BCR-2013-010017]; Naito T, 1999, NEPHROL DIAL TRANSPL, V14, P2716, DOI 10.1093/ndt/14.11.2716; QI QL, 1995, AM J KIDNEY DIS, V26, P622, DOI 10.1016/0272-6386(95)90599-5; Quack I, 2007, J MED CASE REPORTS, V3, P164; Rocker RR, 1988, J BONE MINER RES, V3, P133; Sato T, 2006, INTERNAL MED, V45, P363, DOI 10.2169/internalmedicine.45.1521; Tanizawa T, 1999, BONE, V25, P493, DOI 10.1016/S8756-3282(99)00183-0; TAYLOR RL, 1963, AM J MED, V34, P221, DOI 10.1016/0002-9343(63)90055-X; Yamada S, 2009, NEPHROLOGY, V14, P452, DOI 10.1111/j.1440-1797.2009.01097.x	35	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	APR	2015	26	4					1435	1441		10.1007/s00198-014-2987-8		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CD6PD	WOS:000351210500022		
J	Mokuda, S				Mokuda, S.			Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in rheumatoid arthritis patients	OSTEOPOROSIS INTERNATIONAL			English	Letter									Dohgo Spa Hosp, Ctr Rheumat Dis, Dept Internal Med, Matsuyama, Ehime 7900858, Japan	Mokuda, S (reprint author), Dohgo Spa Hosp, Ctr Rheumat Dis, Dept Internal Med, 21-21 Otsu Dohgo Himezuka, Matsuyama, Ehime 7900858, Japan.	sho-mokuda@hiroshima-u.ac.jp					Roux C, 2011, OSTEOPOROSIS INT, V22, P421, DOI 10.1007/s00198-010-1319-x; Mokuda S, 2012, J ENDOCRINOL INVEST, V35, P796; Ebina K, 2014, OSTEOPOROSIS INT, V25, P2755, DOI 10.1007/s00198-014-2819-x	3	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	APR	2015	26	4					1443	1443		10.1007/s00198-014-2958-0		1	Endocrinology & Metabolism	Endocrinology & Metabolism	CD6PD	WOS:000351210500023		
J	Ebina, K; Hashimoto, J; Shi, K; Kashii, M; Hirao, M; Yoshikawa, H				Ebina, K.; Hashimoto, J.; Shi, K.; Kashii, M.; Hirao, M.; Yoshikawa, H.			Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in RA patients: response to Mokuda	OSTEOPOROSIS INTERNATIONAL			English	Letter							RHEUMATOID-ARTHRITIS		[Ebina, K.; Shi, K.; Kashii, M.; Hirao, M.; Yoshikawa, H.] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan; [Hashimoto, J.] Natl Hosp Org, Dept Rheumatol, Osaka Minami Med Ctr, Kawachi Nagano, Osaka 5868521, Japan	Ebina, K (reprint author), Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	k-ebina@umin.ac.jp					Booth SL, 2013, NAT REV ENDOCRINOL, V9, P43, DOI 10.1038/nrendo.2012.201; Mokuda S, 2014, UNDERCARBOXYLATED OS, DOI [10.1007/s00198-014-2958-0, DOI 10.1007/S00198-014-2958-0]; Mokuda S, 2012, J ENDOCRINOL INVEST, V35, P796; Ebina K, 2014, OSTEOPOROSIS INT, V25, P2755, DOI 10.1007/s00198-014-2819-x	4	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	APR	2015	26	4					1445	1445		10.1007/s00198-014-2993-x		1	Endocrinology & Metabolism	Endocrinology & Metabolism	CD6PD	WOS:000351210500024		
J	Sugiyama, T; Yoshioka, H; Sakaguchi, K; Kim, YT; Oda, H				Sugiyama, T.; Yoshioka, H.; Sakaguchi, K.; Kim, Y. T.; Oda, H.			An evidence-based perspective on vitamin D and the growing skeleton	OSTEOPOROSIS INTERNATIONAL			English	Letter							CEREBRAL-PALSY; BONE; FRACTURES; CHILDREN		[Sugiyama, T.; Yoshioka, H.; Sakaguchi, K.; Kim, Y. T.; Oda, H.] Saitama Med Univ, Dept Orthopaed Surg, Moroyama, Saitama 3500495, Japan	Sugiyama, T (reprint author), Saitama Med Univ, Dept Orthopaed Surg, 38 Morohongo, Moroyama, Saitama 3500495, Japan.	tsugiym@saitama-med.ac.jp					Miller M, 2014, OSTEOPOROSIS INT, V25, P1861, DOI 10.1007/s00198-014-2690-9; Thacher TD, 2014, J CLIN ENDOCR METAB, V99, P4174, DOI 10.1210/jc.2014-2092; Wort UU, 2013, DEV MED CHILD NEUROL, V55, P821, DOI 10.1111/dmcn.12178; Michalopoulou M, 2013, METABOLISM, V62, P1811, DOI 10.1016/j.metabol.2013.08.006; Moon RJ, 2014, OSTEOPOROSIS INT, V25, P2673, DOI 10.1007/s00198-014-2783-5; Arundel P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f964; Beck-Nielsen SS, 2013, OSTEOPOROSIS INT, V24, P2215, DOI 10.1007/s00198-013-2286-9; Chen CL, 2013, OSTEOPOROSIS INT, V24, P1399, DOI 10.1007/s00198-012-2137-0; Christen P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5855; Finbraten AK, 2015, OSTEOPOROSIS INT, V26, P141, DOI 10.1007/s00198-014-2840-0; Sugiyama T, 2013, LANCET, V382, P767, DOI 10.1016/S0140-6736(13)61829-2; Sugiyama T, 2014, OSTEOPOROSIS INT, V25, P2497, DOI 10.1007/s00198-014-2798-y; Sugiyama T, 2004, LANCET, V364, P28, DOI 10.1016/S0140-6736(04)16585-9; Sugiyama T, 2002, LANCET, V359, P1160, DOI 10.1016/S0140-6736(02)08147-3; Veilleux LN, 2013, J CLIN ENDOCR METAB, V98, pE990, DOI 10.1210/jc.2012-4146	15	2	2	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	APR	2015	26	4					1447	1448		10.1007/s00198-014-2975-z		2	Endocrinology & Metabolism	Endocrinology & Metabolism	CD6PD	WOS:000351210500025		
J	Sakai, A; Ito, M; Tomomitsu, T; Tsurukami, H; Ikeda, S; Fukuda, F; Mizunuma, H; Inoue, T; Saito, H; Nakamura, T				Sakai, A.; Ito, M.; Tomomitsu, T.; Tsurukami, H.; Ikeda, S.; Fukuda, F.; Mizunuma, H.; Inoue, T.; Saito, H.; Nakamura, T.			Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis (vol 26, pg 1193, 2015)	OSTEOPOROSIS INTERNATIONAL			English	Correction									[Sakai, A.] Univ Occupat & Environm Hlth, Dept Orthopaed Surg, Kitakyushu, Fukuoka 807, Japan; [Ito, M.] Nagasaki Univ Hosp, Med Work Life Balance Ctr, Nagasaki, Japan; [Tomomitsu, T.] Kawasaki Coll Allied Hlth Profess, Dept Radiol Technol, Kurashiki, Okayama, Japan; [Tsurukami, H.] Orthopaed & Rheumatol Hosp, Tsurukami Clin, Kumamoto, Japan; [Ikeda, S.] Ken Ai Mem Hosp, Onga, Japan; [Fukuda, F.] Kitakyushu Gen Hosp, Kitakyushu, Fukuoka, Japan; [Mizunuma, H.] Hirosaki Univ, Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori 036, Japan; [Inoue, T.] Taisho Pharmaceut Co Ltd, Tokyo, Japan; [Saito, H.] Chugai Pharmaceut Co Ltd, Tokyo, Japan; [Nakamura, T.] Natl Ctr Global Hlth & Med, Shinjyuku Ku, Tokyo 1628655, Japan	Nakamura, T (reprint author), Natl Ctr Global Hlth & Med, Shinjyuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	t-nak@utopia.ocn.ne.jp					Sakai A, 2015, OSTEOPOROSIS INT, V26, P1193, DOI 10.1007/s00198-014-2991-z	1	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-941X	1433-2965		OSTEOPOROSIS INT	Osteoporosis Int.	APR	2015	26	4					1453	1453		10.1007/s00198-015-3049-6		1	Endocrinology & Metabolism	Endocrinology & Metabolism	CD6PD	WOS:000351210500027		
J	Dai, YY; Senge, M; Ito, K; Onishi, T; Yoshiyama, K				Dai, Yanyan; Senge, Masateru; Ito, Kengo; Onishi, Takeo; Yoshiyama, Kohei			Experimental evaluation of irrigation methods for soil desalinization	PADDY AND WATER ENVIRONMENT			English	Article						Soil desalinization; Leaching; Electrical conductivity; Salt removal rate; Infiltration capacity; Irrigation intensity	SODIC SOILS; SALINIZATION; WATER	Soil salinization has provided a serious threat for global agriculture throughout human history. It is becoming ever more prevalent as human land use intensifies in recent years, and the reclamation is one of major challenges in agroecology. Flood irrigation is a typical method for leaching saline soil. Yet the practice needs a large amount of water, and it is difficult to remove salt uniformly throughout soil layers. In this study, an experiment was conducted to evaluate leaching efficiencies of four different methods, namely: flood irrigation, spray irrigation, paper-covered flood irrigation, and puddling irrigation. Flood irrigation was applied at three plots with different infiltration capacities. Spray irrigation, paper-covered flood irrigation, and puddling irrigation were applied at other three plots with medium infiltration capacities. Results showed that salt removal rates of flood irrigation tended to be higher near the surface of soil with smaller infiltration capacity, and that spray irrigation, paper-covered flood irrigation, and puddling irrigation were more efficient in removing salt than flood irrigation. Paper-covered irrigation was the only leaching method that reduced horizontal heterogeneities in salt content, while flood irrigation and puddling irrigation significantly increased the horizontal heterogeneities. The present study indicated that leaching efficiencies were highly affected by irrigation intensity and also by irrigation water volume only when irrigation intensity was considerably low, and that paper-covered irrigation is an efficient method in removing salt homogeneously from soil profile. Further studies need to be conducted to optimize irrigation intensity and water volume for given soil and water environmental conditions.	[Dai, Yanyan] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Senge, Masateru; Ito, Kengo; Onishi, Takeo] Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan; [Yoshiyama, Kohei] Gifu Univ, River Basin Res Ctr, Gifu 5011193, Japan	Yoshiyama, K (reprint author), Gifu Univ, River Basin Res Ctr, 1-1 Yanagido, Gifu 5011193, Japan.	kyoshi@gifu-u.ac.jp			Gifu University Rearing Program for Basin Water Environmental Leaders; Japan Science and Technology Agency	We thank two anonymous reviewers for comments on the manuscript. This research was partially supported by the Gifu University Rearing Program for Basin Water Environmental Leaders and funded by the Japan Science and Technology Agency.	Hafele S, 1999, SOIL TILL RES, V51, P35, DOI 10.1016/S0167-1987(99)00028-8; Rengasamy P, 2006, J EXP BOT, V57, P1017, DOI 10.1093/jxb/erj108; RENGASAMY P, 1991, AUST J SOIL RES, V29, P935, DOI 10.1071/SR9910935; Flowers TJ, 1995, AUST J PLANT PHYSIOL, V22, P875; Kitamura Y, 2006, AGR WATER MANAGE, V85, P1, DOI 10.1016/j.agwat.2006.03.007; Qadir M, 1998, SOIL TILL RES, V45, P119, DOI 10.1016/S0933-3630(96)00130-4; Chen C, 2002, AGR WATER MANAGE, V54, P166; Games P.A., 1976, J EDUCATIONAL STATIS, V1, P113, DOI DOI 10.2307/1164979; Haraguti N, 2012, WATER LAND ENV ENG, V80, P53; Keren R, 2000, HDB SOIL SCI, pG3; KOSMAS C, 1991, GEODERMA, V49, P139, DOI 10.1016/0016-7061(91)90097-D; MITCHELL AR, 1993, SOIL SCI SOC AM J, V57, P490; Okuda T, 2012, WATER LAND ENV ENG, V80, P5; Richards LA, 1954, AGR HDB, V60; Rohlf FJ, 2012, BIOMETRY; Stockle CO, 2001, ENV IMPACT IRRIGATIO; SUMNER ME, 1993, AUST J SOIL RES, V31, P683, DOI 10.1071/SR9930683; Szabolcs I, 1994, TRANSACTIONS, V1, P123; Tejada M, 2005, EUR J AGRON, V23, P336, DOI 10.1016/j.eja.2005.02.005; TOPP GC, 1981, GEODERMA, V26, P13, DOI 10.1016/0016-7061(81)90073-2; Yu H, 2011, SOIL SCI SOC AM J, V75, P1359; Zar J. H., 2010, BIOSTATISTICAL ANAL	22	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1611-2490	1611-2504		PADDY WATER ENVIRON	Paddy Water Environ.	APR	2015	13	2					159	165		10.1007/s10333-014-0417-3		7	Agricultural Engineering; Agronomy	Agriculture	CD6AA	WOS:000351169100002		
J	Liu, HS; Yoshikawa, N; Miyazu, S; Watanabe, K				Liu, Haisheng; Yoshikawa, Natsuki; Miyazu, Susumu; Watanabe, Kouhei			Influence of saltwater wedges on irrigation water near a river estuary	PADDY AND WATER ENVIRONMENT			English	Article						Saltwater wedge; Acoustic profiling system; Numerical simulation; Halocline	SALT INTRUSION; SALINITY INTRUSION	Paddy fields irrigated using water from the Shinkawa River in Niigata, Japan, are subject to adverse effects associated with the occurrence of saltwater wedges in the river. The extent of saltwater intrusion in the river varies, depending on river discharge and tidal amplitude. In this study, field observations and numerical simulation of the Shinkawa River estuary were applied to ascertain the influence of saltwater wedges on paddy cultivation during the irrigation period. The saltwater wedge was surveyed using an echo-sounding profiling system (SC-3); results indicated that the longitudinal profiles of the saltwater wedge were 4.7 and 2.2 km from the river mouth sluice gate at the high water mark of spring tide and at the low water mark of neap tide, respectively. According to the vertical profiling using electrical conductivity (EC) meters at bridges crossing the river, there was a rigid interface between freshwater and saltwater with a thin halocline zone of approximately 0.25 m. These profiles were well reproduced by the one-dimensional, two-layer, unsteady flow model. The results of the model simulation and EC observation indicate that when the vertical position of the halocline rises to 1.2 m below the inlet of the water intake pumping station, the EC value rises sharply to 1,500 mu s/cm, which is an unsuitable level for irrigation water. It is estimated that for about 23 % of the total irrigation period, pump operation is halted as a result of this mechanism.	[Liu, Haisheng; Miyazu, Susumu] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9502181, Japan; [Yoshikawa, Natsuki] Niigata Univ, Inst Sci & Technol, Nishi Ku, Niigata 9502181, Japan; [Watanabe, Kouhei] Kowa, Chuo Ku, Niigata 9508565, Japan	Yoshikawa, N (reprint author), Niigata Univ, Inst Sci & Technol, Nishi Ku, 8050 Ikarashi 2 Nocho, Niigata 9502181, Japan.	natsuky@agr.niigata-u.ac.jp					Uncles RJ, 1996, ESTUAR COAST SHELF S, V43, P271, DOI 10.1006/ecss.1996.0070; ELDER JW, 1959, J FLUID MECH, V5, P544, DOI 10.1017/S0022112059000374; Gong WP, 2011, CONT SHELF RES, V31, P769, DOI 10.1016/j.csr.2011.01.011; Ralston DK, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005806; Jeong S, 2010, J ENVIRON SCI-CHINA, V22, P934, DOI 10.1016/S1001-0742(09)60201-1; Brockway R, 2006, ESTUAR COAST SHELF S, V66, P1, DOI 10.1016/j.ecss.2005.07.014; Chen XJ, 2004, ESTUAR COAST SHELF S, V61, P477, DOI 10.1016/j.ecss.2004.06.012; Farmer HG, 1951, EXPT STUDY SALT WEDG, P3; Keulegan G. H., 1966, ESTUARY COASTLINE HY, P546; Liu WC, 2004, J HYDRAUL ENG-ASCE, V130, P849, DOI 10.1061/(ASCE)0733-9429(2004)130:9(849); Liu WC, 2007, CONT SHELF RES, V27, P900, DOI 10.1016/j.csr.2006.12.005; MacCready P, 2001, J GEOPHYS RES-OCEANS, V106, P11629, DOI 10.1029/2001JC900006; Suga K, 1981, CIVIL ENG J, V23-11, P31; Suga K, 1976, P 31 ANN M JSCE, VII, P383; Suga K, 1977, 24 P COAST ENG, P544; Suga K, 1979, 26 P COAST ENG, P567; Suga K, 1975, P 30 ANN M JSCE, VII, P470; Tateishi M, 2007, SCI REP NIIGATA U E, V22, P57; Tateshi M, 2006, LAGUNA, V13, P43; Tokuoka T, 2005, LAGUNA, V12, P81; Zahed F, 2008, CAN J CIVIL ENG, V35, P1476, DOI 10.1139/L08-087	21	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1611-2490	1611-2504		PADDY WATER ENVIRON	Paddy Water Environ.	APR	2015	13	2					179	189		10.1007/s10333-014-0419-1		11	Agricultural Engineering; Agronomy	Agriculture	CD6AA	WOS:000351169100004		
J	Takahara, N; Isayama, H; Nakai, Y; Sasaki, T; Saito, K; Hamada, T; Mizuno, S; Miyabayashi, K; Mohri, D; Kogure, H; Matsubara, S; Yamamoto, N; Hirano, K; Ijichi, H; Tateishi, K; Tada, M; Koike, K				Takahara, Naminatsu; Isayama, Hiroyuki; Nakai, Yousuke; Sasaki, Takashi; Saito, Kei; Hamada, Tsuyoshi; Mizuno, Suguru; Miyabayashi, Koji; Mohri, Dai; Kogure, Hirofumi; Matsubara, Saburo; Yamamoto, Natsuyo; Hirano, Kenji; Ijichi, Hideaki; Tateishi, Keisuke; Tada, Minoru; Koike, Kazuhiko			Pancreatic Cancer With Malignant Ascites Clinical Features and Outcomes	PANCREAS			English	Article						pancreatic cancer; malignant ascites; peritoneal carcinomatosis; chemotherapy	GASTRIC OUTLET OBSTRUCTION; PERITONEAL CARCINOMATOSIS; INTRAPERITONEAL CHEMOTHERAPY; COMBINATION CHEMOTHERAPY; PHASE-II; S-1; GEMCITABINE; PACLITAXEL; METASTASIS; IMPACT	Objectives: Malignant ascites (MA) caused by peritoneal carcinomatosis is not uncommon in patients with pancreatic cancer. However, the clinical features and outcomes in these patients remain to be elucidated. Methods: Baseline characteristics and overall survival (OS) of consecutive patients with advanced pancreatic cancer who presented with MA were retrospectively evaluated. Results: Of 494 patients with advanced pancreatic cancer, 73 (15%) presented with MA. Patients with synchronous MA (n = 21), compared with those with metachronous MA (n = 52), had better performance status (P - 0.02), smaller amount of ascites (P < 0.01), and higher chance of receiving chemotherapy (57% vs 17%, P < 0.01), and resulted in longer OS (115 vs 42 days, P < 0.01). Overall survival was significantly longer in patients receiving chemotherapy than in those with best supportive care alone (124 vs 50 days, P < 0.01). In a multivariate analysis, chemotherapy was prognostic in addition to performance status, CRP, and small amount of MA; the hazard ratio of chemotherapy was 0.46, compared with best supportive care alone (P = 0.02). Conclusions: Although the prognosis of pancreatic cancer patients with MA remains poor, selected patients may be candidate for chemotherapy, regardless of the timing of appearance of MA.	[Takahara, Naminatsu; Isayama, Hiroyuki; Nakai, Yousuke; Sasaki, Takashi; Saito, Kei; Hamada, Tsuyoshi; Mizuno, Suguru; Miyabayashi, Koji; Mohri, Dai; Kogure, Hirofumi; Matsubara, Saburo; Yamamoto, Natsuyo; Hirano, Kenji; Ijichi, Hideaki; Tateishi, Keisuke; Tada, Minoru; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138655, Japan	Isayama, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	isayama-2im@h.u-tokyo.ac.jp					Sadeghi B, 2000, CANCER, V88, P358, DOI 10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O; Sasaki T, 2013, DIGEST ENDOSC, V25, P1, DOI 10.1111/j.1443-1661.2012.01319.x; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Kerscher AG, 2013, BRIT J CANCER, V108, P1432, DOI 10.1038/bjc.2013.82; Nakai Y, 2012, BRIT J CANCER, V106, P1934, DOI 10.1038/bjc.2012.183; Ishigami H, 2010, ANN ONCOL, V21, P67, DOI 10.1093/annonc/mdp260; Yamaguchi H, 2013, CANCER-AM CANCER SOC, V119, P3354, DOI 10.1002/cncr.28204; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Isayama H, 2012, GASTROINTEST ENDOSC, V75, P757, DOI 10.1016/j.gie.2011.11.035; Sasaki T, 2012, DIGEST ENDOSC, V24, P226, DOI 10.1111/j.1443-1661.2011.01208.x; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Blastik M, 2011, PANCREAS, V40, P478, DOI 10.1097/MPA.0b013e318205e332; DeWitt J, 2010, GASTROINTEST ENDOSC, V71, P260, DOI 10.1016/j.gie.2009.08.025; Glehen O, 2010, CANCER-AM CANCER SOC, V116, P5608, DOI 10.1002/cncr.25356; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Matharu G, 2011, BRIT J SURG, V98, P1225, DOI 10.1002/bjs.7586; Nakai Y, 2010, PANCREAS, V39, P989, DOI 10.1097/MPA.0b013e3181d91936; Nakai Y, 2009, ONCOLOGY-BASEL, V77, P300, DOI 10.1159/000259616; Nakai Y, 2012, J GASTROEN HEPATOL, V27, P1796, DOI 10.1111/j.1440-1746.2012.07241.x; Nakai Y, 2010, JPN J CLIN ONCOL, V40, P774, DOI 10.1093/jjco/hyq059; Stefanidis D, 2006, ANN ONCOL, V17, P189, DOI 10.1093/annonc/mdj013; Takahara Naminatsu, 2014, J Gastrointest Cancer, V45, P307, DOI 10.1007/s12029-014-9603-1; Takahara N, 2013, CANCER CHEMOTH PHARM, V71, P85, DOI 10.1007/s00280-012-1981-0; Takahara N, 2013, CANCER CHEMOTH PHARM, V72, P985, DOI 10.1007/s00280-013-2278-7; Thomassen I, 2013, PANCREAS, V42, P72, DOI 10.1097/MPA.0b013e31825abf8c; Yamada S, 2013, BRIT J SURG, V100, P1791, DOI 10.1002/bjs.9307	27	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	APR	2015	44	3					380	385				6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3SB	WOS:000350999700003		
J	Izumi, S; Nakamura, S; Mano, S; Akaki, S				Izumi, Sadanobu; Nakamura, Satoko; Mano, Shohei; Akaki, Shiro			Well Differentiation and Intact Smad4 Expression Are Specific Features of Groove Pancreatic Ductal Adenocarcinomas	PANCREAS			English	Article						groove pancreatic carcinoma; pancreatic ductal adenocarcinoma; duodenal adenocarcinoma; well differentiation; Smad4; immunohistochemistry	INTRAEPITHELIAL NEOPLASIA; DPC4 INACTIVATION; PROGRESSION; CARCINOMAS; PROFILE; LESIONS	Objectives: We aimed to select true groove pancreatic ductal adenocarcinomas (GPDACs) and define their specific features. Methods: We performed histopathologic and immunohistochemical comparisons of 6 GPDACs with 6 duodenal adenocarcinomas (DACs) and 24 conventional pancreatic ductal adenocarcinomas (cPDACs). Both groups were adjusted to ensure similar mean tumor size. Results: Representative loupe image showed prominent duodenal invasion and slight pancreatic invasion. Groove pancreatic ductal adenocarcinomas exhibited different mucins and cytokeratin profiles in DACs, but cPDACs and small branch pancreatic ducts had the same profiles. Histopathologic analysis of GPDACs showed a significantly higher incidence of duodenal invasion and well differentiation than cPDACs, although the incidences of lymph node metastasis, angiolymphatic invasion, and neural invasion were similar. Immunohistochemical analysis of GPDACs showed a significantly lower frequency of abnormal Smad4 immunolabeling, and fewer GPDAC samples exhibited abnormal immunolabeling forMUC1, p16, Smad4, and p53 than cPDACs. Conclusions: These results suggest that GPDACs arise from small branch pancreatic ducts around accessory pancreatic duct penetrating the groove and duodenum and are distinguishable from DACs. Molecular immunohistochemistry suggests the accumulation of genetic abnormalities during tumor progression is slow in comparison with cPDACs. Thus, the site of PDAC occurrence, such as the border or inner area of the pancreas head, may determine genetic progressivity.	[Izumi, Sadanobu] Kagawa Prefectural Cent Hosp, Dept Surg Gastroenterol, Takamatsu, Kagawa 7608557, Japan; [Nakamura, Satoko; Mano, Shohei] Kagawa Prefectural Cent Hosp, Dept Pathol, Takamatsu, Kagawa 7608557, Japan; [Akaki, Shiro] Kagawa Prefectural Cent Hosp, Dept Radiol, Takamatsu, Kagawa 7608557, Japan	Izumi, S (reprint author), Kagawa Prefectural Cent Hosp, 1-2-1 Asahimachi, Takamatsu, Kagawa 7608557, Japan.	s-izumi@chp-kagawa.jp					Aimoto T, 2006, PANCREAS, V33, P255, DOI 10.1097/01.mpa.0000236723.41919.90; HO SB, 1993, CANCER RES, V53, P641; Wilentz RE, 2000, AM J PATHOL, V156, P37, DOI 10.1016/S0002-9440(10)64703-7; Hruban RH, 2000, AM J PATHOL, V156, P1821, DOI 10.1016/S0002-9440(10)65054-7; Nagata K, 2007, J HEPATO-BILIARY-PAN, V14, P243, DOI 10.1007/s00534-006-1169-2; Lee MJ, 2003, MODERN PATHOL, V16, P403, DOI 10.1097/01.MP0000067683.84284.66; STOLTE M, 1982, HEPATO-GASTROENTEROL, V29, P198; Chen ZME, 2004, AM J SURG PATHOL, V28, P1352, DOI 10.1097/01.pas.0000135520.72965.50; Chu PG, 2000, MODERN PATHOL, V13, P962, DOI 10.1038/modpathol.3880175; Maitra A, 2003, MODERN PATHOL, V16, P902, DOI 10.1097/01.MP.0000086072.56290.FB; Wilentz RE, 2000, CANCER RES, V60, P2002; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Arai T, 1999, PATHOL INT, V49, P23, DOI 10.1046/j.1440-1827.1999.00820.x; Arikawa S, 2009, SUIZO, V24, P108; Badia BC, 2009, GASTROENTEROL HEPATO, V32, P22; Fukumoto M, 2010, NIHON RINSHO GEKAGAK, V71, P2134, DOI 10.3919/jjsa.71.2134; Funamizu N, 2009, HEPATO-GASTROENTEROL, V56, P1742; Gabata T, 2003, EUR RADIOL, V13, P1679, DOI 10.1007/s00330-002-1743-1; Hijioka S, 2009, SUIZO, V24, P155; Ishigami K, 2010, EUR J RADIOL, V74, pE96, DOI 10.1016/j.ejrad.2009.04.026; Izumi S, 2014, SURG TODAY, V44, P2058, DOI 10.1007/s00595-013-0804-1; Japan Pancreas Society, 2007, SUIZO, V22, pe49; Klimstra DS, 2005, HISTOLOGY PATHOLOGIS; Kuwatani Masaki, 2008, Nihon Shokakibyo Gakkai Zasshi, V105, P1061; Malde Deep J, 2011, JOP, V12, P598; Megro T, 2008, NIHON SHOKAKIBYO GAK, V105, P1078; Nakahara K, 2011, SUIZO, V26, P619; Nogita H, 2011, NIHON RINSHO GEKAGAK, V72, P1252; Ohnishi Y, 2008, KAN TAN SUI CHIRYO K, V6, P41; Oneyama M, 2012, SHOKAKIGEKA, V35, P117; Sato N, 2013, TAN TO SUI, V34, P297; Suda K, 2010, DIGEST SURG, V27, P137, DOI 10.1159/000286920; Tan CH, 2006, DIGEST DIS SCI, V51, P1294, DOI 10.1007/s10620-006-8052-5; Yamazawa K, 2007, SUIZO, V22, P65, DOI 10.2958/suizo.22.65	34	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	APR	2015	44	3					394	400				7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3SB	WOS:000350999700005		
J	Ohuchida, J; Chijiiwa, K; Imamura, N; Nagano, M; Hiyoshi, M				Ohuchida, Jiro; Chijiiwa, Kazuo; Imamura, Naoya; Nagano, Motoaki; Hiyoshi, Masahide			Randomized Controlled Trial for Efficacy of Nafamostat Mesilate in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis	PANCREAS			English	Article						ERCP; post-ERCP pancreatitis; nafamostat mesilate; prevention	HIGH-RISK PATIENTS; ERCP PANCREATITIS; PROSPECTIVE MULTICENTER; GABEXATE MESYLATE; BILIARY SPHINCTEROTOMY; THERAPEUTIC ERCP; CLINICAL-TRIAL; BILE-DUCT; COMPLICATIONS; ULINASTATIN	Objective: The objective of this study was to investigate whether prophylactic administration of nafamostat mesilate reduces the incidence of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP), its efficacy, and risk factors for PEP. Methods: Potential subjects comprised 876 patients who underwent ERCP between September 2008 and February 2011. Of these, 58 patients were excluded after meeting exclusion criteria, and 818 patients were randomized. Patients in the nafamostat mesilate group were administered 20 mg of nafamostat mesilate dissolved in 500 mL of 5% glucose solution, whereas the control group received 500 mL of 5% glucose solution alone, over 2 hours from the start of ERCP. Results: Post-ERCP pancreatitis occurred in 5.1% (41 patients) overall, with a significantly lower frequency in the nafamostat mesilate group (3.5%) than in the control group (6.7%; P - 0.0349). Analysis of the 322 patients who had undergone ERCP for the first time (n = 158 in the nafamostat mesilate group; n = 164 in the control group) found that PEP again significantly less frequently occurred in the nafamostat mesilate group (5.7%) than in the control group (13.4%; P = 0.0172). Conclusions: Our randomized controlled study suggested that short-term administration of nafamostat mesilate 20 mg may reduce the incidence of PEP.	[Ohuchida, Jiro; Chijiiwa, Kazuo; Imamura, Naoya; Nagano, Motoaki; Hiyoshi, Masahide] Miyazaki Univ, Sch Med, Dept Surg Oncol & Regulat Organ Funct, Miyazaki 8891692, Japan	Chijiiwa, K (reprint author), Miyazaki Univ, Sch Med, Dept Surg Oncol & Regulat Organ Funct, Miyazaki 8891692, Japan.	kazuochi@med.miyazaki-u.ac.jp					Akizawa T, 1988, HINYOKIKA KIYO, V34, P176; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Park KT, 2011, PANCREAS, V40, P1215, DOI 10.1097/MPA.0b013e31822116d5; Andriulli A, 2000, GASTROINTEST ENDOSC, V51, P1, DOI 10.1016/S0016-5107(00)70377-4; Omata F, 2010, J GASTROENTEROL, V45, P885, DOI 10.1007/s00535-010-0234-4; Wang P, 2009, AM J GASTROENTEROL, V104, P31, DOI 10.1038/ajg.2008.5; Manes G, 2007, GASTROINTEST ENDOSC, V65, P982, DOI 10.1016/j.gie.2007.02.055; Andriulli A, 2007, GASTROINTEST ENDOSC, V65, P624, DOI 10.1016/j.gie.2006.10.030; Masci E, 2001, AM J GASTROENTEROL, V96, P417; AKIZAWA T, 1993, NEPHRON, V64, P376, DOI 10.1159/000187357; Artifon ELA, 2007, AM J GASTROENTEROL, V102, P2147, DOI 10.1111/j.1572-0241.2007.01378.x; Bailey AA, 2008, ENDOSCOPY, V40, P296, DOI 10.1055/s-2007-995566; Freeman ML, 2001, GASTROINTEST ENDOSC, V54, P425, DOI 10.1067/mge.2001.117550; Cheng CL, 2006, AM J GASTROENTEROL, V101, P139, DOI 10.1111/j.1572-0241.2006.00380.x; Yoo KS, 2011, PANCREAS, V40, P181, DOI 10.1097/MPA.0b013e3181f94d46; Lella F, 2004, GASTROINTEST ENDOSC, V59, P830, DOI 10.1016/S0016-5107(04)00363-3; Testoni PA, 2010, AM J GASTROENTEROL, V105, P1753, DOI 10.1038/ajg.2010.136; Murray B, 2003, GASTROENTEROLOGY, V124, P1786, DOI 10.1016/S0016-5085(03)00384-6; Sofuni A, 2011, CLIN GASTROENTEROL H, V9, P851, DOI 10.1016/j.cgh.2011.06.033; Meister T, 2011, ENDOSCOPY, V43, P331, DOI 10.1055/s-0030-1256194; Andriulli A, 2002, GASTROINTEST ENDOSC, V56, P488, DOI 10.1067/mge.2002.128130; FUJII S, 1981, BIOCHIM BIOPHYS ACTA, V661, P342, DOI 10.1016/0005-2744(81)90023-1; Elmunzer BJ, 2012, NEW ENGL J MED, V366, P1414, DOI 10.1056/NEJMoa1111103; Tarnasky PR, 1998, GASTROENTEROLOGY, V115, P1518, DOI 10.1016/S0016-5085(98)70031-9; Nambu T, 2011, SCAND J GASTROENTERO, V46, P109, DOI 10.3109/00365521.2010.521889; SMITHLINE A, 1993, GASTROINTEST ENDOSC, V39, P652; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; Loperfido S, 1998, GASTROINTEST ENDOSC, V48, P1, DOI 10.1016/S0016-5107(98)70121-X; IWAKI M, 1986, JPN J PHARMACOL, V41, P155, DOI 10.1254/jjp.41.155; Andriulli A, 2004, CLIN GASTROENTEROL H, V2, P713, DOI 10.1053/S1542-3565(04)00295-2; Ueki T, 2007, J GASTROENTEROL, V42, P161, DOI 10.1007/s00535-006-1986-8; Sofuni A, 2007, CLIN GASTROENTEROL H, V5, P1339, DOI 10.1016/j.cgh.2007.07.008; Cavallini G, 1996, NEW ENGL J MED, V335, P919, DOI 10.1056/NEJM199609263351302; Chen SY, 2010, PANCREAS, V39, P1231, DOI 10.1097/MPA.0b013e3181dc67e7; Choi CW, 2009, GASTROINTEST ENDOSC, V69, pE11, DOI 10.1016/j.gie.2008.10.046; Fazel A, 2003, GASTROINTEST ENDOSC, V57, P194; Fujishiro H, 2006, J GASTROEN HEPATOL, V21, P1065, DOI 10.1111/j.1440-1746.2006.04085.x; Keck T, 2001, SURGERY, V130, P175, DOI 10.1067/msy.2001.115827; Khoshbaten M, 2008, J GASTROEN HEPATOL, V23, pE11, DOI 10.1111/j.1440-1746.2007.05096.x; KINUGASA E, 1992, INT J ARTIF ORGANS, V15, P595; Kwon Yong Hwan, 2012, Korean J Gastroenterol, V59, P232; Lee TH, 2009, GASTROINTEST ENDOSC, V69, P444, DOI 10.1016/j.gie.2008.04.064; Masci E, 2003, AM J GASTROENTEROL, V98, P2182, DOI 10.1016/S0002-9270(03)00704-4; Montaño Loza A, 2007, Rev Esp Enferm Dig, V99, P330; Skshintala VS, 2013, ALIMENT PHARM THER, V38, P1325; Sotoudehmanesh R, 2007, AM J GASTROENTEROL, V102, P978, DOI 10.1111/j.1572-0241.2007.01165.x; Tsuchiya T, 2007, J HEPATO-BILIARY-PAN, V14, P302, DOI 10.1007/s00534-006-1147-8; Tsujino T, 2005, CLIN GASTROENTEROL H, V3, P376, DOI 10.1053/S1542-3565(04)00671-8; Xiong GS, 2006, BRAZ J MED BIOL RES, V39, P85, DOI 10.1590/S0100-879X2006000100010; Yoo JW, 2008, PANCREAS, V37, P366, DOI 10.1097/MPA.0b013e31817f528f; Zhang AF, 2010, CLIN MED J, V123, P2600	51	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	APR	2015	44	3					415	421				7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3SB	WOS:000350999700009		
J	Ohyama, H; Mikata, R; Ishihara, T; Tsuyuguchi, T; Sakai, Y; Sugiyama, H; Yasui, S; Ishii, K; Itoh, S; Nishikawa, T; Watanabe, Y; Yokosuka, O				Ohyama, Hiroshi; Mikata, Rintaro; Ishihara, Takeshi; Tsuyuguchi, Toshio; Sakai, Yuji; Sugiyama, Harutoshi; Yasui, Shin; Ishii, Kiyofumi; Itoh, Sadahiro; Nishikawa, Takao; Watanabe, Yuto; Yokosuka, Osamu			Efficacy of Stone Density on Noncontrast Computed Tomography in Predicting the Outcome of Extracorporeal Shock Wave Lithotripsy for Patients With Pancreatic Stones	PANCREAS			English	Article						chronic pancreatitis; pancreatic stone; attenuation values; abdominal pain; stone removal; extracorporeal shock wave lithotripsy	CHRONIC CALCIFIC PANCREATITIS; ENDOSCOPIC TREATMENT; DUCT STONES; REMOVAL; DISINTEGRATION; DRAINAGE; CALCULI; PAIN	Objectives: Patients with chronic pancreatitis are managed by extracorporeal shock wave lithotripsy (ESWL) for pancreatic stones. Stone density on noncontrast computed tomography (NCCT) is used to predict stone composition and fragility, but no report investigating the pancreatic stone density has been documented. We aimed to assess the usefulness of pancreatic stone density on NCCT in predicting the ESWL outcome. Methods: We evaluated 128 consecutive patients with pancreatic stones who underwent ESWL. Pancreatic stone density on NCCT was measured in Hounsfield units. Patients with complete stone removal were compared with those with incomplete stone removal. Patient characteristics; imaging findings, including stone density; and interventions were evaluated as potential predictors. The optimal cutoff value of variables to differentiate complete removal from incomplete removal was determined by receiver operating characteristic analysis. Results: Complete stone removal was achieved in 66 patients (51.6%). When the density threshold was set at 820.5 Hounsfield units, complete stone removal was achieved in 52 patients (78.8%) with lower-density stones. In multivariate analysis, single stone (P = 0.007) and lower-density stone (P < 0.001) revealed significant association with complete stone removal. Conclusions: The measurement of pancreatic stone density before therapy can help predict therapeutic outcomes.	[Ohyama, Hiroshi; Mikata, Rintaro; Ishihara, Takeshi; Tsuyuguchi, Toshio; Sakai, Yuji; Sugiyama, Harutoshi; Yasui, Shin; Ishii, Kiyofumi; Itoh, Sadahiro; Nishikawa, Takao; Watanabe, Yuto; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608677, Japan	Ohyama, H (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ward, Inohana1-8-1, Chiba 2608677, Japan.	h_ohyama227@yahoo.co.jp					American Diabetes Association, 2012, DIABETES CARE, V35, P564; Dumonceau JM, 2012, ENDOSCOPY, V44, P784, DOI 10.1055/s-0032-1309840; SCHNEIDER HT, 1994, AM J GASTROENTEROL, V89, P2042; Inui K, 2005, PANCREAS, V30, P26; Gupta NP, 2005, BJU INT, V95, P1285, DOI 10.1111/j.1464-410X.2005.05520.x; STEER ML, 1995, NEW ENGL J MED, V332, P1482, DOI 10.1056/NEJM199506013322206; Pareek G, 2005, UROLOGY, V66, P941, DOI 10.1016/j.urolog.2005.05.011; Parsi MA, 2010, PANCREAS, V39, P153, DOI 10.1097/MPA.0b013e3181bb1733; Brand B, 2000, AM J GASTROENTEROL, V95, P3428; Cahen DL, 2007, NEW ENGL J MED, V356, P676, DOI 10.1056/NEJMoa060610; DELHAYE M, 1992, GASTROENTEROLOGY, V102, P610; Nakada SY, 2000, UROLOGY, V55, P816, DOI 10.1016/S0090-4295(00)00518-5; Mitchell RMS, 2003, LANCET, V361, P1447, DOI 10.1016/S0140-6736(03)13139-X; El-Nahas AR, 2007, EUR UROL, V51, P1688, DOI 10.1016/j.eururo.2006.11.048; Cotton PB, 2010, GASTROINTEST ENDOSC, V71, P446, DOI 10.1016/j.gie.2009.10.027; Dumonceau JM, 2007, GUT, V56, P545, DOI 10.1136/gut.2006.096883; Dumonceau JM, 1996, GASTROINTEST ENDOSC, V43, P547, DOI 10.1016/S0016-5107(96)81583-5; Adamek HE, 1999, GUT, V45, P402; Seven G, 2012, GASTROINTEST ENDOSC, V75, P997, DOI 10.1016/j.gie.2012.01.014; Tadenuma H, 2005, CLIN GASTROENTEROL H, V3, P1128, DOI 10.1053/S1542-3565(05)00530-6; Karasawa Y, 2002, J GASTROENTEROL, V37, P369, DOI 10.1007/s005350200051; LANKISCH PG, 1995, PANCREAS, V10, P338, DOI 10.1097/00006676-199505000-00003; MCCULLOUGH EC, 1977, RADIOLOGY, V124, P99; Merrill JT, 2011, PANCREAS, V40, P1087, DOI 10.1097/MPA.0b013e3182207d05; Ohara H, 1996, AM J GASTROENTEROL, V91, P1388; Ouzaid I, 2012, BJU INT, V110, P438; Sasahira N, 2013, GASTROINTEST ENDOSC, V78, P925, DOI 10.1016/j.gie.2013.07.041; SCHNEIDER MU, 1985, ENDOSCOPY, V17, P8, DOI 10.1055/s-2007-1018444; SHERMAN S, 1991, GASTROINTEST ENDOSC, V37, P511, DOI 10.1016/S0016-5107(91)70818-3; Suzuki Y, 2013, PANCREAS, V42, P584, DOI 10.1097/MPA.0b013e31827308c8	30	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	APR	2015	44	3					422	428				7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3SB	WOS:000350999700010		
J	Ueki, T; Kawamoto, K; Otsuka, Y; Minoda, R; Maruo, T; Matsumura, K; Noma, E; Mitsuyasu, T; Otani, K; Aomi, Y; Yano, Y; Hisabe, T; Matsui, T; Ota, A; Iwashita, A				Ueki, Toshiharu; Kawamoto, Kenichiro; Otsuka, Yuichiro; Minoda, Ryohei; Maruo, Toru; Matsumura, Keiichiro; Noma, Eijiro; Mitsuyasu, Tomoko; Otani, Keisuke; Aomi, Yoshiaki; Yano, Yutaka; Hisabe, Takashi; Matsui, Toshiyuki; Ota, Atsuko; Iwashita, Akinori			Prevalence and Clinicopathological Features of Autoimmune Pancreatitis in Japanese Patients With Inflammatory Bowel Disease	PANCREAS			English	Article						autoimmune pancreatitis; type 2 autoimmune pancreatitis; inflammatory bowel disease; Crohn disease; ulcerative colitis	LYMPHOPLASMACYTIC SCLEROSING PANCREATITIS; ULCERATIVE-COLITIS; CROHNS-DISEASE; DIAGNOSTIC-CRITERIA; EXTRAPANCREATIC LESIONS; CLINICAL-FEATURES; IMMUNOGLOBULIN G4; CONSENSUS; EPIDEMIOLOGY; ASSOCIATION	Objectives: The purpose of this study was to clarify the clinicopathological characteristics of autoimmune pancreatitis (AIP) in Japanese patients with inflammatory bowel disease (IBD). Methods: The clinicopathological findings of 7 patients with IBD whose definite AIP was diagnosed in our hospital according to the International Consensus Diagnostic Criteria were reviewed. Results: Five (0.5%) of 961 patients with ulcerative colitis (UC) and 2 (0.3%) of 790 patients with Crohn disease had AIP. All of 7 patients whose AIP was diagnosed were type 2. The rate of elevated values of serum immunoglobulin G4 was 0%. Most patients with the diagnosis of IBD preceded that of AIP, and disease activity of IBD were active. Granulocyte epithelial lesion is similar to the cryptitis seen in colonic tissue of UC. All of 7 patients were given corticosteroids, immunomodulators, and/or biological agents for IBD. One patient had a recurrence. Conclusions: The frequency of AIP in Japanese patients with IBD was low. All cases were type 2 and responded well to corticosteroids, immunomodulators, and biological agents. Autoimmune pancreatitis in UC patients may be an extraintestinal manifestation of UC.	[Ueki, Toshiharu; Kawamoto, Kenichiro; Otsuka, Yuichiro; Minoda, Ryohei; Maruo, Toru; Matsumura, Keiichiro; Noma, Eijiro; Mitsuyasu, Tomoko; Otani, Keisuke; Aomi, Yoshiaki; Yano, Yutaka; Hisabe, Takashi; Matsui, Toshiyuki] Fukuoka Univ, Chikushi Hosp, Dept Gastroenterol, Fukuoka 8188502, Japan; [Ota, Atsuko; Iwashita, Akinori] Fukuoka Univ, Chikushi Hosp, Dept Pathol, Fukuoka 8188502, Japan	Ueki, T (reprint author), Fukuoka Univ, Chikushi Hosp, Dept Gastroenterol, 1-1-1 Zokumyoin, Fukuoka 8188502, Japan.	tosiueki@fukuoka-u.ac.jp					Okazaki K, 2006, J GASTROENTEROL, V41, P626, DOI 10.1007/s00535-006-1868-0; Kiriyama S, 2010, J HEPATO-BIL-PAN SCI, V17, P24, DOI 10.1007/s00534-009-0214-3; Frulloni L, 2009, AM J GASTROENTEROL, V104, P2288, DOI 10.1038/ajg.2009.327; Barthet M, 1999, AM J GASTROENTEROL, V94, P2141; Zamboni G, 2004, VIRCHOWS ARCH, V445, P552, DOI 10.1007/s00428-004-1140-z; KAWAGUCHI K, 1991, HUM PATHOL, V22, P387, DOI 10.1016/0046-8177(91)90087-6; Ito T, 2007, J GASTROENTEROL, V42, P50, DOI 10.1007/s00535-007-2051-y; Maire F, 2011, AM J GASTROENTEROL, V106, P151, DOI 10.1038/ajg.2010.314; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; KARCH FE, 1975, JAMA-J AM MED ASSOC, V234, P1236, DOI 10.1001/jama.234.12.1236; Kamisawa T, 2011, PANCREAS, V40, P809, DOI 10.1097/MPA.0b013e3182258a15; Song TJ, 2012, J GASTROEN HEPATOL, V27, P700, DOI 10.1111/j.1440-1746.2011.06934.x; Sandanayake NS, 2009, CLIN GASTROENTEROL H, V7, P1089, DOI 10.1016/j.cgh.2009.03.021; Hart PA, 2013, GUT, V62, P1771, DOI 10.1136/gutjnl-2012-303617; Loftus EV, 2007, CLIN GASTROENTEROL H, V5, P1383, DOI 10.1016/j.cgh.2007.10.016; Chari ST, 2010, PANCREAS, V39, P549, DOI 10.1097/MPA.0b013e3181e4d9e5; Mizuno N, 2009, J GASTROENTEROL, V44, P742, DOI 10.1007/s00535-009-0062-6; Yang SK, 2008, INFLAMM BOWEL DIS, V14, P542, DOI 10.1002/ibd.20310; Broide E, 2011, J PEDIATR GASTR NUTR, V52, P714, DOI 10.1097/MPG.0b013e3182065cad; Navaneethan U, 2010, INFLAMM BOWEL DIS, V16, P1598, DOI 10.1002/ibd.21219; Asakura K, 2009, J GASTROENTEROL, V44, P659, DOI 10.1007/s00535-009-0057-3; Ravi K, 2009, INFLAMM BOWEL DIS, V15, P1326, DOI 10.1002/ibd.20898; Strehl JD, 2011, J CLIN PATHOL, V64, P237, DOI 10.1136/jcp.2010.085613; Notohara K, 2003, AM J SURG PATHOL, V27, P1119, DOI 10.1097/00000478-200308000-00009; Sah RP, 2010, GASTROENTEROLOGY, V139, P140, DOI 10.1053/j.gastro.2010.03.054; Deshpande V, 2011, AM J SURG PATHOL, V35, P26, DOI 10.1097/PAS.0b013e3182027717; Park SH, 2013, J CLIN GASTROENTEROL, V47, P520, DOI 10.1097/MCG.0b013e31827fd4a2; Kanno A, 2012, PANCREAS, V41, P835, DOI 10.1097/MPA.0b013e3182480c99; Rebours V, 2012, CLIN GASTROENTEROL H, V10, P91, DOI 10.1016/j.cgh.2011.09.008; Wada Y, 2003, DIS COLON RECTUM, V46, pS59, DOI 10.1097/01.DCR.0000087486.21981.C6; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Berre NL, 1995, J CLIN PATHOL, V48, P749; Gouni-Berthold I, 1999, HEPATO-GASTROENTEROL, V46, P1720; Ikeura T, 2012, INTERNAL MED, V51, P733, DOI 10.2169/internalmedicine.51.6859; Irie H, 1998, AM J ROENTGENOL, V170, P1323; Kusuda T, 2010, INTERNAL MED, V49, P2569, DOI 10.2169/internalmedicine.49.4165; Kuwata G, 2014, GUT LIVER, V8, P29, DOI [10.5009/gnl.2014.8.1.29, 10.5009/gn1.2014.8.1.29]; Moolsintong P, 2005, INFLAMM BOWEL DIS, V11, P1080, DOI 10.1097/01.MIB.0000186485.30623.ad; Naitoh I, 2009, INTERNAL MED, V48, P2003, DOI 10.2169/internalmedicine.48.2695; Ohara H, 2005, PANCREAS, V31, P232, DOI 10.1097/01.mpa.0000175178.85786.1d; Oishi Y, 2004, J GASTROENTEROL, V39, P26, DOI 10.1007/s00535-003-1241-5; RACHMILEWITZ D, 1989, BRIT MED J, V298, P82; Yao T, 2000, DIS COLON RECTUM, V43, pS85, DOI 10.1007/BF02237231	43	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	APR	2015	44	3					434	440				7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3SB	WOS:000350999700012		
J	Shimizu, Y; Yamaue, H; Maguchi, H; Yamao, K; Hirono, S; Osanai, M; Hijioka, S; Kanemitsu, Y; Sano, T; Senda, Y; Bhatia, V; Yanagisawa, A				Shimizu, Yasuhiro; Yamaue, Hiroki; Maguchi, Hiroyuki; Yamao, Kenji; Hirono, Seiko; Osanai, Manabu; Hijioka, Susumu; Kanemitsu, Yukihide; Sano, Tsuyoshi; Senda, Yoshiki; Bhatia, Vikram; Yanagisawa, Akio			Validation of a Nomogram for Predicting the Probability of Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasm in 180 Pancreatic Resection Patients at 3 High-Volume Centers	PANCREAS			English	Article						IPMN; nomogram; external validation; multicenter	INTERNATIONAL CONSENSUS GUIDELINES; TERM-FOLLOW-UP; CANCER RECURRENCE; COLORECTAL-CANCER; MALIGNANCY; DUCT; SURVIVAL; IPMN; ADENOCARCINOMA; EXPERIENCE	Objective: We previously published a nomogram for prediction of carcinoma in patients with intraductal papillary mucinous neoplasm (IPMN). The objective of the current study was to validate this nomogram in an external cohort of patients at multiple institutions. Methods: The clinical details of 180 patients with IPMN who underwent a pancreatic resection at 3 hospitals were collected. Four significant predictive factors (sex, lesion type, nodule height, and pancreatic juice cytology) were analyzed. Results: Of the 180 patients, 66 (36.7%) had a main pancreatic duct-type IPMN and 114 (63.3%) had a branch pancreatic duct-type IPMN. The final pathological diagnosis was benign IPMN in 95 (52.8%) patients and malignant IPMN in 85 (47.2%) patients. The area under the receiver operating characteristic curve for the model was 0.760. The area under the receiver operating characteristic curve of the IPMN nomogram for prediction of malignancy was 0.747 in main pancreatic duct-type IPMN and 0.752 in branch pancreatic duct-type IPMN. The sensitivity and specificity of the model were 80.0% and 57.9%, respectively, when the predictive probability of more than 10% was used to indicate the presence of carcinoma. Conclusions: This nomogram for predicting the probability of carcinoma in patients with IPMN was accurate in an external validation patient cohort.	[Shimizu, Yasuhiro; Sano, Tsuyoshi; Senda, Yoshiki] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Yamaue, Hiroki; Hirono, Seiko] Wakayama Med Univ, Sch Med, Dept Surg 2, Wakayama, Japan; [Maguchi, Hiroyuki; Osanai, Manabu] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan; [Hijioka, Susumu] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi 4648681, Japan; [Kanemitsu, Yukihide] Natl Canc Ctr, Div Colorectal Surg, Tokyo, Japan; [Bhatia, Vikram] Inst Liver & Biliary Sci, Dept Med Hepatol, Delhi, India; [Yanagisawa, Akio] Kyoto Prefectural Univ Med, Dept Pathol, Kyoto 602, Japan	Shimizu, Y (reprint author), Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	yshimizu@aichi-cc.jp					Sugiyama M, 2003, BRIT J SURG, V90, P1244, DOI 10.1002/bjs.4265; Hijioka S, 2014, PANCREAS, V43, P367, DOI 10.1097/MPA.0000000000000033; Jang JY, 2005, ANN SURG ONCOL, V12, P124, DOI 10.1245/ASO.2005.02.030; Kattan MW, 2008, ANN SURG, V247, P282, DOI 10.1097/SLA.0b013e31815ed67b; Yamaguchi K, 2011, PANCREAS, V40, P571, DOI 10.1097/MPA.0b013e318215010c; Weiser MR, 2008, J CLIN ONCOL, V26, P380, DOI 10.1200/JCO.2007.14.1291; Tanaka M, 2006, PANCREATOLOGY, V6, P17, DOI 10.1159/000090023; Karakiewicz PI, 2005, J UROLOGY, V173, P1930, DOI 10.1097/01.ju.0000158039.94467.5d; Terris B, 2000, AM J SURG PATHOL, V24, P1372, DOI 10.1097/00000478-200010000-00006; Salvia R, 2004, ANN SURG, V239, P678, DOI 10.1097/01.sla.0000124386.54496.15; [Anonymous], 2003, JAP PANCR SOC CLASS; HANLEY JA, 1982, RADIOLOGY, V143, P29; Shimizu Y, 2010, WORLD J SURG, V34, P2932, DOI 10.1007/s00268-010-0785-9; Sadakari Y, 2010, PANCREAS, V39, P232, DOI 10.1097/MPA.0b013e3181bab60e; Shimizu Y, 2013, PANCREAS, V42, P883, DOI 10.1097/MPA.0b013e31827a7b84; [Anonymous], 2011, JAP PANCR SOC CLASS; Nagai K, 2008, WORLD J SURG, V32, P271, DOI 10.1007/s00268-007-9281-2; Kanemitsu Y, 2004, BRIT J SURG, V91, P112, DOI 10.1002/bjs.4370; Yamaguchi K, 2005, PANCREATOLOGY, V5, P416, DOI 10.1159/000086555; Schmidt CM, 2007, ANN SURG, V246, P644, DOI 10.1097/SLA.0b013e318155a7b6; Hirono S, 2012, ANN SURG, V255, P517, DOI 10.1097/SLA.0b013e3182444231; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Sohn TA, 2004, ANN SURG, V239, P788, DOI 10.1097/01.sla.0000128306.90650.aa; Stephenson AJ, 2005, J CLIN ONCOL, V23, P7005, DOI 10.1200/JCO.2005.01.867; Brennan MF, 2004, ANN SURG, V240, P293, DOI 10.1097/01.sla.0000133125.85489.07; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Longnecker D, 2000, WHO CLASSIFICATION T, P237; Ohashi K, 1982, PROG DIG ENDOSC, V20, P348; Yang AD, 2007, SURGERY, V142, P529, DOI 10.1016/j.surg.2007.07.007	29	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	APR	2015	44	3					459	464				6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3SB	WOS:000350999700016		
J	Fujii, T; Yamada, S; Suenaga, M; Kanda, M; Takami, H; Sugimoto, H; Nomoto, S; Nakao, A; Kodera, Y				Fujii, Tsutomu; Yamada, Suguru; Suenaga, Masaya; Kanda, Mitsuro; Takami, Hideki; Sugimoto, Hiroyuki; Nomoto, Shuji; Nakao, Akimasa; Kodera, Yasuhiro			Preoperative Internal Biliary Drainage Increases the Risk of Bile Juice Infection and Pancreatic Fistula After Pancreatoduodenectomy A Prospective Observational Study	PANCREAS			English	Article						biliary drainage; endoscopic retrograde biliary drainage; endoscopic nasobiliary drainage; pancreatoduodenectomy; pancreatic fistula; ERBD	PROSPECTIVE-RANDOMIZED-TRIAL; SURGICAL SITE INFECTION; CONSECUTIVE PATIENTS; JAUNDICED PATIENTS; STENT PLACEMENT; CANCER; HEAD; CHOLANGIOCARCINOMA; COMPLICATIONS; OBSTRUCTION	Objectives: The objective of this study was to identify the most appropriate endoscopic biliary drainage method in patients with pancreatic head cancer. Methods: A prospectively collected database comprising 122 consecutive patients who underwent pancreatoduodenectomy, including 72 patients treated by endoscopic retrograde biliary drainage (ERBD) and 50 patients treated by endoscopic nasobiliary drainage (ENBD) procedures, was analyzed. Results: All bile cultures collected intraoperatively were positive in the ERBD group, and the positive rates of drainage fluid cultures on postoperative days 1, 3, and 5 and the incidence of postoperative abdominal abscess formation were significantly higher than those in the ENBD group. Moreover, ERBD was identified as an independent predictive factor for postoperative pancreatic fistula (POPF) formation (hazards ratio, 11.81; P < 0.001). The receiver operating characteristic curve analysis for the preoperative drainage period in the ERBD group revealed that the determined cutoff level for the onset of POPF was 29 days. Conclusions: Endoscopic retrograde biliary drainage resulted in more frequent postoperative complications, including POPF, compared with ENBD. Postoperative pancreatic fistula is more likely to occur if the ERBD period exceeds 1 month in patients scheduled to undergo pancreatoduodenectomy.	[Fujii, Tsutomu; Yamada, Suguru; Suenaga, Masaya; Kanda, Mitsuro; Takami, Hideki; Sugimoto, Hiroyuki; Nomoto, Shuji; Nakao, Akimasa; Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi 4668550, Japan	Fujii, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	fjt@med.nagoya-u.ac.jp					Nagai S, 2011, ANN SURG ONCOL, V18, P2329, DOI 10.1245/s10434-011-1604-8; Kloek JJ, 2010, J GASTROINTEST SURG, V14, P119, DOI 10.1007/s11605-009-1009-1; Singhirunnusorn J, 2013, LANGENBECK ARCH SURG, V398, P295, DOI 10.1007/s00423-012-1000-2; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Nagino M, 2008, J HEPATO-BILIARY-PAN, V15, P25, DOI 10.1007/s00534-007-1277-7; Shigeta H, 2002, LANGENBECK ARCH SURG, V387, P117, DOI 10.1007/s00423-002-0301-2; Lee DWH, 2002, GASTROINTEST ENDOSC, V56, P361, DOI 10.1067/mge.2002.126886; Sugiura T, 2012, WORLD J SURG, V36, P2888, DOI 10.1007/s00268-012-1742-6; Cortes A, 2006, J AM COLL SURGEONS, V202, P93, DOI 10.1016/j.jamcollsurg.2005.09.006; Bassi C, 2010, ANN SURG, V252, P207, DOI 10.1097/SLA.0b013e3181e61e88; de Bellis M, 2012, CURR DRUG TARGETS, V13, P753; Sewnath ME, 2001, J AM COLL SURGEONS, V192, P726, DOI 10.1016/S1072-7515(01)00819-5; van der Gaag NA, 2009, J GASTROINTEST SURG, V13, P814, DOI 10.1007/s11605-008-0618-4; Kawai M, 2006, ANN SURG, V244, P1, DOI 10.1097/01.sla.0000218077.14035.a6; Heinrich S, 2008, ANN SURG, V248, P1014, DOI 10.1097/SLA.0b013e318190a6da; Sharma BC, 2005, ENDOSCOPY, V37, P439, DOI 10.1055/s-2005-861054; Kajiwara T, 2010, LANGENBECK ARCH SURG, V395, P707, DOI 10.1007/s00423-009-0547-z; van der Gaag NA, 2010, NEW ENGL J MED, V362, P129, DOI 10.1056/NEJMoa0903230; Kawashima H, 2013, ANN SURG, V257, P121, DOI 10.1097/SLA.0b013e318262b2e9; Evans DB, 2008, J CLIN ONCOL, V26, P3496, DOI 10.1200/JCO.2007.15.8634; Fujii T, 2012, ANN SURG ONCOL, V19, P176, DOI 10.1245/s10434-011-1901-2; Cavell LK, 2013, AM J GASTROENTEROL, V108, P1168, DOI 10.1038/ajg.2013.93; Isayama H, 2013, DIGEST ENDOSC, V25, P71, DOI 10.1111/den.12078; Isenberg G, 2002, GASTROINTEST ENDOSC, V56, P310, DOI 10.1067/mge.2002.126146; Itoi T, 2013, DIGEST ENDOSC, V25, P117, DOI 10.1111/den.12064; Jeong Young Wook, 2009, Korean J Gastroenterol, V54, P390; Kanda M, 2011, BRIT J SURG, V98, P268, DOI 10.1002/bjs.7305; Mezhir JJ, 2009, J GASTROINTEST SURG, V13, P2163, DOI 10.1007/s11605-009-1046-9; NAKANO T, 1988, HEPATOLOGY, V8, P1560, DOI 10.1002/hep.1840080615; Okabayashi T, 2009, HEPATO-GASTROENTEROL, V56, P519; Povoski SP, 1999, J GASTROINTEST SURG, V3, P496, DOI 10.1016/S1091-255X(99)80103-6; TRAVERSO LW, 1987, J SURG RES, V43, P220, DOI 10.1016/0022-4804(87)90074-6; Vaccaro MI, 1996, INT J PANCREATOL, V19, P49	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-3177	1536-4828		PANCREAS	Pancreas	APR	2015	44	3					465	470				6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD3SB	WOS:000350999700017		
J	Deng, YH; Wu, D; Tachibana, H; Cheng, XJ				Deng, Yihong; Wu, Duo; Tachibana, Hiroshi; Cheng, Xunjia			Molecular cloning and expression of phosphoglycerate dehydrogenase and phosphoserine aminotransferase in the serine biosynthetic pathway from Acanthamoeba castellanii	PARASITOLOGY RESEARCH			English	Article						Acanthamoeba castellanii; Phosphoglycerate dehydrogenase; Phosphoserine aminotransferase; Serine biosynthetic pathway	ENTAMOEBA-HISTOLYTICA; 3-PHOSPHOGLYCERATE DEHYDROGENASE; PHOSPHORYLATED PATHWAY; METABOLIC PATHWAYS; AGENTS; INHIBITION; ATTACHMENT; POSSESSES; CYSTEINE; GLASS	Free-living amoebae of the genus Acanthamoeba are widespread protozoans that can cause serious infectious diseases. This study characterised phosphoglycerate dehydrogenase (PGDH) and phosphoserine aminotransferase (PSAT) in the phosphorylated serine biosynthetic pathway of Acanthamoeba castellanii. The PGDH gene encodes a protein of 442 amino acids with a calculated molecular weight of 47.7 kDa and an isoelectric point (pI) of 7.64. Meanwhile, the PSAT gene encodes a protein of 394 amino acids with a calculated molecular weight of 43.8 kDa and a pI of 5.80. Confocal microscopy suggests that PGDH is mainly diffused in the cytoplasm, whereas PSAT is located in the inner part of the cell membrane. The messenger RNA (mRNA) expression levels of PGDH and PSAT vary depending on growth state under consecutive culture conditions. No significant changes in the mRNA expression levels of both PGDH and PSAT occur after the incubation of L-serine with Acanthamoeba. This result indicates that exogenous serine exerts no influence on the expression of these genes and that the so-called feedback inhibition of both PGDH and PSAT in Acanthamoeba differs from that in bacteria or other organisms. We propose that the enzymes in the phosphorylated serine biosynthetic pathway function in amoeba growth and proliferation.	[Deng, Yihong; Wu, Duo; Cheng, Xunjia] Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol & Parasitol, Shanghai 200032, Peoples R China; [Tachibana, Hiroshi] Tokai Univ, Sch Med, Dept Infect Dis, Isehara, Kanagawa 2591193, Japan	Cheng, XJ (reprint author), Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol & Parasitol, Shanghai 200032, Peoples R China.	xjcheng@shmu.edu.cn			Doctoral Fund of the Ministry of Education of China [20110071110042]; NSFC [81171594]; MEXT KAKENHI [23117009]	This work was supported by the Doctoral Fund of the Ministry of Education of China (20110071110042), NSFC (81171594) and MEXT KAKENHI (23117009). We are grateful to Ke Qiao from Shanghai Medical School, Fudan University, for sharing her excellent technical expertise in confocal microscopy.	Ali V, 2004, EUR J BIOCHEM, V271, P2670, DOI 10.1111/j.1432-1033.2004.04195.x; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Kobayashi T, 2012, J CLIN MICROBIOL, V50, P1606, DOI 10.1128/JCM.06461-11; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; MCKITRICK JC, 1980, J BACTERIOL, V141, P235; GILLIN FD, 1980, J PROTOZOOL, V27, P474, DOI 10.1111/j.1550-7408.1980.tb05402.x; Clarke DW, 2006, TRENDS PARASITOL, V22, P175, DOI 10.1016/j.pt.2006.02.004; Moon EK, 2009, MOL BIOCHEM PARASIT, V168, P43, DOI 10.1016/j.molbiopara.2009.06.005; Tabatabaie L, 2010, MOL GENET METAB, V99, P256, DOI 10.1016/j.ymgme.2009.10.012; Eldin HME, 2014, PARASITOL RES, V113, P1949, DOI 10.1007/s00436-014-3845-5; Baek JY, 2003, BIOCHEM J, V373, P191, DOI 10.1042/BJ20030144; Tey BT, 2000, J BIOTECHNOL, V79, P147, DOI 10.1016/S0168-1656(00)00223-6; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Ali V, 2006, MOL BIOCHEM PARASIT, V145, P71, DOI 10.1016/j.molbiopara.2005.09.008; GILLIN FD, 1981, EXP PARASITOL, V52, P9, DOI 10.1016/0014-4894(81)90055-2; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; SUGIMOTO E, 1968, J BIOL CHEM, V243, P2081; Basurko MJ, 1999, IUBMB LIFE, V48, P525, DOI 10.1080/152165499306630; Cabello-Vilchez AM, 2014, PARASITOL RES, V113, P755, DOI 10.1007/s00436-013-3705-8; Chavez-Munguia B, 2013, PARASITOL RES, V112, P1125, DOI 10.1007/s00436-012-3261-7; Cheng XJ, 2004, MOL BIOCHEM PARASIT, V138, P195, DOI 10.1016/j.molbiopara.2004.08.009; Saito K, 1997, PLANT MOL BIOL, V33, P359, DOI 10.1023/A:1005730725764; SASKI R, 1975, EUR J BIOCHEM, V51, P415, DOI 10.1111/j.1432-1033.1975.tb03941.x; Sifaoui I, 2013, PARASITOL RES, V112, P2825, DOI 10.1007/s00436-013-3453-9; SLAUGHTE.JC, 1968, BIOCHEM J, V109, P749; Vie N, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-14	26	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-0113	1432-1955		PARASITOL RES	Parasitol. Res.	APR	2015	114	4					1387	1395		10.1007/s00436-015-4317-2		9	Parasitology	Parasitology	CE0UV	WOS:000351523900013		
J	Wakiguchi, H; Hasegawa, S; Suzuki, Y; Kudo, K; Ichiyama, T				Wakiguchi, Hiroyuki; Hasegawa, Shunji; Suzuki, Yasuo; Kudo, Keiko; Ichiyama, Takashi			Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease	PEDIATRIC RESEARCH			English	Article							KAPPA-B ACTIVATION; GAMMA-GLOBULIN; IN-VITRO; MONOCYTES/MACROPHAGES; LYMPHOCYTES; SUBSETS; MARKER; SUSCEPTIBILITY; PROFILE	BACKGROUND: Kawasaki disease (KD) is an acute febrile illness associated with the development of vasculitis. Administration of intravenous immunoglobulin (IVIG) is the standard treatment for KD. However, IVIG treatment is not effective in approximately 15% of children with KD. Some reports have presented evidence of immunological responses in IVIG-resistant KD patients. We assessed the possibility that T-cell activation is a contributing mechanism underlying this phenomenon. METHODS: We analyzed human leukocyte antigen-DR (HLA-DR) expression on peripheral blood CD4(+) and CD8(+) T cells in 82 children with KD who were admitted to the hospital between October 2007 and February 2012. We compared the percentages of HLA-DR+ T cells among the CD4(+) T-cell and CD8(+) T-cell populations for the IVIG-effective and IVIG-resistant groups. RESULTS: Among the 82 subjects, 51 had IVIG-effective KD and 31 children had IVIG-resistant KD. The percentages of HLA-DR+ T cells among the CD4(+) T-cell and CD8(+) T-cell populations in the IVIG-effective group were significantly lower than those in the IVIG-resistant group. CONCLUSION: Our results suggest that increased T-cell HLA-DR expression is associated with IVIG resistance in KD patients, indicating that HLA-DR expression would be a useful tool for predicting IVIG responsiveness during KD pathogenesis.	[Wakiguchi, Hiroyuki; Hasegawa, Shunji; Suzuki, Yasuo; Kudo, Keiko; Ichiyama, Takashi] Yamaguchi Univ, Sch Med, Dept Pediat, Yamaguchi, Japan	Wakiguchi, H (reprint author), Yamaguchi Univ, Sch Med, Dept Pediat, Yamaguchi, Japan.	hiroyuki@yamaguchi-u.ac.jp					Abe J, 2008, J ALLERGY CLIN IMMUN, V122, P1008, DOI 10.1016/j.jaci.2008.09.011; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Burns JC, 2005, GENES IMMUN, V6, P438, DOI 10.1038/sj.gene.6364225; Brogan PA, 2008, CLIN EXP IMMUNOL, V151, P267, DOI 10.1111/j.1365-2249.2007.03567.x; Franco A, 2010, AUTOIMMUNITY, V43, P317, DOI 10.3109/08916930903405891; Matsubara T, 2005, CLIN EXP IMMUNOL, V141, P381, DOI 10.1111/j.1365-2249.2005.02821.x; Brown TJ, 2001, J INFECT DIS, V184, P940, DOI 10.1086/323155; Katayama K, 2000, CLIN EXP IMMUNOL, V121, P566, DOI 10.1046/j.1365-2249.2000.01321.x; Evans JH, 2011, EUR J IMMUNOL, V41, P1924, DOI 10.1002/eji.201041180; Ehara H, 2010, CELL IMMUNOL, V265, P57, DOI 10.1016/j.cellimm.2010.07.003; FURUSHO K, 1984, LANCET, V2, P1055; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Matsubara T, 1999, CLIN EXP IMMUNOL, V116, P554; Jia S, 2010, CLIN EXP IMMUNOL, V162, P131, DOI 10.1111/j.1365-2249.2010.04236.x; Reddy M, 2004, J IMMUNOL METHODS, V293, P127, DOI 10.1016/j.jim.2004.07.006; Burns JC, 2005, J INFECT DIS, V192, P344, DOI 10.1086/430953; Ichiyama T, 2004, INFLAMM RES, V53, P253, DOI 10.1007/s00011-004-1255-3; Kato H, 1996, CIRCULATION, V94, P1379; Viallard JF, 2001, CLIN EXP IMMUNOL, V125, P485, DOI 10.1046/j.1365-2249.2001.01623.x; Burns JC, 2007, NEW ENGL J MED, V356, P659, DOI 10.1056/NEJMp068268; FUJIWARA H, 1978, PEDIATRICS, V61, P100; FURUKAWA S, 1992, ARCH DIS CHILD, V67, P706; FURUKAWA S, 1991, CLIN EXP IMMUNOL, V86, P134; FURUKAWA S, 1991, J INFECT DIS, V163, P416; Ichiyama T, 2004, N-S ARCH PHARMACOL, V369, P428, DOI 10.1007/s00210-004-0877-x; Ichiyama T, 2001, CLIN IMMUNOL, V99, P373, DOI 10.1006/clim.2001.5026; Ichiyama T, 2005, RHEUMATOLOGY, V44, P314, DOI 10.1093/rheumatology/keh488; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; Shingadia D, 2001, PEDIATR RES, V50, P538, DOI 10.1203/00006450-200110000-00019; Sleeper LA, 2011, J PEDIATR-US, V158, P831, DOI 10.1016/j.jpeds.2010.10.031; Starska K, 2011, FOLIA HISTOCHEM CYTO, V49, P579, DOI 10.5603/FHC.2011.0081; Suzuki H, 2010, PEDIATR INT, V52, P785, DOI 10.1111/j.1442-200X.2010.03163.x; The Japan Kawasaki Disease Research Committee, 2002, DIAGN GUID KAW DIS; Tincati C, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/935425; Winchester R J, 1979, Adv Immunol, V28, P221	36	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	APR	2015	77	4					536	540		10.1038/pr.2015.12		5	Pediatrics	Pediatrics	CD8HK	WOS:000351335600006		
J	Wada, Y; Lonnerdal, B				Wada, Yasuaki; Loennerdal, Bo			Bioactive peptides released from in vitro digestion of human milk with or without pasteurization	PEDIATRIC RESEARCH			English	Article							HUMAN BETA-CASEIN; MOTHERS OWN MILK; CONVERTING-ENZYME; MASS-SPECTROMETRY; PUBLISHED EVIDENCE; STATISTICAL-MODEL; PRETERM INFANTS; LATER LIFE; PROTEIN; IDENTIFICATION	BACKGROUND: Pasteurized donor human milk (HM) serves as the best alternative for breast-feeding when availability of mother's milk is limited. Pasteurization is also applied to mother's own milk for very low birth weight infants, who are vulnerable to microbial infection. Whether pasteurization affects protein digestibility and therefore modulates the profile of bioactive peptides released from HM proteins by gastrointestinal digestion, has not been examined to date. METHODS: HM with and without pasteurization (62.5 degrees C for 30 min) were subjected to in vitro gastrointestinal digestion, followed by peptidomic analysis to compare the formation of bioactive peptides. RESULTS: Some of the bioactive peptides, such as caseinophosphopeptide homologues, a possible opioid peptide (or propeptide), and an antibacterial peptide, were present in undigested HM and showed resistance to in vitro digestion, suggesting that these peptides are likely to exert their bioactivities in the gastrointestinal lumen, or be stably transported to target organs. In vitro digestion of HM released a large variety of bioactive peptides such as angiotensin I-converting enzyme-inhibitory, antioxidative, and immunomodulatory peptides. Bioactive peptides were released largely in the same manner with and without pasteurization. CONCLUSION: Provision of pasteurized HM may be as beneficial as breast-feeding in terms of milk protein-derived bioactive peptides.	[Wada, Yasuaki; Loennerdal, Bo] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Wada, Yasuaki] Morinaga Milk Ind Co Ltd, Nutr Sci Inst, Zama, Japan	Lonnerdal, B (reprint author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	bllonnerdal@ucdavis.edu					Andersson Y, 2007, ACTA PAEDIATR, V96, P1445, DOI 10.1111/j.1651-2227.2007.00450.x; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Wada Y, 2014, J NUTR BIOCHEM, V25, P503, DOI 10.1016/j.jnutbio.2013.10.012; Tsopmo A, 2011, FOOD CHEM, V126, P1138, DOI 10.1016/j.foodchem.2010.11.146; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Owen CG, 2006, AM J CLIN NUTR, V84, P1043; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Ferranti P, 2004, J DAIRY RES, V71, P74, DOI 10.1017/S0022029903006599; Chatterton DEW, 2013, INT J BIOCHEM CELL B, V45, P1730, DOI 10.1016/j.biocel.2013.04.028; Quiros A, 2008, INT DAIRY J, V18, P279, DOI 10.1016/j.idairyj.2007.09.006; Hayes Maria, 2007, Biotechnology Journal, V2, P435, DOI 10.1002/biot.200700045; Pihlanto-Leppala A, 2000, J DAIRY RES, V67, P53, DOI 10.1017/S0022029999003982; Lonnerdal B, 2003, NUTR REV, V61, P295, DOI [10.1301/nr.2003.sept.295-305, 10.1031/nr.2003.sept.295-305]; Owen CG, 2003, BRIT MED J, V327, P1189, DOI 10.1136/bmj.327.7425.1189; Minervini F, 2003, APPL ENVIRON MICROB, V69, P5297, DOI 10.1128/AEM.69.9.5297-5305.2003; Molto-Puigmarti C, 2011, FOOD CHEM, V124, P697, DOI 10.1016/j.foodchem.2010.05.079; Miguel M, 2006, J DAIRY SCI, V89, P3352; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Akinbi H, 2010, J PEDIATR GASTR NUTR, V51, P347, DOI 10.1097/MPG.0b013e3181e07f0a; Wada Y, 2014, J AGR FOOD CHEM, V62, P4175, DOI 10.1021/jf501617s; MIGLIORESAMOUR D, 1988, EXPERIENTIA, V44, P188, DOI 10.1007/BF01941703; KOHMURA M, 1989, AGR BIOL CHEM TOKYO, V53, P2107; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Yokomizo A, 2002, FOOD SCI TECHNOL RES, V8, P357, DOI 10.3136/fstr.8.357; Panchaud A, 2012, J PROTEOMICS, V75, P3546, DOI 10.1016/j.jprot.2011.12.022; Kim YK, 1999, J DAIRY RES, V66, P431, DOI 10.1017/S0022029999003556; Hamprecht K, 2004, PEDIATR RES, V56, P529, DOI 10.1203/01.PDR.0000139483.35087.BE; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Dallas DC, 2013, J PROTEOME RES, V12, P2295, DOI 10.1021/pr400212z; Dziuba J, 1999, NAHRUNG, V43, P190, DOI 10.1002/(SICI)1521-3803(19990601)43:3<190::AID-FOOD190>3.3.CO;2-1; ASANO M, 1991, AGR BIOL CHEM TOKYO, V55, P825; Cossey V, 2013, NEONATOLOGY, V103, P170, DOI 10.1159/000345419; Hernandez-Ledesma B, 2007, INT DAIRY J, V17, P42, DOI 10.1016/j.idairyj.2005.12.012; Juillerat-Jeanneret L, 2011, J AGR FOOD CHEM, V59, P370, DOI 10.1021/jf102803a; Katz E, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-68; KOCH G, 1985, N-S ARCH PHARMACOL, V331, P351, DOI 10.1007/BF00500818; Ley SH, 2011, PEDIATR RES, V70, P278, DOI [10.1038/pr.2011.503, 10.1203/PDR.0b013e318224287a]; Lonnerdal B, 2014, AM J CLIN NUTR, V99, p712S, DOI 10.3945/ajcn.113.071993; Lönnerdal Bo, 2003, Am J Clin Nutr, V77, p1537S; Mauron J., 1990, J NUTR SCI VITAMINOL, V36, pS57; Tully D B, 2001, J Hum Lact, V17, P152, DOI 10.1177/089033440101700212; UKEDA H, 1992, NIPPON NOGEIK KAISHI, V66, P25	42	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	APR	2015	77	4					546	553		10.1038/pr.2015.10		8	Pediatrics	Pediatrics	CD8HK	WOS:000351335600008		
J	Kitagawa, N; Shinkai, M; Mochizuki, K; Usui, H; Miyagi, H; Nakamura, K; Tanaka, M; Tanaka, Y; Kusano, M; Ohtsubo, S				Kitagawa, Norihiko; Shinkai, Masato; Mochizuki, Kyoko; Usui, Hidehito; Miyagi, Hisayuki; Nakamura, Kaori; Tanaka, Mio; Tanaka, Yukichi; Kusano, Mitsuo; Ohtsubo, Seiji			Navigation using indocyanine green fluorescence imaging for hepatoblastoma pulmonary metastases surgery	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Hepatoblastoma; Navigation; Indocyanine green; Pediatric; Surgery; Metastasis	HEPATOCELLULAR-CARCINOMA; RESECTION; SURVIVAL	To achieve precise and sensitive detection of chemotherapy-resistant hepatoblastoma pulmonary metastases, we performed surgery using indocyanine green (ICG) fluorescence imaging navigation. Lung metastasectomies were performed in 10 patients aged from 1 to 11 years. ICG (0.5 mg/kg) was injected intravenously 24 h before the operation. After a thoracotomy had been performed, a 760-nm infrared ray was applied to the lung using a generator and the 830-nm evoked fluorescence was collected and visualized on a real-time display. In total, 250 fluorescence-positive lesions were extirpated in 37 operations. All of the pathologically positive lesions were clearly fluorescence positive. The diameter of the smallest detectable lesion was 0.062 mm. In two patients, there were 29 extirpated lesions that were pathologically proven not to be hepatoblastoma metastases. Although a problem of false positive remains, this method is very useful for the detection of small pulmonary metastases.	[Kitagawa, Norihiko; Shinkai, Masato; Mochizuki, Kyoko; Usui, Hidehito; Miyagi, Hisayuki; Nakamura, Kaori] Kanagawa Childrens Med Ctr, Dept Surg, Minami Ku, Yokohama, Kanagawa 2328555, Japan; [Tanaka, Mio; Tanaka, Yukichi] Kanagawa Childrens Med Ctr, Dept Pathol, Yokohama, Kanagawa 2328555, Japan; [Kusano, Mitsuo] Kushiro Rosai Hosp, Dept Surg, Kushiro, Hokkaido, Japan; [Ohtsubo, Seiji] Kushiro Rosai Hosp, Dept Oral & Maxillofacial Surg, Kushiro, Hokkaido, Japan	Kitagawa, N (reprint author), Kanagawa Childrens Med Ctr, Dept Surg, Minami Ku, 2-138-4 Mutsukawa, Yokohama, Kanagawa 2328555, Japan.	norihikok@nifty.com					Gotoh K, 2009, J SURG ONCOL, V100, P75, DOI 10.1002/jso.21272; Zsíros József, 2010, J Clin Oncol, V28, P2584, DOI 10.1200/JCO.2009.22.4857; VONSCHWEINITZ D, 1995, J PEDIATR SURG, V30, P845, DOI 10.1016/0022-3468(95)90762-9; Ogata F, 2007, ANN PLAS SURG, V58, P652, DOI 10.1097/01.sap.0000250896.42800.a2; Nitori N, 2014, SURG TODAY, V44, P359, DOI 10.1007/s00595-013-0503-y; Ishizawa T, 2009, CANCER, V115, P2491, DOI 10.1002/cncr.24291; LANDSMAN MLJ, 1976, J APPL PHYSIOL, V40, P575; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Schaafsma BE, 2013, BRIT J SURG, V100, P1037, DOI 10.1002/bjs.9159; Noura S, 2010, ANN SURG ONCOL, V17, P144, DOI 10.1245/s10434-009-0711-2; Aoki T, 2008, WORLD J SURG, V32, P1763, DOI 10.1007/s00268-008-9620-y; BLACK CT, 1991, J PEDIATR SURG, V26, P1082, DOI 10.1016/0022-3468(91)90678-M; CRAANDIJK A, 1976, BRIT J OPHTHALMOL, V60, P377, DOI 10.1136/bjo.60.5.377; HUNTON DB, 1960, GASTROENTEROLOGY, V39, P713; Meyers RL, 2007, J PEDIATR SURG, V42, P2050, DOI 10.1016/j.jpedsurg.2007.08.030; PASSMORE SJ, 1995, MED PEDIATR ONCOL, V24, P58, DOI 10.1002/mpo.2950240113; Satou S, 2013, J GASTROENTEROL, V48, P1136, DOI 10.1007/s00535-012-0709-6; von Schweinitz D, 2011, SEMIN PEDIATR SURG, V21, P21	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	APR	2015	31	4					407	411		10.1007/s00383-015-3679-y		5	Pediatrics; Surgery	Pediatrics; Surgery	CD9RB	WOS:000351434600013		
J	Nakao, A; Miki, T; Shimono, K; Oka, H; Numata, T; Kiyonaka, S; Matsushita, K; Ogura, H; Niidome, T; Noebels, JL; Wakamori, M; Imoto, K; Mori, Y				Nakao, Akito; Miki, Takafumi; Shimono, Ken; Oka, Hiroaki; Numata, Tomohiro; Kiyonaka, Shigeki; Matsushita, Kaori; Ogura, Hiroo; Niidome, Tetsuhiro; Noebels, Jeffrey L.; Wakamori, Minoru; Imoto, Keiji; Mori, Yasuo			Compromised maturation of GABAergic inhibition underlies abnormal network activity in the hippocampus of epileptic Ca2+ channel mutant mice, tottering	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Article						Ca(V)2.1 Ca2+ channel; tottering mice; Absence epilepsy; Hippocampal network activity; GABAergic maturation; Cl- homeostasis	GABA(A) RECEPTOR SUBUNITS; CALCIUM-CHANNEL; MESSENGER-RNAS; INTRACELLULAR CHLORIDE; PATTERNED STIMULATION; COTRANSPORTER KCC2; EXCITATORY ACTIONS; INTERICTAL SPIKES; ABSENCE EPILEPSY; RAT HIPPOCAMPUS	Cholinergically induced network activity is a useful analogue of theta rhythms involved in memory processing or epileptiform activity in the hippocampus, providing a powerful tool to elucidate the mechanisms of synchrony in neuronal networks. In absence epilepsy, although its association with cognitive impairments has been reported, the mechanisms underlying hippocampal synchrony remain poorly investigated. Here we simultaneously recorded electrical activities from 64 sites in hippocampal slices of Ca(V)2.1 Ca2+ channel mutant tottering (tg) mice, a well-established mouse model of spontaneous absence epilepsy, to analyze the spatiotemporal pattern of cholinergically induced hippocampal network activity. The cholinergic agonist carbachol induced oscillatory discharges originating from the CA3 region. In tg/tg mice, this hippocampal network activity was characterized by enhanced occupancy of discharges of relatively high frequency (6-10 Hz) compared to the wild type. Pharmacological analyses of slices, patch clamp electrophysiological characterization of isolated neurons, and altered patterns of hippocampal GABA(A) receptor subunit and Cl- transporter messenger RNA (mRNA) transcript levels revealed that this abnormality is attributable to a developmental retardation of GABAergic inhibition caused by immature intracellular Cl- regulation. These results suggest that the inherited Ca(V)2.1 Ca2+ channel mutation leads to developmental abnormalities in Cl- transporter expression and GABA(A) receptor compositions in hippocampal neurons and that compromised maturation of GABAergic inhibition contributes to the abnormal synchrony in the hippocampus of tg absence epileptic mice.	[Nakao, Akito; Miki, Takafumi; Numata, Tomohiro; Kiyonaka, Shigeki; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan; [Numata, Tomohiro; Kiyonaka, Shigeki; Mori, Yasuo] Kyoto Univ, Dept Technol & Ecol, Hall Global Environm Res, Kyoto 6068501, Japan; [Kiyonaka, Shigeki; Mori, Yasuo] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Shimono, Ken; Oka, Hiroaki] Panasonic Corp, Biosci Technol Dev Off, Kyoto 6190237, Japan; [Matsushita, Kaori; Imoto, Keiji] Natl Inst Physiol Sci, Div Neural Signaling, Dept Informat Physiol, Okazaki, Aichi 4448787, Japan; [Ogura, Hiroo] Eisai & Co Ltd, Prod Creat Headquarters, Tokyo 1128088, Japan; [Niidome, Tetsuhiro] Eisai Ltd, Neurosci Prod Creat Unit, Hatfield AL10 9SN, Herts, England; [Noebels, Jeffrey L.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wakamori, Minoru] Tohoku Univ, Grad Sch Dent, Dept Oral Biol, Sendai, Miyagi 9808575, Japan	Mori, Y (reprint author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan.	mori@sbchem.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Alpha MED Scientific, Inc.	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Society for the Promotion of Science. A.N. is a research fellow of the Japan Society for the Promotion of Science. We thank Alpha MED Scientific, Inc. for supporting the MED system and Dr. T. Manabe (University of Tokyo) for helpful advice.	Aldenkamp Albert, 2004, Epilepsia, V45, P54, DOI 10.1111/j.0013-9580.2004.33403.x; ANGELOTTI TP, 1993, J NEUROSCI, V13, P1418; POULTER MO, 1992, J NEUROSCI, V12, P2888; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Meador KJ, 2006, EPILEPSY RES, V68, P63, DOI 10.1016/j.eplepsyres.2005.09.023; Rajakulendran S, 2010, J PHYSIOL-LONDON, V588, P1905, DOI 10.1113/jphysiol.2009.186437; Mori Y, 2000, J NEUROSCI, V20, P5654; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Dzhala VI, 2003, J NEUROSCI, V23, P1840; Montgomery SM, 2007, P NATL ACAD SCI USA, V104, P14495, DOI 10.1073/pnas.0701826104; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Mehta AK, 1999, BRAIN RES REV, V29, P196, DOI 10.1016/S0165-0173(98)00052-6; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Jouvenceau A, 2001, LANCET, V358, P801, DOI 10.1016/S0140-6736(01)05971-2; Vertes RP, 1997, NEUROSCIENCE, V81, P893; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; Caddick SJ, 1999, J NEUROPHYSIOL, V81, P2066; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; NOEBELS JL, 1979, SCIENCE, V204, P1334, DOI 10.1126/science.572084; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; SUZUKI SS, 1987, ELECTROEN CLIN NEURO, V67, P348, DOI 10.1016/0013-4694(87)90123-4; Khan OI, 2010, NEUROBIOL DIS, V39, P362, DOI 10.1016/j.nbd.2010.05.002; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Qian J, 2000, J NEUROSCI, V20, P163; Cornaggia CM, 2006, EPILEPSIA, V47, P34, DOI 10.1111/j.1528-1167.2006.00685.x; Urrestarazu E, 2006, EPILEPSIA, V47, P1465, DOI 10.1111/j.1528-1167.2006.00618.x; Shin R, 2013, BIPOLAR DISORD, V15, P405, DOI 10.1111/bdi.12064; Caplan R, 2008, EPILEPSIA, V49, P1838, DOI 10.1111/j.1528-1167.2008.01680.x; OKEEFE J, 1976, EXP NEUROL, V51, P78, DOI 10.1016/0014-4886(76)90055-8; Kleen JK, 2010, ANN NEUROL, V67, P250, DOI 10.1002/ana.21896; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Williams JH, 1997, J NEUROPHYSIOL, V78, P2631; Oka H, 1999, J NEUROSCI METH, V93, P61, DOI 10.1016/S0165-0270(99)00113-2; Kowalczyk T, 2013, EUR J NEUROSCI, V37, P679, DOI 10.1111/ejn.12091; Marques CM, 2007, EPILEPSY BEHAV, V10, P477, DOI 10.1016/j.yebeh.2007.02.002; TRAUB RD, 1982, SCIENCE, V216, P745, DOI 10.1126/science.7079735; Sasaki S, 2006, J NEUROSCI, V26, P3056, DOI 10.1523/JNEUROSCI.5422-05.2006; Ballard TM, 2009, PSYCHOPHARMACOLOGY, V202, P207, DOI 10.1007/s00213-008-1357-7; Khazipov R, 2004, EUR J NEUROSCI, V19, P590, DOI 10.1111/j.0953-816X.2003.03152.x; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Austin JK, 2009, EPILEPSY BEHAV, V14, P3, DOI 10.1016/j.yebeh.2008.10.019; Ayata C, 2000, NEUROSCIENCE, V95, P639; Buzsáki G, 1983, Brain Res, V287, P139; GAMBARANA C, 1991, NEUROSCIENCE, V45, P423, DOI 10.1016/0306-4522(91)90238-J; Halász Péter, 2005, Ideggyogy Sz, V58, P21; HELEKAR SA, 1994, J NEUROPHYSIOL, V71, P1; JOHNSTON D, 1984, ANN NEUROL, V16, pS65, DOI 10.1002/ana.410160711; Kaja S, 2007, NEUROSCIENCE, V148, P115, DOI 10.1016/j.neuroscience.2007.03.055; Kleen J. K., 2012, JASPERS BASIC MECH E; LARSON J, 1993, BRAIN RES, V600, P97, DOI 10.1016/0006-8993(93)90406-D; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; Majak K, 2004, EPILEPSY BEHAV, V5, pS35, DOI 10.1016/j.yebeh.2003.11.012; Miki T, 2008, NEUROSCIENCE, V155, P31, DOI 10.1016/j.neuroscience.2008.05.028; NOEBELS JL, 1984, NATURE, V310, P409, DOI 10.1038/310409a0; Shimono K, 2000, J NEUROSCI, V20, P8462; SWANN JW, 1993, J NEUROSCI, V13, P4680; Tehrani MHJ, 1997, EPILEPSY RES, V28, P213, DOI 10.1016/S0920-1211(97)00058-2; Wakamori M, 1998, J BIOL CHEM, V273, P34857, DOI 10.1074/jbc.273.52.34857; Zwingman TA, 2001, J NEUROSCI, V21, P1169	66	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	APR	2015	467	4					737	752		10.1007/s00424-014-1555-6		16	Physiology	Physiology	CE0SM	WOS:000351516300011		
J	Biagini, G; D'Antuono, M; Inaba, Y; Kano, T; Ragsdale, D; Avoli, M				Biagini, Giuseppe; D'Antuono, Margherita; Inaba, Yuji; Kano, Toshiyuki; Ragsdale, David; Avoli, Massimo			Activity-dependent changes in excitability of perirhinal cortex networks in vitro	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Article						Amygdala	LONG-TERM DEPRESSION; VENTRAL HIPPOCAMPAL SLICES; GABA(B) RECEPTORS; OSCILLATORY ACTIVITY; RECOGNITION MEMORY; SPONTANEOUS DISCHARGES; TRANSMITTER RELEASE; PYRAMIDAL NEURONS; SYNAPTIC ACTIVITY; LASTING CHANGES	Rat brain slices comprising the perirhinal cortex (PC) and a portion of the lateral nucleus of the amygdala (LA), in standard medium, can generate synchronous oscillatory activity that is associated with action potential discharge and reflects the activation of glutamatergic and GABAergic receptors. We report here that similar synchronous oscillatory events are recorded in the PC in response to single-shock, electrical stimuli delivered in LA. In addition, we found that the latency of these responses progressively increased when the stimulus interval was varied from 10 to 1 s; for example, the response latency during stimuli delivered at 1 Hz was more than twofold longer than that seen during stimulation at 0.1 Hz. This prolongation in latency occurred after approximately 5 stimuli, attained a steady value after 24-35 stimuli, and recovered to control values 30 s after stimulation arrest. These frequency-dependent changes in latency continued to occur during NMDA receptor antagonism but weakened following application of GABA(A) and/or GABA(B) receptor blockers. Our findings identify a new type of short-term plasticity that is mediated by GABA receptor function and may play a role in decreasing neuronal network synchronization during repeated activation. We propose that this frequency-dependent adaptive mechanism influences the excitability of limbic networks, thus potentially controlling epileptiform synchronization.	[Biagini, Giuseppe; D'Antuono, Margherita; Inaba, Yuji; Kano, Toshiyuki; Ragsdale, David; Avoli, Massimo] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Ragsdale, David; Avoli, Massimo] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Ragsdale, David; Avoli, Massimo] McGill Univ, Dept Physiol, Montreal, PQ H3A 2B4, Canada; [Biagini, Giuseppe] Univ Modena & Reggio Emilia, Dipartimento Sci Biomed Metab & Neurosci, I-41125 Modena, Italy; [Inaba, Yuji] Shinshu Univ, Sch Med, Matsumoto, Nagano 3908621, Japan	Avoli, M (reprint author), McGill Univ, Montreal Neurol Inst, 3801 Rue Univ, Montreal, PQ H3A 2B4, Canada.	massimo.avoli@mcgill.ca	Biagini, Giuseppe/I-3227-2013	Biagini, Giuseppe/0000-0002-7130-2511	Canadian Institutes of Health Research (CIHR) [MOP8109]; Savoy Foundation	This study was supported by the Canadian Institutes of Health Research (CIHR), Grant MOP8109 and the Savoy Foundation.	Engelman HS, 2004, NAT REV NEUROSCI, V5, P135, DOI 10.1038/nrn1297; Kealy J, 2011, PROG NEUROBIOL, V93, P522, DOI 10.1016/j.pneurobio.2011.03.002; De Guzman P, 2004, NEUROSCIENCE, V123, P875, DOI 10.1016/j.neuroscience.2003.11.013; SUZUKI WA, 1993, J NEUROSCI, V13, P2430; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Avoli M, 2011, PROG NEUROBIOL, V95, P104, DOI 10.1016/j.pneurobio.2011.07.003; Cho K, 2000, NAT NEUROSCI, V3, P150; Gonzalez-Burgos G, 2009, J NEUROPHYSIOL, V101, P533, DOI 10.1152/jn.91161.2008; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Weintrob DL, 2007, BRAIN, V130, P1423, DOI 10.1093/brain/awm013; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; TRAUB RD, 1993, J PHYSIOL-LONDON, V461, P525; Avoli M, 2013, NEUROPHARMACOLOGY, V69, P37, DOI 10.1016/j.neuropharm.2012.06.044; Brenowitz S, 1998, NEURON, V20, P135, DOI 10.1016/S0896-6273(00)80441-9; Barbarosie M, 1997, J NEUROSCI, V17, P9308; de Curtis M, 1998, J NEUROSCI, V18, P7543; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Balasubramanian S, 2004, J BIOL CHEM, V279, P18840, DOI 10.1074/jbc.M313470200; Kano T, 2005, NEUROSCIENCE, V130, P1041, DOI 10.1016/j.neuroscience.2004.10.012; Massey PV, 2008, J NEUROSCI, V28, P7548, DOI 10.1523/JNEUROSCI.1935-08.2008; Kohl MM, 2010, ADV PHARMACOL, V58, P205, DOI 10.1016/S1054-3589(10)58009-8; Shi CJ, 1999, J COMP NEUROL, V406, P299, DOI 10.1002/(SICI)1096-9861(19990412)406:3<299::AID-CNE2>3.0.CO;2-9; Kaila K, 1997, J NEUROSCI, V17, P7662; Murray EA, 2012, HIPPOCAMPUS, V22, P1941, DOI 10.1002/hipo.22055; Suzuki WA, 1996, CURR OPIN NEUROBIOL, V6, P179, DOI 10.1016/S0959-4388(96)80071-7; Warburton EC, 2003, NEURON, V38, P987, DOI 10.1016/S0896-6273(03)00358-1; Paz R, 2013, CURR OPIN NEUROBIOL, V23, P381, DOI [10.1016/j.conb.2013.01.008, 10.1016/j.conb.2013.1.008]; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027; Ritz R, 1997, CURR OPIN NEUROBIOL, V7, P536, DOI 10.1016/S0959-4388(97)80034-7; CHURCH J, 1991, J NEUROSCI, V11, P3289; de Curtis M, 2004, PROG NEUROBIOL, V74, P101, DOI 10.1016/j.pneurobio.2004.08.005; Kelly ME, 1996, EPILEPSY RES, V26, P233, DOI 10.1016/S0920-1211(96)00056-3; Oswald AMM, 2009, J NEUROSCI, V29, P10321, DOI 10.1523/JNEUROSCI.1703-09.2009; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V542, P567, DOI 10.1113/jphysiol.2002.019059; ZOLAMORGAN S, 1993, J NEUROSCI, V13, P251; Barker GRI, 2006, J NEUROSCI, V26, P3561, DOI 10.1523/JNEUROSCI.3154-05.2006; Benini R, 2003, NEUROSCIENCE, V120, P75, DOI 10.1016/S0306-4522(03)00262-8; Biagini G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00130; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; Collins DR, 2001, J NEUROPHYSIOL, V85, P1661; D'Antuono M, 2001, HIPPOCAMPUS, V11, P662, DOI 10.1002/hipo.1081; Durand DM, 2010, PHILOS T R SOC B, V365, P2347, DOI 10.1098/rstb.2010.0050; Gloor P, 1997, TEMPORAL LOBE LIMBIC; GUTNICK MJ, 1979, ELECTROEN CLIN NEURO, V47, P329, DOI 10.1016/0013-4694(79)90284-0; Hamid E, 2014, J NEUROSCI, V34, P260, DOI 10.1523/JNEUROSCI.3633-12.2014; Heinemann U, 1986, Adv Neurol, V44, P641; JONES RSG, 1990, NEUROSCIENCE, V34, P657, DOI 10.1016/0306-4522(90)90172-Z; Jones RSG, 2005, J PHYSIOL-LONDON, V562, P107, DOI 10.1113/jphysiol.2004.076133; KONNERTH A, 1984, NATURE, V307, P69, DOI 10.1038/307069a0; McIntyre DC, 2000, EPILEPSY RES, V39, P191, DOI 10.1016/S0920-1211(99)00120-5; McIntyre DC, 2009, CAN J NEUROL SCI, V36, pS33; MCINTYRE DC, 1993, BRAIN RES, V624, P268, DOI 10.1016/0006-8993(93)90086-3; MURRAY EA, 1993, J NEUROSCI, V13, P4549; Papatheodoropoulos C, 2002, NEUROSCI LETT, V319, P17, DOI 10.1016/S0304-3940(01)02505-8; Papatheodoropoulos C, 2002, BRAIN RES BULL, V57, P187, DOI 10.1016/S0361-9230(01)00738-9; Park YY, 2006, NEURON, V49, P95, DOI 10.1016/j.neuron.2005.11.035; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; SQUIRE LR, 1993, BRAIN MECHANISMS OF PERCEPTION AND MEMORY: FROM NEURON TO BEHAVIOR, P219; VALIANTE TA, 1995, J NEUROSCI, V15, P6946; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; von Bohlen und Halbach O, 2002, NEUROSCI RES, V44, P91, DOI 10.1016/S0168-0102(02)00092-5	62	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	APR	2015	467	4					805	816		10.1007/s00424-014-1545-8		12	Physiology	Physiology	CE0SM	WOS:000351516300016		
J	Shibukawa, Y; Sato, M; Kimura, M; Sobhan, U; Shimada, M; Nishiyama, A; Kawaguchi, A; Soya, M; Kuroda, H; Katakura, A; Ichinohe, T; Tazaki, M				Shibukawa, Yoshiyuki; Sato, Masaki; Kimura, Maki; Sobhan, Ubaidus; Shimada, Miyuki; Nishiyama, Akihiro; Kawaguchi, Aya; Soya, Manabu; Kuroda, Hidetaka; Katakura, Akira; Ichinohe, Tatsuya; Tazaki, Masakazu			Odontoblasts as sensory receptors: transient receptor potential channels, pannexin-1, and ionotropic ATP receptors mediate intercellular odontoblast-neuron signal transduction	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Article						Dental pain; Dentinal sensitivity; Odontoblast; Orofacial pain; Trigeminal ganglion neuron; TRP channel	SODIUM-CALCIUM EXCHANGERS; HUMAN DENTAL-PULP; TRIGEMINAL GANGLION NEURONS; QUALITY-OF-LIFE; RAT ODONTOBLASTS; PURINERGIC NEUROTRANSMISSION; INTRADENTAL NERVES; ION-CHANNEL; FLUID-FLOW; TOOTH-PULP	Various stimuli induce pain when applied to the surface of exposed dentin. However, the mechanisms underlying dentinal pain remain unclear. We investigated intercellular signal transduction between odontoblasts and trigeminal ganglion (TG) neurons following direct mechanical stimulation of odontoblasts. Mechanical stimulation of single odontoblasts increased the intracellular free calcium concentration ([Ca2+](i)) by activating the mechanosensitive-transient receptor potential (TRP) channels TRPV1, TRPV2, TRPV4, and TRPA1, but not TRPM8 channels. In cocultures of odontoblasts and TG neurons, increases in [Ca2+](i) were observed not only in mechanically stimulated odontoblasts, but also in neighboring odontoblasts and TG neurons. These increases in [Ca2+](i) were abolished in the absence of extracellular Ca2+ and in the presence of mechanosensitive TRP channel antagonists. A pannexin-1 (ATP-permeable channel) inhibitor and ATP-degrading enzyme abolished the increases in [Ca2+](i) in neighboring odontoblasts and TG neurons, but not in the stimulated odontoblasts. G-protein-coupled P2Y nucleotide receptor antagonists also inhibited the increases in [Ca2+](i). An ionotropic ATP (P2X(3)) receptor antagonist inhibited the increase in [Ca2+](i) in neighboring TG neurons, but not in stimulated or neighboring odontoblasts. During mechanical stimulation of single odontoblasts, a connexin-43 blocker did not have any effects on the [Ca2+](i) responses observed in any of the cells. These results indicate that ATP, released from mechanically stimulated odontoblasts via pannexin-1 in response to TRP channel activation, transmits a signal to P2X(3) receptors on TG neurons. We suggest that odontoblasts are sensory receptor cells and that ATP released from odontoblasts functions as a neurotransmitter in the sensory transduction sequence for dentinal pain.	[Shibukawa, Yoshiyuki; Sato, Masaki; Kimura, Maki; Sobhan, Ubaidus; Nishiyama, Akihiro; Kawaguchi, Aya; Soya, Manabu; Tazaki, Masakazu] Tokyo Dent Coll, Dept Physiol, Tokyo 1010061, Japan; [Shimada, Miyuki] Tokyo Dent Coll, Dept Clin Oral Hlth Sci, Tokyo 1010061, Japan; [Nishiyama, Akihiro; Katakura, Akira] Tokyo Dent Coll, Dept Oral Med Oral & Maxillofacial Surg, Ichikawa 2728513, Japan; [Kawaguchi, Aya; Soya, Manabu; Kuroda, Hidetaka; Ichinohe, Tatsuya] Tokyo Dent Coll, Dept Dent Anesthesiol, Tokyo 1010061, Japan	Shibukawa, Y (reprint author), Tokyo Dent Coll, Dept Physiol, Tokyo 1010061, Japan.	yshibuka@tdc.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23592751/25861762/24792035]	This research was supported by a Grant-in-Aid (nos. 23592751/25861762/24792035) for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Adachi K, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-59; Andrew D, 2000, J PHYSIOL-LONDON, V529, P791, DOI 10.1111/j.1469-7793.2000.00791.x; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Tsumura M, 2010, J ENDODONT, V36, P668, DOI 10.1016/j.joen.2010.01.006; Liu X, 2012, J DENT RES, V91, P261, DOI 10.1177/0022034511431582; Weil A, 2005, MOL PHARMACOL, V68, P518, DOI 10.1124/mol.105.012146; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Lohman AW, 2014, FEBS LETT, V588, P1379, DOI 10.1016/j.febslet.2014.02.004; Magloire H, 2010, J OROFAC PAIN, V24, P335; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Son AR, 2009, J DENT RES, V88, P1014, DOI 10.1177/0022034509343413; Ceruti S, 2008, CELL CALCIUM, V43, P576, DOI 10.1016/j.ceca.2007.10.003; Peralvarez-Marin A, 2013, FEBS J, V280, P5471, DOI 10.1111/febs.12302; Alavi AM, 2001, J DENT RES, V80, P476; Allard B, 2000, J BIOL CHEM, V275, P25556, DOI 10.1074/jbc.M002327200; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Muramatsu T, 2013, MICROSC RES TECHNIQ, V76, P988, DOI 10.1002/jemt.22271; Renton T, 2003, J OROFAC PAIN, V17, P245; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Cui M, 2006, J NEUROSCI, V26, P9385, DOI 10.1523/JNEUROSCI.1246-06.2006; El Karim IA, 2011, PAIN, V152, P2211, DOI 10.1016/j.pain.2010.10.016; Shibukawa Y, 2003, J BONE MINER RES, V18, P30, DOI 10.1359/jbmr.2003.18.1.30; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Cunha-Cruz J, 2010, J AM DENT ASSOC, V141, P1097; Okumura R, 2005, ARCH HISTOL CYTOL, V68, P251, DOI 10.1679/aohc.68.251; Ikeda H, 2013, J DENT RES, V92, P371, DOI 10.1177/0022034513478430; Vongtau HO, 2011, NEUROSCIENCE, V193, P387, DOI 10.1016/j.neuroscience.2011.07.044; Tsumura M, 2012, CELL CALCIUM, V52, P124, DOI 10.1016/j.ceca.2012.05.002; de Oliveira BH, 2006, J OROFAC PAIN, V20, P297; Charoenlarp P, 2007, ARCH ORAL BIOL, V52, P625, DOI 10.1016/j.archoralbio.2006.12.014; Vongsavan N, 2007, ARCH ORAL BIOL, V52, P640, DOI 10.1016/j.archoralbio.2006.12.019; Sato M, 2013, J ENDODONT, V39, P779, DOI 10.1016/j.joen.2013.01.012; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Bond SR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00058; Brannstrom M., 1963, SENSORY MECH DENTINE, P73; Burnstock G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-69; Burnstock G, 2009, HDB EXP PHARM, V194, P333, DOI DOI 10.1007/978-3-540-79090-7_; Canadian Advisory Board on Dentin Hypersensitivity, 2003, J CAN DENT ASSOC, V69, P221; DeFalco J, 2010, BIOORG MED CHEM LETT, V20, P7076, DOI 10.1016/j.bmcl.2010.09.099; Gotoh Masamichi, 2002, Journal of Medical and Dental Sciences, V49, P43; Gysi A, 1900, BR J DENT SCI, V43, P865; Jiang J, 2002, ORAL SURG ORAL MED O, V94, P622, DOI 10.1067/moe.2002.128973; Kinnamon SC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00264; Kuroda H, 2012, NEUROREPORT, V23, P752, DOI 10.1097/WNR.0b013e3283568a29; Kuroda H, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-22; Lin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018068; Luo Y, 2007, J OROFAC PAIN, V21, P63; Magloire H, 2003, J DENT RES, V82, P542; Magloire H, 2011, PAIN, V152, P2191, DOI 10.1016/j.pain.2011.02.042; Rees J S, 2004, Int J Dent Hyg, V2, P64, DOI 10.1111/j.1601-5029.2004.00068.x; SESSLE BJ, 1987, J DENT RES, V66, P962, DOI 10.1177/00220345870660052201; Shibukawa Y, 2002, DENTIN/PULP COMPLEX, P105; Shibukawa Yoshiyuki, 1997, Bulletin of Tokyo Dental College, V38, P177; Tsumura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082233; Wang N, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0309-x; Xiang ZH, 1998, NEUROSCI LETT, V256, P105, DOI 10.1016/S0304-3940(98)00774-5	59	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	APR	2015	467	4					843	863		10.1007/s00424-014-1551-x		21	Physiology	Physiology	CE0SM	WOS:000351516300019		
J	Kitaoka, M; Naritomi, A; Hirakawa, Y; Kamiya, N; Goto, M				Kitaoka, Momoko; Naritomi, Ayaka; Hirakawa, Yuya; Kamiya, Noriho; Goto, Masahiro			Transdermal Immunization using Solid-in-oil Nanodispersion with CpG Oligodeoxynucleotide Adjuvants	PHARMACEUTICAL RESEARCH			English	Article						CpG oligodeoxynucleotide; solid-in-oil nanodispersion; transcutaneous immunization; transdermal drug delivery; vaccine	T-CELL RESPONSES; TRANSCUTANEOUS IMMUNIZATION; DENDRITIC CELLS; DRUG-DELIVERY; IMMUNE-RESPONSES; SKIN; DNA; TECHNOLOGY; LIPOSOMES; BARRIERS	Purpose Simple and noninvasive vaccine administration alternatives to injections are desired. A solid-in-oil (S/O) nanodispersion system was able to overcome skin barriers and induce an immune response; however, antibody levels remained low. We applied an immune potentiator CpG oligodeoxynucleotide (ODN), to enhance the immune response by controlling the T helper 1 (Th1)/T helper 2 (Th2) balance. Methods S/O nanodispersions containing ovalbumin (OVA) and CpG ODN (CpG-A or CpG-B) were characterized by size distribution analysis and a protein release test. The skin permeation of fluorescence-labeled OVA was observed by fluorescence microscopy. Antigen-specific IgG, IgG1, and IgG2a responses were measured by enzyme-linked immunosorbent assay. Results Co-encapsulation of CpG ODNs in S/O nanodispersions enhanced induction of OVA-specific IgG. S/O nanodispersion containing OVA and CpG-A had a smaller mean particle size and permeated the skin more efficiently. In contrast, CpG-B showed the highest protein release and induction of OVA-specific IgG. IgG subclass analysis revealed that OVA induced a Th2-dominant immune response, while the S/O nanodispersion containing CpG-A skewed the immune response toward a Th1-bias. Conclusions In combination with CpG ODN, the S/O nanodispersion system efficiently induced an antigen-specific antibody response. The Th1/Th2 immune balance could be controlled by the selection of CpG ODN type.	[Kitaoka, Momoko; Naritomi, Ayaka; Hirakawa, Yuya; Kamiya, Noriho; Goto, Masahiro] Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Fukuoka 8190395, Japan; [Kamiya, Noriho; Goto, Masahiro] Kyushu Univ, Ctr Future Chem, Fukuoka 8190395, Japan	Goto, M (reprint author), Kyushu Univ, Ctr Future Chem, Fukuoka 8190395, Japan.	m-goto@mail.cstm.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24226019]	This work was financed by a Grant-in-Aid for Scientific Research (S) 24226019 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. G.). We thank Professor Yoshiki Katayama for animal experiments.	Slutter B, 2011, J CONTROL RELEASE, V154, P123, DOI 10.1016/j.jconrel.2011.02.007; Diwan M, 2002, J CONTROL RELEASE, V85, P247, DOI 10.1016/S0168-3659(02)00275-4; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Jabbal-Gill I, 2010, J DRUG TARGET, V18, P771, DOI 10.3109/1061186X.2010.523790; Radford KJ, 2014, CURR OPIN IMMUNOL, V27, P26, DOI 10.1016/j.coi.2014.01.005; Lin L, 2004, EUR J IMMUNOL, V34, P1483, DOI 10.1002/eji.200324736; Klinman DM, 1999, VACCINE, V17, P19, DOI 10.1016/S0264-410X(98)00151-0; Mishra D, 2008, EUR J PHARM SCI, V33, P424, DOI 10.1016/j.ejps.2008.01.015; Rothenfusser S, 2004, BLOOD, V103, P2162, DOI 10.1182/blood-2003-04-1091; Ziegler A, 2009, BLOOD, V113, P3494, DOI 10.1182/blood-2008-08-175109; Illum L, 2002, DRUG DISCOV TODAY, V7, P1184, DOI 10.1016/S1359-6446(02)02529-1; Alexander A, 2012, J CONTROL RELEASE, V164, P26, DOI 10.1016/j.jconrel.2012.09.017; Roberts TL, 2005, J IMMUNOL, V174, P605; Combadiere B, 2011, HUM VACCINES, V7, P811, DOI 10.4161/hv.7.8.16274; Fonseca DE, 2009, ADV DRUG DELIVER REV, V61, P256, DOI 10.1016/j.addr.2008.12.007; Inoue J, 2005, PHARM RES, V22, P1627, DOI 10.1007/s11095-005-6834-7; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kitaoka M, 2014, MEDCHEMCOMM, V5, P20, DOI 10.1039/c3md00164d; Kitaoka M, 2013, INT J PHARMACEUT, V458, P334, DOI 10.1016/j.ijpharm.2013.10.006; Klinman Dennis M, 2004, Nat Rev Immunol, V4, P249, DOI 10.1038/nri1329; Lee MY, 2013, BMB REP, V46, P17, DOI 10.5483/BMBRep.2013.46.1.001; Li N, 2011, VACCINE, V29, P6179, DOI 10.1016/j.vaccine.2011.06.086; Mishra DK, 2013, EXPERT OPIN DRUG DEL, V10, P183, DOI 10.1517/17425247.2013.746660; Mishra N, 2008, INDIAN J BIOTECHNOL, V7, P283; Schattenberg D, 2000, EUR J IMMUNOL, V30, P2824, DOI 10.1002/1521-4141(200010)30:10<2824::AID-IMMU2824>3.0.CO;2-3; Seid RC, 2012, VACCINE, V30, P4349, DOI 10.1016/j.vaccine.2011.09.113; Sugita K, 2007, CLIN EXP IMMUNOL, V147, P176, DOI 10.1111/j.1365-2249.2006.03258.x; Tahara Y, 2010, CHEM COMMUN, V46, P9200, DOI 10.1039/c0cc03600e; Tahara Y, 2008, J CONTROL RELEASE, V131, P14, DOI 10.1016/j.jconrel.2008.07.015; Tahara Y, 2012, INT J PHARMACEUT, V438, P249, DOI 10.1016/j.ijpharm.2012.09.007; Vabulas RM, 2000, J IMMUNOL, V164, P2372	31	2	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-8741	1573-904X		PHARM RES-DORDR	Pharm. Res.	APR	2015	32	4					1486	1492		10.1007/s11095-014-1554-5		7	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	CD6AG	WOS:000351169800026		
J	Kimura, Y; Kasuga, S; Unno, M; Furusawa, T; Osoegawa, S; Sasaki, Y; Ohno, T; Wang-Otomo, ZY				Kimura, Yukihiro; Kasuga, Sachiko; Unno, Masashi; Furusawa, Takashi; Osoegawa, Shinsuke; Sasaki, Yuko; Ohno, Takashi; Wang-Otomo, Zheng-Yu			The roles of C-terminal residues on the thermal stability and local heme environment of cytochrome c' from the thermophilic purple sulfur bacterium Thermochromatium tepidum	PHOTOSYNTHESIS RESEARCH			English	Article						Cytochrome c '; Thermochromatium tepidum; Purple bacteria; Thermal stability; Differential scanning calorimetry; Resonance Raman spectroscopy	RESONANCE RAMAN-SPECTROSCOPY; RESOLUTION CRYSTAL-STRUCTURE; SPIN-STATE; PHOTOSYNTHETIC BACTERIUM; RHODOSPIRILLUM-RUBRUM; NITRIC-OXIDE; RHODOPSEUDOMONAS-PALUSTRIS; RHODOBACTER-CAPSULATUS; CHROMATIUM-VINOSUM; FERRICYTOCHROME C'	A soluble cytochrome (Cyt) c' from thermophilic purple sulfur photosynthetic bacterium Thermochromatium (Tch.) tepidum exhibits marked thermal tolerance compared with that from the closely related mesophilic counterpart Allochromatium vinosum. Here, we focused on the difference in the C-terminal region of the two Cyts c' and examined the effects of D131 and R129 mutations on the thermal stability and local heme environment of Cyt c' by differential scanning calorimetry (DSC) and resonance Raman (RR) spectroscopy. In the oxidized forms, D131K and D131G mutants exhibited denaturing temperatures significantly lower than that of the recombinant control Cyt c'. In contrast, R129K and R129A mutants denatured at nearly identical temperatures with the control Cyt c', indicating that the C-terminal D131 is an important residue maintaining the enhanced thermal stability of Tch. tepidum Cyt c'. The control Cyt c' and all of the mutants increased their thermal stability upon the reduction. Interestingly, D131K exhibited narrow DSC curves and unusual thermodynamic parameters in both redox states. The RR spectra of the control Cyt c' exhibited characteristic bands at 1,635 and 1,625 cm(-1), ascribed to intermediate spin (IS) and high spin (HS) states, respectively. The IS/HS distribution was differently affected by the D131 and R129 mutations and pH changes. Furthermore, R129 mutants suggested the lowering of their redox potentials. These results strongly indicate that the D131 and R129 residues play significant roles in maintaining the thermal stability and modulating the local heme environment of Tch. tepidum Cyt c'.	[Kimura, Yukihiro; Kasuga, Sachiko; Sasaki, Yuko; Ohno, Takashi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Unno, Masashi; Osoegawa, Shinsuke] Saga Univ, Grad Sch Sci & Engn, Dept Chem & Appl Chem, Saga 8408502, Japan; [Furusawa, Takashi; Wang-Otomo, Zheng-Yu] Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan	Kimura, Y (reprint author), Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Nada Ku, Kobe, Hyogo 6578501, Japan.	ykimura@people.kobe-u.ac.jp; wang@ml.ibaraki.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24570158]	This work was supported by Grants-in-aid for Scientific Research (C) (24570158) (Y.K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We appreciate the Instrument Center of the Institute for Molecular Science for assistance of DSC measurements.	AMBLER RP, 1981, P NATL ACAD SCI-BIOL, V78, P6854, DOI 10.1073/pnas.78.11.6854; Tateishi Y, 2011, BIOCHEMISTRY-US, V50, P2135, DOI 10.1021/bi1019572; STURTEVANT JM, 1987, ANNU REV PHYS CHEM, V38, P463, DOI 10.1146/annurev.pc.38.100187.002335; Sot B, 2003, J BIOL CHEM, V278, P32083, DOI 10.1074/jbc.M303958200; STREKAS TC, 1974, BIOCHIM BIOPHYS ACTA, V351, P237, DOI 10.1016/0005-2795(74)90186-X; Kimura Y, 2008, J BIOL CHEM, V283, P13867, DOI 10.1074/jbc.M800256200; Sekine F, 2012, PHOTOSYNTH RES, V111, P9, DOI 10.1007/s11120-011-9658-9; MADIGAN MT, 1984, SCIENCE, V225, P313, DOI 10.1126/science.225.4659.313; Tezcan FA, 1998, J AM CHEM SOC, V120, P13383, DOI 10.1021/ja982536e; MALTEMPO MM, 1974, J CHEM PHYS, V61, P2540, DOI 10.1063/1.1682376; Niwa S, 2014, NATURE, V508, P228, DOI 10.1038/nature13197; Kimura Y, 2009, J BIOL CHEM, V284, P93, DOI 10.1074/jbc.M806840200; Weiss R, 2006, CHEM REV, V106, P2550, DOI 10.1021/cr040416l; DESBOIS A, 1994, BIOCHIMIE, V76, P693, DOI 10.1016/0300-9084(94)90145-7; Benini S, 2008, J INORG BIOCHEM, V102, P1322, DOI 10.1016/j.jinorgbio.2008.01.017; CASTILLO MCG, 1994, ARCH BIOCHEM BIOPHYS, V315, P262, DOI 10.1006/abbi.1994.1498; COHEN DS, 1995, J AM CHEM SOC, V117, P1675, DOI 10.1021/ja00111a001; CUSANOVI.MA, 1973, J BIOL CHEM, V248, P822; CUSANOVI.MA, 1971, BIOCHIM BIOPHYS ACTA, V236, P238, DOI 10.1016/0005-2795(71)90171-1; DESBOIS A, 1981, BIOCHIM BIOPHYS ACTA, V671, P168, DOI 10.1016/0005-2795(81)90131-8; DOYLE ML, 1986, BIOCHEMISTRY-US, V25, P2509, DOI 10.1021/bi00357a034; EHRENBER.A, 1965, BIOCHIM BIOPHYS ACTA, V102, P333, DOI 10.1016/0926-6585(65)90122-6; EMPTAGE MH, 1977, BIOCHIM BIOPHYS ACTA, V495, P12, DOI 10.1016/0005-2795(77)90235-5; FINZEL BC, 1985, J MOL BIOL, V186, P627, DOI 10.1016/0022-2836(85)90135-4; Fujii S, 2013, BIOSCI BIOTECH BIOCH, V77, P1677, DOI 10.1271/bbb.130226; GIBSON QH, 1966, J BIOL CHEM, V241, P1969; Higuchi M, 2009, PHOTOSYNTH RES, V102, P77, DOI 10.1007/s11120-009-9492-5; Hirano Y, 2012, BIOCHEMISTRY-US, V51, P6556, DOI 10.1021/bi3005522; Hough MA, 2011, J MOL BIOL, V405, P395, DOI 10.1016/j.jmb.2010.10.035; Huston WM, 2006, BIOCHEMISTRY-US, V45, P4388, DOI 10.1021/bi052605j; KAMEN MD, 1973, P NATL ACAD SCI USA, V70, P1851, DOI 10.1073/pnas.70.6.1851; KASSNER RJ, 1985, BIOCHIM BIOPHYS ACTA, V831, P155, DOI 10.1016/0167-4838(85)90163-3; Kekilli D, 2014, ACTA CRYSTALLOGR D, V70, P1289, DOI 10.1107/S1399004714004039; KITAGAWA T, 1977, BIOCHIM BIOPHYS ACTA, V495, P1, DOI 10.1016/0005-2795(77)90234-3; Kobayashi M, 2005, B CHEM SOC JPN, V78, P2164, DOI 10.1246/bcsj.78.2164; Kobayashi M, 2005, BIOSCI BIOTECH BIOCH, V69, P1130, DOI 10.1271/bbb.69.1130; LAMAR GN, 1981, J AM CHEM SOC, V103, P4405, DOI 10.1021/ja00405a020; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; Liu LJ, 2002, ACTA CRYSTALLOGR D, V58, P1085, DOI 10.1107/S0907444902006261; MALTEMPO MM, 1976, Q REV BIOPHYS, V9, P181; MEYER TE, 1982, ADV PROTEIN CHEM, V35, P105, DOI 10.1016/S0065-3233(08)60469-6; MEYER TE, 1986, BIOCHEMISTRY-US, V25, P1383, DOI 10.1021/bi00354a029; Moore G.R., 1990, CYTOCHROMES C EVOLUT; MOULIS JM, 1993, ARCH BIOCHEM BIOPHYS, V305, P186, DOI 10.1006/abbi.1993.1409; NAGAI K, 1980, J MOL BIOL, V136, P271, DOI 10.1016/0022-2836(80)90374-5; Othman S, 1996, BIOCHEMISTRY-US, V35, P9224, DOI 10.1021/bi952818g; Pixton DA, 2009, J AM CHEM SOC, V131, P4846, DOI 10.1021/ja809587q; Ramirez LM, 2003, J CHEM CRYSTALLOGR, V33, P413, DOI 10.1023/A:1024286215637; RAWLINGS J, 1977, BIOCHEMISTRY-US, V16, P1725, DOI 10.1021/bi00627a032; REN Z, 1993, J MOL BIOL, V234, P433, DOI 10.1006/jmbi.1993.1597; RUBINOW SC, 1984, BIOCHEMISTRY-US, V23, P2590, DOI 10.1021/bi00307a008; Shibata N, 1998, J MOL BIOL, V284, P751, DOI 10.1006/jmbi.1998.2190; SPIRO TG, 1990, COORDIN CHEM REV, V100, P541, DOI 10.1016/0010-8545(90)85019-O; SPIRO TG, 1974, J AM CHEM SOC, V96, P338, DOI 10.1021/ja00809a004; Tahirov TH, 1996, J MOL BIOL, V259, P467, DOI 10.1006/jmbi.1996.0333; TANIGUCHI S, 1963, BIOCHIM BIOPHYS ACTA, V74, P438, DOI 10.1016/0006-3002(63)91387-8; TERAOKA J, 1980, J PHYS CHEM-US, V84, P1928, DOI 10.1021/j100452a013; Watson AJ, 2005, PHOTOSYNTH RES, V86, P81, DOI 10.1007/s11120-005-4047-x; WEBER PC, 1982, BIOCHEMISTRY-US, V21, P5116, DOI 10.1021/bi00264a001; Yoshimura T, 1996, BBA-PROTEIN STRUCT M, V1292, P39, DOI 10.1016/0167-4838(95)00187-5; Yu LJ, 2013, PHOTOSYNTH RES, V118, P249, DOI 10.1007/s11120-013-9922-2	61	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0166-8595	1573-5079		PHOTOSYNTH RES	Photosynth. Res.	APR	2015	124	1					19	29		10.1007/s11120-014-0069-6		11	Plant Sciences	Plant Sciences	CE0TI	WOS:000351519000003		
J	Fukayama, H; Koga, A; Hatanaka, T; Misoo, S				Fukayama, Hiroshi; Koga, Atsushi; Hatanaka, Tomoko; Misoo, Shuji			Small subunit of a cold-resistant plant, timothy, does not significantly alter the catalytic properties of Rubisco in transgenic rice	PHOTOSYNTHESIS RESEARCH			English	Article						CO2 fixation; Cold-resistant plant; Rice; Rubisco; Timothy	PHOTOSYNTHETIC CO2 ASSIMILATION; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; LEAVES; TEMPERATURE; SPECIFICITY; C-3; IMPROVEMENT; INCREASES; EVOLUTION; OXYGENASE	Effects of overexpression of high activity-type Rubisco small subunit (RbcS) from a cold-resistant plant, timothy (Phleum pratense), on kinetic properties of Rubisco were studied in rice (Oryza sativa). The full-length mRNA sequence of timothy RbcS (PpRbcS1) was determined by 5'RACE and 3'RACE. The coding sequence of PpRbcS1 was fused to the chlorophyll a/b-binding protein promoter and introduced into rice. PpRbcS was highly expressed in leaf blade and accounted for approximately 30 % of total RbcS in homozygous transgenic lines. However, the catalytic turnover rate and K (m) for CO2 of Rubisco did not significantly change in these transgenic lines compared to non-transgenic rice, suggesting that PpRbcS1 is not effective for improvement of catalytic efficiency of rice Rubisco. The photosynthetic rate and growth were essentially unchanged, whereas the photosynthetic rate at low CO2 condition was marginally increased in transgenic lines. Rubisco content was significantly increased, whereas soluble protein, nitrogen, and chlorophyll contents were unchanged in transgenic lines compared to non-transgenic rice. Because the kinetic properties were similar, observed slight increase in photosynthetic rate at low CO2 is considered to be large due to increase in Rubisco content in transgenic lines. Introduction of foreign RbcS is an effective approach for the improvement of Rubisco kinetics and photosynthesis. However, in this study, it was suggested that RbcS of high activity-type Rubisco, even showing higher amino acid identity with rice RbcS, did not always enhance the catalytic turnover rate of Rubisco in rice. Thus, we should carefully select RbcS to be overexpressed before introduction.	[Fukayama, Hiroshi; Koga, Atsushi; Hatanaka, Tomoko; Misoo, Shuji] Kobe Univ, Grad Sch Agr Sci, Lab Crop Sci, Nada Ku, Kobe, Hyogo 6578501, Japan	Fukayama, H (reprint author), Kobe Univ, Grad Sch Agr Sci, Lab Crop Sci, Nada Ku, Kobe, Hyogo 6578501, Japan.	fukayama@people.kobe-u.ac.jp			Ministry of Education, Culture, Sport, Science, and Technology of Japan [24580021]	This work was supported in part by a Grant-in Aid for Scientific Research (No. 24580021) from the Ministry of Education, Culture, Sport, Science, and Technology of Japan.	DEAN C, 1989, ANNU REV PLANT PHYS, V40, P415; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; MAKINO A, 1985, PLANT PHYSIOL, V79, P57, DOI 10.1104/pp.79.1.57; Masumoto C, 2010, P NATL ACAD SCI USA, V107, P5226, DOI 10.1073/pnas.0913127107; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; Fukayama H, 2006, PLANT J, V47, P258, DOI 10.1111/j.1365-313X.2006.02779.x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Sage RF, 2002, J EXP BOT, V53, P609, DOI 10.1093/jexbot/53.369.609; Studer RA, 2014, P NATL ACAD SCI USA, V111, P2223, DOI 10.1073/pnas.1310811111; Ishikawa C, 2011, PLANT PHYSIOL, V156, P1603, DOI 10.1104/pp.111.177030; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Taniguchi Y, 2008, J EXP BOT, V59, P1799, DOI 10.1093/jxb/ern016; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; JORDAN DB, 1984, PLANTA, V161, P308, DOI 10.1007/BF00398720; Morita K, 2014, PLANT PHYSIOL, V164, P69, DOI 10.1104/pp.113.228015; Spreitzer RJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P141, DOI 10.1016/S0003-9861(03)00171-1; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Matsuoka M, 2001, ANNU REV PLANT PHYS, V52, P297, DOI 10.1146/annurev.arplant.52.1.297; SEEMANN JR, 1984, PLANT PHYSIOL, V74, P791, DOI 10.1104/pp.74.4.791; Whitney SM, 2011, P NATL ACAD SCI USA, V108, P14688, DOI 10.1073/pnas.1109503108; Suzuki Y, 2007, PLANT CELL PHYSIOL, V48, P626, DOI 10.1093/pcp/pcm035; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Fukayama H, 2012, PLANT CELL PHYSIOL, V53, P976, DOI 10.1093/pcp/pcs042; Genkov T, 2009, J BIOL CHEM, V284, P30105, DOI 10.1074/jbc.M109.044081; Getzoff TP, 1998, PLANT PHYSIOL, V116, P695, DOI 10.1104/pp.116.2.695; Ishikawa C, 2009, PLANT PROD SCI, V12, P345, DOI 10.1626/pps.12.345; KANEVSKI I, 1994, P NATL ACAD SCI USA, V91, P1969, DOI 10.1073/pnas.91.5.1969; Tsuchida H, 2001, PLANT CELL PHYSIOL, V42, P138, DOI 10.1093/pcp/pce013; Uchida N, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P687; von Caemmerer S, 2000, PHOTOSYNTHESIS ADV P, V9, P85	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0166-8595	1573-5079		PHOTOSYNTH RES	Photosynth. Res.	APR	2015	124	1					57	65		10.1007/s11120-015-0085-1		9	Plant Sciences	Plant Sciences	CE0TI	WOS:000351519000006		
J	Tonouchi, N; Kosumi, D; Sugisaki, M; Nango, M; Hashimoto, H				Tonouchi, Noriyuki; Kosumi, Daisuke; Sugisaki, Mitsuru; Nango, Mamoru; Hashimoto, Hideki			How do surrounding environments influence the electronic and vibrational properties of spheroidene?	PHOTOSYNTHESIS RESEARCH			English	Article						Carotenoid; LH2; Raman spectroscopy; Vibrational decay; Polarizability; Viscosity	RESONANCE RAMAN-SPECTRA; RHODOBACTER-SPHAEROIDES 2.4.1; VISCOELASTIC CONTINUUM MODEL; LIGHT-HARVESTING COMPLEXES; ALL-TRANS-NEUROSPORENE; ENERGY-GAP LAW; BETA-CAROTENE; INTERNAL-CONVERSION; EXCITED-STATES; RHODOPSEUDOMONAS-ACIDOPHILA	Absorption and Raman spectra of spheroidene dissolved in various organic solvents and bound to peripheral light-harvesting LH2 complexes from photosynthetic purple bacteria Rhodobacter (Rba.) sphaeroides 2.4.1 were measured. The results showed that the peak energies of absorption and C-C and C=C stretching Raman lines are linearly proportional to the polarizability of solvents, as has already been reported. When comparing these results with those measured on LH2 complexes, it was confirmed that spheroidene is surrounded by a media with high polarizability. However, the change in the spectral width of the Raman lines, which reflect vibrational decay time, cannot be explained simply by a similar dependence of solvent polarizability. The experimental results were analyzed using a potential theoretical model. Consequently, a systematic change in the Raman line widths in the ground state can be satisfactorily explained as a function of the viscosity of the surrounding media. Even when the absorption peaks appear at the same energy, the vibrational decay time of spheroidene in the LH2 complexes is approximately 15-20 % slower than that in organic solvents.	[Tonouchi, Noriyuki; Sugisaki, Mitsuru; Hashimoto, Hideki] Osaka City Univ, Dept Phys, Grad Sch Sci, Sumiyoshi Ku, Osaka 5588585, Japan; [Kosumi, Daisuke; Nango, Mamoru; Hashimoto, Hideki] Osaka City Univ, Adv Res Inst Nat Sci & Technol OCARINA, Sumiyoshi Ku, Osaka 5588585, Japan	Sugisaki, M (reprint author), Osaka City Univ, Dept Phys, Grad Sch Sci, Sumiyoshi Ku, Osaka 5588585, Japan.	mitsuru@sci.osaka-cu.ac.jp	Kosumi, Daisuke/F-6753-2010		Japanese Ministry of Education, Culture, Sports, Science, and Technology [22340085, 26610133]; Japan Society for the Promotion of Science (JSPS) [24107002H]	This work was conducted with financial support from the Grant-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Grants No. 22340085 and No. 26610133). HH thanks Scientific Research on Innovative Area "All Nippon Artificial Photosynthesis Project for Living Earth (AnApple)" (No. 24107002H) from the Japan Society for the Promotion of Science (JSPS) for financial support.	TAVAN P, 1986, J CHEM PHYS, V85, P6602, DOI 10.1063/1.451442; Frank HA, 2000, J PHYS CHEM B, V104, P4569, DOI 10.1021/jp000079u; Buckup T, 2014, ANNU REV PHYS CHEM, V65, P39, DOI [10.1146/annurev-physchem-040513-103619, 10.1146/annurev-physchem-040413-103619]; Ricci M, 1996, CHEM PHYS LETT, V259, P381, DOI 10.1016/0009-2614(96)00832-9; Polivka T, 2001, J PHYS CHEM B, V105, P1072, DOI 10.1021/jp002206s; Polivka T, 2013, BBA-BIOENERGETICS, V1827, P248, DOI 10.1016/j.bbabio.2012.10.005; Kosumi D, 2006, CHEM PHYS LETT, V425, P66, DOI 10.1016/j.cplett.2006.05.023; Nagae H, 2009, CHEM PHYS LETT, V474, P342, DOI 10.1016/j.cplett.2009.04.039; Konradi J, 2006, J RAMAN SPECTROSC, V37, P697, DOI 10.1002/jrs.1502; Kosumi D, 2009, CHEM PHYS LETT, V483, P95, DOI 10.1016/j.cplett.2009.10.077; KJAER AM, 1989, CHEM PHYS LETT, V157, P447; Polli D, 2006, BIOPHYS J, V90, P2486, DOI 10.1529/biophysj.105.069286; Kukura P, 2004, J PHYS CHEM A, V108, P5921, DOI 10.1021/jp0482971; OXTOBY DW, 1981, ANNU REV PHYS CHEM, V32, P77, DOI 10.1146/annurev.pc.32.100181.000453; Maiuri M, 2012, PHYS CHEM CHEM PHYS, V14, P6312, DOI 10.1039/c2cp23585d; Shimada R, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2950092; ENGLMAN R, 1970, MOL PHYS, V18, P145, DOI 10.1080/00268977000100171; Hauer J, 2007, J PHYS CHEM A, V111, P10517, DOI 10.1021/jp073727j; Krueger BP, 1998, J PHYS CHEM B, V102, P5378, DOI 10.1021/jp9811171; Mendes-Pinto MM, 2013, J PHYS CHEM B, V117, P11015, DOI 10.1021/jp309908r; Zhang JP, 2000, CHEM PHYS LETT, V332, P351, DOI 10.1016/S0009-2614(00)01275-6; LEE SA, 1986, J CHEM PHYS, V84, P2497, DOI 10.1063/1.450369; Finkelstein IJ, 2004, J CHEM PHYS, V121, P877, DOI 10.1063/1.1758940; TAVAN P, 1987, PHYS REV B, V36, P4337, DOI 10.1103/PhysRevB.36.4337; Christensen RL, 2008, J PHYS CHEM A, V112, P12629, DOI 10.1021/jp8060202; Siebert T, 2002, J AM CHEM SOC, V124, P6242, DOI 10.1021/ja0173831; Frank HA, 1997, PURE APPL CHEM, V69, P2117, DOI 10.1351/pac199769102117; Kosumi D, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3147008; Nagasawa Y, 2005, J PHYS CHEM B, V109, P11946, DOI 10.1021/jp051187p; Fujii R, 1998, CHEM PHYS LETT, V288, P847, DOI 10.1016/S0009-2614(98)00376-5; Rondonuwu FS, 2004, CHEM PHYS LETT, V390, P314, DOI 10.1016/j.cplett.2004.03.089; Marek MS, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818164; EVANS MB, 1988, BIOCHIM BIOPHYS ACTA, V935, P292, DOI 10.1016/0005-2728(88)90224-1; Polivka T, 2004, CHEM REV, V104, P2021, DOI 10.1021/cr020674n; Berg MA, 1998, CHEM PHYS, V233, P257, DOI 10.1016/S0301-0104(98)00065-2; Dokter AM, 2002, J PHYS CHEM A, V106, P9463, DOI 10.1021/jp026164e; Macpherson AN, 2001, BIOPHYS J, V80, P923; SUE J, 1988, J OPT SOC AM B, V5, P1462, DOI 10.1364/JOSAB.5.001462; Marek MS, 2011, J PHYS CHEM B, V115, P8328, DOI 10.1021/jp202753j; Nagae H, 2000, J PHYS CHEM A, V104, P4155, DOI 10.1021/jp9924833; Sugisaki M, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245408; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; Nagasawa Y, 2003, J PHYS CHEM A, V107, P2431, DOI 10.1021/jp027012m; Frank HA, 2002, J PHYS CHEM B, V106, P2083, DOI 10.1021/jp013321l; Ikuta M, 2006, CHEM PHYS LETT, V422, P95, DOI 10.1016/j.cplett.2006.02.042; Macpherson AN, 1998, J PHYS CHEM A, V102, P5049, DOI 10.1021/jp980979z; Burt JA, 2004, J CHEM PHYS, V120, P4344, DOI 10.1063/1.1644534; NAGAE H, 1994, J CHEM PHYS, V101, P6750, DOI 10.1063/1.468501; PARISER R, 1953, J CHEM PHYS, V21, P767, DOI 10.1063/1.1699030; Berg M, 1998, J PHYS CHEM A, V102, P17, DOI 10.1021/jp9722061; Boereboom JM, 2011, CHEMPHYSCHEM, V12, P3157, DOI 10.1002/cphc.201100545; COGDELL RJ, 1983, BIOCHIM BIOPHYS ACTA, V722, P427, DOI 10.1016/0005-2728(83)90058-0; Fujiwara M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.205118; KOK P, 1994, BBA-BIOENERGETICS, V1185, P188, DOI 10.1016/0005-2728(94)90209-7; Koyama Y, 2004, BIOPOLYMERS, V74, P2, DOI 10.1002/bip.20034; KUKI M, 1994, PHOTOCHEM PHOTOBIOL, V59, P116; Landrum J. T., 2009, CAROTENOIDS PHYS CHE; Macernis M, 2014, J PHYS CHEM A, V118, P1817, DOI 10.1021/jp406449c; Maekawa H, 2004, J PHYS CHEM A, V108, P9484, DOI 10.1021/jp047870d; Miki T, 2008, CHEM PHYS LETT, V457, P222, DOI 10.1016/j.cplett.2008.03.069; Mukai-Kuroda Y, 2002, J PHYS CHEM A, V106, P3566, DOI 10.1021/jp0130822; Ostroumov EE, 2014, ADV PHOTOSYNTH RESP, V40, P97, DOI 10.1007/978-94-017-9032-1_4; Parson WW, 2006, MODERN OPTICAL SPECT; Polli D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.163002; Rondonuwu FS, 2003, CHEM PHYS LETT, V376, P292, DOI 10.1016/S0009-2614(03)00983-7; Sakamoto A, 2010, J MOL STRUCT, V976, P310, DOI 10.1016/j.molstruc.2010.04.012; Shim S, 2008, J PHYS CHEM B, V112, P4826, DOI 10.1021/jp710518y; Sugisaki M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155110; Sugisaki M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245112; van Amerongen H, 2000, PHOTOSYNTHETIC EXCIT, DOI [10.1007/978-94-017-9032-1, DOI 10.1007/978-94-017-9032-1]; Wirtz AC, 2007, BIOPHYS J, V93, P981, DOI 10.1529/biophysj.106.103473; Yoshizawa M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.180301; ZERBETTO F, 1988, J CHEM PHYS, V89, P3681, DOI 10.1063/1.454888; ZERBETTO F, 1987, J CHEM PHYS, V87, P2505, DOI 10.1063/1.453090	74	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0166-8595	1573-5079		PHOTOSYNTH RES	Photosynth. Res.	APR	2015	124	1					77	86		10.1007/s11120-015-0095-z		10	Plant Sciences	Plant Sciences	CE0TI	WOS:000351519000008		
J	Jishi, T; Matsuda, R; Fujiwara, K				Jishi, Tomohiro; Matsuda, Ryo; Fujiwara, Kazuhiro			A kinetic model for estimating net photosynthetic rates of cos lettuce leaves under pulsed light	PHOTOSYNTHESIS RESEARCH			English	Article						Duty ratio; Fluctuating light; Frequency; Photosynthetic intermediate; Lightfleck	CHLOROPHYLL FLUORESCENCE; STOMATAL CONDUCTANCE; INTERMITTENT LIGHT; EFFICIENCY; LIGHTFLECKS; ACTIVATION	Time-averaged net photosynthetic rate (P (n)) under pulsed light (PL) is known to be affected by the PL frequency and duty ratio, even though the time-averaged photosynthetic photon flux density (PPFD) is unchanged. This phenomenon can be explained by considering that photosynthetic intermediates (PIs) are pooled during light periods and then consumed by partial photosynthetic reactions during dark periods. In this study, we developed a kinetic model to estimate P (n) of cos lettuce (Lactuca sativa L. var. longifolia) leaves under PL based on the dynamics of the amount of pooled PIs. The model inputs are average PPFD, duty ratio, and frequency; the output is P (n). The rates of both PI accumulation and consumption at a given moment are assumed to be dependent on the amount of pooled PIs at that point. Required model parameters and three explanatory variables (average PPFD, frequency, and duty ratio) were determined for the simulation using P (n) values under PL based on several combinations of the three variables. The model simulation for various PL levels with a wide range of time-averaged PPFDs, frequencies, and duty ratios further demonstrated that P (n) under PL with high frequencies and duty ratios was comparable to, but did not exceed, P (n) under continuous light, and also showed that P (n) under PL decreased as either frequency or duty ratio was decreased. The developed model can be used to estimate P (n) under various light environments where PPFD changes cyclically.	[Jishi, Tomohiro; Matsuda, Ryo; Fujiwara, Kazuhiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biol & Environm Engn, Bunkyo Ku, Tokyo 1138657, Japan	Jishi, T (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biol & Environm Engn, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	8934408333@mail.ecc.u-tokyo.ac.jp					Yoshimoto N, 2005, J APPL PHYCOL, V17, P207, DOI 10.1007/s10811-005-7908-y; TENNESSEN DJ, 1995, PHOTOSYNTH RES, V44, P261, DOI 10.1007/BF00048599; Warburg O, 1919, BIOCHEM Z, V100, P230; Nedbal L, 1996, J APPL PHYCOL, V8, P325, DOI 10.1007/BF02178575; Emerson R, 1932, J GEN PHYSIOL, V15, P391, DOI 10.1085/jgp.15.4.391; Oxborough K, 1997, PHOTOSYNTH RES, V54, P135, DOI 10.1023/A:1005936823310; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87; CHAZDON RL, 1986, OECOLOGIA, V69, P524, DOI 10.1007/BF00410358; GROSS LJ, 1991, PLANT CELL ENVIRON, V14, P881, DOI 10.1111/j.1365-3040.1991.tb00957.x; Jishi T, 2012, J LIGHT VISUAL ENV, V36, P88; Kirschbaum MUF, 1998, PLANTA, V204, P16; KIRSCHBAUM MUF, 1988, PLANTA, V174, P527, DOI 10.1007/BF00634483; KLUETER HH, 1980, T ASAE, V23, P437; Mori Y., 2002, Journal of Society of High Technology in Agriculture, V14, P136; SAGER JC, 1980, AGR METEOROL, V22, P289, DOI 10.1016/0002-1571(80)90008-4; SHARKEY TD, 1986, PLANT PHYSIOL, V82, P1063, DOI 10.1104/pp.82.4.1063	17	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0166-8595	1573-5079		PHOTOSYNTH RES	Photosynth. Res.	APR	2015	124	1					107	116		10.1007/s11120-015-0107-z		10	Plant Sciences	Plant Sciences	CE0TI	WOS:000351519000010		
J	Kaneyoshi, T				Kaneyoshi, T.			Unique magnetic properties of an Ising nanowire with a spin glass like disorder at the surface	PHYSICA B-CONDENSED MATTER			English	Article						Magnetic nanowire; Ising model; Phase diagrams; Magnetizations; Effective field theory	PHASE-DIAGRAMS; SITE DILUTION; FIELD; BOND; TEMPERATURE; NANOTUBE; FILMS; FERRIMAGNETISM; DISTRIBUTIONS; BEHAVIORS	The phase diagram and magnetizations in an Ising nanowire based on the core-shell concept are examined by using the effective-field theory with correlations. The nanowire is constructed from the ferromagnetic core and the spin glass like disordered surface shell. The effects of surface disorder and interlayer coupling between the core and the shell on the magnetic properties are examined. We have found a lot of novel phenomena in them. (C) 2015 Elsevier B.V. All rights reserved,	Nagoya Univ, Midori Ku, Nagoya, Aichi 4580003, Japan	Kaneyoshi, T (reprint author), Nagoya Univ, Midori Ku, 1-510 Kurosawadai, Nagoya, Aichi 4580003, Japan.	kaneyosi@is.nagoya-u.ac.jp					Akinci U, 2012, J MAGN MAGN MATER, V324, P4237, DOI 10.1016/j.jmmm.2012.07.051; Boughrara M, 2014, J MAGN MAGN MATER, V368, P169, DOI 10.1016/j.jmmm.2014.04.075; Kaneyoshi T, 2011, J MAGN MAGN MATER, V323, P1145, DOI 10.1016/j.jmmm.2010.12.026; Kaneyoshi T, 2013, PHYSICA E, V53, P14, DOI 10.1016/j.physe.2013.04.004; Kaneyoshi T, 2014, PHYSICA B, V436, P208, DOI 10.1016/j.physb.2013.12.016; Zernike F, 1940, PHYSICA, V7, P565, DOI 10.1016/S0031-8914(40)90008-8; SCHNEIDER CM, 1990, PHYS REV LETT, V64, P1059, DOI 10.1103/PhysRevLett.64.1059; Kaneyoshi T, 2012, PHYSICA A, V391, P3616, DOI 10.1016/j.physa.2012.02.025; Kaneyoshi T, 2011, J MAGN MAGN MATER, V323, P2483, DOI 10.1016/j.jmmm.2011.05.023; HONMURA R, 1979, J PHYS C SOLID STATE, V12, P3979, DOI 10.1088/0022-3719/12/19/016; Chiba D, 2011, NAT MATER, V10, P853, DOI [10.1038/nmat3130, 10.1038/NMAT3130]; Akinci U, 2012, J MAGN MAGN MATER, V324, P3951, DOI 10.1016/j.jmmm.2012.07.002; Kaneyoshi T, 2013, PHYSICA B, V414, P72, DOI 10.1016/j.physb.2013.01.022; Leite VS, 2005, PHYSICA A, V350, P379, DOI 10.1016/j.physa.2004.11.036; Kodama RH, 1999, J MAGN MAGN MATER, V200, P359, DOI 10.1016/S0304-8853(99)00347-9; Kaneyoshi T, 2011, PHYSICA A, V390, P3697, DOI 10.1016/j.physa.2011.06.003; Kaneyoshi T, 2013, PHYSICA B, V408, P126, DOI 10.1016/j.physb.2012.09.046; Kaneyoshi T, 1996, PHYSICA A, V229, P166, DOI 10.1016/0378-4371(96)00012-X; Fishmann S., 1979, J PHYS C SOLID STATE, V12, pL72; Kaneyoshi T, 2012, PHASE TRANSIT, V85, P995, DOI 10.1080/01411594.2012.666548; Kaneyoshi T, 2011, PHYS STATUS SOLIDI B, V248, P250, DOI 10.1002/pssb.201046067; Kaneyoshi T, 2014, PHASE TRANSIT, V87, P111, DOI 10.1080/01411594.2013.789105; Kaneyoshi T, 1992, INTRO AMORPHOUS MAGN; Kaneyoshi T., 2011, SOLID STATE COMMUN, V151; Kaneyoshi T., 2014, J MAGN MAGN MAT, V322; Kaneyoshi T., 2013, J MAGN MAGN MATER, V330, P151; Kaneyoshi T., 2014, UNPUB; Kaneyoshi T., 2010, J MAGN MAGN MATER, V323, P3410; KANEYOSHI T, 1993, ACTA PHYS POL A, V83, P703; Liu J. W., 2013, CHINESE PHYS B, V22; Moorjani K, 1984, MAGNETIC GLASSES; Oitmaa J, 2003, PHYSICA A, V328, P185, DOI 10.1016/S0378-4371(03)00522-3; Strecka J, 2012, PHYSICA A, V391, P4763, DOI 10.1016/j.physa.2012.05.011; Yamada TK, 2012, J MAGN SOC JPN, V36, P100; Zhang T, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4895117	35	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526	1873-2135		PHYSICA B	Physica B	APR 1	2015	462						34	39		10.1016/j.physb.2015.01.016		6	Physics, Condensed Matter	Physics	CD1CR	WOS:000350812000007		
J	Xu, CW; Zhai, SM; Ye, LJ; Higo, YJ				Xu, Chaowen; Zhai, Shuangmeng; Ye, Lijin; Higo, Yuji			Equation of state of Ca2AlSiO5.5 oxygen defect perovskite	PHYSICS AND CHEMISTRY OF MINERALS			English	Article						Ca2AlSiO5.5; Oxygen defect perovskite; In situ X-ray diffraction; Equation of state	V-T EQUATION; TRANSITION ZONE CONDITIONS; LOWER MANTLE; CASIO3 PEROVSKITE; THERMAL EQUATION; PHASE-RELATIONS; EARTHS MANTLE; STABILITY; BEARING; GPA	The elastic properties of synthetic low-pressure and high-pressure Ca2AlSiO5.5 oxygen defect perovskites were investigated by in situ X-ray diffraction in a large-volume high-pressure apparatus. The P-V-T data were collected up to 22.75 GPa at room temperature, up to 12.88 GPa and 1,300 K for low-pressure phase and up to 25.76 GPa at room temperature for high-pressure phase. The P-V data at room temperature were fitted using a third-order Birch-Murnaghan equation of state to obtain K (0) = 146.1(9) GPa and = 3.64(9) for the monoclinic low-pressure phase, and K (0) = 150.4(19) GPa and = 3.16(23) for the rhombohedral high-pressure phase. If was fixed at 4.0, the isothermal bulk moduli were obtained as 142.6(3) and 144.0(8) GPa for low-pressure and high-pressure phase, respectively. Both the low-pressure and high-pressure Ca2AlSiO5.5 oxygen defect perovskites are much softer than pure CaSiO3 perovskite. The P-V-T data of low-pressure phase were fitted by the high-temperature Birch-Murnaghan equation of state to get thermoelastic properties as V (0) = 827.0(3) a"<<(3), K (T) = 146.8(22) GPa, = 3.55(21), (a,K (T) /a,T)(P) = -0.037(2) GPa/K and alpha (T) = 7.67(20) x 10(-5) - 3.20(30) x 10(-8) T. Based on the results, the density profiles of low-pressure and high-pressure Ca2AlSiO5.5 oxygen defect perovskites were calculated and compared with those of some mantle silicate minerals to discuss the potential occurrence of Ca2AlSiO5.5 oxygen defect perovskite in the Earth's interior.	[Xu, Chaowen; Ye, Lijin] Peking Univ, MOE, Key Lab Orogen Belts & Crustal Evolut, Beijing 100871, Peoples R China; [Xu, Chaowen; Ye, Lijin] Peking Univ, Sch Earth & Space Sci, Beijing 100871, Peoples R China; [Zhai, Shuangmeng] Chinese Acad Sci, Inst Geochem, Key Lab High Temp & High Pressure Study Earths In, Guiyang 550002, Guizhou, Peoples R China; [Higo, Yuji] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Zhai, SM (reprint author), Chinese Acad Sci, Inst Geochem, Key Lab High Temp & High Pressure Study Earths In, Guiyang 550002, Guizhou, Peoples R China.	zhaishuangmeng@vip.gyig.ac.cn			National Natural Science Foundation of China [41372040]; Knowledge Innovation Program of the Institute of Geochemistry, Chinese Academy of Sciences; Visiting Researcher's Program of the Institute for Study of the Earth's Interior, Okayama University	The Ca<INF>2</INF>AlSiO<INF>5.5</INF> oxygen defect perovskite samples were kindly provided by H. Kojitani. The authors thank S. Nie for helpful discussion on the crystal structure of low-pressure Ca<INF>2</INF>AlSiO<INF>5.5</INF> oxygen defect perovskite, D. Yamazaki, N. Tsujino, M. Sakurai and E. Ito for experimental helps. We thank Prof. T. Tsuchiya for his editorial handling. Critical comments and suggestion from two anonymous reviewers are helpful to improve the manuscript. The synchrotron radiation experiments were carried out at BL04B1, SPring-8, Japan (Proposal No. 2013B1257 and 2014A1736). This work was financially supported by National Natural Science Foundation of China (Grant No. 41372040), the Knowledge Innovation Program of the Institute of Geochemistry, Chinese Academy of Sciences and the Visiting Researcher's Program of the Institute for Study of the Earth's Interior, Okayama University.	Akber-Knutson S., 2002, Geophysical Research Letters, V29; Andrault D, 2007, EARTH PLANET SC LETT, V263, P167, DOI 10.1016/j.epsl.2007.08.012; BIRCH F, 1947, PHYS REV, V71, P809, DOI 10.1103/PhysRev.71.809; SAXENA SK, 1990, PHYS CHEM MINER, V17, P45, DOI 10.1007/BF00209225; Shim SH, 2000, J GEOPHYS RES-SOL EA, V105, P25955, DOI 10.1029/2000JB900183; Angel RJ, 2000, REV MINERAL GEOCHEM, V41, P35; Ono S, 1998, J GEOPHYS RES-SOL EA, V103, P18253, DOI 10.1029/98JB01351; Hirose K, 2002, GEOCHIM COSMOCHIM AC, V66, P2099, DOI 10.1016/S0016-7037(02)00847-5; Wang YB, 1998, PHYS EARTH PLANET IN, V105, P59, DOI 10.1016/S0031-9201(97)00072-1; Kudo Y, 2012, EARTH PLANET SC LETT, V349, P1, DOI 10.1016/j.epsl.2012.06.040; Brodholt JP, 2000, NATURE, V407, P620, DOI 10.1038/35036565; Noguchi M, 2013, PHYS CHEM MINER, V40, P81, DOI 10.1007/s00269-012-0549-1; Navrotsky A, 1999, SCIENCE, V284, P1788, DOI 10.1126/science.284.5421.1788; IRIFUNE T, 1994, EARTH PLANET SC LETT, V126, P351, DOI 10.1016/0012-821X(94)90117-1; Hirose K, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000597; Blass UW, 2004, PHYS CHEM MINER, V31, P52, DOI 10.1007/s00269-003-0375-6; Blass UW, 2007, PHYS CHEM MINER, V34, P363, DOI 10.1007/s00269-007-0154-x; Fitz Gerald J, 1991, PHYS CHEM MINER, V18, P40, DOI DOI 10.1007/BF00199042; Guignot N, 2004, PHYS EARTH PLANET IN, V143, P107, DOI 10.1016/j.pepi.2003.09.014; Holland TJB, 1997, J APPL CRYSTALLOGR, V30, P84, DOI 10.1107/S0021889896011673; Irifune T., 2007, TREATISE GEOPHYS, V2, P33; Kanzaki M, 2012, JAP GEOSC UN M CHIB; KESSON SE, 1995, EARTH PLANET SC LETT, V134, P187, DOI 10.1016/0012-821X(95)00112-P; Kojitani H, 2009, PHYS EARTH PLANET IN, V173, P349, DOI 10.1016/j.pepi.2009.02.001; Kurashina T, 2004, PHYS EARTH PLANET IN, V145, P67, DOI 10.1016/j.pepi.2004.02.005; Litasov KD, 2007, PHYS CHEM MINER, V34, P159, DOI 10.1007/s00269-006-0136-4; MAO HK, 1989, J GEOPHYS RES-SOLID, V94, P17889, DOI 10.1029/JB094iB12p17889; Nishihara Y, 2003, AM MINERAL, V88, P80; Nishihara Y, 2005, PHYS CHEM MINER, V31, P660, DOI 10.1007/s00269-004-0426-7; Ono S, 2002, AM MINERAL, V87, P1486; Ono S, 2004, AM MINERAL, V89, P1480; Ono S, 2001, EARTH PLANET SC LETT, V190, P57, DOI 10.1016/S0012-821X(01)00375-2; Ricolleau A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036759; Ross NL, 2002, PHYS EARTH PLANET IN, V129, P145, DOI 10.1016/S0031-9201(01)00269-2; Shim SH, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016148; Stixrude L, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.024108; Tsuchiya T, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002446; Wang YB, 1996, J GEOPHYS RES-SOL EA, V101, P661, DOI 10.1029/95JB03254; Zhai SM, 2013, AM MINERAL, V98, P1811, DOI 10.2138/am.2013.4403; Zhai SM, 2011, PHYS CHEM MINER, V38, P357, DOI 10.1007/s00269-010-0409-9; Zhang JZ, 1999, SCIENCE, V284, P782, DOI 10.1126/science.284.5415.782	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-1791	1432-2021		PHYS CHEM MINER	Phys. Chem. Miner.	APR	2015	42	4					327	336		10.1007/s00269-014-0723-8		10	Materials Science, Multidisciplinary; Mineralogy	Materials Science; Mineralogy	CE0AF	WOS:000351463100008		
J	Seymour, RS; Ito, K; Umekawa, Y; Matthews, PDG; Pirintsos, SA				Seymour, Roger S.; Ito, Kikukatsu; Umekawa, Yui; Matthews, Philip D. G.; Pirintsos, Stergios Arg			The oxygen supply to thermogenic flowers	PLANT CELL AND ENVIRONMENT			English	Article						diffusion; flower; gas conductance; oxygen consumption; respiration; thermogenesis	RESPIRATORY DOWN-REGULATION; PHILODENDRON-SELLOUM KOCH; INTERNAL OXYGEN; TEMPERATURE REGULATION; ALTERNATIVE PATHWAY; HEAT-PRODUCTION; CARBON-DIOXIDE; GAS-EXCHANGE; SACRED LOTUS; INFLORESCENCE	Thermogenic flowers produce heat by intense respiration, and the rates of O-2 consumption (Mo-2) in some species can exceed those of all other tissues of plants and most animals. By exposing intact flowers to a range of O-2 pressures (Po-2) and measuring Mo-2, we demonstrate that the highest respiration rates exceed the capacity of the O-2 diffusive pathway and become diffusion limited in atmospheric air. The male florets on the inflorescence of Arum concinnatum have the highest known mass-specific Mo-2 and can be severely diffusion limited. Intact spadices of Japanese skunk cabbage Symplocarpus renifolius are diffusion limited in air only when Mo-2 is maximal, but not at lower levels. True flowers of the sacred lotus Nelumbo nucifera and the appendix of Arum concinnatum are never diffusion limited in air. Mo-2 - Po-2 curves are evaluated quantitatively with the Regulation Index', a new tool to measure dependence of Mo-2 on ambient Po-2, as well as the conventional Critical Po-2'. The study also includes measurements of Po-2 within thermogenic tissues with O-2-sensitive fibre optics, and reveals that the diffusion pathway is complicated and that O-2 can be provided not only from the surface of the tissues but also from the pith of the flower's peduncle.	[Seymour, Roger S.; Matthews, Philip D. G.] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia; [Ito, Kikukatsu; Umekawa, Yui] Iwate Univ, Fac Agr, Cryobiofrontier Res Ctr, Morioka, Iwate 0208550, Japan; [Pirintsos, Stergios Arg] Univ Crete, Dept Biol, Iraklion 71409, Greece; [Pirintsos, Stergios Arg] Univ Crete, Bot Garden, Rethimnon 74100, Greece	Seymour, RS (reprint author), Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia.	roger.seymour@adelaide.edu.au			Australian Research Council [DP0771854]; Japanese Society for the Promotion of Science (KAKENHI) [24380182]; Alexander von Humboldt Foundation	We appreciate the technical help of Sophie Angove, Fotis Bekris, Kyriakos Kotzabasis, Konstantina Koutroumba, Ingolf Lamprecht, Freya McDougall, Robin Seymour and Shannyn Siemens. The research was supported by the Australian Research Council (Discovery Project DP0771854), the Japanese Society for the Promotion of Science (KAKENHI grant 24380182), and the Alexander von Humboldt Foundation. Two referees and an associate editor helped clarify our ideas and greatly improve the manuscript.	Hertog MLATM, 1998, POSTHARVEST BIOL TEC, V14, P335, DOI 10.1016/S0925-5214(98)00058-1; Geigenberger P, 2000, BIOL CHEM, V381, P723, DOI 10.1515/BC.2000.093; Zabalza A, 2009, PLANT PHYSIOL, V149, P1087, DOI 10.1104/pp.108.129288; GUY RD, 1989, PLANTA, V177, P483, DOI 10.1007/BF00392616; YEAGER DP, 1989, PHYSIOL ZOOL, V62, P888; Scandurra FM, 2010, ADV EXP MED BIOL, V662, P7, DOI 10.1007/978-1-4419-1241-1_2; Mueller CA, 2011, PHYSIOL BIOCHEM ZOOL, V84, P522, DOI 10.1086/661953; Gupta KJ, 2009, PHYSIOL PLANTARUM, V137, P383, DOI 10.1111/j.1399-3054.2009.01253.x; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Miller RE, 2011, NEW PHYTOL, V189, P1013, DOI 10.1111/j.1469-8137.2010.03547.x; Armstrong W, 2011, NEW PHYTOL, V190, P276, DOI 10.1111/j.1469-8137.2011.03695.x; Armstrong W, 2011, NEW PHYTOL, V190, P431, DOI 10.1111/j.1469-8137.2010.03537.x; Armstrong W, 2009, ANN BOT-LONDON, V103, P281, DOI 10.1093/aob/mcn177; Berry AD, 2009, POSTHARVEST BIOL TEC, V52, P240, DOI 10.1016/j.postharvbio.2009.01.007; DEJOURS P., 1981, PRINCIPLES COMP RESP; DUGGLEBY RG, 1984, COMPUT BIOL MED, V14, P447, DOI 10.1016/0010-4825(84)90045-3; KANO H, 1977, PLANT CELL PHYSIOL, V18, P1149; Lammertyn J, 2001, J EXP BOT, V52, P1769, DOI 10.1093/jexbot/52.362.1769; MILLAR AH, 1994, PLANT PHYSIOL BIOCH, V32, P847; NAGY KA, 1972, SCIENCE, V178, P1195, DOI 10.1126/science.178.4066.1195; Nobel P.S., 1999, PHYSICOCHEMICAL ENV; Onda Y, 2008, PLANT PHYSIOL, V146, P636, DOI 10.1104/pp.107.113563; Peppelenbos HW, 1996, POSTHARVEST BIOL TEC, V9, P283, DOI 10.1016/S0925-5214(96)00029-4; Porterfield DM, 1999, CAN J BOT, V77, P1439, DOI 10.1139/cjb-77-10-1439; Saenmuang S, 2012, FOOD BIOPROCESS TECH, V5, P1950, DOI 10.1007/s11947-010-0503-5; Seymour RS, 2001, J EXP BOT, V52, P1465, DOI 10.1093/jexbot/52.360.1465; Seymour RS, 2009, PLANT CELL ENVIRON, V32, P1467, DOI 10.1111/j.1365-3040.2009.02015.x; SEYMOUR RS, 1984, PLANTA, V161, P229, DOI 10.1007/BF00982917; Seymour RS, 2010, PLANTA, V231, P1291, DOI 10.1007/s00425-010-1128-7; SEYMOUR RS, 1983, PLANTA, V157, P336, DOI 10.1007/BF00397405; Seymour RS, 1998, PHILOS T ROY SOC B, V353, P935, DOI 10.1098/rstb.1998.0258; Seymour RS, 2010, PLANT CELL ENVIRON, V33, P1474, DOI 10.1111/j.1365-3040.2010.02190.x; Watling JR, 2006, PLANT PHYSIOL, V140, P1367, DOI 10.1104/pp.105.075523	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7791	1365-3040		PLANT CELL ENVIRON	Plant Cell Environ.	APR	2015	38	4					827	837		10.1111/pce.12454		11	Plant Sciences	Plant Sciences	CD8XC	WOS:000351378800018		
J	Kobayashi, K; Fujii, S; Sato, M; Toyooka, K; Wada, H				Kobayashi, Koichi; Fujii, Sho; Sato, Mayuko; Toyooka, Kiminori; Wada, Hajime			Specific role of phosphatidylglycerol and functional overlaps with other thylakoid lipids in Arabidopsis chloroplast biogenesis	PLANT CELL REPORTS			English	Article						Chloroplast; Galactolipid; Phosphatidylglycerol; Photosynthesis; Sulfoquinovosyldiacylglycerol; Thylakoid membrane	CHLOROPHYLL A/B COMPLEX; PHOTOSYSTEM-II; SYNTHASE GENES; DIGALACTOSYLDIACYLGLYCEROL SYNTHASE; CHLAMYDOMONAS-REINHARDTII; SULFOLIPID BIOSYNTHESIS; GALACTOLIPID SYNTHESIS; PHOSPHATE STARVATION; THALIANA; REQUIREMENT	With phosphate deficiency, the role of phosphatidylglycerol is compensated by increased glycolipid content in thylakoid membrane biogenesis but not photosynthetic electron transport in Arabidopsis chloroplasts. In plants and cyanobacteria, anionic phosphatidylglycerol (PG) is the only major phospholipid in thylakoid membranes, where neutral galactolipids monogalactosyldiacylglycerol (MGDG) and digalactosyldiacylglycerol (DGDG) are predominant. In addition to provide a lipid bilayer matrix, PG plays a specific role in photosynthetic electron transport. Non-phosphorous sulfoquinovosyldiacylglycerol (SQDG) is another anionic lipid in thylakoids; it substitutes for PG under phosphate (Pi) deficiency to maintain proper balance of anionic charge in thylakoid membranes. Although the crucial role of PG in photosynthesis has been deeply analyzed in cyanobacteria, its physiological function in seed plants other than photosynthesis remains unclear. To reveal specific roles of PG and functional overlaps with other thylakoid lipids, we characterized a PG-deficient Arabidopsis mutant (pgp1-2) under Pi-controlled conditions. Under Pi-sufficient conditions, the proportion of PG and other thylakoid lipids was decreased in pgp1-2, which led to severe disruption of thylakoid membrane biogenesis. Under Pi-deficient conditions, the proportion of all glycolipids in the mutant was greatly increased, with that of PG further decreased. In Pi-deficient pgp1-2, thylakoid membranes remarkably developed, which was accompanied by a change in nucleoid morphology and restored expression of nuclear- and plastid-encoded photosynthesis genes. Increase in glycolipid content with Pi deficiency may compensate for the loss of PG in terms of thylakoid membrane biogenesis. Although Pi deficiency increased chlorophyll and photosynthesis protein content in pgp1-2, it critically decreased photochemical activity in PSII. Further deprivation of PG in photosynthesis complexes may abolish the PSII activity in Pi-deficient pgp1-2, which suggests that glycolipids cannot replace PG in photosynthesis.	[Kobayashi, Koichi; Fujii, Sho; Wada, Hajime] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Sato, Mayuko; Toyooka, Kiminori] RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Wada, Hajime] JST, CREST, Kawaguchi, Saitama 3320012, Japan	Wada, H (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.	hwada@bio.c.u-tokyo.ac.jp	Wada, Hajime/K-2186-2015; Kobayashi, Koichi/A-8514-2011; Toyooka, Kiminori/B-5027-2011		JST CREST from the Ministry of Education, Sports, Science and Culture in Japan;  [24770055]	We thank Mayumi Wakazaki and Kei Hashimoto (CSRS, RIKEN, Yokaham, Japan) for electron microscopy. This work was supported by Grants-in-Aid for Scientific Research on Priority Areas (No. 24770055) and JST CREST from the Ministry of Education, Sports, Science and Culture in Japan.	Haselier A, 2010, PLANT PHYSIOL, V153, P1372, DOI 10.1104/pp.110.156422; Sakurai I, 2007, PLANT PHYSIOL, V144, P1336, DOI 10.1104/pp.107.098731; Schweer J, 2010, EUR J CELL BIOL, V89, P940, DOI 10.1016/j.ejcb.2010.06.016; Hagio M, 2002, PLANT CELL PHYSIOL, V43, P1456, DOI 10.1093/pcp/pcf185; Kobayashi K, 2007, P NATL ACAD SCI USA, V104, P17216, DOI 10.1073/pnas.0704680104; Gombos Z, 2002, BIOCHEMISTRY-US, V41, P3796, DOI 10.1021/bi011884h; Sato N, 2000, P NATL ACAD SCI USA, V97, P10655, DOI 10.1073/pnas.97.19.10655; Jarvis P, 2000, P NATL ACAD SCI USA, V97, P8175, DOI 10.1073/pnas.100132197; Okazaki Y, 2009, PLANT CELL, V21, P892, DOI 10.1105/tpc.108.063925; DORMANN P, 1995, PLANT CELL, V7, P1801; Kobayashi K, 2009, PLANT J, V57, P322, DOI 10.1111/j.1365-313X.2008.03692.x; HOBE S, 1994, EMBO J, V13, P3423; Tanoue R, 2014, FEBS LETT, V588, P1680, DOI 10.1016/j.febslet.2014.03.010; Sakurai I, 2003, PLANT PHYSIOL, V133, P1376, DOI 10.1104/pp.103.026955; Wada H, 2007, PHOTOSYNTH RES, V92, P205, DOI 10.1007/s11120-007-9203-z; Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Zhou YH, 2013, PLANT J, V75, P867, DOI 10.1111/tpj.12248; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; KUANG TY, 1984, ARCH BIOCHEM BIOPHYS, V235, P618, DOI 10.1016/0003-9861(84)90236-4; Domonkos I, 2004, PLANT PHYSIOL, V134, P1471, DOI 10.1104/pp.103.037754; Kakizaki T, 2009, PLANT PHYSIOL, V151, P1339, DOI 10.1104/pp.109.145987; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Sato N, 2004, BBA-BIOENERGETICS, V1658, P235, DOI 10.1016/j.bbabio.2004.06.008; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Yu B, 2002, P NATL ACAD SCI USA, V99, P5732, DOI 10.1073/pnas.082696499; Kelly AA, 2002, J BIOL CHEM, V277, P1166, DOI 10.1074/jbc.M110066200; HOBE S, 1995, BIOCHEMISTRY-US, V34, P10224, DOI 10.1021/bi00032a016; Mizusawa N, 2012, BBA-BIOENERGETICS, V1817, P194, DOI 10.1016/j.bbabio.2011.04.008; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; Kirchhoff H, 2003, BBA-BIOENERGETICS, V1606, P105, DOI 10.1016/S0005-2728(03)00105-1; Hagio M, 2000, PLANT PHYSIOL, V124, P795, DOI 10.1104/pp.124.2.795; Babiychuk E, 2003, PLANT J, V33, P899, DOI 10.1046/j.1365-313X.2003.01680.x; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; Kobayashi K, 2004, PLANT PHYSIOL, V134, P640, DOI 10.1104/pp.103.032656; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; De Santis-Maciossek G, 1999, PLANT J, V18, P477, DOI 10.1046/j.1365-313X.1999.00473.x; Droppa M, 1995, PHOTOSYNTH RES, V46, P287, DOI 10.1007/BF00020442; DUBERTRET G, 1994, EUR J BIOCHEM, V226, P473, DOI 10.1111/j.1432-1033.1994.tb20072.x; El Maanni A, 1998, PLANT PHYSIOL BIOCH, V36, P609, DOI 10.1016/S0981-9428(98)80009-0; Fujii S, 2014, PLANT PHYSIOL, V166, P1436, DOI 10.1104/pp.114.250050; Gao JP, 2009, PLANT J, V60, P832, DOI 10.1111/j.1365-313X.2009.04001.x; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; JORDAN BR, 1983, BIOCHIM BIOPHYS ACTA, V725, P77, DOI 10.1016/0005-2728(83)90226-8; Kelly AA, 2003, PLANT CELL, V15, P2694, DOI 10.1105/tpc.016675; Kobayashi K, 2013, PLANT J, V73, P250, DOI 10.1111/tpj.12028; Kobayashi K, 2009, PLANT PHYSIOL BIOCH, V47, P518, DOI 10.1016/j.plaphy.2008.12.012; Kobayashi K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00272; Li-Beisson Yonghua, 2013, Arabidopsis Book, V11, pe0161, DOI 10.1199/tab.0161; MCCOURT P, 1985, PLANT PHYSIOL, V78, P853, DOI 10.1104/pp.78.4.853; MELIS A, 1987, PHOTOCHEM PHOTOBIOL, V45, P129, DOI 10.1111/j.1751-1097.1987.tb08413.x; Okazaki Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2512; Powikrowska M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00424; Toyooka K, 2000, J CELL BIOL, V148, P453, DOI 10.1083/jcb.148.3.453; Yu B, 2003, PLANT J, V36, P762, DOI 10.1046/j.1365-313X.2003.01918.x	54	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-7714	1432-203X		PLANT CELL REP	Plant Cell Reports	APR	2015	34	4			SI		631	642		10.1007/s00299-014-1719-z		12	Plant Sciences	Plant Sciences	CE2AA	WOS:000351613300010		
J	Kaewubon, P; Hutadilok-Towatana, N; da Silva, JAT; Meesawat, U				Kaewubon, Paveena; Hutadilok-Towatana, Nongporn; da Silva, Jaime A. Teixeira; Meesawat, Upatham			Ultrastructural and biochemical alterations during browning of pigeon orchid (Dendrobium crumenatum Swartz) callus	PLANT CELL TISSUE AND ORGAN CULTURE			English	Article						Browning; Phenolic content; Pigeon orchid; Polyphenol oxidase; Swollen chloroplast; Tannin	PROGRAMMED CELL-DEATH; IN-VITRO; POLYPHENOL OXIDASE; OXIDATIVE STRESS; SOMATIC EMBRYOGENESIS; PLANT-REGENERATION; PHENOLIC-COMPOUNDS; TISSUE-CULTURE; ARABIDOPSIS-THALIANA; ANTIOXIDANT ENZYMES	The phenomenon of browning can be a major limitation for orchid callus culture, causing a loss of regenerative capacity and subsequent cell death. This research was conducted to determine the effect of in vitro culture period (1-3 months) on the appearance of tissue browning. Biological alterations at the cellular and subcellular levels, as well as biochemical aspects, were examined. Callus derived from bisected pigeon orchid (Dendrobium crumenatum Swartz) protocorms were cultured on modified Vacin and Went solid medium supplemented with 0.5 mg L-1 1-naphthaleneacetic acid and 1 mg L-1 6-benzyladenine. Callus that was not subcultured was collected at 1-month intervals and examined for structural (using scanning electron microscopy and transmission electron microscopy) and biochemical alterations associated with browning. Three-month-old unsubcultured callus cells were loosely arranged and major organelles were deformed, exhibiting nuclear envelope breakage, dysfunctional mitochondria, tannin-filled vesicles and swollen chloroplasts, relative to 1-month-old green callus, which served as the control. Ultrastructural disorganization involving the nucleus, mitochondria and chloroplasts typified enzymatic oxidative browning. Browning 3-month-old callus had significantly higher polyphenol oxidase (PPO) activity and total phenolic content than control callus. The levels of PPO and total phenolics may serve as useful biochemical markers when selecting suitable callus for subsequent regeneration trials or for particle bombardment in genetic transformation experiments.	[Kaewubon, Paveena; Meesawat, Upatham] Prince Songkla Univ, Fac Sci, Dept Biol, Hat Yai 90112, Thailand; [Hutadilok-Towatana, Nongporn] Prince Songkla Univ, Dept Biochem, Fac Sci, Hat Yai 90112, Thailand; [Hutadilok-Towatana, Nongporn] Prince Songkla Univ, Nat Prod Res Ctr Excellence, Hat Yai 90112, Thailand; [da Silva, Jaime A. Teixeira] Miki Cho Post Off, Ikenobe, Kagawa 7610799, Japan	Meesawat, U (reprint author), Prince Songkla Univ, Fac Sci, Dept Biol, Hat Yai 90112, Thailand.	upatham.m@gmail.com			Department of Biology at Faculty of Science, Graduate School of Prince of Songkla University; Science Achievement Scholarship of Thailand (SAST) [28/2554]	This work was supported by the Department of Biology at Faculty of Science, Graduate School of Prince of Songkla University and by a grant from Science Achievement Scholarship of Thailand (SAST) (28/2554). We thank Dr. Brian Hodgson from the Faculty of Pharmaceutical Science, Prince of Songkla University, for assistance with the English of the manuscript.	Adelberg JW, 1997, PLANT CELL TISS ORG, V48, P1, DOI 10.1023/A:1005751030212; Ahmad I, 2013, J AGR ENV SCI, V13, P539; Amirjani M.R., 2010, EUR J BIOL SCI, V3, P6; Arnaldos TL, 2001, PHYSIOL PLANTARUM, V113, P315; da Silva JAT, 2006, J PLANT GROWTH REGUL, V25, P203, DOI 10.1007/s00344-005-0104-0; FEDER N, 1968, AM J BOT, V55, P123, DOI 10.2307/2440500; Zhang XZ, 2005, J AM SOC HORTIC SCI, V130, P836; Cassells AC, 2001, PLANT CELL TISS ORG, V64, P145, DOI 10.1023/A:1010692104861; Debnath M, 2006, CURR PHARM BIOTECHNO, V7, P33, DOI 10.2174/138920106775789638; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; Stefanowska M, 2002, ANN BOT-LONDON, V90, P637, DOI 10.1093/aob/mcf241; Naz S, 2008, PAK J BOT, V40, P2525; Bairu MW, 2011, PLANT GROWTH REGUL, V63, P147, DOI 10.1007/s10725-010-9554-x; Hofius D, 2009, CELL, V137, P773, DOI 10.1016/j.cell.2009.02.036; Kratsch HA, 2000, PLANT CELL ENVIRON, V23, P337, DOI 10.1046/j.1365-3040.2000.00560.x; Benson EE, 2000, IN VITRO CELL DEV-PL, V36, P141; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Toivonen PMA, 2008, POSTHARVEST BIOL TEC, V48, P1, DOI 10.1016/j.postharvbio.2007.09.004; Gunawardena AHLAN, 2007, AM J BOT, V94, P1116, DOI 10.3732/ajb.94.7.1116; Wi SG, 2005, J PLANT BIOL, V48, P195; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; Verdeil JL, 2007, TRENDS PLANT SCI, V12, P245, DOI 10.1016/j.tplants.2007.04.002; Bi YH, 2009, BIOL CELL, V101, P629, DOI 10.1042/BC20090015; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; El-Tayeb MA, 2005, PLANT GROWTH REGUL, V45, P215, DOI 10.1007/s10725-005-4928-1; Belarmino MM, 2000, PLANT CELL REP, V19, P435, DOI 10.1007/s002990050752; Oren-Shamir M, 2009, PLANT SCI, V177, P310, DOI 10.1016/j.plantsci.2009.06.015; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Santiago LJM, 2000, ANN BOT-LONDON, V86, P1023, DOI 10.1006/anbo.2000.1271; Zhao P, 2008, IN VITRO CELL DEV-PL, V44, P178, DOI 10.1007/s11627-007-9101-2; Ramel F, 2012, PLANT PHYSIOL, V158, P1267, DOI 10.1104/pp.111.182394; Chang C, 1998, PLANT CELL REP, V17, P251, DOI 10.1007/s002990050387; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Hu JP, 2012, PLANT CELL, V24, P2279, DOI 10.1105/tpc.112.096586; He Y, 2009, PLANT CELL TISS ORG, V98, P11, DOI 10.1007/s11240-009-9533-y; Brehelin C, 2007, TRENDS PLANT SCI, V12, P260, DOI 10.1016/j.tplants.2007.04.003; Fortes AM, 2000, AM J BOT, V87, P971, DOI 10.2307/2656996; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Wang XD, 2011, ANN BOT-LONDON, V107, P599, DOI 10.1093/aob/mcq269; Chapman KD, 2012, J LIPID RES, V53, P215, DOI 10.1194/jlr.R021436; Gacche RN, 2006, INDIAN J CHEM TECHN, V13, P459; Yoruk R, 2003, J FOOD BIOCHEM, V27, P361, DOI 10.1111/j.1745-4514.2003.tb00289.x; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; Gunawardena AHLAN, 2005, PLANTA, V221, P607, DOI 10.1007/s00425-005-1545-1; Weisany W, 2012, PLANT OMICS, V5, P60; Sevengor S, 2011, AFR J AGR RES, V6, P4920; Steinmacher DA, 2011, ANN BOT-LONDON, V108, P1463, DOI 10.1093/aob/mcr033; Stewart SL, 2002, AQUAT BOT, V72, P25, DOI 10.1016/S0304-3770(01)00214-5; Brillouet JM, 2013, ANN BOT-LONDON, V112, P1003, DOI 10.1093/aob/mct168; Pitzschke A, 2009, MOL PLANT, V2, P120, DOI 10.1093/mp/ssn079; Yingsanga P, 2008, POSTHARVEST BIOL TEC, V50, P164, DOI 10.1016/j.postharvbio.2008.05.004; Appezzato-da-Gloria Beatriz, 2004, Revista Brasileira de Botanica, V27, P429, DOI 10.1590/S0100-84042004000300004; BEGUM AA, 1994, J JPN SOC HORTIC SCI, V63, P419; Bennici A., 2009, Caryologia, V62, P124; Bewick V, 2004, CRIT CARE, V8, P130, DOI 10.1186/cc2836; Bian W, 2011, J BOT; Bobak M, 2004, ACTA PHYSIOL PLANT, V26, P353, DOI 10.1007/s11738-004-0025-8; Boguszewska D, 2012, OXIDATIVE STRESS MOL, P341, DOI DOI 10.5772/33589; Dai J, 1993, THESIS U HAWAII; de Pinto MC, 2004, J EXP BOT, V55, P2559, DOI 10.1093/jxb/erh253; Dubravina GA, 2005, RUSS J PLANT PHYSL+, V52, P672, DOI 10.1007/s11183-005-0100-z; Fu ZZ, 2011, MAEJO INT J SCI TECH, V5, P252; George EF, 2008, PLANT PROPAGATION TI, V1, P1, DOI DOI 10.1007/S11240-008-9357-1; Ghozlène I., 2013, Annals of Biological Research, V4, P11; Hazubska-Przybyl T, 2008, DENDROBIOLOGY, V60, P19; Huang LC, 2002, IN VITRO CELL DEV-PL, V38, P358, DOI 10.1079/IVP2002298; Jones AMP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076802; Khosravi AR, 2008, AFR J BIOTECHNOL, V7, P4093; Laukkanen H, 2000, TREE PHYSIOL, V20, P467; Lee SH, 2002, J EXP BOT, V53, P2225, DOI 10.1093/jxb/erf071; Leng PS, 2009, ACTA HORTIC, V829, P127; Leong TM, 2013, NAT SINGAP, V6, P91; Ling ACK, 2007, J TROP AGR FOOD SCI, V35, P147; Liu Fu-Ping, 2010, Wuhan Zhiwuxue Yanjiu, V28, P737, DOI 10.3724/SP.J.1142.2010.60737; Marín-Méndez Walter, 2009, Rev. biol. trop, V57, P129; MATILE P, 1968, PLANTA, V80, P159, DOI 10.1007/BF00385592; Mauseth JD, 2014, BOT INTRO PLANT BIOL; Meesawat U, 2007, ORCHID SCI BIOTECH, V1, P6; Misra P, 2010, BIOMASS BIOENERG, V34, P1861, DOI 10.1016/j.biombioe.2010.07.027; Mondal Tustu, 2013, Plant Tissue Culture & Biotechnology, V23, P251; MUELLER WC, 1978, J EXP BOT, V29, P757, DOI 10.1093/jxb/29.3.757; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Najafi S., 2014, Journal of Stress Physiology & Biochemistry, V10, P316; North J. J., 2012, International Journal of Physical Sciences, V7, P638; Palama TL, 2010, BMC PLANT BIOL, V10, P1; Park SY, 2006, J PLANT BIOL, V49, P358; Peng H, 2009, PROG NAT SCI-MATER, V19, P1037, DOI 10.1016/j.pnsc.2008.10.014; PIHAKASKIMAUNSBACH K, 1993, PHYSIOL PLANTARUM, V87, P167, DOI 10.1111/j.1399-3054.1993.tb00139.x; Reynolds SS, 1963, J CELL BIOL, V17, P208, DOI DOI 10.1083/JCB.17.1.208; Ribeiro LD, 2012, ACTA SCI-AGRON, V34, P423, DOI 10.4025/actasciagron.v34i4.14501; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Sandalio LM, 2013, PEROXISOMES THEIR KE, P231; Sapers GM, 2002, FOOD ADDITIVES, P543; Sharma P., 2012, J BOT, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/217037]; Shi Q, 2011, THESIS SICHUAN AGR U; Ajeet Singh, 2009, International Journal of Integrative Biology, V7, P117; Speranza A, 2007, CHEMOSPHERE, V66, P1165, DOI 10.1016/j.chemosphere.2006.08.019; STEIN VC, 2010, PENN REV ARVORE, V34, P789; Sunkar R, 2010, METHODS MOL BIOL, V639, P1, DOI 10.1007/978-1-60761-702-0; Tang W, 2004, PLANT SCI, V167, P621, DOI 10.1016/j.plantsci.2004.05.024; da Silva JAT, 2013, SCI HORTIC-AMSTERDAM, V159, P59, DOI 10.1016/j.scienta.2013.05.001; Teixeira da Silva JA, 2012, ASIAN AUSTRALAS J PL, V6, P125; Terzi R, 2013, TURK J BIOL, V37, P614, DOI 10.3906/biy-1210-27; Tokuhara K, 2001, IN VITRO CELL DEV-PL, V37, P457; Tripathy Baishnab Charan, 2012, Plant Signal Behav, V7, P1621, DOI 10.4161/psb.22455; Wang JB, 2010, ACTA HORTIC, V863, P613; Wang W, 2012, BMC PLANT BIOL, V12, P1; Wu Z, 2009, IN VITRO CELL DEV-PL, V45, P483, DOI 10.1007/s11627-008-9180-8; Xu CJ, 2010, N HORTIC, V21, P90; Xu ChuanJun, 2006, Acta Horticulturae Sinica, V33, P671; Xu ChuanJun, 2005, Acta Horticulturae Sinica, V32, P1111; Yamauchi Naoki, 2004, Phytochemistry Reviews, V3, P221, DOI 10.1023/B:PHYT.0000047796.98784.06; Yang LiYan, 2013, American Journal of Plant Sciences, V4, P1285, DOI 10.4236/ajps.2013.46159; Yin Fang, 2006, Acta Horticulturae Sinica, V33, P1137; Yoshinaga K, 2005, ANN BOT-LONDON, V96, P337, DOI 10.1093/aob/mci181; Zenkteler E., 2007, BIODIVERS RES CONSER, V5-8, P81; Zhao Ying, 2010, Acta Horticulturae Sinica, V37, P963; Zhou W, 2009, GENES GENOMES GENOMI, V3, P68	118	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6857	1573-5044		PLANT CELL TISS ORG	Plant Cell Tissue Organ Cult.	APR	2015	121	1					53	69		10.1007/s11240-014-0678-y		17	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CE0UZ	WOS:000351524900006		
J	Duan, XW; Zhang, WN; Huang, J; Zhao, LM; Ma, C; Hao, L; Yuan, H; Harada, T; Li, TZ				Duan, Xuwei; Zhang, Wenna; Huang, Jing; Zhao, Limin; Ma, Chao; Hao, Li; Yuan, Hui; Harada, Takeo; Li, Tianzhong			KNOTTED1 mRNA undergoes long-distance transport and interacts with movement protein binding protein 2C in pear (Pyrus betulaefolia)	PLANT CELL TISSUE AND ORGAN CULTURE			English	Article						Pyrus betulaefolia Bunge; PbKN1; PbMPB2C; mRNA transport; Interaction	TO-CELL TRAFFICKING; HOMEODOMAIN PROTEIN; PHLOEM-MOBILE; TOBACCO; POTATO; VIRUS; TOMATO; MPB2C; IDENTIFICATION; ARABIDOPSIS	KNOTTED1 (KN1)-like homologous box is a homeodomain transcription factor that is transported intercellularly through plasmodesmata and over long distances via phloem transport in plants. In this study, we investigated KN1 long-distance transport and its regulation by the viral movement protein binding protein of 'Du Li' (Pyrus betulaefolia, PbMPB2C) in two species of fruit trees, 'Du Li' (rootstock) and 'Ya Li' (P. bretschneideri, scion), using grafting experiments. The results showed that PbKN1 mRNA was present in the phloem in both transport directions across the graft junctions of tissue-cultured grafted plants and orchard saplings. To investigate the relationship between PbKN1 and PbMPB2C, we conducted interaction assays to demonstrate their physical interaction. An RNA-protein pull-down assay revealed that PbKN1 mRNA interacted with PbMPB2C protein in vitro but not with PbKN1 and that PbKN1 repressed the binding of PbMPB2C to PbKN1 mRNA. Additionally, using p35S:GFP-PbKN1 transgenic tobacco grafted with wild-type plants, we found that the movement of PbKN1 was increased by the silencing of NtMPB2C. Based on the above findings, we first demonstrate evidence of the bidirectional transport of PbKN1 mRNA and propose that PbMPB2C could act as a negative regulator of the phloem-mediated long-distance transport of PbKN1 mRNA.	[Duan, Xuwei; Zhang, Wenna; Huang, Jing; Zhao, Limin; Ma, Chao; Hao, Li; Yuan, Hui; Li, Tianzhong] China Agr Univ, Coll Agron & Biotech, Lab Fruit Cell & Mol Breeding, Beijing 100193, Peoples R China; [Harada, Takeo] Hirosaki Univ, Fac Agr & Life Sci, Lab Plant Breeding & Genet, Hirosaki, Aomori 0368561, Japan	Li, TZ (reprint author), China Agr Univ, Coll Agron & Biotech, Lab Fruit Cell & Mol Breeding, Beijing 100193, Peoples R China.	litianzhong1535@163.com			Doctoral Program Special Fund of the Ministry of Education in China [20130008110006]; National Natural Science Foundation of China [31372035]	We thank Dr. Aide Wang (Shenyang Agricultural University, Shenyang, China) and Dr. Alexander Ivakov (Max-Planck Institute of Molecular Plant Physiology-Golm) for giving the helpful comments and examining the English usage in the manuscript. This work was supported by the Doctoral Program Special Fund of the Ministry of Education in China (20130008110006) and National Natural Science Foundation of China (31372035).	Kim M, 2001, SCIENCE, V293, P287, DOI 10.1126/science.1059805; Deeken R, 2008, PLANT J, V55, P746, DOI 10.1111/j.1365-313X.2008.03555.x; KERSTETTER R, 1994, PLANT CELL, V6, P1877, DOI 10.1105/tpc.6.12.1877; Mahajan A, 2012, PLANT MOL BIOL, V79, P595, DOI 10.1007/s11103-012-9931-0; Gomez G, 2005, PLANT J, V41, P107, DOI 10.1111/j.1365-313X.2004.02278.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Kudo H, 2007, HORTSCIENCE, V42, P225; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275; Meng D, 2014, PLANT CELL TISS ORG, V117, P465, DOI 10.1007/s11240-014-0457-9; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Kim JY, 2003, DEVELOPMENT, V130, P4351, DOI 10.1242/dev.00618; Xu HY, 2010, TREE GENET GENOMES, V6, P1013, DOI 10.1007/s11295-010-0309-7; Ham BK, 2009, PLANT CELL, V21, P197, DOI 10.1105/tpc.108.061317; Banerjee AK, 2006, PLANT CELL, V18, P3443, DOI 10.1105/tpc.106.042473; Haywood V, 2005, PLANT J, V42, P49, DOI 10.1111/j.1365-313X.2005.02351.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Shani E, 2006, CURR OPIN PLANT BIOL, V9, P484, DOI 10.1016/j.pbi.2006.07.008; Banerjee AK, 2009, PLANT PHYSIOL, V151, P1831, DOI 10.1104/pp.109.144428; Box MS, 2012, J EXP BOT, V63, P695; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Cho SY, 2012, VIROLOGY, V427, P166, DOI 10.1016/j.virol.2012.02.005; Curin M, 2007, PLANT PHYSIOL, V143, P801, DOI 10.1104/pp.106.091488; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Fichtenbauer Daniela, 2012, Plant Signal Behav, V7, P318, DOI 10.4161/psb.19152; Kanehira A, 2009, TREE GENET GENOMES, V6, P635; Kim JY, 2005, GENE DEV, V19, P788, DOI 10.1101/gad.332805; Kragler F, 2003, PLANT PHYSIOL, V132, P1870, DOI 10.1104/pp.103.022269; Kragler F, 1998, PLANT J, V15, P367, DOI 10.1046/j.1365-313X.1998.00219.x; Kuijt SJH, 2004, PLANT MOL BIOL, V55, P781, DOI 10.1007/s11103-004-1967-3; Mallory C, 2003, PLANT J, V35, P82; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ratanasut K, 2015, PLANT CELL TISS ORG, V120, P643, DOI 10.1007/s11240-014-0632-z; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sambrook J., 1989, MOL CLONING LAB MANU; Schmitt B, 2008, PLANT PHYSIOL, V148, P187, DOI 10.1104/pp.108.120410; Winter N, 2007, PLANT CELL, V19, P3001, DOI 10.1105/tpc.107.044354; Xu XM, 2011, SCIENCE, V333, P1141, DOI 10.1126/science.1205727; Zhang WN, 2013, BIOL PLANTARUM, V57, P224, DOI 10.1007/s10535-012-0293-x; Zhang WN, 2012, PLANT MOL BIOL REP, V30, P614, DOI 10.1007/s11105-011-0365-7	41	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6857	1573-5044		PLANT CELL TISS ORG	Plant Cell Tissue Organ Cult.	APR	2015	121	1					109	119		10.1007/s11240-014-0685-z		11	Biotechnology & Applied Microbiology; Plant Sciences	Biotechnology & Applied Microbiology; Plant Sciences	CE0UZ	WOS:000351524900010		
J	Chowdhury, MTI; Naito, M; Yanagita, RC; Kawanami, Y				Chowdhury, Md Tazul Islam; Naito, Madoka; Yanagita, Ryo C.; Kawanami, Yasuhiro			Synthesis of 6-O-decanoyl-D-altrose and 6-O-decanoyl-D-gulose and evaluation of their biological activity on plant growth	PLANT GROWTH REGULATION			English	Article						Rare sugar; Rare sugar ester; Regioselective transesterification; Inhibitory activity	D-ALLOSE; D-PSICOSE; BIOPRODUCTION; SPECIFICITY	Two new growth inhibitory compounds, 6-O-decanoyl-d-altrose and 6-O-decanoyl-d-gulose, were synthesized from d-altrose (C-2 epimer of d-allose) and d-gulose (C-4 epimer of d-allose), respectively, via lipase-catalyzed transesterification using vinyl decanoate. Furthermore, the inhibitory activity of 6-O-decanoyl-d-altrose and 6-O-decanoyl-d-gulose on different plant growths were examined. These two new rare sugar derivatives exhibited the inhibitory activity on the growth of cress, Italian rye grass, and rice seedlings similar to 6-O-decanoyl-d-allose, but in the case of lettuce, they showed the weaker inhibitory activity than 6-O-decanoyl-d-allose. In addition, we found that the co-addition of gibberellins (GAs) with a test solution of 6-O-decanoyl-d-altrose or 6-O-decanoyl-d-gulose on rice seedlings brought the recovery of inhibition. These results suggest that the d-altrose and d-gulose esters as well as the d-allose ester inhibited the biosynthesis of GAs to exhibit the plant growth inhibitory activity.	[Chowdhury, Md Tazul Islam; Naito, Madoka; Yanagita, Ryo C.; Kawanami, Yasuhiro] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 7610795, Japan	Kawanami, Y (reprint author), Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 7610795, Japan.	kawanami@ag.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	The first author is grateful to the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan for providing financial support and also thankful to Dr. Mirza Hasanuzzaman, Department of Agronomy, Sher-e-Bangla Agricultural University, Bangladesh for critically reading of the manuscript.	Afach G, 2006, BIOSCI BIOTECH BIOCH, V70, P2010, DOI 10.1271/bbb.60150; Afach G, 2005, BIOSCI BIOTECH BIOCH, V69, P833, DOI 10.1271/bbb.69.833; CHARI VM, 1981, PHYTOCHEMISTRY, V20, P1977, DOI 10.1016/0031-9422(81)84048-4; Takeshita K, 2000, J BIOSCI BIOENG, V90, P453, DOI 10.1263/jbb.90.453; GRAEBE JE, 1987, ANNU REV PLANT PHYS, V38, P419; Weckwerth W, 2004, P NATL ACAD SCI USA, V101, P7809, DOI 10.1073/pnas.0303415101; RIDDELL JA, 1962, SCIENCE, V136, P391, DOI 10.1126/science.136.3514.391; Gumina G, 2001, FEMS MICROBIOL LETT, V202, P9, DOI 10.1016/S0378-1097(01)00285-3; Izumori K, 2006, J BIOTECHNOL, V124, P717, DOI 10.1016/j.jbiotec.2006.04.016; Murata A, 2003, J BIOSCI BIOENG, V96, P89, DOI 10.1016/S1389-1723(03)90104-6; Mu WM, 2012, APPL MICROBIOL BIOT, V94, P1461, DOI 10.1007/s00253-012-4093-1; Lim YR, 2011, APPL MICROBIOL BIOT, V91, P229, DOI 10.1007/s00253-011-3370-8; Bae J, 2005, BIOCHEM BIOPH RES CO, V334, P754, DOI 10.1016/j.bbrc.2005.06.160; Bhuiyan SH, 1998, J FERMENT BIOENG, V85, P539, DOI 10.1016/S0922-338X(98)80104-9; CATHEY HENRY M., 1961, BOT GAZ, V123, P51, DOI 10.1086/336129; Chenault HK, 1997, J ORG CHEM, V62, P331, DOI 10.1021/jo961715g; Fujii T, 1996, J JPN OIL CHEM SOC, V45, P1013; Hoshikawa H, 2011, CANCER LETT, V306, P60, DOI 10.1016/j.canlet.2011.02.032; Hossain Mohammad Akram, 2003, J Hepatobiliary Pancreat Surg, V10, P218, DOI 10.1007/s00534-002-0785-8; Hossain MA, 2000, TRANSPLANT P, V32, P2021, DOI 10.1016/S0041-1345(00)01540-2; Izumori K, 2002, NATURWISSENSCHAFTEN, V89, P120, DOI 10.1007/s00114-002-0297-z; JENSEN SR, 1981, PHYTOCHEMISTRY, V20, P71, DOI 10.1016/0031-9422(81)85221-1; Kobayashi M, 2010, BIOSCI BIOTECH BIOCH, V74, P216, DOI 10.1271/bbb.90713; LEVIN GV, 1995, AM J CLIN NUTR, V62, P1161; MARTH PC, 1953, BOT GAZ, V115, P200, DOI 10.1086/335816; OGAWA Y, 1963, PLANT CELL PHYSIOL, V4, P227; Ogino K, 1996, J JPN OIL CHEM SOC, V45, P921; PEROLD GW, 1973, J CHEM SOC PERK T 1, P643, DOI 10.1039/p19730000643; RADEMACHER W, 1991, GIBBERELLINS, P296; Sui L, 2005, INT J ONCOL, V27, P907; Tolbert NE, 1961, ADV CHEM SER, V28, P145	31	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6903	1573-5087		PLANT GROWTH REGUL	Plant Growth Regul.	APR	2015	75	3					707	713		10.1007/s10725-014-9972-2		7	Plant Sciences	Plant Sciences	CD6PF	WOS:000351210700012		
J	Zhang, LC; Ma, G; Yamawaki, K; Ikoma, Y; Matsumoto, H; Yoshioka, T; Ohta, S; Kato, M				Zhang, Lancui; Ma, Gang; Yamawaki, Kazuki; Ikoma, Yoshinori; Matsumoto, Hikaru; Yoshioka, Terutaka; Ohta, Satoshi; Kato, Masaya			Regulation of ascorbic acid metabolism by blue LED light irradiation in citrus juice sacs	PLANT SCIENCE			English	Article						AsA; Continuous irradiation; Pulsed irradiation; Regulatory mechanism	VITAMIN-C CONTENT; FRUIT-DEVELOPMENT; L-GALACTONO-1,4-LACTONE DEHYDROGENASE; POSTHARVEST BROCCOLI; HARVESTED BROCCOLI; HYDROGEN-PEROXIDE; GENE-EXPRESSION; HIGHER-PLANTS; IN-VITRO; ARABIDOPSIS	In the present study, the effects of red and blue LED lights on the accumulation of ascorbic acid (AsA) were investigated in the juice sacs of three citrus varieties, Satsuma mandarin, Valencia orange, and Lisbon lemon. The results showed that the blue LED light treatment effectively increased the AsA content in the juice sacs of the three citrus varieties, whereas the red LED light treatment did not. By increasing the blue LED light intensity, the juice sacs of the three citrus varieties accumulated more AsA. Moreover, continuous irradiation with blue LED light was more effective than pulsed irradiation for increasing the AsA content in the juice sacs of the three citrus varieties. Gene expression results showed that the modulation of AsA accumulation by blue LED light was highly regulated at the transcription level. The up-regulation of AsA biosynthetic genes (CitVTC1,CitVTC2, CitVTC4, and CitGLDH), AsA regeneration genes (CitMDAR1, CitMDAR2, and CitDHAR) and two GSH-producing genes (CitGR and CitchGR) contributed to these increases in the AsA content in the three citrus varieties. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Zhang, Lancui; Ma, Gang; Yamawaki, Kazuki; Kato, Masaya] Shizuoka Univ, Fac Agr, Dept Biol & Environm Sci, Shizuoka 4228529, Japan; [Ikoma, Yoshinori; Matsumoto, Hikaru; Yoshioka, Terutaka; Ohta, Satoshi] NARO Inst Fruit Tree Sci, Dept Citrus Res, Shimizu, Shizuoka 4240292, Japan	Kato, M (reprint author), Shizuoka Univ, Fac Agr, Dept Biol & Environm Sci, 836 Ohya, Shizuoka 4228529, Japan.	amkato@ipc.shizuoka.ac.jp					SAEBO A, 1995, PLANT CELL TISS ORG, V41, P177; Mhamdi A, 2010, PLANT PHYSIOL, V153, P1144, DOI 10.1104/pp.110.153767; Tokunaga T, 2005, PLANTA, V220, P854, DOI 10.1007/s00425-004-1406-3; Briggs WR, 2001, PLANT CELL, V13, P993, DOI 10.1105/tpc.13.5.993; Pateraki I, 2004, J EXP BOT, V55, P1623, DOI 10.1093/jxb/erh186; Lin KH, 2013, SCI HORTIC-AMSTERDAM, V150, P86, DOI 10.1016/j.scienta.2012.10.002; Gallie DR, 2013, J EXP BOT, V64, P433, DOI 10.1093/jxb/ers330; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; Mori T, 2009, POSTHARVEST BIOL TEC, V52, P134, DOI 10.1016/j.postharvbio.2008.10.001; Karpinski S, 1997, PLANT CELL, V9, P627, DOI 10.1105/tpc.9.4.627; Mittova V, 2000, PHYSIOL PLANTARUM, V110, P42, DOI 10.1034/j.1399-3054.2000.110106.x; Gatzek S, 2002, PLANT J, V30, P541, DOI 10.1046/j.1365-313X.2002.01315.x; Bartoli CG, 2006, J EXP BOT, V57, P1621, DOI 10.1093/jxb/erl005; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wu MC, 2007, FOOD CHEM, V101, P1753, DOI 10.1016/j.foodchem.2006.02.010; Chen Z, 2003, P NATL ACAD SCI USA, V100, P3525, DOI 10.1073/pnas.0635176100; Liu LH, 2009, FOOD CHEM, V115, P495, DOI 10.1016/j.foodchem.2008.12.042; Ma G, 2014, POSTHARVEST BIOL TEC, V94, P97, DOI 10.1016/j.postharvbio.2014.03.010; Alba R, 2000, PLANT PHYSIOL, V123, P363, DOI 10.1104/pp.123.1.363; Fryer MJ, 2003, PLANT J, V33, P691, DOI 10.1046/j.1365-313X.2003.01656.x; Zhang LC, 2012, J EXP BOT, V63, P871, DOI 10.1093/jxb/err318; Ioannidi E, 2009, J EXP BOT, V60, P663, DOI [10.1093/jxb/ern322, 10.1093/jxb/em322]; Hancock RD, 2005, J AGR FOOD CHEM, V53, P5248, DOI 10.1021/jf0503863; Bulley SM, 2009, J EXP BOT, V60, P765, DOI 10.1093/jxb/ern327; Mastropasqua L, 2012, PLANT SCI, V183, P57, DOI 10.1016/j.plantsci.2011.11.009; Bartoli CG, 2009, FEBS LETT, V583, P118, DOI 10.1016/j.febslet.2008.11.034; Nishikawa F, 2003, J EXP BOT, V54, P2439, DOI 10.1093/jxb/erg283; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437; Davey MW, 2000, J SCI FOOD AGR, V80, P825, DOI 10.1002/(SICI)1097-0010(20000515)80:7<825::AID-JSFA598>3.0.CO;2-6; Cruz-Rus E, 2010, J PLANT PHYSIOL, V167, P739, DOI 10.1016/j.jplph.2009.12.017; Kato M, 2000, PLANT CELL PHYSIOL, V41, P440; Linster CL, 2008, TRENDS PLANT SCI, V13, P567, DOI 10.1016/j.tplants.2008.08.005; Du J, 2012, BBA-REV CANCER, V1826, P443, DOI 10.1016/j.bbcan.2012.06.003; Alos E, 2014, PLANTA, V239, P1113, DOI 10.1007/s00425-014-2044-z; Charles F, 2013, INNOV FOOD SCI EMERG, V18, P190, DOI 10.1016/j.ifset.2013.02.004; Diplock AT, 1998, BR J NUTR S1, V1, P77, DOI 10.1079/BJN19980106; Eltayeb A.E., 2007, PLANTA, V225, P1225; Felipe KB, 2013, BIOCHEM BIOPH RES CO, V433, P573, DOI 10.1016/j.bbrc.2013.03.028; Food and Drug Administration (FDA), 2000, KIN MICR IN ALT FOOD; Gallie DR, 2013, SCIENTIFICA, V2013; Gomez MLPA, 2008, J SCI FOOD AGR, V88, P756, DOI 10.1002/jsfa.3042; Imai T, 2009, PHYSIOL PLANTARUM, V136, P139, DOI 10.1111/j.1399-3054.2009.01213.x; Li MJ, 2008, PLANT SCI, V174, P606, DOI 10.1016/j.plantsci.2008.03.008; Li MJ, 2010, PLANT PHYSIOL BIOCH, V48, P216, DOI 10.1016/j.plaphy.2010.01.015; Ma G, 2010, POSTHARVEST BIOL TEC, V58, P121, DOI 10.1016/j.postharvbio.2010.05.011; Ma G, 2012, POSTHARVEST BIOL TEC, V74, P19, DOI 10.1016/j.postharvbio.2012.07.001; Ma G, 2012, J AGR FOOD CHEM, V60, P197, DOI 10.1021/jf203364m; Muller-Moule P, 2008, PLANT MOL BIOL, V68, P31, DOI 10.1007/s11103-008-9350-4; Nishikawa F, 2003, POSTHARVEST BIOL TEC, V27, P147, DOI 10.1016/S0925-5214(02)00094-7; Nishikawa F, 2001, J JPN SOC HORTIC SCI, V70, P709; Oms-Oliu G, 2010, POSTHARVEST BIOL TEC, V56, P216, DOI 10.1016/j.postharvbio.2009.12.011; Schofield A, 2005, PLANT PHYSIOL BIOCH, V43, P1052, DOI 10.1016/j.plaphy.2005.10.006; Xu HL, 2012, SCI HORTIC-AMSTERDAM, V148, P190, DOI 10.1016/j.scienta.2012.06.044; Yang XY, 2011, J PLANT PHYSIOL, V168, P2196, DOI 10.1016/j.jplph.2011.07.015	55	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-9452			PLANT SCI	Plant Sci.	APR	2015	233						134	142		10.1016/j.plantsci.2015.01.010		9	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CD7CB	WOS:000351247300014		
J	Subbarao, GV; Yoshihashi, T; Worthington, M; Nakahara, K; Ando, Y; Sahrawat, KL; Rao, IM; Lata, JC; Kishii, M; Braun, HJ				Subbarao, Guntur Venkata; Yoshihashi, Tadashi; Worthington, Margaret; Nakahara, Kazuhiko; Ando, Yasuo; Sahrawat, Kanwar Lal; Rao, Idupulapati Madhusudhana; Lata, Jean-Christophe; Kishii, Masahiro; Braun, Hans-Joachim			Suppression of soil nitrification by plants	PLANT SCIENCE			English	Review						Biological nitrification inhibition (BNI); Climate change; Global warming; Nitrification inhibitors; Nitrous oxide emissions; Nitrogen use efficiency (NUE)	NITROGEN-USE EFFICIENCY; BRACHIARIA-HUMIDICOLA ROOTS; INHIBITION BNI; AGRICULTURAL SYSTEMS; NITRIFYING BACTERIA; CLIMAX ECOSYSTEMS; MODELING APPROACH; CEREAL PRODUCTION; ORGANIC-MATTER; SORGHUM	Nitrification, the biological oxidation of ammonium to nitrate, weakens the soil's ability to retain N and facilitates N-losses from production agriculture through nitrate-leaching and denitrification. This process has a profound influence on what form of mineral-N is absorbed, used by plants, and retained in the soil, or lost to the environment, which in turn affects N-cycling, N-use efficiency (NUE) and ecosystem health and services. As reactive-N is often the most limiting in natural ecosystems, plants have acquired a range of mechanisms that suppress soil-nitrifier activity to limit N-losses via N-leaching and denitrification. Plants' ability to produce and release nitrification inhibitors from roots and suppress soil-nitrifier activity is termed 'biological nitrification inhibition' (BNI). With recent developments in methodology for in-situ measurement of nitrification inhibition, it is now possible to characterize BNI function in plants. This review assesses the current status of our understanding of the production and release of biological nitrification inhibitors (BNIs) and their potential in improving NUE in agriculture. A suite of genetic, soil and environmental factors regulate BNI activity in plants. BNI-function can be genetically exploited to improve the BNI-capacity of major food- and feed-crops to develop next-generation production systems with reduced nitrification and N2O emission rates to benefit both agriculture and the environment. The feasibility of such an approach is discussed based on the progresses made. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Subbarao, Guntur Venkata; Yoshihashi, Tadashi; Nakahara, Kazuhiko; Ando, Yasuo] Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki 3058686, Japan; [Worthington, Margaret; Rao, Idupulapati Madhusudhana] CIAT, Cali 6713, Colombia; [Sahrawat, Kanwar Lal] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Lata, Jean-Christophe] Univ Paris 06, Univ Paris 04, Ecole Normale Super, UMR 7618,Inst EESParis, F-75230 Paris, France; [Lata, Jean-Christophe] Tomsk Polytech Univ, Inst Nat Resources, Dept Geoecol & Geochem, Tomsk 634050, Russia; [Kishii, Masahiro; Braun, Hans-Joachim] CIMMYT Int Maize & Wheat Improvement Ctr, Mexico City 06600, DF, Mexico	Subbarao, GV (reprint author), Japan Int Res Ctr Agr Sci, 1-1 Ohwashi, Tsukuba, Ibaraki 3058686, Japan.	subbarao@jircas.affrc.go.jp	Lata, Jean-Christophe/A-8733-2008; 	Worthington, Margaret/0000-0001-8019-165X	MAFF (Japanese Ministry of Agriculture, Forest and Fisheries); JSPS; BMZ-GIZ, Germany; MADR, Colombia; MOFA, Japan; MAFF, Japan; SIDA, Sweden	Funding for BNI research at JIRCAS is mostly provided by MAFF (Japanese Ministry of Agriculture, Forest and Fisheries) and JSPS research grant on wheat-BNI. The research on BNI at CIAT is supported by BMZ-GIZ, Germany; MADR, Colombia; MOFA and MAFF, Japan; and SIDA, Sweden.	Raun WR, 1999, AGRON J, V91, P357; Magill AH, 2000, ECOSYSTEMS, V3, P238, DOI 10.1007/s100210000023; FISHER MJ, 1994, NATURE, V371, P236, DOI 10.1038/371236a0; Schlesinger WH, 2009, P NATL ACAD SCI USA, V106, P203, DOI 10.1073/pnas.0810193105; Osbourn A, 2010, TRENDS GENET, V26, P449, DOI 10.1016/j.tig.2010.07.001; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Smolander A, 2012, PLANT SOIL, V350, P1, DOI 10.1007/s11104-011-0895-7; Celik I, 2005, SOIL TILL RES, V83, P270, DOI 10.1016/j.still.2004.08.001; Ashton IW, 2010, ECOLOGY, V91, P3252, DOI 10.1890/09-1849.1; Turner RE, 2008, ENVIRON SCI TECHNOL, V42, P2323, DOI 10.1021/es071617k; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Subbarao GV, 2007, PLANT SOIL, V294, P5, DOI 10.1007/s11104-006-9159-3; Subbarao GV, 2007, PLANT SOIL, V299, P55, DOI 10.1007/s11104-007-9360-z; Dinnes DL, 2002, AGRON J, V94, P153; Bending GD, 2000, SOIL BIOL BIOCHEM, V32, P1261, DOI 10.1016/S0038-0717(00)00043-2; Snyder AJ, 2010, APPL SOIL ECOL, V46, P73, DOI 10.1016/j.apsoil.2010.06.011; Philippot L, 2011, TRENDS PLANT SCI, V16, P476, DOI 10.1016/j.tplants.2011.05.007; Weigelt A, 2005, OECOLOGIA, V142, P627, DOI 10.1007/s00442-004-1765-2; Smith KA, 1997, SOIL USE MANAGE, V13, P296, DOI 10.1111/j.1475-2743.1997.tb00601.x; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Subbarao GV, 2009, P NATL ACAD SCI USA, V106, P17302, DOI 10.1073/pnas.0903694106; Sutton MA, 2011, NATURE, V472, P159, DOI 10.1038/472159a; Russell AE, 2009, ECOL APPL, V19, P1102, DOI 10.1890/07-1919.1; MujeebKazi A, 1996, GENET RESOUR CROP EV, V43, P129, DOI 10.1007/BF00126756; Okada K, 2011, BIOSCI BIOTECH BIOCH, V75, P1219, DOI 10.1271/bbb.110228; KROEZE C, 1994, SCI TOTAL ENVIRON, V143, P193, DOI 10.1016/0048-9697(94)90457-X; BREMNER JM, 1978, SCIENCE, V199, P295, DOI 10.1126/science.199.4326.295; Brown PD, 2009, J AGR FOOD CHEM, V57, P7706, DOI 10.1021/jf901516h; Finzi AC, 2007, P NATL ACAD SCI USA, V104, P14014, DOI 10.1073/pnas.0706518104; Dayan FE, 2009, J EXP BOT, V60, P2107, DOI 10.1093/jxb/erp082; de Boer AH, 2012, TRENDS PLANT SCI, V17, P360, DOI 10.1016/j.tplants.2012.02.007; Subbarao GV, 2006, PLANT SOIL, V288, P101, DOI 10.1007/s11104-006-9094-3; Perveen N, 2014, GLOBAL CHANGE BIOL, V20, P1174, DOI 10.1111/gcb.12493; Subbarao GV, 2013, PLANT SOIL, V366, P243, DOI 10.1007/s11104-012-1419-9; Gopalakrishnan S, 2009, SOIL SCI PLANT NUTR, V55, P725, DOI 10.1111/j.1747-0765.2009.00398.x; Glass ADM, 2003, CRIT REV PLANT SCI, V22, P453, DOI 10.1080/07352680390243512; Matson PA, 1999, BIOGEOCHEMISTRY, V46, P67, DOI 10.1023/A:1006152112852; PROSSER JI, 1989, ADV MICROB PHYSIOL, V30, P125; Dayan FE, 2010, PHYTOCHEMISTRY, V71, P1032, DOI 10.1016/j.phytochem.2010.03.011; Norton JM, 2011, METHOD ENZYMOL, V486, P343, DOI [10.1016/B978-0-12-381294-0.00015-8, 10.1016/S0076-6879(11)86015-5]; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627; Chu HY, 2011, PLANT J, V66, P66, DOI 10.1111/j.1365-313X.2011.04503.x; Subbarao GV, 2007, PLANT SOIL, V290, P245, DOI 10.1007/s11104-006-9156-6; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; PETERJOHN WT, 1990, BIOGEOCHEMISTRY, V10, P67; Mulvaney RL, 2009, J ENVIRON QUAL, V38, P2295, DOI 10.2134/jeq2008.0527; Toyomasu T, 2007, P NATL ACAD SCI USA, V104, P3084, DOI 10.1073/pnas.0608426104; McCarty GW, 1999, BIOL FERT SOILS, V29, P1, DOI 10.1007/s003740050518; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Chu HY, 2007, APPL ENVIRON MICROB, V73, P485, DOI 10.1128/AEM.01536-06; Shimizu T, 2012, BIOENGINEERED, V3, P352, DOI 10.4161/bioe.21546; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; HAYNES RJ, 1978, BIOL REV, V53, P465, DOI 10.1111/j.1469-185X.1978.tb00862.x; Subbarao GV, 2006, CRIT REV PLANT SCI, V25, P303, DOI 10.1080/07352680600794232; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Nasholm T, 1998, NATURE, V392, P914, DOI 10.1038/31921; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Paavolainen L, 1998, PLANT SOIL, V205, P147, DOI 10.1023/A:1004335419358; Crews TE, 1999, BIOGEOCHEMISTRY, V46, P233, DOI 10.1023/A:1006141221938; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Boudsocq S, 2012, AM NAT, V180, P60, DOI 10.1086/665997; Subbarao GV, 2012, ADV AGRON, V114, P249, DOI 10.1016/B978-0-12-394275-3.00001-8; Baerson Scott R, 2008, Plant Signal Behav, V3, P667; BALDWIN IT, 1983, SOIL BIOL BIOCHEM, V15, P419, DOI 10.1016/0038-0717(83)90006-8; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Boudsocq S, 2009, FUNCT ECOL, V23, P220, DOI 10.1111/j.1365-2435.2008.01476.x; COOPER AB, 1986, PLANT SOIL, V93, P383, DOI 10.1007/BF02374289; FAO, 2011, FAOSTAT DAT AGR PROD; Fortuna A, 2003, AGR ECOSYST ENVIRON, V97, P285, DOI 10.1016/S0167-8809(02)00232-3; Gopalakrishnan S, 2007, J AGR FOOD CHEM, V55, P1385, DOI 10.1021/jf062593o; HAHN J, 1982, PHILOS T ROY SOC B, V296, P521, DOI 10.1098/rstb.1982.0024; Hart S. C., 1994, METHODS SOIL ANAL 2, V5, P985; Haynes R.J., 1986, MINERAL NITROGEN PLA, P149; Iizumi T, 1998, APPL ENVIRON MICROB, V64, P3656; Intergovernmental Panel on Climate Change (IPCC), 2014, 5 IPCC WORLD MET ORG; JORDAN CF, 1979, OECOLOGIA, V39, P123, DOI 10.1007/BF00346002; Kahrl E., 2010, ENVIRON SCI POLICY, V13, P688, DOI DOI 10.1016/J.ENVSCI.2010.07.006; Lata J.C., 1999, THESIS U PARIS FRANC; Lata JC, 2004, FUNCT ECOL, V18, P605, DOI 10.1111/j.0269-8463.2004.00880.x; Lata JC, 1999, FUNCT ECOL, V13, P762, DOI 10.1046/j.1365-2435.1999.00380.x; Leninger S., 2006, NATURE, V442, P806, DOI DOI 10.1038/NATURE04983; MARSCHNER H., 1995, MINERAL NUTR HIGHER; Moreta D. E., 2014, Tropical Grasslands - Forrajes Tropicales, V2, P88, DOI 10.17138/TGFT(2)88-91; Mujeeb-Kazi A., 2000, ANN WHEAT NEWSL, V46, P76; MUROMTSEV GS, 1994, J PLANT GROWTH REGUL, V13, P39, DOI 10.1007/BF00210706; Northup P.R., 1995, NATURE, V377, P227, DOI DOI 10.1038/377227A0; Okada A, 2009, J BIOL CHEM, V284, P26510, DOI 10.1074/jbc.M109.036871; Osbourn A., 2010, PLANT PHYSIOL, V154, P532; RICE EL, 1972, AM J BOT, V59, P1033, DOI 10.2307/2441488; RICE EL, 1974, AM J BOT, V61, P1095, DOI 10.2307/2441927; ROSS SM, 1993, PROG PHYS GEOG, V17, P265, DOI 10.1177/030913339301700301; Smits NAC, 2010, PLANT SOIL, V337, P435, DOI 10.1007/s11104-010-0539-3; Stelzer H., 1988, ECOSYSTEMS, V1, P464; Subbarao GV, 2013, ANIMAL, V7, P322, DOI 10.1017/S1751731113000761; Subbarao GV, 2013, ANN BOT-LONDON, V112, P297, DOI 10.1093/aob/mcs230; Subbarao GV, 2008, PLANT SOIL, V313, P89, DOI 10.1007/s11104-008-9682-5; Subbarao GV, 2009, BREEDING SCI, V59, P529, DOI 10.1270/jsbbs.59.529; Subbarao G. V., 2013, Tropical Grasslands - Forrajes Tropicales, V1, P168; Tesfamariam T, 2014, PLANT SOIL, V379, P325, DOI 10.1007/s11104-014-2075-z; Tubiello FN, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015009; VITOUSEK PM, 1984, SCIENCE, V225, P51, DOI 10.1126/science.225.4657.51; WHITE CS, 1991, BIOGEOCHEMISTRY, V12, P43; WHITE CS, 1988, ECOLOGY, V69, P1631, DOI 10.2307/1941663; Yang XH, 2004, J EXP BOT, V55, P2251, DOI 10.1093/jxb/erh252; Zahn L.M., 2007, SCIENCE, V318, P171; Zakir HAKM, 2008, NEW PHYTOL, V180, P442, DOI 10.1111/j.1469-8137.2008.02576.x; Zhu YY, 2012, PLANT SOIL, V358, P125, DOI 10.1007/s11104-012-1151-5	107	1	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-9452			PLANT SCI	Plant Sci.	APR	2015	233						155	164		10.1016/j.plantsci.2015.01.012		10	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CD7CB	WOS:000351247300016		
J	Kadomura-Ishikawa, Y; Miyawaki, K; Takahashi, A; Masuda, T; Noji, S				Kadomura-Ishikawa, Yasuko; Miyawaki, Katsuyuki; Takahashi, Akira; Masuda, Toshiya; Noji, Sumihare			Light and abscisic acid independently regulated FaMYB10 in Fragaria x ananassa fruit	PLANTA			English	Article						Abscisic acid (ABA); Anthocyanins; Flavonoid pathway; Light; MYB transcription factor; Strawberry fruit	VACCINIUM-MYRTILLUS L.; STRAWBERRY FRUIT; BLUE-LIGHT; ANTHOCYANIN ACCUMULATION; ARABIDOPSIS-THALIANA; PROANTHOCYANIDIN BIOSYNTHESIS; FLAVONOID BIOSYNTHESIS; ETHYLENE BIOSYNTHESIS; TRANSGENIC TOBACCO; NEGATIVE REGULATOR	Light and ABA independently regulated anthocyanin biosynthesis via activation of FaMYB10 expression. FaMYB10 accelerated anthocyanin synthesis of pelargonidin 3-glucoside and cyanidin 3-glucoside during strawberry fruit ripening. Light is an integral factor in fruit ripening. Ripening in non-climacteric fruit is also effected by the plant hormone abscisic acid (ABA). However, how light and/or ABA regulate fruit ripening processes, such as strawberry color development remains elusive. Results of the present study showed light and ABA regulated strawberry fruit coloration via activation of FaMYB10 expression, an R2R3 MYB transcription factor. Light exposure increased FaMYB10 transcript levels, flavonoid pathway genes, and anthocyanin content. Exogenous ABA promoted FaMYB10 expression, and anthocyanin content, accompanied by increased ABA-responsive transcript levels and flavonoid pathway genes. ABA biosynthesis inhibitor treatment, and RNAi-mediated down-regulation of the ABA biosynthetic gene (9-cis epoxycarotenoid dioxygenase: FaNCED1), and ABA receptor (magnesium chelatase H subunit: FaCHLH/ABAR) showed inverse ABA effects. Furthermore, additive effects were observed in anthocyanin accumulation under combined light and ABA, indicating independent light and ABA signaling pathways. FaMYB10 down-regulation by Agrobacterium-mediated RNA interference (RNAi) in strawberry fruits showed decreased pelargonidin 3-glucoside and cyanidin 3-glucoside levels, accompanied by consistent flavonoid pathway gene expression levels. FaMYB10 over-expression showed opposite FaMYB10 RNAi phenotypes, particularly cyanidin 3-glucoside synthesis by FaMYB10, which was correlated with FaF3'H transcript levels. These data provided evidence that light and ABA promoted FaMYB10 expression, resulting in anthocyanin accumulation via acceleration of flavonoid pathway gene expression. Finally, our results suggested FaMYB10 serves a role as a signal transduction mediator from light and ABA perception to anthocyanin synthesis in strawberry fruit.	[Kadomura-Ishikawa, Yasuko; Takahashi, Akira] Univ Tokushima, Fac Med, Dept Nutr, Tokushima 7708503, Japan; [Kadomura-Ishikawa, Yasuko; Miyawaki, Katsuyuki; Noji, Sumihare] Univ Tokushima, Inst Sci & Technol, Dept Life Syst, Tokushima 7708506, Japan; [Masuda, Toshiya] Univ Tokushima, Dept Integrated Arts & Sci, Tokushima 7708502, Japan	Kadomura-Ishikawa, Y (reprint author), Univ Tokushima, Fac Med, Dept Nutr, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	ishikawa-kd@tokushima-u.ac.jp; miyawaki@bio.tokushima-u.ac.jp; akiratak@nutr.med.tokushima-u.ac.jp; masuda.ias@tokushima-u.ac.jp; noji@tokushima-u.ac.jp			Ourgenic Co. Ltd (Tokushima, Japan); LED-Life project of the University of Tokushima, Japan	We thank Koichi Hayashi for cultivating and donating strawberry fruit samples. We also thank Toshifumi Miki and Keisuke Hirota (Tokushima Agricultural Research Center, Japan) for invaluable advice, and additional strawberry fruit samples. Ourgenic Co. Ltd (Tokushima, Japan) supported this research. LED-Life project of the University of Tokushima, Japan, also provided financial support for this work.	Matsui K, 2008, PLANT J, V55, P954, DOI 10.1111/j.1365-313X.2008.03565.x; Jia HF, 2013, NEW PHYTOL, V198, P453, DOI 10.1111/nph.12176; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Giliberto L, 2005, PLANT PHYSIOL, V137, P199, DOI 10.1104/pp.104.051987; Almeida JRM, 2007, ARCH BIOCHEM BIOPHYS, V465, P61, DOI 10.1016/j.abb.2007.04.040; Chai YM, 2011, J EXP BOT, V62, P5079, DOI 10.1093/jxb/err207; Salvatierra A, 2010, PHYTOCHEMISTRY, V71, P1839, DOI 10.1016/j.phytochem.2010.08.005; Uleberg E, 2012, J AGR FOOD CHEM, V60, P10406, DOI 10.1021/jf302924m; Rodrigo MJ, 2003, J EXP BOT, V54, P727, DOI 10.1093/jxb/erg083; Azuma A, 2012, PLANTA, V236, P1067, DOI 10.1007/s00425-012-1650-x; Carbone F, 2009, PLANT CELL ENVIRON, V32, P1117, DOI 10.1111/j.1365-3040.2009.01994.x; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Chernys JT, 2000, PLANT PHYSIOL, V124, P343, DOI 10.1104/pp.124.1.343; AHMAD M, 1995, PLANT J, V8, P653, DOI 10.1046/j.1365-313X.1995.08050653.x; Daminato M, 2013, J EXP BOT, V64, P3775, DOI 10.1093/jxb/ert214; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Josuttis M, 2010, J AGR FOOD CHEM, V58, P12692, DOI 10.1021/jf102937e; Tamagnone L, 1998, PLANT CELL, V10, P135; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Zhang M, 2009, J PLANT PHYSIOL, V166, P1241, DOI 10.1016/j.jplph.2009.01.013; Gapper NE, 2013, PLANT MOL BIOL, V82, P575, DOI 10.1007/s11103-013-0050-3; Cominelli E, 2008, J PLANT PHYSIOL, V165, P886, DOI 10.1016/j.jplph.2007.06.010; DUSSI MC, 1995, J AM SOC HORTIC SCI, V120, P785; Nakashima K, 2013, PLANT CELL REP, V32, P959, DOI 10.1007/s00299-013-1418-1; Kim SH, 2003, PLANT SCI, V165, P403, DOI 10.1016/S0168-9452(03)00201-2; Fait A, 2008, PLANT PHYSIOL, V148, P730, DOI 10.1104/pp.108.120691; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Rook F, 2006, PLANT CELL ENVIRON, V29, P426, DOI 10.1111/j.1365-3040.2005.01477.x; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; Jiang YM, 2003, PLANT GROWTH REGUL, V39, P171, DOI 10.1023/A:1022539901044; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Zhou Y, 2004, J BIOMED BIOTECHNOL, P259; Anttonen MJ, 2006, J AGR FOOD CHEM, V54, P2614, DOI 10.1021/jf052947w; Chatterjee M, 2006, PLANT PHYSIOL, V141, P61, DOI 10.1104/pp.105.076323; Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Rodrigo MJ, 2006, J EXP BOT, V57, P633, DOI 10.1093/jxb/erj048; Li YY, 2013, PLANT CELL REP, V32, P555, DOI 10.1007/s00299-013-1387-4; Jia HF, 2013, J EXP BOT, V64, P1677, DOI 10.1093/jxb/ert028; Davies C, 1997, PLANT PHYSIOL, V115, P1155; Jia HJ, 2005, POSTHARVEST BIOL TEC, V35, P61, DOI 10.1016/j.postharvbio.2004.06.004; Symons GM, 2012, J EXP BOT, V63, P4741, DOI 10.1093/jxb/ers147; Dubos C, 2008, PLANT J, V55, P940, DOI 10.1111/j.1365-313X.2008.03564.x; Medina-Puche L, 2014, J EXP BOT, V65, P401, DOI 10.1093/jxb/ert377; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Deikman J, 1997, PHYSIOL PLANTARUM, V100, P561, DOI 10.1034/j.1399-3054.1997.1000318.x; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Hoffmann T, 2006, PLANT J, V48, P818, DOI 10.1111/j.1365-313X.2006.02913.x; Kadomura-Ishikawa Y, 2013, J PLANT RES, V126, P847, DOI 10.1007/s10265-013-0582-2; KANO Y, 1981, J JPN SOC HORTIC SCI, V50, P31; Karppinen K, 2013, PHYTOCHEMISTRY, V95, P127, DOI 10.1016/j.phytochem.2013.06.023; Kataoka I, 2004, HORTSCIENCE, V39, P1234; Kobashi K, 1999, J JPN SOC HORTIC SCI, V68, P465; Kortstee AJ, 2011, TRANSGENIC RES, V20, P1253, DOI 10.1007/s11248-011-9490-1; Li Chunli, 2011, Plant Signal Behav, V6, P1950, DOI 10.4161/psb.6.12.18024; Lin-Wang Kui, 2010, BMC Plant Biol, V10, P50, DOI 10.1186/1471-2229-10-50; Lopes da Silva F., 2007, LWT -- Food Science and Technology, V40, P374, DOI 10.1016/j.lwt.2005.09.018; Miyawaki K, 2012, PLANT BIOTECHNOL-NAR, V29, P271, DOI 10.5511/plantbiotechnology.12.0406a; Pan QH, 2005, PHYSIOL PLANTARUM, V125, P157, DOI 10.1111/j.1399-3054.2005.00552.x; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoshida Y, 2002, J JPN SOC HORTIC SCI, V71, P355	66	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0032-0935	1432-2048		PLANTA	Planta	APR	2015	241	4					953	965		10.1007/s00425-014-2228-6		13	Plant Sciences	Plant Sciences	CD9RF	WOS:000351435000013		
J	Hossain, MK; Kitajima, M; Imura, K; Okamoto, H				Hossain, Mohammad Kamal; Kitajima, Masahiro; Imura, Kohei; Okamoto, Hiromi			A Topography-Metrology Correlation in Nanoscale Probed by Near-Field Scanning Optical Microscopy	PLASMONICS			English	Article						Near-field scanning optical microscopy; Plasmon coupling; Two-photon-induced photoluminescence; Gold nanoparticles; Finite different time domain analysis	ENHANCED RAMAN-SCATTERING; SURFACE-PLASMON EXCITATION; GOLD NANOPARTICLES; 2-PHOTON PHOTOLUMINESCENCE; NOBLE-METALS; SPECTROSCOPY	Near-field scanning optical microscopy was used to probe single nanoparticles, close-packed dimer, well-defined trimeric nanoaggregate, and separated dimer of gold nanoparticles. Surface plasmon (SP)-coupled electromagnetic (EM) field confinement at interstitials was confirmed through two-photon-induced photoluminescence (TPI-PL) imaging. A fairly well correlation between topography and metrology in nanoscale was reported with sufficient high spatial resolution. A strong excitation of SP-assisted TPI-PL was observed at gold dimer and trimeric nanoaggregate, whereas single particles and separated dimer showed negligible TPI-PL excitation. A confined distribution of TPI-PL was revealed in close-packed dimer with reference to those at isolated nanoparticles and trimer. Strong optical distribution of TPI-PL was observed at trimer, but the distribution was found broadened with reference to those at dimer. A plausible explanation of such broadened distribution was interpreted as the coalescence of surface plasmon-assisted confined optical signal of TPI-PL. Such a direct and distinguished correlation between local topography and optical field distribution with high resolution is indispensable and further addition to realize surface plasmon coupling at the interstitials. Finite different time domain analysis was carried out to elucidate the results observed herein. For a small model of three nanoobjects keeping the geometry and parameters very similar to that of the close-packed trimeric nanoaggregate under investigation, multiple confined EM fields were found at the out-of-plane polarization to the interparticle axes. With the step sizes (i.e., 50 nm), these nearby localized EM near-field-mediated optical distributions open up a possibility to coalescence and thus get broadened.	[Hossain, Mohammad Kamal] Univ Tsukuba, Tsukuba, Ibaraki 3058571, Japan; [Hossain, Mohammad Kamal] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Kitajima, Masahiro] Natl Def Acad, Dept Appl Phys, Yokosuka, Kanagawa, Japan; [Imura, Kohei] Waseda Univ, Fac Sci & Engn, Tokyo 1698555, Japan; [Okamoto, Hiromi] Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Okamoto, Hiromi] Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan	Hossain, MK (reprint author), King Fahd Univ Petr Minerals, Ctr Res Excellence Renewable Energy, Dhahran 131261, Saudi Arabia.	kamalhossain@kfupm.edu.sa					Amran TST, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-35; Bouillard JSG, 2014, CHEMPHYSCHEM, V15, P619, DOI 10.1002/cphc.201300826; Stiles PL, 2008, ANNU REV ANAL CHEM, V1, P601, DOI 10.1146/annurev.anchem.1.031207.112814; Han F, 2012, ACS APPL MATER INTER, V4, P4746, DOI 10.1021/am301121k; BOYD GT, 1986, PHYS REV B, V33, P7923, DOI 10.1103/PhysRevB.33.7923; Guan ZP, 2013, J AM CHEM SOC, V135, P7272, DOI 10.1021/ja400364f; Shimada T, 2013, PHYS CHEM CHEM PHYS, V15, P4265, DOI 10.1039/c2cp43128a; MOSKOVITS M, 1985, REV MOD PHYS, V57, P783, DOI 10.1103/RevModPhys.57.783; Gao NY, 2014, J PHYS CHEM C, V118, P13904, DOI 10.1021/jp502038v; APELL P, 1988, PHYS SCRIPTA, V38, P174, DOI 10.1088/0031-8949/38/2/012; Okamoto H, 2013, J PHYS CHEM LETT, V4, P2230, DOI 10.1021/jz401023d; Wang YQ, 2010, J NANOPART RES, V12, P655, DOI 10.1007/s11051-009-9612-3; Nordlander P, 2004, NANO LETT, V4, P899, DOI 10.1021/nl049681c; Hossain MK, 2013, NANOSCALE, V5, P8945, DOI 10.1039/c3nr03021k; Hossain MK, 2009, ANAL BIOANAL CHEM, V394, P1747, DOI 10.1007/s00216-009-2762-4; Jain PK, 2007, NANO TODAY, V2, P18, DOI 10.1016/S1748-0132(07)70016-6; Imura K, 2006, NANO LETT, V6, P2173, DOI 10.1021/nl061650p; Hossain MK, 2009, CURR SCI INDIA, V97, P192; Hossain MK, 2009, CHEM PHYS LETT, V477, P130, DOI 10.1016/j.cplett.2009.06.043; Hossain MK, 2014, ADV MAT RES, V938, P118; Hossain MK, 2013, MATER SCI FORUM, V754, P143, DOI 10.4028/www.scientific.net/MSF.754.143; Hossain MK, 2009, J PHYS CHEM C, V113, P11689, DOI 10.1021/jp901635d; Hossain MK, 2008, LANGMUIR, V24, P241; Hossain MK, 2008, J MICROSC-OXFORD, V229, P327, DOI 10.1111/j.1365-2818.2008.01908.x; Imura K, 2005, J CHEM PHYS, V122; MOORADIA.A, 1969, PHYS REV LETT, V22, P185, DOI 10.1103/PhysRevLett.22.185; Okamoto H, 2011, J PHOTOCH PHOTOBIO A, V221, P154, DOI 10.1016/j.jphotochem.2011.01.017	27	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1557-1955	1557-1963		PLASMONICS	Plasmonics	APR	2015	10	2					447	454		10.1007/s11468-014-9826-9		8	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CD7SQ	WOS:000351292500026		
J	Takahara, S; Iwamura, N; Ema, Y; Sato, Y; Mizukoshi, M; Nagano, T; Ichikuni, N				Takahara, Shigeru; Iwamura, Naoki; Ema, Yusuke; Sato, Yusuke; Mizukoshi, Masanori; Nagano, Tomoki; Ichikuni, Nobuyuki			Formation and dichroism of poly( vinyl alcohol)iodine complex in photocurable film	POLYMERS FOR ADVANCED TECHNOLOGIES			English	Article						crosslinking; polarization; photo-dimerization; hypervalent; polyiodine; Raman spectroscopy	AMYLOSE-IODINE COMPLEX; BORIC-ACID TREATMENT; PHOTO-CROSS-LINKING; ALCOHOL)-IODINE COMPLEX; X-RAY; POLYVINYL-ALCOHOL); STABILITY; PHASE	The formation of polyiodine complexes was investigated in a photocurable poly(vinyl alcohol) modified N-methyl-4(4-formylstyryl)pyridinium methosulfate acetal (PVA-SbQ), which is a photofunctional group that causes photodimerization. PVA-SbQ films with polyiodine complexes were prepared to be photocured, iodinated and soaked in a boric acid solution. The formation of PVA-polyiodine complexes was studied during iodinating and while in the boric acid treatment through UV-vis absorption spectrometry, resonance Raman spectrometry and IR absorption spectrometry. As a result, polyiodines were formed in the photocurable PVA-SbQ films, and the formation of PVA-polyiodine complexes was enhanced by boric acid treatment. It was found that the SbQ-ratio of PVA-SbQ affects the formation of PVA-polyiodine complexes. The photocrosslinking by the dimerization of SbQ groups helps to form the PVA-I-5(-) complex during the boric acid treatment. Based on this effect, we demonstrated a unique recording method by the PVA-polyiodine complex formation. The PVA-SbQ film cured by the irradiation of the liner polarized light showed that dichroism of the PVA-polyiodine complexes formed after iodination. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Takahara, Shigeru; Iwamura, Naoki; Ema, Yusuke; Sato, Yusuke; Mizukoshi, Masanori; Nagano, Tomoki] Chiba Univ, Grad Sch Adv Integrat Sci, Dept Image & Mat Sci, Inage Ku, Chiba 2638522, Japan; [Ichikuni, Nobuyuki] Chiba Univ, Grad Sch Engn, Dept Appl Chem & Biotechnol, Inage Ku, Chiba 2638522, Japan	Takahara, S (reprint author), Chiba Univ, Grad Sch Adv Integrat Sci, Dept Image & Mat Sci, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	takahara@faculty.chiba-u.jp					Ichimura K, 2012, J POLYM SCI POL CHEM, V50, P4094, DOI 10.1002/pola.26211; SCHADT M, 1992, JPN J APPL PHYS 1, V31, P2155, DOI 10.1143/JJAP.31.2155; Miyazaki T, 2010, POLYMER, V51, P5539, DOI 10.1016/j.polymer.2010.09.048; YOKOYAMA T, 1995, B CHEM SOC JPN, V68, P469, DOI 10.1246/bcsj.68.469; Calabrese VT, 1999, J POLYM SCI POL CHEM, V37, P2711; CHOI YS, 1994, J APPL POLYM SCI, V51, P613, DOI 10.1002/app.1994.070510404; CHOI YS, 1993, J APPL POLYM SCI, V48, P313, DOI 10.1002/app.1993.070480215; CHOI YS, 1991, POLYM J, V23, P977, DOI 10.1295/polymj.23.977; Cockburn ES, 1996, J PHOTOCH PHOTOBIO A, V94, P83, DOI 10.1016/1010-6030(95)04193-1; FONSLICK J, 1989, J POLYM SCI POL CHEM, V27, P4161, DOI 10.1002/pola.1989.080271222; GUNNING WJ, 1983, APPL OPTICS, V22, P3229; HIRAI T, 1988, J POLYM SCI POL LETT, V26, P299, DOI 10.1002/pol.1988.140260705; ICHIMURA K, 1982, J POLYM SCI POL CHEM, V20, P1411, DOI 10.1002/pol.1982.170200604; ICHIMURA K, 1982, J POLYM SCI POL CHEM, V20, P1419, DOI 10.1002/pol.1982.170200605; INAGAKI F, 1972, B CHEM SOC JPN, V45, P3384, DOI 10.1246/bcsj.45.3384; Ishihara M, 1996, J POLYM SCI POL PHYS, V34, P587, DOI 10.1002/(SICI)1099-0488(199602)34:3<587::AID-POLB18>3.0.CO;2-E; Lyoo WS, 2003, COLLOID POLYM SCI, V281, P416, DOI 10.1007/s00396-002-0788-7; Maeshima K., 1999, J PHOTOPOLYM SCI TEC, V12, P249, DOI 10.2494/photopolymer.12.249; MOHARRAM MA, 1991, J APPL POLYM SCI, V42, P3025, DOI 10.1002/app.1991.070421121; Noguchi H, 1997, POLYM INT, V42, P315, DOI 10.1002/(SICI)1097-0126(199703)42:3<315::AID-PI735>3.0.CO;2-3; Noguchi H, 1997, J POLYM SCI POL PHYS, V35, P1701, DOI 10.1002/(SICI)1099-0488(199708)35:11<1701::AID-POLB4>3.3.CO;2-5; Noguchi H, 1998, POLYM INT, V47, P428, DOI 10.1002/(SICI)1097-0126(199812)47:4<428::AID-PI56>3.0.CO;2-W; Ohishi K, 2010, POLYMER, V51, P687, DOI 10.1016/j.polymer.2009.01.044; OISHI Y, 1987, POLYM J, V19, P1261, DOI 10.1295/polymj.19.1261; Rouillon R, 2000, J CHEM TECHNOL BIOT, V75, P1003, DOI 10.1002/1097-4660(200011)75:11<1003::AID-JCTB296>3.0.CO;2-0; Sengupta A, 1996, CHEM PHYS LETT, V263, P25, DOI 10.1016/S0009-2614(96)01187-6; Shin EJ, 2011, J APPL POLYM SCI, V120, P1950, DOI 10.1002/app.33284; Shin EJ, 2008, J APPL POLYM SCI, V109, P1143, DOI 10.1002/app.28181; Shin EJ, 2012, J APPL POLYM SCI, V123, P672, DOI 10.1002/app.34490; Song S, 1998, JPN J APPL PHYS 1, V37, P2620, DOI 10.1143/JJAP.37.2620; TAKAMIYA H, 1993, J APPL POLYM SCI, V50, P1807, DOI 10.1002/app.1993.070501017; Woo JY, 2010, POLYM BULL, V65, P169, DOI 10.1007/s00289-010-0279-9; Young H., 2007, POLYMER, V49, P785	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7147	1099-1581		POLYM ADVAN TECHNOL	Polym. Adv. Technol.	APR	2015	26	4					338	344		10.1002/pat.3457		7	Polymer Science	Polymer Science	CE0CU	WOS:000351472700008		
J	Sumino, E; Saito, T; Noguchi, T; Sawada, H				Sumino, Eisaku; Saito, Tomoya; Noguchi, Tsuyoshi; Sawada, Hideo			Facile creation of superoleophobic and superhydrophilic surface by using perfluoropolyether dicarboxylic acid/silica nanocomposites	POLYMERS FOR ADVANCED TECHNOLOGIES			English	Article						perfluoropolyether dicarboxylic acid; silica nanocomposite; superoleophobicity; superhydrophilicity; low molecular weight aromatic compound; oil/water separation	FLUORINATED SILICON OLIGOMERS; OIL-REPELLENT SURFACES; CARBOXYLIC-ACID GROUPS; END-CAPPED OLIGOMERS; POLY(PERFLUOROALKYLETHYL METHACRYLATE); POLYMERS; COATINGS; WATER; COPOLYMERS; PEROXIDE	Perfluoropolyether dicarboxylic acid [HO(O)CCF(CF3){OCF2CF(CF3)}(n)O(CF2)(5)O{CF(CF3)CF2O}(m)?CF(CF3)C(O)OH; n+m=6-12; PFPE-DAcD] was applied to the preparation of PFPE-DAcD/SiO2 nanocomposites by the sol-gel reactions of the corresponding diacid with tetraethoxysilane in the presence of silica nanoparticles under alkaline conditions. PFPE-DAcD/SiO2 nanocomposites thus obtained were found to exhibit a good dispersibility and stability in not only water but also the traditional organic solvents such as methanol, ethanol, 2-propanol, tetrahydrofuran, and 1,2-dichloroethane. Field emission scanning electron micrograph (FE-SEM) and dynamic light-scattering (DLS) measurements show that these fluorinated composites are nanometer size-controlled very fine particles. Dodecane and water contact angle measurements on the modified glass, filter paper, and polyester fabric surfaces treated with these fluorinated nanocomposites were found to exhibit the superoleophobicity and superhydrophilicity. Especially, the modified polyester fabric swatch was applied to the oil/water separation to give the high separation efficiency. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Sumino, Eisaku; Saito, Tomoya; Sawada, Hideo] Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, Hirosaki, Aomori 0368561, Japan; [Sumino, Eisaku; Noguchi, Tsuyoshi] Daikin Ind Ltd, Div Chem, Settsu, Osaka 5668585, Japan	Sawada, H (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, Bunkyo Cho, Hirosaki, Aomori 0368561, Japan.	hideosaw@cc.hirosaki-u.ac.jp					Ameduri B, 2004, WELL ARCHITECTURED F; Taurino R, 2008, J COLLOID INTERF SCI, V325, P149, DOI 10.1016/j.jcis.2008.05.007; Imae T, 2003, CURR OPIN COLLOID IN, V8, P307, DOI 10.1016/S1359-0294(03)00050-5; Ye HH, 2013, J APPL POLYM SCI, V127, P402, DOI 10.1002/app.37632; Srinivasan S, 2011, POLYMER, V52, P3209, DOI 10.1016/j.polymer.2011.05.008; Zaggia A, 2012, CURR OPIN COLLOID IN, V17, P188, DOI 10.1016/j.cocis.2012.04.001; Yao X, 2011, ADV MATER, V23, P719, DOI 10.1002/adma.201002689; Berret JF, 2003, CURR OPIN COLLOID IN, V8, P296, DOI 10.1016/S1359-0294(03)00048-7; An QF, 2013, J APPL POLYM SCI, V127, P1519, DOI 10.1002/app.37553; Zhang JP, 2011, ADV FUNCT MATER, V21, P4699, DOI 10.1002/adfm.201101090; Tsujii K, 1997, ANGEW CHEM INT EDIT, V36, P1011, DOI 10.1002/anie.199710111; Allan SE, 2012, ENVIRON SCI TECHNOL, V46, P2033, DOI 10.1021/es202942q; Furukawa Y, 2003, J APPL POLYM SCI, V87, P1085, DOI 10.1002/app.11505; Yang J, 2012, J MATER CHEM, V22, P2834, DOI 10.1039/c2jm15987b; Shibuichi S, 1998, J COLLOID INTERF SCI, V208, P287, DOI 10.1006/jcis.1998.5813; Park IJ, 1996, J COLLOID INTERF SCI, V181, P284, DOI 10.1006/jcis.1996.0379; Kota AK, 2012, ADV MATER, V24, P5838, DOI 10.1002/adma.201202554; Ceria A, 2010, SURF COAT TECH, V204, P1535, DOI 10.1016/j.surfcoat.2009.09.077; Caminade AM, 2003, CURR OPIN COLLOID IN, V8, P282, DOI 10.1016/S1359-0294(03)00051-7; Yang J, 2014, CELLULOSE, V21, P1851, DOI 10.1007/s10570-014-0244-0; Feng J, 2009, J COLLOID INTERF SCI, V336, P268, DOI 10.1016/j.jcis.2009.03.025; Liu KS, 2013, PROG MATER SCI, V58, P503, DOI 10.1016/j.pmatsci.2012.11.001; ANTON P, 1993, MAKROMOL CHEM, V194, P1; Cochin D, 1995, COLLOID POLYM SCI, V273, P1138, DOI 10.1007/BF00653081; Morita M, 1996, COLLOID SURFACE A, V109, P183, DOI 10.1016/0927-7757(95)03485-4; Nakagawa J, 1998, LANGMUIR, V14, P2061, DOI 10.1021/la971201s; Nakagawa J, 1998, LANGMUIR, V14, P2055, DOI 10.1021/la9712000; PARK IJ, 1994, J APPL POLYM SCI, V54, P1449, DOI 10.1002/app.1994.070541008; Sawada H, 2003, J FLUORINE CHEM, V121, P111, DOI 10.1016/S0022-1139(03)00040-X; SAWADA H, 1994, LANGMUIR, V10, P994, DOI 10.1021/la00016a005; Sawada H, 2008, POLYM ADVAN TECHNOL, V19, P739, DOI 10.1002/pat.1050; Sawada H, 2011, J POLYM SCI POL CHEM, V49, P1070, DOI 10.1002/pola.24516; Sawada H, 2011, MACROMOLECULES, V44, P1114, DOI 10.1021/ma102532k; Sawada H, 2007, PROG POLYM SCI, V32, P509, DOI 10.1016/j.progpolymsci.2007.02.002; Sawada H, 2007, POLYM J, V39, P637, DOI 10.1295/polymj.PJ2006242; SAWADA H, 1995, J FLUORINE CHEM, V74, P21, DOI 10.1016/0022-1139(95)03254-B; SAWADA H, 1994, J CHEM SOC CHEM COMM, P143, DOI 10.1039/c39940000143; Sawada H, 2012, POLYM CHEM-UK, V3, P46, DOI 10.1039/c1py00325a; Sawada H, 2010, POLYM J, V42, P167, DOI 10.1038/pj.2009.316; Sawada H, 2002, MACROMOLECULES, V35, P4306, DOI 10.1021/ma012217z; Sawada H., 1997, MATER TECHNOL, V15, P79; Sawada H, 1996, CHEM REV, V96, P1779, DOI 10.1021/cr9411482; Shi ZQ, 2005, MACROMOLECULES, V38, P4193, DOI 10.1021/ma0477549; Sumino E, 2014, COLLOID POLYM SCI, V292, P369, DOI 10.1007/s00396-013-3078-7	44	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1042-7147	1099-1581		POLYM ADVAN TECHNOL	Polym. Adv. Technol.	APR	2015	26	4					345	352		10.1002/pat.3459		8	Polymer Science	Polymer Science	CE0CU	WOS:000351472700009		
J	Kitarnura, T; Kunieda, M; Abe, K				Kitarnura, Tomoo; Kunieda, Masanori; Abe, Kohzoh			Observation of relationship between bubbles and discharge locations in EDM using transparent electrodes	PRECISION ENGINEERING-JOURNAL OF THE INTERNATIONAL SOCIETIES FOR PRECISION ENGINEERING AND NANOTECHNOLOGY			English	Article						Electrical discharge machining; Transparent electrode; SIC single crystal; Bubble; Discharge location		This paper describes the observation of EDM gap phenomena through a transparent electrode from the direction normal to the machining surface using a high-speed video camera. To visualize the gap, SiC single crystal was used as the electrode material since it is optically transparent and electrically conductive. It was found that more than 70% of the working surface was occupied by bubbles generated by discharge after a few hundred pulse discharges from the start of machining. Electrical discharge occurs not only in liquid but also in bubble and at the boundary between liquid and bubble. The probability of discharge occurrence per unit area of each atmosphere was highest at the boundary between liquid and bubble. Furthermore, the probability of discharge occurrence through debris particles located at this boundary generated by the last discharge was highest. (C) 2014 Elsevier Inc. All rights reserved.	[Kitarnura, Tomoo; Kunieda, Masanori] Univ Tokyo, Bunkyo Ku, Tokyo 1138656, Japan; [Abe, Kohzoh] Hamada Heavy Ind Ltd, Kikuchigun, Kumamoto 8691232, Japan	Kitarnura, T (reprint author), Univ Tokyo, Dept Precis Engn, Bunkyo Ku, Room 833,Engn Bldg 14,7-3-1 Hongo, Tokyo 1138656, Japan.	tkita@edm.t.u-tokyo.ac.jp; kunieda@edm.t.u-tokyo.ac.jp; Kohzoh.abe@nmc-net.co.jp			JSPS [25630020]	This research was supported by the Grant-in-Aid from JSPS (25630020). The authors are grateful to Sodick Co. Ltd., and HODEN SEIMITSU KAKO KENKYUSHO CO., LTD. for their kind support in conducting the experiments.	Kojima A, 2008, CIRP ANN-MANUF TECHN, V57, P203, DOI 10.1016/j.cirp.2008.03.097; Han F, 2001, P ISEM 13, P185; Hayakawa S, 1996, P S MOL MICR HEAT TR, p[368, 1]; Hayakawa S, 2009, INT J ELECT MACHININ, V14, P29; Ikeda M, 1972, J JSEME, V6, P12; Kojima H, 1992, P 10 INT S, P144; Kunieda M, 1997, INT J ELECT MACH, V2, P43; Kunieda M, 2008, IJEM, V8, P51; Kunieda M., 2005, ANN CIRP, V54, P64; Miyajima J, 1987, P 87 SPRING M JSPE, P723; Schumacher BM, 1990, ANN CIRP, V39, P197; Takeuchi H, 2007, PROCEEDINGS OF THE 15TH INTERNATIONAL SYMPOSIUM ON ELECTROMACHINING, P63; Yoshida M., 1998, IJEM, V3, P39	13	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0141-6359	1873-2372		PRECIS ENG	Precis. Eng.-J. Int. Soc. Precis. Eng. Nanotechnol.	APR	2015	40						26	32		10.1016/j.precisioneng.2014.09.009		7	Engineering, Multidisciplinary; Engineering, Manufacturing; Nanoscience & Nanotechnology; Instruments & Instrumentation	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation	CD7CI	WOS:000351248000004		
J	Aida, H; Kim, SW; Ikejiri, K; Doi, T; Yamazaki, T; Seshimo, K; Koyama, K; Takeda, H; Aota, N				Aida, Hideo; Kim, Seong-Woo; Ikejiri, Kenjiro; Doi, Toshiro; Yamazaki, Tsutomu; Seshimo, Kiyoshi; Koyama, Koji; Takeda, Hidetoshi; Aota, Natsuko			Precise mechanical polishing of brittle materials with free diamond abrasives dispersed in micro-nano-bubble water	PRECISION ENGINEERING-JOURNAL OF THE INTERNATIONAL SOCIETIES FOR PRECISION ENGINEERING AND NANOTECHNOLOGY			English	Article						Micro-nano bubbles; Mechanical polishing; Brittle materials; Diamond abrasive; Removal rate; Subsurface damage	SUBSURFACE DAMAGE; COLLOIDAL SILICA; GALLIUM NITRIDE; GAN; MICROBUBBLE; FLOTATION; SURFACES; BULK	We have studied the effects of using water containing micro-nano-bubbles (MNB water) as the solution in which the diamond abrasives with a mean diameter of 0.5 mu m are dispersed for the polishing slurry used in the precise mechanical polishing (PMP) of brittle material of GaN. While the formation of small number of clusters of abrasives was seen in the MNB water, the abrasives were basically well dispersed, which were almost comparable to that in pure water with a dispersion agent such as ethylene glycol. Since flocculation was observed for dispersion in pure-water without the addition of the dispersion agent, it was found that MNBs have dispersion effect for micro-sized abrasive particles. Regarding the polishing properties of GaN substrate with the MNB water based polishing slurry, we observed a remarkable increase in the removal rate with no additional surface or subsurface degradation. Additionally, we observed a significantly reduced subsurface damage (SSD) for chemically weak N-face of GaN substrate. It was suggested that these observed effects were most probably a result of the cluster formation in the MNB water and the chemical effect in relation to high energy generation through bubble collapse, respectively. (C) 2014 Elsevier Inc. All rights reserved.	[Aida, Hideo; Kim, Seong-Woo; Ikejiri, Kenjiro; Koyama, Koji; Takeda, Hidetoshi; Aota, Natsuko] Namiki Precis Jewel Co Ltd, Adachi Ku, Tokyo 1238511, Japan; [Aida, Hideo; Doi, Toshiro; Yamazaki, Tsutomu; Seshimo, Kiyoshi] Kyushu Univ, Kastec, Kasuga, Fukuoka 8168580, Japan	Aida, H (reprint author), Namiki Precis Jewel Co Ltd, Adachi Ku, 3-8-22 Shinden, Tokyo 1238511, Japan.	h-aida@namiki.net					Aida H, 2011, J ELECTROCHEM SOC, V158, pH1206, DOI 10.1149/2.024112jes; Burns SE, 1997, SEP PURIF TECHNOL, V11, P221, DOI 10.1016/S1383-5866(97)00024-5; GUTSCHE HW, 1978, J ELECTROCHEM SOC, V125, P136, DOI 10.1149/1.2131378; Ng HM, 2003, J APPL PHYS, V94, P650, DOI 10.1063/1.1582233; Ago K, 2005, J CHEM ENG JPN, V38, P757, DOI 10.1252/jcej.38.757; Aida H, 2014, APPL SURF SCI, V292, P531, DOI 10.1016/j.apsusc.2013.12.005; Takahashi M, 2003, J PHYS CHEM B, V107, P2171, DOI 10.1021/jp02210z; Held R, 1999, J APPL PHYS, V85, P7697, DOI 10.1063/1.370574; Hayashi S, 2008, J ELECTROCHEM SOC, V155, pH113, DOI 10.1149/1.2818776; Neauport J, 2009, OPT EXPRESS, V17, P20448, DOI 10.1364/OE.17.020448; Attard P, 2002, PHYSICA A, V314, P696, DOI 10.1016/S0378-4371(02)01191-3; Hanser D, 2007, J CRYST GROWTH, V305, P372, DOI 10.1016/j.jcrysgro.2007.03.039; Ushikubo FY, 2010, COLLOID SURFACE A, V361, P31, DOI 10.1016/j.colsurfa.2010.03.005; BLOEMBER.N, 1973, APPL OPTICS, V12, P661, DOI 10.1364/AO.12.000661; Doi TK, 1988, SENS MATER, V3, P153; DYMENT JC, 1971, J ELECTROCHEM SOC, V118, P1346, DOI 10.1149/1.2408319; Gao Y, 2004, JPN J APPL PHYS 2, V43, pL637, DOI 10.1143/JJAP.43.L637; Kasai T, 2000, J SURF SCI SOC JPN, V21, P688; Koyama K, 2014, INT J AUTOM TECHNOL, V8, P121; Lachapelle RL, 1967, US Patent, Patent No. [3,328,141, 3328141]; Marui T, 2013, SYST CYBERN INFORM, V11, P68; Ohnari H., 2002, US Patent, Patent No. [6,382,601, 6382601]; Onari H., 2001, J HEAT TRANSFER SOC, V40, P2; Oshita S, 2009, EXT M JPN SOC MULT F; Pandey PK, 2012, INT J ENG SCI TECHNO, V4, P4734; Park JS, 2009, HORTTECHNOLOGY, V19, P212; DERIJK SE, 1994, WATER RES, V28, P465, DOI 10.1016/0043-1354(94)90284-4; Suzuki K, 2004, P JSPE SEM M A, V2004A, pB07; Takahashi M, 2007, PHYS CHEM B, V111, P1343; Tavernier PR, 2002, ELECTROCHEM SOLID ST, V5, pG61, DOI 10.1149/1.1485807; Weyher JL, 1997, J CRYST GROWTH, V182, P17, DOI 10.1016/S0022-0248(97)00320-5; ZABEL T, 1985, J AM WATER WORKS ASS, V77, P42	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0141-6359	1873-2372		PRECIS ENG	Precis. Eng.-J. Int. Soc. Precis. Eng. Nanotechnol.	APR	2015	40						81	86		10.1016/j.precisioneng.2014.10.008		6	Engineering, Multidisciplinary; Engineering, Manufacturing; Nanoscience & Nanotechnology; Instruments & Instrumentation	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation	CD7CI	WOS:000351248000009		
J	Morimoto, Y; He, D; Hijikata, W; Shinshi, T; Nakai, T; Nakamura, N				Morimoto, Yoshihiro; He, Dongjue; Hijikata, Wataru; Shinshi, Tadahiko; Nakai, Takahiro; Nakamura, Naoyuki			Effect of high-frequency orbital and vertical oscillations of the laser focus position on the quality of the cut surface in a thick plate by laser beam machining	PRECISION ENGINEERING-JOURNAL OF THE INTERNATIONAL SOCIETIES FOR PRECISION ENGINEERING AND NANOTECHNOLOGY			English	Article						Laser cutting; Thick plate; Laser focus oscillation; Maglev multi-DOF lens drive actuator; Striation formation	MILD-STEEL; FIBER LASER; ASSIST GAS; YAG LASER; STRIATION; ACTUATOR; NOZZLE	In laser beam machining with oxygen gas, striations are formed on the cut surface due to the cyclic oxidization reaction, which is affected by the cutting conditions and the thermal properties of the workpiece. The formation of striations causes an increase in surface roughness. In order to reduce the surface roughness, we propose controlling the formation of striations by utilizing multi-DOF oscillation of the focus position of the laser. In this paper, we construct a laser machining system in which positioning control of the focus position is achieved by driving the focal lens. The effect of orbital oscillation of the laser focus position parallel to the top surface of the workpiece and vertical oscillation perpendicular to this surface on the formation of striations was evaluated by performing laser cutting tests on thick mild steel plates. The experimental results show that control of the formation of striations can be realized by choosing the appropriate oscillation conditions. The surface roughness with oscillation was less than half that without oscillation. (C) 2014 Elsevier Inc. All rights reserved.	[Morimoto, Yoshihiro; He, Dongjue] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan; [Morimoto, Yoshihiro] Japan Soc Promot Sci, Tokyo, Japan; [Hijikata, Wataru; Shinshi, Tadahiko] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan; [Nakai, Takahiro; Nakamura, Naoyuki] Mitsubishi Electr Corp, Adv Technol R&D Ctr, Amagasaki, Hyogo, Japan	Shinshi, T (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan.	shinshi@pi.titech.ac.jp	Shinshi, Tadahiko/E-5261-2014		JSPS KAKENHI [26.7519]	This work was supported by JSPS KAKENHI Grant Number 26.7519.	Quintero F, 2006, OPT LASER ENG, V44, P1158, DOI 10.1016/j.optlaseng.2005.10.001; Powell J, 2011, OPT LASER ENG, V49, P1069, DOI 10.1016/j.optlaseng.2011.03.011; Salem HG, 2008, J MATER PROCESS TECH, V196, P64, DOI 10.1016/j.jmatprotec.2007.05.013; Wandera C, 2009, J LASER APPL, V21, P154, DOI 10.2351/1.3184429; Dubey AK, 2008, INT J MACH TOOL MANU, V48, P609, DOI 10.1016/j.ijmachtools.2007.10.017; Quintero F, 2004, OPT LASER ENG, V42, P327, DOI 10.1016/j.optlaseng.2003.10.001; Caiazzo F, 2005, J MATER PROCESS TECH, V159, P279, DOI 10.1016/j.jmatprotec.2004.02.019; Sobih M, 2007, J PHYS D APPL PHYS, V40, P6908, DOI 10.1088/0022-3727/40/22/009; Bordatchev EV, 2006, APPL SURF SCI, V253, P1122, DOI 10.1016/j.apsusc.2006.01.047; Arai T., 2014, P JSPE SPRING M, P187; Arata Y., 1979, T JWRI, V8, P15; Brandt AD, 1997, J LASER APPL, V9, P269, DOI 10.2351/1.4745469; Ermolaev GV, 2006, J PHYS D APPL PHYS, V39, P4236, DOI 10.1088/0022-3727/39/19/017; Harris J, 2001, J MAT FORUM, V25, P88; He DJ, 2013, PRECIS ENG, V37, P255, DOI 10.1016/j.precisioneng.2012.09.003; Ketting HO, 1992, P INT C LASER ADV MA, p[607, 7]; Morimoto Y, 2012, J ADV MECH DES SYST, V6, P875, DOI 10.1299/jamdsm.6.875; Rajpurohit S. R., 2012, INT J ENG RES APPL, V2, P457	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0141-6359	1873-2372		PRECIS ENG	Precis. Eng.-J. Int. Soc. Precis. Eng. Nanotechnol.	APR	2015	40						112	123		10.1016/j.precisioneng.2014.10.012		12	Engineering, Multidisciplinary; Engineering, Manufacturing; Nanoscience & Nanotechnology; Instruments & Instrumentation	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation	CD7CI	WOS:000351248000013		
J	Okabe, T; Utsumi, K; Somaya, K; Miyatake, M; Yoshimoto, S; Taniguchi, J; Sasaki, S				Okabe, Takao; Utsumi, Keita; Somaya, Kei; Miyatake, Masaaki; Yoshimoto, Shigeka; Taniguchi, Jun; Sasaki, Shinya			Development of a vacuum-compatible hydrodynamic spindle using an ionic liquid as a lubricant	PRECISION ENGINEERING-JOURNAL OF THE INTERNATIONAL SOCIETIES FOR PRECISION ENGINEERING AND NANOTECHNOLOGY			English	Article						Vacuum-compatible; Ionic liquid; Outgassed gases; Rotational accuracy	ELECTRON-BEAM RECORDER; JOURNAL BEARINGS; AIR-BEARING; SYSTEM; STAGE	The importance of beam machining and extreme ultraviolet lithography technologies in the area of precise and fine machining used for high-density optical discs, integrated circuits and patterned media of hard disc drives (HDDs) is rapidly increasing. In this paper, a very simple vacuum-compatible rotary spindle is proposed that uses an ionic liquid as a lubricant with a very low vapor pressure. The usefulness of the proposed spindle lubricated by an ionic liquid was experimentally confirmed by measuring the partial pressures of outgassed products during rotation of the spindle in the vacuum chamber, measuring the accuracy of movement of the rotary table and machining circular grooves by an electron beam in a scanning electron microscope (SEM). It was found that the proposed spindle could be used in vacuum, and the partial pressures of outgassed products were almost the same as those of a clean, empty vacuum chamber. In addition, it was confirmed that by using the proposed spindle, circular grooves with diameters of 200 and 400 mu m, 450 nm width and 40 nm depth could be machined on a photoresist surface coated on a silicon wafer in vacuum of an SEM. (C) 2014 Elsevier Inc. All rights reserved.	[Okabe, Takao; Utsumi, Keita] Tokyo Univ Sci, Dept Mech Engn, Katsushika Ku, Tokyo 1258585, Japan; [Somaya, Kei; Miyatake, Masaaki; Yoshimoto, Shigeka; Sasaki, Shinya] Tokyo Univ Sci, Dept Mech Engn, Katsushika Ku, Tokyo 1258585, Japan; [Taniguchi, Jun] Tokyo Univ Sci, Dept Appl Elect, Katsushika Ku, Tokyo 1258585, Japan	Okabe, T (reprint author), Tokyo Univ Sci, Dept Mech Engn, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	saisinei0324a@gmail.com			MEXT-supported Program for the Strategic Research Foundation at Private Universities;  [21560151]	This research was supported partly by Grant-in-Aid for Scientific Research (C), grant no. 21560151 and partly by a MEXT-supported Program for the Strategic Research Foundation at Private Universities, 2011-2015.	Wada Y, 2001, JPN J APPL PHYS 1, V40, P1653, DOI 10.1143/JJAP.40.1653; Yagi T, 2009, P I MECH ENG J-J ENG, V223, P1083, DOI 10.1243/13506501JET576; Khim G, 2014, VACUUM, V105, P39, DOI 10.1016/j.vacuum.2014.01.031; VOHR JH, 1965, J BASIC ENG-T ASME, V87, P568; Street KW, 2011, TRIBOL T, V54, P911, DOI 10.1080/10402004.2011.606963; Yoshimoto S, 2004, J TRIBOL-T ASME, V126, P310, DOI 10.1115/1.1611498; Wada Y, 2008, JPN J APPL PHYS, V47, P6007, DOI 10.1143/JJAP.47.6007; Morales W, 2012, TRIBOL T, V55, P815, DOI 10.1080/10402004.2012.715322; Bisschops THJ, 2002, US patent no. US, Patent No. [6,421,112 B1, 6421112]; Heidler N, 2012, PRECIS ENG, V36, P37, DOI 10.1016/j.precisioneng.2011.07.005; Khim G, 2006, VACUUM, V81, P466, DOI 10.1016/j.vacuum.2006.06.015; Pollock JD, 1988, US patent no. US, Patent No. [4,726,689, 4726689]; Yokomatsu T, 1988, US patent no. US, Patent No. [4,749,283, 4749283]	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0141-6359	1873-2372		PRECIS ENG	Precis. Eng.-J. Int. Soc. Precis. Eng. Nanotechnol.	APR	2015	40						124	130		10.1016/j.precisioneng.2014.10.013		7	Engineering, Multidisciplinary; Engineering, Manufacturing; Nanoscience & Nanotechnology; Instruments & Instrumentation	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation	CD7CI	WOS:000351248000014		
J	Hama, T; Sato, K				Hama, Tadashi; Sato, Kaiji			High-speed and high-precision tracking control of ultrahigh-acceleration moving-permanent-magnet linear synchronous motor	PRECISION ENGINEERING-JOURNAL OF THE INTERNATIONAL SOCIETIES FOR PRECISION ENGINEERING AND NANOTECHNOLOGY			English	Article						Linear motor; Precision; Positioning; Control; Learning; High acceleration; High velocity	MACHINE-TOOL; DESIGN; SYSTEM	This paper describes the high-speed and high-precision tracking control of an ultrahigh-acceleration, high-velocity linear synchronous motor (LSM). The linear motor can produce a thrust force of more than 3000 N, an acceleration greater than 70 G (=686 m/s(2)), and move at a velocity of over 10 m/s. However, it has highly nonlinear characteristics, and it is difficult to provide an exact dynamic model for the controller design. Thus, a suitable controller that does not require a dynamic model in the design was selected and used for the high-precision tracking control of the linear motor. The design procedure for the suitable controller consists of two steps. In the first step, a two-degree-of-freedom controller with additional control elements was designed, and its performance was examined. The additional elements were used to suppress the negative influences characterizing permanent-magnet LSMs with cored electromagnets. The controller showed high tracking accuracy at low speed, but not at high speed. To overcome this problem, the controller was improved with a learning control element in the second step. The learning control element does not require a dynamic model in the design, and it is effective at reducing reproducible errors at high speed. The effectiveness of the controller was examined and demonstrated experimentally. The improved controller with the learning control element reduced the maximum tracking error to 1.62 mu m in the sinusoidal reference motion at a frequency of 20 Hz and an amplitude of 10 mm. (C) 2014 Elsevier Inc. All rights reserved.	[Hama, Tadashi; Sato, Kaiji] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Midori Ku, Yokohama, Kanagawa 2268502, Japan	Sato, K (reprint author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268502, Japan.	sato.k.ah@m.titech.ac.jp					Olsson H, 1998, EUR J CONTROL, V4, P176; Sawano H, 2012, PRECIS ENG, V36, P538, DOI 10.1016/j.precisioneng.2012.02.007; Sato K, 2012, IEEE T MAGN, V48, P4866, DOI 10.1109/TMAG.2012.2204763; Suh JD, 2002, CIRP ANN-MANUF TECHN, V51, P285, DOI 10.1016/S0007-8506(07)61518-2; Lee C, 2009, P AMER CONTR CONF, P1664, DOI 10.1109/ACC.2009.5160185; Kim K, 2012, INT J PRECIS ENG MAN, V13, P407, DOI 10.1007/s12541-012-0052-0; Sato K, 2013, IEEE-ASME T MECH, V18, P307, DOI 10.1109/TMECH.2011.2174374; Park CH, 2009, INT J PRECIS ENG MAN, V10, P85, DOI 10.1007/s12541-009-0075-3; Braembussche PVD, 1996, MECHATRONICS, V6, P507; Chen YQ, 2001, P IEEE INT S COMP IN, P59; Chen YQ, 2004, IEEE T NEURAL NETWOR, V15, P355, DOI 10.1109/TNN.2004.824268; Christof R, 2001, 3 INT S LIN DRIV IND; Fanuc Corp, 2012, FANUC LIN MOT LIS SE; Fesperman R, 2012, PRECIS ENG, V36, P517, DOI 10.1016/j.precisioneng.2012.03.002; Fukuta M, 2006, P 21 ASPE ANN M; Kakino Y, 1996, INT J JPN S PREC ENG, V30, P295; Kim HJ, 2005, J MAGN SOC JAPAN, V29, P199; Lee MG, 2002, P 17 ASPE ANN M, P162; Messen KJ, 2010, IEEE T IND APPL, V46, P1891; Mu HH, 2009, MECHATRONICS, V19, P577, DOI 10.1016/j.mechatronics.2008.12.004; Oiwa T., 2011, INT J AUTOMATION TEC, V5, P766; Sugiura M, 1996, AMC '96-MIE - 1996 4TH INTERNATIONAL WORKSHOP ON ADVANCED MOTION CONTROL, PROCEEDINGS, VOLS 1 AND 2, P59, DOI 10.1109/AMC.1996.509380; Yao B, 2007, P 1 INT C INT COMM M	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0141-6359	1873-2372		PRECIS ENG	Precis. Eng.-J. Int. Soc. Precis. Eng. Nanotechnol.	APR	2015	40						151	159		10.1016/j.precisioneng.2014.11.005		9	Engineering, Multidisciplinary; Engineering, Manufacturing; Nanoscience & Nanotechnology; Instruments & Instrumentation	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation	CD7CI	WOS:000351248000017		
J	Komori, M; Takeoka, F; Kiten, T; Kondo, Y; Osawa, S; Sato, O; Takatsuji, T; Takeda, R				Komori, Masaharu; Takeoka, Fumi; Kiten, Takashi; Kondo, Yohan; Osawa, Sonko; Sato, Osamu; Takatsuji, Toshiyuki; Takeda, Ryohei			Magnetically self-aligned multiball pitch artifact using geometrically simple features	PRECISION ENGINEERING-JOURNAL OF THE INTERNATIONAL SOCIETIES FOR PRECISION ENGINEERING AND NANOTECHNOLOGY			English	Article						Pitch; Artifact; Measurement; Accuracy; Angle; Magnet	TOOTH FLANK FORM; GEAR; VIBRATION	The vibration/noise of gears is influenced by micrometer-order tooth pitch deviation, and therefore, advanced quality control is needed in the gear manufacturing process using measuring instrument. The accuracy of the pitch measuring instrument is verified using a master gear or artifact, but its accuracy is not sufficiently high, and its manufacturing is not easy. In our previous report, a novel high-precision pitch artifact composed of simple-shape parts ("multiball pitch artifact") was proposed for the calibration of pitch measuring instruments. Simple-shape parts such as balls, cylinders, and planes can be manufactured with several-ten-nanometer-order accuracy. Therefore, this artifact can also have high accuracy. In this study, a magnetically self-aligned multiball pitch artifact is proposed in which the simple-shape parts are assembled with high precision using magnetic force without any special assembly technique. The artifact is designed and manufactured. A measurement experiment using a pitch measuring instrument is performed, and it is verified that the proposed pitch artifact is fundamentally valid for calibration. (C) 2014 Elsevier Inc. All rights reserved.	[Komori, Masaharu; Takeoka, Fumi; Kiten, Takashi] Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto, Kyoto, Japan; [Kondo, Yohan; Osawa, Sonko; Sato, Osamu; Takatsuji, Toshiyuki] AIST, Natl Metrol Inst Japan, Dimens Stand Sect, Tsukuba, Ibaraki, Japan; [Takeda, Ryohei] Osaka Seimitsu Kikai Co Ltd, Higashiosaka, Osaka 5770032, Japan	Komori, M (reprint author), Kyoto Univ, Dept Mech Engn & Sci, Nishikyo Ku, Kyoto, Kyoto, Japan.	komorim@me.kyoto-u.ac.jp			NEDO in Japan	This research is supported by NEDO in Japan.	Kondo Y, 2009, J MANUF SCI E-T ASME, V131, DOI 10.1115/1.4000104; Kondo Y, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/10/105105; [Anonymous], ISO3290; Kondo Y, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/6/065101; OKUYAMA E, 1994, PRECIS ENG, V16, P117, DOI 10.1016/0141-6359(94)90196-1; Kniel K, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/11/115110; Komori M, 2010, J MECH DESIGN, V132, DOI 10.1115/1.4001668; Komori M, 2003, JSME INT J C-MECH SY, V46, P1572, DOI 10.1299/jsmec.46.1572; Mohamad EN, 2010, J ADV MECH DES SYST, V4, P1166, DOI 10.1299/jamdsm.4.1166; [Anonymous], 1501 JISB; Goch G, 2003, CIRP ANN-MANUF TECHN, V52, P659, DOI 10.1016/S0007-8506(07)60209-1; Beyer W, 1996, VDI BERICHT, V1230, P937; Takeoka F, 2008, J MECH DESIGN, V130, DOI 10.1115/1.2890114; Frazer RC, 2004, METROLOGIA, V41, P12, DOI 10.1088/0026-1394/41/1/003; Beyer W, 1996, TECHNICAL PAPER AM G; Beyer W, 1999, P 4 WORLD C GEAR POW, p[2, 1757]; Sammartini MP, 2000, PRECIS ENG, V24, P302, DOI 10.1016/S0141-6359(00)00040-4; Fujio H, 1999, T JPN SOC MECH ENG-C, V58, P295; Haertig F, 2005, GEAR TECHNOL, V22, P16; Haertig F, 2003, P DECT 03 ASME 2003, V22; Komori M, 2000, P DETC2000 ASME 8 IN; Komori M, 2009, J MECH DESIGN, V131, DOI 10.1115/1.3087535; Komori M, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/2/025109; Komori M, 2010, J MECH DESIGN, V132, DOI 10.1115/1.4001875; NeoMag Co. Ltd, DEM CURV MAGN; Och R, 2006, GEAR PRODUCT NEW OCT; Oguma T, 2001, P MPT 2001 JSME INT, P623; Rasnick B, 1998, P MEAS SCI C; Sato O, 2010, PRECIS ENG, V34; Takeoka F, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/4/045105	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0141-6359	1873-2372		PRECIS ENG	Precis. Eng.-J. Int. Soc. Precis. Eng. Nanotechnol.	APR	2015	40						160	171		10.1016/j.precisioneng.2014.11.006		12	Engineering, Multidisciplinary; Engineering, Manufacturing; Nanoscience & Nanotechnology; Instruments & Instrumentation	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation	CD7CI	WOS:000351248000018		
J	Azami, S; Kudo, H; Mizumoto, Y; Tanabe, T; Yan, JW; Kakinuma, Y				Azami, Shunya; Kudo, Hiroshi; Mizumoto, Yuta; Tanabe, Takasumi; Yan, Jiwang; Kakinuma, Yasuhiro			Experimental study of crystal anisotropy based on ultra-precision cylindrical turning of single-crystal calcium fluoride	PRECISION ENGINEERING-JOURNAL OF THE INTERNATIONAL SOCIETIES FOR PRECISION ENGINEERING AND NANOTECHNOLOGY			English	Article						Ultra-precision cylindrical turning; Single-crystal calcium fluoride; Crystal anisotropy; Surface quality; Micro-Vickers; Orthogonal cutting	SURFACE; TOOL	To realize ultimately efficient signal processing, it is necessary to replace electrical signal processing circuits with optical ones. The optical micro-resonator, which localizes light at a certain spot, is an essential component in optical signal processing. Single-crystal calcium fluoride (CaF2) is the most suitable material for a highly efficient optical micro-resonator. The CaF2 resonator can only be manufactured by ultra-precision machining processes, because its crystal anisotropy does not allow the application of chemical etching. However, the optical micro-resonator's performance depends definitely on the surface integrity. This study investigated the relationship between surface quality after ultra-precision machining and crystal anisotropy. Firstly, crack initiation was investigated on the (1 0 0), (1 1 0), and (1 1 1) planes using the micro-Vickers hardness test. Secondly, brittle-ductile transition was investigated by orthogonal cutting tests. Finally, cutting performance of cylindrical turning was evaluated, which could be a suitable method for manufacturing the CaF2 resonator. The most difficult point in cylindrical turning of CaF2 is that the crystalline plane and cutting direction vary continuously. In order to manufacture the CaF2 optical micro-resonator more efficiently, analysis was conducted on crack initiation and surface quality of all crystallographic orientations from the perspective of slip system and cleavage. (C) 2014 Elsevier Inc. All rights reserved.	[Azami, Shunya; Mizumoto, Yuta; Kakinuma, Yasuhiro] Keio Univ, Fac Sci & Technol, Dept Syst Design Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Kudo, Hiroshi; Tanabe, Takasumi] Keio Univ, Fac Sci & Technol, Dept Elect & Elect Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Yan, Jiwang] Keio Univ, Fac Sci & Technol, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Azami, S (reprint author), Keio Univ, Fac Sci & Technol, Dept Syst Design Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	azami@ams.sd.keio.ac.jp	Tanabe, Takasumi/B-4230-2009; Yan, Jiwang/D-6058-2014	Tanabe, Takasumi/0000-0001-5984-4265; Yan, Jiwang/0000-0002-5155-3604	Takahashi Industrial and Economic Research Foundation	The authors gratefully acknowledge technical support from Dr. Katsutoshi Tanaka and Dr. Masahiko Fukuda of TOSHIBA MACHINE CO., LTD. This study was partially supported by the Takahashi Industrial and Economic Research Foundation. The authors would like to express their sincere appreciation for the support.	Yan JW, 2002, J MATER PROCESS TECH, V121, P363, DOI 10.1016/S0924-0136(01)01218-3; Fang FZ, 2005, INT J MACH TOOL MANU, V45, P1681, DOI [10.1016/j.ijmachtools.2005.03.010, 10.1016/j.ij,machtools.2005.03.010]; Savchenkov AA, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.051804; Foy K, 2009, INT J MACH TOOL MANU, V49, P315, DOI 10.1016/j.ijmachtools.2008.10.007; Tanabe T, 2007, NAT PHOTONICS, V1, P49, DOI 10.1038/nphoton.2006.51; Grudinin IS, 2006, OPT COMMUN, V265, P33, DOI 10.1016/j.optcom.2006.03.028; Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371; Vollmer F, 2008, NAT METHODS, V5, P591, DOI 10.1038/nmeth.1221; Azami S, 2013, JPN SOC PRECIS ENG, V60, P601; Kudo H, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807924; Lodes MS, 2011, ACTA MAT, V59, P4246; Maleki L, 2009, OPT SCI ENG-CRC, V146, P133; Matsumura T, 2013, J MATER PROCESS TECH, V213, P1523, DOI 10.1016/j.jmatprotec.2013.02.002; Min S, 2006, P I MECH ENG B-J ENG, V220, P479, DOI 10.1243/095440506X77599; Mizumoto Y, 2011, PROCEDIA ENGINEER, V19, DOI 10.1016/j.proeng.2011.11.110; Namba Y, 2005, CIRP ANN-MANUF TECHN, V54, P503, DOI 10.1016/S0007-8506(07)60155-3; Namba Y, 2004, CIRP ANN-MANUF TECHN, V53, P459, DOI 10.1016/S0007-8506(07)60739-2; Takechi T, 2011, J JPN SOC ABRAS TECH, V55, P113; Takeuchi Y, 1996, CIRP ANN-MANUF TECHN, V45, P401, DOI 10.1016/S0007-8506(07)63090-X; Tang XR, 2013, CIRP ANN-MANUF TECHN, V62, P51, DOI 10.1016/j.cirp.2013.03.094; Wiston SB, 2005, J AM CERAM SOC, V73, P3113; Yan JW, 2004, J VAC SCI TECHNOL B, V22, P46, DOI 10.1116/1.1633770; Yan JW, 2004, INT J ADV MANUF TECH, V24, P640, DOI 10.1007/s00170-003-1747-2	23	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0141-6359	1873-2372		PRECIS ENG	Precis. Eng.-J. Int. Soc. Precis. Eng. Nanotechnol.	APR	2015	40						172	181		10.1016/j.precisioneng.2014.11.007		10	Engineering, Multidisciplinary; Engineering, Manufacturing; Nanoscience & Nanotechnology; Instruments & Instrumentation	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation	CD7CI	WOS:000351248000019		
J	Sugihara, T; Nishimoto, Y; Enomoto, T				Sugihara, Tatsuya; Nishimoto, Yuki; Enomoto, Toshiyuki			On-machine tool resharpening process for dry machining of aluminum alloys employing LME phenomenon	PRECISION ENGINEERING-JOURNAL OF THE INTERNATIONAL SOCIETIES FOR PRECISION ENGINEERING AND NANOTECHNOLOGY			English	Article						Cutting; Cutting tool; Tool resharpening; Adhesion; Liquid metal embrittlement; Aluminum alloys; Gallium; Dry machining	LIQUID-METAL EMBRITTLEMENT; GRAIN-BOUNDARIES; PENETRATION; DLC	Dry machining of aluminum alloys is known to be one of the most difficult metal cutting operations. The issues involved are that without use of cutting fluids, these materials severely adhere to the tool surface and form a built-up edge due to their low melting point and high ductility, leading to deterioration of the surface integrity of the workpiece and tool failure. To overcome this problem, the present study proposes a novel strategy for removing the adhesion layer from the tool surface and recovering the cutting tool performance without detaching the cutting tool from the machine tool, namely, an on-machine tool resharpening process. To achieve efficient removal of the aluminum adhesion layer from the tool surface, the phenomenon of liquid metal embrittlement (LME), which is defined as a brittle fracture, or loss in ductility, of a ductile material in the presence of a liquid metal is employed. A series of experiments using a WC-Co cemented carbide tool and liquid gallium showed that the newly developed strategy employing LME is highly effective in removing the adhesion layer without damage to the tool substrate and has great potential for addressing the issues related to the dry machining of aluminum alloys. (C) 2014 Elsevier Inc. All rights reserved.	[Sugihara, Tatsuya; Nishimoto, Yuki; Enomoto, Toshiyuki] Osaka Univ, Grad Sch Engn, Dept Mech Engn, Suita, Osaka 5650871, Japan	Sugihara, T (reprint author), Osaka Univ, Grad Sch Engn, Dept Mech Engn, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	t-sugihara@mech.eng.osaka-u.ac.jp			JSPS KAKENHI [24860040]; Mazak Foundation	This work was supported by JSPS KAKENHI Grant Number 24860040 and also by Mazak Foundation.	Joseph B, 1999, EUR PHYS J-APPL PHYS, V5, P19, DOI 10.1051/epjap:1999108; Weinert K, 2004, CIRP ANN-MANUF TECHN, V53, P511, DOI 10.1016/S0007-8506(07)60027-4; Ludwig W, 2005, ACTA MATER, V53, P151, DOI 10.1016/j.actamat.2004.09.012; Ludwig W, 2000, MAT SCI ENG A-STRUCT, V281, P198, DOI 10.1016/S0921-5093(99)00733-9; LYNCH SP, 1992, MATER CHARACT, V28, P279, DOI 10.1016/1044-5803(92)90017-C; Fukui H, 2004, SURF COAT TECH, V187, P70, DOI 10.1016/j.surfcoat.2004.01.014; Sreejith PS, 2000, J MATER PROCESS TECH, V101, P287, DOI 10.1016/S0924-0136(00)00445-3; Vandevelde TCS, 1999, SURF COAT TECH, V113, P80, DOI 10.1016/S0257-8972(98)00831-7; NICHOLAS MG, 1979, J MATER SCI, V14, P1, DOI 10.1007/BF01028323; Sutthiruangwong S, 2003, INT J REFRACT MET H, V21, P135, DOI 10.1016/S0263-4368(03)00027-1; Dosbaeva J, 2008, J MATER ENG PERFORM, V17, P346, DOI 10.1007/s11665-008-9209-5; Fernandes PJL, 1996, ENG FAIL ANAL, V3, P299, DOI 10.1016/S1350-6307(96)00022-2; Katahira K, 2011, CIRP ANN-MANUF TECHN, V60, P591, DOI 10.1016/j.cirp.2011.03.013; Klocke F, 1997, ANN CIRP, V46, P519; Kurahashi K, 2004, T JSME C, V70, P590; Kurahashi K, 2004, CIRP ANN-MANUF TECHN, V53, P53, DOI 10.1016/S0007-8506(07)60643-X; Masuzawa T., 1991, ANN CIRP, V40, P199; Sukanta B, 2008, INT J MACH TOOL MANU, V48, P1429; Yoshimura H, 2006, JSME INT J C-MECH SY, V49, P83, DOI 10.1299/jsmec.49.83	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0141-6359	1873-2372		PRECIS ENG	Precis. Eng.-J. Int. Soc. Precis. Eng. Nanotechnol.	APR	2015	40						241	248		10.1016/j.precisioneng.2014.12.005		8	Engineering, Multidisciplinary; Engineering, Manufacturing; Nanoscience & Nanotechnology; Instruments & Instrumentation	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation	CD7CI	WOS:000351248000025		
J	Harauma, A; Tomita, M; Muto, D; Moriguchi, T				Harauma, Akiko; Tomita, Makiko; Muto, Daiki; Moriguchi, Toru			Effect of long-term administration of arachidonic acid on n-3 fatty acid deficient mice	PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS			English	Article						Arachidonic acid; Spontaneous motor activity; Motor coordination; Rota-Rod test; Brain function; Mice	AGED RATS; SPATIAL COGNITION; BRAIN; PERFORMANCE; INFANTS; LIVER; DIET; SUPPLEMENTATION; NUTRITION; PREGNANCY	The effect of long-term oral administration of arachidonic acid (ARA, 240 mg/kg/day) on brain function was assessed for mice maintained on an n-3 fatty acid adequate or deficient diet. The administration of ARA for 13 weeks resulted in an elevation of spontaneous motor activity, or the tendency thereof, in both the n-3 fatty acid adequate and deficient groups. However, the n-3 fatty acid deficient mice that were administered with ARA revealed marked deterioration in motor function in a motor coordination test. In the experiment to investigate changes over time, the motor activity of the ARA-administered group continued to increase mildly in n-3 deficient mice, although that of the control group showed a decrease involving habituation for both diet groups from the second week. The fatty acid composition of the brain at the end of the behavioral experiments indicated an increase in the levels of ARA and other n-6 fatty acids, as well as a decrease in the levels of docosahexaenoic acid. These results suggest that long-term administration of ARA causes an increase of futile spontaneous motor activity and the diminution of motor function by aggravation of n-3 fatty acid deficiency. (C) 2015 Elsevier Ltd. All rights reserved.	[Harauma, Akiko; Moriguchi, Toru] Azabu Univ, Lab Funct Anal Marine Mat, Sch Life & Environm Sci, Sagamihara, Kanagawa 2525201, Japan; [Tomita, Makiko; Muto, Daiki; Moriguchi, Toru] Azabu Univ, Lab Food & Nutr Sci, Dept Food & Life Sci, Sch Life & Environm Sci, Sagamihara, Kanagawa 2298501, Japan	Moriguchi, T (reprint author), Azabu Univ, Lab Food & Nutr Sci, Dept Food & Life Sci, Sch Life & Environm Sci, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 2298501, Japan.	moriguchi@azabu-u.ac.jp			Health and Labor Sciences Research Grant [H22-Shokuhin-Ippan-002]	This research was supported in part by the Health and Labor Sciences Research Grant (H22-Shokuhin-Ippan-002).	REEVES PG, 1993, J NUTR, V123, P1939; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Birch EE, 2000, DEV MED CHILD NEUROL, V42, P174, DOI 10.1017/S0012162200000311; Moriguchi T, 2003, J NEUROCHEM, V87, P297, DOI 10.1046/j.1471-4159.2003.01966.x; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Yokota S, 2013, J TOXICOL SCI, V38, P13; DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200; Masood A, 2005, J LIPID RES, V46, P2299, DOI 10.1194/jlr.D500022-JLR200; Monteiro J, 2014, FOOD FUNCT, V5, P426, DOI 10.1039/c3fo60551e; CARLSON SE, 1993, P NATL ACAD SCI USA, V90, P1073, DOI 10.1073/pnas.90.3.1073; Lim SY, 2005, PEDIATR RES, V58, P741, DOI [10.1203/01.PDR.0000180547.46725.CC, 10.1203/00006450-200510000-00039]; Nelson GJ, 1997, LIPIDS, V32, P415, DOI 10.1007/s11745-997-0054-8; Ohtsuka Y, 2011, J PEDIATR SURG, V46, P489, DOI 10.1016/j.jpedsurg.2010.07.032; Moriguchi T, 2004, J LIPID RES, V45, P1437, DOI 10.1194/jlr.M400087; Ryan AS, 2010, PROSTAG LEUKOTR ESS, V82, P305, DOI 10.1016/j.plefa.2010.02.007; LEPAGE G, 1986, J LIPID RES, V27, P114; Hashimoto M, 2005, J NUTR, V135, P549; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Gamoh S, 2001, CLIN EXP PHARMACOL P, V28, P266, DOI 10.1046/j.1440-1681.2001.03437.x; Bosch G, 2007, NUTR RES REV, V20, P180, DOI 10.1017/S095442240781331X; Harauma A, 2011, LIPIDS, V46, P409, DOI 10.1007/s11745-010-3523-z; Kotani S, 2003, NEUROSCI RES, V46, P453, DOI 10.1016/S0168-0102(03)00123-8; Moriguchi T, 2001, J LIPID RES, V42, P419; Okaichi Y, 2005, PHYSIOL BEHAV, V84, P617, DOI 10.1016/j.physbeh.2005.02.008; Szklenar M, 2013, J VASC RES, V50, P372, DOI 10.1159/000350865; van Goor SA, 2010, BRIT J NUTR, V103, P235, DOI 10.1017/S0007114509991528; Yoshizawa K, 2013, ONCOL LETT, V5, P76, DOI 10.3892/ol.2012.1009	27	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0952-3278	1532-2823		PROSTAG LEUKOTR ESS	Prostaglandins Leukot. Essent. Fatty Acids	APR	2015	95						41	45		10.1016/j.plefa.2014.12.004		5	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Cell Biology; Endocrinology & Metabolism	CE4NE	WOS:000351806500005		
J	Yamamoto, S; Ibayashi, S; Fuchi, M; Yasui, T				Yamamoto, Sumiko; Ibayashi, Setsuro; Fuchi, Masako; Yasui, Tadashi			Immediate-term effects of use of an ankle-foot orthosis with an oil damper on the gait of stroke patients when walking without the device	PROSTHETICS AND ORTHOTICS INTERNATIONAL			English	Article						Ankle-foot orthosis; therapeutic effect; stroke patient; gait analysis	CHRONIC HEMIPARESIS; HEMIPLEGIC PATIENTS; ROCKER FUNCTION; NEUROPROSTHESIS; STIMULATION; PERFORMANCE; ASYMMETRY; SPEED	Background: An ankle-foot orthosis using an oil damper is designed to enable natural movement of the ankle joint. Wearing an ankle-foot orthosis using an oil damper has been demonstrated to assist the first rocker in stroke patients, but its effect on their gait when not wearing it is unclear. Objectives: To determine the effect of use of ankle-foot orthosis using an oil damper on the gait of stroke patients with hemiparesis when not wearing the ankle-foot orthosis. Study design: Crossover study. Methods: The gait of eight stroke patients in the chronic phase when not wearing an ankle-foot orthosis was measured, using a three-dimensional motion analysis system, before using the ankle-foot orthosis using an oil damper and then without and with using the ankle-foot orthosis using an oil damper after 3 weeks of use. Differences in gait were compared between the three measurement conditions. Results: Use of ankle-foot orthosis using an oil damper significantly decreased preswing time and significantly increased the positive ankle joint power in stance when not wearing the ankle-foot orthosis using an oil damper. Conclusions: These changes indicate the promising therapeutic effects of ankle-foot orthosis using an oil damper use and suggest the ankle-foot orthosis using an oil damper's potential as a therapeutic device. Clinical relevance After 3 weeks of use of an ankle-foot orthosis using an oil damper, which assists the first rocker, the gait of stroke patients in the chronic phase when not wearing the ankle-foot orthosis using an oil damper was improved. Preswing time was significantly decreased and positive ankle joint power was significantly increased. The ankle-foot orthosis using an oil damper, which assists the first rocker function with natural movement of the ankle joint during gait, has the potential to improve the gait of stroke patients after immediate-term use.	[Yamamoto, Sumiko] Int Univ Hlth & Welf, Grad Sch, Dept Assist Technol Sci, Tokyo 1070062, Japan; [Ibayashi, Setsuro; Fuchi, Masako] Seiai Rehabil Hosp, Onojo, Japan; [Yasui, Tadashi] Kawamura Gishi Co Ltd, Daito, Japan	Yamamoto, S (reprint author), Int Univ Hlth & Welf, Minato Ku, 1-3-3 Minami Aoyama, Tokyo 1070062, Japan.	sumiko-y@iuhw.ac.jp					Everaert DG, 2013, NEUROREHAB NEURAL RE, V27, P579, DOI 10.1177/1545968313481278; DeQuervain IAK, 1996, J BONE JOINT SURG AM, V78A, P1506; Balasubramanian CK, 2007, ARCH PHYS MED REHAB, V88, P43, DOI 10.1016/j.apmr.2006.10.004; Chen G, 2005, GAIT POSTURE, V22, P51, DOI 10.1016/j.gaitpost.2004.06.009; Desloovere K, 2006, GAIT POSTURE, V24, P142, DOI 10.1016/j.gaitpost.2006.08.003; Gok H, 2003, CLIN REHABIL, V17, P137, DOI 10.1191/0269215503cr605oa; Jagadamma KC, 2010, PROSTHET ORTHOT INT, V34, P270, DOI 10.3109/03093646.2010.503225; Cruz TH, 2009, GAIT POSTURE, V30, P312, DOI 10.1016/j.gaitpost.2009.05.018; Balasubramanian CK, 2009, GAIT POSTURE, V29, P408, DOI 10.1016/j.gaitpost.2008.10.061; Hsu AL, 2003, ARCH PHYS MED REHAB, V84, P1185, DOI 10.1016/S0003-9993(03)00030-3; Kobayashi T, 2011, GAIT POSTURE, V33, P721, DOI 10.1016/j.gaitpost.2011.02.005; Yamamoto S, 2005, PROSTHET ORTHOT INT, V29, P209, DOI 10.1080/03093640500199455; Ring H, 2009, J STROKE CEREBROVASC, V18, P41, DOI 10.1016/j.jstrokecerebrovasdis.2008.08.006; Robbins SM, 2006, ARCH PHYS MED REHAB, V87, P853, DOI 10.1016/j.apmr.2006.02.026; Jonsdottir J, 2009, GAIT POSTURE, V29, P355, DOI 10.1016/j.gaitpost.2009.01.008; [Anonymous], 1996, GAIT POSTURE, DOI 10.1016/0966-6362(96)01063-6; Yamamoto S, 2009, PROSTHET ORTHOT INT, V33, P307, DOI 10.3109/03093640903176563; Lamontagne A, 2002, GAIT POSTURE, V15, P244, DOI 10.1016/S0966-6362(01)00190-4; Burridge JH, 2000, J NEUROL NEUROSUR PS, V69, P353, DOI 10.1136/jnnp.69.3.353; Hausdorff JM, 2008, AM J PHYS MED REHAB, V87, P4, DOI 10.1097/PHM.0b013e31815e6680; Burridge JH, 1998, REV CLIN GERONTOL, V8, P155, DOI 10.1017/S0959259898008260; Mulroy SJ, 2010, PROSTHET ORTHOT INT, V34, P277, DOI 10.3109/03093646.2010.501512; Nolan KJ, 2010, NEUROREHABILITATION, V27, P343, DOI 10.3233/NRE-2010-0618; OLNEY SJ, 1991, ARCH PHYS MED REHAB, V72, P309; Yamamoto S, 2011, PROSTHET ORTHOT INT, V35, P350, DOI 10.1177/0309364611420200; Yokoyama O, 2005, ARCH PHYS MED REHAB, V86, P162, DOI 10.1016/j.apmr.2003.11.026	26	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0309-3646	1746-1553		PROSTHET ORTHOT INT	Prosthet. Orthot. Int.	APR	2015	39	2					140	149		10.1177/0309364613518340		10	Orthopedics; Rehabilitation	Orthopedics; Rehabilitation	CD9UD	WOS:000351443100007		
J	Kobayashi, C; Koike, R; Ota, M; Sugita, Y				Kobayashi, Chigusa; Koike, Ryotaro; Ota, Motonori; Sugita, Yuji			Hierarchical domain-motion analysis of conformational changes in sarcoplasmic reticulum Ca2+-ATPase	PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS			English	Article						Motion Tree; multi-domain protein; conformational change; Ca2+-ATPase; reaction cycle; molecular dynamics; ligand-induced conformational changes	MOLECULAR-DYNAMICS SIMULATIONS; COARSE-GRAINED SIMULATIONS; NORMAL-MODE ANALYSIS; SEARCH-AND-CATCH; CA-ATPASE SERCA; CALCIUM-PUMP; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; INACTIVE CONFORMATIONS; STRUCTURAL-CHANGES	Sarco(endo)plasmic reticulum Ca2+-ATPase transports two Ca2+ per ATP-hydrolyzed across biological membranes against a large concentration gradient by undergoing large conformational changes. Structural studies with X-ray crystallography revealed functional roles of coupled motions between the cytoplasmic domains and the transmembrane helices in individual reaction steps. Here, we employed Motion Tree (MT), a tree diagram that describes a conformational change between two structures, and applied it to representative Ca2+-ATPase structures. MT provides information of coupled rigid-body motions of the ATPase in individual reaction steps. Fourteen rigid structural units, common rigid domains (CRDs) are identified from seven MTs throughout the whole enzymatic reaction cycle. CRDs likely act as not only the structural units, but also the functional units. Some of the functional importance has been newly revealed by the analysis. Stability of each CRD is examined on the morphing trajectories that cover seven conformational transitions. We confirmed that the large conformational changes are realized by the motions only in the flexible regions that connect CRDs. The Ca2+-ATPase efficiently utilizes its intrinsic flexibility and rigidity to response different switches like ligand binding/dissociation or ATP hydrolysis. The analysis detects functional motions without extensive biological knowledge of experts, suggesting its general applicability to domain movements in other membrane proteins to deepen the understanding of protein structure and function. Proteins 2015; 83:746-756. (c) 2015 Wiley Periodicals, Inc.	[Kobayashi, Chigusa; Sugita, Yuji] RIKEN Adv Inst Computat Sci, Computat Biophys Res Team, Div Res, Chuo Ku, Kobe, Hyogo 6400047, Japan; [Koike, Ryotaro; Ota, Motonori] Nagoya Univ, Grad Sch Informat Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Sugita, Yuji] RIKEN Theoret Mol Sci Lab, Wako, Saitama 3510198, Japan; [Sugita, Yuji] RIKEN Quantitat Biol Ctr, Lab Biomol Funct Simulat, Computat Biol Res Core, Chuo Ku, Kobe, Hyogo 6400047, Japan; [Sugita, Yuji] RIKEN ITHES, Wako, Saitama 3510198, Japan	Sugita, Y (reprint author), RIKEN Theoret Mol Sci Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	sugita@riken.jp	Sugita, Yuji/L-6726-2014	Sugita, Yuji/0000-0001-9738-9216	MEXT [26119006]; Strategic Programs for Innovation Research	Grant sponsor: MEXT Grant-in-Aid for Scientific Research on Innovative Areas; Grant number: 26119006 (to Y.S.); Grant sponsor: Strategic Programs for Innovation Research (Y.S.).	Alexandrov V, 2005, PROTEIN SCI, V14, P633, DOI 10.1110/ps.04882105; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; KITAO A, 1991, CHEM PHYS, V158, P447, DOI 10.1016/0301-0104(91)87082-7; Gao YQ, 2005, CELL, V123, P195, DOI 10.1016/j.cell.2005.10.001; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; BOUTONNET NS, 1995, J MOL BIOL, V253, P633, DOI 10.1006/jmbi.1995.0578; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Shatsky M, 2002, PROTEINS, V48, P242, DOI 10.1002/prot.10100; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; POST RL, 1972, J BIOL CHEM, V247, P6530; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; LEVY RM, 1984, MACROMOLECULES, V17, P1370, DOI 10.1021/ma00137a013; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Wriggers W, 1997, PROTEINS, V29, P1; Yao XQ, 2013, J AM CHEM SOC, V135, P7474, DOI 10.1021/ja310548h; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Verbitsky G, 1999, PROTEINS, V34, P232, DOI 10.1002/(SICI)1097-0134(19990201)34:2<232::AID-PROT9>3.0.CO;2-9; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Koike R, 2014, J MOL BIOL, V426, P752, DOI 10.1016/j.jmb.2013.10.034; Hinsen K, 1999, PROTEINS, V34, P369, DOI 10.1002/(SICI)1097-0134(19990215)34:3<369::AID-PROT9>3.0.CO;2-F; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; LEVY RM, 1984, J PHYS CHEM-US, V88, P4233, DOI 10.1021/j150663a009; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; Daiho T, 2014, J BIOL CHEM, V289, P31241, DOI 10.1074/jbc.M114.584086; Espinoza-Fonseca LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026936; Flores SC, 2008, PROTEINS, V73, P299, DOI 10.1002/prot.22060; Fujita K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1934; Gao YQ, 2003, P NATL ACAD SCI USA, V100, P11339, DOI 10.1073/pnas.1334188100; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Howard J., 2001, MECH MOTOR PROTEINS; Iwaki M, 2009, NAT CHEM BIOL, V5, P403, DOI 10.1038/nchembio.171; Kekenes-Huskey PM, 2012, PROTEIN SCI, V21, P1429, DOI 10.1002/pro.2129; Lee RA, 2003, BIOINFORMATICS, V19, P1290, DOI 10.1093/bioinformatics/btg137; Li GH, 2002, BIOPHYS J, V83, P2457; Li GH, 2004, BIOPHYS J, V86, P743; Nagarajan A, 2012, J MOL BIOL, V422, P575, DOI 10.1016/j.jmb.2012.06.001; Nagarajan A, 2012, PROTEINS, V80, P1929, DOI 10.1002/prot.24070; Qi GY, 2005, BIOINFORMATICS, V21, P2832, DOI 10.1093/bioinformatics/bti420; Qi GY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-13; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Salem S, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-12; Shatsky M, 2004, J COMPUT BIOL, V11, P83, DOI 10.1089/106652704773416902; Takano M, 2010, P NATL ACAD SCI USA, V107, P7769, DOI 10.1073/pnas.0911830107; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Weiss DR, 2009, J MOL BIOL, V385, P665, DOI 10.1016/j.jmb.2008.10.064; Yanagida T, 2000, CURR OPIN CELL BIOL, V12, P20, DOI 10.1016/S0955-0674(99)00052-6; Yang W, 2003, P NATL ACAD SCI USA, V100, P874, DOI 10.1073/pnas.0337432100; Yao XQ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1116; Zhang ZS, 2001, J BIOL CHEM, V276, P15232, DOI 10.1074/jbc.M010813200	67	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-3585	1097-0134		PROTEINS	Proteins	APR	2015	83	4					746	756		10.1002/prot.24763		11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CE0TW	WOS:000351520400014		
J	Ukisu, Y				Ukisu, Yuji			Preparation of silica-supported Pd nanoparticle catalysts by an alcohol reduction method and evaluation of their catalytic properties in the dechlorination of an aromatic chloride	REACTION KINETICS MECHANISMS AND CATALYSIS			English	Article						Palladium catalyst; Metal particle size; Dechlorination activity; Alkaline alcohol	HYDROGEN-TRANSFER HYDRODECHLORINATION; NOBLE-METAL CATALYSTS; PALLADIUM CATALYSTS; SIZE CONTROL; ACTIVITY ENHANCEMENT; 2-PROPANOL	Reduction of a Pd(II) precursor in refluxing 2-propanol, ethanol, or methanol in the presence of dissolved NaOH afforded silica-supported Pd catalysts designated Pd/SiO2(Pr), Pd/SiO2(Et), and Pd/SiO2(Me), respectively. Pd/SiO2(Pr) consisted of metallic Pd particles (average particle size, 5.1 nm) dispersed in the porous structure of SiO2, whereas the Pd particles on Pd/SiO2(Et) and Pd/SiO2(Me) were larger. The catalytic activity of Pd/SiO2(Pr) in the dechlorination of 2,4,6-trichloroanisole in a solution of 2-propanol containing NaOH was greatly enhanced by the addition of methanol; the optimum rate occurred at 1 % v/v methanol. The activity of Pd/SiO2(Et) was also enhanced by methanol but to a lesser extent than that of Pd/SiO2(Pr). In contrast, Pd/SiO2(Me) exhibited no activity even in the presence of methanol.	AIST, Natl Inst Adv Ind Sci & Technol AIST, Tsukuba, Ibaraki 3058569, Japan	Ukisu, Y (reprint author), AIST, Natl Inst Adv Ind Sci & Technol AIST, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	y-ukisu@aist.go.jp			National Institute of Advanced Industrial Science and Technology (AIST)	The author gratefully acknowledges financial support from the National Institute of Advanced Industrial Science and Technology (AIST).	Hashimoto N, 2010, CHEM LETT, V39, P49, DOI 10.1246/cl.2010.49; Teranishi T, 1999, J PHYS CHEM B, V103, P3818, DOI 10.1021/jp983478m; Barau A, 2008, CATAL LETT, V124, P204, DOI 10.1007/s10562-008-9465-x; Shen C, 2012, LANGMUIR, V28, P7519, DOI 10.1021/la300825s; Jiao L, 2008, J CATAL, V260, P329, DOI 10.1016/j.jcat.2008.09.022; BRADLEY JS, 1992, CHEM MATER, V4, P1234, DOI 10.1021/cm00024a023; LANGFORD JI, 1978, J APPL CRYSTALLOGR, V11, P102, DOI 10.1107/S0021889878012844; Teranishi T, 1998, CHEM MATER, V10, P594, DOI 10.1021/cm9705808; Toebes ML, 2001, J MOL CATAL A-CHEM, V173, P75, DOI 10.1016/S1381-1169(01)00146-7; Ukisu Y, 1997, J MOL CATAL A-CHEM, V125, P135, DOI 10.1016/S1381-1169(97)00092-7; Gomez-Quero S, 2008, IND ENG CHEM RES, V47, P6841, DOI 10.1021/ie0716565; Ukisu Y, 2004, REACT KINET CATAL L, V81, P305, DOI 10.1023/B:REAC.0000019437.92951.44; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; CONTESCU C, 1991, APPL CATAL, V74, P95, DOI 10.1016/0166-9834(91)90011-V; Jonsson S, 2008, J AGR FOOD CHEM, V56, P4962, DOI 10.1021/jf800230y; Kawabata T, 2006, APPL CATAL B-ENVIRON, V66, P151, DOI 10.1016/j.apcatb.2006.03.007; Keane MA, 2011, CHEMCATCHEM, V3, P800, DOI 10.1002/cctc.201000432; Keane MA, 2004, APPL CATAL B-ENVIRON, V48, P275, DOI 10.1016/j.apcatb.2003.11.004; Kim T, 2004, ELECTROCHIM ACTA, V50, P817, DOI 10.1016/j.electacta.2004.01.124; Murena F, 2000, APPL CATAL B-ENVIRON, V27, P257, DOI 10.1016/S0926-3373(00)00157-0; Semagina N, 2009, CATAL REV, V51, P147, DOI 10.1080/01614940802480379; Ukisu Y, 2006, REACT KINET CATAL L, V89, P341, DOI 10.1007/s11144-006-0146-8; Ukisu Y, 2010, REACT KINET MECH CAT, V100, P93, DOI 10.1007/s11144-010-0176-0; Ukisu Y, 2008, APPL CATAL A-GEN, V349, P229, DOI 10.1016/j.apcata.2008.07.040; Ukisu Y, 2012, REACT KINET MECH CAT, V107, P277, DOI 10.1007/s11144-012-0489-2; Ukisu Y, 2003, APPL CATAL B-ENVIRON, V40, P141, DOI 10.1016/S0926-3373(02)00148-0	26	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1878-5190	1878-5204		REACT KINET MECH CAT	React. Kinet. Mech. Catal.	APR	2015	114	2					385	394		10.1007/s11144-014-0807-y		10	Chemistry, Physical	Chemistry	CD6CW	WOS:000351177700002		
J	Tou, A; Einaga, H; Teraoka, Y				Tou, Akihiro; Einaga, Hisahiro; Teraoka, Yasutake			Effect of co-deposition of LaFeO3 on the catalytic properties of Pd on Al2O3 support for CO-O-2 and NO-CO reactions	REACTION KINETICS MECHANISMS AND CATALYSIS			English	Article						Palladium; La-Fe oxides; CO oxidation; NO-CO reaction	EMISSION CONTROL; CARBON-MONOXIDE; OXIDATION; REDUCTION; COMBUSTION; PD/AL2O3; FE; PARTICLES; MECHANISM; METHANE	Pd/LaFeO3/Al2O3 catalysts were prepared by co-deposition of Pd and LaFeO3 perovskite oxides in the intrapores of Al2O3 by the incipient wetness method. Pd and LaFeO3 perovskite oxides were highly dispersed on Al2O3 in the inside pore. H-2-TPR studies revealed that the oxidation state, dispersion and redox properties of Pd were affected by the presence of LaFeO3 with close proximity. The Pd and LaFeO3 co-deposited Al2O3 catalysts exhibited much higher activity for CO oxidation and NO-CO reaction than Pd/Al2O3 catalysts.	[Tou, Akihiro] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Dept Mol & Mat Sci, Kasuga, Fukuoka 8168580, Japan; [Einaga, Hisahiro; Teraoka, Yasutake] Kyushu Univ, Dept Energy & Mat Sci, Fac Engn Sci, Kasuga, Fukuoka 8168580, Japan	Einaga, H (reprint author), Kyushu Univ, Dept Energy & Mat Sci, Fac Engn Sci, Kasuga, Fukuoka 8168580, Japan.	tr-a-toh@mms.kyushu-u.ac.jp; einaga.hisahiro.399@m.kyushu-u.ac.jp	Hisahiro, Einaga/I-5440-2015	Hisahiro, Einaga/0000-0002-4819-9755			Ahmed F, 2011, J PHYS CHEM C, V115, P24123, DOI 10.1021/jp204348e; Almusaiteer K, 1999, J CATAL, V184, P189, DOI 10.1006/jcat.1999.2417; Ziaei-Azad H, 2011, APPL CATAL B-ENVIRON, V102, P62, DOI 10.1016/j.apcatb.2010.11.025; Burch R, 2004, CATAL REV, V46, P271, DOI 10.1081/CR-200036718; Schmal M, 1999, J CATAL, V185, P138, DOI 10.1006/jcat.1999.2465; Bi YS, 2007, J MOL CATAL A-CHEM, V266, P173, DOI 10.1016/j.molcata.2006.11.011; Nishihata Y, 2002, NATURE, V418, P164, DOI 10.1038/nature00893; SUBRAMANIAN S, 1992, CATAL LETT, V16, P323, DOI 10.1007/BF00764344; Zhang RD, 2006, J CATAL, V237, P368, DOI 10.1016/j.jcat.2005.11.019; Monteiro RS, 2001, CATAL TODAY, V65, P77, DOI 10.1016/S0920-5861(00)00547-2; Tou A, 2013, CATAL TODAY, V201, P103, DOI 10.1016/j.cattod.2012.04.033; Kotobuki M, 2005, J CATAL, V236, P262, DOI 10.1016/j.jcat.2005.09.026; Takeguchi T, 2005, APPL CATAL A-GEN, V293, P91, DOI 10.1016/j.apcata.2005.07.013; Bernal S, 1999, CATAL TODAY, V50, P175, DOI 10.1016/S0920-5861(98)00503-3; Sica AM, 2003, APPL CATAL A-GEN, V239, P121, DOI 10.1016/S0926-860X(02)00380-0; Nagai Y, 2008, ANGEW CHEM INT EDIT, V47, P9303, DOI 10.1002/anie.200803126; Eguchi K, 2001, APPL CATAL A-GEN, V222, P359, DOI 10.1016/S0926-860X(01)00843-2; Asada T., 2008, CATAL TODAY, V15, P37; Cai LL, 2011, J MATER SCI, V46, P5639, DOI 10.1007/s10853-011-5514-8; Cimino S, 2007, APPL CATAL A-GEN, V327, P238, DOI 10.1016/j.apcata.2007.05.021; Einaga H, 2014, CATAL LETT, V144, P1653, DOI 10.1007/s10562-014-1316-3; Ikeue K, 2012, B CHEM SOC JPN, V85, P468, DOI 10.1246/bcsj.20110328; Kolli T, 2007, TOP CATAL, V45, P1; Li M, 2012, CATAL TODAY, V201, P19; Miller DD, 2009, CATAL COMMUN, V10, P1313, DOI 10.1016/j.catcom.2009.02.011; Munteanu G, 1997, THERMOCHIM ACTA, V291, P171, DOI 10.1016/S0040-6031(96)03097-3; MURAKI H, 1986, IND ENG CHEM PROD RD, V25, P202, DOI 10.1021/i300022a014; Neyertz C, 2009, APPL CATAL A-GEN, V368, P146, DOI 10.1016/j.apcata.2009.08.023; PENA MA, 1987, J COLLOID INTERF SCI, V119, P100, DOI 10.1016/0021-9797(87)90248-7; Renouprez AJ, 1998, J CATAL, V179, P390, DOI 10.1006/jcat.1998.2231; Renouprez AJ, 2001, J CATAL, V198, P243, DOI 10.1006/jcat.2000.3129; Tanikawa K, 2011, APPL CATAL A-GEN, V403, P12, DOI 10.1016/j.apcata.2011.06.007; TASCON JMD, 1985, J CATAL, V95, P558, DOI 10.1016/0021-9517(85)90134-4; Valden M, 1996, J CATAL, V161, P614, DOI 10.1006/jcat.1996.0224; WIMMERS OJ, 1986, J PHYS CHEM-US, V90, P1331, DOI 10.1021/j100398a025; Yamazoe N., 1990, CATAL TODAY, V8, P175, DOI DOI 10.1016/0920-5861(90)87017-W; Yazawa Y, 1999, J CATAL, V187, P15, DOI 10.1006/jcat.1999.2583	37	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1878-5190	1878-5204		REACT KINET MECH CAT	React. Kinet. Mech. Catal.	APR	2015	114	2					409	420		10.1007/s11144-014-0823-y		12	Chemistry, Physical	Chemistry	CD6CW	WOS:000351177700004		
J	Osaki, T; Yamada, K; Watari, K; Tajiri, K				Osaki, Toshihiko; Yamada, Kiho; Watari, Koji; Tajiri, Koji			Superior thermal stability and oxygen storage capacity of ceria nanoparticles dispersed on alumina cryogel	REACTION KINETICS MECHANISMS AND CATALYSIS			English	Article						Cryogel; Sol-gel; Freeze drying; CeO2; Al2O3; Thermal stability; Oxygen storage capacity	AUTOMOTIVE PALLADIUM CATALYSTS; SOL-GEL; AEROGELS; OXIDE; SUPPORTS; CO	Cerium-dispersed alumina cryogel was prepared from cerium nitrate and aluminum sec-butoxide by a combination of one-pot sol-gel with freeze drying. The cryogel catalyst exhibited higher thermal stability of ceria and larger oxygen storage capacity than the corresponding xerogel and impregnation catalysts. The better stability and capacity were owing to the homogeneous distribution of cerium in boehmite gel by the one-pot synthesis of cerium-boehmite gel, and also to the suppression of aggregation of the cerium during the subsequent elimination of water from frozen gel by sublimation. As a result, cerium was finely dispersed and stabilized throughout the alumina cryogel, retarding the sintering of ceria at high temperatures. The destruction of fine structures of the catalyst at high temperatures was less pronounced on the cryogel, which also contributed to the stability of ceria.	[Osaki, Toshihiko; Yamada, Kiho; Watari, Koji; Tajiri, Koji] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan	Osaki, T (reprint author), Natl Inst Adv Ind Sci & Technol, Moriyama Ku, 2266-98 Anagahora, Nagoya, Aichi 4638560, Japan.	t-osaki@aist.go.jp					Sugiura M, 2005, B CHEM SOC JPN, V78, P752, DOI 10.1246/bcsj.78.752; OZAWA M, 1993, J ALLOY COMPD, V193, P73, DOI 10.1016/0925-8388(93)90314-D; Kirchnerova J, 2000, APPL CATAL A-GEN, V196, P191, DOI 10.1016/S0926-860X(99)00468-8; Osaki T, 2012, J SOL-GEL SCI TECHN, V61, P268, DOI 10.1007/s10971-011-2623-4; PAJONK GM, 1991, APPL CATAL, V72, P217, DOI 10.1016/0166-9834(91)85054-Y; Vazquez A, 2001, J MOL CATAL A-CHEM, V167, P91, DOI 10.1016/S1381-1169(00)00495-7; PAJONK GM, 1990, J NON-CRYST SOLIDS, V121, P66, DOI 10.1016/0022-3093(90)90106-V; YAO HC, 1984, J CATAL, V86, P254, DOI 10.1016/0021-9517(84)90371-3; Chen JC, 2004, APPL CATAL B-ENVIRON, V48, P25, DOI 10.1016/j.apcatb.2003.09.004; Haneda M, 1997, NIPPON KAGAKU KAISHI, P169; HANEDA M, 1993, B CHEM SOC JPN, V66, P1279, DOI 10.1246/bcsj.66.1279; HoangVan C, 1995, STUD SURF SCI CATAL, V91, P435; HOANGVAN C, 1992, J NON-CRYST SOLIDS, V145, P250, DOI 10.1016/S0022-3093(05)80466-1; KLVANA D, 1989, J PHYS-PARIS, V50, pC429; MIKI T, 1988, CHEM LETT, P565, DOI 10.1246/cl.1988.565; Monte RD, 2005, J MATER CHEM, V15, P633, DOI 10.1039/b414244f; PAJONK GM, 1989, J PHYS-PARIS, V50, pC413; Pajonk GM, 1997, CATAL TODAY, V35, P319, DOI 10.1016/S0920-5861(96)00163-0; Pecchi G, 2004, J NON-CRYST SOLIDS, V345, P624, DOI 10.1016/j.jnoncrysol.2004.08.110; Watanabe M, 2001, CATAL CATAL SHOKUBAI, V34, P144; Wey MY, 2006, J NON-CRYST SOLIDS, V352, P2166, DOI 10.1016/j.jnoncrysol.2006.01.035	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1878-5190	1878-5204		REACT KINET MECH CAT	React. Kinet. Mech. Catal.	APR	2015	114	2					561	570		10.1007/s11144-014-0804-1		10	Chemistry, Physical	Chemistry	CD6CW	WOS:000351177700014		
J	Morgan, AH; Hammond, VJ; Sakoh-Nakatogawa, M; Ohsumi, Y; Thomas, CP; Blanchet, F; Piguet, V; Kiselyov, K; O'Donnell, VB				Morgan, Alwena H.; Hammond, Victoria J.; Sakoh-Nakatogawa, Machiko; Ohsumi, Yoshinori; Thomas, Christopher P.; Blanchet, Fabien; Piguet, Vincent; Kiselyov, Kirill; O'Donnell, Valerie B.			A novel role for 12/15-lipoxygenase in regulating autophagy	REDOX BIOLOGY			English	Article						Lipid; Autophagy Lipoxygenase Mitochondria	LYSOSOMAL STORAGE DISEASES; ESTERIFIED EICOSANOIDS; ORGANELLE DEGRADATION; APOPTOTIC CELLS; LATE ENDOSOMES; MITOCHONDRIA; MACROPHAGES; LIPOXYGENASE; LENS; PHOSPHATIDYLETHANOLAMINE	12/15-Lipoxygenase (LOX) enzymatically generates oxidized phospholipicls in munocytes and macrophages. Herein, we show that cells deficient in 12/15-LOX contain detective mitochondria and numerous cytoplasmic vacuoles containing electron dense material, indicating defects in autophagy or membrane processing, However, both LC3 expression and lipidation were normal both basally and on chloroquine treatment. A LOX-derived oxidized phospholipid, 12-hydroxyeicosatetraenoic acid-phosphatidylethanolamine (12-HETE-PE) was found to be a preferred substrate for yeast Atg8 lipidation, versus native PE, while both native and oxidized PE were effective substrates for LC3 lipidation. Last, phospholipidomics demonstrated altered levels of several phospholipid classes. Thus, we show that oxidized phospholipids generated by 12/15-LOX can act as substrates for key proteins required for effective autophagy and that cells deficient in this enzyme show evidence of autophagic dysfunction. The data functionally link phospholipid oxidation with autophagy for the first time. 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (111:1p :// creative(' ommons.ii rgi tic ensesibyj 3.0/).	[Morgan, Alwena H.; Hammond, Victoria J.; Thomas, Christopher P.; Blanchet, Fabien; Piguet, Vincent; O'Donnell, Valerie B.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [Sakoh-Nakatogawa, Machiko; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 227, Japan; [Kiselyov, Kirill] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	O'Donnell, VB (reprint author), Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales.	o-donnellvb@cardiff.ac.uk					Aflaki E., 2014, SCI TRANSL MED, V6; Alroy J, 2006, ULTRASTRUCT PATHOL, V30, P489, DOI 10.1080/01913120500520986; Kiselyov K, 2007, AUTOPHAGY, V3, P259; Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004; Raben N, 2012, AM J MED GENET C, V160C, P13, DOI 10.1002/ajmg.c.31317; SCHEWE T, 1975, FEBS LETT, V60, P149, DOI 10.1016/0014-5793(75)80439-X; Grullich C, 2001, FEBS LETT, V489, P51, DOI 10.1016/S0014-5793(01)02080-4; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; Osellame LD, 2014, BRIT J PHARMACOL, V171, P1958, DOI 10.1111/bph.12453; BASSNETT S, 1992, DEV DYNAM, V194, P85; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Sun DX, 1996, J BIOL CHEM, V271, P24055; Desideri E, 2012, AUTOPHAGY, V8, P1769, DOI 10.4161/auto.22037; Clark SR, 2011, BLOOD, V117, P2033, DOI 10.1182/blood-2010-04-278887; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Maskrey BH, 2007, J BIOL CHEM, V282, P20151, DOI 10.1074/jbc.M611776200; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Hammond VJ, 2012, J BIOL CHEM, V287, P41651, DOI 10.1074/jbc.M112.405407; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Thomas CP, 2010, J BIOL CHEM, V285, P6891, DOI 10.1074/jbc.M109.078428; Huo YQ, 2004, CIRCULATION, V110, P2024, DOI 10.1161/01.CIR.0000143628.37680.F6; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Osellame LD, 2013, AUTOPHAGY, V9, P1633, DOI 10.4161/auto.25878; Mullock BM, 1998, J CELL BIOL, V140, P591, DOI 10.1083/jcb.140.3.591; van Leyen K, 1998, NATURE, V395, P392; Bassnett S, 1997, J CELL BIOL, V137, P37, DOI 10.1083/jcb.137.1.37; Bright NA, 1997, J CELL SCI, V110, P2027; Dahm R, 1997, BIOCHEM SOC T, V25, pS584; Ferreira AM, 2009, BIOCHEM J, V417, P223, DOI 10.1042/BJ20080701; Giordano S., 2013, REDOX BIOL, V2, P82, DOI DOI 10.1016/J.REDOX.2013.12.013; Haberzettl P., 2013, REDOX BIOL, V1, P56; Harats D., 2007, ARTERIOSCLER THROMB, V450, P1253; Hohn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006; Kiselyov K, 2007, J PHYSIOL-LONDON, V578, P641, DOI 10.1113/jphysiol.2006.119024; Miller YI, 2001, J BIOL CHEM, V276, P19431, DOI 10.1074/jbc.M011276200; Morgan AH, 2009, J BIOL CHEM, V284, P21185, DOI 10.1074/jbc.M109.021634; Ponder KP, 2007, EXPERT OPIN BIOL TH, V7, P1333, DOI 10.1517/14712598.7.91333; Schewe T, 1977, Acta Biol Med Ger, V36, P563; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Tanida I, 2002, BIOCHEM BIOPH RES CO, V296, P1164, DOI 10.1016/S0006-291X(02)02057-0; Taylor P.R., 2012, BLOOD, V119, P6174; Zhang J., 2013, REDOX BIOL, V1, P19	44	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2213-2317			REDOX BIOL	Redox Biol.	APR	2015	4						40	47		10.1016/j.redox.2014.11.005		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CD1DI	WOS:000350813800006		
J	Kumagai, T; Usami, H; Matsukawa, N; Nakashima, F; Chikazawa, M; Shibata, T; Noguchi, N; Uchida, K				Kumagai, Takeshi; Usami, Hiroko; Matsukawa, Nao; Nakashima, Fumie; Chikazawa, Miho; Shibata, Takahiro; Noguchi, Noriko; Uchida, Koji			Functional interaction between cyclooxygenase-2 and p53 in response to an endogenous electrophile	REDOX BIOLOGY			English	Article						4-Hydroxy-2-nonenal Cyclooxygenase p53 Lipid peroxidation; Proteasome	TUMOR-SUPPRESSOR PROTEIN; WILD-TYPE P53; ALCOHOLIC LIVER-DISEASE; CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; OXIDATIVE STRESS; GROWTH-FACTOR; KAPPA-B; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION	Cyclooxygenase-2 (Cox 2) is rapidly expressed by various stimuli and plays a key role in conversion of free arachidonic acid to prostaglandins. We have previously identified 4-hydroxy-2-nonenal (PINE), a lipid peroxidation-derived electrophile, as the potent Cox -2 inducer in rat epithelial RL34 cells and revealed that the HNE-induced Cox -2 expression resulted from the stabilization of Cox -2 mRNA that is mediated by the p38 mitogen-activated protein kinase signaling pathway. In the present study, we investigated an alternative regulatory mechanism of Cox -2 expression mediated by a transcription factor p53. In addition, to characterize the causal role for Cox 2, we examined the effects of Cox -2 over expression in RL34 cells. To examine whether the FINE induced Cox -2 expression was mechanistically linked to the p53 expression, we analyzed changes in Cox -2 and p53 expression levels in response to FINE and observed that the Cox -2 levels were inversely correlated with the p53 levels. Down regulation of p53 followed by the activation of a transcription factor Spl was suggested to be involved in the FINE induced Cox -2 gene expression. To characterize the effect of Cox -2 expression in the cells, we established the Cox-2-overexpressing derivatives of RL34 cells by stable transfection with Cox -2 cDNA. An oligonucleotide microarray analysis revealed a dramatic down-regulation of the proteasome subunit RC1 in the Cox-2 overexpressed cells compared to the empty-vector transfected control cells. Consistent with the Cox-2-mediated down-regulation of proteasome, a moderate reduction of the proteasome activities was observed. This proteasome dysfunction mediated by the Cox-2 overproduction was associated with the enhanced accumulation of p53 and ubiquitinated proteins, leading to the enhanced sensitivity toward electrophiles. These results suggest the existence of a causal link between Cox-2 and p53, which may represent a toxic mechanism of electrophilic lipid peroxidation products. 2014 The Authors. Published by Elsevier By. This is an open access article under the CC BY-NC-ND license (1-41 p :// crealivecommo ris.ur,Y/ licenses/ by-I-lc-n(1J	[Kumagai, Takeshi; Usami, Hiroko; Matsukawa, Nao; Nakashima, Fumie; Chikazawa, Miho; Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Noguchi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Med Life Syst, Syst Life Sci, Kyoto 6100394, Japan	Uchida, K (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp					AKI M, 1992, FEBS LETT, V301, P65, DOI 10.1016/0014-5793(92)80211-X; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Wang QJ, 1998, CANCER RES, V58, P5762; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Smith WL, 1996, J BIOL CHEM, V271, P33157; Li CJ, 1997, HEPATOLOGY, V26, P650, DOI 10.1002/hep.510260317; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; SANTHANAM U, 1991, P NATL ACAD SCI USA, V88, P7605, DOI 10.1073/pnas.88.17.7605; Prescott SM, 2000, BBA-REV CANCER, V1470, pM69, DOI 10.1016/S0304-419X(00)00006-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; RISTIMAKI A, 1994, J BIOL CHEM, V269, P11769; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; JENTSCH S, 1995, CELL, V82, P881, DOI 10.1016/0092-8674(95)90021-7; MISKO TP, 1995, J NEUROIMMUNOL, V61, P195, DOI 10.1016/0165-5728(95)00091-F; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.16248699; BARAK Y, 1993, EMBO J, V12, P461; Adderley SR, 1999, J BIOL CHEM, V274, P5038, DOI 10.1074/jbc.274.8.5038; Schonbeck U, 1999, AM J PATHOL, V155, P1281, DOI 10.1016/S0002-9440(10)65230-3; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; Thornborrow EC, 2001, J BIOL CHEM, V276, P15598, DOI 10.1074/jbc.M011643200; Agarwal ML, 1998, J BIOL CHEM, V273, P1, DOI 10.1074/jbc.273.1.1; Kondo M, 2001, J BIOL CHEM, V276, P12076, DOI 10.1074/jbc.M009630200; Ohlsson C, 1998, ENDOCRINOLOGY, V139, P1101, DOI 10.1210/en.139.3.1101; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj/onc/1205181; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; MIYASHITA T, 1995, CELL, V80, P293; SANO H, 1995, CANCER RES, V55, P3785; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Yamamoto K, 1995, J BIOL CHEM, V270, P31315; Ristimaki A, 1997, CANCER RES, V57, P1276; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Xu Q, 2000, J BIOL CHEM, V275, P24583, DOI 10.1074/jbc.M003894200; Parrett ML, 1997, INT J ONCOL, V10, P503; DUBOIS RN, 1994, J CLIN INVEST, V93, P493, DOI 10.1172/JCI116998; Lee SJ, 2008, FREE RADICAL BIO MED, V45, P1487, DOI 10.1016/j.freeradbiomed.2008.08.022; KARGMAN SL, 1995, CANCER RES, V55, P2556; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Li BQ, 2001, J BIOL CHEM, V276, P29729, DOI 10.1074/jbc.M101167200; APPLEBY SB, 1994, BIOCHEM J, V302, P723; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Trifan OC, 1999, J BIOL CHEM, V274, P34141, DOI 10.1074/jbc.274.48.34141; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Pratico D, 2000, AM J MED, V109, P577, DOI 10.1016/S0002-9343(00)00547-7; Ballif BA, 1996, P NATL ACAD SCI USA, V93, P5544, DOI 10.1073/pnas.93.11.5544; Black AR, 1999, J BIOL CHEM, V274, P1207, DOI 10.1074/jbc.274.3.1207; Cai BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041742; Chen QR, 1997, J BIOL CHEM, V272, P5952; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Dhar SK, 2006, J BIOL CHEM, V281, P21698, DOI 10.1074/jbc.M601083200; Ding BC, 2001, J BIOL CHEM, V276, P8713, DOI 10.1074/jbc.M005248200; Ding QX, 2001, FREE RADICAL BIO MED, V31, P574, DOI 10.1016/S0891-5849(01)00635-9; Halliwell B., 1989, FREE RADICALS BIOL M; Halliwell B, 2002, ANN NY ACAD SCI, V962, P182; Hansen R, 1997, CURR OPIN GENET DEV, V7, P46, DOI 10.1016/S0959-437X(97)80108-6; Ho L, 1999, J NEUROSCI RES, V57, P295; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Kong XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062832; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; Kumagai T, 2000, BIOCHEM BIOPH RES CO, V273, P437, DOI 10.1006/bbrc.2000.2967; Kumagai T, 2002, ARCH BIOCHEM BIOPHYS, V397, P240, DOI 10.1006/abbi.2001.2601; MACK DH, 1993, NATURE, V363, P281, DOI 10.1038/363281a0; Meagher EA, 1999, J CLIN INVEST, V104, P805, DOI 10.1172/JCI5584; MULLERDECKER K, 1995, MOL CARCINOGEN, V12, P31, DOI 10.1002/mc.2940120106; Nanji AA, 1997, GASTROENTEROLOGY, V112, P943, DOI 10.1053/gast.1997.v112.pm9041257; Newton R, 1998, J BIOL CHEM, V273, P32312, DOI 10.1074/jbc.273.48.32312; Perkins DJ, 1997, BIOCHEM J, V321, P677; RYSECK RP, 1992, CELL GROWTH DIFFER, V3, P443; SETO E, 1992, P NATL ACAD SCI USA, V89, P12028, DOI 10.1073/pnas.89.24.12028; Shibata T, 2003, BIOCHEMISTRY-US, V42, P13960, DOI 10.1021/bi035215a; Shinmura K, 2000, P NATL ACAD SCI USA, V97, P10197, DOI 10.1073/pnas.97.18.10197; Steinauer KK, 2000, INT J RADIAT ONCOL, V48, P325, DOI 10.1016/S0360-3016(00)00671-4; Subbaramaiah K, 1999, J BIOL CHEM, V274, P10911, DOI 10.1074/jbc.274.16.10911; Tanahashi N, 1999, MOL BIOL REP, V26, P3, DOI 10.1023/A:1006909522731; Tanaka K, 1998, J BIOCHEM-TOKYO, V123, P195; Tanaka K, 1998, GENES CELLS, V3, P499, DOI 10.1046/j.1365-2443.1998.00207.x; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Wang QJ, 1997, MOL CELL BIOL, V17, P389	81	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2213-2317			REDOX BIOL	Redox Biol.	APR	2015	4						74	86		10.1016/j.redox.2014.11.011		13	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CD1DI	WOS:000350813800009		
J	Yama, K; Sato, K; Abe, N; Murao, Y; Tatsunami, R; Tampo, Y				Yama, Kaori; Sato, Keisuke; Abe, Natsuki; Murao, Yu; Tatsunami, Ryosuke; Tampo, Yoshiko			Epalrestat increases glutathione, thioredoxin, and heme oxygenase-1 by stimulating Nrf2 pathway in endothelial cells	REDOX BIOLOGY			English	Article						Epalrestat Endothelial cell; Glutathione Heine oxyge na se-1; Thiorecloxin Nuclear factor erythroid 2-related factor 2	ALDOSE REDUCTASE INHIBITOR; OXIDATIVE STRESS; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); ANTIOXIDATIVE PROTEINS; DRUG DISCOVERY; MECHANISMS; INDUCTION; COMPLICATIONS; EXPRESSION; INFLAMMATION	Epalrestat ([PS) is the only aldose reductase inhibitor that is currently available for the treatment of diabetic neuropathy. Recently, we found that [PS at near-plasma concentration increases the intracellular levels of glutathione (GSH) in rat Schwann cells. GSH plays a crucial role in protecting endothelial cells from oxidative stress, thereby preventing vascular diseases. Here we show that [PS increases GSH levels in not only Schwann cells but also endothelial cells. Treatment of bovine aortic endothelial cells (BAECs), an in vitro model of the vascular endothelium, with EPS caused a dramatic increase in intracellular GSH levels. This was concomitant with the up-regulation of glutamate cysteine ligase, an enzyme catalyzing the first and rate-limiting step in tie novo GSH synthesis. Moreover, EPS stimulated the expression of thiorecloxin and heme oxygenase-1, which have important redox regulatory functions in endothelial cells. Nuclear factor erythroid 2-related factor 2 (Nr12) is a key transcription factor that regulates the expression of antioxidant genes. [PS increased nuclear Nr12 levels in BAECs. NrI2 knockdown by siRNA suppressed the [PS-induced glutamate cysteine ligase, thiorecloxin-1, and he me oxygenase-1 expression. Interestingly, LY294002, an inhibitor of phosphatidylinositol 3-kinase, abolished the [PS-stimulated GSH synthesis, suggesting that the kinase is associated with Nr12 activation induced by EPS. Furthermore, [PS reduced the cytotoxicity induced by H202 and tert-butylhydroperoxide, indicating that [PS plays a role in protecting cells from oxidative stress. Taken together, the results provide evidence that [PS exerts new beneficial effects on endothelial cells by increasing GSH, thioredoxin, and heme oxygenase-1 levels through the activation of Nr12. We suggest that EPS has the potential to prevent several vascular diseases caused by oxidative stress. c 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (Iii p:// (TIT ativecommons.orgilicenses by-nc-nd/3.(1	[Yama, Kaori; Sato, Keisuke; Abe, Natsuki; Murao, Yu; Tatsunami, Ryosuke; Tampo, Yoshiko] Hokkaido Pharmaceut Univ, Sch Pharm, Otaru, Hokkaido 0470264, Japan	Tampo, Y (reprint author), Hokkaido Pharmaceut Univ, Sch Pharm, 7-1 Katsuraoka Cho, Otaru, Hokkaido 0470264, Japan.	y-tampo@hokuyakudai.ac.jp					VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; El Assar M, 2013, FREE RADICAL BIO MED, V65, P380, DOI 10.1016/j.freeradbiomed.2013.07.003; Yamawaki H, 2003, CIRC RES, V93, P1029, DOI 10.1161/01.RES.0000102869.39150.23; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Shaw A, 2014, BIOCHEM SOC T, V42, P928, DOI 10.1042/BST20140113; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; Choi RJ, 2014, REDOX BIOL, V2, P504, DOI 10.1016/j.redox.2014.02.001; Nakaso K, 2003, FEBS LETT, V546, P181, DOI 10.1016/S0014-5793(03)00517-9; Oh JY, 2008, BIOCHEM J, V411, P297, DOI 10.1042/bj20071189; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Chen HH, 2012, FREE RADICAL BIO MED, V52, P1054, DOI 10.1016/j.freeradbiomed.2011.12.012; Tsukamoto M, 2002, TOXICOL APPL PHARM, V178, P82, DOI 10.1006/taap.2001.9325; Nakaso K, 2006, BIOCHEM BIOPH RES CO, V339, P915, DOI 10.1016/j.bbrc.2005.11.095; Stocker R, 2006, CIRCULATION, V114, P2178, DOI 10.1161/CIRCULATIONAHA.105.598698; Trigona WL, 2006, BIOCHEM J, V394, P207, DOI 10.1042/BJ20050712; Okita Y, 2013, J BIOL CHEM, V288, P20658, DOI 10.1074/jbc.M113.450478; Hotta N, 2012, DIABETIC MED, V29, P1529, DOI 10.1111/j.1464-5491.2012.03684.x; El Hadri K, 2012, ARTERIOSCL THROM VAS, V32, P1445, DOI 10.1161/ATVBAHA.112.249334; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290; Hotta N, 2006, DIABETES CARE, V29, P1538, DOI 10.2337/dc.05-2370; Langston W, 2008, FREE RADICAL BIO MED, V45, P1591, DOI 10.1016/j.freeradbiomed.2008.09.013; Ashino T, 2013, ARTERIOSCL THROM VAS, V33, P760, DOI 10.1161/ATVBAHA.112.300614; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Mizushima T, 2011, J BIOCHEM, V149, P499, DOI 10.1093/jb/mvr032; Samuel SM, 2010, CIRCULATION, V121, P1244, DOI 10.1161/CIRCULATIONAHA.109.872481; Dhanasekaran A, 2004, J BIOL CHEM, V279, P37575, DOI 10.1074/jbc.M404003200; STEELE JW, 1993, DRUG AGING, V3, P532, DOI 10.2165/00002512-199303060-00007; Chen Y, 2005, J BIOL CHEM, V280, P33766, DOI 10.1074/jbc.M504604200; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; BEYERMEARS A, 1985, DIABETES, V34, P15, DOI 10.2337/diabetes.34.1.15; Cepinskas G, 2008, J CLIN BIOCHEM NUTR, V42, P175, DOI 10.3164/jcbn.2008026; CONNOLLY DT, 1986, ANAL BIOCHEM, V152, P136, DOI 10.1016/0003-2697(86)90131-4; Eckersley L, 2002, INT REV NEUROBIOL, V50, P293; Gabbay K.H., 1979, METABOLISM S1, V28, P5471; Hamada Y, 2000, DIABETES CARE, V23, P1539, DOI 10.2337/diacare.23.10.1539; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Kashima K., 1993, ENDOCRINOLOGY, V139, P3404; KAWASAKI N, 1989, BIOCHIM BIOPHYS ACTA, V996, P30, DOI 10.1016/0167-4838(89)90090-3; Kelleher Rory J, 2013, Am J Cardiovasc Dis, V3, P197; Kugiyama K, 1998, CIRCULATION, V97, P2299; Laffin J.A., 2002, PROTEIN PROTOCOLS 1, P45, DOI 10.1385/1-59259-169-8:45; Lam H., 2001, AM J PHYSIOL-CELL PH, V280, pC719; Motterlini R, 2014, ANTIOXID REDOX SIGN, V20, P1810, DOI 10.1089/ars.2013.5658; Ohmura C, 2009, ENDOCR J, V56, P149; Ono Pharmaceutical Co. Ltd., 2009, KIN EP PACK INS; PARTHASARATHY S, 1990, BIOCHIM BIOPHYS ACTA, V1044, P275, DOI 10.1016/0005-2760(90)90314-N; Qi HY, 2012, CHEM BIODIVERS, V9, P739, DOI 10.1002/cbdv.201100133; Sato Keisuke, 2013, Redox Biol, V2, P15, DOI 10.1016/j.redox.2013.11.003; Steele ML, 2013, REDOX BIOL, V1, P441, DOI 10.1016/j.redox.2013.08.006; Taha H, 2010, ARTERIOSCL THROM VAS, V30, P1634, DOI 10.1161/ATVBAHA.110.207316; Vincent AM, 2009, ANTIOXID REDOX SIGN, V11, P425, DOI 10.1089/ars.2008.2235; Yu X, 2006, J BIOL CHEM, V281, P26245, DOI 10.1074/jbc.M604620200	55	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2213-2317			REDOX BIOL	Redox Biol.	APR	2015	4						87	96		10.1016/j.redox.2014.12.002		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CD1DI	WOS:000350813800010		
J	Imaizumi, N; Lee, KK; Zhang, C; Boelsterli, UA				Imaizumi, Naoki; Lee, Kang Kwang; Zhang, Carmen; Boelsterli, Urs A.			Mechanisms of cell death pathway activation following drug-induced inhibition of mitochondrial complex I	REDOX BIOLOGY			English	Article						Sirt3; Efavirenz; Complex I inhibition; Mitochondria; Peroxynitrite; Drug-induced liver injury (DILI)	DEPENDENT DEACETYLASE; PROTEIN ACETYLATION; HEPATIC CELLS; SIR2 HOMOLOG; EFAVIRENZ; IDENTIFICATION; METABOLISM; TOXICITY; HEPATOTOXICITY; APOPTOSIS	Respiratory complex l inhibition by drugs and other chemicals has been implicated as a frequent mode of mitochondria-mediated cell injury. However, the exact mechanisms leading to the activation of cell death pathways are incompletely understood. This study was designed to explore the relative contributions to cell injury of three distinct consequences of complex I inhibition, i.e., impairment of ATP biosynthesis, increased formation of superoxide and, hence, peroxynitrite, and inhibition of the mitochondrial protein deacetylase, Sirt3, due to imbalance of the NADH/NAD(+) ratio. We used the antiviral drug efavirenz (EFV) to model drug-induced complex l inhibition. Exposure of cultured mouse hepatocytes to EFV resulted in a rapid onset of cell injury, featuring a no-effect level at 30 mu M EFV and submaximal effects at 50 mu M EFV. EFV caused a concentration-dependent decrease in cellular ATP levels. Furthermore, EFV resulted in increased formation of peroxynitrite and oxidation of mitochonclrial protein thiols, including cyclophilin D (CypD). This was prevented by the superoxide scavenger. Fe-TCP, or the peroxynitrite decomposition catalyst, Fe-TMPyP. Both ferroporphyrins completely protected from EFV-inclucecl cell injury, suggesting that peroxynitrite contributed to the cell injury. Finally, EFV increased the NADH/NAD(+) ratio, inhibited Sirt3 activity, and led to hyperacetylated lysine residues, including those in CypD. However, hepatocytes isolated from Sirt3-null mice were protected against 40 mu M EFV as compared to their wild-type controls. In conclusion, these data are compatible with the concept that chemical inhibition of complex I activates multiple pathways leading to cell injury; among these, peroxynitrite formation may be the most critical. 2015 The Authors. Published by Elsevier B.V.	[Imaizumi, Naoki; Lee, Kang Kwang; Zhang, Carmen; Boelsterli, Urs A.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Imaizumi, Naoki] Univ Ryukyus, Sch Hlth Sci, Fac Med, Mol Genet Lab, Nishihara, Okinawa 9030215, Japan	Imaizumi, N (reprint author), Univ Ryukyus, Sch Hlth Sci, Fac Med, Mol Genet Lab, Nishihara, Okinawa 9030215, Japan.	imaizum@med.u-ryukyu.ac.jp			Connecticut Innovations [11SCD1S02]; Boehringer lngelheim Endowed Chair in Mechanistic Toxicology at UCONN	This work was supported by a grant from Connecticut Innovations (11SCD1S02, to U.A.B.) and by the Boehringer lngelheim Endowed Chair in Mechanistic Toxicology at UCONN.	Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Blas-Garcia A, 2010, HEPATOLOGY, V52, P115, DOI 10.1002/hep.23647; Lee KK, 2014, REDOX BIOL, V2, P599, DOI 10.1016/j.redox.2014.03.003; Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086; Apostolova N, 2010, BRIT J PHARMACOL, V160, P2069, DOI 10.1111/j.1476-5381.2010.00866.x; Shulga N, 2010, J CELL SCI, V123, P4117, DOI 10.1242/jcs.073502; Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Mutlib AE, 1999, DRUG METAB DISPOS, V27, P1319; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013; Zhang WJ, 2002, DRUG METAB DISPOS, V30, P314, DOI 10.1124/dmd.30.3.314; Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/bse0520023, 10.1042/BSE0520023]; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Lu ZP, 2011, EMBO REP, V12, P840, DOI 10.1038/embor.2011.121; Lee KK, 2013, FREE RADICAL BIO MED, V65, P584, DOI 10.1016/j.freeradbiomed.2013.07.038; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Shulga N, 2010, J CELL SCI, V123, P894, DOI 10.1242/jcs.061846; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Hafner AV, 2010, AGING-US, V2, P914; Nadanaciva S, 2007, TOXICOL IN VITRO, V21, P902, DOI 10.1016/j.tiv.2007.01.011; Apostolova N., 2014, J INFECTIOUS DIS; Burger D, 2006, BRIT J CLIN PHARMACO, V61, P148, DOI 10.1111/j.1365-2125.2005.02536.x; Chan Katie, 2005, Expert Opin Drug Metab Toxicol, V1, P655, DOI 10.1517/17425255.1.4.655; Choi IY, 2001, J NEUROIMMUNOL, V112, P55, DOI 10.1016/S0165-5728(00)00382-9; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222; Fato R., 2009, BIOCHIM BIOPHYS ACTA, V1787, P384; Jones M, 2012, SEMIN LIVER DIS, V32, P167, DOI 10.1055/s-0032-1316472; Linard D, 2009, ARCH BIOCHEM BIOPHYS, V491, P39, DOI 10.1016/j.abb.2009.09.002; Marks BD, 2003, AAPS PHARMSCI, V5; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Pereira Cláudia V, 2009, Curr Drug Saf, V4, P34; Purnell PR, 2014, J PHARMACOL EXP THER, V351, P250, DOI 10.1124/jpet.114.217869	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2213-2317			REDOX BIOL	Redox Biol.	APR	2015	4						279	288		10.1016/j.redox.2015.01.005		10	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CD1DI	WOS:000350813800031		
J	Thapa, RB; Watanabe, M; Motohka, T; Shimada, M				Thapa, Rajesh Bahadur; Watanabe, Manabu; Motohka, Takeshi; Shimada, Masanobu			Potential of high-resolution ALOS-PALSAR mosaic texture for aboveground forest carbon tracking in tropical region	REMOTE SENSING OF ENVIRONMENT			English	Article						L-Band SAR; AFCS; AGB; Biomass modeling; Texture analysis; REDD; Natural forest; Plantation forest; Sumatra	SYNTHETIC-APERTURE RADAR; BIOMASS ESTIMATION; JERS-1 SAR; ETM PLUS; BACKSCATTER; IMAGERY; CLASSIFICATION; SENSITIVITY; LANDSCAPE; INDONESIA	Estimating accurate aboveground forest carbon stocks (AFCS) is always challenging in tropical regions due to the complex mosaic of forest structure and species diversity. This study evaluates the potential of high-resolution ALOS/PALSAR mosaics data in the tropical forests of central Sumatra to improve AFCS estimates. The study region has an average AFCS (47% of the aboveground biomass) of 66 Mg C ha(-1) with a range of 1 to 334 Mg C ha-1 and consists of natural forests including peat swamp, dry moist, regrowth, and mangrove, and plantation forests including rubber, acacia, oil palm, and coconut. Field measurements of AFCS were carried out in 87 (ha(-1)) plots, where half of them were from plantation forests. Various possibilities including direct gamma naught back-scatters and their ratios and various types of textures of dual polarized mosaics from the years 2009 and 2010 were examined applying regression modeling in a five step framework. R-2, variable inflation factor (VIF), p-value, and root mean square errors (RMSE) were the major indicators considered for selection of best model in the calibration process. The potential models selected were cross validated by the leave-one-out (LOO) method where R-2, RMSE, mean deviation (MD), and Nash-Sutcliffe Efficiency (NSE, model performance indicator) were examined. The results indicate that a simple combination of backscatters and their ratios provides an AFCS estimate with a RMSE of 45 Mg C ha(-1), more efficient than the average of field measured AFCS (NSE of 0.54), and R-2 of 0.63. Inclusion of appropriate texture parameters derived from the high-resolution PALSAR mosaics further increases the potential for AFCS estimation by increasing R-2 and model performance (NSE) to 0.84 and 0.83, respectively and decreasing the uncertainty to 28 Mg C ha(-1). This SAR based method offers the low cost wall-to-wall forest carbon mapping with a high level of accuracy in the dense tropical forest regions of Southeast Asia where other methods are still rare. (C) 2015 Elsevier Inc All rights reserved.	[Thapa, Rajesh Bahadur; Watanabe, Manabu; Motohka, Takeshi; Shimada, Masanobu] Japan Aerosp Explorat Agcy JAXA, Earth Observat Res Ctr, Tsukuba, Ibaraki 3058505, Japan	Thapa, RB (reprint author), Japan Aerosp Explorat Agcy JAXA, Earth Observat Res Ctr, 2-1-1 Sengen, Tsukuba, Ibaraki 3058505, Japan.	rajesh.thapa@jaxa.jp		Thapa, Rajesh Bahadur/0000-0003-4467-0148			Saatchi S, 2011, REMOTE SENS ENVIRON, V115, P2836, DOI 10.1016/j.rse.2010.07.015; Sarker MLR, 2012, ISPRS J PHOTOGRAMM, V69, P146, DOI 10.1016/j.isprsjprs.2012.03.002; ULABY FT, 1986, IEEE T GEOSCI REMOTE, V24, P235, DOI 10.1109/TGRS.1986.289643; LETOAN T, 1992, IEEE T GEOSCI REMOTE, V30, P403, DOI 10.1109/36.134089; DOBSON MC, 1992, IEEE T GEOSCI REMOTE, V30, P412, DOI 10.1109/36.134090; Asner GP, 2010, P NATL ACAD SCI USA, V107, P16738, DOI 10.1073/pnas.1004875107; Shimada M, 2010, IEEE J-STARS, V3, P637, DOI 10.1109/JSTARS.2010.2077619; Drake JB, 2002, REMOTE SENS ENVIRON, V81, P378, DOI 10.1016/S0034-4257(02)00013-5; Peregon A, 2013, REMOTE SENS ENVIRON, V137, P139, DOI 10.1016/j.rse.2013.06.012; Englhart S, 2011, REMOTE SENS ENVIRON, V115, P1260, DOI 10.1016/j.rse.2011.01.008; Morel AC, 2012, INT J REMOTE SENS, V33, P3614, DOI 10.1080/01431161.2011.631949; Cutler MEJ, 2012, ISPRS J PHOTOGRAMM, V70, P66, DOI 10.1016/j.isprsjprs.2012.03.011; Thapa RB, 2013, APPL GEOGR, V41, P168, DOI 10.1016/j.apgeog.2013.04.009; McCuen RH, 2006, J HYDROL ENG, V11, P597, DOI 10.1061/(ASCE)1084-0699(2006)11:6(597); Attarchi S, 2014, REMOTE SENS-BASEL, V6, P3693, DOI 10.3390/rs6053693; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Kelsey KC, 2014, REMOTE SENS-BASEL, V6, P6407, DOI 10.3390/rs6076407; Mitchard ETA, 2011, REMOTE SENS ENVIRON, V115, P2861, DOI 10.1016/j.rse.2010.02.022; Singh M, 2014, INT J REMOTE SENS, V35, P3331, DOI 10.1080/01431161.2014.903441; FRANGI JL, 1985, ECOL MONOGR, V55, P351, DOI 10.2307/1942582; Atwood D. K., 2013, IEEE J SELECTED TOPI; Basuki TM, 2013, INT J REMOTE SENS, V34, P4871, DOI 10.1080/01431161.2013.777486; GFOI, 2013, INT REM SENS GROUND; IPCC, 2006, GUIDELINES NATL GREE; Kasischke ES, 1997, REMOTE SENS ENVIRON, V59, P141, DOI 10.1016/S0034-4257(96)00148-4; Kurvonen L, 1999, IEEE T GEOSCI REMOTE, V37, P198, DOI 10.1109/36.739154; Lucas R, 2010, IEEE J-STARS, V3, P576, DOI 10.1109/JSTARS.2010.2086436; Luckman A, 1998, REMOTE SENS ENVIRON, V63, P126, DOI 10.1016/S0034-4257(97)00133-8; Luckman AJ, 1997, INT J REMOTE SENS, V18, P1333, DOI 10.1080/014311697218458; MofF, 2008, IFCA CONS REP RED EM; Motohka T, 2014, REMOTE SENS ENVIRON, V155, P79, DOI 10.1016/j.rse.2014.04.012; Nash J. E., 1970, J HYDROL, V10, P282, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; OTB, 2014, ORF TOOLB COOKB GUID; Pearson T., 2005, SOURCEBOOK LAND USE; Ranson KJ, 1997, J GEOPHYS RES-ATMOS, V102, P29599, DOI 10.1029/96JD03708; Shimada M, 2014, REMOTE SENS ENVIRON, V155, P13, DOI 10.1016/j.rse.2014.04.014; Shiraishi T, 2014, IEEE J-STARS, V7, P1186, DOI 10.1109/JSTARS.2014.2313572; Thapa R. B., 2014, IEEE J SELECTED TOPI; Thapa RB, 2014, REMOTE SENS ENVIRON, V155, P32, DOI 10.1016/j.rse.2013.04.025; Treuhaft RN, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011674; Treuhaft RN, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045608; van Noordwijk M, 2002, SCI CHINA SER C, V45, P75; Watanabe M, 2006, IEEE T GEOSCI REMOTE, V44, P3154, DOI 10.1109/TGRS.2006.880632; Watanabe M., 2013, P INT GEOSC REM SENS, P3919	44	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0034-4257	1879-0704		REMOTE SENS ENVIRON	Remote Sens. Environ.	APR	2015	160						122	133		10.1016/j.rse.2015.01.007		12	Environmental Sciences; Remote Sensing; Imaging Science & Photographic Technology	Environmental Sciences & Ecology; Remote Sensing; Imaging Science & Photographic Technology	CE2KO	WOS:000351644700011		
J	Horimasu, Y; Ohshimo, S; Bonella, F; Tanaka, S; Ishikawa, N; Hattori, N; Kohno, N; Guzman, J; Costabel, U				Horimasu, Yasushi; Ohshimo, Shinichiro; Bonella, Francesco; Tanaka, Sonosuke; Ishikawa, Nobuhisa; Hattori, Noboru; Kohno, Nobuoki; Guzman, Josune; Costabel, Ulrich			MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis	RESPIROLOGY			English	Article						genetic; interstitial lung disease; lung fibrosis; single nucleotide polymorphism	SYSTEMIC-SCLEROSIS; GENE POLYMORPHISMS; ASSOCIATION; VARIANT; GERMAN; RISK	Background and objectiveA single nucleotide polymorphism (SNP) rs35705950 in the promoter of Mucin 5B (MUC5B) has been reported to be associated with idiopathic pulmonary fibrosis (IPF) mainly in Caucasian populations. This study was conducted to confirm the association between rs35705950 and IPF in a Japanese population. MethodsGenomic DNA was extracted from blood samples in 384 Japanese and 137 German subjects, and rs35705950 was detected by commercially available genotyping assay. ResultsThe genotype distributions of rs35705950 in Japanese patients with IPF, nonspecific interstitial pneumonia (NSIP) and healthy subjects (HS) were significantly different from those in the German counterparts (P<0.001, P<0.001 and P=0.010, respectively). The rs35705950 T allele frequencies in patients with IPF, NSIP and HS were 3.4%, 1.7% and 0.8%, respectively in the Japanese, while they were 33.1%, 27.4% and 4.3%, respectively in the German cohort. The T allele frequencies in patients with IPF were significantly higher than those in HS both in the Japanese (P=0.031) and German (P<0.001) cohorts. ConclusionsThe association between rs35705950 and IPF was also present in this Japanese cohort, but was not as strong as the German counterpart. To our knowledge, this is the first study to successfully validate the association between rs35705950 and IPF in a Japanese ethnicity.	[Horimasu, Yasushi; Ohshimo, Shinichiro; Tanaka, Sonosuke; Ishikawa, Nobuhisa; Hattori, Noboru; Kohno, Nobuoki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Internal Med, Hiroshima, Japan; [Bonella, Francesco; Costabel, Ulrich] Univ Duisburg Essen, Univ Hosp, Dept Pneumol Allergy, Ruhrlandklin, D-45239 Essen, Germany; [Guzman, Josune] Ruhr Univ Bochum, Gen & Expt Pathol, Bochum, Germany	Costabel, U (reprint author), Univ Duisburg Essen, Univ Hosp, Dept Pneumol Allergy, Ruhrlandklin, Tueschener Weg 40, D-45239 Essen, Germany.	ulrich.costabel@ruhrlandklinik.uk-essen.de			Ministry of Education, Culture, Sports, Science and Technology of Japan; Arbeitsgemeinschaft zur Forderung der Pneumologie an der Ruhrlandklinik (AFPR)	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Arbeitsgemeinschaft zur Forderung der Pneumologie an der Ruhrlandklinik (AFPR).	American Thoracic Society/European Respiratory Society, 2002, AM J RESP CRIT CARE, V165, P277; Kanehara M, 2008, PULM PHARMACOL THER, V21, P874, DOI 10.1016/j.pupt.2008.09.003; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; Ahn MH, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-73; Peljto AL, 2013, JAMA-J AM MED ASSOC, V309, P2232, DOI 10.1001/jama.2013.5827; Yamane T, 2010, RESPIROLOGY, V15, P313, DOI 10.1111/j.1440-1843.2009.01682.x; Iwamoto H, 2009, AM J RESP CRIT CARE, V179, P35, DOI 10.1164/rccm.200804-560OC; Mushiroda T, 2008, J MED GENET, V45, P654, DOI 10.1136/jmg.2008.057356; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Hodgson U, 2006, AM J HUM GENET, V79, P149, DOI 10.1086/504639; Checa M, 2008, HUM GENET, V124, P465, DOI 10.1007/s00439-008-0571-z; Bouros D, 2002, AM J RESP CRIT CARE, V165, P1581, DOI 10.1164/rccm.2106012; Ishikawa N, 2011, RESPIRATION, V82, P10, DOI 10.1159/000324539; Zhang YZ, 2011, NEW ENGL J MED, V364, P1576, DOI 10.1056/NEJMc1013504; Peljto AL, 2012, CHEST, V142, P1584, DOI 10.1378/chest.12-0110; Stock CJ, 2013, THORAX, V68, P436, DOI 10.1136/thoraxjnl-2012-201786; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Hunninghake GM, 2013, NEW ENGL J MED, V368, P2192, DOI 10.1056/NEJMoa1216076; Borie R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070621; HIYAMA E, 1995, INT J ONCOL, V6, P13; Horimasu Y, 2012, RESP MED, V106, P1756, DOI 10.1016/j.rmed.2012.09.001; Horimasu Y, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-4; Martinelli M, 2011, MOL BIOL REP, V38, P4613, DOI 10.1007/s11033-010-0594-0; National Center for Biotechnology Information, 2014, BUILD 142 NCBI DBSNP; Rubin Bruce K, 2002, Respir Care, V47, P761; Standardization of spirometry, 1995, AM J RESP CRIT CARE, V152, P1107; Wang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104919	27	5	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	APR	2015	20	3					439	444		10.1111/resp.12466		6	Respiratory System	Respiratory System	CD6CE	WOS:000351175700013		
J	Sakamoto, S; Muramatsu, Y; Satoh, K; Ishida, F; Kikuchi, N; Sano, G; Sugino, K; Isobe, K; Takai, Y; Homma, S				Sakamoto, Susumu; Muramatsu, Yoko; Satoh, Keita; Ishida, Fumiaki; Kikuchi, Naoshi; Sano, Go; Sugino, Keishi; Isobe, Kazutoshi; Takai, Yujiro; Homma, Sakae			Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: A case-control study	RESPIROLOGY			English	Article						advanced idiopathic pulmonary fibrosis; combination therapy; N-acetylcysteine; pirfenidone	PLACEBO-CONTROLLED TRIAL; BRONCHOALVEOLAR LAVAGE FLUID; LUNG FIBROSIS; BLEOMYCIN; CAPACITY; EFFICACY	Background and objectiveTreatment with pirfenidone may slow the decline in vital capacity and increase progression-free survival (PFS) in idiopathic pulmonary fibrosis (IPF). The effects of combination therapy with inhaled N-acetylcysteine (NAC) and pirfenidone are unclear. We assessed the effects of this combination therapy in patients with advanced IPF. MethodsPatients with a diagnosis of advanced IPF (Japanese Respiratory Society stage III/IV IPF) and a relative decline in forced vital capacity (FVC) of 10% within the previous 6 (2) months were enrolled. Outcomes were evaluated in a 12-month follow-up pulmonary function test. Treatment was considered ineffective if the decline in FVC was 10% and effective if the decline was <10%. We compared clinical characteristics, effectiveness and PFS between patients receiving inhaled NAC plus pirfenidone (n=24) and those receiving pirfenidone alone (control; n=10). ResultsData from 34 IPF patients (age range, 59-82 years) were analysed. At the 12-month follow-up examination, treatment was deemed effective in 8 of 17 (47%) patients receiving NAC plus pirfenidone and in 2 of 10 (20%) receiving pirfenidone alone. The annual rate of change in FVC was -610mL in the NAC plus pirfenidone group and -1320mL in the pirfenidone group (P<0.01). PFS was longer (304 days) in the NAC plus pirfenidone group than in the pirfenidone group (168 days; P=0.016). ConclusionsCombination treatment with inhaled NAC and oral pirfenidone reduced the rate of annual FVC decline and improved PFS in patients with advanced IPF.	[Sakamoto, Susumu; Muramatsu, Yoko; Satoh, Keita; Ishida, Fumiaki; Kikuchi, Naoshi; Sano, Go; Sugino, Keishi; Isobe, Kazutoshi; Takai, Yujiro; Homma, Sakae] Toho Univ, Omori Med Ctr, Dept Resp Med, Tokyo 1438541, Japan	Sakamoto, S (reprint author), Toho Univ, Omori Med Ctr, Dept Resp Med, Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan.	susumu1029@gmail.com			Ministry of Health, Labour and Welfare of Japan	The present study was supported in part by a Grant for Research on Diffuse Lung Disease from the Ministry of Health, Labour and Welfare of Japan.	Richeldi L, 2012, THORAX, V67, P407, DOI 10.1136/thoraxjnl-2011-201184; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Daniels CE, 2010, AM J RESP CRIT CARE, V181, P604, DOI 10.1164/rccm.200906-0964OC; Misra HP, 2000, MOL CELL BIOCHEM, V204, P119, DOI 10.1023/A:1007023532508; CANTIN AM, 1989, AM REV RESPIR DIS, V139, P370; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Iyer SN, 1999, J PHARMACOL EXP THER, V291, P367; King TE, 2008, AM J RESP CRIT CARE, V177, P75, DOI 10.1164/rccm.200705-732OC; Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; Hagiwara S, 2000, AM J RESP CRIT CARE, V162, P225; Homma S, 2012, RESPIROLOGY, V17, P467, DOI 10.1111/j.1440-1843.2012.02132.x; Demedts M, 2005, NEW ENGL J MED, V353, P2229, DOI 10.1056/NEJMoa042976; BRIDGEMAN MME, 1994, THORAX, V49, P670, DOI 10.1136/thx.49.7.670; Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Mitani Y, 2008, BIOCHEM BIOPH RES CO, V372, P19, DOI 10.1016/j.bbrc.2008.04.093; Behr J, 1997, AM J RESP CRIT CARE, V156, P1897; COTGREAVE IA, 1987, EUR J RESPIR DIS, V70, P73; BALDWIN ED, 1948, MEDICINE, V27, P243; BOROK Z, 1991, LANCET, V338, P215, DOI 10.1016/0140-6736(91)90350-X; BURROWS B, 1961, AM REV RESPIR DIS, V84, P789; Homma Sakae, 2015, Respir Investig, V53, P7, DOI 10.1016/j.resinv.2014.08.003; Hunninghake GW, 2005, NEW ENGL J MED, V353, P2285, DOI 10.1056/NEJMe058210; Martinez FJ, 2014, NEW ENGL J MED, V370, P2093, DOI 10.1056/NEJMoa1401739; Muramatsu Y, 2011, AM J RESP CRIT CARE, V183, pA1529; Oku H, 2008, EUR J PHARMACOL, V590, P400, DOI 10.1016/j.ejphar.2008.06.046; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Sakamoto S, 2013, INTERNAL MED, V52, P2495, DOI 10.2169/internalmedicine.52.8498; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354	30	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-7799	1440-1843		RESPIROLOGY	Respirology	APR	2015	20	3					445	452		10.1111/resp.12477		8	Respiratory System	Respiratory System	CD6CE	WOS:000351175700014		
J	Tomari, Y				Tomari, Yukihide			My encounter with RNA	RNA			English	Editorial Material									Univ Tokyo, Dept Med Genome Sci, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Tomari, Y (reprint author), Univ Tokyo, Dept Med Genome Sci, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan.	tomari@iam.u-tokyo.ac.jp						0	0	0	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1355-8382	1469-9001		RNA	RNA	APR	2015	21	4					747	748		10.1261/rna.050278.115		2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CD6RM	WOS:000351216800122		
J	Koie, T; Mitsuzuka, K; Narita, S; Yoneyama, T; Kawamura, S; Kaiho, Y; Tsuchiya, N; Tochigi, T; Habuchi, T; Arai, Y; Ohyama, C				Koie, Takuya; Mitsuzuka, Koji; Narita, Shintaro; Yoneyama, Takahiro; Kawamura, Sadafumi; Kaiho, Yasuhiro; Tsuchiya, Norihiko; Tochigi, Tatsuo; Habuchi, Tomonori; Arai, Yoichi; Ohyama, Chikara			A solitary positive prostate cancer biopsy does not predict a unilateral lesion in radical prostatectomy specimens	SCANDINAVIAN JOURNAL OF UROLOGY			English	Article						needle biopsy; pathological tumor stage; prostate cancer; radical prostatectomy; single positive core; tumor volume	FOCAL THERAPY; ACTIVE SURVEILLANCE; STAGE MIGRATION; SMALL-VOLUME; MEN; INSIGNIFICANT; OUTCOMES; EXPERIENCE; PATHOLOGY; CONSENSUS	Objective. Prostate cancer (PCa) may be a multifocal and bilateral disease. Patients with low-risk PCa and a low number of positive biopsy cores may choose to undergo active surveillance or focal therapy. The aim of this study was to determine the correlation between a solitary positive prostate biopsy core and the pathological outcome after radical prostatectomy (RP). Material and methods. The Michinoku Japan Urological Cancer Study Group database contains data, including preoperative and postoperative information, on 1268 consecutive patients with PCa treated with RP alone at four institutions. This study focused on 151 patients with a single positive biopsy core, preoperative prostate-specific antigen (PSA) level less than 10 ng/ml, biopsy Gleason score less than 8, and clinical stage T1c/T2a/T2b disease. Potential preoperative predictors of unilateral PCa were age, preoperative PSA level, biopsy Gleason score and clinical T stage. Results. The median age and preoperative PSA level were 65 years (range 47-76 years) and 6.00 ng/ml (range 0.50-9.80 ng/ml), respectively. Unilateral PCa was identified in 41% of the patients. Extraprostatic extension or seminal vesicle invasion was observed in 26% of all patients. Conclusion. Serum PSA levels were significantly higher in the bilateral PCa group than in the unilateral PCa group in the current study. For patients with PCa having a solitary positive prostate biopsy core, definitive therapy such as RP should be considered.	[Koie, Takuya; Yoneyama, Takahiro; Ohyama, Chikara] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori 0368562, Japan; [Mitsuzuka, Koji; Kaiho, Yasuhiro; Arai, Yoichi] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi 980, Japan; [Narita, Shintaro; Tsuchiya, Norihiko; Habuchi, Tomonori] Akita Univ, Grad Sch Med, Dept Urol, Akita 010, Japan; [Kawamura, Sadafumi; Tochigi, Tatsuo] Miyagi Canc Ctr, Dept Urol, Natori, Miyagi 9811293, Japan	Koie, T (reprint author), Hirosaki Univ, Grad Sch Med, Dept Urol, 5 Zaifucho, Hirosaki, Aomori 0368562, Japan.	goodwin@cc.hirosaki-u.ac.jp					Lecornet E, 2010, J ENDOUROL, V24, P811, DOI 10.1089/end.2009.0654; Wolters T, 2011, J UROLOGY, V185, P121, DOI 10.1016/j.juro.2010.08.082; Eggener SE, 2007, J UROLOGY, V178, P2260, DOI 10.1016/j.juro.2007.08.072; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Gallina A, 2008, BJU INT, V101, P1513, DOI 10.1111/j.1464-410X.2008.07519.x; Arora R, 2004, CANCER, V100, P2362, DOI 10.1002/cncr.20243; Koie T, 2011, EJSO-EUR J SURG ONC, V37, P805, DOI 10.1016/j.ejso.2011.06.009; van den Bos W, 2014, EUR UROL, V65, P1078, DOI 10.1016/j.eururo.2014.01.001; van den Bergh RCN, 2007, EUR UROL, V52, P1560, DOI 10.1016/j.eururo.2007.05.011; Scales CD, 2007, J UROLOGY, V178, P1249, DOI 10.1016/j.juro.2007.05.151; Ahmed HU, 2007, NAT CLIN PRACT ONCOL, V4, P632, DOI 10.1038/ncponc0959; Dong F, 2007, UROLOGY, V70, P839, DOI 10.1016/j.urology.2007.09.001; Miller DC, 2006, J NATL CANCER I, V98, P1134, DOI 10.1093/jnci/djj308; Mitsuzuka K, 2013, BJU INT, V111, P914, DOI 10.1111/j.1464-410X.2012.11658.x; BASTACKY SI, 1995, J UROLOGY, V153, P987, DOI 10.1016/S0022-5347(01)67619-5; Carter HB, 2007, J UROLOGY, V178, P2359, DOI 10.1016/j.juro.2007.08.039; Chen ME, 2003, AM J SURG PATHOL, V27, P1291, DOI 10.1097/00000478-200310000-00001; Edge S, 2010, AJCC CANC STAGING MA, P457; Gallina A, 2012, BJU INT, V110, pE64, DOI 10.1111/j.1464-410X.2011.10762.x; Hashimoto Y, 2012, INT J CLIN ONCOL, V17, P119, DOI 10.1007/s10147-011-0267-6; Hong SK, 2008, BJU INT, V102, P1214; Isbarn H, 2010, INT J RADIAT ONCOL, V77, P784, DOI 10.1016/j.ijrobp.2009.05.068; Kakehi Y, 2008, JPN J CLIN ONCOL, V38, P122, DOI 10.1093/jjco/hym161; Karavitakis M, 2012, PROSTATE, V72, P1464, DOI 10.1002/pros.22498; Marien A, 2014, UROL ONCOL-SEMIN ORI, V32, P912, DOI 10.1016/j.urolonc.2013.10.014; Muezzinoglu A, 2006, MODERN PATHOL S1, V19, p151A; van Oort IM, 2009, UROL ONCOL-SEMIN ORI, V27, P509, DOI 10.1016/j.urolonc.2008.04.014; Yoon GS, 2008, J UROLOGY, V179, P2203, DOI 10.1016/j.juro.2008.01.114	28	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	2168-1805	2168-1813		SCAND J UROL	Scand. J. Urol.	APR	2015	49	2					103	107		10.3109/21681805.2014.951959		5	Urology & Nephrology	Urology & Nephrology	CD9CU	WOS:000351395600004		
J	Kikuchi, K; Imura, S; Miyakawa, K; Ohtake, H; Kubota, M; Ohta, E				Kikuchi, Kenji; Imura, Shigeyuki; Miyakawa, Kazunori; Ohtake, Hiroshi; Kubota, Misao; Ohta, Eiji			Photocurrent multiplication in Ga2O3/CuInGaSe2 heterojunction photosensors	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						Image sensor; CIGS; Dark current; Avalanche multiplication; Dark current	CU(IN,GA)SE-2 SOLAR-CELLS; CONDUCTION-BAND OFFSET; OXIDE THIN-FILMS; ELECTRICAL-PROPERTIES; AMORPHOUS SELENIUM; OPTICAL-PROPERTIES; WORK FUNCTION; CUINSE2; SEMICONDUCTORS; EFFICIENCY	Photocurrent multiplication was observed in gallium oxide (Ga2O3)/Cu(In,Ga)Se-2 (CIGS) heterojunction photosensors. In this study, we investigated the electrical and optical properties of Ga2O3/CIGS heterojunction photodiodes for possible use as high-sensitivity visible-light sensors. To achieve low current density J under dark conditions, a thin layer of Ga2O3, which is an n-type wide band gap (4.7-4.9 eV) semiconductor, was grown on the CIGS layer. This Ga2O3 layer functioned as a hole-blocking layer and buffer layer. The effect of oxygen partial pressure during the deposition of the Ga2O3 layer was also examined. With no applied voltage, the quantum efficiency of a photodiode with a Ga2O3 layer deposited with no oxygen partial pressure was considerably high. On the other hand, when the Ga2O3 layer was deposited with oxygen partial pressure, the depletion region almost spread into the Ga2O3 layer with no applied voltage. Considering J, under low oxygen deposition conditions, dark current J increased due to more oxygen vacancies, and with higher oxygen partial pressure during deposition, dark current J increased due to oxygen plasma damage at the Ga2O3/CIGS interface during the sputtering deposition. The photodiode with the lowest dark current J of 10(-9) A/cm(2) at applied voltages less than 3 V had a Ga2O3 layer deposited at an optimum oxygen partial pressure of 6.0 x 10(-2) Pa. The average quantum efficiency for this photodiode in the visible light range (400-700 nm) was 85% at an applied voltage of 3 V. Moreover, at higher applied voltages, carrier multiplication phenomena were observed, and the average quantum efficiency (400-700 nm) was over 100% at applied voltages over 4V. (C) 2015 Elsevier B.V. All rights reserved.	[Kikuchi, Kenji; Imura, Shigeyuki; Miyakawa, Kazunori; Ohtake, Hiroshi; Kubota, Misao] NHK Sci & Technol Res Labs, Setagaya Ku, Tokyo 1578510, Japan; [Ohta, Eiji] Keio Univ, Grad Sch Sci & Technol, Kouhoku Ku, Yokohama, Kanagawa 2238522, Japan	Kikuchi, K (reprint author), NHK Sci & Technol Res Labs, Setagaya Ku, 1-10-11 Kinuta, Tokyo 1578510, Japan.	kikuchi.k-oa@nhk.or.jp			Foundation for Promotion of Material Science and Technology of Japan (MST Foundation)	We would like to acknowledge an especially fruitful discussion with Prof. Tokio Nakada of the Tokyo University of Science. This study was supported in part by the Foundation for Promotion of Material Science and Technology of Japan (MST Foundation).	Abbaszadeh S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03360; Minami T, 1998, SURF COAT TECH, V108, P583, DOI 10.1016/S0257-8972(98)00592-1; Reinhard P, 2013, IEEE J PHOTOVOLT, V3, P572, DOI 10.1109/JPHOTOV.2012.2226869; FLEISCHER M, 1993, J APPL PHYS, V74, P300, DOI 10.1063/1.354107; NOUFI R, 1984, APPL PHYS LETT, V45, P668, DOI 10.1063/1.95350; Minemoto T, 2001, SOL ENERG MAT SOL C, V67, P83, DOI 10.1016/S0927-0248(00)00266-X; Nakada T, 1999, APPL PHYS LETT, V74, P2444, DOI 10.1063/1.123875; ROCKETT A, 1991, J APPL PHYS, V70, pR81, DOI 10.1063/1.349175; TELL B, 1971, PHYS REV B, V4, P2463, DOI 10.1103/PhysRevB.4.2463; Bubon O, 2012, J NON-CRYST SOLIDS, V358, P2431, DOI 10.1016/j.jnoncrysol.2011.12.093; Puttnins S, 2014, SOL ENERG MAT SOL C, V120, P506, DOI 10.1016/j.solmat.2013.09.031; Arai T, 2013, IEEE T ELECTRON DEV, V60, P3450, DOI 10.1109/TED.2013.2276005; Kokubun Y, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2432946; GABOR AM, 1994, APPL PHYS LETT, V65, P198, DOI 10.1063/1.112670; JAFFE JE, 1984, PHYS REV B, V29, P1882, DOI 10.1103/PhysRevB.29.1882; Minemoto T, 2001, J APPL PHYS, V89, P8327, DOI 10.1063/1.1366655; CHERNYAK L, 1995, J PHYS CHEM SOLIDS, V56, P1165, DOI 10.1016/0022-3697(95)00050-X; LORENZ MR, 1967, J PHYS CHEM SOLIDS, V28, P403, DOI 10.1016/0022-3697(67)90305-8; Kikuchi K, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201084055; Jackson P, 2011, PROG PHOTOVOLTAICS, V19, P894, DOI 10.1002/pip.1078; Chkoda L, 2000, SYNTHETIC MET, V111, P315, DOI 10.1016/S0379-6779(99)00355-0; CONTRERAS M. A., 1994, 24 IEEE PHOT SPEC C, P68; HARWIG T, 1978, J SOLID STATE CHEM, V23, P205, DOI 10.1016/0022-4596(78)90066-X; Hayashida T., 1999, IEICE TECH REP, V99, P29; Kikuchi K, 2014, THIN SOLID FILMS, V550, P635, DOI 10.1016/j.tsf.2013.10.036; Komaki H., 2012, PROG PHOTOVOLTAICS, P595; Kushiya K., 2006, P IEEE PVSC, V348; KUSHIYA K, 1994, IEEE PHOT SPEC CONF, P87, DOI 10.1109/WCPEC.1994.519814; Mainz R, 2009, PHYS STATUS SOLIDI A, V206, P1017, DOI 10.1002/pssa.200881216; MALHERBE JB, 1994, CRIT REV SOLID STATE, V19, P129, DOI 10.1080/10408439408244589; Marie P, 2008, PHYS STATUS SOLIDI A, V205, P1943, DOI 10.1002/pssa.200778856; Matsushima O., 2008, EL DEV M 2008 IEDM 2, P1; Nakada T, 1999, SENSOR MATER, V11, P21; Nakayama M., 1999, J I IMAGE INFORM TEL, V53, P142; Naoe M., 1986, OYO BUTURI, V55, P119; Ohkawa Yuji, 2008, Journal of the Institute of Image Information and Television Engineers, V62; Reznik A, 2008, J NON-CRYST SOLIDS, V354, P2691, DOI [10.1016/j.jnoncrysol.2007.09.058, 10.1016/j.jnoncryso1.2007.09.058]; Robertson J, 2006, MAT SCI ENG B-SOLID, V135, P267, DOI 10.1016/j.mseb.2006.08.017; Shimamoto H., 2013, SMPTE C P, V2013, P1; Sugiyama M, 2001, JPN J APPL PHYS 2, V40, pL428, DOI 10.1143/JJAP.40.L428; Sze S M, 2001, SEMICONDUCTOR DEVICE; Takiguchi Y, 1997, IEEE T ELECTRON DEV, V44, P1783, DOI 10.1109/16.628837; TANAKA K, 1993, JPN J APPL PHYS 1, V32, P113; TANIOKA K, 1987, IEEE ELECTR DEVICE L, V8, P392, DOI 10.1109/EDL.1987.26671; TELL B, 1973, J APPL PHYS, V44, P4988, DOI 10.1063/1.1662075; Tsurumi T, 1999, JPN J APPL PHYS 1, V38, P3682, DOI 10.1143/JJAP.38.3682; Wronski M, 2012, MED PHYS, V39, P7102, DOI 10.1118/1.4760989; Yamaguchi K., 2010, ITE TECH REP, V34, P35; Zhao W, 2013, ECS TRANSACTIONS, V54, P305, DOI 10.1149/05401.0305ecst	49	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	APR 1	2015	224						24	29		10.1016/j.sna.2015.01.001		6	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CE4OM	WOS:000351809900004		
J	Haroun, A; Yamada, I; Warisawa, S				Haroun, Ahmed; Yamada, Ichiro; Warisawa, Shin'ichi			Micro electromagnetic vibration energy harvester based on free/impact motion for low frequency-large amplitude operation	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						Micro-electromagnetic vibration energy harvester; Free/impact motion; Non-resonant; Modes of motion; Low frequencies; High amplitudes	MAGNETIC-LEVITATION; GENERATORS; OPTIMIZATION; DESIGN	This paper presents design, simulation, and experimentation of a novel micro-electromagnetic vibration energy harvester based on free/impact motion. Power harvesting is simply achieved from relative oscillation between a permanent magnet allowed to move freely inside a tube-carrying electrical coil with two end stoppers and directly connected to the vibration source. The proposed harvester with free/impact motion shows a non-resonant behaviour in which the output power continuously increase with the input frequency and/or amplitude. In addition, the allowable free motion permits significant power scavenging at low frequencies. Hence, the proposed harvester is well suited for the applications involved variable large amplitude-low frequency vibrations such as human-powered devices. A nonlinear mathematical model of the proposed harvester including electromagnetic and impact characteristics is derived and used further for a case study model prediction. A unique way of oscillation is observed, in which four modes of magnet/tube relative motion appear over the range of exciting amplitudes and frequencies. Two experiments are conducted on different fabricated prototypes. The first shows the effect of different magnet shapes on the harvesting performance, and the second is carried out to investigate the performance of two different size prototypes with variable large amplitude-low frequency vibrations. A harvester with cylindrical total size of D9 x L12 mm can generate RMS power of 71.8 mu W at (2.5 Hz and 5.2 ms(-2)) and 113.3 mu W at (3.33 Hz and 12.38 ms(-2)). Another of D7 x L12 mm size can generate RMS power of 28.4 mu W at (2.5 Hz and 5.2 ms(-2)) and 82.9 mu W at (3.33 Hz and 12.38 ms(-2)). Comparison with some previously fabricated low frequency energy harvesters is made which shows the advantageous of the new harvester in size minimization as well as the significant power raise with the input amplitude. (C) 2015 Elsevier B.V. All rights reserved.	[Haroun, Ahmed] Univ Tokyo, Grad Sch Engn, Bunkyo Ku, Tokyo 1138654, Japan; [Haroun, Ahmed] Cairo Univ, Fac Engn, Giza, Egypt; [Yamada, Ichiro; Warisawa, Shin'ichi] Univ Tokyo, Grad Sch Frontier Sci, Chiba, Japan	Haroun, A (reprint author), Univ Tokyo, Grad Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan.	eng.ahmedharoun@gmail.com; yamada@k.u-tokyo.ac.jp; warisawa@k.u-tokyo.ac.jp					Rao Y, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/11/114012; Yang J, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4847755; Miao P, 2006, MICROSYST TECHNOL, V12, P1079, DOI 10.1007/s00542-006-0152-9; Moss S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3521265; Zhang CL, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3176981; Mitcheson PD, 2012, IEEE T CIRCUITS-I, V59, P3098, DOI 10.1109/TCSI.2012.2206432; Dai XZ, 2011, SENSOR ACTUAT A-PHYS, V166, P94, DOI 10.1016/j.sna.2010.12.025; Mann BP, 2009, J SOUND VIB, V319, P515, DOI 10.1016/j.jsv.2008.06.011; Zhu Y, 2012, IEEE T MAGN, V48, P3344, DOI 10.1109/TMAG.2012.2199289; Le CP, 2012, J INTEL MAT SYST STR, V23, P1409, DOI 10.1177/1045389X12436739; Galchev TV, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/10/104005; Jung SM, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3360219; Bowers BJ, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/9/094008; Moss SD, 2012, SENSOR ACTUAT A-PHYS, V175, P165, DOI 10.1016/j.sna.2011.12.023; Mitcheson PD, 2004, J MICROELECTROMECH S, V13, P429, DOI 10.1109/JMEMS.2004.830151; von Buren T, 2007, SENSOR ACTUAT A-PHYS, V135, P765, DOI 10.1016/j.sna.2006.08.009; von Buren T, 2006, IEEE SENS J, V6, P28, DOI 10.1109/JSEN.2005.853595; Pillatsch P, 2014, SENSOR ACTUAT A-PHYS, V206, P178, DOI 10.1016/j.sna.2013.10.003; Blystad LCJ, 2011, MICROSYST TECHNOL, V17, P505, DOI 10.1007/s00542-010-1163-0; Yang J, 2014, SENSOR ACTUAT A-PHYS, V205, P47, DOI 10.1016/j.sna.2013.10.005; Beeby S. P., 2006, MEAS SCI TECHNOL, V17, P175; Chow T. L., 2006, INTRO ELECTROMAGNETI, P146; Cu L., 2011, SMART MATER STRUCT, V20; EPSRC, 2011, 1 WORKSH HUM POW LON; Isarakorn D., 2010, POW MEMS, P203; Jacquelin E, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/10/105008; Jo S. E., 2012, ELECTRON LETT, V48; Kiziroglou M. E., 2007, POWERMEMS FREIB GERM; Kulah H., 2004, IEEE MEMS; LANKARANI HM, 1990, J MECH DESIGN, V112, P369, DOI 10.1115/1.2912617; Le CP, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/7/074013; Lee B.-C., 2013, T ELECT ELECT MAT, V14, P143; Lee D. -G., 2007, P 14 INT C SOL STAT; Mak K. H., 2011, ENOC ROM IT; Mitcheson PD, 2004, SENSOR ACTUAT A-PHYS, V115, P523, DOI 10.1016/j.sna.2004.04.026; Moss S, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/4/045013; Moss S. D., 2014, P SPIE, V9057; Muralt P., 2009, POWERMEMS WASH DC; Naruse Y, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/9/094002; Renaud M, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/3/035001; Roundy S., 2005, IMPROVING POWER OUTP; Sneddon IN, 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4; Soliman MSM, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/11/115021; Vandewater LA, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/9/094025; Wang P., 2012, J SEMICOND, V10, P1; Yun J., 2010, COMPUTING, V8, P1	46	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	APR 1	2015	224						87	98		10.1016/j.sna.2015.01.025		12	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CE4OM	WOS:000351809900013		
J	Jung, JW; Wakuya, H; Zhang, BT				Jung, Jin-Woo; Wakuya, Hiroshi; Zhang, Byoung-Tak			Special Issue on Advanced Intelligent Systems Preface	SOFT COMPUTING			English	Editorial Material									[Jung, Jin-Woo] Dongguk Univ, Seoul, South Korea; [Wakuya, Hiroshi] Saga Univ, Saga 840, Japan; [Zhang, Byoung-Tak] Seoul Natl Univ, Seoul, South Korea	Jung, JW (reprint author), Dongguk Univ, Seoul, South Korea.	jwjung@dongguk.edu; wakuya@cc.saga-u.ac.jp; btzhang@bi.snu.ac.kr						0	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-7643	1433-7479		SOFT COMPUT	Soft Comput.	APR	2015	19	4			SI		813	814		10.1007/s00500-015-1628-2		2	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications	Computer Science	CD9HG	WOS:000351408300001		
J	Tamura, Y; Iizuka, H; Yamamoto, M; Furukawa, M				Tamura, Yasumasa; Iizuka, Hiroyuki; Yamamoto, Masahito; Furukawa, Masashi			Application of local clustering organization to reactive job-shop scheduling	SOFT COMPUTING			English	Article						Reactive scheduling; Job-shop scheduling; Local clustering organization		This study focuses on the reactive scheduling in manufacturing systems. In practical situations, the predetermined schedule often changes under the influence of the unpredictable or variable environment in the factory. The reactive scheduling (RS) is a methodology to modify the predetermined schedule to cope with variable situations without suspending the proceeding of the processes on the schedule. Therefore, the RS requires a method to improve the schedule with fast computational time. To obtain an effective method for the RS, this paper proposes a novel RS method using local clustering organization. Also, this paper examines its effectiveness by a numerical experiment. Our results suggest that the proposed method is more effective than the method using genetic algorithm.	[Tamura, Yasumasa; Iizuka, Hiroyuki; Yamamoto, Masahito] Hokkaido Univ, Kita Ku, Sapporo, Hokkaido 0600814, Japan; [Furukawa, Masashi] Hokkaido Informat Univ, Sapporo, Hokkaido, Japan	Tamura, Y (reprint author), Hokkaido Univ, Kita Ku, Kita 14,Nishi 9, Sapporo, Hokkaido 0600814, Japan.	tamura@complex.ist.hokudai.ac.jp					Kohonen T, 1998, NEUROCOMPUTING, V21, P1, DOI 10.1016/S0925-2312(98)00030-7; BIERWIRTH C, 1995, OR SPEKTRUM, V17, P87; Coffman E. G., 1976, COMPUTER JOB SHOP SC; Conway R. W., 2003, THEORY OF SCHEDULING; French S., 1982, SEQUENCING SCHEDULIN; Furukawa M, 2006, J JAPAN SOC PRECISIO, V72, P867; Furukawa M, 2005, J ROBOTICS MECHATRON, V17, P560; Garey M. R., 1976, Mathematics of Operations Research, V1, DOI 10.1287/moor.1.2.117; Garey M.R., 1979, COMPUTERS INTRACTABI; Ono I., 1996, Proceedings of 1996 IEEE International Conference on Evolutionary Computation (ICEC'96) (Cat. No.96TH8114), DOI 10.1109/ICEC.1996.542658; Tanimizu Y, 2003, T JAPAN SOC MECH E C, V69, P2458; Zweben M., 1994, INTELLIGENT SCHEDULI	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-7643	1433-7479		SOFT COMPUT	Soft Comput.	APR	2015	19	4			SI		891	899		10.1007/s00500-014-1416-4		9	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications	Computer Science	CD9HG	WOS:000351408300010		
J	Yamane, H; Hagiwara, M				Yamane, Hiroaki; Hagiwara, Masafumi			Oxymoron generation using an association word corpus and a large-scale N-gram corpus	SOFT COMPUTING			English	Article						Oxymoron; Association word; N-gram; Sentence generation; Sensibility		Oxymorons are combinations of contradictory or incongruous words and are typically used to draw readers' attention to a text. This paper proposes a method to generate oxymorons using an association word corpus and a large-scale -gram corpus. First, adjectives are fed as input into the proposed system. Then, antonym pairs are extracted from the -gram corpus. Using the antonym pairs and the association word corpus, candidates are generated. Candidates are finalized or eliminated according to their suitability and attractiveness. To determine suitability, pointwise mutual information (PMI) is employed to exclude grammatically unnatural expressions. To determine attractiveness, PMI, gap of frequency of the oxymoron candidates, and WordNet are used. The generated combinations of oxymorons indicate the potential effectiveness of the proposed method.	[Yamane, Hiroaki; Hagiwara, Masafumi] Keio Univ, Dept Informat & Comp Sci, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Yamane, H (reprint author), Keio Univ, Dept Informat & Comp Sci, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	yamane@soft.ics.keio.ac.jp; hagiwara@soft.ics.keio.ac.jp			 [25-5423]	This research was supported by the Grant-in-Aid for JSPS Fellows (Grant No. 25-5423).	Abbasi A, 2008, IEEE T KNOWL DATA EN, V20, P1168, DOI 10.1109/TKDE.2008.51; Akita K, 2012, SCALING VARIOUS KIND; MCGINNIES E, 1949, PSYCHOL REV, V56, P244, DOI 10.1037/h0056508; Ben-Shachar M, 2011, J COGNITIVE NEUROSCI, V23, P2387, DOI 10.1162/jocn.2011.21615; Bond F, 2012, 6 INT C GLOB WORDNET; Croft W., 2004, COGNITIVE LINGUISTIC; GIBBS RW, 1994, J PSYCHOLINGUIST RES, V23, P75, DOI 10.1007/BF02143177; Kozareva Z, 2008, P 4 INT WORKSH SEM E; Kudo T, 2009, WEB JAPANESE N GRAM; Mizushima R, 2011, ASS WORD FREQUENCY C; Nishihara Y, 2008, IEEE INT C DAT MIN W; Shimizu K, 2010, T JPN SOC KANSEI ENG, V10, P505; Tokuhisa R., 2008, P 22 INT C COMP LING, V1, P881, DOI 10.3115/1599081.1599192	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-7643	1433-7479		SOFT COMPUT	Soft Comput.	APR	2015	19	4			SI		919	927		10.1007/s00500-014-1430-6		9	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications	Computer Science	CD9HG	WOS:000351408300013		
J	Harano, T; Shibata, G; Yoshimatsu, K; Ishigami, K; Verma, VK; Takahashi, Y; Kadono, T; Yoshida, T; Fujimori, A; Koide, T; Chang, FH; Lin, HJ; Huang, DJ; Chen, CT; Xiang, PH; Yamada, H; Sawa, A				Harano, T.; Shibata, G.; Yoshimatsu, K.; Ishigami, K.; Verma, V. K.; Takahashi, Y.; Kadono, T.; Yoshida, T.; Fujimori, A.; Koide, T.; Chang, F. -H.; Lin, H. -J.; Huang, D. -J.; Chen, C. -T.; Xiang, P. -H.; Yamada, H.; Sawa, A.			Phase diagram of Ca1-xCexMnO3 thin films studied by X-ray magnetic circular dichroism (vol 174, pg 30, 2013)	SOLID STATE COMMUNICATIONS			English	Correction									[Harano, T.; Shibata, G.; Yoshimatsu, K.; Verma, V. K.; Takahashi, Y.; Kadono, T.; Yoshida, T.; Fujimori, A.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Ishigami, K.] Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan; [Koide, T.] High Energy Accelerator Res Org KEK Photon Factor, Tsukuba, Ibaraki 3050016, Japan; [Chang, F. -H.; Lin, H. -J.; Huang, D. -J.; Chen, C. -T.] NSRRC, Hsinchu 300, Taiwan; [Xiang, P. -H.; Yamada, H.; Sawa, A.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Xiang, P. -H.] E China Normal Univ, Minist Educ, Key Lab Polar Mat & Devices, Shanghai 200241, Peoples R China	Harano, T (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan.	harano@wyvern.phys.s.u-tokyo.ac.jp					Harano T, 2013, SOLID STATE COMMUN, V174, P30, DOI 10.1016/j.ssc.2013.09.005	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1098	1879-2766		SOLID STATE COMMUN	Solid State Commun.	APR	2015	207						49	49		10.1016/j.ssc.2014.08.002		1	Physics, Condensed Matter	Physics	CD8JK	WOS:000351340900011		
J	Harano, T; Shibata, G; Yoshimatsu, K; Ishigami, K; Verma, VK; Takahashi, Y; Kadono, T; Yoshida, T; Fujimori, A; Koide, T; Chang, FH; Lin, HJ; Huang, DJ; Chen, CT; Xiang, PH; Yamada, H; Sawa, A				Harano, T.; Shibata, G.; Yoshimatsu, K.; Ishigami, K.; Verma, V. K.; Takahashi, Y.; Kadono, T.; Yoshida, T.; Fujimori, A.; Koide, T.; Chang, F. -H.; Lin, H. -J.; Huang, D. -J.; Chen, C. -T.; Xiang, P. -H.; Yamada, H.; Sawa, A.			Phase diagram of Ca1-xCexMnO3 thin films studied by X-ray magnetic circular dichroism	SOLID STATE COMMUNICATIONS			English	Article							MANGANITES	In the perovskite-type Ca1-xCexMnO3 (CCMO), one can control the transport and magnetic properties through varying Ce content. In the case of thin films, the properties can also be controlled by epitaxial strain from the substrate through changing it such as YAlO3 (YAO), NdAlO3 (NAO), and LaSrAlO4 (LSAO). However, one cannot measure the magnetization of thin films on NAO substrates by conventional magnetization measurements because of the strong paramagnetic signals from the Nd3+ ions. In order to eliminate the influence of Nd3+ and to identify magnetic phases of the CCMO thin films, we have performed element-selective X-ray magnetic circular dichroism (XMCD) measurements of the Mn 2p core level. By studying the anisotropy of the XMCD intensity, we could unambiguously determine the magnetic phase diagram of the CCMO thin films. (C) 2015 Elsevier Ltd. All rights reserved.	[Harano, T.; Shibata, G.; Yoshimatsu, K.; Verma, V. K.; Takahashi, Y.; Kadono, T.; Yoshida, T.; Fujimori, A.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Ishigami, K.] Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan; [Koide, T.] High Energy Accelerator Res Org KEK Photon Factor, Tsukuba, Ibaraki 3050016, Japan; [Chang, F. -H.; Lin, H. -J.; Huang, D. -J.; Chen, C. -T.] NSRRC, Hsinchu 300, Taiwan; [Xiang, P. -H.; Yamada, H.; Sawa, A.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058562, Japan; [Xiang, P. -H.] E China Normal Univ, Minist Educ, Key Lab Polar Mat & Devices, Shanghai 200241, Peoples R China	Harano, T (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan.	fujimori@phys.s.u-tokyo.ac.jp	Sawa, Akihito/G-6588-2014		JSPS [S22224005]; "Quantum Beam Technology Development Program" from JST	We thank H. Ohnishi for useful discussion. Technical advice and support by K. Amemiya and M. Sakamaki are gratefully acknowledged. This work was supported by a Grant-in-Aid for Scientific Research from JSPS (S22224005) and the "Quantum Beam Technology Development Program" from JST. The experiment was done under the approval of the Photon Factory Program Advisory Committee (proposal nos. 2012G667 and 2010S2-001). The experiment was done under the approval of the National Synchrotron Radiation Research Center (proposal no. 2011-3-106-2).	Kan D, 2013, ADV FUNCT MATER, V23, P1129, DOI 10.1002/adfm.201202402; Vailionis A, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.064101; Takamura Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2908051; Konishi Y, 1999, J PHYS SOC JPN, V68, P3790, DOI 10.1143/JPSJ.68.3790; Dho J, 2003, APPL PHYS LETT, V82, P1434, DOI 10.1063/1.1556967; Caspi EN, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.104402; Johann F., 2011, PHYS REV B, V84; Ohnishi H, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.165128; Salamon B. Myron, 2001, REV MOD PHYS, V73, P583; Xiang PH, 2012, J APPL PHYS, V112, DOI 10.1063/1.4768198; Xiang PH, 2011, ADV MATER, V23, P5822, DOI 10.1002/adma.201102968; Yanagida T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.132405	12	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0038-1098	1879-2766		SOLID STATE COMMUN	Solid State Commun.	APR	2015	207						50	53		10.1016/j.ssc.2014.08.003		4	Physics, Condensed Matter	Physics	CD8JK	WOS:000351340900012		
J	Hori-Tanaka, Y; Yura, K; Takai-Igarashi, T; Tanaka, H				Hori-Tanaka, Yasuha; Yura, Kei; Takai-Igarashi, Takako; Tanaka, Hiroshi			Structural classification of steroid-binding sites on proteins by coarse-grained atomic environment and its correlation with their biological function	STEROIDS			English	Article						Function-unknown protein; Principle component analysis; Side effect; Structural bioinformatics; Three-dimensional structure	GLUCOCORTICOID-RECEPTOR; CRYSTAL-STRUCTURE; HORMONE; MECHANISMS; RESOLUTION; EVOLUTION; DATABASE; REVEALS; SYSTEM	Steroid hormone is extensively used for transmitting variety of biological signals in organisms. Natural steroid hormone is synthesized from cholesterol in adrenal cortex and in sexual gland in vertebrates. Appropriately dosed synthetic steroid hormones can be used for medication. Despite their positive effects as medicine, they sometimes cause significant side effects due to their wide range of actions, and the studies for discovering the mechanisms of side effects were carried out aiming to reduce the side effects. The fundamental cause of the side effects seems to be interactions between the steroid and a non-target protein. To understand the possible range of interaction of steroid molecule, we gathered all the three-dimensional structures of protein-steroid complex determined by X-ray crystallography, compared the atomic environments of the steroid-binding sites in proteins and classified the pattern of steroid binding. Protein Data Bank contained 871 structures of steroid-protein complexes in 382 entries. For this study, we selected 832 steroid binding proteins. Using a newly developed method to describe the atomic environments of these steroid molecules and their function, we were able to separate the environments into six patterns. This classification had a potential to predict the function of function-unknown proteins with a co-crystallized steroid molecule. We speculated that the proteins grouped into the same pattern of nuclear receptors were the candidates of non-targeted proteins causing a side effect by a therapeutic prescription of steroid hormone. (C) 2015 Elsevier Inc. All rights reserved.	[Hori-Tanaka, Yasuha; Takai-Igarashi, Takako; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo 1138510, Japan; [Yura, Kei] Ochanomizu Univ, Grad Sch Humanities & Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Yura, Kei] Ochanomizu Univ, Ctr Informat Biol, Bunkyo Ku, Tokyo 1128610, Japan; [Yura, Kei] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Takai-Igarashi, Takako; Tanaka, Hiroshi] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 9808573, Japan	Yura, K (reprint author), Ochanomizu Univ, Ctr Informat Biol, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	yura.kei@ocha.ac.jp			Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; JSPS KAKENHI [25290070]; MEXT Tohoku Medical Megabank Project	This work was supported by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. In addition, HT was supported by JSPS KAKENHI, Grant-in-Aid for Scientific Research (B), Grant Number 25290070 and TTI was supported by MEXT Tohoku Medical Megabank Project.	Allard STM, 2005, ACTA CRYSTALLOGR F, V61, P647, DOI 10.1107/S1744309105019743; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P3538, DOI 10.1021/bi9723055; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Song YL, 2014, PROTEIN SCI, V23, P1, DOI 10.1002/pro.2385; MACLUSKY NJ, 1980, ENDOCRINOLOGY, V106, P192; Haller J, 2008, FRONT NEUROENDOCRIN, V29, P273, DOI 10.1016/j.yfrne.2007.10.004; Yamaguchi A, 2004, J BIOCHEM, V135, P79, DOI 10.1093/jb/mvh009; Eick GN, 2011, MOL CELL ENDOCRINOL, V334, P31, DOI 10.1016/j.mce.2010.09.003; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Rich RL, 2002, P NATL ACAD SCI USA, V99, P8562, DOI 10.1073/pnas.142288199; Grishkovskaya I, 2002, J BIOL CHEM, V277, P32086, DOI 10.1074/jbc.M203999200; Chinenov Y, 2007, MOL CELL ENDOCRINOL, V275, P30, DOI 10.1016/j.mce.2007.04.014; Gu RY, 2007, J MOL BIOL, V372, P583, DOI 10.1016/j.jmb.2007.06.072; Berman H.B., 2003, NAT STRUCT BIOL, V10, P98, DOI DOI 10.1038/NSB1203-980; Cherney MM, 2008, BBA-PROTEINS PROTEOM, V1784, P1625, DOI 10.1016/j.bbapap.2008.05.012; Christ M, 1998, CARDIOVASC RES, V40, P34, DOI 10.1016/S0008-6363(98)00147-3; Esmailpour N, 1998, EUR J PHARM SCI, V6, P219, DOI 10.1016/S0928-0987(97)00082-1; GRANITZER M, 1995, PFLUG ARCH EUR J PHY, V430, P493, DOI 10.1007/BF00373885; Laan S, 2008, EUR J PHARMACOL, V585, P483; Maekawa M, 2014, FRONT NEUROSCI, V8, P242; Matias PM, 2002, J MED CHEM, V45, P1439, DOI 10.1021/jm011072j; Ollikainen N, 2006, INTEGR COMP BIOL, V46, P815, DOI 10.1093/icb/icl035; Pan Y, 2008, NAT CHEM BIOL, V11, P708; Spreafico M, 2009, CHEMMEDCHEM, V4, P100, DOI 10.1002/cmdc.200800274; Team R. R, 2012, LANG ENV STAT COMP; Waller BR, 2007, EUR J ENDOCRINOL, V157, P545	28	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0039-128X	1878-5867		STEROIDS	Steroids	APR	2015	96						81	88		10.1016/j.steroids.2015.01.015		8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CE4HF	WOS:000351791000011		
J	Yokoyama, Y; Kawashima, T; Ohkawa, M; Iwai, H; Aoyagi, S				Yokoyama, Yuta; Kawashima, Tomoko; Ohkawa, Mayumi; Iwai, Hideo; Aoyagi, Satoka			Extraction of hidden information of ToF-SIMS data using different multivariate analyses	SURFACE AND INTERFACE ANALYSIS			English	Article						time-of-flight secondary ion mass spectrometry (ToF-SIMS); principal component analysis (PCA); multivariate curve resolution (MCR); polymers; contamination; Ar cluster beam sputtering	ION MASS-SPECTROMETRY; CURVE RESOLUTION; POLYMER; IMAGES; SYSTEMS	Time-of-flight secondary ion mass spectrometry (ToF-SIMS) is a powerful tool for determining surface information of complex systems such as polymers and biological materials. However, the interpretation of ToF-SIMS raw data is often difficult. Multivariate analysis has become effective methods for the interpretation of ToF-SIMS data. Some of multivariate analysis methods such as principal component analysis and multivariate curve resolution are useful for simplifying ToF-SIMS data consisting of many components to that explained by a smaller number of components. In this study, the ToF-SIMS data of four layers of three polymers was analyzed using these analysis methods. The information acquired by using each method was compared in terms of the spatial distribution of the polymers and identification. Moreover, in order to investigate the influence of surface contamination, the ToF-SIMS data before and after Ar cluster ion beam sputtering was compared. As a result, materials in the sample of multiple components, including unknown contaminants, were distinguished. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Yokoyama, Yuta; Aoyagi, Satoka] Seikei Univ, Dept Mat & Life Sci, Tokyo 1808633, Japan; [Kawashima, Tomoko] Panasonic Corp, Life Mat Grp, Device Solut Ctr, Seika, Kyoto 6190237, Japan; [Ohkawa, Mayumi] Panasonic Corp, Green Chem Grp, Device Solut Ctr, Moriguchi, Osaka 5708501, Japan; [Iwai, Hideo] Natl Inst Mat Sci, Mat Anal Stn, Tsukuba, Ibaraki 3050047, Japan	Aoyagi, S (reprint author), Seikei Univ, Dept Mat & Life Sci, 3-3-1 Kichijoji Kitamachi, Tokyo 1808633, Japan.	aoyagi@st.seikei.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	The work was partly supported by NIMS microstructural characterization platform as a program of 'Nanotechnology Platform' of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Tyler BJ, 2006, APPL SURF SCI, V252, P6875, DOI 10.1016/j.apsusc.2006.02.160; Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t; Wagner MS, 2006, APPL SURF SCI, V252, P6575, DOI 10.1016/j.apsusc.2006.02.073; Miyasaka T, 2008, APPL SURF SCI, V255, P1576, DOI 10.1016/j.apsusc.2008.05.137; Graham DJ, 2006, APPL SURF SCI, V252, P6860, DOI 10.1016/j.apsusc.2006.02.149; Tauler R, 2001, J CHEMOMETR, V15, P627, DOI 10.1002/cem.654; Muto S, 2009, MATER TRANS, V50, P964, DOI 10.2320/matertrans.MC200805; Aoyagi S, 2012, SURF INTERFACE ANAL, V44, P789, DOI 10.1002/sia.4824; Aoyagi S, 2014, SURF INTERFACE ANAL, V46, P131, DOI 10.1002/sia.5588; Graham DJ, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0049-3; Ito H, 2008, APPL SURF SCI, V255, P1044, DOI 10.1016/j.apsusc.2008.05.080; Karen A, 2003, APPL SURF SCI, V203, P541, DOI 10.1016/S0169-4332(02)00623-2; Kono T, 2008, APPL SURF SCI, V255, P997, DOI 10.1016/j.apsusc.2008.05.079; Lee JLS, 2009, SURF INTERFACE ANAL, V41, P653, DOI 10.1002/sia.3070	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0142-2421	1096-9918		SURF INTERFACE ANAL	Surf. Interface Anal.	APR	2015	47	4					439	446		10.1002/sia.5731		8	Chemistry, Physical	Chemistry	CD9CV	WOS:000351395700002		
J	Okamoto, T; Onda, S; Yanaga, K; Suzuki, N; Hattori, A				Okamoto, Tomoyoshi; Onda, Shinji; Yanaga, Katsuhiko; Suzuki, Naoki; Hattori, Asaki			Clinical application of navigation surgery using augmented reality in the abdominal field	SURGERY TODAY			English	Review						Navigation surgery; Augmented reality; Abdominal field; Video see through system	LAPAROSCOPIC RADICAL PROSTATECTOMY; IMAGE-GUIDED SURGERY; OPEN LIVER SURGERY; PARTIAL NEPHRECTOMY; ENDOSCOPIC SURGERY; SYSTEM; VISUALIZATION; REGISTRATION; IMPACT; CHOLECYSTECTOMY	This article presents general principles and recent advancements in the clinical application of augmented reality-based navigation surgery (AR based NS) for abdominal procedures and includes a description of our clinical trial and subsequent outcomes. Moreover, current problems and future aspects are discussed. The development of AR-based NS in the abdomen is delayed compared with another field because of the problem of intraoperative organ deformations or the existence of established modalities. Although there are a few reports on the clinical use of AR-based NS for digestive surgery, sophisticated technologies in urology have often been reported. However, the rapid widespread use of video- or robot assisted surgeries requires this technology. We have worked to develop a system of AR-based NS for hepatobiliary and pancreatic surgery. Then we developed a short rigid scope that enables surgeons to obtain 3D view. We recently focused on pancreatic surgery, because intraoperative organ shifting is minimal. The position of each organ in overlaid image almost corresponded with that of the actual organ with about 5 mm of mean registration errors. Intraoperative information generated from this system provided us with useful navigation. However, AR-based NS has several problems to overcome such as organ deformity, evaluation of utility, portability or cost.	[Okamoto, Tomoyoshi] Jikei Univ, Daisan Hosp, Dept Surg, Komae, Tokyo, Japan; [Onda, Shinji; Yanaga, Katsuhiko] Jikei Univ, Sch Med, Div Digest Surg, Minato Ku, Tokyo, Japan; [Suzuki, Naoki; Hattori, Asaki] Jikei Univ, Sch Med, Inst High Dimens Med Imaging, Komae, Tokyo, Japan	Okamoto, T (reprint author), Jikei Univ, Daisan Hosp, Dept Surg, 4-11-1 Izumihoncho, Komae, Tokyo, Japan.	tomoka@jikei.ac.jp					Shekhar R, 2010, SURG ENDOSC, V24, P1976, DOI 10.1007/s00464-010-0890-8; Marescaux J, 1998, ANN SURG, V228, P627, DOI 10.1097/00000658-199811000-00001; Aggarwal R, 2009, BRIT J SURG, V96, P1086, DOI 10.1002/bjs.6679; Ukimura O, 2009, UROL CLIN N AM, V36, P115, DOI 10.1016/j.ucl.2009.02.012; Marescaux J, 2004, JAMA-J AM MED ASSOC, V292, P2214, DOI 10.1001/jama.292.18.2214-c; Ukimura O, 2006, J UROLOGY, V175, P1304, DOI 10.1016/S0022-5347(05)00688-9; Konishi K, 2005, INT CONGR SER, V1281, P537, DOI 10.1016/j.ics.2005.03.234; Herline AJ, 1999, ARCH SURG-CHICAGO, V134, P644, DOI 10.1001/archsurg.134.6.644; Grunert P, 2003, NEUROSURG REV, V26, P73, DOI 10.1007/s10143-003-0262-0; Lamade W, 2000, ARCH SURG-CHICAGO, V135, P1256, DOI 10.1001/archsurg.135.11.1256; Cash DM, 2005, IEEE T MED IMAGING, V24, P1479, DOI 10.1109/TMI.2005.855434; Onda S, 2014, J HEPATO-BIL-PAN SCI, V21, P281, DOI 10.1002/jhbp.25; Su LM, 2009, UROLOGY, V73, P896, DOI 10.1016/j.urology.2008.11.040; Kowalczuk J, 2012, SURG ENDOSC, V26, P3413, DOI 10.1007/s00464-012-2355-8; Endo I, 2007, SURGERY, V142, P666, DOI 10.1016/j.surg.2007.05.018; Harders M, 2009, IEEE T VIS COMPUT GR, V15, P138, DOI 10.1109/TVCG.2008.63; Liao HE, 2010, COMPUT MED IMAG GRAP, V34, P46, DOI 10.1016/j.compmedimag.2009.07.003; Liao HE, 2010, IEEE T BIO-MED ENG, V57, P1476, DOI 10.1109/TBME.2010.2040278; Hohlweg-Majert B, 2005, WORLD J SURG, V29, P1530, DOI 10.1007/s00268-005-0091-0; Gavaghan KA, 2011, IEEE T BIO-MED ENG, V58, P1855, DOI 10.1109/TBME.2011.2126572; Baumhauer M, 2008, J ENDOUROL, V22, P751, DOI 10.1089/end.2007.9827; Beller S, 2009, J HEPATO-BILIARY-PAN, V16, P165, DOI 10.1007/s00534-008-0040-z; Yamanaka J, 2007, WORLD J SURG, V31, P1249, DOI 10.1007/s00268-007-9020-8; Marvik R, 2004, SURG ENDOSC, V18, P1242, DOI 10.1007/s00464-003-9190-x; Shuhaiber JH, 2004, ARCH SURG-CHICAGO, V139, P170, DOI 10.1001/archsurg.139.2.170; Sugimoto M, 2010, J HEPATO-BIL-PAN SCI, V17, P629, DOI 10.1007/s00534-009-0199-y; Teber D, 2009, EUR UROL, V56, P332, DOI 10.1016/j.eururo.2009.05.017; Hansen C, 2010, INT J COMPUT ASS RAD, V5, P133, DOI 10.1007/s11548-009-0365-3; Nicolau S, 2011, SURG ONCOL, V20, P189, DOI 10.1016/j.suronc.2011.07.002; Wong DY, 2008, J NEUROTRAUM, V25, P1027, DOI 10.1089/neu.2007.0473; Cash DM, 2007, J GASTROINTEST SURG, V11, P844, DOI 10.1007/s11605-007-0090-6; Peterhans M, 2011, INT J MED ROBOT COMP, V7, P7, DOI 10.1002/rcs.360; Satava RM, 1999, ARCH SURG-CHICAGO, V134, P1197, DOI 10.1001/archsurg.134.11.1197; Mezger U, 2013, LANGENBECK ARCH SURG, V398, P501, DOI 10.1007/s00423-013-1059-4; Aoki T, 2013, TAN TO SUI, V34, P27; Aoki T, 2012, J JPN SOC COMPUT AID, V14, P164; Argotti Y, 2002, COMPUT GRAPH-UK, V26, P919, DOI 10.1016/S0097-8493(02)00180-2; Das M, 2006, RADIOLOGY, V240, P230, DOI 10.1148/radiol.2401040018; Ferrari V, 2009, IEEE T BIO-MED ENG, V56, P2627, DOI 10.1109/TBME.2009.2028013; Gavaghan K, 2012, INT J COMPUT ASS RAD, V7, P547, DOI 10.1007/s11548-011-0660-7; Hamada H, 2005, MINIM INVAS NEUROSUR, V48, P197, DOI 10.1055/s-2005-870907; Hattori A, 2003, ST HEAL T, V94, P110; Hostettler A, 2010, PROG BIOPHYS MOL BIO, V103, P169, DOI 10.1016/j.pbiomolbio.2010.09.017; Ieiri S, 2012, PEDIATR SURG INT, V28, P341, DOI 10.1007/s00383-011-3034-x; Lamadé Wolfram, 2002, J Hepatobiliary Pancreat Surg, V9, P592, DOI 10.1007/s005340200079; Markiewicz MR, 2012, ORAL MAXILLOFAC SURG, V24, P573, DOI [10.1016/j.coms.2012.08.004, DOI 10.1016/J.COMS.2012.08.004]; Masamune K, 2002, LNCS, V2489, P77; Matsuki M, 2005, ABDOM IMAGING, V30, P698, DOI 10.1007/s00261-005-0328-2; Nakamoto M, 2012, CURR OPIN UROL, V22, P121, DOI 10.1097/MOU.0b013e3283501774; Nicolau S A, 2011, Stud Health Technol Inform, V163, P403; Okamoto T, 2013, J HEPATO-BIL-PAN SCI, V20, P249, DOI 10.1007/s00534-012-0504-z; Okamoto T, 2010, J JPN SOC COMPUT AID, V12, P312; Onda S, 2013, J HEPATO-BIL-PAN SCI, V20, P448, DOI 10.1007/s00534-012-0582-y; Onda S, 2011, J JPN SOC COMPUT AID, V13, P258; Onda S, 2012, J JPN SOC COMPUT AID, V14, P222; Robb RA, 1994, 1 INT S COMP AID SUR, P18; Satou S, 2005, HEPATOLOGY, V41, P1297; Simpfendorfer T, 2011, J ENDOUROL, V25, P1841, DOI 10.1089/end.2010.0724; Sugimoto M, 2010, J HEPATO-BIL-PAN SCI, V17, P574, DOI 10.1007/s00534-009-0192-5; Zhou F, 2013, SURG TODAY, V43, P1371, DOI 10.1007/s00595-012-0425-0	60	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					397	406		10.1007/s00595-014-0946-9		10	Surgery	Surgery	CD7OU	WOS:000351280900001		
J	Kobayashi, J; Kusachi, S; Sawa, Y; Motomura, N; Imoto, Y; Makuuchi, H; Tanemoto, K; Shimahara, Y; Sumiyama, Y				Kobayashi, Junjiro; Kusachi, Shinya; Sawa, Yoshiki; Motomura, Noboru; Imoto, Yutaka; Makuuchi, Haruo; Tanemoto, Kazuo; Shimahara, Yusuke; Sumiyama, Yoshinobu			Socioeconomic effects of surgical site infection after cardiac surgery in Japan	SURGERY TODAY			English	Article						Cardiopulmonary bypass; Heart disease; Surgery; Surgical site infection	STERNAL WOUND COMPLICATIONS; PRACTICE GUIDELINE SERIES; LONG-TERM SURVIVAL; LENGTH-OF-STAY; RISK-FACTORS; ANTIBIOTIC-PROPHYLAXIS; UNITED-STATES; MORTALITY; COST; IMPACT	Surgical site infection (SSI) increases medical costs and prolongs hospitalization; however, there has been no multicenter study examining the socioeconomic effects of SSI after cardiovascular surgery in Japan. A retrospective 1:1 matched, case-controlled study on hospital stay and health care expenditure after cardiovascular surgery was performed in four hospitals. Patients selected for the study had undergone coronary artery bypass grafting and/or valve surgery between April, 2006 and March, 2008. Data were obtained for 30 pairs of patients. The mean postoperative stay for the SSI group was 49.1 days, being 3.7 times longer than that for the non-SSI group. The mean postoperative health care expenditure for the SSI group was Ayen2,763,000 (US$27,630), being five times higher than that for the non-SSI group. Charges for drug infusion and hospitalization for inpatient care were significantly higher for the SSI group than for the non-SSI group. The increased health care expenditure was mainly attributed to the cost of antibiotics and antimicrobial agents. SSI after cardiovascular surgery not only prolonged the length of hospital stay, but also increased medical expenditure. Thus, the prevention of SSI after cardiovascular surgery is of great socioeconomic importance.	[Kobayashi, Junjiro; Shimahara, Yusuke] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, Suita, Osaka 5658565, Japan; [Kusachi, Shinya] Toho Univ, Ohashi Hosp, Med Ctr, Dept Surg, Tokyo, Japan; [Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Osaka, Japan; [Motomura, Noboru] Univ Tokyo, Grad Sch Med, Dept Cardiac Surg, Tokyo, Japan; [Imoto, Yutaka] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Thorac & Cardiovasc Surg, Kagoshima 890, Japan; [Makuuchi, Haruo] St Marianna Univ, Sch Med, Dept Cardiovasc Surg, Kawasaki, Kanagawa, Japan; [Tanemoto, Kazuo] Kawasaki Med Univ, Div Thorac & Cardiovasc Surg, Kurashiki, Okayama, Japan; [Sumiyama, Yoshinobu] Toho Univ, Tokyo, Japan	Kobayashi, J (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Surg, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	jkobayas@hsp.ncvc.go.jp	Kobayashi, Junjiro/J-8547-2015		Johnson Johnson KK	This study was carried out by the Clinical Trial Committee of the Japan Society for Surgical Infection supported by Johnson & Johnson KK. None of the authors has a conflict of interest to declare.	Abboud CS, 2004, ANN THORAC SURG, V77, P676, DOI 10.1016/S0003-4975(03)01523-6; Toumpoulis IK, 2005, CHEST, V127, P464, DOI 10.1378/chest.127.2.464; de Lissovoy G, 2009, AM J INFECT CONTROL, V37, P387, DOI 10.1016/j.ajic.2008.12.010; Imai-Kamata S, 2011, INT J QUAL HEALTH C, V23, P167, DOI 10.1093/intqhc/mzq080; MILANO CA, 1995, CIRCULATION, V92, P2245; Kashimura N, 2012, SURG TODAY, V42, P639, DOI 10.1007/s00595-012-0126-8; [Anonymous], 2008, STAT MED DIR LETT 08; Graf K, 2010, EUR J CARDIO-THORAC, V37, P893, DOI 10.1016/j.ejcts.2009.10.005; Ridderstolpe L, 2001, EUR J CARDIO-THORAC, V20, P1168, DOI 10.1016/S1010-7940(01)00991-5; Coello R, 2005, J HOSP INFECT, V60, P93, DOI 10.1016/j.jhin.2004.10.019; Stahle E, 1997, EUR J CARDIO-THORAC, V11, P1146, DOI 10.1016/S1010-7940(97)01210-4; Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572; Borger MA, 1998, ANN THORAC SURG, V65, P1050, DOI 10.1016/S0003-4975(98)00063-0; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Engelman R, 2007, ANN THORAC SURG, V83, P1569, DOI 10.1016/j.athoracsur.2006.09.046; Braxton John H, 2004, Semin Thorac Cardiovasc Surg, V16, P70, DOI 10.1053/j.semtcvs.2004.01.006; Coskun D, 2005, J HOSP INFECT, V60, P176, DOI 10.1016/j.jhin.2004.10.017; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Edwards FH, 2006, ANN THORAC SURG, V81, P397, DOI 10.1016/j.athoracsur.2005.06.034; Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e; Hollenbeak CS, 2000, CHEST, V118, P317; Jenney AWJ, 2001, ANZ J SURG, V71, P662, DOI 10.1046/j.1445-1433.2001.02225.x; Kusachi S, 2012, SURG INFECT, V13, P257, DOI 10.1089/sur.2011.007; Kuwano Hiroyuki, 2012, Gen Thorac Cardiovasc Surg, V60, P680, DOI 10.1007/s11748-012-0119-y; LOOP FD, 1990, ANN THORAC SURG, V49, P179; Upton Arlo, 2005, N Z Med J, V118, pU1316	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					422	428		10.1007/s00595-014-0969-2		7	Surgery	Surgery	CD7OU	WOS:000351280900004		
J	Nagasaki, T; Akiyoshi, T; Ueno, M; Fukunaga, Y; Nagayama, S; Fujimoto, Y; Konishi, T; Arai, M; Yamaguchi, T				Nagasaki, Toshiya; Akiyoshi, Takashi; Ueno, Masashi; Fukunaga, Yosuke; Nagayama, Satoshi; Fujimoto, Yoshiya; Konishi, Tsuyoshi; Arai, Masami; Yamaguchi, Toshiharu			Feasibility and safety of laparoscopic surgery for metachronous colorectal cancer	SURGERY TODAY			English	Article						Laparoscopic surgery; Metachronous colorectal cancer; Previous abdominal surgery; Lynch syndrome; Hereditary nonpolyposis colorectal cancer	PREVIOUS ABDOMINAL-SURGERY; SHORT-TERM OUTCOMES; COLON-CANCER; RANDOMIZED-TRIAL; COLECTOMY; OPERATIONS; IMPACT	This study assessed the feasibility and safety of laparoscopic surgery for metachronous colorectal cancer in patients who had previously undergone surgery for primary colorectal cancer. Of the 52 patients who underwent curative resection for metachronous colorectal cancer from August 2004 to April 2013, 26 each underwent laparoscopic and open surgery. Their clinical characteristics and surgical and postoperative outcomes were compared. The percentage of patients who underwent previous open surgery was significantly higher in the open group than in the laparoscopic group (92.3 vs. 65.4 %). The body mass index was higher in the laparoscopic group than in the open group (23.8 vs. 21.1 kg/m(2)), and the amount of blood loss was significantly smaller in the laparoscopic than in the open group (30 vs. 195 ml); however, the mean operative time did not differ significantly. The time to first flatus (1 vs. 3 days) and first stool (2 vs. 3.5 days), as well as the length of postoperative hospital stay (10 vs. 16 days), was significantly shorter in the laparoscopic group than in the open group, although the rates of postoperative complications did not differ (15.4 vs. 23.1 %). Laparoscopic surgery for metachronous colorectal cancer shows short-term benefits compared with open surgery and should be considered as a treatment option in these patients.	[Nagasaki, Toshiya; Akiyoshi, Takashi; Ueno, Masashi; Fukunaga, Yosuke; Nagayama, Satoshi; Fujimoto, Yoshiya; Konishi, Tsuyoshi; Yamaguchi, Toshiharu] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Koto Ku, Tokyo 1358550, Japan; [Arai, Masami] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Clin Genet Oncol, Koto Ku, Tokyo 1358550, Japan	Akiyoshi, T (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	takashi.akiyoshi@jfcr.or.jp					Akiyoshi T, 2010, J GASTROINTEST SURG, V14, P818, DOI 10.1007/s11605-010-1182-2; Gonzalez IA, 2006, SURG LAPARO ENDO PER, V16, P8, DOI 10.1097/01.sle.0000202188.57537.07; Akiyoshi T, 2010, SURG ENDOSC, V24, P2749, DOI 10.1007/s00464-010-1039-5; Barleben A, 2009, AM SURGEON, V75, P1015; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Hamel CT, 2000, SURG ENDOSC-ULTRAS, V14, P853, DOI 10.1007/s004640000218; Belizon A, 2006, SURG ENDOSC, V20, P947, DOI 10.1007/s00464-005-0553-3; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Offodile AC, 2008, DIS COLON RECTUM, V51, P1669, DOI 10.1007/s10350-008-9278-4; Nagasue Y, 2013, J GASTROINTEST SURG, V17, P1299, DOI 10.1007/s11605-013-2222-5; Law WL, 2005, SURG ENDOSC, V19, P326, DOI 10.1007/s00464-004-8114-8; Bhardwaj R, 2007, COLORECTAL DIS, V9, P45, DOI 10.1111/j.1463-1318.2007.01357.x; Bouvier AM, 2008, EUR J CANCER, V44, P522, DOI 10.1016/j.ejca.2008.01.007; CALI RL, 1993, DIS COLON RECTUM, V36, P388, DOI 10.1007/BF02053945; Franko Jan, 2006, JSLS, V10, P169; Lam AKY, 2012, INT J COLORECTAL DIS, V27, P1303, DOI 10.1007/s00384-012-1474-y; Park IJ, 2006, COLORECTAL DIS, V8, P323, DOI 10.1111/j.1463-1318.2006.00949.x; Park SY, 2011, SURG ENDOSC, V25, P3551, DOI 10.1007/s00464-011-1756-4; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Vignali A, 2007, Tech Coloproctol, V11, P241, DOI 10.1007/s10151-007-0358-6	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					434	438		10.1007/s00595-014-0925-1		5	Surgery	Surgery	CD7OU	WOS:000351280900006		
J	Ikeda, M; Bando, T; Yamada, T; Sato, M; Menjyu, T; Aoyama, A; Sato, T; Chen, FS; Sonobe, M; Omasa, M; Date, H				Ikeda, Masaki; Bando, Toru; Yamada, Tetsu; Sato, Masaaki; Menjyu, Toshi; Aoyama, Akihiro; Sato, Toshihiko; Chen, Fengshi; Sonobe, Makoto; Omasa, Mitsugu; Date, Hiroshi			Clinical application of ET-Kyoto solution for lung transplantation	SURGERY TODAY			English	Article						Deceased donor; ET-Kyoto solution; Japan; Long ischemic time; Lung transplantation; Primary graft dysfunction	INTERNATIONAL-SOCIETY; PRESERVATION; REGISTRY; HEART	Because of the severe donor shortage in Japan, even after the revision of the Organ Transplant Law in 2010, the frequency of recovery of extended criteria lungs has increased in Japan. We developed a new lung preservation solution, "ET-Kyoto solution," to enhance lung preservation, to minimize primary graft dysfunction (PGD) and to improve the post-transplant outcomes. In this study, we retrospectively analyzed our results of lung transplantation using the ET-Kyoto solution. From 2002 to 2012, 26 patients underwent transplantation of lungs preserved with ET-Kyoto solution from brain-dead donors. We retrospectively reviewed the post-transplant pulmonary function and long-term survival. The graft performance was assessed by the PGD grading system. The mean graft ischemic time was 483.8 +/- A 19.0 min. The oxygenation capacity after reperfusion and recovery of respiratory function were both acceptable despite the long ischemic time. The survival rate at 5 years after transplantation was 85.1 %. Lungs preserved by ET-Kyoto solution had satisfactory postoperative lung function, despite the long preservation time, with excellent long-term survival. The results were acceptable for the use of grafts with a long ischemic time.	[Ikeda, Masaki; Bando, Toru; Yamada, Tetsu; Sato, Masaaki; Menjyu, Toshi; Aoyama, Akihiro; Sato, Toshihiko; Chen, Fengshi; Sonobe, Makoto; Omasa, Mitsugu; Date, Hiroshi] Kyoto Univ Hosp, Dept Thorac Surg, Kyoto 606, Japan; [Ikeda, Masaki] Nagara Med Ctr, Dept Thorac Surg, Gifu, Japan; [Bando, Toru] St Lukes Int Hosp, Dept Thorac Surg, Chuo Ku, Tokyo 1048560, Japan	Bando, T (reprint author), Kyoto Univ Hosp, Dept Thorac Surg, Kyoto 606, Japan.	i_msk_11_7@yahoo.co.jp; tobando@luke.ac.jp					Christie JD, 2005, J HEART LUNG TRANSPL, V24, P1454, DOI 10.1016/j.healun.2004.11.049; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; BANDO T, 1994, J THORAC CARDIOV SUR, V108, P92; Bando Toru, 2008, Gen Thorac Cardiovasc Surg, V56, P17, DOI 10.1007/s11748-007-0161-3; Gomez MP, 2012, TRANSPL P, V44, P1592, DOI 10.1016/j.transproceed.2012.04.005; Okada Y, 2012, SURG TODAY, V42, P152, DOI 10.1007/s00595-011-0052-1; Omasa M, 2004, ANN THORAC SURG, V77, P338, DOI 10.1016/S0003-4975(03)01036-1; Oto Takahiro, 2013, Gen Thorac Cardiovasc Surg, V61, P208, DOI 10.1007/s11748-013-0215-7; Wada H, 1996, ANN THORAC SURG, V61, P1099, DOI 10.1016/0003-4975(96)00030-6	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					439	443		10.1007/s00595-014-0918-0		5	Surgery	Surgery	CD7OU	WOS:000351280900007		
J	Iwagami, Y; Eguchi, H; Wada, H; Tomimaru, Y; Hama, N; Kawamoto, K; Kobayashi, S; Mori, M; Doki, Y; Nagano, H				Iwagami, Yoshifumi; Eguchi, Hidetoshi; Wada, Hiroshi; Tomimaru, Yoshito; Hama, Naoki; Kawamoto, Koichi; Kobayashi, Shogo; Mori, Masaki; Doki, Yuichiro; Nagano, Hiroaki			Implications of peritoneal lavage cytology in resectable left-sided pancreatic cancer	SURGERY TODAY			English	Article						Peritoneal lavage cytology; CY; Left-sided pancreatic cancer	ADENOCARCINOMA; SURVIVAL; TAIL; BODY; RESECTION; SURGERY; LAPAROSCOPY; MANAGEMENT	The aim of this study was to determine the utility of the peritoneal lavage cytology findings in predicting the clinical outcomes of resectable left-sided pancreatic cancer. Peritoneal lavage samples were collected from 39 consecutive patients who underwent surgery for left-sided pancreatic cancer between January 2000 and December 2010. We analyzed the correlations between the peritoneal lavage cytology findings and the clinical outcomes. Five patients (12.8 %) had malignant cells in the cytology samples (positive cytology). This occurred more frequently in patients with vascular invasion (P = 0.008). Positive cytology was significantly associated with lower overall (P = 0.0007) and recurrent-free (P < 0.0001) survival rates. Positive cytology was an independent prognostic factor for recurrence (P = 0.022); it was closely associated with local recurrence, peritoneal recurrence and distant metastasis. Surgeons should carefully consider the intraoperative diagnosis of peritoneal lavage cytology in patients with resectable left-sided pancreatic cancers, because patients with positive cytology are likely to experience recurrence.	[Iwagami, Yoshifumi; Eguchi, Hidetoshi; Wada, Hiroshi; Tomimaru, Yoshito; Hama, Naoki; Kawamoto, Koichi; Kobayashi, Shogo; Mori, Masaki; Doki, Yuichiro; Nagano, Hiroaki] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka 5650871, Japan	Nagano, H (reprint author), Osaka Univ, Grad Sch Med, Dept Surg, Yamadaoka 2-2 E2, Suita, Osaka 5650871, Japan.	yiwagami@gesurg.med.osaka-u.ac.jp; hnagano@gesurg.med.osaka-u.ac.jp					Tempero MA, 2010, J NATL COMPR CANC NE, V8, P972; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Shoup M, 2003, J GASTROINTEST SURG, V7, P946, DOI 10.1016/j.gassur.08.004; Eguchi H, 2013, HEPATO-GASTROENTEROL, V60, P904, DOI 10.5754/hge12974; Isaji S, 2004, PANCREAS, V28, P231, DOI 10.1097/00006676-200404000-00003; Clark CJ, 2010, AM J SURG, V199, P657, DOI 10.1016/j.amjsurg.2010.01.021; Brennan MF, 1996, ANN SURG, V223, P506, DOI 10.1097/00000658-199605000-00006; Sener SF, 1999, J AM COLL SURGEONS, V189, P1, DOI 10.1016/S1072-7515(99)00075-7; Ferrone CR, 2006, J GASTROINTEST SURG, V10, P1347, DOI 10.1016/j.gassur.2006.07.013; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Bergenfeldt Magnus, 2006, HPB (Oxford), V8, P211, DOI 10.1080/13651820500497165; BRAMHALL SR, 1995, BRIT J SURG, V82, P111, DOI 10.1002/bjs.1800820137; Brennan MF, 1996, ANN SURG, V223, P11; Edge SB, 2010, AJCC CANC STAGING HD, Vxix, P718; Eguchi H, 2009, SURGERY, V146, P888, DOI 10.1016/j.surg.2009.04.021; Fabre JM, 1996, BRIT J SURG, V83, P1065, DOI 10.1002/bjs.1800830810; Falconi M, 2003, DIGEST LIVER DIS, V35, P421, DOI 10.1016/S1590-8658(03)00158-0; FERNANDEZDELCASTILLO C, 1995, BRIT J SURG, V82, P1127; Jimenez R E, 2000, J Hepatobiliary Pancreat Surg, V7, P15, DOI 10.1007/s005340050148; Jimenez RE, 2000, ARCH SURG-CHICAGO, V135, P14; Jimenez RE, 2000, ARCH SURG-CHICAGO, V135, P409, DOI 10.1001/archsurg.135.4.409; JOHNSON CD, 1993, BRIT J SURG, V80, P1177, DOI 10.1002/bjs.1800800937; Konishi M, 2002, ARCH SURG-CHICAGO, V137, P475, DOI 10.1001/archsurg.137.4.475; LEACH SD, 1995, SURGERY, V118, P472, DOI 10.1016/S0039-6060(05)80361-7; Lillemoe KD, 1999, ANN SURG, V229, P8; Lillemoe K D, 1997, Gastroenterology, V112, P1046, DOI 10.1053/gast.1997.v112.agast971046; Lillemoe KD, 1999, ANN SURG, V229, P693, DOI 10.1097/00000658-199905000-00012; Liu RC, 2005, SURG ENDOSC, V19, P638, DOI 10.1007/s00464-004-8165-x; Makary MA, 1998, ARCH SURG-CHICAGO, V133, P361, DOI 10.1001/archsurg.133.4.361; Merchant NB, 1999, J AM COLL SURGEONS, V188, P421, DOI 10.1016/S1072-7515(98)00327-5; Meszoely IM, 2004, AM SURGEON, V70, P208; Meszoely IM, 2004, AM SURGEON, V70, P208; Nakao A, 2006, WORLD J GASTROENTERO, V12, P4466; Shoup M, 2003, J GASTROINTEST SURG, V7, P52; Sobin LH, 2010, TNM CLASSIFICATION M, Vxx, P309; Warshaw AL, 1991, AM J SURG, V161, P9; WARSHAW AL, 1991, AM J SURG, V161, P26, DOI 10.1016/0002-9610(91)90356-I; Yachida S, 2002, BRIT J SURG, V89, P573, DOI 10.1046/j.1365-2168.2002.02061.x; Yamada S, 2007, ANN SURG, V246, P254, DOI 10.1097/01.sla.0000261596.43439.92; Yoshioka R, 2012, WORLD J SURG, V36, P2187, DOI 10.1007/s00268-012-1622-0	40	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					444	450		10.1007/s00595-014-0964-7		7	Surgery	Surgery	CD7OU	WOS:000351280900008		
J	Sugimoto, M; Miyachi, H; Morimae, H; Kodama, A; Narita, H; Banno, H; Yamamoto, K; Komori, K				Sugimoto, Masayuki; Miyachi, Hiroki; Morimae, Hirofumi; Kodama, Akio; Narita, Hiroshi; Banno, Hiroshi; Yamamoto, Kiyohito; Komori, Kimihiro			The fate of ischemic limbs in patients with Buerger's disease based on our 30-year experience: does smoking have a definitive impact on the late loss of limbs?	SURGERY TODAY			English	Article						Buerger's disease; Critical limb ischemia; Peripheral arterial disease	THROMBOANGIITIS-OBLITERANS; THERAPEUTIC ANGIOGENESIS; TRANSPLANTATION; TRIAL; JAPAN; CELLS	We herein review the long-term results of our series of critical ischemic limbs caused by Buerger's disease. A retrospective review of 103 patients with critical limb ischemia who were diagnosed with Buerger's disease by Shionoya's criteria between 1980 and 2010. The age of onset was 38.0 +/- A 9.7 years (mean +/- A SD). The median follow-up was 97 months. Thirty-three patients had pain at rest, and 65 patients presented with ischemic ulcers in their toes and/or fingers. Gangrene was present in five patients. Sixteen patients achieved remission with medical therapy and smoking cessation. Sixty-six patients underwent sympathectomy. Bypass to the crural arteries was performed in 23 limbs, with assisted primary patency rates of 67.0 and 45.6 % at five and 10 years. Graft failure caused major amputation in two out of 10 smokers, but no limbs were lost among the 12 ex-smokers. Therapeutic angiogenesis using cell transplantation led to improvement in three ex-smokers; however, amputation was unavoidable in the one smoker who was treated. The limb salvage rate at 20 years was 90 % in ex-smokers and 69 % in smokers, which was not significantly different. This study demonstrated no significant difference in the limb salvage rate between ex-smokers and smokers. Our results do not support any advantageous effect of smoking cessation on the long-term remission in patients with Buerger's disease.	[Sugimoto, Masayuki; Miyachi, Hiroki; Morimae, Hirofumi; Kodama, Akio; Narita, Hiroshi; Banno, Hiroshi; Yamamoto, Kiyohito; Komori, Kimihiro] Nagoya Univ, Grad Sch Med, Dept Surg, Div Vasc Surg,Showa Ku, Nagoya, Aichi 4648601, Japan	Sugimoto, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Surg, Div Vasc Surg,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4648601, Japan.	msugi@med.nagoya-u.ac.jp					Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Matoba S, 2008, AM HEART J, V156, P1010, DOI 10.1016/j.ahj.2008.06.025; MATSUSHITA M, 1991, J VASC SURG, V14, P53; Matsushita M, 1998, SURGERY, V124, P498, DOI 10.1016/S0039-6060(98)70095-9; Sasajima T, 1997, EUR J VASC ENDOVASC, V13, P186, DOI 10.1016/S1078-5884(97)80017-2; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Kobayashi M, 2006, ANN VASC SURG, V20, P148, DOI 10.1007/s10016-005-9436-2; Nishikimi N, 2000, INT J CARDIOL, V75, pS183, DOI 10.1016/S0167-5273(00)00195-9; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Ohta T, 2004, J VASC SURG, V39, P176, DOI 10.1016/j.jvs.2003.08.006; Olin JW, 2000, NEW ENGL J MED, V343, P864, DOI 10.1056/NEJM200009213431207; Shigematsu H, 1999, INT ANGIOL, V18, P58; SHIONOYA S, 1983, WORLD J SURG, V7, P544	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					466	470		10.1007/s00595-014-0904-6		5	Surgery	Surgery	CD7OU	WOS:000351280900011		
J	Karashima, R; Watanabe, M; Imamura, Y; Ida, S; Baba, Y; Iwagami, S; Miyamoto, Y; Sakamoto, Y; Yoshida, N; Baba, H				Karashima, Ryuichi; Watanabe, Masayuki; Imamura, Yu; Ida, Satoshi; Baba, Yoshifumi; Iwagami, Shiro; Miyamoto, Yuji; Sakamoto, Yasuo; Yoshida, Naoya; Baba, Hideo			Advantages of FDG-PET/CT over CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancer	SURGERY TODAY			English	Article						Diagnostic imaging; Computed tomography; Positron emission tomography; Lymph node metastasis; Esophageal cancer	POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-FACTORS; CLINICAL ONCOLOGY; ADDITIONAL VALUE; SURVIVAL; RATIO; CHEMOTHERAPY; NUMBER; JAPAN	The aim of this study was to determine the benefits of F-18-fluorodeoxyglucose positron emission tomography (PET)/computed tomography (CT) compared to CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancer. One-hundred and seven patients who underwent esophagectomy with lymph node dissection between March 2007 and December 2009 were eligible. Sixty-seven patients were treated with surgery alone (SA group), while 40 patients received preoperative treatment prior to surgery (PT group). The pathological results of 1,403 dissected lymph node stations were compared with the results obtained using each imaging modality. PET/CT showed a significantly higher specificity and positive predictive value (PPV) than CT alone (97.7 vs. 94.1 % and 64.6 vs. 44.0 %, respectively), when analyzed by the lymph node stations. The PPV of PET/CT for N1 cases was significantly better than that of CT alone (78.9 vs. 53.9 %), particularly in the PT group (91.3 vs. 65.4 %). Among the patients in the SA group, the number of metastatic nodes was significantly higher in PET-N1 cases than in PET-N0 cases (5.78 vs. 1.90). PET/CT is useful for selecting patients with multiple lymph node metastases and also for detecting residual metastatic nodes after PT, and thus is beneficial to decide on the appropriate treatment strategy for patients with esophageal cancer.	[Karashima, Ryuichi; Watanabe, Masayuki; Imamura, Yu; Ida, Satoshi; Baba, Yoshifumi; Iwagami, Shiro; Miyamoto, Yuji; Sakamoto, Yasuo; Yoshida, Naoya; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Watanabe, Masayuki] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Koto Ku, Tokyo 1358550, Japan	Watanabe, M (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	masayuki.watanabe@jfcr.or.jp					Bar-Shalom R, 2003, J NUCL MED, V44, P1200; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Nomori H, 2004, J THORAC CARDIOV SUR, V127, P1087, DOI 10.1016/j.jtcvs.2003.08.010; Kato H, 2005, CANCER, V103, P148, DOI 10.1002/cncr.20724; Eloubeidi MA, 2002, CANCER, V95, P1434, DOI 10.1002/cncr.10808; Yoon YC, 2003, RADIOLOGY, V227, P764, DOI 10.1148/; Kato H, 2008, ONCOL REP, V20, P857, DOI 10.3892/or_00000083; Poeppel TD, 2009, EUR J RADIOL, V70, P382, DOI 10.1016/j.ejrad.2009.03.051; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Ando N, 2003, J CLIN ONCOL, V21, P4592, DOI 10.1200/JCO.2003.12.095; TOHNOSU N, 1989, J CLIN ULTRASOUND, V17, P101, DOI 10.1002/jcu.1870170206; Beyer T, 2000, J NUCL MED, V41, P1369; Kato H, 2002, CANCER, V94, P921, DOI 10.1002/cncr.10330; BECK JR, 1986, ARCH PATHOL LAB MED, V110, P685; DWYER AJ, 1991, RADIOLOGY, V178, P328; Funai T, 2000, BRIT J SURG, V87, P1234, DOI 10.1046/j.1365-2168.2000.01527.x; Hiyoshi Y, 2009, ONCOLOGY-BASEL, V76, P286, DOI 10.1159/000207505; Igaki H, 2008, 2008 ASCO ANN M BOST; Kim K, 2001, ANN THORAC SURG, V71, P290, DOI 10.1016/S0003-4975(00)02221-9; Kneist W, 2003, WORLD J SURG, V27, P1105, DOI 10.1007/s00268-003-6921-z; Mariette C, 2008, ANN SURG, V247, P365, DOI 10.1097/SLA.0b013e31815aaadf; Rizk N, 2006, J THORAC CARDIOV SUR, V132, P1374, DOI 10.1016/j.jtcvs.2006.07.039; RODER JD, 1994, BRIT J SURG, V81, P410, DOI 10.1002/bjs.1800810330; Smith EC, 2011, WORLD J GASTROENTERO, V17, P5059; SUGIMACHI K, 1993, HEPATO-GASTROENTEROL, V40, P203; Tachimori Y, 2014, ESOPHAGUS-TOKYO, V11, P21, DOI 10.1007/s10388-013-0393-5; Yamada H, 2013, SURG TODAY	27	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					471	477		10.1007/s00595-014-0965-6		7	Surgery	Surgery	CD7OU	WOS:000351280900012		
J	Karashima, R; Watanabe, M; Imamura, Y; Ida, S; Baba, Y; Iwagami, S; Miyamoto, Y; Sakamoto, Y; Yoshida, N; Baba, H				Karashima, Ryuichi; Watanabe, Masayuki; Imamura, Yu; Ida, Satoshi; Baba, Yoshifumi; Iwagami, Shiro; Miyamoto, Yuji; Sakamoto, Yasuo; Yoshida, Naoya; Baba, Hideo			Advantages of FDG-PET/CT over CT alone in the preoperative assessment of lymph node metastasis in patients with esophageal cancer (vol 45, pg 471, 2015)	SURGERY TODAY			English	Correction									[Karashima, Ryuichi; Watanabe, Masayuki; Imamura, Yu; Ida, Satoshi; Baba, Yoshifumi; Iwagami, Shiro; Miyamoto, Yuji; Sakamoto, Yasuo; Yoshida, Naoya; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Watanabe, Masayuki] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Koto Ku, Tokyo 1358550, Japan	Watanabe, M (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	masayuki.watanabe@jfcr.or.jp					Karashima R, 2015, SURG TODAY, V45, P471, DOI 10.1007/s00595-014-0965-6	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					478	478		10.1007/s00595-015-1130-6		1	Surgery	Surgery	CD7OU	WOS:000351280900013		
J	Karimata, H; Shimoji, H; Nishimaki, T				Karimata, Hiroyuki; Shimoji, Hideaki; Nishimaki, Tadashi			Clinicopathological factors predicting R0 resection and long-term survival after esophagectomy in patients with T4 esophageal cancer undergoing induction chemotherapy or chemoradiotherapy	SURGERY TODAY			English	Article						T4 esophageal cancer; Induction therapy; R0 resection; Chemoradiotherapy	RADICAL ESOPHAGECTOMY; NEOADJUVANT THERAPY; OUTCOMES; CHEMORADIATION; CARCINOMA; SURGERY	To identify clinicopathological factors predicting R0 resection and long-term survival after esophagectomy in patients with T4 esophageal cancer following induction chemotherapy or chemoradiotherapy. Of 48 patients with T4 esophageal cancer who underwent induction treatment, 30 underwent R0 esophagectomy. The factors predicting R0 resection and prognostic indicators were assessed in the 48 and 30 patients, respectively, using univariate and multivariate analyses. In the univariate analyses, the primary tumor response, improvement of dysphagia, the post-induction therapy Glasgow Prognostic Score, an early tumor response and the post-induction therapy serum albumin and C-reactive protein levels were significantly correlated with R0 resection. Multivariate logistic regression analyses revealed that the response status and improvement of dysphagia were independent predictors of R0 resection. The univariate analyses identified a yp-T classification (yp-T0/1 vs. yp-T2/3/4), yp-nodal status and the number of pathologically positive nodes post-therapy (a parts per thousand currency sign1 vs. a parts per thousand yen2) as significant prognostic factors. The multivariate analysis revealed that the number of pathologically positive nodes was the only significant independent prognostic indicator. Patients showing an early tumor response to induction treatment and improvement of dysphagia may be appropriate candidates for esophagectomy, and individualized postoperative management strategies should be developed for patients with initially unresectable T4 esophageal cancer who have a parts per thousand yen2 positive nodes post-treatment.	[Karimata, Hiroyuki; Shimoji, Hideaki; Nishimaki, Tadashi] Univ Ryukyus, Grad Sch Med, Dept Digest & Gen Surg, Nishihara, Okinawa 9030215, Japan	Nishimaki, T (reprint author), Univ Ryukyus, Grad Sch Med, Dept Digest & Gen Surg, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	nishimak@med.u-ryukyu.ac.jp					Urschel JD, 2002, AM J SURG, V183, P274, DOI 10.1016/S0002-9610(02)00795-X; Markar SR, 2014, ANN SURG ONCOL, V21, P922, DOI 10.1245/s10434-013-3364-0; Noguchi T, 2003, DIS ESOPHAGUS, V16, P94, DOI 10.1046/j.1442-2050.2003.00304.x; Leers JM, 2009, J AM COLL SURGEONS, V208, P553, DOI 10.1016/j.jamcollsurg.2009.01.017; Piessevaux H, 2013, J CLIN ONCOL, V31, P3764, DOI 10.1200/JCO.2012.42.8532; Kim TJ, 2009, RADIOGRAPHICS, V29, P403, DOI 10.1148/rg.292085106; Vashist YK, 2011, ANN SURG ONCOL, V18, P1130, DOI 10.1245/s10434-010-1383-7; Nishimaki T, 1998, J AM COLL SURGEONS, V186, P306, DOI 10.1016/S1072-7515(98)00013-1; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Nishimaki T, 1999, ANN THORAC SURG, V68, P2059, DOI 10.1016/S0003-4975(99)01171-6; Shimoji H, 2013, WORLD J SURG, V37, P2180, DOI 10.1007/s00268-013-2074-x; Meredith KL, 2010, ANN SURG ONCOL, V17, P1159, DOI 10.1245/s10434-009-0862-1; Mariette C, 2008, ANN SURG, V247, P365, DOI 10.1097/SLA.0b013e31815aaadf; Miyata H, 2010, ONCOL REP, V23, P1331, DOI 10.3892/or_00000768; Pimiento LM, 2013, ANN SURG ONCOL, V20, P2706; Shimoji H, 2014, SURG TODAY, V44, P1273, DOI 10.1007/s00595-013-0700-8; Sobin LH, 2002, UICC TNM CLASSIFICAT; Tachimori Yuji, 2009, Gen Thorac Cardiovasc Surg, V57, P71, DOI 10.1007/s11748-008-0337-5; The Japan Esophageal Society, 2008, JAP CLASS ES CANC	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					479	486		10.1007/s00595-014-0980-7		8	Surgery	Surgery	CD7OU	WOS:000351280900014		
J	Izumi, H; Hirabayashi, K; Nakamura, N; Nakagohri, T				Izumi, Hideki; Hirabayashi, Kenichi; Nakamura, Naoya; Nakagohri, Toshio			Nectin expression in pancreatic adenocarcinoma: nectin-3 is associated with a poor prognosis	SURGERY TODAY			English	Article						Pancreatic adenocarcinoma; Nectins; E-cadherin; Cell adhesion molecules; Prognosis	E-CADHERIN EXPRESSION; CELL-ADHESION; MESENCHYMAL TRANSITION; BREAST-CANCER; LUNG-CANCER; AFADIN; PROGRESSION; METASTASIS; BIOMARKERS; MOLECULES	Nectins are cell adhesion molecules that regulate the formation of adherens junctions and are linked with E-cadherin-based cell-cell adherens junctions. In pancreatic cancer, the expression of E-cadherin and nectins is considered to be related to metastasis, invasion and prognosis. We evaluated the distribution of cells that were positive for nectin subtypes and E-cadherin using immunohistochemistry in specimens of human pancreatic adenocarcinoma, and correlated these results with the clinicopathological features and patient outcomes. The immunohistochemical distribution of nectin-1 and E-cadherin showed a good correlation (r = 0.523, p < 0.01). Tumors over 4 cm in diameter had more intense staining for nectin-4 than smaller tumors (p = 0.035). Nectin-2 expression correlated with a poorer histological grade (p = 0.04). The cases that showed diffuse nectin-3 expression had a better prognosis than those with negative expression (p = 0.018). Our results showed that the expression of nectin-3 in pancreatic cancer can be a prognostic factor.	[Izumi, Hideki; Nakagohri, Toshio] Tokai Univ, Sch Med, Dept Surg, Isehara, Kanagawa 2591193, Japan; [Hirabayashi, Kenichi; Nakamura, Naoya] Tokai Univ, Sch Med, Dept Pathol, Isehara, Kanagawa 2591193, Japan	Hirabayashi, K (reprint author), Tokai Univ, Sch Med, Dept Pathol, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	deehii@is.icc.u-tokai.ac.jp; khira@is.icc.u-tokai.ac.jp					Miao XY, 2013, INT J CLIN EXP PATHO, V6, P179; PIGNATELLI M, 1994, J PATHOL, V174, P243, DOI 10.1002/path.1711740403; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Ohashi M, 2009, BIOMED RES-TOKYO, V30, P79; Vetter G, 2010, ONCOGENE, V29, P4436, DOI 10.1038/onc.2010.181; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Takai Y, 2003, CANCER SCI, V94, P655, DOI 10.1111/j.1349-7006.2003.tb01499.x; Yu ZK, 2007, MOL THER, V15, P103, DOI 10.1038/sj.mt.6300009; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Takano A, 2009, CANCER RES, V69, P6694, DOI 10.1158/0008-5472.CAN-09-0016; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Furukawa K, 2013, SURG TODAY, V43, P171, DOI 10.1007/s00595-012-0279-5; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Hong SM, 2011, MODERN PATHOL, V24, P1237, DOI 10.1038/modpathol.2011.74; Sun XD, 2013, ONCOL REP, V29, P2401, DOI 10.3892/or.2013.2385; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Aoki Rika, 2007, J Med Invest, V54, P159, DOI 10.2152/jmi.54.159; Cai J, 2001, Gastric Cancer, V4, P66, DOI 10.1007/PL00011726; Fabre-Lafay S, 2007, BMC CANCER, V7, DOI 10.1186/1171-2407-7-73; Guo S, 2013, INT J CLIN ONCOL, V19, P319; Guzman G, 2006, ARCH PATHOL LAB MED, V130, P1193; Kouso H, 2013, SURG TODAY, V43, P73, DOI 10.1007/s00595-012-0344-0; Maniwa Y, 2012, THORAC CANCER, V3, P175, DOI 10.1111/j.1759-7714.2011.00104.x; Matsushima H, 2003, BRIT J DERMATOL, V148, P755, DOI 10.1046/j.1365-2133.2003.05225.x; Richardson F, 2012, ANTICANCER RES, V32, P537; Shin SJ, 2005, JPN J CLIN ONCOL, V35, P342, DOI 10.1093/jjco/hyi094; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822	28	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					487	494		10.1007/s00595-015-1126-2		8	Surgery	Surgery	CD7OU	WOS:000351280900015		
J	Ozawa, H; Kawata, H; Iwai, S; Yamauchi, S; Kanaya, T; Kishimoto, H				Ozawa, Hideto; Kawata, Hiroaki; Iwai, Shigemitsu; Yamauchi, Sanae; Kanaya, Tomomitsu; Kishimoto, Hidefumi			Pulmonary artery rupture after bilateral pulmonary artery banding in a neonate with Loeys-Dietz syndrome and an interrupted aortic arch complex: report of a case	SURGERY TODAY			English	Article						Loeys-Dietz syndrome; Pulmonary artery rupture; Bilateral pulmonary artery banding	ROOT	Loeys-Dietz syndrome (LDS) is a recognized connective tissue disorder characterized by progressive aortic aneurysm and dissection. Patients are at high risk of aortic dissection or rupture at an early age, but to our knowledge, surgery on the great arteries has never been attempted in the neonatal period. We report a case of LDS with dilated pulmonary arteries and an interrupted aortic arch complex in a neonate. We performed bilateral pulmonary artery banding, but 12 days after the procedure, the infant died of rupture of the distal portion of the banding sites following massive dilatation.	[Ozawa, Hideto; Kawata, Hiroaki; Iwai, Shigemitsu; Yamauchi, Sanae; Kanaya, Tomomitsu; Kishimoto, Hidefumi] Osaka Med Ctr, Dept Cardiovasc Surg, Izumi Ku, Osaka, Japan; [Ozawa, Hideto; Kawata, Hiroaki; Iwai, Shigemitsu; Yamauchi, Sanae; Kanaya, Tomomitsu; Kishimoto, Hidefumi] Res Inst Maternal & Child Hlth, Izumi Ku, Osaka, Japan; [Ozawa, Hideto] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650871, Japan	Ozawa, H (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	h.ozawa@f7.dion.ne.jp					Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Muramatsu Y, 2010, AM J MED GENET A, V152A, P417, DOI 10.1002/ajmg.a.33263; Watanabe Y, 2008, AM J MED GENET A, V146A, P3070, DOI 10.1002/ajmg.a.32567; Viassolo V, 2006, PRENATAL DIAG, V26, P1081, DOI 10.1002/pd.1565; Williams JA, 2007, ANN THORAC SURG, V83, P757; Yetman AT, 2007, PEDIATRICS, V119, P1199; Zanotti G, 2008, PEDIAT CARD SURG ANN, V11, P11	7	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					495	497		10.1007/s00595-014-0910-8		3	Surgery	Surgery	CD7OU	WOS:000351280900016		
J	Kijima, Y; Yoshinaka, H; Hirata, M; Nakajo, A; Arima, H; Shinden, Y; Ijichi, T; Eguchi, Y; Okumura, H; Uenosono, Y; Kurahara, H; Ishigami, S; Natsugoe, S				Kijima, Yuko; Yoshinaka, Heiji; Hirata, Munetsugu; Nakajo, Akihiro; Arima, Hideo; Shinden, Yoshiaki; Ijichi, Tetsuya; Eguchi, Yuka; Okumura, Hiroshi; Uenosono, Yoshikazu; Kurahara, Hiroshi; Ishigami, Sumiya; Natsugoe, Shoji			Impaired wound healing and expansion of a large ulcer after bevacizumab with paclitaxel for skin metastases from breast cancer: report of a case	SURGERY TODAY			English	Article						Breast cancer; Recurrence; Bevacizumab; Wound healing; Skin metastasis; Chemotherapy	ENDOTHELIAL GROWTH-FACTOR; PHASE-III TRIAL; TUMOR ANGIOGENESIS; PLUS BEVACIZUMAB; DOUBLE-BLIND; DOCETAXEL; THERAPY; FLUOROURACIL; COMBINATION; PERFORATION	A 48-year-old Japanese woman was found to have local recurrence of breast cancer in the chest wall following neoadjuvant chemotherapy, total mastectomy with axillary lymphadenectomy, postoperative radiation therapy to the chest wall, and adjuvant systemic therapy using trastuzumab. As a third line of treatment after recurrence, bevacizumab with paclitaxel was initiated for several metastatic lesions on the skin of the chest wall, left internal costal lymph nodes, and right axillary lymph nodes. The wound on the chest wall continued to expand in diameter and depth after the third course of bevacizumab with paclitaxel until the rib was exposed. After stopping the bevacizumab, granulation tissue expanded and by 3 months, had covered the bottom of the ulcer. The patient died soon thereafter, despite systemic chemotherapy with eribulin; however, there was no further bleeding from the ulcer on the chest wall or the exposed ribs.	[Kijima, Yuko; Yoshinaka, Heiji; Hirata, Munetsugu; Nakajo, Akihiro; Arima, Hideo; Shinden, Yoshiaki; Ijichi, Tetsuya; Eguchi, Yuka; Okumura, Hiroshi; Uenosono, Yoshikazu; Kurahara, Hiroshi; Ishigami, Sumiya; Natsugoe, Shoji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest Surg Breast & Thyroid Surg, Kagoshima 8908520, Japan	Kijima, Y (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Digest Surg Breast & Thyroid Surg, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	ykijima@m3.kufm.kagoshima-u.ac.jp					Chen HX, 2009, NAT REV CLIN ONCOL, V6, P465, DOI 10.1038/nrclinonc.2009.94; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; GASPARINI G, 1995, J CLIN ONCOL, V13, P765; BROWN LF, 1995, HUM PATHOL, V26, P86, DOI 10.1016/0046-8177(95)90119-1; Miles DW, 2013, BRIT J CANCER, V108, P1052, DOI 10.1038/bjc.2013.69; Sweeney CJ, 2001, CANCER RES, V61, P3369; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Hamilton EP, 2011, ONCOLOGY-BASEL, V80, P314, DOI 10.1159/000328757; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Banerjee S, 2007, NAT CLIN PRACT ONCOL, V4, P536, DOI 10.1038/ncponc0905; Brufsky AM, 2011, J CLIN ONCOL, V29, P4286, DOI 10.1200/JCO.2010.34.1255; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Balduzzi A, 2009, ANTI-CANCER DRUG, V20, P197, DOI 10.1097/CAD.0b013e3283264719; Burkart CM, 2008, LARYNGOSCOPE, V118, P1539, DOI 10.1097/MLG.0b013e31817c4296; Cottu PH, 2011, J WOUND CARE, V20, P403; Cottu PH, 2011, J WOUND CARE, V20, P406; Cottu PH, 2011, J WOUND CARE, V20, P408; Fox SB, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1796; Goyal S, 2011, INT J RADIAT ONCOL, V79, P408, DOI 10.1016/j.ijrobp.2009.11.021; Lazzati V, 2010, AESTHET PLAST SURG, V34, P796, DOI 10.1007/s00266-010-9535-5; Mellor JD, 2011, ASIA-PAC J CLIN ONCO, V7, P106, DOI 10.1111/j.1743-7563.2011.01394.x; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Pignot G, 2011, PROG UROL, V21, P166, DOI 10.1016/j.purol.2010.09.023; Ruiz N, 2007, J CLIN ONCOL, V25, P3376, DOI 10.1200/JCO.2007.12.0006; Sandler A, 2007, NEW ENGL J MED, V356, P318; Tsumuraya M, 2011, JPN J CANC CHEMOTHER, V38, P1869; Yoshioka Y, 2013, SURG TODAY	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					498	502		10.1007/s00595-014-0912-6		5	Surgery	Surgery	CD7OU	WOS:000351280900017		
J	Suzumura, K; Hai, S; Kuroda, N; Hirano, T; Asano, Y; Okada, T; Iimuro, Y; Tanaka, S; Nakasho, K; Fujimoto, J				Suzumura, Kazuhiro; Hai, Seikan; Kuroda, Nobukazu; Hirano, Tadamichi; Asano, Yasukane; Okada, Toshihiro; Iimuro, Yuji; Tanaka, Shogo; Nakasho, Keiji; Fujimoto, Jiro			Primary adenocarcinoma of the minor duodenal papilla with mass-forming chronic pancreatitis: report of a case	SURGERY TODAY			English	Article						Adenocarcinoma; Minor duodenal papilla; Mass-forming; Pancreatitis; Pancreaticoduodenectomy	ENDOSCOPIC RESECTION; CARCINOMA; DUCT	A 70-year-old male was treated for gastric ulcers. Follow-up upper gastrointestinal endoscopy revealed an irregular, elevated tumor in the second portion of the duodenum. Upon pathological inspection of a biopsy specimen, a diagnosis of adenocarcinoma was made, and the patient was admitted to our hospital. Computed tomography showed an irregular mass in the pancreatic head and dilatation of the main pancreatic duct and bile duct. Pancreatic head carcinoma with infiltration of the duodenum was diagnosed, and pylorus-preserving pancreaticoduodenectomy was performed. A histopathological examination of the resected specimen showed moderately differentiated adenocarcinoma in the minor duodenal papilla and chronic pancreatitis in the pancreatic head. Therefore, primary adenocarcinoma of the minor duodenal papilla with mass-forming chronic pancreatitis was diagnosed. Currently, the patient is alive without recurrence 17 months after the surgery. Primary adenocarcinoma of the minor duodenal papilla is extremely rare. We herein report this case, and also provide a review of the literature.	[Suzumura, Kazuhiro; Hai, Seikan; Kuroda, Nobukazu; Hirano, Tadamichi; Asano, Yasukane; Okada, Toshihiro; Iimuro, Yuji; Tanaka, Shogo; Fujimoto, Jiro] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; [Nakasho, Keiji] Hyogo Coll Med, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan	Suzumura, K (reprint author), Hyogo Coll Med, Dept Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	ssuzumu@hyo-med.ac.jp					Jung S, 2001, GASTROINTEST ENDOSC, V54, P622, DOI 10.1067/mge.2001.117765; PONCHON T, 1989, CANCER, V64, P161, DOI 10.1002/1097-0142(19890701)64:1<161::AID-CNCR2820640127>3.0.CO;2-D; Morikawa T, 2013, SURG TODAY, V43, P26, DOI 10.1007/s00595-012-0345-z; Baldwin WM, 1911, ANAT REC, V5, P197, DOI 10.1002/ar.1090050502; Borobia FG, 2001, EUR J SURG, V167, P154; Fujimoto J, 2012, J JPN SOC CLIN SURG, V73, P1970; Fukuda A, 2005, GASTROINTEST ENDOSC, V61, P475, DOI 10.1016/S0016-5107(04)02784-1; GOLDBERG M, 1987, AM J GASTROENTEROL, V82, P1169; Kajiwara M, 2007, VIRCHOWS ARCH, V451, P1075, DOI 10.1007/s00428-007-0496-2; Kamisawa T, 2004, J GASTROENTEROL, V39, P605, DOI 10.1007/s00535-004-1390-1; Matheus AS, 2008, J GASTROINTEST SURG, V12, P1301, DOI 10.1007/s11605-007-0317-6; Nakamura T, 2002, GASTROINTEST ENDOSC, V55, P270, DOI 10.1067/mge.2002.120782; NODA Y, 1992, CANCER, V70, P1825, DOI 10.1002/1097-0142(19921001)70:7<1825::AID-CNCR2820700703>3.0.CO;2-W; Ohya T, 2006, GASTROENTEROL ENDOSC, V48, P2662; Okuma T, 2011, SURG TODAY, V41, P568, DOI 10.1007/s00595-010-4314-0; Parthasarathy Sriram, 2008, JOP, V9, P332; Suda K, 2010, DIGEST SURG, V27, P137, DOI 10.1159/000286920; Sugiyama M, 1999, HEPATO-GASTROENTEROL, V46, P189; Takami Kazuhiro, 2011, Case Rep Gastroenterol, V5, P172, DOI 10.1159/000326926; Wakatsuki T, 2008, YONSEI MED J, V49, P333, DOI 10.3349/ymj.2008.49.2.333; Yamao K, 1998, GASTROINTEST ENDOSC, V48, P634, DOI 10.1016/S0016-5107(98)70050-1	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					506	510		10.1007/s00595-014-0860-1		5	Surgery	Surgery	CD7OU	WOS:000351280900019		
J	Yamashita, S; Hasegawa, K; Takahashi, M; Arita, J; Sakamoto, Y; Aoki, T; Sugawara, Y; Kokudo, N				Yamashita, Suguru; Hasegawa, Kiyoshi; Takahashi, Michiro; Arita, Junichi; Sakamoto, Yoshihiro; Aoki, Taku; Sugawara, Yasuhiko; Kokudo, Norihiro			Hobson's choice two-stage hepatectomy for multiple and bilobar colorectal liver metastases with portal vein embolization: report of two cases	SURGERY TODAY			English	Article						Portal vein embolization; Multiple and bilobar colorectal liver metastases; Future remnant liver; Two-stage hepatectomy procedure	LONG-TERM SURVIVAL; RESECTION; REGENERATION; CANCER; TUMORS	Liver resection is recognized as the preferred treatment for patients with colorectal liver metastases (CLM) because it offers long-term survival; it is the only hope for a cure. However, in the majority of cases, liver surgery is contraindicated due to the small volume of the future remnant liver. To extend the surgical indications for CLM, a planned two-stage hepatectomy procedure with portal vein embolization (PVE) was developed specifically for patients with multiple and bilobar CLM. The rationale for performing the procedure was a concern about the possible overgrowth of intrafuture remnant liver lesions following PVE, and it was therefore recommended for all multiple bilobar CLM cases, even when one-stage hepatectomy was technically feasible. We recently performed Hobson's choice two-stage hepatectomy in two cases for reasons different from those of the original planned two-stage hepatectomy. In the present report, we describe our Hobson's choice two-stage hepatectomy strategy, which provided favorable short-term outcomes.	[Yamashita, Suguru; Hasegawa, Kiyoshi; Takahashi, Michiro; Arita, Junichi; Sakamoto, Yoshihiro; Aoki, Taku; Sugawara, Yasuhiko; Kokudo, Norihiro] Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div,Bunkyo Ku, Tokyo 1138655, Japan	Kokudo, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	KOKUDO-2SU@h.u-tokyo.ac.jp					Elias D, 1999, BRIT J SURG, V86, P784, DOI 10.1046/j.1365-2168.1999.01154.x; Taketomi A, 2012, SURG TODAY, V42, P46, DOI 10.1007/s00595-011-0021-8; Shaw IM, 2006, BRIT J SURG, V93, P457, DOI 10.1002/bjs.5323; Levi F, 1997, LANCET, V350, P681, DOI 10.1016/S0140-6736(97)03358-8; Kokudo N, 2001, HEPATOLOGY, V34, P267, DOI 10.1053/jhep.2001.26513; Jaeck D, 2003, AM J SURG, V185, P221, DOI 10.1016/S0002-9610(02)01373-9; Mise Y, 2010, ANN SURG, V251, P902, DOI 10.1097/SLA.0b013e3181c9868a; Jaeck D, 2004, ANN SURG, V240, P1037, DOI 10.1097/01.sla.0000145965.86383.89; Wicherts DA, 2010, BRIT J SURG, V97, P240, DOI 10.1002/bjs.6756; Tanaka K, 2007, J GASTROINTEST SURG, V11, P1154, DOI 10.1007/s11605-007-0221-0; Adam R, 2000, ANN SURG, V232, P777, DOI 10.1097/00000658-200012000-00006; Barugel ME, 2009, EXPERT REV ANTICANC, V9, P1829, DOI [10.1586/era.09.143, 10.1586/ERA.09.143]; Galndiuk S, 1992, SURG GYNECOL OBSTET, V174, P27; HUGHES KS, 1988, SURGERY, V103, P278; KAWASAKI S, 1994, SURGERY, V115, P674; Yamashita S, 2013, WORLD J SURG, V37, P622, DOI 10.1007/s00268-012-1861-0	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					511	516		10.1007/s00595-014-0953-x		6	Surgery	Surgery	CD7OU	WOS:000351280900020		
J	Tsuda, Y; Morita, M; Saeki, H; Ando, K; Ida, S; Kimura, Y; Oki, E; Ohga, T; Kusumoto, T; Abe, K; Baba, S; Isoda, T; Maehara, Y				Tsuda, Yasuo; Morita, Masaru; Saeki, Hiroshi; Ando, Koji; Ida, Satoshi; Kimura, Yasue; Oki, Eiji; Ohga, Takefumi; Kusumoto, Tetsuya; Abe, Koichiro; Baba, Shingo; Isoda, Takuro; Maehara, Yoshihiko			Esophagectomy-related thoracic duct injury detected by lymphoscintigraphy with Tc-99m-diethylenetriamine pentaacetic acid-human serum albumin: report of a case	SURGERY TODAY			English	Article						Chylothorax; Esophagectomy; Lymphoscintigraphy	CHYLOTHORAX; LYMPHANGIOMATOSIS; MANAGEMENT; CHYLE	Chylothorax is an uncommon but potentially life-threatening complication of esophagectomy. A 72-year-old man underwent thoracoscopy-assisted subtotal esophagectomy and reconstruction with a gastric tube, through a retrosternal route, after preoperative chemoradiotherapy. Chylothorax was detected after starting enteral feeding on postoperative day (POD) 7. Despite conservative therapy such as fasting, total parenteral nutrition, and octreotide administration, massive fluid drainage continued. On POD 19, lymphoscintigraphy with Tc-99m-diethylenetriamine pentaacetic acid-human serum albumin (HSA-D) was performed and the site of leakage was detected at the level of the fourth thoracic vertebra. On POD 23, the thoracic duct was ligated, following which the volume of chylothorax decreased. Lymphoscintigraphy 12 days after the reoperation showed no leakage from the thoracic duct. We recommend lymphoscintigraphy with Tc-99m-HSA-D for locating the chyle leakage site and helping decide about the operative indication.	[Tsuda, Yasuo; Morita, Masaru; Saeki, Hiroshi; Ando, Koji; Ida, Satoshi; Kimura, Yasue; Oki, Eiji; Ohga, Takefumi; Kusumoto, Tetsuya; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan; [Abe, Koichiro; Baba, Shingo; Isoda, Takuro] Kyushu Univ, Grad Sch Med Sci, Clin Radiol, Fukuoka 8128582, Japan	Tsuda, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 8128582, Japan.	yasauo@med.kyushu-u.ac.jp					Dugue L, 1998, BRIT J SURG, V85, P1147; Lagarde SM, 2005, ANN THORAC SURG, V80, P449, DOI 10.1016/j.athoracsur.2005.02.076; Merrigan BA, 1997, BRIT J SURG, V84, P15, DOI 10.1002/bjs.1800840107; Wemyss-Holden SA, 2001, BRIT J SURG, V88, P1442, DOI 10.1046/j.0007-1323.2001.01896.x; Faul JL, 2000, AM J RESP CRIT CARE, V161, P1037; Kayano D, 2011, CLIN NUCL MED, V36, P1056, DOI 10.1097/RLU.0b013e31821a2ba3; BAULIEU F, 1987, EUR J NUCL MED, V13, P264; Dikken JL, 2013, BRIT J SURG, V100, P83, DOI 10.1002/bjs.8966; BOLGER C, 1991, BRIT J SURG, V78, P587, DOI 10.1002/bjs.1800780521; Chen Eric, 2011, Semin Intervent Radiol, V28, P63, DOI 10.1055/s-0031-1273941; Guzman AE, 2002, LYMPHOLOGY, V35, P4; Kaburagi T, 2013, SURG TODAY, V43, P206, DOI 10.1007/s00595-012-0391-6; Kotani Kohei, 2012, Indian J Nucl Med, V27, P208, DOI 10.4103/0972-3919.112749; Moadel-Sernick RM, 2000, CLIN NUCL MED, V25, P335, DOI 10.1097/00003072-200005000-00002; Rao DVLN, 2004, DIS ESOPHAGUS, V17, P141, DOI 10.1111/j.1442-2050.2004.00391.x; Takagi M, 2006, NIHON SYOKAKIGEKA GA, V39, P164; TAMAKI N, 1988, Kaku Igaku, V25, P579; The Japan Esophageal Society, 2007, JAP CLASS ES CANC, P13; Tsubokawa N, 2012, ANN THORAC SURG, V93, pE131, DOI 10.1016/j.athoracsur.2011.11.070; Uemura M, 2005, NIHON SYOKAKIGEKA GA, V38, P7; WATTS MA, 1982, ANN THORAC SURG, V34, P324	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					517	521		10.1007/s00595-014-0968-3		5	Surgery	Surgery	CD7OU	WOS:000351280900021		
J	Toshima, T; Ikegami, T; Matsumoto, Y; Yoshiya, S; Harimoto, N; Yamashita, Y; Yoshizumi, T; Ikeda, T; Shirabe, K; Maehara, Y				Toshima, Takeo; Ikegami, Toru; Matsumoto, Yoshihiro; Yoshiya, Shohei; Harimoto, Norifumi; Yamashita, Yo-ichi; Yoshizumi, Tomoharu; Ikeda, Tetsuo; Shirabe, Ken; Maehara, Yoshihiko			One-step venous reconstruction using the donor's round ligament in right-lobe living-donor liver transplantation	SURGERY TODAY			English	Article						Umbilical vein; Venous reconstruction; Right lobe; Liver transplantation	INFERIOR VENA-CAVA; UMBILICAL VEIN; GRAFT; PATCH; CONGESTION; RESECTION; EXPERIENCE; SEGMENT	We herein report the use of an opened round ligament as a venous patch graft for inferior right hepatic vein (IRHV) reconstruction and anastomosis to the inferior vena cava (IVC) in living-donor liver transplantation (LDLT) using a right-lobe (RL) graft. After laparotomy, the donor's round ligament was harvested and opened, and the semi-transparent umbilical vein, which was 7.0 cm in length and 3.0 cm in width, was carefully trimmed on the back table for use as a patch graft. The right hepatic vein of the graft was anastomosed to the harvested patch, and the IRHV was anastomosed to an independent hole made in the wall on the other side of the patch, to form a bridged vascular patch for anastomosis to the IVC. The interposition graft filled promptly and provided a good outflow from the posterior segment. This is the first report of venous reconstruction using a donor's round ligament graft in RL-LDLT.	[Toshima, Takeo; Ikegami, Toru; Matsumoto, Yoshihiro; Yoshiya, Shohei; Harimoto, Norifumi; Yamashita, Yo-ichi; Yoshizumi, Tomoharu; Ikeda, Tetsuo; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan	Toshima, T (reprint author), Kyushu Univ, Grad Sch Med, Dept Surg & Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	toshima@surg2.med.kyushu-u.ac.jp					Lee SG, 2002, TRANSPLANTATION, V74, P54; Togo S, 2002, DIGEST SURG, V19, P340, DOI 10.1159/000065830; Lee S, 2001, TRANSPLANTATION, V71, P812, DOI 10.1097/00007890-200103270-00021; Azoulay D, 2006, ANN SURG, V244, P80, DOI 10.1097/01.sla.0000218092.83675.bc; Yonemura Y, 2005, LIVER TRANSPLANT, V11, P1556, DOI 10.1002/lt.20537; EMRE S, 1993, ANN SURG, V217, P15, DOI 10.1097/00000658-199301000-00004; Ikegami T, 2007, TRANSPLANTATION, V84, P836, DOI 10.1097/01.tp.0000282790.66889.a5; Ikegami T, 2008, J HEPATO-BILIARY-PAN, V15, P581, DOI 10.1007/s00534-007-1319-1; Ikegami T, 2013, LIVER TRANSPLANT, V19, P1245, DOI 10.1002/lt.23716; Krom Ruud A F, 2004, Liver Transpl, V10, P951, DOI 10.1002/lt.20197; Kubota K, 1997, HEPATO-GASTROENTEROL, V44, P378; Mizuno S, 2006, CLIN TRANSPLANT, V20, P509, DOI 10.1111/j.1399-0012.2006.00515.x; Ohwada S, 2007, WORLD J SURG, V31, P1215, DOI 10.1007/s00268-007-9015-5; Raja S, 1989, LANCET, V2, P497; Ribbe EB, 1998, BRIT J SURG, V75, P357; Rocca JP, 2006, J HEPATO-BILIARY-PAN, V13, P454, DOI 10.1007/s00534-005-1094-9; Shimada M, 2002, ARCH SURG-CHICAGO, V137, P1174, DOI 10.1001/archsurg.137.10.1174; Soejima Y, 2008, LIVER TRANSPLANT, V14, P706, DOI 10.1002/lt.21401; Soejima Y, 2006, AM J TRANSPLANT, V6, P1004, DOI 10.1111/j.1600-6143.2006.01284.x; TESCH C, 1990, LANGENBECK ARCH CHIR, V375, P130, DOI 10.1007/BF00206804; Watanabe M, 2007, J HEPATO-BILIARY-PAN, V14, P270, DOI 10.1007/s00534-006-1183-4; Yamanaka N, 2000, J AM COLL SURGEONS, V190, P497, DOI 10.1016/S1072-7515(99)00288-4	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	APR	2015	45	4					522	525		10.1007/s00595-014-1004-3		4	Surgery	Surgery	CD7OU	WOS:000351280900022		
J	Kobori, Y; Suzuki, K; Iwahata, T; Shin, T; Sato, R; Nishio, K; Yagi, H; Arai, G; Soh, S; Okada, H				Kobori, Yoshitomo; Suzuki, Keisuke; Iwahata, Toshiyuki; Shin, Takeshi; Sato, Ryo; Nishio, Kojiro; Yagi, Hiroshi; Arai, Gaku; Soh, Shigehiro; Okada, Hiroshi			Hormonal therapy (hCG and rhFSH) for infertile men with adult-onset idiopathic hypogonadotropic hypogonadism	SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE			English	Article						Adult-onset idiopathic male hypogonadotropic hypogonadism; human chorionic gonadotropin; recombinant human follicle-stimulating hormone; spermatogenesis	SPERMATOGENESIS	Adult-onset idiopathic male hypogonadotropic hypogonadism (IMHH) is a very rare but treatable disease. This study was conducted to examine the efficacy and safety of a combination of human chorionic gonadotropin (hCG) and recombinant human follicle-stimulating hormone (rhFSH) for inducing spermatogenesis in men with adult-onset IMHH. Seven men (34-45 years of age) with azoospermia and/or sexual dysfunction, with a low serum testosterone concentration, and apulsatile secretion of luteinizing hormone, were referred to our hospital for infertility. All had normal secondary sexual characteristics. Thorough endocrinologic examination and magnetic resonance imaging revealed no identifiable cause of hypogonadotropic hypogonadism. Adult-onset IMHH was diagnosed in all cases and treatment was started with 150 IU rhFSH and 5,000 IU hCG, both administered two times per week. Spermatogenesis was restored in five of the seven patients. During treatment one patient achieved spontaneous pregnancy with his wife, and spermatozoa recovered from the other four patients were frozen for future use in intracytoplasmic sperm injection.	[Kobori, Yoshitomo; Suzuki, Keisuke; Iwahata, Toshiyuki; Shin, Takeshi; Sato, Ryo; Nishio, Kojiro; Yagi, Hiroshi; Arai, Gaku; Soh, Shigehiro; Okada, Hiroshi] Dokkyo Med Univ, Koshigaya Hosp, Dept Urol, Oshigaya, Saitama, Japan; [Kobori, Yoshitomo] Univ Illinois, Dept Urol, Chicago, IL 60612 USA	Kobori, Y (reprint author), Univ Illinois, Dept Urol, 820 S Wood St Clin Sci North Suite 515, Chicago, IL 60612 USA.	ykobori@uic.edu					Nachtigall LB, 1997, NEW ENGL J MED, V336, P410, DOI 10.1056/NEJM199702063360604; Dwyer AA, 2010, J CLIN ENDOCR METAB, V95, P4235, DOI 10.1210/jc.2010-0245; Kobayashi T, 2002, INT J UROL, V9, P604, DOI 10.1046/j.1442-2042.2002.00522.x; Mannaerts B, 1996, FERTIL STERIL, V65, P406; Mao JF, 2010, ASIAN J ANDROL, V12, P611, DOI 10.1038/aja.2010.34; Matsumoto AM, 2009, FERTIL STERIL, V92, P979, DOI 10.1016/j.fertnstert.2008.07.1742; OKADA Y, 1992, ENDOCRINOL JAPON, V39, P31; SCHOPOHL J, 1991, FERTIL STERIL, V56, P1143; Whitten SJ, 2006, FERTIL STERIL, V86, P1664, DOI 10.1016/j.fertnstert.2006.05.042	9	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1939-6368	1939-6376		SYST BIOL REPROD MED	Syst. Biol. Reprod. Med.	APR	2015	61	2					110	112		10.3109/19396368.2014.994789		3	Andrology; Reproductive Biology	Endocrinology & Metabolism; Reproductive Biology	CE1YQ	WOS:000351609300007		
J	Takemoto-Kuno, Y; Mitsueda, H; Suzuki, K; Hirabayashi, H; Ideta, O; Aoki, N; Umemoto, T; Ishii, T; Ando, I; Kato, H; Nemoto, H; Imbe, T; Takeuchi, Y				Takemoto-Kuno, Yoko; Mitsueda, Hiroki; Suzuki, Keitaro; Hirabayashi, Hideyuki; Ideta, Osamu; Aoki, Noriaki; Umemoto, Takayuki; Ishii, Takuro; Ando, Ikuo; Kato, Hiroshi; Nemoto, Hiroshi; Imbe, Tokio; Takeuchi, Yoshinobu			qAC2, a novel QTL that interacts with Wx and controls the low amylose content in rice (Oryza sativa L.)	THEORETICAL AND APPLIED GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; GENETIC-ANALYSIS; EATING QUALITY; GRAIN QUALITY; MESSENGER-RNA; COOKED RICE; ENDOSPERM; POPULATION; PROTEIN	This manuscript reports the fine mapping of a novel QTL, qAC2 controlling the low amylose in rice. The action mechanism of the qAC2 is also investigated by the analysis of genetic interactions to Wx (a) , Wx (b) , du1, du2 and du3. Amylose content of the rice (Oryza sativa L.) endosperm greatly affects starch properties and eating quality of cooked rice. Seeds of japonica rice cultivar Kuiku162 have low amylose content (AC) and good eating quality. Our analysis revealed a novel QTL, designated as qAC2 that contributed to the low AC of Kuiku162. qAC2 was fine mapped within a 74.9-kb region between two insertion and deletion markers, KID3001 and KID5101, on the long arm of chromosome 2. Seven genes are predicted in this region, but none of them is known to be related to the regulation of AC. The AC of a near-isogenic line (NIL110) carrying qAC2 (Kuiku) , the Kuiku162 allele of qAC2, in the genetic background of japonica cultivar Itadaki was lower by 1.1 % points than that of Itadaki. The chain length distributions of amylopectin were similar in NIL110 and Itadaki; therefore, the low AC of NIL110 was caused by a decrease in the actual AC, but not by a difference in the amylopectin structure. The interaction analyses revealed that qAC2 (Kuiku) has epistatic interaction with Wx (a) . The qAC2 (Kuiku) has epistatic interactions with two loci, du1 and du2, on Wx (b) , whereas the genetic effect of qAC2 (Kuiku) has additive to that of du3 on Wx (b) . Thus, similar to du1 and du2, qAC2 may have a function related to Wx (b) mRNA splicing.	[Takemoto-Kuno, Yoko; Suzuki, Keitaro; Hirabayashi, Hideyuki; Ishii, Takuro; Ando, Ikuo; Takeuchi, Yoshinobu] NARO Inst Crop Sci, Rice Breeding Res Team, Tsukuba, Ibaraki 3058518, Japan; [Mitsueda, Hiroki] Miyazaki Agr Res Inst, Miyazaki, Miyazaki 8800212, Japan; [Ideta, Osamu] NARO Western Reg Agr Res Ctr, Fukuyama, Hiroshima 7218514, Japan; [Aoki, Noriaki; Imbe, Tokio] NARO, Tsukuba, Ibaraki 3058666, Japan; [Umemoto, Takayuki] NARO Hokkaido Agr Res Ctr, Sapporo, Hokkaido 0628555, Japan; [Kato, Hiroshi] Natl Inst Agrobiol Sci, Ibaraki 3192293, Japan; [Nemoto, Hiroshi] Natl Inst Agrobiol Sci, Tsukuba, Ibaragi 3058602, Japan	Takeuchi, Y (reprint author), NARO Inst Crop Sci, Rice Breeding Res Team, 2-1-18 Kannondai, Tsukuba, Ibaraki 3058518, Japan.	ytakeuch@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [QT2011, DM1001, DM1002, QTL4010, RBS2011]	We thank Dr. T. Kumamaru (Kyushu University), for providing EM2, EM12 and EM23 seeds, and the local independent administrative agency Hokkaido Research Organization for providing Kuiku162 seeds. We thank Y. Yabuki, R. Mikami, and S. Kinoshita for their technical assistance. This work was supported by a Grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Integrated research project for plant, insect and animal using genome technology, QT2011, DM1001 and DM1002, Genomics for Agricultural Innovation, QTL4010, and Genomics-based Technology for Agricultural Improvement, RBS2011).	Ando I, 2010, BREEDING SCI, V60, P187, DOI 10.1270/jsbbs.60.187; Li JJ, 2011, BREEDING SCI, V61, P338, DOI 10.1270/jsbbs.61.338; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; Wan XY, 2004, THEOR APPL GENET, V110, P71, DOI 10.1007/s00122-004-1744-3; Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI 10.1104/pp.127.2.459; TAKEDA Y, 1987, CARBOHYD RES, V168, P79, DOI 10.1016/0008-6215(87)80008-3; LANDER ES, 1989, GENETICS, V121, P185; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1433, DOI 10.1007/s00122-003-1376-z; He P, 1999, THEOR APPL GENET, V98, P502, DOI 10.1007/s001220051098; Ikeno S, 1914, Z PFLANZENZUCHT, V2, P495; Isshiki M, 2000, PLANT J, V23, P451, DOI 10.1046/j.1365-313x.2000.00803.x; Isshiki M, 2008, PLANT BIOTECHNOL, V25, P483, DOI 10.5511/plantbiotechnology.25.483; Juliano B. O., 1993, GRAIN QUALITY EVALUA; Juliano BO, 1985, RICE CHEM TECHNOLOGY; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li ZF, 2003, BREEDING SCI, V53, P209, DOI 10.1270/jsbbs.53.209; Morishima H, 1992, OXFORD SURV EVOL BIO, V8, P135; Nagamine T, 1996, J CHROMATOGR A, V732, P255, DOI 10.1016/0021-9673(95)01229-X; Preiss J, 1996, PHOTOASSIMILATE DIST, P63; SANO Y, 1984, THEOR APPL GENET, V68, P467, DOI 10.1007/BF00254822; Sano Y, 1991, P INT RIC GEN S 2 IR, P11; Sato H, 2002, BREEDING SCI, V52, P131, DOI 10.1270/jsbbs.52.131; SATOH H, 1981, JPN J BREED, V31, P316; Satoh H, 1986, P INT RICE GENETICS, P707; Takeuchi Y, 2007, BREEDING SCI, V57, P231, DOI 10.1270/jsbbs.57.231; Umemoto T, 2002, FUNCT PLANT BIOL, V29, P1121, DOI 10.1071/PP01145; Wan XY, 2003, RICE GENET NEWSL, V20, P57; Webb B. D., 1980, RICE PRODUCTION UTIL, P543; YANO M, 1988, THEOR APPL GENET, V76, P183, DOI 10.1007/BF00257844; Zeng D, 2007, PLANT MOL BIOL, V65, P501, DOI 10.1007/s11103-007-9186-3	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0040-5752	1432-2242		THEOR APPL GENET	Theor. Appl. Genet.	APR	2015	128	4					563	573		10.1007/s00122-014-2432-6		11	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	CD9RY	WOS:000351437100001		
J	Tsunewaki, K				Tsunewaki, Koichiro			Fine mapping of the first multi-fertility-restoring gene, Rf (multi) , of wheat for three Aegilops plasmons, using 1BS-1RS recombinant lines	THEORETICAL AND APPLIED GENETICS			English	Article							COMMON WHEAT; TRITICUM WHEAT; MALE-STERILITY; CYTOPLASM; CHLOROSIS; KOTSCHYI; CH1	Fertility-restoring genes, Rfv1, Rfm1 and Rfn1 , respectively, for the male sterile cytoplasms of Aegilops kotschyi, Ae. mutica and Ae. uniaristata to common wheat were located on the same locus of Pavon wheat 1BS arm. The male sterile cytoplasm (plasmon) and the fertility-restoring gene are essential genetic components for breeding hybrid seed crops. This article represents information on the genetic similarity of three Aegilops plasmons usable as the male sterile cytoplasm for hybrid wheat and provides an evidence on the possible genetic unity of three fertility-restoring genes reported for these plasmons by their genetic mapping using the 1BS-1RS recombinant lines of Pavon 76 wheat on to a single subsegment of the 1BS chromosome arm less than 2.9 cM in size: the locus is designated Rf (multi) , meaning "Restoration of fertility in multiple CMS systems". Unresolved problems were discussed in the use of the present cytoplasmic male sterility-fertility restoration system for hybrid wheat breeding.	Kyoto Univ, Nishi Ku, Kobe, Hyogo 6512276, Japan	Tsunewaki, K (reprint author), Kyoto Univ, Nishi Ku, Kasugadai 6-14-10, Kobe, Hyogo 6512276, Japan.	kkcqn857@yahoo.co.jp					Luo DP, 2013, NAT GENET, V45, P573, DOI 10.1038/ng.2570; HERMSEN JGT, 1972, EUPHYTICA, V21, P204, DOI 10.1007/BF00036760; LIU YG, 1991, JPN J GENET, V66, P617, DOI 10.1266/jjg.66.617; Longin CFH, 2012, THEOR APPL GENET, V125, P1087, DOI 10.1007/s00122-012-1967-7; Ishida Y, 2015, P 12 INT WHEAT GEN S; Lukaszewski AJ, 2000, CROP SCI, V40, P216; May CE, 1988, P 7 INT WHEAT GEN S, V2, P577; MUKAI Y, 1992, JPN J GENET, V67, P199, DOI 10.1266/jjg.67.199; MUKAI Y, 1979, THEOR APPL GENET, V54, P153, DOI 10.1007/BF00263045; MUKAI Y, 1983, Memoirs of Osaka Kyoiku University Series III Natural Science and Applied Science, V32, P43; Pickett AA, 1993, ADV PLANT BREED S, V15, P1; Rieger R., 1991, Glossary of genetics.; SEARS E R, 1984, P295; Sharma S, 2009, THEOR APPL GENET, V119, P783, DOI 10.1007/s00122-009-1088-0; Tsujimoto H, 1984, WHEAT INFORM SERV, V58, P4; Tsunewaki K, 2002, GENES GENET SYST, V77, P409, DOI 10.1266/ggs.77.409; Tsunewaki K, 1988, P 7 INT WHEAT GEN S, P53; Tsunewaki K, 1996, GENES GENET SYST, V71, P293, DOI 10.1266/ggs.71.293; Tsunewaki K, 1973, P 4 INT WHEAT GEN S, P123; TSUNEWAKI K, 1975, JPN J GENET, V50, P151, DOI 10.1266/jjg.50.151; TSUNEWAKI K, 1964, CAN J GENET CYTOL, V6, P1; Tsunewaki Koichiro, 1996, P271; Wilson J.A., 1962, WHEAT INFORM SERV, V14, P29; WISE RP, 1987, PLANT MOL BIOL, V9, P121, DOI 10.1007/BF00015644; Zeller F. J., 1973, Proceedings of the fourth international wheat genetics symposium. Alien genetic material., P209	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0040-5752	1432-2242		THEOR APPL GENET	Theor. Appl. Genet.	APR	2015	128	4					723	732		10.1007/s00122-015-2467-3		10	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	CD9RY	WOS:000351437100014		
J	Sasaki, K; Takeuchi, Y; Miura, K; Yamaguchi, T; Ando, T; Ebitani, T; Higashitani, A; Yamaya, T; Yano, M; Sato, T				Sasaki, K.; Takeuchi, Y.; Miura, K.; Yamaguchi, T.; Ando, T.; Ebitani, T.; Higashitani, A.; Yamaya, T.; Yano, M.; Sato, T.			Fine mapping of a major quantitative trait locus, qLG-9, that controls seed longevity in rice (Oryza sativa L.)	THEORETICAL AND APPLIED GENETICS			English	Article							TREHALOSE ACCUMULATION; ABIOTIC STRESSES; MOISTURE-CONTENT; IDENTIFICATION; STORABILITY; TOLERANCE; MAP; CULTIVARS; MARKERS; QTL	We fine-mapped a quantitative trait locus, qLG - 9, for seed longevity detected between Japonica-type and Indica-type cultivars. qLG - 9 was mapped in a 30-kb interval of the Nipponbare genome sequence. A quantitative trait locus, qLG-9, for seed longevity in rice has previously been detected on chromosome 9 by using backcross inbred lines derived from a cross between Japonica-type (Nipponbare) and Indica-type (Kasalath) cultivars. In the present study, the chromosomal location of qLG-9 was precisely determined by fine-scale mapping. Firstly, allelic difference in qLG-9 was verified by QTL analysis of an F-2 population derived from a cross between Nipponbare and NKSL-1, in which a segment of Kasalath chromosome 9 was substituted in Nipponbare genetic background. Then, we selected F-2 plants in which recombination had occurred near qLG-9 and performed F-3 progeny testing on these plants to determine the genotype classes of qLG-9. Eventually, qLG-9 was mapped in a 30-kb interval (defined by two markers, CAPSb and CHPa12) of the Nipponbare genome sequence. This allowed us to nominate positional candidate genes of qLG-9. Additionally, we developed near-isogenic lines (NIL) for qLG-9 by marker-assisted selection. qLG-9 NIL showed significantly higher seed longevity than isogenic control of Nipponbare. These results will facilitate cloning of the gene(s) underlying qLG-9 as well as marker-assisted transfer of desirable genes for seed longevity improvement in rice.	[Sasaki, K.; Higashitani, A.; Sato, T.] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Takeuchi, Y.] Natl Agr & Food Res Org, Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan; [Miura, K.] Natl Agr & Food Res Org, Agr Res Ctr, Tsukuba, Ibaraki 3058666, Japan; [Yamaguchi, T.; Ebitani, T.] Toyama Prefectural Agr Forestry & Fisheries Res C, Toyama, Toyama 9398153, Japan; [Ando, T.; Yano, M.] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Yamaya, T.] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan	Sasaki, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Inst Sustainable Agroecosyst Serv, 1-1-1 Midoricho, Tokyo 1880002, Japan.	sasaki@isas.a.u-tokyo.ac.jp	Higashitani, Atsushi/G-7086-2015	Higashitani, Atsushi/0000-0001-6920-0594	Ministry of Agriculture, Forestry and Fisheries, Japan [QT-2008, QTL-4009]; Japan Society for the Promotion of Science [18-5156]	This work was supported in part by a Grant-in-Aid from the Ministry of Agriculture, Forestry and Fisheries, Japan (Green Technology Project QT-2008 and Genomics for Agricultural Innovation, QTL-4009). K. Sasaki was a recipient of a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science (18-5156). Grateful acknowledgement is extended to Dr. K. Sugimoto and Mr. T. Shimizu (National Institute of Agrobiological Sciences), Dr. M. Obara (Japan International Research Centre for Agricultural Sciences) and Ms. E. Hanzawa (Tohoku University) for their helpful suggestions in analyzing the data.	Stein N, 2007, THEOR APPL GENET, V114, P823, DOI 10.1007/s00122-006-0480-2; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Iordachescu M, 2008, J INTEGR PLANT BIOL, V50, P1223, DOI 10.1111/j.1744-7909.2008.00736.x; Obara M, 2004, THEOR APPL GENET, V110, P1, DOI 10.1007/s00122-004-1828-0; Clerkx EJM, 2004, PHYSIOL PLANTARUM, V121, P448, DOI 10.1111/j.1399-3054.2004.00339.x; [Anonymous], 2014, RIC ANN PROJ DAT; Nagel M, 2009, EUPHYTICA, V170, P5, DOI 10.1007/s10681-009-9975-7; Takeuchi Y, 2003, THEOR APPL GENET, V107, P1174, DOI 10.1007/s00122-003-1364-3; Miura K, 2002, THEOR APPL GENET, V104, P981, DOI 10.1007/s00122-002-0872-x; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Harushima Y, 1998, GENETICS, V148, P479; Zeng DL, 2006, PLANT BREEDING, V125, P57, DOI 10.1111/j.1439-0523.2006.01169.x; Xue Y, 2008, EUPHYTICA, V164, P739, DOI 10.1007/s10681-008-9696-3; Jang IC, 2003, PLANT PHYSIOL, V131, P516, DOI 10.1104/pp.007237; Sasaki K, 2005, PLANT BREEDING, V124, P361, DOI 10.1111/j.1439-0523.2005.01109.x; CHANG T T, 1991, International Rice Research Newsletter, V16, P5; ELLIS RH, 1992, ANN BOT-LONDON, V69, P53; ELLIS RH, 1994, ANN BOT-LONDON, V73, P501, DOI 10.1006/anbo.1994.1062; Ikehashi H, 1973, J CENT AGR EXP STAN, V19, P1; Rao NK, 1996, ANN BOT-LONDON, V77, P251; KURATA N, 1994, NAT GENET, V8, P365, DOI 10.1038/ng1294-365; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Landjeva S, 2010, EUPHYTICA, V171, P129, DOI 10.1007/s10681-009-0016-3; Li LF, 2012, PLANT BREEDING, V131, P739, DOI 10.1111/j.1439-0523.2012.02007.x; MCKENZIE KS, 1994, AUST J EXP AGR, V34, P897, DOI 10.1071/EA9940897; ROBERTS EH, 1961, ANN BOT-LONDON, V25, P381; Siddique SB, 1988, IRRI RES PAP SER, V131, P2; Wang S, 2007, WINDOWS QTL CARTOGRA; Yamaguchi T., 2007, Breeding Research, V9, P103, DOI 10.1270/jsbbr.9.103; Yamauchi M, 1996, CROP SCI, V36, P680	31	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0040-5752	1432-2242		THEOR APPL GENET	Theor. Appl. Genet.	APR	2015	128	4					769	778		10.1007/s00122-015-2471-7		10	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	CD9RY	WOS:000351437100018		
J	Ikeda, N; Kojima, H; Nishikawa, M; Hayashi, K; Futagami, T; Tsujino, T; Kusunoki, Y; Fujii, N; Suegami, S; Miyazaki, Y; Middleton, D; Tanaka, H; Saji, H				Ikeda, N.; Kojima, H.; Nishikawa, M.; Hayashi, K.; Futagami, T.; Tsujino, T.; Kusunoki, Y.; Fujii, N.; Suegami, S.; Miyazaki, Y.; Middleton, D.; Tanaka, H.; Saji, H.			Determination of HLA-A, -C, -B,-DRB1 allele and haplotype frequency in Japanese population based on family study	TISSUE ANTIGENS			English	Article						allele frequency; family study; haplotype frequency; human leucocyte antigen; Japanese population	WT1 PEPTIDE VACCINE; BONE-MARROW-TRANSPLANTATION; CYTOTOXIC T-LYMPHOCYTES; LEUKOCYTE ANTIGEN-A; CLASS-I; HAN POPULATION; AND-DRB1 ALLELES; SOUTHWEST CHINA; POLYMORPHISMS; IMPACT	The present study investigates the human leucocyte antigen (HLA) allele and haplotype frequencies in Japanese population. We carried out the frequency analysis in 5824 families living across Japanese archipelago. The studied population has mainly been typed for the purpose of transplant, especially the hematopoietic stem cell transplantation (HSCT). We determined HLA class I (A, B, and C) and HLA class II (DRB1) using Luminex technology. The haplotypes were directly counted by segregation. A total of 44 HLA-A, 29 HLA-C, 75 HLA-B, and 42 HLA-DRB1 alleles were identified. In the HLA haplotypes of A-C-B-DRB1 and C-B, the pattern of linkage disequilibrium peculiar to Japanese population has been confirmed. Moreover, the haplotype frequencies based on family study was compared with the frequencies estimated by maximum likelihood estimation (MLE), and the equivalent results were obtained. The allele and haplotype frequencies obtained in this study could be useful for anthropology, transplantation therapy, and disease association studies.	[Ikeda, N.; Kojima, H.; Nishikawa, M.; Hayashi, K.; Futagami, T.; Tsujino, T.; Kusunoki, Y.; Fujii, N.; Suegami, S.; Miyazaki, Y.; Tanaka, H.; Saji, H.] HLA Fdn Lab, Kyoto 6008813, Japan; [Middleton, D.] Royal Liverpool Univ Hosp Trust, Transplant Immunol, Liverpool, Merseyside, England; [Middleton, D.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England	Saji, H (reprint author), HLA Fdn Lab, 2F 1 Kyoto Res Pk,134 Chudoji Minami Machi, Kyoto 6008813, Japan.	hla@hla.or.jp					Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Chen SW, 2007, HUM IMMUNOL, V68, P550, DOI 10.1016/j.humimm.2007.02.006; Lee KW, 2005, TISSUE ANTIGENS, V65, P437, DOI 10.1111/j.1399-0039.2005.00386.x; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kanda Y, 2013, BRIT J HAEMATOL, V161, P566, DOI 10.1111/bjh.12279; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Shi L, 2010, TISSUE ANTIGENS, V75, P159, DOI 10.1111/j.1399-0039.2009.01407.x; Ogata S, 2007, TISSUE ANTIGENS, V69, P154, DOI 10.1111/j.1399-0039.2006.00698.x; Tsuboi A, 2002, CANCER IMMUNOL IMMUN, V51, P614, DOI 10.1007/s00262-002-0328-9; Saito S, 2000, TISSUE ANTIGENS, V56, P522, DOI 10.1034/j.1399-0039.2000.560606.x; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Wang ZT, 2014, WORLD J GASTROENTERO, V20, P2397, DOI 10.3748/wjg.v20.i9.2397; Morishima S, 2010, BLOOD, V115, P4664, DOI 10.1182/blood-2009-10-251157; Horan J, 2012, BLOOD, V120, P2918, DOI 10.1182/blood-2012-03-417758; Yang G, 2006, TISSUE ANTIGENS, V67, P146, DOI 10.1111/j.1399-0039.2005.00529.x; Yao Y, 2009, TISSUE ANTIGENS, V73, P561, DOI 10.1111/j.1399-0039.2009.01237.x; Tokunaga K, 1997, IMMUNOGENETICS, V46, P199, DOI 10.1007/s002510050262; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; LEWONTIN RC, 1964, GENETICS, V49, P49; HEDRICK PW, 1987, GENETICS, V117, P331; Imanishi T, 1992, HLA 1991, V1, P627; Kaida M, 2011, J IMMUNOTHER, V34, P92, DOI 10.1097/CJI.0b013e3181fb65b9; Lai MJ, 2010, HUM IMMUNOL, V71, P777, DOI 10.1016/j.humimm.2010.05.013; Moriyama Y., 2006, MHC, V12, P183; Nakaoka H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060793; Ohno S, 2012, ANTICANCER RES, V32, P2263; RAYMOND M, 1995, J HERED, V86, P248; Shichi D, 2005, TISSUE ANTIGENS, V66, P200, DOI 10.1111/j.1399-0039.2005.00457.x; Wen SH, 2008, HUM IMMUNOL, V69, P430, DOI 10.1016/j.humimm.2008.05.012; Zhao HY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05116	33	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-2815	1399-0039		TISSUE ANTIGENS	Tissue Antigens	APR	2015	85	4					252	259		10.1111/tan.12536		8	Cell Biology; Immunology; Pathology	Cell Biology; Immunology; Pathology	CE0ZK	WOS:000351540300004		
J	Yamauchi, T				Yamauchi, Takamitsu			Asymptotic property C of the countable direct sum of the integers	TOPOLOGY AND ITS APPLICATIONS			English	Article						Asymptotic property C; Direct sum	DECOMPOSITION COMPLEXITY; CONJECTURE; DIMENSION	It is proved that the countable direct sum of the integers with a proper invariant metric has asymptotic property C, which answers a question posed by A. Dranishnikov and M. Zarichnyi. (C) 2015 Elsevier B.V. All rights reserved.	Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan	Yamauchi, T (reprint author), Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan.	yamauchi.takamitsu.ts@ehime-u.ac.jp			JSPS KAKENHI Grant [26800040]	This work was supported by JSPS KAKENHI Grant Number 26800040.	Higson N, 2000, J REINE ANGEW MATH, V519, P143; Yu GL, 2000, INVENT MATH, V139, P201; Banakh T., 2007, OPEN PROBLEMS TOPOLO, P655, DOI 10.1016/B978-044452208-5/50060-0; Bell G. C., PREPRINT; Dranishnikov A, 2014, TOPOL APPL, V169, P99, DOI 10.1016/j.topo1.2014.02.035; Dranishnikov AN, 2000, RUSS MATH SURV+, V55, P1085, DOI 10.1070/RM2000v055n06ABEH000334; Gromov M., 1993, LONDON MATH SOC LECT, V182, P1; Guentner E, 2012, INVENT MATH, V189, P315, DOI 10.1007/s00222-011-0366-z; Guentner E, 2013, GROUP GEOM DYNAM, V7, P377, DOI 10.4171/GGD/186; Haver W. E., 1974, LECT NOTES MATH, V375, P108; Nowak PW, 2012, EMS TEXTB MATH, P1, DOI 10.4171/112; Roe J., 2003, U LECT SER, V31; Smith J, 2006, TOPOL APPL, V153, P2047, DOI 10.1016/j.topol.2005.07.011	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-8641	1879-3207		TOPOL APPL	Topology Appl.	APR 1	2015	184						50	53		10.1016/j.topol.2015.01.013		4	Mathematics, Applied; Mathematics	Mathematics	CD7CW	WOS:000351249400005		
J	Kotorii, Y; Yasuhara, A				Kotorii, Yuka; Yasuhara, Akira			Milnor invariants of length 2k+2 for links with vanishing Milnor invariants of length <= k	TOPOLOGY AND ITS APPLICATIONS			English	Article						Milnor (mu)over-bar-invariant; HOMFLYPT polynomial; Clasper	EQUIVALENCE	J.-B. Meilhan and the second author showed that any Milnor (mu) over bar -invariant of length between 3 and 2k + 1 can be represented as a combination of HOMFLYPT polynomial of knots obtained by certain band sum of the link components, if all A-invariants of length <= k vanish. They also showed that their formula does not hold for length 2k + 2. In this paper, we improve their formula to give the (mu) over bar -invariants of length 2k + 2 by adding correction terms. The correction terms can be given by a combination of HOMFLYPT polynomial of knots determined bSr (mu) over bar -invariants of length k + 1. In particular, for any 4-component link the (mu) over bar -invariants of length 4 are given by our formula, since all (mu) over bar -invariants of length 1 vanish. (C) 2015 Elsevier B.V. All rights reserved.	[Kotorii, Yuka] Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan; [Yasuhara, Akira] Tokyo Gakugei Univ, Dept Math, Tokyo 1848501, Japan	Kotorii, Y (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	kotorii@ms.u-tokyo.ac.jp; yasuhara@u-gakugei.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science [26400081]	The first author is partially supported by Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The second author is partially supported by a Grant-in-Aid for Scientific Research (C) (#26400081) of the Japan Society for the Promotion of Science.	Habiro K, 2000, GEOM TOPOL, V4, P1, DOI 10.2140/gt.2000.4.1; MILNOR J, 1954, ANN MATH, V59, P177, DOI 10.2307/1969685; LICKORISH WBR, 1987, TOPOLOGY, V26, P107, DOI 10.1016/0040-9383(87)90025-5; Fleming T, 2009, P AM MATH SOC, V137, P761; Kanenobu T., 1998, BANACH CTR PUBLICATI, V42, P165; Meilhan JB, 2012, GEOM TOPOL, V16, P889, DOI 10.2140/gt.2012.16.889; Milnor J., 1957, ALGEBRAIC GEOMETRY T, P280; Polyak M, 1997, CR ACAD SCI I-MATH, V325, P77, DOI 10.1016/S0764-4442(97)83937-7; Yasuhara A, 2009, T AM MATH SOC, V361, P4721	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-8641	1879-3207		TOPOL APPL	Topology Appl.	APR 1	2015	184						87	100		10.1016/j.topol.2015.01.003		14	Mathematics, Applied; Mathematics	Mathematics	CD7CW	WOS:000351249400009		
J	Kurata, T; Lukic, V; Kozuki, M; Wada, D; Miyazaki, K; Morimoto, N; Ohta, Y; Deguchi, K; Yamashita, T; Hishikawa, N; Matsuzono, K; Ikeda, Y; Kamiya, T; Abe, K				Kurata, Tomoko; Lukic, Violeta; Kozuki, Miki; Wada, Daisuke; Miyazaki, Kazunori; Morimoto, Nobutoshi; Ohta, Yasuyuki; Deguchi, Kentaro; Yamashita, Toru; Hishikawa, Nozomi; Matsuzono, Kosuke; Ikeda, Yoshio; Kamiya, Tatsushi; Abe, Koji			Long-term Effect of Telmisartan on Alzheimer's Amyloid Genesis in SHR-SR After tMCAO	TRANSLATIONAL STROKE RESEARCH			English	Article						Alzheimer's disease; Amyloid beta; Metabolic syndrome; Spontaneously hypertensive rat; Telmisartan; Transient middle cerebral artery occlusion	SPONTANEOUSLY HYPERTENSIVE RATS; II RECEPTOR ANTAGONIST; ANGIOTENSIN-II; COGNITIVE IMPAIRMENT; BLOOD-PRESSURE; INFLAMMATORY RESPONSES; VASCULAR DEMENTIA; TRUNCATED TAU; DOWN-SYNDROME; MOUSE MODEL	Telmisartan is expected to reduce not only the level of blood pressure but also neuroinflammation and neurotoxicity via pleiotrophic effects as a metabo-sartan. We examined the effects of telmisartan on Alzheimer's disease (AD) pathology in spontaneously hypertensive rat stroke resistant (SHR-SR) after transient middle cerebral artery occlusion (tMCAO) by giving either telmisartan at 0 (vehicle), 0.3 mg/kg/day (low dose, with no reduction of blood pressure), or 3 mg/kg/day (high dose, with a significant reduction of blood pressure) p.o. from 3 months (M) of age, and performed immunohistological analysis at 6, 12, and 18 M of age. The numbers of amyloid beta (A beta)-positive neurons in the cerebral cortex and hippocampus and senile plaque (SP) in the ipsilateral cerebral cortex progressively increased with age until 18 M in the SHR-SR after tMCAO. On the other hand, low-dose telmisartan significantly reduced the number of A beta-positive neuron as well as SP at 6, 12, and 18 M. High-dose telmisartan showed further reductions of the above AD pathology. The present study suggests that telmisartan reduced both intracellular A beta and extracellular SP accumulations after tMCAO in SHR-SR, with a further improvement by combined BP lowering. Such a strong effect of telmisartan could provide a preventative approach for AD in post-stroke patients with hypertension.	[Kurata, Tomoko; Lukic, Violeta; Kozuki, Miki; Wada, Daisuke; Miyazaki, Kazunori; Morimoto, Nobutoshi; Ohta, Yasuyuki; Deguchi, Kentaro; Yamashita, Toru; Hishikawa, Nozomi; Matsuzono, Kosuke; Ikeda, Yoshio; Kamiya, Tatsushi; Abe, Koji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Kita Ku, Okayama 7008558, Japan	Abe, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Kita Ku, 2-5-1 Shikatacho, Okayama 7008558, Japan.	toko11@cc.okayama-u.ac.jp; toko11@cc.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan;  [21390267]	This work was partly supported by a Grant-in-Aid for Scientific Research (B) 21390267 and the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Grants-in-Aid for Aoki M, Matsuoka Y, Mizusawa H, Nakano I, Nishizawa M, Sasaki H, from the Ministry of Health, Labour and Welfare of Japan.	Abe K., 1992, Neurological Research, V14, P381; Mori C, 2002, AMYLOID, V9, P88; Gohlke P, 2001, J PHARMACOL EXP THER, V298, P62; Hayden KM, 2006, ALZ DIS ASSOC DIS, V20, P93, DOI 10.1097/01.wad.0000213814.43047.86; Zilka N, 2006, FEBS LETT, V580, P3582, DOI 10.1016/j.febslet.2006.05.029; Murray MD, 2002, ARCH INTERN MED, V162, P2090, DOI 10.1001/archinte.162.18.2090; Carnevale D, 2012, HYPERTENSION, V60, P188, DOI 10.1161/HYPERTENSIONAHA.112.195511; Haraguchi T, 2010, BRAIN RES, V1353, P125, DOI 10.1016/j.brainres.2010.07.017; Mogi M, 2011, CIRC J, V75, P1042, DOI 10.1253/circj.CJ-11-0121; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Zilka N, 2009, J NEUROIMMUNOL, V209, P16, DOI 10.1016/j.jneuroim.2009.01.013; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Rastas S, 2007, STROKE, V38, P1454, DOI 10.1161/STROKEAHA.106.477299; Alexander RW, 2006, ARTERIOSCL THROM VAS, V26, P240, DOI 10.1161/01.ATV.0000199680.42737.ca; Guo ZC, 1999, ARCH NEUROL-CHICAGO, V56, P991, DOI 10.1001/archneur.56.8.991; Sabbatini M, 2002, MECH AGEING DEV, V123, P547, DOI 10.1016/S0047-6374(01)00362-1; Wienen W, 2001, J RENIN-ANGIO-ALDO S, V2, P123; Poon IO, 2008, PHARMACOTHERAPY, V28, P366, DOI 10.1592/phco.28.3.366; Reitz C, 2008, STROKE, V39, P36, DOI 10.1161/STROKEAHA.107.490334; Kehoe PG, 2007, LANCET NEUROL, V6, P373, DOI 10.1016/S1474-4422(07)70077-7; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JC131547; Kurata T, 2011, BRAIN RES, V1371, P161, DOI 10.1016/j.brainres.2010.11.067; Tota S, 2009, BEHAV BRAIN RES, V199, P235, DOI 10.1016/j.bbr.2008.11.044; Pravenec M, 2003, PHYSIOL RES, V52, P681; Maillard MP, 2002, J PHARMACOL EXP THER, V302, P1089, DOI 10.1124/jpet.102.036772; Skoog I, 2006, NEUROL RES, V28, P605, DOI 10.1179/016164106X130506; Aoki A, 2012, HEART VESSELS, V25, P195; Araki K, 2006, HYPERTENSION, V48, P51, DOI 10.1161/01.HYP.0000225402.69580.1d; Derosa G, 2004, HYPERTENS RES, V27, P457, DOI 10.1291/hypres.27.457; Hajjar I, 2012, ARCH NEUROL-CHICAGO, V1, P7; Korenov M, 2009, J NEUROSCI METH, V177, P108, DOI 10.1016/j.jneumeth.2008.09.027; Kumai Y, 2008, EXP NEUROL, V210, P441, DOI 10.1016/j.expneurol.2007.11.028; Kurata T, 2012, NEUROL RES, V34, P601, DOI 10.1179/1743132812Y.0000000054; Li NC, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5465; Rong X, 2009, J PHARMACOL EXP THER, V331, P1096, DOI 10.1124/jpet.109.157099; Sanz-Rosa D, 2005, AM J PHYSIOL-HEART C, V288, pH111, DOI 10.1152/ajpheart.01061.2003; Saxby BK, 2008, NEUROLOGY, V70, P1858, DOI 10.1212/01.wnl.0000311447.85948.78; Sugimoto K, 2006, HYPERTENSION, V47, P1003, DOI 10.1161/01.HYP.0000215181.60228.f7	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	APR	2015	6	2					107	115		10.1007/s12975-013-0321-y		9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CD8AH	WOS:000351317000003		
J	Araki, MG; Kajimoto, T; Han, QM; Kawasaki, T; Utsugi, H; Gyokusen, K; Chiba, Y				Araki, Masatake G.; Kajimoto, Takuya; Han, Qingmin; Kawasaki, Tatsuro; Utsugi, Hajime; Gyokusen, Koichiro; Chiba, Yukihiro			Effect of stem radial growth on seasonal and spatial variations in stem CO2 efflux of Chamaecyparis obtusa	TREES-STRUCTURE AND FUNCTION			English	Article						Stem respiration; Seasonal change; Vertical gradient; Scaling; Tree- and stand-level estimates; Stem carbon use efficiency	WOODY-TISSUE RESPIRATION; TROPICAL RAIN-FOREST; BETWEEN-TREE VARIATION; LOBLOLLY-PINE TREES; NORWAY SPRUCE TREES; MAINTENANCE RESPIRATION; FAGUS-SYLVATICA; CARBON-DIOXIDE; ABOVEGROUND RESPIRATION; CONTRASTING CLIMATES	Key message Besides stem temperature, seasonality and vertical gradient in stem diameter growth strongly affect both seasonal and vertical variations in stem CO2 efflux. Abstract Stem CO2 efflux (E-s) is known to vary seasonally and vertically along tree stems. We measured E-s at various heights in a 50-year-old hinoki cypress [Chamaecyparis obtusa (Sieb. et Zucc) Endl.] stand over 2 consecutive years in Central Japan. Effects of stem temperature (T-s), daily stem diameter increment (D-i), and difference in vapor pressure deficit between nighttime and daytime (VPDdiff) on seasonal variation in daily E-s were examined by a generalized linear model (GLM). Daily E-s exhibited a substantial seasonal variation, which was mostly affected by T-s and D-i. Any effect of VPDdiff, which was assumed to be an index of daily sap flow rate, was not detected. The GLM prediction of daily E-s from the combination of T-s and D-i showed good agreement with the observed seasonal trend in daily E-s. These results suggest that, in addition to stem temperature as the important environmental factor, stem radial growth is a significant phenological factor influencing seasonal variation in E-s. Additionally, the intercept of GLM, which indicates the basal daily efflux that is independent of T-s and D-i, was closely related to the annual diameter increment. Furthermore, a strong relationship was found between annual E-s and annual diameter increment. These findings suggest that variation in stem diameter growth along stems is considerably responsible for the observed vertical variation in E-s. Therefore, stem radial growth can affect both seasonal and spatial variations in stem CO2 efflux.	[Araki, Masatake G.] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan; [Kajimoto, Takuya; Han, Qingmin; Kawasaki, Tatsuro; Utsugi, Hajime; Chiba, Yukihiro] Forestry & Forest Prod Res Inst, Dept Plant Ecol, Tsukuba, Ibaraki 3058687, Japan; [Gyokusen, Koichiro] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan	Araki, MG (reprint author), Kyushu Res Ctr, Forestry & Forest Prod Res Inst, Chuou Ku, Kurokami 4-11-16, Kumamoto 8600862, Japan.	gaku@ffpri.affrc.go.jp			Forestry and Forest Products Research Institute [199903, 201104]	The authors thank the two anonymous reviewers for valuable and helpful comments on a previous version of the manuscript. We also thank Dr. Daisuke Kabeya, Department of Plant Ecology, Forestry and Forest Products Research Institute, for advice on statistical analysis. This study was supported by research grants #199903 and #201104 of Forestry and Forest Products Research Institute.	Acosta M, 2008, ANN BOT-LONDON, V101, P469, DOI 10.1093/aob/mcm304; AduBredu S, 1996, TREE PHYSIOL, V16, P239; Adu-Bredu S, 1997, ANN BOT-LONDON, V80, P753, DOI 10.1006/anbo.1997.0517; Aiba SI, 1996, J ECOL, V84, P207, DOI 10.2307/2261356; Amthor JS, 1989, RESP CROP PRODUCTIVE; AMTHOR JS, 1984, PLANT CELL ENVIRON, V7, P561, DOI 10.1111/j.1365-3040.1984.tb01856.x; RYAN MG, 1990, CAN J FOREST RES, V20, P48, DOI 10.1139/x90-008; Gartner BL, 2004, TREE PHYSIOL, V24, P1239; Pruyn ML, 2002, TREE PHYSIOL, V22, P105; Teskey RO, 2007, PLANT CELL ENVIRON, V30, P570, DOI 10.1111/j.1365-3040.2007.01649.x; Wittmann C, 2006, PLANT CELL ENVIRON, V29, P1149, DOI 10.1111/j.1365-3040.2006.01495.x; Etzold S, 2013, NEW PHYTOL, V197, P1173, DOI 10.1111/nph.12115; Stockfors J, 1998, TREE PHYSIOL, V18, P155; MCCREE KJ, 1974, CROP SCI, V14, P509; Damesin C, 2003, NEW PHYTOL, V158, P465, DOI 10.1046/j.1469-8137.2003.00756.x; Teskey RO, 2002, PLANT CELL ENVIRON, V25, P1571, DOI 10.1046/j.1365-3040.2002.00961.x; Bowman WP, 2005, NEW PHYTOL, V167, P815, DOI 10.1111/j.1469-8137.2005.01478.x; Vose JM, 2002, GLOBAL CHANGE BIOL, V8, P182, DOI 10.1046/j.1365-2486.2002.00464.x; Bloemen J, 2013, NEW PHYTOL, V197, P555, DOI 10.1111/j.1469-8137.2012.04366.x; McGuire MA, 2004, TREE PHYSIOL, V24, P571; Aubrey DP, 2009, NEW PHYTOL, V184, P35, DOI 10.1111/j.1469-8137.2009.02971.x; Wittmann C, 2007, J EXP BOT, V58, P4293, DOI 10.1093/jxb/erm313; Zha TS, 2004, ANN BOT-LONDON, V94, P889, DOI 10.1093/aob/mch218; Levy PE, 1999, TREE PHYSIOL, V19, P53; RYAN MG, 1995, OECOLOGIA, V101, P133, DOI 10.1007/BF00317276; Sorz J, 2006, TREES-STRUCT FUNCT, V20, P34, DOI 10.1007/s00468-005-0010-x; Cavaleri MA, 2006, GLOBAL CHANGE BIOL, V12, P2442, DOI 10.1111/j.1365-2486.2006.01269.x; Bloemen J, 2014, NEW PHYTOL, V201, P897, DOI 10.1111/nph.12568; Ryan MG, 1996, TREE PHYSIOL, V16, P333; Utsugi H, 2006, FOREST ECOL MANAG, V225, P104, DOI 10.1016/j.foreco.2005.12.028; Steppe K, 2007, FUNCT PLANT BIOL, V34, P785, DOI 10.1071/FP07077; Amthor JS, 2000, ANN BOT-LONDON, V86, P1, DOI 10.1006/anbo.2000.1175; Deslauriers A, 2005, TREES-STRUCT FUNCT, V19, P402, DOI 10.1007/s00468-004-0398-8; Trumbore SE, 2013, NEW PHYTOL, V197, P353, DOI 10.1111/nph.12065; Teskey RO, 2008, NEW PHYTOL, V177, P17, DOI 10.1111/j.1469-8137.2007.02286.x; Dannoura M, 2011, NEW PHYTOL, V190, P181, DOI 10.1111/j.1469-8137.2010.03599.x; Ubierna N, 2009, TREE PHYSIOL, V29, P1563, DOI 10.1093/treephys/tpp089; Tarvainen L, 2014, TREE PHYSIOL, V34, P488, DOI 10.1093/treephys/tpu036; Carey EV, 1997, OECOLOGIA, V111, P19, DOI 10.1007/s004420050203; Gruber A, 2009, TREE PHYSIOL, V29, P641, DOI 10.1093/treephys/tpp001; Wertin TM, 2008, TREE PHYSIOL, V28, P1831; Pfanz H, 2002, NATURWISSENSCHAFTEN, V89, P147, DOI 10.1007/s00114-002-0309-z; Araki MG, 2010, J FOREST RES-JPN, V15, P115, DOI 10.1007/s10310-009-0163-3; Araki MG, 2006, KYUSHU J FOR RES, V59, P85; Atkin OK, 2005, ADV PHOTO RESPIRAT, V18, P95; Bowman WP, 2008, TREE PHYSIOL, V28, P1553; Brito P, 2010, TREES-STRUCT FUNCT, V24, P523, DOI 10.1007/s00468-010-0423-z; Carey EV, 1996, TREE PHYSIOL, V16, P125; Ceschia E, 2002, ANN FOR SCI, V59, P801, DOI 10.1051/forest:2002078; Chambers JQ, 2004, ECOL APPL, V14, pS72; Crawley MJ, 2002, STAT COMPUTING INTRO; Damesin C, 2002, NEW PHYTOL, V153, P159, DOI 10.1046/j.0028-646X.2001.00296.x; Edwards NT, 2002, NEW PHYTOL, V155, P239, DOI 10.1046/j.1469-8137.2002.00458.x; Forest soil division, 1976, B GOV FOREST EXP STN, V280, P1; Fujiwara T, 2007, B FFPRI, V6, P215; Fukatsu E, 2006, B KNATOU JPN FOR SOC, V57, P143; Hagihara A., 1983, Journal of the Japanese Forestry Society, V65, P357; Hagihara A., 1981, Journal of the Japanese Forestry Society, V63, P156; Holtta T, 2009, TREE PHYSIOL, V29, P1447, DOI 10.1093/treephys/tpp073; Japan Meteorology Agency, 2013, CLIM STAT; Kakubari Y., 1988, Journal of the Japanese Forestry Society, V70, P64; Katayama A, 2014, TREE PHYSIOL, V34, P503, DOI 10.1093/treephys/tpu041; Katayama A, 2013, J PLANT RES, V126, P505, DOI 10.1007/s10265-012-0544-0; KIRA TATUO, 1967, JAP J ECOL, V17, P70; Kozlowski T.T., 1991, PHYSL ECOLOGY WOODY; Kramer P.J., 1979, PHYSL WOODY PLANTS; Landsberg JJ, 1997, APPL PHYSL ECOLOGY F; Lavigne MB, 2004, NEW PHYTOL, V162, P81, DOI 10.1111/j.1469-8137.2004.01004.x; Lavigne MB, 1997, TREE PHYSIOL, V17, P543; Lavigne MB, 1996, TREE PHYSIOL, V16, P847; Lendzian KJ, 2006, J EXP BOT, V57, P2535, DOI 10.1093/jxb/erl014; Maier CA, 2001, TREE PHYSIOL, V21, P1183; Maier CA, 2010, NEW PHYTOL, V185, P502, DOI 10.1111/j.1469-8137.2009.03063.x; Maier CA, 2006, PLANT CELL ENVIRON, V29, P1471, DOI 10.1111/j.1365-3040.2006.01511.x; McGuire MA, 2007, J EXP BOT, V58, P2159, DOI 10.1093/jxb/erm069; Meir P, 2002, PLANT CELL ENVIRON, V25, P963, DOI 10.1046/j.1365-3040.2002.00877.x; Mori S, 1988, J JPN FOREST SOC, V70, P187; Negisi K., 1979, Journal of the Japanese Forestry Society, V61, P88; Ninomiya I., 1983, Journal of the Japanese Forestry Society, V65, P193; Ogawa H, 1977, PRIMARY PRODUCTIVIE, V16, P15; Ogawa K, 2006, SCAND J FOREST RES, V21, P293, DOI 10.1080/02827580600866188; Oohata S, 1972, B KYOTO U FOR, V43, P63; Oohata S, 1971, B KYOTO U FOR, V42, P103; PAEMBONAN SA, 1991, TREE PHYSIOL, V8, P399; PAEMBONAN SA, 1992, TREE PHYSIOL, V10, P101; Pruyn ML, 2002, NEW PHYTOL, V154, P359, DOI 10.1046/j.1469-8137.2002.00380.x; R Core Team, 2014, R LANG ENV STAT COMP; Rossi Sergio, 2003, Dendrochronologia, V21, P33, DOI 10.1078/1125-7865-00034; Ryan MG, 1997, J GEOPHYS RES-ATMOS, V102, P28871, DOI 10.1029/97JD01236; RYAN MG, 1992, ECOLOGY, V73, P2100, DOI 10.2307/1941458; Sakai Y, 2012, SOIL SCI PLANT NUTR, V58, P526, DOI 10.1080/00380768.2012.710526; Saveyn A, 2008, OECOLOGIA, V154, P637, DOI 10.1007/s00442-007-0868-y; Saveyn A, 2008, TREES-STRUCT FUNCT, V22, P165, DOI 10.1007/s00468-006-0099-6; Sprugel DG, 1990, TREES-STRUCT FUNCT, V4, P88; Sprugel DG, 1995, RESOURCE PHYSL CONIF, P255; Sprugel DG, 1991, TECHNIQUES APPROACHE, P329; Stockfors J, 2000, TREE PHYSIOL, V20, P1057; Teskey RO, 2005, TREES-STRUCT FUNCT, V19, P357, DOI 10.1007/s00468-004-0386-z; Utsugi H, 1999, TREES-STRUCT FUNCT, V14, P1; Waring RH, 1985, FOREST ECOSYSTEMS CO; Wieser G, 2004, TREES-STRUCT FUNCT, V18, P576, DOI 10.1007/s00468-004-0341-z; Wieser G, 2009, TREE PHYSIOL, V29, P457, DOI 10.1093/treephys/tpp008; YODA KYOJI, 1965, J BIOL OSAKA CITY UNIV, V16, P15; Yokota T, 1998, TREE PHYSIOL, V18, P37; YOKOTA T, 1994, TREE PHYSIOL, V14, P467; Zha TS, 2005, TREE PHYSIOL, V25, P49	106	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0931-1890	1432-2285		TREES-STRUCT FUNCT	Trees-Struct. Funct.	APR	2015	29	2					499	514		10.1007/s00468-014-1127-6		16	Forestry	Forestry	CD5NQ	WOS:000351135300016		
J	Kume, T; Laplace, S; Komatsu, H; Chu, CR				Kume, Tomonori; Laplace, Sophie; Komatsu, Hikaru; Chu, Chia-Ren			Transpiration in response to wind speed: can apparent leaf-type differences between conifer and broadleaf trees be a practical indicator?	TREES-STRUCTURE AND FUNCTION			English	Article						Wind tunnel; Sap flux; Aerodynamic control; Penman-Monteith equation; Conifers and broadleaf	CANOPY CONDUCTANCE; SAP FLUX; STOMATAL CONDUCTANCE; SURFACE CONDUCTANCE; BOUNDARY-LAYERS; TIME-SERIES; WATER-USE; FOREST; FLOW; EVAPORATION	Key message Transpiration in conifer species was controlled by wind speed, similar to broadleaf species, indicating that caution is required when using the simplified Penman-Monteith equation. Abstract The significance of aerodynamic controls on tree transpiration (E) is critical when modeling E using the simplified Penman-Monteith equation. However, few studies have explicitly compared the significance of aerodynamic controls on E between conifer-type needles and broadleaf leaves. Although previous studies assumed that the response of E to wind speed (w) could be insignificant in conifers, we hypothesized based on the evapotranspiration theory that the significance of E regulation by w is difficult to determine based on apparent such leaf-type differences. We performed sap flux measurements using a wind tunnel on two conifer species, Chamaecyparis obtusa var. formosana and Araucaria cunninghamii, and three broadleaf species, Swietenia mahagoni, Michelia compressa, and Plumeria rubra. Chamaecyparis obtusa and P. rubra showed no distinctive E response to w, while A. cunninghamii, S. mahagoni, and M. compressa had significant increases in E due to w, supporting our hypothesis. Our experimental and model calculation data suggested that the aerodynamic controls on E by w probably result from differences in stomatal conductance rather than leaf type. We emphasize the need to confirm the significance of aerodynamic controls on E using both direct and indirect measurements for coupling conditions between the leaf surface and atmosphere when modeling E, irrespective of leaf type.	[Kume, Tomonori; Laplace, Sophie] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10764, Taiwan; [Komatsu, Hikaru] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto, Japan; [Komatsu, Hikaru] Kyoto Univ, Fac Agr, Kyoto, Japan; [Chu, Chia-Ren] Natl Cent Univ, Dept Civil Engn, Zhongli, Taiwan	Chu, CR (reprint author), Natl Cent Univ, Dept Civil Engn, Zhongli, Taiwan.	crchu@cc.ncu.edu.tw			National Science Council of the Republic of China (NSC) [100-2313-B-002-033-MY3]	This work was partly supported by the National Science Council of the Republic of China (NSC; 100-2313-B-002-033-MY3). We are grateful to the Experimental Forest, National Taiwan University, for providing the samples. Technical support was provided by Mr. Tsung-Chiang Liu, Mr. Yu-Feng Chang (National Central University), Ms. Mei-Li Chen, Ms. I-Fang Hsieh, and Mr. Yan-Fu Lin (National Taiwan University). We also thank three anonymous reviewers for their comments.	Chu CR, 2009, J EXP BOT, V60, P249, DOI 10.1093/jxb/ern282; Komatsu H, 2005, HYDROL PROCESS, V19, P3873, DOI 10.1002/hyp.5987; MEINZER FC, 1993, PLANT CELL ENVIRON, V16, P429, DOI 10.1111/j.1365-3040.1993.tb00889.x; Ewers BE, 2005, PLANT CELL ENVIRON, V28, P660, DOI 10.1111/j.1365-3040.2005.01312.x; Kitaya Y, 2004, ADV SPACE RES-SERIES, V34, P1466, DOI 10.1016/j.asr.2003.08.031; DIXON M, 1984, ANN BOT-LONDON, V53, P811; Kume T, 2010, TREE PHYSIOL, V30, P129, DOI 10.1093/treephys/tpp074; Roderick ML, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031166; Naithani KJ, 2012, J HYDROL, V464, P176, DOI 10.1016/j.jhydrol.2012.07.008; SCHUEPP PH, 1993, NEW PHYTOL, V125, P477, DOI 10.1111/j.1469-8137.1993.tb03898.x; MEINZER FC, 1995, OECOLOGIA, V101, P514, DOI 10.1007/BF00329432; James SA, 2002, TREE PHYSIOL, V22, P277; Wullschleger SD, 1998, TREE PHYSIOL, V18, P499; Kostner B, 1998, ANN SCI FOREST, V55, P125, DOI 10.1051/forest:19980108; Komatsu H, 2012, AGR FOREST METEOROL, V156, P111, DOI 10.1016/j.agrformet.2012.01.004; KELLIHER FM, 1995, AGR FOREST METEOROL, V73, P1, DOI 10.1016/0168-1923(94)02178-M; GRACE J, 1980, PLANT CELL ENVIRON, V3, P443; Campbell G. S., 1998, INTRO ENV BIOPHYSICS; Cheng WT, 1999, ILLUSTRATED FLORA TA, VI; DRAKE BG, 1970, PLANT PHYSIOL, V46, P324, DOI 10.1104/pp.46.2.324; Granier A, 1985, ANN SCI FOREST, V42, P81; Hubbard RM, 2004, GLOBAL CHANGE BIOL, V10, P427, DOI 10.1111/j.1529-8817.2003.00741.x; Jones HG, 1992, PLANTS MICROCLIMATE; Komatsu H, 2006, HYDROL PROCESS, V20, P1309, DOI 10.1002/hyp.6093; Komatsu H, 2003, HYDROL PROCESS, V17, P2503, DOI 10.1002/hyp.5141; Komatsu H., 2003, J JAPAN SOC HYDROLOG, V16, P423, DOI 10.3178/jjshwr.16.423; Korner CH, 1994, ECOL STUD, V100, P463; Kostner B, 1996, THEOR APPL CLIMATOL, V53, P105, DOI 10.1007/BF00866415; LANDSBER.JJ, 1970, J APPL ECOL, V7, P187, DOI 10.2307/2401619; Laplace S., 2013, British Journal of Environment and Climate Change, V3, P160; Magnani F, 1998, PLANT CELL ENVIRON, V21, P867, DOI 10.1046/j.1365-3040.1998.00328.x; McNaughton K.G., 1983, WATER DEFICITS PLANT, VVII, P1; Monteith J.L., 1990, PRINCIPLES ENV PHYS; Phillips N, 2002, TREE PHYSIOL, V22, P205; Phillips N, 1997, TREES-STRUCT FUNCT, V11, P412, DOI 10.1007/s004680050102; Phillips NG, 2004, TREE PHYSIOL, V24, P879; Tateishi M, 2010, TREE PHYSIOL, V30, P748, DOI 10.1093/treephys/tpq023; Zhang Y., 2007, J GEOPHYS RES-ATMOS, V1984-2012, P112, DOI DOI 10.1029/2006JD008161	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0931-1890	1432-2285		TREES-STRUCT FUNCT	Trees-Struct. Funct.	APR	2015	29	2					605	612		10.1007/s00468-014-1066-2		8	Forestry	Forestry	CD5NQ	WOS:000351135300025		
J	Houdellier, F; de Knoop, L; Gatel, C; Masseboeuf, A; Mamishin, S; Taniguchi, Y; Delmas, M; Monthioux, M; Hytch, MJ; Snoeck, E				Houdellier, F.; de Knoop, L.; Gatel, C.; Masseboeuf, A.; Mamishin, S.; Taniguchi, Y.; Delmas, M.; Monthioux, M.; Hytch, M. J.; Snoeck, E.			Development of TEM and SEM high brightness electron guns using cold-field emission from a carbon nanotip	ULTRAMICROSCOPY			English	Article						Field emission; Electrons sources; Electron holography; Carbon tips	WORK FUNCTION; NANOTUBES; MICROSCOPY; HOLOGRAPHY; EMITTER	A newly developed carbon cone nanotip (CCnT) has been used as field emission cathode both in low voltage SEM (30 kV) electron source and high voltage TEM (200 kV) electron source. The results clearly show, for both technologies, an unprecedented stability of the emission and the probe current with almost no decay during 1 h, as well as a very small noise (rms less than 0.5%) compared to standard sources which use tungsten tips as emitting cathode. In addition, quantitative electric field mapping around the FE tip have been performed using in situ electron holography experiments during the emission of the new tip. These results show the advantage of the very high aspect ratio of the new CCnT which induces a strong enhancement of the electric held at the apex of the tip, leading to very small extraction voltage (some hundred of volts) for which the field emission will start. The combination of these experiments with emission current measurements has also allowed to extract an exit work function value of 4.8 eV. (C) 2014 Elsevier B.V. All rights reserved.	[Houdellier, F.; de Knoop, L.; Gatel, C.; Masseboeuf, A.; Delmas, M.; Monthioux, M.; Hytch, M. J.; Snoeck, E.] CEMES CNRS, F-31055 Toulouse, France; [Mamishin, S.; Taniguchi, Y.] Hitachi High Technol Corp, Hitachinaka, Ibaraki 3128504, Japan	Houdellier, F (reprint author), CEMES CNRS, 29 Rue Jeanne Marvig, F-31055 Toulouse, France.		Gatel, Christophe/F-6046-2014	Gatel, Christophe/0000-0001-5549-7008	European Integrated Infrastructure Initiative [312483-ESTEEM2]; French "Investissement d'Avenir" Program [ANR-10-EQPX-38-01]; French ANR-Emergence Program [ANR-12-EMMA-0044-01]	The authors acknowledge the European Integrated Infrastructure Initiative Reference 312483-ESTEEM2, and the French "Investissement d'Avenir" Program Reference no. ANR-10-EQPX-38-01, and the French ANR-Emergence Program ANR-12-EMMA-0044-01 for partial funding.	ALBREKTSEN O, 1994, J VAC SCI TECHNOL B, V12, P3187, DOI 10.1116/1.587497; CREWE AV, 1970, SCIENCE, V168, P1338, DOI 10.1126/science.168.3937.1338; Nilsson L, 2001, J APPL PHYS, V90, P768, DOI 10.1063/1.1379559; Jacobsen RL, 1997, NATURE, V385, P211, DOI 10.1038/385211b0; Collins PG, 1996, APPL PHYS LETT, V69, P1969, DOI 10.1063/1.117638; Bonard JM, 2001, SOLID STATE ELECTRON, V45, P893, DOI 10.1016/S0038-1101(00)00213-6; Wang QH, 1998, APPL PHYS LETT, V72, P2912, DOI 10.1063/1.121493; Houdellier F, 2012, CARBON, V50, P2037, DOI 10.1016/j.carbon.2012.01.023; Gatel C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.025501; TONOMURA A, 1992, ADV PHYS, V41, P59, DOI 10.1080/00018739200101473; Allouche H, 2003, CARBON, V41, P2897, DOI 10.1016/S0008-6223(03)00329-4; Gao RP, 2001, APPL PHYS LETT, V78, P1757, DOI 10.1063/1.1356442; Liu P, 2008, NANO LETT, V8, P647, DOI 10.1021/nl0730817; Chen G, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/31/315201; Collins P., 1997, PHYS REV B, V55, P93; Crewe A.V., 1964, P AMU ANL HIGH VOLT, P68; de Jonge N., 2004, PHILOS T R SOC A; de Jonge N., 2002, NATURE, V420, P3; de Knoop L., 2014, THESIS U P SABATIER; de Knoop L, 2014, MICRON, V63, P2, DOI 10.1016/j.micron.2014.03.005; Dolan W.W., 1956, ADV ELECT ELECTRON P, V8, P89, DOI 10.1016/S0065-2539(08)61226-3; Dyke W.P., 1956, ADV ELECT ELECT PHYS, VIII, P129; Fowler F.R.S. R., 1928, P R SOC LOND, V119, P1; Krivanek O.L., 2013, MICROSCOPY, V62; MULLER EW, 1951, Z PHYS, V131, P136, DOI 10.1007/BF01329651; Saito Y., 2000, CARBON, V38, P1; SHIMOYAMA H, 1989, J ELECTRON MICROSC, V38, pS1; Swanson L.W., 1978, SURF SCI, V70, P1; Swanson L.W., 1973, ADV ELECTRON ELECTRO, V32, P193, DOI 10.1016/S0065-2539(08)60236-X; TODOKORO H, 1982, JPN J APPL PHYS 1, V21, P1513, DOI 10.1143/JJAP.21.1513; TONOMURA A, 1984, J ELECTRON MICROSC, V33, P101	31	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3991	1879-2723		ULTRAMICROSCOPY	Ultramicroscopy	APR	2015	151						107	115		10.1016/j.ultramic.2014.11.021		9	Microscopy	Microscopy	CD6YU	WOS:000351237800015		
J	Ishikawa, R; Lupini, AR; Hinuma, Y; Pennycook, SJ				Ishikawa, Ryo; Lupini, Andrew R.; Hinuma, Yoyo; Pennycook, Stephen J.			Large-angle illumination STEM: Toward three-dimensional atom-by-atom imaging	ULTRAMICROSCOPY			English	Article						Scanning transmission electron microscopy (STEM); Annular dark-field (ADF); Atomic-depth resolution imaging; Surface imaging	TRANSMISSION ELECTRON-MICROSCOPY; AUGMENTED-WAVE METHOD; ABERRATION; FIELD; CORRECTORS; SCATTERING; SURFACES; PROBE; TEM	To fully understand and control materials and their properties, it is of critical importance to determine their atomic structures in all three dimensions. Recent revolutionary advances in electron optics - the inventions of geometric and chromatic aberration correctors as well as electron source monochromators - have provided fertile ground for performing optical depth sectioning at atomic-scale dimensions. In this study we theoretically demonstrate the imaging of top/sub-surface atomic structures and identify the depth of single clopants, single vacancies and the other point defects within materials by large-angle illumination scanning transmission electron microscopy (LAl-STEM). The proposed method also allows us to measure specimen properties such as thickness or three-dimensional surface morphology using observations from a single crystallographic orientation. (C) 2014 Elsevier B.V. All rights reserved.	[Ishikawa, Ryo] Univ Tokyo, Inst Engn Innovat, Tokyo 1138656, Japan; [Lupini, Andrew R.] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Hinuma, Yoyo] Kyoto Univ, Dept Mat Sci & Engn, Kyoto 6068501, Japan; [Pennycook, Stephen J.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA	Ishikawa, R (reprint author), Univ Tokyo, Inst Engn Innovat, Tokyo 1138656, Japan.	ishikawa@sigma.t.u-tokyo.ac.jp	Ishikawa, Ryo/M-4206-2014	Ishikawa, Ryo/0000-0001-5801-0971	Office of Science of the U.S. DOE [DE-AC02- 05CH11231]; Materials Science and Engineering Division of the US Department of Energy	RA, acknowledges Prof. Fumiyasu Oba (Kyoto University), Dr. Nathan Lugg, Prof. Naoya Shibata and Prof. Yuichi Ikuhara (University of Tokyo) for helpful discussion careful reading of this manuscript. R.I. and Y.H. support by a Grant-in-Aid for Scientific Research on Innovative Areas "Nano Informatics". RA. used resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the U.S. DOE under Contract no. DE-AC02- 05CH11231. A.R.L. is supported by the Materials Science and Engineering Division of the US Department of Energy.	Ishikawa R, 2014, MICROSC MICROANAL, V20, P99, DOI 10.1017/S1431927613013664; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Cosgriff EC, 2007, ULTRAMICROSCOPY, V107, P626, DOI 10.1016/j.ultramic.2006.12.004; Kabius B, 2009, J ELECTRON MICROSC, V58, P147, DOI 10.1093/jmicro/dfp021; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Matsukawa M, 2014, NANO LETT, V14, P1038, DOI 10.1021/nl404688h; Van Aert S, 2011, NATURE, V470, P374, DOI 10.1038/nature09741; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Krivanek OL, 2008, ULTRAMICROSCOPY, V108, P179, DOI 10.1016/j.ultramic.2007.07.010; PENNYCOOK SJ, 1988, NATURE, V336, P565, DOI 10.1038/336565a0; Ishikawa R, 2014, NANO LETT, V14, P1903, DOI 10.1021/nl500564b; Mukai M, 2014, ULTRAMICROSCOPY, V140, P37, DOI 10.1016/j.ultramic.2014.02.004; Hosokawa F, 2013, MICROSCOPY-JPN, V62, P23, DOI 10.1093/jmicro/dfs134; Sawada H, 2009, J ELECTRON MICROSC, V58, P357, DOI 10.1093/jmicro/dfp030; WOLKOW RA, 1992, PHYS REV LETT, V68, P2636, DOI 10.1103/PhysRevLett.68.2636; ROSE H, 1990, OPTIK, V85, P19; ROSE H, 1974, OPTIK, V39, P416; Uhlemann S, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.046101; LOANE RF, 1991, ACTA CRYSTALLOGR A, V47, P267, DOI 10.1107/S0108767391000375; Reich ES, 2013, NATURE, V499, P135, DOI 10.1038/499135a; SCHERZER O, 1947, OPTIK, V2, P114; Cosgriff EC, 2008, ULTRAMICROSCOPY, V108, P1558, DOI 10.1016/j.ultramic.2008.05.009; Perdew JP, 1997, PHYS REV LETT, V78, P1396, DOI 10.1103/PhysRevLett.78.1396; Shibata N, 2008, SCIENCE, V322, P570, DOI 10.1126/science.1165044; Forbes BD, 2011, ULTRAMICROSCOPY, V111, P1670, DOI 10.1016/j.ultramic.2011.09.017; Arslan I, 2005, SCIENCE, V309, P2195, DOI 10.1126/science.1116745; Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823; Krivanek OL, 1999, ULTRAMICROSCOPY, V78, P1, DOI 10.1016/S0304-3991(99)00013-3; SCHULZ H, 1977, SOLID STATE COMMUN, V23, P815, DOI 10.1016/0038-1098(77)90959-0; Krivanek OL, 2013, MICROSCOPY-JPN, V62, P3, DOI 10.1093/jmicro/dfs089; Zhu GZ, 2012, NATURE, V490, P384, DOI 10.1038/nature11563; ARCHARD GD, 1954, BRIT J APPL PHYS, V5, P294, DOI 10.1088/0508-3443/5/8/307; BECK VD, 1979, OPTIK, V53, P241; Borisevich AY, 2006, P NATL ACAD SCI USA, V103, P3044, DOI 10.1073/pnas.0507105103; Born M., 1999, PRINCIPLES OPTICS; Chen C.J., INTRO SCANNING TUNNE; CREWE AV, 1980, OPTIK, V57, P313; Egerton R. F., 1996, ELECT ENERGY LOSS SP; Erni R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096101; Feynman R. P., 1992, Journal of Microelectromechanical Systems, V1, DOI 10.1109/84.128057; Hwang J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.266101; Ishikawa R., 2014, SCI REP, V4; Kirkland EJ, 2010, ADVANCED COMPUTING IN ELECTRON MICROSCOPY, SECOND ED, P1, DOI 10.1007/978-1-4419-6533-2; KRESSE G, 1993, PHYS REV B, V48, P13115, DOI 10.1103/PhysRevB.48.13115; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Pennycook S J, 2011, SCANNING TRANSMISSIO; ROSE H, 1976, OPTIK, V45, P139; Rotunno E, 2014, ULTRAMICROSCOPY, V146, P62, DOI 10.1016/j.ultramic.2014.07.003; Sawada H, 2009, J ELECTRON MICROSC, V58, P341, DOI 10.1093/jmicro/dfp033; SCHLIER RE, 1959, J CHEM PHYS, V30, P917, DOI 10.1063/1.1730126; Xin H.L., 2009, J ELECT MICROSC	51	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3991	1879-2723		ULTRAMICROSCOPY	Ultramicroscopy	APR	2015	151						122	129		10.1016/j.ultramic.2014.11.009		8	Microscopy	Microscopy	CD6YU	WOS:000351237800017		
J	Lugg, NR; Kothleitner, G; Shibata, N; Ikuhara, Y				Lugg, N. R.; Kothleitner, G.; Shibata, N.; Ikuhara, Y.			On the quantitativeness of EDS STEM	ULTRAMICROSCOPY			English	Article						Scanning transmission electron microscopy (STEM); Energy-dispersive X-ray specu scopy (EDS); Chemical mapping; Tilting	TRANSMISSION ELECTRON-MICROSCOPY; DIFFRACTION INTENSITIES; GRAIN-BOUNDARY; SCATTERING; CRYSTALS; SEGREGATION; PRECESSION; DOPANT; ATOMS; HAADF	Chemical mapping using energy dispersive X-ray spectroscopy (EDS) in scanning transmission electron microscopy (STEM) has recently shown to be a powerful technique in analyzing the elemental identity and location of atomic columns in materials at atomic resolution. However, most applications of EDS STEM have been used only to qualitatively map whether elements are present at specific sites. Obtaining calibrated EDS STEM maps so that they are on an absolute scale is a difficult task and even if one achieves this, extracting quantitative information about the specimen - such as the number or density of atoms under the probe - adds yet another layer of complexity to the analysis due to the multiple elastic and inelastic scattering of the electron probe. Quantitative information may be obtained by comparing calibrated EDS STEM with theoretical simulations, but in this case a model of the structure must be assumed a priori. Here we first theoretically explore how exactly elastic and thermal scattering of the probe confounds the quantitative information one is able to extract about the specimen from an [DS STEM map. We then show using simulation how tilting the specimen (or incident probe) can reduce the effects of scattering and how it can provide quantitative information about the specimen. We then discuss drawbacks of this method - such as the loss of atomic resolution along the tilt direction - but follow this with a possible remedy: precession averaged EDS STEM mapping. (C) 2014 Elsevier B.V. All rights reserved.	[Lugg, N. R.; Shibata, N.; Ikuhara, Y.] Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, Tokyo 1138656, Japan; [Kothleitner, G.] Graz Univ Technol, Inst Electron Microscopy & Nanoanal, A-8010 Graz, Austria; [Kothleitner, G.] Ctr Electron Microscopy, A-8010 Graz, Austria	Lugg, NR (reprint author), Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, 2-11-16 Yuyoi, Tokyo 1138656, Japan.		Shibata, Naoya/E-5327-2013; Ikuhara, Yuichi/N-1001-2015; Ikuhara, Yuichi/F-3066-2010	Ikuhara, Yuichi/0000-0003-3886-005X; 	MEXT, Japan [12024046]	A part of this work was conducted in Research Hub for Advanced Nano Characterization, The University of Tokyo, under the support of "Nanotechnology Platform" (Project no. 12024046) by MEXT, Japan. N.R.L. was supported as a Japan Society for the Promotion of Science (JSPS) fellow for this work.	Ishikawa R, 2014, MICROSC MICROANAL, V20, P99, DOI 10.1017/S1431927613013664; BIRD DM, 1990, ACTA CRYSTALLOGR A, V46, P202, DOI 10.1107/S0108767389011906; Bosman M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.086102; Chen JH, 1997, ACTA CRYSTALLOGR A, V53, P576, DOI 10.1107/S0108767397005539; D'Alfonso AJ, 2007, ULTRAMICROSCOPY, V108, P17, DOI 10.1016/j.ultramic.2007.02.026; Dwyer C, 2005, ULTRAMICROSCOPY, V104, P141, DOI 10.1016/j.ultramic.2005.03.005; Ishikawa R, 2014, NANO LETT, V14, P1903, DOI 10.1021/nl500564b; Kothleitner G, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.085501; De Backer A, 2013, ULTRAMICROSCOPY, V134, P23, DOI 10.1016/j.ultramic.2013.05.003; Forbes BD, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.024108; Shibata N, 2009, NAT MATER, V8, P654, DOI [10.1038/nmat2486, 10.1038/NMAT2486]; Watanabe M, 2006, J MICROSC-OXFORD, V221, P89, DOI 10.1111/j.1365-2818.2006.01549.x; Van Aert S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.064107; Allen LJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.105503; Oxley MP, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.203906; Zhu Y, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4823704; Dwyer C, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4711766; Krivanek OL, 2010, NATURE, V464, P571, DOI 10.1038/nature08879; VINCENT R, 1994, ULTRAMICROSCOPY, V53, P271, DOI 10.1016/0304-3991(94)90039-6; COWLEY JM, 1957, ACTA CRYSTALLOGR, V10, P609, DOI 10.1107/S0365110X57002194; Muller DA, 2008, SCIENCE, V319, P1073, DOI 10.1126/science.1148820; Findlay SD, 2008, MICROSC MICROANAL, V14, P48, DOI 10.1017/S1431927608080112; Kimoto K, 2007, NATURE, V450, P702, DOI 10.1038/nature06352; Chang T.-Y., 2013, NANO LETT, V14, P134; Chu MW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.196101; D'Alfonso AJ, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.100101; Findlay S.D., 2008, PHYS REV LETT, V100; Forbes BD, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.104103; Gjonnes K, 1997, ULTRAMICROSCOPY, V69, P1, DOI 10.1016/S0304-3991(97)00031-4; Ishikawa R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.065504; Joy D., 1986, PRINCIPLES OF ANALYT; Kirkland EJ, 2010, ADVANCED COMPUTING IN ELECTRON MICROSCOPY, SECOND ED, P1, DOI 10.1007/978-1-4419-6533-2; Klenov DO, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3645632; Lartigue-Korinek S, 2011, ACTA MATER, V59, P3519, DOI 10.1016/j.actamat.2011.02.025; Lee J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2671; Liao YF, 2013, ULTRAMICROSCOPY, V126, P19, DOI 10.1016/j.ultramic.2012.11.007; Lugg NR, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4765657; Lugg NR, 2014, MICROSC MICROANAL, V20, P1078, DOI 10.1017/S1431927614000804; Roh JY, 2014, J CERAM SOC JPN, V122, P381, DOI 10.2109/jcersj2.122.381; Wang P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.236102; Xin HLL, 2014, ULTRAMICROSCOPY, V139, P38, DOI 10.1016/j.ultramic.2014.01.006; Zhu Y, 2014, MICROSC MICROANAL, V20, P1070, DOI 10.1017/S1431927614000877	42	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3991	1879-2723		ULTRAMICROSCOPY	Ultramicroscopy	APR	2015	151						150	159		10.1016/j.ultramic.2014.11.029		10	Microscopy	Microscopy	CD6YU	WOS:000351237800020		
J	Takeda, S; Kuwauchi, Y; Yoshida, H				Takeda, Seiji; Kuwauchi, Yasufumi; Yoshida, Hideto			Environmental transmission electron microscopy for catalyst materials using a spherical aberration corrector	ULTRAMICROSCOPY			English	Article						Cs corrector; Environmental transmission electron microscopy; Catalyst; Gold; Platinum; Nanoparticle; Quantification	CARBON NANOTUBE GROWTH; GAS-SOLID INTERACTIONS; IN-SITU TEM; ATOMIC-SCALE; CO OXIDATION; NANOCLUSTER CATALYSTS; MATERIALS SCIENCE; NANOWIRE GROWTH; OXIDE SUPPORTS; TILT BOUNDARY	Atomic resolution has been obtained using environmental transmission electron microscopy (ETEM) by installing a spherical aberration corrector (Cs-corrector) on the objective lens. Simultaneously, the technology for controlling the environment around a specimen in ETEM has advanced significantly in the past decade. Quantification methodology has recently been established for deriving relevant experimental data in catalyst materials from substantial and systematic ETEM observation at the atomic scale. With this background, this paper summarizes aspects of the evolutional microscopy technique: necessary conditions for atomic resolution in ETEM; reduction of the scattering of electrons by the medium surrounding a specimen; and an environmental cell for structural imaging of a crystalline specimen. The high spatial resolution of a Cs-corrected ETEM is demonstrated for different observation conditions. After statistical analysis combined with numerical image analysis of ETEM data is briefly described, the recent applications of the Cs-corrected ETEM to catalyst materials are reviewed. For gold nanoparticulate catalysts, the structural information on the reaction sites and adsorption sites are deduced. For Pt nanoparticulate catalysts, ETEM studies elucidate the correlation between the catalytic activity and the morphology of the nanoparticles. These studies also reveal oxidation and reduction on the topmost Pt surface layer at the atomic scale. Finally, current issues and the future perspectives of Cs-corrected ETEM are summarized, including the reproducibility of ETEM observation data the control of environments, the critical evaluation of electron irradiation effects, the full implementation of transmission electron microscopy technology in ETEM, and the safety issues for an ETEM laboratory. (C) 2014 Elsevier B.V. All rights reserved	[Takeda, Seiji; Kuwauchi, Yasufumi; Yoshida, Hideto] Osaka Univ, Nanosci & Nanotechnol Ctr, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Takeda, S (reprint author), Osaka Univ, Nanosci & Nanotechnol Ctr, Inst Sci & Ind Res, 8-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	takeda@sanken.osaka-u.ac.jp			Japan Society from the Ministry of Education, Culture, Sports, Science and Technology, Japan [25246003, 19001005]	This study was partly supported by a Japan Society for the Grant-in-Aid (No. 25246003) and a Grant-in-Aid (No. 19001005), from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors sincerely thank Drs. Stan Konings, Joerg Jinschek, and Stephan Kujawa of FEI Company for developing the robust ETEM apparatus that were used in our quantitative atomic-resolution ETEM studies and for their continuous support.	Almeida TP, 2014, CRYSTENGCOMM, V16, P1540, DOI 10.1039/c3ce41866a; Yoshida H, 2008, NANO LETT, V8, P2082, DOI 10.1021/nl080452q; Shimada S, 2010, STUD SURF SCI CATAL, V175, P843, DOI 10.1016/S0167-2991(10)75174-0; Hansen PL, 2002, SCIENCE, V295, P2053, DOI 10.1126/science.1069325; Prieto G, 2013, NAT MATER, V12, P34, DOI [10.1038/nmat3471, 10.1038/NMAT3471]; Kuwauchi Y, 2012, ANGEW CHEM INT EDIT, V51, P7729, DOI 10.1002/anie.201201283; Hansen TW, 2014, ACS CATAL, V4, P1673, DOI 10.1021/cs401148d; Ward MR, 2013, CHEMCATCHEM, V5, P2655, DOI 10.1002/cctc.201300047; Kaiser U, 2011, ULTRAMICROSCOPY, V111, P1239, DOI 10.1016/j.ultramic.2011.03.012; Sun KJ, 2014, J PHYS CHEM C, V118, P1611, DOI 10.1021/jp4099254; Ortalan V, 2010, NAT NANOTECHNOL, V5, P506, DOI [10.1038/nnano.2010.92, 10.1038/NNANO.2010.92]; BAKER RTK, 1972, J CATAL, V26, P51, DOI 10.1016/0021-9517(72)90032-2; [Anonymous], 2014, CHEM COMMUN; Gamalski AD, 2014, NANO LETT, V14, P1288, DOI 10.1021/nl404244u; Hansen TW, 2013, ACCOUNTS CHEM RES, V46, P1720, DOI 10.1021/ar3002427; Yokosawa T, 2012, ULTRAMICROSCOPY, V112, P47, DOI 10.1016/j.ultramic.2011.10.010; Simonsen SB, 2008, J CATAL, V255, P1, DOI 10.1016/j.jcat.2008.01.004; Boyes ED, 1997, ULTRAMICROSCOPY, V67, P219, DOI 10.1016/S0304-3991(96)00099-X; Miller BK, 2014, MICROSC MICROANAL, V20, P815, DOI 10.1017/S1431927614000749; Yaguchi T, 2011, J ELECTRON MICROSC, V60, P217, DOI 10.1093/jmicro/dfr011; Koh AL, 2013, ACS NANO, V7, P2566, DOI 10.1021/nn305949h; Wirth CT, 2012, CHEM MATER, V24, P4633, DOI 10.1021/cm301402g; Simonsen SB, 2010, J AM CHEM SOC, V132, P7968, DOI 10.1021/ja910094r; Raabe S, 2012, ADV FUNCT MATER, V22, P3378, DOI 10.1002/adfm.201103173; Uchiyama T, 2011, ANGEW CHEM INT EDIT, V50, P10157, DOI 10.1002/anie.201102487; Koshino M, 2007, SCIENCE, V316, P853, DOI 10.1126/science.1138690; Chou YC, 2014, SCIENCE, V343, P281, DOI 10.1126/science.1244623; Xin HLL, 2013, MICROSC MICROANAL, V19, P1558, DOI 10.1017/S1431927613013433; Sun KJ, 2013, CHEMCATCHEM, V5, P2217, DOI 10.1002/cctc.201300134; ROSE H, 1990, OPTIK, V85, P19; Vendelbo SB, 2014, NAT MATER, V13, P884, DOI [10.1038/nmat4033, 10.1038/NMAT4033]; Helveg S, 2004, NATURE, V427, P426, DOI 10.1038/nature02278; Zhang SR, 2013, NANO LETT, V13, P3310, DOI 10.1021/nl4015292; Yoshida H, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.065001; LEE TC, 1991, REV SCI INSTRUM, V62, P1438, DOI 10.1063/1.1142464; Hansen TW, 2010, MATER SCI TECH-LOND, V26, P1338, DOI 10.1179/026708310X12756557336355; Jinschek JR, 2014, CHEM COMMUN, V50, P2696, DOI 10.1039/c3cc49092k; Grogan JM, 2014, NANO LETT, V14, P359, DOI 10.1021/nl404169a; Jeangros Q, 2013, J MATER SCI, V48, P2893, DOI 10.1007/s10853-012-7001-2; Kolar HR, 1996, PHYS REV LETT, V77, P4031, DOI 10.1103/PhysRevLett.77.4031; Jinschek JR, 2012, MICRON, V43, P1156, DOI 10.1016/j.micron.2012.01.006; Krivanek OL, 2010, NATURE, V464, P571, DOI 10.1038/nature08879; Baldi A, 2014, NAT MATER, V13, P1143, DOI [10.1038/nmat4086, 10.1038/NMAT4086]; Lin M, 2007, NANO LETT, V7, P2234, DOI 10.1021/nl070681x; Yoshida H, 2012, SCIENCE, V335, P317, DOI 10.1126/science.1213194; Tao F, 2010, SCIENCE, V327, P850, DOI 10.1126/science.1182122; Ruska E, 1942, KOLLOID Z, V100, P212, DOI 10.1007/BF01519549; Mazzucco S, 2014, J CATAL, V319, P54, DOI 10.1016/j.jcat.2014.07.023; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654; Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823; Kuwauchi Y, 2013, NANO LETT, V13, P3073, DOI 10.1021/nl400919c; Tao F, 2011, SCIENCE, V331, P171, DOI 10.1126/science.1197461; Boyes ED, 2013, ANN PHYS-BERLIN, V525, P423, DOI 10.1002/andp.201300068; TAKAYANAGI K, 1985, SURF SCI, V164, P367, DOI 10.1016/0039-6028(85)90753-8; Herzing AA, 2008, SCIENCE, V321, P1331, DOI 10.1126/science.1159639; Picher M, 2014, NANO LETT, V14, P6104, DOI [10.1021/nl501977b, 10.1021/n1501977b]; Zhang SR, 2013, ACCOUNTS CHEM RES, V46, P1731, DOI 10.1021/ar300245g; MARKS LD, 1983, NATURE, V303, P316, DOI 10.1038/303316a0; Sharma R, 1998, MICROSC RES TECHNIQ, V42, P270, DOI 10.1002/(SICI)1097-0029(19980915)42:4<270::AID-JEMT6>3.0.CO;2-U; Creemer JF, 2008, ULTRAMICROSCOPY, V108, P993, DOI 10.1016/j.ultramic.2008.04.014; Xin HLL, 2014, NANO LETT, V14, P3203, DOI 10.1021/nl500553a; Zhang SR, 2013, J AM CHEM SOC, V135, P8283, DOI 10.1021/ja401967y; Yoshida H, 2014, CARBON, V70, P266, DOI 10.1016/j.carbon.2014.01.006; Kisielowski C, 2008, MICROSC MICROANAL, V14, P469, DOI 10.1017/S1431927608080902; Botton GA, 2010, ULTRAMICROSCOPY, V110, P926, DOI 10.1016/j.ultramic.2010.03.008; Strayer ME, 2014, J AM CHEM SOC, V136, P5687, DOI 10.1021/ja412933k; Lentzen M, 2002, ULTRAMICROSCOPY, V92, P233, DOI 10.1016/S0304-3991(02)00139-0; Fujita T, 2012, NAT MATER, V11, P775, DOI [10.1038/nmat3391, 10.1038/NMAT3391]; Urban KW, 2008, SCIENCE, V321, P506, DOI 10.1126/science.1152800; Pattinson SW, 2013, CHEM MATER, V25, P2921, DOI 10.1021/cm401216q; DATYE AK, 1992, CATAL REV, V34, P129, DOI 10.1080/01614949208021920; Benavidez AD, 2012, ACS CATAL, V2, P2349, DOI 10.1021/cs3005117; BOURRET A, 1979, PHILOS MAG A, V39, P405; Cavalca F, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/7/075705; CHERNS D, 1979, SURF SCI, V90, P339, DOI 10.1016/0039-6028(79)90348-0; CHERNS D, 1982, PHILOS MAG A, V46, P849; de Jonge N, 2010, NANO LETT, V10, P1028, DOI 10.1021/nl904254g; Doole R.C., 1991, I PHYS C SER, V119, P157; Flower H.M., 1972, J MICROSC-OXFORD, V97, P171; FRANK J, 1976, OPTIK, V44, P379; FUKUSHIMA K, 1985, J ELECTRON MICROSC, V34, P47; GIBSON JM, 1985, PHYS REV LETT, V55, P1765, DOI 10.1103/PhysRevLett.55.1765; Giorgio S, 2006, ULTRAMICROSCOPY, V106, P503, DOI 10.1016/j.ultramic.2006.01.006; Hansen PL, 2006, ADV CATAL, V50, P77, DOI 10.1016/S0360-0564(06)50002-1; Haruta M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4704558; HASHIMOT.H, 1968, JPN J APPL PHYS, V7, P946, DOI 10.1143/JJAP.7.946; He MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01460; Helveg S, 2006, CATAL TODAY, V111, P68, DOI 10.1016/j.cattod.2005.10.019; ICHINOSE H, 1981, PHILOS MAG A, V43, P1253; IIJIMA S, 1971, J APPL PHYS, V42, P5891, DOI 10.1063/1.1660042; Jeangros Q, 2014, CHEM COMMUN, V50, P1808, DOI 10.1039/c3cc46682e; Jinschek JR, 2011, CARBON, V49, P556, DOI 10.1016/j.carbon.2010.09.058; Kamino T, 2005, J ELECTRON MICROSC, V54, P497, DOI 10.1093/jmicro/dfi071; Kawasaki T, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3250862; Kohigashi Y, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4893460; Koto K, 1997, APPL PHYS LETT, V71, P1661, DOI 10.1063/1.119787; Krivanek OL, 2014, NATURE, V514, P209, DOI 10.1038/nature13870; MUTO S, 1995, PHILOS MAG A, V72, P1057; OHNO Y, 1995, REV SCI INSTRUM, V66, P4866, DOI 10.1063/1.1146166; RODRIGUEZ NM, 1990, REV SCI INSTRUM, V61, P1863, DOI 10.1063/1.1141109; Sharma R., 2012, IN SITU TEM MICRON, V43, P1077; Sharma R, 2005, HANDBOOK OF MICROSCOPY FOR NANOTECHNOLOGY, P531, DOI 10.1007/1-4020-8006-9_17; Sharma R, 2004, APPL PHYS LETT, V84, P990, DOI 10.1063/1.1646465; Suenaga K, 2012, J ELECTRON MICROSC, V61, P285, DOI 10.1093/jmicro/dfs054; Sun KJ, 2011, J COMPUT CHEM, V32, P3276, DOI 10.1002/jcc.21913; Sun KJ, 2012, J PHYS CHEM A, V116, P9568, DOI 10.1021/jp306906j; Suzuki M, 2013, MICROSCOPY-JPN, V62, P437, DOI 10.1093/jmicro/dft001; Takeda S, 1997, PHYS REV LETT, V79, P2994, DOI 10.1103/PhysRevLett.79.2994; TAKEDA S, 1994, PHILOS MAG A, V70, P287; Takeda S, 2013, MICROSCOPY-JPN, V62, P193, DOI 10.1093/jmicro/dfs096; Takeda S., 2004, MICROSCOPY MICROA S3, V10, P18; Yaguchi T, 2012, J ELECTRON MICROSC, V61, P199, DOI 10.1093/jmicro/dfs041; Yoshida H, 2009, NANO LETT, V9, P3810, DOI 10.1021/nl9019903; Yoshida H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.195428; Yoshida H, 2012, MICRON, V43, P1176, DOI 10.1016/j.micron.2012.04.008; Yoshida H, 2007, JPN J APPL PHYS 2, V46, pL917, DOI 10.1143/JJAP.46.L917; Yoshida H, 2014, NANOSCALE, V6, P13113, DOI 10.1039/c4nr04352a; Yoshida K, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/6/065705; Zhang LB, 2013, FLORA CHINA, V2-3, P13; Zhou GW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.235502	120	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3991	1879-2723		ULTRAMICROSCOPY	Ultramicroscopy	APR	2015	151						178	190		10.1016/j.ultramic.2014.11.017		13	Microscopy	Microscopy	CD6YU	WOS:000351237800023		
J	Yamasaki, J; Mori, M; Hirata, A; Hirotsu, Y; Tanaka, N				Yamasaki, Jun; Mori, Masayuki; Hirata, Akihiko; Hirotsu, Yoshihiko; Tanaka, Nobuo			Depth-resolution imaging of crystalline nanoclusters attached on and embedded in amorphous films using aberration-corrected TEM	ULTRAMICROSCOPY			English	Article						Aberration-corrected TEM; Depth-resolution imaging; Medium range order; Bulk metallic glass; ZrNi; Gold clusters on a carbon film	TRANSMISSION ELECTRON-MICROSCOPY; METALLIC GLASSES; NI; INFORMATION; TOMOGRAPHY; ZR	For observations of crystalline nanoclusters, the features and capabilities of depth-resolution imaging by aberration-corrected transmission electron microscopy (TEM) were investigated using image simulations and experiments for two types of samples. The first sample was gold clusters attached on an amorphous carbon film. The experimental through-focal series indicated that the focal plane for the cluster was shifted 3 nm from that for the supporting film. This difference is due to the depth-resolution imaging of the cluster and film, the mid-planes of which are separated by 3 nm along the depth direction (the electron incident direction). On the basis of this information, the three-dimensional configuration of the sample, such as the film thickness of 2 nm, was successfully illustrated. The second sample was a Zr66.7Ni33.3 metallic glass including a medium-range-order (MRO) structure, which was approximately considered to be a crystalline cluster with a diameter of 1.6 nm, In the experimental through local series, the lattice fringe of the MRO cluster was visible at limited focal conditions. Image simulations reproduced well the focal conditions and also indicated a structural condition for the visualization that the embedded cluster must be apart from the mid plane of the matrix film. Similar to the case of the first sample, this result can be explained by the idea that the "effective focal planes" for the film and cluster are at different heights. This type of depth resolution phase contrast imaging is possible only in aberration-corrected TEM and when the sample has a simple structure and is sufficiently thin for the kinematical scattering approximation. (C) 2014 Elsevier B.V. All rights reserved.	[Yamasaki, Jun] Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, Ibaraki, Osaka 5670047, Japan; [Yamasaki, Jun; Tanaka, Nobuo] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Mori, Masayuki] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Hirata, Akihiko] Tohoku Univ, Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9805577, Japan; [Hirotsu, Yoshihiko] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Yamasaki, J (reprint author), Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, 7-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	yamasaki@uhvem.osaka-u.ac.jp	Hirata, Akihiko/A-4850-2010		MEXT [18029011]; JSPS [26105001]	The authors are grateful to Prof. M. Hasegawa of Nagoya University and Dr. H. Kato of Tohoku University for producing the Zi<INF>66.7</INF>Ni<INF>33.3</INF> ribbon sample and Mr. A. Ishida for experimental help. This study was partly supported by Grant-in-Aids for Scientific Research on Priority Areas "Materials Science of Bulk Metallic Glasses" (No.18029011) by MEXT and on Innovative Areas "3D active site science" (No. 26105001) by JSPS.	Hirata A, 2011, NAT MATER, V10, P28, DOI [10.1038/nmat2897, 10.1038/NMAT2897]; Goris B, 2012, NAT MATER, V11, P930, DOI [10.1038/nmat3462, 10.1038/NMAT3462]; Van Aert S, 2011, NATURE, V470, P374, DOI 10.1038/nature09741; Ohkubo T, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.094201; McGreevy RL, 1988, MOL SIMULAT, V1, P359, DOI 10.1080/08927028808080958; Treacy MMJ, 1996, ACTA CRYSTALLOGR A, V52, P212, DOI 10.1107/S0108767395012876; Scott MC, 2012, NATURE, V483, P444, DOI 10.1038/nature10934; Van Dyck D, 2012, NATURE, V486, P243, DOI 10.1038/nature11074; Yu R, 2012, ULTRAMICROSCOPY, V112, P15, DOI 10.1016/j.ultramic.2011.10.006; Kisielowski C, 2008, MICROSC MICROANAL, V14, P469, DOI 10.1017/S1431927608080902; Hirata A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.214206; Fukunaga T, 2006, INTERMETALLICS, V14, P893, DOI 10.1016/j.intermet.2006.01.006; BONHOMME P, 1983, J PHYS D APPL PHYS, V16, P705, DOI 10.1088/0022-3727/16/5/003; Cosgriff E.C., 2008, ULTRAMICROSCOPY, V108, P1558; D'Alfonso A.J., 2008, ULTRAMICROSCOPY, V108, P1567; Gaskell P.H., 1978, NATURE, V276, P484; Hashimoto A, 2009, J APPL PHYS, V106, DOI 10.1063/1.3225103; Hirahara K, 2006, NANO LETT, V6, P1778, DOI 10.1021/nl060458k; Hirata A, 2007, ULTRAMICROSCOPY, V107, P116, DOI 10.1016/j.ultramic.2006.06.002; Hirata A, 2007, MATER TRANS, V48, P1299, DOI 10.2320/matertrans.MF200618; Hirotsu Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.012205; Jia C.L, 2014, NAT MATER, V13, P1044; Jinschek J.R., 2011, CARBON, V49, P556; Kim S., 2010, APPL PHYS EXP, V3; Miracle D.B., 2006, ACTA MAT, V54, P4317; Miracle D.B., 2004, NAT MATER, V3, P697; Takai Y., 2006, APPL PHYS LETT, P89; Tanaka N, 2004, NANOTECHNOLOGY, V15, P1779, DOI 10.1088/0957-4484/15/12/015; van Benthem K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1991989; Voyles PM, 2002, ULTRAMICROSCOPY, V93, P147, DOI 10.1016/S0304-3991(02)00155-9; Wang A, 2010, ULTRAMICROSCOPY, V110, P527, DOI 10.1016/j.ultramic.2009.11.024; Wang P., 2010, PHYS REV LETT, V104; Wu Z.D., 2014, J NONCRYST SOLIDS, V385, P40; Xin H.L., 2009, J ELECTRON MICROSC, V58, P157; Xin H.L., 2010, MICROSC MICROANAL, V16, P445; Yamasaki J., 2004, PHILOS MAG, V84, P2814; Yamasaki J, 2014, MICROSCOPY-JPN, V63, P345, DOI 10.1093/jmicro/dfu020; Zaluzec2 N.J., 2003, MICROSCOPY TODAY, V6, P8	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3991	1879-2723		ULTRAMICROSCOPY	Ultramicroscopy	APR	2015	151						224	231		10.1016/j.ultramic.2014.11.005		8	Microscopy	Microscopy	CD6YU	WOS:000351237800027		
J	Zahoranova, T; Mori, T; Yan, P; Sevcikova, K; Vaclavu, M; Matolin, V; Nehasil, V				Zahoranova, T.; Mori, T.; Yan, P.; Sevcikova, K.; Vaclavu, M.; Matolin, V.; Nehasil, V.			Study of the character of gold nanoparticles deposited onto sputtered cerium oxide layers by deposition-precipitation method: Influence of the preparation parameters	VACUUM			English	Article						Gold nanoparticles; Growth; Cerium oxide; Deposition-precipitation magnetron sputtering; Preparation parameters; SEM; XPS	SUPPORTED AU CATALYSTS; THIN-FILM CATALYSTS; CO OXIDATION; CARBON-MONOXIDE; HYDROGENATION; CEO2; STABILIZATION; ADSORPTION; TIO2(110); STABILITY	Au/CeOx/Si system was prepared by a combination of physical and chemical methods for application in the heterogeneous catalysis. Gold nanoparticles were loaded by the deposition-precipitation method (HAuCl4 center dot 4H(2)O used as a precursor) onto radio frequency magnetron sputtered layers of cerium oxide. The study focuses on the influence of the experimental parameters (pH of the solution, time of immersion) on the nature of gold deposit. After the preparation process, the samples were characterised by electron microscopy and X-ray photoelectron spectroscopy methods. The amount of gold loaded and its morphological parameters are discussed. We show that gold particles with high density and the mean diameter of around 4 nm are deposited from the solution with pH 7. In the case of higher value of pH, the uptake of gold significantly decreases and particles with slightly bigger mean diameter are deposited onto the substrate. (C) 2015 Elsevier Ltd. All rights reserved.	[Zahoranova, T.; Mori, T.; Yan, P.] Natl Inst Mat Sci, Global Res Ctr Environm & Energy Based Nanomat Sc, Tsukuba, Ibaraki 3050044, Japan; [Zahoranova, T.; Sevcikova, K.; Vaclavu, M.; Matolin, V.; Nehasil, V.] Charles Univ Prague, Fac Math & Phys, CR-18000 Prague 8, Czech Republic; [Sevcikova, K.] SPring 8 BL15XU SPring 8, Synchrotron Xray Stn, Sayo, Hyogo 6795148, Japan; [Vaclavu, M.] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050003, Japan	Zahoranova, T (reprint author), Natl Inst Mat Sci, Global Res Ctr Environm & Energy Based Nanomat Sc, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	t.zahoranova@gmail.com			Charles University - NIMS Joint Graduate School Program; Czech Ministry of Education [LD13054]	This work was supported by the "Charles University - NIMS Joint Graduate School Program." The authors also acknowledge financial support by the project LD13054, this project was financed by the Czech Ministry of Education.	Aboukais A, 2012, MATER CHEM PHYS, V137, P34, DOI 10.1016/j.matchemphys.2012.07.022; Liu SY, 2008, APPL CATAL A-GEN, V334, P92, DOI 10.1016/j.apcata.2007.09.037; Fu Q, 2003, CHEM ENG J, V93, P41, DOI 10.1016/S1385-8947(02)00107-9; Matolin V, 2010, LANGMUIR, V26, P12824, DOI 10.1021/la100399t; Rodriguez JA, 2007, TOP CATAL, V44, P73, DOI 10.1007/s11244-007-0280-1; FUJIMORI A, 1983, PHYS REV B, V28, P4489, DOI 10.1103/PhysRevB.28.4489; Zanella R, 2002, J PHYS CHEM B, V106, P7634, DOI 10.1021/jp0144810; Parvulescu VI, 2006, CHEM-EUR J, V12, P2343, DOI 10.1002/chem.200500971; Tang ZR, 2007, J CATAL, V249, P208, DOI 10.1016/j.jcat.2007.04.016; Chen YJ, 2001, J CATAL, V200, P59, DOI 10.1006/jcat.2001.3199; Oh HS, 2002, J CATAL, V210, P375, DOI 10.1006/jcat.2002.3710; Moreau F, 2005, J CATAL, V231, P105, DOI 10.1016/j.jcat.2005.01.030; Zhang L, 1999, SURF SCI, V439, P73, DOI 10.1016/S0039-6028(99)00734-7; Bond GC, 2000, GOLD BULL, V33, P41; BRUNELLE JP, 1978, PURE APPL CHEM, V50, P1211, DOI 10.1351/pac197850091211; Concepcion P, 2006, APPL CATAL A-GEN, V307, P42, DOI 10.1016/j.apcata.2006.03.004; Huang XS, 2009, APPL CATAL B-ENVIRON, V90, P224, DOI 10.1016/j.apcatb.2009.03.015; [Anonymous], 2010, NANOSCALE RES LETT, DOI [DOI 10.1007/S11671-010-9772-1, 10.1007/s11671-010-9772-1]; Corma A, 2006, SCIENCE, V313, P332, DOI 10.1126/science.1128383; Kung HH, 2003, J CATAL, V216, P425, DOI 10.1016/S0021-9517(02)00111-2; Chen Y, 2008, SURF SCI, V602, P1736, DOI 10.1016/j.susc.2008.02.036; Skala T, 2009, J ELECTRON SPECTROSC, V169, P20, DOI 10.1016/j.elspec.2008.10.003; Haruta M, 1997, CATAL TODAY, V36, P153, DOI 10.1016/S0920-5861(96)00208-8; Bondzie VA, 1999, CATAL LETT, V63, P143, DOI 10.1023/A:1019012903936; Milone C, 2003, CHEM COMMUN, P868, DOI 10.1039/b212441f; Hashmi ASK, 2006, ANGEW CHEM INT EDIT, V45, P7896, DOI 10.1002/anie.200602454; Gomez-Cortes A, 2009, J PHYS CHEM C, V113, P9710, DOI 10.1021/jp810905n; Veith GM, 2009, J CATAL, V262, P92, DOI 10.1016/j.jcat.2008.12.005; Briggs D., 1990, PRACTICAL SURFACE AN; Carrettin S, 2005, APPL CATAL A-GEN, V291, P247, DOI 10.1016/j.apcata.2005.01.047; Fiala R, 2011, J NANOSCI NANOTECHNO, V11, P5062, DOI 10.1166/jnn.2011.4128; Fiala R, 2015, CATAL TODAY, V240, P236, DOI 10.1016/j.cattod.2014.03.069; Iordanova I, 2007, THIN SOLID FILMS, V515, P8078, DOI 10.1016/j.tsf.2007.04.021; Kosmulski M., 2001, CHEM PROPERTIES MAT; Radnik J., 2003, Physical Chemistry Chemical Physics, V5, DOI 10.1039/b207290d; ZAFIRIS GS, 1993, J CATAL, V143, P86, DOI 10.1006/jcat.1993.1255; Zheng XL, 2010, IND ENG CHEM RES, V49, P10428, DOI 10.1021/ie100547f	37	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-207X			VACUUM	Vacuum	APR	2015	114				SI		86	92		10.1016/j.vacuum.2015.01.005		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CD7CF	WOS:000351247700016		
J	Kato, H; Nakayama, T; Uruma, M; Okuyama, Y; Handa, M; Tomiyama, Y; Shimodaira, S; Takamoto, S				Kato, H.; Nakayama, T.; Uruma, M.; Okuyama, Y.; Handa, M.; Tomiyama, Y.; Shimodaira, S.; Takamoto, S.			A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history	VOX SANGUINIS			English	Article						adverse transfusion reaction; allergic reaction; first transfusion; haemovigilance; transfusion episode	CONTROLLED-TRIAL; PLATELETS; FEBRILE; PRESTORAGE; LEUKOREDUCTION; ACETAMINOPHEN; HEMOVIGILANCE; REDUCTION; RISK	Background and ObjectivesThis study compares the frequency of adverse transfusion reactions (ATRs) after first transfusions with the frequency of ATRs for subsequent (non-first) transfusions. Materials and MethodsFive hospitals agreed to systematically collect and share 2years of data. This was a retrospective observational analysis of data including the number of transfusion episodes and ATRs for red blood cells (RBCs), fresh frozen plasma (FFP) and platelet concentrates (PCs) given to first-time transfusion recipients and to those previously transfused. ResultsFirst transfusion ATRs to RBCs, FFP and PCs were 108%, 284% and 334%, respectively. These are higher than ATR incidences to RBCs (069%), FFP (191%) and PCs (275%) on subsequent transfusions. Specifically, first transfusion incidences of febrile non-haemolytic transfusion reactions (FNHTRs) to RBCs (043%) and allergic reactions to FFP (251%) were higher than on subsequent transfusions (RBCs: 023%, FFP: 165%). ConclusionThere are risks of ATRs on the first transfusion as well as transfusions of patients with transfusion history.	[Kato, H.; Nakayama, T.; Uruma, M.; Takamoto, S.] Aichi Med Univ, Dept Transfus Med, Nagakute, Aichi 4801195, Japan; [Okuyama, Y.] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Transfus & Cell Therapy, Tokyo, Japan; [Handa, M.] Keio Univ, Dept Transfus Med & Cell Therapy, Tokyo, Japan; [Tomiyama, Y.] Osaka Univ Hosp, Dept Blood Transfus, Suita, Osaka, Japan; [Shimodaira, S.] Shinshu Univ Hosp, Div Transfus Med, Matsumoto, Nagano, Japan; [Takamoto, S.] Japanese Red Cross Hokkaido Block Blood Ctr, Sapporo, Hokkaido, Japan	Kato, H (reprint author), Aichi Med Univ, Dept Transfus Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	hkato@aichi-med-u.ac.jp			Ministry of Health Labour and Welfare of Japan	All authors contributed to the design, analysis and manuscript preparation. The authors thank Dr. Kenneth Nollet (Fukushima Medical University) for valuable discussion of the article. This study was supported by a grant from the Ministry of Health Labour and Welfare of Japan (Research on Regulatory Science of Pharmaceutical and Medical Devices 'Establishing a monitoring system for adverse reaction of blood transfusion').	Ahmed S G, 2002, Niger Postgrad Med J, V9, P137; Osselaer JC, 2008, VOX SANG, V94, P315, DOI 10.1111/j.1423-0410.2007.01035.x; Kennedy LD, 2008, TRANSFUSION, V48, P2285, DOI 10.1111/j.1537-2995.2008.01858.x; Tobian AAR, 2011, TRANSFUSION, V51, P1676, DOI 10.1111/j.1537-2995.2010.03008.x; Wang RR, 2012, AM J CLIN PATHOL, V138, P255, DOI 10.1309/AJCP5H7EKZTGGBKZ; Savage WJ, 2011, TRANSFUSION, V51, P1716, DOI 10.1111/j.1537-2995.2010.03009.x; Dodd RY, 2007, CURR OPIN HEMATOL, V14, P671; Andreu G, 2002, TRANSFUSION, V42, P1356, DOI 10.1046/j.1537-2995.2002.00202.x; Paglino JC, 2004, TRANSFUSION, V44, P16, DOI 10.1046/j.0041-1132.2004.00608.x; Heddle NM, 1999, TRANSFUSION, V39, P231, DOI 10.1046/j.1537-2995.1999.39399219278.x; Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754; Phipps RP, 2001, LANCET, V357, P2023, DOI 10.1016/S0140-6736(00)05108-4; Tobian AAR, 2007, TRANSFUSION, V47, P1089, DOI 10.1111/j.1537-2995.2007.01242.x; Savage W, 2014, TRANSFUSION, V54, P496, DOI 10.1111/trf.12488; Stainsby D, 2006, TRANSFUS MED REV, V20, P273, DOI 10.1016/j.tmrv.2006.05.002; Kato H, 2013, AM J CLIN PATHOL, V140, P219, DOI 10.1309/AJCP6SBPOX0UWHEK; Brozovic B, 1986, MANUAL CLIN BLOOD TR, P95; Chudziak D, 2009, VOX SANG, V96, P163, DOI 10.1111/j.1423-0410.2008.01132.x; Edvardsen L, 1998, BRIT J HAEMATOL, V103, P445, DOI 10.1046/j.1365-2141.1998.00990.x; Garraud O, 2012, TRANSFUS CLIN BIOL, V19, P104, DOI 10.1016/j.tracli.2012.02.004; Geiger TL, 2007, TRANSFUS MED REV, V21, P1, DOI 10.1016/j.tmrv.2006.09.001; Heddle N M, 1999, Curr Opin Hematol, V6, P420, DOI 10.1097/00062752-199911000-00012; International Haemovigilance Network, 2011, ISBT WORK PART HAEM; Jo J, 2014, MEDIAT INFLAMM, DOI 10.1155/2014/249784; Klein HG, 2001, AABB ASS B; Marti-Carvajal AJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007539.pub2; Maunsell K, 1944, Br Med J, V2, P236; Strong DM, 2008, ISBT SCI SERIES, V3, P77, DOI 10.1111/j.1751-2824.2008.00168.x; U. S. Food and Drug Administration, 2011, FAT REP FDA FOLL BLO; Wadhwa M, 1996, BRIT J HAEMATOL, V93, P225, DOI 10.1046/j.1365-2141.1996.4611002.x; Wakamoto S, 2003, TRANSFUSION, V43, P1038, DOI 10.1046/j.1537-2995.2003.00458.x	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0042-9007	1423-0410		VOX SANG	Vox Sang.	APR	2015	108	3					243	250		10.1111/vox.12208		8	Hematology	Hematology	CE0CW	WOS:000351473000005		
J	Sano, R; Nogawa, M; Nakajima, T; Takahashi, Y; Takahashi, K; Kubo, R; Kominato, Y; Yokohama, A; Tsukada, J; Yamao, H; Kishida, T; Ogasawara, K; Uchikawa, M				Sano, R.; Nogawa, M.; Nakajima, T.; Takahashi, Y.; Takahashi, K.; Kubo, R.; Kominato, Y.; Yokohama, A.; Tsukada, J.; Yamao, H.; Kishida, T.; Ogasawara, K.; Uchikawa, M.			Blood group B gene is barely expressed in in vitro erythroid culture of B-m-derived CD34(+) cells without an erythroid cell-specific regulatory element	VOX SANGUINIS			English	Article						ABO gene; B-m; enhancer	POLYMERASE-CHAIN-REACTION; ABO TRANSCRIPT LEVELS; CHROMATIN OCCUPANCY; A(M) PHENOTYPE; HYBRID ALLELE; GROUP SYSTEM; DIFFERENTIATION; INDIVIDUALS; DIVERSITY; PATTERNS	Background and Objectives Previously, a weak phenotype A(m) or B-m was assumed to be caused by a reduction of A or B gene expression in bone marrow cells, but not in mucus-secreting cells. However, ABO expression has not been examined in erythroid progenitor cells of A(m) or B-m individuals. Materials and Methods We carried out in vitro erythroid differentiation of CD34(+) cells from peripheral blood of a B-m individual harbouring a 3.0-kb deletion including an erythroid cell-specific regulatory element, named the +5.8-kb site, in intron 1 of the human ABO blood group gene. Results During the in vitro differentiation of CD34(+) cells from this B-m individual into erythroid cells, B-antigens were not detectable on the cultured cells by flow cytometric analysis, and allele-specific RT-PCR consistently detected the transcripts from the O allele, but not from the B allele. Moreover, chromatin immunoprecipitation assay demonstrated that both RUNX1 and GATA-2 or GATA-1 were bound to the +5.8-kb site in cultured erythroid cells expressing ABO. Conclusion It is likely that the +5.8-kb site enhances transcription from the ABO promoter in erythroid cells through binding of RUNX1 and GATA-2 or GATA-1.	[Sano, R.; Nakajima, T.; Takahashi, Y.; Takahashi, K.; Kubo, R.; Kominato, Y.] Gunma Univ, Dept Legal Med, Grad Sch Med, Maebashi, Gumma 3718511, Japan; [Nogawa, M.; Ogasawara, K.] Japanese Red Cross Cent Blood Inst, Div Blood Res, Tokyo, Japan; [Yokohama, A.] Gunma Univ Hosp, Blood Transfus Serv, Maebashi, Gumma, Japan; [Tsukada, J.] Univ Occupat & Environm Hlth, Canc Chemotherapy Ctr & Hematol, Kitakyushu, Japan; [Yamao, H.] Inoue Hosp, Obstet & Gynecol, Nobeoka, Japan; [Kishida, T.] Oita Univ, Sch Med, Legal Med, Yuhu, Japan; [Uchikawa, M.] Japanese Red Cross Kanto Koshinetsu Block Blood C, Div Blood Res, Tokyo, Japan	Sano, R (reprint author), Gunma Univ, Dept Legal Med, Grad Sch Med, Maebashi, Gumma 3718511, Japan.	takagirie@gunma-u.ac.jp			Japan Society for the Promotion of Science [25460861, 25860486, 26293161]	This work was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science (25460861 to T.N., 25860486 to Y.T., 26293161 to Y.K.).	Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Ogasawara K, 1996, BLOOD, V88, P2732; Miharada K, 2006, NAT BIOTECHNOL, V24, P1255, DOI 10.1038/nbt1245; Hosseini-Maaf B, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-17; Bresnick EH, 2005, J CELL PHYSIOL, V205, P1, DOI 10.1002/jcp.20393; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Sano R, 2014, BLOOD TRANSFUS-ITALY, V12, P431, DOI 10.2450/2014.0162-13; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Pencovich N, 2011, BLOOD, V117, pE1, DOI 10.1182/blood-2010-07-295113; Yu LC, 2002, BLOOD, V100, P1490, DOI 10.1182/blood-2002-01-0188; Chester MA, 2001, TRANSFUS MED REV, V15, P177, DOI 10.1053/tm.2001.24591; Asamura H, 2002, VOX SANG, V83, P263, DOI 10.1046/j.1423-0410.2002.00221.x; Cai XH, 2013, TRANSFUSION, V53, P2910, DOI 10.1111/trf.12168; Daniels G., 2013, HUMAN BLOOD GROUPS; Edvardsson L, 2004, BRIT J HAEMATOL, V127, P451, DOI 10.1111/j.1365-2141.2004.05227.x; Hansen T, 1998, VOX SANG, V75, P47, DOI 10.1159/000030957; Iwasaki M, 2000, JPN J TRANSFUS MED, V46, P532; Kamaleldin EE, 2003, BLOOD, V101, P4333; Koda Y, 1997, J BIOL CHEM, V272, P7501; Kominato Y, 2007, BBA-GEN SUBJECTS, V1770, P1567, DOI 10.1016/j.bbagen.2007.08.012; Kominato Y, 2002, J BIOL CHEM, V277, P37936, DOI 10.1074/jbc.M204238200; Langlois RG, 1990, CYTOMETRY, V3, P67; Lin M, 2005, TRANSFUSION, V45, P63, DOI 10.1111/j.1537-2995.2005.04132.x; Nakajima T, 2013, TRANSFUSION, V53, P2917, DOI 10.1111/trf.12181; Noh SJ, 2010, TRANSFUS CLIN BIOL, V17, P120, DOI 10.1016/j.tracli.2010.06.010; Ogasawara K, 2001, IMMUNOGENETICS, V53, P190, DOI 10.1007/s002510100315; OLSSON ML, 1995, BIOCHEM BIOPH RES CO, V216, P642, DOI 10.1006/bbrc.1995.2670; Sano R, NOVEL 3 0 K IN PRESS; Sano R, 2012, BLOOD, V119, P5301, DOI 10.1182/blood-2011-10-387167; Selsam A, 2005, TRANSFUSION, V45, P1663; Takahashi Y, 2014, VOX SANG, V106, P165; Takahashi Y, 2014, VOX SANG, V106, P167, DOI 10.1111/vox.12077; Thuresson B, 2012, VOX SANG, V102, P55, DOI 10.1111/j.1423-0410.2011.01497.x; Thuresson B, 2008, TRANSFUSION, V48, P493, DOI 10.1111/j.1537-2995.2007.01554.x; Yamamoto F, 2000, VOX SANG, V78, P91	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0042-9007	1423-0410		VOX SANG	Vox Sang.	APR	2015	108	3					302	309		10.1111/vox.12220		8	Hematology	Hematology	CE0CW	WOS:000351473000013		
J	Sano, R; Kuboya, E; Nakajima, T; Takahashi, Y; Takahashi, K; Kubo, R; Kominato, Y; Takeshita, H; Yamao, H; Kishida, T; Isa, K; Ogasawara, K; Uchikawa, M				Sano, R.; Kuboya, E.; Nakajima, T.; Takahashi, Y.; Takahashi, K.; Kubo, R.; Kominato, Y.; Takeshita, H.; Yamao, H.; Kishida, T.; Isa, K.; Ogasawara, K.; Uchikawa, M.			A 3.0-kb deletion including an erythroid cell-specific regulatory element in intron 1 of the ABO blood group gene in an individual with the B-m phenotype	VOX SANGUINIS			English	Article						ABO gene; B-m; enhancer; SSP-PCR; transcription	TRANSCRIPT LEVELS; ENHANCER	We developed a sequence-specific primer PCR (SSP-PCR) for detection of a 58-kb deletion (B(m)58) involving an erythroid cell-specific regulatory element in intron 1 of the ABO blood group gene. Using this SSP-PCR, we performed genetic analysis of 382 individuals with B-m or AB(m). The 58-kb deletion was found in 380 individuals, and disruption of the GATA motif in the regulatory element was found in one individual. Furthermore, a novel 30-kb deletion involving the element (B(m)30) was demonstrated in the remaining individual. Comparisons of single-nucleotide polymorphisms and microsatellites in intron 1 between B(m)58 and B(m)30 suggested that these deletions occurred independently.	[Sano, R.; Kuboya, E.; Nakajima, T.; Takahashi, Y.; Takahashi, K.; Kubo, R.; Kominato, Y.] Gunma Univ, Grad Sch Med, Dept Legal Med, Maebashi, Gumma 3718511, Japan; [Takeshita, H.] Shimane Univ, Sch Med, Dept Legal Med, Izumo, Shimane, Japan; [Yamao, H.] Inoue Hosp, Nobeoka, Japan; [Kishida, T.] Oita Univ, Dept Legal Med, Yuhu, Japan; [Isa, K.; Ogasawara, K.] Japanese Red Cross Cent Blood Inst, Tokyo, Japan; [Uchikawa, M.] Japanese Red Cross Kanto Koshinetsu Block Blood C, Tokyo, Japan	Sano, R (reprint author), Gunma Univ, Grad Sch Med, Dept Legal Med, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	takagirie@gunma-u.ac.jp			Japan Society for the Promotion of Science [25460861, 25860486, 26293161]	This work was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science (25460861 to T.N., 25860486 to Y.T., 26293161 to Y.K.).	Daniels G., 2013, HUMAN BLOOD GROUPS; Nakajima T, 2013, TRANSFUSION, V53, P2917, DOI 10.1111/trf.12181; Sano R, 2012, BLOOD, V119, P5301, DOI 10.1182/blood-2011-10-387167; Seltsam A, 2007, TRANSFUSION, V47, P2330, DOI 10.1111/j.1537-2995.2007.01475.x; Takahashi Y, 2014, VOX SANG, V107, P171, DOI 10.1111/vox.12136; Takahashi Y, 2014, VOX SANG, V106, P165; Thuresson B, 2012, VOX SANG, V102, P55, DOI 10.1111/j.1423-0410.2011.01497.x; Thuresson B, 2008, TRANSFUSION, V48, P493, DOI 10.1111/j.1537-2995.2007.01554.x; Yamamoto F, 2000, VOX SANG, V78, P91	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0042-9007	1423-0410		VOX SANG	Vox Sang.	APR	2015	108	3					310	313		10.1111/vox.12216		4	Hematology	Hematology	CE0CW	WOS:000351473000014		
J	Marquez, GPB; Reichardt, WT; Azanza, RV; Onda, DFL; Lluisma, AO; Montano, MNE				Marquez, Gian Powell B.; Reichardt, Wolfgang T.; Azanza, Rhodora V.; Onda, Deo Florence L.; Lluisma, Arturo O.; Montano, Marco Nemesio E.			Dominance of Hydrogenotrophic Methanogens at the Peak of Biogas Production in Thalassic Digesters	WASTE AND BIOMASS VALORIZATION			English	Article						Fluorescence in situ hybridization; Methane; Methanogens; Seaweed; Thalassic	OLIGONUCLEOTIDE PROBES; BACTERIA; COMMUNITIES; SALINITY; ARCHAEA; ACETATE; BIOMASS; WASTE	Marine biomasses used in biogasification system are usually treated as terrestrial feedstock after salt removal. However, biogas production of sea wrack biomass run under thalassic (marine) conditions, and seeded with different inocula [cow manure (CM), marine sediment (MS) and sea wrack-associated (SWA) microflora] showed the potential for cheaper alternative to freshwater utilization (terrestrial conditions). To understand how methane yield is affected by the different inoculants under thalassic conditions, methanogenic communities in these digesters (CM, MS, SWA) were quantified using double-labeled oligonucleotide probes to a modified fluorescence in situ hybridization at the peak of biogas production. Total targeted methanogens were highest in SWA (1.51 +/- A 0.53 x 10(7) cells ml(-1)) while lowest in CM (1.79 +/- A 0.20 x 10(6) cells ml(-1)). Among all types of targeted methanogens, hydrogenotrophs (Methanobacteriales and Methanomicrobiales) dominated in all digesters (CM 73.2 +/- A 7 %, MS 58.4 +/- A 8.0 %, SWA 61.2 +/- A 5.4 %). Moreover, MS showed mixotrophic Methanosarcinaceae (30.2 +/- A 8.1 %) co-dominance, suggesting that their population could have influenced the higher methane yield in MS.	[Marquez, Gian Powell B.] Nagoya Univ, EcoTopia Sci Inst, Grad Sch Engn, Hasegawas Lab,Dept Aerosp Engn, Nagoya, Aichi 4648603, Japan; [Reichardt, Wolfgang T.; Azanza, Rhodora V.; Onda, Deo Florence L.; Lluisma, Arturo O.; Montano, Marco Nemesio E.] Univ Philippines, Inst Marine Sci, Quezon City 1101, Philippines	Marquez, GPB (reprint author), Nagoya Univ, EcoTopia Sci Inst, Grad Sch Engn, Hasegawas Lab,Dept Aerosp Engn, Room 524, Nagoya, Aichi 4648603, Japan.	g.p.b.marquez@yuki.esi.nagoya-u.ac.jp			Marine Science Institute; DOST-PCAMRD Scholarship; DA-Biotech through Fucoidan Project; SPEX Project; DOST-PCAMRD through the PhilHABS project	This work was supported by the Marine Science Institute, the DOST-PCAMRD Scholarship, the DA-Biotech through Fucoidan Project and SPEX Project, and the DOST-PCAMRD through the PhilHABS project. The corresponding author would also like to acknowledge the unwavering support of Engr. Joselito P. Marquez, Alper James Alcaraz, Dang Marviluz Espita, Joyce Nieva, Deanna Luciano, Wilfred John Santianez, and the rest of the Seaweed Chemistry and HAB Laboratory staff; and the critical discussion, technical support and probes provision of Dr. Michael Klocke and Dr. Ingo Bergmann of the Leibnitz Institut fur Agrartechnik, Potsdam, Germany. This is the Marine Science Institute (University of the Philippines) contribution no. 434.	Shah FA, 2014, SCI WORLD J, DOI 10.1155/2014/183752; Rademacher A, 2012, FEMS MICROBIOL ECOL, V79, P785, DOI 10.1111/j.1574-6941.2011.01265.x; Pope PB, 2013, 3 BIOTECH, V3, P407, DOI 10.1007/s13205-012-0097-x; Loy A, 2003, NUCLEIC ACIDS RES, V31, P514, DOI 10.1093/nar/gkg015; Marquez GPB, 2013, BIORESOURCE TECHNOL, V133, P612, DOI 10.1016/j.biortech.2013.01.082; Santegoeds CM, 1999, APPL ENVIRON MICROB, V65, P4618; Imachi H, 2011, ISME J, V5, P1913, DOI 10.1038/ismej.2011.64; Crocetti G, 2006, J MICROBIOL METH, V65, P194, DOI 10.1016/j.mimet.2005.07.007; Karakashev D, 2006, APPL ENVIRON MICROB, V72, P5138, DOI 10.1128/AEM.00489-06; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232; LOWE SE, 1993, MICROBIOL REV, V57, P451; Marquez GPB, 2014, RENEW SUST ENERG REV, V38, P1056, DOI 10.1016/j.rser.2014.07.056; Pfluger K, 2003, APPL ENVIRON MICROB, V69, P6047, DOI 10.1128/AEM.69.10.6047-6055.2003; Nettmann E, 2010, APPL ENVIRON MICROB, V76, P2540, DOI 10.1128/AEM.01423-09; Daims H, 2005, ADV METHODS MOL MICR, P213; KADAM PC, 1989, FEMS MICROBIOL ECOL, V62, P343; Kumar S, 2011, NATURWISSENSCHAFTEN, V98, P457, DOI 10.1007/s00114-011-0791-2; MACKIE RI, 1981, APPL ENVIRON MICROB, V41, P1363; Sakai S, 2008, INT J SYST EVOL MICR, V58, P929, DOI 10.1099/ijs.0.65571-0; Stahl DA, 1991, NUCL ACID TECHNIQUES, P205; Traversi D, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-28; Vavilin VA, 2008, ANTON LEEUW INT J G, V94, P593, DOI 10.1007/s10482-008-9279-2; Zinder SH, 1993, METHANOGENESIS ECOLO, V1, P128	23	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-2641	1877-265X		WASTE BIOMASS VALORI	Waste Biomass Valorization	APR	2015	6	2					201	207		10.1007/s12649-014-9325-4		7	Environmental Sciences	Environmental Sciences & Ecology	CD7TY	WOS:000351297300007		
J	Chen, F; Yamashita, K; Kurokawa, J; Klimont, Z				Chen, Fang; Yamashita, Ken; Kurokawa, Junichi; Klimont, Zbigniew			Cost-Benefit Analysis of Reducing Premature Mortality Caused by Exposure to Ozone and PM2.5 in East Asia in 2020	WATER AIR AND SOIL POLLUTION			English	Article						Cost-benefit analysis; GAINS-China; VSL; Ozone; PM2.5; East Asia	WILLINGNESS-TO-PAY; AIR-POLLUTION; CONTINGENT VALUATION; EMISSION INVENTORY; GREENHOUSE GASES; RISK REDUCTIONS; BOUNDARY-LAYER; QUALITY; HEALTH; CHINA	In this paper, we compared the costs and benefits of reducing premature mortality caused by exposure to surface ozone and particulate matter with an aerodynamic diameter <2.5 mu m (PM2.5) in East Asia in 2020. The cost of ozone and PM2.5 emission reduction is estimated using the Greenhouse Gas and Air Pollution Interactions and Synergies (GAINS)-China model. The benefit of reducing premature mortality caused by exposure to corresponding ozone and PM2.5 emission is valued by the value of statistical life (VSL). The costs and benefits are evaluated for two emission reduction policies in 2020 with varying stringency in China: Case FS (the strict policy implementation case in China) and Case FR (the less strict policy implementation case in China). For ozone, the emission reduction cost and the benefit of life saving are 33,000 and 8200, 36,60099,700 and 22,200-60,700 (million int. $, 2005), for Case FS and Case FR, respectively. The corresponding cost and benefit for PM2.5 are 3580 and 523, 292,000797,000 and 194,000-530,000 (million int. $, 2005), respectively. In total (ozone and PM2.5), the respective values are 36,400 and 8720, 329,000-897,000 and 217,000-591,000 (million int. $, 2005). Owing to these large benefits and also relatively low PM control costs, the benefits of controlling PM2.5 surpass control costs significantly. The benefit/cost ratio is especially high for PM2.5 for both policies and highlight the priority of controlling aerosol emissions in East Asia.	[Chen, Fang; Yamashita, Ken; Kurokawa, Junichi] Asia Ctr Air Pollut Res, Nishi Ku, Niigata, Niigata 9502144, Japan; [Klimont, Zbigniew] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria	Chen, F (reprint author), Asia Ctr Air Pollut Res, Nishi Ku, 1182 Sowa, Niigata, Niigata 9502144, Japan.	chenfang614@gmail.com; yamashita.ken@home.nifty.jp; kurokawa@acap.asia; klimont@iiasa.ac.at	Klimont, Zbigniew/P-7641-2015	Klimont, Zbigniew/0000-0003-2630-198X	Ministry of Environment, Japan [S7-33]	We thank emeritus Prof. Iwao Uchiyama, Kyoto University; Prof. Kazuhiko Kobayashi, The University of Tokyo; Dr. Hajime Akimoto, ACAP; and Dr. Amin Nawahda, Sohar University, for their support and useful comments. We also thank the Ministry of Environment, Japan, for the Environment Research and Technology Development Fund within Project S7-33: Research on Science-Policy Interactions in Environmental Atmospheric Management in East Asia.	Alberini A, 2006, ENVIRON RESOUR ECON, V33, P251, DOI 10.1007/s10640-005-3106-2; Li J, 2004, J ENVIRON MANAGE, V70, P49, DOI 10.1016/j.jenvman.2003.10.007; Krupnick A, 2002, J RISK UNCERTAINTY, V24, P161, DOI 10.1023/A:1014020027011; Yamaji K, 2006, ATMOS ENVIRON, V40, P1856, DOI 10.1016/j.atmosenv.2005.10.067; Hammitt JK, 2006, ENVIRON RESOUR ECON, V33, P399, DOI 10.1007/s10640-005-3606-0; Wang H, 2006, SCI TOTAL ENVIRON, V367, P50, DOI 10.1016/j.scitotenv.2006.02.049; Amann M, 2011, ENVIRON MODELL SOFTW, V26, P1489, DOI 10.1016/j.envsoft.2011.07.012; Kurokawa J, 2009, ATMOS CHEM PHYS, V9, P6287; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419; Nawahda A, 2012, WATER AIR SOIL POLL, V223, P3445, DOI 10.1007/s11270-012-1123-7; Kurokawa J, 2013, ATMOS CHEM PHYS, V13, P11019, DOI 10.5194/acp-13-11019-2013; Kan HD, 2004, SCI TOTAL ENVIRON, V322, P71, DOI 10.1016/j.scitoenv.2003.09.010; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; Amann M, 2000, J HAZARD MATER, V78, P41, DOI 10.1016/S0304-3894(00)00216-8; Bickel P., 2004, EXTERNE EXTERNALITIE; Birol F., 2011, WORLD ENERGY OUTLOOK; Brajer V, 2004, URBAN STUD, V41, P1567, DOI 10.1080/0042098042000227019; Cofala J., 1998, NITROGEN OXIDES EMIS; Hammitt JK, 2011, J BENEFIT COST ANAL, V2, P1, DOI DOI 10.2202/2152-2812; Itaoka K., 2005, AGE HLTH WILLINGNESS; Johnson T., 1997, CLEAR WATER BLUE SKI, V2; Klimont Z., 2000, IR0051 INT I APPL SY; Klimont Z., 2002, IR02076 IIASA; Lim SS, 2013, LANCET, V380, P2224, DOI DOI 10.1016/S0140-6736(12)61766-8; Nawahda A, 2013, ATMOS ENVIRON, V81, P538, DOI 10.1016/j.atmosenv.2013.09.049; Nawahda A., 2013, WATER AIR SOIL POLL, V224, P1; OECD, 2012, MORT RISK VAL ENV HL, DOI [10.1787/9789264130807-en, DOI 10.1787/9789264130807-EN]; Pan X., 2012, DANGEROUS BREATHE HL; Ramanathan V., 2008, IMPACTS ATMOSPHERIC; Robinson LA, 2007, REV ENV ECON POLICY, V1, P283, DOI 10.1093/reep/rem018; Rosen S., 1986, HDB LABOR EC, P641, DOI 10.1016/S1573-4463(86)01015-5; Thaler R., 1976, HOUSEHOLD PRODUCTION, P265; Tuinstra W, 2007, ENVIRON SCI POLICY, V10, P434, DOI 10.1016/j.envsci.2007.01.006; US Environmental Protection Agency Office of Air and Radiation (USEPA), 2011, BEN COSTS CLEAN AIR; Wang H., 2010, 5421 WORLD BANK DEV; Zhang M., 2004, SCI TOTAL ENVIRON, V376, P100; Zhang X., 2002, VALUING MORTALITY RI	37	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0049-6979	1573-2932		WATER AIR SOIL POLL	Water Air Soil Pollut.	APR	2015	226	4							108	10.1007/s11270-015-2316-7		17	Environmental Sciences; Meteorology & Atmospheric Sciences; Water Resources	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences; Water Resources	CE0UT	WOS:000351523700025		
J	He, SL; Huang, Q; Zhang, Y; Nie, YL				He, Shi-Long; Huang, Qing; Zhang, Yong; Nie, Yu-Lun			Evaluation of the Performance of Different Anodes in the Electrochemical Oxidation of Ammonia	WATER AIR AND SOIL POLLUTION			English	Article						Anode; Electrochemical properties; Electrochemical techniques; Ammonia removal	NITROGEN REMOVAL; WASTE-WATER; ELECTROOXIDATION; ELECTROCATALYSTS; ELECTRODE; LEACHATE; KINETICS	Three commercial electrodes, Ta-Ir/TiO2, RhIr/TiO2, and PbO2/TiO2, were used as electrochemical anodes, and their performance was evaluated by the electrochemical oxidation of ammonia at neutral pH in a continuous electrochemical quadrangular reactor. Based on the cyclic voltammetry scans and voltampere relation analysis, in direct oxidation, the oxygen evolution from H2O2 decomposition was completely inhibited, and more center dot OH radicals could be then generated over PbO2/TiO2 and in the presence of powder activated carbon (PAC). PbO2/TiO2 can be indicated as an appropriate for the direct electrooxidation of ammonia in an unpacked bed reactor. While the efficiency for direct oxidation of ammonia was similar for the three anodes in a PAC packed reactor due to the presence of PAC could avoid short circuit and enhance electric efficiency. In indirect oxidation mediated by active free chlorine, Rh-Ir/TiO2 was the most effective in ammonia removal when chloride was present in the reaction system, and the disappeared ammonia was mainly transferred to N-2, and only a small part was converted into nitrate (there was no nitrite detected during the reaction). The results indicated that Rh-Ir/TiO2 had the highest oxidation capability for ammonia compared with Ta-Ir/TiO2 and PbO2/TiO2. Hence, Rh-Ir/TiO2 based on a PAC packed bed reactor provides an alternative for the treatment of ammonia wastewater with high chloride concentration.	[Nie, Yu-Lun] Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, Sendai, Miyagi 9808579, Japan; [He, Shi-Long; Huang, Qing] China Univ Min & Technol, Sch Environm & Spatial Informat, Xuzhou 221116, Jiangsu, Peoples R China; [Zhang, Yong] Res Ctr Ecoenvironm Sci Shanxi, Taiyuan 030009, Peoples R China	Nie, YL (reprint author), Tohoku Univ, Grad Sch Environm Studies, Aoba Ku, 6-6-06 Aza Aoba, Sendai, Miyagi 9808579, Japan.	hslongrcees@163.com; nieyulun@gmail.com			Fundamental Research Funds for the Central Universities [2014QNA31]	The authors gratefully acknowledge the financial support by the Fundamental Research Funds for the Central Universities (2014QNA31).	Kapalka A, 2010, ELECTROCHEM COMMUN, V12, P1714, DOI 10.1016/j.elecom.2010.10.004; Cabeza A, 2007, IND ENG CHEM RES, V46, P1439, DOI 10.1021/ie061373x; Zheng YA, 2012, CHEM ENG J, V179, P90, DOI 10.1016/j.cej.2011.10.064; Li XZ, 1999, WASTE MANAGE, V19, P409, DOI 10.1016/S0956-053X(99)00148-8; Li M, 2009, J HAZARD MATER, V171, P724, DOI 10.1016/j.jhazmat.2009.06.066; Kuypers MMM, 2003, NATURE, V422, P608, DOI 10.1038/nature01472; Perez G, 2012, CHEM ENG J, V197, P475, DOI 10.1016/j.cej.2012.05.062; Wang LZ, 2008, J HAZARD MATER, V160, P608, DOI 10.1016/j.jhazmat.2008.03.034; Jorgensen TC, 2003, WATER RES, V37, P1723, DOI 10.1016/S0043-1354(02)00571-7; Wang YQ, 2006, J HAZARD MATER, V136, P735, DOI 10.1016/j.jhazmat.2006.01.002; Diaz LA, 2013, ELECTROCHIM ACTA, V89, P413, DOI 10.1016/j.electacta.2012.11.064; Szpyrkowicz L, 2005, WATER RES, V39, P1601, DOI 10.1016/j.watres.2005.01.016; Xiao SH, 2009, WATER RES, V43, P1432, DOI 10.1016/j.watres.2008.12.023; Khuntia S, 2013, IND ENG CHEM RES, V52, P318, DOI 10.1021/ie302212p; Bonmati A, 2003, WASTE MANAGE, V23, P261, DOI 10.1016/S0956-053X(02)00144-7; Zhong C, 2013, J MATER CHEM A, V1, P3216, DOI 10.1039/c2ta00607c; APHA, 2012, STANDARD METHODS EXA; Candido L, 2011, MATER CHEM PHYS, V129, P1146, DOI 10.1016/j.matchemphys.2011.05.080; Choi JW, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2059-x; Kalyuzhnyi S, 2006, WATER RES, V40, P3637, DOI 10.1016/j.watres.2006.06.010; Liang WZ, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-013-1812-x; Liu J., 2014, BIORESOURCE TECHNOLO, V143, P32; Lomocso T. L., 2011, ELECTROCHIMICA ACTA, V56; Michels NL, 2010, ELECTROCHEM COMMUN, V12, P1199, DOI 10.1016/j.elecom.2010.06.018; Nie YL, 2009, APPL CATAL B-ENVIRON, V87, P30, DOI 10.1016/j.apcatb.2008.08.022; OBAIDURREHMAN S, 1990, J ENVIRON SCI HEAL A, V25, P343; PRESSLEY TA, 1972, ENVIRON SCI TECHNOL, V6, P622, DOI 10.1021/es60066a006; TRAMPER J, 1986, ENZYME MICROB TECH, V8, P477, DOI 10.1016/0141-0229(86)90051-7; Yao K, 2008, MATER CHEM PHYS, V108, P247, DOI 10.1016/j.matchemphys.2007.09.030; Yao K, 2007, J POWER SOURCES, V173, P96, DOI 10.1016/j.jpowsour.2007.04.081	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0049-6979	1573-2932		WATER AIR SOIL POLL	Water Air Soil Pollut.	APR	2015	226	4							89	10.1007/s11270-015-2364-z		7	Environmental Sciences; Meteorology & Atmospheric Sciences; Water Resources	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences; Water Resources	CE0UT	WOS:000351523700006		
J	Harada, N; Shirabe, K; Maeda, T; Kayashima, H; Ishida, T; Maehara, Y				Harada, Noboru; Shirabe, Ken; Maeda, Takashi; Kayashima, Hiroto; Ishida, Teruyoshi; Maehara, Yoshihiko			Blood Transfusion is Associated with Recurrence of Hepatocellular Carcinoma After Hepatectomy in Child-Pugh Class A Patients	WORLD JOURNAL OF SURGERY			English	Article							MARGINAL STRUCTURAL MODELS; RESECTION; INFERENCE; SURVIVAL; UPDATE	Previous reports have indicated an association between blood transfusion and prognosis of hepatocellular carcinoma (HCC) after hepatectomy. However, clinicopathological biases were not adjusted in these studies. We aimed to clarify the effect of blood transfusions in patients with HCC and Child-Pugh class A after hepatectomy by using inverse probability of treatment weighting (IPTW) analysis for selection bias control. We enrolled 479 patients with primary HCC and Child-Pugh class A retrospectively (91 transfused and 388 nontransfused patients) who underwent curative hepatectomy. After adjusting for different covariate distributions for both groups by IPTW, we analyzed the prognostic outcomes. In the unweighted analyses, overall survival (OS) rate of transfused patients was significantly lower than in nontransfused patients (P < 0.0001). Recurrence-free survival (RFS) rate of transfused patients was significantly lower than that of nontransfused patients (P = 0.0024). Multivariate analysis showed that blood transfusion was an independent prognostic factor of OS and RFS. The different distributive covariates between the two groups were age, presence of liver cirrhosis, serum level of alpha-fetoprotein, maximum tumor diameter, and amount of intraoperative blood loss. After IPTW by these covariates, OS rate of transfused patients was not significantly lower than those of nontransfused patients, whereas RFS rate of transfused patients remained significantly lower than those of nontransfused patients (P = 0.038, adjusted HR 1.45; 95 % CI 1.0-2.1). These results suggest that blood transfusion was associated with recurrence of HCC after hepatectomy in patients with HCC and Child-Pugh class A.	[Harada, Noboru; Maeda, Takashi; Kayashima, Hiroto; Ishida, Teruyoshi] Hiroshima Red Cross Hosp, Dept Surg, Hiroshima, Japan; [Harada, Noboru; Maeda, Takashi; Kayashima, Hiroto; Ishida, Teruyoshi] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Dept Surg & Med Sci, Grad Sch Med Sci, Fukuoka 812, Japan	Harada, N (reprint author), Hiroshima Red Cross Hosp, Dept Surg, Hiroshima, Japan.	nharada@surg2.med.kyushu-u.ac.jp					Shirabe K, 2011, WORLD J SURG, V35, P1072, DOI 10.1007/s00268-011-1013-y; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Joffe MM, 2004, AM STAT, V58, P272, DOI 10.1198/000313004X5824; Blajchman MA, 1998, VOX SANG, V74, P315; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Kuroda S, 2012, WORLD J SURG, V36, P651, DOI 10.1007/s00268-012-1425-3; Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Asahara T, 1999, WORLD J SURG, V23, P676; YAMAMOTO J, 1994, SURGERY, V115, P303; Takeishi K, 2011, WORLD J SURG, V35, P1063, DOI 10.1007/s00268-011-1017-7; Katz SC, 2009, ANN SURG, V249, P617, DOI 10.1097/SLA.0b013e31819ed22f; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Vamvakas EC, 2007, BLOOD REV, V21, P327, DOI 10.1016/j.blre.2007.07.003; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Austin PC, 2012, STAT MED, V32, P2837; Halpern EF, 2014, RADIOLOGY, V271, P625, DOI 10.1148/radiol.14140035; Hanazaki K, 2005, HEPATO-GASTROENTEROL, V52, P524; Itasaka H, 1995, HEPATO-GASTROENTEROL, V42, P465; Kew Michael C, 2014, Liver Cancer, V3, P31, DOI 10.1159/000343856; Makino Y, 2000, AM J GASTROENTEROL, V95, P1294; Yamashita YI, 2013, AM J SURG, V13, P522	29	1	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	APR	2015	39	4					1044	1051		10.1007/s00268-014-2891-6		8	Surgery	Surgery	CD6WN	WOS:000351231100029		
J	Inamori, T; Satou, Y; Sugawara, Y; Ohsaki, H				Inamori, Takaya; Satou, Yasutaka; Sugawara, Yoshiki; Ohsaki, Hiroyuki			Electromagnetic panel deployment and retraction in satellite missions	ACTA ASTRONAUTICA			English	Article						Extensible structure; Deployment; Retraction; Electromagnetic force	FUROSHIKI SATELLITE; POWER; PROPULSION; GRAPHENE; SYSTEM	An increasing number of satellites is presently utilizing extensible and deployable large area structures after launch, while in orbit. A deployment and retracting method using an electromagnetic force for extensible panels on satellites is proposed. Using the proposed method, a satellite can retract panels to a much smaller volume to avoid damage from space debris and achieve agile attitude maneuvers. Furthermore, panels can be deployed quasi-statically using electromagnetic forces to reduce the impulsive force exerted on fragile panels in the deployment operation. Finally, numerical simulations were conducted to assess the usefulness of the proposed method using multibody dynamics (MBD). From these simulations, the satellite can deploy 10 panels in 6000 s using 1 A current for a small cubic satellite of 20 cm dimension. Under the same conditions, the satellite can retract the 10 panels in 1400 s. (C) 2014 IAA. Published by Elsevier Ltd. All rights reserved.	[Inamori, Takaya; Ohsaki, Hiroyuki] Univ Tokyo, SYS C, Expt Room Elect Energy Syst 2F, Kashiwa, Chiba 2778561, Japan; [Satou, Yasutaka] Tokyo Inst Technol, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Sugawara, Yoshiki] Akita Univ, Engn & Resource Studies, Akita 010, Japan	Inamori, T (reprint author), Univ Tokyo, SYS C, Expt Room Elect Energy Syst 2F, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan.	takayainamori@gmail.com			JSPS KAKENHI [24-10554]; Hattori Hokokai Foundation [12-003]	This research was supported by JSPS KAKENHI (Grant number 24-10554) and by the Hattori Hokokai Foundation (Grant number 12-003).	Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Nakasuka S, 2001, ACTA ASTRONAUT, V48, P461, DOI 10.1016/S0094-5765(01)00056-X; Nakasuka S, 2006, ACTA ASTRONAUT, V58, P395, DOI 10.1016/j.actaastro.2005.12.010; Nagatomo M, 1996, SOL ENERGY, V56, P111, DOI 10.1016/0038-092X(95)00098-C; Wei YJ, 2013, NANO LETT, V13, P26, DOI 10.1021/nl303168w; Herbeck L, 2000, P EUR C SPAC STRUCT; Inamori T., 2012, P NAG UN JAP NAN S, V2008; Inamori Takaya, 2012, P SPAC SCI TECHN C; Lu Q, 2009, J PHYS D, V42; Mori B.O., 2008, DEV DEPLOYMENT SYSTE; Powell J, 2007, AIP CONF PROC, V880, P795; Powell J, 2010, AIP CONF PROC, V1208, P571, DOI 10.1063/1.3326287; Sawada H., 2011, P 52 AIAA ASME ASCE; Sugawara Y., 2013, P 22 SPAC ENG C TOK; Wittenburg J., 2008, DYNAMICS MULTIBODY S	15	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0094-5765	1879-2030		ACTA ASTRONAUT	Acta Astronaut.	APR-MAY	2015	109						14	24		10.1016/j.actaastro.2014.11.035		11	Engineering, Aerospace	Engineering	CD2SO	WOS:000350929500002		
J	McKenna-Lawlor, S; Bhardwaj, A; Ferrari, F; Kuznetsov, N; Lal, AK; Li, YH; Nagamatsu, A; Nymmik, R; Panasyuk, M; Petrov, V; Reitz, G; Pinsky, L; Shukor, M; Singhvi, AK; Straube, U; Tomi, L; Townsend, L				McKenna-Lawlor, Susan; Bhardwaj, Anil; Ferrari, Franco; Kuznetsov, Nikolay; Lal, Ajay K.; Li, Yinghui; Nagamatsu, Aiko; Nymmik, Rikho; Panasyuk, Michael; Petrov, Vladislav; Reitz, Guenther; Pinsky, Lawrence; Shukor, Muszaphar (Sheikh); Singhvi, Ashok K.; Straube, Ulrich; Tomi, Leena; Townsend, Lawrence			Recommendations to mitigate against human health risks incurred due to energetic particle irradiation beyond low earth orbit/BLEO	ACTA ASTRONAUTICA			English	Article						Galactic Cosmic Radiation/GCR; Solar Energetic Particles/SEPs; Hard spectrum SEPs; Onboard risk management	INTERNATIONAL-SPACE-STATION; RADIATION ENVIRONMENT; EVENTS; MARS; MODELS; FLARES; CODE; SUN	An account is provided of the main sources of energetic particle radiation in interplanetary space (Galactic Cosmic Radiation and Solar Energetic Particles) and career dose limits presently utilized by NASA to mitigate against the cancer and non-cancer effects potentially incurred by astronauts due to irradiation by these components are presented. Certain gaps in knowledge that presently militate against mounting viable human exploration in deep space due to the inherent health risks are identified and recommendations made as to how these gaps might be closed within a framework of global international cooperation. (C) 2014 Published by Elsevier Ltd. on behalf of IAA.	[McKenna-Lawlor, Susan] Space Technol Ireland Ltd, Nui Maynooth, Kildare, Ireland; [Bhardwaj, Anil] ISRO, Vikram Sarabhai Space Ctr, Space Phys Lab, Planetary Sci Branch, Trivandrum, Kerala, India; [Ferrari, Franco] Inst Phys, Krakow, Poland; [Kuznetsov, Nikolay; Nymmik, Rikho; Panasyuk, Michael] SINP MSU, Moscow, Russia; [Lal, Ajay K.] Sci Eng ESMG, Ahmadabad, Gujarat, India; [Li, Yinghui] China ACC, Astronaut Res & Training Ctr, Beijing, Peoples R China; [Nagamatsu, Aiko] JAXA, Chofu, Tokyo, Japan; [Petrov, Vladislav] Russian Acad Sci, IMBP, Moscow, Russia; [Reitz, Guenther] DLR, Cologne, Germany; [Pinsky, Lawrence] Univ Houston, Houston, TX 77004 USA; [Shukor, Muszaphar (Sheikh)] Univ Kebangsaan Malaysia, Bangi 43600, Malaysia; [Singhvi, Ashok K.] Phys Res Lab, Ahmadabad 380009, Gujarat, India; [Tomi, Leena] Canadian Space Agcy, St Hubert, PQ, Canada; [Townsend, Lawrence] Univ Tennessee, Knoxville, TN 37996 USA	McKenna-Lawlor, S (reprint author), Space Technol Ireland Ltd, Nui Maynooth, Kildare, Ireland.	stil@nuim.ie	Ferrari, Franco/O-8431-2014; Panasyuk, Mikhail/E-2005-2012; Bhardwaj, Anil/B-4579-2011	Bhardwaj, Anil/0000-0003-1693-453X			Adams Jr J.H., 1981, 4506 NRL 1; Aghara SK, 2009, NUCL INSTRUM METH B, V267, P1115, DOI 10.1016/j.nimb.2009.01.136; Parsons JL, 2000, RADIAT RES, V153, P729, DOI 10.1667/0033-7587(2000)153[0729:ICDRFT]2.0.CO;2; CANE HV, 1986, ASTROPHYS J, V301, P448, DOI 10.1086/163913; Lario D, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010940; HERAS AM, 1995, ASTROPHYS J, V445, P497, DOI 10.1086/175714; Benton ER, 2001, NUCL INSTRUM METH B, V184, P255, DOI 10.1016/S0168-583X(01)00748-0; Tylka AJ, 1997, IEEE T NUCL SCI, V44, P2150, DOI 10.1109/23.659030; Slaba TC, 2010, J COMPUT PHYS, V229, P9397, DOI 10.1016/j.jcp.2010.09.010; Zeitlin C, 2013, SCIENCE, V340, P1080, DOI 10.1126/science.1235989; Ehresmann B, 2014, J GEOPHYS RES-PLANET, V119, P468, DOI 10.1002/2013JE004547; Reitz G, 2009, RADIAT RES, V171, P225, DOI 10.1667/RR1559.1; Mewaldt RA, 2013, AIP CONF PROC, V1539, P116, DOI 10.1063/1.4811002; Kohler J, 2014, J GEOPHYS RES-PLANET, V119, P594, DOI 10.1002/2013JE004539; Aran A, 2006, ADV SPACE RES, V37, P1240, DOI 10.1016/j.asr.2005.09.019; Armstrong T.P., 2014, STRATEGIES MITIGATIO, pChapter 4; Cherry JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053275; Cucinotta F.A., 2013, TP2013217375 NASA; Dietze G., 2013, ANN ICRP, V123; Hassler D.M., 2013, SCIENCE, V343, P343; ICRP, 1991, CONV REC INT COMM RA; Jiggens P., 2014, J SPACE WEATHER SPAC, V4, P4, DOI DOI 10.1051/SWSC/2014017; Jiggens PTA, 2012, IEEE T NUCL SCI, V59, P1066, DOI 10.1109/TNS.2012.2198242; Jiggens PTA, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014291; Kahler SW, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/66; Kim M.-H.Y., 2014, J GEOPHYS RES-PLANET, V119, P119; KIPLINGER AL, 1995, ASTROPHYS J, V453, P973, DOI 10.1086/176457; Koshiishi H, 2007, RADIAT MEAS, V42, P1510, DOI 10.1016/j.radmeas.2007.02.072; Lario D, 2004, GEOPH MONOG SERIES, V141, P195; Luszik-Bhadra M, 2001, RADIAT MEAS, V33, P305, DOI 10.1016/S1350-4487(00)00151-7; Machrafi R., 2009, RAD PROTECT DOSIM AD; McGregor SL, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012330; McKenna-Lawlor S., 2014, OVERVIEW ENERGETIC P; McKenna-Lawlor S, 2012, PLANET SPACE SCI, V63-64, P123, DOI 10.1016/j.pss.2011.06.017; McKenna-Lawlor S, 2012, ICARUS, V218, P723, DOI 10.1016/j.icarus.2011.04.004; McKenna-Lawlor S, 2014, ACTA ASTRONAUT, V104, P565, DOI 10.1016/j.actaastro.2014.07.011; McNutt Jr R., 2013, P 64 INT ASTR C IAC; NCRP, 2000, 132 NCRP; NCRP-National Council on Radiation Protection and Measurements, 2003, 142 NCRP; Nealy J. E., 1997, P NASA C PUBL WORKSH, P3360; Nymmik RA, 2007, ADV SPACE RES, V40, P313, DOI 10.1016/j.asr.2006.12.028; Odstrcil D., 2003, ADV SPACE RES, V32, P32; Posner A, 2007, SPACE WEATHER, V5, DOI 10.1029/2006SW000268; Rafkin S.C.R., 2014, J GEOPHYS RES-PLANET, V119, P119; Reames DV, 1999, SPACE SCI REV, V90, P413, DOI 10.1023/A:1005105831781; Reames DV, 2001, AIP CONF PROC, V552, P1185; Reitz G., 2014, PARTICLE RAD HAZARD; Santin G, 2005, IEEE T NUCL SCI, V52, P2294, DOI 10.1109/TNS.2005.860749; SCHWADRON NA, 2010, SPACE WEATHER, V8, DOI DOI 10.1029/2010; Simonsen L.C., 1991, 3079 NASA; Townsend LW, 2003, IEEE T NUCL SCI, V50, P2307, DOI 10.1109/TNS.2003.821602; Wilson J. W., 1991, TP3146 NASA; Wilson JW, 2004, ADV SPACE RES, V34, P1281, DOI 10.1016/j.asr.2003.10.052; Zeitlin C.J., 2012, P AM GEOPH UN AGU FA	54	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0094-5765	1879-2030		ACTA ASTRONAUT	Acta Astronaut.	APR-MAY	2015	109						182	193		10.1016/j.actaastro.2014.11.009		12	Engineering, Aerospace	Engineering	CD2SO	WOS:000350929500020		
J	Jomaas, G; Torero, JL; Eigenbrod, C; Niehaus, J; Olson, SL; Ferkul, PV; Legros, G; Fernandez-Pello, AC; Cowlard, AJ; Rouvreau, S; Smirnov, N; Fujita, O; T'ien, JS; Ruff, GA; Urban, DL				Jomaas, Grunde; Torero, Jose L.; Eigenbrod, Christian; Niehaus, Justin; Olson, Sandra L.; Ferkul, Paul V.; Legros, Guillaume; Fernandez-Pello, A. Carlos; Cowlard, Adam J.; Rouvreau, Sebastien; Smirnov, Nickolay; Fujita, Osamu; T'ien, James S.; Ruff, Gary A.; Urban, David L.			Fire safety in space - beyond flammability testing of small samples	ACTA ASTRONAUTICA			English	Article						Flame propagation; Microgravity; Fire safety; Experiments; Flammability		An international research team has been assembled to reduce the uncertainty and risk in the design of spacecraft fire safety systems by testing material samples in a series of flight experiments (Saffire 1, 2, and -3) to be conducted in an Orbital Science Corporation Cygnus vehicle after it has undocked from the International Space Station (ISS). The tests will be fully automated with the data downlinked at the conclusion of the test before the Cygnus vehicle re-enters the atmosphere. The unmanned, pressurized environment in the Saffire experiments allows for the largest sample sizes ever to be tested for material flammability in microgravity, which will be based on the characteristics of flame spread over the surface of the combustible material. Furthermore, the experiments will have a duration that is unmatched in scale compared to earth based microgravity research facilities such as drop towers (about 5 s) and parabolic flights (about 20 s). In contrast to sounding rockets, the experiments offer a much larger volume, and the reduction in the oxygen concentration during the Saffire experiments will be minimal. The selection of the experimental settings for the first three Saffire experiments has been based on existing knowledge of scenarios that are relevant, yet challenging, for a spacecraft environment. Given that there is always airflow in the space station, all the experiments are conducted with flame spread in either concurrent or opposed flow, though with the flow being stopped in some tests, to simulate the alarm mode environment in the ISS and thereby also to study extinguishment The materials have been selected based on their known performance in NASA STD-6001Test-1, and with different materials being classified as charring, thermally thin, and thermally thick. Furthermore, materials with non-uniform surfaces will be investigated. (C) 2014 IAA. Published by Elsevier Ltd. All rights reserved.	[Jomaas, Grunde] Tech Univ Denmark, Dept Civil Engn, DK-2800 Lyngby, Denmark; [Torero, Jose L.] Univ Queensland, Brisbane, Qld, Australia; [Eigenbrod, Christian] Univ Bremen ZARM, Bremen, Germany; [Niehaus, Justin; Olson, Sandra L.; Ruff, Gary A.; Urban, David L.] NASA, Glenn Res Ctr, Cleveland, OH USA; [Ferkul, Paul V.] Univ Space Res Assoc, Cleveland, OH USA; [Legros, Guillaume] Univ Paris 06, Paris, France; [Fernandez-Pello, A. Carlos] Univ Calif Berkeley, Berkeley, CA USA; [Cowlard, Adam J.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Rouvreau, Sebastien] Belisama R&D, Toulouse, France; [Smirnov, Nickolay] Moscow MV Lomonosov State Univ, Moscow, Russia; [Fujita, Osamu] Hokkaido Univ, Sapporo, Hokkaido, Japan; [T'ien, James S.] Case Western Reserve Univ, Cleveland, OH 44106 USA	Jomaas, G (reprint author), Tech Univ Denmark, Dept Civil Engn, DK-2800 Lyngby, Denmark.	grujo@byg.dtu.dk			ESTEC [4000103397]; JAXA; ESA; RSA; CNES; DLR; Russian Academy of Sciences; NASA Advanced Exploration Systems Program	The topical team on fire safety in space was established under ESTEC Contract number 4000103397 with Dr. Olivier Minster as the coordinator. Project scientist at ESA, Dr. Balks Toth, has been of great support during the experimental development. The authors acknowledge the support of the various space and research agencies that have supported this work including but not limited to JAXA, ESA, RSA, CNES, DLR, the Russian Academy of Sciences and the NASA Advanced Exploration Systems Program.	[Anonymous], 2011, RECAPTURING FUTURE S; [Anonymous], 2011, 6001B NASA; [Anonymous], 2008, 6001A NASA; Torero JL, 2013, P COMBUST INST, V34, P99, DOI 10.1016/j.proci.2012.09.007; [Anonymous], 2003, ASS DIR MICR PHYS SC; Olson SL, 2001, COMBUST FLAME, V125, P852, DOI 10.1016/S0010-2180(00)00249-2; Bhattacharjee S., 1990, 23 S INT COMB COMB I, P1727; Dietrich D.L., 2013, P 43 INT C ENV SYST; DiNenno PJ, 2008, SFPE HDB FIRE PROTEC; Fereres S., 2012, P 42 INT C ENV SYST; Ferkul P., 2004, MICROGRAVITY SCI TEC, VXV; Ferkul Paul V., 2013, P 8 US NAT COMB M OR; Freier A., 2014, THESIS U BREMEN BREM; Friedman R., 1999, 29 INT C ENV SYST; Hirsch D.B., 2001, P HAL OPT TECHN WORK; Hirsch D.B., 2009, P 39 INT C ENV SYST; Ivanov A.V., 1999, NASACR1999209405; Kimzey J.H., 1974, P 3 SPAC PROC S NASA, V1, P115; Nastac G.C., 2014, EFFECT CORRUGATION T; Ohlemiller T.J., 1991, 4591 NISTIR; Olson Sandra L, 2014, INT WORKSH ISS MAT F; Olson S.L., 2009, P 39 INT C ENV SYST; Olson S.L., 1988, 22 S INT COMB COMB I, P1213; Olson S.L., 2014, P COMBUST I, V35; Osorio A., 2012, P 42 INT C ENV SYST; Ross Howard D, 2001, MICROGRAVITY COMBUST; Ruff G.A., 2009, FIRE SAFETY; Schwenteck T., 2014, THESIS U BREMEN BREM; Smimov NN, 2007, ACTA ASTRONAUT, V61, P626, DOI 10.1016/j.actaastro.2006.12.014; T'ien J.S., 1990, COMBUST FLAME, V80, P335, DOI DOI 10.1016/0010-2180(90)90111-4; T'ien J.S., MECH FLAME SPREAD SM; Tseng YT, 2010, J HEAT TRANS-T ASME, V132, DOI 10.1115/1.4001645	32	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0094-5765	1879-2030		ACTA ASTRONAUT	Acta Astronaut.	APR-MAY	2015	109						208	216		10.1016/j.actaastro.2014.11.025		9	Engineering, Aerospace	Engineering	CD2SO	WOS:000350929500023		
J	Xiao, F; Fukuda, T; Kakeshita, T; Jin, XJ				Xiao, Fei; Fukuda, Takashi; Kakeshita, Tomoyuki; Jin, Xuejun			Elastocaloric effect by a weak first-order transformation associated with lattice softening in an Fe-31.2Pd (at.%) alloy	ACTA MATERIALIA			English	Article						Elastocaloric effect; Shape memory alloy; Martensitic transformation; Elastic behavior	SHAPE-MEMORY ALLOYS; FE-PD ALLOYS; PHASE-TRANSITIONS; REFRIGERATION; DRIVEN; STRAIN; FCC	In typical shape memory alloys, significant elastocaloric effects appear in association with stress-induced martensitic transformations. However, we report here that in an Fe-31.2Pd (at.%) alloy, a significant elastocaloric effect appears due to lattice softening, which causes a weak first-order martensitic transformation at T-0 (similar to 230K). We found that in a wide temperature range of between 175 K (<T-0) and 335 K (>T-0), the alloy exhibits an adiabatic temperature decrease of more than 1.5 K when a compressive stress of 200 MPa applied in the [0 0 1] direction is removed. The refrigeration capacity calculated in this temperature range is 5 MJ/m(3). (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Xiao, Fei; Fukuda, Takashi; Kakeshita, Tomoyuki] Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, Suita, Osaka 5650871, Japan; [Xiao, Fei; Jin, Xuejun] Shanghai Jiao Tong Univ, Sch Mat Sci & Engn, State Key Lab Met Matrix Composite, Shanghai 200240, Peoples R China	Fukuda, T (reprint author), Osaka Univ, Grad Sch Engn, Dept Mat Sci & Engn, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	fukuda@mat.eng.osaka-u.ac.jp			JSPS KAKENHI [23360280, 26289230]; National Basic Research Program of China (973 Program) [2012CB619400]; National Science Foundation of China [51174251]	This work was supported by JSPS KAKENHI Grant Numbers 23360280, 26289230. It was also supported by the National Basic Research Program of China (973 Programs Grant No. 2012CB619400) and the National Science Foundation of China (No. 51174251).	Bruck E, 2005, J PHYS D APPL PHYS, V38, pR381, DOI 10.1088/0022-3727/38/23/R01; Xiao F, 2013, ACTA MATER, V61, P4044, DOI 10.1016/j.actamat.2013.03.025; Dan'kov SY, 1998, PHYS REV B, V57, P3478, DOI 10.1103/PhysRevB.57.3478; Bonnot E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.125901; MIYAZAKI S, 1981, SCRIPTA METALL MATER, V15, P287, DOI 10.1016/0036-9748(81)90346-X; Krenke T, 2005, NAT MATER, V4, P450, DOI 10.1038/nmat1395; OTSUKA K, 1976, ACTA METALL MATER, V24, P207, DOI 10.1016/0001-6160(76)90071-7; Pecharsky VK, 1997, PHYS REV LETT, V78, P4494, DOI 10.1103/PhysRevLett.78.4494; Xiao F, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803168; MUTO S, 1990, ACTA METALL MATER, V38, P685, DOI 10.1016/0956-7151(90)90224-5; Gschneidner KA, 2005, REP PROG PHYS, V68, P1479, DOI 10.1088/0034-4885/68/6/R04; Fujita A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.104416; Cui J, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4746257; Liu J, 2012, NAT MATER, V11, P620, DOI [10.1038/nmat3334, 10.1038/NMAT3334]; Moya X, 2014, NAT MATER, V13, P439, DOI [10.1038/nmat3951, 10.1038/NMAT3951]; Cui J, 2004, ACTA MATER, V52, P35, DOI 10.1016/j.actamat.2003.08.024; WOOD ME, 1985, CRYOGENICS, V25, P667, DOI 10.1016/0011-2275(85)90187-0; Choi MS, 2005, SCRIPTA MATER, V53, P869, DOI 10.1016/j.scriptamat.2005.05.040; Lagoudas D.C., 2008, SHAPE MEMORY ALLOY M; Mafiosa L., 2013, APPL PHYS LETT, V103; Kakeshita T, 2006, MAT SCI ENG A-STRUCT, V438, P12, DOI 10.1016/j.msea.2006.02.193; Xiao F., IN PRESS; Xiao F, 2013, J ALLOY COMPD, V577, pS323, DOI 10.1016/j.jallcom.2012.02.011	23	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	APR 1	2015	87						8	14		10.1016/j.actamat.2015.01.004		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CC6ZO	WOS:000350517700002		
J	Georgarakis, K; Hennet, L; Evangelakis, GA; Antonowicz, J; Bokas, GB; Honkimaki, V; Bytchkov, A; Chen, MW; Yavari, AR				Georgarakis, K.; Hennet, L.; Evangelakis, G. A.; Antonowicz, J.; Bokas, G. B.; Honkimaki, V.; Bytchkov, A.; Chen, M. W.; Yavari, A. R.			Probing the structure of a liquid metal during vitrification	ACTA MATERIALIA			English	Article						Metallic glasses; Vitrification; Atomic structure; Levitation; Synchrotron radiation	GLASS-FORMING LIQUID; TO-STRONG TRANSITION; X-RAY-DIFFRACTION; AMORPHOUS-ALLOYS; SYNCHROTRON-RADIATION; SUPERCOOLED LIQUID; RANGE ORDER; FRAGILITY; CU; NEUTRON	Using aerodynamic levitation, vitrification of a ternary Zr-Cu-Al alloy was observed in-situ by high energy synchrotron radiation X-ray diffraction in the temperature range from above the liquidus T-liq to well below the glass transition temperature T-g. The evolution of the atomic structure was studied using pair distribution functions (PDF) and molecular dynamic (MD) simulations. Vitrification was rendered possible due to the enhanced stability of the undercooled Zr-Cu melt after Al addition. Results indicate three regimes in the liquid alloy's structural pathway to vitrification. Short (SRO) and medium range order (MRO) develop significantly during cooling the liquid phase to the glassy state. The rate of structural rearrangements is enhanced in the super-cooled liquid between T-liq-140 K and T-g. The populations of atomic clusters with icosahedral local symmetry become predominant as T-g is approached and facilitate vitrification and suppression of crystal nucleation and growth. The scenario of a possible fragile to strong transition in the super-cooled liquid is discussed. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Georgarakis, K.; Yavari, A. R.] Inst Natl Polytech Grenoble, Euronano SIMaP, F-38402 St Martin Dheres, France; [Georgarakis, K.; Chen, M. W.] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Hennet, L.] Univ Orleans, F-45071 Orleans 02, France; [Evangelakis, G. A.; Bokas, G. B.] Univ Ioannina, Dept Phys, GR-45110 Ioannina, Greece; [Antonowicz, J.] Warsaw Univ Technol, Fac Phys, PL-00662 Warsaw, Poland; [Honkimaki, V.] European Synchrotron Radiat Facil, F-38042 Grenoble, France; [Bytchkov, A.] Inst Laue Langevin, F-38042 Grenoble, France	Yavari, AR (reprint author), Inst Natl Polytech Grenoble, Euronano SIMaP, F-38402 St Martin Dheres, France.	euronano@minatec.inpg.fr	Chen, Mingwei/A-4855-2010; Georgarakis, Konstantinos/E-6390-2010; Antonowicz, Jerzy/G-5852-2012; Georgarakis, Konstantinos/K-1939-2015; HENNET, Louis/C-1711-2008	Chen, Mingwei/0000-0002-2850-8872; Antonowicz, Jerzy/0000-0002-7781-7540; 	ANR project "Vitrified metal implants" [ANR-11-IS09-006-01]; ANR project "Vitrified metal springs" [ANR-12-EMMA-0054]; JSPS KAKENHI [25820340]	Support from ANR projects "Vitrified metal implants" (ANR-11-IS09-006-01) and "Vitrified metal springs" (ANR-12-EMMA-0054) is gratefully acknowledged. KG acknowledges support from JSPS KAKENHI (Grant Number 25820340). The authors thank Prof. AL Greer for fruitful discussions. GAE thank G. Almyras for his help in computational procedure.	Angell C.A., 1995, SCIENCE, V267, P1927; Hirata A, 2011, NAT MATER, V10, P28, DOI [10.1038/nmat2897, 10.1038/NMAT2897]; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Saika-Voivod I, 2001, NATURE, V412, P514, DOI 10.1038/35087524; Artacho E, 1999, PHYS STATUS SOLIDI B, V215, P809, DOI 10.1002/(SICI)1521-3951(199909)215:1<809::AID-PSSB809>3.0.CO;2-0; Kelton KF, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.195504; Georgarakis K, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3136428; Fischer HE, 2006, REP PROG PHYS, V69, P233, DOI 10.1088/0034-4885/69/1/R05; Ding J, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4864106; Juhas P, 2013, J APPL CRYSTALLOGR, V46, P560, DOI 10.1107/S0021889813005190; Martinez LM, 2001, NATURE, V410, P663, DOI 10.1038/35070517; Johnson WL, 1999, MRS BULL, V24, P42; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6; Cheng YQ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.245501; Miracle DB, 2004, NAT MATER, V3, P697, DOI 10.1038/nmat1219; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Mukherjee S, 2004, ACTA MATER, V52, P3689, DOI 10.1016/j.actamat.2004.04.023; Han G, 2011, ACTA MATER, V59, P5917, DOI 10.1016/j.actamat.2011.05.065; Dong C, 2007, J PHYS D APPL PHYS, V40, pR273, DOI 10.1088/0022-3727/40/15/R01; Lou HB, 2013, P NATL ACAD SCI USA, V110, P10068, DOI 10.1073/pnas.1307967110; Busch R, 2007, MRS BULL, V32, P620, DOI 10.1557/mrs2007.122; Takeuchi A, 2005, MATER TRANS, V46, P2817, DOI 10.2320/matertrans.46.2817; Antonowicz J, 2012, PHILOS MAG, V92, P1865, DOI 10.1080/14786435.2012.659008; Liu L, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.117802; SanchezPortal D, 1997, INT J QUANTUM CHEM, V65, P453, DOI 10.1002/(SICI)1097-461X(1997)65:5<453::AID-QUA9>3.0.CO;2-V; YAVARI AR, 1983, PHYS LETT A, V95, P165, DOI 10.1016/0375-9601(83)90825-3; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Lekka CE, 2009, SCRIPTA MATER, V61, P974, DOI 10.1016/j.scriptamat.2009.08.008; Angell CA, 2008, MRS BULL, V33, P544, DOI 10.1557/mrs2008.108; Cheng YQ, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2987727; Cheng YQ, 2011, PROG MATER SCI, V56, P379, DOI 10.1016/j.pmatsci.2010.12.002; Zhang Y, 2011, J APPL PHYS, V110, DOI 10.1063/1.3658252; Landron C, 2000, REV SCI INSTRUM, V71, P1745, DOI 10.1063/1.1150531; Yavari AR, 2005, ACTA MATER, V53, P1611, DOI 10.1016/j.actamat.2004.12.011; Hirata A, 2013, SCIENCE, V341, P376, DOI 10.1126/science.1232450; Mattern N, 2012, ACTA MATER, V60, P517, DOI 10.1016/j.actamat.2011.10.032; Angell CA, 2000, J APPL PHYS, V88, P3113, DOI 10.1063/1.1286035; SACHDEV S, 1984, PHYS REV LETT, V53, P1947, DOI 10.1103/PhysRevLett.53.1947; Sheng HW, 2006, NATURE, V439, P419, DOI 10.1038/nature04421; CHEN HS, 1979, PHYS STATUS SOLIDI A, V51, P593, DOI 10.1002/pssa.2210510235; FRANK FC, 1952, PROC R SOC LON SER-A, V215, P43, DOI 10.1098/rspa.1952.0194; KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0; Hennet L, 2011, EUR PHYS J-SPEC TOP, V196, P151, DOI 10.1140/epjst/e2011-01425-0; BENNETT CH, 1971, ACTA METALL MATER, V19, P1295, DOI 10.1016/0001-6160(71)90064-2; BERNAL JD, 1960, NATURE, V185, P68, DOI 10.1038/185068a0; KLEINMAN L, 1982, PHYS REV LETT, V48, P1425, DOI 10.1103/PhysRevLett.48.1425; Ito K, 1999, NATURE, V398, P492; COHEN MH, 1959, J CHEM PHYS, V31, P1164, DOI 10.1063/1.1730566; Way C, 2007, ACTA MATER, V55, P2977, DOI 10.1016/j.actamat.2006.12.032; Bednarcik J, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/25/254204; Boer F.R., 1988, COHESION METALS TRAN; Botta WJ, 2008, J NON-CRYST SOLIDS, V354, P325, DOI 10.1016/j.jnoncrysol.2007.07.043; Crocombette JP, 1998, J NUCL MATER, V257, P282, DOI 10.1016/S0022-3115(98)00454-1; Dubois J.M., 1823, P ROY SOC LOND A MAT, V1985, P323; Egami T., 2003, BRAGG PEAKS; Fontana GD, 2013, ACTA MAT, V61, P2260; Gangopadhyay AK, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4876125; Georgarakis K, 2011, ACTA MATER, V59, P708, DOI 10.1016/j.actamat.2010.10.009; Georgarakis K, 2012, CR PHYS, V13, P218, DOI 10.1016/j.crhy.2011.12.010; Georgarakis K, 2010, J APPL PHYS, V108, DOI 10.1063/1.3446131; Georgarakis K., TRACING PATHWA UNPUB; Guo YF, 2012, J ALLOY COMPD, V536, pS91, DOI 10.1016/j.jallcom.2011.11.085; Hajlaoui K, 2011, PHIL MAG LETT, V91, P122, DOI 10.1080/09500839.2010.537701; Holland-Moritz D, 2005, MEAS SCI TECHNOL, V16, P372, DOI 10.1088/0957-0233/16/2/007; Jagla EA, 1999, J PHYS-CONDENS MAT, V11, P10251, DOI 10.1088/0953-8984/11/50/317; Jiang QK, 2010, METALL MATER TRANS A, V41A, P1634, DOI 10.1007/s11661-009-0041-9; Junquera J, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.235111; Kelton K.F., 2010, PERGAMON MAT SERIES; Lad KN, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3692610; Li JJZ, 2011, ACTA MATER, V59, P2166, DOI 10.1016/j.actamat.2010.12.017; Li Y, 2009, INTERMETALLICS, V17, P231, DOI 10.1016/j.intermet.2008.08.015; Louzguine-Luzgin DV, 2011, J APPL PHYS, V110, DOI 10.1063/1.3624745; Matsubara E, 2007, J ALLOY COMPD, V434, P119, DOI 10.1016/j.jallcom.2006.08.141; Mauro NA, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813389; Mauro NA, 2013, J NON-CRYST SOLIDS, V362, P237, DOI 10.1016/j.jnoncrysol.2012.11.022; Mauro NA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5616; Mauro NA, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3554437; Pineda E, 2009, J ALLOY COMPD, V483, P578, DOI 10.1016/j.jallcom.2008.07.194; Qu DD, 2012, MAT SCI ENG A-STRUCT, V555, P36, DOI 10.1016/j.msea.2012.06.030; STEEB S, 1984, J NON-CRYST SOLIDS, V61-2, P237, DOI 10.1016/0022-3093(84)90557-X; Tanaka H, 2003, J PHYS-CONDENS MAT, V15, pL703, DOI 10.1088/0953-8984/15/45/L03; VITEK JM, 1975, ACTA METALL MATER, V23, P165, DOI 10.1016/0001-6160(75)90180-7; Warren B. E., 1990, XRAY DIFFRACTION; Waseda Y., 1980, STRUCTURE NONCRYSTAL; Wei S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3083; Yavari A.R., ATOMIC STRUCTURE SUP; Yavari AR, 2004, MAT SCI ENG A-STRUCT, V375, P709, DOI [10.1016/j.msea.2003.10.224, 10.1016/j.msca.2003.10.224]; Yuan CC, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4734390; Zhang CZ, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3457670	90	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	APR 1	2015	87						174	186		10.1016/j.actamat.2015.01.005		13	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CC6ZO	WOS:000350517700018		
J	Shimokawa, T; Tsuboi, M				Shimokawa, Tomotsugu; Tsuboi, Masaaki			Atomic-scale intergranular crack-tip plasticity in tilt grain boundaries acting as an effective dislocation source	ACTA MATERIALIA			English	Article						Grain boundary; Disclination; Dislocation; Interfacial fracture toughness; Molecular dynamics	MOLECULAR-DYNAMICS; FRACTURE-TOUGHNESS; TENSILE-STRENGTH; BRITTLE BEHAVIOR; NANOCRYSTALLINE; METALS; NUCLEATION; DUCTILE; COPPER; MICROSTRUCTURE	The intergranular fracture toughness of plastic deformable crystalline materials is strongly controlled by the plastic work ahead of the intergranular crack tip. Therefore, in studies of intergranular fracture toughness, the grain boundaries (GBs) should be regarded as both a cleavage plane and dislocation source. Combining continuum analyses and atomic simulations, this study investigates the atomic-scale mechanism of intergranular crack tip plasticity in aluminum < 112 > tilt GBs as an effective dislocation source. To quantitatively predict the first plastic deformation near the intergranular crack tip, we first model the dislocation emission from the GBs ahead of the intergranular crack tip and analytically derive the critical stress intensity factor. If the predicted first plastic phenomenon is dislocation emission from the GBs, the resulting wedge disclination can shield the stress field near the crack. Dislocation emissions from the crack tip are accompanied by dislocation emissions from the GBs, despite the predicted difficulty of the latter. The lattice defect evolution nucleates a nanograin with a disclination at the triple-junction ahead of the crack tip, which can weaken the mechanical field near the crack tip. Consequently, when improving the intergranular fracture toughness of materials, the role of GBs as dislocation sources cannot be ignored. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Shimokawa, Tomotsugu] Kanazawa Univ, Sch Mech Engn, Kanazawa, Ishikawa 9201192, Japan; [Tsuboi, Masaaki] Kanazawa Univ, Div Mech Sci & Engn, Kanazawa, Ishikawa 9201192, Japan	Shimokawa, T (reprint author), Kanazawa Univ, Sch Mech Engn, Kanazawa, Ishikawa 9201192, Japan.	simokawa@se.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [22102007]; Japan Science and Technology Agency (JST) under Collaborative Research Based on Industrial Demand "Heterogeneous Structure Control: Towards Innovative Development of Metallic Structural Materials"	The authors would like to thank K. Higashida and M. Yamaguchi for helpful discussions. This research was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grant Number 22102007 and the Japan Science and Technology Agency (JST) under Collaborative Research Based on Industrial Demand "Heterogeneous Structure Control: Towards Innovative Development of Metallic Structural Materials."	Allen M. P., 1987, COMPUTER SIMULATION; Anderson T.J., 1989, FRACTURE MECH FUNDAM; Mishin Y, 2010, ACTA MATER, V58, P1117, DOI 10.1016/j.actamat.2009.10.049; Yamakov V, 2006, J MECH PHYS SOLIDS, V54, P1899, DOI 10.1016/j.jmps.2006.03.004; RICE JR, 1974, PHILOS MAG, V29, P73, DOI 10.1080/14786437408213555; Yamaguchi M, 2014, PHILOS MAG, V94, P2131, DOI 10.1080/14786435.2014.906757; Watanabe T, 1999, ACTA MATER, V47, P4171, DOI 10.1016/S1359-6454(99)00275-X; Tsuji N, 2004, MATER TRANS, V45, P2272, DOI 10.2320/matertrans.45.2272; Valiev R, 2004, NAT MATER, V3, P511, DOI 10.1038/nmat1180; Shimokawa T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174122; Ovid'ko IA, 2010, ACTA MATER, V58, P5286, DOI 10.1016/j.actamat.2010.05.058; LAKSHMANAN V, 1988, MAT SCI ENG A-STRUCT, V104, P95, DOI 10.1016/0025-5416(88)90410-7; Noronha SJ, 2004, MAT SCI ENG A-STRUCT, V365, P156, DOI 10.1016/j.msea.2003.09.022; Shimokawa T, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.214113; Wang YM, 2002, NATURE, V419, P912, DOI 10.1038/nature01133; Gleiter H, 2000, ACTA MATER, V48, P1, DOI 10.1016/S1359-6454(99)00285-2; JOKL ML, 1980, ACTA METALL MATER, V28, P1479, DOI 10.1016/0001-6160(80)90048-6; Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/S1359-6454(02)00421-4; Lu L, 2004, SCIENCE, V304, P422, DOI 10.1126/science.1092905; Tschopp MA, 2008, INT J PLASTICITY, V24, P191, DOI 10.1016/j.ijplas.2007.02.010; Spearot DE, 2007, ACTA MATER, V55, P705, DOI 10.1016/j.actamat.2006.08.060; Moller JJ, 2014, ACTA MATER, V73, P1, DOI 10.1016/j.actamat.2014.03.035; Tanaka M, 2009, MATER TRANS, V50, P56, DOI 10.2320/matertrans.MD200817; Zeng XH, 2010, ACTA MATER, V58, P301, DOI 10.1016/j.actamat.2009.09.005; Cheng S, 2003, ACTA MATER, V51, P4505, DOI 10.1016/S1359-6454(03)00286-6; Romanov AE, 2009, PROG MATER SCI, V54, P740, DOI 10.1016/j.pmatsci.2009.03.002; Hutchinson JW, 1997, ADVANCES IN FRACTURE RESEARCH, VOLS 1-6, P1; [Anonymous], 1992, DISLOCATIONS SOLIDS; Zhou K, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045410; Ovid'ko IA, 2010, SCRIPTA MATER, V62, P387, DOI 10.1016/j.scriptamat.2009.11.035; Mishin Y, 1999, PHYS REV B, V59, P3393, DOI 10.1103/PhysRevB.59.3393; RICE JR, 1992, J MECH PHYS SOLIDS, V40, P239, DOI 10.1016/S0022-5096(05)80012-2; Cheng Y, 2010, ACTA MATER, V58, P2293, DOI 10.1016/j.actamat.2009.11.033; Beausir B, 2013, INT J SOLIDS STRUCT, V50, P137, DOI 10.1016/j.ijsolstr.2012.09.016; Griffith A.A., 1920, Philosophical Transactions of the Royal Society of London, V221; Guttmann M., 1979, GRAIN BOUNDARY SEGRE, P261; Hirth J., 1968, THEORY DISLOCATIONS; HONEYCUTT JD, 1987, J PHYS CHEM-US, V91, P4950, DOI 10.1021/j100303a014; Irwin G.R., 1948, FRACTURING METALS, P147; Janssen M., 2006, FRACTURE MECH; Kato M, 2009, MAT SCI ENG A-STRUCT, V516, P276, DOI 10.1016/j.msea.2009.03.035; Morozov NF, 2010, J MECH PHYS SOLIDS, V58, P1088, DOI 10.1016/j.jmps.2010.04.003; Murayama M, 2002, SCIENCE, V295, P2433, DOI 10.1126/science.1067430; Orowan E., 1948, Reports on Progress in Physics, V12; Sutton A.R., 1995, INTERFACES CRYSTALLI; TSUREKAWA S, 1994, MAT SCI ENG A-STRUCT, V176, P341, DOI 10.1016/0921-5093(94)90997-0; Voigt W, 1928, LEHRBUCH KRISTALLPHY; WOLF D, 1990, J MATER RES, V5, P1708, DOI 10.1557/JMR.1990.1708; Zhou K, 2008, PHILOS MAG, V88, P3181, DOI 10.1080/14786430802537746	49	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1359-6454	1873-2453		ACTA MATER	Acta Mater.	APR 1	2015	87						233	247		10.1016/j.actamat.2015.01.002		15	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CC6ZO	WOS:000350517700023		
J	Fujita, H; Miyajima, R; Sakoda, A				Fujita, Hirotaka; Miyajima, Risa; Sakoda, Akiyoshi			Limitation of adsorptive penetration of cesium into Prussian blue crystallite	ADSORPTION-JOURNAL OF THE INTERNATIONAL ADSORPTION SOCIETY			English	Article						Adsorptive penetration; Prussian blue; Cesium	WATER-MOLECULES; ANALOGS; DIFFRACTION; EXCHANGE; ELEMENTS; LOSSES; SITES; CS	The adsorption of cesium (Cs) onto Prussian blue (PB) with different crystallite sizes is investigated to examine the limitations of the adsorptive penetration of Cs+ into PB crystallite. The adsorption of Cs+ onto soluble PB occurs via ion exchange with a charge-compensation cation like K+, which originally resides in the crystalline lattice. The ratio of the compensation cation sites that are replaced by Cs+ after adsorption time of 2 weeks significantly increases with decreasing crystallite size, meaning that the adsorption occurs only near the surface of the crystallite during the adsorption time. The depth of Cs+ penetration after 2 weeks is only within approximately 1-2 nm (or 1-2 units of the crystalline lattice) from the external surface of the crystallite at ambient temperature, regardless of the crystallite size. Hence, the crystallite size is the most important factor governing the adsorption performance.	[Fujita, Hirotaka; Sakoda, Akiyoshi] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Miyajima, Risa] Meiji Univ, Sch Sci & Technol, Tama Ku, Kawasaki, Kanagawa 2148571, Japan	Fujita, H (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	fujiozon@iis.u-tokyo.ac.jp					Wu XL, 2006, CRYST GROWTH DES, V6, P26, DOI 10.1021/cg050371x; BUSER HJ, 1977, INORG CHEM, V16, P2704, DOI 10.1021/ic50177a008; Hu M, 2009, CRYSTENGCOMM, V11, P2257, DOI 10.1039/b911613n; Mimura H, 1997, J NUCL SCI TECHNOL, V34, P484, DOI 10.3327/jnst.34.484; HERREN F, 1980, INORG CHEM, V19, P956, DOI 10.1021/ic50206a032; Hu M, 2012, ANGEW CHEM INT EDIT, V51, P984, DOI 10.1002/anie.201105190; Ishizaki M, 2013, DALTON T, V42, P16049, DOI 10.1039/c3dt51637g; Cafun JD, 2010, J AM CHEM SOC, V132, P11552, DOI 10.1021/ja102660b; Okubo M, 2010, J PHYS CHEM LETT, V1, P2063, DOI 10.1021/jz100708b; Her JH, 2010, INORG CHEM, V49, P1524, DOI 10.1021/ic901903f; Torad NL, 2012, J MATER CHEM, V22, P18261, DOI 10.1039/c2jm32805d; Zheng XJ, 2007, J PHYS CHEM C, V111, P4499, DOI 10.1021/jp065055n; ITO A, 1968, J CHEM PHYS, V48, P3597, DOI 10.1063/1.1669656; ITAYA K, 1986, ACCOUNTS CHEM RES, V19, P162, DOI 10.1021/ar00126a001; Bleuzen A, 2008, J PHYS CHEM C, V112, P17709, DOI 10.1021/jp805852n; Fujita H, 2014, ADSORPTION, V20, P905, DOI 10.1007/s10450-014-9635-7; Gotoh A., 2007, NANOTECHNOLOGY, V18; Hu M., 2012, CRYSTENGCOMM, V14, P3387; Hu M, 2012, EUR J INORG CHEM, P4795, DOI 10.1002/ejic.201200654; Kareis CM, 2012, J AM CHEM SOC, V134, P2246, DOI 10.1021/ja209799y; Keggin J., 1936, NATURE, V137, P577, DOI DOI 10.1038/137577A0; Louise S., 2013, J PHYS CHEM C, V117, P9693; Matsuda T, 2012, DALTON T, V41, P7620, DOI 10.1039/c2dt12296k; Moritomo Y, 2013, ADV COND MATTER PHYS, DOI 10.1155/2013/539620; NONAKA N, 1985, BUNSEKI KAGAKU, V34, P360; NONAKA N, 1981, BUNSEKI KAGAKU, V30, P599; Omura A, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.057101; Thanapon S., 2010, J HAZARD MATER, V182, P225; Tsukada H, 1999, SCI TOTAL ENVIRON, V228, P111, DOI 10.1016/S0048-9697(99)00009-1	29	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5607	1572-8757		ADSORPTION	Adsorpt.-J. Int. Adsorpt. Soc.	APR	2015	21	3					195	204		10.1007/s10450-015-9662-z		10	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CD5RR	WOS:000351146000004		
J	Sultan, M; El-Sharkawy, II; Miyazaki, T; Saha, BB; Koyama, S; Maruyama, T; Maeda, S; Nakamura, T				Sultan, Muhammad; El-Sharkawy, Ibrahim I.; Miyazaki, Takahiko; Saha, Bidyut B.; Koyama, Shigeru; Maruyama, Tomohiro; Maeda, Shinnosuke; Nakamura, Takashi			Insights of water vapor sorption onto polymer based sorbents	ADSORPTION-JOURNAL OF THE INTERNATIONAL ADSORPTION SOCIETY			English	Article						Adsorption isotherm; Water vapor; Polymer; Adsorption models	GLASS-TRANSITION TEMPERATURE; ADSORPTION COOLING CYCLE; ACTIVATED CARBON; NET ADSORPTION; SILICA-GEL; ISOTHERMS; EQUATION; PERFORMANCE; ETHANOL; SOLIDS	Two polymer based sorbents PS-I and PS-II are analyzed for water sorption applications. Adsorption/desorption isotherms of water vapor onto PS-I and PS-II have been experimentally measured using a magnetic suspension adsorption measurement unit for adsorber temperature ranges 20-80 A degrees C and evaporator temperature ranges 2-73 A degrees C. The equilibrium adsorption uptake of water vapors corresponding to saturation condition at 30 A degrees C by PS-I and PS-II was found nearly 2 and 2.5 times higher than the conventional silica-gel, respectively. Adsorption data has been analyzed for various adsorption models which include Brunauer-Emmett-Teller (BET); Freundlich; Dubinin-Astakhov (D-A); Oswin; and Guggenheim-Anderson-de Boer (GAB) model. The GAB and BET model give the good fit for relative pressure range of 0.10-0.90 and 0.05-0.35, respectively. At all adsorption temperatures of both sorbents, the monolayer uptake by the GAB model is found higher than the BET model. Effect of adsorption potential on adsorption uptake is highlighted in relation with water vapor adsorption mechanism. The isosteric heat of water vapor adsorption is determined for both sorbents using Clausius-Clapeyron equation.	[Sultan, Muhammad; Saha, Bidyut B.] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Sultan, Muhammad; El-Sharkawy, Ibrahim I.; Miyazaki, Takahiko; Saha, Bidyut B.; Koyama, Shigeru] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 8168580, Japan; [El-Sharkawy, Ibrahim I.; Miyazaki, Takahiko; Koyama, Shigeru] Kyushu Univ, Fac Engn Sci, Kasuga, Fukuoka 8168580, Japan; [El-Sharkawy, Ibrahim I.] Mansoura Univ, Fac Engn, Dept Power Mech Engn, Mansoura, Egypt; [Maruyama, Tomohiro; Maeda, Shinnosuke; Nakamura, Takashi] Calson Kansei Corp, Global Technol Div, Green Technol Dev Grp, Sano, Tochigi 3270816, Japan	Miyazaki, T (reprint author), Kyushu Univ, Fac Engn Sci, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	miyazaki.takahiko.735@m.kyushu-u.ac.jp	Sultan, Muhammad/E-7040-2014; 	Sultan, Muhammad/0000-0003-0332-8135; El-Sharkawy, Ibrahim I./0000-0003-2690-9661	TherMAT Project, Japan Ministry of Economy, Trade and Industry (METI)	This work was supported by TherMAT Project, Japan Ministry of Economy, Trade and Industry (METI).	Akanbi CT, 2006, J FOOD ENG, V73, P157, DOI 10.1016/j.jfoodeng.2005.01.015; Rezk A, 2012, INT J HEAT MASS TRAN, V55, P7366, DOI 10.1016/j.ijheatmasstransfer.2012.07.068; Fan YF, 2014, INT J GREENH GAS CON, V21, P61, DOI 10.1016/j.ijggc.2013.11.021; Demir H, 2013, INT J REFRIG, V36, P2289, DOI 10.1016/j.ijrefrig.2013.07.005; SMITH SE, 1947, J AM CHEM SOC, V69, P646, DOI 10.1021/ja01195a053; Jribi S, 2013, APPL THERM ENG, V50, P1570, DOI 10.1016/j.applthermaleng.2011.11.066; SIPS R, 1948, J CHEM PHYS, V16, P490, DOI 10.1063/1.1746922; RAND B, 1976, J COLLOID INTERF SCI, V56, P337, DOI 10.1016/0021-9797(76)90259-9; Saha BB, 1997, ENERGY, V22, P437, DOI 10.1016/S0360-5442(96)00102-8; Gumma S, 2010, LANGMUIR, V26, P17013, DOI 10.1021/la102186q; Sward BK, 1999, APPL THERM ENG, V19, P1, DOI 10.1016/S1359-4311(98)00013-1; El-Sharkawy II, 2014, INT J HEAT MASS TRAN, V73, P445, DOI 10.1016/j.ijheatmasstransfer.2014.02.046; Hutson ND, 1997, ADSORPTION, V3, P189, DOI 10.1007/BF01650130; El-Sharkawy II, 2009, INT J REFRIG, V32, P1579, DOI 10.1016/j.ijrefrig.2009.06.011; ANDERSON RB, 1946, J AM CHEM SOC, V68, P686, DOI 10.1021/ja01208a049; Rezk A, 2013, APPL ENERG, V112, P1025, DOI 10.1016/j.apenergy.2013.06.041; Goula AM, 2008, J FOOD ENG, V85, P73, DOI 10.1016/j.jfoodeng.2007.07.015; SIPS R, 1950, J CHEM PHYS, V18, P1024, DOI 10.1063/1.1747848; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Saha BB, 2007, INT J REFRIG, V30, P96, DOI 10.1016/j.ijrefrig.2006.08.005; Askalany AA, 2014, APPL THERM ENG, V72, P237, DOI 10.1016/j.applthermaleng.2014.04.075; Basu S, 2013, J FOOD SCI TECH MYS, V50, P585, DOI 10.1007/s13197-011-0327-y; De Boer J.H., 1953, DYNAMICAL CHARACTER; DUBININ MM, 1967, J COLLOID INTERF SCI, V23, P487, DOI 10.1016/0021-9797(67)90195-6; Dubinin M. M., 1971, B ACAD SCI USSR CH, V20, P3, DOI 10.1007/BF00849307; Duranoglu D, 2010, CHEM ENG J, V165, P56, DOI 10.1016/j.cej.2010.08.054; Freundlich H., 1926, COLLOID CAPILLARY CH; Guggenheim E.A., 1966, APPL STAT MECH; Gun'ko VM, 2014, J COLLOID INTERF SCI, V426, P48, DOI 10.1016/j.jcis.2014.03.055; Hayward D.O., 1964, CHEMISORPTION; MAROULIS Z B, 1988, Journal of Food Engineering, V7, P63, DOI 10.1016/0260-8774(88)90069-6; Menkov ND, 1999, J AGR ENG RES, V74, P261, DOI 10.1006/jaer.1999.0459; Mihoubi D, 2006, J CHEM THERMODYN, V38, P1105, DOI 10.1016/j.jct.2005.11.010; OSWIN C. R., 1946, Journal of the Society of Chemical Industry, V65, P419, DOI 10.1002/jctb.5000651216; Pakowski Z, 2011, FUEL, V90, P3330, DOI 10.1016/j.fuel.2011.06.044; PERRET EA, 1972, HELV CHIM ACTA, V55, P1987, DOI 10.1002/hlca.19720550617; Ribeyre Q, 2014, CHEM ENG SCI, V113, P1, DOI 10.1016/j.ces.2014.03.027; Saha BB, 2012, INT J REFRIG, V35, P499, DOI 10.1016/j.ijrefrig.2011.05.002; Saha BB, 2008, INT J HEAT MASS TRAN, V51, P1582, DOI 10.1016/j.ijheatmasstransfer.2007.07.031; Sultan M., 2014, EVERGR JT J NOV CARB, V01, P5; Szekely J., 1976, GAS SOLID REACTIONS; Talu O, 2013, J PHYS CHEM C, V117, P13059, DOI 10.1021/jp4021382; TamainotTelto Z, 1997, INT J REFRIG, V20, P146, DOI 10.1016/S0140-7007(96)00053-9; Toribio F, 2004, J COLLOID INTERF SCI, V280, P315, DOI 10.1016/j.jcis.2004.08.009; Umpleby RJ, 2001, ANAL CHIM ACTA, V435, P35, DOI 10.1016/S0003-2670(00)01211-3	45	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5607	1572-8757		ADSORPTION	Adsorpt.-J. Int. Adsorpt. Soc.	APR	2015	21	3					205	215		10.1007/s10450-015-9663-y		11	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	CD5RR	WOS:000351146000005		
J	Komiya, T; Ito, N; Imai, R; Itoh, M; Naito, M; Matsubayashi, J; Matsumura, H				Komiya, Takako; Ito, Norihito; Imai, Ryutaro; Itoh, Masahiro; Naito, Munekazu; Matsubayashi, Jun; Matsumura, Hajime			Anatomy of the Superficial Layer of Superficial Fascia Around the Nipple-Areola Complex	AESTHETIC PLASTIC SURGERY			English	Article						Superficial fascial system; Superficial layer of superficial fascia; Nipple-areolar complex; Periareolar incision	REDUCTION MAMMAPLASTY; MASTOPEXY; PTOSIS; BREAST	The periareolar incision is the preferred method for mammaplasty because of the minimal scarring, and suturing of the superficial fascial system (SFS) is useful for avoiding hypertrophic scarring. In this report, we describe the anatomical location of the SFS around the nipple-areolar complex (NAC) and its histological structure. To define the location of the SFS, 20 healthy women were assessed by ultrasonography, and sections of the NAC of 10 female cadavers were examined under a light microscope. Ultrasonographic examination of sagittal sections of the breast revealed a hyperdense line immediately beneath the skin, which ran parallel with the skin and turned under the NAC. At the turning point, the line thickened to an average of 3.09 mm. The distance between the nipple and the thickest point of the hyperdense line was 10.14 mm on average. Histological structures of the line were collagen and elastic fibers containing smooth muscles that were connected to the dermis and adipose tissue. At the turning point, nerves, blood vessels, and mammary ducts were irregularly observed in the area of collagen and elastic fibers. These structures were intermingled, and the fiber bundle was very thick. The thickest area of the turning point is an area of the superficial layer of superficial fascia, which is a key structure around the NAC. The detailed anatomical data shown in our study provide good morphological landmarks for the closure of periareolar incisions. This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors http://www.springer.com/00266	[Komiya, Takako; Ito, Norihito; Imai, Ryutaro; Matsumura, Hajime] Tokyo Med Univ, Dept Plast & Reconstruct Surg, Shinjuku Ku, Tokyo 1600023, Japan; [Itoh, Masahiro; Naito, Munekazu] Tokyo Med Univ, Dept Anat, Tokyo 1600023, Japan; [Matsubayashi, Jun] Tokyo Med Univ, Dept Anat Pathol, Tokyo 1600023, Japan	Matsumura, H (reprint author), Tokyo Med Univ, Dept Plast & Reconstruct Surg, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	hmatsu-tki@umin.ac.jp					SPEAR SL, 1990, PLAST RECONSTR SURG, V85, P961, DOI 10.1097/00006534-199006000-00023; Hinderer UT, 2001, AESTHET PLAST SURG, V25, P404; BENELLI L, 1990, AESTHET PLAST SURG, V14, P93, DOI 10.1007/BF01578332; Bostwick JIII, 2000, PLASTIC RECONSTRUCTI; Cho BC, 2008, J PLAST RECONSTR AES, V61, P275, DOI 10.1016/j.bjps.2007.10.024; Gonzalez R, 2012, AESTHET SURG J, V32, P175, DOI 10.1177/1090820X11431578; Imanishi N, 2011, JPN J BREAST CANC, V26, P649; Lockwood T, 1999, PLAST RECONSTR SURG, V103, P1411, DOI 10.1097/00006534-199904050-00009; LOCKWOOD TE, 1991, PLAST RECONSTR SURG, V87, P1009, DOI 10.1097/00006534-199106000-00001; Sarrabayrouse M, 2006, AESTHET PLAST SURG, V30, P9, DOI 10.1007/s00266-005-0072-6; Stecco Carla, 2011, Ital J Anat Embryol, V116, P127	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-216X	1432-5241		AESTHET PLAST SURG	Aesthet. Plast. Surg.	APR	2015	39	2					209	213		10.1007/s00266-015-0455-2		5	Surgery	Surgery	CD5RV	WOS:000351146500005		
J	Li, MS; Ogilvie, H; Ochala, J; Artemenko, K; Iwamoto, H; Yagi, N; Bergquist, J; Larsson, L				Li, Meishan; Ogilvie, Hannah; Ochala, Julien; Artemenko, Konstantin; Iwamoto, Hiroyuki; Yagi, Naoto; Bergquist, Jonas; Larsson, Lars			Aberrant post-translational modifications compromise human myosin motor function in old age	AGING CELL			English	Article						aging; function; myosin; post-translational modification; skeletal muscle	SKELETAL-MUSCLE CELLS; SHORTENING VELOCITY; OXIDATIVE STRESS; ELDERLY PEOPLE; LIGHT-CHAINS; PROTEIN; ACTIN; FIBERS; RATS; GLYCATION	Novel experimental methods, including a modified single fiber in vitro motility assay, X-ray diffraction experiments, and mass spectrometry analyses, have been performed to unravel the molecular events underlying the aging-related impairment in human skeletal muscle function at the motor protein level. The effects of old age on the function of specific myosin isoforms extracted from single human muscle fiber segments, demonstrated a significant slowing of motility speed (P<0.001) in old age in both type I and IIa myosin heavy chain (MyHC) isoforms. The force-generating capacity of the type I and IIa MyHC isoforms was, on the other hand, not affected by old age. Similar effects were also observed when the myosin molecules extracted from muscle fibers were exposed to oxidative stress. X-ray diffraction experiments did not show any myofilament lattice spacing changes, but unraveled a more disordered filament organization in old age as shown by the greater widths of the 1, 0 equatorial reflections. Mass spectrometry (MS) analyses revealed eight age-specific myosin post-translational modifications (PTMs), in which two were located in the motor domain (carbonylation of Pro79 and Asn81) and six in the tail region (carbonylation of Asp900, Asp904, and Arg908; methylation of Glu1166; deamidation of Gln1164 and Asn1168). However, PTMs in the motor domain were only observed in the IIx MyHC isoform, suggesting PTMs in the rod region contributed to the observed disordering of myosin filaments and the slowing of motility speed. Hence, interventions that would specifically target these PTMs are warranted to reverse myosin dysfunction in old age.	[Li, Meishan; Ogilvie, Hannah; Larsson, Lars] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Li, Meishan; Ogilvie, Hannah; Larsson, Lars] Karolinska Inst, Dept Clin Neurosci, Clin Neurophysiol, SE-17177 Stockholm, Sweden; [Ochala, Julien] Kings Coll London, Fac Life Sci & Med, Ctr Human & Aerosp Physiol Sci, London SE1 1UL, England; [Artemenko, Konstantin; Bergquist, Jonas] Uppsala Univ, Dept Chem, Biomed Ctr, Analyt Chem, S-75124 Uppsala, Sweden; [Artemenko, Konstantin; Bergquist, Jonas] Uppsala Univ, SciLifeLab, S-75124 Uppsala, Sweden; [Iwamoto, Hiroyuki; Yagi, Naoto] SPring 8, Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Larsson, L (reprint author), Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden.	lars.larsson@ki.se	Bergquist, Jonas/C-5894-2015; 	Larsson, Lars/0000-0003-3722-035X	Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Swedish Research Council [8651, 4423]; European Commission (MyoAge) [EC Fp7 CT-223756, COST CM1001]; Uppsala University Hospital; Harald och Greta Jeanssons Stiftelse	This study was supported by grants from the Swedish Foundation for International Cooperation in Research and Higher Education (STINT) to LL, JB, NY, the Swedish Research Council (8651), the European Commission (MyoAge, EC Fp7 CT-223756 and COST CM1001), and Uppsala University Hospital to L. L, the Swedish Research Council (4423) to JB, and the Swedish Research Council and Harald och Greta Jeanssons Stiftelse to J.O.	Hook P, 1999, J PHYSIOL-LONDON, V520, P463, DOI 10.1111/j.1469-7793.1999.00463.x; WHIPPLE RH, 1987, J AM GERIATR SOC, V35, P13; LARSSON L, 1995, PROG NEUROBIOL, V45, P397, DOI 10.1016/0301-0082(95)98601-Z; Baraibar MA, 2013, J PROTEOMICS, V92, P63, DOI 10.1016/j.jprot.2013.05.008; Iwamoto H, 2009, J MOL BIOL, V390, P99, DOI 10.1016/j.jmb.2009.05.002; ROBBINS AS, 1989, ARCH INTERN MED, V149, P1628, DOI 10.1001/archinte.149.7.1628; D'Antona G, 2003, J PHYSIOL-LONDON, V552, P499, DOI 10.1113/jphysiol.2003.046276; Larsson L, 1997, AM J PHYSIOL-CELL PH, V272, pC638; Ochala J, 2011, FASEB J, V25, P1903, DOI 10.1096/fj.10-176727; Hook P, 2000, J MUSCLE RES CELL M, V21, P357, DOI 10.1023/A:1005614212575; Hook P, 2001, AM J PHYSIOL-CELL PH, V280, pC782; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Iwamoto H, 2001, J MOL BIOL, V305, P863, DOI 10.1006/jmbi.2000.4334; Iwamoto H, 2002, J MOL BIOL, V317, P707, DOI 10.1006/jmbi.2002.5449; Iwamoto H, 2003, BIOPHYS J, V85, P2492, DOI 10.1016/S0006-3495(03)74672-4; Dargelos E, 2010, EXP CELL RES, V316, P115, DOI 10.1016/j.yexcr.2009.07.025; Koubassova NA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1484, DOI 10.1134/S0006297911130086; Ramamurthy B, 2001, FASEB J, V15, P2415, DOI 10.1096/fj.01-0183com; Colson BA, 2007, J MOL BIOL, V367, P36, DOI 10.1016/j.jmb.2006.12.063; Li MS, 2010, J PHYSIOL-LONDON, V588, P5105, DOI 10.1113/jphysiol.2010.199067; Baraibar MA, 2011, FREE RADICAL BIO MED, V51, P1522, DOI 10.1016/j.freeradbiomed.2011.06.032; Blankenfeldt W, 2006, P NATL ACAD SCI USA, V103, P17713, DOI 10.1073/pnas.0606741103; Cammarato A, 2011, J MOL BIOL, V414, P477, DOI 10.1016/j.jmb.2011.10.019; Cristea A, 2010, SARCOPENIA AGE RELAT, P55; CROWDER MS, 1984, J MUSCLE RES CELL M, V5, P131, DOI 10.1007/BF00712152; GREASER ML, 1988, J PHYSIOL-LONDON, V406, P85; HAYASHIBARA T, 1994, BIOCHEMISTRY-US, V33, P12821, DOI 10.1021/bi00209a013; LARSSON L, 1993, ACTA PHYSIOL SCAND, V147, P227, DOI 10.1111/j.1748-1716.1993.tb09493.x; Li M, 2006, NEUROMUSCULAR DISORD, V16, P782, DOI 10.1016/j.nmd.2006.07.023; Li XP, 1996, AM J PHYSIOL-CELL PH, V270, pC352; Lowey S, 2007, J MOL BIOL, V371, P902, DOI 10.1016/j.jmb.2007.05.080; LOWEY S, 1993, NATURE, V365, P454, DOI 10.1038/365454a0; Ochala J, 2012, MUSCLE FUNDAMENTAL B, P1023; Ochala J, 2006, PFLUG ARCH EUR J PHY, V452, P464, DOI 10.1007/s00424-006-0065-6; Oh-Ishi M, 2003, FREE RADICAL BIO MED, V34, P11, DOI 10.1016/S0891-5849(02)01239-X; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Ramamurthy B, 2013, BIOGERONTOLOGY, V14, P293, DOI 10.1007/s10522-013-9430-y; Schultz A B, 1997, Muscle Nerve Suppl, V5, pS60; Smith K, 1996, BAILLIERE CLIN ENDOC, V10, P469, DOI 10.1016/S0950-351X(96)80651-3; SYROVY I, 1992, GEN PHYSIOL BIOPHYS, V11, P301; Thompson LV, 2009, EXP GERONTOL, V44, P106, DOI 10.1016/j.exger.2008.05.003; Thompson LV, 2006, J APPL PHYSIOL, V101, P1581, DOI 10.1152/japplphysiol.00426.2006; WATANABE H, 1992, BIOSCI BIOTECH BIOCH, V56, P1109; Yagi N, 1988, Adv Exp Med Biol, V226, P369	44	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1474-9718	1474-9726		AGING CELL	Aging Cell	APR	2015	14	2					228	235		10.1111/acel.12307		8	Cell Biology; Geriatrics & Gerontology	Cell Biology; Geriatrics & Gerontology	CC9AN	WOS:000350659900009		
J	Pham, HT; Miyagawa, S; Kosaka, Y				Pham, Ha T.; Miyagawa, Shuichi; Kosaka, Yasuyuki			Distribution patterns of trees in paddy field landscapes in relation to agro-ecological settings in northeast Thailand	AGRICULTURE ECOSYSTEMS & ENVIRONMENT			English	Article						Agroforestiy; Land sharing; Landform; Microhabitat; Sustainable agriculture	CONSERVATION; FOREST	Deforestation accompanied by the expansion of agricultural land makes tree resources less available in many regions in the tropics, and small-scale farmers often incorporate trees with agricultural lands to meet their demands for food, timber, fuelwood, or fodder. This study analyzed the distribution patterns and management of multiple tree species grown in the rice paddy fields of a forest-depleted region in northeast Thailand - a region whose forestland represents only 16.32% of the total land area. Twenty villages from 11 provinces were selected for the remote sensing analysis of tree density and microhabitat. Interview surveys were conducted among villagers on their tree use and management, and field observations were performed to determine tree species' composition. The average tree-unit density (based on the number of tree crowns, either of a single tree or of cohesive trees, appearing in satellite images) was 6.27 units/ha, and was correlated with both density on the levee (5.30 units/ha on average) and levee length per unit paddy area (475.25 m/ha on average). The levees were more significant as tree habitats in the villages on the floodplain where the early introduction of agricultural machinery and direct seeding reduced the number of trees inside the fields where rice crops are grown. In total, 79 tree species representing 66 genera and 33 families were observed in the paddy fields. Remnant trees from the original forest, mostly Dipterocarpaceae and Fabaceae, have decreased due to cutting for use as timber and fuel. More recently, eucalypt and teak for timber, and mango and tamarind for edible fruits, have been planted on the levees as income sources. Farmers have recognized that while leaf litter fertilizes the soil, excess shading reduces the rice yield. The coppicing of eucalypt and pollarding of Mitragyna diversifolia were conducted for the sustainable harvest of timber and fuelwood, and also to avoid creating excess shade. Paddy rice fields are the monoculture of a staple crop, but they can harbor multiple trees on their levees, which play a counteractive role in forestland decline. (C) 2014 Elsevier B.V. All rights reserved.	[Pham, Ha T.] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Miyagawa, Shuichi] Gifu Univ, Grad Sch Appl Biol Sci, Gifu 5011193, Japan; [Kosaka, Yasuyuki] Kyoto Univ, Grad Sch Asian, Sakyo Ku, Kyoto 6068501, Japan; [Kosaka, Yasuyuki] Kyoto Univ, African Area Studies, Sakyo Ku, Kyoto 6068501, Japan	Miyagawa, S (reprint author), Gifu Univ, Grad Sch Appl Biol Sci, 1-1 Yanagido, Gifu 5011193, Japan.	hami_chan_89@yahoo.com; miya@gifu-u.ac.jp; kosaka@asafas.kyoto-u.ac.jp			JSPS (Japan Society for the Promotion of Science) [23255008]	The authors wish to express profound gratitude to Ms. Ratchaporn Seetho and Mr. Thanutchaporn Seetho for their contributions. Gratitude is also extended to Prof. Kazuo Funahashi and Dr. Kazuo Watanabe for their valuable advices. This research would never have been completed without the generous hospitality of the people at the study sites in northeast Thailand. Special thanks to Mr. Tanongsak Kitpanaprai and Mr. Somkid Naprom for their helpful hands throughout the duration of field investigation. This work was supported by a Grant-in-Aid for Scientific Research of JSPS (Japan Society for the Promotion of Science) (No. 23255008).	Crews-Meyer KA, 2004, AGR ECOSYST ENVIRON, V101, P155, DOI 10.1016/j.agee.2003.09.024; Walsh SJ, 2001, AGR ECOSYST ENVIRON, V85, P47, DOI 10.1016/S0167-8809(01)00202-X; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Asian Development Bank and United Nations Environment Programme (ADB and UNEP), 2004, GREAT MEK SUBR ATL E; Fukui H, 1993, FOOD POPULATION NE T; Grandstaff S. W., 1986, Traditional agriculture in Southeast Asia. A human ecology perspective., P273; Kosaka Y, 2006, AGROFOREST SYST, V67, P1, DOI 10.1007/s10457-005-1109-1; Land Development Department S., 1972, MAIN LAND FORMS THAI; Miyagawa, 2006, TROPICS, V15, P39; Miyagawa S, 2013, PLANT PROD SCI, V16, P325, DOI 10.1626/pps.16.325; Nair PKR, 2005, J FOREST, V103, P417; Nansaior A, 2013, BIOMASS BIOENERG, V52, P113, DOI 10.1016/j.biombioe.2013.03.011; Natuhara Y, 2012, LANDSC ECOL ENG, V8, P115, DOI 10.1007/s11355-011-0172-1; Niskanen A, 1998, FOREST ECOL MANAG, V104, P57, DOI 10.1016/S0378-1127(97)00263-6; Prachaiyo B, 2000, SE ASIAN STUD, V38, P273; Santisuk T., 1997, FLORA THAILAND FORES; Smitinand T., 1970, FLORA THAILAND FORES; Takaya Y., 1972, SE AS STUD, V10, P77; Vityakon P, 2001, SE ASIAN STUDIES, V39, P398; Vityakon P, 2005, AGROFOREST SYST, V63, P225, DOI 10.1007/s10457-005-4161-y; Vityakon P., 2004, SE ASIAN STUDIES, V41, P444; Watanabe H., 1990, SE ASIAN STUD, V28, P45; Watanabe M, 2014, ENVIRON MANAGE, V53, P343, DOI 10.1007/s00267-013-0206-6; Wester L, 2005, GEOFORUM, V36, P735, DOI 10.1016/j.geoforum.2004.08.007	24	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8809	1873-2305		AGR ECOSYST ENVIRON	Agric. Ecosyst. Environ.	APR 1	2015	202						42	47		10.1016/j.agee.2014.12.011		6	Agriculture, Multidisciplinary; Ecology; Environmental Sciences	Agriculture; Environmental Sciences & Ecology	CD0PO	WOS:000350776600006		
J	Jansson, J; Sadakane, K; Sung, WK				Jansson, Jesper; Sadakane, Kunihiko; Sung, Wing-Kin			Linked Dynamic Tries with Applications to LZ-Compression in Sublinear Time and Space	ALGORITHMICA			English	Article						Data structures; Dynamic trie; Longest common prefix query; LZ-compression	EFFICIENT CONSTRUCTION; REPRESENTATION; ALGORITHM; TREES; DICTIONARIES; BEHAVIOR; SEARCH; MEMORY; TEXT	The dynamic trie is a fundamental data structure with applications in many areas of computer science. This paper proposes a new technique for maintaining a dynamic trie T of size at most 2 (w) nodes under the unit-cost RAM model with a fixed word size w. It is based on the idea of partitioning T into a set of linked small tries, each of which can be maintained efficiently. Our method is not only space-efficient, but also allows the longest common prefix between any query pattern P and the strings currently stored in T to be computed in o(|P|) time for small alphabets, and allows any leaf to be inserted into or deleted from T in o(log|T|) time. To demonstrate the usefulness of our new data structure, we apply it to LZ-compression. Significantly, we obtain the first algorithm for generating the lz78 encoding of a given string of length n over an alphabet of size sigma in sublinear (o(n)) time and sublinear (o(nlog sigma) bits) working space for small alphabets (). Moreover, the working space for our new algorithm is asymptotically less than or equal to the space for storing the output compressed text, regardless of the alphabet size.	[Jansson, Jesper] Kyoto Univ, Inst Chem Res, Lab Math Bioinformat, Akutsu Lab, Uji, Kyoto 6110011, Japan; [Sadakane, Kunihiko] Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Sung, Wing-Kin] Natl Univ Singapore, Sch Comp, Singapore 117417, Singapore; [Sung, Wing-Kin] Genome Inst Singapore, Singapore 138672, Singapore	Jansson, J (reprint author), Kyoto Univ, Inst Chem Res, Lab Math Bioinformat, Akutsu Lab, Uji, Kyoto 6110011, Japan.	jj@kuicr.kyoto-u.ac.jp; sada@nii.ac.jp; ksung@comp.nus.edu.sg			Kyoto University; Japan Society for the Promotion of Science (JSPS); Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; MOE [R-252-000-444-112]	J.J. was funded by the Hakubi Project at Kyoto University and the Japan Society for the Promotion of Science (JSPS).; K.S. was partially supported by the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)".; W.-K.S. was partially supported by the MOE AcRF Tier 2 funding R-252-000-444-112.	ANDERSSON A, 1993, INFORM PROCESS LETT, V46, P295, DOI 10.1016/0020-0190(93)90068-K; ZIV J, 1978, IEEE T INFORM THEORY, V24, P530, DOI 10.1109/TIT.1978.1055934; Hagerup T, 1998, LECT NOTES COMPUT SC, V1373, P366; FREDKIN E, 1960, COMMUN ACM, V3, P490, DOI 10.1145/367390.367400; Raman R, 2003, LECT NOTES COMPUT SC, V2719, P357; Ferragina P, 2005, J ACM, V52, P552, DOI 10.1145/1082036.1082039; Ferragina P, 1999, J ACM, V46, P236, DOI 10.1145/301970.301973; MORRISON DR, 1968, J ACM, V15, P514, DOI 10.1145/321479.321481; DARRAGH JJ, 1993, SOFTWARE PRACT EXPER, V23, P277, DOI 10.1002/spe.4380230305; Arroyuelo D, 2008, LECT NOTES COMPUT SC, V5029, P277, DOI 10.1007/978-3-540-69068-9_26; Arroyuelo D, 2011, INFORM COMPUT, V209, P1070, DOI 10.1016/j.ic.2011.03.001; Beame P, 2002, J COMPUT SYST SCI, V65, P38, DOI 10.1006/jcss.2002.1822; Blandford DK, 2005, PROCEEDINGS OF THE SIXTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1; Devroye L, 2005, RANDOM STRUCT ALGOR, V27, P185, DOI 10.1002/rsa.20067; GABOW HN, 1985, J COMPUT SYST SCI, V30, P209, DOI 10.1016/0022-0000(85)90014-5; Geary RF, 2006, THEOR COMPUT SCI, V368, P231, DOI 10.1016/j.tcs.2006.09.014; Hon WK, 2007, ALGORITHMICA, V48, P23, DOI 10.1007/s00453-006-1228-8; Karkkainen J, 1998, ALGORITHMICA, V21, P137, DOI 10.1007/PL00009205; Kosaraju SR, 2000, SIAM J COMPUT, V29, P893, DOI 10.1137/S0097539797331105; Lippert RA, 2005, J COMPUT BIOL, V12, P943, DOI 10.1089/cmb.2005.12.943; MEHLHORN K, 1990, INFORM PROCESS LETT, V35, P183, DOI 10.1016/0020-0190(90)90022-P; Munro J. I., 2001, SIAM J COMPUT, V31, P762, DOI 10.1137/S0097539799364092; Navarro G., 2004, Journal of Discrete Algorithms, V2, DOI 10.1016/S1570-8667(03)00066-2; Nilsson S, 1999, IEEE J SEL AREA COMM, V17, P1083, DOI 10.1109/49.772439; Overmars M.H., 1983, LECT NOTES COMPUTER, V156; Sadakane K, 2006, PROCEEDINGS OF THE SEVENTHEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1230, DOI 10.1145/1109557.1109693; Welch T., 1984, IEEE COMPUT, V17, P8, DOI DOI 10.1109/MC.1984.1659158; WILLARD DE, 1983, INFORM PROCESS LETT, V17, P81, DOI 10.1016/0020-0190(83)90075-3; WILLARD DE, 1984, J COMPUT SYST SCI, V28, P379, DOI 10.1016/0022-0000(84)90020-5	29	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-4617	1432-0541		ALGORITHMICA	Algorithmica	APR	2015	71	4					969	988		10.1007/s00453-013-9836-6		20	Computer Science, Software Engineering; Mathematics, Applied	Computer Science; Mathematics	CD1ZS	WOS:000350873800008		
J	Matsubayashi, A				Matsubayashi, Akira			Asymptotically Optimal Online Page Migration on Three Points	ALGORITHMICA			English	Article						Page migration; Work function algorithm; Competitive analysis; Server problem	DISTRIBUTED DATA-MANAGEMENT; ALGORITHMS	This paper addresses the page migration problem: given online requests from nodes on a network for accessing a page stored in a node, output online migrations of the page. Serving a request costs the distance between the request and the page, and migrating the page costs the migration distance multiplied by the page size Da parts per thousand yen1. The objective is to minimize the total sum of service costs and migration costs. Black and Sleator conjectured that there exists a 3-competitive deterministic algorithm for every graph. Although the conjecture was disproved for the case D=1, whether or not an asymptotically (with respect to D) 3-competitive deterministic algorithm exists for every graph is still open. In fact, we did not know if there exists a 3-competitive deterministic algorithm for an extreme case of three nodes with Da parts per thousand yen2. As the first step toward an asymptotic version of the Black and Sleator conjecture, we present 3- and (3+1/D)-competitive algorithms on three nodes with D=2 and Da parts per thousand yen3, respectively, and a lower bound of 3+Omega(1/D) that is greater than 3 for every Da parts per thousand yen3. In addition to the results on three nodes, we also derive rho-competitiveness on complete graphs with edge-weights between 1 and 2-2/rho for any rho a parts per thousand yen3, extending the previous 3-competitive algorithm on uniform networks.	Kanazawa Univ, Div Elect Engn & Comp Sci, Kanazawa, Ishikawa 9201192, Japan	Matsubayashi, A (reprint author), Kanazawa Univ, Div Elect Engn & Comp Sci, Kanazawa, Ishikawa 9201192, Japan.	mbayashi@t.kanazawa-u.ac.jp	Matsubayashi, Akira/C-3345-2015	Matsubayashi, Akira/0000-0002-7861-4876			KARLIN AR, 1988, ALGORITHMICA, V3, P79, DOI 10.1007/BF01762111; Awerbuch B, 2003, INFORM COMPUT, V185, P1, DOI 10.1016/S0890-5401(03)00055-5; Awerbuch B, 1998, J ALGORITHMS, V28, P67, DOI 10.1006/jagm.1998.0924; Bartal Y, 2001, THEOR COMPUT SCI, V268, P43, DOI 10.1016/S0304-3975(00)00259-0; Bartal Y, 1995, J COMPUT SYST SCI, V51, P341, DOI 10.1006/jcss.1995.1073; Bein WW, 2002, THEOR COMPUT SCI, V289, P335, DOI 10.1016/S0304-3975(01)00305-X; Bienkowski M., 2009, J DISCRETE ALGORITHM, V7, P545, DOI 10.1016/j.jda.2008.07.006; Bienkowski Marcin, 2012, Computer Science - Research and Development, V27, DOI 10.1007/s00450-011-0150-8; Black D.L., 1989, CMUCS89201 DEP COMP; Chrobak M, 1997, J ALGORITHM, V24, P124, DOI 10.1006/jagm.1996.0853; El-Yaniv R., 1998, ONLINE COMPUTATION C; KOUTSOUPIAS E, 1995, J ASSOC COMPUT MACH, V42, P971, DOI 10.1145/210118.210128; Lund C, 1999, SIAM J COMPUT, V28, P1086; Matsubayashi A., 2008, INT J PURE APPL MATH, V42, P161; WESTBROOK J, 1994, SIAM J COMPUT, V23, P951, DOI 10.1137/S0097539791199796	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-4617	1432-0541		ALGORITHMICA	Algorithmica	APR	2015	71	4					1035	1064		10.1007/s00453-013-9841-9		30	Computer Science, Software Engineering; Mathematics, Applied	Computer Science; Mathematics	CD1ZS	WOS:000350873800012		
J	Tanigawa, SI; Yoshida, Y				Tanigawa, Shin-Ichi; Yoshida, Yuichi			Testing the Supermodular-Cut Condition	ALGORITHMICA			English	Article						Property testing; Bounded-degree model; Supermodularity	GRAPHS	For a function on a finite set V with f(a...)=f(V)=0, a digraph D=(V,A) is called f-connected if it satisfies the f-cut condition, that is, delta (D) (X)a parts per thousand yenf(X) for any XaS dagger V, where delta (D) (X) is the number of arcs from X to Va-X. We show that, for any crossing supermodular function f, the f-connectivity can be tested with a constant number of queries in the general digraph model with average degree bound. As immediate corollaries, we obtain constant-time testers for k-edge-connectivity, rooted-(k,l)-edge-connectivity, and the property of having k arc-disjoint arborescences. We also give a corresponding result for the undirected case.	[Tanigawa, Shin-Ichi] Kyoto Univ, Math Sci Res Inst, Kyoto, Japan; [Yoshida, Yuichi] Natl Inst Informat, Tokyo, Japan; [Yoshida, Yuichi] Preferred Infrastruct Inc, Tokyo, Japan	Yoshida, Y (reprint author), Natl Inst Informat, Tokyo, Japan.	tanigawa@kurims.kyoto-u.ac.jp; yyoshida@nii.ac.jp			JSPS; JSPS [24800082]; MEXT [24106001]; JST, ERATO	We thank anonymous referees for helpful comments and simpler proofs of Lemmas 1 and 2. Shin-ichi Tanigawa is supported by JSPS Grant-in-Aid for Scientific Research (B). Yuichi Yoshida is supported by JSPS Grant-in-Aid for Research Activity Start-up (24800082), MEXT Grant-in-Aid for Scientific Research on Innovative Areas (24106001), and JST, ERATO, Kawarabayashi Large Graph Project.	Frank A, 2009, RESEARCH TRENDS IN COMBINATORIAL OPTIMIZATION, P87, DOI 10.1007/978-3-540-76796-1_6; Benczur AA, 1999, MATH PROGRAM, V84, P483, DOI 10.1007/s101070050034; Edmonds J, 1973, COURANT COMPUTER SCI, V9, P91; Frank A., 2011, OXFORD LECT SERIES M; Frank A, 1994, MATH PROGRAMMING STA, P34; Goldreich O, 2002, ALGORITHMICA, V32, P302, DOI 10.1007/s00453-001-0078-7; Goldreich O, 1998, J ACM, V45, P653, DOI 10.1145/285055.285060; Ito H., 2012, P 39 INT C AUT LANG, P498; Kaufman T, 2004, SIAM J COMPUT, V33, P1441, DOI 10.1137/S0097539703436424; Orenstein Y, 2010, THESIS TEL AVIV U; Parnas M, 2002, RANDOM STRUCT ALGOR, V20, P165, DOI 10.1002/rsa.10013; Yoshida Y, 2010, J SYST SCI COMPLEX, V23, P91, DOI 10.1007/s11424-010-9280-5; Yoshida Y, 2012, ALGORITHMICA, V62, P701, DOI 10.1007/s00453-010-9477-y	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-4617	1432-0541		ALGORITHMICA	Algorithmica	APR	2015	71	4					1065	1075		10.1007/s00453-013-9842-8		11	Computer Science, Software Engineering; Mathematics, Applied	Computer Science; Mathematics	CD1ZS	WOS:000350873800013		
J	Jenkins, H; Sakurai, Y; Nishimura, A; Okamoto, H; Hibberd, M; Jenkins, R; Yoneyama, T; Ashida, K; Ogama, Y; Warrington, S				Jenkins, H.; Sakurai, Y.; Nishimura, A.; Okamoto, H.; Hibberd, M.; Jenkins, R.; Yoneyama, T.; Ashida, K.; Ogama, Y.; Warrington, S.			Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects	ALIMENTARY PHARMACOLOGY & THERAPEUTICS			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; MONOFUMARATE TAK-438; MAINTENANCE THERAPY; EROSIVE ESOPHAGITIS; ESOMEPRAZOLE; SUPPRESSION; LANSOPRAZOLE; EFFICACY	BackgroundTAK-438 (vonoprazan) is a potassium-competitive acid blocker that reversibly inhibits gastric H+, K+-ATPase. AimTo evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of TAK-438 in healthy Japanese and non-Japanese men. MethodsIn two Phase I, randomised, double-blind, placebo-controlled studies, healthy men (Japan N=60; UK N=48) received TAK-438 10-40mg once daily at a fixed dose level for 7 consecutive days. Assessments included safety, tolerability, pharmacokinetics and pharmacodynamics (intragastric pH). ResultsPlasma concentration-time profiles of TAK-438 at all dose levels showed rapid absorption (median T-max 2h). Mean elimination half-life was up to 9h. Exposure was slightly greater than dose proportional, with no apparent time-dependent inhibition of metabolism. There was no important difference between the two studies in AUC(0-tau) on Day 7. TAK-438 caused dose-dependent acid suppression. On Day 7, mean 24-h intragastric pH>4 holding time ratio (HTR) with 40mg TAK-438 was 100% (Japan) and 93.2% (UK), and mean night-time pH>4 HTR was 100% (Japan) and 90.4% (UK). TAK-438 was well tolerated. The frequency of adverse events was similar at all dose levels and there were no serious adverse events. There were no important increases in serum alanine transaminase activity. Serum gastrin and pepsinogen I and II concentrations increased with TAK-438 dose. ConclusionsTAK-438 in multiple rising oral dose levels of 10-40mg once daily for 7days was safe and well tolerated in healthy men and caused rapid, profound and sustained suppression of gastric acid secretion throughout each 24-h dosing interval. Clinicaltrials.gov identifiers: NCT02123953 and NCT02141711.	[Jenkins, H.; Hibberd, M.; Jenkins, R.] Takeda Dev Ctr Europe Ltd, London WC2B 4AE, England; [Sakurai, Y.; Nishimura, A.; Okamoto, H.] Takeda Pharmaceut Co Ltd, Osaka, Japan; [Yoneyama, T.] Takeda Pharmaceut Co Ltd, Fujisawa, Kanagawa, Japan; [Ashida, K.] Saiseikai Nakatsu Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan; [Ogama, Y.] Med Co LTA Honjo Clin, Tokyo, Japan; [Warrington, S.] Hammersmith Med Res, London, England	Jenkins, H (reprint author), Takeda Dev Ctr Europe Ltd, 61 Aldwych, London WC2B 4AE, England.	helen.jenkins@takeda.com			Takeda Pharmaceutical Company Ltd; Susan Crawford of Absolute Healthcare Communications, London, UK; Takeda Pharmaceuticals International, Inc.	Writing support was provided by Hiroaki Itoh of Interface, Kanagawa, Japan and funded by Takeda Pharmaceutical Company Ltd and by Susan Crawford of Absolute Healthcare Communications, London, UK and funded by Takeda Pharmaceuticals International, Inc.	Sachs G, 2007, J CLIN GASTROENTEROL, V41, pS226, DOI 10.1097/MCG.0b013e31803233b7; Nishida H, 2012, BIOORGAN MED CHEM, V20, P3925, DOI 10.1016/j.bmc.2012.04.014; Scarpignato C, 2006, ALIMENT PHARM THERAP, V23, P23, DOI 10.1111/j.1365-2036.2006.02945.x; Shin JM, 2008, CELL MOL LIFE SCI, V65, P264, DOI 10.1007/s00018-007-7249-x; Katz PO, 2004, ALIMENT PHARM THERAP, V20, P399, DOI 10.1111/j.1365-2036.2004.02079.x; Fennerty MB, 2005, ALIMENT PHARM THERAP, V21, P455, DOI 10.1111/j.1365-2036.2005.02339.x; BELL NJV, 1992, DIGESTION, V51, P59; Dent J, 2008, AM J GASTROENTEROL, V103, P20, DOI 10.1111/j.1572-0241.2007.01544.x; Arikawa Y, 2012, J MED CHEM, V55, P4446, DOI 10.1021/jm300318t; Hori Y, 2010, J PHARMACOL EXP THER, V335, P231, DOI 10.1124/jpet.110.170274; Shin JM, 2011, J PHARMACOL EXP THER, V339, P412, DOI 10.1124/jpet.111.185314; BIEMOND I, 1993, DIGEST DIS SCI, V38, P932, DOI 10.1007/BF01295923; Chey WD, 2008, GASTROENTEROLOGY, V134, pA323; Chiba T, 2013, DDW; Cicala M, WORLD J GASTROENTERO, V19, P6529; Gough K, 1995, DRUG INF J, V29, P1039; Hori Y, 2011, J PHARMACOL EXP THER, V337, P797, DOI 10.1124/jpet.111.179556; Kalaitzakis Evangelos, 2007, Ther Clin Risk Manag, V3, P653; Kraft WK, 2009, EXPERT REV CLIN PHAR, V2, P295, DOI 10.1586/ecp.09.8; Matsukawa J, 2011, BIOCHEM PHARMACOL, V81, P1145, DOI 10.1016/j.bcp.2011.02.009; Modlin IM, 2004, ACID RELATED DIS BIO, V2nd; Orlando LA, 2007, DIGEST DIS SCI, V52, P2482, DOI 10.1007/s10620-006-9419-3; Sakurai Y, 2012, UEGW; Shin JM, 2009, EXPERT REV CLIN PHAR, V2, P461, DOI 10.1586/ecp.09.33; Tutuian R, 2004, MEDGENMED, V6, P11; Vakil NB, 2001, ALIMENT PHARM THERAP, V15, P927, DOI 10.1046/j.1365-2036.2001.01024.x; Yuan Y, 2010, J NANOSCI NANOTECHNO, V10, P1	27	6	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-2813	1365-2036		ALIMENT PHARM THER	Aliment. Pharmacol. Ther.	APR	2015	41	7					636	648		10.1111/apt.13121		13	Gastroenterology & Hepatology; Pharmacology & Pharmacy	Gastroenterology & Hepatology; Pharmacology & Pharmacy	CD4IO	WOS:000351046200004		
J	Matsunaga, S; Kishi, T; Iwata, N				Matsunaga, Shinji; Kishi, Taro; Iwata, Nakao			Memantine for Lewy Body Disorders: Systematic Review and Meta-Analysis	AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY			English	Article						Memantine; Lewy body disorders; systematic review; meta-analysis	PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CLINICAL-TRIALS; DOUBLE-BLIND; DEMENTIA; GLUTAMATE; ANTAGONISTS; PREVALENCE; DISABILITY; INVENTORY	Objective: To clarify whether memantine is more efficacious in several outcomes and safer than placebo in patients with Lewy body disorders, we performed a meta-analysis of memantine in patients with Lewy body disorders. Methods: The meta-analysis included randomized controlled trials of memantine for Lewy body disorders in all patients with Lewy body disorders. Motor function, activities of daily living, Neuropsychiatric Inventory, Mini-Mental State Exam, discontinuation rate, and individual side effects were evaluated. Results: No significant effects of memantine on motor function scores, Mini-Mental State Exam scores, Neuropsychiatric Inventory scores, and activity of daily living scores were found. However, memantine was superior to placebo in Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change scores (standardized mean difference: -0.26; 95% confidence interval: -0.51 to -0.02; z = 2.08; p = 0.04; two studies; N = 258). Dropout due to all causes, inefficacy, or adverse events were similar in both groups. Moreover, no significant differences in serious adverse events, somnolence/tiredness, stroke, dizziness/vertigo, and confusion were found between the groups. Conclusion: Our results suggest that memantine did not have a benefit for the treatment of Lewy body disorders in cognition and motor function. However, memantine may be superior to placebo for the overall impression of the disorders. Further, memantine is well tolerated.	[Matsunaga, Shinji; Kishi, Taro; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 4701192, Japan; [Matsunaga, Shinji] Okehazama Hosp, Dept Psychiat, Toyoake, Aichi, Japan	Kishi, T (reprint author), Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 4701192, Japan.	tarok@fujita-hu.ac.jp					Kishi T, 2013, J PSYCHIATR RES, V47, P1143, DOI 10.1016/j.jpsychires.2013.04.013; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moreau C, 2013, J NEUROL NEUROSUR PS, V84, P552, DOI 10.1136/jnnp-2012-303182; Lippa CF, 2007, NEUROLOGY, V68, P812, DOI 10.1212/01.wnl.0000256715.13907.d3; Gelinas I, 1999, AM J OCCUP THER, V53, P471; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Merello M, 1999, CLIN NEUROPHARMACOL, V22, P273; Schneider LS, 1997, ALZ DIS ASSOC DIS, V11, pS22; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308; Emre M, 2010, LANCET NEUROL, V9, P969, DOI [10.1016/S1474-4422(10)70194-0, 10.1016/S1474-4422(10)20194-0]; Ballard C, 1997, ACTA NEUROL SCAND, V96, P366; Boada M, 2013, DEMENT GERIATR COGN, V35, P23, DOI 10.1159/000345989; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; Weintraub D, 2013, AM J GERIAT PSYCHIAT, V21, P497, DOI 10.1016/j.jagp.2013.02.020; Ondo WG, 2011, PARKINSONISM RELAT D, V17, P156, DOI 10.1016/j.parkreldis.2010.12.003; Leroi I, 2009, MOVEMENT DISORD, V24, P1217, DOI 10.1002/mds.22495; Aarsland D, 2009, LANCET NEUROL, V8, P613, DOI 10.1016/S1474-4422(09)70146-2; Danysz W, 2003, INT J GERIATR PSYCH, V18, pS23, DOI 10.1002/gps.938; Berman K, 2012, AM J GERIAT PSYCHIAT, V20, P104, DOI 10.1097/JGP.0b013e31822001a6; Dalfo E, 2004, BRAIN PATHOL, V14, P388; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Donaghy P, 2015, AM J GERIAT PSYCHIAT, V23, P23, DOI 10.1016/j.jagp.2013.03.001; Fahn S, 1987, MACMILLAN HEALTHCARE, V2, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hoegh M, 2013, AM J GERIAT PSYCHIAT, V21, P529, DOI 10.1016/j.jagp.2012.12.007; Kucheryanu VG, 2000, B EXP BIOL MED+, V130, P629, DOI 10.1007/BF02682089; Li Wei, 2011, Zhonghua Yi Xue Za Zhi, V91, P301; Moher D, 2009, BMJ-BRIT MED J, V21, P339, DOI DOI 10.1136/BMJ.B2535; Olin JT, 1996, J GERIATR PSYCH NEUR, V9, P176; STARR MS, 1995, SYNAPSE, V19, P264, DOI 10.1002/syn.890190405; Yamawaki M, 2009, NEUROEPIDEMIOLOGY, V32, P263, DOI 10.1159/000201565	33	3	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1064-7481	1545-7214		AM J GERIAT PSYCHIAT	Am. J. Geriatr. Psychiatr.	APR	2015	23	4					373	383		10.1016/j.jagp.2013.11.007		11	Geriatrics & Gerontology; Gerontology; Psychiatry	Geriatrics & Gerontology; Psychiatry	CD1IW	WOS:000350829600004		
J	Motoyama, H; Kobayashi, A; Yokoyama, T; Shimizu, A; Sakai, H; Furusawa, N; Notake, T; Kitagawa, N; Arai, T; Yokoi, K; Okubo, Y; Miyagawa, S				Motoyama, Hiroaki; Kobayashi, Akira; Yokoyama, Takahide; Shimizu, Akira; Sakai, Hiroshi; Furusawa, Norihiko; Notake, Tsuyoshi; Kitagawa, Noriyuki; Arai, Takuma; Yokoi, Kenta; Okubo, Yohei; Miyagawa, Shin-ichi			Impact of advanced age on the short- and long-term outcomes in patients undergoing hepatectomy for hepatocellular carcinoma: a single-center analysis over a 20-year period	AMERICAN JOURNAL OF SURGERY			English	Article						Advanced age; Hepatocellular carcinomas; Comorbidity	MALIGNANT HEPATOBILIARY DISEASES; 1222 CONSECUTIVE PATIENTS; HEPATIC RESECTION; ELDERLY-PATIENTS; MULTIVARIATE-ANALYSIS; PROSPECTIVE DATABASE; SURVIVAL; LIVER; PREDICTORS; SURGERY	BACKGROUND: The purpose of this study was to analyze the influence of age on both the risk of hepatectomy and the prognosis in patients with hepatocellular carcinoma (HCC). METHODS: Patients undergoing an initial hepatectomy for HCC were classified into 2 age groups: 75 years or over (n = 113) and less than 75 years (n = 499). RESULTS: A zero 90-day mortality was achieved in the elderly. Although the recurrence rate and recurrence sites were almost similar between the 2 groups, the 5-year survival rate in the elderly patients was significantly lower than that in the younger patients (46.0% vs 57.6%; P = .018), possibly because of the higher incidence of deaths from other causes (26.8% vs 10.4%; P = .011) in the elderly. CONCLUSION: Selected elderly HCC patients can undergo a hepatectomy safely and can benefit from long-term HCC control comparable with that of their younger counterparts. (C) 2015 Elsevier Inc. All rights reserved.	[Motoyama, Hiroaki; Kobayashi, Akira; Yokoyama, Takahide; Shimizu, Akira; Sakai, Hiroshi; Furusawa, Norihiko; Notake, Tsuyoshi; Kitagawa, Noriyuki; Arai, Takuma; Yokoi, Kenta; Okubo, Yohei; Miyagawa, Shin-ichi] Shinshu Univ, Sch Med, Dept Surg 1, Matsumoto, Nagano 3908621, Japan	Kobayashi, A (reprint author), Shinshu Univ, Sch Med, Dept Surg 1, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	kbys@shinshu-u.ac.jp					Alfieri S, 2001, DIGEST LIVER DIS, V33, P341, DOI 10.1016/S1590-8658(01)80089-X; LIEBMAN HA, 1984, NEW ENGL J MED, V310, P1427, DOI 10.1056/NEJM198405313102204; Oishi K, 2009, J GASTROINTEST SURG, V13, P695, DOI 10.1007/s11605-008-0758-6; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Hanazaki K, 2001, J AM COLL SURGEONS, V192, P38, DOI 10.1016/S1072-7515(00)00778-X; Pavelka JC, 2006, CANCER, V107, P1520, DOI 10.1002/cncr.22194; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; Makuuchi M, 1998, ULTRASOUND MED BIOL, V24, P1229, DOI 10.1016/S0301-5629(98)00112-4; Meyerhardt JA, 2008, J CLIN ONCOL, V26, P4109, DOI 10.1200/JCO.2007.15.6687; ABELEV GI, 1963, TRANSPLANTATION, V1, P174; Ercolani G, 2003, ANN SURG, V237, P536, DOI 10.1097/00000658-200304000-00016; Poon RTP, 1999, AM J GASTROENTEROL, V94, P2460; Fleisher LA, 2007, CIRCULATION, V116, pE418, DOI 10.1161/CIRCULATIONAHA.107.185699; Dimick JB, 2003, ARCH SURG-CHICAGO, V138, P185, DOI 10.1001/archsurg.138.2.185; Huang J, 2009, J GASTROINTEST SURG, V13, P1627, DOI 10.1007/s11605-009-0933-4; Nathan H, 2009, ANN SURG, V249, P799, DOI 10.1097/SLA.0b013e3181a38eb5; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; Tzeng CWD, 2014, HPB, V16, P459, DOI 10.1111/hpb.12155; Al-Refaie WB, 2010, ANN SURG, V251, P311, DOI 10.1097/SLA.0b013e3181b6b04c; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Yancik R, 1996, ANN EPIDEMIOL, V6, P399, DOI 10.1016/S1047-2797(96)00063-4; Yancik R, 1998, CANCER, V82, P2123, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2123::AID-CNCR6>3.3.CO;2-N; Kaibori M, 2009, J SURG ONCOL, V99, P154, DOI 10.1002/jso.21221; BROUWER A, 1985, HEPATOLOGY, V5, P362, DOI 10.1002/hep.1840050304; Poon RT, 2004, ANN SURG, V240, P698, DOI 10.1097/01.sla.0000141195.66155.0c; Poon RTP, 2001, ANN SURG, V234, P63, DOI 10.1097/00000658-200107000-00010; Lee CR, 2012, J GASTROINTEST SURG, V16, P1736, DOI 10.1007/s11605-012-1966-7; ARAKI T, 1980, AM J ROENTGENOL, V135, P1037; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Couinaud C., 1957, FOIE ETUDES ANATOMIQ; DRIPPS RD, 1961, JAMA-J AM MED ASSOC, V178, P261; Edge SB, 2010, AJCC CANC STAGING MA, P191; HODGSON WJB, 1992, AM J SURG, V163, P246, DOI 10.1016/0002-9610(92)90110-D; Jarnagin William R, 2002, Ann Surg, V236, P397; KAKAZU T, 1993, HEPATO-GASTROENTEROL, V40, P337; MullerHocker J, 1997, HEPATOLOGY, V26, P709; Nagorney DM, 2004, ANN SURG, V240, P708; Sastre J, 1996, HEPATOLOGY, V24, P1199; Shirabe K, 2009, WORLD J SURG, V33, P1927, DOI 10.1007/s00268-009-0122-3; Tsujita E, 2010, SURGERY, V147, P696, DOI 10.1016/j.surg.2009.10.054; Wayne JD, 2002, ANN SURG, V235, P722, DOI 10.1097/00000658-200205000-00015; Wayne JD, 2002, ANN SURG, V235, P730; Zhou L, 2006, EJSO-EUR J SURG ONC, V32, P767, DOI 10.1016/j.ejso.2006.03.050	44	3	3	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	APR	2015	209	4					733	741		10.1016/j.amjsurg.2014.05.026		9	Surgery	Surgery	CD6FC	WOS:000351183900022		
J	Hayashi, K; Sugisaki, M; Kino, K; Ishikawa, T; Kawashima, S; Amemiya, T				Hayashi, K.; Sugisaki, M.; Kino, K.; Ishikawa, T.; Kawashima, S.; Amemiya, T.			Morphological Characteristics of the Temporomandibular Joint in the Pouch Young of the Tasmanian Devil	ANATOMIA HISTOLOGIA EMBRYOLOGIA			English	Article							GROWTH	We recently reported the absence of the articular disc, which is a constant structure in mammals, in the temporomandibular joint of the adult Tasmanian devil. However, whether the articular disc disappears with growth of the animal was unknown. The aim of this study was to determine whether a pouch young of the Tasmanian devil has the articular disc. The temporomandibular joint of a fresh carcass of the pouch young, whose crown-rump length was 43mm, was examined microscopically and by microcomputed tomography. The absence of the articular disc in the pouch young temporomandibular joint was histologically confirmed. It is suggested that the articular disc of the Tasmanian devil is naturally absent.	[Hayashi, K.; Sugisaki, M.] Jikei Univ, Sch Med, Dept Dent, Minato Ku, Tokyo 1058461, Japan; [Kino, K.; Ishikawa, T.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Temporomandibular Joint & Oral Funct, Bunkyo Ku, Tokyo 1138510, Japan; [Kawashima, S.; Amemiya, T.] Nihon Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Chiyoda Ku, Tokyo 1018310, Japan	Hayashi, K (reprint author), Jikei Univ, Sch Med, Dept Dent, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	katsuh@jikei.ac.jp					Phillips BT, 2003, ZOO BIOL, V22, P497, DOI 10.1002/zoo.10092; CUNAT J. J., 1956, JOUR DENTAL RES, V35, P533, DOI 10.1177/00220345560350040601; FROMMER J, 1964, ANAT REC, V150, P449, DOI 10.1002/ar.1091500414; Harris G. P., 1807, T LINN SOC LOND, V9, P174; Hayashi K, 2013, ANAT HISTOL EMBRYOL, V42, P415, DOI 10.1111/ahe.12031; KANOUSE MC, 1969, J DENT RES, V48, P1171, DOI 10.1177/00220345690480061401; Parsons F. G., 1900, J ANAT PHYSL, V34, P41; SCOTT JH, 1951, J ANAT, V85, P36; Unozawa Hideki, 1993, Shikwa Gakuho, V93, P1037; Weinmann J. P., 1947, BONE AND BONES, P56; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0340-2096	1439-0264		ANAT HISTOL EMBRYOL	Anat. Histol. Embryol.	APR	2015	44	2					157	160		10.1111/ahe.12118		4	Anatomy & Morphology; Veterinary Sciences	Anatomy & Morphology; Veterinary Sciences	CD5SL	WOS:000351148100010		
J	Hara, M; Ando, M; Tsuchiya, K; Nitta, K				Hara, Masaki; Ando, Minoru; Tsuchiya, Ken; Nitta, Kosaku			Serum hepcidin-25 level linked with high mortality in patients with non-Hodgkin lymphoma	ANNALS OF HEMATOLOGY			English	Article						Anemia of inflammation; Ferritin; Interleukin-6; International prognostic index	CLINICAL-SIGNIFICANCE; DISEASE; ANEMIA; IRON; DIAGNOSIS	Hepatic hepcidin-25 production is stimulated by systemic inflammation, and it interferes with the body's utilization of iron, leading to anemia. A 1-year prospective study was conducted to elucidate an association of serum hepcidin-25 concentration with mortality in anemic patients with non-Hodgkin lymphoma (NHL). Serum hepcidin-25 levels were measured in 50 NHL patients using liquid chromatography-tandem mass spectrometry. The patients were stratified into a high- and a low-hepcidin-25 group according to the median of serum hepcidin-25 concentrations. Factors associated with hemoglobin (Hb) were determined by multivariate regression analysis, incorporating serum hepcidin-25 and inflammatory markers including ferritin and interleukin-6 (IL-6) as covariates. The association between serum hepcidin-25 and mortality was analyzed using both the Kaplan-Meier method and a multivariate proportional hazards regression model. The median of serum hepcidin-25 concentrations was 49.8 (0.6-269) ng/mL, a level approximately nine times greater than the reference value for healthy individuals. Hb level was significantly lower in the high than in the low-hepcidin-25 group. Serum hepcidin-25 was extracted as the significant factor associated with Hb, but neither ferritin nor IL-6 was. The cumulative mortality was significantly greater in the high than in the low-hepcidin-25 group (56.0 vs. 24.0 %; P = 0.0222). The mortality risk for the presence of high hepcidin-25 was four times greater (hazard ratio [95 % confidence interval]: 3.66 [1.12-16.4]). In conclusion, serum hepcidin-25 levels are elevated in anemic NHL patients, and in this study, the group with higher hepcidin-25 levels manifested advanced anemia and poor survival.	[Hara, Masaki; Ando, Minoru; Tsuchiya, Ken; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Internal Med 4, Shinjuku Ku, Tokyo 1620054, Japan; [Hara, Masaki; Ando, Minoru] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Renal, Dept Med,Bunkyo Ku, Tokyo 1130021, Japan	Ando, M (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Renal, Dept Med,Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1130021, Japan.	hdcn@cick.jp					Ganz T, 2007, J AM SOC NEPHROL, V18, P394, DOI 10.1681/ASN.2006070802; Kemna EHJM, 2008, HAEMATOL-HEMATOL J, V93, P90, DOI 10.3324/haematol.11705; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Moullet I, 1998, ANN ONCOL, V9, P1109, DOI 10.1023/A:1008498705032; Hohaus S, 2010, J CLIN ONCOL, V28, P2538, DOI 10.1200/JCO.2009.27.6873; Tanno T, 2010, CURR OPIN HEMATOL, V17, P184, DOI 10.1097/MOH.0b013e328337b52f; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; LISTER TA, 1989, J CLIN ONCOL, V7, P1630; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; SHIPP MA, 1993, NEW ENGL J MED, V329, P987; Pardanani A, 2013, AM J HEMATOL, V88, P312, DOI 10.1002/ajh.23406; Chen J, 2013, EUR REV MED PHARMACO, V17, P1769; CONLAN MG, 1991, CANCER, V67, P1389, DOI 10.1002/1097-0142(19910301)67:5<1389::AID-CNCR2820670519>3.0.CO;2-Q; Kamai T, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-270; Kautz L, 2013, BLOOD; Murao N, 2007, RAPID COMMUN MASS SP, V21, P4033, DOI 10.1002/rcm.3319; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scisignal.3001127, 10.1126/scitranslmed.3001127]; Roy Cindy N, 2010, Hematology Am Soc Hematol Educ Program, V2010, P276, DOI 10.1182/asheducation-2010.1.276; Tisi MC, 2014, LEUKEMIA LYMPHOMA, V55, P270, DOI 10.3109/10428194.2013.802314; Uehata T, 2012, NEPHROL DIAL TRANSPL, V27, P1076, DOI 10.1093/ndt/gfr431; Ukarma L, 2009, CLIN CHEM, V55, P1354, DOI 10.1373/clinchem.2008.121285; van der Weerd NC, 2013, NEPHROL DIAL TRANSPL, V28, P3062, DOI 10.1093/ndt/gfs488	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	APR	2015	94	4					603	608		10.1007/s00277-014-2255-1		6	Hematology	Hematology	CD1YF	WOS:000350869900008		
J	Higo, T; Miyagaki, T; Nakamura, F; Shinohara, A; Asano, H; Abe, H; Senda, N; Yoshizaki, A; Fukayama, M; Kurokawa, M				Higo, Takashi; Miyagaki, Tomomitsu; Nakamura, Fumihiko; Shinohara, Akihito; Asano, Hiroki; Abe, Hiroyuki; Senda, Naoyuki; Yoshizaki, Ayumi; Fukayama, Masashi; Kurokawa, Mineo			Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma	ANNALS OF HEMATOLOGY			English	Letter							NON-HODGKINS-LYMPHOMA; FLUDARABINE		[Higo, Takashi; Nakamura, Fumihiko; Shinohara, Akihito; Asano, Hiroki; Kurokawa, Mineo] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, Tokyo 1138655, Japan; [Miyagaki, Tomomitsu; Senda, Naoyuki; Yoshizaki, Ayumi] Univ Tokyo, Grad Sch Med, Dept Dermatol, Bunkyo Ku, Tokyo 1138655, Japan; [Abe, Hiroyuki; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Bunkyo Ku, Tokyo 1138655, Japan; [Kurokawa, Mineo] Tokyo Univ Hosp, Dept Cell Therapy & Transplantat Med, Bunkyo Ku, Tokyo 1138655, Japan	Kurokawa, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurokawa-tky@umin.ac.jp					ANHALT GJ, 1990, NEW ENGL J MED, V323, P1729, DOI 10.1056/NEJM199012203232503; Zhu XJ, 2007, J DERMATOL, V34, P503, DOI 10.1111/j.1346-8138.2007.00322.x; Gooptu C, 2001, BRIT J DERMATOL, V144, P1255, DOI 10.1046/j.1365-2133.2001.04244.x; Reich K, 1999, BRIT J DERMATOL, V141, P739; Anhalt GJ, 2004, J INVEST DERM SYMP P, V9, P29, DOI 10.1111/j.1087-0024.2004.00832.x; BAZARBACHI A, 1995, ANN ONCOL, V6, P730; Braess J, 1997, ANN HEMATOL, V75, P227, DOI 10.1007/s002770050347; FRIED R, 1993, J AM ACAD DERMATOL, V29, P815, DOI 10.1016/0190-9622(93)70244-N; Lee M S, 1995, Australas J Dermatol, V36, P206, DOI 10.1111/j.1440-0960.1995.tb00976.x; Plumb R, 1996, AM J HEMATOL, V52, P58, DOI 10.1002/(SICI)1096-8652(199605)52:1<58::AID-AJH10>3.0.CO;2-3	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	APR	2015	94	4					683	685		10.1007/s00277-014-2202-1		3	Hematology	Hematology	CD1YF	WOS:000350869900018		
J	Kuroda, J; Mizutani, S; Shimura, Y; Maegawa, S; Nagoshi, H; Chinen, Y; Tatekawa, S; Tsukamoto, T; Mizuno, Y; Yamamoto-Sugitani, M; Kobayashi, T; Matsumoto, Y; Horiike, S; Taniwaki, M				Kuroda, Junya; Mizutani, Shinsuke; Shimura, Yuji; Maegawa, Saori; Nagoshi, Hisao; Chinen, Yoshiaki; Tatekawa, Shotaro; Tsukamoto, Taku; Mizuno, Yoshimi; Yamamoto-Sugitani, Mio; Kobayashi, Tsutomu; Matsumoto, Yosuke; Horiike, Shigeo; Taniwaki, Masafumi			Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy	ANNALS OF HEMATOLOGY			English	Letter							RESISTANCE		[Kuroda, Junya; Mizutani, Shinsuke; Shimura, Yuji; Maegawa, Saori; Nagoshi, Hisao; Chinen, Yoshiaki; Tatekawa, Shotaro; Tsukamoto, Taku; Mizuno, Yoshimi; Yamamoto-Sugitani, Mio; Kobayashi, Tsutomu; Matsumoto, Yosuke; Horiike, Shigeo; Taniwaki, Masafumi] Kyoto Prefectural Univ Med, Dept Med, Div Hematol & Oncol, Kamigyo Ku, Kyoto 6028566, Japan	Kuroda, J (reprint author), Kyoto Prefectural Univ Med, Dept Med, Div Hematol & Oncol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	junkuro@koto.kpu-m.ac.jp					Kumar SK, 2012, LEUKEMIA, V26, P149, DOI 10.1038/leu.2011.196; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Kale AJ, 2012, J MED CHEM, V55, P10317, DOI 10.1021/jm300434z; Hideshima T, 2001, CANCER RES, V61, P3071; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; Dimopoulos MA, 2010, J CLIN ONCOL, V28, P4976, DOI 10.1200/JCO.2010.30.8791; Mateos MV, 2014, HAEMATOLOGICA, V99, P1114, DOI 10.3324/haematol.2013.099341; Moore S, 2013, EUR J HAEMATOL, V90, P420, DOI 10.1111/ejh.12070	8	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	APR	2015	94	4					687	689		10.1007/s00277-014-2214-x		3	Hematology	Hematology	CD1YF	WOS:000350869900019		
J	Taguchi, M; Imaizumi, Y; Sasaki, D; Higuchi, T; Tsuruda, K; Hasegawa, H; Taguchi, J; Sawayama, Y; Imanishi, D; Hata, T; Yanagihara, K; Yoshie, O; Miyazaki, Y				Taguchi, Masataka; Imaizumi, Yoshitaka; Sasaki, Daisuke; Higuchi, Tomonori; Tsuruda, Kazuto; Hasegawa, Hiroo; Taguchi, Jun; Sawayama, Yasushi; Imanishi, Daisuke; Hata, Tomoko; Yanagihara, Katsunori; Yoshie, Osamu; Miyazaki, Yasushi			Molecular analysis of loss of CCR4 expression during mogamulizumab monotherapy in an adult T cell leukemia/lymphoma patient	ANNALS OF HEMATOLOGY			English	Letter							MONOCLONAL-ANTIBODY KW-0761; LEUKEMIA-LYMPHOMA; FRA-2		[Taguchi, Masataka; Taguchi, Jun; Hata, Tomoko; Miyazaki, Yasushi] Nagasaki Univ, Atom Bomb Dis & Hibakusha Med Unit, Atom Bomb Dis Inst, Grad Sch Biomed Sci,Dept Hematol, Nagasaki 852, Japan; [Imaizumi, Yoshitaka; Sawayama, Yasushi; Imanishi, Daisuke] Nagasaki Univ Hosp, Dept Hematol, Nagasaki 8528501, Japan; [Sasaki, Daisuke; Tsuruda, Kazuto; Hasegawa, Hiroo; Yanagihara, Katsunori] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki Univ Hosp, Cent Diagnost Lab, Nagasaki 852, Japan; [Higuchi, Tomonori; Yoshie, Osamu] Kinki Univ, Fac Med, Dept Microbiol, Osaka, Japan	Imaizumi, Y (reprint author), Nagasaki Univ Hosp, Dept Hematol, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	y-imaizm@nagasaki-u.ac.jp					Ishii T, 2010, CLIN CANCER RES, V16, P1520, DOI 10.1158/1078-0432.CCR-09-2697; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Hiraga J, 2009, BLOOD, V113, P4885, DOI 10.1182/blood-2008-08-175208; Higuchi T, 2013, BLOOD, V121, P3640, DOI 10.1182/blood-2012-07-441022; Yoshie O, 2002, BLOOD, V99, P1505, DOI 10.1182/blood.V99.5.1505; Kamihira S, 2003, CLIN LAB HAEMATOL, V25, P111, DOI 10.1046/j.1365-2257.2003.00503.x; Nakayama T, 2008, ONCOGENE, V27, P3221, DOI 10.1038/sj.onc.1210984; Ohno N, 2013, BRIT J HAEMATOL, V163, P683, DOI 10.1111/bjh.12555	8	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	APR	2015	94	4					693	695		10.1007/s00277-014-2239-1		3	Hematology	Hematology	CD1YF	WOS:000350869900021		
J	Sirachainan, N; Komwilaisak, P; Kitamura, K; Hongeng, S; Sekine, T; Kunishima, S				Sirachainan, Nongnuch; Komwilaisak, Patcharee; Kitamura, Katsumasa; Hongeng, Suradej; Sekine, Takashi; Kunishima, Shinji			The first two cases of MYH9 disorders in Thailand: an international collaborative study	ANNALS OF HEMATOLOGY			English	Letter							IMMUNOFLUORESCENCE ANALYSIS; R702 MUTATIONS; DISEASE; LOCALIZATION		[Sirachainan, Nongnuch; Hongeng, Suradej] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat, Bangkok 10400, Thailand; [Komwilaisak, Patcharee] KhonKaen Univ, Srinagarind Hosp, Khon Kaen, Thailand; [Kitamura, Katsumasa; Kunishima, Shinji] Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Dept Adv Diag, Naka Ku, Nagoya, Aichi 4600001, Japan; [Sekine, Takashi] Toho Univ, Ohashi Hosp, Sch Med, Dept Pediat, Tokyo, Japan	Kunishima, S (reprint author), Natl Hosp Org Nagoya Med Ctr, Clin Res Ctr, Dept Adv Diag, Naka Ku, 4-1-1 Sannomaru, Nagoya, Aichi 4600001, Japan.	kunishis@nnh.hosp.go.jp					Sekine T, 2010, KIDNEY INT, V78, P207, DOI 10.1038/ki.2010.21; Kunishima S, 2003, LAB INVEST, V83, P115, DOI 10.1097/01.LAB.0000050960.48774.17; Kunishima S, 2010, CURR OPIN HEMATOL, V17, P405, DOI 10.1097/MOH.0b013e32833c069c; Kunishima S, 2007, EUR J HAEMATOL, V78, P220, DOI 10.1111/j.1600-0609.2006.00806.x; Balduini CL, 2011, BRIT J HAEMATOL, V154, P161, DOI 10.1111/j.1365-2141.2011.08716.x; Pecci A, 2008, NEPHROL DIAL TRANSPL, V23, P2690, DOI 10.1093/ndt/gfn277; Pecci A, 2014, HUM MUTAT, V35, P236, DOI 10.1002/humu.22476; Glembotsky AC, 2012, J THROMB HAEMOST, V10, P1653, DOI 10.1111/j.1538-7836.2012.04805.x; Kitamura K, 2013, J THROMB HAEMOST, V11, P2071, DOI 10.1111/jth.12406; Savoia A, 2010, THROMB HAEMOSTASIS, V103, P826, DOI 10.1160/TH09-08-0593	10	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0939-5555	1432-0584		ANN HEMATOL	Ann. Hematol.	APR	2015	94	4					707	709		10.1007/s00277-014-2234-6		3	Hematology	Hematology	CD1YF	WOS:000350869900026		
J	Takamatsu, K; Takegami, H; Ito, C; Suzuki, K; Ohnuma, H; Hino, R; Okumura, T				Takamatsu, Kuniyoshi; Takegami, Hiroaki; Ito, Chikara; Suzuki, Keiichi; Ohnuma, Hiroshi; Hino, Ryutaro; Okumura, Tadahiko			Cosmic-ray muon radiography for reactor core observation	ANNALS OF NUCLEAR ENERGY			English	Article						Muon; Radiography; Nuclear reactor; HTTR; Fukushima Daiichi; Nondestructive inspection		One of the critical problems that have arisen from the accident at TEPCO's Fukushima Daiichi nuclear power plant is the removal of fuel debris. For solving this problem, an examination of the internal reactors has been planned to identify the fuel debris. However, the high radiation dose around the reactors has necessitated the development of a remote sensing method that would enable observation of the internal reactors from the outside. In our study, we focused on a nondestructive inspection method by which cosmic-ray muons could be used to observe the internal reactor from outside the reactor pressure vessel (RPV) and containment vessel (CV). We conducted an observation test on the high-temperature engineering test reactor (HTTR) at the Japan Atomic Energy Agency to evaluate the applicability of the method to the internal visualization of a reactor. We also analytically evaluated the resolution of existing muon telescopes to assess their suitability for the HTTR observation, and were able to detect the major structures of the HTTR based on the distribution of the surface densities calculated from the coincidences measured by the telescopes. Our findings suggested that existing muon telescopes could be used for muon observation of the internal reactor from outside the RPV and CV. (C) 2014 Elsevier Ltd. All rights reserved.	[Takamatsu, Kuniyoshi; Takegami, Hiroaki; Hino, Ryutaro] Japan Atom Energy Agcy, Nucl Hydrogen & Heat Applicat Res Ctr, Oarai, Ibaraki 3111393, Japan; [Ito, Chikara] Japan Atom Energy Agcy, O Arai Res & Dev Ctr, Oarai, Ibaraki 3111393, Japan; [Suzuki, Keiichi; Ohnuma, Hiroshi] Kawasaki Geol Engn Co Ltd, Minato Ku, Tokyo 1088337, Japan; [Okumura, Tadahiko] Engn Adv Assoc Japan, Minato Ku, Tokyo 1050001, Japan; [Okumura, Tadahiko] Energy Soc Japan, Minato Ku, Tokyo 1050004, Japan	Takamatsu, K (reprint author), Japan Atom Energy Agcy, Nucl Hydrogen & Heat Applicat Res Ctr, 4002 Narita Cho, Oarai, Ibaraki 3111393, Japan.	takamatsu.kuniyoshi@jaea.go.jp			JKA Foundation	This study used some results obtained by the Mechanical Social Systems Foundation and was supported by the JKA Foundation. The authors would also like to thank the chairperson of "Preliminary Test for Visualization of Inner HTTR Committee", Prof. T. Tokunaga, as well as the committee members for their helpful comments.	Akiyama N., 1991, Radioisotopes, V40; Borozdin K, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.152501; Knoll G. F., 2010, RAD DETECTION MEASUR; MINATO S, 1986, APPL RADIAT ISOTOPES, V37, P941; Miyake S., 1979, J PHYS SOC JPN, V34, P292; Morris CL, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862475; Nagamine K., 2003, INTRO MUON SCI; Saito S., 1994, DESIGN HIGH TEMPERAT, P1332; Shiratori Y., 2010, EIT ISCE S ENG GEO H, P31; Shoji D., 2011, NUCL INSTRUM METHO A, V654; Suzuki K., 2011, P 10 SEGJ INT S NOV; Tanaka HKM, 2010, EARTH PLANETS SPACE, V62, P119, DOI 10.5047/eps.2009.06.003	12	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4549			ANN NUCL ENERGY	Ann. Nucl. Energy	APR	2015	78						166	175		10.1016/j.anucene.2014.12.017		10	Nuclear Science & Technology	Nuclear Science & Technology	CD0QQ	WOS:000350779400020		
J	Vu, TM; Kitada, T				Thanh Mai Vu; Kitada, Takanori			Seed and blanket ADS using thorium-reprocessed fuel: Parametric survey on TRU transmutation performance and safety characteristics	ANNALS OF NUCLEAR ENERGY			English	Article						ADS; Thorium based fuel; Reprocessed fuel; TRU transmutation; Void coefficient		Conceptual designs of accelerator driven systems (ADS) that utilize thorium fuel as blanket and reprocessed fuel as seed for fission reaction in order to transmute the transuranic elements in spent nuclear fuel and produce energy from thorium utilization was proposed. In order to analyze the TRU transmutation performance of the system while the safety margin during the operation is satisfied, a parametric survey is done in this study. The impact of minor actinide (MA) amount and the reactor size on transmutation efficiency and safety characteristics of the ADS is investigated using MCNPX code using the ENDF/B-VII. As the results, with increasing MA content, TRU transmutation rate is increased while void reactivity of the system becomes less negative. Besides, increasing the core size by introducing more thorium and reprocessed fuel assemblies into the system reduces the TRU transmutation rate and reactivity swing due to bumup of the system. In order to match the efficient transmutation purpose and safety features during operation, higher MA content is suggested to introduce into the system. (C) 2014 Elsevier Ltd. All rights reserved.	[Thanh Mai Vu; Kitada, Takanori] Osaka Univ, Suita, Osaka 5650871, Japan	Vu, TM (reprint author), Osaka Univ, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	m-vu@ne.see.eng.osaka-u.ac.jp					Chadwick MB, 2006, NUCL DATA SHEETS, V107, P2931, DOI 10.1016/j.nds.2006.11.001; Tsujimoto K, 2004, J NUCL SCI TECHNOL, V41, P21, DOI 10.3327/jnst.41.21; Barros G. P., 2012, SCI TECHNOL NUCL INS; Pelowitz D. B., 2011, MCNPX USERS MANUAL V; Trellue H. R., 2003, THESIS U NEW MEXICO; Vu T.M., 2013, SCI TECHNOL NUCL INS, P5	6	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4549			ANN NUCL ENERGY	Ann. Nucl. Energy	APR	2015	78						176	179		10.1016/j.anucene.2014.12.018		4	Nuclear Science & Technology	Nuclear Science & Technology	CD0QQ	WOS:000350779400021		
J	Hishida, H; Adachi, T; Sakai, K; Hishida, H				Hishida, Hirotoshi; Adachi, Takashi; Sakai, Katsuhiro; Hishida, Hisashi			3D numerical evaluation on Strouhal frequency associated with flow-induced lift acting on an elastically supported cylindrical rod under axial flow with different velocity	ANNALS OF NUCLEAR ENERGY			English	Article						Numerical simulation; Three-dimensional coupled flow-structure interaction problem; Alternating lift on elastically supported cylinder; Axial flow-induced vibration		Influence of the motion of a cylindrical rod under the axial flow on the Strouhal frequency of the flow-induced lift was numerically investigated where the cylindrical rod was elastically supported and movable in the x-y plane orthogonal to the flow direction z. For typical examples, realistic input data in engineering aspects such as the damping coefficient, the mass per unit length of the cylindrical rod and the stiffness of the elastic spring supporting the rod were chosen in the numerical analysis with Re = 1000 and 2500. Under Re = 1000, the Fourier power spectra of the time variations in the x-directional cylindrical rod displacement and the associated lift acting on the cylindrical rod under the axial flow showed a sharp peak at the Strouhal frequency f(peak) = 8.9, that is sufficiently apart from the fluid dynamic excitation Strouhal frequency peak f(peak)* 0.1 numerically obtained in the previous studies for a rigidly fixed cylindrical rod under the identical flow condition. The above f(peak) deviated a little to the higher side of the natural Strouhal frequency f(0) = 8.5 of the cylindrical rod under the influence of alternating lift acting on the rod. In case Re = 2500, Fourier power spectrum of the time variation in the lift acting on the rod showed the dominant peak at the same Strouhal frequency f(peak) = 8.9 as in the case of Re = 1000 with minor intensity peaks in the higher frequency domain due to the flow transition, however these higher frequency components showed no significant effect on the motion of the cylindrical rod. (C) 2014 Elsevier Ltd. All rights reserved.	[Hishida, Hirotoshi] Kougakuin Univ, Fac Engn, Dept Mech Engn, Shinjuku Ku, Tokyo 1638677, Japan; [Adachi, Takashi] Saitama Inst Technol, Fac Mech Engn, Saitama 3690203, Japan; [Sakai, Katsuhiro; Hishida, Hisashi] Saitama Inst Technol, Grad Sch Syst Engn, Saitama 3690203, Japan	Hishida, H (reprint author), Saitama Inst Technol, Grad Sch Syst Engn, 1690 Fusaiji, Saitama 3690203, Japan.	hishida@cb.wakwak.com					Adachi T., 2005, COMPUT FLUID DYN J, V13, P69; THOMPSON JF, 1982, J COMPUT PHYS, V47, P1, DOI 10.1016/0021-9991(82)90066-3; BLEVINS R. D., 1977, FLOW INDUCED VIBRATI; Hishida H., 2000, 9 INT S FLOW VIS ED, V133, P1; Hishida H., 2002, INT C COMP FLUID DYN, P785; Hishida H., 2002, COMPUT FLUID DYN J, V11, P271; Hishida H., 2003, COMPUT FLUID DYN J, V12, P527; Hishida H., 2000, INT J APPL MATH, V2, P353; Hishida H., 2003, 7 INT S FLUID CONTR, P1; Hishida H., 2002, COMPUT FLUID DYN J, V11, P257; Hishida Hir., 2009, COMPUT FLUID DYN J, V18, P104; Hishida Hir., 2003, COMPUT FLUID DYN J, V12, P540; Hishida Hit., 2006, COMPUT FLUID DYN J, V15, P233; Kawamura T., 1983, THESIS U TOKYO	14	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4549			ANN NUCL ENERGY	Ann. Nucl. Energy	APR	2015	78						201	207		10.1016/j.anucene.2014.12.007		7	Nuclear Science & Technology	Nuclear Science & Technology	CD0QQ	WOS:000350779400024		
J	Harada, K; Baba, Y; Ishimoto, T; Chikamoto, A; Kosumi, K; Hayashi, H; Nitta, H; Hashimoto, D; Beppu, T; Baba, H				Harada, Kazuto; Baba, Yoshifumi; Ishimoto, Takatsugu; Chikamoto, Akira; Kosumi, Keisuke; Hayashi, Hiromitsu; Nitta, Hidetoshi; Hashimoto, Daisuke; Beppu, Toru; Baba, Hideo			LINE-1 Methylation Level and Patient Prognosis in a Database of 208 Hepatocellular Carcinomas	ANNALS OF SURGICAL ONCOLOGY			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN CANCER-CELLS; CLINICOPATHOLOGICAL FEATURES; CHROMOSOMAL INSTABILITY; DNA HYPOMETHYLATION; CURATIVE RESECTION; COLORECTAL-CANCER; POOR-PROGNOSIS; COLON-CANCER; TUMORS	The level of long interspersed nucleotide element-1 (LINE-1) methylation has become regarded as a surrogate marker of global DNA methylation. Previously, we demonstrated that LINE-1 hypomethylation might contribute to the acquisition of aggressive tumor behavior through genomic gains of oncogenes such as cyclin-dependent kinase 6 (CDK6) in esophageal squamous cell carcinoma. However, the relationship between LINE-1 hypomethylation and clinical outcome in hepatocellular carcinoma (HCC) remains unclear. LINE-1 methylation level in 208 samples of curatively resected HCCs was measured by pyrosequencing assay, and the prognostic value of LINE-1 methylation level in HCC was examined. LINE-1 methylation levels in the 208 HCC patients investigated were distributed as follows: mean 64.7; median 64.6; standard deviation (SD) 13.6; range 21.5-99.1; interquartile range 62.9-66.6. Univariate Cox regression analysis revealed a significantly higher cancer recurrence rate in the low-methylation-level group than in the high-methylation-level group (hazard ratio 1.58; 95 % CI 1.05-2.47; p = 0.028). Interestingly, the influence of LINE-1 hypomethylation on patient outcome was modified by hepatitis virus infection (p of interaction = 0.023); LINE-1 hypomethylation was associated with a higher cancer recurrence rate in patients without hepatitis virus infection (log-rank p = 0.0047). CDK6 messenger RNA expression levels were inversely associated with LINE-1 methylation levels (p = 0.0075; R = -0.37). Genome-wide DNA hypomethylation, as measured by LINE-1 levels, might be associated with poor disease-free survival in HCC patients, suggesting a potential role for LINE-1 methylation level as a biomarker for identifying patients who will experience an unfavorable clinical outcome.	[Harada, Kazuto; Baba, Yoshifumi; Ishimoto, Takatsugu; Chikamoto, Akira; Kosumi, Keisuke; Hayashi, Hiromitsu; Nitta, Hidetoshi; Hashimoto, Daisuke; Beppu, Toru; Baba, Hideo] Kumamoto Univ, Dept Surg Gastroenterol, Grad Sch Med Sci, Kumamoto, Japan	Baba, H (reprint author), Kumamoto Univ, Dept Surg Gastroenterol, Grad Sch Med Sci, Kumamoto, Japan.	hdobaba@kumamoto-u.ac.jp					Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Iwagami S, 2012, ANN SURG ONCOL, V19, P2726, DOI 10.1245/s10434-011-2176-3; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Pattamadilok J, 2008, INT J GYNECOL CANCER, V18, P711, DOI 10.1111/j.1525-1438.2007.01117.x; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Cho NY, 2007, J PATHOL, V211, P269, DOI 10.1002/path.2106; Shahrzad S, 2007, EPIGENETICS, V2, P119; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Nishida N, 2011, CURR GENOMICS, V12, P130, DOI 10.2174/138920211795564359; Weber B, 2010, ONCOGENE, V29, P5775, DOI 10.1038/onc.2010.227; Saito K, 2010, CLIN CANCER RES, V16, P2418, DOI 10.1158/1078-0432.CCR-09-2819; Choi GH, 2008, ANN SURG ONCOL, V15, P618, DOI 10.1245/s10434-007-9671-6; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Poon RTP, 1999, ANN SURG, V229, P216, DOI 10.1097/00000658-199902000-00009; Feng GS, 2012, CANCER CELL, V21, P150, DOI 10.1016/j.ccr.2012.01.001; Iakova P, 2011, SEMIN CANCER BIOL, V21, P28, DOI 10.1016/j.semcancer.2010.09.001; Cruickshanks HA, 2009, GENOMICS, V94, P397, DOI 10.1016/j.ygeno.2009.08.013; Shigaki H, 2013, GASTRIC CANCER, V16, P480, DOI 10.1007/s10120-012-0209-7; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Herath NI, 2006, J GASTROEN HEPATOL, V21, P15, DOI 10.1111/j.1440-1746.2005.04043.x; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Iwagami S, 2013, ANN SURG, V257, P449, DOI 10.1097/SLA.0b013e31826d8602; Bjornsson HT, 2007, J NATL CANCER I, V99, P1270, DOI 10.1093/jnci/djm069; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; McShane LM, 2005, J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Baba Y, 2014, CLIN CANCER RES, V20, P1114, DOI 10.1158/1078-0432.CCR-13-1645; Pogribny IP, 2014, CANCER LETT, V342, P223, DOI 10.1016/j.canlet.2012.01.038; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Baba Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-125; CHEAH MSC, 1984, J NATL CANCER I, V73, P1057; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472; Kinoshita H, 2013, MOL CLIN ONCOL, V1, P309; Li J, 2014, CANCER CELL, V25, P118, DOI 10.1016/j.ccr.2013.12.008; Ohka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023332; Roman-Gomez J, 2005, ONCOGENE, V24, P7213, DOI 10.1038/sj.onc.1208866; SASAKI Y, 1992, SURGERY, V112, P515; Schulz WA, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/83672; Shirabe K, 1998, CANCER, V83, P2312, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2312::AID-CNCR10>3.0.CO;2-6; Sigalotti L, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-78; Sobin LH, 2010, TNM CLASSIFICATION M; Zhang CS, 2011, ANN SURG ONCOL, V18, P2373, DOI 10.1245/s10434-011-1599-1; Zhu C, ANN SURG ONCOL	55	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	APR	2015	22	4					1280	1287		10.1245/s10434-014-4134-3		8	Oncology; Surgery	Oncology; Surgery	CC7MY	WOS:000350553300037		
J	Ei, S; Hibi, T; Tanabe, M; Itano, O; Shinoda, M; Kitago, M; Abe, Y; Yagi, H; Okabayashi, K; Sugiyama, D; Wakabayashi, G; Kitagawa, Y				Ei, Shigenori; Hibi, Taizo; Tanabe, Minoru; Itano, Osamu; Shinoda, Masahiro; Kitago, Minoru; Abe, Yuta; Yagi, Hiroshi; Okabayashi, Koji; Sugiyama, Daisuke; Wakabayashi, Go; Kitagawa, Yuko			Cryoablation Provides Superior Local Control of Primary Hepatocellular Carcinomas of > 2 cm Compared with Radiofrequency Ablation and Microwave Coagulation Therapy: An Underestimated Tool in the Toolbox	ANNALS OF SURGICAL ONCOLOGY			English	Article							LIVER-TRANSPLANTATION; HEPATIC CRYOTHERAPY; TREATMENT STRATEGY; PROGNOSTIC-FACTORS; CHEMOEMBOLIZATION; MECHANISM; DEVICES; MALIGNANCIES; RESECTION	Although cryoablation (Cryo) has been advocated as an effective locoregional therapy for hepatocellular carcinoma (HCC), few studies have compared the outcomes with those of radiofrequency ablation (RFA) and microwave coagulation therapy (MCT). Consecutive patients with primary HCCs of < 5 cm received Cryo or RFA/MCT between 1998 and 2011 and were monitored for local recurrence (defined as a recurrent tumor at or in direct contact with the ablated area) and overall complication rates. The median tumor size was 2.5 cm in the Cryo group (n = 55) and 1.9 cm in the RFA/MCT group (n = 64; P < 0.001), but other patient characteristics were similar. Multivariate Cox regression analysis revealed Cryo as the only independent factor for improved 2-year local recurrence-free survival, with a hazard ratio (HR) of 0.3 (95 % confidence interval, 0.1-0.9; P = 0.02). Tumor diameter was a negative indicator of local recurrence-free survival (HR, 2.0; 95 % confidence interval, 1.1-3.5; P = 0.02). Subgroup analysis of patients with tumors of > 2 cm demonstrated significantly better local recurrence rates in the Cryo group compared with the RFA/MCT group (21 vs. 56 % at 2 years; P = 0.006). Overall complication rates and incidences of Clavien-Dindo classification grade a parts per thousand yenIII were identical (both P = 1.00). No in-hospital mortality occurred. Appropriate use of Cryo, as shown in this series, is safe and provides significantly improved local control for the treatment of primary HCCs of > 2 cm compared with RFA/MCT.	[Ei, Shigenori; Hibi, Taizo; Itano, Osamu; Shinoda, Masahiro; Kitago, Minoru; Abe, Yuta; Yagi, Hiroshi; Okabayashi, Koji; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan; [Tanabe, Minoru] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan; [Sugiyama, Daisuke] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Wakabayashi, Go] Iwate Med Univ, Dept Surg, Morioka, Iwate, Japan	Hibi, T (reprint author), Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan.	taizohibi@z3.keio.jp					Belghiti J, 2008, ANN SURG ONCOL, V15, P993, DOI 10.1245/s10434-007-9787-8; Shimizu T, 2009, J HEPATO-BILIARY-PAN, V16, P816, DOI 10.1007/s00534-009-0124-4; Simo KA, 2011, J SURG ONCOL, V104, P822, DOI 10.1002/jso.21933; Lubner MG, 2010, J VASC INTERV RADIOL, V21, pS192, DOI 10.1016/j.jvir.2010.04.007; Yao FY, 2008, HEPATOLOGY, V48, P819, DOI 10.1002/hep.22412; Adam R, 2002, ARCH SURG-CHICAGO, V137, P1332, DOI 10.1001/archsurg.137.12.1332; Pearson AS, 1999, AM J SURG, V178, P592, DOI 10.1016/S0002-9610(99)00234-2; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Takami Y, 2013, J HEPATO-BIL-PAN SCI, V20, P332, DOI 10.1007/s00534-012-0527-5; Lam VWT, 2008, J AM COLL SURGEONS, V207, P20, DOI 10.1016/j.jamcollsurg.2008.01.020; Erinjeri JP, 2010, J VASC INTERV RADIOL, V21, pS187, DOI 10.1016/j.jvir.2009.12.403; Tashiro H, 2011, J SURG ONCOL, V104, P3, DOI 10.1002/jso.21745; Bilchik AJ, 2000, ARCH SURG-CHICAGO, V135, P657, DOI 10.1001/archsurg.135.6.657; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Hong K, 2010, J VASC INTERV RADIOL, V21, pS179, DOI 10.1016/j.jvir.2010.04.008; Bhardwaj N, 2009, PATHOLOGY, V41, P168, DOI 10.1080/00313020802579292; Kim JH, 2011, ANN SURG ONCOL, V18, P1624, DOI 10.1245/s10434-011-1673-8; Awad Michael M, 2007, HPB (Oxford), V9, P357, DOI 10.1080/13651820701646222; Chen HW, 2011, INT J SURG, V9, P188, DOI 10.1016/j.ijsu.2010.11.008; Clavien PA, 2012, LANCET ONCOL, V13, pE11, DOI 10.1016/S1470-2045(11)70175-9; Eggstein S, 2003, EUR SURG RES, V35, P67, DOI 10.1159/000069398; Heckman JT, 2008, ANN SURG ONCOL, V15, P3169, DOI 10.1245/s10434-008-0071-3; Jungraithmayr W, 2004, J SURG RES, V116, P32, DOI 10.1016/S0022-4804(03)00054-4; Kim JW, 2012, EUR J RADIOL, V81, pE189, DOI 10.1016/j.ejrad.2011.01.122; Kim SK, 2005, ABDOM IMAGING, V30, P727, DOI 10.1007/s00261-005-0304-x; Osada S, 2009, ANTICANCER RES, V29, P5203; Seifert JK, 1998, J ROY COLL SURG EDIN, V43, P141; Shi M, 2004, WORLD J SURG, V28, P376, DOI 10.1007/s00268-003-7308-x; Shibata T, 2000, J Hepatobiliary Pancreat Surg, V7, P592, DOI 10.1007/s005340070009; Tateishi R, 2009, J GASTROENTEROL, V44, P142, DOI 10.1007/s00535-008-2247-9; Yang YP, 2012, J HEPATO-BIL-PAN SCI, V19, P674, DOI 10.1007/s00534-011-0490-6	33	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9265	1534-4681		ANN SURG ONCOL	Ann. Surg. Oncol.	APR	2015	22	4					1294	1300		10.1245/s10434-014-4114-7		7	Oncology; Surgery	Oncology; Surgery	CC7MY	WOS:000350553300039		
J	Zheng, HZ; Fu, JQ; Xue, P; Zhao, R; Dong, J; Liu, DX; Yamamoto, M; Tong, QC; Teng, WP; Qu, WD; Zhang, Q; Andersen, ME; Pi, JB				Zheng, Hongzhi; Fu, Jingqi; Xue, Peng; Zhao, Rui; Dong, Jian; Liu, Dianxin; Yamamoto, Masayuki; Tong, Qingchun; Teng, Weiping; Qu, Weidong; Zhang, Qiang; Andersen, Melvin E.; Pi, Jingbo			CNC-bZIP Protein Nrf1-Dependent Regulation of Glucose-Stimulated Insulin Secretion	ANTIOXIDANTS & REDOX SIGNALING			English	Article							PANCREATIC BETA-CELLS; INDUCED ANTIOXIDANT RESPONSE; TRANSCRIPTION FACTOR NRF1; OXIDATIVE STRESS; HEXOKINASE-I; ENDOPLASMIC-RETICULUM; TARGETED DISRUPTION; HUMAN KERATINOCYTES; ISOLATED ISLETS; INDUCED OBESITY	Aims: The inability of pancreatic beta-cells to secrete sufficient insulin in response to glucose stimulation is a major contributing factor to the development of type 2 diabetes (T2D). We investigated both the in vitro and in vivo effects of deficiency of nuclear factor-erythroid 2-related factor 1 (Nrf1) in beta-cells on beta-cell function and glucose homeostasis. Results: Silencing of Nrf1 in beta-cells leads to a pre-T2D phenotype with disrupted glucose metabolism and impaired insulin secretion. Specifically, MIN6 beta-cells with stable knockdown of Nrf1 (Nrf1-KD) and isolated islets from beta-cell-specific Nrf1-knockout [Nrf1(b)-KO] mice displayed impaired glucose responsiveness, including elevated basal insulin release and decreased glucose-stimulated insulin secretion (GSIS). Nrf1(b)-KO mice exhibited severe fasting hyperinsulinemia, reduced GSIS, and glucose intolerance. Silencing of Nrf1 in MIN6 cells resulted in oxidative stress and altered glucose metabolism, with increases in both glucose uptake and aerobic glycolysis, which is associated with the elevated basal insulin release and reduced glucose responsiveness. The elevated glycolysis and reduced glucose responsiveness due to Nrf1 silencing likely result from altered expression of glucose metabolic enzymes, with induction of high-affinity hexokinase 1 and suppression of low-affinity glucokinase. Innovation: Our study demonstrated a novel role of Nrf1 in regulating glucose metabolism and insulin secretion in beta-cells and characterized Nrf1 as a key transcription factor that regulates the coupling of glycolysis and mitochondrial metabolism and GSIS. Conclusion: Nrf1 plays critical roles in regulating glucose metabolism, mitochondrial function, and insulin secretion, suggesting that Nrf1 may be a novel target to improve the function of insulin-secreting beta-cells. Antioxid. Redox Signal. 22, 819-831.	[Zheng, Hongzhi; Teng, Weiping] China Med Univ, Affiliated Hosp 1, Shenyang 110001, Peoples R China; [Zheng, Hongzhi; Fu, Jingqi; Xue, Peng; Dong, Jian; Zhang, Qiang; Andersen, Melvin E.; Pi, Jingbo] Hamner Inst Hlth Sci, Inst Chem Safety Sci, Res Triangle Pk, NC USA; [Fu, Jingqi; Pi, Jingbo] China Med Univ, Sch Publ Hlth, Shenyang 110013, Peoples R China; [Xue, Peng; Qu, Weidong] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Zhao, Rui] China Med Univ, Sch Forens Med, Shenyang 110001, Peoples R China; [Dong, Jian] Wuhan Univ Sci & Technol, Inst Med & Biol, Wuhan, Peoples R China; [Liu, Dianxin] Sanford Burnham Med Res Inst, Metab Signaling & Dis Program, Orlando, FL USA; [Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Sendai, Miyagi 980, Japan; [Tong, Qingchun] Univ Texas Hlth Sci Ctr Houston, Ctr Metab & Degenerat Dis, Houston, TX 77030 USA	Pi, JB (reprint author), China Med Univ, Sch Publ Hlth, Shenyang North New Area, 77 Puhe Rd, Shenyang 110013, Peoples R China.	twp@vip.163.com; jingbopi@163.com	xue, peng/K-4159-2015		National Institutes of Health [ES016005]; Startup Funding of China Medical University; Liaoning Pandeng Scholar Program; Chinese Nature Science Foundation [81102156, 81372943]; Key Laboratory of Public Health Safety (Fudan Univeristy), Ministry of Education, China [GW2014-1]	This work was supported in part by National Institutes of Health Grant ES016005 (J.P.), Startup Funding of China Medical University (J.P.), Liaoning Pandeng Scholar Program (J.P.), Chinese Nature Science Foundation 81102156 (R.Z.) and 81372943 (R.Z.), and the Key Laboratory of Public Health Safety (Fudan Univeristy), Ministry of Education, China GW2014-1 (J.F.). The authors thank Lisa H. Webb (The Hamner Institutes), Carol Bobbitt (The Hamner Institutes), Yongyong Hou (China Medical University), and Yuanyuan Xu (China Medical University) for their careful management of animal care and breeding.	Robertson RP, 2006, CURR OPIN PHARMACOL, V6, P615, DOI 10.1016/j.coph.2006.09.002; Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Xue P, 2011, BIOCHEM BIOPH RES CO, V407, P360, DOI 10.1016/j.bbrc.2011.03.024; Zhao R, 2011, ENVIRON HEALTH PERSP, V119, P56, DOI 10.1289/ehp.1002304; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Zhao R, 2012, ENVIRON HEALTH PERSP, V120, P583, DOI 10.1289/ehp.1104580; Kwong M, 1999, J BIOL CHEM, V274, P37491, DOI 10.1074/jbc.274.52.37491; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Xue P, 2013, DIABETES, V62, P845, DOI 10.2337/db12-0584; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Kobayashi A, 2011, GENES CELLS, V16, P692, DOI 10.1111/j.1365-2443.2011.01522.x; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Henquin JC, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003325; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; Kong D, 2012, CELL, V151, P645, DOI 10.1016/j.cell.2012.09.020; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Costes S, 2011, DIABETES, V60, P227, DOI 10.2337/db10-0522; Henquin JC, 2011, DIABETES RES CLIN PR, V93, pS27, DOI 10.1016/S0168-8227(11)70010-9; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Zhang Y, 2007, BIOCHEM J, V408, P161, DOI 10.1042/BJ20070761; Kim J, 2010, PHYSIOL GENOMICS, V40, P100, DOI 10.1152/physiolgenomics.00105.2009; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Hirotsu Y, 2012, MOL CELL BIOL, V32, P2760, DOI 10.1128/MCB.06706-11; Hartley T, 2009, AM J PHYSIOL-ENDOC M, V296, pE1, DOI 10.1152/ajpendo.90538.2008; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Ainscow EK, 2000, DIABETES, V49, P1149, DOI 10.2337/diabetes.49.7.1149; BECKER TC, 1994, J BIOL CHEM, V269, P21234; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Becker TC, 1996, J BIOL CHEM, V271, P390; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lee CS, 2011, P NATL ACAD SCI USA, V108, P8408, DOI 10.1073/pnas.1019209108; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Schuit F, 2012, DIABETES, V61, P969, DOI 10.2337/db11-1564; Buettner C, 2012, CELL METAB, V16, P691, DOI 10.1016/j.cmet.2012.11.009; Fu J, 2011, ENV HLTH PERSPECT, V118, P864; Henquin JC, 2004, DIABETES, V53, pS48, DOI 10.2337/diabetes.53.suppl_3.S48; Kwong EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048404; Maiztegui B, 2006, J ENDOCRINOL, V189, P311, DOI 10.1677/joe.1.06662; Malmgren S, 2009, J BIOL CHEM, V284, P32395, DOI 10.1074/jbc.M109.026708; Zhang Y. H., 2013, SCI REP, V3, P1, DOI DOI 10.1038/SREP02006	50	2	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1523-0864	1557-7716		ANTIOXID REDOX SIGN	Antioxid. Redox Signal.	APR 1	2015	22	10					819	831		10.1089/ars.2014.6017		13	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CD5US	WOS:000351154200002		
J	Nakagawa, K				Nakagawa, Kenji			Tail probability and singularity of Laplace-Stieltjes transform of a Pareto type random variable	APPLICATIONS OF MATHEMATICS			English	Article						tail probability; Pareto type; Laplace-Stieltjes transform; Tauberian theorem	EXPONENTIAL DECAY	We give a sufficient condition for a non-negative random variable X to be of Pareto type by investigating the Laplace-Stieltjes transform of the cumulative distribution function. We focus on the relation between the singularity at the real point of the axis of convergence and the asymptotic decay of the tail probability. For the proof of our theorems, we apply Graham-Vaaler's complex Tauberian theorem. As an application of our theorems, we consider the asymptotic decay of the stationary distribution of an M/G/1 type Markov chain.	Nagaoka Univ Technol, Nagaoka, Niigata 9402188, Japan	Nakagawa, K (reprint author), Nagaoka Univ Technol, Nagaoka, Niigata 9402188, Japan.	nakagawa@nagaokaut.ac.jp					Nakagawa K, 2007, IEEE T INFORM THEORY, V53, P3239, DOI 10.1109/TIT.2007.903114; GRAHAM SW, 1981, T AM MATH SOC, V265, P283, DOI 10.2307/1998495; Bingham N. H., 1987, ENCY MATH ITS APPL, V27; Bingham N. H., 1974, Advances in Applied Probability, V6, DOI 10.2307/1426188; Falkenberg E., 1994, COMMUN STAT STOCHAST, V10, P75; FELLER W., 1971, WILEY SERIES PROBABI, VII; Ikehara S., 1931, J MATH PHYS, V10, P1; Korevaar J., 2004, GRUNDLEHREN MATH WIS, V329; Moriguchi K., 1957, TABLE MATH FORMULAS; Nakagawa K, 2004, STOCH MODELS, V20, P31, DOI 10.1081/STM-120028389; Nakagawa K., 2005, APPL ANAL, V84, P499, DOI 10.1080/00036810410001724436; Rudin W., 1987, REAL COMPLEX ANAL; Widder D. V., 1941, PRINCETON MATH SERIE, V6	13	0	0	ACAD SCIENCES CZECH REPUBLIC, INST MATHEMATICS	PRAHA 1	ZITNA 25, PRAHA 1, 115 67, CZECH REPUBLIC	0862-7940	1572-9109		APPL MATH-CZECH	Appl. Mat.	APR	2015	60	2					157	184		10.1007/s10492-015-0089-3		28	Mathematics, Applied	Mathematics	CD5TR	WOS:000351151500003		
J	Kuribayashi, K; Matsuo, K				Kuribayashi, Katsuhiko; Matsuo, Kentaro			Association Schemoids and Their Categories	APPLIED CATEGORICAL STRUCTURES			English	Article						Association scheme; Small category; Baues-Wirsching cohomology	SPIN MODELS; MATRICES; ALGEBRAS; SCHEMES	We propose the notion of association schemoids generalizing that of association schemes from small categorical points of view. In particular, a generalization of the Bose-Mesner algebra of an association scheme appears as a subalgebra in the category algebra of the underlying category of a schemoid. In this paper, the equivalence between the categories of groupoids and that of thin association schemoids is established. Moreover linear extensions of schemoids are considered. A general theory of the Baues-Wirsching cohomology deduces a classification theorem for such extensions of a schemoid. We also introduce two relevant categories of schemoids into which the categories of schemes due to Hanaki and due to French are embedded, respectively.	[Kuribayashi, Katsuhiko; Matsuo, Kentaro] Shinshu Univ, Dept Math Sci, Fac Sci, Matsumoto, Nagano 3908621, Japan	Kuribayashi, K (reprint author), Shinshu Univ, Dept Math Sci, Fac Sci, Matsumoto, Nagano 3908621, Japan.	kuri@math.shinshu-u.ac.jp; kmatsuo@math.shinshu-u.ac.jp			Japan Society for the Promotion of Science [25610002]	This research was partially supported by a Grant-in-Aid for Scientific Research HOUGA 25610002 from Japan Society for the Promotion of Science.	BAUES HJ, 1985, J PURE APPL ALGEBRA, V38, P187, DOI 10.1016/0022-4049(85)90008-8; Assem I., 2006, LOND MATH SOC STUD T, V1, P65, DOI DOI 10.1017/CB09780511614309; Bang SJ, 2005, EUR J COMBIN, V26, P59, DOI 10.1016/j.ejc.2004.02.003; Bannai E., 1984, ALGEBRAIC COMBINATOR, VI; Baues H. J., 1989, CAMBRIDGE STUDIES AD, V15; Baues H.-J., 1989, K-THEORY, V3, P307, DOI 10.1007/BF00584524; Berger C, 2008, HOMOL HOMOTOPY APPL, V10, P41; Delsarte P., 1973, PHILIPS RES REPORT S, V10; French C, 2013, J COMB THEORY A, V120, P1141, DOI 10.1016/j.jcta.2013.03.001; Gabriel P., 1967, ERGEBNISSE MATH IHRE, V35; Hanaki A, 2010, J COMB THEORY A, V117, P1207, DOI 10.1016/j.jcta.2009.10.004; Jaeger F, 1998, J ALGEBR COMB, V8, P39, DOI 10.1023/A:1008691327727; Jaeger F., 1996, ADV STUDIES PURE MAT, V24, P197; JONES VFR, 1985, B AM MATH SOC, V12, P103, DOI 10.1090/S0273-0979-1985-15304-2; Latch D.M., 1977, J PURE APPL ALGEBRA, V9, P221, DOI 10.1016/0022-4049(77)90068-8; NOMURA K, 1994, J COMB THEORY A, V68, P251, DOI 10.1016/0097-3165(94)90106-6; Ponomarenko I, 2009, EUR J COMBIN, V30, P1387, DOI 10.1016/j.ejc.2008.11.002; Terwilliger P., 1992, J ALGEBR COMB, V1, P363, DOI 10.1023/A:1022494701663; Thomason R.W., 1980, CAHIERS TOPOLOGIE GE, V21, P305; Zieschang PH, 1995, J ALGEBRA, V178, P677, DOI 10.1006/jabr.1995.1373; Zieschang P.-H., 2005, SPRINGER MONOGRAPHS	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0927-2852	1572-9095		APPL CATEGOR STRUCT	Appl. Categ. Struct.	APR	2015	23	2					107	136		10.1007/s10485-013-9327-6		30	Mathematics	Mathematics	CD1YK	WOS:000350870400001		
J	Hanada, K; Yoshida, T; Nakagawa, Y; Gima, H; Tominaga, A; Hirakawa, M; Agawa, Y; Sugiyama, T; Yoshitake, T				Hanada, Kenji; Yoshida, Tomohiro; Nakagawa, You; Gima, Hiroki; Tominaga, Aki; Hirakawa, Masaaki; Agawa, Yoshiaki; Sugiyama, Takeharu; Yoshitake, Tsuyoshi			Hardness and modulus of ultrananocrystalline diamond/hydrogenated amorphous carbon composite films prepared by coaxial arc plasma deposition	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							DIAMOND-LIKE CARBON; MECHANICAL-PROPERTIES; THIN-FILMS; NANOCRYSTALLINE DIAMOND; DLC FILMS; MICROSTRUCTURE; DEVICES	Ultrananocrystalline diamond (UNCD)/hydrogenated amorphous carbon (a-C:H) composite (UNCD/a-C:H) films were deposited in hydrogen atmospheres by coaxial arc plasma deposition, and the effects of hydrogenation on the mechanical properties were studied on the basis of spectroscopic structural evaluations. The existence of UNCD grains in the films was confirmed by transmission electron microscopy and X-ray diffraction. Non-hydrogenated films prepared in no hydrogen atmosphere exhibited a 22 GPa hardness and 222 GPa Young's modulus, and the sp (3)/(sp (2) + sp (3)) ratio estimated from the X-ray photoemission spectra was 41 %. For the films prepared in a 53.3-Pa hydrogen atmosphere, whereas the hardness increases to 23 GPa, the modulus decreases to 184 GPa. The UNCD grain size estimated using Scherrer's equation and the sp (3)/(sp (2) + sp (3)) ratio were 2.3 nm and 64 %, respectively, both of which are remarkably increased as compared with those of the non-hydrogenated films. From the near-edge X-ray absorption fine structure spectra, it is considered that sigma*C-H bonds are alternatively formed instead of pi*C=C, which probably results in the enhanced hardness and reduced modulus by hydrogenation. In addition, it was found that the formation of olefinic and aromatic structures remarkably softens the UNCD/a-C:H film.	[Hanada, Kenji; Tominaga, Aki; Sugiyama, Takeharu; Yoshitake, Tsuyoshi] Kyushu Univ, Res Ctr Synchrotron Light Applicat, Fukuoka 8168580, Japan; [Yoshida, Tomohiro; Nakagawa, You; Gima, Hiroki; Tominaga, Aki; Yoshitake, Tsuyoshi] Kyushu Univ, Dept Appl Sci Elect & Mat, Fukuoka 8168580, Japan; [Yoshida, Tomohiro] Kurume Natl Coll Technol, Dept Elect & Elect Engn, Kurume, Fukuoka 8308555, Japan; [Hirakawa, Masaaki] ULVAC, Chiba 2891226, Japan; [Agawa, Yoshiaki] ULVAC RIKO, Yokohama, Kanagawa 2240053, Japan	Hanada, K (reprint author), Kyushu Univ, Res Ctr Synchrotron Light Applicat, Fukuoka 8168580, Japan.	kenji_hanada@kyudai.jp; tsuyoshi_yoshitake@kyudai.jp			Nanotechnology Network Japan (Kyushu Synchrotron Light Research Center) [081152N, 090423]	This work was partially supported by Nanotechnology Network Japan (Kyushu Synchrotron Light Research Center, Proposal Nos. 081152N and 090423).	Al-Riyami S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.08JD05; Sanchez-Lopez JC, 2001, DIAM RELAT MATER, V10, P1063, DOI 10.1016/S0925-9635(00)00428-3; Jiao S, 2001, J APPL PHYS, V90, P118, DOI 10.1063/1.1377301; Hanada K, 2010, DIAM RELAT MATER, V19, P899, DOI 10.1016/j.diamond.2010.02.019; Krauss AR, 2001, DIAM RELAT MATER, V10, P1952, DOI 10.1016/S0925-9635(01)00385-5; Wiora M, 2009, DIAM RELAT MATER, V18, P927, DOI 10.1016/j.diamond.2008.11.026; SAVVIDES N, 1993, THIN SOLID FILMS, V228, P289, DOI 10.1016/0040-6090(93)90618-Y; Popov C, 2006, THIN SOLID FILMS, V494, P92, DOI 10.1016/j.tsf.2005.07.163; Yoshitake T, 2007, JPN J APPL PHYS 2, V46, pL936, DOI 10.1143/JJAP.46.L936; Espinosa HD, 2003, EXP MECH, V43, P256, DOI 10.1177/0014485103036019; Yoshitake T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.015503; Popov C, 2004, DIAM RELAT MATER, V13, P1371, DOI 10.1016/j.diamond.2003.11.040; Yoshitake T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.020222; Hanada K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.125503; Gruen DM, 1999, ANNU REV MATER SCI, V29, P211, DOI 10.1146/annurev.matsci.29.1.211; Badziag P., 1990, NATURE, V343, P224; DEMICHELIS F, 1993, DIAM RELAT MATER, V2, P890, DOI 10.1016/0925-9635(93)90245-W; Hanada K, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.08JF09; HOSHINO S, 1989, J APPL PHYS, V65, P1918, DOI 10.1063/1.342877; Hsu JS, 2008, VACUUM, V83, P622, DOI 10.1016/j.vacuum.2008.04.070; Remediakis IN, 2008, ACTA MATER, V56, P5340, DOI 10.1016/j.actamat.2008.07.014; SAVVIDES N, 1992, J APPL PHYS, V72, P2791, DOI 10.1063/1.351530; TAMOR MA, 1991, APPL PHYS LETT, V58, P592, DOI 10.1063/1.104597	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	APR	2015	119	1					205	210		10.1007/s00339-014-8949-3		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CD6AV	WOS:000351171600027		
J	Babu, GA; Ravi, G; Hayakawa, Y				Babu, G. Anandha; Ravi, G.; Hayakawa, Y.			Microwave synthesis and effect of CTAB on ferromagnetic properties of NiO, Co3O4 and NiCo2O4 nanostructures	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							NICKEL-OXIDE; CATALYTIC PERFORMANCE; SONOCHEMICAL METHOD; NANOPARTICLES; SIZE; ROUTE; SUPERCAPACITOR; FABRICATION; COBALT; NANORODS	Cubic-structured NiO, Co3O4 and spinel-structured NiCo2O4 were synthesized via microwave route. The structural properties of NiO, Co3O4 and NiCo2O4 nanostructures were investigated by X-ray diffraction analysis, and it showed smaller crystallite size for NiO than Co3O4 and NiCo2O4 by using Williamson-Hall method. Flake-like and hexagonal plate-like morphologies were ascertained from HRSEM and TEM analyses. Optical properties of these materials were investigated by photoluminescence study, and it presents the band edge emission for all materials with supplementary emissions in visible region due to the presence of defects such as vacancy and interstitial. Raman and FTIR spectra provide the functional characteristics of NiO, Co3O4 and NiCo2O4 nanostructures. XPS measurement revealed the purity and composition of these nanostructures. Room temperature magnetic measurements were investigated using vibrating sample magnetometer. The low coercivity and remanent magnetization for NiO, Co3O4 and NiCo2O4 nanostructures confirmed that these nanoparticles exhibit a weak ferromagnetic behaviour.	[Babu, G. Anandha; Ravi, G.] Alagappa Univ, Dept Phys, Karaikkudi 630004, Tamil Nadu, India; [Hayakawa, Y.] Shizuoka Univ, Elect Res Inst, Hamamatsu, Shizuoka 4328011, Japan	Ravi, G (reprint author), Alagappa Univ, Dept Phys, Karaikkudi 630004, Tamil Nadu, India.	gravicrc@gmail.com			DST, India under the scheme of INSPIRE Fellowship [IF110040]	The one of the authors G. Anandha Babu gratefully acknowledge financial support for this study from DST, India under the scheme of INSPIRE Fellowship (Grant No. IF110040).	Babu GA, 2015, J MAGN MAGN MATER, V375, P184, DOI 10.1016/j.jmmm.2014.09.062; Li Q, 2007, MATER LETT, V61, P1615, DOI 10.1016/j.matlet.2006.07.113; Salavati-Niasari M, 2009, INORG CHIM ACTA, V362, P3691, DOI 10.1016/j.ica.2009.04.025; Ngo AT, 1999, EUR PHYS J B, V9, P583, DOI 10.1007/s100510050801; Jin HX, 2012, J PHYS CHEM C, V116, P13374, DOI 10.1021/jp300645c; Jiao QZ, 2012, INORG CHEM, V51, P11513, DOI 10.1021/ic3013602; Liu MC, 2012, ACS APPL MATER INTER, V4, P4631, DOI 10.1021/am301010u; Varghese B, 2008, CHEM MATER, V20, P3360, DOI 10.1021/cm703512k; Meybodi SM, 2012, ULTRASON SONOCHEM, V19, P841, DOI 10.1016/j.ultsonch.2011.11.017; Kodama RH, 1997, PHYS REV LETT, V79, P1393, DOI 10.1103/PhysRevLett.79.1393; Ding Y, 2010, BIOSENS BIOELECTRON, V26, P542, DOI 10.1016/j.bios.2010.07.050; Wei ZQ, 2009, J ALLOY COMPD, V479, P855, DOI 10.1016/j.jallcom.2009.01.064; Li JT, 2011, NANOSCALE, V3, P5103, DOI 10.1039/c1nr10802f; Liu JP, 2006, MATER CHEM PHYS, V98, P523, DOI 10.1016/j.matchemphys.2005.09.075; Ghosh D, 2013, ACS SUSTAIN CHEM ENG, V1, P1135, DOI 10.1021/sc400055z; Roginskaya YE, 1997, LANGMUIR, V13, P4621, DOI 10.1021/la9609128; Winkler E, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.132409; Wu ZY, 2005, J PHYS CHEM B, V109, P2512, DOI 10.1021/jp0466183; Ren Y, 2010, J AM CERAM SOC, V93, P3560, DOI 10.1111/j.1551-2916.2010.04090.x; Xu LP, 2008, CHEM MATER, V20, P308, DOI 10.1021/cm702207w; Chen SQ, 2010, J MATER CHEM, V20, P9735, DOI 10.1039/c0jm01573c; Bilecka I, 2010, NANOSCALE, V2, P1358, DOI 10.1039/b9nr00377k; Xia XH, 2011, J MATER CHEM, V21, P9319, DOI 10.1039/c1jm10946d; Wang GX, 2009, J PHYS CHEM C, V113, P4357, DOI 10.1021/jp8106149; Askarinejad A, 2010, APPL SURF SCI, V256, P6678, DOI 10.1016/j.apsusc.2010.04.069; Vijayakumar S, 2013, ACS APPL MATER INTER, V5, P2188, DOI 10.1021/am400012h; Hwa Y, 2013, J PHYS CHEM C, V117, P7013, DOI 10.1021/jp401333v; Wang X, 2004, J PHYS CHEM B, V108, P16401, DOI 10.1021/jp048016p; Mohandes F, 2010, J MAGN MAGN MATER, V322, P872, DOI 10.1016/j.jmmm.2009.11.019; Meher SK, 2011, ACS APPL MATER INTER, V3, P2063, DOI 10.1021/am200294k; Gesheva KA, 2012, PROG ORG COAT, V74, P635, DOI 10.1016/j.porgcoat.2011.07.016; Wang X, 2007, CRYST GROWTH DES, V7, P2415, DOI 10.1021/cg060957z; Babu GA, 2014, J PHYS CHEM C, V118, P23335, DOI 10.1021/jp504573c; Zhu GX, 2012, RSC ADV, V2, P4236, DOI 10.1039/c2ra01307j; Cui L, 2009, J APPL ELECTROCHEM, V39, P1871, DOI 10.1007/s10800-009-9891-5; Patil D, 2010, TALANTA, V81, P37, DOI 10.1016/j.talanta.2009.11.034; Ambrose T, 1996, PHYS REV LETT, V76, P1743, DOI 10.1103/PhysRevLett.76.1743; Liu X, 2014, RSC ADV, V4, P6397, DOI 10.1039/c3ra44186e; Ozkaya T, 2009, J MAGN MAGN MATER, V321, P2145, DOI 10.1016/j.jmmm.2009.01.003; Salavati-Niasari M, 2009, POLYHEDRON, V28, P1065, DOI 10.1016/j.poly.2009.01.012; Batlle X, 2002, J PHYS D APPL PHYS, V35, pR15, DOI 10.1088/0022-3727/35/6/201; Bhatt AS, 2011, MATER CHEM PHYS, V125, P347, DOI 10.1016/j.matchemphys.2010.11.003; Chen ZP, 2010, CURR APPL PHYS, V10, P967, DOI 10.1016/j.cap.2009.11.083; Farhadi S., 2013, J NANOSTRUCT CHEM, V3, P69; Gandhi AC, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-485; Huang HL, 1999, APPL PHYS LETT, V75, P710, DOI 10.1063/1.124490; Kumari L, 2009, CRYST RES TECHNOL, V44, P495, DOI 10.1002/crat.200800583; Liu JP, 2006, MATER LETT, V60, P1354, DOI 10.1016/j.matlet.2005.11.056; Liu S., 2012, J MAGN MAGN MATER, V324, P2556; Mochizuki S, 2009, PHYSICA B, V404, P4850, DOI 10.1016/j.physb.2009.08.166; Neel L., 1962, LOW TEMP PHYS, P413; Path J., 2010, MATER CHARACT, V61, P575; Tiwari SD, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.104433; Tsuji T, 2005, APPL SURF SCI, V243, P214, DOI 10.1016/j.apsusc.2004.09.065; Zhu Z., 2011, ADV POWDER TECHNOL, V21, P422	55	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0947-8396	1432-0630		APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	APR	2015	119	1					219	232		10.1007/s00339-014-8951-9		14	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CD6AV	WOS:000351171600029		
J	Peng, H; Kitagawa, G; Tamura, Y; Xi, YH; Qin, YM; Chen, XH				Peng, Hui; Kitagawa, Genshiro; Tamura, Yoshiyasu; Xi, Yanhui; Qin, Yemei; Chen, Xiaohong			A modeling approach to financial time series based on market microstructure model with jumps	APPLIED SOFT COMPUTING			English	Article						Financial time series; Microstructure modeling; Jump-diffusion model; Jump detection; Extended Kalman filter; Maximum likelihood estimation	CONDITIONAL HETEROSCEDASTICITY; ASSET ALLOCATION; NEURAL-NETWORK; VOLATILITY; VARIANCE; RETURNS; NOISE	A continuous-time generalized market microstructure (GMMS) model and its discretized model are proposed for characterizing a class of financial time series. The GMMS model is a kind of jump-diffusion model that may describe the dynamic behaviors of measurable market price, immeasurable market excess demand and market liquidity, as well as the interaction among the three variates in a market. The model includes a jump component that is used to capture the large abnormal variations of financial assets, which may occur when a market is affected by some special events happened suddenly, such as release of important financial information. On the basis of the discrete-time GMMS model, an online recursive jump detection algorithm is proposed, which is developed in accordance with the Markov property of financial time series and the Bayes theorem. Simulations and case studies demonstrate the feasibility and effectiveness of the model and its estimation approach presented in this paper. (C) 2014 Elsevier B.V. All rights reserved.	[Peng, Hui; Qin, Yemei] Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Hunan, Peoples R China; [Kitagawa, Genshiro] Res Org Informat & Syst, Minato Ku, Tokyo 1050001, Japan; [Tamura, Yoshiyasu] Inst Stat Math, Tachikawa, Tokyo 1908562, Japan; [Xi, Yanhui] Changsha Univ Sci & Technol, Hunan Prov Higher Educ Key Lab Power Syst Safety, Changsha 410004, Hunan, Peoples R China; [Chen, Xiaohong] Cent S Univ, Sch Business, Changsha 410083, Hunan, Peoples R China; [Peng, Hui; Xi, Yanhui; Qin, Yemei; Chen, Xiaohong] Collaborat Innovat Ctr Resource Conserving Enviro, Changsha 410083, Hunan, Peoples R China	Peng, H (reprint author), Cent S Univ, Sch Informat Sci & Engn, Changsha 410083, Hunan, Peoples R China.	huipeng@mail.csu.edu.cn			National Natural Science Foundation of China [71271215, 71221061]; Collaborative Innovation Center of Resource-Conserving & Environment-Friendly Society and Ecological Civilization	This work was supported by the National Natural Science Foundation of China (No. 71271215, No. 71221061), and the Collaborative Innovation Center of Resource-Conserving & Environment-Friendly Society and Ecological Civilization. The authors would like to thank the editors and referees for their valuable comments and suggestions that largely improved the quality of this paper.	Andersen TG, 2007, J ECONOMETRICS, V138, P125, DOI 10.1016/j.jeconom.2006.05.018; Ait-Sahalia Y, 2002, J FINANC, V57, P2075, DOI 10.1111/1540-6261.00489; Bisoi R, 2014, APPL SOFT COMPUT, V19, P41, DOI 10.1016/j.asoc.2014.01.039; Eraker B, 2003, J FINANC, V58, P1269, DOI 10.1111/1540-6261.00566; Piazzesi M, 2005, J POLIT ECON, V113, P311, DOI 10.1086/427466; Ait-Sahalia Y, 2009, ANN STAT, V37, P184, DOI 10.1214/07-AOS568; VLAAR PJG, 1993, J BUS ECON STAT, V11, P351, DOI 10.2307/1391960; Hsieh TJ, 2011, APPL SOFT COMPUT, V11, P2510, DOI 10.1016/j.asoc.2010.09.007; Lee SS, 2008, REV FINANC STUD, V21, P2535, DOI 10.1093/rfs/hhm056; Carr P, 2003, J FINANC, V58, P2581, DOI 10.1046/j.1540-6261.2003.00616.x; Jiang GJ, 2008, J ECONOMETRICS, V144, P352, DOI 10.1016/j.jeconom.2008.04.009; Barndorff-Nielsen O. E., 2006, J FINANCIAL ECONOMET, V4, P1; Bates D.S., 1996, HANDB STAT, V14, P567, DOI 10.1016/S0169-7161(96)14022-0; Bollerslev T., 1986, ECONOM, V51, P307; Bouchaud JP, 1998, EUR PHYS J B, V6, P543, DOI 10.1007/s100510050582; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Hanson FB, 2007, ADV DES CONTROL, P1; Huang X., 2005, J FINANCIAL ECONOMET, V3, P456, DOI 10.1093/jjfinec/nbi025; Iino M., 2000, 787 I STAT MATH; Lipton A., 2001, MATH METHODS FOREIGN; NELSON DB, 1991, ECONOMETRICA, V59, P347, DOI 10.2307/2938260; O'Hara M., 1995, MARKET MICROSTRUCTUR; Peng H, 2003, EUR PHYS J B, V31, P285, DOI 10.1140/epjb.e2003-00033-7; Peng H, 2005, INT J SYST SCI, V36, P315, DOI 10.1080/00207720500089408; Yu L, 2009, APPL SOFT COMPUT, V9, P563, DOI 10.1016/j.asoc.2008.08.001	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-4946	1872-9681		APPL SOFT COMPUT	Appl. Soft. Comput.	APR	2015	29						40	51		10.1016/j.asoc.2014.10.048		12	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications	Computer Science	CC8WA	WOS:000350648100004		
J	Fotopoulou, C; Kraetschell, R; Dowdy, S; Fujiwara, K; Yaegashi, N; Larusso, D; Casado, A; Mahner, S; Herzog, TJ; Kehoe, S; Vergote, I; Miller, DS; Marth, C; Fujii, S; Sehouli, J				Fotopoulou, Christina; Kraetschell, Robert; Dowdy, Sean; Fujiwara, Keiichi; Yaegashi, Nobuo; Larusso, Domenica; Casado, Antonio; Mahner, Sven; Herzog, Thomas J.; Kehoe, Sean; Vergote, Ignace; Miller, David Scott; Marth, Christian; Fujii, Shingo; Sehouli, Jalid			Surgical and systemic management of endometrial cancer: an international survey	ARCHIVES OF GYNECOLOGY AND OBSTETRICS			English	Article						Endometrial cancer; Survey; Lymph node dissection; Toxicity; Chemotherapy	QUALITY-OF-LIFE; OPERATIVE RADIATION-THERAPY; LYMPH-NODE METASTASIS; RANDOMIZED-TRIAL; VAGINAL BRACHYTHERAPY; PELVIC RADIOTHERAPY; PORTEC-2 TRIAL; CARCINOMA; INTERMEDIATE; CHEMOTHERAPY	To ascertain the spectrum of clinical management of endometrial carcinoma (EC) the largest international survey was conducted to evaluate and identify differences worldwide. After validation of a 15-item questionnaire regarding surgical and adjuvant treatment of EC in Germany, an English-adapted questionnaire was put online and posted to all the major gynecological cancer Societies worldwide for further distribution commencing in 2010 and continued for 26 months. A total of 618 Institutions around the world participated: Central Europe (CE), Southern Europe (SE), Northern Europe (NE), Asia and USA/Canada/UK. Both a therapeutic and staging value was attributed to systematic pelvic and paraaortic lymph node dissection (LND) in CE (74.6 %) and in Asia (67.2 %), as opposed to USA/UK where LND was mainly for staging purposes (53.5 %; p < 0.001). LND was performed up to the renal veins in CE in 86.8 %, in Asia in 80.8 %, in USA/UK in 51.2 % and in SE in 45.1 % (p < 0.001) of cases. In advanced disease, centers from Asia were treated most with adjuvant chemotherapy alone (93.6 %), as opposed to centers in SE, CE and UK/USA that employed combination chemo-radiotherapy in 90.9 % (p < 0.001) of cases. Paclitaxel/carboplatin was mostly used followed by doxorubicin/cisplatin (75 vs. 23.3 %; p < 0.001). In total, 94 % of all participants supported the concept of treating EC patients within appropriate clinical trials. There is broad range in both the surgical and adjuvant treatment of EC across different countries. Large-scale multicenter prospective trials are warranted to establish consistent, evidence-based guidelines to optimize treatment worldwide.	[Fotopoulou, Christina; Kraetschell, Robert; Sehouli, Jalid] Univ Klin Charite, Frauenklin, Berlin, Germany; [Fotopoulou, Christina] Univ London Imperial Coll Sci Technol & Med, Ovarian Canc Act Res Ctr, London, England; [Dowdy, Sean] Mayo Clin, Coll Med, Rochester, MN USA; [Fujiwara, Keiichi] Saitama Med Univ, Saitama Int Med Ctr, Saitama, Japan; [Yaegashi, Nobuo] Tohoku Univ, Sendai, Miyagi 980, Japan; [Larusso, Domenica] Natl Canc Inst, I-20133 Milan, Italy; [Casado, Antonio] San Carlos Univ, Madrid, Spain; [Mahner, Sven] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany; [Herzog, Thomas J.] Columbia Univ, Med Ctr, New York, NY USA; [Kehoe, Sean] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England; [Vergote, Ignace] Katholieke Univ Leuven, Louvain, Belgium; [Miller, David Scott] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Marth, Christian] Univ Klin Frauenheilkunde, Innsbruck, Austria; [Fujii, Shingo] Kitano Hosp, Tazuke Kofukai Med Res Inst, Kita Ku, Osaka, Japan; [Sehouli, Jalid] Campus Virchow Clin Univ Hosp, Charite, Dept Gynecol, D-13353 Berlin, Germany	Fotopoulou, C (reprint author), Univ Klin Charite, Frauenklin, Campus Virchow, Berlin, Germany.	chfotopoulou@gmail.com; sehouli@aol.com	Miller, David/H-4604-2011	Miller, David/0000-0002-8215-5887			American College of Obstetricians and Gynecologists, 2005, OBSTET GYNECOL, V106, P413; Kitchener HC, 2009, INT J GYNECOL CANCER, V19, P134, DOI 10.1111/IGC.0b013e3181995f90; AALDERS J, 1980, OBSTET GYNECOL, V56, P419; Bakkum-Gamez JN, 2008, MAYO CLIN PROC, V83, P97, DOI 10.4065/83.1.97; Creasman WT, 2010, GYNECOL ONCOL, V116, P293, DOI 10.1016/j.ygyno.2009.10.065; Mariani A, 2009, INT J GYNECOL OBSTET, V105, P110, DOI 10.1016/j.ijgo.2009.02.008; Nout RA, 2010, LANCET, V375, P816, DOI 10.1016/S0140-6736(09)62163-2; Nugent EK, 2012, GYNECOL ONCOL, V125, P94, DOI 10.1016/j.ygyno.2011.11.049; Kiess AP, 2012, GYNECOL ONCOL, V127, P321, DOI 10.1016/j.ygyno.2012.07.112; Creutzberg CL, 2003, GYNECOL ONCOL, V89, P201, DOI 10.1016/S0090-8258(03)00126-4; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Kong A, 2012, J NATL CANCER I, V104, P1625, DOI 10.1093/jnci/djs374; Nout RA, 2009, J CLIN ONCOL, V27, P3547, DOI 10.1200/JCO.2008.20.2424; Nout RA, 2011, J CLIN ONCOL, V29, P1692, DOI 10.1200/JCO.2010.32.4590; Fotopoulou C, 2010, EUR J OBSTET GYN R B, V149, P199, DOI 10.1016/j.ejogrb.2009.12.021; Todo Y, 2010, LANCET, V375, P1165, DOI 10.1016/S0140-6736(09)62002-X; Nout RA, 2012, EUR J CANCER, V48, P1638, DOI 10.1016/j.ejca.2011.11.014; Mariani A, 2008, GYNECOL ONCOL, V109, P11, DOI 10.1016/j.ygyno.2008.01.023; Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Wright JD, 2012, LANCET, V379, P1352, DOI 10.1016/S0140-6736(12)60442-5; Bakkum-Gamez JN, 2011, GYNECOL ONCOL, V123, P58, DOI 10.1016/j.ygyno.2011.06.018; Benedetti Panici Pierluigi, 2008, J Natl Cancer Inst, V100, P1707, DOI 10.1093/jnci/djn397; Colombo N, 2013, ANN ONCOL SUPPL 6, V24, pvi33, DOI DOI 10.1093/ANN0NC/MDT353; Creutzberg CL, 2011, CURR ONCOL REP, V13, P472, DOI 10.1007/s11912-011-0191-y; Creutzberg CL, 2004, J CLIN ONCOL, V22, P1234, DOI 10.1200/JCO.2004.08.159; Duska LR, 2005, GYNECOL ONCOL, V96, P198, DOI 10.1016/j.ygyno.2004.09.022; Hirahatake K, 1997, J SURG ONCOL, V65, P82, DOI 10.1002/(SICI)1096-9098(199706)65:2<82::AID-JSO3>3.0.CO;2-J; Lindemann Kristina, 2012, JCO S, V30; Mariani A, 2001, GYNECOL ONCOL, V81, P100, DOI 10.1006/gyno.2000.6111; Marnitz S, 2012, STRAHLENTHER ONKOL, V188, P12, DOI 10.1007/s00066-011-0004-0; SEHOULI J, 2004, GYNAKOLOGE, V37, P245, DOI DOI 10.1007/s00129-004-1497-8; Walsh CS, 2008, J NATL CANCER I, V100, P1660, DOI 10.1093/jnci/djn413	32	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0932-0067	1432-0711		ARCH GYNECOL OBSTET	Arch. Gynecol. Obstet.	APR	2015	291	4					897	905		10.1007/s00404-014-3510-3		9	Obstetrics & Gynecology	Obstetrics & Gynecology	CD5UA	WOS:000351152400032		
J	Suganuma, I; Mori, T; Takahara, T; Torii, H; Fujishiro, M; Kihira, T; Urabe, Y; Urabe, M; Kitawaki, J				Suganuma, Izumi; Mori, Taisuke; Takahara, Tokuei; Torii, Hiroko; Fujishiro, Masanori; Kihira, Tomohisa; Urabe, Yuko; Urabe, Mamoru; Kitawaki, Jo			Autoamputation of a pedunculated, subserosal uterine leiomyoma presenting as a giant peritoneal loose body	ARCHIVES OF GYNECOLOGY AND OBSTETRICS			English	Article						Peritoneal loose body; Pedunclated subserosal uterine leiomyoma; Autoamputation; Parasitic leiomyoma; Laparoscopic surgery	MYOMAS	Peritoneal loose bodies (PLBs) are defined as fibrotic or calcified-free bodies within the peritoneal cavity; they commonly autoamputate from appendices epiploicae that have undergone torsion. Pedunculated, subserosal uterine leiomyomas (PSULs) are subserosal uterine leiomyomas connected to the uterus via a pedicle. In the present report, we describe the case of a PLB that originated from the autoamputation of a PSUL, confirmed based on histological evidence consistent with a uterine leiomyoma and the laparoscopic findings of a broken pedicle. This case clearly demonstrates the potential for a uterine leiomyoma to be the source of a PLB. Our findings contribute to the understanding of the etiological relationship between PLBs and uterine leiomyomas.	[Suganuma, Izumi; Mori, Taisuke; Kitawaki, Jo] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Obstet & Gynecol, Kamigyo Ku, Kyoto 6028566, Japan; [Takahara, Tokuei; Torii, Hiroko; Fujishiro, Masanori; Kihira, Tomohisa; Urabe, Yuko; Urabe, Mamoru] Kusatsu Gen Hosp, Dept Obstet & Gynecol, Kusatsu, Shiga 5258585, Japan	Suganuma, I (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Obstet & Gynecol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	i-suganu@koto.kpu-m.ac.jp					Parker WH, 2007, FERTIL STERIL, V87, P725, DOI 10.1016/j.fertnstert.2007.01.093; Kho KA, 2009, OBSTET GYNECOL, V114, P611, DOI 10.1097/AOG.0b013e3181b2b09a; Ghosh P, 2006, J CLIN GASTROENTEROL, V40, P427, DOI 10.1097/00004836-200605000-00012; Jang Joung Teak, 2012, J Korean Soc Coloproctol, V28, P108, DOI 10.3393/jksc.2012.28.2.108; Mc CE, 1958, AM J SURG, V96, P588; Robbins SL, 1984, PATHOLOGIC BASIS DIS	6	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0932-0067	1432-0711		ARCH GYNECOL OBSTET	Arch. Gynecol. Obstet.	APR	2015	291	4					951	953		10.1007/s00404-014-3580-2		3	Obstetrics & Gynecology	Obstetrics & Gynecology	CD5UA	WOS:000351152400038		
J	Molnarfi, N; Benkhoucha, M; Funakoshi, H; Nakamura, T; Lalive, PH				Molnarfi, Nicolas; Benkhoucha, Mahdia; Funakoshi, Hiroshi; Nakamura, Toshikazu; Lalive, Patrice H.			Hepatocyte growth factor: A regulator of inflammation and autoimmunity	AUTOIMMUNITY REVIEWS			English	Review						HGF; c-Met; Inflammation; Autoimmunity; Autoimmune regulator; Therapy	FACTOR SCATTER FACTOR; INDUCED LEUCINE-ZIPPER; HUMAN DENDRITIC CELLS; RECEPTOR C-MET; FACTOR-KAPPA-B; RENAL INTERSTITIAL FIBROSIS; TUBULAR EPITHELIAL-CELLS; FACTOR GENE-EXPRESSION; MARROW STROMAL CELLS; VERSUS-HOST-DISEASE	Hepatocyte growth factor (HGF) is a pleiotropic cytokine that has been extensively studied over several decades, but was only recently recognized as a key player in mediating protection of many types of inflammatory and autoimmune diseases. HGF was reported to prevent and attenuate disease progression by influencing multiple pathophysiological processes involved in inflammatory and immune response, including cell migration, maturation, cytokine production, antigen presentation, and T cell effector function. In this review, we discuss the actions and mechanisms of HGF in inflammation and immunity and the therapeutic potential of this factor for the treatment of inflammatory and autoimmune diseases. (C) 2014 Elsevier B.V. All rights reserved.	[Molnarfi, Nicolas; Benkhoucha, Mahdia; Lalive, Patrice H.] Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland; [Molnarfi, Nicolas; Benkhoucha, Mahdia; Lalive, Patrice H.] Univ Hosp Geneva, Unit Neuroimmunol & Multiple Sclerosis, Dept Clin Neurosci, Div Neurol, CH-1211 Geneva 14, Switzerland; [Lalive, Patrice H.] Univ Hosp Geneva, Lab Med Serv, Dept Genet & Lab Med, CH-1211 Geneva 14, Switzerland; [Funakoshi, Hiroshi] Asahikawa Med Univ, Ctr Adv Res & Educ, Asahikawa, Hokkaido, Japan; [Nakamura, Toshikazu] Neurogen Inc, Ibaraki, Osaka, Japan	Lalive, PH (reprint author), Univ Hosp Geneva, Fac Med, Dept Clin Neurosci, Div Neurol,Unit Neuroimmunol & Multiple Sclerosis, Gabrielle Perret Gentil 4, CH-1211 Geneva 14, Switzerland.	patrice.lalive@hcuge.ch			Swiss National Foundation [310000-113653, 310030-153164]; Swiss Multiple Sclerosis Society	N.M., M.B., and P.H.L. wrote the paper. H.F. and T.N. provided assistance for preparation of the article. P.H.L. received support from the Swiss National Foundation (#310000-113653 and #310030-153164); P.H.L. and N.M. received support from the Swiss Multiple Sclerosis Society.	ADAMS DH, 1994, P NATL ACAD SCI USA, V91, P7144, DOI 10.1073/pnas.91.15.7144; Aguilar-Valenzuela R, 2014, J GASTROEN HEPATOL, V29, P878, DOI 10.1111/jgh.12456; Oh K, 2005, AM J PHYSIOL-GASTR L, V288, pG729, DOI 10.1152/ajpgi.00438.2004.; Homsi E, 2009, AM J NEPHROL, V29, P283, DOI 10.1159/000159275; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; ZARNEGAR R, 1995, J CELL BIOL, V129, P1177, DOI 10.1083/jcb.129.5.1177; Moransard M, 2010, GLIA, V58, P559, DOI 10.1002/glia.20945; Tjin EPM, 2005, J IMMUNOL, V175, P2807; Beilmann M, 2000, BLOOD, V95, P3964; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Scarpino S, 2000, AM J PATHOL, V156, P831, DOI 10.1016/S0002-9440(10)64951-6; Galimi F, 2001, J IMMUNOL, V166, P1241; Ware LB, 2002, AM J PHYSIOL-LUNG C, V282, pL924, DOI 10.1152/ajplung.00439.2001; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Watanabe M, 2005, MOL THER, V12, P58, DOI 10.1016/j.ymthe.2005.02.019; Numata M, 2005, INFLAMM BOWEL DIS, V11, P551, DOI 10.1097/01.MIB.0000164192.71381.5c; Yaekashiwa M, 1997, AM J RESP CRIT CARE, V156, P1937; BERDICHEVSKY F, 1994, J CELL SCI, V107, P3557; WEIDNER KM, 1991, P NATL ACAD SCI USA, V88, P7001, DOI 10.1073/pnas.88.16.7001; McCourt M, 2001, EUR J SURG ONCOL, V27, P396; Baek JH, 2012, J IMMUNOL, V189, P1699, DOI 10.4049/jimmunol.1200729; Wang H, 2013, HUM GENE THER, V24, P343, DOI 10.1089/hum.2012.177; Ueda H, 2001, CARDIOVASC RES, V51, P41, DOI 10.1016/S0008-6363(01)00272-3; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Kusunoki H, 2014, HYPERTENS RES, V37, P500, DOI 10.1038/hr.2014.41; Gual P, 2000, ONCOGENE, V19, P1509, DOI 10.1038/sj.onc.1203514; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Petrelli A, 2006, P NATL ACAD SCI USA, V103, P5090, DOI 10.1073/pnas.0508156103; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; WEIDNER KM, 1990, J CELL BIOL, V111, P2097, DOI 10.1083/jcb.111.5.2097; Imado T, 2004, BLOOD, V104, P1542, DOI 10.1182/blood-2003-12-4309; Chen PM, 2014, J LEUKOCYTE BIOL, V96, P295, DOI 10.1189/jlb.3A0513-242R; SONNENBERG E, 1993, J CELL BIOL, V123, P223, DOI 10.1083/jcb.123.1.223; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; PRAT M, 1991, MOL CELL BIOL, V11, P5954; GALVANI AP, 1995, BIOCHEM PHARMACOL, V50, P959, DOI 10.1016/0006-2952(95)00219-P; Daha MR, 2000, NEPHROL DIAL TRANSPL, V15, P41, DOI 10.1093/ndt/15.suppl_6.41; HAN S, 1991, BIOCHEMISTRY-US, V30, P9768, DOI 10.1021/bi00104a029; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Romo-Tena J, 2013, AUTOIMMUN REV, V12, P1171, DOI 10.1016/j.autrev.2013.07.002; Gong RJ, 2004, J AM SOC NEPHROL, V15, P2868, DOI 10.1097/01.ASN.0000141962.44300.3A; Benkhoucha M, 2010, P NATL ACAD SCI USA, V107, P6424, DOI 10.1073/pnas.0912437107; Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; DONATE LE, 1994, PROTEIN SCI, V3, P2378; Fierabracci A, 2011, AUTOIMMUN REV, V10, P137, DOI 10.1016/j.autrev.2010.08.019; Morimoto K, 2001, AM J RESP CELL MOL, V24, P608; Rutella S, 2006, BLOOD, V108, P218, DOI 10.1182/blood-2005-08-3141; Cohen N, 2006, BLOOD, V107, P2037, DOI 10.1182/blood-2005-07-2760; Matsumoto K, 1998, J BIOL CHEM, V273, P22913, DOI 10.1074/jbc.273.36.22913; Arthur LG, 2004, J PEDIATR SURG, V39, P139, DOI 10.1016/j.jpedsurg.2003.10.001; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; GRAZIANI A, 1991, J BIOL CHEM, V266, P22087; MICHALOPOULOS G, 1984, CANCER RES, V44, P4414; KAWAIDA K, 1994, P NATL ACAD SCI USA, V91, P4357, DOI 10.1073/pnas.91.10.4357; Ohda Y, 2005, DIGEST DIS SCI, V50, P914, DOI 10.1007/s10620-005-2664-z; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Beilmann M, 1997, BLOOD, V90, P4450; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Oku M, 2012, TRANSPLANTATION, V93, P148, DOI 10.1097/TP.0b013e31823be83f; Hanawa T, 2006, J GENE MED, V8, P623, DOI 10.1002/jgm.880; Ueki T, 1999, NAT MED, V5, P226; Chen QY, 1996, CELL GROWTH DIFFER, V7, P821; Bendinelli P, 2010, J CELL PHYSIOL, V225, P757, DOI 10.1002/jcp.22274; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Bevan D, 2004, J PATHOL, V203, P831, DOI 10.1002/path.1578; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Date I, 2004, BIOCHEM BIOPH RES CO, V319, P1152, DOI 10.1016/j.bbrc.2004.05.100; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Takai K, 1997, BLOOD, V89, P1560; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Okunishi K, 2005, J IMMUNOL, V175, P4745; Chakraborty S, 2013, EXPERT OPIN INV DRUG, V22, P499, DOI 10.1517/13543784.2013.778972; Flaquer M, 2012, DIABETOLOGIA, V55, P2059, DOI 10.1007/s00125-012-2535-z; Yang JW, 2002, J AM SOC NEPHROL, V13, P96; Miller MA, 2013, P NATL ACAD SCI USA, V110, pE2074, DOI 10.1073/pnas.1222387110; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Gianchecchi E, 2013, AUTOIMMUN REV, V12, P1091, DOI 10.1016/j.autrev.2013.05.003; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; Kuroiwa T, 2001, J CLIN INVEST, V107, P1365, DOI 10.1172/JCI11808; Mellado-Gil J, 2011, DIABETES, V60, P525, DOI 10.2337/db09-1305; Lalive PH, 2005, EUR J IMMUNOL, V35, P727, DOI 10.1002/eji.200425430; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Fiaschi-Taesch NM, 2004, J AM SOC NEPHROL, V15, P112, DOI 10.1097/01.ASN.0000102470.12285.C6; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Yang JW, 2001, HEPATOLOGY, V33, P848, DOI 10.1053/jhep.2001.23438; Corinti S, 2001, J IMMUNOL, V166, P4312; Skibinski G, 2001, IMMUNOLOGY, V102, P506, DOI 10.1046/j.1365-2567.2001.01186.x; Benkhoucha M, 2014, J IMMUNOL, V193, P2743, DOI 10.4049/jimmunol.1302338; Hamdi H, 2007, BLOOD, V110, P211, DOI 10.1182/blood-2006-10-052506; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Mizuno S, 1998, J CLIN INVEST, V101, P1827, DOI 10.1172/JCI1709; vanderVoort R, 1997, J EXP MED, V185, P2121; Athauda G, 2006, CLIN CANCER RES, V12, P4154, DOI 10.1158/1078-0432.CCR-06-0250; Dohi M, 2000, AM J RESP CRIT CARE, V162, P2302; Arthur LG, 2003, J GASTROINTEST SURG, V7, P1062, DOI 10.1016/j.gassur.2003.09.014; Benkhoucha M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-154; Bolanos-Garcia VM, 2005, MOL CELL BIOCHEM, V276, P149, DOI 10.1007/s11010-005-3696-6; Coudriet GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015384; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; da Silva CG, 2012, J CELL PHYSIOL, V227, P1382, DOI 10.1002/jcp.22851; Delaney B, 1993, LIFE SCI, V53, pL89; Dworkin LD, 2004, KIDNEY INT, V65, P409, DOI 10.1111/j.1523-1755.2004.00417.x; Falenta K, 2013, J MICROSC-OXFORD, V250, P200, DOI 10.1111/jmi.12035; Feuerherm AJ, 2001, SCAND J RHEUMATOL, V30, P229; Francavilla A, 1997, HEPATOLOGY, V25, P411; Funakoshi H, 2011, CURR SIGNAL TRANSD T, V6, P156; Futamatsu H, 2005, CIRC RES, V96, P823, DOI 10.1161/01.RES.0000163016.52653.2e; GAUDINO G, 1994, EMBO J, V13, P3524; Gong R, 2003, J AM SOC NEPHROL, V14, P3047, DOI 10.1097/01.ASN.0000098686.72971.DB; Gong RJ, 2006, J AM SOC NEPHROL, V17, P2464, DOI 10.1681/ASN.2006020185; Gordin M, 2010, J IMMUNOL, V185, P2020, DOI 10.4049/jimmunol.0902566; Grandaunet B, 2011, ARTHRITIS RHEUM-US, V63, P662, DOI 10.1002/art.30163; Grenier A, 2002, BLOOD, V99, P2997, DOI 10.1182/blood.V99.8.2997; INABA M, 1993, BLOOD, V82, P53; Inoue Tsutomu, 2003, FASEB Journal, V17, P268; ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6; Ito W, 2005, AM J RESP CELL MOL, V32, P268, DOI 10.1165/rcmb.2004-0058OC; Jayasankar V, 2003, CIRCULATION, V108, P230, DOI 10.1161/01.cir.0000087444.53354.66; Jiang Q, 2001, CLIN EXP IMMUNOL, V125, P222, DOI 10.1046/j.1365-2249.2001.01591.x; JIANG W, 1992, IMMUNOLOGY, V77, P147; Katz MS, 2012, J PEDIATR SURG, V47, P194, DOI 10.1016/j.jpedsurg.2011.10.043; KMIECIK TE, 1992, BLOOD, V80, P2454; Koch AE, 1996, ARTHRITIS RHEUM, V39, P1566, DOI 10.1002/art.1780390917; Kosai K, 1998, BIOCHEM BIOPH RES CO, V244, P683, DOI 10.1006/bbrc.1998.8293; Kuroiwa T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2012; Kurz SM, 2002, EUR J IMMUNOL, V32, P1832, DOI 10.1002/1521-4141(200207)32:7<1832::AID-IMMU1832>3.0.CO;2-2; Lee YJ, 2012, EUR RESPIR J, V40, P424, DOI 10.1183/09031936.00096711; MATSUMOTO K, 1992, BIOCHEM BIOPH RES CO, V188, P235, DOI 10.1016/0006-291X(92)92375-8; MATSUMOTO K, 1992, J BIOL CHEM, V267, P24917; Matsushima A, 2004, J TRAUMA, V56, P259, DOI 10.1097/01.TA.0000111752.60500.DA; Matteucci E, 2006, CELL MOL LIFE SCI, V63, P2016, DOI 10.1007/s00018-006-6137-0; Michalopoulos G K, 1993, EXS, V65, P275; MILLER SB, 1994, AM J PHYSIOL, V266, pF129; Min JK, 2005, CIRC RES, V96, P300, DOI 10.1161/01.RES.0000155330.07887.EE; Mine S, 1998, LAB INVEST, V78, P1395; Mizuno S, 2004, AM J PHYSIOL-RENAL, V286, pF134, DOI 10.1152/ajprenal.00199.2003; Mizuno S, 2001, KIDNEY INT, V59, P1304, DOI 10.1046/j.1523-1755.2001.0590041304.x; MOGHUL A, 1994, ONCOGENE, V9, P2045; Molnar C, 2004, EUR CYTOKINE NETW, V15, P303; Molnarfi N, 2014, J NEUROIMMUNOL, V267, P105, DOI 10.1016/j.jneuroim.2013.12.004; Molnarfi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049882; MORITA M, 1995, HEPATOLOGY, V21, P1585, DOI 10.1016/0270-9139(95)90463-8; Muller AM, 2012, J NEUROIMMUNOL, V251, P80, DOI 10.1016/j.jneuroim.2012.06.008; Nagashima M, 2001, J RHEUMATOL, V28, P1772; NAKAMURA T, 1991, Progress in Growth Factor Research, V3, P67, DOI 10.1016/0955-2235(91)90014-U; Nishimura S, 1998, J GASTROENTEROL, V33, P172, DOI 10.1007/s005350050066; NISHINO T, 1995, BLOOD, V85, P3093; Oe S, 2003, J CONTROL RELEASE, V88, P193, DOI 10.1016/S0168-3659(02)00463-7; Okunishi K, 2007, J IMMUNOL, V179, P5504; Ozeki M, 2001, J DRUG TARGET, V9, P461; Paleolog Ewa M, 2002, Arthritis Res, V4 Suppl 3, pS81, DOI 10.1186/ar575; Payne NL, 2012, CELL ADHES MIGR, V6, P179, DOI 10.4161/cam.20341; PELICCI G, 1995, ONCOGENE, V10, P1631; ROOS F, 1992, ENDOCRINOLOGY, V131, P2540, DOI 10.1210/en.131.6.2540; Saiura A, 2001, TRANSPLANTATION, V72, P320, DOI 10.1097/00007890-200107270-00027; Sakai T, 1997, AM J RESP CELL MOL, V16, P388; SEKI T, 1991, GENE, V102, P213; SHIMA N, 1991, CELL BIOL INT REP, V15, P397, DOI 10.1016/0309-1651(91)90128-6; Shimizu K, 2012, ARTERIOSCL THROM VAS, V32, P2687, DOI 10.1161/ATVBAHA.112.300041; Shulda MN, 2009, AM J RESP CELL MOL B, V40, P643; Singhal E, 2011, INT J BIOCHEM CELL B, V43, P1134, DOI 10.1016/j.biocel.2011.04.006; Singhal E, 2011, J BIOL CHEM, V286, P32054, DOI 10.1074/jbc.M111.271247; SKEEL A, 1991, J EXP MED, V173, P1227, DOI 10.1084/jem.173.5.1227; Srivastava M, 2001, J PEDIATR GASTR NUTR, V33, P548, DOI 10.1097/00005176-200111000-00007; Tahara V.IdA, 2003, J PHARMACOL EXP THER, V307, P146; Tamura S, 1998, SCAND J IMMUNOL, V47, P296; Tang QZ, 2008, INT J CARDIOL, V127, P442, DOI 10.1016/j.ijcard.2008.01.009; Taniyama Y, 2002, HYPERTENSION, V40, P47, DOI 10.1161/01.HYP.0000020755.56955.BF; Wajih N, 2002, CIRC RES, V90, P46, DOI 10.1161/hh0102.102756; Wang X, 2002, MOL CELL, V9, P411, DOI 10.1016/S1097-2765(02)00439-2; Weimar IS, 1997, BLOOD, V89, P990; Yamada Y, 1998, AM J REPROD IMMUNOL, V40, P112; Yamaura K, 2004, CIRCULATION, V110, P1650, DOI 10.1161/01.CIR.0000143052.45956.71; Yasuda H, 1996, HEPATOLOGY, V24, P636, DOI 10.1002/hep.510240328; Yu CZ, 1998, STEM CELLS, V16, P66; YUKIOKA K, 1994, J RHEUMATOL, V21, P2184; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067303; Zhang YW, 2004, CANCER CELL, V6, P5, DOI 10.1016/j.ccr.2004.07.003; Zhou D, 2013, KIDNEY INT, V84, P509, DOI 10.1038/ki.2013.102	188	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-9972	1873-0183		AUTOIMMUN REV	Autoimmun. Rev.	APR	2015	14	4					293	303		10.1016/j.autrev.2014.11.013		11	Immunology	Immunology	CD2XO	WOS:000350942500004		
J	Teramura, Y				Teramura, Yuji			Cell surface modification with ssDNA-PEG-lipid for analysing intercellular interactions between different cells	BIOMATERIALS			English	Article						Surface modification; Poly(ethylene glycol)-conjugated; phospholipid (PEG-lipid); Cell-cell interaction; Cell-cell attachment; DNA	EMBRYONIC STEM-CELLS; LIVING CELLS; ADHESION; CADHERIN	Intercellular interactions are important in the development, immune responses, and functions of tissues and organs. Few methods are currently available for experimentally inducing and analysing cell cell interaction in vitro. Here I propose a method to induce cell cell attachment by cell surface modification with single-stranded DNA (ssDNA) and poly(ethylene glycol)-conjugated phospholipid (PEG lipid) derivatives. The incorporation of an ssDNA pair (polyA20 and polyT20) into the cell membranes of two different cells was utilized to attach distinct cells through DNA hybridization. This technique enabled induction of cell cell attachment between the same cell lines or different cell lines by controlling the contact area of two cells. Using this method, I investigated intercellular interactions, including the cell-in-cell invasion process, without impairing the interaction. I found that the normal cells MCF-10A were internalized into the cancer cells MCF-7, and that the intercellular interactions between them mainly involved the interaction of E-cadherin. (C) 2015 Elsevier Ltd. All rights reserved.	Univ Tokyo, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan	Teramura, Y (reprint author), Univ Tokyo, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	teramura@bioeng.t.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [26702017, 26106709]; Mukai Science and Technology Foundation [H26]; Japan Diabetes Foundation [H25]	Y.T. thanks Prof Hiroo Iwata, Kyoto University for useful discussion. This work was supported in part by a Grant-in-Aid for Young Scientists (A) (No. 26702017) and Grant-in-Aid for Scientific Research on Innovative Areas (No. 26106709) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, a research grant from the Mukai Science and Technology Foundation (H26, 2014), and a research grant from the Japan Diabetes Foundation (H25, 2013).	Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809; Ishihara K, 2011, BBA-GEN SUBJECTS, V1810, P268, DOI 10.1016/j.bbagen.2010.04.008; Gartner ZJ, 2009, P NATL ACAD SCI USA, V106, P4606, DOI 10.1073/pnas.0900717106; Teramura Y, 2010, BIOCONJUGATE CHEM, V21, P792, DOI 10.1021/bc900494x; Parekkadan B, 2008, NEUROSCI LETT, V438, P190, DOI 10.1016/j.neulet.2008.03.094; Selden NS, 2012, J AM CHEM SOC, V134, P765, DOI 10.1021/ja2080949; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Teramura Y, 2010, SOFT MATTER, V6, P1081, DOI 10.1039/b913621e; Teramura Y, 2010, ADV DRUG DELIVER REV, V62, P827, DOI 10.1016/j.addr.2010.01.005; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Yamazoe H, 2005, J BIOSCI BIOENG, V100, P292, DOI 10.1263/jbb.100.292; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teramura Y, 2010, BIOMATERIALS, V31, P2229, DOI 10.1016/j.biomaterials.2009.11.098; Keller G, 1999, NAT MED, V5, P151, DOI 10.1038/5512; Chan YHM, 2008, BIOINTERPHASES, V3, pFA17, DOI 10.1116/1.2889062; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; Teramura Y, 2009, BIOMATERIALS, V30, P2270, DOI 10.1016/j.biomaterials.2009.01.036	21	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	APR	2015	48						119	128		10.1016/j.biomaterials.2015.01.032		10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CD2SF	WOS:000350928600011		
J	Maruyama, N; Shibata, Y; Mochizuki, A; Yamada, A; Maki, K; Inoue, T; Kamijo, R; Miyazaki, T				Maruyama, Noriko; Shibata, Yo; Mochizuki, Ayako; Yamada, Atsushi; Maki, Koutaro; Inoue, Tornio; Kamijo, Ryutaro; Miyazaki, Takashi			Bone micro-fragility caused by the mimetic aging processes in alpha-klotho deficient mice: In situ nanoindentation assessment of dilatational bands	BIOMATERIALS			English	Article						Bone; Mechanical properties; Ageing; Dynamic mechanical analysis; Nanoindentation	AGE-RELATED-CHANGES; CORTICAL BONE; INSTRUMENTED INDENTATION; MECHANICAL-PROPERTIES; BIOLOGICAL-MATERIALS; ELASTIC-MODULUS; FRACTURE; MINERALIZATION; DEFORMATION; OSTEOCALCIN	The nanoscale structure-function relationship is a key determinant of bone toughness or micro-fragility. The loss of bone toughness during the aging process has been accepted based on empirical evidence, but this concept has not yet been fully supported by evidence at the material level. Here, we demonstrate a reduction in bone toughening mechanism in mimetic aged cortical bone obtained from alpha-klotho deficient (alpha-klotho(-/-)) mice and assessed by in situ dynamic mechanical analysis. The strain-rate nanoindentation tests showed enhanced stiffening of the wild-type calvarial bone and a large dimensional recovery during rapid loading following the constant displacement test. Such strain-dependent stiffening was likely associated with nanoscale dilatational bands and subsequent strain-energy transfer to the superior wild-type cross-linked collagen matrix network. The absence of dilatational bands formed by hydroxyapatite crystals and non-collagenous proteins in the alpha-klotho(-/-) bone samples likely diminished the intrinsic bone toughening mechanisms almost independent of viscoelastic behaviors. Such nanoscale structural alternations that occur during aging processes lead to crack propagation and result in overall bone fractures under large external stresses. In addition, dynamic mechanical analysis using instrumented nanoindentation was useful for the evaluation of bone mechanical properties in this pathological model of a genetic knockout mouse. (C) 2015 Elsevier Ltd. All rights reserved.	[Maruyama, Noriko; Maki, Koutaro] Showa Univ, Sch Dent, Dept Orthodont, Ohta Ku, Tokyo 1458515, Japan; [Shibata, Yo; Miyazaki, Takashi] Showa Univ, Div Biomat & Engn, Dept Conservat Dent, Sch Dent,Shinagawa Ku, Tokyo 1428555, Japan; [Mochizuki, Ayako; Inoue, Tornio] Showa Univ, Sch Dent, Dept Oral Physiol, Shinagawa Ku, Tokyo 1428555, Japan; [Yamada, Atsushi; Kamijo, Ryutaro] Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 1428555, Japan	Shibata, Y (reprint author), Showa Univ, Div Biomat & Engn, Dept Conservat Dent, Sch Dent,Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	yookun@dent.showa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [B:24390445, C:24592966]	This work was supported by a Grant-in-Aid for Scientific Research (B:24390445) and (C:24592966) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. None of the authors have any conflicts of interest to declare.	Poundarik AA, 2012, P NATL ACAD SCI USA, V109, P19178, DOI 10.1073/pnas.1201513109; Bar-On B, 2013, J STRUCT BIOL, V183, P149, DOI 10.1016/j.jsb.2013.05.012; Taylor D, 2007, J MATER SCI, V42, P8911, DOI 10.1007/s10853-007-1698-3; Isaksson H, 2010, J BIOMECH, V43, P2410, DOI 10.1016/j.jbiomech.2010.04.017; Felsenberg D, 2005, CLIN THER, V27, P1, DOI 10.1016/j.clinthera.2004.12.020; Janmey PA, 2007, NAT MATER, V6, P48, DOI 10.1038/nmat1810; FIELD JS, 1995, J MATER RES, V10, P101, DOI 10.1557/JMR.1995.0101; Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Sanctuary CS, 2005, J APPL PHYSIOL, V99, P2369, DOI 10.1152/japplphysiol.00486.2005; Cristofolini L, 1996, J BIOMECH, V29, P525, DOI 10.1016/0021-9290(95)00084-4; Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428; Xu CQ, 2009, J RAMAN SPECTROSC, V40, P1780, DOI 10.1002/jrs.2320; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Maruyama N, 2014, NANOSCALE, V6, P14863, DOI 10.1039/c4nr03180f; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; RITTER NM, 1992, J BONE MINER RES, V7, P877; Jang IK, 2014, NANOMED-NANOTECHNOL, V10, P629, DOI 10.1016/j.nano.2013.09.007; Suzuki H, 2008, J ANAT, V212, P275, DOI 10.1111/j.1469-7580.2008.00859.x; Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006; Oyen ML, 2008, J MATER RES, V23, P1307, DOI 10.1557/JMR.2008.0156; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.0002; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Cheng YT, 2005, J MATER RES, V20, P3061, DOI 10.1557/JMR.2005.0389; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9; Pattin CA, 1996, J BIOMECH, V29, P69, DOI 10.1016/0021-9290(94)00156-1; Zimmermann EA, 2014, BIOMATERIALS, V35, P5472, DOI 10.1016/j.biomaterials.2014.03.066; Gupta HS, 2005, NANO LETT, V5, P2108, DOI 10.1021/nl051584b; MCCALDEN RW, 1993, J BONE JOINT SURG AM, V75A, P1193; Grampp S, 1997, J BONE MINER RES, V12, P697, DOI 10.1359/jbmr.1997.12.5.697; Barthelat F, 2012, MATER RES SOC S P, P61; BOBYN JD, 1990, CLIN ORTHOP RELAT R, P196; Carden A, 2003, CALCIFIED TISSUE INT, V72, P166, DOI 10.1007/s00223-002-1039-0; Katsamenis OL, 2012, J MECH BEHAV BIOMED, V17, P152; KAWAMOTO T, 1986, STAIN TECHNOL, V61, P169; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Sasaki M, 2013, BONE, V57, P206, DOI 10.1016/j.bone.2013.08.008; Spiegelberg SH, 1996, J NON-NEWTON FLUID, V67, P49, DOI 10.1016/S0377-0257(96)01475-9; Ulrich D, 1997, ST HEAL T, V40, P97; Wenchang T, 2003, INT J NONLIN MECH, V38, P645, DOI DOI 10.1016/S0020-7462(01)00121-4	42	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	APR	2015	47						62	71		10.1016/j.biomaterials.2015.01.004		10	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CC7DN	WOS:000350528000007		
J	Okuda, S; Inoue, Y; Eiraku, M; Adachi, T; Sasai, Y				Okuda, Satoru; Inoue, Yasuhiro; Eiraku, Mototsugu; Adachi, Taiji; Sasai, Yoshiki			Vertex dynamics simulations of viscosity-dependent deformation during tissue morphogenesis	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Multicellular morphogenesis; Dynamic deformation process; Viscous property; Vertex dynamics model; Computational biomechanics; Developmental biomechanics	EPITHELIAL MORPHOGENESIS; APICAL CONSTRICTION; CELL-DIVISION; PROLIFERATION; MECHANICS; VISCOELASTICITY; GASTRULATION; INVAGINATION; MAINTENANCE; ELONGATION	In biological development, multiple cells cooperate to form tissue morphologies based on their mechanical interactions; namely active force generation and passive viscoelastic response. In particular, the dynamic processes of tissue deformations are governed by the viscous properties of the tissues. These properties are spatially inhomogeneous because they depend on the tissue constituents, such as cytoplasm, cytoskeleton, basement membrane and extracellular matrix. The multicellular mechanics of tissue morphogenesis have been investigated in vertex dynamics models. However, conventional models are applicable only to quasi-static deformation processes, which do not account for tissue viscosities. We propose a vertex dynamics model that simulates the viscosity-dependent dynamic deformation processes during tissue morphogenesis. By incorporating local velocity fields into the governing equation of vertex movements, the model turns Galilean invariant. In addition, the viscous properties of tissue components are newly expressed by formulating friction forces on vertices as functions of the relative velocities among the vertices. The advantages of the proposed model are examined by epithelial growth simulations under the employed condition for quasi-static processes. As a result, the epithelial vesicle simulated by the proposed model is linearly elongated with nearly free stress, while that simulated by the conventional model is undulated with compressive residual stress. Therefore, the proposed model is able to reflect the timescale of deformations by satisfying Galilean invariance. Next, the applicability of the proposed model is assessed in epithelial growth simulations of viscous extracellular materials. In this test, the epithelial vesicles are deformed into tubular shapes by oriented cell divisions, and their morphologies are extremely sensitive to extracellular viscosity. Therefore, the dynamic deformations in the proposed model depend on the viscous properties of tissue components. The proposed model will be useful for simulating dynamic deformation processes of tissue morphogenesis depending on viscous properties of various tissue components.	[Okuda, Satoru; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Inoue, Yasuhiro; Adachi, Taiji] Kyoto Univ, Dept Biomech, Inst Frontier Med Sci, Kyoto, Japan; [Eiraku, Mototsugu] RIKEN, Ctr Dev Biol, Dimens Tissue Anal Unit 4, Chuo Ku, Kobe, Hyogo 6500047, Japan	Okuda, S (reprint author), RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	okuda@cdb.riken.jp			JSPS KAKENHI [25889070]	The authors appreciate valuable comments from Dr. Yoshihiro Morishita, Katsuhiko Sato and Yukitaka Ishimoto at the RIKEN Center for Developmental Biology, Japan. This study was supported by JSPS KAKENHI Grant Numbers 25889070.	DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; HARDY RJ, 1982, J CHEM PHYS, V76, P622, DOI 10.1063/1.442714; Mao YL, 2013, EMBO J, V32, P2790, DOI 10.1038/emboj.2013.197; Taniguchi K, 2011, SCIENCE, V333, P339, DOI 10.1126/science.1200940; Okuda S, 2013, BIOMECH MODEL MECHAN, V12, P987, DOI 10.1007/s10237-012-0458-8; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Park S, 2005, BIOPHYS J, V89, P4330, DOI 10.1529/biophysj.104.053462; Borghi N, 2009, CURR TOP DEV BIOL, V89, P1, DOI 10.1016/S0070-2153(09)89001-7; He B, 2014, NATURE, V508, P392, DOI 10.1038/nature13070; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Honda H, 2004, J THEOR BIOL, V226, P439, DOI 10.1016/j.jtbi.2003.10.001; Woolner S, 2012, DEV CELL, V22, P775, DOI 10.1016/j.devcel.2012.01.002; Mittal R, 2005, ANNU REV FLUID MECH, V37, P239, DOI 10.1146/annurev.fluid.37.061903.175743; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; Osterfield M, 2013, DEV CELL, V24, P400, DOI 10.1016/j.devcel.2013.01.017; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Lye CM, 2011, CURR TOP DEV BIOL, V95, P145, DOI 10.1016/B978-0-12-385065-2.00005-0; Brochard-Wyart F, 2003, CR PHYS, V4, P281, DOI 10.1016/S1631-0705(03)00048-3; Davidson L, 2007, METHOD CELL BIOL, V83, P425, DOI 10.1016/S0091-679X(07)83018-4; Davies J.A., 2005, MECH MORPHOGENESIS C; Goldstein H., 2000, CLASSICAL MECH; HONDA H, 1984, J THEOR BIOL, V106, P423, DOI 10.1016/0022-5193(84)90039-0; Honda H, 2008, DEV DYNAM, V237, P1826, DOI 10.1002/dvdy.21609; Ishimoto Y, ARXIV14053839; Letizia A, 2011, J CELL SCI, V124, P240, DOI 10.1242/jcs.073601; Okuda S, 2013, J BIOMECH, V46, P1705, DOI 10.1016/j.jbiomech.2013.03.035; Okuda S, 2013, BIOMECH MODEL MECHAN, V12, P627, DOI 10.1007/s10237-012-0430-7; Unterberger MJ, 2013, ACTA BIOMATER, V9, P7343, DOI 10.1016/j.actbio.2013.03.008; von Dassow M, 2009, DEV DYNAM, V238, P2, DOI 10.1002/dvdy.21809	37	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	APR	2015	14	2					413	425		10.1007/s10237-014-0613-5		13	Biophysics; Engineering, Biomedical	Biophysics; Engineering	CD1YQ	WOS:000350871000015		
J	Kataoka, S; Furuita, K; Hattori, Y; Kobayashi, N; Ikegami, T; Shiozaki, K; Fujiwara, T; Kojima, C				Kataoka, Saori; Furuita, Kyoko; Hattori, Yoshikazu; Kobayashi, Naohiro; Ikegami, Takahisa; Shiozaki, Kazuhiro; Fujiwara, Toshimichi; Kojima, Chojiro			H-1, N-15 and C-13 resonance assignments of the conserved region in the middle domain of S-pombe Sin1 protein	BIOMOLECULAR NMR ASSIGNMENTS			English	Article						Sin1; CRIM domain; TOR complex 2; Binding domain; Kinase	RICTOR-MTOR COMPLEX; CHEMICAL-SHIFTS; AGC KINASES; NMR DATA; YEAST; PHOSPHORYLATION; TARGETS	SAPK-interacting protein 1 (Sin1) is an important component of the target of rapamycin (TOR) complex 2 (TORC2). TOR is a serine/threonine-specific protein kinase and forms functionally distinct protein complexes referred to as TORC1 and TORC2. TORC2, conserved from yeast to humans, phosphorylates AGC-family protein kinases and has many cellular functions including the regulation of actin cytoskeleton. The Sin1 subunit of TORC2 is required for the binding of TORC2 to substrates, and the conserved region in the middle (CRIM) domain of Sin1 is important in the substrate recognition of TORC2. Here, we report on the H-1, C-13 and N-15 resonance assignments of fission yeast Schizosaccharomyces pombe Sin1 (amino acids 247-400) (Sin1(CRIM)), which possesses the CRIM domain. These data contribute toward the structure determination of Sin1(CRIM) and an understanding of the interactions of Sin1(CRIM) with substrates of TORC2.	[Kataoka, Saori; Furuita, Kyoko; Hattori, Yoshikazu; Kobayashi, Naohiro; Ikegami, Takahisa; Fujiwara, Toshimichi; Kojima, Chojiro] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Shiozaki, Kazuhiro] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	Furuita, K (reprint author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	k-furuit@protein.osaka-u.ac.jp; kojima@protein.osaka-u.ac.jp			MEXT/JSPS KAKENHI; TPRP; Platform for Drug Discovery, Informatics, and Structural Life Science	We thank Yuki Nishigaya for the mass spectrometry, and Izuru Ohki, Shinichi Murayama and Hisashi Tatebe for helpful comments. This work was supported in part by grants from MEXT/JSPS KAKENHI, TPRP, Platform for Drug Discovery, Informatics, and Structural Life Science to K.S., T.F. and C.K., and Grants-in-Aid for JSPS Fellows to S.K. and K.F.	Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Cameron AJM, 2011, BIOCHEM J, V439, P287, DOI 10.1042/BJ20110678; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Hayashi K, 2008, PROTEIN EXPRES PURIF, V62, P120, DOI 10.1016/j.pep.2008.07.007; Rovnyak D, 2004, J MAGN RESON, V170, P15, DOI 10.1016/j.jmr.2004.05.016; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Ikeda K, 2008, CELL CYCLE, V7, P358; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Pan DQ, 2012, ACTA CRYSTALLOGR F, V68, P386, DOI 10.1107/S1744309112007178; Goddard T. D., 2008, SPARKY 3; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Schroder W, 2004, GENE, V339, P17, DOI 10.1016/j.gene.2004.07.001	23	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1874-2718	1874-270X		BIOMOL NMR ASSIGN	Biomol. NMR Assign.	APR	2015	9	1					89	92		10.1007/s12104-014-9550-6		4	Biophysics; Spectroscopy	Biophysics; Spectroscopy	CD2HW	WOS:000350898000017		
J	Korste, A; Wulfhorst, H; Ikegami, T; Nowaczyk, MM; Stoll, R				Korste, Annika; Wulfhorst, Hannes; Ikegami, Takahisa; Nowaczyk, Marc M.; Stoll, Raphael			H-1, C-13 and N-15 chemical shift assignments of the NDH-1 complex subunit CupS	BIOMOLECULAR NMR ASSIGNMENTS			English	Article						Cyanobacteria; CupS; NDH-1 complex; NMR assignments	THERMOSYNECHOCOCCUS-ELONGATUS	The cyanobacterial NDH-1 complex is involved in respiratory as well as in cyclic electron transfer around photosystem I. Here, we report both backbone and side chain chemical shift assignments of CupS, a small subunit of the multisubunit membrane protein complex NDH-1 from Thermosynechococcus elongatus. The construct contains 159 amino acids including a Strep-tag and two additional amino acids.	[Korste, Annika; Stoll, Raphael] Ruhr Univ Bochum, Fac Chem & Biochem, Biomol NMR, Bochum, Germany; [Wulfhorst, Hannes; Nowaczyk, Marc M.] Ruhr Univ Bochum, Fac Biol, Plant Biochem, Bochum, Germany; [Ikegami, Takahisa] Osaka Univ, Inst Prot Res, Osaka, Japan	Stoll, R (reprint author), Ruhr Univ Bochum, Fac Chem & Biochem, Biomol NMR, Univ Str 150, Bochum, Germany.	marc.m.nowaczyk@rub.de; raphael.stoll@ruhr-uni-bochum.de	Nowaczyk, Marc/D-4214-2014	Nowaczyk, Marc/0000-0002-9269-0672	RUB Research School; Deutsche Forschungsgemeinschaft	Part of this work was performed under the Cooperative Research Program of Institute for Protein Research, Osaka Univ. with a lot of help from members of Prof Genji Kurisu's group at IPR. This work was supported by the RUB Research School (H.W.) and by a grant of the Deutsche Forschungsgemeinschaft (H.W. and M.M.N).	Nowaczyk MM, 2011, BIOCHEMISTRY-US, V50, P1121, DOI 10.1021/bi102044b; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Folea IM, 2008, FEBS LETT, V582, P249, DOI 10.1016/j.febslet.2007.12.012; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Battchikova N, 2011, J BIOL CHEM, V286, P36992, DOI 10.1074/jbc.M111.263780; Arteni AA, 2006, BBA-BIOENERGETICS, V1757, P1469, DOI 10.1016/j.bbabio.2006.05.042	7	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1874-2718	1874-270X		BIOMOL NMR ASSIGN	Biomol. NMR Assign.	APR	2015	9	1					169	171		10.1007/s12104-014-9567-x		3	Biophysics; Spectroscopy	Biophysics; Spectroscopy	CD2HW	WOS:000350898000034		
J	Harada, E; Sugishima, M; Harada, J; Noguchi, M; Fukuyama, K; Sugase, K				Harada, Erisa; Sugishima, Masakazu; Harada, Jiro; Noguchi, Masato; Fukuyama, Keiichi; Sugase, Kenji			Backbone assignments of the apo and Zn(II) protoporphyrin IX-bound states of the soluble form of rat heme oxygenase-1	BIOMOLECULAR NMR ASSIGNMENTS			English	Article						Heme oxygenase; NMR resonance assignments; Cellular homeostasis; Heme protein	CRYSTAL-STRUCTURE; COMPLEX; SUBSTRATE	In nature, heme is a prosthetic group that is universally used as a cofactor for heme proteins. It is necessary for the execution of fundamental biological processes including electron transfer, oxidation and metabolism. However, free heme is toxic to cells, because of its capability to enhance oxidative stress, hence its cellular concentration is strictly regulated through multiple mechanisms. Heme oxygenase (HO) serves as an irreplaceable member in the heme degradation system. It is a ubiquitous protein, existing in many species including mammals, higher plants, and interestingly, certain pathogenic bacteria. In the HO reaction, HO catalyzes oxidative cleavage of heme to generate biliverdin and release carbon monoxide and ferrous iron. Because of the beneficial effects of these heme catabolism products, HO plays a key role in iron homeostasis and in defense mechanism against oxidative stress. HO is composed of an N-terminal structured region and a C-terminal membrane-bound region. Furthermore, the soluble form of HO, which is obtainable by excision of the membrane-bound region, retains its catalytic activity. Here, we present the backbone resonance assignments of the soluble form (residues 1-232) of HO-1 in the free and Zn(II) protoporphyrin IX (ZnPP)-bound states, and analyzed the structural differences between the states. ZnPP is a potent enzyme inhibitor, and the ZnPP-bound structure of HO-1 mimics the heme-bound structure. These assignments provide the structural basis for a detailed investigation of the HO-1 function.	[Harada, Erisa; Sugase, Kenji] Suntory Fdn Life Sci, Bioorgan Res Inst, Mishima, Osaka 6188503, Japan; [Sugishima, Masakazu; Harada, Jiro; Noguchi, Masato] Kurume Univ, Sch Med, Kurume, Fukuoka 8300011, Japan; [Fukuyama, Keiichi] Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan	Sugase, K (reprint author), Suntory Fdn Life Sci, Bioorgan Res Inst, 1-1-1 Wakayamadai, Mishima, Osaka 6188503, Japan.	sugase@sunbor.or.jp	Sugishima, Masakazu/B-1049-2010	Sugishima, Masakazu/0000-0002-0840-4929	Ministry of Education, Culture, Sports and Technology of Japan	We thank Naohiro Kobayashi for assistance in NMR chemical shift assignments. This work was supported by Grants-in-Aid for Scientific Research for KS, MS, JH, MN, and KF from the Ministry of Education, Culture, Sports and Technology of Japan.	Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Li YM, 2004, J BIOL CHEM, V279, P10195, DOI 10.1074/jbc.M308379200; Li YM, 2002, J BIOL CHEM, V277, P33018, DOI 10.1074/jbc.M204216200; Omata Y, 1998, ACTA CRYSTALLOGR D, V54, P1017, DOI 10.1107/S0907444998003448; Sugishima M, 2000, FEBS LETT, V471, P61, DOI 10.1016/S0014-5793(00)01353-3; Sugishima M, 2002, BIOCHEMISTRY-US, V41, P7293, DOI 10.1021/bi025662a	10	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1874-2718	1874-270X		BIOMOL NMR ASSIGN	Biomol. NMR Assign.	APR	2015	9	1					197	200		10.1007/s12104-014-9573-z		4	Biophysics; Spectroscopy	Biophysics; Spectroscopy	CD2HW	WOS:000350898000040		
J	Takeuchi, K; Sun, ZYJ; Li, S; Gal, M; Wagner, G				Takeuchi, Koh; Sun, Zhen-Yu J.; Li, Shuai; Gal, Maayan; Wagner, Gerhard			NMR resonance assignments of the catalytic domain of human serine/threonine phosphatase calcineurin in unligated and PVIVIT-peptide-bound states	BIOMOLECULAR NMR ASSIGNMENTS			English	Article						Calcineurin; Phosphatase; NFAT; T-cell	LARGE PROTEINS; NFAT; COMPLEX; ACTIVATION; TROSY	Calcineurin (Cn) is a serine/threonine phosphatase that plays pivotal roles in many physiological processes. In T cell, Cn targets the nuclear factors of activated T-cell (NFATs), transcription factors that activate cytokine genes. Elevated intracellular calclium concentration activates Cn to dephosphorylate multiple serine residues within the NFAT regulatory domain, which triggers joint nuclear translocation of NFAT and Cn. This relies on the interaction between the catalytic domain of Cn (CnA) and the conserved PxIxIT motif. Here, we present the assignment of CnA resonances in unligated form and in complex with a 14-residue peptide containing a PVIVIT sequence that was derived from affinity driven peptide selection based on the conserved PxIxIT motif of NFATs. Although a complete assignment was not possible mainly due to the paramagnetic line broadening induced by an iron in the CnA catalytic center, the assignment was extensively verified by amino-acid selective labeling of Arg, Leu, Lys, and Val, which cover one third of the CnA residues. Nevertheless, the assignments were used to determine the structure of the CnA-PVIVIT peptide complex and provide the basis for investigation of the interactions of CnA with physiological interaction partners and small organic compounds that disrupt the Cn-NFAT interaction.	[Takeuchi, Koh; Sun, Zhen-Yu J.; Li, Shuai; Gal, Maayan; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biochem & Mol Pharmacol, Boston, MA 02115 USA; [Takeuchi, Koh] Natl Inst Adv Ind Sci & Technol, Biomedicinal Informat Res Ctr, Koto Ku, Tokyo 135006, Japan; [Takeuchi, Koh] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo 135006, Japan; [Gal, Maayan] Migal Res Ctr, IL-11016 Kiryat Shmona, Israel	Wagner, G (reprint author), Harvard Univ, Sch Med, Dept Biochem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	koh-takeuchi@aist.go.jp; gerhard_wagner@hms.harvard.edu			NIH [AI37581, GM047467, EB002026]	This work was supported by a grant from the NIH (Grant AI37581). Purchase, maintenance and operation of the instruments used here were supported by NIH Grants GM047467 and EB002026.	GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Aramburu J, 2004, EMBO REP, V5, P343, DOI 10.1038/sj.embor.7400133; Takeuchi K, 2007, J BIOMOL NMR, V38, P89, DOI 10.1007/s10858-007-9152-z; Gal M, 2014, STRUCTURE, V22, P1016, DOI 10.1016/j.str.2014.05.006; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Mondragon A, 1997, BIOCHEMISTRY-US, V36, P4934, DOI 10.1021/bi9631935; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Rusnak F, 2000, PHYSIOL REV, V80, P1483; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Li HM, 2007, J MOL BIOL, V369, P1296, DOI 10.1016/j.jmb.2007.04.032; Takeuchi K, 2007, STRUCTURE, V15, P587, DOI 10.1016/j.str.2007.03.015; Roehrl MHA, 2004, P NATL ACAD SCI USA, V101, P7554, DOI 10.1073/pnas.0401835101; Aramburu J, 2000, CURR TOP CELL REGUL, V36, P237; Frueh DP, 2006, J AM CHEM SOC, V128, P5757, DOI 10.1021/ja0584222; Goddard TD, 2006, SPARKY 3 NMR ASSIGNM; Hemenway Charles S., 1999, Cell Biochemistry and Biophysics, V30, P115, DOI 10.1007/BF02737887; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Hogan PG, 2005, CURR BIOL, V15, pR442, DOI 10.1016/j.cub.2005.06.006; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16067, DOI 10.1021/bi048232o	25	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1874-2718	1874-270X		BIOMOL NMR ASSIGN	Biomol. NMR Assign.	APR	2015	9	1					201	205		10.1007/s12104-014-9574-y		5	Biophysics; Spectroscopy	Biophysics; Spectroscopy	CD2HW	WOS:000350898000041		
J	Miyazawa, K; Inoue, S; Nakazawa, Y; Nakai, D; Morita, N; Suzuki, K				Miyazawa, K.; Inoue, S.; Nakazawa, Y.; Nakai, D.; Morita, N.; Suzuki, K.			Role of protease-activated receptors for calcium oxalate stone formation in renal tubular epithelial cells	BJU INTERNATIONAL			English	Meeting Abstract	68th Annual Scientific Meeting of the Urological-Society-of-Australia-and-New Zealand	APR 11-14, 2015	Adelaide, AUSTRALIA	Urol Soc Australia & New Zealand					[Miyazawa, K.; Inoue, S.; Nakazawa, Y.; Nakai, D.; Morita, N.; Suzuki, K.] Kanazawa Med Univ, Dept Urol, Uchinada, Ishikawa 92002, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1464-4096	1464-410X		BJU INT	BJU Int.	APR	2015	115			4	SI	77	40	40				1	Urology & Nephrology	Urology & Nephrology	CD9CQ	WOS:000351395100078		
J	Takahashi, H; Yoshika, M; Yokoi, T				Takahashi, Hakuo; Yoshika, Masamichi; Yokoi, Toyohiko			Validation of three automatic devices for the self-measurement of blood pressure according to the European Society of Hypertension International Protocol revision 2010: the Omron HEM-7130, HEM-7320F, and HEM-7500F	BLOOD PRESSURE MONITORING			English	Article						blood pressure measurement; device; European Society of Hypertension International Protocol revision 2010; guideline	MASKED HYPERTENSION; WHITE-COAT; ADULTS	Objective The aim of the present study was to validate the Omron HEM-7130, HEM-7320F, and HEM-7500F for monitoring upper arm blood pressure (BP) according to the European Society of Hypertension International Protocol revision 2010 (ESH-IP revision 2010). Methods Three trained medical doctors validated the performance of these devices by comparing the data obtained from the devices with those of a standard mercury sphygmomanometer. We included 33 participants (20 men and 13 women for the HEM-7130 experiment; 18 men and 15 women for the HEM-7320F experiment; and 21 men and 12 women for the HEM-7500F experiment). The mean age of the participants was 49 +/- 15, 50 +/- 11, and 50 +/- 11 years in the respective studies. Results The mean differences between the device and the mercury readings for systolic and diastolic BP were as follows: HEM-7130, - 1.8 +/- 5.3 and - 0.1 +/- 4.0 mmHg, respectively; HEM-7320F, - 0.9 +/- 4.7 and - 1.9 +/- 4.4 mmHg, respectively; and HEM-7500F, - 1.0 +/- 4.6 and - 1.1 +/- 4.0 mmHg, respectively. These findings indicated that the device was reading lower than the mercury. However, the number of absolute differences between the devices and observers fulfilled the requirement of the ESH-IP revision 2010. Conclusion The Omron HEM-7130, HEM-7320F, and HEM-7500F passed all the requirements of the ESH-IP 2010 revision. Therefore, we recommend these devices for the home measurement of BP in adults. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Takahashi, Hakuo; Yoshika, Masamichi; Yokoi, Toyohiko] Kansai Med Univ, Dept Clin Sci & Lab Med, Hirakata, Osaka 5731010, Japan	Takahashi, H (reprint author), Kansai Med Univ, Dept Clin Sci & Lab Med, Shin Machi 2-5-1, Hirakata, Osaka 5731010, Japan.	takahash@hirakata.kmu.ac.jp			Kansai Medical University	This research received no special grant from any funding agency by public, commercial, or not-for-profit organizations, but was supported by the Kansai Medical University.	O'Brien E, 2010, BLOOD PRESS MONIT, V15, P23, DOI 10.1097/MBP.0b013e3283360e98; Stergiou GS, 2014, HYPERTENSION, V63, P675, DOI 10.1161/HYPERTENSIONAHA.113.02741; Chockalingam A, 2008, CAN J CARDIOL, V24, P441; Grassi G, 2012, CURR HYPERTENS REP, V14, P333, DOI 10.1007/s11906-012-0273-8; de la Sierra A, 2013, HYPERTENSION, V62, P16, DOI 10.1161/HYPERTENSIONAHA.113.01565; Dasgupta K, 2014, CAN J CARDIOL, V30, P485, DOI 10.1016/j.cjca.2014.02.002; Fukuhara M, 2013, STROKE, V44, P1512, DOI 10.1161/STROKEAHA.111.000704; O'Brien E, 2002, BLOOD PRESS MONIT, V7, P3, DOI 10.1097/00126097-200202000-00002; Takahashi H, 2011, HYPERTENS RES, V34, P1147, DOI 10.1038/hr.2011.105; Association for the Advancement of Medical Instrumentation, 2009, AM NAT STAND NON S 2, P81060; Bobrie G, 2007, AM J HYPERTENS, V20, P1314, DOI 10.1016/j.amjhyper.2007.08.011; Imai Y, 2014, CLIN EXP NEPHROL, V18, P24, DOI 10.1007/s10157-013-0831-7; Mourad JJ, 2013, AM J HYPERTENS, V26, P1205, DOI 10.1093/ajh/hpt084	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1359-5237	1473-5725		BLOOD PRESS MONIT	Blood Press. Monit.	APR	2015	20	2					92	97		10.1097/MBP.0000000000000096		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CD2GW	WOS:000350894300007		
J	Tago, A; Ikeda, M				Tago, Atsushi; Ikeda, Maki			An 'A' for Effort: Experimental Evidence on UN Security Council Engagement and Support for US Military Action in Japan	BRITISH JOURNAL OF POLITICAL SCIENCE			English	Article							INTERNATIONAL INSTITUTIONS; DOMESTIC POLITICS; LEGITIMACY; FORCE; LOGIC	Existing research emphasizes how United Nations Security Council (UNSC) approval helps convey information to domestic audiences that military action is conducted with good intentions, for desirable consequences and in a legitimate manner. This information transmission mechanism can also increase support for UNSC-endorsed military action in countries unlikely to provide major contributions to military actions. There is some cross-national evidence supporting the information transmission mechanism in the United States. Examining the causal mechanisms underlying foreign public support for US military action through a survey experiment with approximately 2,000 respondents in Japan shows that foreign public support varies depending on whether the military action has UNSC approval. The process of presenting draft resolutions to the UNSC also affects public support.	[Tago, Atsushi] Kobe Univ, Grad Sch Law, Kobe, Hyogo, Japan; [Ikeda, Maki] Univ Tokyo, Grad Sch Humanities & Sociol, Tokyo 1138654, Japan	Tago, A (reprint author), Kobe Univ, Grad Sch Law, Kobe, Hyogo, Japan.	tago@dragon.kobe-u.ac.jp			JSPS KAKENHI [24683004]; Nomura Foundation; Suntory Foundation	The authors wish to thank Erik Gartzke, Kristian Skrede Gleditsch, Takeshi Iida, Yukiko Muramoto, Steve Pickering and participants of the Workshop on the Frontiers of Statistical Analysis and Formal Theory of Political Science 2013 (Gakushuin University) and the Kobe Sakura Meeting 2013 (Kobe University) for their comments and suggestions for this project. They are also grateful to the editor and reviewers of the Journal whose careful readings have greatly improved this article. This study is supported by the JSPS KAKENHI Grant Number: 24683004, Nomura Foundation and Suntory Foundation. Data replication materials and online appendices are available at http://dx.doi.org/doi: 10.1017/S0007123413000343. This study has been screened and approved by the institutional review board of the Department of Social Psychology, Graduate School of Humanities and Sociology, University of Tokyo.	Thompson A, 2006, INT ORGAN, V60, P1, DOI 10.1017/S0020818306060012; Barabas J, 2010, AM POLIT SCI REV, V104, P226, DOI 10.1017/S0003055410000092; Voeten E, 2005, INT ORGAN, V59, P527, DOI 10.1017/S0020818305050198; Voeten E, 2001, AM POLIT SCI REV, V95, P845, DOI 10.1017/S000305540101005X; BERGER TU, 1993, INT SECURITY, V17, P119, DOI 10.2307/2539024; CLAUDE IL, 1966, INT ORGAN, V20, P367; Chapman Terrence L., 2011, SECURING APPROVAL DO; Chapman TL, 2007, J CONFLICT RESOLUT, V51, P134, DOI 10.1177/0022002706296177; Fang SY, 2008, AM J POLIT SCI, V52, P304, DOI 10.1111/j.1540-5907.2007.00314.x; Finnemore Martha, 2003, THE PURPOSE OF INTER; Grieco JM, 2011, INT STUD QUART, V55, P563, DOI 10.1111/j.1468-2478.2011.00660.x; Horiuchi Y, 2007, AM J POLIT SCI, V51, P669, DOI 10.1111/j.1540-5907.2007.00274.x; Hurd I, 2007, AFTER ANARCHY: LEGITIMACY AND POWER IN THE UNITED NATIONS SECURITY COUNCIL, P1; Ikeda Maki, 2013, PAPER PRESENTED AT T; Johansson Patrik, 2003, UN SECURITY COUNCIL; JOHANSSON PATRIK, 2009, NORDIC J INT LAW, V78, P309; Norris Pippa, 2009, THE INTERNATIONAL SY, P17; Tago A, 2007, INT RELAT ASIA-PAC, V7, P179, DOI 10.1093/irap/lcl001; Tago A, 2005, J PEACE RES, V42, P585, DOI 10.1177/0022343305056235; Thompson Alexander, 2009, CHANNELS OF POWER TH	20	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0007-1234	1469-2112		BRIT J POLIT SCI	Br. J. Polit. Sci.	APR	2015	45	2					391	410		10.1017/S0007123413000343		20	Political Science	Government & Law	CD1CE	WOS:000350810600007		
J	Wali, A; Kawachi, A; Bougi, MSM; Ben Dhia, H; Isoda, H; Tsujimura, M; Ksibi, M				Wali, Ahmed; Kawachi, Atsushi; Bougi, Mohamed Seddik Mahmoud; Ben Dhia, Hamed; Isoda, Hiroko; Tsujimura, Maki; Ksibi, Mohamed			Effects of Metal Pollution on Sediments in a Highly Saline Aquatic Ecosystem: Case of the Moknine Continental Sebkha (Eastern Tunisia)	BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY			English	Article						Sebkha of Moknine; Sediment degradation; Heavy metals; Anthropogenic origin		Potential contamination of the sediments in the Sebkha of Moknine (Tunisia) ecosystem was assessed by means of enrichment factors (EFs) estimated against reference sediment located a parts per thousand 70 km away from the Sebkha. The use of EFs is recommended as a reliable method for heavy metal contamination assessment, provided that (1) element contents are corrected following a careful normalization procedure, and (2) the reference sediment is unaffected by anthropogenic alterations. The degree of contamination was assessed by the modified contamination degree approach. The obtained results indicated that surface sediments were enriched up to 22.9, 13.2, 5.46 and 3.19 times with Pb, Cu, Cr and Zn, respectively. Lower enrichment factors for Ni and Co suggested that anthropogenic sources were less important for these metals. The modified degree of contamination showed that the sediments in the Sebkha of Moknine have suffered significant systematic heavy metal contamination following catchment urbanization and industrialization .	[Wali, Ahmed; Bougi, Mohamed Seddik Mahmoud; Ben Dhia, Hamed; Ksibi, Mohamed] Univ Sfax, Natl Sch Engn Sfax ENIS, Lab Water Energy & Environm, Sfax 3038, Tunisia; [Kawachi, Atsushi; Isoda, Hiroko; Tsujimura, Maki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Ksibi, M (reprint author), Univ Sfax, Natl Sch Engn Sfax ENIS, Lab Water Energy & Environm, Route Soukra Km 3,5,POB 1173, Sfax 3038, Tunisia.	mohamed.ksibi@isbs.rnu.tn			JST/JICA, SATREPS project	This research was partially supported by the JST/JICA, SATREPS project.	Amisah S., 2009, International Journal of Fisheries and Aquaculture, V1, P14; Morillo J, 2007, J COASTAL RES, V23, P352, DOI 10.2112/04-0246.1; Pekey H, 2006, ENVIRON MONIT ASSESS, V123, P219, DOI 10.1007/s10661-006-9192-y; [Anonymous], 1993, 31109 NF X; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Naji A, 2010, MICROCHEM J, V95, P285, DOI 10.1016/j.microc.2009.12.015; Sekabira K, 2010, INT J ENVIRON SCI TE, V7, P435, DOI 10.1007/BF03326153; Liu WH, 2005, ENVIRON INT, V31, P805, DOI 10.1016/j.envint.2005.05.042; BOYLE M, 1987, J ENVIRON QUAL, V16, P357; Chairi R, 2010, ORG GEOCHEM, V41, P637, DOI 10.1016/j.orggeochem.2010.04.006; Norville W, 2005, REV BIOL TROP, V53, P33; OMAFRA, 1998, SOIL FERT HDB; Pereira R, 2008, SCI TOTAL ENVIRON, V390, P377, DOI 10.1016/j.scitotenv.2007.08.051; Rayment GE, 2002, AUSTR HDB SOIL WATER; Tagina S, 1999, HOUILLE BLANCHE, V54, P114; United States Salinity Laboratory Staff, 1954, US DEP AGR HDB, V60, P57; Visco G, 2005, MICROCHEM J, V79, P185, DOI 10.1016/j.microc.2004.10.018; Wali A, 2013, ENV RES ENG MANG, V3, P20; Zoller WH, 1974, SCIENCE, V183, P199	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4861	1432-0800		B ENVIRON CONTAM TOX	Bull. Environ. Contam. Toxicol.	APR	2015	94	4					511	518		10.1007/s00128-015-1469-9		8	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CD2AD	WOS:000350874900018		
J	Li, FY; Zhang, Y; Fan, ZP; Oh, K				Li, Fayun; Zhang, Ying; Fan, Zhiping; Oh, Kokyo			Accumulation of De-icing Salts and Its Short-Term Effect on Metal Mobility in Urban Roadside Soils	BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY			English	Article						Heavy metal mobility; Roadside soils; De-icing salts; Cadmium; Lead; Northeastern China	CHLORIDE; MOBILIZATION; ENVIRONMENT; TRANSPORT; CHEMICALS; HIGHWAY; DEICERS; IMPACT	In this study, a field investigation combined with a laboratory column leaching experiment were carried out to assess the effects of de-icing salts application on the heavy metal mobilization in roadside soils in an old and large industrial zone in Northeastern China. In the field investigation, 41 roadside soils were collected from the industrial zone, and the results showed a strong rise in deicing salts related concentrations of Na (352-513 mg/kg) and Cl (577-2,353 mg/kg) and high values of Cd (1.2-7.6 mg/kg) and Pb (28.7-101.6 mg/kg). The most serious contaminated roadside soil was used for column leaching experiment alternately with de-icing salts solution and deionized water to simulate the runoff of de-icing salts into roadside soils followed by snowmelt or rainwater. The results showed that an extensive mobilization of Cd (20.90 % of the total Cd in the soil) occurred in the salt leachate, and a high correlation with Cl were found, indicating that Cl complexes are important for the mobilization. Conversely, only 2.34 % of the total amount of Pb in the soil was leached, confirming the usual hypotheses about the high immobility of Pb in soils. However, it was found that high Pb concentration coincided with peaks in Fe and TOC concentrations, and the proportion of Pb in the > 0.45 A mu m phase was much low, which implied an extensive Pb mobilization with small-sized colloids.	[Li, Fayun; Fan, Zhiping] Liaoning Shihua Univ, Inst Ecoenvironm Sci, Fushun 113001, Peoples R China; [Li, Fayun; Zhang, Ying] Hunan Agr Univ, Sch Resources & Environm Sci, Changsha 410128, Hunan, Peoples R China; [Zhang, Ying] Liaoning Univ, Sch Environm Sci, Shenyang 110036, Peoples R China; [Oh, Kokyo] Ctr Environm Sci Saitama, Kisai, Saitama 3470115, Japan	Li, FY (reprint author), Liaoning Shihua Univ, Inst Ecoenvironm Sci, Fushun 113001, Peoples R China.	lifayun15@hotmail.com			National Natural Science Foundation of China [41071317]; National Key Technology Project of Water Contamination Controlling and Management of China [2012ZX07505-001]; Natural Science Foundation of Liaoning Province [20092013]; "211" Projects Foundation of Liaoning University [HJ211001]; Natural Science Foundation of Liaoning University [2012LDQN12]	The work in this paper was jointly supported by the National Natural Science Foundation of China (No. 41071317), National Key Technology Project of Water Contamination Controlling and Management of China (No. 2012ZX07505-001), Natural Science Foundation of Liaoning Province (No. 20092013), "211" Projects Foundation of Liaoning University (No. HJ211001), and Natural Science Foundation of Liaoning University (No. 2012LDQN12).	Allert AL, 2012, B ENVIRON CONTAM TOX, V89, P296, DOI 10.1007/s00128-012-0673-0; AMRHEIN C, 1992, ENVIRON SCI TECHNOL, V26, P703, DOI 10.1021/es00028a006; Lundmark A, 2007, WATER AIR SOIL POLL, V182, P173, DOI 10.1007/s11270-006-9330-8; Norrstrom AC, 2005, APPL GEOCHEM, V20, P1907, DOI 10.1016/j.apgeochem.2005.06.002; Grolimund D, 2005, ENVIRON SCI TECHNOL, V39, P6378, DOI 10.1021/es050207y; Linde M, 2007, WATER AIR SOIL POLL, V183, P69, DOI 10.1007/s11270-007-9357-5; Nelson SS, 2009, J ENVIRON ENG-ASCE, V135, P505, DOI 10.1061/(ASCE)0733-9372(2009)135:7(505); Findlay SEG, 2011, ANN NY ACAD SCI, V1223, P58, DOI 10.1111/j.1749-6632.2010.05942.x; Norrstrom AC, 2001, WATER AIR SOIL POLL, V127, P281, DOI 10.1023/A:1005221314856; Ramakrishna DM, 2005, WATER AIR SOIL POLL, V166, P49, DOI 10.1007/s11270-005-8265-9; Backstrom M, 2004, WATER RES, V38, P720, DOI 10.1016/j.watres.2003.11.006; Tang XY, 2009, ENVIRON POLLUT, V157, P2266, DOI 10.1016/j.envpol.2009.03.034; BAUSKE B, 1993, ACTA HYDROCH HYDROB, V21, P38, DOI 10.1002/aheh.19930210106; Czerniawska-Kusza I, 2004, ENVIRON TOXICOL, V19, P296, DOI 10.1002/tox.20037; French HK, 2014, ENVIRON SCI POLLUT R, V21, P8897, DOI 10.1007/s11356-013-2284-7; Kakuturu S, 2012, WORLD ENV WAT RES C, P411; Kim SY, 2013, BIOGEOCHEMISTRY, V112, P343, DOI 10.1007/s10533-012-9728-x; Li F, 2008, ENVIRON GEOL, V57, P1815, DOI 10.1007/s00254-008-1469-8; Luo Xuemei CX, 2003, ENV PROT SCI, V29, P43; Mills GE, 2002, COMMUN SOIL SCI PLAN, V33, P67; Rasa K, 2006, SCI TOTAL ENVIRON, V366, P819, DOI 10.1016/j.scitotenv.2005.08.007; Um W, 2002, ENVIRON GEOL, V43, P209, DOI 10.1007/s00254-002-0646-4; Wahlstrom M, 1996, SCI TOTAL ENVIRON, V178, P95, DOI 10.1016/0048-9697(95)04801-4; [王金达 Wang Jinda], 2003, [中国环境科学, China Environmental Science], V23, P300; Yan Xia, 2008, Shengtaixue Zazhi, V27, P2209; [张营 Zhang Ying], 2012, [生态学报, Acta Ecologica Sinica], V32, P4300	26	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0007-4861	1432-0800		B ENVIRON CONTAM TOX	Bull. Environ. Contam. Toxicol.	APR	2015	94	4					525	531		10.1007/s00128-015-1481-0		7	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CD2AD	WOS:000350874900020		
J	Yamada, S; Tatsumoto, N; Tokumoto, M; Noguchi, H; Ooboshi, H; Kitazono, T; Tsuruya, K				Yamada, S.; Tatsumoto, N.; Tokumoto, M.; Noguchi, H.; Ooboshi, H.; Kitazono, T.; Tsuruya, K.			Phosphate Binders Prevent Phosphate-Induced Cellular Senescence of Vascular Smooth Muscle Cells and Vascular Calcification in a Modified, Adenine-Based Uremic Rat Model	CALCIFIED TISSUE INTERNATIONAL			English	Article						Calcium carbonate; Cellular senescence; Chronic kidney disease; Phosphate; Phosphate binder; Vascular smooth muscle cell; Vascular calcification	CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; ARTERIAL MEDIAL CALCIFICATION; LANTHANUM CARBONATE; ANIMAL-MODEL; HEMODIALYSIS-PATIENTS; CALCIUM-CARBONATE; OXIDATIVE STRESS; SEVELAMER; HYPERPHOSPHATEMIA	Clinical and experimental studies have reported that phosphate overload plays a central role in the pathogenesis of vascular calcification in chronic kidney disease. However, it remains undetermined whether phosphate induces cellular senescence during vascular calcification. We established a modified uremic rat model induced by a diet containing 0.3 % adenine that showed more slowly progressive kidney failure, more robust vascular calcification, and longer survival than the conventional model (0.75 % adenine). To determine the effect of phosphate on senescence of vascular smooth muscle cells (VSMCs) and the protective effect of phosphate binders, rats were divided into four groups: (1) normal control rats; (2) rats fed with the modified adenine-based diet (CKD); (3) CKD rats treated with 6 % lanthanum carbonate (CKD-LaC); and (4) CKD rats treated with 6 % calcium carbonate (CKD-CaC). After 8 weeks, CKD rats showed circumferential arterial medial calcification, which was inhibited in CKD-LaC and CKD-CaC rats. CKD rats showed increased protein expression of senescence-associated beta-galactosidase, bone-related proteins, p16 and p21, and increased oxidative stress levels in the calcified area, which were inhibited by both phosphate binders. However, serum levels of oxidative stress and inflammatory markers, serum fibroblast growth factor 23, and aortic calcium content in CKD-CaC rats were higher than those in CKD-LaC rats. In conclusion, phosphate induces cellular senescence of VSMCs in the modified uremic rat model, and phosphate binders can prevent both cellular senescence and calcification of VSMCs via phosphate unloading. Our modified adenine-based uremic rat model is useful for evaluating uremia-related complications, including vascular calcification.	[Yamada, S.; Tatsumoto, N.; Noguchi, H.; Kitazono, T.; Tsuruya, K.] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan; [Yamada, S.; Tokumoto, M.; Ooboshi, H.] Fukuoka Dent Coll, Dept Internal Med, Fukuoka 8140193, Japan; [Tsuruya, K.] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Higashi Ku, Fukuoka 8128582, Japan	Tsuruya, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	tsuruya@intmed2.med.kyusyu-u.ac.jp					Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Qunibi W, 2008, AM J KIDNEY DIS, V51, P952, DOI 10.1053/j.ajkd.2008.02.298; Neven E, 2009, NEPHROL DIAL TRANSPL, V24, P1790, DOI 10.1093/ndt/gfn737; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Pazar B, 2011, J IMMUNOL, V186, P2495, DOI 10.4049/jimmunol.1001284; Zhao GX, 2012, KIDNEY INT, V82, P34, DOI 10.1038/ki.2012.40; Jimbo R, 2014, KIDNEY INT, V85, P1103, DOI 10.1038/ki.2013.332; Yang HC, 2010, J AM SOC NEPHROL, V21, P1436, DOI 10.1681/ASN.2010020205; Burton DGA, 2010, EXP GERONTOL, V45, P819, DOI 10.1016/j.exger.2010.07.005; Burton DGA, 2009, EXP GERONTOL, V44, P659, DOI 10.1016/j.exger.2009.07.004; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Shobeiri N, 2010, AM J NEPHROL, V31, P471, DOI 10.1159/000299794; Kawata T, 2008, KIDNEY INT, V74, P1270, DOI 10.1038/ki.2008.407; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; Sun PP, 2009, KIDNEY INT, V76, pS20, DOI 10.1038/ki.2009.403; Nakano-Kurimoto R, 2009, AM J PHYSIOL-HEART C, V297, pH1673, DOI 10.1152/ajpheart.00455.2009; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; Vlassara H, 2012, CLIN J AM SOC NEPHRO, V7, P934, DOI 10.2215/CJN.12891211; Gruber HE, 2007, SPINE, V32, P321, DOI 10.1097/01.brs.0000253960.57051.de; Shroff RC, 2010, J AM SOC NEPHROL, V21, P103, DOI 10.1681/ASN.2009060640; YOKOZAWA T, 1986, NEPHRON, V44, P230, DOI 10.1159/000183992; Atkinson J, 2008, J APPL PHYSIOL, V105, P1643, DOI 10.1152/japplphysiol.90476.2008; Zhao MM, 2011, KIDNEY INT, V79, P1071, DOI 10.1038/ki.2011.18; Yamada S, 2012, J BONE MINER RES, V27, P474, DOI 10.1002/jbmr.539; Di Iorio B, 2012, CLIN J AM SOC NEPHRO, V7, P487, DOI 10.2215/CJN.03820411; Price PA, 2006, KIDNEY INT, V70, P1577, DOI 10.1038/sj.ki.5001841; Adijiang A, 2010, BIOCHEM BIOPH RES CO, V399, P637, DOI 10.1016/j.bbrc.2010.07.130; Takemura A, 2011, ARTERIOSCL THROM VAS, V31, P2054, DOI 10.1161/ATVBAHA.110.216739; Daugirdas JT, 2011, SEMIN DIALYSIS, V24, P41, DOI 10.1111/j.1525-139X.2011.00849.x; Hutchison AJ, 2005, NEPHRON CLIN PRACT, V100, pC8, DOI 10.1159/000084653; Moe SM, 2009, KIDNEY INT, V75, P176, DOI 10.1038/ki.2008.456; Tamagaki K, 2006, NEPHROL DIAL TRANSPL, V21, P651, DOI 10.1093/ndt/gfi273; Zhou RH, 2012, ARTERIOSCL THROM VAS, V32, P745, DOI 10.1161/ATVBAHA.111.243121; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Katsumata K, 2003, KIDNEY INT, V64, P441, DOI 10.1046/j.1523-1755.2003.00126.x; De Schutter TM, 2013, KIDNEY INT, V83, P1109, DOI 10.1038/ki.2013.34; Cozzolino M, 2003, KIDNEY INT, V64, P1653, DOI 10.1046/j.1523-1755.2003.00284.x; Hauser AB, 2010, BLOOD PURIFICAT, V30, P153, DOI 10.1159/000319850; Kooman JP, 2013, NEPHROL DIAL TRANSPL, V28, P48, DOI 10.1093/ndt/gfs451; Moe SM, 2014, J BONE MINER RES, V29, P902, DOI 10.1002/jbmr.2089; Shigematsu T, 2008, CLIN NEPHROL, V70, P404; Six I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093423; Takashima T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097859; Yu C, 2013, LIFE SCI, V93, P646, DOI 10.1016/j.lfs.2013.08.013	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-967X	1432-0827		CALCIFIED TISSUE INT	Calcif. Tissue Int.	APR	2015	96	4					347	358		10.1007/s00223-014-9929-5		12	Endocrinology & Metabolism	Endocrinology & Metabolism	CD6KS	WOS:000351198600009		
J	Fujimoto, K; Sugiyama, H; Yazaki, S				Fujimoto, Kazuto; Sugiyama, Hisashi; Yazaki, Satoshi			Use of triple ultra-high-pressure balloons for obstructed right ventricular outflow conduits in adults can be safe and effective	CARDIOLOGY IN THE YOUNG			English	Article						Balloon angioplasty; ventricular outflow obstruction; adult; congenital heart disease	PULMONARY-VALVE STENOSIS; VALVULOPLASTY; STENTS; IMPLANTATION; ANGIOPLASTY; TRACT	To date, no transcatheter valve has been approved for placement in the pulmonary position in Japan. Consequently, percutaneous balloon dilatation may be advised for stenotic right ventricular outflow lesions; however, technical difficulties persist, particularly in adults. We describe the acute haemodynamic changes and outcome of balloon dilatation of right ventricular outflow obstruction using triple ultra-high pressure balloons. This is the first report of such a technical development, which seems to be safe and effective. A total of three adult patients, aged 25, 29, and 37 years, with severe conduit obstruction were referred for balloon dilatation. A triple ultra-high-pressure balloon technique was used in the three patients after unsuccessful double-balloon dilatation, or for highly calcified lesions, which were expected to require ultra-high pressure for effective relief. Following balloon dilatation, the pressure gradient decreased from 24, 30, 65 to 3, 25, 30 mmHg, respectively. There were no procedural complications except slightly increased pulmonary regurgitation. Balloon dilatation using a triple ultra-high pressure balloon technique can be a safe and effective palliative procedure for conduit obstruction in adult patients.	[Fujimoto, Kazuto; Sugiyama, Hisashi; Yazaki, Satoshi] Natl Cerebral & Cardiovasc Ctr, Dept Pediat, Osaka, Japan	Fujimoto, K (reprint author), Showa Univ, Northern Yokohama Hosp, Ctr Cardiovasc, Tsuzuki Ku, 35-1 Chigasakichuo, Yokohama, Kanagawa 2248503, Japan.	kfkazuto@med.showa-u.ac.jp					McElhinney DB, 2010, CIRCULATION, V122, P507, DOI 10.1161/CIRCULATIONAHA.109.921692; ROCCHINI AP, 1984, J AM COLL CARDIOL, V3, P1005; Warnes CA, 2008, CIRCULATION, V118, pE714, DOI 10.1161/CIRCULATIONAHA.108.190690; Cazaniga M, 1987, REV LAT CARDIOL CIRU, V3, P59; Escalera RB, 2005, CATHETER CARDIO INTE, V66, P446, DOI 10.1002/ccd.20513; GAYLORD GM, 1988, RADIOLOGY, V166, P541; INO T, 1992, JPN CIRC J, V56, P535; KAN JS, 1982, NEW ENGL J MED, V307, P540, DOI 10.1056/NEJM198208263070907; Law MA, 2010, CATHETER CARDIO INTE, V75, P757, DOI 10.1002/ccd.22356; Maglione J, 2009, CIRC-CARDIOVASC INTE, V2, P52, DOI 10.1161/CIRCINTERVENTIONS.108.826263; Pedra CAC, 2006, CATHETER CARDIO INTE, V68, P193, DOI 10.1002/ccd.20838; PEPINE CJ, 1982, AM J CARDIOL, V50, P1442, DOI 10.1016/0002-9149(82)90491-X; POWELL AJ, 1995, CIRCULATION, V92, P3282; Sanatani S, 2001, PEDIATR CARDIOL, V22, P228, DOI 10.1007/s002460010209; Sugiyama H, 2005, HEART, V91, P1058, DOI 10.1136/hrt.2004.034819	15	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	1047-9511	1467-1107		CARDIOL YOUNG	Cardiol. Young	APR	2015	25	4					731	736		10.1017/S1047951114000821		6	Cardiac & Cardiovascular Systems; Pediatrics	Cardiovascular System & Cardiology; Pediatrics	CC8QG	WOS:000350632600018		
J	Sreedhar, R; Arumugam, S; Thandavarayan, RA; Giridharan, VV; Karuppagounder, V; Pitchaimani, V; Afrin, R; Miyashita, S; Nomoto, M; Harima, M; Gurusamy, N; Suzuki, K; Watanabe, K				Sreedhar, Remya; Arumugam, Somasundaram; Thandavarayan, Rajarajan A.; Giridharan, Vijayasree V.; Karuppagounder, Vengadeshprabhu; Pitchaimani, Vigneshwaran; Afrin, Rejina; Miyashita, Shizuka; Nomoto, Mayumi; Harima, Meilei; Gurusamy, Narasimman; Suzuki, Kenji; Watanabe, Kenichi			Myocardial 14-3-3 eta protein protects against mitochondria mediated apoptosis	CELLULAR SIGNALLING			English	Article						14-3-3 eta protein; Diabetes mellitus; Cardiomyocyte apoptosis; Cytochrome c; Apoptosis signal-regulating kinase-1; High fat diet	INDUCED DIABETES-MELLITUS; ERS-INITIATED APOPTOSIS; RETICULUM STRESS ERS; OXIDATIVE STRESS; HEART-FAILURE; PATHWAY; SIGNAL; TRANSLOCATION; ACTIVATION; CELLS	There is a definite cardioprotective role for 14-3-3 eta protein against pressure overload induced cardiac hypertrophy and streptozotocin induced cardiac dysfunction in type 1 diabetes mellitus (DM). But it is not conclusive whether it has any influence on mitochondrial mediated cardiomyocyte apoptosis in type 2 DM. In order to test this hypothesis, we have used C57BL6/J (WT) mice with cardiac specific dominant negative mutation of 14-3-3 eta protein (DN 14-3-3 eta). Both WT and DN 14-3-3 eta mice were fed with high fat diet (HFD) for 12 weeks. Their body weight and blood glucose levels were measured weekly and compared with standard diet (SD) fed mice. By the end of 12 weeks, echocardiography was performed. Frozen myocardial sections were prepared to stain the apoptotic cardiomyocytes using TUNEL staining. DN 14-3-3 eta mice fed with HFD showed cardiac dysfunction as identified by the decreased fractional shortening and ejection fraction and increased cardiomyocyte apoptosis in TUNEL staining. Western blotting analysis using mitochondrial fraction of the ventricular tissue homogenates showed a significant reduction in the level of cytochrome c suggesting its translocation into cytoplasm, which may be crucial in inducing cardiomyocyte apoptosis. In addition, DN 14-3-3 eta mice depicted significantly increased levels of NADPH oxidase subunits suggesting oxidative stress, a significant reduction in phospho apoptosis signal-regulating kinase-1 (p-Ask-1) and increase in Ask-1 and phospho c-Jun N-terminal kinase (p-JNK) levels suggesting activation of Ask-1/JNK signaling. These results suggest that 14-3-3 eta has a protective role against mitochondria mediated cardiomyocyte apoptosis with the involvement of Ask-1/JNK signaling during HFD induced type 2 DM. (c) 2015 Elsevier Inc. All rights reserved.	[Sreedhar, Remya; Arumugam, Somasundaram; Karuppagounder, Vengadeshprabhu; Pitchaimani, Vigneshwaran; Afrin, Rejina; Miyashita, Shizuka; Nomoto, Mayumi; Harima, Meilei; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Niigata 9568603, Japan; [Thandavarayan, Rajarajan A.] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA; [Giridharan, Vijayasree V.] JKK Nattraja Coll Pharm, Komarapalayam 638183, Tamil Nadu, India; [Gurusamy, Narasimman] King Khalid Univ, Coll Pharm, Dept Pharmacol, Abha, Saudi Arabia; [Suzuki, Kenji] Niigata Univ Grad Sch Med & Dent Sci, Dept Gastroenterol, Niigata 9518510, Japan	Watanabe, K (reprint author), Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Niigata 9568603, Japan.	watanabe@nupals.ac.jp			JSPS KAKENHI, Japan [26460239]	This research was supported by JSPS KAKENHI Grant (Number 26460239), Japan.	Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Thandavarayan RA, 2008, BIOCHEM PHARMACOL, V75, P1797, DOI 10.1016/j.bcp.2008.02.003; MacKay RK, 2011, ALCOHOL CLIN EXP RES, V35, P1041, DOI 10.1111/j.1530-0277.2011.01436.x; Thandavarayan RA, 2009, AM J PHYSIOL-HEART C, V297, pH911, DOI 10.1152/ajpheart.00124.2009; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Kumar S, 2012, BBA-GEN SUBJECTS, V1820, P907, DOI 10.1016/j.bbagen.2012.02.010; Yang WH, 2011, J CELL BIOCHEM, V112, P1601, DOI 10.1002/jcb.23072; Li YZ, 2011, SHOCK, V35, P579, DOI 10.1097/SHK.0b013e318211601a; Moe GW, 2004, AM J PHYSIOL-HEART C, V287, pH1813, DOI 10.1152/ajpheart.00036.2004; Sari FR, 2010, J PHARMACOL SCI, V113, P325, DOI 10.1254/jphs.10047FP; Wang Q, 2011, J RECEPT SIG TRANSD, V31, P307, DOI 10.3109/10799893.2011.592536; Sari FR, 2010, CELL PHYSIOL BIOCHEM, V26, P167, DOI 10.1159/000320548; Takeda K, 2000, J BIOL CHEM, V275, P9805, DOI 10.1074/jbc.275.13.9805; Sukumaran V, 2011, INT J BIOL SCI, V7, P1077; Li XH, 2005, J BIOL CHEM, V280, P15061, DOI 10.1074/jbc.M414262200; Gurusamy N, 2004, BIOCHEM BIOPH RES CO, V320, P773, DOI 10.1016/j.bbrc.2004.06.023; Thandavarayan RA, 2011, CELL PHYSIOL BIOCHEM, V28, P911, DOI 10.1159/000335805; Fan J, 2012, INT J NEUROSCI, V122, P665, DOI 10.3109/00207454.2012.707714; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Graham John M, 2002, ScientificWorldJournal, V2, P1638; Guo CX, 2012, INT J MOL SCI, V13, P11923, DOI 10.3390/ijms130911923; Gurusamy N, 2005, BIOL PHARM BULL, V28, P957, DOI 10.1248/bpb.28.957; Kanno T, 2011, J CELL PHYSIOL, V226, P2329, DOI 10.1002/jcp.22571; Sari FR, 2011, CELL PHYSIOL BIOCHEM, V27, P487, DOI 10.1159/000329970; Soetikno V, 2012, EUR J PHARM SCI, V47, P604, DOI 10.1016/j.ejps.2012.04.018	25	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0898-6568	1873-3913		CELL SIGNAL	Cell. Signal.	APR	2015	27	4					770	776		10.1016/j.cellsig.2014.12.021		7	Cell Biology	Cell Biology	CD2UG	WOS:000350933900004		
J	Hamamoto, A; Kobayashi, Y; Saito, Y				Hamamoto, Akie; Kobayashi, Yuki; Saito, Yumiko			Identification of amino acids that are selectively involved in Gi/o activation by rat melanin-concentrating hormone receptor 1	CELLULAR SIGNALLING			English	Article						GPCR; Melanin-concentrating hormone (MCH); Melanin-concentrating hormone receptor 1 (MCHR1); Mutation; Signal transduction; G-protein	PROTEIN-COUPLED RECEPTORS; 2ND INTRACELLULAR LOOP; MOLECULAR CHARACTERIZATION; FEEDING-BEHAVIOR; BASIC RESIDUES; MESSENGER-RNA; HORMONE-RECEPTOR-1; CELLS; COMPLEX; ANTAGONIST	Many G-protein-coupled receptors (GPCRs) are known to functionally couple to multiple G-protein subfamily members. Although promiscuous G-protein coupling enables GPCRs to mediate diverse signals, only a few GPCRs have been identified with differential determinants for coupling to distinct G alpha proteins. Mammalian melanin-concentrating hormone receptor 1 (MCHR1) couples to dual G-protein subfamilies. However, the selectivity mechanisms between MCHR1 and different subtypes of G alpha proteins are unclear. Our previous studies demonstrated that mammalian MCHR1 couples to both Gi/o and Gq, whereas goldfish MCHR1 exclusively couples to Gq. In his study, we analyzed multiple sequence alignments between rat and goldfish MCHR1s, and designed three multisubstituted mutants of rat MCHR1 by replacing corresponding residues with those in goldfish MCHR1, focusing on regions around the cytosolic intracellular loops. By measurement of intracellular Ca2+ mobilization, we found that two MCHR1 mutants, i2_6sub and i3_6sub, which contained six simultaneously substituted residues in the second intracellular loop or a combination of substituted residues in the third intracellular loop and fifth transmembrane domain, respectively, significantly reduced Gi/o-sensitive pertussis toxin responsiveness without altering Gq-mediated activity. Analyses of 10 other substitutions revealed that the multiple substitutions in i2_6sub and i3_6sub were necessary for Gi/o-selective responses. As judged by Gi/o-dependent GTP gamma S binding and cyclic AMP assays, i2_6sub and i3_6sub elicited phenotypes for impaired Gi/o-mediated signaling. We also monitored the dynamic mass redistribution (DMR) in living cells, which reveals receptor activity as an optical trace containing activation of all GPCR coupling classes. Cells transfected with i2_6sub or i3_6sub exhibited reduced Gi/o-mediated DMR responses compared with those transfected with MCHR1. These data suggest that two different regions independently affect the Gi/o-protein preference, and that multiple residues comprise a conformation favoring Gi/o-protein coupling and subsequently result in Gi/o-selective signaling. (c) 2015 Elsevier Inc. All rights reserved.	[Hamamoto, Akie; Kobayashi, Yuki; Saito, Yumiko] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Hiroshima 7398521, Japan	Saito, Y (reprint author), Hiroshima Univ, Grad Sch Integrated Arts & Sci, 1-7-1 Kagamiyama, Hiroshima 7398521, Japan.	yumist@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, and Technology of Japan [KAKENHI 20500337, 23500449]; Japan Society for the Promotion of Science [13J01969]	This study was supported by research grants from the Ministry of Education, Culture, Sports, and Technology of Japan (KAKENHI 20500337 and 23500449 to Y.S.) and a Grant-in-Aid for JSPS Fellows (13J01969 to A.H.) from the Japan Society for the Promotion of Science.	Aizaki Y, 2009, PEPTIDES, V30, P974, DOI 10.1016/j.peptides.2009.01.017; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Saito Y, 1999, NATURE, V400, P265; Tan CP, 2002, GENOMICS, V79, P785, DOI 10.1006/geno.2002.6771; Tetsuka M, 2004, ENDOCRINOLOGY, V145, P3712, DOI 10.1210/en.2003-1638; An SZ, 2001, P NATL ACAD SCI USA, V98, P7576, DOI 10.1073/pnas.131200698; Saito Y, 2001, J COMP NEUROL, V435, P26, DOI 10.1002/cne.1191; Hermans E, 2003, PHARMACOL THERAPEUT, V99, P25, DOI 10.1016/S0163-7258(03)00051-2; Borowsky B, 2002, NAT MED, V8, P825, DOI 10.1038/nm741; Chen YY, 2002, ENDOCRINOLOGY, V143, P2469, DOI 10.1210/en.143.7.2469; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Sundstrom L, 2013, FEBS LETT, V587, P2399, DOI 10.1016/j.febslet.2013.05.067; Shimada M, 1998, NATURE, V396, P670; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; McCoy KL, 2012, CELL SIGNAL, V24, P1351, DOI 10.1016/j.cellsig.2012.01.011; Hawes BE, 2000, ENDOCRINOLOGY, V141, P4524, DOI 10.1210/en.141.12.4524; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Georgescu D, 2005, J NEUROSCI, V25, P2933, DOI 10.1523/JNEUROSCI.1714-04.2005; Verlaet M, 2002, FEBS LETT, V527, P205, DOI 10.1016/S0014-5793(02)03232-5; Wong SKF, 2003, NEUROSIGNALS, V12, P1, DOI 10.1159/000068914; KAWAUCHI H, 1983, NATURE, V305, P321, DOI 10.1038/305321a0; IidaKlein A, 1997, J BIOL CHEM, V272, P6882; Chambers J, 1999, NATURE, V400, P261, DOI 10.1038/22313; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; Fan J, 2005, MOL ENDOCRINOL, V19, P2579, DOI 10.1210/me.2004-0301; Fry D, 2006, INT J BIOCHEM CELL B, V38, P1290, DOI 10.1016/j.biocel.2006.01.007; Gao XB, 2001, J PHYSIOL-LONDON, V533, P237, DOI 10.1111/j.1469-7793.2001.0237b.x; Hamamoto A., 2012, FRONT ENDOCRINOL LAU, V26, P147; Hamamoto A, 2011, REGUL PEPTIDES, V169, P6, DOI 10.1016/j.regpep.2011.04.001; Kleinau G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009745; Kobayashi Y., 2014, GEN COMP ENDOCRINOL; Kuniyeda K, 2007, J BIOL CHEM, V282, P3998, DOI 10.1074/jbc.M610540200; Macdonald D, 2000, MOL PHARMACOL, V58, P217; Matsuda K, 2009, PEPTIDES, V30, P2060, DOI 10.1016/j.peptides.2009.02.015; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Mizusawa K, 2009, PEPTIDES, V30, P1990, DOI 10.1016/j.peptides.2009.04.010; Moreira IS, 2014, BBA-GEN SUBJECTS, V1840, P16, DOI 10.1016/j.bbagen.2013.08.027; Nagata A, 2013, GEN COMP ENDOCR, V188, P159, DOI 10.1016/j.ygcen.2013.02.020; Saito Yumiko, 2013, Front Endocrinol (Lausanne), V4, P154, DOI 10.3389/fendo.2013.00154; Saito Y, 2003, FEBS LETT, V533, P29, DOI 10.1016/S0014-5793(02)03744-4; Saito Y, 2001, BIOCHEM BIOPH RES CO, V289, P44, DOI 10.1006/bbrc.2001.5926; Saito Y, 2005, ENDOCRINOLOGY, V146, P3452, DOI 10.1210/en.2005-0115; Saito Y, 2004, PEPTIDES, V25, P1597, DOI 10.1016/j.peptides.2004.03.026; Schlumberger SE, 2002, BIOCHEM BIOPH RES CO, V298, P54, DOI 10.1016/S0006-291X(02)02400-2; Shearman LP, 2003, EUR J PHARMACOL, V475, P37, DOI 10.1016/S0014-2999(03)02146-0; Takekawa S, 2002, EUR J PHARMACOL, V438, P129, DOI 10.1016/S0014-2999(02)01314-6; Wade SM, 1999, MOL PHARMACOL, V56, P1005	49	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0898-6568	1873-3913		CELL SIGNAL	Cell. Signal.	APR	2015	27	4					818	827		10.1016/j.cellsig.2015.01.008		10	Cell Biology	Cell Biology	CD2UG	WOS:000350933900009		
J	Hamamura, K; Nishimura, A; Chen, A; Takigawa, S; Sudo, A; Yokota, H				Hamamura, Kazunori; Nishimura, Akinobu; Chen, Andy; Takigawa, Shinya; Sudo, Akihiro; Yokota, Hiroki			Salubrinal acts as a Dusp2 inhibitor and suppresses inflammation in anti-collagen antibody-induced arthritis	CELLULAR SIGNALLING			English	Article						Salubrinal; CAIA; Microarray; Inflammation; Dusp2 (PAC1)	DUAL-SPECIFICITY PHOSPHATASES; COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; IMMUNE-RESPONSES; OSTEOCLASTOGENESIS; UPDATE; CELLS; OSTEOBLASTS; ACTIVATION; EXPRESSION	Dual-specificity phosphatase 2 (Dusp2; also called phosphatase of activated cells 1, PAC1) is highly expressed in activated immune cells. We examined whether a potential inhibitor of Dusp2, salubrinal, prevents inflammatory cytokine expression in immune cells and arthritic responses in a mouse model of anti-collagen antibody-induced arthritis (CAIA). Salubrinal is a synthetic chemical that inhibits de-phosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2 alpha). In this study, we examined the effects of salubrinal on expression of inflammation linked genes as well as a family of DUSP genes using genome-wide microarrays, qPCR, and RNA interference. We also evaluated the effects of salubrinal on arthritic responses in CAIA mice using clinical and histological scores. The results revealed that salubrinal decreased inflammatory gene expression in macrophages, T lymphocytes, and mast cells. Dusp2 was suppressed by salubrinal in LPS-activated macrophages as well as PMA/ionomycin-activated T lymphocytes and mast cells. Furthermore, a partial silencing of Dusp2 downregulated IL1 beta and Cox2, and the inflammatory signs of CAIA mice were significantly suppressed by salubrinal. Collectively, this study presents a novel therapeutic possibility of salubrinal for inflammatory arthritis such as RA through inhibition of Dusp2. (c) 2015 Elsevier Inc. All rights reserved.	[Hamamura, Kazunori; Nishimura, Akinobu; Chen, Andy; Takigawa, Shinya; Yokota, Hiroki] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Nishimura, Akinobu; Takigawa, Shinya; Sudo, Akihiro] Mie Univ Grad Sch Med, Dept Orthopaed Surg, Tsu, Mie 514, Japan; [Yokota, Hiroki] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA	Hamamura, K (reprint author), Aichi Gakuin Univ, Sch Dent, Dept Pharmacol, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi 4648650, Japan.	hamak@dpc.agu.ac.jp			CTSA [U54-TR001012]	The microarray analysis was supported by CTSA U54-TR001012.	Selmi C, 2014, IMMUNOL RES, V60, P277, DOI 10.1007/s12026-014-8565-5; Arend WP, 2001, ARTHRIT RHEUM-ARTHR, V45, P101; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Hamamura K, 2007, FEBS LETT, V581, P1769, DOI 10.1016/j.febslet.2007.03.063; Khachigian LM, 2006, NAT PROTOC, V1, P2512, DOI 10.1038/nprot.2006.393; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Shrestha N, 2012, J BIOL CHEM, V287, P28738, DOI 10.1074/jbc.M112.375915; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Lang R, 2006, J IMMUNOL, V177, P7497; Page TH, 2009, CURR MOL MED, V9, P69; Nandakumar KS, 2005, J IMMUNOL METHODS, V304, P126, DOI 10.1016/j.jim.2005.06.017; Blohmke CJ, 2012, J IMMUNOL, V189, P5467, DOI 10.4049/jimmunol.1103661; Agarwal SK, 2011, J MANAGE CARE PHARM, V17, pS14; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Bauerova K, 2009, TOXICOL IND HEALTH, V25, P329, DOI 10.1177/0748233709102945; Bencsath M, 2003, PATHOL ONCOL RES, V9, P24; Bingham Clifton O 3rd, 2008, Bull NYU Hosp Jt Dis, V66, P210; Chang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045378; Gomez-Reino J., 2012, RHEUMATOLOGY OXFO S5, V51, pv31; Gould DJ, 2004, ARTHRITIS RES THER, V6, pR103, DOI 10.1186/ar1036; Hamamura K, 2013, OSTEOARTHR CARTILAGE, V21, P764, DOI 10.1016/j.joca.2013.02.657; Hamamura K, 2013, J BONE MINER METAB, V31, P618, DOI 10.1007/s00774-013-0450-0; Hamamura K, 2015, CELL SIGNAL, V27, P353, DOI 10.1016/j.cellsig.2014.11.020; Hamamura K, 2014, CELL SIGNAL, V26, P2358, DOI 10.1016/j.cellsig.2014.07.018; Joshi Poorvashree, 2014, Inflammation & Allergy Drug Targets, V13, P249; Jung SM, 2014, J IMMUNOL RES, DOI 10.1155/2014/263625; Lefevre S., 2014, CURR PHARM DESIGN, V21, P130; Morris JC, 2000, ANN RHEUM DIS, V59, P109; Wan QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105699; Yokota H, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-197	31	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0898-6568	1873-3913		CELL SIGNAL	Cell. Signal.	APR	2015	27	4					828	835		10.1016/j.cellsig.2015.01.010		8	Cell Biology	Cell Biology	CD2UG	WOS:000350933900010		
J	Matsuda, S; Matsumoto, H; Furubayashi, T; Fukuda, H; Hanajima, R; Tsuji, S; Ugawa, Y; Terao, Y				Matsuda, Shunichi; Matsumoto, Hideyuki; Furubayashi, Toshiaki; Fukuda, Hideki; Hanajima, Ritsuko; Tsuji, Shoji; Ugawa, Yoshikazu; Terao, Yasuo			Visual Scanning Area is Abnormally Enlarged in Hereditary Pure Cerebellar Ataxia	CEREBELLUM			English	Article						Spinocerebellar degeneration; Vision; Eye movement; Saccade; Visual memory	PARKINSONS-DISEASE; SACCADIC DYSMETRIA; NYSTAGMUS; PRIMATE; TYPE-6; EXPLORATION; DEFICITS; LESIONS; CORTEX; SCA6	The aim of paper was to investigate abnormalities in visual scanning using an eye-tracking device with patients with spinocerebellar ataxia type 6 (SCA6) and SCA31, pure cerebellar types of spinocerebellar degeneration. Nineteen SCA patients (12 patients with SCA6 and 7 patients with SCA31) and 19 normal subjects in total participated in the study. While the subjects viewed images of varying complexity for later recall, we compared the visual scanning parameters between SCA patients and normal subjects. SCA patients had lower image recall scores. The scanned area in SCA patients was consistently larger than that in normal subjects. The amplitude of saccades was slightly larger in SCA patients than that in normal subjects, although it did not statistically differ between the two groups and correlated significantly with the scanned area in most images in SCA patients. The instability ratio of fixation, reflecting gaze-evoked nystagmus and downbeat nystagmus, was higher in SCA patients than that in normal subjects. Since SCA patients showed low scores despite wide visual scanning, the scanned area is considered to be abnormally enlarged. The larger scanned area in SCA patients was supposed mainly to result from the slightly larger saccade amplitude. Additionally, SCA patients showed prominent fixation disturbances probably due to gaze-evoked nystagmus and downbeat nystagmus. Consequently, SCA patients suffer from recognizing various objects in daily life, probably due to the impaired saccade control and impaired fixation.	[Matsuda, Shunichi; Matsumoto, Hideyuki; Hanajima, Ritsuko; Tsuji, Shoji; Terao, Yasuo] Univ Tokyo, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan; [Furubayashi, Toshiaki; Ugawa, Yoshikazu] Fukushima Med Univ, Sch Med, Dept Neurol, Fukushima, Japan; [Fukuda, Hideki] Segawa Neurol Clin Children, Tokyo, Japan	Matsumoto, H (reprint author), Univ Tokyo, Dept Neurol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hideyukimatsumoto.jp@gmail.com			Ministry of Education, Culture, Sports, Science, and Technology of Japan and Research; Dainippon Sumitomo Pharma. Co., Ltd; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health and Welfare of Japan; Research Committee on insomnia in Parkinson's disease from the Ministry of Health and Welfare of Japan; Committee of the Study of Human Exposure from the Ministry of Public Management, Home Affairs, Post and Telecommunications; Uehara Memorial Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan Research; GlaxoSmithKline; Boehringer Ingelheim	Dr. Hanajima was supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Research, and Dainippon Sumitomo Pharma. Co., Ltd; and has received a speaker's honorarium from Kyowa Hakko Kilin Co., Ltd.; Dr. Ugawa was supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by grants for the Research Committee on degenerative ataxia from the Ministry of Health and Welfare of Japan; by the Research Committee on insomnia in Parkinson's disease from the Ministry of Health and Welfare of Japan; by a grant from the Committee of the Study of Human Exposure to EMF from the Ministry of Public Management, Home Affairs, Post and Telecommunications; and by a grant from the Uehara Memorial Foundation.; Dr. Terao was supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research and GlaxoSmithKline and Boehringer Ingelheim, and has received a speaker's honorarium from Boehringer Ingelheim.	Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Owada K, 2005, NEUROLOGY, V65, P629, DOI 10.1212/01.wnl.0000173065.75680.e2; Hallett M, 2011, MOVEMENT DISORD, V26, P1579, DOI 10.1002/mds.23730; Terao Y, 2013, CLIN NEUROPHYSIOL, V124, P1491, DOI 10.1016/j.clinph.2013.01.021; Mosimann UP, 2004, BRAIN, V127, P431, DOI 10.1093/brain/awh051; Barash S, 1999, J NEUROSCI, V19, P10931; Ishikawa K, 1999, J NEUROL NEUROSUR PS, V67, P86, DOI 10.1136/jnnp.67.1.86; Archibald NK, 2013, BRAIN, V136, P739, DOI 10.1093/brain/awt005; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; Anderson TJ, 2013, NAT REV NEUROL, V9, P74, DOI 10.1038/nrneurol.2012.273; SCHMAHMANN JD, 1991, ARCH NEUROL-CHICAGO, V48, P1178; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; BURR DC, 1982, VISION RES, V22, P479, DOI 10.1016/0042-6989(82)90196-1; Andreasen NC, 1996, P NATL ACAD SCI USA, V93, P9985, DOI 10.1073/pnas.93.18.9985; Kelly RM, 2003, J NEUROSCI, V23, P8432; BUTTNER U, 1995, J NEUROL, V242, P384, DOI 10.1007/BF00868394; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frings M, 2007, CEREBELLUM, V6, P328, DOI 10.1080/14734220701200063; Gomez CM, 1997, ANN NEUROL, V42, P933, DOI 10.1002/ana.410420616; Hocking DR, 2010, CEREBELLUM, V9, P411, DOI 10.1007/s12311-010-0178-5; Ignashchenkova A, 2009, J NEUROPHYSIOL, V102, P3156, DOI 10.1152/jn.00659.2009; Iwamoto Y, 2002, NEUROSCI LETT, V325, P211, DOI 10.1016/S0304-3940(02)00268-9; JACOBS RJ, 1979, VISION RES, V19, P1187, DOI 10.1016/0042-6989(79)90183-4; Kawai Y, 2008, J NEUROL SCI, V271, P68, DOI 10.1016/j.jns.2008.03.018; Kertesz A., 1982, W APHASIA BATTERY; Machner B, 2005, NEUROREPORT, V16, P1507, DOI 10.1097/01.wnr.0000177015.75096.b6; Matsumoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028928; Matsumoto H, 2013, BRAIN, V136, DOI 10.1093/brain/awt124; Matsumoto H, 2012, PARKINSONS DIS, V2, P73; Matsumoto H, 2011, MOVEMENT DISORD, V26, P1619, DOI 10.1002/mds.23683; Osterrieth PA, 1944, ARCH PSYCHOL, V30, P286; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Riddoch M.J., 1993, BIRMINGHAM OBJECT RE; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; Shaikh AG, 2013, NEUROREHABILITATION, V32, P493, DOI 10.3233/NRE-130872; SHIMIZU N, 1981, J NEUROL NEUROSUR PS, V44, P509, DOI 10.1136/jnnp.44.6.509; Suenaga M, 2008, J NEUROL NEUROSUR PS, V79, P496, DOI 10.1136/jnnp.2007.119883; Suzuki Y, 2003, JPN J OPHTHALMOL, V47, P535, DOI 10.1016/S0021-5155(03)00144-8; Yabe I, 2003, J NEUROL, V250, P440, DOI 10.1007/s00415-003-1020-5; ZEE DS, 1976, BRAIN, V99, P207, DOI 10.1093/brain/99.2.207	40	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1473-4222	1473-4230		CEREBELLUM	Cerebellum	APR	2015	14	2					63	71		10.1007/s12311-014-0600-5		9	Neurosciences	Neurosciences & Neurology	CD2HU	WOS:000350897800001		
J	De Luca, A; Parmigiani, E; Tosatto, G; Martire, S; Hoshino, M; Buffo, A; Leto, K; Rossi, F				De Luca, A.; Parmigiani, E.; Tosatto, G.; Martire, S.; Hoshino, M.; Buffo, A.; Leto, K.; Rossi, F.			Exogenous Sonic Hedgehog Modulates the Pool of GABAergic Interneurons During Cerebellar Development	CEREBELLUM			English	Article						Pax-2-positive interneurons; Cell proliferation; Organotypic slices; Gli1 expression	RHOMBIC LIP; MOUSE CEREBELLUM; WHITE-MATTER; PRECURSORS; EXPRESSION; CELLS; GENE; PROLIFERATION; SPECIFICATION; PROGENITORS	All cerebellar GABAergic interneurons were derived from a common pool of precursor cells residing in the embryonic ventricular zone (VZ) and migrating in the prospective white matter (PWM) after birth, where both intrinsic and extrinsic factors contribute to regulate their amplification. Among the environmental factors, we focused on Sonic hedgehog (Shh), a morphogen well known to regulate neural progenitor cell proliferation. We asked if and how exogenous Shh treatment affects the lineage of cerebellar GABAergic interneurons. To address these issues, exogenous Shh was administered to embryonic and postnatal organotypic slices. We found that Shh is able to expand the pool of interneuron progenitors residing in the embryonic epithelium and in the postnatal PWM. In particular, Shh signalling pathway was highly mitogenic at early developmental stages of interneuron production, whereas its effect decreased after the first postnatal week. Gene expression analysis of sorted cells and in situ hybridization further showed that immature interneurons express both the Shh receptor patched and the Shh target gene Gli1. Thus, within the interneuron lineage, Shh might exert regulatory functions also in postmitotic cells. On the whole, our data enlighten the role of Shh during cerebellar maturation and further broaden our knowledge on the amplification mechanisms of the interneuron progenitor pool.	[De Luca, A.; Parmigiani, E.; Tosatto, G.; Buffo, A.; Leto, K.; Rossi, F.] Univ Turin, Dept Neurosci Rita Levi Montalcini, I-10026 Turin, Italy; [De Luca, A.; Parmigiani, E.; Tosatto, G.; Martire, S.; Buffo, A.; Leto, K.; Rossi, F.] Univ Turin, Neurosci Inst Cavalieri Ottolenghi, I-10043 Turin, Italy; [Hoshino, M.] Natl Ctr Neurol & Psychiat, Dept Biochem & Cellular Biol, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan	Leto, K (reprint author), Univ Turin, Neurosci Inst Cavalieri Ottolenghi, Reg Gonzole 10, I-10043 Turin, Italy.	ketty.leto@unito.it			Ministero dell'Universita e della Ricerca (PRIN) [TBCZJB]; Ministero dell'Universita e della Ricerca (Ricerca Fondo per l'Incentivazione della Ricerca di Base research grant) [RBFR10A01S]	We would like to dedicate this work in memoriam of Prof F. Rossi, for continuous support and encouragement. We thank Dr. Paola Bernabei for help in FAC Sorter analysis. This work was supported by grants from Ministero dell'Universita e della Ricerca (PRIN 2009 program no. TBCZJB to F.R. and Ricerca Fondo per l'Incentivazione della Ricerca di Base research grant RBFR10A01S to K.L.).	Simat M, 2007, J COMP NEUROL, V500, P71, DOI 10.1002/cne.21142; Bullock WM, 2009, NEUROCHEM INT, V55, P775, DOI 10.1016/j.neuint.2009.07.010; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Fleming JT, 2013, DEV CELL, V27, P278, DOI 10.1016/j.devcel.2013.10.008; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Varjosalo M, 2007, J CELL SCI, V120, P3, DOI 10.1242/jcs.03309; Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Charytoniuk D, 2002, J PHYSIOLOGY-PARIS, V96, P9, DOI 10.1016/S0928-4257(01)00075-4; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Englund C, 2006, J NEUROSCI, V26, P9184, DOI 10.1523/JNEUROSCI.1610-06.2006; Bragina O, 2010, NEUROSCI LETT, V482, P81, DOI 10.1016/j.neulet.2010.06.068; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Pfeffer PL, 2002, DEVELOPMENT, V129, P307; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Carletti B, 2008, NEUROSCIENTIST, V14, P91, DOI 10.1177/1073858407304629; Zhang L, 1996, NEURON, V16, P47, DOI 10.1016/S0896-6273(00)80022-7; Yamada M, 2014, J NEUROSCI, V34, P4786, DOI 10.1523/JNEUROSCI.2722-13.2014; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Hoshino M, 2005, NEURON, V47, P201, DOI 10.1016/j.neuron.2005.06.007; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Leto K, 2009, J NEUROSCI, V29, P7079, DOI 10.1523/JNEUROSCI.0957-09.2009; Flora A, 2009, SCIENCE, V326, P1424, DOI 10.1126/science.1181453; AKAZAWA C, 1995, J BIOL CHEM, V270, P8730; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huang X, 2010, P NATL ACAD SCI USA, V107, P8422, DOI 10.1073/pnas.0911838107; Fink AJ, 2006, J NEUROSCI, V26, P3066, DOI 10.1523/JNEUROSCI.5203-05.2006; Jacob L, 2007, SCIENCE, V318, P66, DOI 10.1126/science.1147314; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Fucillo M, 2006, NAT REV, V7, P772; Ghoumari AM, 2000, EUR J NEUROSCI, V12, P2935, DOI 10.1046/j.1460-9568.2000.00186.x; Hoshino M, 2012, DEV GROWTH DIFFER, V54, P317, DOI 10.1111/j.1440-169X.2012.01330.x; Huard JMT, 1999, DEVELOPMENT, V126, P1927; Lee SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071455; Leto K, 2011, DEVELOPMENT, V138, P3463, DOI 10.1242/dev.064378; Leto K, 2010, ARCH ITAL BIOL, V138, P137; Leto K, 2012, FRONT NEUROANAT, V6, P1; Petralia RS, 2012, CEREBELLUM, V11, P972, DOI 10.1007/s12311-012-0374-6; Pons S, 2001, DEVELOPMENT, V128, P1481; Schilling C, 2008, HISTOCHEM CELL BIOL, V130, P601; Seto Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4337; Weisheit G, 2006, EUR J NEUROSCI, V24, P466, DOI 10.1111/j.1460-9568.2006.04915.x; Yokoo H, 2000, PATHOL INT, V50, P291, DOI 10.1046/j.1440-1827.2000.01038.x	48	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1473-4222	1473-4230		CEREBELLUM	Cerebellum	APR	2015	14	2					72	85		10.1007/s12311-014-0596-x		14	Neurosciences	Neurosciences & Neurology	CD2HU	WOS:000350897800002		
J	Muneoka, K; Kuwagata, M; Ogawa, T; Shioda, S				Muneoka, Katsumasa; Kuwagata, Makiko; Ogawa, Tetsuo; Shioda, Seiji			Mother/Offspring Co-administration of the Traditional Herbal Remedy Yokukansan During the Nursing Period Influences Grooming and Cerebellar Serotonin Levels in a Rat Model of Neurodevelopmental Disorders	CEREBELLUM			English	Article						Yokukansan; Mother-infant; Monoamines; Cerebellum; Autism	YI-GAN-SAN; AUTISM SPECTRUM DISORDERS; OPEN-LABEL; PSYCHOLOGICAL SYMPTOMS; JAPANESE MEDICINE; MESSENGER-RNA; INDIVIDUAL-DIFFERENCES; REPETITIVE BEHAVIORS; TARDIVE-DYSKINESIA; 5-HT1A RECEPTORS	Neurodevelopmental impairment in the serotonergic system may be involved in autism spectrum disorder. Yokukansan is a traditional herbal remedy for restlessness and agitation in children, and mother-infant co-administration (MICA) to both the child and the nursing mother is one of the recommended treatment approaches. Recent studies have revealed the neuropharmacological properties of Yokukansan (YKS), including its 5-HT1A (serotonin) receptor agonistic effects. We investigated the influence of YKS treatment on behavior in a novel environment and on brain monoamine metabolism during the nursing period in an animal model of neurodevelopmental disorders, prenatally BrdU (5-bromo-2'-deoxyuridine)-treated rats (BrdU-rats). YKS treatment did not influence locomotor activity in BrdU-rats but reduced grooming in open-field tests. YKS treatment without MICA disrupted the correlation between locomotor behaviors and rearing and altered levels of serotonin and its metabolite in the cerebellum. These effects were not observed in the group receiving YKS treatment with MICA. These data indicate a direct pharmacological effect of YKS on the development of grooming behavior and profound effects on cerebellar serotonin metabolism, which is thought to be influenced by nursing conditions.	[Muneoka, Katsumasa; Ogawa, Tetsuo; Shioda, Seiji] Showa Univ, Dept Anat 1, Sch Med, Shinagawa Ku, Tokyo 1428555, Japan; [Kuwagata, Makiko] Food & Drug Safety Ctr, Div Toxicol, Hatano Res Inst, Pathol Lab, Hatano, Kanagawa 2578523, Japan	Muneoka, K (reprint author), Showa Univ, Dept Anat 1, Sch Med, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	kmuneoka@med.showa-u.ac.jp					Thiel CM, 1999, NEUROSCIENCE, V93, P243, DOI 10.1016/S0306-4522(99)00158-X; DUNN AJ, 1981, PHARMACOL BIOCHEM BE, V15, P605, DOI 10.1016/0091-3057(81)90217-3; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Nin MS, 2012, PHARMACOL BIOCHEM BE, V103, P359, DOI 10.1016/j.pbb.2012.09.002; Mizukami K, 2009, INT J NEUROPSYCHOPH, V12, P191, DOI 10.1017/S146114570800970X; MICZEK KA, 1995, PSYCHOPHARMACOLOGY, V121, P38, DOI 10.1007/BF02245590; Sekerkova G, 2004, J COMP NEUROL, V470, P221, DOI 10.1002/cne.11016; Chugani DC, 2002, MOL PSYCHIATR, V7, pS16, DOI 10.1038/sj.mp.4001167; Kuwagata M, 2004, TOXICOL LETT, V152, P63, DOI 10.1016/j.toxlet.2004.03.019; BERRIDGE KC, 1992, EXP BRAIN RES, V90, P275; Chugani DC, 1999, ANN NEUROL, V45, P287, DOI 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9; Kanno H, 2009, J PHARM PHARMACOL, V61, P1249, DOI 10.1211/jpp/61.09.0016; Kuwagata M, 2007, NEUROTOXICOLOGY, V28, P780, DOI 10.1016/j.neuro.2006.07.017; Hollander E, 2012, AM J PSYCHIAT, V169, P292, DOI 10.1176/appi.ajp.2011.10050764; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Mizoguchi K, 2010, J ETHNOPHARMACOL, V127, P70, DOI 10.1016/j.jep.2009.09.048; Roth A, 2013, PROG NEURO-PSYCHOPH, V40, P312, DOI 10.1016/j.pnpbp.2012.10.015; Pierce K, 2001, BIOL PSYCHIAT, V49, P655, DOI 10.1016/S0006-3223(00)01008-8; Strazielle C, 1998, PHYSIOL BEHAV, V64, P57, DOI 10.1016/S0031-9384(98)00014-6; DUNN AJ, 1987, PEPTIDES, V8, P841, DOI 10.1016/0196-9781(87)90069-6; Chugani DC, 1999, PROG NEURO-PSYCHOPH, V23, P635, DOI 10.1016/S0278-5846(99)00022-6; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Kondoh M, 2004, NEUROSCI RES, V48, P101, DOI 10.1016/j.neures.2003.10.001; Kolb B, 1999, J NEUROSCI, V19, P2337; Bolivar VJ, 1996, BEHAV BRAIN RES, V75, P49, DOI 10.1016/0166-4328(96)00156-8; Makkonen I, 2008, DEV MED CHILD NEUROL, V50, P593, DOI 10.1111/j.1469-8749.2008.03027.x; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P248; Boccuto L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-16; Carrasco M, 2013, PEDIATRICS, V129, pe1301; COOK EH, 1994, PSYCHIAT RES, V52, P25, DOI 10.1016/0165-1781(94)90117-1; Croonenberghs J, 2000, NEUROPSYCHOPHARMACOL, V22, P275, DOI 10.1016/S0893-133X(99)00131-1; Croonenberghs J, 2005, LIFE SCI, V76, P2171, DOI 10.1016/j.lfs.2004.06.032; DAGATA V, 1993, PHYSIOL BEHAV, V53, P173, DOI 10.1016/0031-9384(93)90027-D; del Olmo E, 1998, MOL BRAIN RES, V60, P123, DOI 10.1016/S0169-328X(98)00149-1; Doo AR, 2010, J ETHNOPHARMACOL, V131, P433, DOI 10.1016/j.jep.2010.07.008; Duxon MS, 2001, PSYCHOPHARMACOLOGY, V153, P203, DOI 10.1007/s002130000550; Egashira N, 2008, PROG NEURO-PSYCHOPH, V32, P1516, DOI 10.1016/j.pnpbp.2008.05.010; Egashira N, 2011, J PHARMACOL SCI, V116, P316, DOI 10.1254/jphs.11079SC; GLICK SD, 1989, BRAIN RES, V504, P231, DOI 10.1016/0006-8993(89)91362-0; GLICK SD, 1988, BRAIN RES, V450, P334, DOI 10.1016/0006-8993(88)91572-7; Goldberg J, 2009, J AUTISM DEV DISORD, V39, P97, DOI 10.1007/s10803-008-0604-4; HARTGRAVES SL, 1986, PSYCHOPHARMACOLOGY, V90, P358; Hollander E, 2000, NEUROPSYCHOPHARMACOL, V22, P163, DOI 10.1016/S0893-133X(99)00121-9; Kamei J, 2009, PROG NEURO-PSYCHOPH, V33, P1431, DOI 10.1016/j.pnpbp.2009.07.023; KAMPO Terasawa K., 1993, KAMPO JAPANESE ORIEN; Kane MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048975; Kawakami Z, 2009, NEUROSCIENCE, V159, P1397, DOI 10.1016/j.neuroscience.2009.02.004; Kawakami Z, 2010, EUR J PHARMACOL, V626, P154, DOI 10.1016/j.ejphar.2009.09.046; Kawakami Z, 2011, CELL MOL NEUROBIOL, V31, P1203, DOI 10.1007/s10571-011-9722-1; Kennett GA, 1997, NEUROPHARMACOLOGY, V36, P233, DOI 10.1016/S0028-3908(96)00171-2; Kuwagata M, 2011, BRAIN RES BULL, V85, P207, DOI 10.1016/j.brainresbull.2011.03.005; Kuwagata M, 2011, CONGENIT ANOM, V51, P177, DOI 10.1111/j.1741-4520.2011.00331.x; Kuwagata M, 1998, REPROD TOXICOL, V12, P541, DOI 10.1016/S0890-6238(98)00037-9; Kuwagata Makiko, 2001, Congenital Anomalies, V41, P312, DOI 10.1111/j.1741-4520.2001.tb00841.x; Kyzar EJ, 2012, BRAIN RES BULL, V89, P168, DOI 10.1016/j.brainresbull.2012.08.004; Lucki I, 1996, J CLIN PSYCHIAT, V57, P5; MATTHIESSEN L, 1993, NEUROREPORT, V4, P763, DOI 10.1097/00001756-199306000-00042; MIQUEL MC, 1994, DEV BRAIN RES, V80, P149, DOI 10.1016/0165-3806(94)90099-X; Miyaoka T, 2008, PROG NEURO-PSYCHOPH, V32, P761, DOI 10.1016/j.pnpbp.2007.12.003; Miyaoka T, 2009, CLIN NEUROPHARMACOL, V32, P6, DOI 10.1097/WNF.0b013e31817e08c3; Miyaoka T, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-215; Miyaoka T, 2009, CURR PSYCHIAT REV, V5, P271; Miyaoka T, 2008, PROG NEURO-PSYCHOPH, V32, P150, DOI 10.1016/j.pnpbp.2007.07.026; Mizoguchi K, 2011, NEUROSCIENCE, V177, P127, DOI 10.1016/j.neuroscience.2010.12.045; Muneoka Katsumasa, 2006, Congenital Anomalies, V46, P155, DOI 10.1111/j.1741-4520.2006.00119.x; Muneoka KT, 2002, NEUROENDOCRINOLOGY, V75, P288, DOI 10.1159/000057338; Nakagawa T, 2012, NEUROSCIENCE, V227, P336, DOI 10.1016/j.neuroscience.2012.09.079; Nishi A, 2012, NEUROSCIENCE, V207, P124, DOI 10.1016/j.neuroscience.2012.01.037; Nogami A, 2011, J NAT MED-TOKYO, V65, P275, DOI 10.1007/s11418-010-0487-5; Oblak A, 2013, AUTISM RES, V6, P571, DOI 10.1002/aur.1317; Ogawa Tetsuo, 2005, Congenital Anomalies, V45, P14, DOI 10.1111/j.1741-4520.2005.00055.x; Okahara K, 2010, PROG NEURO-PSYCHOPH, V34, P532, DOI 10.1016/j.pnpbp.2010.02.013; Oostland M, 2013, NEUROSCIENCE, V248, P201, DOI 10.1016/j.neuroscience.2013.05.029; Orito K, 2009, INT J DEV NEUROSCI, V27, P81, DOI 10.1016/j.ijdevneu.2008.09.002; Pawlak CR, 2008, NEUROSCI BIOBEHAV R, V32, P1544, DOI 10.1016/j.neubiorev.2008.06.007; Sekiguchi K, 2012, BRAIN RES BULL, V89, P151, DOI 10.1016/j.brainresbull.2012.08.008; Shinno H, 2007, PROG NEURO-PSYCHOPH, V31, P1543, DOI 10.1016/j.pnpbp.2007.07.002; Shinno H, 2010, PROG NEURO-PSYCHOPH, V34, P252, DOI 10.1016/j.pnpbp.2009.11.007; Sokol DK, 2004, J NEUROIMAGING, V14, P8, DOI 10.1177/1051228403258145; Sundström E, 1993, Brain Res Dev Brain Res, V75, P1; Takeda A, 2008, NUTR NEUROSCI, V11, P41, DOI 10.1179/147683008X301414; Terawaki K, 2010, J ETHNOPHARMACOL, V127, P306, DOI 10.1016/j.jep.2009.11.003; Uchida N, 2009, BIOL PHARM BULL, V32, P372; Ueki T, 2012, CELL MOL NEUROBIOL, V33, P129; VANERP AMM, 1993, EUR J PHARMACOL, V232, P217, DOI 10.1016/0014-2999(93)90776-E; VANERP AMM, 1993, BRAIN RES, V603, P296, DOI 10.1016/0006-8993(93)91251-M; WHITAKERAZMITIA PM, 1990, BRAIN RES, V528, P155, DOI 10.1016/0006-8993(90)90210-3; Yamada M, 2011, J ETHNOPHARMACOL, V135, P737, DOI 10.1016/j.jep.2011.04.010	88	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1473-4222	1473-4230		CEREBELLUM	Cerebellum	APR	2015	14	2					86	96		10.1007/s12311-014-0611-2		11	Neurosciences	Neurosciences & Neurology	CD2HU	WOS:000350897800003		
J	Nakamura, K; Mieda, T; Suto, N; Matsuura, S; Hirai, H				Nakamura, Kazuhiro; Mieda, Tokue; Suto, Nana; Matsuura, Serina; Hirai, Hirokazu			Mesenchymal Stem Cells as a Potential Therapeutic Tool for Spinocerebellar Ataxia	CEREBELLUM			English	Review						Mesenchymal stem cells; Motor coordination; Mouse; Purkinje cells; Spinocerebellar ataxia	BONE-MARROW; MOUSE MODEL; HUNTINGTONS-DISEASE; CEREBELLAR-ATAXIA; TRANSGENIC MICE; PURKINJE-CELLS; STROMAL CELLS; IN-VIVO; SCA1; NEURODEGENERATION	Spinocerebellar ataxia (SCA) is a devastating progressive neurodegenerative disorder, for which no effective treatments have been developed. However, some studies have shown that an intracerebellar or intrathecal injection of mesenchymal stem cells (MSCs) was partially effective in some genetic mouse models of cerebellar ataxia such as SCA1 and Lurcher mutant. MSCs likely exert their therapeutic efficacy by secreting innate factors to induce neuronal growth and synaptic connection and reduce apoptosis. In this review, we introduce the therapeutic influence of MSCs on each mouse model for cerebellar ataxia and the possible mechanisms underlying the action of MSCs. We also introduce studies on the safety and effectiveness of umbilical cord MSCs for patients with SCA.	[Nakamura, Kazuhiro; Suto, Nana; Matsuura, Serina; Hirai, Hirokazu] Gunma Univ, Dept Neurophysiol, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Mieda, Tokue] Gunma Univ, Orthoped Surg, Grad Sch Med, Maebashi, Gunma 3718511, Japan	Hirai, H (reprint author), Gunma Univ, Dept Neurophysiol, Grad Sch Med, 3-39-2 Showa Machi, Maebashi, Gunma 3718511, Japan.	hirai@gunma-u.ac.jp					Jones J, 2010, NEUROBIOL DIS, V40, P415, DOI 10.1016/j.nbd.2010.07.001; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Jin JL, 2013, CURR NEUROVASC RES, V10, P11; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Mazzini L, 2010, EXP NEUROL, V223, P229, DOI [10.1016/j.expneurol.2009.08.007, 10.1016/j.expneuro1.2009.08.007]; Clark HB, 1997, J NEUROSCI, V17, P7385; Zhang MJ, 2011, BRAIN RES, V1402, P122, DOI 10.1016/j.brainres.2011.05.055; HARDING AE, 1983, LANCET, V1, P1151; Torashima T, 2008, EMBO REP, V9, P393, DOI 10.1038/embor.2008.31; Zuo J, 1997, NATURE, V388, P769; Gahan PB, 2010, CELL BIOCHEM FUNCT, V28, P529, DOI 10.1002/cbf.1690; Joyce N, 2010, REGEN MED, V5, P933, DOI [10.2217/rme.10.72, 10.2217/RME.10.72]; Bonab MM, 2012, CURR STEM CELL RES T, V7, P407; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Olson SD, 2012, MOL NEUROBIOL, V45, P87, DOI 10.1007/s12035-011-8219-8; Paul G, 2013, BIOCHIMIE, V95, P2246, DOI 10.1016/j.biochi.2013.07.013; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Newman Robert E., 2009, Inflammation & Allergy Drug Targets, V8, P110; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Orr HT, 2012, J CELL BIOL, V197, P167, DOI 10.1083/jcb.201105092; Aizman I, 2009, J NEUROSCI RES, V87, P3198, DOI 10.1002/jnr.22146; Manto MU, 2005, CEREBELLUM, V4, P2, DOI 10.1080/14734220510007914; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Chintawar S, 2009, J NEUROSCI, V29, P13126, DOI 10.1523/JNEUROSCI.0647-09.2009; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; ROBITAILLE Y, 1995, ACTA NEUROPATHOL, V90, P572; Dongmei Han, 2011, Cytotherapy, V13, P913, DOI 10.3109/14653249.2011.579958; Hirai H, 2008, CEREBELLUM, V7, P273, DOI 10.1007/s12311-008-0012-5; Le Blanc K, 2006, CYTOTHERAPY, V8, P559, DOI 10.1080/14653240601045399; Li Yi, 2005, Glia, V49, P407, DOI 10.1002/glia.20126; Liu J, 2013, CYTOTHERAPY, V15, P185, DOI 10.1016/j.jcyt.2012.09.005; Matilla-Duenas A, 2008, CEREBELLUM, V7, P106, DOI 10.1007/s12311-008-0009-0; Matsuura S, 2014, CEREBELLUM, V13, P323, DOI 10.1007/s12311-013-0536-1; Meyerrose T, 2010, ADV DRUG DELIVER REV, V62, P1167, DOI 10.1016/j.addr.2010.09.013; Meyerrose TE, 2008, STEM CELLS, V26, P1713, DOI 10.1634/stemcells.2008-0008; Olson SD, 2012, MOL CELL NEUROSCI, V49, P271, DOI 10.1016/j.mcn.2011.12.001; Sawada Y, 2010, CEREBELLUM, V9, P291, DOI 10.1007/s12311-010-0161-1; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1473-4222	1473-4230		CEREBELLUM	Cerebellum	APR	2015	14	2					165	170		10.1007/s12311-014-0604-1		6	Neurosciences	Neurosciences & Neurology	CD2HU	WOS:000350897800011		
J	Sato, K; Yamaguchi, Y; Ishida, Y; Ohizumi, Y				Sato, Kazuki; Yamaguchi, Yoko; Ishida, Yukisato; Ohizumi, Yasushi			Roles of Basic Amino Acid Residues in the Activity of mu-Conotoxin GIIIA and GIIIB, Peptide Blockers of Muscle Sodium Channels	CHEMICAL BIOLOGY & DRUG DESIGN			English	Article						basic residue; sodium channel; structure-activity relationship; mu-conotoxin GIIIA	CONUS-GEOGRAPHUS; BINDING-SITE; SUBTYPES; TOXINS; VENOM; DISCRIMINATION; TETRODOTOXIN; SAXITOXIN; GEOMETRY; ANALOGS	To study in detail the roles of basic amino acid residues in the activity of -conotoxin GIIIA (-GIIIA) and GIIIB (-GIIIB), specific blockers of muscle sodium channels, seven analogs of -GIIIA, and two analogs of -GIIIB were synthesized. -GIIIA analogs were synthesized by replacing systematically the three Arg residues (Arg(1), Arg(13), and Arg(19)) with one, two, and three Lys residues. -GIIIB analogs were synthesized by replacing simultaneously all four Lys residues (Lys(9), Lys(11), Lys(16), and Lys(19)) with Arg residues and further replacement of acidic Asp residues with neutral Ala residues. Circular dichroism spectra of the synthesized analogs suggested that the replacement did not affect the three dimensional structure. The inhibitory effects on the twitch contractions of the rat diaphragm showed that the side chain guanidino group of Arg(13) of -GIIIA was important for the activity, whereas that of Arg(19) had little role for biological activity. Although [Arg(9,11,16,19)]-GIIIB showed higher activity than native -GIIIB, highly basic [Ala(2,12), Arg(9,11,16,19)]-GIIIB showed lower activity, suggesting that there was an appropriate molecular basicity for the maximum activity.	[Sato, Kazuki; Yamaguchi, Yoko] Fukuoka Womens Univ, Dept Environm Sci, Higashi Ku, Fukuoka 8138529, Japan; [Ishida, Yukisato] Bunkyo Gakuin Univ, Fac Hlth Sci Technol, Fujimino, Saitama 3568533, Japan; [Ohizumi, Yasushi] Univ Shizuoka, Fac Pharmaceut Sci, Suruga Ku, Shizuoka, Shizuoka 4228526, Japan; [Ohizumi, Yasushi] Tohoku Fukushi Univ, Kansei Res Inst, Aoba Ku, Sendai, Miyagi 9818523, Japan	Sato, K (reprint author), Fukuoka Womens Univ, Dept Environm Sci, Higashi Ku, 1-1-1 Kasumigaoka, Fukuoka 8138529, Japan.	sato@fwu.ac.jp					Shon KJ, 1998, J BIOL CHEM, V273, P33, DOI 10.1074/jbc.273.1.33; McIntosh JM, 1999, ANNU REV BIOCHEM, V68, P59, DOI 10.1146/annurev.biochem.68.1.59; SATO S, 1983, FEBS LETT, V155, P277, DOI 10.1016/0014-5793(82)80620-0; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P12577, DOI 10.1021/bi00165a006; Sato K, 2014, INT J PEPT RES THER, V20, P253, DOI 10.1007/s10989-013-9389-1; Hill JM, 1996, BIOCHEMISTRY-US, V35, P8824, DOI 10.1021/bi960073o; BECKER S, 1992, BIOCHEMISTRY-US, V31, P8229, DOI 10.1021/bi00150a016; SATO K, 1991, J BIOL CHEM, V266, P16989; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; OLIVERA BM, 1987, BIOCHEMISTRY-US, V26, P2086, DOI 10.1021/bi00382a004; GRAY WR, 1988, ANNU REV BIOCHEM, V57, P665; Miljanich GP, 2004, CURR MED CHEM, V11, P3029; MOCZYDLOWSKI E, 1986, P NATL ACAD SCI USA, V83, P5321, DOI 10.1073/pnas.83.14.5321; Chahine M, 1995, RECEPTOR CHANNEL, V3, P161; Chang NS, 1998, BIOCHEMISTRY-US, V37, P4407, DOI 10.1021/bi9724927; Dudley SC, 1995, BIOPHYS J, V69, P1657; FAINZILBER M, 1991, EUR J BIOCHEM, V202, P589, DOI 10.1111/j.1432-1033.1991.tb16412.x; French RJ, 1996, NEURON, V16, P407, DOI 10.1016/S0896-6273(00)80058-6; Han TS, 2009, CHEMMEDCHEM, V4, P406, DOI 10.1002/cmdc.200800292; HIDAKA Y, 1990, FEBS LETT, V264, P29, DOI 10.1016/0014-5793(90)80756-9; Hill JM, 1997, STRUCTURE, V5, P571, DOI 10.1016/S0969-2126(97)00212-8; Jones R M, 2000, Curr Opin Drug Discov Devel, V3, P141; KOTAKI Y, 1993, J AM CHEM SOC, V115, P827, DOI 10.1021/ja00056a001; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; McIntosh J M, 1999, Methods Enzymol, V294, P605; NAKAMURA H, 1983, EXPERIENTIA, V39, P590, DOI 10.1007/BF01971110; Nakamura M, 2004, J PEPT RES, V64, P110, DOI 10.1111/j.1399-3011.2004.00175.x; Sato K, 2014, INT J PEPT RES THER, V20, P435, DOI 10.1007/s10989-014-9407-y	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1747-0277	1747-0285		CHEM BIOL DRUG DES	Chem. Biol. Drug Des.	APR	2015	85	4					488	493		10.1111/cbdd.12433		6	Biochemistry & Molecular Biology; Chemistry, Medicinal	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CD6EC	WOS:000351181300009		
J	Yasmin, H; Rahman, MS; Shibata, T; Kabashima, T; Kai, M				Yasmin, Hasina; Rahman, Mohammed Shafikur; Shibata, Takayuki; Kabashima, Tsutomu; Kai, Masaaki			Sensitive and selective determination of peptides, PG and PGP, using a novel fluorogenic reagent 4-chlorobenzene-1,2-diol	CHEMICAL PAPERS			English	Article						fluorescence; 4-chlorobenzene-1,2-diol; selectivity; PG; PGP	GLYCINE-PROLINE-GLUTAMATE; N-TERMINAL TRIPEPTIDE; GROWTH-FACTOR-I; RAT; BRAIN; ACID	A novel fluorometric method was developed for the sensitive and selective detection of Pro-Gly (PG) and Pro-Gly-Pro (PGP) using 4-chlorobenzene-1,2-diol (4-CBD) as a fluorogenic reagent. The reaction was performed at 37 degrees C for 30 min in the presence of a borate buffer (pH 7.0) and sodium periodate. The resulting fluorescence intensity was measured using a spectrofluorometer with excitation and emission wavelengths of 450 nm and 535 nm. To obtain a stable fluorescent signal and maximise its intensity, different reaction conditions such as the concentrations of the reagents, the reaction time, and the pH were optimised. Under the optimised conditions, a linear relationship was obtained between fluorescence intensity and peptide concentrations from 1.0-40.0 mu mol L-1 with a limit of detection of 1.0 mu mol L-1 (S/N = 3). Both PG and PGP generated a strong signal out of all the peptides tested and no other biogenic substances such as amino acids or proteins produced any fluorescence. The reaction thus developed is simple, rapid, selective, and sensitive. It can be applied to the determination of peptides as biomarkers or substrates. (c) 2014 Institute of Chemistry, Slovak Academy of Sciences	[Yasmin, Hasina; Rahman, Mohammed Shafikur; Shibata, Takayuki; Kabashima, Tsutomu; Kai, Masaaki] Nagasaki Univ, Fac Pharmaceut Sci, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Yasmin, Hasina; Rahman, Mohammed Shafikur] State Univ Bangladesh, Dept Pharm, Dhaka 1205, Bangladesh	Rahman, MS (reprint author), Nagasaki Univ, Fac Pharmaceut Sci, Grad Sch Biomed Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	novolemon@yahoo.com			Ministry of Education, Culture, Sports and Technology of Japan; Global Centre of Excellence Programme at Nagasaki University	This work was financially supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports and Technology of Japan and the Global Centre of Excellence Programme at Nagasaki University.	Gaggar A, 2008, J IMMUNOL, V180, P5662; Kabashima T, 2008, PEPTIDES, V29, P356, DOI 10.1016/j.peptides.2007.11.014; Gentilucci L, 2004, CURR TOP MED CHEM, V4, P19, DOI 10.2174/1568026043451663; Sizonenko SV, 2001, BRAIN RES, V922, P42, DOI 10.1016/S0006-8993(01)03148-1; Baker AM, 2005, NEUROPEPTIDES, V39, P81, DOI 10.1016/j.npep.2004.11.001; Ioudina M, 2003, EXP NEUROL, V184, P923, DOI 10.1016/S0014-4886(03)00314-5; Lyapina LA, 2000, BLOOD COAGUL FIBRIN, V11, P409, DOI 10.1097/00001721-200007000-00002; Pan W, 2007, PEPTIDES, V28, P2411, DOI 10.1016/j.peptides.2007.10.006; PICKART L, 1980, NATURE, V288, P715, DOI 10.1038/288715a0; RAMESH CV, 1995, INT J PEPT PROT RES, V45, P386; SARA VR, 1989, BIOCHEM BIOPH RES CO, V165, P766, DOI 10.1016/S0006-291X(89)80032-4; TOYOOKA T, 1994, J CHROMATOGR A, V661, P105, DOI 10.1016/0021-9673(94)85182-4; Yasmin H, 2012, ANAL CHIM ACTA, V721, P162, DOI 10.1016/j.aca.2012.01.035	13	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0366-6352	1336-9075		CHEM PAP	Chem. Pap.	APR	2015	69	4					504	509		10.1515/chempap-2015-0057		6	Chemistry, Multidisciplinary	Chemistry	CD0FE	WOS:000350745200002		
J	Sato, K; Takayanagi, T				Sato, Kazuma; Takayanagi, Toshiyuki			Quantum reactive scattering study of the S(P-3) + NH(X3 Sigma) -> NS(X-2 Pi) + H(S-2)/SH(X-2 Pi) + N(S-4) reaction on the lowest three ((1)A ', (1)A '', and (3)A '') potential energy surfaces: Contribution of HNS/HSN isomerization and spin-forbidden process	CHEMICAL PHYSICS			English	Article						Quantum reactive scattering; Potential energy surface; Cross section; Isomerization; HNS molecule; Wave packet dynamics	NITROGEN SULFIDE; HALE-BOPP; AB-INITIO; HNS; APPROXIMATION; DYNAMICS; SPECTRA; CLOUDS; STATES; NSH	Quantum dynamics for the reaction between S(P-3) and NH(X-3 Sigma) has been investigated on the lowest three adiabatic (1)A', (1)A '', and (3)A '' potential energy surfaces, which have been recently developed on the basis of accurate ab initio electronic structure calculations. We employed both time-dependent and time-independent quantum reactive scattering methods. We report collision energy dependence of reactive cross sections and product NS vibrational distributions calculated within adiabatic treatment. The reaction proceeds with a complex-forming mechanism via an initial barrier-less process; however, the results of quantum reactive scattering calculations suggest non-statistical behaviors. The contribution of the HNS/HSN isomerization as well as singlet-triplet spin-forbidden process on the overall reactivity is also discussed. (C) 2015 Elsevier B.V. All rights reserved.	[Sato, Kazuma; Takayanagi, Toshiyuki] Saitama Univ, Dept Chem, Sakura Ku, Saitama, Saitama 3388570, Japan	Takayanagi, T (reprint author), Saitama Univ, Dept Chem, Sakura Ku, 255 Shimo Okubo, Saitama, Saitama 3388570, Japan.	tako@mail.saitama-u.ac.jp					Sato K, 2014, CHEM PHYS, V439, P63, DOI 10.1016/j.chemphys.2014.05.009; Gersdorf P, 1997, J PHYS CHEM A, V101, P8778, DOI 10.1021/jp9710190; Guo H, 2012, INT REV PHYS CHEM, V31, P1, DOI 10.1080/0144235X.2011.649999; TALEZER H, 1984, J CHEM PHYS, V81, P3967, DOI 10.1063/1.448136; Nyman G, 2000, REP PROG PHYS, V63, P1001, DOI 10.1088/0034-4885/63/7/201; Denis PA, 2004, J PHYS CHEM A, V108, P5073, DOI 10.1021/jp0498466; MCGONAGLE D, 1994, ASTROPHYS J, V422, P621, DOI 10.1086/173755; Crovisier J, 2004, ASTRON ASTROPHYS, V418, P1141, DOI 10.1051/0004-6361:20035688; WATTS JD, 1995, J PHYS CHEM-US, V99, P5331, DOI 10.1021/j100015a015; LIGHT JC, 1985, J CHEM PHYS, V82, P1400, DOI 10.1063/1.448462; McGonagle D, 1997, ASTROPHYS J, V477, P711, DOI 10.1086/303749; MCGUIRE P, 1974, J CHEM PHYS, V60, P2488, DOI 10.1063/1.1681388; Skouteris D, 2000, COMPUT PHYS COMMUN, V133, P128, DOI 10.1016/S0010-4655(00)00167-3; Pereira PSS, 2010, J PHYS CHEM A, V114, P509, DOI 10.1021/jp907384d; Li AY, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4774026; MEHLHORN A, 1995, THEOCHEM-J MOL STRUC, V339, P219; GOTTLIEB CA, 1975, ASTROPHYS J, V200, pL147, DOI 10.1086/181918; Irvine WM, 2000, ICARUS, V143, P412, DOI 10.1006/icar.1999.6281; KUIPER TBH, 1975, ASTROPHYS J, V200, pL151, DOI 10.1086/181919; Peebles LR, 2002, CHEM PHYS LETT, V366, P520, DOI 10.1016/S0009-2614(02)01619-6; Werner H.-J., MOLPRO IS PACKAGE AB; Yaghlane SB, 2014, J CHEM PHYS, V140; Yaghlane S. B., 2002, THEOCHEM, V577	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-0104	1873-4421		CHEM PHYS	Chem. Phys.	APR 1	2015	450						74	82		10.1016/j.chemphys.2015.02.011		9	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CD1XP	WOS:000350868100008		
J	Takahashi, O; Kimoto, M; Pettersson, LGM				Takahashi, Osamu; Kimoto, Mai; Pettersson, Lars G. M.			Theoretical study of the X-ray natural circular dichroism of some crystalline amino acids	CHEMICAL PHYSICS			English	Article						XNCD; K-shell; DFT; Amino acid	POLARIZING UNDULATOR; ABSORPTION SPECTRA; CHIRAL MOLECULES; 1ST OBSERVATION; EDGE; CLUSTERS; ACCURATE; ALANINE; ENERGY	X-ray natural circular dichroism (XNCD) spectra of alanine and serine were calculated at the C, N, and O K-edges within the framework of density functional theory. Basis set and gauge dependence of D-alanine were examined as a test case. XNCD spectra of crystalline D-alanine and L-serine were obtained using cluster models of increasing size. The absolute intensities of the XNCD spectra were found to be reduced in the solid phase compared to the gas phase monomers, suggesting that a monomer model is not necessarily a good representation of the solid phase. (C) 2015 Elsevier B.V. All rights reserved.	[Takahashi, Osamu] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 7398526, Japan; [Kimoto, Mai] Hiroshima Univ, Dept Chem, Higashihiroshima 7398526, Japan; [Pettersson, Lars G. M.] Univ Stockholm, Dept Phys, AlbaNova Univ Ctr, S-10691 Stockholm, Sweden	Takahashi, O (reprint author), Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 7398526, Japan.	shu@hiroshima-u.ac.jp	Pettersson, Lars/J-4925-2013	Pettersson, Lars/0000-0003-1133-9934	JSPS KAKENHI [23540476]; Asahi Glass Foundation; Swedish research council (VR)	The authors thank the Information Media Center at Hiroshima University for the use of a grid with high-performance PCs, and the Research Center for Computational Science, Okazaki, Japan for the use of the Fujitsu PRIMEQUEST. This work was supported by JSPS KAKENHI Grant Number 23540476, by the Asahi Glass Foundation and the Swedish research council (VR).	Alagna L, 1998, PHYS REV LETT, V80, P4799, DOI 10.1103/PhysRevLett.80.4799; PERDEW JP, 1986, PHYS REV B, V33, P8800, DOI 10.1103/PhysRevB.33.8800; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; Autschbach J, 2009, CHIRALITY, V21, pE116, DOI 10.1002/chir.20789; PETTERSSON LGM, 1987, J CHEM PHYS, V86, P2176, DOI 10.1063/1.452115; Feyer V, 2008, J PHYS CHEM A, V112, P7806, DOI 10.1021/jp803017y; Triguero L, 1998, PHYS REV B, V58, P8097, DOI 10.1103/PhysRevB.58.8097; Kolczewski C, 2001, J CHEM PHYS, V115, P6426, DOI 10.1063/1.1397797; Takahashi O, 2004, J CHEM PHYS, V121, P10339, DOI 10.1063/1.1809610; Freedman TB, 2003, CHIRALITY, V15, P743, DOI 10.1002/chir.10287; AGREN H, 1994, CHEM PHYS LETT, V222, P75, DOI 10.1016/0009-2614(94)00318-1; Bernadotte S, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4766359; Berova N., 2012, COMPREHENSIVE CHIROP; Boldyreva EV, 2005, Z KRISTALLOGR, V220, P58, DOI 10.1524/zkri.220.1.58.58893; Carravetta V, 1997, CHEM PHYS LETT, V275, P70, DOI 10.1016/S0009-2614(97)00687-8; Frisch M. J., 2004, GAUSSIAN 03 REVISION; Hansen A. E., 1980, ADV CHEM PHYS, V44, P545, DOI 10.1002/9780470142639.ch5; Hermann K., 2006, STOBE DEMON VERSION; Izumi Y, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4790599; Jiemchooroj A, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2800024; Leetmaa M, 2010, J ELECTRON SPECTROSC, V177, P135, DOI 10.1016/j.elspec.2010.02.004; Nakagawa K, 2009, RADIAT PHYS CHEM, V78, P1198, DOI 10.1016/j.radphyschem.2009.07.010; Plashkevych O, 1998, CHEM PHYS, V232, P49, DOI 10.1016/S0301-0104(98)00055-X; Stewart B, 1999, J AM CHEM SOC, V121, P10233, DOI 10.1021/ja9920720; Stohr J., 1992, NEXAFS SPECTROSCOPY; Takahashi O, 2006, CHEM PHYS LETT, V419, P501, DOI 10.1016/j.cplett.2005.12.027; Tanaka M, 2005, PHYS SCRIPTA, VT115, P873; Tanaka M, 2009, J SYNCHROTRON RADIAT, V16, P455, DOI 10.1107/S0909049509012291; Turchini S, 2004, J AM CHEM SOC, V126, P4532, DOI 10.1021/ja039348v; Wilson CC, 2005, NEW J CHEM, V29, P1318, DOI 10.1039/b419295h	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-0104	1873-4421		CHEM PHYS	Chem. Phys.	APR 1	2015	450						109	114		10.1016/j.chemphys.2015.01.012		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CD1XP	WOS:000350868100013		
J	Daimon, M; Konta, T; Oizumi, T; Kameda, W; Susa, S; Terui, K; Nigawara, T; Kageyama, K; Ueno, Y; Kubota, I; Yamashita, H; Kayama, T; Kato, T				Daimon, Makoto; Konta, Tsuneo; Oizumi, Toshihide; Kameda, Wataru; Susa, Shinji; Terui, Ken; Nigawara, Takeshi; Kageyama, Kazunori; Ueno, Yoshiyuki; Kubota, Isao; Yamashita, Hidetoshi; Kayama, Takamasa; Kato, Takeo			Lower aldosterone-renin ratio is a risk factor for total and cancer death in Japanese individuals: the Takahata study	CLINICAL ENDOCRINOLOGY			English	Article							ANGIOTENSIN SYSTEM; MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; INHIBITORS; HYPERTENSIVES; POLYMORPHISM; DYSFUNCTION; EPLERENONE; MORTALITY; DIAGNOSIS	ObjectiveA higher plasma aldosterone-renin ratio (ARR) is an established marker for screening for primary aldosteronism (PA). The association between higher ARR and mortality in a general population has not been fully explored. We here examined whether higher ARR is a risk factor for total and cause-specific mortality in a Japanese population. Subjects and MethodsA population-based, longitudinal study of 1,310 Japanese individuals (age: 63998years) enrolled in the Takahata study between 2004 and 2006 and followed for up to 8years. The incidence and causes of death were monitored annually until 10 January 2012 (median follow-up: 2691days). ResultsDuring the follow-up period, 64 subjects died. Kaplan-Meier analysis showed a significantly increased risk for total and cancer mortality in subjects with lower ARR (log-rank P<0001). Cox's proportional hazard model analyses with adjustment for age and gender showed that lower ARR was associated with increased total and cancer mortality in subjects with low (72) vs high (>72) ARR (hazard ratios and 95% confidential intervals: 256, 144-456 and 278, 116-665, respectively). ConclusionsLower ARR was a significant and independent risk factor for increased total and cancer mortality in this Japanese population. Subjects with higher ARR were not-at-risk for total death in general. These findings increase the necessity for identifying people with PA from those with higher ARR. People with higher ARR without PA may be at very low risk for total and cancer death.	[Daimon, Makoto; Terui, Ken; Nigawara, Takeshi; Kageyama, Kazunori] Hirosaki Univ Sch Med & Hosp, Dept Endocrinol Metab & Infect Dis, Hirosaki, Aomori 0368562, Japan; [Konta, Tsuneo; Ueno, Yoshiyuki; Kubota, Isao; Yamashita, Hidetoshi; Kayama, Takamasa; Kato, Takeo] Yamagata Univ Fac Med, Inst Promot Med Sci Res, Yamagata, Japan; [Oizumi, Toshihide; Kameda, Wataru; Susa, Shinji; Kato, Takeo] Yamagata Univ Fac Med, DNHMED, Yamagata, Japan	Daimon, M (reprint author), Hirosaki Univ Sch Med & Hosp, Dept Endocrinol Metab & Infect Dis, Hirosaki, Aomori 0368562, Japan.	mdaimon@cc.hirosaki-u.ac.jp			Global Center of Excellence Program [F03]; Ministry of Health, Labour and Welfare of Japan [H22-seishuu-005]	This work was supported in part by the Global Center of Excellence Program (no. F03) founded by the Japan Society for the Promotion of Science, Japan, and by Health Sciences Research Grants (H22-seishuu-005) from the Ministry of Health, Labour and Welfare of Japan.	Albanis E, 2006, AM J TRANSPLANT, V6, P12, DOI 10.1111/j.1600-6143.2005.01143.x; Farquharson CAJ, 2002, CLIN SCI, V103, P425; Weir MR, 2007, CLIN THER, V29, P1803, DOI 10.1016/j.clinthera.2007.09.019; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Kim S, 2000, PHARMACOL REV, V52, P11; Scheen AJ, 2004, DRUGS, V64, P2537, DOI 10.2165/00003495-200464220-00004; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Young WF, 2007, CLIN ENDOCRINOL, V66, P607, DOI 10.1111/j.1365-2265.2007.02775.x; Beygui F, 2006, CIRCULATION, V114, P2604, DOI 10.1161/CIRCULATIONAHA.106.634626; Ferrario CM, 2006, J RENIN-ANGIO-ALDO S, V7, P3, DOI 10.3317/jraas.2006.003; Daimon M, 2008, BIOCHEM BIOPH RES CO, V374, P576, DOI 10.1016/j.bbrc.2008.07.065; Lindholm LH, 2001, LANCET, V358, P539, DOI 10.1016/S0140-6736(01)05704-X; Tomaschitz A, 2010, EUR HEART J, V31, P1237, DOI 10.1093/eurheartj/ehq019; Lever AF, 1998, LANCET, V352, P179, DOI 10.1016/S0140-6736(98)03228-0; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Yvan-Charvet L, 2011, KIDNEY INT, V79, P162, DOI 10.1038/ki.2010.391; van der Knaap R, 2008, CANCER, V112, P748, DOI 10.1002/cncr.23215; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Daimon M, 2012, METABOLISM, V61, P504, DOI 10.1016/j.metabol.2011.08.004; Ager EI, 2008, CARCINOGENESIS, V29, P1675, DOI 10.1093/carcin/bgn171; Brunner H. R., 2001, AM J CARDIOL, V87, P3, DOI 10.1016/S0002-9149(01)01538-7; Dusing R, 2009, CURR MED RES OPIN, V25, P2287, DOI 10.1185/03007990903152045; Lamarre-Cliche M, 2005, AM J HYPERTENS, V18, P56, DOI 10.1016/j.amjhyper.2004.08.025; Manolopoulou J, 2009, STEROIDS, V74, P853, DOI 10.1016/j.steroids.2009.05.006; Padfield PL, 2002, J HUM HYPERTENS, V16, P159, DOI 10.1038/sj/jhh/1001321; Qin WN, 2003, CIRC RES, V93, P69, DOI 10.1161/01.RES.0000080521.15238.E5; Satoh M, 2012, AM J HYPERTENS, V25, P777, DOI 10.1038/ajh.2012.33; Schmidt BMW, 2003, AM J HYPERTENS, V16, P80, DOI 10.1016/S0895-7061(02)03199-0; Tanabe A, 2003, J CLIN ENDOCR METAB, V88, P2489, DOI 10.1210/jc.2002-021476; The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus, 2010, J JAPAN DIAB SOC, V53, P450; Ward MR, 2001, CIRCULATION, V104, P467, DOI 10.1161/hc3001.091458; Yang XL, 2010, DIABETES RES CLIN PR, V87, P117, DOI 10.1016/j.diabres.2009.10.012	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	APR	2015	82	4					489	496		10.1111/cen.12615		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CD3MN	WOS:000350982900005		
J	Ito, H				Ito, Hiroshi			CORR Insights(A (R)): Are There Sex-dependent Differences in Acetabular Dysplasia Characteristics?	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Editorial Material							BERNESE PERIACETABULAR OSTEOTOMY; FOLLOW-UP		Asahikawa Med Univ, Dept Orthopaed Surg, Asahikawa, Hokkaido 0788510, Japan	Ito, H (reprint author), Asahikawa Med Univ, Dept Orthopaed Surg, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	itohiro@asahikawa-med.ac.jp					Hartig-Andreasen C, 2012, CLIN ORTHOP RELAT R, V470, P2978, DOI 10.1007/s11999-012-2386-4; Matheney T, 2009, J BONE JOINT SURG AM, V91A, P2113, DOI 10.2106/JBJS.G.00143; Ziebarth K, 2011, CLIN ORTHOP RELAT R, V469, P447, DOI 10.1007/s11999-010-1544-9; Nassif NA, 2012, J BONE JOINT SURG AM, V94A, P1959, DOI 10.2106/JBJS.K.01038; Steppacher SD, 2008, CLIN ORTHOP RELAT R, V466, P1633, DOI 10.1007/s11999-008-0242-3; Ito H, 2011, J BONE JOINT SURG AM, V93, P1337	6	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	APR	2015	473	4					1440	1441		10.1007/s11999-015-4188-y		2	Orthopedics; Surgery	Orthopedics; Surgery	CD2DY	WOS:000350885600038		
J	Kamiya, N; Yamaguchi, R; Aruwajoye, O; Adapala, NS; Kim, HKW				Kamiya, Nobuhiro; Yamaguchi, Ryosuke; Aruwajoye, Olumide; Adapala, Naga Suresh; Kim, Harry K. W.			Development of a Mouse Model of Ischemic Osteonecrosis	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							CAPITAL FEMORAL EPIPHYSIS; CALVE-PERTHES DISEASE; GLUCOCORTICOID-INDUCED OSTEONECROSIS; STEROID-INDUCED OSTEONECROSIS; AVASCULAR OSTEONECROSIS; CELL-DEATH; HEAD; NECROSIS; RABBITS; FRACTURES	Availability of a reliable mouse model of ischemic osteonecrosis could accelerate the development of novel therapeutic strategies to stimulate bone healing after ischemic osteonecrosis; however, no mouse model of ischemic osteonecrosis is currently available. To develop a surgical mouse model of ischemic osteonecrosis, we asked, (1) if the blood vessels that contribute to the blood supply of the distal femoral epiphysis are cauterized, can we generate an osteonecrosis mouse model; (2) what are the histologic changes observed in this mouse model, and (3) what are the morphologic changes in the model. We performed microangiography to identify blood vessels supplying the distal femoral epiphysis in mice, and four vessels were cauterized using microsurgical techniques to induce ischemic osteonecrosis. Histologic assessment of cell death in the trabecular bone was performed using terminal deoxynucleotidyl transferase mediated dUTP nick-end labeling (TUNEL) and counting the empty lacunae in three serial sections. Quantitation of osteoclast and osteoblast numbers was performed using image analysis software. Morphologic assessments of the distal femoral epiphysis for deformity and for trabecular bone parameters were performed using micro-CT. We identified four blood vessels about the knee that had to be cauterized to induce total ischemic osteonecrosis of the distal femoral epiphysis. Qualitative assessment of histologic sections of the epiphysis showed a loss of nuclear staining of marrow cells, disorganized marrow structure, and necrotic blood vessels at 1 week. By 2 weeks, vascular tissue invasion of the necrotic marrow space was observed with a progressive increase in infiltration of the necrotic marrow space with the vascular tissue at 4 and 6 weeks. TUNEL staining showed extensive cell death in the marrow and trabecular bone 24 hours after the induction of ischemia. The mean percent of TUNEL-positive osteocytes in the trabecular bone increased from 2% +/- A 1% in the control group to a peak of 98% +/- A 3% in the ischemic group 1 week after induction of ischemia (mean difference, 96%; 95% CI, 81%-111%; p < 0.0001). The mean percent of empty lacunae increased from 1% +/- A 1% in the control group to a peak of 78% +/- A 15% in the ischemic group at 4 weeks (mean difference, 77%; 95% CI, 56%-97%; p < 0.0001). Quantitative analysis showed that the mean number of osteoclasts per bone surface was decreased in the ischemic group at 1, 2, and 4 weeks (p < 0.0001, < 0.0001, and p = 0.02, respectively) compared with the control group. The mean number of osteoclasts increased to a level similar to that of the control group at 6 weeks (p = 0.23). The numbers of osteoblasts per bone surface were decreased in the ischemic group at 1, 2 and 4 weeks (p < 0.0001 for each) compared with the numbers in the control group. The mean number of osteoblasts also increased to a level similar to that of the control group at 6 weeks (p = 0.91). Mean bone volume percent assessed by micro-CT was lower in the ischemic group compared with the control group from 2 to 6 weeks. The mean differences in the percent bone volume between the control and ischemic groups at 2, 4, and 6 weeks were 5.5% (95% CI, 0.9%-10.2%; p = 0.01), 5.3% (95% CI, 0.6%-9.9%; p = 0.02), and 6.0% (95% CI, 1.1%-10.9%; p = 0.008), respectively. A deformity of the distal femoral epiphysis was observed at 6 weeks with the mean epiphyseal height to width ratio of 0.74 +/- A 0.03 in the control group compared with 0.66 +/- A 0.06 in the ischemic group (mean difference, 0.08; 95% CI, 0.00-0.16; p = 0.03). We developed a novel mouse model of ischemic osteonecrosis that produced extensive cell death in the distal femoral epiphysis which developed a deformity with time. The new mouse model may be a useful tool to test potential therapeutic strategies to improve bone healing after ischemic osteonecrosis.	[Kamiya, Nobuhiro; Yamaguchi, Ryosuke; Aruwajoye, Olumide; Adapala, Naga Suresh; Kim, Harry K. W.] Texas Scottish Rite Hosp Children, Ctr Excellence Hip Disorders, Dallas, TX 75219 USA; [Kamiya, Nobuhiro; Yamaguchi, Ryosuke; Adapala, Naga Suresh; Kim, Harry K. W.] Univ Texas SW Med Ctr Dallas, Dept Orthopaed Surg, Dallas, TX 75390 USA; [Kamiya, Nobuhiro] Tenri Univ, Sports Med, Tenri, Nara, Japan	Kim, HKW (reprint author), Texas Scottish Rite Hosp Children, Ctr Excellence Hip Disorders, 2222 Welborn St, Dallas, TX 75219 USA.	Harry.Kim@tsrh.org			Pediatric Orthopaedic Society of North America; Texas Scottish Rite Hospital for Children	The institution of one or more of the authors has received, during the study period, funding from the Pediatric Orthopaedic Society of North America (HKWK), and an intramural grant from Texas Scottish Rite Hospital for Children (NK and HKWK).	Kim HKW, 2004, J BONE MINER RES, V19, P2041, DOI 10.1359/JBMR.040911; Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; Rammelt S, 2009, INJURY, V40, P120, DOI 10.1016/j.injury.2008.01.021; Mont MA, 2006, J BONE JOINT SURG AM, V88A, P1117, DOI 10.2106/JBJS.E.01041; Yeranosian M, 2013, BONE JOINT J, V95B, P135, DOI 10.1302/0301-620X.95B1.30161; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Yang L, 2009, J ORTHOP RES, V27, P169, DOI 10.1002/jor.20733; Loizou CL, 2009, INJURY, V40, P1143, DOI 10.1016/j.injury.2008.11.003; Drescher W, 2011, J ORTHOP RES, V29, P1517, DOI 10.1002/jor.21420; Duvall CL, 2004, AM J PHYSIOL-HEART C, V287, pH302, DOI 10.1152/ajpheart.00928.2003; Kabata T, 2005, RHEUMATOLOGY, V44, P1233, DOI 10.1093/rheumatology/keh721; Conzemius MG, 2002, J ORTHOPAED RES, V20, P303, DOI 10.1016/S0736-0266(01)00108-5; Seiler JG, 1996, ACTA ORTHOP SCAND, V67, P249; Calder JDF, 2004, J BONE JOINT SURG BR, V86B, P1209, DOI 10.1302/0301-620X.86B8.14834; Komatsu DE, 2010, J ORTHOP RES, V28, P928, DOI 10.1002/jor.21078; Boss JH, 2003, VET PATHOL, V40, P345, DOI 10.1354/vp.40-4-345; Kim HKW, 2012, J BONE JOINT SURG AM, V94A, P659, DOI 10.2106/JBJS.J.01834; Weinstein RS, 2012, ENDOCRINE, V41, P183, DOI 10.1007/s12020-011-9580-0; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Kim HKW, 2002, J BONE JOINT SURG AM, V84A, P1329; Nishino M, 1997, ARCH ORTHOP TRAUM SU, V116, P259, DOI 10.1007/BF00390048; Boss JH, 2001, CURR ORTHOPAED, V15, P57, DOI 10.1054/cuor.2001.0140; CALVERT PT, 1984, ACTA ORTHOP SCAND, V55, P526; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Fan M, 2011, RHEUMATOL INT, V31, P983, DOI 10.1007/s00296-011-1819-9; Heilmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084232; HIRANO T, 1988, ACTA ORTHOP SCAND, V59, P530, DOI 10.3109/17453678809148778; Hofstaetter JG, 2006, CELLS TISSUES ORGANS, V184, P138, DOI 10.1159/000099620; Irisa T, 2001, BONE, V28, P641, DOI 10.1016/S8756-3282(01)00460-4; Iwakiri K, 2008, J ORTHOP SCI, V13, P463, DOI 10.1007/s00776-008-1257-z; Jerome C, 2012, COMP ANATOMY HISTOLO, P53; Keijser LCM, 1999, ARCH ORTHOP TRAUM SU, V119, P440, DOI 10.1007/s004020050017; KENZORA JE, 1978, CLIN ORTHOP RELAT R, P8; Kim HK, 2011, CLIN REV BONE MINER, V9, P2; Kim HKW, 2001, J BONE JOINT SURG AM, V83A, P688; Kothapalli R, 2007, PATHOLOGY, V39, P241, DOI 10.1080/00313020701230765; Levin D, 1999, EXP MOL PATHOL, V67, P99, DOI 10.1006/exmp.1999.2273; MALIZOS KN, 1993, J ORTHOPAED RES, V11, P350, DOI 10.1002/jor.1100110306; MATSUI M, 1995, VIRCHOWS ARCH, V427, P205; MCANDREW MP, 1984, J BONE JOINT SURG AM, V66A, P860; MICKELSON MR, 1981, CLIN ORTHOP RELAT R, P287; Nakata K, 1996, BONE, V18, P609, DOI 10.1016/8756-3282(96)00078-6; Norman D, 1998, INT J EXP PATHOL, V79, P173; Reed KL, 2003, J BIOMECH, V36, P1317, DOI 10.1016/S0021-9290(03)00154-4; SZABO RM, 1988, CLIN ORTHOP RELAT R, P30; Velez R, 2011, ARCH ORTHOP TRAUM SU, V131, P5, DOI 10.1007/s00402-010-1084-5; Wang YS, 2008, CLIN ORTHOP RELAT R, V466, P1059, DOI 10.1007/s11999-008-0178-7; Youm Yoon-Seok, 2010, Clin Orthop Surg, V2, P250, DOI 10.4055/cios.2010.2.4.250	49	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	APR	2015	473	4					1486	1498		10.1007/s11999-015-4172-6		13	Orthopedics; Surgery	Orthopedics; Surgery	CD2DY	WOS:000350885600047		
J	Peng, B; Li, L				Peng, Bo; Li, Lei			An improved localization algorithm based on genetic algorithm in wireless sensor networks	COGNITIVE NEURODYNAMICS			English	Article						Wireless sensor network; Localization; DV-Hop; Genetic algorithm		Wireless sensor network (WSN) are widely used in many applications. A WSN is a wireless decentralized structure network comprised of nodes, which autonomously set up a network. The node localization that is to be aware of position of the node in the network is an essential part of many sensor network operations and applications. The existing localization algorithms can be classified into two categories: range-based and range-free. The range-based localization algorithm has requirements on hardware, thus is expensive to be implemented in practice. The range-free localization algorithm reduces the hardware cost. Because of the hardware limitations of WSN devices, solutions in range-free localization are being pursued as a cost-effective alternative to more expensive range-based approaches. However, these techniques usually have higher localization error compared to the range-based algorithms. DV-Hop is a typical range-free localization algorithm utilizing hop-distance estimation. In this paper, we propose an improved DV-Hop algorithm based on genetic algorithm. Simulation results show that our proposed algorithm improves the localization accuracy compared with previous algorithms.	[Peng, Bo] Hosei Univ, Grad Sch Engn, Koganei, Tokyo 1848584, Japan; [Li, Lei] Hosei Univ, Fac Sci & Engn, Koganei, Tokyo 1848584, Japan	Peng, B (reprint author), Hosei Univ, Grad Sch Engn, Koganei, Tokyo 1848584, Japan.	pengbo1002@hotmail.com					Akyildiz IF, 2002, COMPUT NETW, V38, P393, DOI 10.1016/S1389-1286(01)00302-4; Kazarlis SA, 1996, IEEE T POWER SYST, V11, P83, DOI 10.1109/59.485989; Bulusu N, 2000, IEEE PERS COMMUN, V7, P28, DOI 10.1109/98.878533; Girod L, 2002, PR IEEE COMP DESIGN, P214, DOI 10.1109/ICCD.2002.1106773; Doherty L, 2001, P IEEE INFOCOM ANCH, P1478; Forrest S., 1993, FDN GENETIC ALGORITH, V2; Gao Y, 2010, P IEEE 5 INT C BIO I, P439; Girod L., 2001, IEEE INT C INT ROB S, V3, P1312, DOI DOI 10.1109/IROS.2001.977164; Goldberg DE, 1989, GENETIC ALGORITHMS S, V432; Gu MS, 2013, J INF COMPUT SCI, V10, P1497; He T., 2003, P 9 ANN INT C MOB CO, P81, DOI DOI 10.1145/938985.938995; Holland J. H., 1975, ADAPTATION NATURAL A; Li Wenwen, 2011, P 7 INT C NAT COMP I, P2096; Liu D., 2010, J SOFTWARE, V5, P1243; Nagpal R, 1999, 1666 MIT AI LAB; Nan G.F., 2007, P INT C MACH LEARN C, V2, P873; Nicolescu D., 2003, J TELECOMMUNICATION, V22, P267; Nicolescu D, 2001, P 2001 IEEE GLOB TEL, V5, P2926; Niculescu D, 2003, P IEEE INFOCOM 03 SA, P3; Parkinson BW, 1996, PROGR AERONAUTICS AS, V793; Savvides A., 2001, P 7 ANN INT C MOB CO, P166, DOI DOI 10.1145/381677.381693	21	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1871-4080	1871-4099		COGN NEURODYNAMICS	Cogn. Neurodynamics	APR	2015	9	2					249	256		10.1007/s11571-014-9324-y		8	Neurosciences	Neurosciences & Neurology	CD2BF	WOS:000350877900010		
J	Yudhanto, A; Lubineau, G; Ventura, IA; Watanabe, N; Iwahori, Y; Hoshi, H				Yudhanto, Arief; Lubineau, Gilles; Ventura, Isaac Aguilar; Watanabe, Naoyuki; Iwahori, Yutaka; Hoshi, Hikaru			Damage characteristics in 3D stitched composites with various stitch parameters under in-plane tension	COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING			English	Article						3-Dimensional reinforcement; Polymer-matrix composites (PMCs); Transverse cracking; Delamination	LOW-VELOCITY IMPACT; CARBON/EPOXY COMPOSITES; DELAMINATION TOUGHNESS; MECHANICAL-PROPERTIES; COMPRESSION; BEHAVIOR; STRENGTH; CRACKING; DENSITY; WOVEN	Three-dimensional (3D) reinforcement by stitching is effective in improving the impact resistance of composites. Stitching, however, adversely affects the composite's in-plane mechanical responses, and alters its damage mechanisms due to stitch-induced irregularities. We experimentally investigate the effect of two important stitch parameters, stitch density and thread diameter, on the damage characteristics of 3D stitched multidirectional composites under in-plane tension using X-ray radiography, X-ray micro-computed tomography and digital image correlation (DIC). Our study shows that composites stitched with thicker thread exhibit improved tensile strength due to effective hindrance of edge-delamination. We also found that stitch thread affects damage behaviors. A higher number of transverse cracks develops in the middle portion of thin 90 fiber tows; the inter-crack distance is reduced by dense stitching. DIC is able to identify the cracks that appear in resin-rich channels and distinguish strain fields due to different stitch densities. (C) 2015 Elsevier Ltd. All rights reserved.	[Yudhanto, Arief; Lubineau, Gilles; Ventura, Isaac Aguilar] KAUST, Phys Sci & Engn Div, COHMAS Lab, Thuwal 239556900, Saudi Arabia; [Watanabe, Naoyuki] Tokyo Metropolitan Univ, Dept Aerosp Engn, Tokyo 1910065, Japan; [Iwahori, Yutaka; Hoshi, Hikaru] Japan Aerosp Explorat Agcy JAXA, Inst Aeronaut Technol, Adv Composite Res Ctr, Tokyo 1810015, Japan	Yudhanto, A (reprint author), KAUST, Phys Sci & Engn Div, COHMAS Lab, Thuwal 239556900, Saudi Arabia.	arief.yudhanto@kaust.edu.sa; gilles.lubineau@kaust.edu.sa		Yudhanto, Arief/0000-0002-8839-415X; lubineau, gilles/0000-0002-7370-6093	Tokyo Metropolitan Government; MUST baseline research funds	The authors would like to thank the Tokyo Metropolitan Government for the research funding provided under Asian Network of Major Cities 21 (ANMC-21) project. Part of this research was supported by MUST baseline research funds. We acknowledge the advise from Mr. Ali Moussawi on the DIC technique. We also thank Dr. Karl Leo of the Solar and Photovoltaic Engineering Research Center (SPERC) of MUST for the use of the micro-CF facility.	Larsson F, 1997, COMPOS PART A-APPL S, V28, P923, DOI 10.1016/S1359-835X(97)00063-8; Koissin V, 2009, COMPOS SCI TECHNOL, V69, P2701, DOI 10.1016/j.compscitech.2009.08.015; PARVIZI A, 1978, J MATER SCI, V13, P2131, DOI 10.1007/BF00541666; Tan KT, 2012, COMPOS SCI TECHNOL, V72, P587, DOI 10.1016/j.compscitech.2012.01.003; Liotier PJ, 2010, COMPOS PART A-APPL S, V41, P653, DOI 10.1016/j.compositesa.2010.01.015; Liotier PJ, 2011, COMPOS PART A-APPL S, V42, P425, DOI 10.1016/j.compositesa.2011.01.003; Jain LK, 1998, COMPOS SCI TECHNOL, V58, P829, DOI 10.1016/S0266-3538(97)00186-3; Wu EB, 1995, J COMPOS MATER, V29, P2254; Dransfield KA, 1998, COMPOS SCI TECHNOL, V58, P815, DOI 10.1016/S0266-3538(97)00229-7; Yaofeng S, 2007, OPT LASER ENG, V45, P967, DOI 10.1016/j.optlaseng.2007.01.012; Tan KT, 2012, COMPOS PART A-APPL S, V43, P823, DOI 10.1016/j.compositesa.2011.12.022; Yokozeki T, 2005, INT J SOLIDS STRUCT, V42, P2785, DOI 10.1016/j.ijsolstr.2004.09.040; Mouritz AP, 2007, COMPOS PART A-APPL S, V38, P2383, DOI 10.1016/j.compositesa.2007.08.016; Hosur MV, 2003, COMPOS STRUCT, V61, P89, DOI 10.1016/S0263-8223(03)00032-1; Mouritz AP, 2010, COMPOS PART A-APPL S, V41, P709, DOI 10.1016/j.compositesa.2010.02.001; Aymerich F, 2003, COMPOS SCI TECHNOL, V63, P907, DOI 10.1016/S0266-3538(02)00314-7; Bergan A, 2014, COMPOS STRUCT, V113, P174, DOI 10.1016/j.compstruct.2014.03.011; Dickinson LC, 1995, DESIGNED EXPT STITCH; JAIN LK, 1994, INT J FRACTURE, V68, P219, DOI 10.1007/BF00013069; Kamiya R, 2000, METALL MATER TRANS A, V31, P899, DOI 10.1007/s11661-000-0033-2; Ladeveze P, 2001, COMPOS SCI TECHNOL, V61, P2149, DOI 10.1016/S0266-3538(01)00109-9; Lubineau G, 2010, INT J DAMAGE MECH, V19, P1; Nairn JA, 2000, MATRIX MICROCRACKING, V2; Pan B, 2008, OPT EXPRESS, V16, P967; Aymerich F, 2008, INT J IMPACT ENG, V35, P591, DOI 10.1016/j.ijimpeng.2007.02.009; Sridharan S, 2008, WOODHEAD PUBL MATER, P1; Summerscales J, 1987, RADIOGRAPHY NONDESTR, V1; Thuis HGSJ, 1996, EFFECT STITCHING DEN; Tong L, 2002, 3D FIBRE REINFORCED; Truong TC, 2008, COMPOS PART A-APPL S, V39, P1380, DOI 10.1016/j.compositesa.2008.05.004; Yasui Y, 1998, METHOD APPARATUS PRO; Yoshimura A, 2007, ADV COMPOS MATER, V16, P223, DOI 10.1163/156855107781393740; Yudhanto A, 2013, COMPOS SCI TECHNOL, V86, P52, DOI 10.1016/j.compscitech.2013.07.002; Yudhanto A, 2013, COMPOS PART B-ENG, V46, P151, DOI 10.1016/j.compositesb.2012.10.003	34	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-835X	1878-5840		COMPOS PART A-APPL S	Compos. Pt. A-Appl. Sci. Manuf.	APR	2015	71						17	31		10.1016/j.compositesa.2014.12.012		15	Engineering, Manufacturing; Materials Science, Composites	Engineering; Materials Science	CD1MU	WOS:000350839800003		
J	Ogawa, F; Masuda, C				Ogawa, Fumio; Masuda, Chitoshi			Microstructure evolution during fabrication and microstructure-property relationships in vapour-grown carbon nanofibre-reinforced aluminium matrix composites fabricated via powder metallurgy	COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING			English	Article						Metal matrix composites (MMCs); Mechanical properties; Microstructures; Powder processing	MECHANICAL-PROPERTIES; DEFORMATION; NANOTUBES; BEHAVIOR; METALS	Microstructure evolution of vapour-grown carbon nanofibre (VGCF)-reinforced aluminium matrix composites during fabrication and microstructure property relationships of these materials were studied. Composites were fabricated using powder metallurgy, i.e. by mixing VGCFs and aluminium powder via ball-milling followed by sintering or hot extrusion. The mixing condition was selected to achieve small powder particle size and homogeneously dispersed VGCFs. Aluminium grains and VGCFs were elongated along the longitudinal direction of aluminium particles in the mixed powder. Detailed observation of the aluminium grains in the composites found grain size and morphology dominated by recrystallization. Apparently, grain growth was inhibited by VGCFs. Theoretical models considering strength increment due to grain refinement resulting from VGCF addition, load bearing of VGCFs, thermal mismatch of VGCFs and aluminium and Orowan effect were developed. Theoretical values coincided well with hardness, yield strength, and ultimate tensile strength of the composites, and thus the models could precisely explain the microstructure property relationships. (C) 2015 Elsevier Ltd. All rights reserved.	[Ogawa, Fumio; Masuda, Chitoshi] Waseda Univ, Kagami Mem Inst Mat Sci & Technol, Shinjuku Ku, Tokyo 1690051, Japan	Ogawa, F (reprint author), Waseda Univ, Kagami Mem Inst Mat Sci & Technol, Shinjuku Ku, 2-8-26 Nishi Waseda, Tokyo 1690051, Japan.	f.ogawa@akane.waseda.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Mitsubishi Material Corporation (MMC); Light Metal Educational Foundation Inc.; Japan Aluminium Association	This work was partly supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The first author (F. O.) would like to express his sincere gratitude to the Mitsubishi Material Corporation (MMC) for financial support. Financial supports from the Light Metal Educational Foundation Inc. and the Japan Aluminium Association are also greatly acknowledged.	Advani SG, 2006, PROCESSING AND PROPERTIES OF NANOCOMPOSITES, P61, DOI 10.1142/9789812772473_0002; Xu ZF, 2010, MATER TRANS, V51, P510, DOI 10.2320/matertrans.MBW200918; Hu N, 2012, COMPOS PART B-ENG, V43, P3, DOI 10.1016/j.compositesb.2011.04.022; Queyreau S, 2010, ACTA MATER, V58, P5586, DOI 10.1016/j.actamat.2010.06.028; Spowart JE, 2001, MAT SCI ENG A-STRUCT, V307, P51, DOI 10.1016/S0921-5093(00)01962-6; George R, 2005, SCRIPTA MATER, V53, P1159, DOI 10.1016/j.scriptamat.2005.07.022; Li QQ, 2009, COMPOS SCI TECHNOL, V69, P1193, DOI 10.1016/j.compscitech.2009.02.020; Rodriguez-Reyes M, 2011, CERAM INT, V37, P2719, DOI 10.1016/j.ceramint.2011.04.028; ARSENAULT RJ, 1986, MATER SCI ENG, V81, P175, DOI 10.1016/0025-5416(86)90261-2; Basariya MR, 2014, MATER DESIGN, V64, P542, DOI 10.1016/j.matdes.2014.08.019; Qiao XG, 2012, PHILOS MAG, V92, P446, DOI 10.1080/14786435.2011.616865; Kwon H, 2010, COMPOS SCI TECHNOL, V70, P546, DOI 10.1016/j.compscitech.2009.11.025; Choi HJ, 2008, SCRIPTA MATER, V59, P360, DOI 10.1016/j.scriptamat.2008.04.006; Choi H, 2009, J MATER RES, V24, P2610, DOI 10.1557/JMR.2009.0318; Liu ZY, 2012, CARBON, V50, P1843, DOI 10.1016/j.carbon.2011.12.034; Choi HJ, 2012, COMPOS PART A-APPL S, V43, P1061, DOI 10.1016/j.compositesa.2012.02.008; Wu YF, 2012, MAT SCI ENG A-STRUCT, V538, P164, DOI 10.1016/j.msea.2012.01.025; Esawi AMK, 2010, COMPOS SCI TECHNOL, V70, P2237, DOI 10.1016/j.compscitech.2010.05.004; Hayes RW, 2004, ACTA MATER, V52, P4259, DOI 10.1016/j.actamat.2004.05.042; Poirier D, 2009, COMPOS PART A-APPL S, V40, P1482, DOI 10.1016/j.compositesa.2009.05.025; Segal VM, 2006, MAT SCI ENG A-STRUCT, V422, P321, DOI 10.1016/j.msea.2006.02.016; Esawi AMK, 2009, MAT SCI ENG A-STRUCT, V508, P167, DOI 10.1016/j.msea.2009.01.002; Casati R, 2014, METALS-BASEL, V4, P65, DOI 10.3390/met4010065; CHRISTMAN T, 1988, ACTA METALL MATER, V36, P1691, DOI 10.1016/0001-6160(88)90236-2; CHRISTMAN T, 1989, MAT SCI ENG A-STRUCT, V107, P49, DOI 10.1016/0921-5093(89)90374-2; COX HL, 1952, BRIT J APPL PHYS, V3, P72, DOI 10.1088/0508-3443/3/3/302; HALL JN, 1994, MAT SCI ENG A-STRUCT, V183, P69, DOI 10.1016/0921-5093(94)90891-5; KELLY A, 1965, J MECH PHYS SOLIDS, V13, P329, DOI 10.1016/0022-5096(65)90035-9; Khan AS, 2006, INT J PLASTICITY, V22, P195, DOI 10.1016/j.ijplas.2004.07.008; Kwon H, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/41/415701; Sasaki G, 2007, MATER SCI FORUM, V561-565, P729; Uozumi H, 2006, ADV MAT RES, V15-17, P209; Watanabe H., 1988, Journal of Japan Institute of Light Metals, V38	33	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-835X	1878-5840		COMPOS PART A-APPL S	Compos. Pt. A-Appl. Sci. Manuf.	APR	2015	71						84	94		10.1016/j.compositesa.2015.01.005		11	Engineering, Manufacturing; Materials Science, Composites	Engineering; Materials Science	CD1MU	WOS:000350839800008		
J	Liu, RC; Jiang, YJ; Li, B; Wang, XS				Liu, Richeng; Jiang, Yujing; Li, Bo; Wang, Xiaoshan			A fractal model for characterizing fluid flow in fractured rock masses based on randomly distributed rock fracture networks	COMPUTERS AND GEOTECHNICS			English	Article						Fracture network; Permeability; Fractal dimension; Geometric distribution; Tortuosity	HYDRAULIC-PROPERTIES; LENGTH DISTRIBUTION; POROUS-MEDIA; PERMEABILITY MODEL; APERTURE; LAW; CONNECTIVITY; JOINTS; TRANSPORT; SURFACES	A fractal model that represents the geometric characteristics of rock fracture networks is proposed to link the fractal characteristics with the equivalent permeability of the fracture networks. The fracture networks are generated using the Monte Carlo method and have a power law size distribution. The fractal dimension D-T is utilized to represent the tortuosity of the fluid flow, and another fractal dimension D-f is utilized to represent the geometric distribution of fractures in the networks. The results indicate that the equivalent permeability of a fracture network can be significantly influenced by the tortuosity of the fluid flow, the aperture of the fractures and a random number used to generate the fractal length distribution of the fractures in the network. The correlation of fracture number and fracture length agrees well with the results of previous studies, and the calculated fractal dimensions D-f are consistent with their theoretical values, which confirms the reliability of the proposed fractal length distribution and the stochastically generated fracture network models. The optimal hydraulic path can be identified in the longer fractures along the fluid flow direction. Using the proposed fractal model, a mathematical expression between the equivalent permeability K and the fractal dimension D-f is proposed for models with large values of D-f. The differences in the calculated flow volumes between the models that consider and those that do not consider the influence of fluid flow tortuosity are as high as 17.64-19.51%, which emphasizes that the effects of tortuosity should not be neglected and should be included in the fractal model to accurately estimate the hydraulic behavior of fracture networks. (C) 2014 Elsevier Ltd. All rights reserved.	[Liu, Richeng; Wang, Xiaoshan] Nagasaki Univ, Grad Sch Engn, Nagasaki 8528521, Japan; [Jiang, Yujing; Li, Bo] Nagasaki Univ, Sch Engn, Nagasaki 8528521, Japan; [Jiang, Yujing] Shandong Univ Sci & Technol, State Key Lab Min Disaster Prevent & Control Cofo, Qingdao 266510, Peoples R China; [Jiang, Yujing] Shandong Univ Sci & Technol, Minist Sci & Technol, Qingdao 266510, Peoples R China	Jiang, YJ (reprint author), Nagasaki Univ, Grad Sch Engn, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	jiang@nagasaki-u.ac.jp			China Scholarship Council (CSC), Japan [24760690]	This study was partially funded by the China Scholarship Council (CSC) and a Grant-in-Aid for Young Scientists (B) (No. 24760690), Japan. This support is gratefully acknowledged.	VERMILYE JM, 1995, J STRUCT GEOL, V17, P423, DOI 10.1016/0191-8141(94)00058-8; Jafari A, 2012, J PETROL SCI ENG, V92-93, P110, DOI 10.1016/j.petrol.2012.06.007; Cai JC, 2010, CHEM ENG SCI, V65, P5178, DOI 10.1016/j.ces.2010.06.013; KULATILAKE PHSW, 1995, INT J ROCK MECH MIN, V32, P673, DOI 10.1016/0148-9062(95)00022-9; Zhao ZH, 2011, COMPUT GEOTECH, V38, P113, DOI 10.1016/j.compgeo.2010.10.001; Bejan A, 2011, PHYS LIFE REV, V8, P209, DOI 10.1016/j.plrev.2011.05.010; Jiang YJ, 2006, TUNN UNDERGR SP TECH, V21, P485, DOI 10.1016/j.tust.2005.10.004; Yu BM, 2002, INT J HEAT MASS TRAN, V45, P2983, DOI 10.1016/S0017-9310(02)00014-5; Koyama T, 2008, INT J ROCK MECH MIN, V45, P1082, DOI 10.1016/j.ijrmms.2007.11.006; Renshaw CE, 1997, NATURE, V386, P482, DOI 10.1038/386482a0; Yu BM, 2002, POLYM COMPOSITE, V23, P201, DOI 10.1002/pc.10426; Baghbanan A, 2008, INT J ROCK MECH MIN, V45, P1320, DOI 10.1016/j.ijrmms.2008.01.015; Xu P, 2006, PHYSICA A, V369, P884, DOI 10.1016/j.physa.2006.03.023; Kulatilake PHSW, 1999, INT J ROCK MECH MIN, V36, P5, DOI 10.1016/S0148-9062(98)00170-3; Xu P, 2008, PHYSICA A, V387, P6471, DOI 10.1016/j.physa.2008.08.021; de Dreuzy JR, 2001, WATER RESOUR RES, V37, P2065, DOI 10.1029/2001WR900011; Zheng Q, 2012, J APPL PHYS, V111, DOI 10.1063/1.3679070; Baghbanan A, 2007, INT J ROCK MECH MIN, V44, P704, DOI 10.1016/j.ijrmms.2006.11.001; Barenblatt G. I., 1960, SOV APPL MATH MECH E, V24, P852; Barenblatt GI, 1960, SOVIET DOKL AKAD NAU, V13, P545; Barton CC, 1989, 28 INT GEOL C WASH D; BARTON C.C., 1985, P INT S FUND ROCK JO, P77; Barton N., 1977, Rock Mechanics, V10, DOI 10.1007/BF01261801; Bejan A, 2013, DESIGN NATURE CONSTR; Bour O, 1997, WATER RESOUR RES, V33, P1567, DOI 10.1029/96WR00433; de Dreuzy JR, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR001009; de Dreuzy JR, 2001, WATER RESOUR RES, V37, P2079, DOI 10.1029/2001WR900010; DVERSTORP B, 1989, WATER RESOUR RES, V25, P540, DOI 10.1029/WR025i003p00540; Harrison J.P., 1997, ENG ROCK MECH INTRO; HATTON CG, 1994, NATURE, V367, P160, DOI 10.1038/367160a0; Itasca Consulting Group Inc, 2004, UDEC US GUID VET 4 0; Jang BA, 2006, P IAEG; LAPOINTE PR, 1988, INT J ROCK MECH MIN, V25, P421, DOI 10.1016/0148-9062(88)90982-5; [刘日成 Liu Richeng], 2014, [岩土力学, Rock and Soil Mechanics], V35, P2394; MAJUMDAR A, 1990, J TRIBOL-T ASME, V112, P205, DOI 10.1115/1.2920243; Mandelbrot BB, 1982, FRACTAL GEOMETRY NAT, V15; National Research Council (US), 1996, FRACT FLUID FLOW CON; Oliveira R, 1987, GROUND ENG REFERENCE; Olsson R, 2001, INT J ROCK MECH MIN, V38, P317, DOI 10.1016/S1365-1609(00)00079-4; STONE D, 1984, INT J ROCK MECH MIN, V21, P183, DOI 10.1016/0148-9062(84)90795-2; Tsang YW, 1996, WATER RESOUR RES, V32, P3077, DOI 10.1029/96WR01397; Wakabayashi N, 1995, FRACTURED JOINTED RO, P125; Yu BM, 2005, INT J HEAT MASS TRAN, V48, P2787, DOI 10.1016/j.ijheatmasstransfer.2005.02.008; Zhang L., 2005, ENG PROPERTIES ROCKS; Zou MQ, 2007, PHYSICA A, V386, P176, DOI 10.1016/j.physa.2007.07.058	45	2	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0266-352X	1873-7633		COMPUT GEOTECH	Comput. Geotech.	APR	2015	65						45	55		10.1016/j.compgeo.2014.11.004		11	Computer Science, Interdisciplinary Applications; Engineering, Geological; Geosciences, Multidisciplinary	Computer Science; Engineering; Geology	CD0QK	WOS:000350778800004		
J	Gomes, JAP; Tan, D; Rapuano, CJ; Belin, MW; Ambrosio, R; Guell, JL; Malecaze, F; Nishida, K; Sangwan, VS				Gomes, Jose A. P.; Tan, Donald; Rapuano, Christopher J.; Belin, Michael W.; Ambrosio, Renato, Jr.; Guell, Jose L.; Malecaze, Francois; Nishida, Kohji; Sangwan, Virender S.		Grp Panelists Global Delphi Panel	Global Consensus on Keratoconus and Ectatic Diseases	CORNEA			English	Article						keratoconus; corneal ectasia; consensus; corneal cross-linking; corneal transplantation	COLLAGEN CROSS-LINKING; ANTERIOR LAMELLAR KERATOPLASTY; IMPLANTABLE COLLAMER LENS; LATIN-AMERICAN CONSENSUS; PENETRATING KERATOPLASTY; FEMTOSECOND LASER; CORNEAL; OUTCOMES; ASTIGMATISM; GUIDELINES	Background: Despite extensive knowledge regarding the diagnosis and management of keratoconus and ectatic corneal diseases, many controversies still exist. For that reason, there is a need for current guidelines for the diagnosis and management of these conditions. Purpose: This project aimed to reach consensus of ophthalmology experts from around the world regarding keratoconus and ectatic diseases, focusing on their definition, concepts, clinical management, and surgical treatments. Methods: The Delphi method was followed with 3 questionnaire rounds and was complemented with a face-to-face meeting. Thirty-six panelists were involved and allocated to 1 of 3 panels: definition/diagnosis, nonsurgical management, or surgical treatment. The level of agreement considered for consensus was two thirds. Results: Numerous agreements were generated in definitions, methods of diagnosing, and management of keratoconus and other ectatic diseases. Nonsurgical and surgical treatments for these conditions, including the use of corneal cross-linking and corneal transplantations, were presented in a stepwise approach. A flowchart describing a logical management sequence for keratoconus was created. Conclusions: This project resulted in definitions, statements, and recommendations for the diagnosis and management of keratoconus and other ectatic diseases. It also provides an insight into the current worldwide treatment of these conditions.	[Gomes, Jose A. P.] Fed Univ Sao Paulo Escola Paulista Med UNIFESP EP, Dept Ophthalmol & Visual Sci, R Sao Paulo, SP, Brazil; [Tan, Donald] Singapore Natl Eye Ctr, Cornea Serv, Singapore, Singapore; [Rapuano, Christopher J.] Wills Eye Hosp & Res Inst, Cornea Serv, Philadelphia, PA USA; [Belin, Michael W.] Univ Arizona, Dept Ophthalmol & Vis Sci, Tucson, AZ USA; [Ambrosio, Renato, Jr.] Inst Olhos Renato Ambrosio, Rio De Janeiro, Brazil; [Guell, Jose L.] Univ Autonoma Barcelona, Dept Ophthalmol, E-08193 Barcelona, Spain; [Malecaze, Francois] CHU Toulouse Purpan, Serv Ophtalmol, Toulouse, France; [Nishida, Kohji] Osaka Univ, Sch Med, Dept Ophthalmol, Osaka, Japan; [Sangwan, Virender S.] LV Prasad Eye Inst, Ctr Ocular Regenerat CORE, Hyderabad, Andhra Pradesh, India	Gomes, JAP (reprint author), Fed Univ Sao Paulo Escola Paulista Med UNIFESP EP, Dept Ophthalmol & Visual Sci, R Sao Paulo, SP, Brazil.	japgomes@uol.com.br			Asia Cornea Society; Cornea Society; EuCornea; Panamerican Cornea Society (PanCornea); PanCornea; Asia Cornea Foundation	Supported by the Asia Cornea Society, The Cornea Society, EuCornea, and the Panamerican Cornea Society (PanCornea).; Asia Cornea Society, Cornea Society, EuCornea, and PanCornea also contributed in both logistical support and in funding the face-to-face meeting in Chicago.; This project was primarily funded by an independent educational grant by the Asia Cornea Foundation. The funding body had no role in the design, implementation, or interpretation of the results of this project. This funding defrayed the cost of statistical analysis, 4 rounds of the Delphi Panels, printed materials, portfolio, supplements, questionnaires, and travel of coordinators of Eurotrials to the face-to-face meeting in Chicago. All the corneal societies contributed in both logistical support and also in funding the face-to-face meeting in Chicago and potential publication expenses.	Abad JC, 2010, J CATARACT REFR SURG, V36, P865, DOI 10.1016/j.jcrs.2010.03.008; Amayem AF, 2013, CORNEA, V32, pE2, DOI 10.1097/ICO.0b013e31825ca70b; Ambrosio R, 2014, INT J KERAT IN PRESS, V3; Kim M, 2014, INVEST OPHTH VIS SCI, V55, P3247, DOI 10.1167/iovs.13-13703; JONES J, 1995, BRIT MED J, V311, P376; Jonas JB, 2009, AM J OPHTHALMOL, V148, P760, DOI 10.1016/j.ajo.2009.06.024; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Koller T, 2011, J CATARACT REFR SURG, V37, P1488, DOI 10.1016/j.jcrs.2011.03.041; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Young LJ, 2003, AGE AGEING, V32, P525, DOI 10.1093/ageing/afg094; Ambrosio R, 2011, J REFRACT SURG, V27, P753, DOI 10.3928/1081597X-20110721-01; Barr JT, 2006, CORNEA, V25, P16, DOI 10.1097/01.ico.0000164831.87593.08; Kanellopoulos AJ, 2009, J REFRACT SURG, V25, pS812, DOI 10.3928/1081597X-20090813-10; Koller T, 2006, OPHTHALMOLOGY, V113, P2198, DOI 10.1016/j.ophtha.2006.06.032; KENNEDY RH, 1986, AM J OPHTHALMOL, V101, P267; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; McMahon TT, 2006, CORNEA, V25, P794, DOI 10.1097/01.ico.0000226359.26678.d1; Behrens A, 2006, CORNEA, V25, P900, DOI 10.1097/01.ico.0000214802.40313.fa; Buratto L, 2007, AM J OPHTHALMOL, V143, P737, DOI 10.1016/j.ajo.2007.01.056; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; Kanellopoulos AJ, 2011, J REFRACT SURG, V27, P323, DOI 10.3928/1081597X-20101105-01; Krumeich JH, 1998, J CATARACT REFR SURG, V24, P456; Belin MW, 2014, EYE CONTACT LENS, V40, P326, DOI 10.1097/ICL.0000000000000077; Bottos KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066408; Buzzonetti L, 2012, CORNEA, V31, P1083, DOI 10.1097/ICO.0b013e31823f8efc; Chen WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026103; Coia L R, 1998, Radiat Med, V16, P321; Darling G, 2014, ANN THORAC SURG, V98, P183, DOI 10.1016/j.athoracsur.2014.03.001; Douglas RS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1155, DOI 10.1001/archophthalmol.2009.232; Faria-Correia F, 2015, EXPERT REV OPHTHALMO, V10, P33; Fitch K, 2001, RAND UCLA APPROPRIAT; Gokhale NS, 2013, INDIAN J OPHTHALMOL, V61, P382, DOI 10.4103/0301-4738.116054; Gordon T. J., 1994, THE DELPHI METHOD; Hashemian SJ, 2013, CLIN EXP OPTOM, V96, P225, DOI 10.1111/j.1444-0938.2012.00800.x; Holmes Erin R, 2002, Health Mark Q, V20, P3, DOI 10.1300/J026v20n02_02; Jee D, 2014, INVEST OPHTH VIS SCI, V55, P5081, DOI 10.1167/iovs.14-14483; Kook D, 2009, CORNEA, V28, P795, DOI 10.1097/ICO.0b013e31819839c6; Kwitko S, 2004, J CATARACT REFR SURG, V30, P812, DOI 10.1016/j.jcrs.2003.12.005; Kymionis George D, 2011, Ophthalmic Surg Lasers Imaging, V42 Online, pe22, DOI 10.3928/15428877-20110210-05; Kymionis GD, 2014, J CATARACT REFR SURG, V40, P1439, DOI 10.1016/j.jcrs.2014.01.040; Lee PP, 2010, J GLAUCOMA, V19, P281, DOI 10.1097/IJG.0b013e3181b4ca8d; Ma Quintana José, 2006, BMC Health Serv Res, V6, P24, DOI 10.1186/1472-6963-6-24; PELTON JN, 1981, J COMMUN, V31, P177, DOI 10.1111/j.1460-2466.1981.tb01217.x; Pena-Garcia P, 2014, J CATARACT REFR SURG, V40, P1633, DOI 10.1016/j.jcrs.2014.01.047; Richter A, 2001, CLIN THER, V23, P160, DOI 10.1016/S0149-2918(01)80038-2; Sackman H., 1975, DELPHI CRITIQUE; dos Santos MS, 2011, ARQ BRAS OFTALMOL, V74, P452, DOI 10.1590/S0004-27492011000600016; Shaheen MS, 2014, CORNEA, V33, P475, DOI 10.1097/ICO.0000000000000094; Tan DTH, 2010, BRIT J OPHTHALMOL, V94, P1295, DOI 10.1136/bjo.2009.167528; Vinciguerra Paolo, 2014, J Refract Surg, V30, P746, DOI 10.3928/1081597X-20141021-06	52	7	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-3740	1536-4798		CORNEA	Cornea	APR	2015	34	4					359	369				11	Ophthalmology	Ophthalmology	CD3MP	WOS:000350983100006		
J	Elias, KM; Moromizato, T; Gibbons, FK; Christopher, KB				Elias, Kevin M.; Moromizato, Takuhiro; Gibbons, Fiona K.; Christopher, Kenneth B.			Derivation and Validation of the Acute Organ Failure Score to Predict Outcome in Critically Ill Patients: A Cohort Study	CRITICAL CARE MEDICINE			English	Article						acute organ failure; intensive care; mortality prediction	CRITICAL-CARE INITIATION; NEIGHBORHOOD POVERTY RATE; BLOOD-STREAM INFECTIONS; HOSPITAL MORTALITY; PROGNOSTIC MODEL; CRITICAL ILLNESS; RISK PREDICTION; LIVER-DISEASE; APACHE-II; ASSOCIATION	Objectives: Prediction models for ICU mortality rely heavily on physiologic variables that may not be available in large retrospective studies. An alternative approach when physiologic variables are absent stratifies mortality risk by acute organ failure classification. Design: Retrospective cohort study. Setting: Two large teaching hospitals in Boston, MA. Subjects: Ninety-two thousand eight hundred eighty-six patients aged 18 years old or older admitted between November 3, 1997, and February 25, 2011, who received critical care. Interventions: None. Measurements and Main Results: The derivation cohort consisted of 35,566 patients from Brigham and Women's Hospital, and the validation cohort comprised 57,320 patients from Massachusetts General Hospital. Acute organ failure was determined for each patient based on International Classification of Diseases, 9th Revision, Clinical Modification code combinations. The main outcome measure was 30-day mortality. A clinical prediction model was created based on a logistic regression model describing the risk of 30-day mortality as a function of age, medical versus surgical patient type, Deyo-Charlson index, sepsis, and type acute organ failure (respiratory, renal, hepatic, hematologic, metabolic, and neurologic) after ICU admission. We computed goodness-of fit statistics and c-statistics as measures of model calibration and 30-day mortality discrimination, respectively. Thirty-day mortality occurred in 5,228 of 35,566 patients (14.7%) assigned to the derivation cohort. The clinical prediction model was predictive for 30-day mortality. The c-statistic for the clinical prediction model was 0.7447 (95% CI, 0.74-0.75) in the derivation cohort and 0.7356 (95% CI, 0.73-0.74) in the validation cohort. For both the derivation and validation cohorts, the Hosmer-Lemeshow chi-square p values indicated good model fit. In a smaller cohort of 444 patients with Acute Physiologic and Chronic Health Evaluation II scores determined, differences in model discrimination of 30-day mortality between the clinical prediction model and Acute Physiologic and Chronic Health Evaluation II were not significant (chi-square = 0.76; p = 0.38). Conclusions: An acute organ failure-based clinical prediction model shows good calibration and discrimination for 30-day mortality in the critically ill. The clinical prediction model compares favorably to Acute Physiologic and Chronic Health Evaluation II score in the prediction of 30-day mortality in the critically ill. This score may be useful for severity of illness risk adjustment in observational studies where physiologic data are unavailable.	[Elias, Kevin M.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Moromizato, Takuhiro] Okinawa Hokubu Prefectural Hosp, Dept Med, Okinawa, Japan; [Gibbons, Fiona K.] Massachusetts Gen Hosp, Pulm & Crit Care Div, Boston, MA 02114 USA; [Christopher, Kenneth B.] Brigham & Womens Hosp, Div Renal, Nathan E Hellman Mem Lab, Boston, MA 02115 USA	Christopher, KB (reprint author), Brigham & Womens Hosp, Div Renal, Nathan E Hellman Mem Lab, Boston, MA 02115 USA.	kbchristopher@partners.org			White Foundation	Dr. Elias consulted for Firefly Bioworks; is employed by Brigham and Women's Hospital; and received support for travel from Tracon Pharmaceuticals. His institution received grant support from the White Foundation. The remaining authors have disclosed that they do not have any potential conflicts of interest.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altman DG, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b605; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Zager S, 2011, CHEST, V139, P1368, DOI 10.1378/chest.10-2594; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Braun AB, 2012, CRIT CARE MED, V40, P63, DOI 10.1097/CCM.0b013e31822d74f3; Mendu ML, 2012, CRIT CARE MED, V40, P1427, DOI 10.1097/CCM.0b013e318241e51e; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Moreno RP, 2008, INTENS CARE MED, V34, P496, DOI 10.1007/s00134-007-0943-1; McMahon GM, 2012, INTENS CARE MED, V38, P1834, DOI 10.1007/s00134-012-2636-7; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0; Bagshaw SM, 2009, NEPHROL DIAL TRANSPL, V24, P2739, DOI 10.1093/ndt/gfp159; Paul P, 2013, STAT MED, V32, P67, DOI 10.1002/sim.5525; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Purtle SW, 2014, CRIT CARE MED, V42, P918, DOI 10.1097/CCM.0000000000000118; Moromizato T, 2014, CRIT CARE MED, V42, P97, DOI 10.1097/CCM.0b013e31829eb7af; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; RAPOPORT J, 1992, ARCH INTERN MED, V152, P2207, DOI 10.1001/archinte.152.11.2207; Levey AS, 1999, ANN INTERN MED, V130, P461; Hug BL, 2009, SWISS MED WKLY, V139, P737, DOI smw-12686; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bouch DC, 2008, CONTIN ED ANAESTH CR, V8, P181, DOI DOI 10.1093/BJACEACCP/MKN033; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christensen Steffen, 2011, Clin Epidemiol, V3, P203, DOI 10.2147/CLEP.S20247; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cooke CR, 2012, CRIT CARE MED, V40, P1532, DOI 10.1097/CCM.0b013e31824518f2; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; Lipnick MS, 2013, CRIT CARE MED, V41, P49, DOI 10.1097/CCM.0b013e31826764cd; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McKane CK, 2014, J CRIT CARE, V29, P70, DOI 10.1016/j.jcrc.2013.08.019; Mendu ML, 2013, J CRIT CARE, V28, P928, DOI 10.1016/j.jcrc.2013.07.057; Murphy SN, 2002, P AMIA S, V2002, P552; Nalichowski R, 2006, AMIA ANN S P, P1044; Quach S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-129; Palmer G, 2001, Health Serv Manage Res, V14, P71, DOI 10.1258/0951484011912564; Schisterman EF, 2004, POPUL HEALTH METR, V2, P2, DOI 10.1186/1478-7954-2-2; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Umegaki Takeshi, 2011, J Anaesthesiol Clin Pharmacol, V27, P180, DOI 10.4103/0970-9185.81816; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wade A, 2000, ARCH DIS CHILD, V83, P459, DOI 10.1136/adc.83.6.459	48	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	APR	2015	43	4					856	864		10.1097/CCM.0000000000000858		9	Critical Care Medicine	General & Internal Medicine	CD3TI	WOS:000351004100024		
J	Ishii, K				Ishii, Keisuke			Prenatal diagnosis and management of monoamniotic twins	CURRENT OPINION IN OBSTETRICS & GYNECOLOGY			English	Review						monoamniotic twins; perinatal outcome; prenatal fetal surveillance; umbilical cord entanglement	OF-THE-LITERATURE; CORD ENTANGLEMENT; SINGLE-CENTER; CASE SERIES; PREGNANCIES; GESTATION; INPATIENT; SURVIVAL; OUTCOMES	Purpose of review The purpose of this article is to investigate the perinatal outcomes of monoamniotic twins under current standards of prenatal management involving intensive fetal surveillance. Recent findings The incidence of perinatal mortality in monoamniotic twins has fallen over the last 2 decades. Umbilical cord entanglement has long been considered one of the main causes of poor outcome among monoamniotic twins; however, new evidence shows that it appears to be less important than prematurity and congenital anomalies. If intensive fetal surveillance is provided, the risk of perinatal mortality is acceptably low regardless of setting. In uncomplicated monoamniotic twin pregnancies, delivery at around 33 weeks of gestation might reduce the risk of neonatal adverse events without increasing the risk of perinatal death. Summary Perinatal outcome in monoamniotic twins improved if intensive fetal surveillance was performed under either outpatient or inpatient management. Planned delivery in uncomplicated monoamniotic twin pregnancies can be considered at around 33 weeks of gestation.	[Ishii, Keisuke] Osaka Med Ctr, Dept Maternal Fetal Med, Izumi, Osaka, Japan; [Ishii, Keisuke] Res Inst Maternal & Child Hlth, Izumi, Osaka, Japan	Ishii, K (reprint author), Osaka Med Ctr, Dept Maternal Fetal Med, 840 Murodo, Izumi, Osaka, Japan.	keisui@mch.pref.osaka.jp					Cordero L, 2006, J PERINATOL, V26, P170, DOI 10.1038/sj.jp.7211457; Murata M, 2013, J OBSTET GYNAECOL RE, V39, P922, DOI 10.1111/jog.12014; Allen VM, 2001, BRIT J OBSTET GYNAEC, V108, P931, DOI 10.1111/j.1471-0528.2001.00216.x; Rossi AC, 2013, ULTRASOUND OBST GYN, V41, P131, DOI 10.1002/uog.12345; Nakayama S, 2012, J OBSTET GYNAECOL RE, V38, P692, DOI 10.1111/j.1447-0756.2011.01759.x; Heyborne KD, 2005, AM J OBSTET GYNECOL, V192, P96, DOI 10.1016/j.ajog.2004.06.037; Dias T, 2010, ULTRASOUND OBST GYN, V35, P201, DOI 10.1002/uog.7501; Peeters SHP, 2014, PRENATAL DIAG, V34, P586, DOI 10.1002/pd.4353; Hack KE, 2009, OBSTET GYNECOL, V113, P353, DOI 10.1097/AOG.0b013e318195bd57; Baxi LV, 2010, J MATERN-FETAL NEO M, V23, P506, DOI 10.3109/14767050903214590; Van Mieghem T, 2014, OBSTET GYNECOL, V124, P498, DOI 10.1097/AOG.0000000000000409; CARR SR, 1990, AM J OBSTET GYNECOL, V163, P719; DeFalco LM, 2006, AM J PERINAT, V23, P205, DOI 10.1055/s-2006-934091; Lewi L, 2008, AM J OBSTET GYNECOL, V199, P514; Roqué H, 2003, J Matern Fetal Neonatal Med, V13, P414, DOI 10.1080/jmf.13.6.414.421; Sau AK, 2003, TWIN RES, V6, P270, DOI 10.1375/136905203322296601; Su LL, 2002, ACTA OBSTET GYN SCAN, V81, P995, DOI 10.1034/j.1600-0412.2002.811101.x; Suzuki S., 2001, Archives of Gynecology and Obstetrics, V265, P57, DOI 10.1007/s004040000127	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-872X	1473-656X		CURR OPIN OBSTET GYN	Curr. Opin. Obstet. Gynecol.	APR	2015	27	2					159	164		10.1097/GCO.0000000000000160		6	Obstetrics & Gynecology	Obstetrics & Gynecology	CD0MB	WOS:000350766500007		
J	Fukui, A; Yokoo, T				Fukui, Akira; Yokoo, Takashi			Kidney regeneration using developing xenoembryo	CURRENT OPINION IN ORGAN TRANSPLANTATION			English	Review						blastocyst complementation; metanephros; stem cells; ureteric bud; Wolffian duct	PLURIPOTENT STEM-CELLS; IN-VIVO; BLASTOCYST COMPLEMENTATION; INTERMEDIATE MESODERM; WOLFFIAN DUCT; GENERATION; ORGANOGENESIS; PROGENITORS; EMBRYO; LIVER	Purpose of review We provide an overview of the recent progress in kidney regeneration with a particular focus on our previous study, which used developing xenoembryos for differentiating human mesenchymal stem cells (hMSCs). The principle of the methodology, recent advances, and limitations and challenges associated with kidney regeneration are outlined. Recent findings Our primary study objective is to generate neokidney from dialysis patient-derived hMSCs. We previously showed that glial cell-derived neurotrophic factor-expressing hMSCs can differentiate into functional chimeric nephrons in developing mammalian embryos. Recently, we succeeded in eliminating xenotissues in transgenic oestrogen receptor-E2F transcription factor 1 (ER-E2F1) mice by introducing a suicide gene. We also showed MSCs derived from dialysis patients can be used for kidney regeneration. Blastocyst complementation strategy was used to generate chimeric nephrons by injecting mouse pluripotent stem cells into spalt-like transcription factor 1 (Sall1) knockout mouse blastocysts. Summary Kidney tissue can be generated from human mouse pluripotent stem cells or MSCs by several methods. The size and function of regenerated kidney tissue do not meet the transplantation requirements for clinical applications. Although many outstanding problems remain for kidney regeneration, including ethical issues and the formation of chimeric structures, the neokidney generation exclusively from dialysis patient-derived cells is expected to be a reality in the future.	[Fukui, Akira; Yokoo, Takashi] Jikei Univ, Div Nephrol & Hypertens, Dept Internal Med, Sch Med, Tokyo 1058461, Japan	Yokoo, T (reprint author), Jikei Univ, Div Nephrol & Hypertens, Dept Internal Med, Sch Med,Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	tyokoo@jikei.ac.jp					Diep CQ, 2011, NATURE, V470, P95, DOI 10.1038/nature09669; Yokoo T, 2006, J AM SOC NEPHROL, V17, P1026, DOI 10.1681/ASN.2005101043; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Yamada A, 2014, HUM CELL, V27, P59, DOI 10.1007/s13577-013-0082-7; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Obara-Ishihara T, 1999, DEVELOPMENT, V126, P1103; Attia L, 2012, DEVELOPMENT, V139, P4143, DOI 10.1242/dev.085258; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Espejel S, 2010, J CLIN INVEST, V120, P3120, DOI 10.1172/JCI43267; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Noh H, 2012, NEPHROL DIAL TRANSPL, V27, P218, DOI 10.1093/ndt/gfr267; Yokoo T, 2005, P NATL ACAD SCI USA, V102, P3296, DOI 10.1073/pnas.0406878102; Hammerman MR, 2004, J AM SOC NEPHROL, V15, P1126, DOI 10.1097/01.ASN.0000106020.64930.64; Yokoo T, 2008, TRANSPLANTATION, V85, P1654, DOI 10.1097/TP.0b013e318173a35d; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Usui JI, 2012, AM J PATHOL, V180, P2417, DOI 10.1016/j.ajpath.2012.03.007; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Matsumoto K, 2012, STEM CELLS, V30, P1228, DOI 10.1002/stem.1101; Atsuta Y, 2013, DEV GROWTH DIFFER, V55, P579, DOI 10.1111/dgd.12047; Boyle SC, 2014, DEVELOPMENT, V141, P346, DOI 10.1242/dev.100271; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Drewa T, 2008, TRANSPL P, V40, P1668, DOI 10.1016/j.transproceed.2008.03.141; Fukui A, 2009, BIOCHEM BIOPH RES CO, V385, P330, DOI 10.1016/j.bbrc.2009.05.052; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Normile D, 2013, SCIENCE, V340, P1509, DOI 10.1126/science.340.6140.1509; Sean VM, 2014, NAT BIOTECHNOL, V32, P773; Song B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046453; Syranoski D, 2013, NAT MED, V19, P510; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takahashi K, 2007, CELL, V131, P1; Tan T.-S., 2014, J MED IMAGING HLTH I, V4; Yamanaka S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102311; Yokoo T, 2008, FRONT BIOSCI-LANDMRK, V13, P2814, DOI 10.2741/2888	38	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1087-2418	1531-7013		CURR OPIN ORGAN TRAN	Curr. Opin. Organ Transpl.	APR	2015	20	2					160	164		10.1097/MOT.0000000000000176		5	Transplantation	Transplantation	CD3VH	WOS:000351010300008		
J	Mae, SI; Osafune, K				Mae, Shin-Ichi; Osafune, Kenji			Kidney regeneration from human induced pluripotent stem cells	CURRENT OPINION IN ORGAN TRANSPLANTATION			English	Review						directed differentiation; human embryonic stem cell; human induced pluripotent stem cell; nephrogenic progenitor	INTERMEDIATE MESODERM; MAMMALIAN KIDNEY; IN-VIVO; DIFFERENTIATION; PROGENITORS; POPULATION; EPITHELIA; INDUCTION	Purpose of review Human induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) are potential unlimited cell sources for renal cells in regenerative medicine. This review highlights recent advance in the directed differentiation of human iPSCs into kidney lineages and discusses the remaining challenges to generate functional or mature renal cells from human iPSCs. Recent findings Recently, directed differentiation methods from human iPSCs/ESCs into embryonic renal progenitor cells, such as those included in metanephric mesenchyme and ureteric bud, that mimic embryonic development have been reported. These studies show the developmental potential of progenitor cells by forming renal tubule-like or glomerulus-like structures in vitro. However, it has not been verified whether the physiological functions of the induced progenitors are equivalent to their in-vivo counterparts. The establishment of definitive marker genes for kidney lineages and functional assay systems is essential for the verification. Such achievement is needed before kidney regeneration can provide cell replacement therapy, reliable disease models and elucidation of the mechanisms of kidney development. Summary In conclusion, this review outlines milestones in directed differentiation methods for functional renal cell types from human iPSCs toward clinical application and practical use.	[Mae, Shin-Ichi; Osafune, Kenji] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan	Osafune, K (reprint author), Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	osafu@cira.kyoto-u.ac.jp			Japan Society for the Promotion of Science through 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)'; Japan Science and Technology Agency through research grant 'Core Center for iPS Cell Research and Technological Development, Research Center Network for Realization of Regenerative Medicine'	This work was supported by the Japan Society for the Promotion of Science through its 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)', and by the Japan Science and Technology Agency through its research grant 'Core Center for iPS Cell Research and Technological Development, Research Center Network for Realization of Regenerative Medicine'.	Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Rumballe BA, 2011, DEV BIOL, V360, P110, DOI 10.1016/j.ydbio.2011.09.011; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Vigneau C, 2007, J AM SOC NEPHROL, V18, P1709, DOI 10.1681/ASN.2006101078; Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154; Lam AQ, 2014, J AM SOC NEPHROL, V25, P1211, DOI 10.1681/ASN.2013080831; Brown AC, 2013, P NATL ACAD SCI USA, V110, P4640, DOI 10.1073/pnas.1213971110; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Bertram JF, 2011, PEDIATR NEPHROL, V26, P1529, DOI 10.1007/s00467-011-1843-8; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1172482; Tena JJ, 2007, DEV BIOL, V301, P518, DOI 10.1016/j.ydbio.2006.08.063; Bruce SJ, 2007, DIFFERENTIATION, V75, P337, DOI 10.1111/j.1432-0436.2006.00149.x; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; James RG, 2006, DEVELOPMENT, V133, P2995, DOI 10.1242/dev.02442; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Morizane R, 2009, BIOCHEM BIOPH RES CO, V390, P1334, DOI 10.1016/j.bbrc.2009.10.148; Araoka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084881; Kang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094888; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Mae SI, 2010, BIOCHEM BIOPH RES CO, V393, P877, DOI 10.1016/j.bbrc.2010.02.111; Song B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046453; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894	26	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1087-2418	1531-7013		CURR OPIN ORGAN TRAN	Curr. Opin. Organ Transpl.	APR	2015	20	2					171	177		10.1097/MOT.0000000000000170		7	Transplantation	Transplantation	CD3VH	WOS:000351010300010		
J	Britz, T; Shiromoto, K; Westerback, T				Britz, Thomas; Shiromoto, Keisuke; Westerbaeck, Thomas			Demi-matroids from codes over finite Frobenius rings	DESIGNS CODES AND CRYPTOGRAPHY			English	Article						Codes over rings; Demi-matroid; MacWilliams identity	LINEAR CODES; MODULES; DUALITY; THEOREM	We present a construction of demi-matroids, a generalization of matroids, from linear codes over finite Frobenius rings, as well as a Greene-type identity for rank generating functions of demi-matroids. We also prove a MacWilliams-type identity for Hamming support enumerators of linear codes over finite Frobenius rings. As a special case, these results give a combinatorial proof of the MacWilliams identity for Hamming weight enumerators of linear codes over finite Frobenius rings.	[Britz, Thomas] Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia; [Shiromoto, Keisuke] Kumamoto Univ, Dept Math & Engn, Kumamoto 8608555, Japan; [Westerbaeck, Thomas] KTH Royal Inst Technol, Dept Math, S-10044 Stockholm, Sweden	Britz, T (reprint author), Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia.	britz@unsw.edu.au; keisuke@kumamoto-u.ac.jp; thowest@math.kth.se			UNSW Faculty of Science Silverstar Grant	Thomas Britz and Thomas Westerback were partly supported by a UNSW Faculty of Science Silverstar Grant.	Honold T, 2001, ARCH MATH, V76, P406, DOI 10.1007/PL00000451; Wood JA, 2009, SER CODING TH CRYPTO, V6, P124, DOI 10.1142/9789812837691_0004; WEI VK, 1991, IEEE T INFORM THEORY, V37, P1412, DOI 10.1109/18.133259; HAMMONS AR, 1994, IEEE T INFORM THEORY, V40, P301, DOI 10.1109/18.312154; Wood JA, 1999, AM J MATH, V121, P555, DOI 10.1353/ajm.1999.0024; Barg A, 1997, APPL ALGEBR ENG COMM, V8, P165, DOI 10.1007/s002000050060; Britz T, 2007, DISCRETE MATH, V307, P2300, DOI 10.1016/j.disc.2006.12.001; Britz T, 2005, DISCRETE MATH, V305, P55, DOI 10.1016/j.disc.2005.10.002; Britz T, 2010, IEEE T INFORM THEORY, V56, P4350, DOI 10.1109/TIT.2010.2054654; Britz T, 2012, DESIGN CODE CRYPTOGR, V62, P331, DOI 10.1007/s10623-011-9524-y; Britz T., 2002, ELECT J COMB, V9; Britz T, 2008, DISCRETE MATH, V308, P4551, DOI 10.1016/j.disc.2007.08.064; Crapo H.H., 1970, FDN COMBINATORIAL TH; GREENE C, 1976, STUD APPL MATH, V55, P119; Honold T, 2001, FINITE FIELDS AND APPLICATIONS, P276; Huffman W.C., 2003, FUNDAMENTALS ERROR C; Lam T. Y., 1999, LECT MODULES RINGS; MacWilliams F.J., 1963, BELL SYST TECH J, V42, P79; Shiromoto K., 1996, HOKKAIDO MATH J, V25, P651; van Lint J. H., 2001, COURSE COMBINATORICS; Welsh D.J.A., 1976, MATROID THEORY	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-1022	1573-7586		DESIGN CODE CRYPTOGR	Designs Codes Cryptogr.	APR	2015	75	1					97	107		10.1007/s10623-013-9895-3		11	Computer Science, Theory & Methods; Mathematics, Applied	Computer Science; Mathematics	CD5WB	WOS:000351158100008		
J	Fernandez, G; Shaw, R				Fernandez, Glenn; Shaw, Rajib			Youth participation in disaster risk reduction through science clubs in the Philippines	DISASTERS			English	Article						disaster risk reduction; Philippines; science clubs; schools; young people; youth participation		With the UN-led celebration of the International Year of Youth from August 2010 to August 2011 there has been a renewed interest in young people and the vital role they can play in important issues, such as disaster risk reduction (DRR). This study aims to examine the potential of science clubs as a vehicle for youth participation in DRR in the Philippines. A questionnaire survey was conducted to obtain quantitative and qualitative data. A total of 658 science club members from different provinces of the Philippines participated in the survey. The result of the survey is used to explain how the major barriers to youth participation in DRR can be overcome. Through science clubs, the youth can become a link between their school, home and community and can contribute to spreading knowledge about disaster prevention, preparedness and response learned inside and outside the classroom.	[Fernandez, Glenn; Shaw, Rajib] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto 6068501, Japan	Fernandez, G (reprint author), Kyoto Univ, Grad Sch Global Environm Studies, Int Environm & Disaster Management Lab, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	glenn.fernandez.62u@st.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Environmental Management Leadership (EML) Program of Kyoto University	We thank the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan for the generous scholarship grant that made it possible for the first author to pursue his Master's and PhD degrees at Kyoto University. We also acknowledge the financial support for the fieldwork from the Environmental Management Leadership (EML) Program of Kyoto University.	Anderson WA, 2005, INT J MASS EMERGENCI, V23, P159; Allen KM, 2006, DISASTERS, V30, P81, DOI 10.1111/j.1467-9523.2006.00308.x; Checkoway B, 2011, CHILD YOUTH SERV REV, V33, P340, DOI 10.1016/j.childyouth.2010.09.017; Pelling M, 2007, DISASTERS, V31, P373, DOI 10.1111/j.0361-3666.2007.01014.x; Bartlett S, 2008, CHILDREN YOUTH ENV, V18, P71; Boyden J., 2003, CHILDREN YOUTH ENV, V13; Cadag JRD, 2012, AREA, V44, P100, DOI 10.1111/j.1475-4762.2011.01065.x; Carver R., 1996, J EXPT ED, V19, P8; CRED (Center for Research on the Epidemiology of Disasters), 2007, ANN DIS STAT REV; CRED (Center for Research on the Epidemiology of Disasters), 2012, ANN DIS STAT REV; CRED (Center for Research on the Epidemiology of Disasters), 2014, ANN DIS STAT REV; CRED (Center for Research on the Epidemiology of Disasters), 2010, ANN DIS STAT REV; CRED (Center for Research on the Epidemiology of Disasters), 2013, ANN DIS STAT REV; CRED (Center for Research on the Epidemiology of Disasters), 2009, ANN DIS STAT REV; CRED (Center for Research on the Epidemiology of Disasters), 2008, ANN DIS STAT REV; CRED (Center for Research on the Epidemiology of Disasters), 2011, ANN DIS STAT REV; DepEd (Department of Education), 2010, 8 YOUTH ENV SUMM YES; FEMA (Federal Emergency Management Agency - USA), 2010, BRING YOUTH PREP ED; Fernandez G, 2012, THESIS KYOTO U KYOTO; IFRC and ADPC (Asian Disaster Preparedness Center), 2009, P PRACT WORKSH 15 17; IFRC (International Federation of Red Cross and Red Crescent Societies), 2009, PHIL PLAN 2009 2010; Izadkhah Y.O., 2005, INT J EMERGENCY MANA, V2, P138, DOI 10.1504/IJEM.2005.007355; Jabry A., 2005, CAMERAS HAVE GONE CH; Kirschke J., 2005, CHILDREN YOUTH ENV, V15, P378; Kolb D. A., 1999, EXPT LEARNING THEORY; Luna E., 2008, MAINSTREAMING DISAST; Manila Observatory, 2005, FIND HARMS WAY MAPP; Mitchell J. T., 2009, INT RES GEOGRAPHICAL, V18, P134; Mitchell T., 2008, CHILDREN YOUTH ENV, V18, P254; Mitchell T., 2009, 1 I DEV STUD; NYC (National Youth Commission), 2005, THE MTYDP AND BEYOND; Peek L., 2008, CHILDREN YOUTH ENV, V18, P1; Sales R. F., 2007, COMMUNITY HABITAT J, V13; Shaw R., 2009, 1 2 3 DISASTER ED; SHIWAKU K, 2011, DISASTER ED, V7, P45; UN International Strategy for Disaster Reduction (UNISDR), 2007, BUILD DIS RES COMM G; UNFPA, 2011, STAT WORLD POP 2011; UNISDR, 2011, GLOB ASS REP DIS RIS; UNISDR, 2010, LOC GOV DIS RISK RED; UNISDR, 2011, HFA PROGR AS PAC REG; United Nations International Strategy for Disaster Reduction Secretariat (UNISDR), 2011, HYOG FRAM ACT 2005 2; United Nations (UN), 2011, WORLD POP PROSP 2010; Wachtendorf T, 2008, CHILD YOUTH ENV, V18, P456; Walden D, 2009, CHILDREN FRONTLINE C; Wisner B., 2006, LET OUR CHILDREN TEA; World Bank & National Disaster Coordinating Council, 2005, NAT DIS RISK MAN PHI	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0361-3666	1467-7717		DISASTERS	Disasters	APR	2015	39	2					279	294		10.1111/disa.12100		16	Planning & Development	Public Administration	CD0IU	WOS:000350755500006		
J	Tsunoda, A; Ohta, T; Kiyasu, Y; Kusanagi, H				Tsunoda, Akira; Ohta, Tomoyuki; Kiyasu, Yoshiyuki; Kusanagi, Hiroshi			Laparoscopic Ventral Rectopexy for Rectoanal Intussusception: Postoperative Evaluation With Proctography	DISEASES OF THE COLON & RECTUM			English	Article						Laparoscopic ventral rectopexy; Rectoanal intussusception; Evacuation proctography	TRANSANAL RECTAL RESECTION; FECAL INCONTINENCE; OBSTRUCTED DEFECATION; POSTERIOR RECTOPEXY; OUTLET OBSTRUCTION; MESH RECTOPEXY; PROLAPSE; DEFECOGRAPHY; CONSTIPATION; COMPLICATIONS	BACKGROUND: Laparoscopic ventral rectopexy can relieve symptoms of obstructed defecation and fecal incontinence in patients with rectoanal intussusception. However, pelvic floor imaging after surgery has not been reported. OBJECTIVE: This study was designed to assess the outcome of patients who underwent laparoscopic ventral rectopexy for rectoanal intussusception, with special reference to the postoperative findings on evacuation proctography. DESIGN: This study was a retrospective analysis of prospectively collected data. SETTING: The study was conducted from 2012 to 2013 at the Department of Surgery, Kameda Medical Center, Japan. PATIENTS: We included 26 patients with symptomatic rectoanal intussusception. INTERVENTION: Laparoscopic ventral rectopexy was performed. MAIN OUTCOME MEASURE: Evacuation proctography was performed before and 6 months after the procedure. Defecatory function was evaluated using the Constipation Scoring System and Fecal Incontinence Severity Index. RESULTS: Of 26 patients with rectoanal intussusception preoperatively, 22 had symptoms of obstructed defecation and 21 complained of fecal incontinence. Postoperatively, rectoanal intussusception was eliminated in all patients, though 8 developed recto rectal intussusception. There was an overall reduction in both grade 2 rectocele size (median preop 26 mm vs. postop 11 mm; p < 0.0001) and pelvic floor descent (median preop 26 mm vs. postop 20 mm; p < 0.0001). 6 months after surgery, a reduction of at least 50% was observed in the Constipation Scoring System score for 9 patients (41%) with obstructive defecation and in the Fecal Incontinence Severity Index score for 14 incontinent patients (67%). LIMITATIONS: This was a preliminary study with a small sample size, no control group, and short follow-up time. CONCLUSION: Evacuation proctography showed anatomical correction in patients with rectoanal intussusception who underwent laparoscopic ventral rectopexy. However, the data also indicate that such correction does not necessarily result in meaningful symptomatic relief.	[Tsunoda, Akira; Ohta, Tomoyuki; Kiyasu, Yoshiyuki; Kusanagi, Hiroshi] Kameda Med Ctr, Dept Surg, Kamogawa City, Chiba 2968602, Japan	Tsunoda, A (reprint author), Kameda Med Ctr, Dept Surg, 929 Higashi Cho, Kamogawa City, Chiba 2968602, Japan.	a.tsunoda@kameda.jp			Kameda Medical Center Foundation for Surgical Research	This work was supported in part by the Kameda Medical Center Foundation for Surgical Research.	D'Hoore A, 2004, BRIT J SURG, V91, P1500, DOI 10.1002/bjs.4779; Agachan F, 1996, DIS COLON RECTUM, V39, P681, DOI 10.1007/BF02056950; Lauretta A, 2012, TECH COLOPROCTOL, V16, P477, DOI 10.1007/s10151-012-0918-2; Boccasanta P, 2004, DIS COLON RECTUM, V47, P1285, DOI 10.1007/s10350-004-0582-3; Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199; SHORVON PJ, 1989, GUT, V30, P1737, DOI 10.1136/gut.30.12.1737; Slawik S, 2008, COLORECTAL DIS, V10, P138, DOI 10.1111/j.1463-1318.2007.01259.x; Jonkers HAF, 2013, COLORECTAL DIS, V15, P695, DOI 10.1111/codi.12113; Badrek-Al Amoudi AH, 2013, COLORECTAL DIS, V15, P707, DOI 10.1111/codi.12164; BARTRAM CI, 1988, GASTROINTEST RADIOL, V13, P72, DOI 10.1007/BF01889028; Boons P, 2010, COLORECTAL DIS, V12, P526, DOI 10.1111/j.1463-1318.2009.01859.x; Collinson R, 2009, COLORECTAL DIS, V11, P77, DOI 10.1111/j.1463-1318.2008.01539.x; Collinson R, 2010, COLORECTAL DIS, V12, P97, DOI 10.1111/j.1463-1318.2009.02049.x; DELEMARRE JBVM, 1991, DIS COLON RECTUM, V34, P311, DOI 10.1007/BF02050590; Dippolito Anthony, 2005, Curr Surg, V62, P609, DOI 10.1016/j.cursur.2005.08.003; Faccioli N, 2010, DIAGN INTERV RADIOL, V16, P209, DOI 10.4261/1305-3825.DIR.2584-09.1; Gagliardi G, 2008, DIS COLON RECTUM, V51, P186, DOI 10.1007/s10350-007-9096-0; GOEI R, 1990, RADIOLOGY, V174, P124; Gosselink MP, 2013, DIS COLON RECTUM, V56, P1409, DOI 10.1097/DCR.0b013e3182a85aa6; Hayden Dana M, 2011, Clin Colon Rectal Surg, V24, P64, DOI 10.1055/s-0031-1272825; MAHIEU P, 1984, GASTROINTEST RADIOL, V9, P253, DOI 10.1007/BF01887846; ORROM WJ, 1991, DIS COLON RECTUM, V34, P41, DOI 10.1007/BF02050205; Portier G, 2011, COLORECTAL DIS, V13, P914, DOI 10.1111/j.1463-1318.2010.02327.x; PRASAD ML, 1986, DIS COLON RECTUM, V29, P547; Sileri P, 2012, J GASTROINTEST SURG, V16, P622, DOI 10.1007/s11605-011-1793-2; van den Esschert JW, 2008, SURG ENDOSC, V22, P2728, DOI 10.1007/s00464-008-9771-9; Wong MTC, 2011, COLORECTAL DIS, V13, pE320, DOI 10.1111/j.1463-1318.2011.02688.x	27	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0012-3706	1530-0358		DIS COLON RECTUM	Dis. Colon Rectum	APR	2015	58	4					449	456		10.1097/DCR.0000000000000328		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CD3IX	WOS:000350972900019		
J	Yukita, M; Machida, S; Nishiguchi, KM; Tsuda, S; Yokoyama, Y; Yasuda, M; Maruyama, K; Nakazawa, T				Yukita, Masayoshi; Machida, Shigeki; Nishiguchi, Koji M.; Tsuda, Satoru; Yokoyama, Yu; Yasuda, Masayuki; Maruyama, Kazuichi; Nakazawa, Toru			Molecular, anatomical and functional changes in the retinal ganglion cells after optic nerve crush in mice	DOCUMENTA OPHTHALMOLOGICA			English	Article						Axonal injury; Glaucoma; Retinal ganglion cell; Electroretinogram; Scotopic threshold response	PHOTOPIC NEGATIVE RESPONSE; FLASH ELECTRORETINOGRAM; EXPERIMENTAL GLAUCOMA; INTRAOCULAR-PRESSURE; REDUCTION; CALPAIN; MACAQUE; ATROPHY; DEATH	Optic nerve crush (ONC) and subsequent axonal damage can be used in rodents to study the mechanism of retinal ganglion cell (RGC) degeneration. Here, we examined electroretinograms (ERGs) in post-ONC mice to investigate changes in the positive scotopic threshold response (pSTR). We then compared these changes with molecular and morphological changes to identify early objective biomarkers of RGC dysfunction. Fifty 12-week-old C57BL/6 mice were included. ONC was used to induce axonal injury in the right eye of each animal, with the left eye used as a control. The expression of the RGC markers Brn3a and Brn3b was measured on days 1, 2, 3, 5 and 7 after ONC with quantitative real-time PCR. ERGs were recorded under dark adaptation with the stimulus intensity increasing from -6.2 to 0.43 log cd-s/m(2) on days 1, 2, 3, 5, 7 and 10 after ONC. The pSTR, a- and b-wave amplitudes were measured. Inner retinal thickness around the optic nerve head was measured with spectral-domain optical coherence tomography on days 0, 2, 5, 7 and 10 after ONC. The expression of Brn3a and Brn3b began to significantly decrease on day 1 and day 2, respectively (P < 0.01). The amplitude of the pSTR underwent rapid, significant deterioration on day 3, after which it fell gradually (P < 0.01), while the a- and b-wave amplitudes remained unchanged throughout the experiment. Inner retinal thickness gradually decreased, with the most significant reduction on day 10 (P < 0.01). Decrease in pSTR likely reflected the early loss of RGC function after ONC and that declining expression of RGC-specific genes preceded anatomical and functional changes in the RGCs.	[Yukita, Masayoshi; Tsuda, Satoru; Yokoyama, Yu; Yasuda, Masayuki; Maruyama, Kazuichi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Machida, Shigeki] Dokkyo Med Univ, Koshigaya Hosp, Dept Ophthalmol, Saitama, Japan; [Machida, Shigeki] Iwate Med Univ, Sch Med, Dept Ophthalmol, Morioka, Iwate 020, Japan; [Nishiguchi, Koji M.; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi 9808574, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi 9808574, Japan	Nakazawa, T (reprint author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Aoba Ku, 1-1 Seiryo, Sendai, Miyagi 9808574, Japan.	ntoru@oph.med.tohoku.ac.jp			JSPS KAKENHI [26293372, 26670751, 26670263]; JST Center for Revitalization Promotion	We thank Ms. Junko Sato for her technical assistance. This work was supported in part by JSPS KAKENHI Grants-in-Aid for Scientific Research B (T.N. 26293372) and for Challenging Exploratory Research (Y.T. 26670263 and T.N. 26670751). This study was also supported by the JST Center for Revitalization Promotion (Y.T. and T.N.).	SIEVING PA, 1986, J NEUROPHYSIOL, V56, P1049; Machida S, 2008, INVEST OPHTH VIS SCI, V49, P2201, DOI 10.1167/iovs.07-0887; Himori N, 2013, J NEUROCHEM, V127, P669, DOI 10.1111/jnc.12325; Alarcon-Martinez L, 2010, VISION RES, V50, P2176, DOI 10.1016/j.visres.2010.08.014; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Shanab AY, 2012, NEUROBIOL DIS, V48, P556, DOI 10.1016/j.nbd.2012.07.025; Bui BV, 2004, J PHYSIOL-LONDON, V555, P153, DOI 10.1113/jphysiol.2003.052738; Frishman LJ, 1996, INVEST OPHTH VIS SCI, V37, P125; Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Viswanathan S, 2001, INVEST OPHTH VIS SCI, V42, P514; Ryu M, 2012, J NEUROSCI RES, V90, P802, DOI 10.1002/jnr.22800; Musch DC, 2009, OPHTHALMOLOGY, V116, P200, DOI 10.1016/j.ophtha.2008.08.051; Smith BJ, 2014, DOC OPHTHALMOL, V128, P155, DOI 10.1007/s10633-014-9433-2; Viswanathan S, 1999, INVEST OPHTH VIS SCI, V40, P1124; Rangaswamy NV, 2004, INVEST OPHTH VIS SCI, V45, P3827, DOI 10.1167/iovs.04-0458; Gotoh Y, 2004, ARCH OPHTHALMOL-CHIC, V122, P341, DOI 10.1001/archopht.122.3.341; Porciatti V, 2007, DOC OPHTHALMOL, V115, P145, DOI 10.1007/s10633-007-9059-8; Kohzaki K, 2008, INVEST OPHTH VIS SCI, V49, P3595, DOI 10.1167/iovs.08-1679; Fujita Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.298; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268; Machida S, 2008, INVEST OPHTH VIS SCI, V49, P442, DOI 10.1167/iovs.07-0291; Miyata K, 2007, INVEST OPHTH VIS SCI, V48, P820, DOI 10.1167/iovs.06-0845; Mojumder DK, 2008, J PHYSIOL-LONDON, V586, P2551, DOI 10.1113/jphysiol.2008.150755; Sajgo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091435; Shi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076347; Wang J, 2012, INVEST OPHTH VIS SCI, V53, P1315, DOI 10.1167/iovs.11-8461; Yasuda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093258	27	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0012-4486	1573-2622		DOC OPHTHALMOL	Doc. Ophthalmol.	APR	2015	130	2					149	156		10.1007/s10633-014-9478-2		8	Ophthalmology	Ophthalmology	CD2BM	WOS:000350878600007		
J	Piani, L; Robert, F; Remusat, L				Piani, Laurette; Robert, Francois; Remusat, Laurent			Micron-scale D/H heterogeneity in chondrite matrices: A signature of the pristine solar system water?	EARTH AND PLANETARY SCIENCE LETTERS			English	Article						chondrite; solar system; water; organic matter; hydrogen isotopes; NanoSIMS	HYDROGEN ISOTOPIC COMPOSITION; O1 HALE-BOPP; ORGANIC-MATTER; CARBONACEOUS CHONDRITES; PROTOPLANETARY DISKS; GIANT PLANETS; METEORITES; DEUTERIUM; CHEMISTRY; EVOLUTION	Organic matter and hydrous silicates are intimately mixed in the matrix of chondrites and in-situ determination of their individual D/H ratios is therefore challenging. Nevertheless, the D/H ratio of each pure component in this mixture should yield a comprehensible signature of the origin and evolution of water and organic matter in our solar system. We measured hydrogen isotope ratios of organic and hydrous silicates in the matrices of two carbonaceous chondrites (Orgueil CI1 and Renazzo CR2) and one unequilibrated ordinary chondrite (Semarkona, LL3.0). A novel protocol was adopted, involving NanoSIMS imaging of H isotopes of monoatomatic (H-) and molecular (OH-) secondary ions collected at the same location. This allowed the most enriched component with respect to D to be identified in the mixture. Using this protocol, we found that in carbonaceous chondrites the isotopically homogeneous hydrous silicates are mixed with D-rich organic matter. The opposite was observed in Semarkona. Hydrous silicates in Semarkona display highly heterogeneous D/H ratios, ranging from 150 to 1800 x 10(-6) (delta D-SMOW = -40 to 10 600%). Organic matter in Semarkona does not show such large isotopic variations. This suggests limited isotopic exchange between the two phases during aqueous alteration. Our study greatly expands the range of water isotopic values measured so far in solar system objects. This D-rich water reservoir was sampled by the LL ordinary chondrite parent body and an estimate (<= 9%) of its relative contribution to the D/H ratio of water in Oort cloud family comets is proposed. (C) 2015 Elsevier B.V. All rights reserved.	[Piani, Laurette; Robert, Francois; Remusat, Laurent] Univ Paris 06, Univ Paris 04, Museum Natl Hist Nat, UMR CNRS 7590,Inst Mineral Phys Mat & Cosmochim, F-75231 Paris 5, France	Piani, L (reprint author), Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan.	laurette@ep.sci.hokudai.ac.jp			Programme National de Planetologie (PNP INSU); ANR T-Tauri Chem; CNRS, Region Ile de France; Ministere delegue a l'Enseignement superieur et a la Recherche	Jean Duprat, Etienne Deloule, Yves Marrocchi, Corentin Le Guillou, Alice Williams and Shoichi Itoh are thanked for stimulating discussions or help for preparing the paper. Larry Nittler and one anonymous reviewer are thanked for their thorough and constructive comments. We are also grateful to Editor Tim Elliott for his helpful reviews and careful editing. This work has been supported by the Programme National de Planetologie (PNP INSU) and the ANR T-Tauri Chem. The National NanoSIMS facility at the Museum National d'Histoire Naturelle was established by funds from the CNRS, Region Ile de France, Ministere delegue a l'Enseignement superieur et a la Recherche, and the Museum itself.	Aleon J., 2001, Geochimica et Cosmochimica Acta, V65, DOI 10.1016/S0016-7037(01)00720-7; ALEXANDER CMO, 1989, GEOCHIM COSMOCHIM AC, V53, P3045, DOI 10.1016/0016-7037(89)90180-4; Alexander CMO, 2007, GEOCHIM COSMOCHIM AC, V71, P4380, DOI 10.1016/j.gca.2007.06.052; Hartogh P, 2011, NATURE, V478, P218, DOI 10.1038/nature10519; Geiss J, 2003, SPACE SCI REV, V106, P3, DOI 10.1023/A:1024651232758; Grossman JN, 2000, METEORIT PLANET SCI, V35, P467; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; Mousis O, 2000, ICARUS, V148, P513, DOI 10.1006/icar.2000.6499; Le Guillou C, 2014, GEOCHIM COSMOCHIM AC, V131, P368, DOI 10.1016/j.gca.2013.11.020; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Remusat L, 2009, ASTROPHYS J, V698, P2087, DOI 10.1088/0004-637X/698/2/2087; Alexander CMO, 2012, SCIENCE, V337, P721, DOI 10.1126/science.1223474; Alexander CMO, 2010, GEOCHIM COSMOCHIM AC, V74, P4417, DOI 10.1016/j.gca.2010.05.005; Lecuyer C, 1998, CHEM GEOL, V145, P249, DOI 10.1016/S0009-2541(97)00146-0; ROBERT F, 1982, GEOCHIM COSMOCHIM AC, V46, P81, DOI 10.1016/0016-7037(82)90293-9; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Hersant F, 2001, ASTROPHYS J, V554, P391, DOI 10.1086/321355; Dartois E, 2003, ASTRON ASTROPHYS, V399, P1009, DOI 10.1051/0004-6361:20021558; HUTCHISON R, 1987, GEOCHIM COSMOCHIM AC, V51, P1875, DOI 10.1016/0016-7037(87)90178-5; Le Guillou C, 2012, METEORIT PLANET SCI, V47, P345, DOI 10.1111/j.1945-5100.2012.01336.x; Meier R, 1998, SCIENCE, V279, P842, DOI 10.1126/science.279.5352.842; Horner J, 2007, EARTH MOON PLANETS, V100, P43, DOI 10.1007/s11038-006-9096-4; SAVIN SM, 1970, GEOCHIM COSMOCHIM AC, V34, P25, DOI 10.1016/0016-7037(70)90149-3; YANG J, 1983, GEOCHIM COSMOCHIM AC, V47, P2199, DOI 10.1016/0016-7037(83)90043-1; Bland PA, 2009, EARTH PLANET SC LETT, V287, P559, DOI 10.1016/j.epsl.2009.09.004; Remusat L, 2010, ASTROPHYS J, V713, P1048, DOI 10.1088/0004-637X/713/2/1048; Drouart A, 1999, ICARUS, V140, P129, DOI 10.1006/icar.1999.6137; Jacquet E, 2013, ICARUS, V223, P722, DOI 10.1016/j.icarus.2013.01.022; Young ED, 1999, SCIENCE, V286, P1331, DOI 10.1126/science.286.5443.1331; Bockelee-Morvan D, 1998, ICARUS, V133, P147, DOI 10.1006/icar.1998.5916; Yang L, 2013, ICARUS, V226, P256, DOI 10.1016/j.icarus.2013.05.027; Busemann H, 2006, SCIENCE, V312, P727, DOI 10.1126/science.1123878; Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; HUTCHEON ID, 1989, NATURE, V337, P238, DOI 10.1038/337238a0; Duprat J, 2010, SCIENCE, V328, P742, DOI 10.1126/science.1184832; Meier R, 1998, SCIENCE, V279, P1707, DOI 10.1126/science.279.5357.1707; MCSWEEN HY, 1979, REV GEOPHYS, V17, P1059, DOI 10.1029/RG017i005p01059; Deloule E, 1998, GEOCHIM COSMOCHIM AC, V62, P3367, DOI 10.1016/S0016-7037(98)00232-4; WEISBERG MK, 1993, GEOCHIM COSMOCHIM AC, V57, P1567, DOI 10.1016/0016-7037(93)90013-M; LECLUSE C, 1994, GEOCHIM COSMOCHIM AC, V58, P2927, DOI 10.1016/0016-7037(94)90126-0; Willacy K, 2009, ASTROPHYS J, V703, P479, DOI 10.1088/0004-637X/703/1/479; BARBER DJ, 1981, GEOCHIM COSMOCHIM AC, V45, P945, DOI 10.1016/0016-7037(81)90120-4; Bergin E. A., 2007, PROTOSTARS PLANETS, VV, P751; Bockelee-Morvan D, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219744; Bonal L, 2013, GEOCHIM COSMOCHIM AC, V106, P111, DOI 10.1016/j.gca.2012.12.009; Brearley A.J., 2006, METEORITES EARLY SOL, P587; Brearley A.J., 2003, TREATISE GEOCHEMISTR, P247; Ceccarelli C., 2014, PROTOPLANETARY PLANE; Cleeves LI, 2014, SCIENCE, V345, P1590, DOI [10.1126/science.1258055, 10.1126/science.1258066]; DELOULE E, 1995, GEOCHIM COSMOCHIM AC, V59, P4695, DOI 10.1016/0016-7037(95)00313-4; Fletcher IR, 2008, INT J MASS SPECTROM, V278, P59, DOI 10.1016/j.ijms.2008.08.010; Gounelle M, 2011, ELEMENTS, V7, P29, DOI 10.2113/gselements.7.1.29; JAROSEWICH E, 1990, METEORITICS, V25, P323; Le Guillou C., 2013, GEOCHIM COSMOCHIM AC; Piani L, 2012, ANAL CHEM, V84, P10199, DOI 10.1021/ac301099u; Quirico E, 2003, METEORIT PLANET SCI, V38, P795; Remusat L, 2013, 44 LUN PLAN SCI C; Robert F., 2006, METEORITES EARLY SOL, P341; Willacy K, 2007, ASTROPHYS J, V660, P441, DOI 10.1086/512796; Yurimoto H., 2014, GEOCHEM J, V48, P1	60	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0012-821X	1385-013X		EARTH PLANET SC LETT	Earth Planet. Sci. Lett.	APR 1	2015	415						154	164		10.1016/j.epsl.2015.01.039		11	Geochemistry & Geophysics	Geochemistry & Geophysics	CD2SP	WOS:000350929600015		
J	Nakao, M; Hasegawa, G; Yasuhara, T; Ishihara, Y				Nakao, Motoyuki; Hasegawa, Go; Yasuhara, Tadashi; Ishihara, Yoko			Degradation of jatropha curcas phorbol esters derived from Jatropha oil cake and their tumor-promoting activity	ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY			English	Article						Jatropha curcas; Phorbol ester; Esterase; Soil; Biodegradation	TOXICITY; LIPASE	Large amount of oil cake is generated during biodiesel production from Jatropha seeds. Although Jatropha oil cake is rich in plant nutrients, presence of toxic phorbol esters restricts the usage of oil cake as a fertilizer. The objective of this study is to evaluate the components and tumor promoting activity of phorbol esters in Jatropha oil cake-supplemented soil and plants grown in the treated soil. Contents and their biological activity of Jatropha phorbol esters in soil and plants were sequentially analyzed by high-performance liquid chromatography (HPLC) and in vitro cell transformation assay, respectively. Disappearance of Jatropha phorbol-ester-specific peaks were followed with HPLC during incubation of Jatropha oil cake with soil for five weeks. Along with the degradation of Jatropha phorbol ester in soil, tumor-promoting activity in the sample was also attenuated and ultimately disappeared. Jatropha phorbol esters and tumor promoting activity were not detected from mustard spinach grown in the Jatropha oil cake-supplemented soil. In addition, the esterase KM109 degrades DHPB (see definition below; Jatropha phorbol ester) and reduced its tumor-promoting activity. From these data, we conclude: (1) components and tumor promoting activity of Jahropha phorbol esters in the oil cake disappeared completely by incubation with soil for five-week, (2) Jatropha phorbol esters did not transfer into plants grown in the Jatropha oil cake-supplemented soil, and (3) DHPB can be degraded by esterase from soil bacterium. These observations are useful for utilization of Jatropha oil cake as a fertilizer. (C) 2014 Elsevier Inc. All rights reserved.	[Nakao, Motoyuki; Hasegawa, Go; Ishihara, Yoko] Kurume Univ, Sch Med, Dept Publ Hlth, Kurume, Fukuoka 8300011, Japan; [Yasuhara, Tadashi] Kitasato Univ, Grad Sch Pharmaceut Sci, Minato Ku, Minato 1088641, Japan	Ishihara, Y (reprint author), Kurume Univ, Sch Med, Dept Publ Hlth, 67 Asahimachi, Kurume, Fukuoka 8300011, Japan.	guni0you@gmail.com			JICA/JST, SATREPS (Science and Technology Research Partnership for Sustainable Development), Japan	The authors express gratitude to Dr. Paul S. Satoh, an adjunct professor at Michigan State University, East Lansing, Lansing, MI, for his suggestions and review during the preparation of this article, and Dr. Yumi Shimizu and Ms. Satoko Kinoshita for their technical assistance. Jatropha seeds and oil cakes were provided by courtesy of TOYOTA TSUSHO Corporation (Tokyo, Japan). This study was supported by JICA/JST, SATREPS (Science and Technology Research Partnership for Sustainable Development), Japan.	Mahanta N, 2008, BIORESOURCE TECHNOL, V99, P1729, DOI 10.1016/j.biortech.2007.03.046; Makkar HPS, 1997, J AGR FOOD CHEM, V45, P3152, DOI 10.1021/jf970036j; Kumar A, 2008, IND CROP PROD, V28, P1, DOI 10.1016/j.indcrop.2008.01.001; Rakshit KD, 2008, FOOD CHEM TOXICOL, V46, P3621, DOI 10.1016/j.fct.2008.09.010; Chikusa Y, 2003, ORG PROCESS RES DEV, V7, P289, DOI 10.1021/op034014b; Goel G, 2007, INT J TOXICOL, V26, P279, DOI 10.1080/10915810701464641; Joshi C, 2011, BIORESOURCE TECHNOL, V102, P4815, DOI 10.1016/j.biortech.2011.01.039; Aregheore E. M., 2003, S PAC J NAT SCI, V21, P51, DOI DOI 10.1071/SP03010; Haas W, 2002, J NAT PROD, V65, P1434, DOI 10.1021/np020060d; Hasegawa G, 2012, J APPL TOXICOL, V32, P72, DOI 10.1002/jat.1719; He Y., 2011, E.P. Patent, Patent No. [2397240 A1, 2397240]; Makkar H, 2009, J AM OIL CHEM SOC, V86, P173, DOI 10.1007/s11746-008-1327-6; Mitsuhashi K, 1999, BIOSCI BIOTECH BIOCH, V63, P1959, DOI 10.1271/bbb.63.1959; Ohmori K, 2004, MUTAT RES-GEN TOX EN, V557, P191, DOI 10.1016/j.mrgentox.2003.10.014	14	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0147-6513	1090-2414		ECOTOX ENVIRON SAFE	Ecotox. Environ. Safe.	APR	2015	114						357	364		10.1016/j.ecoenv.2014.07.009		8	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	CD2SH	WOS:000350928800042		
J	Gao, HF; Xiang, JW; Zheng, CJ; Jiang, YY; Matsumoto, T				Gao, Haifeng; Xiang, Jiawei; Zheng, Changjun; Jiang, Yongying; Matsumoto, Toshiro			BEM-based analysis of elastic banded material by using a contour integral method	ENGINEERING ANALYSIS WITH BOUNDARY ELEMENTS			English	Article						BEM; Phononic crystals; Eigenvalue problem; Contour integral method	BOUNDARY-ELEMENT METHOD; 2-DIMENSIONAL PHONONIC CRYSTALS; STOP-BANDS; EIGENVALUE PROBLEMS; NUMERICAL SOLUTION; APPROXIMATION; FORMULATION; EXPANSION; MATRICES; ARRAYS	The combination of boundary element method (BEM) and a contour integral method is proposed for the first time to determine the band structures for banded elastic materials named as phononic/sonic crystals. Applying the Bloch theorem to a unit cell, the Bloch eigenvalue problem is derived to determine the dispersion relation which presents the band structures of the phononic crystals. Owing to the nonlinear form of the fundamental solution, the circular frequency; however, is involved in the coefficient matrix as the eigenvalue parameter implicitly, and the transcendental eigenequation makes it a nonlinear eigenvalue problem. To solve the nonlinear eigenvalue problem, the block Sakurai-Sugiura (SS) method is employed as an eigensolver, which extracts the eigenfrequencies within a closed contour integration path by evaluating the contour integral numerically. To avoid the complex fictitious eigenvalues, a new fusiform integration path is proposed to confine the solving domain to the neighborhood of the real axis. Numerical examples are presented to demonstrate the effectiveness of the proposed methodology for band structure calculation in 2D elastic problems. (C) 2015 Elsevier Ltd. All rights reserved.	[Gao, Haifeng; Xiang, Jiawei; Jiang, Yongying] Wenzhou Univ, Coll Mech & Elect Engn, Wenzhou 325035, Peoples R China; [Zheng, Changjun] Hefei Univ Technol, Inst Sound & Vibrat Res, Hefei 230009, Anhui, Peoples R China; [Matsumoto, Toshiro] Nagoya Univ, Dept Mech Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648604, Japan	Gao, HF (reprint author), Wenzhou Univ, Coll Mech & Elect Engn, Wenzhou 325035, Peoples R China.	gao_h@wzu.edu.cn; jwxiang@wzu.edu.cn; chjunzheng@gmail.com; yyjiang2003@126.com; t.matsumoto@nuem.nagoya-u.ac.jp	Xiang, Jiawei/G-1177-2011; Zheng, Chang-Jun/A-2332-2014		Zhejiang Provincial Natural Science Foundation of China [LQ14A020004, LR13E050002]; National Science Foundation of China [51175097, 11402071]; Zhejiang Technologies R&D Program of China [2014C31103]; SRF for ROCS, SEM	The authors are grateful to the support from the Zhejiang Provincial Natural Science Foundation of China (Nos. LQ14A020004 and LR13E050002), the National Science Foundation of China (No. 51175097), the Zhejiang Technologies R&D Program of China (No. 2014C31103) and the National Science Foundation of China (No. 11402071) and the Project sponsored by SRF for ROCS, SEM.	Qiu CY, 2005, SOLID STATE COMMUN, V134, P765, DOI 10.1016/j.ssc.2005.02.034; Mei J, 2005, J PHYS-CONDENS MAT, V17, P3735, DOI 10.1088/0953-8984/17/25/003; Yan ZZ, 2008, CMES-COMP MODEL ENG, V38, P59; Li FL, 2013, ENG ANAL BOUND ELEM, V37, P225, DOI 10.1016/j.enganabound.2012.10.003; BURTON AJ, 1971, PROC R SOC LON SER-A, V323, P201, DOI 10.1098/rspa.1971.0097; Kushwaha MS, 1997, APPL PHYS LETT, V70, P3218, DOI 10.1063/1.119130; KUSHWAHA MS, 1993, PHYS REV LETT, V71, P2022, DOI 10.1103/PhysRevLett.71.2022; Cao YJ, 2004, PHYS LETT A, V327, P247, DOI 10.1016/j.physleta.2004.05.030; Wang YF, 2011, J APPL PHYS, V110, DOI 10.1063/1.3665205; CRUSE TA, 1968, J MATH ANAL APPL, V22, P341, DOI 10.1016/0022-247X(68)90177-7; Wang PB, 2006, COMPUT MECH, V38, P223, DOI 10.1007/s00466-005-0743-9; Cheng H, 1999, J COMPUT PHYS, V155, P468, DOI 10.1006/jcph.1999.6355; Kushwaha MS, 1996, APPL PHYS LETT, V69, P31, DOI 10.1063/1.118108; Yan ZZ, 2008, ACTA MECH SOLIDA SIN, V21, P104, DOI 10.1007/s10338-008-0813-6; SIGALAS M, 1993, SOLID STATE COMMUN, V86, P141, DOI 10.1016/0038-1098(93)90888-T; Ikegami T, 2010, J COMPUT APPL MATH, V233, P1927, DOI 10.1016/j.cam.2009.09.029; Rjasanow S, 2013, COMPUT MECH, V51, P431, DOI 10.1007/s00466-012-0731-9; Bebendorf M, 2003, COMPUTING, V70, P1, DOI 10.1007/s00607-002-1469-6; Bebendorf M, 2000, NUMER MATH, V86, P565, DOI 10.1007/s002110000192; Chen JT, 2001, P ROY SOC A-MATH PHY, V457, P2521; Gao HF, 2013, CMES-COMP MODEL ENG, V90, P283; Beyn WJ, 2012, LINEAR ALGEBRA APPL, V436, P3839, DOI 10.1016/j.laa.2011.03.030; Cao YJ, 2004, SOLID STATE COMMUN, V132, P539, DOI 10.1016/j.ssc.2004.09.003; Liu ZY, 2000, SCIENCE, V289, P1734, DOI 10.1126/science.289.5485.1734; MARTINEZSALA R, 1995, NATURE, V378, P241, DOI 10.1038/378241a0; Zheng CJ, 2012, ENG ANAL BOUND ELEM, V36, P361, DOI 10.1016/j.enganabound.2011.09.001; Gao HF, 2013, ENG ANAL BOUND ELEM, V37, P914, DOI 10.1016/j.enganabound.2013.03.015; Hussein MI, 2009, P ROY SOC A-MATH PHY, V465, P2825, DOI 10.1098/rspa.2008.0471; Asakura J., 2009, JSIAM LETT, V1, P52; Barnett A, 2010, J COMPUT PHYS, V229, P6898, DOI 10.1016/j.jcp.2010.05.029; Brebbia C. A., 1984, BOUNDARY ELEMENT TEC; Effenberger Cedric, 2012, Proceedings in Applied Mathematics and Mechanics, V12, DOI 10.1002/pamm.201210305; Kushwaha MS, 1998, EUR PHYS J B, V3, P155, DOI 10.1007/s100510050296; Li FL, 2008, IEEE INT ULTRASON S, V1-4, P1468; Liu YJ, 2008, COMPUT MECH, V42, P761, DOI 10.1007/s00466-008-0274-2; Maeda Yasuyuki, 2011, JSIAM Letters, V3; Sakurai Tetsuya, 2013, Journal of Algorithms & Computational Technology, V7; Vasseur JO, 1993, SOLID STATE COMMUN, V86, P141	38	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0955-7997	1873-197X		ENG ANAL BOUND ELEM	Eng. Anal. Bound. Elem.	APR	2015	53						56	64		10.1016/j.enganabound.2015.01.002		9	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications	Engineering; Mathematics	CD0SG	WOS:000350783600007		
J	Sudo, S; Hattori, N; Manabe, O; Kato, F; Mimura, R; Magota, K; Sugimori, H; Hirata, K; Sakuragi, N; Tamaki, N				Sudo, Satoko; Hattori, Naoya; Manabe, Osamu; Kato, Fumi; Mimura, Rie; Magota, Keiichi; Sugimori, Hiroyuki; Hirata, Kenji; Sakuragi, Noriaki; Tamaki, Nagara			FDG PET/CT diagnostic criteria may need adjustment based on MRI to estimate the presurgical risk of extrapelvic infiltration in patients with uterine endometrial cancer	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						Magnetic resonance imaging; Radionuclide imaging; Uterine neoplasms; Risk assessment; Tomography, emission computed	F-18-FDG PET/CT; SUVMAX	Purpose The staging of endometrial cancer requires surgery which carries the risk of morbidity. FDG PET/CT combined with anatomical imaging may reduce the number of unnecessary lymphadenectomies by demonstrating the risk of extrapelvic infiltration. The purpose of this study was to optimize FDG PET/CT diagnostic criteria for risk assessment in endometrial cancer after first-line risk triage with MRI. Methods The study population comprised 37 patients who underwent curative surgery for the treatment of endometrial cancer. First, the risk of extrapelvic infiltration was triaged using MRI. Second, multiple glucose metabolic profiles of the primary lesion were assessed with FDG PET/CT, and these were correlated with the histopathological risk of extrapelvic infiltration including lymphovascular space invasion (LVSI) and high-grade malignancy (grades 2 and 3). The results of histological correlation were used to adjust FDG PET/CT diagnostic criteria. Results Presurgical assessment using MRI was positive for deep (>50%) myometrial invasion in 17 patients. The optimal FDG PET/CT diagnostic criteria vary depending on the results of MRI. Specifically, SUVmax (>= 16.0) was used to indicate LVSI risk with an overall diagnostic accuracy of 88.2 % in patients with MRI findings showing myometrial invasion. High-grade malignancy did not correlate with any of metabolic profiles in this patient group. In the remaining patients without myometrial invasion, lesion glycolysis (LG) or metabolic volume were better indicators of LVSI than SUVmax with the same diagnostic accuracy of 80.0 %. In addition, LG (>= 26.9) predicted high-grade malignancy with an accuracy of 72.2 %. Using the optimized cut-off criteria for LVSI, glucose metabolic profiling of primary lesions correctly predicted lymph node metastasis with an accuracy of 73.0 %, which was comparable with the accuracy of visual assessment for lymph node metastasis using MRI and FDG PET/CT. Conclusion FDG PET/CT diagnostic criteria may need adjustment based on the anatomical information provided by MRI. The optimized criteria can predict the risk of pathology-proven LVSI correctly in 83.8 % of patients before surgery, and thus would improve presurgical treatment planning.	[Sudo, Satoko; Sakuragi, Noriaki] Hokkaido Univ, Dept Gynecol, Grad Sch Med, Sapporo, Hokkaido, Japan; [Hattori, Naoya; Manabe, Osamu; Hirata, Kenji; Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Kita Ku, Sapporo, Hokkaido, Japan; [Kato, Fumi; Mimura, Rie; Magota, Keiichi; Sugimori, Hiroyuki] Hokkaido Univ, Dept Diagnost & Intervent Radiol, Grad Sch Med, Sapporo, Hokkaido, Japan	Hattori, N (reprint author), Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Kita Ku, Sapporo, Hokkaido, Japan.	nhattori@med.hokudai.ac.jp					Todo Y, 2013, INT J CLIN ONCOL, V18, P200, DOI 10.1007/s10147-012-0499-0; Tozzi R, 2005, GYNECOL ONCOL, V97, P4, DOI 10.1016/j.ygyno.2004.12.048; Antonsen SL, 2013, GYNECOL ONCOL, V129, P298, DOI 10.1016/j.ygyno.2013.01.019; Avril N, 2011, METHODS MOL BIOL, V727, P171, DOI 10.1007/978-1-61779-062-1_10; Beiderwellen K, 2015, EUR J NUCL MED MOL I, V42, P56, DOI 10.1007/s00259-014-2902-8; Hirata K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105682; Kitajima K, 2012, EUR J NUCL MED MOL I, V39, P840, DOI 10.1007/s00259-011-2057-9; Lee HJ, 2011, NUKLEARMED-NUCL MED, V50, P204, DOI 10.3413/nukmed-0375-10-12; McMeekin DS, 2001, GYNECOL ONCOL, V82, P375, DOI 10.1006/gyno.2001.6278; Nakamura K, 2010, INT J GYNECOL CANCER, V20, P110, DOI 10.1111/IGC.0b013e3181c3a288; Patel S, 2010, INSIGHTS IMAGING, V1, P309, DOI DOI 10.1007/S13244-010-0042-7; Shim SH, 2014, BJOG-INT J OBSTET GY, V121, P1097, DOI 10.1111/1471-0528.12543	12	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	APR	2015	42	5					676	684		10.1007/s00259-014-2964-7		9	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CC9JQ	WOS:000350686300003		
J	Kasama, S; Toyama, T; Funada, R; Takama, N; Koitabashi, N; Ichikawa, S; Suzuki, Y; Matsumoto, N; Sato, Y; Kurabayashi, M				Kasama, Shu; Toyama, Takuji; Funada, Ryuichi; Takama, Noriaki; Koitabashi, Norimichi; Ichikawa, Shuichi; Suzuki, Yasuyuki; Matsumoto, Naoya; Sato, Yuichi; Kurabayashi, Masahiko			Effects of adding intravenous nicorandil to standard therapy on cardiac sympathetic nerve activity and myocyte dysfunction in patients with acute decompensated heart failure	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						Nicorandil; Acute heart failure; Sympathetic nervous system	VENTRICULAR EJECTION FRACTION; DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; TROPONIN-T; PLASMA NOREPINEPHRINE; PROGNOSTIC VALUE; REPERFUSION; ISCHEMIA; EFFICACY; RELEASE	Purpose Nicorandil, an adenosine triphosphate-sensitive potassium channel opener, improves cardiac sympathetic nerve activity (CSNA) in ischemic heart disease or chronic heart failure. However, its effects on CSNA and myocyte dysfunction in acute heart failure (AHF) remain unclear. We investigated the effects of adding intravenous nicorandil to standard therapy on CSNA and myocyte dysfunction in AHF. Methods We selected 70 patients with mild to moderate nonischemic AHF who were treated with standard conventional therapy soon after admission. Thirty-five patients were assigned to additionally receive intravenous nicorandil (412 mg/h; group A), whereas the remaining patients continued their current drug regimen (group B). Delayed total defect score (TDS), delayed heart to mediastinum count (H/M) ratio, and washout rate (WR) were determined by I-123-metaiodobenzylguanidine (MIBG) scintigraphy within 3 days of admission and 4 weeks later. High sensitivity troponin T (hs-TnT) level was also measured at the same time points. Results After treatment, MIBG scintigraphic parameters significantly improved in both groups. However, the extent of the changes in these parameters in group A significantly exceeded the extent of the changes in group B [ TDS -11.3 +/- 4.3 in group Avs -4.0 +/- 6.0 in group B (p<0.01); H/M ratio 0.31 +/- 0.16 vs 0.14 +/- 0.16 (p<0.01); WR -13.8 +/- 7.8 % vs -6.1 +/- 8.9 % (p<0.01)]. The hs-TnT level decreased significantly from 0.052 +/- 0.043 to 0.041 +/- 0.033 ng/ml (p<0.05) in group A, but showed no significant change in group B. Moreover, in both groups, no relationships between the extent of changes in MIBG parameters and hs-TnT level were observed. Conclusion Adding intravenous nicorandil to standard therapy provides additional benefits for CSNA and myocyte dysfunction over conventional therapy alone in AHF patients. Furthermore, the mechanisms of improvement in CSNA and myocyte dysfunction after nicorandil treatment in AHF patients were distinct.	[Kasama, Shu; Toyama, Takuji; Funada, Ryuichi; Takama, Noriaki; Koitabashi, Norimichi; Kurabayashi, Masahiko] Gunma Univ, Grad Sch Med, Dept Med & Biol Sci Cardiovasc Med, Maebashi, Gunma 3718511, Japan; [Kasama, Shu; Ichikawa, Shuichi] Kitakanto Cardiovasc Hosp, Dept Cardiovasc Med, Cardiovasc Hosp Cent Japan, Gunma, Japan; [Suzuki, Yasuyuki; Matsumoto, Naoya] Nihon Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Sato, Yuichi] Hlth Pk Clin, Dept Imaging, Takasaki, Gumma, Japan	Kasama, S (reprint author), Gunma Univ, Grad Sch Med, Dept Med & Biol Sci Cardiovasc Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	s-kasama@bay.wind.ne.jp					Sato Y, 2012, J CARDIOL, V60, P160, DOI 10.1016/j.jjcc.2012.06.007; Sato Y, 2001, CIRCULATION, V103, P369; Neglia D, 2002, CIRCULATION, V105, P186, DOI 10.1161/hc0202.102119; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Kasama S, 2005, J AM COLL CARDIOL, V45, P661, DOI 10.1016/j.jacc.2004.11.038; Burgdorf C, 2004, J PHARMACOL EXP THER, V309, P42, DOI 10.1124/jpet.103.059832; Takeishi Y, 1997, J NUCL MED, V38, P1085; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Peacock WF, 2008, NEW ENGL J MED, V358, P2117, DOI 10.1056/NEJMoa0706824; Perna ER, 2004, CIRCULATION, V110, P2376, DOI 10.1161/01.CIR.0000145158.33801.F3; Nakata T, 2013, JACC-CARDIOVASC IMAG, V6, P772, DOI 10.1016/j.jcmg.2013.02.007; WIELAND DM, 1980, J NUCL MED, V21, P349; Kasama S, 2008, J NUCL MED, V49, P907, DOI 10.2967/jnumed.107.047548; THOMAS JA, 1978, AM J CARDIOL, V41, P233, DOI 10.1016/0002-9149(78)90162-5; MERLET P, 1992, J NUCL MED, V33, P471; Yamazaki J, 2001, AM HEART J, V141, P645, DOI 10.1067/mhj.2001.112783; Del Carlo CH, 1999, AM HEART J, V138, P646, DOI 10.1016/S0002-8703(99)70178-X; HENDERSON EB, 1988, CIRCULATION, V78, P1192; Dargie HJ, 2002, LANCET, V359, P1269; Ishihara S, 2012, CIRC J, V76, P1169, DOI 10.1253/circj.CJ-11-1110; Ishii H, 2005, CIRCULATION, V112, P1284, DOI 10.1161/CIRCULATIONAHA.104.530329; Kang CS, 2009, AM J PHYSIOL-HEART C, V296, pH1949, DOI 10.1152/ajpheart.00903.2008; Kasama S, 2013, INT J CARDIOL, V167, P244, DOI 10.1016/j.ijcard.2011.12.080; Kasama S, 2014, EUR J NUCL MED MOL I, V41, P144, DOI 10.1007/s00259-013-2538-0; Kasama S, 2005, EUR J NUCL MED MOL I, V32, P322, DOI 10.1007/s00259-004-1672-0; KRUMENACKER M, 1992, J CARDIOVASC PHARM, V20, pS93; Lee TM, 2007, AM J PHYSIOL-HEART C, V293, pH3617, DOI 10.1152/ajpheart.00875.2007; Lopez JR, 1996, J THORAC CARDIOV SUR, V112, P820, DOI 10.1016/S0022-5223(96)70070-3; Matsubara T, 2000, J AM COLL CARDIOL, V35, P345, DOI 10.1016/S0735-1097(99)00539-2; Matsuo S, 2009, EUR J NUCL MED MOL I, V36, P560, DOI 10.1007/s00259-008-0971-2; MIZUMURA T, 1995, CARDIOVASC RES, V29, P482; Nakajima K, 2013, EUR J NUCL MED MOL I, V40, P1163, DOI 10.1007/s00259-013-2431-x; Pollack Jr CV, 2007, ANN EMERG MED, V51, P591; Sakhuja R, 2007, CLIN CHEM, V53, P412, DOI 10.1373/clinchem.2006.074047; Sanbe A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018922; Sato Y, 2004, HEART, V90, P1110, DOI 10.1136/hrt.2003.023895; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; TAIRA N, 1989, AM J CARDIOL, V63, pJ18, DOI 10.1016/0002-9149(89)90200-2; Toyama T, 2003, J NUCL MED, V44, P1604; YONEYAMA F, 1990, CARDIOVASC DRUG THER, V4, P1119, DOI 10.1007/BF01856508	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	APR	2015	42	5					761	770		10.1007/s00259-015-2990-0		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CC9JQ	WOS:000350686300012		
J	Kamohara, R; Yamaza, H; Tsuchiya, T; Komatsu, T; Park, S; Hayashi, H; Chiba, T; Mori, R; Otabe, S; Yamada, K; Nagayasu, T; Shimokawa, I				Kamohara, Ryotaro; Yamaza, Haruyoshi; Tsuchiya, Tomoshi; Komatsu, Toshimitsu; Park, Seongjoon; Hayashi, Hiroko; Chiba, Takuya; Mori, Ryoichi; Otabe, Shuichi; Yamada, Kentaro; Nagayasu, Takeshi; Shimokawa, Isao			Overexpression of the adiponectin gene mimics the metabolic and stress resistance effects of calorie restriction, but not the anti-tumor effect	EXPERIMENTAL GERONTOLOGY			English	Article						Adiponectin; Calorie restriction; p53; Insulin; ER stress; Tumor growth	ADIPOSE-TISSUE; AMES DWARF; MICE; FAT; EXPRESSION; DIET; ADIPOCYTOKINES; HORMONES; OBESITY	Adiponectin (Adipoq), a peptide hormone secreted from the white adipose tissue, may play a role in the anti-aging and/or anti-tumor effects of calorie restriction (CR). We analyzed metabolic traits in Adipoq gene-overexpressing mice fed ad libitumwith a regular diet (RD) or a high-fat diet (HFD), or fed 30% CR of RD initiated at 12weeks of age. Adipoq-RD and -HFDmice at 6 months of age showed reduced blood glucose and insulin concentrations, and thus increased insulin sensitivity, compared with WT mice fed a RD or a HFD. In the epididymal white adipose tissue in Adipoq mice, senescence-like changes such as upregulation of p53 protein and of biomarkers of inflammation, Cd68 and Ccl2 mRNA, were ameliorated compared with WT-RD and WT-HFD mouse tissues. Resistance to stress induced by lipopolysaccharide was also strengthened in Adipoq mice compared with WT mice. These metabolic changes and stress resistance were also noted in the WT-CR mice, suggesting that Adipoq plays a part in the effect of CR. In contrast, in an allograft tumor growth model, tumor growth was not inhibited in Adipoq mice. The present findings suggest that Adipoq plays a part in the anti-aging, but not in the anti-tumor, effects of CR. (C) 2015 Elsevier Inc. All rights reserved.	[Kamohara, Ryotaro; Yamaza, Haruyoshi; Komatsu, Toshimitsu; Park, Seongjoon; Hayashi, Hiroko; Chiba, Takuya; Mori, Ryoichi; Shimokawa, Isao] Nagasaki Univ, Sch Med, Dept Pathol, Nagasaki 8528523, Japan; [Kamohara, Ryotaro; Yamaza, Haruyoshi; Komatsu, Toshimitsu; Park, Seongjoon; Hayashi, Hiroko; Chiba, Takuya; Mori, Ryoichi; Shimokawa, Isao] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528523, Japan; [Kamohara, Ryotaro; Tsuchiya, Tomoshi; Nagayasu, Takeshi] Nagasaki Univ, Sch Med, Dept Surg Oncol, Nagasaki 8528501, Japan; [Kamohara, Ryotaro; Tsuchiya, Tomoshi; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528501, Japan; [Otabe, Shuichi; Yamada, Kentaro] Kurume Univ, Sch Med, Dept Med, Kurume, Fukuoka 8111346, Japan	Shimokawa, I (reprint author), Nagasaki Univ, Sch Med, Dept Pathol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	shimo@nagasaki-u.ac.jp			Japan Society for the Promotion of Science [19590227]; JSPS Asian CORE Program [FY2010-5]	We are grateful to Professor Masanori Kitamura at University of Yamanashi for providing ESTRAP mice. We also thank the staff at the Laboratory Animal Center for Biomedical Research at the Center for Frontier Life Sciences, Nagasaki University for their animal care and technical assistance, and Yutaka Araki, Yuko Moriyama, Rieko Tahara, and Chika Matsumoto for their excellent technical assistance. The study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (I.S., nos. 19590227) and the JSPS Asian CORE Program (I.S., nos. FY2010-5).	Wang ZH, 2006, J GERONTOL A-BIOL, V61, P323; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Zhu M, 2004, EXP GERONTOL, V39, P1049, DOI 10.1016/j.exger.2004.03.024; Otabe S, 2007, AM J PHYSIOL-ENDOC M, V293, pE210, DOI 10.1152/ajpendo.00645.2006; Ntikoudi E, 2014, CANCER TREAT REV, V40, P22, DOI 10.1016/j.ctrv.2013.06.005; Barb D, 2007, AM J CLIN NUTR, V86, p858S; Qiao LP, 2011, AM J PHYSIOL-ENDOC M, V300, pE809, DOI 10.1152/ajpendo.00004.2011; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Yakar S, 2006, ENDOCRINOLOGY, V147, P5826, DOI 10.1210/en.2006-0311; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Barnea M, 2006, OBESITY, V14, P2145, DOI 10.1038/oby.2006.251; Boddu Neeraja J, 2014, Adipocyte, V3, P10, DOI 10.4161/adip.26684; Dogan S, 2010, ONCOL LETT, V1, P167, DOI 10.3892/ol_00000031; Higami Yoshikazu, 2004, FASEB Journal, V18, P415; Hiramatsu N, 2006, J IMMUNOL METHODS, V315, P202, DOI 10.1016/j.jim.2006.07.003; Kitamura M, 2011, METHOD ENZYMOL, V490, P93, DOI 10.1016/B978-0-12-385114-7.00005-2; Masoro EJ, 1998, J TOXICOL ENV HEAL B, V1, P243; Masoro Edward J, 2003, Sci Aging Knowledge Environ, V2003, pRE2, DOI 10.1126/sageke.2003.8.re2; Park S, 2009, EXP GERONTOL, V44, P646, DOI 10.1016/j.exger.2009.07.002; WEINDRUCH R, 1988, RETARDATION AGING DI; Wiesenborn DS, 2014, AGING-US, V6, P900; Yamaza H, 2010, AGING CELL, V9, P372, DOI 10.1111/j.1474-9726.2010.00563.x	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0531-5565	1873-6815		EXP GERONTOL	Exp. Gerontol.	APR	2015	64						46	54		10.1016/j.exger.2015.02.011		9	Geriatrics & Gerontology	Geriatrics & Gerontology	CD1CZ	WOS:000350812800006		
J	Charles, LF; Woodman, JL; Ueno, D; Gronowicz, G; Hurley, MM; Kuhn, LT				Charles, Lyndon F.; Woodman, Jessica L.; Ueno, Daisuke; Gronowicz, Gloria; Hurley, Marja M.; Kuhn, Liisa T.			Effects of low dose FGF-2 and BMP-2 on healing of calvarial defects in old mice	EXPERIMENTAL GERONTOLOGY			English	Article							BONE MORPHOGENETIC PROTEIN-2; FIBROBLAST GROWTH FACTOR-2; MESENCHYMAL STEM-CELLS; COLLOIDAL GELATIN GELS; AGE-RELATED-CHANGES; OSTEOBLASTIC DIFFERENTIATION; OSTEOINDUCTIVE ACTIVITY; STROMAL CELLS; UP-REGULATION; SPINE FUSION	There is an age-associated reduction in the bone healing activity of bone morphogenetic protein-2 (BMP-2) that is currently addressed by administering higher doses of BMP-2 in elderly patients. The unwanted medical complications from high dose BMP-2 motivated this investigation to determine whether the addition of a low dose of fibroblast growth factor 2 (FGF-2) could enhance the ability of a lower dose of BMP-2 to heal calvarial bone defects in old mice (18-20 months old). FGF-2 (5 ng) and BMP-2 (2 mu g) were administered by a controlled release two-phase biomaterial scaffold placed into the bone defect. FGF-2 released more rapidly and completely in vitro than BMP-2 (40% vs 2%). In vivo, both BMP-2 and FGF-2 + BMP-2 groups formed more new bone in calvarial defects than scaffold alone (p < 0.001) or FGF-2 only groups (p < 0.01). The overall total volume of new bone was not statistically increased by the addition of FGF-2 to BMP-2 as measured by microCT, but the pattern of bone deposition was different. In old mice, but not young, there was enhanced bony fill in the central bone defect area when the BMP-2 was supplemented with FGF-2. Histological analysis of the center of the defect revealed an increased bone volume (%BV/TV (p = 0.004)) from the addition of FGF-2. These studies suggest that combining a low dose of FGF-2 with a low dose of BMP-2 has the potential to increase bone healing in old mice relative to BMP-2 alone. (C) 2015 Elsevier Inc. All rights reserved.	[Charles, Lyndon F.; Woodman, Jessica L.; Kuhn, Liisa T.] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Farmington, CT 06030 USA; [Ueno, Daisuke] Tsurumi Univ, Sch Dent Med, Unit Oral & Maxillofacial Implantol, Yokohama, Kanagawa, Japan; [Gronowicz, Gloria] Univ Connecticut, Ctr Hlth, Dept Surg, Farmington, CT 06030 USA; [Hurley, Marja M.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA	Kuhn, LT (reprint author), Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, MC1615,263 Farmington Ave, Farmington, CT 06030 USA.	lkuhn@uchc.edu		Gronowicz, Gloria/0000-0001-7158-3598	International Team for Implantology (ITI; Basel, Switzerland) [348/2004]; National Institute of Dental & Craniofacial Research of the National Institutes of Health [R01DE021103]	Research reported in this publication was supported by the International Team for Implantology (ITI; Basel, Switzerland) grant # 348/2004 and the National Institute of Dental & Craniofacial Research of the National Institutes of Health under award number R01DE021103. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors would like to thank Dr. Qin Amy Wang, Dr. Jin Pan, and Dr. Roberta Kelm for assistance in conducting animal surgeries. We would also like to acknowledge Dr. Doug Adams and the MicroCT Imaging Facility at the UConn Health Center for the microCT imaging and Dr. James Grady, UCONN Health Center for help with the statistical analysis. The nonglycosylated human recombinant BMP-2 was kindly provided by Dr. Peter Hortschansky from the Hans Knoll Institute, Jena, Germany and the PEG-hydrogel was kindly provided by Institut Straumann.	Aalami OO, 2004, PLAST RECONSTR SURG, V114, P713, DOI 10.1097/01.PRS.0000131016.12754.30; CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490; Nakamura Y, 2005, BONE, V36, P399, DOI 10.1016/j.bone.2004.11.010; Fujimura K, 2002, ARCH ORAL BIOL, V47, P577, DOI 10.1016/S0003-9969(02)00046-8; YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659; Bergman RJ, 1996, J BONE MINER RES, V11, P568; Wen B, 2011, J BIOMED MATER RES B, V97B, P315, DOI 10.1002/jbm.b.31817; Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606; Fakhry A, 2005, BONE, V36, P254, DOI 10.1016/j.bone.2004.10.003; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Glassman SD, 2011, SPINE, V36, P1849, DOI 10.1097/BRS.0b013e3181d133d0; van der Stok J, 2013, TISSUE ENG PT A, V19, P2605, DOI [10.1089/ten.TEA.2013.0181, 10.1089/ten.tea.2013.0181]; Wang L, 2010, ANN BIOMED ENG, V38, P77, DOI 10.1007/s10439-009-9841-8; Behr B, 2010, BONE, V47, P281, DOI 10.1016/j.bone.2010.05.008; Kuhn LT, 2013, J GERONTOL A-BIOL, V68, P1170, DOI 10.1093/gerona/glt018; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Nadon NL, 2006, AGING CELL, V5, P9, DOI 10.1111/j.1474-9726.2006.00185.x; Justesen J, 2002, CALCIFIED TISSUE INT, V71, P36, DOI 10.1007/s00223-001-2059-x; Kakudo N, 2006, WOUND REPAIR REGEN, V14, P336, DOI 10.1111/j.1743-6109.2006.00129.x; PARFITT AM, 1987, J BONE MINER RES, V2, P595; Wang J, 2014, J BIOMED MATER RES A, V102, P4234, DOI 10.1002/jbm.a.35102; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123; Maegawa N, 2007, J TISSUE ENG REGEN M, V1, P306, DOI 10.1002/term.41; Marie PJ, 2012, GROWTH FACTORS, V30, P117, DOI 10.3109/08977194.2012.656761; Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]; Wang HN, 2013, J CONTROL RELEASE, V166, P172, DOI 10.1016/j.jconrel.2012.12.015; Chen WJ, 2004, J BONE MINER METAB, V22, P303, DOI 10.1007/s00774-004-0487-6; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Farhadi J, 2005, PLAST RECONSTR SURG, V116, P1379, DOI 10.1097/01.prs.0000182355.67397.5a; GLOBUS RK, 1988, ENDOCRINOLOGY, V123, P98; Hak DJ, 2006, J ORTHOP RES, V24, P11, DOI 10.1002/jor.20022; Heersche JNM, 1998, J PROSTHET DENT, V79, P14, DOI 10.1016/S0022-3913(98)70187-8; Howell T H, 1997, Int J Periodontics Restorative Dent, V17, P124; Jeon E, 2009, PROTEIN PEPTIDE LETT, V16, P664; KENLEY R, 1994, J BIOMED MATER RES, V28, P1139, DOI 10.1002/jbm.820281004; King WJ, 2010, J BIOMED MATER RES A, V93A, P1110, DOI 10.1002/jbm.a.32601; Kodama N, 2009, BONE, V44, P699, DOI 10.1016/j.bone.2008.12.017; Kotev-Emeth S, 2000, BONE, V27, P777, DOI 10.1016/S8756-3282(00)00389-6; Luong LN, 2012, BIOMATERIALS, V33, P283, DOI 10.1016/j.biomaterials.2011.09.052; Minamide A, 2007, SPINE, V32, P1067, DOI 10.1097/01.brs.0000261626.32999.8a; Naganawa T, 2008, J CELL BIOCHEM, V103, P1975, DOI 10.1002/jcb.21589; Ono I, 1996, J CRANIOFAC SURG, V7, P418, DOI 10.1097/00001665-199611000-00006; Ou GM, 2010, J GERONTOL A-BIOL, V65, P1051, DOI 10.1093/gerona/glq114; Pradhan BB, 2006, SPINE, V31, pE277, DOI 10.1097/01.brs.0000216442.12092.01; Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011; Singhatanadgit W, 2006, J CELL PHYSIOL, V209, P912, DOI 10.1002/jcp.20799; Takita H, 1997, EUR J ORAL SCI, V105, P588, DOI 10.1111/j.1600-0722.1997.tb00222.x; Tanaka E, 2006, ANN BIOMED ENG, V34, P717, DOI 10.1007/s10439-006-9092-x; Varkey Mathew, 2006, Clin Orthop Relat Res, V443, P113, DOI 10.1097/01.blo.0000200236.84189.87; Zhang H, 2004, J ORTHOPAED RES, V22, P30, DOI 10.1016/S0736-0266(03)00155-4	50	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0531-5565	1873-6815		EXP GERONTOL	Exp. Gerontol.	APR	2015	64						62	69		10.1016/j.exger.2015.02.006		8	Geriatrics & Gerontology	Geriatrics & Gerontology	CD1CZ	WOS:000350812800008		
J	Ma, JK; Zhang, H; Tsuchiya, T; Akiyama, Y; Chen, JY				Ma, Jin-Kui; Zhang, Han; Tsuchiya, Tomohiro; Akiyama, Yoshinobu; Chen, Jie-Yu			Frying stability of rapeseed Kizakinonatane (Brassica napus) oil in comparison with canola oil	FOOD SCIENCE AND TECHNOLOGY INTERNATIONAL			English	Article						Deep-fat frying; canola oil; Kizakinonatane oil; rapeseed oil; oxidative stability	OXIDATIVE STABILITY; OLIVE OIL; SUNFLOWER OILS; VEGETABLE-OILS; FRENCH FRIES; CORN OILS; PALM OIL; QUALITY; CHEMISTRY; FOODS	This study was carried out to investigate the frying performance of Kizakinonatane (Brassica napus) oil during deep-fat frying of frozen French fries with/without replenishment. Commercial regular canola oil was used for comparison. The frying oils were used during intermittent frying of frozen French fries at 180, 200, and 220? for 7h daily over four consecutive days. The Kizakinonatane oil exhibited lower levels of total polar compounds, carbonyl value, and viscosity as well as comparable color (optical density) values to that of the canola oil. The monounsaturated fatty acid/polyunsaturated fatty acid ratios were lower than that of canola oil, whereas the polyunsaturated fatty acid/saturated fatty acid ratios are higher than that of canola oil after heating. Results showed that fresh Kizakinonatane oil contains higher levels of acid value, viscosity, optical density values, tocopherols, and total phenolics contents than that of canola oil. Replenishment with fresh oil had significant effects on all chemical and physical parameters, except the acid value of the Kizakinonatane oil during frying processes. Based on the results, the Kizakinonatane oil is inherently suitable for preparing deep-fried foods at high temperatures.	[Ma, Jin-Kui; Zhang, Han; Tsuchiya, Tomohiro; Akiyama, Yoshinobu; Chen, Jie-Yu] Akita Prefectural Univ, Fac Bioresource Sci, Akita 0100195, Japan	Chen, JY (reprint author), Akita Prefectural Univ, Fac Bioresource Sci, 241-438 Kaidobata Nishi, Akita 0100195, Japan.	jiey_chen@akita-pu.ac.jp					ALHARBI MM, 1993, FOOD CHEM, V48, P395, DOI 10.1016/0308-8146(93)90324-9; Casal S, 2010, FOOD CHEM TOXICOL, V48, P2972, DOI 10.1016/j.fct.2010.07.036; Koski A, 2002, EUR FOOD RES TECHNOL, V214, P294, DOI 10.1007/s00217-001-0479-5; DAUN JK, 1984, J AM OIL CHEM SOC, V61, P1117, DOI 10.1007/BF02636236; Mariod A, 2006, J AM OIL CHEM SOC, V83, P529, DOI 10.1007/s11746-006-1236-5; Paul S, 1997, CRIT REV FOOD SCI, V37, P635; Berasategi I, 2012, FOOD CHEM, V132, P439, DOI 10.1016/j.foodchem.2011.11.018; Abdulkarim SM, 2007, FOOD CHEM, V105, P1382, DOI 10.1016/j.foodchem.2007.05.013; Matthaus B, 2006, EUR J LIPID SCI TECH, V108, P200, DOI 10.1002/ejlt.200500249; Kim I, 2005, J FOOD SCI, V70, pC48; Kalogianni EP, 2009, J AM OIL CHEM SOC, V86, P561, DOI 10.1007/s11746-009-1380-9; Fasina OO, 2006, J AM OIL CHEM SOC, V83, P899, DOI 10.1007/s11746-006-5044-8; Romero A, 1998, J AM OIL CHEM SOC, V75, P161, DOI 10.1007/s11746-998-0028-5; Choe E, 2007, J FOOD SCI, V72, pR77, DOI 10.1111/j.1750-3841.2007.00352.x; Farhoosh R, 2009, EUR J LIPID SCI TECH, V111, P1259, DOI 10.1002/ejlt.200900081; Aladedunye FA, 2009, J AM OIL CHEM SOC, V86, P149, DOI 10.1007/s11746-008-1328-5; Gertz C, 2000, EUR J LIPID SCI TECH, V102, P566, DOI 10.1002/1438-9312(200009)102:8/9<566::AID-EJLT566>3.0.CO;2-B; Yamsaengsung R, 2002, J FOOD ENG, V53, P11, DOI 10.1016/S0260-8774(01)00135-2; Antolovich M, 2002, ANALYST, V127, P183, DOI 10.1039/b009171p; Farhoosh R, 2009, J AM OIL CHEM SOC, V86, P71, DOI 10.1007/s11746-008-1315-x; Farhoosh R, 2009, FOOD CHEM, V115, P933, DOI 10.1016/j.foodchem.2009.01.035; AOCS, 2009, OFFICIAL METHODS REC; AOCS, 1997, OFFICIAL METHODS REC; BLUMENTHAL MM, 1991, FOOD TECHNOL-CHICAGO, V45, P68; Dobarganes C, 2003, CURR OPIN CLIN NUTR, V6, P157, DOI 10.1097/01.mco.0000058585.27240.ee; Embaby H. E., 2010, African Journal of Food, Agriculture, Nutrition and Development, V10, P2967; Euromonitor International, 2012, OILS FATS JAP, P56; Fillion L, 1998, INT J FOOD SCI NUTR, V49, P157, DOI 10.3109/09637489809089395; FRITSCH CW, 1981, J AM OIL CHEM SOC, V58, P272, DOI 10.1007/BF02582355; Gupta M. K., 2004, Frying technology and practices, P76; GUTFINGER T, 1981, J AM OIL CHEM SOC, V58, P966, DOI 10.1007/BF02659771; Hara S., 2006, Journal of Oleo Science, V55, P167; Japan for Sustainability, 2003, LOC PROD OIL FOOD EN; JOCS, 2003, TENT 13 2003 CARB VA; Lee Junsoo, 2000, Journal of Food Composition and Analysis, V13, P45, DOI 10.1006/jfca.1999.0845; Matthaus B, 2008, EUR J LIPID SCI TECH, V110, P611, DOI 10.1002/ejlt.200700275; MAZZA G, 1992, J AM OIL CHEM SOC, V69, P847, DOI 10.1007/BF02636331; Moreira R, 1999, DEEP FAT FRYING FUND, P111; Normand L, 2006, J AM OIL CHEM SOC, V83, P331, DOI 10.1007/s11746-006-1208-9; Ogunsina BS, 2014, J FOOD SCI TECH MYS, V51, P503, DOI 10.1007/s13197-011-0519-5; Okuyama Y, 1994, B TOHOKU NATL AGR EX, V88, P1; Pekkarinen S, 1998, FETT-LIPID, V100, P69, DOI 10.1002/(SICI)1521-4133(199803)100:3<69::AID-LIPI69>3.3.CO;2-8; Petukhov I, 1999, J AM OIL CHEM SOC, V76, P627, DOI 10.1007/s11746-999-0014-6; Przybylski R., 2005, BAILEYS IND OIL FAT, P61; Shahidi F., 2002, Food lipids: chemistry, nutrition, and biotechnology, P465; Tekin L, 2009, FOOD SCI TECHNOL RES, V15, P519; Totani Nagao, 2007, J Oleo Sci, V56, P449; Tyagi VK, 1996, J AM OIL CHEM SOC, V73, P499, DOI 10.1007/BF02523926; Warner K., 2004, Frying technology and practices, P16; Warner K, 1997, J AM OIL CHEM SOC, V74, P1317, DOI 10.1007/s11746-997-0063-7	50	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1082-0132	1532-1738		FOOD SCI TECHNOL INT	Food Sci. Technol. Int.	APR	2015	21	3					163	174		10.1177/1082013213520173		12	Chemistry, Applied; Food Science & Technology	Chemistry; Food Science & Technology	CD3KN	WOS:000350977400001		
J	Fukasawa, Y; Takahashi, K; Arikawa, T; Hattori, T; Maekawa, N				Fukasawa, Yu; Takahashi, Kazunari; Arikawa, Tomotsugu; Hattori, Tsutomu; Maekawa, Nitaro			Fungal wood decomposer activities influence community structures of myxomycetes and bryophytes on coarse woody debris	FUNGAL ECOLOGY			English	Article						Brown rot; Decay type; Fungi; Log; Pinus densiflora; White rot	BROWN-ROT FUNGI; DIVERSE LIGNICOLOUS FUNGI; DECAYING BEECH LOGS; WHITE-ROT; DEAD WOOD; PICEA-ABIES; FALLEN LOGS; PHYSARUM-POLYCEPHALUM; CRYPTOGAM COMMUNITIES; SUBSTRATE QUALITY	Dead wood is an important habitat for forest organisms, and wood decay fungi are the principal agents determining the dead wood properties that influence the communities of organisms inhabiting dead wood. In this study, we investigated the effects of wood decomposer fungi on the communities of myxomycetes and bryophytes inhabiting decayed logs. On 196 pine logs, 72 species of fungi, 34 species and seven varieties of myxomycetes, and 16 species of bryophytes were identified. Although white rot was the dominant decay type in sapwood and heartwood, brown and soft rots were also prevalent, particularly in sapwood. Moreover, white rot and soft rot were positively and brown rot negatively correlated with wood pH. Ordination analyses clearly showed a succession of cryptogam species during log decomposition and showed significant correlations of communities with the pH, water content, and decay type of wood. These analyses indicate that fungal wood decomposer activities strongly influence the cryptogam communities on dead wood. (C) 2014 Elsevier Ltd and The British Mycological Society. All rights reserved.	[Fukasawa, Yu] Tohoku Univ, Grad Sch Agr Sci, Lab Forest Ecol, Osaki, Miyagi 9896711, Japan; [Takahashi, Kazunari] Okayama Univ, Sci High Sch, Kita Ku, Okayama 7000005, Japan; [Arikawa, Tomotsugu] Keio Univ, Dept Biol, Kohoku Ku, Yokohama, Kanagawa 2238521, Japan; [Hattori, Tsutomu] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Maekawa, Nitaro] Tottori Univ, Fac Agr, Fungus Mushroom Resource & Res Ctr, Tottori 6808553, Japan	Fukasawa, Y (reprint author), Tohoku Univ, Grad Sch Agr Sci, Lab Forest Ecol, Osaki, Miyagi 9896711, Japan.	fukasawayuu@gmail.com			Fujiwara Natural History Foundation; Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [23780156]	We thank the staffs of Higashiyamato Park for providing study area. We are also grateful to Dr. T. Shirouzu for identification of Dacrymycetous fungi. This study was financially supported by Grants related to the Fujiwara Natural History Foundation and by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 23780156 to YF.	A'Bear AD, 2014, FUNGAL ECOL, V10, P34, DOI 10.1016/j.funeco.2013.01.009; Greene DF, 1999, CAN J FOREST RES, V29, P824, DOI 10.1139/cjfr-29-6-824; ESPEJO E, 1991, APPL ENVIRON MICROB, V57, P1980; Kato J, 2006, ECOL RES, V21, P503, DOI 10.1007/s11284-005-0145-7; Odor P, 2006, BIOL CONSERV, V131, P58, DOI 10.1016/j.biocon.2006.02.004; Heilmann-Clausen J, 2003, BIODIVERS CONSERV, V12, P953, DOI 10.1023/A:1022825809503; Fukasawa Y, 2014, ECOL RES, V29, P257, DOI 10.1007/s11284-013-1120-3; TANESAKA E, 1993, MYCOLOGIA, V85, P347, DOI 10.2307/3760693; COLLINS OR, 1973, MYCOLOGIA, V65, P232, DOI 10.2307/3757810; Fukasawa Y, 2011, MYCOLOGIA, V103, P474, DOI 10.3852/10-246; Zhang XY, 2007, INT BIODETER BIODEGR, V60, P159, DOI 10.1016/j.ibiod.2007.02.003; Pyle C, 1999, FOREST ECOL MANAG, V114, P253, DOI 10.1016/S0378-1127(98)00356-9; Iijima H, 2010, J FOREST RES-JPN, V15, P46, DOI 10.1007/s10310-009-0133-9; Schroter D, 2003, OIKOS, V102, P294, DOI 10.1034/j.1600-0579.2003.12064.x; SHINNICK TM, 1978, CURR MICROBIOL, V1, P163, DOI 10.1007/BF02601670; Rajala T, 2012, FEMS MICROBIOL ECOL, V81, P494, DOI 10.1111/j.1574-6941.2012.01376.x; Lindhe A, 2004, BIOL CONSERV, V119, P443, DOI 10.1016/j.biocon.2004.01.005; Partel M, 2004, BIOL CONSERV, V120, P525, DOI 10.1016/j.biocon.2004.03.025; Worrall JJ, 1997, MYCOLOGIA, V89, P199, DOI 10.2307/3761073; SODERSTROM L, 1988, NORD J BOT, V8, P89, DOI 10.1111/j.1756-1051.1988.tb01709.x; Ovaskainen O, 2010, ECOLOGY, V91, P2514, DOI 10.1890/10-0173.1; Heilmann-Clausen J, 2001, MYCOL RES, V105, P575, DOI 10.1017/S0953756201003665; Mallik AU, 2003, CRIT REV PLANT SCI, V22, P341, DOI 10.1080/713610860; Lindner DL, 2011, FUNGAL ECOL, V4, P449, DOI 10.1016/j.funeco.2011.07.001; Weslien J, 2011, J ANIM ECOL, V80, P1155, DOI 10.1111/j.1365-2656.2011.01860.x; Lindblad I, 1998, NORD J BOT, V18, P243, DOI 10.1111/j.1756-1051.1998.tb01877.x; Caruso A, 2009, BRYOLOGIST, V112, P520, DOI 10.1639/0007-2745-112.3.520; Iijima H, 2006, CAN J FOREST RES, V36, P664, DOI 10.1139/X05-285; Takahashi M, 2000, CAN J FOREST RES, V30, P1148, DOI 10.1139/cjfr-30-7-1148; Homma H, 2007, J WOOD SCI, V53, P80, DOI 10.1007/s10086-006-0810-7; Heilmann-Clausen J, 2005, BIODIVERS CONSERV, V14, P2061, DOI 10.1007/s10531-004-4284-x; [Anonymous], 2001, ECOL B; HARMON ME, 1989, AM MIDL NAT, V121, P112, DOI 10.2307/2425662; Wiklund K, 2004, FUNCT ECOL, V18, P907, DOI 10.1111/j.0269-8463.2004.00906.x; Everhart SE, 2008, MYCOLOGIA, V100, P191, DOI 10.3852/mycologia.100.2.191; Schnittler M, 2006, MYCOLOGIA, V98, P223, DOI 10.3852/mycologia.98.2.223; Rojas C, 2007, MYCOLOGIA, V99, P534, DOI 10.3852/mycologia.99.4.534; Heilmann-Clausen J, 2004, FOREST ECOL MANAG, V201, P105, DOI 10.1016/j.foreco.2004.07.010; Stephenson SL, 2011, SOIL BIOL BIOCHEM, V43, P2237, DOI 10.1016/j.soilbio.2011.07.007; Odor P, 2004, J BRYOL, V26, P79, DOI 10.1179/037366804225021038; Ovaskainen O, 2013, ISME J, V7, P1696, DOI 10.1038/ismej.2013.61; Garcia-Sandoval R, 2011, MYCOLOGIA, V103, P510, DOI 10.3852/10-209; Kubartova A, 2012, MOL ECOL, V21, P4514, DOI 10.1111/j.1365-294X.2012.05723.x; Bunnell FL, 2010, ENVIRON REV, V18, P397, DOI 10.1139/A10-019; Fukasawa Y, 2012, FOREST ECOL MANAG, V266, P232, DOI 10.1016/j.foreco.2011.11.027; ARAYA K, 1993, APPL ENTOMOL ZOOL, V28, P27; Bace R, 2012, FOREST ECOL MANAG, V266, P254, DOI 10.1016/j.foreco.2011.11.025; Bardgett RD, 2010, ABOVEGROUND BELOWGRO; BELSARE DK, 1988, APPL MICROBIOL BIOT, V28, P301; BODDY L, 1983, SOIL BIOL BIOCHEM, V15, P149, DOI 10.1016/0038-0717(83)90096-2; Cornelius ML, 2002, J ECON ENTOMOL, V95, P121, DOI 10.1603/0022-0493-95.1.121; Delach A, 2002, BRYOLOGIST, V105, P249, DOI 10.1639/0007-2745(2002)105[0249:TEOPPO]2.0.CO;2; ENOKI A, 1989, WOOD SCI TECHNOL, V23, P1; Folman LB, 2008, FEMS MICROBIOL ECOL, V63, P181, DOI 10.1111/j.1574-6941.2007.00425.x; Gabriel R, 2005, PLANT ECOL, V177, P125, DOI 10.1007/s11258-005-2243-6; Gray W. D., 1968, BIOL MYXOMYCETES; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Hillis W. E., 1987, HEARTWOOD TREE EXUDA; Hintikka V., 1970, COMMUNICATIONES I FO, V62, P1; Hoppe B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088141; Ikeda Y., 2010, HOKURIKU NO KINOKO Z; Imazeki R., 1989, COLORED ILLUSTRATION, VII; Jongman R. H. G., 1995, DATA ANAL COMMUNITY; JURGENSEN MF, 1989, PLANT SOIL, V115, P117, DOI 10.1007/BF02220701; McAlister S, 1997, J VEG SCI, V8, P115, DOI 10.2307/3237249; MCCULLOUGH HA, 1948, ECOLOGY, V29, P508, DOI 10.2307/1932645; Michel P, 2011, OIKOS, V120, P1272, DOI 10.1111/j.1600-0706.2010.19148.x; Muhle H., 1975, J HATTORI BOT LAB, V39, P1; R Development Core Team, 2012, R LANG STAT COMP; Rayner ADM, 1988, FUNGAL DECOMPOSITION; Renvall Pertti, 1995, Karstenia, V35, P1; Sand-Jensen K, 2012, OECOLOGIA, V170, P305, DOI 10.1007/s00442-012-2314-z; Smilauer P., 2002, CANOCO REFERENCE MAN; Son E, 2011, CAN J MICROBIOL, V57, P33, DOI 10.1139/w10-102; Stevenson F.J., 1982, HUMUS CHEM; Stokland JN, 2012, ECOL BIODIVERS CONS, P1, DOI 10.1017/CBO9781139025843; Takahashi K., 2013, NATURALISTAE, V17, P9; Takahashi K, 2009, MYCOSCIENCE, V50, P253, DOI 10.1007/s10267-008-0479-4; Takahashi KH, 2005, ECOL RES, V20, P215, DOI 10.1007/s11284-004-0025-6; Tedersoo L, 2008, ENVIRON MICROBIOL, V10, P1189, DOI 10.1111/j.1462-2920.2007.01535.x; Temnuhin VB, 1996, FOREST ECOL MANAG, V81, P249, DOI 10.1016/0378-1127(95)03660-1; VANTOOREN BF, 1988, OIKOS, V53, P41, DOI 10.2307/3565661; Wardlaw T., 2009, Tasforests, V18, P17; Yamashita S, 2010, MYCOLOGIA, V102, P11, DOI 10.3852/09-008	84	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1754-5048	1878-0083		FUNGAL ECOL	Fungal Ecol.	APR	2015	14						44	52		10.1016/j.funeco.2014.11.003		9	Ecology; Mycology	Environmental Sciences & Ecology; Mycology	CD2VE	WOS:000350936300005		
J	Pontieri, P; De Stefano, M; Massardo, DR; Gunge, N; Miyakawa, I; Sando, N; Pignone, D; Pizzolante, G; Romano, R; Alifano, P; Del Giudice, L				Pontieri, Paola; De Stefano, Mario; Massardo, Domenica Rita; Gunge, Norio; Miyakawa, Isamu; Sando, Nobundo; Pignone, Domenico; Pizzolante, Graziano; Romano, Roberta; Alifano, Pietro; Del Giudice, Luigi			Tellurium as a valuable tool for studying the prokaryotic origins of mitochondria	GENE			English	Article						Tellurite; Saccharomyces cerevisiae; Mitochondria; Transmission electronic microscopy; Endosymbiosis; Proteobacteria	ANAEROBICALLY GROWN YEAST; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; ALPHA-PROTEOBACTERIA; EARLY EVOLUTION; WILD-TYPE; REDUCTION; GENOME; EUKARYOTES; RESISTANCE	Mitochondria are eukaryotic organelles which contain the own genetic material and evolved from free-living Eubacteria, namely hydrogen-producing Alphaproteobacteria. Since 1965, biologists provided, by research at molecular level, evidence for the prokaryotic origins of mitochondria. However, determining the precise origins of mitochondria is challenging due to inherent difficulties in phylogenetically reconstructing ancient evolutionary events. The use of new tools to evidence the prokaryotic origin of mitochondria could be useful to gain an insight into the bacterial endosymbiotic event that resulted in the permanent acquisition of bacteria, from the ancestral cell, that through time were transformed into mitochondria. Electron microscopy has shown that both proteobacterial and yeast cells during their growth in the presence of increasing amount of tellurite resulted in dose-dependent blackening of the culture due to elemental tellurium (Te degrees) that formed large deposits either along the proteobacterial membrane or along the yeast cell wall and mitochondria. Since the mitochondrial inner membrane composition is similar to that of proteobacterial membrane, in the present work we evidenced the black tellurium deposits on both, cell wall and mitochondria of rho(+) and respiratory deficient rho(-) mutants of yeast. A possible role of tellurite in studying the evolutionary origins of mitochondria will be discussed. (C) 2015 Published by Elsevier B.V.	[Pontieri, Paola; Massardo, Domenica Rita; Del Giudice, Luigi] IBBR UOS Portici, Inst Biosci & Bioresources, CNR, Dipartimento Biol,Sez Igiene,Portici NA, I-80134 Naples, Italy; [De Stefano, Mario] Univ Naples 2, Dept Environm Sci, I-81100 Caserta, Italy; [Gunge, Norio] Sojo Univ, Kumamoto 8600082, Japan; [Miyakawa, Isamu; Sando, Nobundo] Yamaguchi Univ, Dept Biol, Fac Sci, Yamaguchi 7538512, Japan; [Pignone, Domenico] CNR, Inst Biosci & Bioresources IBBR, I-70126 Bari, Italy; [Pizzolante, Graziano; Romano, Roberta; Alifano, Pietro] Univ Salento, Dept Biol & Environm Sci & Technol, I-73100 Lecce, Italy	Del Giudice, L (reprint author), IBBR UOS Portici, Inst Biosci & Bioresources, CNR, Dipartimento Biol,Sez Igiene,Portici NA, I-80134 Naples, Italy.	delgiudilg@virgilio.it			Compagnia di San Paolo special grant "iniziativa"; Istituto Banco di Napoli, Fondazione	We are grateful to Prof. Giorgio Bernardi for critically reading the manuscript. Thanks to both Tate Rosarita, Integrated Microscopy Facility, IGB-ABT-CNR and Sergio Sorbo, Sezione Microscopia CeSMA Universita Federico II, Naples for TEM technical support. Thanks also to Mariarosaria Aletta for bibliographic support. The research was supported by Compagnia di San Paolo special grant "iniziativa" to L Del Giudice. P. Pontieri was supported by a postdoctoral grant from the Istituto Banco di Napoli, Fondazione.	Borsetti F, 2005, RES MICROBIOL, V156, P807, DOI 10.1016/j.resmic.2005.03.011; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; GERRARD TL, 1974, J BACTERIOL, V119, P1057; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; Klonowska A, 2005, APPL ENVIRON MICROB, V71, P5607, DOI 10.1128/AEM.71.9.5607-5609.2005; SCHATZ G, 1974, ANNU REV BIOCHEM, V43, P51, DOI 10.1146/annurev.bi.43.070174.000411; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Taylor DE, 1999, TRENDS MICROBIOL, V7, P111, DOI 10.1016/S0966-842X(99)01454-7; Trutko SM, 2000, ARCH MICROBIOL, V173, P178, DOI 10.1007/s002039900123; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; MIYAKAWA I, 1994, J GEN APPL MICROBIOL, V40, P1, DOI 10.2323/jgam.40.1; SCHWARTZ RM, 1978, SCIENCE, V199, P395, DOI 10.1126/science.202030; Lloyd JR, 2003, FEMS MICROBIOL REV, V27, P411, DOI 10.1016/S0168-6445(03)00044-5; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Ettema TJG, 2009, BIOL LETTERS, V5, P429, DOI 10.1098/rsbl.2008.0793; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Andersson SGE, 2003, PHILOS T ROY SOC B, V358, P165, DOI 10.1098/rstb.2002.1193; Esser C, 2007, BIOL LETT-UK, V3, P180, DOI 10.1098/rsbl.2006.0582; Tala A, 2013, INT J SYST EVOL MICR, V63, P72, DOI 10.1099/ijs.0.032060-0; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Zannoni D, 2008, ADV MICROB PHYSIOL, V53, P1, DOI 10.1016/S0065-2911(07)53001-8; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Gharieb MM, 1998, BIOMETALS, V11, P101, DOI 10.1023/A:1009221810760; Barmett R.J., 1957, J BIOPHYS BIOCH CYTO, V3, P577; Bernardi G, 2005, GENE, V354, P189, DOI 10.1016/j.gene.2005.03.024; BLANC H, 1980, P NATL ACAD SCI-BIOL, V77, P3942, DOI 10.1073/pnas.77.7.3942; BORST P, 1972, ANNU REV BIOCHEM, V41, P333, DOI 10.1146/annurev.bi.41.070172.002001; Borst P., 1976, GENETICS BIOGENESIS, P525; BORST P, 1971, FEBS LETT, V13, P73, DOI 10.1016/0014-5793(71)80204-1; Cantalupo G, 2001, FEBS LETT, V495, P178, DOI 10.1016/S0014-5793(01)02388-2; CORFIELD PS, 1970, J GEN MICROBIOL, V63, P311; De Grassi A, 2005, GENE, V354, P181, DOI 10.1016/j.gene.2005.03.046; DELGIUDICE L, 1979, J BACTERIOL, V137, P673; Del Giudice L, 2005, GENE, V354, P9, DOI 10.1016/j.gene.2005.03.020; Dujon B, 1981, MOL BIOL YEAST SACCH, P505; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Gray MW, 2001, GENOME BIOL, V2; Gray MW, 1998, NATURE, V396, P109, DOI 10.1038/24030; GROOT GSP, 1971, P NATL ACAD SCI USA, V68, P308, DOI 10.1073/pnas.68.2.308; Hamer M., 2011, EMBO J, V30, P4356; HUGHES DE, 1962, J GEN MICROBIOL, V29, P39; Karlin S, 1999, P NATL ACAD SCI USA, V96, P9190, DOI 10.1073/pnas.96.16.9190; KOLAROV J, 1972, BIOCHIM BIOPHYS ACTA, V267, P457, DOI 10.1016/0005-2728(72)90173-9; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Lopez-Garcia P, 1999, TRENDS BIOCHEM SCI, V24, P88, DOI 10.1016/S0968-0004(98)01342-5; Massardo DR, 2009, BIOMETALS, V22, P1089, DOI 10.1007/s10534-009-9259-7; Minegishi H, 2012, INT J SYST EVOL MICR, V62, P2160, DOI 10.1099/ijs.0.036905-0; MUDD S, 1953, J HISTOCHEM CYTOCHEM, V1, P248; NAGAI S, 1965, J BACTERIOL, V90, P220; Ollivier P. R. L., 2008, APPL ENVIRON MICROB, V74, P7163; Ottosson LG, 2010, EUKARYOT CELL, V9, P1635, DOI 10.1128/EC.00078-10; PACKER L, 1973, BIOCHIM BIOPHYS ACTA, V292, P92, DOI 10.1016/0005-2728(73)90254-5; PEL HJ, 1994, MOL BIOL REP, V19, P183, DOI 10.1007/BF00986960; Perez J.M., 2007, PLOS ONE, V2, P1; PLATTNER H, 1969, BIOCHEMISTRY-US, V8, P339, DOI 10.1021/bi00829a047; SCHATZ G, 1983, CELL, V32, P316, DOI 10.1016/0092-8674(83)90450-6; SMITH DG, 1974, J GEN MICROBIOL, V83, P389; SUMMERS AO, 1977, J BACTERIOL, V129, P276; TAYLOR DE, 1988, J ULTRA MOL STRUCT R, V99, P18, DOI 10.1016/0889-1605(88)90029-8; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; TUCKER FL, 1962, J BACTERIOL, V83, P1313; Turner RJ, 1999, MICROBIOL-UK, V145, P2549; VANITERSON W, 1964, J CELL BIOL, V20, P361, DOI 10.1083/jcb.20.3.361; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; Williamson D H, 1979, Methods Enzymol, V56, P728; WOLF K, 1988, ADV GENET, V25, P186; Xu N, 2005, GENE, V354, P37, DOI 10.1016/j.gene.2005.03.018; Yabuuchi E., 2005, BERGEYS MANUAL SYSTE, V2, P230	71	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1119	1879-0038		GENE	Gene	APR 1	2015	559	2					177	183		10.1016/j.gene.2015.01.060		7	Genetics & Heredity	Genetics & Heredity	CD0SN	WOS:000350784300011		
J	Ito, H; Fujii, M; Masago, Y; Waite, TD; Omura, T				Ito, Hiroaki; Fujii, Manabu; Masago, Yoshifumi; Waite, T. David; Omura, Tatsuo			Effect of ionic strength on ligand exchange kinetics between a mononuclear ferric citrate complex and siderophore desferrioxamine B	GEOCHIMICA ET COSMOCHIMICA ACTA			English	Article							NATURAL ORGANIC-MATTER; TRANSFERRIN-BOUND IRON; COASTAL WATERS; BINDING LIGANDS; SEAWATER; FE(III); SOLUBILITY; IRON(III); CHEMISTRY; PHYTOPLANKTON	The effect of ionic strength (I) on the ligand exchange reaction between a mononuclear ferric citrate complex and the siderophore, desferrioxamine B (DFB), was examined in the NaCl concentration range of 0.01-0.5 M, particularly focusing on the kinetics and mechanism of ligand exchange under environmentally relevant conditions. Overall ligand exchange rate constants were determined by spectrophotometrically measuring the time course of ferrioxamine B formation at a water temperature of 25 degrees C, pH 8.0, and citrate/Fe molar ratios of 500-5000. The overall ligand exchange rate decreased by 2-11-fold (depending on the citrate/Fe molar ratios) as I increased from approximately 0.01 to 0.5 M. In particular, a relatively large decrease was observed at lower I (<0.1 M). A ligand exchange model describing the effect of I on the ligand exchange rate via disjunctive and adjunctive pathways was developed by considering the pseudo-equilibration of ferric citrate complexes and subsequent ferrioxamine formation on the basis of the Eigen-Wilkins metal-ligand complexation theory. The model and experimental data consistently suggest that the adjunctive pathway (i.e., direct association of DFB with ferric mono-and di-citrate complexes following dissociation of citrate from the parent complexes) dominates in ferrioxamine formation under the experimental conditions used. The model also predicts that the higher rate of ligand exchange at lower I is associated with the decrease in the ferric dicitrate complex stability because of the relatively high electrical repulsion between ferric monocitrate and free citrate at lower I (note that the reactivity of ferric dicitrate with DFB is smaller than that for the monocitrate complex). Overall, the findings of this study contribute to the understanding of the potential effect of I on ligand exchange kinetics in natural waters and provide fundamental knowledge on iron transformation and bioavailability. (C) 2015 Elsevier Ltd. All rights reserved.	[Ito, Hiroaki] Yamagata Univ, Dept Food Life & Environm Sci, Tsuruoka, Yamagata 9978555, Japan; [Fujii, Manabu] Tokyo Inst Technol, Dept Civil Engn, Tokyo 1528552, Japan; [Masago, Yoshifumi; Omura, Tatsuo] Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Waite, T. David] Univ New S Wales, Sch Civil & Environm Engn, Sydney, NSW 2032, Australia	Fujii, M (reprint author), Tokyo Inst Technol, Dept Civil Engn, 2-12-1-M1-4 Ookayama, Tokyo 1528552, Japan.	fujii.m.ah@m.titech.ac.jp			Japan Society for the Promotion of Science (JSPS) [24860013, 25709045]; Bilateral Joint Research Project; Ministry of Environment - Japan (Environment Research and Technology Development Fund) [S-13-2-3]	We appreciate the financial supports from Japan Society for the Promotion of Science (JSPS) for Grant-in-Aid for Research Activity Start-up (24860013), and Young Scientists (A) (25709045) and the Bilateral Joint Research Project. The financial support from the Ministry of Environment - Japan (Environment Research and Technology Development Fund S-13-2-3) is also appreciated.	Andrews J. E., 2013, INTRO ENV CHEM; Liu XW, 1999, GEOCHIM COSMOCHIM AC, V63, P3487, DOI 10.1016/S0016-7037(99)00270-7; Saito MA, 2011, P NATL ACAD SCI USA, V108, P2184, DOI 10.1073/pnas.1006943108; RUE EL, 1995, MAR CHEM, V50, P117, DOI 10.1016/0304-4203(95)00031-L; Fujii M, 2014, ENVIRON SCI TECHNOL, V48, P365, DOI 10.1021/es404090h; Alexova R, 2011, ENVIRON MICROBIOL, V13, P1064, DOI 10.1111/j.1462-2920.2010.02412.x; Fujii M, 2008, GEOCHIM COSMOCHIM AC, V72, P6079, DOI 10.1016/j.gca.2008.09.029; Pierre JL, 2000, BIOMETALS, V13, P91, DOI 10.1023/A:1009225701332; Sterner RW, 2004, LIMNOL OCEANOGR, V49, P495; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; Laglera LM, 2009, LIMNOL OCEANOGR, V54, P610, DOI 10.4319/lo.2009.54.2.0610; Witter AE, 2000, MAR CHEM, V69, P1, DOI 10.1016/S0304-4203(99)00087-0; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Batchelli S, 2010, ENVIRON SCI TECHNOL, V44, P8485, DOI 10.1021/es101081c; Silva AMN, 2009, DALTON T, P8616, DOI 10.1039/b910970f; MILLERO FJ, 1995, MAR CHEM, V50, P21, DOI 10.1016/0304-4203(95)00024-L; Rose AL, 2002, ENVIRON SCI TECHNOL, V36, P433, DOI 10.1021/es0109242; Vraspir JM, 2009, ANNU REV MAR SCI, V1, P43, DOI 10.1146/annurev.marine.010908.163712; VAN DEN BERG CMG, 1995, MAR CHEM, V50, P139, DOI 10.1016/0304-4203(95)00032-M; Rose AL, 2003, MAR CHEM, V84, P85, DOI 10.1016/S0304-4203(03)00113-0; OCHS M, 1995, MOL MICROBIOL, V15, P119, DOI 10.1111/j.1365-2958.1995.tb02226.x; FAUST BC, 1993, ENVIRON SCI TECHNOL, V27, P2517, DOI 10.1021/es00048a032; Macrellis HM, 2001, MAR CHEM, V76, P175, DOI 10.1016/S0304-4203(01)00061-5; Barbeau K, 2001, NATURE, V413, P409, DOI 10.1038/35096545; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; BLESA MA, 1989, ADV COLLOID INTERFAC, V29, P173, DOI 10.1016/0001-8686(89)80009-0; EVERS A, 1989, INORG CHEM, V28, P2189, DOI 10.1021/ic00310a035; Hopkinson BM, 2012, ENVIRON MICROBIOL, V14, P114, DOI 10.1111/j.1462-2920.2011.02539.x; Kuma K, 1996, LIMNOL OCEANOGR, V41, P396; Liu XW, 2002, MAR CHEM, V77, P43, DOI 10.1016/S0304-4203(01)00074-3; Pham AN, 2006, GEOCHIM COSMOCHIM AC, V70, P640, DOI 10.1016/j.gca.2005.10.018; HERING JG, 1990, ENVIRON SCI TECHNOL, V24, P242, DOI 10.1021/es00072a014; Rose AL, 2003, ENVIRON SCI TECHNOL, V37, P3897, DOI 10.1021/es034102b; Bruland K. W., 2001, BIOGEOCHEMISTRY IRON; Bruno J, 2000, GEOCHIM COSMOCHIM AC, V64, P2173, DOI 10.1016/S0016-7037(00)00328-8; Byrne RH, 2000, MAR CHEM, V70, P23, DOI 10.1016/S0304-4203(00)00012-8; Celo V, 2001, ENVIRON SCI TECHNOL, V35, P1084, DOI 10.1021/es001203q; Crichton RR, 2001, INORGANIC BIOCH IRON; Eigen M., 1965, ADV CHEM SER; Evans RW, 2008, J BIOL INORG CHEM, V13, P57, DOI 10.1007/s00775-007-0297-8; Fujii M, 2008, GEOCHIM COSMOCHIM AC, V72, P1335, DOI 10.1016/j.gca.2007.12.017; Gautier-Luneau I, 2005, CHEM-EUR J, V11, P2207, DOI 10.1002/chem.200401087; GUERINOT ML, 1990, J BACTERIOL, V172, P3298; Ito H, 2011, J PHYS CHEM A, V115, P5371, DOI 10.1021/jp202440e; KOWALAK A, 1967, J AM CHEM SOC, V89, P3126, DOI 10.1021/ja00989a009; LIN CT, 1973, INORG CHEM, V12, P2402, DOI 10.1021/ic50128a037; Morel F. M. M., 1993, PRINCIPLES APPL AQUA; Morel FMM, 2008, LIMNOL OCEANOGR, V53, P400, DOI 10.4319/lo.2008.53.1.0400; Nicolaisen K, 2008, J BACTERIOL, V190, P7500, DOI 10.1128/JB.01062-08; North RL, 2007, LIMNOL OCEANOGR, V52, P315; PARKES HG, 1991, J PHARMACEUT BIOMED, V9, P29, DOI 10.1016/0731-7085(91)80233-Y; Ribas X., 1989, J CHEM RES S, V332, P332; Schuman M. S., 1992, ENVIRON SCI TECHNOL, V26, P593; Serratrice G, 2004, EUR J INORG CHEM, P1552, DOI 10.1002/ejic.200300396; SPIRO TG, 1967, J AM CHEM SOC, V89, P5559, DOI 10.1021/ja00998a009; Stumm W., 1996, AQUATIC CHEM CHEM EQ; TIFFIN LO, 1966, PLANT PHYSIOL, V41, P515, DOI 10.1104/pp.41.3.515; Tipping E., 2002, CATION BINDING HUMIC	58	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0016-7037	1872-9533		GEOCHIM COSMOCHIM AC	Geochim. Cosmochim. Acta	APR 1	2015	154						81	97		10.1016/j.gca.2015.01.020		17	Geochemistry & Geophysics	Geochemistry & Geophysics	CC7PP	WOS:000350560800006		
J	Farrer, J; Greenspan, A				Farrer, James; Greenspan, Anna			Raising cosmopolitans: localized educational strategies of international families in Shanghai	GLOBAL NETWORKS-A JOURNAL OF TRANSNATIONAL AFFAIRS			English	Article						COSMOPOLITANISM; INTERNATIONAL EDUCATION; EXPATRIATES; CHINA; SHANGHAI	SCHOOLS	This qualitative research documents the educational strategies of international migrants to Shanghai who are attempting to raise their children as cosmopolitans through immersion in local Chinese schools. We distinguish this localizing educational strategy from the established network of international schools designed to serve the families of corporate expatriates. Instead, our research subjects consist of self-initiated expatriates, or middling transnationals', who have chosen to prioritize immersion in the language and culture of China by sending their children to local schools. This localized, or Sinocentric, model exposes non-Chinese children to a challenging and nationalistic Chinese curriculum. Our analysis of these practices as a form of cosmopolitan education challenges both the goal of teaching a universal and placeless ethical cosmopolitanism and the assumption that a meaningful cosmopolitan education must take place in the idealized setting of a liberal cosmopolitan school system. We also highlight the difficulties families face in this approach, describing this as an entangled cosmopolitanism', an enriching but uncomfortable engagement with both local and home-country educational cultures.	[Farrer, James] Sophia Univ, Grad Program Global Studies, Chiyoda Ku, Tokyo 1028554, Japan; [Greenspan, Anna] New York Univ Shanghai, Shanghai, Peoples R China	Farrer, J (reprint author), Sophia Univ, Grad Program Global Studies, Chiyoda Ku, Kioicho 7-1, Tokyo 1028554, Japan.	j-farrer@sophia.ac.jp; annagreenspan@gmail.com			National Research Foundation of Korea [NRF-2010-32A-B00009]; Sophia Institute of Comparative Culture; Sophia University	A grant from the government-funded National Research Foundation of Korea (NRF-2010-32A-B00009), the Sophia Institute of Comparative Culture, and a Sophia University intra-university research grant supported this work.	Hayden MC, 2000, OXFORD REV EDUC, V26, P107; Waters JL, 2006, T I BRIT GEOGR, V31, P179, DOI 10.1111/j.1475-5661.2006.00202.x; Farrer J, 2010, J ETHN MIGR STUD, V36, P1211, DOI 10.1080/13691831003687675; Yeoh BSA, 2005, J ETHN MIGR STUD, V31, P269, DOI 10.1080/1369183042000339927; Mitchell K, 2003, T I BRIT GEOGR, V28, P387, DOI 10.1111/j.0020-2754.2003.00100.x; Delanty G, 2006, BRIT J SOCIOL, V57, P25, DOI 10.1111/j.1468-4446.2006.00092.x; King PM, 2005, J COLL STUDENT DEV, V46, P571, DOI 10.1353/csd.2005.0060; Appiah KA, 2008, YEARB NATL SOC STUD, V107, P83, DOI 10.1002/9781444307214.ch6; Appiah Kwame Anthony, 2006, NY TIMES; Bracher M, 2013, NEW FRONT EDUC CULT, P25; Brown P., 2011, SCH INT GLOBALISATIO, P39; Calhoun Craig, 2002, CONCEIVING COSMOPOLI, P86; Callahan W. A., 2010, CHINA PESSOPTIMIST N; Conradson D, 2005, J ETHN MIGR STUD, V31, P227, DOI 10.1080/1369183042000339891; Farrer James, 2008, ASIAN STUDIES REV, V32, P7, DOI 10.1080/10357820701870742; Freedman J., 2005, NY TIMES; Greenspan A, 2012, CHINESE CHARACTERS: PROFILES OF FAST-CHANGING LIVES IN A FAST-CHANGING LAND, P177; HAYDEN M, 1995, OXFORD REV EDUC, V21, P327, DOI 10.1080/0305498950210306; Iyer Pico, 2000, GLOBAL SOUL JET LAG; Kuka R., 2013, SHANGHAI DAILY  0207, P1; Lau J, 2013, INT HERALD TRIBUNE; Mackenzie P, 2003, OXFORD REV EDUC, V29, P299, DOI 10.1080/0305498032000120265; Matthews M., 1989, INT SCH J, V17, P7; Nussbaum M., 1994, BOSTON REV, V19, P3; Pott F. L. H., 1928, SHORT HIST SHANGHAI; Sennett R., 1970, USES DISORDER PERSON; Vertovec S., 2002, CONCEIVING COSMOPOLI, P1; Xiang B., 2009, INT J EDUC DEV, V29, P513, DOI [10.1016/j.ijedudev.2009.04.006, DOI 10.1016/J.IJEDUDEV.2009.04.006]	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1470-2266	1471-0374		GLOBAL NETW	Glob. Netw.	APR	2015	15	2					141	160		10.1111/glob.12068		20	Anthropology; Geography; Sociology	Anthropology; Geography; Sociology	CD0JI	WOS:000350757700001		
J	Hayakawa, Y; Jin, GC; Wang, HS; Chen, XW; Westphalen, CB; Asfaha, S; Renz, BW; Ariyama, H; Dubeykovskaya, ZA; Takemoto, Y; Lee, Y; Muley, A; Tailor, Y; Chen, D; Muthupalani, S; Fox, JG; Shulkes, A; Worthley, DL; Takaishi, S; Wang, TC				Hayakawa, Yoku; Jin, Guangchun; Wang, Hongshan; Chen, Xiaowei; Westphalen, Christoph B.; Asfaha, Samuel; Renz, Bernhard W.; Ariyama, Hiroshi; Dubeykovskaya, Zinaida A.; Takemoto, Yoshihiro; Lee, Yoomi; Muley, Ashlesha; Tailor, Yagnesh; Chen, Duan; Muthupalani, Sureshkumar; Fox, James G.; Shulkes, Arthur; Worthley, Daniel L.; Takaishi, Shigeo; Wang, Timothy C.			CCK2R identifies and regulates gastric antral stem cell states and carcinogenesis	GUT			English	Article							METHYL-N-NITROSOUREA; IN-VIVO; DYNAMIC HISTOLOGY; GLANDULAR STOMACH; EXPRESSION MARKS; PROGENITOR CELLS; GENE-EXPRESSION; TRANSGENIC MICE; MOUSE STOMACH; PROGASTRIN	Objective Progastrin is the incompletely cleaved precursor of gastrin that is secreted by G-cells in the gastric antrum. Both gastrin and progastrin bind to the CCK2 receptor (Cckbr or CCK2R) expressed on a subset of gastric epithelial cells. Little is known about how gastrin peptides and CCK2R regulate gastric stem cells and carcinogenesis. Interconversion among progenitors in the intestine is documented, but the mechanisms by which this occurs are poorly defined. Design We generated CCK2R-CreERT mice and performed inducible lineage tracing experiments. CCK2R+ antral cells and Lgr5+ antral stem cells were cultured in a three-dimensional in vitro system. We crossed progastrin-overexpressing mice with Lgr5-GFP-CreERT mice and examined the role of progastrin and CCK2R in Lgr5+ stem cells during MNU-induced carcinogenesis. Results Through lineage tracing experiments, we found that CCK2R defines antral stem cells at position + 4, which overlapped with an Lgr5(neg or low) cell population but was distinct from typical antral Lgr5(high) stem cells. Treatment with progastrin interconverts Lgr5(neg) (or low) CCK2R+ cells into Lgr5(high) cells, increases CCK2R+ cell numbers and promotes gland fission and carcinogenesis in response to the chemical carcinogen MNU. Pharmacological inhibition or genetic ablation of CCK2R attenuated progastrin-dependent stem cell expansion and carcinogenesis. Conclusions CCK2R labels + 4 antral stem cells that can be activated and expanded by progastrin, thus identifying one hormonal trigger for gastric stem cell interconversion and a potential target for gastric cancer chemoprevention and therapy.	[Hayakawa, Yoku; Jin, Guangchun; Wang, Hongshan; Chen, Xiaowei; Westphalen, Christoph B.; Asfaha, Samuel; Renz, Bernhard W.; Ariyama, Hiroshi; Dubeykovskaya, Zinaida A.; Takemoto, Yoshihiro; Lee, Yoomi; Muley, Ashlesha; Tailor, Yagnesh; Worthley, Daniel L.; Takaishi, Shigeo; Wang, Timothy C.] Columbia Univ, Med Ctr, Dept Med, Div Digest & Liver Dis, New York, NY USA; [Westphalen, Christoph B.] Klinikum Univ Munchen, Dept Internal Med 3, Munich, Germany; [Chen, Duan] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Muthupalani, Sureshkumar; Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Shulkes, Arthur] Univ Melbourne, Austin Hlth, Dept Surg, Melbourne, Vic, Australia; [Takaishi, Shigeo] Kyushu Univ, Ctr Adv Med Innovat, Fukuoka 812, Japan	Wang, TC (reprint author), Columbia Univ, Med Ctr, Dept Med, Div Digest & Liver Dis, 1130 St Nicholas Ave,ICRC 923, New York, NY USA.	tcw21@columbia.edu			NIH [R01CA093405, R01CA120979, R01DK052778, R01AI37750]; Mitsukoshi Health and Welfare Foundation; JSPS Postdoctoral Fellowships for Research Abroad; Uehara Memorial Foundation; German Research Foundation Fellowship Grant	NIH grants R01CA093405, R01CA120979, R01DK052778 (TCW), NIH grants R01AI37750 (JGF), Mitsukoshi Health and Welfare Foundation, JSPS Postdoctoral Fellowships for Research Abroad, and Uehara Memorial Foundation (YH). German Research Foundation Fellowship Grant (CBW).	Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; LEE ER, 1985, AM J ANAT, V172, P205, DOI 10.1002/aja.1001720304; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Stange DE, 2013, CELL, V155, P357, DOI 10.1016/j.cell.2013.09.008; Takaishi S, 2011, AM J PHYSIOL-GASTR L, V300, pG334, DOI 10.1152/ajpgi.00134.2010; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Potten CS, 2002, J CELL SCI, V115, P2381; Quante M, 2010, GASTROENTEROLOGY, V139, P2018, DOI 10.1053/j.gastro.2010.08.003; Singh P, 2000, GASTROENTEROLOGY, V119, P162, DOI 10.1053/gast.2000.8527; Jin GC, 2013, GASTROENTEROLOGY, V145, P820, DOI 10.1053/j.gastro.2013.07.034; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Tomita H, 2011, GASTROENTEROLOGY, V140, P879, DOI 10.1053/j.gastro.2010.11.037; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Leushacke M, 2013, CELL REP, V5, P349, DOI 10.1016/j.celrep.2013.09.025; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; [Anonymous], 2012, CANC INVEST, V30, P275; Dockray GJ, 2001, ANNU REV PHYSIOL, V63, P119, DOI 10.1146/annurev.physiol.63.1.119; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; WANG TC, 1993, J CLIN INVEST, V92, P1349, DOI 10.1172/JCI116708; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Jin GC, 2009, J CLIN INVEST, V119, P2691, DOI 10.1172/JCI38918; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.3.CO;2-U; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; KOPIN AS, 1992, P NATL ACAD SCI USA, V89, P3605, DOI 10.1073/pnas.89.8.3605; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4; FUCHS CS, 1995, NEW ENGL J MED, V333, P32, DOI 10.1056/NEJM199507063330107; Hayakawa Yoku, 2013, Cancers (Basel), V5, P92, DOI 10.3390/cancers5010092; Kazumori H, 2001, FEBS LETT, V489, P208, DOI 10.1016/S0014-5793(01)02084-1; Koh TJ, 1997, GASTROENTEROLOGY, V113, P1015, DOI 10.1016/S0016-5085(97)70199-9; Konturek PC, 2003, DIGEST DIS SCI, V48, P2005, DOI 10.1023/A:1026387908165; Langhans N, 1997, GASTROENTEROLOGY, V112, P280, DOI 10.1016/S0016-5085(97)90000-7; LEBLOND CP, 1948, SCIENCE, V108, P531, DOI 10.1126/science.108.2811.531; LEE ER, 1985, AM J ANAT, V172, P187, DOI 10.1002/aja.1001720303; Nagata A, 1996, P NATL ACAD SCI USA, V93, P11825, DOI 10.1073/pnas.93.21.11825; Nakajima T, 2002, AM J PHYSIOL-GASTR L, V282, pG359; TATEMATSU M, 1992, JPN J CANCER RES, V83, P915; TATEMATSU M, 1993, JPN J CANCER RES, V84, P1258; Wang TC, 1996, J CLIN INVEST, V98, P1918, DOI 10.1172/JCI118993	48	6	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	APR	2015	64	4					544	553		10.1136/gutjnl-2014-307190		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD0YK	WOS:000350800100007		
J	Cao, QZ; Didelot, X; Wu, ZB; Li, ZW; He, LH; Li, YS; Ni, M; You, YH; Lin, X; Li, Z; Gong, YN; Zheng, MQ; Zhang, ML; Liu, J; Wang, WJ; Bo, XC; Falush, D; Wang, SQ; Zhang, JZ				Cao, Qizhi; Didelot, Xavier; Wu, Zhongbiao; Li, Zongwei; He, Lihua; Li, Yunsheng; Ni, Ming; You, Yuanhai; Lin, Xi; Li, Zhen; Gong, Yanan; Zheng, Minqiao; Zhang, Minli; Liu, Jie; Wang, Weijun; Bo, Xiaochen; Falush, Daniel; Wang, Shengqi; Zhang, Jianzhong			Progressive genomic convergence of two Helicobacter pylori strains during mixed infection of a patient with chronic gastritis	GUT			English	Article							NATURAL TRANSFORMATION; RECOMBINATION; RESISTANCE; EVOLUTION; SEQUENCE; MUTATION; GENES; COLONIZATION; RESTRICTION; POPULATIONS	Objective To study the detailed nature of genomic microevolution during mixed infection with multiple Helicobacter pylori strains in an individual. Design We sampled 18 isolates from a single biopsy from a patient with chronic gastritis and nephritis. Whole-genome sequencing was applied to these isolates, and statistical genetic tools were used to investigate their evolutionary history. Results The genomes fall into two clades, reflecting colonisation of the stomach by two distinct strains, and these lineages have accumulated diversity during an estimated 2.8 and 4.2 years of evolution. We detected about 150 clear recombination events between the two clades. Recombination between the lineages is a continuous ongoing process and was detected on both clades, but the effect of recombination in one clade was nearly an order of magnitude higher than in the other. Imputed ancestral sequences also showed evidence of recombination between the two strains prior to their diversification, and we estimate that they have both been infecting the same host for at least 12 years. Recombination tracts between the lineages were, on average, 895 bp in length, and showed evidence for the interspersion of recipient sequences that has been observed in in vitro experiments. The complex evolutionary history of a phage-related protein provided evidence for frequent reinfection of both clades by a single phage lineage during the past 4 years. Conclusions Whole genome sequencing can be used to make detailed conclusions about the mechanisms of genetic change of H. pylori based on sampling bacteria from a single gastric biopsy.	[Cao, Qizhi; He, Lihua; You, Yuanhai; Gong, Yanan; Liu, Jie; Zhang, Jianzhong] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing 102206, Peoples R China; [Cao, Qizhi; He, Lihua; You, Yuanhai; Gong, Yanan; Liu, Jie; Zhang, Jianzhong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Cao, Qizhi] Binzhou Med Univ, Dept Immunol, Yantai, Peoples R China; [Didelot, Xavier] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Wu, Zhongbiao; Li, Yunsheng; Lin, Xi; Zheng, Minqiao; Wang, Weijun] Wenzhou Med Coll, Affiliated Wenling Hosp, Peoples Hosp Wenling 1, Wenzhou, Zhejiang, Peoples R China; [Li, Zongwei; Ni, Ming; Li, Zhen; Zhang, Minli; Bo, Xiaochen; Wang, Shengqi] Beijing Inst Radiat Med, Beijing 100850, Peoples R China; [Falush, Daniel] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Falush, Daniel] Univ Tokyo, Grad Sch Frontier Sci, Tokyo, Japan	Zhang, JZ (reprint author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, 155 Changbai Rd Changping Dist, Beijing 102206, Peoples R China.	sqwang@bmi.ac.cn; zhangjianzhong@icdc.cn	Didelot, Xavier/H-1608-2013	Didelot, Xavier/0000-0003-1885-500X	Science and Technology Program of Zhejiang Province Public Technology Social Development Project [2010C33035]; Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2012BAI06B02]; SKLID grant [2014SKLID102]; NIHR	This work was supported by the Science and Technology Program of Zhejiang Province Public Technology Social Development Project (No. 2010C33035), Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (No. 2012BAI06B02) and SKLID grant (No. 2014SKLID102). XD would like to acknowledge the NIHR for Health Protection Research Unit funding.	Akopyants NS, 1997, HELICOBACTER, V2, P48, DOI 10.1111/j.1523-5378.1997.tb00058.x; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101; Sun QJ, 2010, WORLD J GASTROENTERO, V16, P5118, DOI 10.3748/wjg.v16.i40.5118; Kuipers EJ, 2000, J INFECT DIS, V181, P273, DOI 10.1086/315173; Didelot X, 2009, SYST APPL MICROBIOL, V32, P81, DOI 10.1016/j.syapm.2009.01.001; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Didelot X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/j.tim.2010.04.002; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Yahara K, 2013, MOL BIOL EVOL, V30, P1454, DOI 10.1093/molbev/mst055; Avasthi TS, 2011, J BACTERIOL, V193, P3385, DOI 10.1128/JB.05006-11; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Ando T, 2000, MOL MICROBIOL, V37, P1052, DOI 10.1046/j.1365-2958.2000.02049.x; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Su P, 2013, HELICOBACTER, V18, P274, DOI 10.1111/hel.12046; Sheppard SK, 2013, MOL ECOL, V22, P1051, DOI 10.1111/mec.12162; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Didelot X, 2007, GENOME RES, V17, P61, DOI 10.1101/gr.5512906; Li Ruiqiang, 2010, Genome Res, V20, P265, DOI 10.1101/gr.097261.109; Didelot X, 2013, P NATL ACAD SCI USA, V110, P13880, DOI 10.1073/pnas.1304681110; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496; Figueiredo C, 2001, SCAND J GASTROENTERO, V36, P128, DOI 10.1080/003655201750065861; Golubchik T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061319; Jorgensen M, 1996, J INFECT DIS, V174, P631; Kang J, 2006, NAT REV MICROBIOL, V4, P826, DOI 10.1038/nrmicro1528; Kawai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-104; Kulick S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003797; Lin EA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000337; Moccia C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-67; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Patra R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043370; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Secka O, 2013, ANTIMICROB AGENTS CH, V57, P1231, DOI 10.1128/AAC.00517-12; Tanih NF, 2011, ANN TROP MED PARASIT, V105, P251, DOI 10.1179/136485911X12899838683485	50	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	APR	2015	64	4					554	561		10.1136/gutjnl-2014-307345		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD0YK	WOS:000350800100008		
J	Shigeyasu, K; Tazawa, H; Hashimoto, Y; Mori, Y; Nishizaki, M; Kishimoto, H; Nagasaka, T; Kuroda, S; Urata, Y; Goel, A; Kagawa, S; Fujiwara, T				Shigeyasu, Kunitoshi; Tazawa, Hiroshi; Hashimoto, Yuuri; Mori, Yoshiko; Nishizaki, Masahiko; Kishimoto, Hiroyuki; Nagasaka, Takeshi; Kuroda, Shinji; Urata, Yasuo; Goel, Ajay; Kagawa, Shunsuke; Fujiwara, Toshiyoshi			Fluorescence virus-guided capturing system of human colorectal circulating tumour cells for non-invasive companion diagnostics	GUT			English	Article							BREAST-CANCER PATIENTS; REPLICATION-SELECTIVE ADENOVIRUS; MULTIPLE MOLECULAR MARKERS; LUNG-CANCER; CLINICAL-IMPLICATIONS; MUTATION STATUS; GASTRIC-CANCER; TELOMERASE; METASTASIS; KRAS	Background Molecular-based companion diagnostic tests are being used with increasing frequency to predict their clinical response to various drugs, particularly for molecularly targeted drugs. However, invasive procedures are typically required to obtain tissues for this analysis. Circulating tumour cells (CTCs) are novel biomarkers that can be used for the prediction of disease progression and are also important surrogate sources of cancer cells. Because current CTC detection strategies mainly depend on epithelial cell-surface markers, the presence of heterogeneous populations of CTCs with epithelial and/or mesenchymal characteristics may pose obstacles to the detection of CTCs. Methods We developed a new approach to capture live CTCs among millions of peripheral blood leukocytes using a green fluorescent protein (GFP)-expressing attenuated adenovirus, in which the telomerase promoter regulates viral replication (OBP-401, TelomeScan). Results Our biological capturing system can image epithelial and mesenchymal tumour cells with telomerase activities as GFP-positive cells. After sorting, direct sequencing or mutation-specific PCR can precisely detect different mutations in KRAS, BRAF and KIT genes in epithelial, mesenchymal or epithelial-mesenchymal transition-induced CTCs, and in clinical blood samples from patients with colorectal cancer. Conclusions This fluorescence virus-guided viable CTC capturing method provides a non-invasive alternative to tissue biopsy or surgical resection of primary tumours for companion diagnostics.	[Shigeyasu, Kunitoshi; Tazawa, Hiroshi; Hashimoto, Yuuri; Mori, Yoshiko; Nishizaki, Masahiko; Kishimoto, Hiroyuki; Nagasaka, Takeshi; Kuroda, Shinji; Kagawa, Shunsuke; Fujiwara, Toshiyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama 7008558, Japan; [Tazawa, Hiroshi] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan; [Urata, Yasuo] Oncolys BioPharma Inc, Tokyo, Japan; [Goel, Ajay] Baylor Univ, Med Ctr, Dept Internal Med, Div Gastroenterol,Charles A Sammons Canc Ctr, Dallas, TX USA; [Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX USA	Fujiwara, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	toshi_f@md.okayama-u.ac.jp	TAZAWA, Hiroshi/B-2247-2011	TAZAWA, Hiroshi/0000-0003-4658-1050	Ministry of Education Culture, Sports, Science and Technology, Japan; Ministry of Health, Labour and Welfare, Japan	This study was supported by grants-in-aid from the Ministry of Education Culture, Sports, Science and Technology, Japan (T. Fujiwara, H. Tazawa, S. Kagawa) and grants from the Ministry of Health, Labour and Welfare, Japan (T. Fujiwara).	Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Pecot CV, 2011, CANCER DISCOV, V1, P580, DOI 10.1158/2159-8290.CD-11-0215; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Kyo S, 2002, ONCOGENE, V21, P688, DOI 10.1038/sj.onc.1205163; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Anderson SM, 2011, EXPERT REV MOL DIAGN, V11, P635, DOI [10.1586/erm.11.42, 10.1586/ERM.11.42]; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Taniguchi M, 1999, CANCER RES, V59, P4297; Zieba A, 2012, NEW BIOTECHNOL, V29, P634, DOI 10.1016/j.nbt.2012.05.004; Konigsberg R, 2011, ACTA ONCOL, V50, P700, DOI 10.3109/0284186X.2010.549151; Menen R, 2012, ANTICANCER RES, V32, P2881; Menen RS, 2011, ANTICANCER RES, V31, P3125; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Joosse SA, 2013, CANCER RES, V73, P8, DOI 10.1158/0008-5472.CAN-12-3422; Cross NCP, 2012, LEUKEMIA, V26, P2172, DOI 10.1038/leu.2012.104; Fridlyand J, 2013, NAT REV DRUG DISCOV, V12, P743, DOI 10.1038/nrd4101; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.20.6.1692; Magbanua MJM, 2013, CANCER RES, V73, P30, DOI 10.1158/0008-5472.CAN-11-3017; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; Kolostova K, 2011, ANTICANCER RES, V31, P1535; Ong FS, 2012, EXPERT REV MOL DIAGN, V12, P593, DOI [10.1586/erm.12.59, 10.1586/ERM.12.59]; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Bertorelle R, 2013, BRIT J CANCER, V108, P278, DOI 10.1038/bjc.2012.602; Zhang LX, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005109; Hiyama E, 2003, CANCER LETT, V194, P221, DOI 10.1016/S0304-3835(02)00709-7; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Hurvitz SA, 2013, CANCER TREAT REV, V39, P219, DOI 10.1016/j.ctrv.2012.04.008; Liu Z, 2013, ONCOGENE, V32, P4203, DOI 10.1038/onc.2012.441; Yokobori T, 2013, CANCER RES, V73, P2059, DOI 10.1158/0008-5472.CAN-12-0326; Mostert B, 2013, INT J CANCER, V133, P130, DOI 10.1002/ijc.27987; Kim SJ, 2011, BREAST CANCER RES TR, V128, P765, DOI 10.1007/s10549-011-1603-2; Ashworth T., 1869, AUSTR MED J, V14, P146; Ito H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-346; Kishimoto H, 2006, NAT MED, V12, P1213, DOI 10.1038/nm1404; Kojima T, 2009, J CLIN INVEST, V119, P3172, DOI 10.1172/JCI38609; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Miller M. C., 2010, J ONCOL, DOI [10.1155/2010/617421, DOI 10.1155/2010/617421]; Mitsiades CS, 2003, CANCER RES, V63, P6689; Morlan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004584; Pietrantonio F, 2013, ANTICANCER RES, V33, P1257; Sasaki T, 2013, GENE THER, V20, P112, DOI 10.1038/gt.2011.213; Takakura M, 2012, BRIT J CANCER, V107, P448, DOI 10.1038/bjc.2012.276; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; Uen YH, 2007, ANN SURG, V246, P1040, DOI 10.1097/SLA.0b013e318142d918; Umeda Y, 2013, J HEPATO-BIL-PAN SCI, V20, P223, DOI 10.1007/s00534-012-0531-9; Wang JY, 2007, CLIN CANCER RES, V13, P2406, DOI 10.1158/1078-0432.CCR-06-2054	51	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749	1468-3288		GUT	Gut	APR	2015	64	4					627	635		10.1136/gutjnl-2014-306957		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CD0YK	WOS:000350800100018		
J	Ichikawa, H; Sugimoto, M; Uotani, T; Sahara, S; Yamade, M; Iwaizumi, M; Yamada, T; Osawa, S; Sugimoto, K; Miyajima, H; Yamaoka, Y; Furuta, T				Ichikawa, Hitomi; Sugimoto, Mitsushige; Uotani, Takahiro; Sahara, Shu; Yamade, Mihoko; Iwaizumi, Moriya; Yamada, Takanori; Osawa, Satoshi; Sugimoto, Ken; Miyajima, Hiroaki; Yamaoka, Yoshio; Furuta, Takahisa			Influence of Prostate Stem Cell Antigen Gene Polymorphisms on Susceptibility to Helicobacter pylori-associated Diseases: A Case-control Study	HELICOBACTER			English	Article						PSCA; dupA; H; pylori; duodenal ulcer; gastric cancer	SERUM PEPSINOGEN-I; GASTRIC-CANCER; DUODENAL-ULCER; STOMACH-CANCER; INCREASED RISK; ATROPHIC GASTRITIS; CHINESE POPULATION; INFECTION; PSCA; EXPRESSION	BackgroundPatients with duodenal ulcer have a reduced risk of developing gastric cancer compared to those without. Recently, the prostate stem cell antigen (PSCA) rs2294008 C>T polymorphism was found to be associated with different pathogenesis of duodenal ulcer and gastric cancer developments. However, whether PSCA rs2294008 C>T polymorphism is associated with severity of gastric mucosal atrophy is unclear. We examined the influence of the PSCA rs2294008 C>T polymorphism on susceptibility to H.pylori-related diseases and the relationships between PSCA polymorphism and gastric mucosal atrophy. MethodsPSCA rs2294008 C>T polymorphism was assessed in H.pylori-positive Japanese patients (n=488) with noncardia gastric cancer (n=193), gastric ulcer (n=84), duodenal ulcer (n=61), and atrophic gastritis (n=150), as well as in H.pylori-negatives (n=266). ResultsFrequency of PSCA rs2294008 C/C genotype in duodenal ulcer was 36.1%, which was significantly higher than those with gastric cancer (12.4%), gastric ulcer (19.0%), gastritis (10.7%), and H.pylori-negatives (19.5%) (p<.001). Compared with duodenal ulcer, having the T allele significantly increased the risk of gastric cancer (OR: 3.97, 95% CI: 2.02-7.80; p<.001), gastric ulcer (2.40, 1.13-5.10; p=.023), and gastritis (4.72, 2.26-9.86; p<.001). Mean pepsinogen (PG) I/PG II ratio in T allele carriers (2.170.75) was significantly lower than that in C/C genotype (3.39 +/- 1.27, p<.001). ConclusionsThe PSCA rs2294008 C>T polymorphism is associated with differing susceptibilities to H.pylori-associated diseases. The PSCA rs2294008 C>T polymorphism may be acting through induction of gastric mucosal atrophy, finally leading to development of gastric ulcer and gastric cancer in PSCA rs2294008 T allele carriers, but not duodenal ulcer.	[Ichikawa, Hitomi; Sugimoto, Mitsushige; Uotani, Takahiro; Sahara, Shu; Yamade, Mihoko; Iwaizumi, Moriya; Yamada, Takanori; Sugimoto, Ken; Miyajima, Hiroaki] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4313192, Japan; [Osawa, Satoshi] Hamamatsu Univ Sch Med, Dept Endoscop & Photodynam Med, Hamamatsu, Shizuoka 4313192, Japan; [Yamaoka, Yoshio] Oita Univ, Dept Environm & Prevent Med, Fac Med, Yufu, Japan; [Furuta, Takahisa] Hamamatsu Univ Sch Med, Clin Res Ctr, Hamamatsu, Shizuoka 4313192, Japan	Sugimoto, M (reprint author), Hamamatsu Univ Sch Med, Dept Med 1, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	mitsu@hama-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22790640, 24590912]	This study was supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (22790640 and 24590912).	An IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC MONOGR EVAL CAR, V83, P1; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; SAMLOFF IM, 1982, GASTROENTEROLOGY, V83, P204; Argani P, 2001, CANCER RES, V61, P4320; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Sugimoto M, 2009, CANCER SCI, V100, P2152, DOI 10.1111/j.1349-7006.2009.01291.x; Yoshida T, 2010, CANCER SCI, V101, P1582, DOI 10.1111/j.1349-7006.2010.01590.x; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P414, DOI 10.1053/gast.2002.34781; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; Joossens JV, 1996, INT J EPIDEMIOL, V25, P494, DOI 10.1093/ije/25.3.494; Yamaoka Y, 1997, GUT, V41, P442; Machado JC, 2003, GASTROENTEROLOGY, V125, P364, DOI 10.1016/S0016-5085(03)00899-0; Correa P, 2012, J DIGEST DIS, V13, P2, DOI 10.1111/j.1751-2980.2011.00550.x; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Hruska M, 2009, J NEUROSCI, V29, P14847, DOI 10.1523/JNEUROSCI.2271-09.2009; MIKI K, 1995, ADV EXP MED BIOL, V362, P139; Correa P, 2008, DIGEST LIVER DIS, V40, P490, DOI 10.1016/j.dld.2008.02.035; Lu Y, 2010, INT J CANCER, V127, P2183, DOI 10.1002/ijc.25228; Lu H, 2005, GASTROENTEROLOGY, V128, P833, DOI 10.1053/j.gastro.2005.01.009; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Lochhead P, 2011, GASTROENTEROLOGY, V140, P435, DOI 10.1053/j.gastro.2010.11.001; Saeki N, 2010, CLIN CANCER RES, V16, P3533, DOI 10.1158/1078-0432.CCR-09-3169; BORCH K, 1989, SCAND J GASTROENTERO, V24, P870, DOI 10.3109/00365528909089228; Sugimoto M, 2009, J CLIN MICROBIOL, V47, P738, DOI 10.1128/JCM.01563-08; ASAKA M, 1992, GASTROENTEROLOGY, V102, P760; Zeng ZR, 2011, MOL CARCINOGEN, V50, P353, DOI 10.1002/mc.20718; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; Atherton JC, 1997, GASTROENTEROLOGY, V112, P92, DOI 10.1016/S0016-5085(97)70223-3; Carrasco G, 2013, GASTROENT RES PRACT, DOI 10.1155/2013/393015; Chen TS, 2005, J CLIN GASTROENTEROL, V39, P699, DOI 10.1097/01.mcg.0000173854.55172.ee; Elsamman EM, 2006, BJU INT, V98, P668, DOI 10.1111/j.1464-410X.2006.06350.x; Fujino Y, 2005, J EPIDEMIOL, V15, pS113, DOI 10.2188/jea.15.S113; Graham DY, 1997, GASTROENTEROLOGY, V113, P1983, DOI 10.1016/S0016-5085(97)70019-2; Kimura K, 1969, ENDOSCOPY, V3, P87, DOI DOI 10.1055/S-0028-1098086; Matsuo K, 2009, INT J CANCER, V125, P1961, DOI 10.1002/ijc.24519; Rizzato C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073100; Sala N, 2012, INT J CANCER, V130, P2417, DOI 10.1002/ijc.26243; Shi DN, 2012, J CANCER RES CLIN, V138, P1339, DOI 10.1007/s00432-012-1210-6; Song HR, 2011, MOL CARCINOGEN, V50, P871, DOI 10.1002/mc.20796; Tanikawa C., 2012, NAT GENET, V44, pS1; Wang SZ, 2010, CARCINOGENESIS, V31, P621, DOI 10.1093/carcin/bgp323; Wu C, 2009, MOL CARCINOGEN, V48, P1131, DOI 10.1002/mc.20565	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1083-4389	1523-5378		HELICOBACTER	Helicobacter	APR	2015	20	2					106	113		10.1111/hel.12183		8	Gastroenterology & Hepatology; Microbiology	Gastroenterology & Hepatology; Microbiology	CD5UH	WOS:000351153100004		
J	Okuda, M; Osaki, T; Lin, YL; Yonezawa, H; Maekawa, K; Kamiya, S; Fukuda, Y; Kikuchi, S				Okuda, Masumi; Osaki, Takako; Lin, Yingsong; Yonezawa, Hideo; Maekawa, Kohei; Kamiya, Shigeru; Fukuda, Yoshihiro; Kikuchi, Shogo			Low Prevalence and Incidence of Helicobacter pylori Infection in Children: A Population-Based Study in Japan	HELICOBACTER			English	Article						children; epidemiology; Helicobacter pylori infection; family	POTENTIAL RISK-FACTORS; GASTROESOPHAGEAL JUNCTION; DEVELOPING-COUNTRY; EARLY-CHILDHOOD; GASTRIC-CANCER; TRANSMISSION; AGE; DNA; FAMILIES; STRAINS	BackgroundInfection of Helicobacter pylori mainly occurs in childhood. In Japan, incidence of gastric cancer is still high in the senior citizen population, but little is known about the current H.pylori infection status among children or their family members. MethodsAs a population-based study, the prevalence of H.pylori infection and change in infection status over a 1-year interval in children were determined. Family members of some participants were also invited to participate in the study to determine their infection status. All children of specific ages attending 16 schools in Sasayama, Hyogo Prefecture, were invited to participate. H.pylori infection was determined by the stool antigen test and diagnosis confirmed by polymerase chain reaction and the urea breath test. ResultsHelicobacter pylori prevalence was 1.9% among 689 children aged 0-8years in 2010 and 1.8% among 835 children aged 0-11 in 2011. No feco-conversion was observed in 430 children aged 0-8years (170 were aged 0-4years) who provided follow-up stool samples after 1year. The prevalence of infection was 6% (2 of 33) and 38% (6 of 16) in mothers of negative and positive probands (p=.04), respectively, and 12% (3 of 25) and 50% (8 of 16) (p=.01), respectively, in fathers. ConclusionHelicobacter pylori prevalence in Japanese children is approximately 1.8%, which is much lower than that reported in Japanese adults. New infection may be rare. Parent-to-child infection is thought to be the main infection route of the infrequent infection for children in Japan.	[Okuda, Masumi; Maekawa, Kohei; Fukuda, Yoshihiro] Hyogo Coll Med, Dept Gen Med & Community Hlth Sci, Sasayama, Hyogo, Japan; [Osaki, Takako; Yonezawa, Hideo; Kamiya, Shigeru] Kyorin Univ, Sch Med, Dept Infect Dis, Mitaka, Tokyo 181, Japan; [Lin, Yingsong; Kikuchi, Shogo] Aichi Med Univ, Dept Publ Hlth, Sch Med, Nagakute, Aichi 4801195, Japan	Kikuchi, S (reprint author), Aichi Med Univ, Dept Publ Hlth, Sch Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	kikuchis@aichi-med-u.ac.jp			Ministry of Health, Labour and Welfare, Japan; Japan Society for the Promotion of Science [22590613]	This project was partially supported by Health and Labour Sciences Research Grants for Clinical Cancer Research from the Ministry of Health, Labour and Welfare, Japan and grants for Scientific Research (#22590613) from the Japan Society for the Promotion of Science. The authors would like to thank the participants, their guardians, the staffs of the Sasayama Local Government, and the 16 schools for their great support, and Mss. Junko Ueda, Kiyoko Yagyu, Satomi Okamoto, Yuriko Kojima, Mayuko Masuda, Kumiko Takaba, and Tomoko Nozaki for their excellent technical assistance.	Goodman KJ, 2000, LANCET, V355, P358, DOI 10.1016/S0140-6736(99)05273-3; Weyermann M, 2009, AM J GASTROENTEROL, V104, P182, DOI 10.1038/ajg.2008.61; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Ekstrom AM, 2001, GASTROENTEROLOGY, V121, P784, DOI 10.1053/gast.2001.27999; Osaki T, 2013, J MED MICROBIOL, V62, P761, DOI 10.1099/jmm.0.053140-0; Konno M, 2008, PEDIATR INFECT DIS J, V27, P999, DOI 10.1097/INF.0b013e31817d756e; Konno M, 2005, J CLIN MICROBIOL, V43, P2246, DOI 10.1128/JCM.43.5.2246; Rowland M, 2006, GASTROENTEROLOGY, V130, P65, DOI 10.1053/j.gastro.2005.11.004; BANATVALA N, 1993, J INFECT DIS, V168, P219; Kivi M, 2003, J CLIN MICROBIOL, V41, P5604, DOI 10.1128/JCM.41.12.5604-5608.2003; Lin DB, 2007, HELICOBACTER, V12, P258, DOI 10.1111/j.1523-5378.2007.00496.x; ASAKA M, 1992, GASTROENTEROLOGY, V102, P760; Egorov AI, 2010, INT J INFECT DIS, V14, pE788, DOI 10.1016/j.ijid.2010.03.013; Dattoli VCC, 2010, HELICOBACTER, V15, P273, DOI 10.1111/j.1523-5378.2010.00766.x; DENSHOED CM, 2011, HELICOBACTER, V16, P405; Duque X, 2012, J PEDIATR GASTR NUTR, V55, P209, DOI 10.1097/MPG.0b013e318248877f; Etukudo Ofonime Michael, 2012, Pan Afr Med J, V12, P39; Fukuda Y, 2004, JPN J MED PHARM SCI, V52, P261; Herrera PM, 2008, J CLIN MICROBIOL, V46, P3912, DOI 10.1128/JCM.01453-08; Ito Y, 1997, J CLIN MICROBIOL, V35, P1710; Jafri W, 2010, ACTA PAEDIATR, V99, P279, DOI 10.1111/j.1651-2227.2009.01542.x; Kikuchi S, 2000, JPN J CANCER RES, V91, P774; Kobayashi Takanori, 2004, Gastric Cancer, V7, P233, DOI 10.1007/s10120-004-0297-0; Kumagai T, 1998, J INFECT DIS, V178, P717; Miyaji H, 2000, J GASTROEN HEPATOL, V15, P257, DOI 10.1046/j.1440-1746.2000.02070.x; Naito Y, 2008, PEDIATR INT, V50, P291, DOI 10.1111/j.1442-200X.2008.02587.x; Okuda M, 2007, HELICOBACTER, V12, P324, DOI 10.1111/j.1523-5378.2007.00510.x; Parfitt JR, 2006, CAN J GASTROENTEROL, V20, P271; Tam YH, 2008, HELICOBACTER, V13, P219, DOI 10.1111/j.1523-5378.2008.00603.x; Ueda J, 2014, HELICOBACTER, V19, P105, DOI 10.1111/hel.12110; Ueda M, 2003, CANCER SCI, V94, P914, DOI 10.1111/j.1349-7006.2003.tb01375.x; Urita Y, 2013, J PAEDIATR CHILD H, V49, P394, DOI 10.1111/jpc.12191; Wijnhoven BPL, 2002, EUR J GASTROEN HEPAT, V14, P115, DOI 10.1097/00042737-200202000-00004	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1083-4389	1523-5378		HELICOBACTER	Helicobacter	APR	2015	20	2					133	138		10.1111/hel.12184		6	Gastroenterology & Hepatology; Microbiology	Gastroenterology & Hepatology; Microbiology	CD5UH	WOS:000351153100007		
J	Hiyama, T; Quach, DT; Le, QD; Ho, LX; Vu, NHT; Shimamoto, F; Ito, M; Tanaka, S; Yoshihara, M; Uemura, N; Chayama, K				Hiyama, Toru; Duc Trong Quach; Quang Dinh Le; Linh Xuan Ho; Nhu Hanh Thi Vu; Shimamoto, Fumio; Ito, Masanori; Tanaka, Shinji; Yoshihara, Masaharu; Uemura, Naomi; Chayama, Kazuaki			Rate of Unintended Helicobacter pylori Eradication in the Vietnamese	HELICOBACTER			English	Letter							INFECTION		[Hiyama, Toru; Yoshihara, Masaharu] Hiroshima Univ, Hlth Serv Ctr, Higashihiroshima, Japan; [Duc Trong Quach; Quang Dinh Le; Nhu Hanh Thi Vu] Univ Med Ctr, Dept Endoscopy, Ho Chi Minh, Vietnam; [Linh Xuan Ho] Gia Dinh Peoples Hosp, Dept Gastroenterol, Ho Chi Minh, Vietnam; [Shimamoto, Fumio] Prefectural Univ Hiroshima, Fac Human Culture & Sci, Hiroshima, Japan; [Ito, Masanori; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Metab, Hiroshima, Japan; [Tanaka, Shinji] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan; [Uemura, Naomi] Kohnodai Hosp, Dept Gastroenterol & Hepatol, Natl Ctr Global Hlth & Med, Ichikawa, Japan	Hiyama, T (reprint author), Hiroshima Univ, Hlth Serv Ctr, 1-7-1 Kagamiyama, Higashihiroshima 7398514, Japan.	tohiyama@hiroshima-u.ac.jp		Quach, Duc/0000-0003-0141-921X			Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Ono S, 2012, DIGESTION, V86, P59, DOI 10.1159/000339176; Boda T, 2013, HELICOBACTER, V19, P1; Matsuo K, 2011, HELICOBACTER, V16, P415; Ohkusa T, 2004, ALIMENT PHARM THERAP, V20, P25, DOI 10.1111/j.1365-2036.2004.01970.x; Quach DT, 2014, WORLD J GASTROENTERO, V20, P5087, DOI 10.3748/wjg.v20.i17.5087	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1083-4389	1523-5378		HELICOBACTER	Helicobacter	APR	2015	20	2					156	157		10.1111/hel.12210		2	Gastroenterology & Hepatology; Microbiology	Gastroenterology & Hepatology; Microbiology	CD5UH	WOS:000351153100010		
J	Sakurai, D; Iwatani, Y; Ohtani, H; Naruse, TK; Terunuma, H; Sugiura, W; Kimura, A				Sakurai, Daisuke; Iwatani, Yasumasa; Ohtani, Hitoshi; Naruse, Taeko K.; Terunuma, Hiroshi; Sugiura, Wataru; Kimura, Akinori			APOBEC3H polymorphisms associated with the susceptibility to HIV-1 infection and AIDS progression in Japanese	IMMUNOGENETICS			English	Article						APOBEC3H; HIV-1 infection; AIDS progression; Polymorphism; Haplotype; Japanese	CYTIDINE DEAMINASE APOBEC3H; GENOME-WIDE ASSOCIATION; ANTIVIRAL ACTIVITY; VARIANTS; RESTRICTION; VIF; DETERMINES; HEMOPHILIA; EVOLUTION; COPY	Human APOBEC3H (A3H) is a member of APOBEC3 cytidine deaminase family that potently restricts HIV-1 replication. Because A3H is genetically divergent with different intracellular stability and anti-HIV-1 activity in vitro, we investigated a possible association of A3H with susceptibility to HIV-1 infection and disease progression in Japanese populations. A total of 191 HIV-1-infected individuals (HIV group), 93 long-term non-progressors to AIDS (LTNP group) and 421 healthy controls were genotyped for two functional APOBEC3H polymorphisms, rs139292 and rs139297. As compared with the controls, minor allele frequency (MAF) for rs139292 was high in the HIV group (MAF in cases vs. controls; 0.322 vs. 0.263, odds ratio (OR) = 1.33, 95 % confidence interval (95 % CI) = 1.02-1.74, p = 0.035) and low in the LTNP group (0.161 vs. 0.263, OR = 0.54, 95 % CI = 0.36-0.82, p = 0.004, pc = 0.007), whereas the MAF for rs139297 was high in the HIV group (0.367 vs. 0.298, OR = 1.36, 95 % CI = 1.07-1.76, p = 0.017, pc = 0.035). In addition, haplotype analyses revealed that the frequencies of A3H-hapC and -hapA were high (0.322 vs. 0.262, OR = 1.33, 95% CI = 1.02-1.74, p = 0.003) and low (0.634 vs. 0.697, OR = 0.75, 95 % CI = 0.58-0.97, p = 0.002), respectively, in the HIV group, whereas the frequencies of A3H-hapC and -hapB were low (0.161 vs. 0.262, OR = 0.54, 95 % CI = 0.36-0.82, p = 0.00003) and high (0.097 vs. 0.040, OR = 2.55, 95 % CI = 1.40-4.62, p = 0.000008), respectively, in the LTNP group, as compared with those in the controls. These observations suggest that the A3H with low anti-HIV-1 activity, A3H-hapC, is associated with the susceptibility to HIV-1 infection, whereas the A3H producing a stable protein, A3H-hapB, may confer a low risk of disease progression to AIDS.	[Sakurai, Daisuke; Ohtani, Hitoshi; Naruse, Taeko K.; Kimura, Akinori] TMDU, Med Res Inst, Dept Mol Pathogenesis, Bunkyo Ku, Tokyo 1138510, Japan; [Iwatani, Yasumasa; Sugiura, Wataru] Natl Hosp Org Nagoya Med Ctr, Dept Infect & Immunol, Clin Res Ctr, Nagoya, Aichi, Japan; [Terunuma, Hiroshi] Biotherapy Inst Japan, Tokyo, Japan	Kimura, A (reprint author), TMDU, Med Res Inst, Dept Mol Pathogenesis, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	akitis@mri.tmd.ac.jp			Ministry of Health, Labor and Welfare, Japan; National Hospital Organization Nagoya Medical Center, Japan	We are grateful Drs. Hanabusa H. (Ogikubo Hospital), Matsuda J. (Teikyo University School of Medicine), Sakai M. (University of Occupational and Environmental Health), Ikeda S. (Sasebo Municipal Hospital), and Fujii T. (Hiroshima University School of Medicine) for blood sampling from HIV-1-infected patients. This work was supported in part by research grants from the Ministry of Health, Labor and Welfare, Japan, and a Joint Research Program of National Hospital Organization Nagoya Medical Center, Japan.	Dang Y, 2008, J BIOL CHEM, V283, P11606, DOI 10.1074/jbc.M707586200; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Chinn LW, 2010, J INFECT DIS, V202, P1836, DOI 10.1086/657322; Le Clerc S, 2011, JAIDS-J ACQ IMM DEF, V56, P279, DOI 10.1097/QAI.0b013e318204982b; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Harari A, 2009, J VIROL, V83, P295, DOI 10.1128/JVI.01665-08; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Zhen AJ, 2010, J VIROL, V84, P1902, DOI 10.1128/JVI.01509-09; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00969; Tan LD, 2009, FASEB J, V23, P279, DOI 10.1096/fj.07-088781; Ooms M, 2010, J VIROL, V84, P7961, DOI 10.1128/JVI.00754-10; Nakajima T, 2007, IMMUNOGENETICS, V59, P793, DOI 10.1007/s00251-007-0252-4; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Imahashi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092861; Itaya S, 2010, J INFECT DIS, V202, P815, DOI 10.1086/655227; Lane J, 2013, HUM MOL GENET, V22, P1903, DOI 10.1093/hmg/ddt033; Li JH, 2014, J MOL BIOL, V426, P1296, DOI 10.1016/j.jmb.2013.12.014; Petrovski S, 2011, AIDS, V25, P513, DOI 10.1097/QAD.0b013e328343817b; Zhen AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038771	21	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0093-7711	1432-1211		IMMUNOGENETICS	Immunogenetics	APR	2015	67	4					253	257		10.1007/s00251-015-0829-2		5	Genetics & Heredity; Immunology	Genetics & Heredity; Immunology	CD6NE	WOS:000351205100005		
J	Nakasone, T; Sato, T; Matsushima, Y; Inoue, T; Kamei, C				Nakasone, Tasuku; Sato, Takumi; Matsushima, Yoshibumi; Inoue, Toshio; Kamei, Chiaki			Characteristics of scratching behavior in ADJM mice (atopic dermatitis from Japanese mice)	IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY			English	Article						ADJM mice; chlorpheniramine; cyproheptadine; nalfurafine; naloxone	NC/NGA MICE; HEMODIALYSIS-PATIENTS; UREMIC PRURITUS; MAST-CELLS; SKIN; RECEPTORS; OPIATES; DISEASE; AGENTS; MOUSE	In order to elucidate the characteristics of scratching behavior in atopic dermatitis from Japanese mice (ADJM) mice, the effects of some antagonists of pruritogens on this behavior were studied. Both male and female ADJM mice showed frequent scratching behavior around the face, abdomen and back. The number of scratching behavior around the face was greater than on the abdomen and back, and scratching behavior in female mice was significantly more frequent than in male mice. Histamine H-1 antagonist, chlorpheniramine, p.o., inhibited this behavior potently and dose-dependently. Histamine H-1 antagonist with serotonin 5-TH(5-hydroxytryptamine) 2 antagonist, cyproheptadine, also inhibited this behavior. However, NK1 antagonist, aprepitant, p.o., had no significant inhibitory effect even at a dose of 100 mg/kg, p.o., Mu antagonist, naloxone, and kappa agonist, nalfurafine, significantly inhibited this behavior at doses of 0.3 mg/kg, s.c., and 0.01 mg/kg, p.o., respectively. Histamine contents in the skin of ADJM mice were significantly higher than in BALB/c mice. These results strongly indicate that scratching behavior in ADJM mice is related with histamine H-1, opioid mu and opioid kappa receptors.	[Nakasone, Tasuku; Kamei, Chiaki] Yasuda Womens Univ, Fac Pharmaceut Sci, Dept Pharmacol, Asaminami Ku, Hiroshima 7310153, Japan; [Sato, Takumi; Inoue, Toshio] Nihon Pharmaceut Univ, Fac Pharmaceut Sci, Dept Pharmacotherapy, Saitama, Japan; [Matsushima, Yoshibumi] Saitama Canc Ctr, Res Inst Clin Oncol, Saitama, Japan	Kamei, C (reprint author), Yasuda Womens Univ, Fac Pharmaceut Sci, Dept Pharmacol, Asaminami Ku, 6-13-1 Yasuhigashi, Hiroshima 7310153, Japan.	kamei-c@yasuda-u.ac.jp			Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; JSPS KAKENHI Grant [70458610]	This work was supported by Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics and JSPS KAKENHI Grant Number 70458610.	Nakao K, 2009, DRUG TODAY, V45, P323, DOI 10.1358/dot.2009.45.5.1362067; Wu BJ, 2011, DEV COMP IMMUNOL, V35, P1186, DOI 10.1016/j.dci.2011.03.027; BALLANTYNE JC, 1988, PAIN, V33, P149, DOI 10.1016/0304-3959(88)90085-1; Andoh T, 1998, J PHARMACOL EXP THER, V286, P1140; Narita I, 2008, J NEPHROL, V21, P161; Togashi Y, 2002, EUR J PHARMACOL, V435, P259, DOI 10.1016/S0014-2999(01)01588-6; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; BERGASA NV, 1995, ANN INTERN MED, V123, P161; Kim DK, 2008, EUR J PHARMACOL, V579, P390, DOI 10.1016/j.ejphar.2007.11.005; MONROE EW, 1989, J AM ACAD DERMATOL, V21, P135, DOI 10.1016/S0190-9622(89)80353-6; Inagaki N, 2001, SKIN PHARMACOL APPL, V14, P87, DOI 10.1159/000056338; BARKE KE, 1993, LIFE SCI, V53, P1391, DOI 10.1016/0024-3205(93)90581-M; Blunk JA, 2004, ANESTH ANALG, V98, P364, DOI 10.1213/01.ANE.0000097168.32472.0D; HANIFIN JM, 1986, CLIN REV ALLERG, V4, P43; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; Matsushima Y, 2010, J IMMUNOL, V185, P2340, DOI 10.4049/jimmunol.0900694; Matsushima Y, 2012, EXP ANIM TOKYO, V61, P25, DOI 10.1538/expanim.61.25; Metze D, 1999, ANN NY ACAD SCI, V885, P430; Shinmei Y, 2009, IMMUNOPHARM IMMUNOT, V31, P688, DOI 10.3109/08923970903078443; Stander S, 2010, PLOS ONE, V5, P1; Sugimoto Y, 1998, EUR J PHARMACOL, V351, P1, DOI 10.1016/S0014-2999(98)00288-X; Sunada Y, 2008, INT IMMUNOPHARMACOL, V8, P1761, DOI 10.1016/j.intimp.2008.08.011; Takano N, 2004, EUR J PHARMACOL, V495, P159, DOI 10.1016/j.ejphar.2004.05.038; Tohda C, 1997, NEUROSCI RES, V29, P209, DOI 10.1016/S0168-0102(97)00090-4; WEITZMAN G, 1985, INT ARCH ALLER A IMM, V77, P189; Yamamoto A, 2010, EUR J PHARMACOL, V627, P162, DOI 10.1016/j.ejphar.2009.10.066	27	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0892-3973	1532-2513		IMMUNOPHARM IMMUNOT	Immunopharmacol. Immunotoxicol.	APR	2015	37	2					202	206		10.3109/08923973.2014.1001903		5	Immunology; Pharmacology & Pharmacy; Toxicology	Immunology; Pharmacology & Pharmacy; Toxicology	CD6WP	WOS:000351231300010		
J	Ozawa, M; Nishida, K; Yoshida, A; Saito, T; Harada, R; Machida, T; Ozaki, T				Ozawa, Masatsugu; Nishida, Keiichiro; Yoshida, Aki; Saito, Taichi; Harada, Ryozo; Machida, Takahiro; Ozaki, Toshifumi			Hyaluronan suppresses mechanical stress-induced expression of catabolic enzymes by human chondrocytes via inhibition of IL-1 beta production and subsequent NF-kappa B activation	INFLAMMATION RESEARCH			English	Article						Chondrocyte; Hyaluronan; Mechanical stress; Aggrecanase; NF-kappa B; RUNX-2	MOLECULAR-WEIGHT; INTERLEUKIN-1 INDUCTION; AGGRECAN DEGRADATION; SIGNALING PATHWAY; GENE-EXPRESSION; ERK INHIBITOR; OSTEOARTHRITIS; ACID; CARTILAGE; INVOLVEMENT	To investigate the inhibitory effect of hyaluronan (HA) on mechanical stress- induced expression of a disintegrin and metalloproteinase with thrombospondin type1 motifs (ADAMTS)-4, -5 and matrix metalloproteinase (MMP)-13 by human chondrocytes. Normal human articular chondrocytes were pre-incubated with or without 1.0 mg/mL HA (2700 kDa) for 12 h at 37 A degrees C in stretch chambers, then they were exposed to uni-axial cyclic tensile strain (CTS, 0.5 Hz, 10 % elongation). The expression of ADAMTS-4, -5, and MMP-13 were analyzed by real-time polymerase chain reaction and Immunocytochemistry. The concentration of IL-1 beta in the supernatant was measured using enzyme-linked immunosorbent assay (ELISA). The nuclear translocation of runt-related transcription factor 2 (RUNX-2) and nuclear factor-kappa B (NF-kappa B) was examined by ELISA and immunocytochemistry, and phosphorylation of NF-kappa B was examined by western blotting. HA inhibited mRNA expression of ADAMTS-4, -5, and MMP13 after 24 h CTS via inhibition of IL-1 beta secretion and NF-kappa B activation. However, HA failed to inhibit CTS-induced RUNX-2 expression and subsequent expression of ADAMTS-5 and MMP-13 1 h after CTS. Our results demonstrated that HA significantly suppressed mechanical stress-induced expression of catabolic proteases by inhibition of the NF-kappa B-IL-1 beta pathway, but did not suppress mechanical stress-induced RUNX-2 signaling.	[Ozawa, Masatsugu; Yoshida, Aki; Harada, Ryozo; Machida, Takahiro; Ozaki, Toshifumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Orthopaed Surg, Okayama, Okayama 7008558, Japan; [Nishida, Keiichiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Human Morphol, Okayama, Okayama 7008558, Japan; [Saito, Taichi] Ako Cent Hosp, Dept Orthopaed Surg, Ako, Hyogo 6780241, Japan	Nishida, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Human Morphol, 2-5-1 Shikata Cho, Okayama, Okayama 7008558, Japan.	knishida@md.okayama-u.ac.jp					Moreland LW, 2003, ARTHRITIS RES THER, V5, P54, DOI 10.1186/ar623; Yoshida M, 2004, ARTHRITIS RES THER, V6, pR514, DOI 10.1186/ar1223; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Migliore A, 2008, CLIN INTERV AGING, V3, P365; Saito T, 2013, OSTEOARTHR CARTILAGE, V21, P165, DOI 10.1016/j.joca.2012.09.003; Wang MN, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4133; Sylvester J, 2012, CELL PHYSIOL BIOCHEM, V30, P563, DOI 10.1159/000341438; Glasson SS, 2004, ARTHRITIS RHEUM, V50, P2547, DOI 10.1002/art.20558; GOTOH S, 1993, ANN RHEUM DIS, V52, P817, DOI 10.1136/ard.52.11.817; Tian Y, 2013, AM J PATHOL, V182, P2310, DOI 10.1016/j.ajpath.2013.02.037; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Hashizume M, 2010, BIOCHEM BIOPH RES CO, V403, P184, DOI 10.1016/j.bbrc.2010.10.135; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Lisignoli G, 2001, ARTHRITIS RHEUM, V44, P1800, DOI 10.1002/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1; Goldberg VM, 2005, OSTEOARTHR CARTILAGE, V13, P216, DOI 10.1016/j.joca.2004.11.010; Katz S, 2006, INT J BIOCHEM CELL B, V38, P2082, DOI 10.1016/j.biocel.2006.05.018; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Julovi SM, 2004, ARTHRITIS RHEUM, V50, P516, DOI 10.1002/art.20004; Rydell N, 1971, Clin Orthop Relat Res, V80, P25, DOI 10.1097/00003086-197110000-00006; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Huang K, 2008, J INT MED RES, V36, P1149; Yatabe T, 2009, ANN RHEUM DIS, V68, P1051, DOI 10.1136/ard.2007.086884; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; Hashizume M, 2009, OSTEOARTHR CARTILAGE, V17, P1513, DOI 10.1016/j.joca.2009.04.018; Hirano Y, 2008, J BIOTECHNOL, V133, P245, DOI 10.1016/j.jbiotee.2007.07.955; Kobayashi H, 2013, J BIOL CHEM, V288, P28620, DOI 10.1074/jbc.M113.452169; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Gigante A, 2011, RHEUMATOL INT, V31, P427, DOI 10.1007/s00296-010-1660-6; Tetsunaga T, 2011, OSTEOARTHR CARTILAGE, V19, P222, DOI 10.1016/j.joca.2010.11.004; Campo GM, 2009, BBA-GEN SUBJECTS, V1790, P1353, DOI 10.1016/j.bbagen.2009.07.003; Fan Xian, 2006, J Cell Physiol, V207, P454, DOI 10.1002/jcp.20581; Lee PB, 2006, J INT MED RES, V34, P77; Naruse K, 1998, AM J PHYSIOL-HEART C, V274, pH1532; Prasadam I, 2013, J MOL MED, V91, P369, DOI 10.1007/s00109-012-0953-5; Rigoglou S, 2013, INT J BIOCHEM CELL B, V45, P2580, DOI 10.1016/j.biocel.2013.08.018; Thirunavukkarasu K, 2007, MOL BIOL REP, V34, P225, DOI 10.1007/s11033-006-9037-3; Uebelhart D, 1999, Curr Opin Rheumatol, V11, P427, DOI 10.1097/00002281-199909000-00018; Yasuda T, 2013, MOD RHEUMATOL, V23, P1116, DOI 10.1007/s10165-012-0804-9	38	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830	1420-908X		INFLAMM RES	Inflamm. Res.	APR	2015	64	3-4					243	252		10.1007/s00011-015-0804-2		10	Cell Biology; Immunology	Cell Biology; Immunology	CD6NI	WOS:000351205500011		
J	Karin, P; Borhanipour, M; Songsaengchan, Y; Laosuwan, S; Charoenphonphanich, C; Chollacoop, N; Hanamura, K				Karin, P.; Borhanipour, M.; Songsaengchan, Y.; Laosuwan, S.; Charoenphonphanich, C.; Chollacoop, N.; Hanamura, K.			Oxidation kinetics of small CI engine's biodiesel particulate matter	INTERNATIONAL JOURNAL OF AUTOMOTIVE TECHNOLOGY			English	Article						Diesel engine; Particulate matter; Biodiesel; Activation energy; Oxidation kinetics	DIESEL SOOT; EMISSIONS; FILTERS	Particulate matters (PMs) oxidation kinetics by Thermo-gravimetric analysis (TGA) was successfully studied. The chemical content percentage of PM can be divided by oxidation temperature zoning in three main regions which are moisture, unburned hydrocarbon (HC) and carbon. It is clearly observed that the amount of each region is strongly depending on engine operating condition, the amount of unburned HC in low load condition of the engine load are larger than that of high load condition. The calculated apparent activation energies of biodiesel PM oxidation are lower than that of diesel PM and carbon black because of unburned oxygenated molecule. The calculated apparent activation energy of biodiesel and diesel PMs oxidize with air is in the range of 147-157 kJ/mole and 153-165 kJ/mole, respectively. The results of this research would be used as basic information for design and develop removing process of particulate matter emitted from engine combustion which using in diesel and biodiesel fuels.	[Karin, P.; Borhanipour, M.; Songsaengchan, Y.] King Mongkuts Inst Technol Ladkrabang, Int Coll, Bangkok 10520, Thailand; [Laosuwan, S.; Charoenphonphanich, C.] King Mongkuts Inst Technol Ladkrabang, Dept Engn, Bangkok 10520, Thailand; [Chollacoop, N.] Natl Sci & Technol Dev Agcy, Pathum Thani 12120, Thailand; [Hanamura, K.] Tokyo Inst Technol, Meguro Ku, Tokyo 1528552, Japan	Karin, P (reprint author), King Mongkuts Inst Technol Ladkrabang, Int Coll, Bangkok 10520, Thailand.	kkpreech@kmitl.ac.th			Thailand Research Fund (TRF), Ministry of Science and Technology, Thailand	The authors gratefully acknowledge the financial support from Thailand Research Fund (TRF), Ministry of Science and Technology, Thailand.	Fino D, 2008, POWDER TECHNOL, V180, P64, DOI 10.1016/j.powtec.2007.03.021; Darcy P, 2007, CATAL TODAY, V119, P252, DOI 10.1016/j.cattod.2006.08.056; Kittelson DB, 1998, J AEROSOL SCI, V29, P575, DOI 10.1016/S0021-8502(97)10037-4; Neeft JPA, 1997, FUEL, V76, P1129, DOI 10.1016/S0016-2361(97)00119-1; Ishiguro T, 1997, COMBUST FLAME, V108, P231, DOI 10.1016/S0010-2180(96)00206-4; Hanamura K, 2009, INT J ENGINE RES, V10, P305, DOI 10.1243/14680874JER04209; Neeft JPA, 1996, FUEL PROCESS TECHNOL, V47, P1, DOI 10.1016/0378-3820(96)01002-8; Maricq MM, 2007, J AEROSOL SCI, V38, P1079, DOI 10.1016/j.jaerosci.2007.08.001; Eastwood P, 2008, PARTICULATE EMISSION; Heywood J.B., 1988, INTERNAL COMBUSTION; Karin P, 2013, ENRGY PROCED, V34, P757, DOI 10.1016/j.egypro.2013.06.811; Karin P., 2013, 2013329150 SAE; Karin P., 2009, SAE INT J FUELS LUBR, V2, P661, DOI DOI 10.4271/2009-01-1476; Karin P., 2010, SAE INT J FUELS LUBR, V3, P368; Lee S., 2013, INT J AUTOMOTIVE TEC, V14, P757; Majewski WA, 2006, DIESEL EMISSIONS THE; Merkel G, 2001, 2001010190 SAE; Myung C. L., 2014, INT J AUTOMOTIVE TEC, V15, P219; Oki H., 2011, SAE INT J ENGINES, V4, P515; SMITH OI, 1981, PROG ENERG COMBUST, V7, P275, DOI 10.1016/0360-1285(81)90002-2; Soylu S, 2014, INT J AUTO TECH-KOR, V15, P369, DOI 10.1007/s12239-014-0039-1; Vander Wal RL, 2007, CARBON, V45, P70, DOI 10.1016/j.carbon.2006.08.005	22	0	0	KOREAN SOC AUTOMOTIVE ENGINEERS-KSAE	SEOUL	#1301, PARADISE VENTURE TOWER, 52-GIL 21, TEHERAN-RO, GANGNAM-GU, SEOUL 135-919, SOUTH KOREA	1229-9138	1976-3832		INT J AUTO TECH-KOR	Int. J. Automot. Technol.	APR	2015	16	2					211	219		10.1007/s12239-015-0023-4		9	Engineering, Mechanical; Transportation Science & Technology	Engineering; Transportation	CD4XP	WOS:000351089700005		
J	Shinozaki-Ushiku, A; Kunita, A; Fukayama, M				Shinozaki-Ushiku, Aya; Kunita, Akiko; Fukayama, Masashi			Update on Epstein-Barr virus and gastric cancer	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Review						Epstein-Barr virus; gastric cancer	LYMPHOEPITHELIOMA-LIKE CARCINOMA; HELICOBACTER-PYLORI INFECTION; HUMAN EPITHELIAL-CELLS; MEMBRANE-PROTEIN 2A; NUCLEAR ANTIGEN 1; NASOPHARYNGEAL CARCINOMA; GENE-EXPRESSION; EBV INFECTION; MICROSATELLITE INSTABILITY; ENCODED MICRORNAS	Epstein-Barr virus-associated gastric carcinoma (EBVaGC) is a distinct subtype that accounts for nearly 10% of gastric carcinomas. EBVaGC is defined by monoclonal proliferation of carcinoma cells with latent EBV infection, as demonstrated by EBV-encoded small RNA (EBER) in situ hybridization. EBVaGC has characteristic clinicopathological features, including predominance among males, a proximal location in the stomach, lymphoepithelioma-like histology and a favorable prognosis. EBVaGC belongs to latency type I or II, in which EBERs, EBNA-1, BARTs, LMP-2A and BART miRNAs are expressed. Previous studies have shown that some EBV latent genes have oncogenic properties. Recent advances in genome-wide and comprehensive molecular analyses have demonstrated that both genetic and epigenetic changes contribute to EBVaGC carcinogenesis. Genetic changes that are characteristic of EBVaGC include frequent mutations in PIK3CA and ARID1A and amplification of JAK2 and PD-L1/L2. Global CpG island hypermethylation, which induces epigenetic silencing of tumor suppressor genes, is also a unique feature of EBVaGC and is considered to be crucial for its carcinogenesis. Furthermore, post-transcriptional gene expression regulation by cellular and/or EBV-derived microRNAs has attracted considerable attention. These abnormalities result in significant alterations in gene expression related to cell proliferation, apoptosis, migration and immune signaling pathways. In the present review we highlight the latest findings on EBVaGC from clinicopathological and molecular perspectives to provide a better understanding of EBV involvement in gastric carcinogenesis.	[Shinozaki-Ushiku, Aya; Kunita, Akiko; Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1130033, Japan	Fukayama, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Pathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mfukayama-tky@umin.org					Ambrosio MR, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-12; Matsusaka K, 2011, CANCER RES, V71, P7187, DOI 10.1158/0008-5472.CAN-11-1349; Chang MS, 2003, J PATHOL, V199, P447, DOI 10.1002/path.1302; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Matsusaka K, 2014, WORLD J GASTROENTERO, V20, P3916, DOI 10.3748/wjg.v20.i14.3916; Rickinson AB, 2014, SEMIN CANCER BIOL, V26, P99, DOI 10.1016/j.semcancer.2014.04.004; Gourzones C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-119; Qiu J, 2014, P NATL ACAD SCI USA, V111, P11157, DOI 10.1073/pnas.1406136111; Lee JH, 2009, J GASTROEN HEPATOL, V24, P354, DOI 10.1111/j.1440-1746.2009.05775.x; Sukawa Y, 2012, WORLD J GASTROENTERO, V18, P6577, DOI 10.3748/wjg.v18.i45.6577; Lung RWM, 2013, INT J MOL SCI, V14, P17378, DOI 10.3390/ijms140917378; Iizasa H, 2010, J BIOL CHEM, V285, P33358, DOI 10.1074/jbc.M110.138362; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Kaneda A, 2012, CANCER RES, V72, P3445, DOI 10.1158/0008-5472.CAN-11-3919; Shannon-Lowe C, 2009, J VIROL, V83, P7749, DOI 10.1128/JVI.00108-09; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Cosmopoulos K, 2009, J VIROL, V83, P2357, DOI 10.1128/JVI.02104-08; Lin TC, 2013, AM J PATHOL, V182, P1865, DOI 10.1016/j.ajpath.2013.01.025; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Tsao SW, 2012, SEMIN CANCER BIOL, V22, P137, DOI 10.1016/j.semcancer.2012.02.004; Song HJ, 2011, GUT LIVER, V5, P143, DOI 10.5009/gnl.2011.5.2.143; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08; Fukayama M, 2011, PATHOL RES PRACT, V207, P529, DOI 10.1016/j.prp.2011.07.004; Chen JN, 2012, J CLIN GASTROENTEROL, V46, P262, DOI 10.1097/MCG.0b013e318249c4b8; Pal AD, 2014, CARCINOGENESIS, V35, P1592, DOI 10.1093/carcin/bgu069; Lung RWM, 2009, NEOPLASIA, V11, P1174, DOI 10.1593/neo.09888; Hino R, 2008, CANCER RES, V68, P1427, DOI 10.1158/0008-5472.CAN-07-3027; zur Hausen A, 2000, CANCER RES, V60, P2745; Choi H, 2013, J VIROL, V87, P8135, DOI 10.1128/JVI.03159-12; Dolan DE, 2014, CANCER CONTROL, V21, P231; Hino R, 2009, CANCER RES, V69, P2766, DOI 10.1158/0008-5472.CAN-08-3070; Abe H, 2012, VIRCHOWS ARCH, V461, P367, DOI 10.1007/s00428-012-1303-2; Marquitz AR, 2014, J VIROL, V88, P1389, DOI 10.1128/JVI.02662-13; Okada T, 2013, CANCER SCI, V104, P1309, DOI 10.1111/cas.12228; NAKAMURA S, 1994, CANCER, V73, P2239, DOI 10.1002/1097-0142(19940501)73:9<2239::AID-CNCR2820730902>3.0.CO;2-#; Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63; Jung YJ, 2014, J VIROL, V88, P9027, DOI 10.1128/JVI.00721-14; Song HJ, 2010, GASTROENTEROLOGY, V139, P84, DOI 10.1053/j.gastro.2010.04.002; EPSTEIN MA, 1964, LANCET, V1, P702; FUKAYAMA M, 1994, LAB INVEST, V71, P73; Luo B, 2005, WORLD J GASTROENTERO, V11, P629; Vereide DT, 2014, ONCOGENE, V33, P1258, DOI 10.1038/onc.2013.71; Al-Mozaini M, 2009, J GEN VIROL, V90, P307, DOI 10.1099/vir.0.006551-0; Iwakiri D, 2010, ADV CANCER RES, V107, P119, DOI 10.1016/S0065-230X(10)07004-1; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Dolken L, 2010, CELL HOST MICROBE, V7, P324, DOI 10.1016/j.chom.2010.03.008; MARSHALL BJ, 1984, LANCET, V1, P1311; Murphy G, 2009, GASTROENTEROLOGY, V137, P824, DOI 10.1053/j.gastro.2009.05.001; SHIBATA D, 1992, AM J PATHOL, V140, P769; SHIBATA D, 1991, AM J PATHOL, V139, P469; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Camargo MC, 2014, INT J CANCER, V134, P948, DOI 10.1002/ijc.28402; Green MR, 2012, CLIN CANCER RES, V18, P1611, DOI 10.1158/1078-0432.CCR-11-1942; Imai S, 1998, J VIROL, V72, P4371; BURKE AP, 1990, MODERN PATHOL, V3, P377; Thornburg NJ, 2004, J VIROL, V78, P12848, DOI 10.1128/JVI.78.23.12848-12856.2004; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Shinozaki A, 2010, CANCER RES, V70, P4719, DOI 10.1158/0008-5472.CAN-09-4620; Yau TO, 2014, WORLD J GASTROENTERO, V20, P6448, DOI 10.3748/wjg.v20.i21.6448; Kusano M, 2006, CANCER, V106, P1467, DOI 10.1002/cncr.21789; WATANABE H, 1976, CANCER, V38, P232, DOI 10.1002/1097-0142(197607)38:1<232::AID-CNCR2820380135>3.0.CO;2-4; Barth S, 2011, BBA-GENE REGUL MECH, V1809, P631, DOI 10.1016/j.bbagrm.2011.05.010; Marquitz AR, 2012, P NATL ACAD SCI USA, V109, P9593, DOI 10.1073/pnas.1202910109; Hoebe EK, 2013, REV MED VIROL, V23, P367, DOI 10.1002/rmv.1758; Sivachandran N, 2012, J VIROL, V86, P60, DOI 10.1128/JVI.05623-11; van Beek J, 2004, J CLIN ONCOL, V22, P664, DOI 10.1200/JCO.2004.08.061; Marquitz AR, 2011, VIROLOGY, V412, P392, DOI 10.1016/j.virol.2011.01.028; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Chen BJ, 2013, CLIN CANCER RES, V19, P3462, DOI 10.1158/1078-0432.CCR-13-0855; Imig J, 2011, NUCLEIC ACIDS RES, V39, P1880, DOI 10.1093/nar/gkq1043; TOKUNAGA M, 1993, AM J PATHOL, V143, P1250; Iwakiri D, 2003, CANCER RES, V63, P7062; Matsunou H, 1996, CANCER, V77, P1998, DOI 10.1002/(SICI)1097-0142(19960515)77:10<1998::AID-CNCR6>3.0.CO;2-D; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; Kuzushima K, 1999, J CLIN INVEST, V104, P163, DOI 10.1172/JCI6062; Saito M, 2013, J MED VIROL, V85, P121, DOI 10.1002/jmv.23405; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Kijima Y, 2003, CANCER LETT, V200, P33, DOI 10.1016/S0304-3835(03)00410-5; Camargo MC, 2011, BRIT J CANCER, V105, P38, DOI 10.1038/bjc.2011.215; Koriyama C, 2002, INT J MOL MED, V10, P635; Haneklaus M, 2012, J IMMUNOL, V189, P3795, DOI 10.4049/jimmunol.1200312; Shinozaki A, 2009, J HISTOCHEM CYTOCHEM, V57, P775, DOI 10.1369/jhc.2009.953810; Banerjee AS, 2013, VIROLOGY, V443, P294, DOI 10.1016/j.virol.2013.05.020; Boyle P, 2008, STOMACH CANC; Camargo MC, 2014, GUT, V63, P236, DOI 10.1136/gutjnl-2013-304531; Chan JYW, 2012, ANTICANCER RES, V32, P3201; Chan WY, 2002, DIAGN MOL PATHOL, V11, P127, DOI 10.1097/00019606-200209000-00001; Chang MS, 2013, J VIROL, V87, P10515, DOI 10.1128/JVI.00955-13; Chapel F, 2000, HISTOPATHOLOGY, V36, P252; Chen JN, 2011, VIRUS RES, V160, P191, DOI 10.1016/j.virusres.2011.06.011; Chen SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012745; Cheng TC, 2010, INT J ONCOL, V36, P151, DOI 10.3892/ijo_00000486; Choi MG, 2012, CANCER-AM CANCER SOC, V118, P5227, DOI 10.1002/cncr.27541; CHONG JM, 1994, CANCER RES, V54, P4595; Fukuda M, 2001, VIROLOGY, V288, P109, DOI 10.1006/viro.2001.1071; Gourzones C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-271; Hayashi K, 1996, AM J GASTROENTEROL, V91, P1481; Hong M, 2006, J CANCER RES CLIN, V132, P1, DOI 10.1007/s00432-005-0036-x; Hsu CY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003974; Ian MX, 2008, CANCER BIOL THER, V7, P1602; Kaizaki Y, 2005, J GASTROENTEROL, V40, P570, DOI 10.1007/s00535-005-1590-3; Kim DN, 2013, J GEN VIROL, V94, P497, DOI 10.1099/vir.0.045237-0; Kim do N, 2012, MOL CELL BIOCHEM, V365, P203; Kim do N, 2007, J VIROL, V81, P1033, DOI DOI 10.1128/JVI.02271-06; Kim SY, 2014, GASTROENTEROLOGY, V148, p[137, e139]; Koriyama C, 2005, J EXP CLIN CANC RES, V24, P547; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038892; Lee JY, 2014, WORLD J GASTROENTERO, V20, P1365, DOI 10.3748/wjg.v20.i5.1365; Liang QY, 2014, GASTROENTEROLOGY, V147, P1350, DOI 10.1053/j.gastro.2014.08.036; Liu XS, 2011, GASTROENT RES PRACT, DOI 10.1155/2011/182832; Lu J, 2011, VIROLOGY, V410, P64, DOI 10.1016/j.virol.2010.10.029; Moritani S, 2002, VIRCHOWS ARCH, V440, P367, DOI 10.1007/s00428-001-0566-9; Motsch N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042193; Naidoo J, 2014, BRIT J CANCER, V11, P2214; Nourse JP, 2012, J VIROL METHODS, V184, P46, DOI 10.1016/j.jviromet.2012.05.005; Park HY, 2012, J SURG ONCOL, V106, P777, DOI 10.1002/jso.23131; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Qiu J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002193; Ramakrishnan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027271; Ross Nathan, 2013, Am J Blood Res, V3, P210; Shinozaki A, 2009, HUM PATHOL, V41, P134; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Strong MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003341; Sugiura M, 1996, BRIT J CANCER, V74, P625, DOI 10.1038/bjc.1996.412; Tang WH, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-21; The Cancer Genome Atlas Research Network, 2014, NATURE, V513, P202; Tokunaga M, 1998, CANCER EPIDEM BIOMAR, V7, P449; Truong CD, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-14; Ushiku T, 2010, PATHOL INT, V60, P551, DOI 10.1111/j.1440-1827.2010.02557.x; van Beek J, 2006, AM J SURG PATHOL, V30, P59, DOI 10.1097/01.pas.0000176428.06629.1e; Wang Q, 2006, CANCER LETT, V238, P90, DOI 10.1016/j.canlet.2005.06.023; Wiech T, 2008, VIRCHOWS ARCH, V452, P621, DOI 10.1007/s00428-008-0594-9; Wong AM, 2011, CANCER, V118, P698; Yin QY, 2006, VIROLOGY, V346, P385, DOI 10.1016/j.virol.2005.11.021; Zhao JH, 2013, CANCER-AM CANCER SOC, V119, P304, DOI 10.1002/cncr.27724; Zong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086097; Zur Hausen A, 2001, GASTROENTEROLOGY, V121, P612, DOI 10.1053/gast.2001.27200	138	4	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1421	1434		10.3892/ijo.2015.2856		14	Oncology	Oncology	CC8KE	WOS:000350616400001		
J	Takano, H; Momota, Y; Kani, K; Aota, K; Yamamura, Y; Yamanoi, T; Azuma, M				Takano, Hideyuki; Momota, Yukihiro; Kani, Kouichi; Aota, Keiko; Yamamura, Yoshiko; Yamanoi, Tomoko; Azuma, Masayuki			gamma-tocotrienol prevents 5-FU-induced reactive oxygen species production in human oral keratinocytes through the stabilization of 5-FU-induced activation of Nrf2	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						oral keratinocytes; oral cancer; mucositis; reactive oxygen species; 5-FU; gamma-tocotrienol; Nrf2	NF-KAPPA-B; CANCER-CELLS; TRANSCRIPTION FACTOR; IONIZING-RADIATION; ENDOTHELIAL DAMAGE; MAMMALIAN-CELLS; NECK-CANCER; MUCOSITIS; HEAD; CHEMOTHERAPY	Chemotherapy-induced oral mucositis is a common adverse event in patients with oral squamous cell carcinoma, and is initiated through a variety of mechanisms, including the generation of reactive oxygen species (ROS). In this study, we examined the preventive effect of gamma-tocotrienol on the 5-FU-induced ROS production in human oral keratinocytes (RT7). We treated RT7 cells with 5-FU and gamma-tocotrienol at concentrations of 10 mu g/ml and 10 nM, respectively. When cells were treated with 5-FU alone, significant growth inhibition was observed as compared to untreated cells. This inhibition was, in part, due to the ROS generated by 5-FU treatment, because N-acetyl cysteine (NAC), a ROS scavenger, significantly ameliorated the growth of RT7 cells. gamma-tocotrienol showed no cytotoxic effect on the growth of RT7 cells. Simultaneous treatment of cells with these agents resulted in the significant recovery of cell growth, owing to the suppression of ROS generation by gamma-tocotrienol. Whereas 5-FU stimulated the expression of NF-E2-related factor 2 (Nrf2) protein in the nucleus up to 12 h after treatment of RT7 cells, gamma-tocotrienol had no obvious effect on the expression of nuclear Nrf2 protein. Of note, the combined treatment with both agents stabilized the 5-FU-induced nuclear Nrf2 protein expression until 24 h after treatment. In addition, expression of Nrf2-dependent antioxidant genes, such as heme oxygenase-1 (HO-1) and NAD(P)H:quinone oxidoreductase-1 (NQO-1), was significantly augmented by treatment of cells with both agents. These findings suggest that gamma-tocotrienol could prevent 5-FU-induced ROS generation by stabilizing Nrf2 activation, thereby leading to ROS detoxification and cell survival in human oral keratinocytes.	[Takano, Hideyuki; Momota, Yukihiro; Kani, Kouichi; Aota, Keiko; Yamamura, Yoshiko; Yamanoi, Tomoko; Azuma, Masayuki] Univ Tokushima, Inst Hlth Biosci, Dept Oral Med, Grad Fac Dent, Tokushima 7708504, Japan	Azuma, M (reprint author), Univ Tokushima, Inst Hlth Biosci, Dept Oral Med, Grad Fac Dent, 3-18-15 Kuramoto Cho, Tokushima 7708504, Japan.	azumamasayuki@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	This study was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Sonis ST, 1998, ORAL ONCOL, V34, P39, DOI 10.1016/S1368-8375(97)00053-5; Keefe DM, 2007, CANCER, V109, P820, DOI 10.1002/cncr.22484; Yates MS, 2007, MOL CANCER THER, V6, P154, DOI 10.1158/1535-7163.MCT-06-0516; Perry G, 2000, FREE RADICAL BIO MED, V28, P831, DOI 10.1016/S0891-5849(00)00158-1; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Kinhult S, 2003, ACTA ONCOL, V42, P304, DOI 10.1080/02841860310004409; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; Elting LS, 2007, INT J RADIAT ONCOL, V68, P1110, DOI 10.1016/j.ijrobp.2007.01.053; SONIS ST, 1994, CANCER RES, V54, P1135; Le QT, 2011, J CLIN ONCOL, V29, P2808, DOI 10.1200/JCO.2010.32.4095; McDonald JT, 2010, CANCER RES, V70, P8886, DOI 10.1158/0008-5472.CAN-10-0171; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Henke M, 2011, J CLIN ONCOL, V29, P2815, DOI 10.1200/JCO.2010.32.4103; BLOOMER WD, 1975, NEW ENGL J MED, V293, P80, DOI 10.1056/NEJM197507102930206; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884; Hui KF, 2013, MOL CANCER THER, V12, P747, DOI 10.1158/1535-7163.MCT-12-0811; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; Wada S, 2005, CANCER LETT, V229, P181, DOI 10.1016/j.canlet.2005.06.036; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Tamatani T, 2001, CANCER LETT, V171, P165, DOI 10.1016/S0304-3835(01)00611-5; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Jiang T, 2010, CANCER RES, V70, P5486, DOI 10.1158/0008-5472.CAN-10-0713; Fujimoto R, 2002, J JPN ORAL MUCO MEMB, V8, P1; Kani K, 2013, INT J ONCOL, V42, P75, DOI 10.3892/ijo.2012.1692; Koukourakis MI, 2002, ANTI-CANCER DRUG, V13, P181, DOI 10.1097/00001813-200203000-00001; Kuenen BC, 2003, J CLIN ONCOL, V21, P2192, DOI 10.1200/JCO.2003.08.046; LOCKHART PB, 1979, ORAL SURG ORAL MED O, V48, P21, DOI 10.1016/0030-4220(79)90230-5; Peterman A, 2001, J NATL CANC I MONOGR, V29, P45; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Sonis ST, 2000, ORAL ONCOL, V36, P373, DOI 10.1016/S1368-8375(00)00012-9; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Wada S, 2012, CURR PHARM BIOTECHNO, V13, P156	41	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1453	1460		10.3892/ijo.2015.2849		8	Oncology	Oncology	CC8KE	WOS:000350616400004		
J	Sakamoto, T; Kodani, M; Takata, M; Chikumi, H; Nakamoto, M; Nishii-Ito, S; Ueda, Y; Izumi, H; Makino, H; Touge, H; Takeda, K; Yamasaki, A; Yanai, M; Tanaka, N; Igishi, T; Shimizu, E				Sakamoto, Tomohiro; Kodani, Masahiro; Takata, Miyako; Chikumi, Hiroki; Nakamoto, Masaki; Nishii-Ito, Shizuka; Ueda, Yasuto; Izumi, Hiroki; Makino, Haruhiko; Touge, Hirokazu; Takeda, Kenichi; Yamasaki, Akira; Yanai, Masaaki; Tanaka, Natsumi; Igishi, Tadashi; Shimizu, Eiji			A novel point-of-care system for high-speed real-time polymerase chain reaction testing for epidermal growth factor receptor mutations in bronchial lavage fluids after transbronchial biopsy in patients with non-small cell lung cancer	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						ultrarapid PCR; EGFR mutation; point-of-care testing; virtual bronchoscopic navigation system; endobronchial ultrasonography using a guide sheath	VIRTUAL BRONCHOSCOPIC NAVIGATION; PERIPHERAL PULMONARY-LESIONS; GUIDE SHEATH; ENDOBRONCHIAL ULTRASONOGRAPHY; SENSITIVE DETECTION; OBSERVER AGREEMENT; RANDOMIZED-TRIAL; EGFR MUTATIONS; OPEN-LABEL; GEFITINIB	Epidermal growth factor receptor (EGFR) gene mutation testing is essential for choosing appropriate treatment options in patients with advanced non-small cell lung cancer (NSCLC). However, a time delay occurs between histological diagnosis and molecular diagnosis in clinical situations. To minimize this delay, we developed a novel point-of-care test for EGFR mutations, based on a high-speed real-time polymerase chain reaction (PCR) system designated here as ultrarapid PCR combined with highly accurate bronchoscopic sampling. We investigated whether our system for detecting EGFR mutations was valid by comparing test results with those obtained using a commercialized EGFR mutation test. We obtained small amounts of bronchial lavage fluids after transbronchial biopsies (TBBs) were performed on enrolled patients (n=168) who underwent endobronchial ultrasonography using a guide sheath (EBUS-GS). EGFR mutation analysis was performed by ultrarapid PCR immediately after EBUS-GS-TBBs were obtained (on the same day). After pathological diagnoses of NSCLC, EGFR mutation status in formalin-fixed, paraffin-embedded samples was confirmed by the PCR-invader method, and the concordance rates between the PCR methods were compared. The total diagnostic yield of EBUS-GS-TBB was 91.0%. The positive concordance rates for detecting 19del and L858R with the ultrarapid PCR and PCR-invader methods were both 100%. Negative concordance rates were 97.2 and 98.1%, respectively. We also demonstrated a dramatic effect of early erlotinib administration, based on ultrarapid PCR results, for a 52-year-old woman suffering from respiratory failure due to severe intrapulmonary metastases with poor performance status. In conclusion, ultrarapid PCR combined with EBUS-GS-TBB enabled rapid and reliable point-of-care testing for EGFR mutations.	[Sakamoto, Tomohiro; Kodani, Masahiro; Takata, Miyako; Chikumi, Hiroki; Nakamoto, Masaki; Nishii-Ito, Shizuka; Ueda, Yasuto; Izumi, Hiroki; Makino, Haruhiko; Touge, Hirokazu; Takeda, Kenichi; Yamasaki, Akira; Yanai, Masaaki; Tanaka, Natsumi; Igishi, Tadashi; Shimizu, Eiji] Tottori Univ, Div Med Oncol & Mol Respirol, Fac Med, Yonago, Tottori 6838504, Japan	Kodani, M (reprint author), Tottori Univ, Div Med Oncol & Mol Respirol, Fac Med, 36-1 Nishi Machi, Yonago, Tottori 6838504, Japan.	kodani@med.tottori-u.ac.jp					Inoue A, 2009, J CLIN ONCOL, V27, P1394, DOI 10.1200/JCO.2008.18.7658; Kurimoto N, 2004, CHEST, V126, P959, DOI 10.1378/chest.126.3.959; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Eberhardt R, 2007, AM J RESP CRIT CARE, V176, P36, DOI 10.1164/rccm.200612-1866OC; Hall JG, 2000, P NATL ACAD SCI USA, V97, P8272, DOI 10.1073/pnas.140225597; Lewandowska MA, 2013, ONCOL REP, V30, P1045, DOI 10.3892/or.2013.2579; Fujimoto T, 2010, JPN J INFECT DIS, V63, P31; Fielding DI, 2012, INTERN MED J, V42, P894, DOI 10.1111/j.1445-5994.2011.02707.x; Gildea TR, 2006, AM J RESP CRIT CARE, V174, P982, DOI 10.1164/rccm.200603-344OC; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Seijo LM, 2010, CHEST, V138, P1316, DOI [10.1378/chest.09-2708, 10.1378/chest.09.2708]; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Buttitta F, 2013, CLIN CANCER RES, V19, P691, DOI 10.1158/1078-0432.CCR-12-1958; Asano H, 2006, CLIN CANCER RES, V12, P43, DOI 10.1158/1078-0432.CCR-05-0934; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Tsai TH, 2013, LUNG CANCER, V82, P420, DOI 10.1016/j.lungcan.2013.10.005; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Sasaki H, 2005, CLIN CANCER RES, V11, P2924, DOI 10.1158/1078-0432.CCR-04-1904; Jurado J, 2013, ANN THORAC SURG, V96, P1196, DOI 10.1016/j.athoracsur.2013.05.066; Yamaguchi F, 2012, LUNG CANCER, V78, P201, DOI 10.1016/j.lungcan.2012.08.014; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Ishida T, 2011, THORAX, V66, P1072, DOI 10.1136/thx.2010.145490; Asano F, 2006, CHEST, V130, P559, DOI 10.1378/chest.130.2.559; Asahina H, 2005, CHEST, V128, P1761, DOI 10.1378/chest.128.3.1761; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Eberhardt R, 2010, J THORAC ONCOL, V5, P1559, DOI 10.1097/JTO.0b013e3181e8b308; Hoshi K, 2007, CLIN CANCER RES, V13, P4974, DOI 10.1158/1078-0432.CCR-07-0509; Naoki K, 2011, INT J CLIN ONCOL, V16, P335, DOI 10.1007/s10147-011-0187-5; Santis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025191; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; Vansteenkiste J, 2013, ANN ONCOL, V24, P89, DOI 10.1093/annonc/mdt241; Watanabe S, 2014, J THORAC ONCOL, V9, P189, DOI 10.1097/JTO.0000000000000048	37	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1473	1480		10.3892/ijo.2015.2875		8	Oncology	Oncology	CC8KE	WOS:000350616400006		
J	Umene, K; Yanokura, M; Banno, K; Irie, H; Adachi, M; Iida, M; Nakamura, K; Nogami, Y; Masuda, K; Kobayashi, Y; Tominaga, E; Aoki, D				Umene, Kiyoko; Yanokura, Megumi; Banno, Kouji; Irie, Haruko; Adachi, Masataka; Iida, Miho; Nakamura, Kanako; Nogami, Yuya; Masuda, Kenta; Kobayashi, Yusuke; Tominaga, Eiichiro; Aoki, Daisuke			Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						Aurora kinase A; endometrial cancer; chemosensitivity; paclitaxel	SQUAMOUS-CELL CARCINOMA; HUMAN PANCREATIC-CANCER; BREAST-CANCER; POOR-PROGNOSIS; AURORA-A/STK15/BTAK EXPRESSION; TUMOR-GROWTH; OVEREXPRESSION; AMPLIFICATION; SUPPRESSION; GENE	Aurora kinase A (AURKA) regulates the cell cycle checkpoint and maintains genomic integrity. AURKA is over-expressed in various malignant tumors and its upregulation induces chromosomal instability, which leads to aneuploidy and cell transformation. To investigate the role of AURKA in endometrial cancer, we evaluated the association of immunohistochemical expression of AURKA with clinicopathological factors. Furthermore, we examined the effects of AURKA inhibition by transfected siRNA in HEC-1B cells on colony-forming ability, invasion and migration capacity, and chemosensitivity. Immunohistochemical staining showed that overexpression of AURKA was significantly associated with tumor grade (P<0.05) and poor histologic differentiation (P<0.05). The recurrence rate also tended to be high in cases with overexpression of AURKA (P<0.1) and these cases also had a tendency for shorter disease-free survival (DFS) (P<0.1). AURKA inhibition in endometrial cancer cell lines significantly decreased cell growth, invasion and migration (P<0.05), and increased chemosensitivity to paclitaxel. We also evaluated the efficacy of a combination of AURKA siRNA and paclitaxel against subcutaneous tumors formed in a nude mouse. After treatment, the tumor volume shrank significantly compared to treatment with paclitaxel only (P<0.05). To our knowledge, this is the first study in endometrial carcinoma to show a correlation between overexpression of AURKA and tumor grade, histological type and sensitivity to paclitaxel. AURKA is a promising therapeutic target in endometrial cancer and the combination therapy with AURKA inhibitors and paclitaxel could be effective for endometrial cancer that is resistant to conventional treatment and has a poor prognosis.	[Umene, Kiyoko; Yanokura, Megumi; Banno, Kouji; Irie, Haruko; Adachi, Masataka; Iida, Miho; Nakamura, Kanako; Nogami, Yuya; Masuda, Kenta; Kobayashi, Yusuke; Tominaga, Eiichiro; Aoki, Daisuke] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 1608582, Japan	Banno, K (reprint author), Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	kbanno@z7.keio.jp	Adachi, Masataka/M-3477-2015	Adachi, Masataka/0000-0003-2974-8795	Keio University; Japan Society for the Promotion of Science (JSPS); Ichiro Kanehara Foundation (Tokyo, Japan); Kobayashi Foundation for Cancer Research (Tokyo, Japan); Keio University Medical Science Fund through a Research Grant for Life Sciences and Medicine;  [22390313];  [22591866];  [24791718]	This study was partially supported by a Keio University Grant-in-Aid for Encouragement of Young Medical Scientists; the Japan Society for the Promotion of Science (JSPS) through a Grant-in-Aid for Scientific Research (KAKENHI), a Grant-in-Aid for Scientific Research (B) (22390313) and (C) (22591866), as well as a Grant-in-Aid for Young Scientists (B) (24791718); the Ichiro Kanehara Foundation (Tokyo, Japan); Kobayashi Foundation for Cancer Research (Tokyo, Japan); and the Keio University Medical Science Fund through a Research Grant for Life Sciences and Medicine.	Agnese V, 2007, ANN ONCOL, V18, P47, DOI 10.1093/annonc/mdm224; Lassmann S, 2007, CLIN CANCER RES, V13, P4083, DOI 10.1158/1078-0432.CCR-06-2775; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Tanaka E, 2005, CLIN CANCER RES, V11, P1827, DOI 10.1158/1078-0432.CCR-04-1627; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Gautschi O, 2008, CLIN CANCER RES, V14, P1639, DOI 10.1158/1078-0432.CCR-07-2179; Lin Y, 2012, BRIT J CANCER, V107, P1692, DOI 10.1038/bjc.2012.450; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Hata T, 2005, CANCER RES, V65, P2899, DOI 10.1158/0008-5472.CAN-04-3981; Tanaka E, 2007, CLIN CANCER RES, V13, P1331, DOI 10.1158/1078-0432.CCR-06-1192; Sen S, 2002, J NATL CANCER I, V94, P1320; Do TV, 2014, ONCOGENE, V33, P539, DOI 10.1038/onc.2012.632; Du J, 2004, P NATL ACAD SCI USA, V101, P8975, DOI 10.1073/pnas.0308484101; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Cazales M, 2005, CELL CYCLE, V4, P1233; Li Y, 2011, MOL MED REP, V4, P739, DOI 10.3892/mmr.2011.494; Guan Z, 2007, CANCER RES, V67, P10436, DOI 10.1158/0008-5472.CAN-07-1379; Tatsuka M, 2005, ONCOGENE, V24, P1122, DOI 10.1038/sj.onc.1208293; Kurai M, 2005, HUM PATHOL, V36, P1281, DOI 10.1016/j.humpath.2005.09.014; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Landen CN, 2007, CLIN CANCER RES, V13, P4098, DOI 10.1158/1078-0432.CCR-07-0431; Li DH, 2003, CLIN CANCER RES, V9, P991; Wan XB, 2008, CARCINOGENESIS, V29, P1930, DOI 10.1093/carcin/bgn176; Cammareri P, 2010, CANCER RES, V70, P4655, DOI 10.1158/0008-5472.CAN-09-3953; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Chen SS, 2002, EMBO J, V21, P4491, DOI 10.1093/emboj/cdf409; Ferlay J, 2010, GLOBOCAN 2008 V2 0 C; Furukawa T, 2006, ONCOGENE, V25, P4831, DOI 10.1038/sj.onc.1209494; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; Goos JACM, 2013, BRIT J CANCER, V109, P2445, DOI 10.1038/bjc.2013.608; Hamada M, 2003, BRIT J HAEMATOL, V121, P439, DOI 10.1046/j.1365-2141.2003.04311.x; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Lee HH, 2008, ENDOCR-RELAT CANCER, V15, P765, DOI 10.1677/ERC-07-0213; Liu Qiyuan, 2004, Journal of Biological Chemistry, V279, P52175, DOI 10.1074/jbc.M406802200; Long M, 2012, CANCER GENE THER, V19, P271, DOI 10.1038/cgt.2011.89; Moreno-Bueno G, 2003, CANCER RES, V63, P5697; Murali R, 2014, LANCET ONCOL, V15, pE268, DOI 10.1016/S1470-2045(13)70591-6; Nishida N, 2007, CANCER BIOL THER, V6, P525; Royce ME, 2004, CANCER, V100, P12, DOI 10.1002/cncr.11879; Sakakura C, 2001, BRIT J CANCER, V84, P824, DOI 10.1054/bjoc.2000.1684; Umene K, 2013, BIOMED REP, V1, P335; Yamamoto S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-217; Yang F, 2011, MODERN PATHOL, V24, P836, DOI 10.1038/modpathol.2011.44; Yang G, 2010, CLIN CANCER RES, V16, P3171, DOI 10.1158/1078-0432.CCR-09-3171; Yang H, 2006, INT J CANCER, V119, P2304, DOI 10.1002/ijc.22154; Yen CC, 2012, ANN SURG ONCOL, V19, P3491, DOI 10.1245/s10434-012-2389-0	47	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1498	1506		10.3892/ijo.2015.2842		9	Oncology	Oncology	CC8KE	WOS:000350616400009		
J	Kuroda, K; Fukuda, T; Isogai, H; Okumura, K; Krstic-Demonacos, M; Isogai, E				Kuroda, Kengo; Fukuda, Tomokazu; Isogai, Hiroshi; Okumura, Kazuhiko; Krstic-Demonacos, Marija; Isogai, Emiko			Antimicrobial peptide FF/CAP18 induces apoptotic cell death in HCT116 colon cancer cells via changes in the metabolic profile	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						HCT116 cell line; antimicrobial peptide; apoptosis; metabolome analysis; CE-TOFMS	IONIZATION MASS-SPECTROMETRY; INNATE HOST DEFENSES; C-TERMINAL DOMAIN; CYTOCHROME-C; HUMAN CAP18; LL-37; ATP; CATHELICIDINS; ACID	Metabolic reprogramming is one of the hallmarks of cancer and can be targeted by therapeutic agents. We previously reported that cathelicidin-related or modified antimicrobial peptides, such as FF/CAP18, have antiproliferative effects on the squamous cell carcinoma cell line SAS-H1, and the colon carcinoma cell line HCT116. Although antimicrobial peptides have potential use in the development of new therapeutic strategies, their effects on the metabolism of cancer cells are poorly understood. Here, we investigated changes in the levels of metabolites in HCT116 cells caused by FF/CAP18, via capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS). Analysis of the 177 intracellular metabolites and 113 metabolites in conditioned medium that were detected by CE-TOFMS, revealed dramatic changes in the metabolic profile of HCT116 cells after treatment with FF/CAP18. The metabolic profile showed that the levels of most metabolites in the major metabolic pathways supported the rapid proliferation of cancer cells. Purine metabolism, glycolysis, and the TCA cycle, were altered in FF/CAP18-treated cells in a dose-dependent manner. Our present study provides mechanistic insights into the anticancer effects of antimicrobial peptides that show great potential as new therapies for colon cancer.	[Kuroda, Kengo; Fukuda, Tomokazu; Isogai, Emiko] Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Isogai, Hiroshi] Sapporo Med Univ, Anim Res Ctr, Sapporo, Hokkaido 0608556, Japan; [Okumura, Kazuhiko] Hlth Sci Univ Hokkaido, Dept Oral & Maxillofacial Surg, Sch Dent, Sapporo, Hokkaido 0610293, Japan; [Krstic-Demonacos, Marija] Univ Salford, Coll Sci & Technol, Sch Environm & Life Sci, Salford M5 4WT, Lancs, England	Isogai, E (reprint author), Tohoku Univ, Grad Sch Agr Sci, Aoba Ku, 1-1 Amamiyama, Sendai, Miyagi 9818555, Japan.	emiko@bios.tohoku.ac.jp					Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Ren SX, 2012, CANCER RES, V72, P6512, DOI 10.1158/0008-5472.CAN-12-2359; Saito K, 2013, CURR OPIN PLANT BIOL, V16, P373, DOI 10.1016/j.pbi.2013.04.001; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661; Kass GEN, 1996, BIOCHEM J, V318, P749; Okumura K, 2004, CANCER LETT, V212, P185, DOI 10.1016/j.canlet.2004.04.006; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Barros LF, 2003, CELL DEATH DIFFER, V10, P687, DOI 10.1038/sj.cdd.4401236; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Gentilucci L, 2006, CURR MED CHEM, V13, P2449, DOI 10.2174/092986706777935041; Mashego MR, 2007, BIOTECHNOL LETT, V29, P1, DOI 10.1007/s10529-006-9218-0; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; [Anonymous], 2008, GLOB BURD DIS 2004 U; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu WKK, 2010, INT J CANCER, V127, P1741, DOI 10.1002/ijc.25489; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179; [Anonymous], CANC STAT WORLDW; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Wu DD, 2014, CANCER LETT, V351, P13, DOI 10.1016/j.canlet.2014.05.002; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Gaspar D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00294; Isogai E, 2003, ORAL MICROBIOL IMMUN, V18, P329, DOI 10.1034/j.1399-302X.2003.00083.x; Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-109; Kuroda K, 2012, ONCOL REP, V28, P829, DOI 10.3892/or.2012.1876; Liem Minh Phan, 2014, Cancer Biology Medicine, V11, P1, DOI 10.7497/j.issn.2095-3941.2014.01.001; Ren SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063641; Zaiou M, 2002, J MOL MED-JMM, V80, P549, DOI 10.1007/s00109-002-0350-6	38	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1516	1526		10.3892/ijo.2015.2887		11	Oncology	Oncology	CC8KE	WOS:000350616400011		
J	Yanagihara, N; Kobayashi, D; Kuribayashi, K; Tanaka, M; Hasegawa, T; Watanabe, N				Yanagihara, Nozomi; Kobayashi, Daisuke; Kuribayashi, Kageaki; Tanaka, Maki; Hasegawa, Tadashi; Watanabe, Naoki			Significance of SALL4 as a drug-resistant factor in lung cancer	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						SALL4; measurement; lung cancer; drug resistance; recurrence; prediction	EMBRYONIC STEM-CELLS; OKIHIRO-SYNDROME; SELF-RENEWAL; LEUKEMIC-CELLS; MURINE HOMOLOG; GENE; PROLIFERATION; EXPRESSION; ONCOGENE; OVEREXPRESSION	We examined first evidence for the significance of SALL4, a transcription factor essential for embryonic development and the self-renewal of embryonic stem (ES) cells, as a natural resistance factor against anticancer drugs in lung cancer. To determine the significance of SALL4 expression in lung cancer cells, small inhibitory RNA (siRNA) against SALL4 was transduced into A549 and SBC-3 cells, resulting in increased sensitivity towards anticancer drugs [cisplatin (CDDP), carboplatin (CBDCA), and paclitaxel (PTX)]. SALL4 cancer tissues from 31 lung cancer patients were used to assess clinical significance. The analysis showed differences in SALL4 expression corresponding to the therapeutic outcomes. SALL4 expression measured before adjuvant chemotherapy was significantly higher in the patients showing recurrence of cancer than in the disease-free patients. In addition, the period until recurrence was shorter in the patients showing high SALL4 expression. These results indicate that SALL4 overexpression acts as a natural resistance factor and may be involved in the recurrence of lung cancer after adjuvant chemotherapy.	[Yanagihara, Nozomi; Kobayashi, Daisuke; Kuribayashi, Kageaki; Tanaka, Maki; Watanabe, Naoki] Sapporo Med Univ, Dept Clin Lab Med, Sch Med, Sapporo, Hokkaido 0608543, Japan; [Hasegawa, Tadashi] Sapporo Med Univ, Dept Surg Pathol, Sch Med, Sapporo, Hokkaido 0608543, Japan	Watanabe, N (reprint author), Sapporo Med Univ, Dept Clin Lab Med, Sch Med, Chuo Ku, South-1,West-16, Sapporo, Hokkaido 0608543, Japan.	watanabn@sapmed.ac.jp			Japan Society for the Promotion of Science (Tokyo, Japan)	This study was supported by the grants from Japan Society for the Promotion of Science (Tokyo, Japan).	Abou el Hassan MAI, 2004, BRIT J CANCER, V91, P171, DOI 10.1038/sj.bjc.6601910; Song LX, 2011, MOL CANCER THER, V10, P481, DOI 10.1158/1535-7163.MCT-10-0502; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Dimri GP, 2002, CANCER RES, V62, P4736; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1172482; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yi H, 2012, INT J ONCOL, V41, P310, DOI 10.3892/ijo.2012.1447; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Kobayashi D, 2011, INT J ONCOL, V38, P933, DOI 10.3892/ijo.2011.929; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Kobayashi D, 2011, ONCOL REP, V26, P965, DOI 10.3892/or.2011.1374; Bard JD, 2009, FASEB J, V23, P1405, DOI 10.1096/fj.08-117721; Cui W, 2006, MODERN PATHOL, V19, P1585, DOI 10.1038/modpathol.3800694; Jeong HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018372; JURGENS G, 1988, EMBO J, V7, P189; Kohlhase J, 2002, CYTOGENET GENOME RES, V98, P274, DOI 10.1159/000071048; Liu L, 2006, ONCOGENE, V25, P4370, DOI 10.1038/sj.onc.1209454; Yasuda S, 2006, GENES CELLS, V11, P1115, DOI 10.1111/j.1365-2443.2006.01000.x	26	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1527	1534		10.3892/ijo.2015.2866		8	Oncology	Oncology	CC8KE	WOS:000350616400012		
J	Noda, T; Kikugawa, T; Tanji, N; Miura, N; Asai, S; Higashiyama, S; Yokoyama, M				Noda, Terutaka; Kikugawa, Tadahiko; Tanji, Nozomu; Miura, Noriyoshi; Asai, Seiji; Higashiyama, Shigeki; Yokoyama, Masayoshi			Long-term exposure to leptin enhances the growth of prostate cancer cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						obesity; prostate cancer; leptin; FOXO1; signaling pathway	FORKHEAD TRANSCRIPTION FACTOR; SERUM LEPTIN; RECEPTOR; OBESITY; FOXO1; PROLIFERATION; PROGRESSION; ACTIVATION; EXPRESSION; APOPTOSIS	Obesity correlates with an increased risk of developing prostate cancer (PCa) and leptin plays an important role in PCa progression. Since leptin is produced by adipocytes, the serum leptin level is higher in obese than in non-obese individuals. However, the effects of leptin remain controversial and unclear. The aim of the present study was to investigate the effect of leptin on PCa cell aggressiveness. Three human PCa cell lines (LNCaP, DU145 and PC-3) were treated with recombinant leptin for 28 days. Cell proliferation, migration, and invasion were estimated using the WST assay, a wound-healing assay, and a BD Matrigel invasion assay, respectively. The mechanism underlying the proliferative effect of leptin was investigated by cell transfections with small interfering RNA (siRNA) against the leptin receptor (ObR) or forkhead box O1 (FOXO1), and by immunocytochemistry. Long-term exposure of PCa cells to leptin enhanced their proliferation, migration and invasion. Leptin increased ObR expression and enhanced Akt phosphorylation constitutively. Leptin also increased the phosphorylation of FOXO1 via PI3K signaling and FOXO1 gene silencing enhanced PCa cell proliferation. Leptin induced the translocation of FOXO1 from the nucleus to the cytoplasm. Furthermore, the PI3K inhibitor, LY294002 suppressed this translocation. These results suggested that leptin regulated the subcellular localization of FOXO1 and induced Akt phosphorylation. Additionally, we revealed that leptin increased the expression of cyclin D1 and decreased the expression of p21 protein. In conclusion, long-term exposure to leptin increased the cell proliferation, migration, and invasion of PCa cells through inactivation of FOXO1. This inactivation resulted from exclusion of FOXO1 from the nucleus and its restriction to the cytoplasm through PI3K/Akt signaling. Our findings contribute to an understanding of the association between obesity and PCa aggressiveness.	[Noda, Terutaka; Kikugawa, Tadahiko; Tanji, Nozomu; Miura, Noriyoshi; Asai, Seiji; Yokoyama, Masayoshi] Ehime Univ, Grad Sch Med, Proteomed Res Ctr, Dept Urol, Toon, Ehime 7910295, Japan; [Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Proteomed Res Ctr, Dept Biochem & Mol Genet, Toon, Ehime 7910295, Japan; [Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Proteomed Res Ctr, Dept Cell Growth & Tumor Regulat, Toon, Ehime 7910295, Japan	Noda, T (reprint author), Ehime Univ, Grad Sch Med, Dept Urol, Toon, Ehime 7910295, Japan.	notel3164@yahoo.ca.jp					Andersson SO, 1997, JNCI-J NATL CANCER I, V89, P385, DOI 10.1093/jnci/89.5.385; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Howard JM, 2010, BRIT J SURG, V97, P1020, DOI 10.1002/bjs.7072; Berry E, 2009, GYNECOL ONCOL, V112, P331, DOI 10.1016/j.ygyno.2008.10.017; Onuma M, 2003, J BIOL CHEM, V278, P42660, DOI 10.1074/jbc.M304984200; Hardwick JCH, 2001, GASTROENTEROLOGY, V121, P79, DOI 10.1053/gast.2001.25490; Garofalo C, 2006, CLIN CANCER RES, V12, P1447, DOI 10.1158/1078-0432.CCR-05-1913; Somasundar P, 2003, J SURG RES, V113, P50, DOI 10.1016/S0022-4804(03)00166-5; Somasundar P, 2004, J SURG RES, V118, P71, DOI 10.1016/j.jss.2004.01.017; Wen Q, 2011, NEUROSCI LETT, V498, P31, DOI 10.1016/j.neulet.2011.04.055; Li R, 2007, HUM PATHOL, V38, P1501, DOI 10.1016/j.humpath.2007.02.016; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Kim JH, 2008, ASIAN J ANDROL, V10, P923, DOI 10.1111/j.1745-7262.2008.00438.x; Hoda MR, 2008, BJU INT, V102, P383, DOI 10.1111/j.1464-410X.2008.07534.x; Liuzzi A, 1999, INT J OBESITY, V23, P1066, DOI 10.1038/sj.ijo.0801036; Chang S, 2001, PROSTATE, V46, P62; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Deo DD, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/163902; Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Mistry AM, 1997, J NUTR, V127, P2065; Giovannucci E, 2003, J NATL CANCER I, V95, P1240, DOI 10.1093/jnci/djg009; Lee SH, 2014, INT J ONCOL, V44, P905, DOI 10.3892/ijo.2014.2257; Bray GA, 2002, J NUTR, V132, p3451S; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; Freedland SJ, 2005, CLIN CANCER RES, V11, P6763, DOI 10.1158/1078-0432.CCR-05-1305; Hoda MR, 2007, BRIT J SURG, V94, P346, DOI 10.1002/bjs.5530; Ishikawa M, 2006, WORLD J GASTROENTERO, V12, P5517; Japanese Ministry of Health, RES KOK KENK EIYOU C; Kaneko G, 2013, UROLOGY, V82, P1304, DOI 10.1016/j.urology.2013.04.077; Liu P, 2008, CANCER RES, V68, P10290, DOI 10.1158/0008-5472.CAN-08-2038; Miller R, 2014, INT J OBESITY, V38, P397, DOI 10.1038/ijo.2013.126; Park Sung-Hoon, 2013, Lab Anim Res, V29, P39, DOI 10.5625/lar.2013.29.1.39; Riolfi M, 2010, BRAIN PATHOL, V20, P481, DOI 10.1111/j.1750-3639.2009.00323.x; Schuurman AG, 2000, AM J EPIDEMIOL, V151, P541; Bilbao PS, 2013, BBA-GEN SUBJECTS, V1830, P4456, DOI 10.1016/j.bbagen.2013.05.034; Tewari R, 2013, CYTOKINE, V63, P130, DOI 10.1016/j.cyto.2013.04.008; Utada M, 2010, ASIAN PAC J CANCER P, V11, P1235; WANG Y, 1995, J NATL CANCER I, V87, P1456, DOI 10.1093/jnci/87.19.1456; Wu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045825; Zhang HT, 2010, PROSTATE, V70, P1265, DOI 10.1002/pros.21162	42	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1535	1542		10.3892/ijo.2015.2845		8	Oncology	Oncology	CC8KE	WOS:000350616400013		
J	Iwasaki, T; Tanaka, K; Kawano, M; Itonaga, I; Tsumura, H				Iwasaki, Tatsuya; Tanaka, Kazuhiro; Kawano, Masanori; Itonaga, Ichiro; Tsumura, Hiroshi			Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						let-7a; E2F2; cell cycle; apoptosis; osteosarcoma	DOWN-REGULATION; BREAST-CANCER; LUNG CANCERS; EXPRESSION; FAMILY; GENES; TRANSFORMATION; TUMORIGENESIS; PROGRESSION; RESISTANCE	MicroRNAs (miRNAs) regulate cell proliferation and differentiation by silencing gene expression at the post-transcriptional level; moreover, by binding to the complementary sequences within mRNAs in cancer cells, these small non-coding RNA molecules can function as tumor suppressors or oncogenes. Recently, the dysregulation of miRNA expression has been found to be associated with increased tumorigenicity and poor prognosis in several cancer types, including osteosarcoma (OS). To identify potential oncogenic factors in OS, we analyzed changes in the expression profile of miRNAs and its downstream mRNAs in five OS cell lines and human mesenchymal stem cells (hMSCs) by a micro-array-based approach. The expression of an miRNA-let-7a was significantly downregulated and E2F2 was significantly upregulated in all tested OS cells compared with hMSCs. When let-7a was transfected into OS cell lines, the expression of E2F2 in the cells was greatly suppressed, suggesting that E2F2 is a target of miRNA-let-7a in OS cells. The transfection of let-7a further inhibited cell cycle progression and proliferation of OS cells. In addition, let-7a overexpression in OS cells significantly suppressed the tumor growth in vivo. The present study demonstrates the novel mechanism that regulates E2F2 expression via miRNA-let-7a in OS cells. Because E2F2 is pivotal in promoting cell growth through the regulation of several genes, our results might facilitate the development of new therapeutic targets for the treatment of OS.	[Iwasaki, Tatsuya; Tanaka, Kazuhiro; Kawano, Masanori; Itonaga, Ichiro; Tsumura, Hiroshi] Oita Univ, Dept Orthopaed Surg, Fac Med, Oita 8795593, Japan	Tanaka, K (reprint author), Oita Univ, Dept Orthopaed Surg, Fac Med, Oita 8795593, Japan.	ktanaka@oita-u.ac.jp			National Cancer Center Research and Development Fund [26-A-4]; Health and Labour Sciences Research Expenses from the Ministry of Health, Labour and Welfare [H26-084]; Japan Society for the Promotion of Science [24592250]	We thank Katsuhiro Hanada and Takashi Kobayashi for their helpful discussions during the present study. This study was supported in part by National Cancer Center Research and Development Fund (26-A-4), the Health and Labour Sciences Research Expenses (H26-084) from the Ministry of Health, Labour and Welfare, and the Grants-in-Aid for Scientific Research (no. 24592250) from Japan Society for the Promotion of Science.	Lin PC, 2013, CANCER RES, V73, P1232, DOI 10.1158/0008-5472.CAN-12-2968; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Yang QY, 2011, CARCINOGENESIS, V32, P713, DOI 10.1093/carcin/bgr035; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Ottaviani G, 2009, CANC TREAT, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Nelson KM, 2008, MOL CANCER THER, V7, P3655, DOI 10.1158/1535-7163.MCT-08-0586; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Fujiwara K, 2011, CANCER RES, V71, P1924, DOI 10.1158/0008-5472.CAN-10-2386; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Acunzo M, 2012, ONCOGENE, V31, P634, DOI 10.1038/onc.2011.260; Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen CX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000912; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Hu XW, 2013, MOL CANCER RES, V11, P240, DOI 10.1158/1541-7786.MCR-12-0432; Marulanda German A, 2008, Cancer Control, V15, P13; Nguyen-Vu T, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3443; Okamoto OK, 2007, BBA-GENE STRUCT EXPR, V1769, P437, DOI 10.1016/j.bbaexp.2007.05.002; Ruvkun G, 2006, SCIENCE, V311, P36; Sharma N, 2006, J BIOL CHEM, V281, P36124, DOI 10.1074/jbc.M604152200; Wong Jeffrey V, 2011, Cell Cycle, V10, P3086	33	0	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1543	1550		10.3892/ijo.2015.2867		8	Oncology	Oncology	CC8KE	WOS:000350616400014		
J	Ying, J; Tsujii, M; Kondo, J; Hayashi, Y; Kato, M; Akasaka, T; Inoue, T; Shiraishi, E; Inoue, T; Hiyama, S; Tsujii, Y; Maekawa, A; Kawai, S; Fujinaga, T; Araki, M; Shinzaki, S; Watabe, K; Nishida, T; Iijima, H; Takehara, T				Ying, Jin; Tsujii, Masahiko; Kondo, Jumpei; Hayashi, Yoshito; Kato, Motohiko; Akasaka, Tomofumi; Inoue, Takuta; Shiraishi, Eri; Inoue, Tahahiro; Hiyama, Satoshi; Tsujii, Yoshiki; Maekawa, Akira; Kawai, Shoichiro; Fujinaga, Tetsuji; Araki, Maekawa; Shinzaki, Shinichiro; Watabe, Kenji; Nishida, Tsutomu; Iijima, Hideki; Takehara, Tetsuo			The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						IL-6; STAT3; Notch 3; cancer stem cells; colon cancer	SERUM INTERLEUKIN-6 LEVELS; HUMAN COLORECTAL-CARCINOMA; STAT3 SIGNALING PATHWAY; SERINE PHOSPHORYLATION; INITIATING CELLS; IN-VIVO; CONSTITUTIVE ACTIVATION; NEGATIVE REGULATION; BREAST-CARCINOMA; BRAIN-TUMORS	Recent studies have demonstrated that cancer stem cells (CSCs) can initiate and sustain tumor growth and exhibit resistance to clinical cytotoxic therapies. Therefore, CSCs represent the main target of anticancer therapy. Interleukin-6 (IL-6) promotes cellular proliferation and drug resistance in colorectal cancer, and its serum levels correlate with patient survival. Therefore, IL-6 and its downstream signaling molecule the signal transducer and activator of transcription-3 (STAT3) represent potential molecular targets. In the present study, we investigated the effects of IL-6 and its downstream signaling components on stem cell biology, particularly the chemoresistance of CSCs, to explore potential molecular targets for cancer therapy. The colon cancer cell line WiDr was cultured in serum-free, non-adherent, and three-dimensional spheroid-forming conditions to enrich the stem cell-like population. Spheroid-forming cells slowly proliferated and expressed high levels of Oct-4, Klf4, Bmi-1, Lgr5, IL-6, and Notch 3 compared with adherent cells. Treatment with an antihuman IL-6 receptor monoclonal antibody reduced spheroid formation, stem cell-related gene expression, and 5-fluorouracil (5-FU) resistance. In addition, IL-6 treatment enhanced the levels of p-STAT3 (Tyr705), the expression of Oct-4, Klf4, Lgr5, and Notch 3, and chemoresistance to 5-FU. siRNA targeting Notch 3 suppressed spheroid formation, Oct-4 and Lgr5 expression, and 5-FU chemoresistance, whereas STAT3 inhibition enhanced Oct-4, Klf4, Lgr5, and Notch 3 expression and 5-FU chemoresistance along with reduced spheroid growth. Taken together, these results indicate that IL-6 functions in dichotomous pathways involving Notch 3 induction and STAT3 activation. The former pathway is involved in cancer stem-like cell biology and enhanced chemoresistance, and the latter pathway leads to accelerated proliferation and reduced chemoresistance. Thus, an anti-human IL-6 receptor monoclonal antibody or Notch 3 inhibition may be superior to STAT3 inhibition for CSC-targeting therapies concomitant with anticancer drugs.	[Ying, Jin; Tsujii, Masahiko; Kondo, Jumpei; Hayashi, Yoshito; Kato, Motohiko; Akasaka, Tomofumi; Inoue, Takuta; Shiraishi, Eri; Inoue, Tahahiro; Hiyama, Satoshi; Tsujii, Yoshiki; Maekawa, Akira; Kawai, Shoichiro; Fujinaga, Tetsuji; Araki, Maekawa; Shinzaki, Shinichiro; Watabe, Kenji; Nishida, Tsutomu; Iijima, Hideki; Takehara, Tetsuo] Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Suita, Osaka 5650871, Japan	Takehara, T (reprint author), Osaka Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Suita, Osaka 5650871, Japan.	takehara@gh.med.osaka-u.ac.jp		Nishida, Tsutomu/0000-0003-4037-9003			Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Corvinus FM, 2005, NEOPLASIA, V7, P545, DOI 10.1593/neo.04571; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Hsu CP, 2006, ANTICANCER RES, V26, P4607; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Christgen M, 2007, MOL CELL BIOCHEM, V306, P201, DOI 10.1007/s11010-007-9570-y; Rajan P, 1998, J NEUROSCI, V18, P3620; BRUCE WR, 1963, NATURE, V199, P79, DOI 10.1038/199079a0; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Lichtenauer UD, 2013, HORM METAB RES, V45, P124, DOI 10.1055/s-0032-1323810; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Singh SK, 2003, CANCER RES, V63, P5821; WILLSON JKV, 1987, CANCER RES, V47, P2704; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Farnie G, 2007, J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; de la Iglesia N, 2009, CURR MOL MED, V9, P580; Zhang HL, 2011, BIOCHEM BIOPH RES CO, V404, P273, DOI 10.1016/j.bbrc.2010.11.106; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; Yi H, 2012, KOREAN J PHYSIOL PHA, V16, P11, DOI 10.4196/kjpp.2012.16.1.11; Lin L, 2011, BIOCHEM BIOPH RES CO, V416, P246, DOI 10.1016/j.bbrc.2011.10.112; Ashizawa T, 2013, INT J ONCOL, V43, P219, DOI 10.3892/ijo.2013.1916; Ma XT, 2004, WORLD J GASTROENTERO, V10, P1569; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; BURGER RA, 1995, J INTERF CYTOK RES, V15, P255, DOI 10.1089/jir.1995.15.255; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yoshimatsu T, 2006, DEVELOPMENT, V133, P2553, DOI 10.1242/dev.02419; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Luo YQ, 2010, J NEUROCHEM, V115, P1337, DOI 10.1111/j.1471-4159.2010.06780.x; Scheller J, 2006, MED MICROBIOL IMMUN, V195, P173, DOI 10.1007/s00430-006-0019-9; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Ohata H, 2012, CANCER RES, V72, P5101, DOI 10.1158/0008-5472.CAN-11-3812; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lin Q, 2005, AM J PATHOL, V167, P969, DOI 10.1016/S0002-9440(10)61187-X; Nagao M, 2007, MOL CELL BIOL, V27, P3982, DOI 10.1128/MCB.00170-07; Kim SY, 2013, CELL SIGNAL, V25, P961, DOI 10.1016/j.cellsig.2013.01.007; Song XD, 2012, TOXICOL MECH METHOD, V22, P679, DOI 10.3109/15376516.2012.717119; Zhang YG, 2001, J BIOL CHEM, V276, P42534, DOI 10.1074/jbc.M106044200; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Wen KM, 2013, CANCER LETT, V333, P56, DOI 10.1016/j.canlet.2013.01.009; Conze D, 2001, CANCER RES, V61, P8851; Knupfer H, 2010, INT J COLORECTAL DIS, V25, P135, DOI 10.1007/s00384-009-0818-8; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Fang DD, 2010, BRIT J CANCER, V102, P1265, DOI 10.1038/sj.bjc.6605610; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Reedijk M, 2008, INT J ONCOL, V33, P1223, DOI 10.3892/ijo_00000112; Bao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050165; Ceresa BP, 1997, ENDOCRINOLOGY, V138, P4131, DOI 10.1210/en.138.10.4131; Ceresa BP, 1996, J BIOL CHEM, V271, P12121; Cheng XA, 2011, NEUROSCI LETT, V493, P18, DOI 10.1016/j.neulet.2011.02.006; Choi B, 2012, AM J PATHOL, V180, P351, DOI 10.1016/j.ajpath.2011.09.030; Coppo P, 2003, ONCOGENE, V22, P4102, DOI 10.1038/sj.onc.1206607; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Fan XL, 2011, INT J COLORECTAL DIS, V26, P1279, DOI 10.1007/s00384-011-1248-y; Fisman EZ, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-62; Gabriel E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044912; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Garzia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004998; Han B., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P31, DOI 10.2174/1568011043482205; Koontongkaew S, 2009, CELL BIOL INT, V33, P165, DOI 10.1016/j.cellbi.2008.10.009; Kwak YD, 2010, NEUROTOX RES, V18, P328, DOI 10.1007/s12640-010-9170-6; Leng ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056082; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Lopez J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-48; Luo M, 2012, LIFE SCI, V90, P509, DOI 10.1016/j.lfs.2012.01.005; Olszewski WL, 2007, SURGERY, V141, P212, DOI 10.1016/j.surg.2006.06.031; Peng H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019439; Sukach A N, 2007, Tsitologiia, V49, P916; Wu CW, 1996, AM J GASTROENTEROL, V91, P1417	79	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1551	1559		10.3892/ijo.2015.2851		9	Oncology	Oncology	CC8KE	WOS:000350616400015		
J	Ishikura, N; Kawata, H; Nishimoto, A; Nakamura, R; Tsunenari, T; Watanabe, M; Tachibana, K; Shiraishi, T; Yoshino, H; Honma, A; Emura, T; Ohta, M; Nakagawa, T; Houjo, T; Corey, E; Vessella, RL; Aoki, Y; Sato, H				Ishikura, Nobuyuki; Kawata, Hiromitsu; Nishimoto, Ayako; Nakamura, Ryo; Tsunenari, Toshiaki; Watanabe, Miho; Tachibana, Kazutaka; Shiraishi, Takuya; Yoshino, Hitoshi; Honma, Akie; Emura, Takashi; Ohta, Masateru; Nakagawa, Toshito; Houjo, Takao; Corey, Eva; Vessella, Robert L.; Aoki, Yuko; Sato, Haruhiko			CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						CH5137291; castration-resistant prostate cancer; androgen receptor pure antagonist; nuclear translocation; helix 12	BREAST-CANCER; PURE ANTAGONIST; DOUBLE-BLIND; POSTMENOPAUSAL WOMEN; ABIRATERONE ACETATE; THERAPY; BICALUTAMIDE; ANTIANDROGEN; PROGRESSION; ACTIVATION	Resistance of prostate cancer to castration is currently an unavoidable problem. The major mechanisms underlying such resistance are androgen receptor (AR) overexpression, androgen-independent activation of AR, and AR mutation. To address this problem, we developed an AR pure antagonist, CH5137291, with AR nuclear translocation-inhibiting activity, and compared its activity and characteristics with that of bicalutamide. Cell lines corresponding to the mechanisms of castration resistance were used: LNCaP-BC2 having AR overexpression and LNCaP-CSIO having androgen-independent AR activation. VCaP and LNCaP were used as hormone-sensitive prostate cancer cells. In vitro functional assay clearly showed that CH5137291 inhibited the nuclear translocation of wild-type ARs as well as W741C- and T877A-mutant ARs. In addition, it acted as a pure antagonist on the transcriptional activity of these types of ARs. In contrast, bicalutamide did not inhibit the nuclear translocation of these ARs, and showed a partial/full agonistic effect on the transcriptional activity. CH5137291 inhibited cell growth more strongly than bicalutamide in VCaP and LNCaP cells as well as in LNCaP-BC2 and LNCaP-CSIO cells in vitro. In xenograft models, CH5137291 strongly inhibited the tumor growth of LNCaP, LNCaP-BC2, and LNCaP-CSIO, whereas bicalutamide showed a weaker effect in LNCaP and almost no effect in LNCaP-BC2 and LNCaP-CSIO xenografts. Levels of prostate-specific antigen (PSA) in plasma correlated well with the antitumor effect of both agents. CH5137291 inhibited the growth of LNCaP tumors that had become resistant to bicalutamide treatment. A docking model suggested that CH5137291 intensively collided with the M895 residue of helix 12, and therefore strongly inhibited the folding of helix 12, a cause of AR agonist activity, in wild-type and W741C-mutant ARs. In cynomolgus monkeys, the serum concentration of CH5137291 increased dose-dependently and PSA level decreased 80% at 100 mg/kg. CH5137291 is expected to offer a novel therapeutic approach against major types of castration-resistant prostate cancers.	[Ishikura, Nobuyuki; Kawata, Hiromitsu; Nishimoto, Ayako; Tsunenari, Toshiaki; Watanabe, Miho; Tachibana, Kazutaka; Shiraishi, Takuya; Yoshino, Hitoshi; Honma, Akie; Emura, Takashi; Ohta, Masateru; Nakagawa, Toshito; Aoki, Yuko; Sato, Haruhiko] Chugai Pharmaceut Co Ltd, Div Res, Kamakura, Kanagawa 2478530, Japan; [Nakamura, Ryo; Houjo, Takao] Chugai Res Inst Med Sci Inc, Kamakura, Kanagawa 2478530, Japan; [Corey, Eva; Vessella, Robert L.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Vessella, Robert L.] Puget Sound VA Hlth Care Syst, Res Career Scientist, Seattle, WA 98195 USA	Ishikura, N (reprint author), Chugai Pharmaceut Co Ltd, Div Res, 200 Kajiwara, Kamakura, Kanagawa 2478530, Japan.	ishikuranby@chugai-pharm.co.jp			Chugai Pharmaceutical Co., Ltd., Kanagawa, Japan	The authors thank Dr Kentaro Furumoto for his technical advice; Dr Yoichiro Moriya for his help in manuscript preparation; and Mr. Hitoshi Arakawa, Mr. Toshio Hani, Mr. Ko Saito, Ms. Hiroko Igarashi, Ms. Yuka Sugiura and Ms. Ayako Takahashi for their excellent technical assistance. Funding assistance for this study was received from Chugai Pharmaceutical Co., Ltd., Kanagawa, Japan.	Shi XB, 2002, CANCER RES, V62, P1496; Ueda T, 2002, J BIOL CHEM, V277, P38087, DOI 10.1074/jbc.M203313200; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; O'Donnell A, 2004, BRIT J CANCER, V90, P2317, DOI 10.1038/sj.bjc.6601879; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Corey E, 2003, PROSTATE, V55, P239, DOI 10.1002/pros.10198; Qiu D, 2009, INT J CANCER, V124, P443, DOI 10.1002/ijc.23911; Fizazi K, 2012, LANCET ONCOL, V13, P983, DOI 10.1016/S1470-2045(12)70379-0; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Bosetti C, 2008, ANN ONCOL, V19, P631, DOI 10.1093/annonc/mdm597; Gregory CW, 2001, CANCER RES, V61, P4315; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Gregory CW, 2005, CLIN CANCER RES, V11, P1704, DOI 10.1158/1078-0432.CCR-04-1158; Hara T, 2003, CANCER RES, V63, P149; Linja MJ, 2001, CANCER RES, V61, P3550; Howell A, 2002, J CLIN ONCOL, V20, P3396, DOI 10.1200/JCO.2002.10.057; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; OSBORNE CK, 1995, J NATL CANCER I, V87, P746, DOI 10.1093/jnci/87.10.746; Kawata H, 2010, PROSTATE, V70, P745, DOI 10.1002/pros.21107; Debes JD, 2002, CANCER RES, V62, P5632; Osborne CK, 2002, J CLIN ONCOL, V20, P3386, DOI 10.1200/JCO.2002.10.058; Hoffmann J, 2004, J NATL CANCER I, V96, P210, DOI 10.1093/jnci/djh022; Ishikura N, 2010, PROSTATE, V70, P457, DOI 10.1002/pros.21079; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; Yoshida T, 2005, CANCER RES, V65, P9611, DOI 10.1158/0008-5472.CAN-05-0817; Culig Z, 2005, J CELL BIOCHEM, V95, P497, DOI 10.1002/jcb.20477; CULIG Z, 1994, CANCER RES, V54, P5474; Zhao XY, 2000, NAT MED, V6, P703; Pienta KJ, 2006, CLIN CANCER RES, V12, P1665, DOI 10.1158/1078-0432.CCR-06-0067; Joffe HV, 2005, HEART FAIL REV, V10, P31, DOI 10.1007/s10741-005-2346-0; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Arai Y, 2008, J CANCER RES CLIN, V134, P1385, DOI 10.1007/s00432-008-0409-z; Hara T, 2003, CANCER RES, V63, P5622; Kawata H, 2011, PROSTATE, V71, P1344, DOI 10.1002/pros.21351; Longui CA, 2007, J PEDIAT, V83, pS163, DOI 10.2223/JPED.1713; Matsuda T, 2008, JPN J CLIN ONCOL, V38, P641, DOI 10.1093/jjco/hyn074; Ponguta LA, 2008, J BIOL CHEM, V283, P20989, DOI 10.1074/jbc.M802392200; Tachibana K, 2007, BIOORG MED CHEM LETT, V17, P5573, DOI 10.1016/j.bmcl.2007.07.090; Tachibana K, 2008, CHEM PHARM BULL, V56, P1555, DOI 10.1248/cpb.56.1555; Tachibana K, 2007, BIOORGAN MED CHEM, V15, P174, DOI 10.1016/j.bmc.2006.09.072; Taplin ME, 2003, J CLIN ONCOL, V21, P2673, DOI 10.1200/JCO.2003.11.102; Tomura A, 2001, J BIOL CHEM, V276, P28395, DOI 10.1074/jbc.M101755200; Yoshino H, 2010, BIOORGAN MED CHEM, V18, P8150, DOI 10.1016/j.bmc.2010.10.023	46	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1560	1572		10.3892/ijo.2015.2860		13	Oncology	Oncology	CC8KE	WOS:000350616400016		
J	Takaya, A; Peng, WX; Ishino, K; Kudo, M; Yamamoto, T; Wada, R; Takeshita, T; Naito, Z				Takaya, Akane; Peng, Wei-Xia; Ishino, Kousuke; Kudo, Mitsuhiro; Yamamoto, Tetsushi; Wada, Ryuichi; Takeshita, Toshiyuki; Naito, Zenya			Cystatin B as a potential diagnostic biomarker in ovarian clear cell carcinoma	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						epithelial ovarian cancer; shotgun proteomics; formalin-fixed paraffin-embedded tissue; clear cell carcinoma; cystatin B; Annexin A4	PARAFFIN-EMBEDDED TISSUES; PROTEIN EXPRESSION; PROTEOMIC ANALYSIS; HEPATOCELLULAR-CARCINOMA; SHOTGUN PROTEOMICS; COLORECTAL-CANCER; GENE-EXPRESSION; ANNEXIN-IV; ADENOCARCINOMA; IDENTIFICATION	Epithelial ovarian cancer (EOC) consists of four major subtypes: clear cell carcinoma (CCC), endometrioid adenocarcinoma (EA), mucinous adenocarcinoma (MA) and serous adenocarcinoma (SA). Relative to the other subtypes, the prognosis of CCC is poor due to a high recurrence rate and chemotherapy resistance, but CCC-specific biomarkers have yet to be identified. With the aim of identifying diagnostic and treatment biomarkers for CCC, we analyzed 96 cases of EOC (32 CCC, 13 EA, 19 MA, 32 SA) using liquid chromatography/mass spectrometry (LC/MS) followed by immunohistochemistry (IHC) and quantitative reverse transcription PCR (RT-qPCR). Semi-quantification of protein differences between subtypes showed upregulation of 150 proteins and downregulation of 30 proteins in CCC relative to the other subtypes. Based on hierarchical clustering that revealed a marked distinction in the expression levels of cystatin B (CYTB) and Annexin A4 (ANXA4) in CCC relative to the other subtypes, we focused the study on CYTB and ANXA4 expression in E0Cs by IHC, RT-qPCR and western blot analyses using tissue specimens and cultured cells. As a result, compared to the other subtypes, CCC showed significantly high expression levels of CYTB and ANXA4 in the analyses. To examine the possibility of CYTB and ANXA4 as serum diagnostic biomarkers of CCC, we checked the protein levels in conditioned media and cell lysates using culture cells. Compared with the other subtypes, CCC cell lines showed a significantly higher level of expression of CYTB in both conditioned media and cell lysates, while ANXA4 showed a higher level of expression in cell lysates only. Our results demonstrate that CYTB and ANXA4 overexpression may be related to carcinogenesis and histopathological differentiation of CCC. CYTB may be a secreted protein, and may serve as a potential serum diagnostic biomarker of CCC, while ANXA4 may be useful as an intracellular marker.	[Takaya, Akane; Peng, Wei-Xia; Ishino, Kousuke; Kudo, Mitsuhiro; Wada, Ryuichi; Naito, Zenya] Nippon Med Sch, Dept Integrated Diagnost Pathol, Tokyo 1138602, Japan; [Takaya, Akane; Takeshita, Toshiyuki] Nippon Med Sch, Grad Sch Med, Div Reprod Med Perinatol & Gynecol Oncol, Tokyo 1138603, Japan; [Yamamoto, Tetsushi] Kinki Univ, Sch Pharm, Osaka 5778502, Japan	Naito, Z (reprint author), Nippon Med Sch, Dept Integrated Diagnost Pathol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	naito@nms.ac.jp			Ministry of Education, Culture, Sport, Science, and Technology (Tokyo, Japan) (MEXT) [S1311022]	We would like to thank Mr. Takenori Fujii, Mr. Kiyoshi Teduka, Ms. Yoko Kawamoto, Ms. Kiyoko Kawahara as well as Ms. Taeko Suzuki for technical assistance (Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan). This study was supported in part by Grants-in-aid for Clinical Rebiopsy Bank Project for Comprehensive Cancer Therapy Development to Z.N. from Ministry of Education, Culture, Sport, Science, and Technology (Tokyo, Japan) (MEXT), 2013-2017 (S1311022).	Zimmermann U, 2004, CANCER LETT, V209, P111, DOI 10.1016/j.canlet.2003.12.022; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Naidoo K, 2012, J PATHOL, V226, P756, DOI 10.1002/path.3959; Kawamura T, 2010, J PROTEOMICS, V73, P1089, DOI 10.1016/j.jprot.2009.11.011; Kim A, 2009, INT J CANCER, V125, P2316, DOI 10.1002/ijc.24587; Jiang XG, 2007, J PROTEOME RES, V6, P1038, DOI 10.1021/pr0605318; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; Rivenbark AG, 2009, FRONT BIOSCI, V14, P453, DOI 10.2741/3254; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r; Feldman AS, 2009, CLIN CANCER RES, V15, P1024, DOI 10.1158/1078-0432.CCR-08-1143; Sprung RW, 2009, MOL CELL PROTEOMICS, V8, P1988, DOI 10.1074/mcp.M800518-MCP200; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; du Bois A, 2003, J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Kajihara H, 2010, ONCOL REP, V23, P1193, DOI 10.3892/or_00000750; Toyama A, 2012, CANCER SCI, V103, P747, DOI 10.1111/j.1349-7006.2012.02224.x; Tan Y, 2011, ONCOL REP, V26, P853, DOI 10.3892/or.2011.1353; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.500084-MCP200; Kos J, 1998, ONCOL REP, V5, P1349; Keppler D, 2006, CANCER LETT, V235, P159, DOI 10.1016/j.canlet.2005.04.001; Bateman NW, 2011, J PROTEOME RES, V10, P1323, DOI 10.1021/pr101073s; Bluemlein K, 2011, NAT PROTOC, V6, P859, DOI 10.1038/nprot.2011.333; Cotoi CG, 2012, ROM J MORPHOL EMBRYO, V53, P893; Gashenko EA, 2013, INT J CIRCUMPOL HEAL, V72, P309, DOI 10.3402/ijch.v72i0.21215; Hayashi M, 2010, J SHOWA MED ASS, V70, P211; Kitawaki J, 2005, HUM REPROD, V20, P1999, DOI 10.1093/humrep/deh890; Kotorashvili A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034683; Lee MJ, 2008, CLIN CANCER RES, V14, P1080, DOI 10.1158/1078-0432.CCR-07-1615; Lin LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044615; Masuishi Y, 2011, FEBS J, V278, P1470, DOI 10.1111/j.1742-4658.2011.08059.x; Mogami T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080359; Morgan TM, 2013, J UROLOGY, V189, P1097, DOI 10.1016/j.juro.2012.09.074; Nakanishi Y, 2013, ACTA HISTOCHEM CYTOC, V46, P85, DOI 10.1267/ahc.12024; Rodriguez-Rigueiro T, 2011, PROTEOMICS, V11, P2555, DOI 10.1002/pmic.201000809; Uekuri C, 2013, ONCOL LETT, V6, P1163, DOI 10.3892/ol.2013.1550; Wang JJ, 2012, ASIAN PAC J CANCER P, V13, P1663, DOI 10.7314/APJCP.2012.13.4.1663; Yamada K, 1999, Hum Cell, V12, P131; Yamamoto T, 2012, ONCOL LETT, V3, P307, DOI 10.3892/ol.2011.466; Yamamoto T, 2013, ONCOL REP, V30, P1609, DOI 10.3892/or.2013.2612; Zhu Y, 2006, PROTEOMICS, V6, P5846, DOI 10.1002/pmic.200600165	41	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1573	1581		10.3892/ijo.2015.2858		9	Oncology	Oncology	CC8KE	WOS:000350616400017		
J	Mori, N; Ishikawa, C; Senba, M				Mori, Naoki; Ishikawa, Chie; Senba, Masachika			Activation of PKC-delta in HTLV-1-infected T cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						protein kinase C-delta; adult T-cell leukemia; human T-cell leukemia virus type 1; Tax; rottlerin; nuclear factor-kappa B	NF-KAPPA-B; KINASE-C-DELTA; VIRUS TYPE-I; HTLV-I; TRANSCRIPTIONAL ACTIVATION; NUCLEAR TRANSLOCATION; MONOCLONAL-ANTIBODY; LEUKEMIA-CELLS; CANCER CELLS; TAX PROTEIN	Protein kinase C (PKC)-delta is a member of the PKC family. It has been implicated in tumor suppression as well as survival of various cancers. The aggressive malignancy of T lymphocytes known as adult T-cell leukemia (ATL) is associated with human T-cell leukemia virus type 1 (HTLV-1) infection. In this study, we show that HTLV-1-infected T cells are characterized by phosphorylation and nuclear translocation of PKC-delta. Expression of HTLV-1 regulatory protein Tax increased PKC-delta phosphorylation. Blockade of PKC-delta by rottlerin suppressed PKC-delta phosphorylation and inhibited cell viability in HTLV-1-infected T-cell lines and primary ATL cells. Rottlerin induced cell cycle arrest at the G(1) phase and caspase-mediated apoptosis of HTLV-1-infected T cells. Rottlerin downregulated the expression of proteins involved in G(1)/S cell cycle transition, cyclin D2, CDK4 and 6, and c-Myc, resulting in dephosphorylation of retinoblastoma protein (pRb). Furthermore, rottlerin reduced the expression of important anti-apoptotic proteins (e.g., survivin, XIAP, Bcl-x(L) and c-FLIP) and Bcl-2 phosphorylation, and activated the pro-apoptotic protein Bax. Our results showed that permanent activation of nuclear factor-kappa B (NF-kappa B) by HTLV-1 Tax allows infected cells to escape cell cycle arrest and apoptosis and that PKC-delta mediates Tax-induced activation of NF-kappa B. Based on these findings, new therapies designed to target PKC-delta could be potentially useful in the treatment of ATL.	[Mori, Naoki] Univ Ryukyus, Grad Sch Med, Dept Microbiol & Oncol, Nishihara, Okinawa 9030215, Japan; [Ishikawa, Chie] Univ Ryukyus, Transdisciplinary Res Org Subtrop & Isl Studies, Nishihara, Okinawa 9030213, Japan; [Senba, Masachika] Nagasaki Univ, Inst Trop Med, Dept Pathol, Nagasaki 8528523, Japan	Mori, N (reprint author), Univ Ryukyus, Grad Sch Med, Dept Microbiol & Oncol, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	naokimori50@gmail.com	Ishikawa, Chie/P-8521-2015				DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Mori N, 1996, BLOOD, V87, P3410; Autret A, 2007, J VIROL, V81, P7504, DOI 10.1128/JVI.02690-06; Cheng H, 2012, PROTEIN CELL, V3, P581, DOI 10.1007/s13238-012-2047-0; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; LI WQ, 1995, J BIOL CHEM, V270, P8311; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Mori N, 1999, BLOOD, V93, P2360; Nicot C, 2000, BLOOD, V96, P275; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Krueger A, 2006, BLOOD, V107, P3933, DOI 10.1182/blood-2005-06-2567; Smolewski P, 2011, CURR MOL MED, V11, P633; Ito T, 1997, J BIOL CHEM, V272, P11671, DOI 10.1074/jbc.272.18.11671; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Basu A, 2010, THESCIENTIFICWORLDJO, V10, P2272, DOI 10.1100/tsw.2010.214; Page K, 2003, J IMMUNOL, V170, P5681; Mori N, 2002, BLOOD, V100, P1828, DOI 10.1182/blood-2002-01-0151; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Wang QD, 2003, J BIOL CHEM, V278, P51091, DOI 10.1074/jbc.M306541200; Kawakami A, 1999, BLOOD, V94, P3847; Iwanaga R, 2008, ONCOGENE, V27, P5635, DOI 10.1038/onc.2008.174; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; SUZUKI T, 1995, ONCOGENE, V10, P1199; Kannian P, 2010, VIRUSES-BASEL, V2, P2037, DOI 10.3390/v2092037; Bazarbachi B, 2004, LANCET ONCOL, V5, P664; Chen XL, 1997, J GEN VIROL, V78, P3277; Dewson G, 2003, ONCOGENE, V22, P2643, DOI 10.1038/sj.onc.1206326; DUYAO MP, 1992, J BIOL CHEM, V267, P16288; Iwanaga R, 2001, ONCOGENE, V20, P2055, DOI 10.1038/sj.onc.1204304; Kawakami H, 2005, INT J CANCER, V115, P967, DOI 10.1002/ijc.20954; Kimura Ryuichiro, 2013, Neoplasia, V15, P1110; Lindholm PF, 1996, J VIROL, V70, P2525; Lu ZG, 2009, CANCER RES, V69, P5927, DOI 10.1158/0008-5472.CAN-08-4786; Maioli E, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/742936; Matsumoto K, 1997, J VIROL, V71, P4445; Minami T, 2003, J BIOL CHEM, V278, P6976, DOI 10.1074/jbc.M208974200; Mori N, 2009, FRONT BIOSCI, V14, P1479, DOI 10.2741/3319; Ogasa M, 2003, GUT, V52, P813, DOI 10.1136/gut.52.6.813; OHTANI K, 1989, NUCLEIC ACIDS RES, V17, P1589, DOI 10.1093/nar/17.4.1589; TANAKA Y, 1990, JPN J CANCER RES, V81, P225; Torricelli C, 2008, LIFE SCI, V82, P638, DOI 10.1016/j.lfs.2007.12.020; Zhang CH, 1996, J IMMUNOL, V157, P3980	44	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1609	1618		10.3892/ijo.2015.2848		10	Oncology	Oncology	CC8KE	WOS:000350616400021		
J	Narita, M; Kanda, T; Abe, T; Uchiyama, T; Iwafuchi, M; Zheng, ZY; Liu, AC; Kaifu, T; Kosugi, S; Minagawa, M; Itoh, K; Takahashi, M				Narita, Miwako; Kanda, Tatsuo; Abe, Takashi; Uchiyama, Takayoshi; Iwafuchi, Minami; Zheng, Zhiyin; Liu, Aichun; Kaifu, Tsutomu; Kosugi, Shinichi; Minagawa, Masahiro; Itoh, Kyogo; Takahashi, Masuhiro			Immune responses in patients with esophageal cancer treated with SART1 peptide-pulsed dendritic cell vaccine	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						dendritic cells; esophageal cancer; SART1; antigen-specific CTL; exosomes; ELISPOT	PRIMARY MALIGNANT-MELANOMA; RESISTANT PROSTATE-CANCER; CLINICAL-TRIAL; SIPULEUCEL-T; PHASE-I; IMMUNOTHERAPY; EXOSOMES; VESICLES; ANTIGENS; TUMORS	Patients with advanced stage of squamous cell carcinoma of esophagus have a poor prognosis with a lethal outcome. In order to explore the feasibility and effectiveness of dendritic cell (DC)-based immunotherapy for squamous cell carcinoma of esophagus, we performed a phase I/II clinical trial of monocyte-derived dendritic cells (moDCs) pulsed with SART1 peptide in seven patients with advanced stage of this disease. Although the feasibility of this therapy was definite, the effectiveness was not clearly confirmed in advanced stage of squamous cell carcinoma of esophagus. However, in vitro study revealed that moDCs generated for this therapy possessed a potent ability of inducing SART1 peptide-specific cytotoxic T lymphocytes (CTLs). In addition, these moDCs were demonstrated to be able to produce exosomes with an antigen presenting ability for inducing SART1 peptide-specific CTLs. ELISPOT assay using cryopreserved patient's lymphocytes demonstrated that IFN-gamma ELISPOTs were increased after four times of SART1 peptide-pulsed moDC vaccinations compared with before the vaccination in a patient. The present study demonstrated that moDCs prepared from advanced stage of squamous cell carcinoma of esophagus possess a good immune function and in vivo immune responses (detected by ELISPOT assay) were evoked by the infusion of these moDCs. These findings suggest that DC-based immunotherapy could be one of the modalities applicable for squamous cell carcinoma of esophagus.	[Narita, Miwako; Uchiyama, Takayoshi; Iwafuchi, Minami; Takahashi, Masuhiro] Niigata Univ, Grad Sch Hlth Sci, Lab Hematol & Oncol, Niigata 9518518, Japan; [Kanda, Tatsuo; Kaifu, Tsutomu; Kosugi, Shinichi; Minagawa, Masahiro] Niigata Univ, Sch Med, Dept Surg, Niigata 9518520, Japan; [Abe, Takashi; Zheng, Zhiyin; Liu, Aichun] Niigata Univ, Sch Med, Dept Hematol Endocrinol & Metab, Niigata 9518520, Japan; [Itoh, Kyogo] Kurume Univ, Canc Vaccine Dev Div, Res Ctr Innovat Canc Therapy, Fukuoka 8300011, Japan	Narita, M (reprint author), Niigata Univ, Grad Sch Hlth Sci, Lab Hematol & Oncol, Chuo Ku, 2-746 Asahimachi Dori, Niigata 9518518, Japan.	naritami@clg.niigata-u.ac.jp					Thery C, 2001, J IMMUNOL, V166, P7309; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594; Shore ND, 2013, CANCER CONTROL, V20, P7; Siewert JR, 2007, SEMIN RADIAT ONCOL, V17, P38, DOI 10.1016/j.semradonc.2006.09.007; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; Berntsen A, 2008, J IMMUNOTHER, V31, P771, DOI 10.1097/CJI.0b013e3181833818; Hao SG, 2007, IMMUNOLOGY, V120, P90, DOI 10.1111/j.1365-2567.2006.02483.x; Dai S, 2008, MOL THER, V16, P782, DOI 10.1038/mt.2008.1; Ueda Y, 2007, JPN J CLIN ONCOL, V37, P140, DOI 10.1093/jjco/hyl136; Ellebaek E, 2012, CANCER IMMUNOL IMMUN, V61, P1791, DOI 10.1007/s00262-012-1242-4; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Taieb J, 2006, J IMMUNOL, V176, P2722; Trepiakas R, 2010, CYTOTHERAPY, V12, P721, DOI 10.3109/14653241003774045; Asakage M, 2005, J GASTROENTEROL, V40, P545, DOI 10.1007/s00535-004-1582-8; Escudier B., 2005, J TRANSL MED, V3, P10, DOI DOI 10.1186/1479-5876-3-10; Fujiwara S, 2012, J IMMUNOTHER, V35, P513, DOI 10.1097/CJI.0b013e3182619cb4; FURUKAWA T, 1994, LEUKEMIA, V8, P171; Kato Yoichi, 2010, Gan To Kagaku Ryoho, V37, P2240; Kikuchi M, 1999, INT J CANCER, V81, P459, DOI 10.1002/(SICI)1097-0215(19990505)81:3<459::AID-IJC21>3.0.CO;2-6; Kono K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-141; Lagergren J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6280; Milano F, 2008, HUM IMMUNOL, V69, P614, DOI 10.1016/j.humimm.2008.07.006; Morse MA, 2005, J TRANSL MED, V3, P9, DOI DOI 10.1186/1479-5876-3-9; Narita M, 2009, MED ONCOL, V26, P429, DOI 10.1007/s12032-008-9142-3; Svane IM, 2004, CANCER IMMUNOL IMMUN, V53, P633, DOI 10.1007/s00262-003-0493-5; Yamahira A, 2011, LEUKEMIA RES, V35, P793, DOI 10.1016/j.leukres.2010.12.003	27	1	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1699	1709		10.3892/ijo.2015.2846		11	Oncology	Oncology	CC8KE	WOS:000350616400031		
J	Nishimura, Y; Takiguchi, S; Ito, S; Itoh, K				Nishimura, Yukio; Takiguchi, Soichi; Ito, Shigeru; Itoh, Kazuyuki			EGF-stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib-resistant human lung cancer cell line	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						epidermal growth factor; epidermal growth factor receptor; serine/threonine kinase AKT; sorting nexin 1; endocytosis; EGFR recycling; MET; endosomes/lysosomes; gefitinib; non-small cell lung cancer	EPIDERMAL-GROWTH-FACTOR; PROTEOLYTIC PROCESSING INVITRO; RICTOR-MTOR COMPLEX; FACTOR RECEPTOR; SORTING NEXIN-1; ENZYMATIC ACTIVATION; PHOSPHORYLATED EGFR; MICROSOMAL LUMEN; KINASE-ACTIVITY; FAMILY	The receptor tyrosine kinase epidermal growth factor receptor (EGFR) and its ligand epidermal growth factor (EGF) are known to play important roles in malignant tumor cells, and the EGFR signaling pathway is one of the most important targets in various tumors, including non-small cell lung cancer (NSCLC). We reported recently that an aberration in certain steps of EGF-stimulated phosphorylated epidermal growth factor receptor (pEGFR) endocytic trafficking from the early endosomes to the late endosomes occurs in the gefitinib-resistant NSCLC cells, in which large amounts of sorting nexin 1 (SNX1) are colocalized with EGFR in the aggregated early endosomes where the internalized pEGFR is also accumulated of these cells. To further investigate the role of SNX1 in EGF-stimulated pEGFR endocytosis, followed by downstream signaling leading to the activation of phosphatidylinositol 3-kinase (PI3K)-the seri ne/threonine kinase AKT pathway, we examined the effect of depletion of SNX1 knock-down expression by si RNA and an inhibition of targeting membrane recycling using monensin. Using immunofluorescence, we observed an efficient endocytic transport of pEGFR from early endosomes to late endosomes/lysosomes after EGF-stimulation in the cells transfected with siRNA-SNX1, whereas the delayed endocytic delivery of pEGFR was evident in the siRNA-control-transfected cells. Furthermore, a large amount of endocytosed pEGFR was accumulated in the presence of monensin in the early endosomes of the SNX1 knock-down cells. In western blot analysis, EGF stimulation of both control and cells transfected with siRNA-SNX1 resulted in rapid phosphorylation of EGFR and enhanced AKT phosphorylation. Monensin-dependent inhibition of AKT phosphorylation was stronger in SNX1 knock-down cells than in controls. In contrast, however, monensin had no effect on AKT phosphorylation triggered by activation of the MET receptor tyrosine kinase. Collectively, we suggest that EGF-stimulated recycling of EGFR to the plasma membrane induces downstream signaling leading to AKT phosphorylation. Suppression of EGFR membrane recycling by SNX1 appears to be critical for the activation of EGFR/PI3K/AKT signaling pathway in human lung cancer cells.	[Nishimura, Yukio] Kyushu Univ, Grad Sch Pharmaceut Sci, Div Pharmaceut Cell Biol, Fukuoka 8128582, Japan; [Takiguchi, Soichi] Kyushu Natl Canc Ctr, Inst Clin Res, Fukuoka 8111395, Japan; [Ito, Shigeru] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan; [Itoh, Kazuyuki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biol, Osaka 5378511, Japan	Nishimura, Y (reprint author), Kyushu Univ, Grad Sch Pharmaceut Sci, Div Pharmaceut Cell Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ynkio443@gmail.com					Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; Nishimura Y, 2012, INT J ONCOL, V41, P1520, DOI 10.3892/ijo.2012.1578; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V261, P64, DOI 10.1016/0003-9861(88)90104-X; Barker AJ, 2001, BIOORG MED CHEM LETT, V11, P1911, DOI 10.1016/S0960-894X(01)00344-4; Nishimura Y, 2007, HISTOCHEM CELL BIOL, V127, P541, DOI 10.1007/s00418-007-0281-y; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Arteaga CL, 2001, CURR OPIN ONCOL, V13, P491, DOI 10.1097/00001622-200111000-00012; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Baselga J, 2000, DRUGS S1, V60, pS33; Engelman JA, 2006, CLIN CANCER RES, V12, p4372S, DOI 10.1158/1078-0432.CCR-06-0795; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; NISHIMURA Y, 1987, BIOCHEM BIOPH RES CO, V148, P335, DOI 10.1016/0006-291X(87)91115-6; Nishimura Y, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-42; Nishimura Y, 2014, INT J ONCOL, V44, P412, DOI 10.3892/ijo.2013.2194; Nishimura Y, 2011, CURR SIGNAL TRANSD T, V6, P383; de Bono JS, 2002, TRENDS MOL MED, V8, pS19, DOI 10.1016/S1471-4914(02)02306-7; SANDOVAL IV, 1994, J BIOL CHEM, V269, P6622; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699	35	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1721	1729		10.3892/ijo.2015.2871		9	Oncology	Oncology	CC8KE	WOS:000350616400033		
J	Nishii, Y; Yamaguchi, M; Kimura, Y; Hasegawa, T; Aburatani, H; Uchida, H; Hirata, K; Sakuma, Y				Nishii, Yukari; Yamaguchi, Miki; Kimura, Yasutoshi; Hasegawa, Tadashi; Aburatani, Hiroyuki; Uchida, Hiroaki; Hirata, Koichi; Sakuma, Yuji			A newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cells	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						pancreatic ductal carcinoma; mucin 13; monoclonal antibody; antibody-drug conjugate; internalization; immunohistochemistry	IMMUNOHISTOCHEMICAL ANALYSIS; SURFACE MUCIN; COLON-CANCER; MUC13 MUCIN; EXPRESSION; THERAPY; LOCALIZATION; GEMCITABINE	Pancreatic cancer is one of the most severe forms of malignancy. Patients with unresectable or metastatic pancreatic cancer usually receive chemotherapy that causes various adverse effects. Antibody-drug conjugates (ADCs), drugs developed by conjugating an anticancer agent to a monoclonal antibody (mAb), can alleviate the side effects of chemotherapy because ADCs selectively bind to cancer cells expressing a particular antigen. We recently developed the recombinant protein DT3C comprising diphtheria toxin (DT) lacking the receptor-binding domain but containing the Cl, C2, and C3 domains of Streptococcus protein G (3C). The mAb-DT3C conjugates can be used to select mAbs that are internalized by cells, because the conjugates decrease cell viability only when they are internalized by cells through Ab-antigen reactions. We developed a new mAb to be internalized by TCC-PAN2 cells, a pancreatic carcinoma cell line. The mAb, designated TCC56, recognized Mucin 13 (MUC13), while TCC56-DT3C conjugates induced cell death in TCC-PAN2 cells expressing MUC13. We found that MUC13 was expressed, at least partially, in all 40 pancreatic ductal carcinoma tissues and adjacent non-cancerous tissues analyzed. The expression levels of MUC13 in pancreatic cancer tissues were greater than those in normal tissues. Our findings suggest that MUC13 can be a target molecule for pancreatic cancer treatment. ADCs, including mAb TCC56, could be promising anticancer agents to alleviate the adverse effects of chemotherapy.	[Nishii, Yukari; Yamaguchi, Miki; Sakuma, Yuji] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Mol Med, Sapporo, Hokkaido 0608556, Japan; [Kimura, Yasutoshi; Hirata, Koichi] Sapporo Med Univ, Sch Med, Dept Surg Surg Oncol & Sci, Sapporo, Hokkaido 0608556, Japan; [Hasegawa, Tadashi] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Sapporo, Hokkaido 0608556, Japan; [Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Uchida, Hiroaki] Tokyo Univ Pharm & Life Sci, Dept Life Sci, Lab Oncol, Tokyo, Japan	Sakuma, Y (reprint author), Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Mol Med,Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	sakuma@sapmed.ac.jp					Shimamura T, 2005, CANCER SCI, V96, P265, DOI 10.1111/j.1349-7006.2005.00043.x; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; Allred DC, 1998, MODERN PATHOL, V11, P155; Gupta BK, 2012, J HISTOCHEM CYTOCHEM, V60, P822, DOI 10.1369/0022155412460678; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Chauhan SC, 2009, CANCER RES, V69, P765, DOI 10.1158/0008-5472.CAN-08-0587; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Kaur S, 2013, NAT REV GASTRO HEPAT, V10, P607, DOI 10.1038/nrgastro.2013.120; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Khan S, 2014, ONCOTARGET, V5, P7599; Murer H, 2004, PFLUG ARCH EUR J PHY, V447, P763, DOI 10.1007/s00424-003-1072-5; Maher DM, 2011, MOL CANCER RES, V9, P531, DOI 10.1158/1541-7786.MCR-10-0443; Chauhan SC, 2012, MOL CANCER THER, V11, P24, DOI 10.1158/1535-7163.MCT-11-0598; Burris HA, 2014, J CLIN ONCOL, V32; Kiyamova R., 2011, Experimental Oncology, V33, P157; Gupta BK, 2014, J GASTROENTEROL, V49, P1378, DOI 10.1007/s00535-013-0885-z; Ishii K, 2008, J GENE MED, V10, P597, DOI 10.1002/jgm.1164; Jonckheere Nicolas, 2010, Cancers (Basel), V2, P1794, DOI 10.3390/cancers2041794; Kindler HL, 2012, AM SOC CLIN ONCOL ED, V2012, P232; Michael M, 1997, Oncology (Williston Park), V11, P1615; Panowski S, 2014, MABS-AUSTIN, V6, P34, DOI 10.4161/mabs.27022; Ritter G, 2013, Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy, Patent No. [US 8603474, 8603474]; Rossi ML, 2014, WORLD J GASTROENTERO, V20, P11142, DOI 10.3748/wjg.v20.i32.11142; Suzuki K, 2007, PROSTATE, V67, P1163, DOI 10.1002/pros.20613; Walsh MD, 2007, HUM PATHOL, V38, P883, DOI 10.1016/j.humpath.2006.11.020; Yamaguchi M, 2014, BIOCHEM BIOPH RES CO, V454, P600, DOI 10.1016/j.bbrc.2014.10.133	28	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1781	1787		10.3892/ijo.2015.2880		7	Oncology	Oncology	CC8KE	WOS:000350616400039		
J	Takahashi, T; Honma, Y; Miyake, T; Adachi, K; Takami, S; Okada, M; Kumanomidou, S; Ikejiri, F; Jo, Y; Onishi, C; Kawakami, K; Moriyama, I; Inoue, M; Tanaka, J; Suzumiya, J				Takahashi, Tsutomu; Honma, Yoshio; Miyake, Takaaki; Adachi, Koji; Takami, Saki; Okada, Masahiro; Kumanomidou, Satoshi; Ikejiri, Fumiyoshi; Jo, Yumi; Onishi, Chie; Kawakami, Koshi; Moriyama, Ichiro; Inoue, Masaya; Tanaka, Junko; Suzumiya, Junji			Synergistic combination therapy with cotylenin A and vincristine in multiple myeloma models	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						myeloma cell; cotylenin A; vincristine; stemness; xenograft	DIFFERENTIATION-INDUCING AGENT; PLANT-GROWTH REGULATOR; LEUKEMIA-CELLS; PROMYELOCYTIC LEUKEMIA; CARCINOMA; INTERFERON; APOPTOSIS; AUTOPHAGY; STRATEGY; ALPHA	Multiple myeloma is a malignant proliferative disease of plasma cells in the bone marrow and remains largely incurable. Cotylenin A, a fusicoccane diterpene glycoside with a complex sugar moiety, was isolated as a plant-growth regulator. Cotylenin A has been shown to inhibit the growth of various cancer cells. Herein, we examined the anti-myeloma effects of cotylenin A using five human myeloma cell lines (RPMI-8226, KMS-11, KMS-26, KMS-12 PE and KMS-12 BM) and xenografts in immunodeficient mice. Cotylenin A and vincristine synergistically inhibited the growth and induced apoptosis in myeloma cells. While other microtubule-disturbing agents also showed co-operative effects with cotylenin A, other anticancer agents, such as doxorubicin, cisplatin, camptothecin, methotrexate, gemcitabine and 5-fluorouracil, did not show such co-operation with cotylenin A. These differences might be attributed to the effects on autophagic responses. Combined treatment with cotylenin A and vincristine induced autophagy (formation of LC3-II and degradation of p62 protein). However, doxorubicin did not enhance the autophagy induced by cotylenin A. A colony-forming assay indicated that the combined treatment with cotylenin A and vincristine more effectively suppressed the formation of large colonies, which have higher self-renewal activity than vincristine alone. Expression of pluripotency-associated transcription factor Sox2 mRNA in RPMI-8226 myeloma cells was significantly suppressed by treatment with cotylenin A. Combined treatment with cotylenin A and vincristine significantly inhibited the growth of KMS-26 myeloma cells as xenografts. Our results suggest that the combination of cotylenin A and vincristine may have therapeutic value. Recently, it was reported that cotylenin A modulates the 14-3-3 intracellular signaling pathway. The 14-3-3 proteins may be novel targets in treating myeloma. However, our study could not explain how the sensitization to vincristine is related to the effects of cotylenin A on the 14-3-3 signaling pathway and further studies will be needed.	[Takahashi, Tsutomu; Honma, Yoshio; Miyake, Takaaki; Adachi, Koji; Takami, Saki; Okada, Masahiro; Kumanomidou, Satoshi; Ikejiri, Fumiyoshi; Jo, Yumi; Onishi, Chie; Kawakami, Koshi; Moriyama, Ichiro; Inoue, Masaya; Tanaka, Junko; Suzumiya, Junji] Shimane Univ Hosp, Dept Hematol Oncol, Izumo, Shimane 6938501, Japan	Takahashi, T (reprint author), Shimane Univ Hosp, 89-1 Enya Chou, Izumo, Shimane 6938501, Japan.	ben2106t@med.shimane-u.ac.jp					Agarwal JR, 2010, ANTI-CANCER AGENT ME, V10, P116; Spisek R, 2007, J EXP MED, V204, P831, DOI 10.1084/jem.20062387; Kasukabe T, 2005, BREAST CANCER RES, V7, pR1097, DOI 10.1186/bcr1344; Marimpietri D, 2007, CLIN CANCER RES, V13, P3977, DOI 10.1158/1078-0432.CCR-06-2757; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Ikegame A, 2012, LEUKEMIA, V26, P2124, DOI 10.1038/leu.2012.78; Hoang B, 2009, MOL CANCER THER, V8, P1974, DOI 10.1158/1535-7163.MCT-08-1177; Boucher K, 2012, CLIN CANCER RES, V18, P6155, DOI 10.1158/1078-0432.CCR-12-0531; White EJ, 2011, AM J CANCER RES, V1, P362; Adiseshaiah PP, 2013, CANCER LETT, V337, P254, DOI 10.1016/j.canlet.2013.04.034; Ishii Y, 2002, CELL GROWTH DIFFER, V13, P19; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Leung-Hagesteijn C, 2013, CANCER CELL, V24, P289, DOI 10.1016/j.ccr.2013.08.009; Kumar A, 2011, ACTA HAEMATOL-BASEL, V125, P8, DOI 10.1159/000318880; Honma Y, 2003, LEUKEMIA RES, V27, P1019, DOI 10.1016/S0145-2126(03)00071-7; Honma Y, 2005, GYNECOL ONCOL, V99, P680, DOI 10.1016/j.ygyno.2005.07.015; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Honma Y, 2002, LEUKEMIA LYMPHOMA, V43, P1169, DOI 10.1080/1042819020026222; Honma Y, 2003, CANCER RES, V63, P3659; Honma Y, 2007, CANCER SCI, V98, P1643, DOI 10.1111/j.1349-7006.2007.00575.x; Kawakami K, 2012, ANTI-CANCER AGENT ME, V12, P791; MANDELLI F, 1990, NEW ENGL J MED, V322, P1430, DOI 10.1056/NEJM199005173222005; Molzan M, 2013, ACS CHEM BIOL, V8, P1869, DOI 10.1021/cb4003464; Niitsu N, 2002, EXP HEMATOL, V30, P1273, DOI 10.1016/S0301-472X(02)00905-0; OECKING C, 1994, FEBS LETT, V352, P163, DOI 10.1016/0014-5793(94)00949-X; QUESADA JR, 1986, BLOOD, V67, P275; SASSA T, 1970, NATURE, V227, P379, DOI 10.1038/227379a0; Suzuki K, 2013, JPN J CLIN ONCOL, V43, P116, DOI 10.1093/jjco/hys215; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; Yamada K, 2001, BRIT J HAEMATOL, V114, P814, DOI 10.1046/j.1365-2141.2001.03029.x; Yamamoto-Yamaguchi Y, 2001, BRIT J HAEMATOL, V112, P697, DOI 10.1046/j.1365-2141.2001.02601.x; Zhou Q, 2012, BIOCHEM PHARMACOL, V83, P1146, DOI 10.1016/j.bcp.2012.01.013	32	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1801	1809		10.3892/ijo.2015.2882		9	Oncology	Oncology	CC8KE	WOS:000350616400041		
J	Toge, M; Yokoyama, S; Kato, S; Sakurai, H; Senda, K; Doki, Y; Hayakawa, Y; Yoshimura, N; Saiki, I				Toge, Masayoshi; Yokoyama, Satoru; Kato, Shinichiro; Sakurai, Hiroaki; Senda, Kazutaka; Doki, Yoshinori; Hayakawa, Yoshihiro; Yoshimura, Naoki; Saiki, Ikuo			Critical contribution of MCL-1 in EMT-associated chemo-resistance in A549 non-small cell lung cancer	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						non-small cell lung cancer; epithelial-to-mesenchymal transition; chemo-resistance; TGF-beta; MCL-1	VINORELBINE PLUS CISPLATIN; MESENCHYMAL TRANSITION; INDUCED APOPTOSIS; DOWN-REGULATION; GROWTH; SENSITIVITY; INHIBITION; CHEMOTHERAPY; DETERMINANT; METASTASIS	Non-small cell lung cancer (NSCLC) is one of the leading causes of death in all lung cancer patients due to its metastatic spread. Even though cisplatin treatment after surgical resection of the primary tumor has been established as a standard chemotherapy for residual disease including metastatic spread, NSCLC often acquires a resistance against chemotherapy, and metastatic disease is often observed. Amongst many potential mechanisms, epithelial-to-mesenchymal transition (EMT) has been considered as an important process in acquiring both metastatic spread and chemo-resistance of NSCLC. In this study, we identified MCL-1 as a critical molecule for chemoresistance in A549 cells associated with TGF-beta-induced EMT. Importantly, downregulation of MCL-1 by siRNA or inhibition of MCL-1 with pan-BCL2 inhibitor to inhibit MCL-1 was able to overcome the EMT-associated chemo-resistance in A549 cells. Collectively, MCL-1 can be a new therapeutic target for overcoming EMT-associated chemo-resistance in NSCLC patients in the context of post-operative chemotherapies.	[Toge, Masayoshi; Senda, Kazutaka; Doki, Yoshinori; Yoshimura, Naoki] Toyama Univ, Dept Thorac & Cardiovasc Surg, Inst Nat Med, Toyama 9300194, Japan; [Yokoyama, Satoru; Kato, Shinichiro; Sakurai, Hiroaki; Hayakawa, Yoshihiro; Saiki, Ikuo] Toyama Univ, Inst Nat Med, Div Pathogen Biochem, Toyama 9300194, Japan; [Sakurai, Hiroaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Canc Cell Biol, Toyama 9300194, Japan	Yokoyama, S (reprint author), Toyama Univ, Inst Nat Med, Div Pathogen Biochem, 2630 Sugitani, Toyama 9300194, Japan.	yokoyama@inm.u-toyama.ac.jp		Sakurai, Hiroaki/0000-0003-0657-9570	Ministry of Education, Culture, Sports, Science, and Technology (Japan) [24701023, 24700971, 24659348]; Hokuriku-Bank	The authors would like to thank David E. Fisher (MGH, Boston, MA, USA) for kindly giving the plasmids and all members of the Saiki laboratory for discussions and suggestions. This study was supported in part by Grant-in-Aid for Young Scientists (B) 24701023 (MT.), and 24700971 (S.Y.), by Grants-in-aid for Challenging Exploratory Research 24659348 (I.S) from the Ministry of Education, Culture, Sports, Science, and Technology (Japan), and by Grant for young scientists from Hokuriku-Bank (S.Y.).	Sanchez-Tillo E, 2014, CELL DEATH DIFFER, V21, P247, DOI 10.1038/cdd.2013.123; Kin R, 2013, INT J ONCOL, V43, P1901, DOI 10.3892/ijo.2013.2139; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Groome PA, 2007, J THORAC ONCOL, V2, P694, DOI 10.1097/JTO.0b013e31812d05d5; Li J, 2008, CANCER CHEMOTH PHARM, V61, P525, DOI 10.1007/s00280-007-0499-3; Shintani Y, 2011, ANN THORAC SURG, V92, P1794, DOI 10.1016/j.athoracsur.2011.07.032; Carr SR, 2012, J THORAC CARDIOV SUR, V143, P390, DOI 10.1016/j.jtcvs.2011.10.023; Kato S, 2014, CANCER SCI, V105, P281, DOI 10.1111/cas.12336; Henson ES, 2003, J CELL BIOCHEM, V89, P1177, DOI 10.1002/jcb.10597; Ledford H, 2011, NATURE, V472, P273, DOI 10.1038/472273a; Rho JK, 2009, LUNG CANCER, V63, P219, DOI 10.1016/j.lungcan.2008.05.017; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Haq R, 2013, P NATL ACAD SCI USA, V110, P4321, DOI 10.1073/pnas.1205575110; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Nishioka T, 2014, BRIT J CANCER, V110, P1785, DOI 10.1038/bjc.2014.78; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351; Chaffer CL, 2012, SCIENCE, V331, P1559; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Ginsberg RJ, 1995, ANN THORAC SURG, V60, P613; Hu PZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028670; Jin HO, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.63; Leu CM, 2000, ONCOGENE, V19, P1665, DOI 10.1038/sj.onc.1203452; Liu H, 2009, MOL BIOL REP, V36, P2099, DOI 10.1007/s11033-008-9422-1; Schulze-Bergkamen H, 2004, HEPATOLOGY, V39, P645, DOI 10.1002/hep.20138; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822	29	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	APR	2015	46	4					1844	1848		10.3892/ijo.2015.2861		5	Oncology	Oncology	CC8KE	WOS:000350616400046		
J	Kuroda, M				Kuroda, Mitsutoshi			A higher-order strain gradient plasticity theory with a corner-like effect	INTERNATIONAL JOURNAL OF SOLIDS AND STRUCTURES			English	Article						Finite strains; Size effect; Shear bands; Flow localization; Finite element method	SUBSEQUENT YIELD SURFACE; CRYSTAL PLASTICITY; PLANE-STRAIN; NONNORMALITY THEORY; FLOW LOCALIZATION; PATH CHANGE; DEFORMATION; SCALE; VISCOPLASTICITY; NECKING	A corner-like plasticity model originally proposed as a size-independent theory is extended to include a size effect resulting from plastic strain gradients. A method of solving boundary value problems at finite strains is also presented. The efficiency of the new theory is demonstrated through two typical numerical examples: a constrained simple shear problem in which an infinitely long strip bounded by two hard materials is subjected to large shear under plane strain conditions, and a problem of shear band formation in plane strain tension. (C) 2014 Elsevier Ltd. All rights reserved.	Yamagata Univ, Grad Sch Sci & Engn, Mech Engn, Yonezawa, Yamagata 9928510, Japan	Kuroda, M (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Mech Engn, Yonezawa, Yamagata 9928510, Japan.	kuroda@yz.yamagata-u.ac.jp					AIFANTIS EC, 1984, J ENG MATER-T ASME, V106, P326; AIFANTIS EC, 1987, INT J PLASTICITY, V3, P211, DOI 10.1016/0749-6419(87)90021-0; Kuroda M, 2010, INT J PLASTICITY, V26, P507, DOI 10.1016/j.ijplas.2009.09.001; Stolken JS, 1998, ACTA MATER, V46, P5109, DOI 10.1016/S1359-6454(98)00153-0; Fredriksson P, 2009, INT J SOLIDS STRUCT, V46, P3977, DOI 10.1016/j.ijsolstr.2009.07.028; Niordson CF, 2004, J MECH PHYS SOLIDS, V52, P2431, DOI 10.1016/j.jmps.2004.05.009; STOREN S, 1975, J MECH PHYS SOLIDS, V23, P421, DOI 10.1016/0022-5096(75)90004-6; Gurtin ME, 2009, J MECH PHYS SOLIDS, V57, P405, DOI 10.1016/j.jmps.2008.12.002; YAMADA Y, 1968, INT J MECH SCI, V10, P343, DOI 10.1016/0020-7403(68)90001-5; ASHBY MF, 1970, PHILOS MAG, V21, P399, DOI 10.1080/14786437008238426; Gudmundson P, 2004, J MECH PHYS SOLIDS, V52, P1379, DOI 10.1016/j.jmps.2003.11.002; Fleck NA, 2001, J MECH PHYS SOLIDS, V49, P2245, DOI 10.1016/S0022-5096(01)00049-7; Niordson CF, 2003, INT J NUMER METH ENG, V56, P961, DOI 10.1002/nme.593; Groma I, 2003, ACTA MATER, V51, P1271, DOI 10.1016/S1359-6454(02)00517-7; Kuroda M, 2008, J MECH PHYS SOLIDS, V56, P2573, DOI 10.1016/j.jmps.2008.03.010; FLECK NA, 1994, ACTA METALL MATER, V42, P475, DOI 10.1016/0956-7151(94)90502-9; Gurtin ME, 2002, J MECH PHYS SOLIDS, V50, P5, DOI 10.1016/S0022-5096(01)00104-1; Kuwabara T, 2000, ACTA MATER, V48, P2071, DOI 10.1016/S1359-6454(00)00048-3; Hutchinson JW, 2012, ACTA MECH SINICA-PRC, V28, P1078, DOI 10.1007/s10409-012-0089-4; Kuroda M, 2011, INT J SOLIDS STRUCT, V48, P3382, DOI 10.1016/j.ijsolstr.2011.08.008; Kuroda M, 2006, J MECH PHYS SOLIDS, V54, P1789, DOI 10.1016/j.jmps.2006.04.002; Evers LP, 2004, J MECH PHYS SOLIDS, V52, P2379, DOI 10.1016/j.jmps.2004.03.007; HUTCHINSON JW, 1981, INT J SOLIDS STRUCT, V17, P451, DOI 10.1016/0020-7683(81)90053-6; TVERGAARD V, 1981, J MECH PHYS SOLIDS, V29, P115, DOI 10.1016/0022-5096(81)90019-3; CHRISTOFFERSEN J, 1979, J MECH PHYS SOLIDS, V27, P465, DOI 10.1016/0022-5096(79)90026-7; Borg U, 2007, INT J PLASTICITY, V23, P1400, DOI 10.1016/j.ijplas.2007.01.003; Borg U, 2006, INT J SOLIDS STRUCT, V43, P4906, DOI 10.1016/j.ijsolstr.2005.05.022; GOTOH M, 1985, ENG FRACT MECH, V21, P673; Hughes T. R., 1986, ENG COMPUT, V3, P116, DOI 10.1108/eb023649; Kuroda M, 2001, EUR J MECH A-SOLID, V20, P893, DOI 10.1016/S0997-7538(01)01169-X; Kuroda M, 1999, ACTA MATER, V47, P3879, DOI 10.1016/S1359-6454(99)00213-X; Kuroda M, 2001, J MECH PHYS SOLIDS, V49, P1239, DOI 10.1016/S0022-5096(00)00080-6; Kuroda M, 2001, INT J SOLIDS STRUCT, V38, P8945, DOI 10.1016/S0020-7683(01)00166-4; Muhlhaus H.-B., 1991, INT J SOLIDS STRUCT, V28, P845; SIMO JC, 1987, COMPUT METHOD APPL M, V62, P169, DOI 10.1016/0045-7825(87)90022-3; YAMADA Y, 1995, INT J MECH SCI, V37, P691, DOI 10.1016/0020-7403(94)00096-3	36	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7683	1879-2146		INT J SOLIDS STRUCT	Int. J. Solids Struct.	APR	2015	58						62	72		10.1016/j.ijsolstr.2014.12.019		11	Mechanics	Mechanics	CD2RT	WOS:000350927400006		
J	Okumura, D; Inagaki, T; Ohno, N				Okumura, Dai; Inagaki, Takahiro; Ohno, Nobutada			Effect of prestrains on swelling-induced buckling patterns in gel films with a square lattice of holes	INTERNATIONAL JOURNAL OF SOLIDS AND STRUCTURES			English	Article						Swelling; Gels; Buckling; Prestrains; Periodic structures; Finite element method	INPLANE BIAXIAL COMPRESSION; INDUCED SURFACE INSTABILITY; ELASTOMERIC MATERIALS; HONEYCOMBS SUBJECT; LARGE-DEFORMATION; POLYMER-SOLUTIONS; PHASE-TRANSITION; CELLULAR SOLIDS; HYDROGEL LAYERS; MECHANICS	We investigate the effect of prestrains on swelling-induced buckling patterns in polymeric films with a square lattice of holes. To reproduce experiments conducted by Zhang et al. (2008), poly(dimethylsiloxane) (PDMS) films are pre-strained in in-plane uniaxial tension in a lattice direction, and subsequently swelled by toluene. Finite element analysis is performed using an inhomogeneous field theory of polymeric gels in equilibrium, and with the aid of artificial damping. Periodic units consisting of 2 x 2 and 10 x 10 unit cells are analyzed under a generalized plane strain assumption. Analysis of the 10 x 10 unit cell shows that the resulting buckling pattern depends on the increase in prestrain of epsilon = 0, 0.2, 0.4 and 0.6, evolving as a diamond plate pattern (epsilon = 0), a slightly distorted diamond plate pattern (epsilon= 0.2), a binary pattern of circles and lines (epsilon = 0.4), and a monotonous pattern of ellipses (epsilon = 0.6). These predictions are in very good agreement with experiments. The 2 x 2 unit cell reveals that these different patterns appear continuously as transitional states during transformation into diamond plate patterns; prestrains in uniaxial tension delay the onset of the pattern transformation and equilibrium swelling interrupts the progress of the transformation. Parametric studies demonstrate that the pattern dependence on prestrains originates from intrinsic swelling features, and is a consequence of a particular combination of the selected polymer and solvent. (C) 2015 Elsevier Ltd. All rights reserved.	[Okumura, Dai; Ohno, Nobutada] Nagoya Univ, Dept Mech Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Okumura, Dai; Inagaki, Takahiro; Ohno, Nobutada] Nagoya Univ, Dept Computat Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Okumura, D (reprint author), Nagoya Univ, Dept Mech Sci & Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	okumura@mech.nagoya-u.ac.jp	Ohno, Nobutada/I-6673-2014; Okumura, Dai/I-6669-2014		Japan Society for the Promotion of Science (JSPS)	This research was supported by the Japan Society for the Promotion of Science (JSPS) under a Grant-in-Aid for Scientific Research (C).	Toh W, 2013, INT J APPL MECH, V5, DOI 10.1142/S1758825113500014; Drozdov AD, 2013, INT J SOLIDS STRUCT, V50, P1494, DOI 10.1016/j.ijsolstr.2013.01.031; Ding ZW, 2013, INT J SOLIDS STRUCT, V50, P2610, DOI 10.1016/j.ijsolstr.2013.04.011; Yang S, 2010, ADV FUNCT MATER, V20, P2550, DOI 10.1002/adfm.201000034; Wu ZG, 2013, INT J SOLIDS STRUCT, V50, P578, DOI 10.1016/j.ijsolstr.2012.10.022; Ohno N, 2002, J MECH PHYS SOLIDS, V50, P1125, DOI 10.1016/S0022-5096(01)00106-5; Guvendiren M, 2010, SOFT MATTER, V6, P5795, DOI 10.1039/c0sm00317d; Gupta S, 2007, MATER LETT, V61, P448, DOI 10.1016/j.matlet.2006.04.078; Zhang Y, 2009, ACS NANO, V3, P2412, DOI 10.1021/nn900650n; Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009; Okumura D, 2004, J MECH PHYS SOLIDS, V52, P641, DOI 10.1016/j.jmps.2003.07.002; Okumura D, 2014, INT J SOLIDS STRUCT, V51, P154, DOI 10.1016/j.ijsolstr.2013.09.018; Cai S, 2011, J MECH PHYS SOLIDS, V59, P1094, DOI 10.1016/j.jmps.2011.02.001; Chester SA, 2010, J MECH PHYS SOLIDS, V58, P1879, DOI 10.1016/j.jmps.2010.07.020; Hong W, 2009, INT J SOLIDS STRUCT, V46, P3282, DOI 10.1016/j.ijsolstr.2009.04.022; TANAKA T, 1987, NATURE, V325, P796, DOI 10.1038/325796a0; Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712; Hong W, 2008, J MECH PHYS SOLIDS, V56, P1779, DOI 10.1016/j.jmps.2007.11.010; Ohno N, 2004, INT J MECH SCI, V46, P1697, DOI 10.1016/j.ijmensci.2004.09.011; Erami K, 2006, INT J PLASTICITY, V22, P1569, DOI 10.1016/j.ijplas.2005.09.003; Jang JH, 2009, NANO LETT, V9, P2113, DOI 10.1021/nl9006112; Matsumoto EA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021604; Bertoldi K, 2008, J MECH PHYS SOLIDS, V56, P2642, DOI 10.1016/j.jmps.2008.03.006; Kang MK, 2010, J MECH PHYS SOLIDS, V58, P1582, DOI 10.1016/j.jmps.2010.07.008; Boyce MC, 2001, MATH MECH SOLIDS, V6, P641, DOI 10.1177/108128650100600605; Guvendiren M, 2009, ADV FUNCT MATER, V19, P3038, DOI 10.1002/adfm.200900622; Zhu XL, 2012, SOFT MATTER, V8, P8088, DOI 10.1039/c2sm25393c; Li B, 2012, SOFT MATTER, V8, P5728, DOI 10.1039/c2sm00011c; Zhang Y, 2008, NANO LETT, V8, P1192, DOI 10.1021/nl0801531; Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792; CHAHAL RS, 1973, J CHEM SOC FARAD T 1, V69, P1834, DOI 10.1039/f19736901834; HUGGINS ML, 1964, J AM CHEM SOC, V86, P3535, DOI 10.1021/ja01071a028; Cai SQ, 2011, J MECH PHYS SOLIDS, V59, P2259, DOI 10.1016/j.jmps.2011.08.008; Breid D, 2011, SOFT MATTER, V7, P4490, DOI 10.1039/c1sm05152k; Breid D, 2009, SOFT MATTER, V5, P425, DOI 10.1039/b807820c; Bitoh Y, 2010, J POLYM SCI POL PHYS, V48, P721, DOI 10.1002/polb.21945; Cai SQ, 2010, SOFT MATTER, V6, P5770, DOI 10.1039/c0sm00451k; Chester SA, 2015, INT J SOLIDS STRUCT, V52, P1, DOI 10.1016/j.ijsolstr.2014.08.015; Degand S, 2014, COLLOID SURFACE A, V442, P164, DOI 10.1016/j.colsurfa.2013.05.024; Hirth J. P., 1982, THEORY DISLOCATIONS; Kang MK, 2010, J APPL MECH-T ASME, V77, DOI 10.1115/1.4001715; Okumura D, 2002, INT J SOLIDS STRUCT, V39, P3487, DOI 10.1016/S0020-7683(02)00165-8; PETRI HM, 1995, MACROMOLECULES, V28, P4975, DOI 10.1021/ma00118a027; Roca-Cusachs P, 2005, LANGMUIR, V21, P5542, DOI 10.1021/la046931w; Singamaneni S, 2009, ADV FUNCT MATER, V19, P1426, DOI 10.1002/adfm.200801675; Treloar L. R. G., 1975, PHYS RUBBER ELASTICI	46	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7683	1879-2146		INT J SOLIDS STRUCT	Int. J. Solids Struct.	APR	2015	58						288	300		10.1016/j.ijsolstr.2015.01.015		13	Mechanics	Mechanics	CD2RT	WOS:000350927400024		
J	Iima, M; Yano, K; Kataoka, M; Umehana, M; Murata, K; Kanao, S; Togashi, K; Le Bihan, D				Iima, Mami; Yano, Kojiro; Kataoka, Masako; Umehana, Masaki; Murata, Katsutoshi; Kanao, Shotaro; Togashi, Kaori; Le Bihan, Denis			Quantitative Non-Gaussian Diffusion and Intravoxel Incoherent Motion Magnetic Resonance Imaging Differentiation of Malignant and Benign Breast Lesions	INVESTIGATIVE RADIOLOGY			English	Article						diffusion-weighted MR imaging; intravoxel incoherent motion; kurtosis; breast cancer; differential diagnosis; noise correction	WEIGHTED MRI; PERFUSION; SIGNAL; COEFFICIENT; CANCER; IMAGES; MODEL; TUMORS; NOISE; WATER	Objectives: The purpose of this study was to explore the potential of non-Gaussian diffusion and perfusion magnetic resonance imaging (MRI) using intravoxel incoherent motion (IVIM) MRI for the diagnosis of breast lesions. Materials and Methods: This study included 26 women with breast lesions. Diffusion-weighted images were acquired using 16 b values up to 2500 s/mm(2) and analyzed using a kurtosis diffusion model (apparent diffusion coefficient [ADC(0)] and kurtosis [K]) for the diffusion component and IVIM model (perfusion fraction [fIVIM] and pseudodiffusion coefficient [D*]) for the perfusion component. Diagnostic performance of diffusion and perfusion parameters was evaluated from receiver operating characteristic analyses. Results: The ADC(0) in malignant lesions was significantly lower than that in benign lesions and normal tissue (P < 0.001, P < 0.001), whereas K was significantly higher (P < 0.05, P < 0.001), as well as fIVIM (P < 0.05, P < 0.01). No significant difference was found in D*. The receiver operating characteristic analysis gave high area under the curve values for ADC(0), K, and fIVIM for distinguishing malignant from benign lesions (0.99, 0.85, and 0.82, respectively). The ADC(0) allowed benign tumors to be identified with 100% negative predictive value and malignant tumors with 100% sensitivity. The malignant/benign diagnosis thresholds were 1.4 +/- 10(-3) mm(2)/s as well as 0.6 and 7%, respectively, for ADC(0), K, and fIVIM. Conclusions: With a proper methodological framework, IVIM MRI can provide valuable information on tissue structure and microvasculature beneficial for the diagnosis of breast cancer lesions.	[Iima, Mami; Yano, Kojiro; Kataoka, Masako; Kanao, Shotaro; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Yano, Kojiro] Osaka Inst Technol, Informat Sci & Technol, Osaka 535, Japan; [Umehana, Masaki] Kyoto Univ, Fac Med, Kyoto, Japan; [Murata, Katsutoshi] Siemens Japan KK, Tokyo, Japan; [Le Bihan, Denis] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan; [Le Bihan, Denis] CEA Saclay, NeuroSpin, F-91191 Gif Sur Yvette, France	Le Bihan, D (reprint author), Bat 145,Point Courrier 156, F-91191 Gif Sur Yvette, France.	denis.lebihan@gmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan [24591756]; Japan Society for the Promotion of Science [25-2430]; Louis D. Foundation of the Institute of France	Supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 24591756); a Grand-in-Aid for Japan Society for the Promotion of Science Fellows from Japan Society for the Promotion of Science (No. 25-2430); and the Louis D. Foundation of the Institute of France.	LEBIHAN D, 1988, RADIOLOGY, V168, P497; Lemke A, 2010, MAGN RESON MED, V64, P1580, DOI 10.1002/mrm.22565; LEBIHAN D, 1986, RADIOLOGY, V161, P401; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Baron P, 2010, NMR BIOMED, V23, P399, DOI 10.1002/nbm.1475; Rosenkrantz AB, 2012, RADIOLOGY, V264, P126, DOI 10.1148/radiol.12112290; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Aja-Fernandez S, 2011, MAGN RESON MED, V65, P1195, DOI 10.1002/mrm.22701; Le Bihan D, 2013, RADIOLOGY, V268, P318, DOI 10.1148/radiol.13130420; Partridge SC, 2010, J MAGN RESON IMAGING, V31, P562, DOI 10.1002/jmri.22078; Koay CG, 2006, J MAGN RESON, V179, P317, DOI 10.1016/j.jmr.2006.01.016; Iima M, 2011, RADIOLOGY, V260, P364, DOI 10.1148/radiol.11101892; Liu CL, 2013, EUR J RADIOL, V82, pE782, DOI 10.1016/j.ejrad.2013.08.006; Eyal E, 2012, INVEST RADIOL, V47, P284, DOI 10.1097/RLI.0b013e3182438e5d; Bogner W, 2009, RADIOLOGY, V253, P341, DOI 10.1148/radiol.2532081718; Park SH, 2010, RADIOLOGY, V257, P56, DOI 10.1148/radiol.10092021; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; Iima M, 2014, INVEST RADIOL, V49, P485, DOI 10.1097/RLI.0000000000000040; Lu HZ, 2004, MAGNET RESON MED, V52, P679, DOI 10.1002/mrm.20178; Pang YX, 2013, MAGN RESON MED, V69, P553, DOI 10.1002/mrm.24277; HENKELMAN RM, 1985, MED PHYS, V12, P232, DOI 10.1118/1.595711; Le Bihan D, 2008, RADIOLOGY, V249, P748, DOI 10.1148/radiol.2493081301; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Woodhams R, 2005, J COMPUT ASSIST TOMO, V29, P644, DOI 10.1097/01.rct.0000171913.74086.1b; Constantinides CD, 1997, MAGNET RESON MED, V38, P852, DOI 10.1002/mrm.1910380524; Bokacheva L, 2013, J MAGN RESON IMAGING; Brion V, 2011, PARALLEL MRI NOISE C, P226; Brown R, 2011, P 19 ANN M ISMRM MON; Buchbender S, 2013, CLIN RADIOL, V68, P123; Eby PR, 2009, AM J ROENTGENOL, V193, P861, DOI 10.2214/AJR.08.2096; Gill P, 1978, AM J NUMER ANAL, V15, P977; Le Bihan D, 2007, PHYS MED BIOL, V52, pR57, DOI 10.1088/0031-9155/52/7/R02; LEBIHAN D, 1992, MAGNET RESON MED, V27, P171; Makkat S, 2007, J MAGN RESON IMAGING, V25, P1159, DOI 10.1002/jmri.20937; Sigmund E, 2011, MAGN RESON MED, V65, P1437; Tavassoli F.A., 2003, WHO CLASSIFICATION T; Turkbey B, 2012, DIAGN INTERV RADIOL, V18, P46, DOI 10.4261/1305-3825.DIR.4708-11.2; Wichmann T, 2009, P 17 ANN M ISMRM HON; Woodhams Reiko, 2005, Magn Reson Med Sci, V4, P35, DOI 10.2463/mrms.4.35; Yablonskiy DA, 2010, NMR BIOMED, V23, P661, DOI 10.1002/nbm.1520	40	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0020-9996	1536-0210		INVEST RADIOL	Invest. Radiol.	APR	2015	50	4					205	211				7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CD2NQ	WOS:000350915500004		
J	Diekhoff, T; Kiefer, T; Stroux, A; Pilhofer, I; Juran, R; Mews, J; Blobel, J; Tsuyuki, M; Ackermann, B; Hamm, B; Hermann, KGA				Diekhoff, Torsten; Kiefer, Tobias; Stroux, Andrea; Pilhofer, Irid; Juran, Ralf; Mews, Juergen; Blobel, Joerg; Tsuyuki, Masaharu; Ackermann, Beate; Hamm, Bernd; Hermann, Kay-Geert A.			Detection and Characterization of Crystal Suspensions Using Single-Source Dual-Energy Computed Tomography A Phantom Model of Crystal Arthropathies	INVESTIGATIVE RADIOLOGY			English	Article						crystal arthritis; monosodium urate; calcium pyrophosphate; dual-energy CT; phantom	RENAL STONE COMPOSITION; MULTIDETECTOR CT; GOUT; RECONSTRUCTION; VALIDATION; DIAGNOSIS; LESIONS; SYSTEM	Objectives: The aim of this study was to perform phantom measurements to prove the feasibility of single-source dual-energy computed tomography (DECT) of the extremities using a volume scan mode. In addition, we, for the first time, wanted to determine which concentrations of monosodium urate (MSU) in gout and calcium pyrophosphate (CP) in pseudogout are needed to detect or distinguish these soft tissue depositions with DECT. Materials and Methods: We created a hand-shaped plastic phantom assembled with a descending order of concentrations of MSU (6.25%-50%) and CP (1.56%-50%) with similar attenuation in conventional computed tomographic (CT) images. Dual-energy imaging was done on a standard 320-row CT scanner with acquisition of 2 volumes: one at 80 and the other at 135 kV. Using linear regression analysis, dual-energy gradients were calculated for MSU and CP. Thereafter, we selected a specific region of interest on the dual-energy graph to color-code MSU and CP on the images. Three blinded readers scored 10 scans of the randomly equipped phantom, corresponding to 60 samples, to determine the sensitivity and specificity of this technique. Receiver operating characteristics analysis was done to determine the diagnostic power. Results: We found a dual-energy gradient for MSU of 1.020 +/- 0.006 and for CP of 0.673 +/- 0.001. Assessment of the randomized phantom scans indicates reliable detection of MSU at concentrations of 12.5% or higher and that of CP at 6.25 % or higher, corresponding to deposits with mean Hounsfield unit values of 59.8 for MSU and 101.1 for CP. The sensitivity for MSU ranged from 83.3% to 97.3% at 15/90mA(135/80 kV) and from 86.7% to 97.3% at 100/570 mA. Specificity was 96.7% to 100% in 15/90 mA and 100% in 100/570 mA of scans. However, there was inferior sensitivity for CP owing to lower concentrations. In the receiver operating characteristics analysis, the area under the curve for MSU ranged from 0.867 to 0.947 at 15/90 mA and from 0.867 to 0.919 at 100/570 mA and that for CP from 0.659 to 0.745 and from 0.718 to 0.750, respectively. Conclusions: This phantom study shows that single-source DECT allows detection and characterization of crystal deposits when present in soft tissue at relatively low concentrations. Further studies in patients have to prove its benefits in diagnostic imaging and treatment monitoring as well as its significance compared with dual-source CT systems.	[Diekhoff, Torsten; Kiefer, Tobias; Pilhofer, Irid; Juran, Ralf; Hamm, Bernd; Hermann, Kay-Geert A.] Charite, Dept Radiol, Humboldt Univ, Free Univ Berlin, D-10117 Berlin, Germany; [Stroux, Andrea] Free Univ Berlin, Dept Med Informat Biometry & Epidemiol, Berlin, Germany; [Mews, Juergen; Blobel, Joerg] Toshiba Med Syst Europe, Zoetermeer, Netherlands; [Tsuyuki, Masaharu] Toshiba Med Syst Corp, Otawara, Tochigi, Japan; [Ackermann, Beate] Charite, Humboldt Univ, Free Univ Berlin, Cent Pharm,Campus Virchow Klinikum, D-10117 Berlin, Germany	Diekhoff, T (reprint author), Charite, Dept Radiol CCM, Charitepl 1, D-10117 Berlin, Germany.	torsten.diekhoff@charite.de			Toshiba Medical Systems	The Department of Radiology of Charite - Universitatsmedizin Berlin Campus Mitte, Humboldt-Universitat zu Berlin, Freie Universitat Berlin has received a research grant from Toshiba Medical Systems. J.M., J.B., and M.T. are employees of Toshiba Medical Systems. For the remaining authors, none were declared.	Karcaaltincaba M, 2011, DIAGN INTERV RADIOL, V17, P181, DOI 10.4261/1305-3825.DIR.3860-10.0; Artmann A, 2010, ROFO-FORTSCHR RONTG, V182, P261, DOI 10.1055/s-0028-1109820; Choi HK, 2009, ANN RHEUM DIS, V68, P1609, DOI 10.1136/ard.2008.099713; Nicolaou S, 2010, AM J ROENTGENOL, V194, P1072, DOI 10.2214/AJR.09.2428; Nicolaou S, 2012, AM J ROENTGENOL, V199, pS78, DOI 10.2214/AJR.12.9117; Mallinson PI, 2014, SKELETAL RADIOL, V43, P277, DOI 10.1007/s00256-013-1771-8; Lu GM, 2012, AM J ROENTGENOL, V199, pS40, DOI 10.2214/AJR.12.9112; BROOKS RA, 1977, J COMPUT ASSIST TOMO, V1, P487; Takahashi N, 2008, AM J ROENTGENOL, V190, P1169, DOI 10.2214/AJR.07.3154; RUTHERFORD RA, 1976, NEURORADIOLOGY, V11, P23; Choi HK, 2012, ANN RHEUM DIS, V71, P1466, DOI 10.1136/annrheumdis-2011-200976; Kaza RK, 2012, RADIOGRAPHICS, V32, P353, DOI 10.1148/rg.322115065; Desai MA, 2011, RADIOGRAPHICS, V31, P1365, DOI 10.1148/rg.315115510; Marin D, 2014, RADIOLOGY, V271, P327, DOI 10.1148/radiol.14131480; Shikhaliev PM, 2012, PHYS MED BIOL, V57, P1595, DOI 10.1088/0031-9155/57/6/1595; Glazebrook KN, 2011, RADIOLOGY, V261, P516, DOI 10.1148/radiol.11102485; Kulkarni NM, 2013, J COMPUT ASSIST TOMO, V37, P37, DOI 10.1097/RCT.0b013e3182720f66; ALVAREZ RE, 1976, PHYS MED BIOL, V21, P733, DOI 10.1088/0031-9155/21/5/002; Boll DT, 2009, RADIOLOGY, V250, P813, DOI 10.1148/radiol.2503080545; Pache G, 2010, RADIOLOGY, V256, P617, DOI 10.1148/radiol.10091230; AVRIN DE, 1978, INVEST RADIOL, V13, P217, DOI 10.1097/00004424-197805000-00007; Bongartz T, 2014, ANN RHEUM DIS, DOI [10.1136/annrheumdis-2013-205095, DOI 10.1136/ANNRHEUMDIS-2013-205095]; Brockmann C, 2009, CARDIOVASC INTER RAD, V32, P630, DOI 10.1007/s00270-008-9491-5; Dalbeth N, 2014, ANN RHEUM DIS, DOI [10.1136/annrheumdis-2013-204273, DOI 10.1136/ANNRHEUMDIS-2013-204273]; Dalbeth N, 2013, CURR RHEUMATOL REP, V15, P1; de Bucourt M, 2012, ARTHRITIS RHEUM-US, V64, P1283, DOI 10.1002/art.33433; DICHIRO G, 1979, RADIOLOGY, V131, P521; Feuerlein S, 2012, INVEST RADIOL, V47, P656, DOI 10.1097/RLI.0b013e31826585bb; Gruber M, 2014, RHEUMATOLOGY, V53, P173, DOI 10.1093/rheumatology/ket341; HAWKES DJ, 1986, BRIT J RADIOL, V59, P537; Heinrich Mattias P, 2012, Med Image Comput Comput Assist Interv, V15, P115; HEMMINGSSON A, 1986, J COMPUT ASSIST TOMO, V10, P490; Koonce JD, 2014, EUR RADIOL, V24, P512, DOI 10.1007/s00330-013-3040-6; MARSHALL W, 1984, J COMPUT ASSIST TOMO, V8, P745; Morsbach F, 2013, INVEST RADIOL, V49, P125; Postma AA, 2012, AM J ROENTGENOL, V199, pS26, DOI 10.2214/AJR.12.9115; Ruder TD, 2013, FORENSIC SCI MED PAT, V9, P163, DOI 10.1007/s12024-012-9398-y	37	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0020-9996	1536-0210		INVEST RADIOL	Invest. Radiol.	APR	2015	50	4					255	260				6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CD2NQ	WOS:000350915500010		
J	Watsuji, TO; Yamamoto, A; Motoki, K; Ueda, K; Hada, E; Takaki, Y; Kawagucci, S; Takai, K				Watsuji, Tomo-o; Yamamoto, Asami; Motoki, Kaori; Ueda, Kenji; Hada, Emi; Takaki, Yoshihiro; Kawagucci, Shinsuke; Takai, Ken			Molecular evidence of digestion and absorption of epibiotic bacterial community by deep-sea crab Shinkaia crosnieri	ISME JOURNAL			English	Article							MID-ATLANTIC RIDGE; RIFTIA-PACHYPTILA JONES; HYDROTHERMAL VENT SITE; BATHYMODIOLUS-AZORICUS; TUBE WORM; SYMBIOSIS; MYTILIDAE; DIVERSITY; BIVALVIA; MUSSELS	The hydrothermal vent crab Shinkaia crosnieri is considered to obtain nutrition from the epibiotic bacteria found on the setae, but previous studies have not shown how nutrients can be transferred from the epibionts to the host. In this study, microscopic observations of S. crosnieri intestinal components detected autofluorescent setae fragments and pigmentation derived from the digestion of epibionts in a dye-stained epibiont tracer experiment. An in vitro digestion experiment with epibiotic populations using an intestinal extract demonstrated the degradation of epibiotic cells by digestive enzymes. A phylogenetic analysis showed that many of the bacterial 16S ribosomal RNA gene sequences obtained from the intestine were closely related to the sequences of the epibionts, thus they were probably derived from the epibionts. A stable isotope tracer experiment also indicated that C-13 assimilated by the epibionts provided a carbon (nutrition) source for the host. Both activity measurements and isotope studies showed that chemosynthetic metabolism by the gut microbial components were inactive. Together with the feeding behaviour of living S. crosnieri, these results indicate that S. crosnieri ingests the epibionts using maxillipeds and assimilates them via its digestive organs as a nutrient source. The results of this study elucidate the mechanism of nutritional transfer in ectosymbiosis between chemosynthetic bacteria and deep-sea invertebrates.	[Watsuji, Tomo-o; Yamamoto, Asami; Motoki, Kaori; Hada, Emi; Takaki, Yoshihiro; Kawagucci, Shinsuke; Takai, Ken] JAMSTEC, Dept Subsurface Geobiol Anal & Res D SUGAR, Yokosuka, Kanagawa 2370061, Japan; [Yamamoto, Asami; Motoki, Kaori; Ueda, Kenji] Nihon Univ, Coll Bioresource Sci, Life Sci Res Ctr, Fujisawa, Kanagawa, Japan	Watsuji, TO (reprint author), JAMSTEC, Dept Subsurface Geobiol Anal & Res D SUGAR, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	watsuji@jamstec.go.jp					Duperron S, 2006, ENVIRON MICROBIOL, V8, P1441, DOI 10.1111/j.1462-2920.2006.01038.x; Polz MF, 1998, LIMNOL OCEANOGR, V43, P1631; Riou V, 2008, BIOGEOSCIENCES, V5, P1681; Petersen JM, 2011, NATURE, V476, P176, DOI 10.1038/nature10325; KUNZE J, 1979, AUST J MAR FRESH RES, V30, P683; FELBECK H, 1981, SCIENCE, V213, P336, DOI 10.1126/science.213.4505.336; POLZ MF, 1995, P NATL ACAD SCI USA, V92, P7232, DOI 10.1073/pnas.92.16.7232; Goffredi SK, 2008, ENVIRON MICROBIOL, V10, P2623, DOI 10.1111/j.1462-2920.2008.01684.x; CHILDRESS JJ, 1986, SCIENCE, V233, P1306, DOI 10.1126/science.233.4770.1306; Ponsard J, 2013, ISME J, V7, P96, DOI 10.1038/ismej.2012.87; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; RAU GH, 1983, ECOLOGY, V64, P1314, DOI 10.2307/1937843; Watsuji T, 2010, MICROBES ENVIRON, V25, P288, DOI 10.1264/jsme2.ME10135; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; Watsuji TO, 2014, ISME J, V8, P1020, DOI 10.1038/ismej.2013.226; Cary SC, 1997, APPL ENVIRON MICROB, V63, P1124; CAVANAUGH CM, 1987, NATURE, V325, P346, DOI 10.1038/325346a0; Durand L, 2009, FEMS MICROBIOL ECOL, V71, P291; Grzymski JJ, 2008, P NATL ACAD SCI USA, V105, P17516, DOI 10.1073/pnas.0802782105; SCHAEFER N, 1970, Zoologica Africana, V5, P309; Thurber AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026243; Watsuji TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046282; Zbinden M, 2003, FEMS MICROBIOL ECOL, V46, P23, DOI 10.1016/S0168-6496(03)00176-4	23	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1751-7362	1751-7370		ISME J	ISME J.	APR	2015	9	4					821	831		10.1038/ismej.2014.178		11	Ecology; Microbiology	Environmental Sciences & Ecology; Microbiology	CD6NC	WOS:000351204900004		
J	Kume, G; Furumitsu, K; Nakata, H; Suzuki, T; Handa, M; Yamaguchi, A				Kume, G.; Furumitsu, K.; Nakata, H.; Suzuki, T.; Handa, M.; Yamaguchi, A.			Spatiotemporal occurrence and feeding habits of tonguefish, Cynoglossus lighti Norman, 1925, larvae in Ariake Bay, Japan	JOURNAL OF APPLIED ICHTHYOLOGY			English	Article							GULF-OF-MEXICO; LIFE-HISTORY; GROWTH; SEA; AGE; PLEURONECTIFORMES; BIOLOGY	Spatiotemporal occurrence and feeding habits of tonguefish (Cynoglossus lighti Norman, 1925) larvae were investigated in an offshore area (>5m in depth) of the inner part of Ariake Bay, Japan. All specimens were symmetric, free-swimming larvae. Although their seasonal abundance and distribution in the study site varied from year to year, spawning started in June and the larval abundance was high in August and September with a wide distribution in the inner part of the bay. Both present and previous study results strongly suggest that larvae may settle primarily in the estuary and near-shore areas of Ariake Bay after their wide distribution in the offshore area of the bay during the free-swimming stage. Larvae showed a clear feeding rhythm in which they fed on prey mainly during the daytime. Larvae fed exclusively on copepods, and identified prey were mostly Paracalanidae (mainly Parvocalanus crassirostris), Microsetella norvegica, and Oithona davisae. Pre-metamorphosis larvae fed primarily on Paracalanidae and O.davisae, whereas O.davisae formed a smaller proportion of the early-metamorphosis diet. In early metamorphoses, larvae fed preferentially on Paracalanidae and M.norvegica.	[Kume, G.] Kagoshima Univ, Fac Fisheries, Kagoshima, Kagoshima 8900056, Japan; [Furumitsu, K.; Nakata, H.; Suzuki, T.; Yamaguchi, A.] Nagasaki Univ, Fac Fisheries, Nagasaki 852, Japan; [Handa, M.] All Japan Seamens Union, Tokyo, Japan	Kume, G (reprint author), Kagoshima Univ, Fac Fisheries, 4-50-20 Shimoarata, Kagoshima, Kagoshima 8900056, Japan.	kume@fish.kagoshima-u.ac.jp			Ministry of the Environment, Government of Japan	We thank the commercial fishermen of the Ohura Fisheries Cooperative Association for their assistance in the field survey. The experiments in this study were performed in accordance with the current laws of Japan. This study was supported financially by the Ministry of the Environment, Government of Japan.	Obenour DR, 2012, ENVIRON SCI TECHNOL, V46, P5489, DOI 10.1021/es204481a; Ostergaard P, 2005, MAR BIOL, V146, P595, DOI 10.1007/s00227-004-1458-8; GOVONI JJ, 1983, MAR ECOL PROG SER, V13, P189, DOI 10.3354/meps013189; Katayama S, 2010, J SEA RES, V64, P451, DOI 10.1016/j.seares.2010.04.004; Rodriguez-Grana L, 2005, MAR ECOL PROG SER, V290, P119, DOI 10.3354/meps290119; Booth AJ, 2000, S AFR J MARINE SCI, V22, P185; Dou SZ, 1995, NETH J SEA RES, V34, P195; Helvik JV, 2001, J EXP BIOL, V204, P2553; Koshiishi Yuichi, 2001, Bulletin of Fisheries Research Agency, V1, P23; Kume G., 2012, RECOVERY ARIAKE BAY, P82; Kusakabe T, 2011, NIPPON SUISAN GAKK, V77, P1, DOI 10.2331/suisan.77.1; MINAMI T, 1983, B JPN SOC SCI FISH, V49, P719; Nilsson J., 2004, Boreal Environment Research, V9, P295; RAJAGURU A, 1992, FISH B-NOAA, V90, P328; Sato M., 2011, KAGAKU, V81, P432; Tsutsumi H., 2011, KAGAKU, V81, P450; Ueda Hiroshi, 2006, Aquabiology (Tokyo), V28, P611; Unoki S., 2007, OCEANOGR JPN, V16, P319; Yagi Y, 2009, ICHTHYOL RES, V56, P363, DOI 10.1007/s10228-009-0109-y; Yamaguchi A., 2012, CURRENT STATUS ISSUE, P76; Yamaguchi A., 2011, KAGAKU, V81, P446; Yamaguchi Atsuko, 2004, Bulletin of the Faculty of Fisheries Nagasaki University, V85, P9; Yamaguchi S., 2006, OCEANOGR JAPAN, V15, P37; Yamamoto Masayuki, 2008, Bulletin of the Japanese Society of Fisheries Oceanography, V72, P174	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0175-8659	1439-0426		J APPL ICHTHYOL	J. Appl. Ichthyol.	APR	2015	31	2					276	281		10.1111/jai.12498		6	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	CD5YU	WOS:000351165600002		
J	Matsuoka, T; Kawai, K; Kimura, T; Kojima, T; Onozawa, M; Miyazaki, J; Nishiyama, H; Hinotsu, S; Akaza, H				Matsuoka, Taeko; Kawai, Koji; Kimura, Tomokazu; Kojima, Takahiro; Onozawa, Mizuki; Miyazaki, Jun; Nishiyama, Hiroyuki; Hinotsu, Shiro; Akaza, Hideyuki			Long-term outcomes of combined androgen blockade therapy in stage IV prostate cancer	JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY			English	Article						Prostate cancer; Primary androgen deprivation therapy; Combined androgen blockade; Stage IV	DEPRIVATION THERAPY; RADICAL PROSTATECTOMY; J-CAP; JAPAN; RATES; CARCINOMA; TRIAL; MEN	To clarify which subset of stage IV prostate cancer patients benefit from combined androgen blockade (CAB) using Japanese nationwide database. A total of 3,752 patients with stage IV disease from the prospective nationwide cohort database of the Japan Study Group of Prostate Cancer (J-CaP) were enrolled. All patients started primary androgen deprivation therapy (PADT) between 2001 and 2003, and the present study was performed using the data set from December 2011. Patients were divided into two groups according to initial treatments: CAB with luteinizing hormone-releasing hormone agonist (LHRH) plus anti-androgen (AA) and non-CAB treatments such as LHRH monotherapy. The overall survival (OS) and cancer-specific survival (CSS) for each group were estimated by the Kaplan-Meier method. A total of 2,967 patients (79.1 %) received CAB. Overall, no significant difference was observed in OS and CSS between the CAB group and the non-CAB group. However, CAB resulted in significantly better OS and CSS compared to non-CAB in patients with very high Japan Cancer of the Prostate Risk Assessment (J-CAPRA) scores of ten or greater (P = 0.007 and 0.013, respectively). Multivariate analysis revealed that CAB was an independent predictive factor for better OS (P = 0.013, hazard ratio = 0.83). Based on large-scale nationwide database, as PADT for prostate cancer patients with very high-risk disease, CAB resulted in better OS than other endocrine treatments.	[Matsuoka, Taeko; Kawai, Koji; Kimura, Tomokazu; Kojima, Takahiro; Miyazaki, Jun; Nishiyama, Hiroyuki] Univ Tsukuba, Inst Clin Med, Fac Med, Dept Urol, Tsukuba, Ibaraki 3058575, Japan; [Onozawa, Mizuki] Tokyo Kita Med Ctr, Dept Urol, Tokyo, Japan; [Hinotsu, Shiro] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan; [Akaza, Hideyuki] Univ Tokyo, Dept Strateg Invest Comprehens Canc Network, Res Ctr Adv Sci & Technol, Tokyo, Japan	Nishiyama, H (reprint author), Univ Tsukuba, Inst Clin Med, Fac Med, Dept Urol, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	taekomatsuoka@gmail.com; nishiuro@md.tsukuba.ac.jp					Akaza Hideyuki, 2013, Prostate Int, V1, P81, DOI 10.12954/PI.12016; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; Akaza H, 2004, JPN J CLIN ONCOL, V34, P329, DOI 10.1093/jjco/hyh061; Samson DJ, 2002, CANCER, V95, P361, DOI 10.1002/cncr.10647; Akaza H, 2009, CANCER, V115, P3437, DOI 10.1002/cncr.24395; Dalesio O, 2000, LANCET, V355, P1491; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Schmitt B, 2001, UROLOGY, V57, P727, DOI 10.1016/S0090-4295(00)01086-4; Nguyen QN, 2013, CANCER-AM CANCER SOC, V119, P3265, DOI 10.1002/cncr.28213; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Hinotsu S, 2007, JPN J CLIN ONCOL, V37, P775, DOI 10.1093/jjco/hym098; Klotz L, 2004, BJU INT, V93, P1177, DOI 10.1111/j.1464-410X.2004.04803.x; Ward JF, 2005, BJU INT, V95, P751, DOI 10.1111/j.1464-410X.2005.05394.x; Fujimoto H, 2011, INT J UROL, V18, P876, DOI 10.1111/j.1442-2042.2011.02895.x; Albertsen PC, 2014, EUR UROL, V65, P565, DOI 10.1016/j.eururo.2013.10.032; Walz J, 2011, BJU INT, V107, P765, DOI 10.1111/j.1464-410X.2010.09594.x; Fukagai T, 2006, BJU INT, V97, P1190, DOI 10.1111/j.1464-410X.2006.06201.x; Cooperberg MR, 2009, J CLIN ONCOL, V27, P4306, DOI 10.1200/JCO.2008.21.5228; Baade Peter D, 2013, Prostate Int, V1, P47, DOI 10.12954/PI.12014; Hong GE, 2010, ASIAN PAC J CANCER P, V11, P1351; Hsiao W, 2010, J UROLOGY, V184, P512, DOI 10.1016/j.juro.2010.04.010; Kimura T, 2013, INT J UROL, V20, P880, DOI 10.1111/iju.12064; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Ministry of Health Labour and Welfare, 2012, VIT STAT JAP; Onukwugha E, 2013, UROLOGY, V77, P1088; Studer UE, 2013, EUR UROL IN PRESS, DOI [10.1016/j.eururo.2013.07.024, DOI 10.1016/J.EURUR0.2013.07.024]	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0171-5216	1432-1335		J CANCER RES CLIN	J. Cancer Res. Clin. Oncol.	APR	2015	141	4					759	765		10.1007/s00432-014-1856-3		7	Oncology	Oncology	CD6NV	WOS:000351206900016		
J	Goldsmith, CE; Hara, Y; Sato, T; Nakajima, T; Nakanishi, S; Mason, C; Moore, JE; Matsuda, M; Coulter, WA				Goldsmith, C. E.; Hara, Y.; Sato, T.; Nakajima, T.; Nakanishi, S.; Mason, C.; Moore, J. E.; Matsuda, M.; Coulter, W. A.			Comparison of antibiotic susceptibility in viridans group streptococci in low and high antibiotic-prescribing General Practices	JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS			English	Article						antibiotic resistance; antibiotics; community; fluoroquinolones; infection; macrolide; penicillin; pneumococcus; prescriptions; tetracycline	IDENTIFICATION	What is known and objectiveAntibiotic resistance has become a global public health issue. Most antibiotics are prescribed in the community, although there is less stewardship of such agents in the community compared to secondary and tertiary care. Few studies have attempted to examine the prescribing practices in General Practice and its impact on antibiotic resistance and, therefore, a study was performed in order to compare antibiotic susceptibilities of commensal viridans group streptococci (VGS) obtained from patient cohorts in General Practices (GP), who were high and low prescribers of oral antibiotics. MethodSixty-five patients (<1month-81years; 77% female: 23% male) were enrolled onto the study, and viridans group streptococci (n=5/patient) were collected from each patient's nasal passages and oropharynx region and tested for antibiotic susceptibility against (i) tetracyclines (doxycycline); (ii) macrolides (erythromycin); (iii) -lactams (penicillin G); and (iv) fluoroquinolones (ofloxacin & levofloxacin). Results and discussionThere were no significant differences in MICs between high and low GP prescribers with doxycycline (P=0094), erythromycin (P=0122), ofloxacin (P=0193) and levofloxacin (P=0058). However, there was a significant difference between high and low GP practices with regard to penicillin G (P=0031). This finding is important as the -lactams are the most commonly prescribed oral antibiotic in the community. What is new and conclusionThis study demonstrates that high prescribing practices may lead to an altered (higher) level of resistance to these agents in the commensal VGS population, which may be important as reservoirs of antibiotic resistance determinants in subsequent horizontal gene transfer events, particularly with newly colonizing pathogens, including pneumococci. Primary care physicians should be aware that increased prescribing of antibiotics may led to increased level of penicillin resistance.	[Goldsmith, C. E.; Hara, Y.; Sato, T.; Nakajima, T.; Nakanishi, S.; Moore, J. E.] Belfast City Hosp, Dept Bacteriol, Northern Ireland Publ Hlth Lab, Belfast BT9 7AD, Antrim, North Ireland; [Hara, Y.; Sato, T.; Nakajima, T.; Nakanishi, S.; Matsuda, M.] Azabu Univ, Sch Environm Hlth Sci, Mol Biol Lab, Sagamihara, Kanagawa, Japan; [Mason, C.] Queens Univ Belfast, Royal Grp Hosp, Sch Dent, Belfast, Antrim, North Ireland; [Moore, J. E.; Coulter, W. A.] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland	Moore, JE (reprint author), Belfast City Hosp, Dept Bacteriol, Northern Ireland Publ Hlth Lab, Belfast BT9 7AD, Antrim, North Ireland.	jemoore@niphl.dnet.co.uk			HSC R&D Office commissioned grant: Antimicrobial Resistance Action Plan (AM-RAP) [COM/2730/04]	This work was financially supported through HSC R&D Office commissioned grant: Antimicrobial Resistance Action Plan (AM-RAP) (COM/2730/04).	Andrewes FW, 1906, LANCET, V2, P708; Millar BC, 2002, J CLIN MICROBIOL, V40, P1575, DOI 10.1128/JCM.40.5.1575-1580.2002; Breed RS, 1957, BERGEYS MANUAL DETER, P518; Chen CC, 2004, J CLIN MICROBIOL, V42, P2651, DOI 10.1128/JCM.42.6.2651-2657.2004; Hardie JM, 1997, J APPL MICROBIOL, V83, pS1, DOI 10.1046/j.1365-2672.83.s1.1.x; HEDGES AJ, 1977, J APPL BACTERIOL, V43, P271, DOI 10.1111/j.1365-2672.1977.tb00751.x; Maeda Y, 2011, BRIT J BIOMED SCI, V68, P190; Nakajima Takuya, 2013, Ulster Med J, V82, P164; Ruiz-Tovar J, 2012, SURG INFECT, V13, P130, DOI 10.1089/sur.2011.082; Wilson Megan, 2012, Clin Med Res, V10, P15, DOI 10.3121/cmr.2011.1001	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-4727	1365-2710		J CLIN PHARM THER	J. Clin. Pharm. Ther.	APR	2015	40	2					204	207		10.1111/jcpt.12245		4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC8UA	WOS:000350642600011		
J	Emoto-Yamamoto, Y; Iida, S; Kawanishi, T; Fukuoka, M				Emoto-Yamamoto, Y.; Iida, S.; Kawanishi, T.; Fukuoka, M.			Population pharmacokinetics of erlotinib in Japanese patients with advanced non-small cell lung cancer	JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS			English	Article						advanced non-small cell lung cancer; erlotinib; interstitial lung disease; nonlinear mixed-effects modelling; population pharmacokinetics	PHASE-II; DISEASE; PLASMA; PERFORMANCE; METABOLISM; SAFETY; MODEL	What is known and objectiveThis study aimed to elucidate the pharmacokinetics of erlotinib in Japanese patients with advanced non-small cell lung cancer (NSCLC) and to investigate the relationship between erlotinib exposure and the occurrence of interstitial lung disease (ILD)-like events. MethodsPopulation pharmacokinetics analysis was performed using nonlinear mixed-effects modelling software (NONMEM) based on 348 plasma samples from 97 patients obtained in two phase II clinical studies. Individual empirical Bayesian estimates (EBEs) of apparent oral clearance (CL/F) and C-max were compared between the patients who developed and did not develop ILD-like events. ResultsA 1-compartment model with first-order absorption and first-order elimination was used to describe the plasma concentrations of erlotinib. The estimated population pharmacokinetics parameters were as follows: 471L/h for CL/F, 163L for apparent volume of distribution (V-c/F) and 197h(-1) for absorption rate constant (K-a). Total bilirubin (TBIL) and alpha 1-acid glycoprotein (AGP) were identified as statistically significant covariates for CL/F. No differences in CL/F and C-max were observed between the patients with ILD-like events and those without ILD-like events. What is new and conclusionsA population pharmacokinetics model of erlotinib was developed and validated in Japanese patients. There was no relationship between exposure of erlotinib before the occurrence of ILD-like events and the occurrence of ILD-like events when erlotinib was administered at the same dosage. The high plasma concentration of erlotinib reported in patients after the onset of ILD-like events may be explained by CL/F decrease which occurs along with increasing levels of AGP which was identified as a covariate for CL/F.	[Emoto-Yamamoto, Y.; Iida, S.; Kawanishi, T.] Chugai Pharmaceut Co Ltd, Clin Res Planning Dept, Tokyo 1038324, Japan; [Fukuoka, M.] Izumi Municipal Hosp, Ctr Canc, Osaka, Japan	Iida, S (reprint author), Chugai Pharmaceut Co Ltd, Clin Res Planning Dept, Chuo Ku, 2-1-1 Nihonbashi Muromachi, Tokyo 1038324, Japan.	iidastf@chugai-pharm.co.jp					Tsubata Y, 2012, J CANCER RES THER, V8, P154, DOI 10.4103/0973-1482.95201; [Anonymous], 2013, GENETECH US; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Niho S, 2006, J CLIN ONCOL, V24, P64, DOI 10.1200/JCO.2005.02.5825; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Fukudo M, 2013, CLIN PHARMACOKINET, V52, P593, DOI 10.1007/s40262-013-0058-5; Liu Y, 2010, DRUG METAB DISPOS, V38, P32, DOI 10.1124/dmd.109.029660; Hamilton M, 2006, CLIN CANCER RES, V12, P2166, DOI 10.1158/1078-0432.CCR-05-2235; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Lu JF, 2006, CLIN PHARMACOL THER, V80, P136, DOI 10.1016/j.clpt.2006.04.007; Kubota K, 2008, J THORAC ONCOL, V3, P1439, DOI 10.1097/JTO.0b013e31818d6702; Parke J, 1999, COMPUT METH PROG BIO, V59, P19, DOI 10.1016/S0169-2607(98)00098-4; Nakagawa K, 2012, J THORAC ONCOL, V7, P1296, DOI 10.1097/JTO.0b013e3182598abb; Hughes AN, 2009, J CLIN ONCOL, V27, P1220, DOI 10.1200/JCO.2008.19.3995; Tsuboi M, 2006, MED ONCOL, V23, P161, DOI 10.1385/MO:23:2:161; Ette EI, 1997, J CLIN PHARMACOL, V37, P486; Ling J, 2006, DRUG METAB DISPOS, V34, P420, DOI 10.1124/dmd.105.007765; Ribbing J, 2004, J PHARMACOKINET PHAR, V31, P109, DOI 10.1023/B:JOPA.0000034404.86036.72; Nishimura Tsutomu, 2006, Pharm Pract (Granada), V4, P168, DOI 10.4321/s1885-642x2006000400004; Nyberg F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022062; Takahashi T, 2010, ANTICANCER RES, V30, P557; tersHeine R, 2012, LUNG CANCER, V75, P391; Van den Heuvel MM, 2000, AM J RESP CRIT CARE, V161, P1972; Zhao M, 2003, J CHROMATOGR B, V793, P413, DOI 10.1016/S1570-0232(03)00356-8	24	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-4727	1365-2710		J CLIN PHARM THER	J. Clin. Pharm. Ther.	APR	2015	40	2					232	239		10.1111/jcpt.12232		8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC8UA	WOS:000350642600016		
J	Hasegawa, T; Sakata, S				Hasegawa, Takayuki; Sakata, Shogo			A model of multisecond timing behaviour under peak-interval procedures	JOURNAL OF COMPUTATIONAL NEUROSCIENCE			English	Article						Akaike information criterion; Basic clock speed; Learning-to-time model; Peak procedure; Scalar property; Scalar expectancy theory	INTERNAL CLOCK; TIME DISCRIMINATION; NEURAL MECHANISMS; MEMORY; PACEMAKER; VARIANCE; DYNAMICS; STIMULI	In this study, the authors developed a fundamental theory of interval timing behaviour, inspired by the learning-to-time (LeT) model and the scalar expectancy theory (SET) model, and based on quantitative analyses of such timing behaviour. Our experiments used the peak-interval procedure with rats. The proposed model of timing behaviour comprises clocks, a regulator, a mixer, a response, and memory. Using our model, we calculated the basic clock speeds indicated by the subjects' behaviour under such peak procedures. In this model, the scalar property can be defined as a kind of transposition, which can then be measured quantitatively. The Akaike information criterion (AIC) values indicated that the current model fit the data slightly better than did the SET model. Our model may therefore provide a useful addition to SET for the analysis of timing behaviour.	[Hasegawa, Takayuki] Toyama Coll, Fac Liberal Arts & Sci, Natl Inst Technol, Toyama, Toyama 9398630, Japan; [Hasegawa, Takayuki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Syst Emot Sci, Toyama 9300194, Japan; [Hasegawa, Takayuki; Sakata, Shogo] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Dept Behav Sci, Higashihiroshima, Hiroshima 7398521, Japan	Hasegawa, T (reprint author), Toyama Coll, Fac Liberal Arts & Sci, Natl Inst Technol, Hongo Campus,13 Hongo Machi, Toyama, Toyama 9398630, Japan.	hhasseggawwwa@nifty.com					AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Clement A, 2006, BEHAV PROCESS, V71, P164, DOI 10.1016/j.beproc.2005.08.007; Spence KW, 1937, PSYCHOL REV, V44, P430, DOI 10.1037/h0062885; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Allman MJ, 2014, ANNU REV PSYCHOL, V65, P743, DOI 10.1146/annurev-psych-010213-115117; Staddon JER, 1999, J EXP ANAL BEHAV, V71, P215, DOI 10.1901/jeab.1999.71-215; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; CHURCH RM, 1984, ANN NY ACAD SCI, V423, P566, DOI 10.1111/j.1749-6632.1984.tb23459.x; KILLEEN PR, 1988, PSYCHOL REV, V95, P274, DOI 10.1037/0033-295X.95.2.274; Meck WH, 2006, BRAIN RES, V1109, P93, DOI 10.1016/j.brainres.2006.06.031; Saigusa T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018101; Alper JS, 1997, SYNTHESE, V110, P143; Matell MS, 2003, BEHAV NEUROSCI, V117, P760, DOI 10.1037/0735-7044.117.4.760; Fetterman JG, 1998, BEHAV PROCESS, V44, P211; Beckmann JS, 2009, J EXP PSYCHOL ANIM B, V35, P525, DOI 10.1037/a0015891; Cheng RK, 2007, BRAIN RES, V1186, P242, DOI [10.1016/j.brainres.2007.10.025, 10.1016/j.brainres.2007.10.002]; CHURCH RM, 1991, ANIM LEARN BEHAV, V19, P207, DOI 10.3758/BF03197878; CHURCH RM, 2003, METH NE FRO NEUROSCI, P3; Dayan P, 2001, THEORETICAL NEUROSCI; FETTERMAN JG, 1991, LEARN MOTIV, V22, P226, DOI 10.1016/0023-9690(91)90024-3; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; KILLEEN P, 1975, PSYCHOL REV, V82, P89, DOI 10.1037/h0076820; Killeen PR, 2000, PSYCHOL REV, V107, P430, DOI 10.1037/0033-295X.107.3.430; KirkpatrickSteger K, 1996, J EXP PSYCHOL ANIM B, V22, P447, DOI 10.1037/0097-7403.22.4.447; Machado A, 2000, J EXP ANAL BEHAV, V74, P25, DOI 10.1901/jeab.2000.74-25; Machado A, 1997, PSYCHOL REV, V104, P241, DOI 10.1037/0033-295X.104.2.241; Matell MS, 1999, BEHAV PROCESS, V45, P159, DOI 10.1016/S0376-6357(99)00016-9; Mazur J. E., 2006, LEARNING BEHAV, V6th; McAuley JD, 2006, BEHAV NEUROSCI, V120, P1163, DOI 10.1037/0735-7044.120.5.1163; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Oprisan Sorinel A, 2011, Front Integr Neurosci, V5, P52, DOI 10.3389/fnint.2011.00052; Oprisan SA, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-84; ROBERTS S, 1981, J EXP PSYCHOL ANIM B, V7, P242, DOI 10.1037/0097-7403.7.3.242; Vlastos G., 1967, ENCYCL PHILOS, V8, P369; Yi LL, 2007, BEHAV PROCESS, V75, P188, DOI 10.1016/j.beproc.2007.01.010; Zentall TR, 2006, BEHAV PROCESS, V71, P88, DOI 10.1016/j.beproc.2005.07.008	37	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0929-5313	1573-6873		J COMPUT NEUROSCI	J. Comput. Neurosci.	APR	2015	38	2					301	313		10.1007/s10827-014-0542-4		13	Mathematical & Computational Biology; Neurosciences	Mathematical & Computational Biology; Neurosciences & Neurology	CC9HS	WOS:000350680100006		
J	Hobara, H; Kobayashi, Y; Yoshida, E; Mochimaru, M				Hobara, Hiroaki; Kobayashi, Yoshiyuki; Yoshida, Eiichi; Mochimaru, Masaaki			Leg stiffness of older and younger individuals over a range of hopping frequencies	JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY			English	Article						Spring-like leg behavior; Spring-mass model; Aging	AGE-RELATED DIFFERENCES; TRICEPS SURAE; MUSCULOSKELETAL STIFFNESS; MORPHOLOGICAL PROPERTIES; GENDER-DIFFERENCES; STRIDE FREQUENCY; ADULTS; MASS; ADJUSTMENT; MUSCLES	The purpose of this study was to compare spring-mass behavior between older and younger individuals at a range of hopping frequencies. A total of 14 elderly and 14 young subjects performed in-place hopping in time with a metronome at frequencies of 2.2, 2.6, and 3.0 Hz. Using a spring-mass model, leg stiffness was calculated as the ratio of maximum ground reaction force to maximum center of mass displacement at the middle of the stance phase during ground contact. The lower extremities of both groups behaved like a simple spring-mass system at all three hopping frequencies. Further, statistical analysis revealed the existence of a significant interaction between hopping frequency and age group on leg stiffness. These results suggest that the sensitivity of leg stiffness to accommodate for variations in hopping frequency is likely to differ between elderly and young individuals. (C) 2015 Elsevier Ltd. All rights reserved.	[Hobara, Hiroaki; Kobayashi, Yoshiyuki; Mochimaru, Masaaki] Natl Inst Adv Ind Sci & Technol, Digital Human Res Ctr, Tokyo 1350064, Japan; [Yoshida, Eiichi] CNRS AIST JRL, Joint Robot Lab, CRT UMI3218, Tokyo, Japan	Hobara, H (reprint author), Natl Inst Adv Ind Sci & Technol, Digital Human Res Ctr, Koto Ku, 2-3-26 Aomi, Tokyo 1350064, Japan.	hobara-hiroaki@aist.go.jp			Priority Project of IS and DHRC, Advanced Industrial Science Technology	This study was supported by a Priority Project of IS and DHRC, Advanced Industrial Science & Technology.	Hoffren M, 2012, EUR J APPL PHYSIOL, V112, P4035, DOI 10.1007/s00421-012-2393-x; Hobara H, 2010, J BIOMECH, V43, P506, DOI 10.1016/j.jbiomech.2009.09.040; Girard O, 2010, SCI SPORT, V25, P99, DOI 10.1016/j.scispo.2009.10.001; Harrison AJ, 2004, J STRENGTH COND RES, V18, P473; Karamanidis K, 2005, J EXP BIOL, V208, P3907, DOI 10.1242/jeb.01830; Stenroth L, 2012, J APPL PHYSIOL, V113, P1537, DOI 10.1152/japplphysiol.00782.2012; Hobara H, 2008, J BIOMECH, V41, P506, DOI 10.1016/j.jbiomech.2007.10.014; Arampatzis A, 2001, J ELECTROMYOGR KINES, V11, P355, DOI 10.1016/S1050-6411(01)00009-8; Liu Y, 2006, J ELECTROMYOGR KINES, V16, P342, DOI 10.1016/j.jelekin.2005.08.001; Laffaye G, 2005, MED SCI SPORT EXER, V37, P536, DOI 10.1249/01.MSS.0000158991.17211.13; FARLEY CT, 1993, J EXP BIOL, V185, P71; Hoffren M, 2011, J ELECTROMYOGR KINES, V21, P483, DOI 10.1016/j.jelekin.2011.01.009; Narici MV, 2008, DISABIL REHABIL, V30, P1548, DOI 10.1080/09638280701831058; Farley CT, 1998, J APPL PHYSIOL, V85, P1044; Hortobagyi T, 2000, J ELECTROMYOGR KINES, V10, P117, DOI 10.1016/S1050-6411(99)00026-7; Padua DA, 2005, J MOTOR BEHAV, V37, P111, DOI 10.3200/JMBR.37.2.111-126; Oliver JL, 2010, J ELECTROMYOGR KINES, V20, P973, DOI 10.1016/j.jelekin.2010.03.011; Hobara H, 2014, J APPL BIOMECH, V30, P154, DOI 10.1123/jab.2012-0285; Hobara H, 2010, J SCI MED SPORT, V13, P106, DOI 10.1016/j.jsams.2008.08.002; Korff T, 2009, J EXP BIOL, V212, P3737, DOI 10.1242/jeb.033191; Baudry S, 2010, J NEUROPHYSIOL, V103, P623, DOI 10.1152/jn.00839.2009; Padua DA, 2006, J ATHL TRAINING, V41, P294; Hobara H, 2007, NEUROSCI LETT, V418, P55, DOI 10.1016/j.neulet.2007.02.064; Barber LA, 2013, EXP GERONTOL, V48, P1147, DOI 10.1016/j.exger.2013.07.007; Lloyd RS, 2012, J ELECTROMYOGR KINES, V22, P37, DOI 10.1016/j.jelekin.2011.09.008; Hobara H, 2012, J BIOMECH, V45, P2750, DOI 10.1016/j.jbiomech.2012.09.008; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Cohen J., 1988, STAT POWER ANAL BEHA; Farley CT, 1996, J BIOMECH, V29, P181, DOI 10.1016/0021-9290(95)00029-1; FARLEY CT, 1991, J APPL PHYSIOL, V71, P2127; Granata KP, 2002, J ELECTROMYOGR KINES, V12, P127, DOI 10.1016/S1050-6411(02)00003-2; Hebert-Losier K, 2014, J BIOMECH, V47, P115, DOI 10.1016/j.jbiomech.2013.09.027; Hobara H, 2013, J APPL BIOMECH, V29, P785; Hobara H, 2009, J BIOMECH, V42, P1768, DOI 10.1016/j.jbiomech.2009.04.047; Hoffren M, 2007, J APPL PHYSIOL, V103, P276; Lamontagne M, 2013, RES SPORTS MED, V21, P380, DOI 10.1080/15438627.2013.825795; Mademli L, 2008, J ELECTROMYOGR KINES, V18, P89, DOI 10.1016/j.jelekin.2006.09.008; Rabita G, 2008, EUR J APPL PHYSIOL, V103, P163, DOI 10.1007/s00421-008-0679-9; Ranavolo A, 2008, J APPL BIOMECH, V24, P271	39	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1050-6411	1873-5711		J ELECTROMYOGR KINES	J. Electromyogr. Kinesiol.	APR	2015	25	2					305	309		10.1016/j.jelekin.2015.02.004		5	Neurosciences; Physiology; Rehabilitation; Sport Sciences	Neurosciences & Neurology; Physiology; Rehabilitation; Sport Sciences	CC6HH	WOS:000350465500014		
J	Yonezu, A; Niwa, M; Chen, X				Yonezu, Akio; Niwa, Michihiro; Chen, Xi			Characterization of Hydrogen-Induced Contact Fracture in High-Strength Steel	JOURNAL OF ENGINEERING MATERIALS AND TECHNOLOGY-TRANSACTIONS OF THE ASME			English	Article						contact loading; spherical indentation test; hydrogen embrittlement cracking; high-strength steel	STRESS INTENSITY FACTOR; ASSISTED CRACK GROWTH; MARAGING-STEEL; INDENTATION CRACKING; EMBRITTLEMENT; TOUGHNESS; FATIGUE; SOLIDS; DAMAGE	This study investigated the hydrogen embrittlement (HE) cracking behavior produced by local contact loading of high-strength steel. When a spherical impression was applied to a hydrogen-absorbed high-strength steel, HE induces contact fracture, where radial cracks are initiated and propagated from the indentation impression. The length of the radial crack was found to be dependent on the hydrogen content in the steel as well as the applied contact force. A combined experimental/computational investigation was conducted in order to clarify the mechanism of hydrogen-induced contact fracture. In the computation, crack propagation was simulated using a cohesive zone model (CZM) in finite element method (FEM), in order to elucidate stress criterion of the present HE crack. It was found that the normal tensile stress was developed around impression, and it initiated and propagated the HE crack. It was also revealed that the hydrogen content enhanced contact fracture damage, especially the resistance of crack propagation (i.e., threshold stress intensity factor, Kth). The findings may be useful for countermeasure of contact fracture coupled with hydrogen in high-strength steel. Such phenomenon is potentially experienced in various contact components in hydrogen environment.	[Yonezu, Akio; Niwa, Michihiro] Chuo Univ, Dept Precis Mech, Bunkyo Ku, Tokyo 1128551, Japan; [Chen, Xi] Columbia Univ, Dept Earth & Environm Engn, New York, NY 10027 USA; [Chen, Xi] Xi An Jiao Tong Univ, Sch Aerosp, Int Ctr Appl Mech, SV Lab, Xian 710049, Peoples R China	Yonezu, A (reprint author), Chuo Univ, Dept Precis Mech, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	yonezu@mech.chuo-u.ac.jp; xichen@columbia.edu	Chen, Xi/B-1539-2008	Chen, Xi/0000-0002-2428-180X	JSPS KAKENHI from the Japan Society for the Promotion of Science (JSPS) [22760077]; Research Grant for Science and Technology of SUZUKI Foundation; National Natural Science Foundation of China [11172231]; DARPA [W91CRB-11-C-0112]; National Science Foundation [CMMI-0643726]	The work of A.Y. was supported in part of by JSPS KAKENHI (Grant No. 22760077) from the Japan Society for the Promotion of Science (JSPS) and Research Grant for Science and Technology of SUZUKI Foundation. The work of X.C. was supported by the National Natural Science Foundation of China (11172231), DARPA (W91CRB-11-C-0112), and the National Science Foundation (CMMI-0643726).	Tsay LW, 2005, CORROS SCI, V47, P965, DOI 10.1016/j.corsci.2004.06.017; Olden V, 2008, ENG FRACT MECH, V75, P2333, DOI 10.1016/j.engfracmech.2007.09.003; PAO PS, 1977, SCRIPTA METALL MATER, V11, P515, DOI 10.1016/0036-9748(77)90170-3; TVERGAARD V, 1992, J MECH PHYS SOLIDS, V40, P1377, DOI 10.1016/0022-5096(92)90020-3; ORIANI RA, 1974, ACTA METALL MATER, V22, P1065, DOI 10.1016/0001-6160(74)90061-3; EVANS AG, 1976, ACTA METALL MATER, V24, P939, DOI 10.1016/0001-6160(76)90042-0; STEIGERWALD EA, 1960, T AM I MIN MET ENG, V218, P832; Kubota M, 2006, TRIBOL INT, V39, P1241, DOI 10.1016/j.triboint.2006.02.014; Xia ZH, 2004, ACTA MATER, V52, P3507, DOI 10.1016/j.actamat.2004.04.004; COOK RF, 1990, J AM CERAM SOC, V73, P787, DOI 10.1111/j.1151-2916.1990.tb05119.x; Lee JH, 2012, ACTA MATER, V60, P5448, DOI 10.1016/j.actamat.2012.07.011; CIRUNA JA, 1973, WEAR, V24, P107, DOI 10.1016/0043-1648(73)90207-X; Yamaguchi Y, 1997, CORROSION, V53, P147; REDDY KG, 1992, J MATER SCI, V27, P5159, DOI 10.1007/BF00553385; Antlovich S. D., 1980, ENG FRAC MECH, V13, P717; Boyer H. E., 1985, METALS HDB DESK EDIT; Chen X, 2005, MECH MATER, V37, P447, DOI 10.1016/j.mechmat.2004.03.005; Chen X, 2007, J MECH PHYS SOLIDS, V55, P1618, DOI 10.1016/j.jmps.2007.01.010; Gangloff R. P., 2003, HYDROGEN ASSISTED CR; GANGLOFF RP, 1974, SCRIPTA METALL MATER, V8, P661, DOI 10.1016/0036-9748(74)90017-9; Hal B. A. E., 2007, MICROELECTRON RELIAB, V47, P1251; Lawn B.R., 1993, FRACTURE BRITTLE SOL; LOUTHAN MR, 1983, SCRIPTA METALL MATER, V17, P451, DOI 10.1016/0036-9748(83)90329-0; Szost BA, 2013, SCRIPTA MATER, V68, P467, DOI 10.1016/j.scriptamat.2012.11.018; Sumitomo Metals, 1999, HIGH STRENGTH HIGH T; Tanaka H., 2013, TRIBOL ONLINE, V8, P90; Tsay LW, 2008, CORROS SCI, V50, P2506, DOI 10.1016/j.corsci.2008.06.044; Yonezu A, 2012, MAT SCI ENG A-STRUCT, V531, P147, DOI 10.1016/j.msea.2011.10.049; Yonezu A, 2010, MECH RES COMMUN, V37, P230, DOI 10.1016/j.mechrescom.2010.01.001	29	1	1	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0094-4289	1528-8889		J ENG MATER-T ASME	J. Eng. Mater. Technol.-Trans. ASME	APR	2015	137	2							021007	10.1115/1.4029530		7	Engineering, Mechanical; Materials Science, Multidisciplinary	Engineering; Materials Science	CD1BX	WOS:000350809900007		
J	Nakatsuji, Y; Salehi, Z; Kawase, Y				Nakatsuji, Yusuke; Salehi, Zeinab; Kawase, Yoshinori			Mechanisms for removal of p-nitrophenol from aqueous solution using zero-valent iron	JOURNAL OF ENVIRONMENTAL MANAGEMENT			English	Article						Zero-valent iron; p-Nitrophenol; Removal mechanism; Solution pH; Dissolved oxygen	PHOTOCATALYTIC DEGRADATION; WASTE-WATER; DISSOLVED-OXYGEN; NITROAROMATIC COMPOUNDS; AEROBIC BIODEGRADATION; OXIDATIVE-DEGRADATION; ORGANIC-COMPOUNDS; REDUCTION; 4-NITROPHENOL; NANOPARTICLES	Batch experiments were conducted to examine mechanisms for removal of p-nitrophenol (PNP) from aqueous solution using zero-valent iron (ZVI). Removal of PNP using ZVI was mainly attributed to three mechanisms: degradation, precipitation and adsorption. A complete removal of 30 mg L-1 PNP with ZVI dosage of 1000 mg L-1 achieved within 30 min at pH 3. The PNP removal rate in the acidic solutions was significantly suppressed at higher pH. The modified Langmuir-Hinshelwood kinetic model could successfully describe the PNP removal process using ZVI at different pH conditions. Total organic carbon (TOC) removal efficiencies were found to be almost independent of pH. While the TOC removal at lower pH was profoundly affected by the reductive and/or oxidative degradation, the adsorption was favorable at higher pH. The effect of dissolved oxygen on PNP removal was investigated at pH 3 where a maximum contribution of oxidative degradation could be expected. The PNP removal in the anoxic system purged with nitrogen gas was quick as well as that in the system being open to the air. However, the TOC removal under the anoxic condition was negligible as compared with that in the oxic system. The profiles of the intermediates formed during the PNP degradation indicated that the reductive degradation was predominant in the initial phase of the removal and subsequently the oxidative degradation occurred. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakatsuji, Yusuke; Kawase, Yoshinori] Toyo Univ, Dept Appl Chem, Res Ctr Chem & Environm Engn, Saitama 3508585, Japan; [Salehi, Zeinab] Univ Tehran, Sch Chem Engn, Tehran, Iran	Kawase, Y (reprint author), Toyo Univ, Dept Appl Chem, Res Ctr Chem & Environm Engn, Kawagoe 2100, Saitama 3508585, Japan.	ykawase@toyonet.toyo.ac.jp		Kawase, Yoshinori/0000-0001-8483-6419			Maezono T, 2011, CHEMOSPHERE, V82, P1422, DOI 10.1016/j.chemosphere.2010.11.052; Triszcz JM, 2009, CHEM ENG J, V150, P431, DOI 10.1016/j.cej.2009.01.029; ALEKABI H, 1988, J PHYS CHEM-US, V92, P5726, DOI 10.1021/j100331a036; Dickinson M, 2010, J HAZARD MATER, V178, P171, DOI 10.1016/j.jhazmat.2010.01.060; Sekler MS, 2004, J APPL TOXICOL, V24, P395, DOI 10.1002/jat.1029; Sun SP, 2011, J MOL CATAL A-CHEM, V349, P71, DOI 10.1016/j.molcata.2011.08.022; Rodriguez-Maroto JM, 2009, CHEMOSPHERE, V74, P804, DOI 10.1016/j.chemosphere.2008.10.020; Agrawal A, 1996, ENVIRON SCI TECHNOL, V30, P153, DOI 10.1021/es950211h; Lee J, 2007, ENVIRON SCI TECHNOL, V41, P3335, DOI 10.1021/es062430g; Zhang YR, 2013, J HAZARD MATER, V244, P295, DOI 10.1016/j.jhazmat.2012.11.038; Keum YS, 2004, CHEMOSPHERE, V54, P255, DOI 10.1016/j.chemosphere.2003.08.003; Lai P, 2009, J HAZARD MATER, V162, P1423, DOI 10.1016/j.jhazmat.2008.06.034; Huang YH, 2005, WATER RES, V39, P1751, DOI 10.1016/j.watres.2005.03.002; Tang DY, 2007, J HAZARD MATER, V143, P49, DOI 10.1016/j.jhazmat.2006.08.066; Bell LS, 2003, J CONTAM HYDROL, V66, P201, DOI 10.1016/S0169-7722(03)00035-4; Zhang XL, 2011, J ENVIRON MANAGE, V92, P1328, DOI 10.1016/j.jenvman.2010.12.020; Herrera-Melian JA, 2012, J ENVIRON MANAGE, V105, P53, DOI 10.1016/j.jenvman.2012.03.044; Feitz AJ, 2005, COLLOID SURFACE A, V265, P88, DOI 10.1016/j.colsurfa.2005.01.038; Gemini VL, 2005, INT BIODETER BIODEGR, V55, P103, DOI 10.1016/j.ibiod.2004.08.003; Mielczarski JA, 2005, APPL CATAL B-ENVIRON, V56, P289, DOI 10.1016/j.apcatb.2004.09.017; Guettai N, 2005, DESALINATION, V185, P439, DOI 10.1016/j.desal.2005.04.049; Lai B, 2014, CHEM ENG J, V249, P143, DOI 10.1016/j.cej.2014.03.108; Lu C, 2012, J ENVIRON MANAGE, V113, P1, DOI 10.1016/j.jenvman.2012.08.023; Huang YH, 2006, WATER RES, V40, P3075, DOI 10.1016/j.watres.2006.06.016; Majidnia Z, 2015, CHEM ENG J, V262, P372, DOI 10.1016/j.cej.2014.09.118; Sun YP, 2006, ADV COLLOID INTERFAC, V120, P47, DOI 10.1016/j.cis.2006.03.001; Klausen J, 2001, CHEMOSPHERE, V44, P511, DOI 10.1016/S0045-6535(00)00385-4; Idris A, 2011, J HAZARD MATER, V186, P629, DOI 10.1016/j.jhazmat.2010.11.101; Lai B, 2013, J HAZARD MATER, V250, P220, DOI 10.1016/j.jhazmat.2013.02.002; de Velosa AC, 2013, J ENVIRON MANAGE, V121, P72, DOI 10.1016/j.jenvman.2013.02.031; Bang S, 2005, J HAZARD MATER, V121, P61, DOI 10.1016/j.jhazmat.2005.01.030; Li XQ, 2006, CRIT REV SOLID STATE, V31, P111, DOI 10.1080/10408430601057611; Keenan CR, 2008, ENVIRON SCI TECHNOL, V42, P1262, DOI 10.1021/es7025664; Wang WD, 2007, APPL CATAL B-ENVIRON, V70, P470, DOI 10.1016/j.apcatb.2005.11.034; Wang KS, 2010, J HAZARD MATER, V182, P886, DOI 10.1016/j.jhazmat.2010.07.002; Crane RA, 2012, J HAZARD MATER, V211, P112, DOI 10.1016/j.jhazmat.2011.11.073; Chen JL, 2001, J HAZARD MATER, V83, P243, DOI 10.1016/S0304-3894(01)00193-5; Joo SH, 2004, ENVIRON SCI TECHNOL, V38, P2242, DOI 10.1021/es035157g; Shimizu A, 2012, J HAZARD MATER, V201, P60, DOI 10.1016/j.jhazmat.2011.11.009; Kanel SR, 2005, ENVIRON SCI TECHNOL, V39, P1291, DOI 10.1021/es048991u; Dieckmann MS, 1996, WATER RES, V30, P1169, DOI 10.1016/0043-1354(95)00240-5; He C, 2013, SEP PURIF TECHNOL, V117, P59, DOI 10.1016/j.seppur.2013.04.028; Choe S, 2001, CHEMOSPHERE, V42, P367, DOI 10.1016/S0045-6535(00)00147-8; Fu FL, 2014, J HAZARD MATER, V267, P194, DOI 10.1016/j.jhazmat.2013.12.062; HELLAND BR, 1995, J HAZARD MATER, V41, P205, DOI 10.1016/0304-3894(94)00111-S; Kulkarni M, 2007, J ENVIRON MANAGE, V85, P496, DOI 10.1016/j.jenvman.2007.06.009; Oh SY, 2005, WATER RES, V39, P5027, DOI 10.1016/j.watres.2005.10.004; Pourrezaei P, 2014, J ENVIRON MANAGE, V139, P50, DOI 10.1016/j.jenvman.2014.03.001; Salehi Z, 2011, PROCESS BIOCHEM, V46, P284, DOI 10.1016/j.procbio.2010.08.024; Shaoqing Y., 2010, RADIAT PHYS CHEM, V79, P1039; Sugiyama M, 2012, WATER SCI TECHNOL, V65, P1882, DOI 10.2166/wst.2012.080; Tokumura M, 2011, APPL CATAL B-ENVIRON, V106, P565, DOI 10.1016/j.apcatb.2011.06.017; Yoshino H, 2014, J ENVIRON SCI HEAL A, V49, P998, DOI 10.1080/10934529.2014.894841; Zhou MH, 2006, CHEMOSPHERE, V63, P1032, DOI 10.1016/j.chemosphere.2005.08.057	54	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0301-4797	1095-8630		J ENVIRON MANAGE	J. Environ. Manage.	APR 1	2015	152						183	191		10.1016/j.jenvman.2015.01.012		9	Environmental Sciences	Environmental Sciences & Ecology	CC7AF	WOS:000350519400022		
J	Kojima, M; Suzuki, Y; Tsai, CY; Sasaki, K; Wake, K; Watanabe, S; Taki, M; Kamimura, Y; Hirata, A; Sasaki, K; Sasaki, H				Kojima, Masami; Suzuki, Yukihisa; Tsai, Cheng-Yu; Sasaki, Kensuke; Wake, Kanako; Watanabe, Soichi; Taki, Masao; Kamimura, Yoshitsugu; Hirata, Akimasa; Sasaki, Kazuyuki; Sasaki, Hiroshi			Characteristics of ocular temperature elevations after exposure to quasi- and millimeter waves (18-40 GHz)	JOURNAL OF INFRARED MILLIMETER AND TERAHERTZ WAVES			English	Article						Quasi-millimeter wave; Millimeter wave; Rabbit eye; Ocular temperature; Frequency-specific difference	ELECTROMAGNETIC-FIELDS; ABSORPTION; MODEL; EYE	In order to investigate changes in ocular temperature in rabbit eyes exposed to different frequencies (18 to 40 GHz) of quasi-millimeter waves, and millimeter waves (MMW). Pigmented rabbits were anesthetized with both general and topical anesthesia, and thermometer probes (0.5 mm in diameter) were inserted into their cornea (stroma), lens (nucleus) and vitreous (center of vitreous). The eyes were exposed unilaterally to 200 mW/cm(2) by horn antenna for 3 min at 18, 22 and 26.5 GHz using a K band exposure system or 26.5, 35 and 40 GHz using a Ka band exposure system. Changes in temperature of the cornea, lens and vitreous were measured with a fluoroptic thermometer. Since the ocular temperatures after exposure to 26.5 GHz generated by the K band and Ka band systems were similar, we assumed that experimental data from these 2 exposure systems were comparable. The highest ocular temperature was induced by 40 GHz MMW, followed by 35 GHz. The 26.5 and 22 GHz corneal temperatures were almost the same. The lowest temperature was recorded at 18 GHz. The elevation in ocular temperature in response to exposure to 200 mW/cm(2) MMW is dependent on MMW frequency. MMW exposure induced heat is conveyed not only to the cornea but also the crystalline lens.	[Kojima, Masami; Tsai, Cheng-Yu; Sasaki, Kazuyuki; Sasaki, Hiroshi] Kanazawa Med Univ, Med Res Inst, Div Vis Res Environm Hlth, Kahoku, Ishikawa 92002, Japan; [Kojima, Masami; Sasaki, Hiroshi] Kanazawa Med Univ, Dept Ophthalmol, Kahoku, Ishikawa 92002, Japan; [Kojima, Masami] Kanazawa Med Univ, Sch Nursing, Uchinada, Ishikawa 9200293, Japan; [Suzuki, Yukihisa; Taki, Masao] Tokyo Metropolitan Univ, Grad Sch Engn, Dept Elect Engn, Tokyo 158, Japan; [Sasaki, Kensuke; Wake, Kanako; Watanabe, Soichi] Natl Inst Informat & Commun Technol, Tokyo, Japan; [Kamimura, Yoshitsugu] Utsunomiya Univ, Grad Sch Engn, Dept Informat Sci, Utsunomiya, Tochigi 321, Japan; [Hirata, Akimasa] Nagoya Inst Technol, Grad Sch Engn, Nagoya, Aichi, Japan	Kojima, M (reprint author), Kanazawa Med Univ, Sch Nursing, 1-1 Daigaku, Uchinada, Ishikawa 9200293, Japan.	m-kojima@kanazawa-med.ac.jp	Hirata, Akimasa/I-8245-2012	Hirata, Akimasa/0000-0001-8336-1140	Committee to Promote Research on the Potential Biological Effects of Electromagnetic Fields, Ministry of Internal Affairs and Communications, Japan	This work was supported by the Committee to Promote Research on the Potential Biological Effects of Electromagnetic Fields, Ministry of Internal Affairs and Communications, Japan.	Alm A., 1992, ADLERS PHYSL EYE, P198; Suzuki Y, 2006, IEEE T DIELECT EL IN, V13, P744, DOI 10.1109/TDEI.2006.1667731; Kojima M, 2009, HEALTH PHYS, V97, P212, DOI 10.1097/HP.0b013e3181abaa57; Riu PJ, 1997, BIOELECTROMAGNETICS, V18, P578, DOI 10.1002/(SICI)1521-186X(1997)18:8<578::AID-BEM6>3.0.CO;2-#; DABIRI D, 1991, EXP FLUIDS, V11, P77; Chalfin S, 2002, HEALTH PHYS, V83, P83, DOI 10.1097/00004032-200207000-00009; Durney C., 1986, 8573 USAFSAM; FERGASON JL, 1968, APPL OPTICS, V7, P1729, DOI 10.1364/AO.7.001729; Foster KR, 2003, HEALTH PHYS, V84, P764, DOI 10.1097/00004032-200306000-00009; GANDHI OP, 1986, IEEE T MICROW THEORY, V34, P228, DOI 10.1109/TMTT.1986.1133316; Hagan G. J., 1976, BIOL EFFECTS ELECTRO, p[77, 143]; Ahlbom A, 1998, HEALTH PHYS, V74, P494; IEEE International Committee on Electromagnetic Safety, 2005, C951 IEEE INT COMM E; Karampatzakis A, 2010, PHYS MED BIOL, V55, P5653, DOI 10.1088/0031-9155/55/19/003; Kojima M, 2004, BIOELECTROMAGNETICS, V25, P228, DOI 10.1002/bem.10195; Kues HA, 1999, BIOELECTROMAGNETICS, V20, P463, DOI 10.1002/(SICI)1521-186X(199912)20:8<463::AID-BEM1>3.0.CO;2-T; Rosenthal S. W., 1976, BIOL EFFECTS ELECTRO, V77-8010, P110	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6892	1866-6906		J INFRARED MILLIM TE	J. Infrared Millim. Terahertz Waves	APR	2015	36	4					390	399		10.1007/s10762-014-0142-4		10	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	CD1GR	WOS:000350823500006		
J	Fujita, S				Fujita, Shinsaku			Combinatorial approach to group hierarchy for stereoskeletons of ligancy 4	JOURNAL OF MATHEMATICAL CHEMISTRY			English	Article						Proligand method; Ligancy 4; Stereoskeleton; Group hierarchy; Stereoisomer; Stereoisogram; Enumeration	SYMMETRY-ITEMIZED ENUMERATION; RS-STEREOISOMERIC GROUPS; SQUARE-PLANAR COMPLEXES; POINT MATRIX-METHOD; CHEMICAL-STRUCTURES; RESTRUCTURING STEREOCHEMISTRY; 3-DIMENSIONAL TREES; SPHERICITY INDEXES; CUBANE DERIVATIVES; GROSS ENUMERATION	Fujita's proligand method developed originally for combinatorial enumeration under point groups (Fujita in Theor Chem Acc 113:73-79, 2005) is extended to meet the group hierarchy, which stems from the stereoisogram approach for integrating geometric aspects and stereoisomerism in stereochemistry (Fujita in J Org Chem 69:3158-3165, 2004). Thereby, it becomes applicable to enumeration under respective levels of the group hierarchy. Combinatorial enumerations are conducted to count inequivalent pairs of (self-)enantiomers under a point group, inequivalent quadruplets of RS-stereoisomers under an RS-stereoisomeric group, inequivalent sets of stereoisomers under a stereoisomeric group, and inequivalent sets of isoskeletomers under an isoskeletal group. In these enumerations, stereoskeletons of ligancy 4 are used as examples, i.e., a tetrahedral skeleton, an allene skeleton, an ethylene skeleton, an oxirane skeleton, a square planar skeleton, and a square pyramidal skeleton. Two kinds of compositions are used for the purpose of representing molecular formulas in an abstract fashion, that is to say, the compositions for differentiating proligands having opposite chirality senses and the compositions for equalizing proligands having opposite chirality senses. Thereby, the classifications of isomers are accomplished in a systematic fashion.	Shonan Inst Chemoinformat & Math Chem, Kawasaki, Kanagawa 2580019, Japan	Fujita, S (reprint author), Shonan Inst Chemoinformat & Math Chem, Kaneko 479-7 Ooimachi, Kawasaki, Kanagawa 2580019, Japan.	shinsaku_fujita@nifty.com					FUJITA S, 1993, POLYHEDRON, V12, P95, DOI 10.1016/S0277-5387(00)87059-X; Fujita S, 2014, J MATH CHEM, V52, P1717, DOI 10.1007/s10910-014-0344-y; Fujita S, 2005, THEOR CHEM ACC, V113, P73, DOI 10.1007/s00214-004-0605-0; Fujita S, 2004, TETRAHEDRON, V60, P11629, DOI 10.1016/j.tet.2004.09.068; FUJITA S, 1991, TETRAHEDRON, V47, P31, DOI 10.1016/0040-4020(91)80005-M; Fujita S, 2014, J MATH CHEM, V52, P508, DOI 10.1007/s10910-013-0276-y; Fujita S, 2004, J ORG CHEM, V69, P3158, DOI 10.1021/jo030393v; Fujita S, 2014, J MATH CHEM, V52, P1751, DOI 10.1007/s10910-014-0345-x; Fujita S, 2012, J MATH CHEM, V50, P2168, DOI 10.1007/s10910-012-0024-8; Fujita S, 2004, J MATH CHEM, V35, P265, DOI 10.1023/B:JOMC.0000033259.61553.25; Fujita S, 2012, TETRAHEDRON-ASYMMETR, V23, P623, DOI 10.1016/j.tetasy.2012.04.020; Balaban A T, 1976, CHEM APPL GRAPH THEO; BALASUBRAMANIAN K, 1985, CHEM REV, V85, P599, DOI 10.1021/cr00070a005; Biggs N. L., 1976, GRAPH THEORY 1736 19; Fujita S, 2010, B CHEM SOC JPN, V83, P1, DOI 10.1246/bcsj.20090008; Fujita S, 2008, J MATH CHEM, V43, P141, DOI 10.1007/s10910-006-9187-5; Fujita S, 2007, THEOR CHEM ACC, V117, P353, DOI 10.1007/s00214-006-0162-9; Fujita S, 2006, THEOR CHEM ACC, V115, P37, DOI 10.1007/s00214-005-0674-8; FUJITA S, 1990, J AM CHEM SOC, V112, P3390, DOI 10.1021/ja00165a021; Fujita S, 2012, MATCH-COMMUN MATH CO, V67, P5; Fujita S, 2003, J MATH CHEM, V33, P113, DOI 10.1023/A:1023251932146; Fujita S., 1991, SYMMETRY COMBINATORI; Fujita S, 2005, MATCH-COMMUN MATH CO, V54, P39; Fujita S., 2005, MEMOIRS FACULTY ENG, V53, P19; Fujita S, 2007, THEOR CHEM ACC, V117, P339, DOI 10.1007/s00214-006-0163-8; Fujita S, 2005, MATCH-COMMUN MATH CO, V53, P147; Fujita S, 2002, J MATH CHEM, V32, P1, DOI 10.1023/A:1021287622494; Fujita S, 2005, THEOR CHEM ACC, V113, P80, DOI 10.1007/s00214-004-0606-z; Fujita S., 2004, MATCH COMMUN MATH CO, V52, P3; Fujita S., 2013, COMBINATORIAL ENUMER; Fujita S, 2012, MATCH-COMMUN MATH CO, V67, P649; FUJITA S, 1990, B CHEM SOC JPN, V63, P315, DOI 10.1246/bcsj.63.315; Fujita S, 2002, HELV CHIM ACTA, V85, P2440, DOI 10.1002/1522-2675(200208)85:8<2440::AID-HLCA2440>3.0.CO;2-Y; Fujita S, 2012, MATCH-COMMUN MATH CO, V67, P25; Fujita S, 2006, CROAT CHEM ACTA, V79, P411; Fujita S, 2004, J CHEM INF COMP SCI, V44, P1719, DOI 10.1021/ci040103r; Harary F., 1973, GRAPHICAL ENUMERATIO; Harary F., 1969, GRAPH THEORY; Harary F., 1976, CHEM APPL GRAPH THEO, P11; Harary F., 1967, GRAPH THEORY THEORET, P1; Helmchen G., 1996, STEREOSELECTIVE SYNT, V1, P1; Hosoya H., 1972, KAGAKU RYOIKI, V26, P989; Liu G.L., 1968, INTRO COMBINATORIAL; Mislow K., 1965, INTRO STEREOCHEMISTR; Polansky O. E., 1975, MATCH COMMUN MATH CO, V1, P11; Polya G., 1983, NOTES INTRO COMBINAT; Polya G, 1937, ACTA MATH-DJURSHOLM, V68, P145, DOI 10.1007/BF02546665; Read R.C., 1987, COMBINATORIAL ENUMER; ROUVRAY DH, 1974, CHEM SOC REV, V3, P355, DOI 10.1039/cs9740300355; Trinajstic N., 1983, CHEM GRAPH THEORY, V2; Trinajstic N., 1983, CHEM GRAPH THEORY, V1	51	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0259-9791	1572-8897		J MATH CHEM	J. Math. Chem.	APR	2015	53	4					1010	1053		10.1007/s10910-014-0467-1		44	Chemistry, Multidisciplinary; Mathematics, Interdisciplinary Applications	Chemistry; Mathematics	CD1GV	WOS:000350823900003		
J	Takaki, K; Kageyama, K; Sunahara, A; Yabuuchi, T; Tanaka, KA				Takaki, Kazushige; Kageyama, Kei; Sunahara, Atsushi; Yabuuchi, Toshinori; Tanaka, Kazuo A.			Simulated ablation of carbon wall by alpha particles for a laser fusion reactor	JOURNAL OF NUCLEAR MATERIALS			English	Article								Thermal reactions of materials heated by charged particles may lead to serious damage in a laser fusion reactor. When charged particles irradiate and heat the wall material with high intensity like at above 10(9) W/cm(2), the material can be ablated. Once the wall is ablated, expanding gas or plasma can disturb the propagation of laser light irradiating the fuel target if it stagnates long enough for next laser shot. In order to understand the ablation dynamics in detail, we have performed 1-D hydro simulation to evaluate this ablation. As a new feature, we introduce the calculation of energy deposition by charged particles focusing on the interaction between ablated material and charged particles. (C) 2015 Elsevier B.V. All rights reserved.	[Takaki, Kazushige; Kageyama, Kei; Yabuuchi, Toshinori; Tanaka, Kazuo A.] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Sunahara, Atsushi] Inst Laser Technol, Suita, Osaka 5650871, Japan	Takaki, K (reprint author), Osaka Univ, Grad Sch Engn, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	takaki-k@eie.eng.osaka-u.ac.jp			JSPS; NSF PIRE: RAIJIN Project; JSPS: ASHULA (Asian core program for High energy density science Using intense LAser photons); Institute of Laser Engineering [2014B2-41]; Osaka University [2014B2-41]	K. Takaki thanks Prof. A Hassanein and Prof. T. S. Sizyuk at Purdue University and Prof. T. Johzaki at Hiroshima University for the grateful discussions. The authors are grateful to the support for high-performance computing in the Institute of Laser Engineering, Osaka University. Part of this work is supported by JSPS and NSF PIRE: RAIJIN Project, JSPS: ASHULA (Asian core program for High energy density science Using intense LAser photons) and the joint research of the Institute of Laser Engineering and Osaka University (2014B2-41).	Andersen H., 1977, HYDROGEN STOPPING PO; Sunahara A, 2010, FUSION ENG DES, V85, P935, DOI 10.1016/j.fusengdes.2010.09.017; Goto T, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075006; MEHLHORN TA, 1981, J APPL PHYS, V52, P6522, DOI 10.1063/1.328602; Goto T, 2007, FUSION SCI TECHNOL, V52, P953; Hassanein A, 2002, FUSION ENG DES, V60, P527, DOI 10.1016/S0920-3796(02)00008-X; Kono T., 2012, PLASMA FUSION RES, V7; Ziegler J., 2008, SRIM STOPPING RANGE	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	APR	2015	459						77	80		10.1016/j.jnucmat.2015.01.005		4	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CC9SE	WOS:000350710700011		
J	Soucek, P; Murakami, T; Claux, B; Meier, R; Malmbeck, R; Tsukada, T; Glatz, JP				Soucek, P.; Murakami, T.; Claux, B.; Meier, R.; Malmbeck, R.; Tsukada, T.; Glatz, J. -P.			Separation of actinides from irradiated An-Zr based fuel by electrorefining on solid aluminium cathodes in molten LiCl-KCl	JOURNAL OF NUCLEAR MATERIALS			English	Article							REACTOR METAL FUELS; MINOR ACTINIDES; ALLOY FUEL; SPENT FUEL	An electrorefining process for metallic spent nuclear fuel treatment is being investigated in ITU. Solid aluminium cathodes are used for homogeneous recovery of all actinides within the process carried out in molten LiCl-KCl eutectic salt at a temperature of 500 degrees C. As the selectivity, efficiency and performance of solid Al has been already shown using un-irradiated An-Zr alloy based test fuels, the present work was focused on laboratory-scale demonstration of the process using irradiated METAPHIX-1 fuel composed of U-67-Pu-19-Zr-10-MA(2)-RE2 (wt.%, MA = Np, Am, Cm, RE = Nd, Ce, Gd, Y). Different electrorefining techniques, conditions and cathode geometries were used during the experiment yielding evaluation of separation factors, kinetic parameters of actinide-aluminium alloy formation, process efficiency and macro-structure characterisation of the deposits. The results confirmed an excellent separation and very high efficiency of the electrorefining process using solid Al cathodes. (C) 2015 The Authors. Published by Elsevier B.V.	[Soucek, P.; Claux, B.; Meier, R.; Malmbeck, R.; Glatz, J. -P.] Commiss European Communities, JRC, Inst Transuranium Elements ITU, D-76125 Karlsruhe, Germany; [Murakami, T.; Tsukada, T.] CRIEPI, Komae, Tokyo 2018511, Japan	Soucek, P (reprint author), Commiss European Communities, JRC, Inst Transuranium Elements ITU, Postfach 2340, D-76125 Karlsruhe, Germany.	Pavel.Soucek@ec.europa.eu			European Commission [323282]	The authors wish to thank B. Lynch and S.V. Winckel for ICP-MS analyses and A. Rodrigues and M. Ougier for experimental support. This work was carried out with the European Commission financial support in the 7th framework program, under the collaborative project "SACSESS", Grant Agreement No. 323282.	Ahluwalia RK, 2001, NUCL TECHNOL, V133, P103; Ohta H, 2011, J NUCL SCI TECHNOL, V48, P654, DOI 10.3327/jnst.48.654; Conocar O, 2006, NUCL SCI ENG, V153, P253; [Anonymous], 2004, TECHN REP SER INT AT; Ohta H, 2009, NUCL TECHNOL, V165, P96; Soucek P, 2008, RADIOCHIM ACTA, V96, P315, DOI 10.1524/ract.2008.1493; Serp J, 2005, J ELECTROCHEM SOC, V152, pC167, DOI 10.1149/1.1859812; Magill J, 2003, NUCL ENERG-J BR NUCL, V42, P263, DOI 10.1680/nuen.42.5.263.37622; Cassayre L, 2007, J NUCL MATER, V360, P49, DOI 10.1016/j.jnucmat.2006.08.013; [Anonymous], 2002, GIF00200 US DOE NUCL; Glatz JP, 2013, MOLTEN SALTS CHEMISTRY: FROM LAB TO APPLICATIONS, P541; Kato T., 2011, P P GLOB 2011 MAK JA; Laidler J. J., 1997, Progress in Nuclear Energy, V31, DOI 10.1016/0149-1970(96)00007-8; Soucek P, 2011, ENRGY PROCED, V7, P396, DOI 10.1016/j.egypro.2011.06.052; Souecek P., 2009, P GLOB 2009 PAR FRAN, P1156; Taxil P., 2003, J MIN METALL B, V39, P177; Westphal B. R., 2009, P GLOB 2009 SEPT 6 1, P1291; Williamson MA, 2011, NUCL ENG TECHNOL, V43, P329, DOI 10.5516/NET.2011.43.4.329	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	APR	2015	459						114	121		10.1016/j.jnucmat.2014.12.103		8	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CC9SE	WOS:000350710700016		
J	Lin, YR; Ku, CS; Ho, CY; Chuang, WT; Kondo, S; Kai, JJ				Lin, Yan-Ru; Ku, Ching-Shun; Ho, Chun-Yu; Chuang, Wei-Tsung; Kondo, Sosuke; Kai, Ji-Jung			Irradiation-induced microstructural evolution and swelling of 3C-SiC	JOURNAL OF NUCLEAR MATERIALS			English	Article							SILICON-CARBIDE; NEUTRON-IRRADIATION; HIGH-TEMPERATURES; DEFECTS; HELIUM	In this study, an ion-irradiated single crystal 3C-SiC under fluences of up to 20 dpa at 400-1350 degrees C was examined using synchrotron based X-ray diffraction and high resolution transmission electron microscopy. Interstitial clusters, dislocation loops, Frank loops, stacking fault loops, and voids in 3C-SiC were investigated. The high resolution TEM results show that clusters collapsed to {1 1 1} small loops when their size reached few nm with increasing temperature, and gradually develop into Frank loops with an added atomic layer along {1 1 1} at 1000 degrees C. Interplanar spacing information of single crystal SiC was obtained from synchrotron XRD radial scan measurements. Irradiation-induced volume swelling at 400-1350 degrees C was measured, and the anisotropic (a = b < c) swelling behavior of SiC was confirmed. In addition, humps on the right side of SiC (0 0 2) were observed, which suggested that C+/Si+-Si < 1 0 0 > and/or C+/Si+-C < 1 0 0 > dumbbells gave rise to diffuse scattering. (C) 2015 Elsevier B.V. All rights reserved.	[Lin, Yan-Ru; Kai, Ji-Jung] Natl Tsing Hua Univ, Dept Engn & Syst Sci, Hsinchu 30013, Taiwan; [Lin, Yan-Ru; Ku, Ching-Shun; Chuang, Wei-Tsung] Natl Synchrotron Radiat Res Ctr, Hsinchu 30076, Taiwan; [Ho, Chun-Yu; Kai, Ji-Jung] Natl Tsing Hua Univ, Inst Nucl Engn & Sci, Hsinchu 30013, Taiwan; [Kondo, Sosuke] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan; [Kai, Ji-Jung] Natl Tsing Hua Univ, Dept Mech & Biomed Engn, Hsinchu 30013, Taiwan	Kai, JJ (reprint author), Natl Tsing Hua Univ, Inst Nucl Engn & Sci, Hsinchu 30013, Taiwan.	ceer0001@gmail.com		KAI, Ji-jung/0000-0001-7848-8753	National Science Council (Taiwan) [NSC102-3113-P-007-014]	This work was supported by the National Science Council (Taiwan) Program NSC102-3113-P-007-014. The authors gratefully thank Mr. Wu for his assistance with sample preparation and Dr. S.C. Tsai, Mr. W.H. Huang, and Mr. I.C. Chiu for their insightful comments.	Kondo S, 2008, J NUCL MATER, V382, P160, DOI 10.1016/j.jnucmat.2008.08.013; Katoh Y, 2006, J NUCL MATER, V351, P228, DOI 10.1016/j.jnucmat.2006.02.007; Bechstedt F, 1997, PHYS STATUS SOLIDI B, V202, P35, DOI 10.1002/1521-3951(199707)202:1<35::AID-PSSB35>3.0.CO;2-8; Katoh Y, 2014, J NUCL MATER, V455, P387, DOI 10.1016/j.jnucmat.2014.06.003; Fissel A, 2003, PHYS REP, V379, P149, DOI 10.1016/S0370-1573(02)00632-4; Ungar T, 2001, MAT SCI ENG A-STRUCT, V309, P14, DOI 10.1016/S0921-5093(00)01685-3; Ivashchenko VI, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.085209; Senor DJ, 2003, J NUCL MATER, V317, P145, DOI 10.1016/S0022-3115(03)00077-1; Gao F, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.245208; Stoller RE, 2007, J NUCL MATER, V367, P269, DOI [10.1016/j.jnucmat.2007.03.019, 10.1016/j.jnuemat.2007.03.019]; Snead LL, 2007, J NUCL MATER, V367, P677, DOI 10.1016/j.jnucmat.2007.03.097; BLACKSTO.R, 1971, J NUCL MATER, V39, P319, DOI 10.1016/0022-3115(71)90152-8; BORODIN VA, 1993, J NUCL MATER, V202, P169, DOI 10.1016/0022-3115(93)90040-6; Chen CH, 2014, J NUCL MATER, V453, P280, DOI 10.1016/j.jnucmat.2014.07.020; Gao F, 2003, APPL PHYS LETT, V82, P913, DOI 10.1063/1.1542686; Ho CY, 2013, J NUCL MATER, V443, P1, DOI 10.1016/j.jnucmat.2013.06.045; Huang HC, 1997, J NUCL MATER, V250, P192, DOI 10.1016/S0022-3115(97)00269-9; Knippenberg W.F., 1963, Philips Research Reports, V18; Kondo S, 2009, J NUCL MATER, V386-88, P222, DOI 10.1016/j.jnucmat.2008.12.095; Lin YR, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869829; Lin YR, 2014, J NUCL MATER, V455, P292, DOI 10.1016/j.jnucmat.2014.06.061; PRICE RJ, 1973, J NUCL MATER, V46, P268, DOI 10.1016/0022-3115(73)90041-X; PRICE RJ, 1969, J NUCL MATER, V33, P17, DOI 10.1016/0022-3115(69)90003-8; Schoner A, 2005, MATER SCI FORUM, V483, P801; Snead LL, 2007, J NUCL MATER, V371, P329, DOI 10.1016/j.jnucmat.2007.05.016; Snead LL, 2002, J NUCL MATER, V307, P1141, DOI 10.1016/S0022-3115(02)01052-8; Yano T, 1998, J NUCL MATER, V253, P78, DOI 10.1016/S0022-3115(97)00331-0	27	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	APR	2015	459						276	283		10.1016/j.jnucmat.2015.01.040		8	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CC9SE	WOS:000350710700036		
J	Liu, WQ; Suzuki, K; Shibanuma, K				Liu, Weiqin; Suzuki, Katsuyuki; Shibanuma, Kazuki			A Two-Dimensional Hydroelastoplasticity Method of a Container Ship in Extreme Waves	JOURNAL OF OFFSHORE MECHANICS AND ARCTIC ENGINEERING-TRANSACTIONS OF THE ASME			English	Article								Extreme waves have led to many accidents and losses of ships at sea. In this paper, a two-dimensional (2D) hydroelastoplasticity method is proposed as a means of studying the nonlinear dynamic response of a container ship when traversing extreme waves, while considering the ultimate strength of the ship. On one hand, traditional ultimate strength evaluations are undertaken by making a quasi-static assumption and the dynamic wave effect is not considered. On the other hand, the dynamic response of a ship as induced by a wave is studied on the basis of the hydroelasticity theory so that the nonlinear structural response of the ship cannot be obtained for large waves. Therefore, a 2D hydroelastoplasticity method, which takes the coupling between time-domain waves and the nonlinear ship beam into account, is proposed. This method is based on an hydroelasticity method and a simplified progressive collapse method that combines the wave load and the structural nonlinearity. A simplified progressive collapse method, which considers the plastic nonlinearity and buckling effect of stiffened, is used to calculate the ultimate strength and nonlinear relationship between the bending moment and curvature, so that the nonlinear relationship between the rigidity and curvature is also obtained. A dynamic reduction in rigidity related to deformation could influence the strength and curvature of a ship's beam; therefore, it is input into a dynamic hydrodynamic formula rather than being regarded as a constant structural rigidity in a hydroelastic equation. A number of numerical extreme wave models are selected for computing the hydroelastoplasticity, such that large deformations occur and nonlinear dynamic vertical bending moment (VBM) is generated when the ship traverses these extreme waves. As the height and Froude number of these extreme waves are increased, a number of hydroelastoplasticity results including VBM and deformational curvature are computed and compared with results obtained with the hydroelasticity method, and then, some differences are observed and conclusions are drawn.	[Liu, Weiqin] Wuhan Univ Technol, Sch Transportat, Dept Naval Architecture Ocean & Struct Engn, Wuhan 430063, Hubei, Peoples R China; [Suzuki, Katsuyuki; Shibanuma, Kazuki] Univ Tokyo, Sch Engn, Dept Syst Innovat, Tokyo 1138656, Japan	Liu, WQ (reprint author), Wuhan Univ Technol, Sch Transportat, Dept Naval Architecture Ocean & Struct Engn, Wuhan 430063, Hubei, Peoples R China.	liuweiqin_123@sina.com; katsu@race.u-tokyo.ac.jp; shibanuma@struct.t.u-tokyo.ac.jp					Iijima K, 2011, J MAR SCI TECH-JAPAN, V16, P379, DOI 10.1007/s00773-011-0142-1; Malenica S, 2013, BRODOGRADNJA, V64, P323; Kharif C, 2003, EUR J MECH B-FLUID, V22, P603, DOI 10.1016/j.euromechflu.2003.09.002; Haver S., 1990, P 10 INT SOC OFFSH P, V3, P123; Huang L.L., 2000, MARINE STRUCTURES, V13, P91, DOI 10.1016/S0951-8339(00)00007-1; Liu W., 2014, P INT SOC OFFSH POL, V4, P652; Minami M., 2006, P 16 INT OFF POL ENG, V3, P272; Muller P., 2005, OCEANOGRAPHY, V18, P66; Senjanovic I, 2014, SHIPS OFFSHORE STRUC, V9, P199, DOI 10.1080/17445302.2012.762728; Senjanovic I, 2009, MAR STRUCT, V22, P387, DOI 10.1016/j.marstruc.2009.03.004; Senjanovic I, 2012, J ENG MATH, V72, P141, DOI 10.1007/s10665-011-9468-2; Waseda T., 2005, P 15 ISOPE SEOUL KOR, V3, P1; Yamamoto Y., 1977, C SOC NAV ARCH JAP S, V3, P214	13	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0892-7219	1528-896X		J OFFSHORE MECH ARCT	J. Offshore Mech. Arct. Eng. Trans. ASME	APR	2015	137	2							021101	10.1115/1.4029484		9	Engineering, Ocean; Engineering, Mechanical	Engineering	CC7TL	WOS:000350571200001		
J	Paik, JK; Lee, SE; Kim, BJ; Seo, JK; Ha, YC; Matsumoto, T; Byeon, SH				Paik, Jeom Kee; Lee, Sang Eui; Kim, Bong Ju; Seo, Jung Kwan; Ha, Yeon Chul; Matsumoto, Toshiyuki; Byeon, Su Hwan			Toward a Probabilistic Approach to Determine Nominal Values of Tank Sloshing Loads in Structural Design of Liquefied Natural Gas FPSOs	JOURNAL OF OFFSHORE MECHANICS AND ARCTIC ENGINEERING-TRANSACTIONS OF THE ASME			English	Article							DEPENDENT CORROSION WASTAGE; METHODOLOGY; MODEL; FLNG	The aim of this study is to develop a new probabilistic approach to determine nominal values for tank sloshing loads in structural design of LNG FPSO (liquefied natural gas, floating production, storage, and offloading units). Details of the proposed procedure are presented in a flow chart showing the key subtasks. The applicability of the method is demonstrated using an example of a hypothetical LNG FPSO operating in a natural gas site off a hypothetical oceanic region. It is noted that the proposed method is still under development for determining reliable estimates of extreme sloshing induced impact loads. It is concluded that the developed method is useful for determining the sloshing design loads in ship-shaped offshore LNG installations in combination with virtual metocean data and operational conditions.	[Paik, Jeom Kee; Lee, Sang Eui; Kim, Bong Ju; Seo, Jung Kwan; Ha, Yeon Chul] Pusan Natl Univ, Korea Ship & Offshore Res Inst, Lloyds Register Fdn, Res Ctr Excellence, Pusan 609735, South Korea; [Paik, Jeom Kee] UCL, Dept Mech Engn, London WC1E 6BT, England; [Matsumoto, Toshiyuki] Nippon Kaiji Kyokai, Tokyo 2670056, Japan; [Byeon, Su Hwan] STX Offshore & Shipbldg Co Ltd, Jinhae 641060, South Korea	Paik, JK (reprint author), Pusan Natl Univ, Korea Ship & Offshore Res Inst, Lloyds Register Fdn, Res Ctr Excellence, Pusan 609735, South Korea.				ClassNK; STX Offshore & Shipbuilding Co., Ltd.; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & future Planning (MSIP) [2014040731]	This work was part of the JDP titled "Limit states design of type B independent LNG cargo tanks," study, which was funded by ClassNK and STX Offshore & Shipbuilding Co., Ltd. It was also supported by Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & future Planning (MSIP) (Grant No. 2014040731). This study was undertaken at The Lloyd's Register Foundation Research Centre of Excellence at Pusan National University. Lloyd's Register Foundation (LRF), a UK registered charity and sole shareholder of Lloyd s Register Group, Ltd, invests in science, engineering and technology for public benefit, worldwide.	Alsobrooks L., 2004, OCEAN 407 DESIGN OCE; American Bureau of Shipping (ABS), 2006, GUID NOT STRENGTH AS; Paik JK, 2012, CORROS SCI, V63, P51, DOI 10.1016/j.corsci.2012.05.015; Paik JK, 2011, MAR STRUCT, V24, P73, DOI 10.1016/j.marstruc.2011.02.002; Brizzolara S, 2011, SHIPS OFFSHORE STRUC, V6, P15, DOI 10.1080/17445302.2010.522372; Sames PC, 2002, J SHIP RES, V46, P186; Graczyk M, 2008, OCEAN ENG, V35, P834, DOI 10.1016/j.oceaneng.2008.01.020; Faltinsen OM, 2005, J FLUID MECH, V523, P199, DOI 10.1017/S002211200400196X; DOANE DP, 1976, AM STAT, V30, P181, DOI 10.2307/2683757; Zhao WH, 2011, OCEAN ENG, V38, P1555, DOI 10.1016/j.oceaneng.2011.07.018; Ye KQ, 1998, J AM STAT ASSOC, V93, P1430, DOI 10.2307/2670057; Lee DH, 2007, OCEAN ENG, V34, P3, DOI 10.1016/j.oceaneng.2006.03.014; ANDERSON TW, 1954, J AM STAT ASSOC, V49, P765, DOI 10.2307/2281537; Rognebakke OF, 2003, J SHIP RES, V47, P208; ANSYS AQWA, 2012, US MAN VER 14 0; Blendermann W., 1993, ASME 12 INT C OFFSH, P183; Buchner B., 2001, 11 INT OFFSH POL ENG; Colagrossi A., 2004, 19 INT WORKSH WAT WA; de Souza J. R., 2002, OMAE200228134 ASME; Garrett D. L., 2002, OMAE200228550 ASME; Gavogy T., 2009, 9 INT OFFSH POL ENG; Graczyk Mateusz, 2007, Ships and Offshore Structures, V2; Heurtier J. M., 2001, 11 INT OFFSH POL ENG; Hong S. Y., 2002, 12 INT OFFSH POL ENG, P841; Hwang J. O., 2014, 24 INT OFFSH POL ENG; Isherwood R.M., 1973, T R I NAV ARCHIT, V114, P327; Ito H., 2008, OMAE200857572 ASME; Koshizuka S., 1995, COMPUT FLUID DYN J, V4, P29; Kuo JF, 2009, INT J OFFSHORE POLAR, V19, P241; Landrini M., 2003, 8 INT C NUM SHIP HYD; Lee B.H., 2010, THESIS PUSAN NATL U; Lee S. J., 2008, 18 INT OFFSH POL ENG; Loots E., 2004, OMAE200451085 ASME; LR, 2009, SHIP RIGHT SLOSH ASS; MacGregor J.R., 1994, P OFFSH 94 C, P53; Malenica S., 2003, 13 INT OFFSH POL ENG; Mamoun N., 2007, OMAE200729756 ASME; Molin B., 2002, 10 INT C INT MAR ASS; Munipalli J., 2007, OMAE200729359 ASME; Nam S. K., 2006, INT C SHIP OFFSH TEC; Newman J. N., 2005, 20 INT WORKSH WAT WA; Nho I. S., 2012, 22 INT OFFSH POL ENG; Paik J. K., 2009, JIP02 EFEF PUS NAT U; Paik J. K., 2011, EXPLOSION FIRE ENG F; Paik JK, 2004, CORROS SCI, V46, P471, DOI 10.1016/S0010-938X(03)00145-8; Paik J. K., 2006, Ships and Offshore Structures, V1, DOI 10.1533/saos.2006.0109; Paik J.K., 2012, INT J MARIT ENG, V154, P1; Paik JK, 2007, SHIP-SHAPED OFFSHORE INSTALLATIONS: DESIGN, BUILDING, AND OPERATION, P1, DOI 10.1017/CBO9780511546082; Paik J.K., 2004, T SOC NAVAL ARCHITEC, V112, P292; Paik J.K., 2010, EFEF03R2 PUS NAT U R; Pastoor W., 2005, SLOSHING LOAD RESPON; Paton C.G., 2006, P OFFSH TECHN C HOUS; Seo JK, 2013, SHIPS OFFSHORE STRUC, V8, P524, DOI 10.1080/17445302.2012.713219; Shin H. C., 2009, 2009 JOINT C KOR ASS, P974; STAR CCM+, 2013, US GUID VER 8 02; Wemmenhove R., 2005, OMAE200567460 ASME; Wichers J. E. W., 2001, P 11 INT OFFSH POL E; Wichers J.E.W., 1988, THESIS DELFT U TECHN; Youssef SAM, 2014, INT J MARIT ENG, V156, P61, DOI 10.3940/rina.ijme.2014.a1.277; Zhao WH, 2013, SHIPS OFFSHORE STRUC, V8, P111, DOI 10.1080/17445302.2012.691272	60	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0892-7219	1528-896X		J OFFSHORE MECH ARCT	J. Offshore Mech. Arct. Eng. Trans. ASME	APR	2015	137	2							021801	10.1115/1.4029666		17	Engineering, Ocean; Engineering, Mechanical	Engineering	CC7TL	WOS:000350571200012		
J	Yamane, A; Higuchi, H; Tomoyasu, Y; Ishii-Maruhama, M; Maeda, S; Miyawaki, T				Yamane, Ayaka; Higuchi, Hitoshi; Tomoyasu, Yumiko; Ishii-Maruhama, Minako; Maeda, Shigeru; Miyawaki, Takuya			Effect of Dexmedetomidine Injected Into the Oral Mucosa in Combination With Lidocaine on Local Anesthetic Potency in Humans: A Crossover Double-Blind Study	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							SCIATIC-NERVE BLOCK; PERINEURAL DEXMEDETOMIDINE; ALPHA-2A ADRENOCEPTOR; GUINEA-PIGS; BUPIVACAINE; PROLONGS; RAT; ANTINOCICEPTION; ROPIVACAINE; CLONIDINE	Purpose: Recently, attention has been paid to dexmedetomidine, a selective alpha-2 adrenoceptor agonist, as a possible additive for local anesthesia. However, the effect of locally injected dexmedetomidine on the anesthetic action in humans has not fully been clarified. Thus, the purpose of the present study was to evaluate the effect of dexmedetomidine injected into the oral mucosa in combination with lidocaine on local anesthetic potency in humans. Materials and Methods: Twenty healthy volunteers were included in the present crossover double-blinded study. Lidocaine solution or lidocaine plus dexmedetomidine solution was submucosally injected into the alveolar mucosa in a crossover and double-blinded manner. The local anesthetic effect of the solutions was evaluated by measuring the current perception threshold (CPT) in the oral mucosa for 120 minutes after injection. Furthermore, the sedation level, blood pressure, and heart rate of the volunteers were evaluated. For statistical analysis, the Wilcoxon signed rank test and 2-way repeated measures analysis of variation were used. Results: The CPT was increased with the 2 solutions and peaked 10 minutes after injection. CPT values 10 and 20 minutes after injection of lidocaine plus dexmedetomidine solution were considerably higher than those with lidocaine solution. The duration of an important increase in the CPT after injection with lidocaine plus dexmedetomidine solution was longer than that with lidocaine. Furthermore, the area under the time curve of CPT was considerably higher with lidocaine plus dexmedetomidine solution than with lidocaine solution. No volunteer showed a change in sedation level, blood pressure, or heart rate after injection with either test solution throughout the experiment. Conclusion: The present study showed that a combination of dexmedetomidine plus lidocaine considerably enhances the local anesthetic potency of lidocaine without any major influences on the cardiovascular system when locally injected into the oral mucosa. (C) 2015 American Association of Oral and Maxillofacial Surgeons	[Yamane, Ayaka; Higuchi, Hitoshi; Ishii-Maruhama, Minako; Maeda, Shigeru] Okayama Univ Hosp, Dept Dent Anesthesiol, Okayama, Japan; [Tomoyasu, Yumiko; Miyawaki, Takuya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dent Anesthesiol & Special Care Dent, Okayama 7008525, Japan	Miyawaki, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dent Anesthesiol & Special Care Dent, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008525, Japan.	miyawaki@md.okayama-u.ac.jp			Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan	The present study was supported by the Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.	Esmaoglu A, 2010, ANESTH ANALG, V111, P1548, DOI 10.1213/ANE.0b013e3181fa3095; Brummett CM, 2009, ANESTHESIOLOGY, V111, P1111, DOI 10.1097/ALN.0b013e3181bbcc26; Sukegawa S, 2014, ANESTH ANALG, V118, P473, DOI 10.1213/ANE.0000000000000060; RAMSAY MAE, 1974, BRIT MED J, V2, P656; Kosugi T, 2010, BRIT J PHARMACOL, V160, P1662, DOI 10.1111/j.1476-5381.2010.00833.x; Yoshitomi T, 2008, ANESTH ANALG, V107, P96, DOI 10.1213/ane.0b013e318176be73; Guo TZ, 1996, ANESTHESIOLOGY, V84, P873, DOI 10.1097/00000542-199604000-00015; Kanazi GE, 2006, ACTA ANAESTH SCAND, V50, P222, DOI 10.1111/j.1399-6576.2006.00919.x; Matsumura H, 2012, INT WOUND J, V9, P451, DOI 10.1111/j.1742-481X.2011.00911.x; Brummett CM, 2011, ANESTHESIOLOGY, V115, P836, DOI 10.1097/ALN.0b013e318221fcc9; Ouchi K, 2014, J ORAL MAXIL SURG, V72, P474, DOI 10.1016/j.joms.2013.09.038; Saadawy I, 2009, ACTA ANAESTH SCAND, V53, P251, DOI 10.1111/j.1399-6576.2008.01818.x; Oda A, 2007, EUR J ANAESTH, V24, P934, DOI 10.1017/S0265021507000543; Ebert TJ, 2000, ANESTHESIOLOGY, V93, P382, DOI 10.1097/00000542-200008000-00016; Brummett CM, 2008, ANESTHESIOLOGY, V109, P502, DOI 10.1097/ALN.0b013e318182c26b; Calasans-Maia JA, 2005, J PHARM PHARMACOL, V57, P1415, DOI 10.1211/jpp.57.11.0006; GAUMANN DM, 1992, ANESTH ANALG, V74, P719; Hiraki M, 2014, SURG ENDOSC, V16; Lee HJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-105; Yabuki A, 2014, REGION ANESTH PAIN M, V39, P133, DOI 10.1097/AAP.0000000000000048	20	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	APR	2015	73	4					616	621		10.1016/j.joms.2014.09.029		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CD6ZN	WOS:000351240100010		
J	Nakano, A; Mishima, K; Katase, N; Ueyama, Y				Nakano, Asuka; Mishima, Katsuaki; Katase, Naoki; Ueyama, Yoshiya			A Case of Squamous Cell Carcinoma Arising From Branchial Cleft Cyst	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							PRIMARY BRANCHIOGENIC CARCINOMA; NECK	Squamous cell carcinoma throughout the epithelium of a lateral cervical cyst is considered extremely rare. This report describes an additional case of this very rare clinical condition. A 70-year-old man presented with a well-defined, immobile, painless mass in the left neck that was excised with a diagnosis of branchial cyst. Histologic findings of the excised specimen were lateral branchial cyst with high-grade dysplasia and carcinoma of the squamous epithelial lining. The patient was followed for more than 2 years 10 months and no evidence of recurrence or other cancer has been found. (C) 2015 American Association of Oral and Maxillofacial Surgeons.	[Nakano, Asuka; Mishima, Katsuaki; Ueyama, Yoshiya] Yamaguchi Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Ube, Yamaguchi 7558505, Japan; [Katase, Naoki] Kawasaki Med Univ, Dept Mol & Dev Biol, Okayama, Japan	Mishima, K (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	kmishima@yamaguchi-u.ac.jp	KATASE, Naoki/B-2344-2011				KHAFIF RA, 1989, HEAD NECK-J SCI SPEC, V11, P153, DOI 10.1002/hed.2880110209; Bhanote M, 2008, DIAGN CYTOPATHOL, V36, P876, DOI 10.1002/dc.20920; Bilgen C, 2001, ENT-EAR NOSE THROAT, V80, P387; Black B, 1977, CLIN OTOLARYNGOL, V3, P27; COMPAGNO J, 1976, ARCH PATHOL LAB MED, V100, P311; Glosser JW, 2003, J AM DENT ASSOC, V134, P81; Hong KH, 1999, J LARYNGOL OTOL, V113, P1031; Jereczek-Fossa BA, 2005, CANCER TREAT REV, V31, P106, DOI 10.1016/j.ctrv.2004.12.007; Mallet Y, 2005, ORAL ONCOL, V41, P429, DOI 10.1016/j.oraloncology.2004.09.016; MARTIN H, 1950, ANN SURG, V132, P867; Maturo SC, 2007, AM J OTOLARYNG, V28, P25, DOI 10.1016/j.amjoto.2006.06.005; Roche JP, 2010, OTOLARYNG HEAD NECK, V143, P167, DOI 10.1016/j.otohns.2010.01.031; Singh B, 1998, ANN OTO RHINOL LARYN, V107, P519; SODERSTROM KO, 1987, ORL J OTO-RHINO-LARY, V49, P149; Thompson LDR, 1998, CANCER, V82, P944, DOI 10.1002/(SICI)1097-0142(19980301)82:5<944::AID-CNCR21>3.0.CO;2-#; Visweswara R. N., 1995, Central African Journal of Medicine, V41, P296; Volkman R, 1882, ZENTRALBL CHIR, V9, P49; Zimmermann CE, 2002, HEAD NECK-J SCI SPEC, V24, P965, DOI 10.1002/hed.10118	18	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	APR	2015	73	4					781	785		10.1016/j.joms.2014.10.036		5	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CD6ZN	WOS:000351240100035		
J	Matsumoto, H; Tsukiyama, Y; Kuwatsuru, R; Koyano, K				Matsumoto, H.; Tsukiyama, Y.; Kuwatsuru, R.; Koyano, K.			The effect of intermittent use of occlusal splint devices on sleep bruxism: a 4-week observation with a portable electromyographic recording device	JOURNAL OF ORAL REHABILITATION			English	Article						sleep bruxism; stabilisation splint; electromyography; randomised controlled trial; masseter muscle	NOCTURNAL BRUXISM; TEMPOROMANDIBULAR DISORDERS; TOOTH WEAR; EFFICACY; EVENTS; SIGNS; PAIN	This randomised controlled study investigated the effect of intermittent use of occlusal splints on sleep bruxism compared with that of continuous use by measuring masseter muscle electromyographic activity using a portable electromyographic recording system. Twenty bruxers were randomly allocated to the continuous group and intermittent group. Subjects in the continuous group wore stabilisation splints during sleep for 29 nights continuously, whereas those in the intermittent group wore splints during sleep every other week, that is they used splints on the 1st-7th, 15th-21st and 29th nights. Electromyographic activity of the masseter muscle during sleep was recorded for the following six time points: before (baseline), immediately after, and 1, 2, 3 and 4weeks after the insertion of a stabilisation splint. The number of nocturnal masseter electromyographic events, duration and the total activity of sleep bruxism were analysed. In the continuous group, nocturnal masseter electromyographic events were significantly reduced immediately and 1week after the insertion of the stabilisation splint, and duration was reduced immediately after the insertion (P<005, Dunnett's test), but no reduction was observed at 2, 3 and 4weeks after insertion. In the intermittent group, nocturnal masseter electromyographic events and duration were significantly reduced immediately after and also 4weeks after insertion of the stabilisation splint (P<005, Dunnett's test). The obtained results of the present exploratory trial indicate that the intermittent use of stabilisation splints may reduce sleep bruxism activity for a longer period compared with that of continuous use.	[Matsumoto, H.; Tsukiyama, Y.; Kuwatsuru, R.; Koyano, K.] Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Implant & Rehabilitat Dent, Fukuoka 8128582, Japan	Tsukiyama, Y (reprint author), Kyushu Univ, Fac Dent Sci, Div Oral Rehabil, Sect Implant & Rehabilitat Dent,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tsuki@dent.kyushu-u.ac.jp			Japan Society for the Promotion of Science [19592248, 21390519]	This study was supported by a Grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (No. 19592248 and 21390519). The authors have declared no conflict of interests.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Landry ML, 2006, INT J PROSTHODONT, V19, P549; CLARK GT, 1979, J AM DENT ASSOC, V99, P607; Lavigne GJ, 2008, J ORAL REHABIL, V35, P476, DOI 10.1111/j.1365-2842.2008.01881.x; Gallo LM, 1997, J SLEEP RES, V6, P259, DOI 10.1111/j.1365-2869.1997.00259.x; Dube C, 2004, J DENT RES, V83, P398; Harada T, 2006, J ORAL REHABIL, V33, P482, DOI 10.1111/j.1365-2842.2005.01576.x; Landry-Schonbeck A, 2009, INT J PROSTHODONT, V22, P251; EKFELDT A, 1990, ACTA ODONTOL SCAND, V48, P343, DOI 10.3109/00016359009033627; Lavigne GJ, 2003, CRIT REV ORAL BIOL M, V14, P30; Dao TTT, 1998, CRIT REV ORAL BIOL M, V9, P345; Baad-Hansen L, 2007, J ORAL REHABIL, V34, P105, DOI 10.1111/j.1365-2842.2006.01717.x; Lavigne GJ, 1996, J DENT RES, V75, P546; Lobbezoo F, 2006, J ORAL REHABIL, V33, P293, DOI 10.1111/j.1365-2842.2005.01609.x; van der Zaag J, 2005, J OROFAC PAIN, V19, P151; Lobbezoo F, 2008, J ORAL REHABIL, V35, P509, DOI 10.1111/j.1365-2842.2008.01853.x; Kampe T, 1997, J ORAL REHABIL, V24, P588, DOI 10.1046/j.1365-2842.1997.00541.x; Lavigne GJ, 2001, J DENT RES, V80, P443; Ommerborn MA, 2007, EUR J ORAL SCI, V115, P7, DOI 10.1111/j.1600-0722.2007.00417.x; Kato T, 2003, J OROFAC PAIN, V17, P191; Pintado MR, 1997, J PROSTHET DENT, V77, P313, DOI 10.1016/S0022-3913(97)70189-6; Rompre PH, 2007, J DENT RES, V86, P837; Dao T. T. T., 1994, Journal of Orofacial Pain, V8, P350; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; HANAMURA H, 1987, J PERIODONTOL, V58, P173; HOLMGREN K, 1993, J PROSTHET DENT, V69, P293, DOI 10.1016/0022-3913(93)90109-2; Ikeda Takashi, 1996, Journal of Orofacial Pain, V10, P270; Kato T, 1999, MOVEMENT DISORD, V14, P865, DOI 10.1002/1531-8257(199909)14:5<865::AID-MDS1025>3.0.CO;2-0; Macedo CR, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005514.pub2; OKESON JP, 1990, J ORAL REHABIL, V17, P411, DOI 10.1111/j.1365-2842.1990.tb01412.x; PIERCE CJ, 1989, J DENT RES, V68, P1110, DOI 10.1177/00220345890680061101; PIERCE CJ, 1988, J DENT RES, V67, P597, DOI 10.1177/00220345880670031501; Rugh J D, 1988, Adv Neurol, V49, P329; van Selms M K A, 2004, J Oral Rehabil, V31, P738; Yap AUJ, 1998, J ORAL REHABIL, V25, P64	35	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	APR	2015	42	4					251	258		10.1111/joor.12251		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CD6BO	WOS:000351173800002		
J	Fujishita, A; Koga, Y; Utsumi, D; Nakamura, A; Yoshimi, T; Yoshida, N				Fujishita, A.; Koga, Y.; Utsumi, D.; Nakamura, A.; Yoshimi, T.; Yoshida, N.			Effects of feeding a soft diet and subsequent rehabilitation on the development of the masticatory function	JOURNAL OF ORAL REHABILITATION			English	Article						mastication; growth and development; jaw relation record; electromyography; masseter muscle; critical period	MASSETER MUSCLE; BRAIN-STEM; JAW; RABBIT; MOUSE; WEAR; CONSISTENCY; GENERATION; FEEDBACK; GROWTH	It has been suggested that feeding a soft diet could possibly inhibit normal development of the masticatory function. However, the consequences of such changes in the alimentary habits have yet to be fully clarified. Therefore, the aim of this study was to determine whether a soft diet prevents the development of masticatory function and whether a critical period for programming the masticatory system exists. To examine these hypotheses, we used a three-dimensional jaw-movement tracking device and jaw muscle electromyography (EMG) to analyse masticatory function changes in mice. Jcl:ICR mice were divided into three groups, with the normal group fed a hard diet, the hypofunctional group fed a soft diet, and the rehabilitation group first fed a soft diet that was then changed to a hard diet. Our results showed that the excursion and duration of late-closing phase (occlusal phase) of the chewing cycle and EMG activity in the masseter muscle were not only reduced in the hypofunctional but also in the rehabilitation group as compared with the normal group. These results suggest that optimisation of the chewing pattern and acquisition of appropriate masticatory function are impeded by feeding a soft diet during the animal's growth period and that no catch-up effect of the masticatory function is observed when there is a prolonged period of time prior to changing the diet from soft to hard. In conclusion, masticatory function can only be fully developed through a learning process such as exposure to chewing various kinds of foods with different food textures.	[Fujishita, A.; Koga, Y.; Utsumi, D.; Nakamura, A.; Yoshimi, T.; Yoshida, N.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Nagasaki 8528501, Japan	Koga, Y (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthodont & Dentofacial Orthoped, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	koga@nagasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24792296, 24659913]	This study was supported in part by grants (No. 24792296 and 24659913) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. None of the authors has any conflict of interests to declare.	HUANG X, 1993, J DENT RES, V72, P980, DOI 10.1177/00220345930720061401; KILIARIDIS S, 1985, EUR J ORTHODONT, V7, P273; NAKAMURA Y, 1995, NEUROSCI RES, V23, P1, DOI 10.1016/0168-0102(95)00925-J; LAVIGNE G, 1987, J NEUROPHYSIOL, V58, P342; HERRING SW, 1985, AM ZOOL, V25, P339; LIU ZJ, 1993, J NEUROPHYSIOL, V69, P569; Lund JP, 2006, DYSPHAGIA, V21, P167, DOI 10.1007/s00455-006-9027-6; Lund JP, 1998, CURR OPIN NEUROBIOL, V8, P718, DOI 10.1016/S0959-4388(98)80113-X; DELLOW PG, 1971, J PHYSIOL-LONDON, V215, P1; Liu ZJ, 1998, J DENT RES, V77, P366; Kiliaridis S, 1999, AM J ORTHOD DENTOFAC, V116, P121, DOI 10.1016/S0889-5406(99)70207-6; MORIMOTO T, 1989, EXP BRAIN RES, V76, P424; DENENBERG VH, 1958, J PSYCHOL, V46, P211; Ekfeldt A, 1996, INT J PROSTHODONT, V9, P539; ITO G, 1988, ANAT ANZEIGER, V165, P151; KILIARIDIS S, 1988, ARCH ORAL BIOL, V33, P467, DOI 10.1016/0003-9969(88)90026-X; Koga Y, 2001, MED ENG PHYS, V23, P201, DOI 10.1016/S1350-4533(01)00038-8; Langenbach G, 2003, EUR J ORAL SCI, V111, P81, DOI 10.1034/j.1600-0722.2003.00008.x; Langenbach GEJ, 2001, ARCH ORAL BIOL, V46, P811, DOI 10.1016/S0003-9969(01)00043-7; LUND J P, 1991, Critical Reviews in Oral Biology and Medicine, V2, P33; MAEDA N, 1987, ACTA ANAT, V128, P326; Okayasu I, 2003, J DENT RES, V82, P318; RUSSELL MD, 1982, J DENT, V10, P69, DOI 10.1016/0300-5712(82)90011-2; TEAFORD MF, 1989, J DENT RES, V68, P1513, DOI 10.1177/00220345890680110901; Utsumi D, 2010, J STOMAT OCC MED, V3, P187	25	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	APR	2015	42	4					266	274		10.1111/joor.12248		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CD6BO	WOS:000351173800004		
J	Arai, E; Hasegawa, M; Nakamura, M; Wakamatsu, K				Arai, Emi; Hasegawa, Masaru; Nakamura, Masahiko; Wakamatsu, Kazumasa			Male pheomelanin pigmentation and breeding onset in Barn Swallows Hirundo rustica gutturalis	JOURNAL OF ORNITHOLOGY			English	Article						Barn Swallow; Depigmentation; Eumelanin; Pheomelanin	FEATHER-DEGRADING BACTERIA; MULTIPLE MALE ORNAMENTS; OWL STRIX-ALUCO; PLUMAGE COLOR; FEMALE CHOICE; REPRODUCTIVE SUCCESS; MELANOCORTIN SYSTEM; EASTERN BLUEBIRDS; SEXUAL SELECTION; PREEN WAXES	Plumage color is a composite trait and each component can provide information regarding individual quality. Melanin-based color is one of the most common plumage coloration in birds. This color comprises two types of melanin pigments: eumelanin (black pigment) and pheomelanin (yellow-reddish pigment), and it is affected by several post-molting processes such as UV damage, staining, and preen oils. In some birds, pheomelanin-based plumage color is related to several measures of sexual selection; however, pheomelanin is almost always expressed together with eumelanin and affected by post-molting processes. Therefore, it is still unclear whether (and to what extent) pheomelanin can explain the observed relationship between plumage color and the measure of sexual selection. Here we examined the melanin (both eumelanin and pheomelanin) concentration in relation to breeding onset, as a fitness component associated with sexual selection in male Barn Swallows (Hirundo rustica gutturalis). We found that throat feathers in males contained more pheomelanin than those in females. The amount of pheomelanin, but not eumelanin, declined throughout the sampling period, indicating that pheomelanin pigmentation conveys different information than eumelanin. Even after correcting for depigmentation of melanin, males with more pheomelanin bred earlier than the others. Together with the results from previous studies, these findings indicate that pheomelanin-based coloration may have evolved via sexual selection for pheomelanin pigmentation in Barn Swallows.	[Arai, Emi] Tohoku Univ, Grad Sch Life Sci, Div Ecol & Evolutionary Biol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Hasegawa, Masaru] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Nakamura, Masahiko] Joetsu Univ Educ, Dept Biol, Anim Ecol Lab, Niigata 9438512, Japan; [Wakamatsu, Kazumasa] Fujita Hlth Univ, Dept Chem, Sch Hlth Sci, Toyoake, Aichi 4701192, Japan	Arai, E (reprint author), Tohoku Univ, Grad Sch Life Sci, Div Ecol & Evolutionary Biol, Aoba Ku, Biological Bldg, Sendai, Miyagi 9808578, Japan.	gutturalis.39@gmail.com					Andersson M., 1994, SEXUAL SELECTION; Siefferman L, 2003, BEHAV ECOL, V14, P855, DOI 10.1093/beheco/arg063; Jenkins BR, 2013, HORM BEHAV, V64, P665, DOI 10.1016/j.yhbeh.2013.08.006; CHEDEKEL MR, 1978, P NATL ACAD SCI USA, V75, P5395, DOI 10.1073/pnas.75.11.5395; McGraw KJ, 2005, FUNCT ECOL, V19, P816, DOI 10.1111/j.1365-2435.2005.01032.x; Saino N, 2013, EVOL BIOL, V40, P521, DOI 10.1007/s11692-013-9228-5; Lopez-Rull I, 2010, BEHAV ECOL, V21, P781, DOI 10.1093/beheco/arq053; Vortman Y, 2013, AM NAT, V182, P514, DOI 10.1086/671908; Shawkey MD, 2003, J AVIAN BIOL, V34, P345, DOI 10.1111/j.0908-8857.2003.03193.x; Gunderson AR, 2009, J AVIAN BIOL, V40, P440, DOI 10.1111/j.1600-048X.2008.04650.x; Arai E, 2009, BIRD STUDY, V56, P411, DOI 10.1080/00063650902968342; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Vortman Y, 2011, BEHAV ECOL, V22, P1344, DOI 10.1093/beheco/arr139; Hoting E, 1995, J SOC COSMET CHEM, V46, P181; ZUK M, 1990, EVOLUTION, V44, P477, DOI 10.2307/2409430; Galvan I, 2012, BIOESSAYS, V34, P565, DOI 10.1002/bies.201200017; Shawkey MD, 2007, AM NAT, V169, pS112, DOI 10.1086/510100; BONSER RHC, 1995, CONDOR, V97, P590, DOI 10.2307/1369048; Vitousek MN, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0539; Gruebler MU, 2010, J AVIAN BIOL, V41, P282, DOI 10.1111/j.1600-048X.2009.04865.x; Roulin A, 2011, EUR J PHARMACOL, V660, P226, DOI 10.1016/j.ejphar.2011.01.036; Safran RJ, 2004, BEHAV ECOL, V15, P455, DOI 10.1093/beheco/arh035; Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x; McGraw KJ, 2002, J EXP BIOL, V205, P3747; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; McGraw KJ, 2004, CAN J ZOOL, V82, P734, DOI 10.1139/Z04-043; Zampiga E, 2004, ETHOL ECOL EVOL, V16, P339; Moller AP, 2006, EVOLUTION, V60, P856; Hasegawa M, 2010, ORNITHOL SCI, V9, P141, DOI 10.2326/osj.9.141; Hill HZ, 2000, PIGM CELL RES, V13, P140, DOI 10.1034/j.1600-0749.13.s8.25.x; Cramp S., 1988, BIRDS W PALEARCTIC, V5; Da Silva A, 2013, BEHAV ECOL SOCIOBIOL, V67, P1041, DOI 10.1007/s00265-013-1529-2; Delhey K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011582; Emaresi G, 2013, MOL ECOL, V22, P4915, DOI 10.1111/mec.12438; ENSTROM DA, 1993, ANIM BEHAV, V45, P435, DOI 10.1006/anbe.1993.1055; Figuerola J, 2005, IBIS, V147, P797, DOI 10.1111/j.1474-919x.2005.00461.x; Foley JD, 1984, FUNDAMENTALS INTERAC, P593; Galvan I, 2013, PHYSIOL BIOCHEM ZOOL, V86, P184, DOI 10.1086/668871; Galvan I, 2010, IBIS, V152, P359; Galvan I, 2009, FUNCT ECOL, V23, P302, DOI 10.1111/j.1365-2435.2008.01504.x; Galvan I, 2010, J AVIAN BIOL, V41, P523, DOI 10.1111/j.1600-048X.2010.04998.x; HAASE E, 1992, J HERED, V83, P64; Hasegawa Masaru, 2008, Ornithological Science, V7, P117, DOI 10.2326/1347-0558-7.2.117; Hasegawa M, 2011, THESIS U TUSUKUBA TU; Hasegawa M, 2010, ORNITHOL SCI, V9, P161, DOI 10.2326/osj.9.161; Hill G. E., 2006, BIRD COLORATION, VII, P137; Jacob J, 1997, Z NATURFORSCH C, V52, P114; Lendvai JK, 2004, ANIM BEHAV, V67, P703; McGraw KJ, 2004, BEHAV ECOL, V15, P889, DOI 10.1093/beheco/arh109; MOLLER AP, 1994, BEHAV ECOL SOCIOBIOL, V35, P115, DOI 10.1007/BF00171501; Omland KE, 1996, BEHAV ECOL SOCIOBIOL, V39, P353, DOI 10.1007/s002650050300; Ozeki H, 1997, ANAL BIOCHEM, V248, P149, DOI 10.1006/abio.1997.2079; PALOKANGAS P, 1994, ANIM BEHAV, V47, P443, DOI 10.1006/anbe.1994.1058; Perez-Rodriguez L, 2011, BEHAV ECOL SOCIOBIOL, V65, P1425, DOI 10.1007/s00265-011-1153-y; Piersma T, 1999, ECOL LETT, V2, P201; R Development Core Team, 2008, R AL ENV STAT COMP; Roulin A, 2008, BEHAV ECOL SOCIOBIOL, V62, P507, DOI 10.1007/s00265-007-0475-2; Roulin A, 2011, J EVOLUTION BIOL, V24, P2241, DOI 10.1111/j.1420-9101.2011.02353.x; Roulin A, 2011, OECOLOGIA, V166, P913, DOI 10.1007/s00442-011-1955-7; Safran RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009420; Saino N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058024; Shawkey MD, 2009, NATURWISSENSCHAFTEN, V96, P123, DOI 10.1007/s00114-008-0462-0; Surmacki A, 2008, IBIS, V150, P335, DOI 10.1111/j.1474-919X.2007.00796.x; Surmacki A, 2007, NATURWISSENSCHAFTEN, V94, P829, DOI 10.1007/s00114-007-0263-x; Tajima Kazuyoshi, 2003, Ornithological Science, V2, P65, DOI 10.2326/osj.2.65; Turner A., 2006, BARN SWALLOW; Williams TD, 2012, PHYSL ADAPTATIONS BR, P52; Willoughby EJ, 2002, WILSON BULL, V114, P380, DOI 10.1676/0043-5643(2002)114[0380:MPAACC]2.0.CO;2	68	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0021-8375	1439-0361		J ORNITHOL	J. Ornithol.	APR	2015	156	2					419	427		10.1007/s10336-014-1140-y		9	Ornithology	Zoology	CD4QU	WOS:000351069300009		
J	Minagawa, K; Iwasaki, M; Ogawa, H; Yoshihara, A; Miyazaki, H				Minagawa, K.; Iwasaki, M.; Ogawa, H.; Yoshihara, A.; Miyazaki, H.			Relationship between metabolic syndrome and periodontitis in 80-year-old Japanese subjects	JOURNAL OF PERIODONTAL RESEARCH			English	Article						elderly; epidemiology; metabolic syndrome; periodontitis	NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; OLDER-ADULTS; RISK-FACTORS; TOOTH LOSS; ASSOCIATION; HISAYAMA; HEALTH; POPULATION	Background and ObjectivePotentially significant associations between metabolic syndrome (MetS) and periodontitis have been reported in recent studies; however, there are limited data on their association in the very old. The aim of this cross-sectional study was to investigate the association between MetS and periodontitis among 80-year-old Japanese subjects. Material and MethodsThe subjects were 234 Japanese aged 80years old who participated in a health and periodontal examination in June 2008 in Niigata city, Japan, and were classified into three groups: (i) severe periodontitis: having six or more interproximal sites with clinical attachment level 6mm and three or more interproximal sites with probing pocket depth (PPD) 5mm (not on the same tooth) (n=19); (ii) moderate periodontitis: having six or more interproximal sites with clinical attachment level 4mm or six or more interproximal sites with PPD 5mm (not on the same tooth) (n=162); and (iii) no or mild periodontitis: neither moderate nor severe periodontitis (n=53). MetS was defined using the modified criteria of the guidelines for the diagnosis of MetS in Japan. An ordinal logistic regression model was used to evaluate the association between MetS and periodontitis. Adjustments for gender, income, education, smoking status, dental visiting patterns, brushing frequency, exercise habits and dietary energy and food intake were considered. ResultsOverall, 57 individuals (24.4%) were diagnosed as having MetS. MetS was associated with the presence and severity of periodontitis (crude odds ratio=2.24, 95% confidence interval=1.14-4.41). This association remained statistically significant after multivariate adjustments (adjusted odds ratio=2.10, 95% confidence interval=1.03-4.28). ConclusionOur findings provide evidence of an association between MetS and periodontitis in elderly Japanese.	[Minagawa, K.; Iwasaki, M.; Ogawa, H.; Miyazaki, H.] Niigata Univ, Grad Sch Med & Dent Sci, Div Prevent Dent, Dept Oral Hlth Sci, Niigata 9518514, Japan; [Yoshihara, A.] Niigata Univ, Grad Sch Med & Dent Sci, Dept Oral Hlth & Welf, Div Oral Sci Hlth Promot, Niigata 9518514, Japan	Minagawa, K (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Prevent Dent, Dept Oral Hlth Sci,Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	sakairi@dent.niigata-u.ac.jp			Ministry of Health and Welfare of Japan [H10-Iryo-001, H13-Iryo-001, H16-Iryo-020];  [23792504]	This work was supported by a grant-in-aid from the Ministry of Health and Welfare of Japan (H10-Iryo-001, H13-Iryo-001 and H16-Iryo-020) and a grant-in-aid for Young Scientists (B) (23792504). The authors declare no conflicts of interest in the publication of this paper.	Akalin Ferda Alev, 2009, J Periodontol, V80, P457, DOI 10.1902/jop.2009.080218 ; Lee JB, 2013, J CLIN PERIODONTOL, V40, P437, DOI 10.1111/jcpe.12095; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Kwon YE, 2011, J CLIN PERIODONTOL, V38, P781, DOI 10.1111/j.1600-051X.2011.01756.x; Montebugnoli L, 2004, J CLIN PERIODONTOL, V31, P25, DOI 10.1111/j.0303-6979.2004.00432.x; Maumus S, 2005, DIABETES CARE, V28, P675, DOI 10.2337/diacare.28.3.675; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Nishimura F, 2003, J PERIODONTOL, V74, P97, DOI 10.1902/jop.2003.74.1.97; Grundy SM, 2005, ARTERIOSCL THROM VAS, V25, P2243, DOI 10.1161/01.ATV.0000189155.75833.c7; SAKKI TK, 1995, COMMUNITY DENT ORAL, V23, P155, DOI 10.1111/j.1600-0528.1995.tb00220.x; Albandar JM, 2000, J PERIODONTOL, V71, P1874, DOI 10.1902/jop.2000.71.12.1874; Chaffee BW, 2010, J PERIODONTOL, V81, P1708, DOI 10.1902/jop.2010.100321; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Butler J, 2006, J AM COLL CARDIOL, V47, P1595, DOI 10.1016/j.jacc.2005.12.046; Fure S, 2003, CARIES RES, V37, P462, DOI 10.1159/000073401; Iwasaki M, 2008, J CLIN PERIODONTOL, V35, P291, DOI 10.1111/j.1600-051X.2008.01215.x; Ghanim H, 2004, CIRCULATION, V110, P1564, DOI 10.1161/01.CIR.0000142055.53122.FA; Chapple ILC, 1997, J CLIN PERIODONTOL, V24, P287, DOI 10.1111/j.1600-051X.1997.tb00760.x; Krustrup U, 2006, ACTA ODONTOL SCAND, V64, P65, DOI 10.1080/00016350500377859; Shimazaki Y, 2005, J PERIODONTOL, V76, P1534, DOI 10.1902/jop.2005.76.9.1534; Wang JJ, 2010, ATHEROSCLEROSIS, V210, P237, DOI 10.1016/j.atherosclerosis.2009.10.042; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Sakurai T, 2010, GERONTOLOGY, V56, P141, DOI 10.1159/000246970; Baltacioglu E, 2008, ARCH ORAL BIOL, V53, P716, DOI 10.1016/j.archoralbio.2008.02.002; Saito T, 2005, J PERIODONTAL RES, V40, P346, DOI 10.1111/j.1600-0765.2005.00813.x; He Y, 2006, J AM COLL CARDIOL, V47, P1588, DOI 10.1016/j.jacc.2005.11.074; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Chapple ILC, 2007, PERIODONTOL 2000, V43, P160, DOI 10.1111/j.1600-0757.2006.00178.x; Saito T, 2004, J DENT RES, V83, P485; Salmenniemi U, 2004, CIRCULATION, V110, P3842, DOI 10.1161/01.CIR.0000150391.38660.9B; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Shimazaki Y, 2007, J DENT RES, V86, P271; Apoorva S M, 2013, J Indian Soc Periodontol, V17, P25, DOI 10.4103/0972-124X.107470; BROWN LF, 1994, J PERIODONTOL, V65, P316; Chapple IL, 1996, CLIN MOL PATHOLOGY, V49, P247; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Engstrom S, 2007, UPSALA J MED SCI, V112, P95; Esposito K, 2007, NUTR METAB CARDIOVAS, V17, P274, DOI 10.1016/j.numecd.2005.11.014; Fukui N, 2012, J PERIODONTOL, V83, P1363, DOI 10.1902/jop.2012.110605; Ishikawa S, 2007, CIRC J, V71, P26, DOI 10.1253/circj.71.26; Khader Y, 2008, J PERIODONTOL, V79, P2048, DOI 10.1902/jop.2008.080022 ; Kushiyama M, 2009, J PERIODONTOL, V80, P1610, DOI 10.1902/jop.2009.090218; Li P, 2009, J PERIODONTOL, V80, P541, DOI 10.1902/jop.2009.080387; Matsuzawa Y, 2005, J JPN SOC INTERN MED, V94, P188; Ministry of Health Labour and Welfare, NAT HLTH NUTR SURV; Miyatake N, 2007, DIABETES RES CLIN PR, V77, P314, DOI 10.1016/j.diabres.2006.11.008; Sasaki S., 2004, RES EVALUATION METHO, P10; Science and Technology Agency, 2005, STAND TABL FOOD COMP; Scuteri A, 2005, DIABETES CARE, V28, P882, DOI 10.2337/diacare.28.4.882; The Ministry of Health Labour and Welfare, SURV DENT DIS; Urashima M., 2005, JMAJ - Japan Medical Association Journal, V48, P441; Veeranna V, 2011, METAB SYNDR RELAT D, V9, P361, DOI 10.1089/met.2011.0032	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	APR	2015	50	2					173	179		10.1111/jre.12190		7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CD2NH	WOS:000350914600004		
J	Monnouchi, S; Maeda, H; Yuda, A; Hamano, S; Wada, N; Tomokiyo, A; Koori, K; Sugii, H; Serita, S; Akamine, A				Monnouchi, S.; Maeda, H.; Yuda, A.; Hamano, S.; Wada, N.; Tomokiyo, A.; Koori, K.; Sugii, H.; Serita, S.; Akamine, A.			Mechanical induction of interleukin-11 regulates osteoblastic/cementoblastic differentiation of human periodontal ligament stem/progenitor cells	JOURNAL OF PERIODONTAL RESEARCH			English	Article						cytokines; periodontal ligament; periodontal maintenance; stem cells	ANGIOTENSIN-II; OSTEOBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; CARDIAC-HYPERTROPHY; MOLECULAR-CLONING; DOWN-REGULATION; STEM-CELLS; BONE MASS; IN-VITRO; EXPRESSION	Background and ObjectiveThe periodontal ligament (PDL) is continually exposed to mechanical loading caused by mastication or occlusion. Physiological loading is thus considered a key regulator of PDL tissue homeostasis; however, it remains unclear how this occurs. We recently reported that an appropriate magnitude of mechanical stretch can maintain PDL tissue homeostasis via the renin-angiotensin system. In the present study, we investigated the expression of interleukin-11 (IL-11) in human primary PDL cells (HPDLCs) exposed to stretch loading, the contribution of angiotensin II (Ang II) to this event and the effects of IL-11 on osteoblastic/cementoblastic differentiation of human PDL progenitor cells (cell line 1-17). Material and MethodsHuman primary PDL cells, derived from human tissues, with or without antagonists against the Ang II receptors AT1 or AT2, were subjected to cyclical stretch loading with 8% elongation for 1h. Expression of IL-11 was measured by ELISA in these cultures and by immunohistochemistry in the sectioned maxillae of rats. The osteoblastic/cementoblastic potential of cell line 1-17 was determined using cell proliferation, gene expression and Alizarin Red staining. ResultsPositive staining for IL-11 was observed in the PDL of rat maxillae and in cultures of HPDLCs. In HPDLCs exposed to stretch, expression of the IL11 gene and the IL-11 protein were up-regulated, concomitant with an increase in Ang II and via AT2. Recombinant human IL-11 (rhIL-11) stimulated an increase in expression of mRNA for the cementoblast-specific marker, CP-23, and for the osteoblastic markers, osteopontin and bone sialoprotein, and promoted proliferation in cell line 1-17. In addition, rhIL-11 also increased the degree of mineralized nodule formation in cell line 1-17 cultures treated with CaCl2. ConclusionMechanical loading appears to control proliferation and osteoblastic/cementoblastic differentiation of human PDL stem/progenitor cells through the regulation of Ang II and AT2 by IL-11.	[Monnouchi, S.; Yuda, A.; Hamano, S.; Tomokiyo, A.; Koori, K.; Sugii, H.; Akamine, A.] Kyushu Univ, Fac Dent Sci, Dept Endodontol & Operat Dent, Div Oral Rehabil, Fukuoka 812, Japan; [Maeda, H.; Wada, N.; Serita, S.; Akamine, A.] Kyushu Univ Hosp, Dept Endodontol, Fukuoka 8128582, Japan	Maeda, H (reprint author), Kyushu Univ Hosp, Dept Endodontol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hide@dent.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25670811, 25293388, 24792028, 24390426, 23689077, 23659890]	We express our thanks to Drs Yamamoto, Hasegawa and Yoshida for their great support in the preparation of this work. This work was supported by Grants-in-Aid for Scientific Research (projects 25670811, 25293388, 24792028, 24390426, 23689077 and 23659890) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Kono K, 2013, CELL TISSUE RES, V352, P249, DOI 10.1007/s00441-012-1543-0; Nandurkar HH, 1996, ONCOGENE, V12, P585; Maeda H, 2010, J ENDODONT, V36, P647, DOI 10.1016/j.joen.2009.12.024; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Walker CG, 2008, EUR J ORAL SCI, V116, P312, DOI 10.1111/j.1600-0722.2008.00545.x; YAMAZAKI T, 1995, CIRC RES, V77, P258; Pinkerton MN, 2008, J PERIODONTAL RES, V43, P343, DOI 10.1111/j.1600-0765.2007.01040.x; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shi L, 2005, ARCH HISTOL CYTOL, V68, P289, DOI 10.1679/aohc.68.289; Matsumoto T, 2012, ENDOCR J, V59, P91; Du XX, 1997, BLOOD, V89, P3897; Bosshardt DD, 2005, J DENT RES, V84, P390; MCCULLOCH CAG, 1985, ANAT REC, V211, P258, DOI 10.1002/ar.1092110305; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Ogasawara T, 2004, J BONE MINER RES, V19, P1128, DOI 10.1359/JBMR.040513; Fujii S, 2008, J CELL PHYSIOL, V215, P743, DOI 10.1002/jcp.21359; Tomokiyo A, 2008, DIFFERENTIATION, V76, P337, DOI 10.1111/j.1432-0436.2007.00233.x; Kido S, 2009, BONE, V45, P1125, DOI 10.1016/j.bone.2009.07.087; Yamaguchi M, 2006, J DENT RES, V85, P751; Alvarez-Perez MA, 2006, BONE, V38, P409, DOI 10.1016/j.bone.2005.09.009; Sims NA, 2005, J BONE MINER RES, V20, P1093, DOI 10.1259/JBMR.050209; GIRASOLE G, 1994, J CLIN INVEST, V93, P1516, DOI 10.1172/JCI117130; Fujii S, 2006, CELL TISSUE RES, V324, P117, DOI 10.1007/s00441-005-0101-4; McKee MD, 1996, ANAT RECORD, V245, P293, DOI 10.1002/(SICI)1097-0185(199606)245:2<293::AID-AR13>3.0.CO;2-K; Fujii S, 2010, CELL TISSUE RES, V342, P233, DOI 10.1007/s00441-010-1037-x; Senbonmatsu T, 2003, EMBO J, V22, P6471, DOI 10.1093/emboj/cdg637; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI 10.1902/jop.2008.070624 ; Izu Y, 2009, J BIOL CHEM, V284, P4857, DOI 10.1074/jbc.M807610200; Chiba M, 2004, CELL BIOCHEM FUNCT, V22, P249, DOI 10.1027/cbf.1097; Harahashi H, 2010, BIOMED RES-TOKYO, V31, P319, DOI 10.2220/biomedres.31.319; Kaneda T, 2006, BONE, V38, P420, DOI 10.1016/j.bone.2005.08.021; KELLER DC, 1993, BLOOD, V82, P1428; Kim HJ, 2007, CELL TISSUE RES, V327, P25, DOI 10.1007/s00441-006-0304-3; Kim JY, 2012, ANGLE ORTHOD, V82, P107, DOI 10.2319/030911-173.1; Kim SG, 2002, CELL STRUCT FUNCT, V27, P139, DOI 10.1247/csf.27.139; Kodama Y, 1998, J BONE MINER RES, V13, P1370, DOI 10.1359/jbmr.1998.13.9.1370; Kook SH, 2011, J APPL PHYSIOL, V111, P1575, DOI 10.1152/japplphysiol.00348.2011; Leon ER, 2007, J PERIODONTAL RES, V42, P527, DOI 10.1111/j.1600-0765.2007.00977.x; Li Y, 2011, J DENT RES, V90, P115, DOI 10.1177/0022034510385237; Maeda H, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt74; Martuscelli G, 2000, J PERIODONTOL, V71, P573, DOI 10.1902/jop.2000.71.4.573; Monnouchi S, 2011, J DENT RES, V90, P181, DOI 10.1177/0022034510382118; Nakashima K, 2009, J PERIODONTAL RES, V44, P622, DOI 10.1111/j.1600-0765.2008.01170.x; NASCIMENTO A, 1975, J PERIODONTAL RES, V10, P44, DOI 10.1111/j.1600-0765.1975.tb00006.x; Sakai K, 1999, J BONE MINER RES, V14, P2089, DOI 10.1359/jbmr.1999.14.12.2089; Seong GJ, 2009, MOL VIS, V15, P2123; Takeuchi Y, 2002, J BIOL CHEM, V277, P49011, DOI 10.1074/jbc.M207804200; Tamura K, 1998, AM J PHYSIOL-REG I, V275, pR1; Terai K, 1999, J BONE MINER RES, V14, P839, DOI 10.1359/jbmr.1999.14.6.839; Tomokiyo A, 2012, J CELL BIOCHEM, V113, P3093, DOI 10.1002/jcb.24186; Trepicchio WL, 1996, J IMMUNOL, V157, P3627; Uribe F, 2011, ANGLE ORTHOD, V81, P284, DOI 10.2319/052410-279.1; Yamamoto N, 2012, J CLIN PERIODONTOL, V39, P556, DOI 10.1111/j.1600-051X.2012.01881.x; Zhong W, 2008, ORAL DIS, V14, P270, DOI 10.1111/j.1601-0825.2007.01375.x	54	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	APR	2015	50	2					231	239		10.1111/jre.12200		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CD2NH	WOS:000350914600011		
J	Kitagaki, J; Miyauchi, S; Xie, CJ; Yamashita, M; Yamada, S; Kitamura, M; Murakami, S				Kitagaki, J.; Miyauchi, S.; Xie, C. J.; Yamashita, M.; Yamada, S.; Kitamura, M.; Murakami, S.			Effects of the proteasome inhibitor, bortezomib, on cytodifferentiation and mineralization of periodontal ligament cells	JOURNAL OF PERIODONTAL RESEARCH			English	Article						bortezomib; cytodifferentiation; mineralization; periodontal ligament	BONE MORPHOGENETIC PROTEINS; FACTOR-KAPPA-B; BETA-CATENIN; MULTIPLE-MYELOMA; OSTEOBLASTIC DIFFERENTIATION; IN-VIVO; UBIQUITIN; DEGRADATION; ACTIVATION; EXPRESSION	Background and ObjectiveThe proteasome inhibitor, bortezomib, is known to induce osteoblastic differentiation in a number of cell lines, such as mesenchymal stem cells and osteoblastic precursor cells. As periodontal ligament (PDL) cells are multipotent, we examined whether bortezomib may induce the differentiation of PDL cells into hard-tissue-forming cells. Material and MethodsA mouse PDL clone cell line, MPDL22 cells, was cultured in mineralization medium in the presence or absence of bortezomib. Expression of calcification-related genes and calcified-nodule formation were evaluated by real-time PCR and Alizarin Red staining, respectively. ResultsBortezomib increased the expression of calcification-related mRNAs, such as tissue nonspecific alkaline phosphatase isoenzyme (ALPase), bone sialoprotein (Bsp), runt-related transcription factor 2 (Runx2) and osteopontin, and calcified-nodule formation in MPDL22 cells. These effects were induced, in part, by increasing the cytosolic accumulation and nuclear translocation of -catenin, leading to an increase in expression of bone morphogenetic protein (Bmp)-2, -4 and -6 mRNAs. In addition, bortezomib enhanced BMP-2-induced expression of Bsp and osteopontin mRNAs and increased calcified-nodule formation in MPDL22 cells. ConclusionBortezomib induced cytodifferentiation and mineralization of PDL cells by enhancing the accumulation of -catenin within the cytosol and the nucleus and increasing the expression of Bmp-2, -4 and -6 mRNAs. Moreover, bortezomib enhanced the BMP-2-induced cytodifferentiation and mineralization of PDL cells, suggesting that bortezomib may be efficacious for use in periodontal regeneration therapy.	[Kitagaki, J.; Miyauchi, S.; Xie, C. J.; Yamashita, M.; Yamada, S.; Kitamura, M.; Murakami, S.] Osaka Univ, Grad Sch Dent, Div Oral Biol & Dis Control, Dept Periodontol, Suita, Osaka 5650871, Japan; [Kitagaki, J.] Osaka Univ, Dent Hosp, Ctr Translat Dent Res, Challenge Intractable Oral Dis, Suita, Osaka 5650871, Japan; [Xie, C. J.] Southern Med Univ, Stomatol Hosp Guangdong Prov, Dept Periodontol, Guangzhou, Guangdong, Peoples R China	Murakami, S (reprint author), Osaka Univ, Grad Sch Dent, Div Oral Biol & Dis Control, Dept Periodontol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	ipshinya@dent.osaka-u.ac.jp			Japan China Sasakawa Medical Fellowship;  [25862045];  [23249086]	This work was supported, in part, by Grants-in-Aid for Scientific Research (No. 25862045, 23249086) and Japan China Sasakawa Medical Fellowship. None of the authors reported any conflict of interest.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Fagotto F, 2013, EMBO REP, V14, P422, DOI 10.1038/embor.2013.45; Yamada S, 2007, J BIOL CHEM, V282, P23070, DOI 10.1074/jbc.M611181200; Lee EC, 2011, CLIN CANCER RES, V17, P7313, DOI 10.1158/1078-0432.CCR-11-0636; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Kobayashi M, 1999, J DENT RES, V78, P1624; Pennisi A, 2009, AM J HEMATOL, V84, P6, DOI 10.1002/ajh.21310; Moreau P, 2008, HAEMATOL-HEMATOL J, V93, P1908, DOI 10.3324/haematol.13285; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Dai JL, 2008, CANCER RES, V68, P5785, DOI 10.1158/0008-5472.CAN-07-6541; Qiang YW, 2009, BLOOD, V113, P4319, DOI 10.1182/blood-2008-08-174300; DAHL LK, 1952, P SOC EXP BIOL MED, V80, P474; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Zhang RR, 2013, BONE, V52, P145, DOI 10.1016/j.bone.2012.09.029; Oyajobi BO, 2007, BRIT J HAEMATOL, V139, P434, DOI 10.1111/j.1365-2141.2007.06829.x; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; HERSHKO A, 1983, CELL, V34, P11, DOI 10.1016/0092-8674(83)90131-9; Mehta V, 2013, DEV BIOL, V376, P125, DOI 10.1016/j.ydbio.2013.01.034; Folmer F, 2006, BIOCHEM PHARMACOL, V71, P1206, DOI 10.1016/j.bcp.2005.12.032; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cantley MD, 2011, J PERIODONTAL RES, V46, P697, DOI 10.1111/j.1600-0765.2011.01392.x; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Uyama M, 2012, GENES CELLS, V17, P548, DOI 10.1111/j.1365-2443.2012.01611.x; Beertsen W, 1997, PERIODONTOL 2000, V13, P20, DOI 10.1111/j.1600-0757.1997.tb00094.x; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Giarre M, 1998, ANN NY ACAD SCI, V857, P43, DOI 10.1111/j.1749-6632.1998.tb10106.x; Hakki S. S., 2013, J BIOMED MATER RES B, V102, P119; Kawabe Y, 1999, BBA-MOL CELL BIOL L, V1436, P307, DOI 10.1016/S0005-2760(98)00119-2; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Mi HW, 2011, J DENT RES, V90, P1318, DOI 10.1177/0022034511418340; Nakamura S, 2013, INT J HEMATOL, V98, P66, DOI 10.1007/s12185-013-1367-z; Suzuki K, 2013, JPN J CLIN ONCOL, V43, P116, DOI 10.1093/jjco/hys215; Yuan HP, 2011, J CLIN PERIODONTOL, V38, P1029, DOI 10.1111/j.1600-051X.2011.01780.x	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	APR	2015	50	2					248	255		10.1111/jre.12202		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CD2NH	WOS:000350914600013		
J	Yoshida, T; Miyaji, H; Otani, K; Inoue, K; Nakane, K; Nishimura, H; Ibara, A; Shimada, A; Ogawa, K; Nishida, E; Sugaya, T; Sun, L; Fugetsu, B; Kawanami, M				Yoshida, T.; Miyaji, H.; Otani, K.; Inoue, K.; Nakane, K.; Nishimura, H.; Ibara, A.; Shimada, A.; Ogawa, K.; Nishida, E.; Sugaya, T.; Sun, L.; Fugetsu, B.; Kawanami, M.			Bone augmentation using a highly porous PLGA/beta-TCP scaffold containing fibroblast growth factor-2	JOURNAL OF PERIODONTAL RESEARCH			English	Article						bone tissue engineering; co-poly lactic acid; glycolic acid; fibroblast growth factor-2; -tricalcium phosphate	BETA-TRICALCIUM PHOSPHATE; PORE-SIZE; IN-VITRO; HYDROXYAPATITE; BIORESORPTION; PROLIFERATION; REGENERATION; IMPLANTATION; OSTEOGENESIS; SUBSTITUTE	Background and ObjectiveBeta-tricalcium phosphate (-TCP), a bio-absorbable ceramic, facilitates bone conductivity. We constructed a highly porous three-dimensional scaffold, using -TCP, for bone tissue engineering and coated it with co-poly lactic acid/glycolic acid (PLGA) to improve the mechanical strength and biological performance. The aim of this study was to examine the effect of implantation of the PLGA/-TCP scaffold loaded with fibroblast growth factor-2 (FGF-2) on bone augmentation. Material and MethodsThe -TCP scaffold was fabricated by the replica method using polyurethane foam, then coated with PLGA. The PLGA/-TCP scaffold was characterized by scanning electron miscroscopy (SEM), transmission electron microscopy (TEM), X-ray diffraction, compressive testing, cell culture and a subcutaneous implant test. Subsequently, a bone-forming test was performed using 52 rats. The -TCP scaffold, PLGA-coated scaffold, and -TCP and PLGA-coated scaffolds loaded with FGF-2, were implanted into rat cranial bone. Histological observations were made at 10 and 35d postsurgery. ResultsSEM and TEM observations showed a thin PLGA layer on the -TCP particles after coating. High porosity (> 90%) of the scaffold was exhibited after PLGA coating, and the compressive strength of the PLGA/-TCP scaffold was six-fold greater than that of the noncoated scaffold. Good biocompatibility of the PLGA/-TCP scaffold was found in the culture and implant tests. Histological samples obtained following implantation of PLGA/-TCP scaffold loaded with FGF-2 showed significant bone augmentation. ConclusionThe PLGA coating improved the mechanical strength of -TCP scaffolds while maintaining high porosity and tissue compatibility. PLGA/-TCP scaffolds, in combination with FGF-2, are bioeffective for bone augmentation.	[Yoshida, T.; Miyaji, H.; Otani, K.; Inoue, K.; Ibara, A.; Shimada, A.; Ogawa, K.; Nishida, E.; Sugaya, T.; Kawanami, M.] Hokkaido Univ, Grad Sch Dent Med, Dept Periodontol & Endodontol, Sapporo, Hokkaido 0608586, Japan; [Nakane, K.; Nishimura, H.] Inoac Corp, Nagoya, Aichi, Japan; [Sun, L.; Fugetsu, B.] Hokkaido Univ, Creat Res Inst Sousei, Res Dept, Div Frontier Res, Sapporo, Hokkaido 0608586, Japan; [Sun, L.; Fugetsu, B.] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 0608586, Japan	Miyaji, H (reprint author), Hokkaido Univ, Grad Sch Dent Med, Dept Periodontol & Endodontol, Sapporo, Hokkaido 0608586, Japan.	miyaji@den.hokudai.ac.jp			JPSP KAKENHI [22791916]	We thank Tomita Pharmaceutical Co., Ltd., for providing the beta-TCP. This work was supported by JPSP KAKENHI Grant Number 22791916.	Kondo N, 2006, BIOMATERIALS, V27, P4419, DOI 10.1016/j.biomaterials.2006.04.016; Yuan HP, 2006, TISSUE ENG, V12, P1607, DOI 10.1089/ten.2006.12.1607; Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u; Gaasbeek RDA, 2005, BIOMATERIALS, V26, P6713, DOI 10.1016/j.biomaterials.2005.04.056; Singer AJ, 1999, NEW ENGL J MED, V341, P738; Takayama S, 2001, J DENT RES, V80, P2075; Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4; Ibara A, 2013, J NANOMATER, DOI 10.1155/2013/639502; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645; Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094; Schnettler R, 2003, BIOMATERIALS, V24, P4603, DOI 10.1016/S0142-9612(03)00354-5; Stavropoulos A, 2010, J PERIODONTOL, V81, P325, DOI 10.1902/jop.2009.090386; Dorozhkin SV, 2008, J MATER SCI, V43, P3028, DOI 10.1007/s10853-008-2527-z; Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528; Roy TD, 2003, J BIOMED MATER RES A, V66A, P283, DOI 10.1002/jbm.a.10582; PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X; Boilly B, 2000, CYTOKINE GROWTH F R, V11, P295, DOI 10.1016/S1359-6101(00)00014-9; Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Tigges U, 2008, DEVELOPMENT, V135, P523, DOI 10.1242/dev.002071; Patrick CW, 1999, TISSUE ENG, V5, P139, DOI 10.1089/ten.1999.5.139; Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017; Chazono M, 2008, J ORTHOP SCI, V13, P550, DOI 10.1007/s00776-008-1271-1; Ishii Y, 2013, ACTA ODONTOL SCAND, V71, P325, DOI 10.3109/00016357.2012.680906; Jansen RG, 2009, J ORAL PATHOL MED, V38, P630, DOI 10.1111/j.1600-0714.2009.00763.x; Kobayashi N, 2010, J ORAL TISSUE ENG, V8, P91; Miyaji H, 2013, J ORAL ENG, V10, P172; Miyamoto S, 2013, CLIN ORAL IMPLAN RES, V24, P134, DOI 10.1111/j.1600-0501.2011.02396.x; Oi Y, 2009, DENT MATER J, V24, P162; Saito M, 2000, J Orthop Sci, V5, P275, DOI 10.1007/s007760050163; Yeo A, 2012, CLIN ORAL IMPLAN RES, V23, P1322, DOI 10.1111/j.1600-0501.2011.02366.x; Yun YR, 2010, J TISSUE ENG, V1, P1, DOI [DOI 10.4061/2010/218142, 10.4061/2010/218142]; Zheng H, 2014, J BIOMED MATER RES B, V102, P376, DOI 10.1002/jbm.b.33016	33	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3484	1600-0765		J PERIODONTAL RES	J. Periodont. Res.	APR	2015	50	2					265	273		10.1111/jre.12206		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CD2NH	WOS:000350914600015		
J	Yamashita, M; Iida, M; Tada, M; Shirasago, Y; Fukasawa, M; Nagase, S; Watari, A; Ishii-Watabe, A; Yagi, K; Kondoh, M				Yamashita, Mayo; Iida, Manami; Tada, Minoru; Shirasago, Yoshitaka; Fukasawa, Masayoshi; Nagase, Shotaro; Watari, Akihiro; Ishii-Watabe, Akiko; Yagi, Kiyohito; Kondoh, Masuo			Discovery of Anti-Claudin-1 Antibodies as Candidate Therapeutics against Hepatitis C Virus	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							REPLICATION IN-VITRO; INFLUENZA-A VIRUS; B TYPE-I; FAB NEUTRALIZES; ENTRY FACTOR; LIFE-CYCLE; INFECTION; RECEPTOR; CELLS; CD81	Claudin-1 (CLDN1), a known host factor for hepatitis C virus (HCV) entry and cell-to-cell transmission, is a target molecule for inhibiting HCV infection. We previously developed four clones of mouse anti-CLDN1 monoclonal antibody (mAb) that prevented HCV infection in vitro. Two of these mAbs showed the highest antiviral activity. Here, we optimized the anti-CLDN1 mAbs as candidates for therapeutics by protein engineering. Although Fab fragments of the mAbs prevented in vitro HCV infection, their inhibitory effects were much weaker than those of the whole mAbs. In contrast, human chimeric IgG1 mAbs generated by grafting the variable domains of the mouse mAb light and heavy chains inhibited in vitro HCV infection as efficiently as the parental mouse mAbs. However, the chimeric IgG1 mAbs activated Fc gamma receptor, suggesting that cytotoxicity against mAb-bound CLDN1-expressing cells occurred through the induction of antibody-dependent cellular cytotoxicity (ADCC). To avoid ADCC-induced side effects, we prepared human chimeric IgG4 mAbs. The chimeric IgG4 mAbs did not activate Fc gamma receptor or induce ADCC, but they prevented in vitro HCV infection as efficiently as did the parental mouse mAbs. These findings indicate that the IgG4 form of human chimeric anti-CLDN1 mAb may be a candidate molecule for clinically applicable HCV therapy.	[Yamashita, Mayo; Iida, Manami; Nagase, Shotaro; Watari, Akihiro; Yagi, Kiyohito; Kondoh, Masuo] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biofunct Mol Chem, Suita, Osaka 5650871, Japan; [Tada, Minoru; Ishii-Watabe, Akiko] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo, Japan; [Shirasago, Yoshitaka; Fukasawa, Masayoshi] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan; [Shirasago, Yoshitaka] Tokyo Univ Sci, Grad Sch Biol Sci, Chiba, Japan	Kondoh, M (reprint author), Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biofunct Mol Chem, Suita, Osaka 5650871, Japan.	fuka@nih.go.jp; masuo@phs.osaka-u.ac.jp			Health and Labor Sciences Research Grant from the Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24390042, 23590104]; Adaptable and Seamless Technology Transfer Program through Target-Driven R&D, Japan Science and Technology Agency [AS242Z01694Q, AS251Z00905Q]; Takeda Science Foundation; Nakatomi Foundation; Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO)	This work was supported by a Health and Labor Sciences Research Grant from the Ministry of Health, Labor, and Welfare of Japan; a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [24390042] (to M.K.); and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [23590104] (to M.F.); and funds from the Adaptable and Seamless Technology Transfer Program through Target-Driven R&D, Japan Science and Technology Agency [AS242Z01694Q and AS251Z00905Q]; the Takeda Science Foundation; the Nakatomi Foundation; and the Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science, and Technology, Japan; and the Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO).	El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Hopkins S, 2010, ANTIMICROB AGENTS CH, V54, P660, DOI 10.1128/AAC.00660-09; Li YP, 2011, P NATL ACAD SCI USA, V108, P4991, DOI 10.1073/pnas.1016606108; Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Timpe JM, 2008, HEPATOLOGY, V47, P17, DOI 10.1002/hep.21959; Meuleman P, 2008, HEPATOLOGY, V48, P1761, DOI 10.1002/hep.22547; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Houot R, 2011, TRENDS IMMUNOL, V32, P510, DOI 10.1016/j.it.2011.07.003; Li XR, 2014, J PHARMACOL EXP THER, V351, P206, DOI 10.1124/jpet.114.216911; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI14011; Levy S, 1998, ANNU REV IMMUNOL, V16, P89, DOI 10.1146/annurev.immunol.16.1.89; Murray CL, 2011, ANNU REV MICROBIOL, V65, P307, DOI 10.1146/annurev-micro-090110-102954; Fofana I, 2010, GASTROENTEROLOGY, V139, P953, DOI 10.1053/j.gastro.2010.05.073; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Tada M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095787; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Edwards MJ, 2000, VIROLOGY, V278, P423, DOI 10.1006/viro.2000.0631; Edwards MJ, 2001, J GEN VIROL, V82, P1387; Fukasawa M, 2015, J VIROL IN PRESS; Iida M, 2014, FASEB J, V28; Kondoh M, 2010, Patent No. [WO2014132307A1, 2014132307]; McInerney TL, 1997, VIROLOGY, V233, P313, DOI 10.1006/viro.1997.8547; Murakami Y, 2009, ANTIVIR RES, V83, P112, DOI 10.1016/j.antiviral.2009.03.008; Murakami Y, 2013, MICROBES INFECT, V15, P45, DOI 10.1016/j.micinf.2012.10.003; Nagase S, 2013, FASEB J, V27; Neergaard MS, 2014, J PHARM SCI-US, V103, P115, DOI 10.1002/jps.23788; Reynolds GM, 2008, HEPATOLOGY, V47, P418, DOI 10.1002/hep.22028; Stockwin LH, 2003, EXPERT OPIN BIOL TH, V3, P1133, DOI 10.1517/14712598.3.7.1133	41	3	3	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	APR	2015	353	1					112	118		10.1124/jpet.114.217653		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CD4HP	WOS:000351043600013		
J	Kaneko, Y; Tachikawa, M; Akaogi, R; Fujimoto, K; Ishibashi, M; Uchida, Y; Couraud, PO; Ohtsuki, S; Hosoya, K; Terasaki, T				Kaneko, Yosuke; Tachikawa, Masanori; Akaogi, Ryo; Fujimoto, Kazuhisa; Ishibashi, Megumi; Uchida, Yasuo; Couraud, Pierre-Olivier; Ohtsuki, Sumio; Hosoya, Ken-ichi; Terasaki, Tetsuya			Contribution of Pannexin 1 and Connexin 43 Hemichannels to Extracellular Calcium-Dependent Transport Dynamics in Human Blood-Brain Barrier Endothelial Cells	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							CEREBRAL-ISCHEMIA; P-GLYCOPROTEIN; QUANTITATIVE ATLAS; JUNCTION PROTEINS; LINE HCMEC/D3; CHANNELS; CA2+; RECEPTORS; PERMEABILITY; MODEL	Dysregulation of blood-brain barrier (BBB) transport function is thought to exacerbate neuronal damage in acute ischemic stroke. The purpose of this study was to clarify the characteristics of pannexin (Px) and/or connexin (Cx) hemichannel(s)-mediated transport of organic anions and cations in human BBB endothelial cell line hCMEC/D3 and to identify inhibitors of hemichannel opening in hCMEC/D3 cells in the absence of extracellular Ca2+, a condition mimicking acute ischemic stroke. In the absence of extracellular Ca2+, the cells showed increased uptake and efflux transport of organic ionic fluorescent dyes. Classic hemichannel inhibitors markedly inhibited the enhanced uptake and efflux. Quantitative targeted absolute proteomics confirmed Px1 and Cx43 protein expression in plasma membrane of hCMEC/D3 cells. Knockdown of Px1 and Cx43 with the small interfering RNAs significantly inhibited the enhanced uptake and efflux of organic anionic and cationic fluorescent dyes. Clinically used cilnidipine and progesterone, which have neuroprotective effects in animal ischemia models, were identified as inhibitors of hemichannel opening. These findings suggest that altered transport dynamics at the human BBB in the absence of extracellular Ca2+ is at least partly attributable to opening of Px1 and Cx43 hemichannels. Therefore, we speculate that Px1 and Cx43 may be potential drug targets to ameliorate BBB transport dysregulation during acute ischemia.	[Kaneko, Yosuke; Tachikawa, Masanori; Akaogi, Ryo; Uchida, Yasuo; Terasaki, Tetsuya] Tohoku Univ, Grad Sch Pharmaceut Sci, Div Membrane Transport & Drug Targeting, Sendai, Miyagi 9808578, Japan; [Fujimoto, Kazuhisa; Ishibashi, Megumi] Kyushu Sangyo Univ, Fac Engn, Dept Appl Chem & Biochem, Fukuoka, Japan; [Couraud, Pierre-Olivier] Inst Cochin, INSERM, U1016, Paris, France; [Couraud, Pierre-Olivier] CNRS, UMR8104, Paris, France; [Couraud, Pierre-Olivier] Univ Paris 05, Paris, France; [Ohtsuki, Sumio] Kumamoto Univ, Fac Life Sci, Dept Pharmaceut Microbiol, Kumamoto, Japan; [Hosoya, Ken-ichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Pharmaceut, Toyama 930, Japan	Tachikawa, M (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, 6-3 Aramaki, Sendai, Miyagi 9808578, Japan.	tachik-dds@umin.ac.jp			Japanese Society for the Promotion of Science (JSPS) [KAKENHI] [23790170, 24249011]; JSPS; Centre National de la Recherche Scientifique (CNRS); Proteomedix Frontiers Co. Ltd.; positions at Proteomedix Frontiers Co. Ltd.	This study was supported in part by four Grants-in-Aid from the Japanese Society for the Promotion of Science (JSPS) for Young Scientists (A) [KAKENHI: 23790170] and for Scientific Research (A) [KAKENHI: 24249011]; and by the JSPS and Centre National de la Recherche Scientifique (CNRS) under the Japan-France Basic Scientific Cooperation Program. T.T. and S.O. are full professors at Tohoku University and Kumamoto University, respectively, and are also directors of Proteomedix Frontiers Co. Ltd. This study was not supported by Proteomedix Frontiers Co. Ltd., and their positions at Proteomedix Frontiers Co. Ltd. did not affect the design of the study, the collection, analysis, and interpretation of the data, the writing of the manuscript, or the decision to publish, and does not present any financial conflicts. The remaining authors declare no competing financial interests.	Bargiotas P, 2012, CHANNELS, V6, P453, DOI 10.4161/chan.22315; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Fang WR, 2013, NEUROCHEM INT, V62, P23, DOI 10.1016/j.neuint.2012.10.012; Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; SIMPSON I, 1977, SCIENCE, V195, P294, DOI 10.1126/science.831276; Koval M, 2014, FEBS LETT, V588, P1193, DOI 10.1016/j.febslet.2014.02.025; Ishrat T, 2009, BRAIN RES, V1257, P94, DOI 10.1016/j.brainres.2008.12.048; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Kamiie J, 2008, PHARM RES, V25, P1469, DOI 10.1007/s11095-008-9532-4; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; De Bock M, 2014, FEBS LETT, V588, P1259, DOI 10.1016/j.febslet.2014.02.060; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Ohtsuki S, 2013, MOL PHARMACEUT, V10, P289, DOI 10.1021/mp3004308; De Bock M, 2011, J CEREBR BLOOD F MET, V31, P1942, DOI 10.1038/jcbfm.2011.86; Shestopalov VI, 2008, CELL MOL LIFE SCI, V65, P376, DOI 10.1007/s00018-007-7200-1; Bai DL, 2006, J PHARMACOL EXP THER, V319, P1452, DOI 10.1124/jpet.106.112045; Poornima V, 2012, J MOL NEUROSCI, V46, P585, DOI 10.1007/s12031-011-9646-8; Takahara A, 2004, BIOL PHARM BULL, V27, P1388, DOI 10.1248/bpb.27.1388; Weksler BB, 2005, FASEB J, V19, P1872; De Bock M, 2012, BRAIN RES, V1487, P78, DOI 10.1016/j.brainres.2012.06.046; Bargiotas P, 2009, CURR MOL MED, V9, P186; Bintig W, 2012, PURINERG SIGNAL, V8, P71, DOI 10.1007/s11302-011-9262-7; Gaete PS, 2014, J CELL PHYSIOL, V229, P1336, DOI 10.1002/jcp.24563; Hoshi Y, 2013, J PHARM SCI-US, V102, P3343, DOI 10.1002/jps.23575; Li Michelle W M, 2012, Adv Exp Med Biol, V763, P260; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; SILVER IA, 1990, J GEN PHYSIOL, V95, P837, DOI 10.1085/jgp.95.5.837; Tachikawa M, 2014, DRUG DELIVERY BRAIN, P23; Tai LM, 2009, BRAIN RES, V1292, P14, DOI 10.1016/j.brainres.2009.07.039; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021108; TEPIKIN AV, 1992, J BIOL CHEM, V267, P3569; YAMAOKA K, 1986, J PHARMACOBIO-DYNAM, V9, P161	37	1	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	APR	2015	353	1					192	200		10.1124/jpet.114.220210		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CD4HP	WOS:000351043600020		
J	Bainsla, L; Raja, MM; Nigam, AK; Varaprasad, BSDCS; Takahashi, YK; Suresh, KG; Hono, K				Bainsla, Lakhan; Raja, M. Manivel; Nigam, A. K.; Varaprasad, B. S. D. Ch S.; Takahashi, Y. K.; Suresh, K. G.; Hono, K.			Investigation of the quaternary Fe2-xCoxMnSi (0 <= x <= 0.6) alloys by structural, magnetic, resistivity and spin polarization measurements	JOURNAL OF PHYSICS D-APPLIED PHYSICS			English	Article						Heusler alloys; Andreev reflection spectroscopy; magnetoresistance; spin polarization	HALF-METALLIC FERROMAGNETS; HEUSLER ALLOYS; ELECTRICAL-RESISTIVITY; AMORPHOUS-ALLOYS; FE3-XMNXSI; HYPERFINE; COMPOUND; BEHAVIOR; MOMENTS; FIELDS	A detailed study of the Fe2-xCoxMnSi (0 <= x <= 0.6) alloys has been carried out by investigating the samples by x-ray diffraction, Mossbauer spectroscopy, magnetization, transport and current spin polarization measurements. A perfectly ordered L2(1) phase is found to exist for x = 0.4. Competing magnetic interactions between ferromagnetic and antiferromagnetic (AFM) phases are seen in the alloys with x < 0.2, whereas the AFM phase is completely absent for x >= 0.2 as revealed by the magnetization and resistivity data. The Curie temperature and saturation magnetization values increase with increase in the Co concentration. Anomalous, non metallic-like behaviour is observed for x = 0.4. Current spin polarization values of 0.61 +/- 0.01 and 0.66 +/- 0.01 were deduced for x = 0.2 and x = 0.4 respectively, using the point contact Andreev reflection spectroscopy. Considering the high spin polarization and Curie temperature, materials with x >= 0.2 appear to be very promising for spintronic devices.	[Bainsla, Lakhan; Suresh, K. G.] Indian Inst Technol, Dept Phys, Bombay 400076, Maharashtra, India; [Raja, M. Manivel] Def Met Res Lab, Hyderabad 500058, Andhra Pradesh, India; [Nigam, A. K.] Tata Inst Fundamental Res, DCMPMS, Bombay 400005, Maharashtra, India; [Varaprasad, B. S. D. Ch S.; Takahashi, Y. K.; Hono, K.] Natl Inst Mat Sci, Magnet Mat Unit, Tsukuba, Ibaraki 3050047, Japan	Bainsla, L (reprint author), Indian Inst Technol, Dept Phys, Bombay 400076, Maharashtra, India.	suresh@phy.iitb.ac.in	Hono, Kazuhiro/B-9202-2008	Hono, Kazuhiro/0000-0001-7367-0193	UGC, Government of India; ISRO cell, IITB	L Bainsla would like to thank UGC, Government of India for granting senior research fellowship (SRF). The authors thank D Buddhikot for his help in the resistivity measurements. KGS thanks ISRO cell, IITB for funding the work.	Al-Nawashi GA, 2002, PHYSICA B, V321, P167, DOI 10.1016/S0921-4526(02)00845-1; Rajanikanth A, 2007, J APPL PHYS, V101, DOI 10.1063/1.2409775; Sakuraba Y, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4772546; WEBSTER PJ, 1973, J PHYS CHEM SOLIDS, V34, P1647, DOI 10.1016/S0022-3697(73)80130-1; Ishida S, 2008, MATER TRANS, V49, P114, DOI 10.2320/matertrans.MRA2007163; ZIEBECK KRA, 1976, PHILOS MAG, V34, P973, DOI 10.1080/00318087608227722; Saito T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.103006; Dung NH, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.045134; Inomata K, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/1/014101; Galanakis I, 2006, J PHYS D APPL PHYS, V39, P765, DOI 10.1088/0022-3727/39/5/S01; DEGROOT RA, 1983, PHYS REV LETT, V50, P2024, DOI 10.1103/PhysRevLett.50.2024; Gupta SB, 2012, J APPL PHYS, V112, DOI 10.1063/1.4766900; Felser C, 2007, ANGEW CHEM INT EDIT, V46, P668, DOI 10.1002/anie.200601815; Du Y, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4829633; MOOIJ JH, 1973, PHYS STATUS SOLIDI A, V17, P521, DOI 10.1002/pssa.2210170217; Soulen RJ, 1998, SCIENCE, V282, P85, DOI 10.1126/science.282.5386.85; WOHLFARTH EP, 1978, J MAGN MAGN MATER, V7, P113, DOI 10.1016/0304-8853(78)90163-4; RHODES P, 1963, PROC R SOC LON SER-A, V273, P247, DOI 10.1098/rspa.1963.0086; Ouardi S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.100401; OTTO MJ, 1989, J PHYS-CONDENS MAT, V1, P2341, DOI 10.1088/0953-8984/1/13/007; Nishino Y, 1997, PHYS REV LETT, V79, P1909, DOI 10.1103/PhysRevLett.79.1909; Karthik SV, 2007, ACTA MATER, V55, P3867, DOI 10.1016/j.actamat.2007.03.003; Pal L, 2013, J APPL PHYS, V113, DOI 10.1063/1.4794126; Strijkers GJ, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.104510; Nakatani TM, 2007, J APPL PHYS, V102, DOI 10.1063/1.2767229; DENTON AR, 1991, PHYS REV A, V43, P3161, DOI 10.1103/PhysRevA.43.3161; Galanakis I, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.174429; Clowes S. K., 2004, J MAGN MAGN MATER, V272, P1471; Ikhtiar H, 2014, J APPL PHYS, V115; Jung V, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/8/084007; Jung V, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2965463; Kowalczyk A, 1997, J ALLOY COMPD, V259, P59, DOI 10.1016/S0925-8388(97)00101-1; Kubota T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3105982; Lezaic M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.094434; Mahmood SH, 2004, PHYS STATUS SOLIDI B, V241, P1186, DOI [10.1002/pssb.200304438, 10.1002/pssb.2004304438]; Maji B, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/37007; MASSENET O, 1979, J PHYS F MET PHYS, V9, P1687, DOI 10.1088/0305-4608/9/8/019; Mohn P, 1998, PHILOS MAG B, V78, P629, DOI 10.1080/13642819808206770; MOODERA JS, 1994, J APPL PHYS, V76, P6101, DOI 10.1063/1.358318; NICULESCU V, 1976, PHYS REV B, V13, P3167, DOI 10.1103/PhysRevB.13.3167; NICULESCU VA, 1983, J MAGN MAGN MATER, V39, P223, DOI 10.1016/0304-8853(83)90084-7; Pal L, 2014, J APPL PHYS, V115, DOI 10.1063/1.4862715; YOON S, 1977, J PHYS F MET PHYS, V7, P1079, DOI 10.1088/0305-4608/7/6/022; YOON S, 1974, PHYS LETT A, VA 48, P381, DOI 10.1016/0375-9601(74)90476-9	44	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0022-3727	1361-6463		J PHYS D APPL PHYS	J. Phys. D-Appl. Phys.	APR 1	2015	48	12							125002	10.1088/0022-3727/48/12/125002		8	Physics, Applied	Physics	CD1GB	WOS:000350821700003		
J	Huang, BD; Takashima, K; Zhu, XM; Pu, YK				Huang, Bang-Dou; Takashima, Keisuke; Zhu, Xi-Ming; Pu, Yi-Kang			The influence of the voltage rise rate on the breakdown of an atmospheric pressure helium nanosecond parallel-plate discharge	JOURNAL OF PHYSICS D-APPLIED PHYSICS			English	Article						voltage rise rate; breakdown; nanosecond discharge	GENERATION; EXCITATION; ELECTRONS; GASES; WAVE	The influence of the voltage rise rate on a nanosecond discharge in atmospheric pressure helium is investigated. The experiment is performed with a parallel-plate discharge configuration. The voltage rise rate is varied between 0.17 kV ns(-1) and 0.42 kV ns(-1). It is found that the rise rate of both the discharge current and the emission intensity increases drastically with the voltage rise rate. This demonstrates the remarkable capability of generating high energy electrons in the discharges with a high voltage rise rate. These arguments are supported by the increase in the measured effective electron temperature during the breakdown processes, namely similar to 18 eV when dV/dt is similar to 0.17 kV ns(-1) and similar to 33 eV when dV/dt is similar to 0.42 kV ns(-1). Furthermore, a higher voltage rise rate results in a shorter rise time of both the discharge current and the emission intensity. Since the breakdown process evolves in the form of a cathode directed ionization wave, a shorter rise time indicates faster propagation of the ionization wave. In addition, a simple fluid model is proposed and its predicted results agree reasonably well with the important discharge parameters measured in the experiment, such as the breakdown voltage, the rise rate and rise time of the discharge current.	[Huang, Bang-Dou; Pu, Yi-Kang] Tsinghua Univ, Dept Engn Phys, Beijing 100084, Peoples R China; [Takashima, Keisuke] Tohoku Univ, Dept Elect Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Zhu, Xi-Ming] Ruhr Univ Bochum, Inst Plasma & Atom Phys, D-44780 Bochum, Germany	Huang, BD (reprint author), Tsinghua Univ, Dept Engn Phys, Beijing 100084, Peoples R China.	hbangdou@gmail.com			Chinese Ministry of Science and Technology [2011ZX02403]	This work is supported in part by the fund from Chinese Ministry of Science and Technology (Nos 2011ZX02403).	ALVES LL, 1992, J PHYS D APPL PHYS, V25, P1713, DOI 10.1088/0022-3727/25/12/007; Yatom S, 2011, J APPL PHYS, V109, DOI 10.1063/1.3573507; Anikin NB, 1998, J PHYS D APPL PHYS, V31, P826, DOI 10.1088/0022-3727/31/7/012; Takashima K, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3619810; LEVATTER JI, 1980, J APPL PHYS, V51, P210, DOI 10.1063/1.327412; Wang Q, 2006, J APPL PHYS, V100, DOI 10.1063/1.2214591; Bruggeman P, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/12/124005; Takashima K, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/1/015013; Adamovich IV, 2009, PLASMA SOURCES SCI T, V18, DOI 10.1088/0963-0252/18/3/034018; Hagelaar GJM, 2005, PLASMA SOURCES SCI T, V14, P722, DOI 10.1088/0963-0252/14/4/011; Ono R, 2003, J PHYS D APPL PHYS, V36, P1952, DOI 10.1088/0022-3727/36/16/306; Starikovskaia SM, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/35/353001; Komuro A, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/4/045002; Starikovskii AY, 2009, PLASMA SOURCES SCI T, V18, DOI 10.1088/0963-0252/18/3/034015; BAILEY M, 1995, J PHYS B-AT MOL OPT, V28, P2655, DOI 10.1088/0953-4075/28/13/017; Bogdanov A, 2004, J PHYS D, V37, P2987; Hoft H, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/46/465206; Huang BD, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/42/422003; Huang BD, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/46/464011; Kakizaki K, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2182744; Korolev Yu., 1998, PHYS PULSED BREAKDOW; Lagarkov A. N., 1994, IONIZATION WAVES ELE; Lieberman M A, 2005, PRINCIPLES PLASMA DI; Macheret SO, 2002, IEEE T PLASMA SCI, V30, P1301, DOI 10.1109/TPS.2002.802142; Nagaraja S, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/15/155205; Naidis G V, 1997, PISMA ZH TEKH FIZ, V23, P89; Nikandrov DS, 2008, IEEE T PLASMA SCI, V36, P131, DOI 10.1109/TPS.2007.913931; Pancheshnyi SV, 1999, J PHYS D APPL PHYS, V32, P2219, DOI 10.1088/0022-3727/32/17/311; Raizer Y P, 1992, GAS DISCHARGE PHYS; Rethmel C, 2011, 2011487 AIAA; Tarasenko VF, 2013, IEEE T PLASMA SCI, V41, P2931, DOI 10.1109/TPS.2013.2278995; Treshchalov AB, 2010, QUANTUM ELECTRON+, V40, P234, DOI 10.1070/QE2010v040n03ABEH014243; Walsh JL, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2825576; Wang D, 2012, AIR POLLUTION COMPRE; Warne LK, 2014, J APPL PHYS, V115, DOI 10.1063/1.4870601; Yagi I, 2011, IEEE T PLASMA SCI, V39, P2232, DOI 10.1109/TPS.2011.2154386	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0022-3727	1361-6463		J PHYS D APPL PHYS	J. Phys. D-Appl. Phys.	APR 1	2015	48	12							125202	10.1088/0022-3727/48/12/125202		10	Physics, Applied	Physics	CD1GB	WOS:000350821700008		
J	Cheoun, MK; Kim, KS; Kim, H; So, WY; Maruyama, T; Kajino, T				Cheoun, Myung-Ki; Kim, K. S.; Kim, Hungchong; So, W. Y.; Maruyama, Tomoyuki; Kajino, Toshitaka			In-medium effect with muon-neutrino and anti-muon-neutrino quasi-elastic scattering from C-12 nucleons	JOURNAL OF PHYSICS G-NUCLEAR AND PARTICLE PHYSICS			English	Article						neutrino scattering; quasi-elastic region; weak and electromagnetic form factors; density dependence	VIOLATING ELECTRON-SCATTERING; MESON COUPLING MODEL; STRANGE FORM-FACTORS; SUPERSCALING PREDICTIONS; OSCILLATIONS; HYPERNUCLEI; MINIBOONE; PROTON; MATTER	We investigated the in-medium effect by density-dependent axial and weak-vector form factors on muon-neutrino (nu(mu)) and anti-muon-neutrino ((nu(mu)) over bar) scattering in the quasi-elastic (QE) region from nucleons (N*) bound in a nucleus or immersed in a nuclear medium via neutral current (NC) and charged current (CC). For the density-dependent form factors, we exploited a quark-meson-coupling (QMC) model. We found that the nu(mu)((nu) over bar (mu))-N* scattering cross sections via NC in the QE region usually decrease with an increased medium density, while those using CC were increased. However, their rate of change was sensitive to the four-momentum transfer given to a bound nucleon through scattering. We compared these results obtained by the elementary process corrected by the in-medium effect to the BNL and MiniBooNE data, which measured nu(mu) scattering cross sections per nucleon through nu(mu) - C-12 scattering in C-12 composite targets. The incident energy range was 550 < E-nu < 3000 MeV. We increased the energy up to 100 GeV to compare our results to the NOMAD experimental data. In order to study the density effects on a nucleon embedded in C-12, we exploited the QMC form factors evaluated at rho = 0.5 rho(0), where the normal density rho(0) similar to 0.15 fm(-3). The strangeness contributions in NC scattering are also incorporated into the form factors for comparison with experimental data. Our numerical results show that most of the experimental data can be explained in a satisfactory manner by the density-dependent elementary process, but there are some remaining deviations resulting from the nuclear structure, particularly in the low and high momentum-transfer regions.	[Cheoun, Myung-Ki] Soongsil Univ, Dept Phys, Seoul 156743, South Korea; [Kim, K. S.] Korea Aerosp Univ, Sch Liberal Arts & Sci, Koyang 412791, South Korea; [Kim, Hungchong] Kookmin Univ, Dept Gen Educ, Seoul 136702, South Korea; [So, W. Y.] Kangwon Natl Univ Dogye, Dept Radiol Sci, Samcheok 245711, South Korea; [Maruyama, Tomoyuki] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2528510, Japan; [Kajino, Toshitaka] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Kajino, Toshitaka] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan	Cheoun, MK (reprint author), Soongsil Univ, Dept Phys, Seoul 156743, South Korea.	cheoun@ssu.ac.kr; kyungsik@kau.ac.kr; hungchong@kookmin.ac.kr; wyso@kangwon.ac.kr; maruyama.tomoyuki@nihon-u.ac.jp; kajino@nao.ac.jp			National Research Foundation of Korea [2012M7A1A2055605, 2014R1A2A2A05003548]	This work was supported by the National Research Foundation of Korea (Grant Nos. 2012M7A1A2055605 and 2014R1A2A2A05003548).	Abe K, 2011, PHYS REV LETT, V108; ABE K, 1986, PHYS REV LETT, V56, P1107, DOI 10.1103/PhysRevLett.56.1107; Alberico WM, 1999, NUCL PHYS A, V651, P277, DOI 10.1016/S0375-9474(99)00142-6; Amaro J E, 2001, PHYS LETT B, V696, P151; Amaro JE, 1996, NUCL PHYS A, V611, P163, DOI 10.1016/S0375-9474(96)00334-X; An FP, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.171803; Gonzalez-Jimenez R, 2013, PHYS LETT B, V718, P1471, DOI 10.1016/j.physletb.2012.11.065; Strumia A, 2003, PHYS LETT B, V564, P42, DOI 10.1016/S0370-2693(03)00616-6; MIKHEEV SP, 1985, SOV J NUCL PHYS+, V42, P913; AHRENS LA, 1987, PHYS REV D, V35, P785, DOI 10.1103/PhysRevD.35.785; Saito K, 2007, PROG PART NUCL PHYS, V58, P1, DOI 10.1016/j.ppnp.2005.07.003; WOLFENSTEIN L, 1978, PHYS REV D, V17, P2369, DOI 10.1103/PhysRevD.17.2369; Cheoun MK, 2008, J PHYS G NUCL PARTIC, V35, DOI 10.1088/0954-3899/35/6/065107; Nieves J, 2012, PHYS LETT B, V707, P72, DOI 10.1016/j.physletb.2011.11.061; Tice BG, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.231801; Cheoun MK, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.065502; Alberico WM, 1998, PHYS LETT B, V438, P9, DOI 10.1016/S0370-2693(98)01043-0; Saito K, 1996, NUCL PHYS A, V609, P339, DOI 10.1016/S0375-9474(96)00263-1; Fiorentini GA, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.022502; Ankowski AM, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.024616; Moreno O, 2009, NUCL PHYS A, V828, P306, DOI 10.1016/j.nuclphysa.2009.07.011; Adamson P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.181802; Cheoun MK, 2013, PHYS LETT B, V723, P464, DOI 10.1016/j.physletb.2013.05.050; Patton K, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.024612; Ahn JK, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.191802; MIKHEYEV SP, 1986, NUOVO CIMENTO C, V9, P17, DOI 10.1007/BF02508049; Aguilar-Arevalo AA, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.092005; Mahn KBM, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.032007; Alberico WM, 2002, PHYS REP, V358, P227, DOI 10.1016/S0370-1573(01)00058-8; Tsushima K, 1998, NUCL PHYS A, V630, P691, DOI 10.1016/S0375-9474(98)00806-9; Suzuki T, 2013, J PHYS G NUCL PARTIC, V40, DOI 10.1088/0954-3899/40/8/083101; Brooks W. K., 2011, Journal of Physics: Conference Series, V299, DOI 10.1088/1742-6596/299/1/012011; Butkevich AV, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.015501; Cloet IC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.082301; Dieterich S, 2001, PHYS LETT B, V500, P47, DOI 10.1016/S0370-2693(01)00052-1; Fischer T, 2011, ASTROPHYS J SUPPL S, V194, DOI 10.1088/0067-0049/194/2/39; Fogli G, 2007, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2007/12/010; Ivanov MV, 2012, PHYS LETT B, V711, P178, DOI 10.1016/j.physletb.2012.03.072; Kim K, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.024201; Kim KS, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.017601; Kim KS, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.067601; Kim KS, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.044615; Lu DH, 1999, PHYS REV C, V60, DOI 10.1103/PhysRevC.60.068201; Lu D-H, 2011, ARXIVNUCLTH0112001; Lu DH, 1998, PHYS LETT B, V417, P217, DOI 10.1016/S0370-2693(97)01385-3; Malace SP, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.052501; Malov S, 2000, PHYS REV C, V62, DOI 10.1103/PhysRevC.62.057302; Martinez MC, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.034604; Martini M, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.055502; Meucci A, 2006, NUCL PHYS A, V773, P250, DOI 10.1016/j.nuclphysa.2006.05.005; Meucci A, 2004, NUCL PHYS A, V739, P277, DOI 10.1016/j.nuclphysa.2004.04.108; Meucci A, 2011, PHYS REV D, V84, DOI 10.1103/PhysRevD.84.113003; Meucci A, 2004, NUCL PHYS A, V744, P307, DOI 10.1016/j.nuclphysa.2004.08.023; MUSOLF MJ, 1992, NUCL PHYS A, V546, P509, DOI 10.1016/0375-9474(92)90545-U; Nieves J, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.045501; Paolone M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.072001; Strauch S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.052301; Tsushima K, 2004, J PHYS G NUCL PARTIC, V30, P1765, DOI 10.1088/0954-3899/30/12/001; Tsushima K, 2003, PHYS REV C, V67, DOI 10.1103/PhysRevC.67.015211	59	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0954-3899	1361-6471		J PHYS G NUCL PARTIC	J. Phys. G-Nucl. Part. Phys.	APR	2015	42	4							045102	10.1088/0954-3899/42/4/045102		14	Physics, Nuclear; Physics, Particles & Fields	Physics	CD1CL	WOS:000350811300004		
J	Zhai, LM; Huang, J; Chen, D; Shibata, M; Katayose, Y; Zhang, Y; Liu, JS; Chen, X; Hu, XB; Lin, YH				Zhai, L. M.; Huang, J.; Chen, D.; Shibata, M.; Katayose, Y.; Zhang, Ying; Liu, J. S.; Chen, Xu; Hu, X. B.; Lin, Y. H.			Sensitivity of YAC to measure the light-component spectrum of primary cosmic rays at the 'knee' energies	JOURNAL OF PHYSICS G-NUCLEAR AND PARTICLE PHYSICS			English	Article						cosmic rays; hadronic interaction; knee; composition; energy spectrum	HELIUM SPECTRA; PROTON; RANGE	A new air-shower core-detector array (YAC: Yangbajing air-shower Core-detector array) has been developed to measure the primary cosmic-ray composition at the `knee' energies in Tibet, China, focusing mainly on the light components. The prototype experiment (YAC-I) consisting of 16 detectors has been constructed and operated at Yangbajing (4300 m a.s.l.) in Tibet since May 2009. YAC-I is installed in the Tibet-III AS array and operates together. In this paper, we performed a Monte Carlo simulation to check the sensitivity of the YAC-I+Tibet-III array to the cosmic-ray light component of cosmic rays around the knee energies, taking account of the observation conditions of the actual YAC-I+Tibet-III array. The selection of light component from others was made by use of an artificial neural network. The simulation shows that the light-component spectrum estimated by our methods can well reproduce the input ones within 10% error, and there will be about 30% systematic errors mostly induced by the primary and interaction models used. It is found that the full-scale YAC and the Tibet-III array is powerful to study the cosmic-ray composition, in particular, to obtain the energy spectra of protons and helium nuclei around the knee energies.	[Zhai, L. M.; Huang, J.; Zhang, Ying; Liu, J. S.; Chen, Xu; Hu, X. B.; Lin, Y. H.] Chinese Acad Sci, Inst High Energy Phys, Key Lab Particle Astrophys, Beijing 100049, Peoples R China; [Chen, D.] Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China; [Shibata, M.; Katayose, Y.] Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa 2408501, Japan; [Hu, X. B.] Shandong Univ, Dept Phys, Jinan 250100, Peoples R China	Zhai, LM (reprint author), Chinese Acad Sci, Inst High Energy Phys, Key Lab Particle Astrophys, Beijing 100049, Peoples R China.	huangjing@ihep.ac.cn			National Natural Science Foundation of China [11078002, 11275212]; Chinese Academy of Sciences [H9291450S3, Y4293211S5]; Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, CAS; Knowledge Innovation Fund of IHEP, China [H95451D0U2, H8515530U1]	The authors would like to express their thanks to the members of the Tibet AS. collaboration for the fruitful discussion. This work is supported by the Grants from the National Natural Science Foundation of China (11078002 and 11275212) and the Chinese Academy of Sciences (H9291450S3, Y4293211S5) and the Key Laboratory of Particle Astrophysics, Institute of High Energy Physics, CAS. The Knowledge Innovation Fund (H95451D0U2 and H8515530U1) of IHEP, China also provide support to this study.	Ahn HS, 2009, ASTROPHYS J, V707, P593, DOI 10.1088/0004-637X/707/1/593; Amenomori M., 2011, P 32 INT COSM RAY C, V3, P301; Amenomori M, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.072007; Amenomori M, 2011, P 32 INT COSM RAY C, V3, P290; Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Horandel JR, 2004, ASTROPART PHYS, V21, P241, DOI 10.1016/j.astropartphys.2004.01.004; Asakimori K, 1998, ASTROPHYS J, V502, P278, DOI 10.1086/305882; Gaisser TK, 2012, ASTROPART PHYS, V35, P801, DOI 10.1016/j.astropartphys.2012.02.010; Amenomori M, 2008, ASTROPHYS J, V678, P1165, DOI 10.1086/529514; Ostapchenko S, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.014018; Apanasenko AV, 2001, ASTROPART PHYS, V16, P13, DOI 10.1016/S0927-6505(00)00163-8; Engel R., 1999, P 26 INT COSM RAY C, V1, P415; Eun-Joo A, 2009, PHYS REV D, V80; Horandel JR, 2003, ASTROPART PHYS, V19, P193, DOI 10.1016/S0927-6505(02)00198-6; Jiang L, 2009, P 31 INT COSM RAY C; PETERSON C, 1994, COMPUT PHYS COMMUN, V81, P185, DOI 10.1016/0010-4655(94)90120-1; Pierog T, 2013, ARXIV1306012HEPPH; Shibata M, 2010, ASTROPHYS J, V716, P1076, DOI 10.1088/0004-637X/716/2/1076; Wefel J P, 2005, P 29 INT COSM RAY C, V3, P105; Yoon YS, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/2/122	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0954-3899	1361-6471		J PHYS G NUCL PARTIC	J. Phys. G-Nucl. Part. Phys.	APR	2015	42	4							045201	10.1088/0954-3899/42/4/045201		14	Physics, Nuclear; Physics, Particles & Fields	Physics	CD1CL	WOS:000350811300012		
J	Tsutsumi, N; Kinashi, K; Masumura, K; Kono, K				Tsutsumi, Naoto; Kinashi, Kenji; Masumura, Kento; Kono, Kenji			Photorefractive Performance of Poly(triarylamine)-Based Polymer Composites: An Approach from the Photoconductive Properties	JOURNAL OF POLYMER SCIENCE PART B-POLYMER PHYSICS			English	Article						charge field; NLO; optical diffraction and optical gain; optics; photoconductivity; poly(triarylamine) photorefractive composite; refractive index; response time; space	CARRIER PHOTOGENERATION; TRANSISTORS; GRATINGS; FILM	Photorefractive (PR) and photoconductive properties of methyl-substituted poly(triarylamine) (PTAA) based PR composite is presented. PR composite consisted of PTAA, piperidinodicyanostyrene, (2,4,6-trimethylphenyl) diphenylamine, and [6,6]-phenyl-C61-butyric acid methyl ester. Photocurrent is simultaneously measured when a transient degenerate four wave mixing is recorded. Diffraction efficiency of 16.6%, response time of 5 ms, and sensitivity of 43 cm(-2) J(-1) are measured under an applied field of 45 V mu m(-1) and 632.8 nm illumination with the intensity of 1.5 W cm 22. Response time of 10.2 ms with diffraction efficiency of 47.0% is obtained under a same field and 532 nm illumination with the intensity of 0.427 W cm(-2). Higher diffraction and faster response is due to the large photocurrent in the order of hundreds mu A measured. The resultant trap density is in the order of 10(14) cm(-3). Thus, space-charge field less than 1 V mu m(-1) is evaluated, which limits the PR response. (C) 2015 Wiley Periodicals, Inc.	[Tsutsumi, Naoto; Kinashi, Kenji; Masumura, Kento; Kono, Kenji] Kyoto Inst Technol, Dept Macromol Sci & Engn, Sakyo Ku, Kyoto 6068585, Japan	Tsutsumi, N (reprint author), Kyoto Inst Technol, Dept Macromol Sci & Engn, Sakyo Ku, Kyoto 6068585, Japan.	tsutsumi@kit.ac.jp			program for Strategic Promotion of Innovative Research and Development (S-Innovation), Japan Science and Technology Agency (JST)	N. T. and K. K. thank Dr. Wataru Sakai fruitful discussions. This work is supported by the program for Strategic Promotion of Innovative Research and Development (S-Innovation), Japan Science and Technology Agency (JST).	Daubler TK, 2000, PHYS REV B, V61, P13515, DOI 10.1103/PhysRevB.61.13515; Sasaki T, 2011, J MATER CHEM, V21, P8678, DOI 10.1039/c1jm10405e; KOGELNIK H, 1969, AT&T TECH J, V48, P2909; SCHILDKRAUT JS, 1992, J APPL PHYS, V72, P1888, DOI 10.1063/1.351662; Smith J, 2012, ADV MATER, V24, P2441, DOI 10.1002/adma.201200088; Cao ZB, 2013, POLYMER, V54, P269, DOI 10.1016/j.polymer.2012.11.028; Dang XD, 2010, ADV FUNCT MATER, V20, P3314, DOI 10.1002/adfm.201000799; Tay S, 2008, NATURE, V451, P694, DOI 10.1038/nature06596; Bobbert PA, 2012, ADV MATER, V24, P1146, DOI 10.1002/adma.201104580; Kober S, 2011, ADV MATER, V23, P4725, DOI 10.1002/adma.201100436; Christenson CW, 2010, OPT EXPRESS, V18, P9358, DOI 10.1364/OE.18.009358; Kinashi K, 2013, ORG ELECTRON, V14, P2987, DOI 10.1016/j.orgel.2013.08.024; Bittner R., 2007, PHOTOREFRACTIVE MAT, V2, P419; Chantharasupawong P, 2014, J MATER CHEM C, V2, P7639, DOI 10.1039/c4tc00782d; Giang HN, 2014, J PHOTOCH PHOTOBIO A, V291, P26, DOI 10.1016/j.jphotochem.2014.06.008; Giang HN, 2012, MACROMOL CHEM PHYS, V213, P982, DOI 10.1002/macp.201100647; Gunter P., 1989, PHOTOREFRACTIVE MAT, VII; Kinashi K, 2013, MACROMOL CHEM PHYS, V214, P1789, DOI 10.1002/macp.201300208; Kober S, 2010, J MATER CHEM, V20, P6170, DOI 10.1039/c0jm01208d; KUKHTAREV NV, 1979, FERROELECTRICS, V22, P949; Li G., 2005, APPL PHYS LETT, V86; Li GQ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3361655; MOERNER WE, 1994, J OPT SOC AM B, V11, P320, DOI 10.1364/JOSAB.11.000320; Solomeshch O, 2006, ADV FUNCT MATER, V16, P2095, DOI 10.1002/adfm.200600146; Tsujimura S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.082601; Tsutsumi N, 2008, J APPL PHYS, V104, DOI 10.1063/1.2978210; TSUTSUMI N, 1988, POLYMER, V29, P1655, DOI 10.1016/0032-3861(88)90278-9	27	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-6266	1099-0488		J POLYM SCI POL PHYS	J. Polym. Sci. Pt. B-Polym. Phys.	APR 1	2015	53	7					502	508		10.1002/polb.23663		7	Polymer Science	Polymer Science	CD4YH	WOS:000351092000005		
J	Shen, WF; Luo, ZK; Wei, DM; Xu, WM; Zhu, X				Shen, Wenfeng; Luo, Zhaokai; Wei, Daming; Xu, Weimin; Zhu, Xin			Load-prediction scheduling algorithm for computer simulation of electrocardiogram in hybrid environments	JOURNAL OF SYSTEMS AND SOFTWARE			English	Article						Computer simulation of ECG; Load-Prediction Scheduling; Sliding Window Mechanism	PRECONDITIONER; CLUSTERS; SYSTEMS	This paper proposes an algorithm that allows fully utilize the Central Processing Unit-Graphics Processing Unit (CPU-GPU) hybrid architecture to conduct parallel computation and reasonable scheduling for computer simulation of electrocardiogram (ECG). This algorithm is realized by accelerating calculation speed and increasing platform adaptability of the parallel algorithm. Today, many algorithms have been proposed to dynamically schedule a set of tasks in CPU-GPU hybrid environments. Among these scheduling algorithms, only Pure Self-Scheduling (PSS) algorithm can achieve load balancing in such an extremely heterogeneous environment. However, Pure Self-Scheduling can neither fully exploit the advantages of GPU performance, nor efficiently minimize the dynamic scheduling overhead. In this paper, Load-Prediction Scheduling (LPS) has been introduced to solve the aforementioned problems. Furthermore, to meet the demand for the best performance in a hybrid environment, which is formed by many heterogeneous computers, we propose an approach to adjust scheduling parameters dynamically. In order to validate our parallel algorithm and scheduling approach, we performed ECG simulation to confirm the efficiency and accuracy of ECG simulation algorithms based on the proposed method. At first, LPS predicts the workloads of each step in the simulation. The prediction results help to schedule heavy workloads to components with strong computational ability and light workloads to components with weak computational ability. LPS also synthesizes dynamic-scheduling and static-scheduling methods to minimize the disadvantages of these two scheduling methods. In the meantime, a Sliding Window Mechanism (SWM) adjusts the boundary between dynamic-scheduling and static-scheduling to make LPS perform better in hybrid environments. Experimental results of LPS on the computer simulation of ECG show that the LPS algorithm is more efficient than PSS. The ECG simulation is improved by about 20 times by using our proposed method. The ECG simulation of LPS with SWM is about 21% faster than that without SWM. (C) 2015 Elsevier Inc. All rights reserved.	[Shen, Wenfeng; Luo, Zhaokai; Wei, Daming; Xu, Weimin] Shanghai Univ, Sch Engn & Comp Sci, Shanghai 200444, Peoples R China; [Wei, Daming] Tohoku Univ, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Zhu, Xin] Univ Aizu, Biomed Informat Technol Lab, Aizu Wakamatsu, Fukushima 9658580, Japan	Shen, WF (reprint author), Shanghai Univ, Sch Engn & Comp Sci, Comp Bldg,333 Nanchen Rd, Shanghai 200444, Peoples R China.	wfshen@mail.shu.edu.cn			Japan Society for the Promotion of Science [24500369, 253303339]; National High-tech R&D Program of China [2009AA012201]; Shanghai Leading Academic Discipline Project [J50103]; Innovation Project of Shanghai University	This study was supported in part by Japan Society for the Promotion of Science under Grants-In-Aid for Scientific Research (No. 24500369 and No. 253303339), National High-tech R&D Program of China (Grant No. 2009AA012201), Shanghai Leading Academic Discipline Project (Project No. J50103), and Innovation Project of Shanghai University.	Plank G, 2007, IEEE T BIO-MED ENG, V54, P585, DOI 10.1109/TBME.2006.889181; Sato D, 2009, MED BIOL ENG COMPUT, V47, P1011, DOI 10.1007/s11517-009-0514-4; Dziekonski A, 2011, IEEE ANTENN WIREL PR, V10, P619, DOI 10.1109/LAWP.2011.2159769; Han S, 2010, ACM SIGCOMM COMP COM, V40, P195, DOI 10.1145/1851275.1851207; Wu CC, 2012, J SUPERCOMPUT, V60, P31, DOI 10.1007/s11227-009-0271-z; Campa S, 2014, FUTURE GENER COMP SY, V37, P354, DOI 10.1016/j.future.2013.12.038; Feichtinger C, 2011, PARALLEL COMPUT, V37, P536, DOI 10.1016/j.parco.2011.03.005; Han Y., 2013, IEEE 27 INT PAR DIST, P1735; Hu J., 2010, IEEE 2010 3 INT S PA, P89; Kerr A, 2010, P 3 WORKSH GEN PURP, P31, DOI DOI 10.1145/1735688.1735696; Liang TY, 2012, IEEE SYM PARA DISTR, P2369, DOI 10.1109/IPDPSW.2012.294; Majo Z, 2011, ACM SIGPLAN NOTICES, V46, P11, DOI 10.1145/2076022.1993481; Shen W., 2012, 2012 IEEE 6 INT S EM, P155; Shen W., 2009, 9 IEEE INT C COMP IN, P280; Shen WF, 2013, 2013 IEEE/ACIS 12TH INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION SCIENCE (ICIS), P167, DOI 10.1109/ICCPS.2013.6893526; Xu D., 2013, P 20 ISPE INT C CONC, P561; Yang CT, 2011, CONCURR COMP-PRACT E, V23, P721, DOI 10.1002/cpe.1627; Zhao X., 2013, 2013 IEEE INT C CLUS, P1; Zhu Hao, 2004, Biomed Eng Online, V3, P29, DOI 10.1186/1475-925X-3-29; Zhu X, 2005, P ANN INT IEEE EMBS, P1071	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0164-1212	1873-1228		J SYST SOFTWARE	J. Syst. Softw.	APR	2015	102						182	191		10.1016/j.jss.2015.01.015		10	Computer Science, Software Engineering; Computer Science, Theory & Methods	Computer Science	CD2RS	WOS:000350927300014		
J	Guo, KH; Pan, W; Lu, MM; Zhou, XK; Ma, JH				Guo, Kehua; Pan, Wei; Lu, Mingming; Zhou, Xiaoke; Ma, Jianhua			An effective and economical architecture for semantic-based heterogeneous multimedia big data retrieval	JOURNAL OF SYSTEMS AND SOFTWARE			English	Article						Heterogeneous multimedia; Semantic based retrieval; Big data	IMAGE RETRIEVAL; ONTOLOGY; WEB; NETWORKS; SYSTEM	Data variety has been one of the most critical features for multimedia big data. Some multimedia documents, although in different data formats and storage structures, often express similar semantic information. Therefore, the way to manage and retrieve multimedia documents reflecting users' intent in heterogeneous big data environments has become an important issue. In this paper, we present an effective and economical architecture named SHMR (Semantic-based Heterogeneous Multimedia Retrieval), which uses low cost to store and retrieve semantic information from heterogeneous multimedia data. Firstly, the particularity of heterogeneous multimedia retrieval in big data environments is addressed. Secondly, an approach to extract and represent semantic information for heterogeneous multimedia documents is proposed. Thirdly, a NoSQL-based approach to semantic storage, in which multimedia can be parallel processed in distributed nodes is provided. Finally, a MapReduce-based retrieval algorithm is presented and a user feedback supported scheme to achieve high retrieval precision and good user experience is designed. The experimental results indicate that the retrieval performance and economic efficiency of SHMR are suitable for multimedia information retrieval in heterogeneous big data environments. (C) 2014 Elsevier Inc. All rights reserved.	[Guo, Kehua; Lu, Mingming; Zhou, Xiaoke] Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China; [Pan, Wei] Cent S Univ, Sch Software, Changsha, Hunan, Peoples R China; [Ma, Jianhua] Hosei Univ, Fac Comp & Informat Sci, Digital Media Dept, Tokyo, Japan	Guo, KH (reprint author), Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China.	guokehua@csu.edu.cn			Hunan Science and Technology Plan [2012RS4054]; Natural Science Foundation of China [61202341]; China Scholarship [201308430049]; Major Science & Technology Research Program for Strategic Emerging Industry of Hunan [2012GK4054]	Thanks for the help of Professor Li Kuang in the research of semantic-based heterogeneous multimedia big data retrieval. This work is supported by Hunan Science and Technology Plan (2012RS4054), Natural Science Foundation of China (61202341), China Scholarship (201308430049) and the Major Science & Technology Research Program for Strategic Emerging Industry of Hunan (2012GK4054). The authors declare that they have no conflict of interests.	Dean J, 2008, COMMUN ACM, V51, P107, DOI 10.1145/1327452.1327492; [Anonymous], 2014, STANFORD TOPIC MODEL; Yang D, 2008, COMPUT AIDED DESIGN, V40, P863, DOI 10.1016/j.cad.2008.05.004; Smeulders AWM, 2000, IEEE T PATTERN ANAL, V22, P1349, DOI 10.1109/34.895972; Hofmann T, 2001, MACH LEARN, V42, P177, DOI 10.1023/A:1007617005950; Zhou GT, 2012, PATTERN RECOGN, V45, P1707, DOI 10.1016/j.patcog.2011.09.016; Yang Y, 2012, IEEE T PATTERN ANAL, V34, P723, DOI 10.1109/TPAMI.2011.170; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Maedche A, 2001, IEEE INTELL SYST APP, V16, P72, DOI 10.1109/5254.920602; Wang JX, 2014, INFORM SCIENCES, V254, P39, DOI 10.1016/j.ins.2013.08.019; Guo KH, 2014, WIRELESS PERS COMMUN, V76, P779, DOI 10.1007/s11277-013-1327-1; Zhang LN, 2012, IEEE T SYST MAN CY B, V42, P282, DOI 10.1109/TSMCB.2011.2165335; Lu B, 2012, J COMPUT SCI TECH-CH, V27, P1140, DOI 10.1007/s11390-012-1292-2; Chang F, 2008, ACM T COMPUT SYST, V26, DOI 10.1145/1365815.1365816; Chen JJ, 2011, ACM T SOFTW ENG METH, V20, DOI 10.1145/2000791.2000793; Chen R, 2011, IET RADAR SONAR NAV, V5, P118, DOI 10.1049/iet-rsn.2009.0294; Datta R, 2008, ACM COMPUT SURV, V40, DOI 10.1145/1348246.1348248; Ghemawat S., 2003, ACM SIGOPS OPERATING, V37, P29, DOI DOI 10.1145/945445.945450; Gijsenij A., 2010, PATTERN ANAL MACHINE, V33, P687; Gun K., 2013, COMPUT MATH METHOD M, V2013; He XF, 2010, IEEE T IMAGE PROCESS, V19, P254, DOI 10.1109/TIP.2009.2032342; Khan I., 2009, P 33 WORKSH AUSTR AS, P213; Leverich J., 2010, ACM SIGOPS OPER SYST, V44, P61; Liu C., 2013, IEEE T PARALLEL DIST, V99; Liu K., 2014, MULTIMED TOOLS APPL; Pereira JC, 2014, IEEE T PATTERN ANAL, V36, P521, DOI 10.1109/TPAMI.2013.142; Rasiwasia N, 2010, P INT C MULT, P251, DOI 10.1145/1873951.1873987; Smith JR, 2011, IEEE MULTIMEDIA, V18, P2, DOI 10.1109/MMUL.2011.47; Smith J. R., 2012, IEEE Multimedia, V19, DOI [10.1109/MMUL.2012.49, 10.1109/MMUL.2012.40]; Wang GJ, 2014, IEEE T PARALL DISTR, V25, P2286, DOI 10.1109/TPDS.2013.135; Wang XY, 2011, APPL SOFT COMPUT, V11, P2787, DOI 10.1016/j.asoc.2010.11.009; Wang XY, 2008, LECT NOTES COMPUT SC, V4993, P335; Wong RCF, 2008, IEEE T PATTERN ANAL, V30, P1933, DOI 10.1109/TPAMI.2008.125; Wu L, 2010, IEEE T IMAGE PROCESS, V19, P1908, DOI 10.1109/TIP.2010.2045169; Zhai XH, 2013, MULTIMEDIA SYST, V19, P395, DOI 10.1007/s00530-012-0297-6; Zhao R, 2002, IEEE T MULTIMEDIA, V4, P189	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0164-1212	1873-1228		J SYST SOFTWARE	J. Syst. Softw.	APR	2015	102						207	216		10.1016/j.jss.2014.09.016		10	Computer Science, Software Engineering; Computer Science, Theory & Methods	Computer Science	CD2RS	WOS:000350927300016		
J	Li, LM; Aoki-Kinoshita, KF; Ching, WK; Jiang, H				Li Limin; Aoki-Kinoshita, Kiyoko F.; Ching Wai-Ki; Jiang Hao			On using physico-chemical properties of amino acids in string kernels for protein classification via support vector machines	JOURNAL OF SYSTEMS SCIENCE & COMPLEXITY			English	Article						AAindex; AA spectrum kernel; correlation spectrum kernel; physico-chemical properties; string kernel; weighted spectrum kernel	LECTIN; PREDICTION; GLYCOMICS	String kernels are popular tools for analyzing protein sequence data and they have been successfully applied to many computational biology problems. The traditional string kernels assume that different substrings are independent. However, substrings can be highly correlated due to their substructure relationship or common physico-chemical properties. This paper proposes two kinds of weighted spectrum kernels: The correlation spectrum kernel and the AA spectrum kernel. We evaluate their performances by predicting glycan-binding proteins of 12 glycans. The results show that the correlation spectrum kernel and the AA spectrum kernel perform significantly better than the spectrum kernel for nearly all the 12 glycans. By comparing the predictive power of AA spectrum kernels constructed by different physico-chemical properties, the authors can also identify the physicochemical properties which contributes the most to the glycan-protein binding. The results indicate that physico-chemical properties of amino acids in proteins play an important role in the mechanism of glycan-protein binding.	[Li Limin] Xi An Jiao Tong Univ, Inst Informat & Syst Sci, Xian 710049, Peoples R China; [Aoki-Kinoshita, Kiyoko F.] Soka Univ, Dept Bioinformat, Fac Engn, Tokyo, Japan; [Ching Wai-Ki] Univ Hong Kong, Dept Math, Adv Modeling & Appl Comp Lab, Hong Kong, Hong Kong, Peoples R China; [Jiang Hao] Renmin Univ China, Sch Informat, Dept Math, Beijing 100872, Peoples R China	Jiang, H (reprint author), Renmin Univ China, Sch Informat, Dept Math, Beijing 100872, Peoples R China.	liminli@mail.xjtu.edu.cn; kkiyoko@soka.ac.jp; wching@hku.hk; jiangh@ruc.edu.cn			Research Grants Council of Hong Kong [17301214]; HKU CERG Grants; Research Funds of Renmin University of China; National Natural Science Foundation of China [11271144, 11101382, 11471256, S201201009985]; Hung Hing Ying Physical Research Grant	This research was supported in part by Research Grants Council of Hong Kong under Grant No. 17301214 and HKU CERG Grants and Hung Hing Ying Physical Research Grant, and the Research Funds of Renmin University of China, and the National Natural Science Foundation of China under Grant Nos. 11271144, 11101382, 11471256, and S201201009985.	Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Oyelaran O, 2009, CURR OPIN CHEM BIOL, V13, P406, DOI 10.1016/j.cbpa.2009.06.021; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; HESTER G, 1995, NAT STRUCT BIOL, V2, P472, DOI 10.1038/nsb0695-472; Chandra NR, 2001, PROTEIN ENG, V14, P857, DOI 10.1093/protein/14.11.857; Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Argos J R A, 1982, INT J PEPT PROT RES, V128, P565; Feizi T, 2003, CURR OPIN STRUC BIOL, V13, P637, DOI 10.1016/j.sbi.2003.09.002; Hamelryck TW, 1998, TRENDS GLYCOSCI GLYC, V10, P349; Hisamatsu K, 2008, J BIOCHEM, V143, P79, DOI 10.1093/jb/mvm195; Jiang H, 2011, INT J INFORM TECHNOL, V2, P1; Jin Y T B, 2007, INFORM SCI, P476; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, P354, DOI DOI 10.1093/NAR/GKJ102; Kuhn H. W., 1951, P 2 BERK S MATH STAT, P481; Leslie C., 2002, P PAC S BIOC, V7, P566; Leslie C, 2003, BIOINFORMATICS, V20, P467; Li LM, 2010, J SYST SCI COMPLEX, V23, P917, DOI 10.1007/s11424-010-0207-y; Ong C, 2008, LECT NOTES BIOINFORM, P168; Ratsch G, 2007, PLOS COMPUT BIOL, V3, P313, DOI 10.1371/journal.pcbi.0030020; Roth V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S12; Rottig M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000636; Scholkopf B., 2004, KERNEL METHODS COMPU; Schultheiss SJ, 2009, BIOINFORMATICS, V25, P2126, DOI 10.1093/bioinformatics/btp278; Schweikert G, 2009, GENOME RES, V19, P2133, DOI 10.1101/gr.090597.108; Sharon N., 2003, LECTINS; Smola A., 2002, LEARNING KERNELS; Someya Seizi, 2010, Advances in Bioinformatics, DOI 10.1155/2010/289301; Toussaint NC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S8-S7; Vapnik V. N., 1979, THEORIE ZEICHENERKEN; Vapnik V. N., 1995, NATURE STAT LEARNING; Varki A., 2008, ESSENTIALS GLYCOBIOL; Wright LM, 1999, BIOCHEM J, V340, P299, DOI 10.1042/0264-6021:3400299	33	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1009-6124	1559-7067		J SYST SCI COMPLEX	J. Syst. Sci. Complex.	APR	2015	28	2					504	516		10.1007/s11424-015-2156-y		13	Mathematics, Interdisciplinary Applications	Mathematics	CC5AV	WOS:000350370200016		
J	Kaneko, M; Tsujita, H				Kaneko, Masanao; Tsujita, Hoshio			Numerical Investigation of Influence of Tip Leakage Flow on Secondary Flow in Transonic Centrifugal Compressor at Design Condition	JOURNAL OF THERMAL SCIENCE			English	Article						Transonic Centrifugal Compressor; Leakage Vortex; Secondary Flow; Shock Wave; Numerical Analysis		In a centrifugal compressor, the leakage flow through the tip clearance generates the tip leakage vortex by the interaction with the main flow, and consequently makes the flow in the impeller passage more complex by the interaction with the passage vortex. In addition, the tip leakage vortex interacts with the shock wave on the suction surface near the blade tip in the transonic centrifugal compressor impeller. Therefore, the detailed examination for the influence of the tip leakage vortex becomes seriously important to improve the aerodynamic performance especially for the transonic centrifugal compressor. In this study, the flows in the transonic centrifugal compressor with and without the tip clearance at the design condition were analyzed numerically by using the commercial CFD code. The computed results revealed that the tip leakage vortex induced by the high loading at the blade tip around the leading edge affected the loss generation by the reduction or the suppression of the shock wave on the suction surface of the blade.	[Kaneko, Masanao] Hosei Univ, Grad Sch Engn, Koganei, Tokyo 1848584, Japan; [Tsujita, Hoshio] Hosei Univ, Fac Sci & Engn, Dept Mech Engn, Koganei, Tokyo 1848584, Japan	Kaneko, M (reprint author), Hosei Univ, Grad Sch Engn, 3-7-2 Kajino Cho, Koganei, Tokyo 1848584, Japan.						Hah C., 2006, P ASME TURB EXP 2006; Ibaraki S., 2007, P ASME TURB EXP 2007; Krain H., 2002, P ASME TURB EXP 2002; Marconcini M., 2008, P ASME TURB EXP 2008; Yamada K, 2007, P ASME TURB EXP 2007	5	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1003-2169	1993-033X		J THERM SCI	J. Therm. Sci.	APR	2015	24	2					117	122		10.1007/s11630-015-0763-5		6	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CC9RW	WOS:000350709800003		
J	Hu, YJ; Wang, YP; Li, GQ; Jin, YZ; Setoguchi, T; Kim, HD				Hu Yongjun; Wang Yanping; Li Guoqi; Jin Yingzi; Setoguchi, Toshiaki; Kim, Heuy Dong			Effects of Perforation Number of Blade on Aerodynamic Performance of Dual-rotor Small Axial Flow Fans	JOURNAL OF THERMAL SCIENCE			English	Article						dual-rotor small axial flow fans; the blade with perforation; perforation number; aerodynamic performance		Compared with single rotor small axial flow fans, dual-rotor small axial flow fans is better regarding the static characteristics. But the aerodynamic noise of dual-rotor small axial flow fans is worse than that of single rotor small axial flow fans. In order to improve aerodynamic noise of dual-rotor small axial flow fans, the pre-stage blades with different perforation numbers are designed in this research. The RANS equations and the standard k-epsilon turbulence model as well as the FW-H noise model are used to simulate the flow field within the fan. Then, the aerodynamic performance of the fans with different perforation number is compared and analyzed. The results show that: (1) Compared to the prototype fan, the noise of fans with perforation blades is reduced. Additionally, the noise of the fans decreases with the increase of the number of perforations. (2) The vorticity value in the trailing edge of the pre-stage blades of perforated fans is reduced. It is found that the vorticity value in the trailing edge of the pre-stage blades decreases with the increase of the number of perforations. (3) Compared to the prototype fan, the total pressure rising and efficiency of the fans with perforation blades drop slightly.	[Hu Yongjun; Wang Yanping; Li Guoqi; Jin Yingzi] Zhejiang Sci Tech Univ, Zhejiang Prov Key Lab Fluid Transmiss Technol, Hangzhou 310018, Zhejiang, Peoples R China; [Setoguchi, Toshiaki] Saga Univ, Dept Mech Engn, Saga 8408502, Japan; [Kim, Heuy Dong] Andong Natl Univ, Sch Mech Engn, Andong 760749, Gyeongsangnuk D, South Korea	Hu, YJ (reprint author), Zhejiang Sci Tech Univ, Zhejiang Prov Key Lab Fluid Transmiss Technol, Hangzhou 310018, Zhejiang, Peoples R China.				National Natural Science Foundation of China [51276172]; National Science and Technology Support Project [2013BAF05B01]; Simultaneously, Natural Science Foundation of Zhejiang Province [LY14E060003]; Zhejiang Province Key Science and Technology Innovation Team [2013TD18]; Fluid Engineering Innovation Team of Zhejiang Sci-Tech University [11132932611309]	This work was supported by National Natural Science Foundation of China (No. 51276172) and National Science and Technology Support Project (No.2013BAF05B01). Simultaneously, Natural Science Foundation of Zhejiang Province (No.LY14E060003), Zhejiang Province Key Science and Technology Innovation Team (2013TD18), and the Fluid Engineering Innovation Team of Zhejiang Sci-Tech University (No. 11132932611309) were also offering support to this research.	Akaike S., 1995, T JAPAN SOC MECH E B, V61, P3269; Brentner KS, 1998, AIAA J, V36, P1379, DOI 10.2514/2.558; Fang K., 2008, J JIANGSU U SCI TECH, V22, P42; Kazuo M., 1993, T JAPAN SOC MECH E B, V59, P3846; Sun Shao-ming, 2009, Journal of Jilin University (Engineering and Technology Edition), V39; Tzuoo K. L., 1992, REV FRANCAISE MECANI, V23, P235; WILLIAMS JE, 1969, PHILOS TR R SOC S-A, V264, P321, DOI 10.1098/rsta.1969.0031	7	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1003-2169	1993-033X		J THERM SCI	J. Therm. Sci.	APR	2015	24	2					123	130		10.1007/s11630-015-0764-4		8	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CC9RW	WOS:000350709800004		
J	Phengpom, T; Kamada, Y; Maeda, T; Murata, J; Nishimura, S; Matsuno, T				Phengpom, Tinnapob; Kamada, Yasunari; Maeda, Takao; Murata, Junsuke; Nishimura, Shogo; Matsuno, Tasuku			Study on Blade Surface Flow around Wind Turbine by Using LDV Measurements	JOURNAL OF THERMAL SCIENCE			English	Article						LDV measurement; Sectional performance; Wind turbine; Boundary layer flow; Span-wise flow		This paper has attempted to study a mechanism of three-dimensional flow around a horizontal axis wind turbine (HAWT) rotor blade. An experimental study of the flow phenomenon in the vicinity of the wind turbine blade is a challenging endeavor. In this research, the HAWT model with 2.4 m diameter was tested in the large wind tunnel. The flow around the rotating blade surface was measured simultaneously for three velocity components, and two probes were used for the synchronized measurement of three-dimensional flow components. The local velocity was detected for the single seeding particle measured in the point where three pairs of laser beams intersected. Blade sections of interest in this study are composed of radial positions r/R = 0.3, 0.5 and 0.7. Optimum and low tip speed ratio flow characteristics were also compared. The velocity flow vector, skin friction coefficient and bound circulation were calculated from LDV measurements, and the experimental research showed reasonably and clearly the experimental results.	[Phengpom, Tinnapob] Mie Univ, Div Syst Engn, Tsu, Mie 5148507, Japan; [Kamada, Yasunari; Maeda, Takao; Murata, Junsuke; Nishimura, Shogo; Matsuno, Tasuku] Mie Univ, Div Mech Engn, Tsu, Mie 5148507, Japan	Phengpom, T (reprint author), Mie Univ, Div Syst Engn, 1577 Kurimamachiya Cho, Tsu, Mie 5148507, Japan.						Burton T., 2011, WIND ENERGY HDB, P139; Dua Zhaohui, 2000, RENEW ENERG, V20, P167; Hansen M., 2000, AERODYNAMICS WIND TU, P48; Johansen J, 2009, WIND ENERGY, V12, P261, DOI 10.1002/we.292; Kamada Y, 2013, P 12 INT S FLUID CON, P1; Martinez G.G., 2007, J PHYS, V37, P12; Phengpom T., 2014, P INT C UT EXH GREEN, VS02.4, P1; Rozenn W., 2009, WIND ENERGY, V12, P348; Suzuki D., 2012, P 2 INT S SUST ENG M, P163; Vermeer L.J., 1990, P 1990 EUR COMM WIND, P218	10	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1003-2169	1993-033X		J THERM SCI	J. Therm. Sci.	APR	2015	24	2					131	139		10.1007/s11630-015-0765-3		9	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CC9RW	WOS:000350709800005		
J	Matsuno, Y; Fukushima, Y; Matsuo, S; Hashimoto, T; Setoguchi, T; Kim, HD				Matsuno, Yuhi; Fukushima, Yusuke; Matsuo, Shigeru; Hashimoto, Tokitada; Setoguchi, Toshiaki; Kim, Heuy Dong			Investigation on Temperature Separation and Flow Behaviour in Vortex Chamber	JOURNAL OF THERMAL SCIENCE			English	Article						Compressible flow; Vortex chamber; Cavity flow; Temperature separation		In the previous researches, it is known that the swirl flow in circular pipe causes the temperature separation. Recently, it is shown that the temperature separation occurs in a vortex chamber when compressed air are pumped into this device from the periphery. Especially, in a cavity installed in the periphery of the chamber, the highest temperature was observed. Therefore, it is expected that this device can be used as a heat source in the engineering field. In recent researches, the mechanism of temperature separation in vortex chamber has been investigated by some researchers. However, there are few researches for the effect of diameter and volume of vortex chamber, height of central rod and position of cavity on the temperature separation. Further, no detailed physical explanation has been made for the temperature separation phenomena in the vortex chamber. In the present study, the effects of chamber configuration and position of the cavity on temperature separation in the vortex chamber were investigated experimentally.	[Matsuno, Yuhi; Fukushima, Yusuke] Saga Univ, Grad Sch Sci & Engn, Saga 8408502, Japan; [Matsuo, Shigeru; Hashimoto, Tokitada] Saga Univ, Dept Adv Technol Fus, Saga 8408502, Japan; [Setoguchi, Toshiaki] Saga Univ, Inst Ocean Energy, Saga 8408502, Japan; [Kim, Heuy Dong] Andong Natl Univ, Sch Mech Engn, Andong 760749, South Korea	Matsuno, Y (reprint author), Saga Univ, Grad Sch Sci & Engn, 1 Honjo Machi, Saga 8408502, Japan.						Anish S., 2013, J MECH ENG SCI, P1; Beliavsky Y., 1980, P 9 INT C HEAT TRANS, P1482; Beliavsky Y., 2013, J MECH ENG AUTOMATIO, V3, P53; Hatori Y., 2006, P JSME FLUIDS ENG C, pG203; Takahama H., 1980, T JAPAN SOC MECH ENG, V46, P584; Yokoo K., 2014, 620 JAP SOC MECH ENG	6	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1003-2169	1993-033X		J THERM SCI	J. Therm. Sci.	APR	2015	24	2					149	154		10.1007/s11630-015-0767-1		6	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	CC9RW	WOS:000350709800007		
J	Elkhoury, M; Kiwata, T; Aoun, E				Elkhoury, M.; Kiwata, T.; Aoun, E.			Experimental and numerical investigation of a three-dimensional vertical-axis wind turbine with variable-pitch	JOURNAL OF WIND ENGINEERING AND INDUSTRIAL AERODYNAMICS			English	Article						Vertical-axis wind turbine; Large eddy simulation; Variable-pitch; Wind tunnel experiments	UNSTEADY WIND; MODEL; AERODYNAMICS	A combined experimental and numerical investigation is carried out to study the performance of a micro vertical-axis wind turbine (VAWT) with variable-pitch. Three-dimensional numerical simulations are essentially employed, for the VAWT involves a low aspect ratio (AR) three straight blades with struts. The performance of the VAWT is experimentally measured using a wind tunnel, while large eddy simulation (LES) with dynamic smagorinsky subgrid scale (SGS) model is employed to help understand the associated flow structure. The effects of wind speed, turbulence intensity, airfoil shape, and strut mechanism with and without variable-pitch on the performance of the turbine are carefully assessed, both experimentally and numerically. The accuracy of the SGS model in predicting the laminar-turbulent transition is also examined. (C) 2015 Elsevier Ltd. All rights reserved.	[Elkhoury, M.; Aoun, E.] Lebanese Amer Univ, Mech Engn, Byblos, Lebanon; [Kiwata, T.] Kanazawa Univ, Mech Engn, Kanazawa, Ishikawa 9201192, Japan	Elkhoury, M (reprint author), Lebanese Amer Univ, Mech Engn, POB 36, Byblos, Lebanon.	mkhoury@lau.edu.lb; kiwata@t.kanazawa-u.ac.jp; elio.aoun@lau.edu.lb					Almohammadi KM, 2013, ENERGY, V58, P483, DOI 10.1016/j.energy.2013.06.012; Lanzafame R, 2014, ENRGY PROCED, V45, P131, DOI 10.1016/j.egypro.2014.01.015; Elkhoury M, 2011, AIAA J, V49, P1399, DOI 10.2514/1.J050648; McLaren K, 2012, WIND ENERGY, V15, P349, DOI 10.1002/we.472; Dana LA, 2014, APPL ENERG, V116, P111, DOI 10.1016/j.apenergy.2013.11.045; Scheurich F, 2013, WIND ENERGY, V16, P91, DOI 10.1002/we.532; GERMANO M, 1991, PHYS FLUIDS A-FLUID, V3, P1760, DOI 10.1063/1.857955; Dai Y., 2009, ICE ENERGY, V162, P67; Elkhoury M., 2013, 12 INT S FLUID CONTR, P1; Ferreira C. S., 2007, P 45 AIAA AER SCI M, P1; Hofemann C., 2008, 3D STEREO PIV STUDY, P1; Lain S, 2010, J SCI IND RES INDIA, V69, P906; Mathey F., 2003, 4 INT S TURB HEAT MA; Menter F. R., 2006, J TURBOMACH, V128, P413; Mertens S., 2006, WIND ENERGY BUILT EN; Nobile R., 2014, J WIND ENG IND AEROD, V125, P168; Stankovic S., 2009, URBAN WIND ENERGY; White F. M., 1991, VISCOUS FLUID FLOW, P183	18	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6105	1872-8197		J WIND ENG IND AEROD	J. Wind Eng. Ind. Aerodyn.	APR	2015	139						111	123		10.1016/j.jweia.2015.01.004		13	Engineering, Civil; Mechanics	Engineering; Mechanics	CD7CS	WOS:000351249000012		
J	Leung, CKY; Wan, KT; Inaudi, D; Bao, XY; Habel, W; Zhou, Z; Ou, JP; Ghandehari, M; Wu, HC; Imai, M				Leung, Christopher K. Y.; Wan, Kai Tai; Inaudi, Daniele; Bao, Xiaoyi; Habel, Wolfgang; Zhou, Zhi; Ou, Jinping; Ghandehari, Masoud; Wu, Hwai Chung; Imai, Michio			Review: optical fiber sensors for civil engineering applications	MATERIALS AND STRUCTURES			English	Article						Optical fiber sensors; Monitoring; Fiber Bragg grating; Distributed sensor; Interferometry; Time domain reflectometry; Frequency domain reflectometry	REINFORCED-CONCRETE STRUCTURES; DISTRIBUTED BRILLOUIN SENSOR; MONITORING-SYSTEM; CRACK DETECTION; DEFORMATION SENSORS; TEMPERATURE SENSORS; INTERNAL-PRESSURE; BRAGG GRATINGS; STRAIN SENSOR; FBG SENSORS	Optical fiber sensor (OFS) technologies have developed rapidly over the last few decades, and various types of OFS have found practical applications in the field of civil engineering. In this paper, which is resulting from the work of the RILEM technical committee "Optical fiber sensors for civil engineering applications", different kinds of sensing techniques, including change of light intensity, interferometry, fiber Bragg grating, adsorption measurement and distributed sensing, are briefly reviewed to introduce the basic sensing principles. Then, the applications of OFS in highway structures, building structures, geotechnical structures, pipelines as well as cables monitoring are described, with focus on sensor design, installation technique and sensor performance. It is believed that the State-of-the-Art review is helpful to engineers considering the use of OFS in their projects, and can facilitate the wider application of OFS technologies in construction industry.	[Leung, Christopher K. Y.] Hong Kong Univ Sci & Technol, Hong Kong, Hong Kong, Peoples R China; [Wan, Kai Tai] Nano & Adv Mat Inst Ltd, Shatin, Hong Kong, Peoples R China; [Inaudi, Daniele] Smartec, Manno, Switzerland; [Bao, Xiaoyi] Univ Ottwa, Ottwa, ON, Canada; [Habel, Wolfgang] BAM, Berlin, Germany; [Zhou, Zhi] Harbin Inst Technol, Harbin 150006, Peoples R China; [Ou, Jinping] Dalian Univ Technol, Dalian, Peoples R China; [Ghandehari, Masoud] NYU, Polytech Inst, Brooklyn, NY USA; [Wu, Hwai Chung] Wayne State Univ, Detroit, MI USA; [Imai, Michio] Kajima Tech Res Inst, Tokyo, Japan	Wan, KT (reprint author), Nano & Adv Mat Inst Ltd, Shatin, Hong Kong, Peoples R China.	ckleung@ust.hk; ktwan@nami.org.hk		Wan, Kai Tai/0000-0002-5418-5501			KINGSLEY SA, 1985, ELECTRON LETT, V21, P434, DOI 10.1049/el:19850309; Liehr S, 2009, IEEE SENS J, V9, P1330, DOI 10.1109/JSEN.2009.2018352; Zou LF, 2005, OPT LETT, V30, P370, DOI 10.1364/OL.30.000370; HORIGUCHI T, 1992, J LIGHTWAVE TECHNOL, V10, P1196, DOI 10.1109/50.156868; Song KY, 2007, IEEE PHOTONIC TECH L, V19, P1928, DOI 10.1109/LPT.2007.908772; Fuhr PL, 1998, SMART MATER STRUCT, V7, P217, DOI 10.1088/0964-1726/7/2/009; Froggatt M, 1998, APPL OPTICS, V37, P1735, DOI 10.1364/AO.37.001735; Rao YJ, 1997, MEAS SCI TECHNOL, V8, P355, DOI 10.1088/0957-0233/8/4/002; Zhou Z, 2012, MECH SYST SIGNAL PR, V28, P36, DOI 10.1016/j.ymssp.2011.10.003; Zhu HH, 2012, SMART STRUCT SYST, V9, P393; Zhou Z, 2009, J INTEL MAT SYST STR, V20, P1901, DOI 10.1177/1045389X09347021; DAKIN JP, 1985, ELECTRON LETT, V21, P569, DOI 10.1049/el:19850402; Hill KO, 1997, J LIGHTWAVE TECHNOL, V15, P1263, DOI 10.1109/50.618320; Soller BJ, 2005, OPT EXPRESS, V13, P666, DOI 10.1364/OPEX.13.000666; BAO X, 1993, OPT LETT, V18, P552, DOI 10.1364/OL.18.000552; Lan CG, 2012, SENSORS-BASEL, V12, P5380, DOI 10.3390/s120505380; Wan KT, 2012, SENSORS-BASEL, V12, P3656, DOI 10.3390/s120303656; Thevenaz L, 1998, P SOC PHOTO-OPT INS, V3407, P374, DOI 10.1117/12.323342; CULVERHOUSE D, 1989, ELECTRON LETT, V25, P913, DOI 10.1049/el:19890612; Ni YQ, 2009, STRUCT CONTROL HLTH, V16, P73, DOI 10.1002/stc.303; He JP, 2013, MECH SYST SIGNAL PR, V35, P84, DOI 10.1016/j.ymssp.2012.08.022; Wan KT, 2007, SENSOR ACTUAT A-PHYS, V135, P458, DOI 10.1016/j.sna.2006.09.004; Zou LF, 2004, APPL OPTICS, V43, P1583, DOI 10.1364/AO.43.001583; MELTZ G, 1989, OPT LETT, V14, P823, DOI 10.1364/OL.14.000823; HILL KO, 1993, APPL PHYS LETT, V62, P1035, DOI 10.1063/1.108786; ANSARI F, 1993, J ENG MECH-ASCE, V119, P1048, DOI 10.1061/(ASCE)0733-9399(1993)119:5(1048); Bao X., 1995, J LIGHTWAVE TECHNOL, V13; Bao XY, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/01/015003; Bronnimann R, 2000, J INTEL MAT SYST STR, V10, P322; Casciati F, 2004, P 3 EUR C STRUCT CON, P12; Cruz PJS, 2009, SENSOR MATER, V21, P65; Dantan N, 2005, P SOC PHOTO-OPT INS, V5758, P274, DOI 10.1117/12.600703; Deif A, 2010, SMART MATER STRUCT, V19; Ezekiel S, 1992, P SPIE 15 ANN C; Froggatt M, 2004, OSA TRENDS OPTICS B, V95B, P691; Fuhr PL, 2000, J INTEL MAT SYST STR, V10, P293; Fuhr PL, 1998, OPT ENG, V37, P1221, DOI 10.1117/1.601958; Ghandehari M, 2004, NDT&E INT, V37, P611, DOI 10.1016/j.ndteint.2004.03.007; Ghandehari M, 2008, J GEOTECH GEOENVIRON, V134, P487, DOI 10.1061/(ASCE)1090-0241(2008)134:4(487); Glisic B, 2002, P 81 ANN M TRANSP RE; Glisic B, 2003, P 5 AS PAC STRUCT EN, P593; Glisic B, 2002, 1 INT WORKSH STRUCT, P285; Glisic B, 2007, P 3 INT C STRUCT HLT; Gloetzl R, 2005, P SOC PHOTO-OPT INS, V5758, P248, DOI 10.1117/12.600848; Gloetzl R, 2006, P SPIE INT SOC OPTIC, V6167; Gogolla T, 1997, P SOC PHOTO-OPT INS, V3105, P168, DOI 10.1117/12.276149; Grosso AD, 2001, P INT ASS BRIDG STRU; Gu X., 2000, J INTEL MAT SYST STR, V10, P266; Gu XL, 2000, ACI STRUCT J, V97, P468; Habel W, 2007, P WORKSH OPT SENS BA; Habel W R, 2011, PHOTONIC SENSORS, V1, P268, DOI DOI 10.1007/S13320-011-0011-X; HABEL WR, 1995, P SOC PHOTO-OPT INS, V2446, P25, DOI 10.1117/12.207742; HABEL WR, 1994, P SOC PHOTO-OPT INS, V2361, P176, DOI 10.1117/12.184819; Habel WR, 2012, P 4 INT FOR OPT SENS; HALE KF, 1992, P SOC PHOTO-OPT INS, V1777, P147; Hartog A. H., 1983, Journal of Lightwave Technology, VLT-1, DOI 10.1109/JLT.1983.1072146; Helmerich R, 2009, CONSTRUCTION PROCESS; Horiguchi T., 1989, PHOTON TECHNOL LETT, V1, P107; Huang MH, 2013, MEASUREMENT, V46, P1363, DOI 10.1016/j.measurement.2012.12.012; HUSTON D, 1992, NONDESTRUCTIVE TESTING OF CONCRETE ELEMENTS AND STRUCTURES, P60; Imai M, 2005, P 2 INT C STRUCT HLT, P241; Imai M, 2010, J STRUCT ENG-ASCE, V136, P1001, DOI 10.1061/(ASCE)ST.1943-541X.0000195; Inaudi D, 1996, P SOC PHOTO-OPT INS, V2895, P34; INAUDI D, 1994, SENSOR ACTUAT A-PHYS, V44, P125, DOI 10.1016/0924-4247(94)00797-7; Inaudi D, 2008, P 7 INT PIP C IPC200; Inaudi D., 2007, P 3 INT C STRUCT HLT; INAUDI D, 1995, OPT ENG, V34, P1912, DOI 10.1117/12.200603; Inaudi D, 2005, P 2 INT C STRUCT HLT; Inaudi D, 2006, P 3 INT C BRIDG MAIN; Inaudi D, 2009, P INT BRIDG C; Inaudi D, 1999, P MON SAF EV EXIST C; Inaudi D, 2011, P 31 USSD ANN M C; KAJENSKI PJ, 1992, J LIGHTWAVE TECHNOL, V10, P1297, DOI 10.1109/50.156882; Kim YS, 2011, SMART STRUCT SYST, V7, P303; Krebber K, 2009, P 18 INT C PLAST OPT; Leung CKY, 2005, J ENG MECH-ASCE, V131, P777, DOI 10.1061/(ASCE)0733-9399(2005)131:8(777); Li DS, 2011, MEASUREMENT, V44, P722, DOI 10.1016/j.measurement.2011.01.005; Li DS, 2008, EARTH SPAC C 2008 P, V323; Li H, 2006, COMPUT-AIDED CIV INF, V21, P306, DOI 10.1111/j.1467-8667.2006.00437.x; Liehr S, 2008, P SPIE INT SOC OPTIC, V7003; Lu YG, 2007, J PHYS, V48, P1387, DOI 10.1088/1742-6596/48/1/257; Mao JH, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/12/125018; MASRI SF, 1994, J ENG MECH, V20, P1696; Matthys S, 2003, STRUCTURAL HLTH MONI, V1, P321; Mokhtar MR, 2012, IEEE SENS J, V12, P1470, DOI 10.1109/JSEN.2011.2172991; Nother N, 2008, P SPIE INT SOC OPTIC, V6933; Ou J, 2008, P SPIE INT SOC OPTIC, V6933; Pei HF, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/2/025007; POUMELLEC B, 1995, OPT MATER, V4, P441, DOI 10.1016/0925-3467(94)00114-6; Ravet F, 2006, OPT FIBER TECHNOL, V12, P305, DOI 10.1016/j.yofte.2005.12.002; Ravet F, 2007, CAN J CIVIL ENG, V34, P291, DOI 10.1139/L06-131; Rossi P., 1989, MATER STRUCT, V22, P437, DOI 10.1007/BF02472221; Schallert M, 2007, P SPIE INT SOC OPTIC, V6530; Schilder C, 2012, P 6 EUR WORKSH STRUC; Shiota AT, 1991, P SPIE INT SOC OPTIC, V1586, P13; TATEDA M, 1990, J LIGHTWAVE TECHNOL, V8, P1269, DOI 10.1109/50.59150; Teng J, 2010, P 12 INT C ENG SCI C, P2543; Vimer C, 2009, J MATER CIVIL ENG, V21, P51, DOI 10.1061/(ASCE)0899-1561(2009)21:2(51); Wan KT, 2007, SENSOR ACTUAT A-PHYS, V135, P370, DOI 10.1016/j.sna.2006.08.002; Wan KT, 2008, SENSOR ACTUAT A-PHYS, V8, P1960; Wang C, 2005, P SOC PHOTO-OPT INS, V5855, P1012, DOI 10.1117/12.623727; WOLFF R, 1992, P SOC PHOTO-OPT INS, V1777, P23; Yu Q, 2011, PHOTONIC SENSORS, V1, P72, DOI 10.1007/s13320-010-0017-9; Zhou Z, 2010, P SPIE INT SOC OPTIC, V7649; Zhou Z, 2008, OPT ENG, V47, DOI 10.1117/1.28355991; Zou L, 2006, APPL OPTICS, V45, P3372, DOI 10.1364/AO.45.003372	106	3	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1359-5997	1871-6873		MATER STRUCT	Mater. Struct.	APR	2015	48	4					871	906		10.1617/s11527-013-0201-7		36	Construction & Building Technology; Engineering, Civil; Materials Science, Multidisciplinary	Construction & Building Technology; Engineering; Materials Science	CD2FD	WOS:000350889100007		
J	Zhang, CF; Aoki, T; Zhang, QJ; Wu, MP				Zhang, Chaofeng; Aoki, Tetsuhiko; Zhang, Qiuju; Wu, Meiping			The performance of low-yield-strength steel shear-panel damper with without buckling	MATERIALS AND STRUCTURES			English	Article						Low-yield-strength shear panel damper; Static test; Dynamic test; Buckling ratio; Damper design	LEAD-RUBBER BEARINGS; BRIDGES; BEHAVIOR; DESIGN	Low-yield-strength steel (LYS100, yield stress 100 N/mm(2)) is utilized here to design a shear panel damper for its high ductility. Deformation capacity of the low-yield-strength steel shear panel damper (LYSPD) is known to be affected by out-of-plane buckling which denies precise prediction by the buckling ratio obtained using empirical equations. Therefore, a preliminary investigation into the relationships between the buckling ratio and the deformation capacity of LYSPD is made via static increment tests. A modified equation is proposed to address plastic deformation for the design. As the loading speed of LYSPD goes rather high with large deformation capacity, dynamic tests are conducted to ascertain whether the out-of-plane buckling is affected by the loading speed. Test results reveal that the influence of loading speed on the LYSPD's out-of-plane buckling is negligible and high deformation capacity is advisable for the application of LYSPD to the design of the damper.	[Zhang, Chaofeng; Zhang, Qiuju; Wu, Meiping] Jiangnan Univ, Sch Mech Engn, Wuxi, Jiangsu, Peoples R China; [Aoki, Tetsuhiko] Aichi Inst Technol, Sch Civil Engn, Toyota, Aichi 47003, Japan	Wu, MP (reprint author), Jiangnan Univ, Sch Mech Engn, Wuxi, Jiangsu, Peoples R China.	wmp169@hotmail.com			Youth Fundation [205205]	The authors acknowledge the timely assistance coming from the staff of Seismic Research Center at Aichi Institute of Technology in Japan. The project is supported by Youth Fundation No. 205205.	Dusicka P, 2007, J CONSTR STEEL RES, V63, P156, DOI 10.1016/j.jcsr.2006.03.006; Jara M, 2006, ENG STRUCT, V28, P869, DOI 10.1016/j.engstruct.2005.10.016; Chen SJ, 2006, THIN WALL STRUCT, V44, P730, DOI 10.1016/j.tws.2006.08.002; Bert CW, 2003, INT J SOLIDS STRUCT, V40, P4097, DOI 10.1016/S0020-7683(03)00205-1; De Matteis G, 2011, EARTHQ ENG STRUCT D, V40, P1143, DOI 10.1002/eqe.1079; Paik JK, 2000, THIN WALL STRUCT, V37, P27, DOI 10.1016/S0263-8231(00)00009-4; Brando G, 2011, THIN WALL STRUCT, V49, P1277, DOI 10.1016/j.tws.2011.05.007; Alinia MM, 2009, J CONSTR STEEL RES, V65, P1631, DOI 10.1016/j.jcsr.2009.04.001; Rai DC, 1998, EARTHQUAKE ENG STRUC, V27, P315, DOI 10.1002/(SICI)1096-9845(199804)27:4<315::AID-EQE703>3.0.CO;2-N; De Matteis G, 2003, ENG STRUCT, V25, P155, DOI 10.1016/S0141-0296(02)00124-4; De Matteis G, 2009, ADV STEEL CONSTR, V5, P106; Fukumoto Y, 1997, STRUCTURAL STABILITY; HWANG JS, 1994, ENG STRUCT, V16, P201, DOI 10.1016/0141-0296(94)90078-7; Jain S, 2008, J APPL MECH ASME, V75; Mistakidis ES, 2007, ADV ENG SOFTW, V38, P626, DOI 10.1016/j.advengsoft.2006.08.043; Nakashima M, 1994, J EARTHQ ENG STRUCT, V23, P1299; NAKASHIMA M, 1995, J STRUCT ENG-ASCE, V121, P1742, DOI 10.1061/(ASCE)0733-9445(1995)121:12(1742); Ricky WK, 2009, J CONSTR STEEL RES, V65, P260; Shih Ming-Hsiang, 2004, J Zhejiang Univ Sci, V5, P326, DOI 10.1631/jzus.2004.0326; Tanaka K, 2000, 12 WORLD C EARTHQ EN, P1; TURKINGTON DH, 1989, ENG STRUCT, V11, P2, DOI 10.1016/0141-0296(89)90026-6; Warn GP, 2004, ENG STRUCT, V26, P1261, DOI 10.1016/j.engstruct.2004.04.006; Zhang CF, 2012, J CONSTR STEEL RES, V75, P116, DOI 10.1016/j.jcsr.2012.03.014	23	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1359-5997	1871-6873		MATER STRUCT	Mater. Struct.	APR	2015	48	4					1233	1242		10.1617/s11527-013-0228-9		10	Construction & Building Technology; Engineering, Civil; Materials Science, Multidisciplinary	Construction & Building Technology; Engineering; Materials Science	CD2FD	WOS:000350889100031		
J	Shi, XL; Xu, LL; Munar, ML; Ishikawa, K				Shi, Xingling; Xu, Lingli; Munar, Melvin L.; Ishikawa, Kunio			Hydrothermal treatment for TiN as abrasion resistant dental implant coating and its fibroblast response	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Titanium implant; Titanium nitride; Hydrothermal treatment; Fibroblast	DISSOLUTION-PRECIPITATION MECHANISM; TITANIUM NITRIDE COATINGS; BARIUM-TITANATE POWDERS; SURFACE MODIFICATION; PERI-IMPLANT; PLAQUE ACCUMULATION; BIOCOMPATIBILITY; CELLS; ATTACHMENT; ROUGHNESS	Dental implant made of pure titanium (Ti) is prone to scratch and abrasion during routine oral hygiene procedures. This results an increase in surface roughness and therefore, facilitates the adhesion of bacteria. In severe cases, this could lead to peri-implantitis. To overcome this problem, surface modification of Ti is necessary to improve its abrasion resistance. Besides, a strong implant-gingiva interface should also be guaranteed to prevent the adhesion of bacteria. In this study, titanium nitride (TiN) coating was first prepared with gas nitriding to increase surface hardness of pure the substrate. Then, the TiN was hydrothermally treated in CaCl2 solution in order to improve its soft tissue biocompatibility. The effect of hydrothermal treatment temperature on surface properties of TiN was investigated and its biocompatibility was assessed in vitro using NIH3T3 fibroblast cell. It was determined that 120 degrees C was the critical temperature for the hydrothermal treatment condition. Treatment below 120 degrees C could incorporate Ca into TIN surface, oxidize TIN surface partially and then improve the wettability while preserving its morphology and hardness. Fibroblast cell attachment and proliferation were improved and cell spreading was enhanced on hydrothermally treated specimens compared with untreated ones. Improved wettability, Ca incorporation and negative surface due to interstitial N were believed to be the main reasons. Hydrothermal treatment is expected to make TIN a promising dental implant coating with excellent abrasion resistance and good soft tissue affinity. (C) 2014 Elsevier B.V. All rights reserved.	[Shi, Xingling; Xu, Lingli] Jiangsu Univ Sci & Technol, Sch Mat Sci & Engn, Zhenjiang 212003, Peoples R China; [Shi, Xingling; Munar, Melvin L.; Ishikawa, Kunio] Kyushu Univ, Fac Dent Sci, Dept Biomat, Fukuoka 8128582, Japan; [Shi, Xingling] Huaiyin Inst Technol, Jiangsu Prov Key Lab Intervent Med Devices, Huaian 223003, Peoples R China	Shi, XL (reprint author), Jiangsu Univ Sci & Technol, Sch Mat Sci & Engn, Zhenjiang 212003, Peoples R China.	shixingling1985@hotmail.com			Jiangsu Provincial Key Laboratory for Interventional Medical Devices [jr1418]; Ph.D. programs foundation of the Jiangsu University of Science and Technology [635061402]	This study was supported in part by the Jiangsu Provincial Key Laboratory for Interventional Medical Devices (jr1418) and Ph.D. programs foundation of the Jiangsu University of Science and Technology (635061402).	Cyster LA, 2003, J BIOMED MATER RES A, V67A, P138, DOI 10.1002/jbm.a.10087; Sawase T, 2005, J ORAL REHABIL, V32, P151, DOI 10.1111/j.1365-2842.2004.01382.x; Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K; Pinceloup P, 1999, J EUR CERAM SOC, V19, P973, DOI 10.1016/S0955-2219(98)00356-2; Shi XL, 2012, J MATER SCI-MATER M, V23, P1281, DOI 10.1007/s10856-012-4596-4; Tamura Y, 2002, DENT MATER J, V21, P355; Annunziata M, 2011, J DENT, V39, P720, DOI 10.1016/j.jdent.2011.08.003; Mengel R, 2004, INT J ORAL MAX IMPL, V19, P232; Att W, 2009, BIOMATERIALS, V30, P1273, DOI 10.1016/j.biomaterials.2008.11.024; Shi XL, 2013, APPL SURF SCI, V270, P445, DOI 10.1016/j.apsusc.2013.01.046; Bollen CML, 1996, CLIN ORAL IMPLAN RES, V7, P201, DOI 10.1034/j.1600-0501.1996.070302.x; Oh TJ, 2002, J PERIODONTOL, V73, P322, DOI 10.1902/jop.2002.73.3.322; Shi XL, 2010, SURF COAT TECH, V205, P1730, DOI 10.1016/j.surfcoat.2010.09.058; Liu XY, 2005, SURF COAT TECH, V191, P43, DOI 10.1016/j.surfcoat.2004.08.118; MEZGER PR, 1992, J DENT, V20, P342, DOI 10.1016/0300-5712(92)90021-4; Yang SM, 2009, ELECTROCHIM ACTA, V55, P305, DOI 10.1016/j.electacta.2009.08.055; Xu HR, 2002, MATER LETT, V57, P490, DOI 10.1016/S0167-577X(02)00817-0; Tsutsumi Y, 2009, MAT SCI ENG C-BIO S, V29, P1702, DOI 10.1016/j.msec.2009.01.016; Hosono E, 2007, LANGMUIR, V23, P7447, DOI 10.1021/1a701117a; VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2; QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801; Aronsson BO, 1997, J BIOMED MATER RES, V35, P49; Piscanec S, 2004, ACTA MATER, V52, P1237, DOI 10.1016/j.actamat.2003.11.020; Lindhe J, 1992, Clin Oral Implants Res, V3, P9, DOI 10.1034/j.1600-0501.1992.030102.x; Esaka F, 1997, J VAC SCI TECHNOL A, V15, P2521, DOI 10.1116/1.580764; COLL BF, 1988, SURF COAT TECH, V36, P867, DOI 10.1016/0257-8972(88)90027-8; MILOSEV I, 1995, SURF INTERFACE ANAL, V23, P529, DOI 10.1002/sia.740230713; Czarnowska E, 1999, J MATER PROCESS TECH, V93, P190; El-Hossary FM, 2006, THIN SOLID FILMS, V497, P196, DOI 10.1016/j.tsf.2005.09.193; Isidor F, 1997, CLIN ORAL IMPLAN RES, V8, P1, DOI 10.1111/j.1600-0501.1997.tb00001.x; Okawachi H, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0027-9; Ruggeri A., 1994, INT J ORAL MAXILLOF, V9, P636; VAAHTONIEMI LH, 1993, J PERIODONTAL RES, V28, P308, DOI 10.1111/j.1600-0765.1993.tb02098.x	33	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	APR 1	2015	49						1	6		10.1016/j.msec.2014.12.059		6	Materials Science, Biomaterials	Materials Science	CC6YE	WOS:000350514100001		
J	Liu, HR; Cui, J; Feng, W; Lv, SY; Du, J; Sun, J; Han, XC; Wang, ZM; Lu, X; Yimin; Oda, K; Amizuka, N; Li, MQ				Liu, Hongrui; Cui, Jian; Feng, Wei; Lv, Shengyu; Du, Juan; Sun, Jing; Han, Xiuchun; Wang, Zhenming; Lu, Xiong; Yimin; Oda, Kimimitsu; Amizuka, Norio; Li, Minqi			Local administration of calcitriol positively influences bone remodeling and maturation during restoration of mandibular bone defects in rats	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Calcitriol; Osteoclast; Osteoblast; Mineralization; Mandibular bone defect	GLUCOCORTICOID-INDUCED OSTEOPOROSIS; RESISTANT ACID-PHOSPHATASE; TISSUE ENGINEERED BONE; VITAMIN-D-RECEPTOR; SURFACE MODIFICATION; 1,25-DIHYDROXYVITAMIN D-3; MORPHOGENETIC PROTEIN-2; OSTEOBLASTIC CELLS; I COLLAGEN; STEM-CELL	The aim of this study was to investigate the influence of calcitriol on osteoinduction following local administration into mandibular bone defects. Calcitriol-loaded absorbable collagen membrane scaffolds were prepared using the polydopamine coating method and characterized by scanning electron microscopy. Composite scaffolds were implanted into rat mandibular bone defects in the following groups: no graft material (control), bare collagen membrane (CM group), collagen membrane bearing polydopamine coating (DOP/CM group), and collagen membrane bearing polydopamine coating absorbed with calcitriol (CAL/DOP/CM group). At 1, 2, 4 and 8 weeks post-surgery, the osteogenic potential of calcitriol was examined by histological and immunohistochemical methods. Following in vivo implantation, calcitriol-loaded composite scaffolds underwent rapid degradation with pronounced replacement by new bone and induced reunion of the bone marrow cavity. Calcitriol showed strong potential in inhibiting osteoclastogenesis and promotion of osteogenic differentiation at weeks 1, and 2. Furthermore, statistical analysis revealed that the newly formed bone volume in the CAL/DOP/CM group was significantly higher than other groups at weeks 1, and 2. At weeks 4, and 8, the CAL/DOP/CM group showed more mineralized bone and uniform collagen structure. These data suggest that local administration of calcitriol is promising in promoting osteogenesis and mineralization for restoration of mandibular bone defects. (C) 2014 Elsevier B.V. All rights reserved.	[Liu, Hongrui; Cui, Jian; Feng, Wei; Lv, Shengyu; Du, Juan; Sun, Jing; Han, Xiuchun; Li, Minqi] Shandong Univ, Dept Bone Metab, Sch Stomatol, Shandong Prov Key Lab Oral Biomed, Jinan 250012, Peoples R China; [Wang, Zhenming; Lu, Xiong] Southwest Jiaotong Univ, Sch Mat Sci & Engn, Minist Educ, Key Lab Adv Technol Mat, Chengdu, Sichuan, Peoples R China; [Yimin] Hokkaido Univ, Grad Sch Med, Dept Adv Med, Sapporo, Hokkaido, Japan; [Oda, Kimimitsu] Niigata Univ, Grad Sch Med & Dent Sci, Div Biochem, Niigata, Japan; [Amizuka, Norio] Hokkaido Univ, Grad Sch Dent Med, Dept Dev Biol Hard Tissue, Sapporo, Hokkaido, Japan	Li, MQ (reprint author), Shandong Univ, Dept Bone Metab, Sch Stomatol, Shandong Prov Key Lab Oral Biomed, Wenhua West Rd 44-1, Jinan 250012, Peoples R China.	liminqi@sdu.edu.cn			National Nature Science Foundation of China [81271965, 81470719, 81311140173]; Specialized Research Fund for the Doctoral Program of Higher Education [20120131110073]	This study was partially supported by the National Nature Science Foundation of China (grant No. 81271965; 81470719; 81311140173) and the Specialized Research Fund for the Doctoral Program of Higher Education (grant No. 20120131110073) to Li M.	Saito H, 2013, J STEROID BIOCHEM, V136, P178, DOI 10.1016/j.jsbmb.2012.10.004; Xia Y, 2010, BIOINTERPHASES, V5, pFA32, DOI 10.1116/1.3467508; Suda T, 2003, J CELL BIOCHEM, V88, P259, DOI 10.1002/jcb.10331; Tatakis DN, 2002, J PERIODONTAL RES, V37, P93, DOI 10.1034/j.1600-0765.2002.00021.x; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; de Nijs RNJ, 2004, OSTEOPOROSIS INT, V15, P589, DOI 10.1007/s00198-004-1614-5; Oda K, 1999, J BIOCHEM-TOKYO, V126, P694; Hammerle CHF, 2002, J CLIN PERIODONTOL, V29, P226, DOI 10.1034/j.1600-051X.29.s3.14.x; Kim SH, 2006, POLYM-KOREA, V30, P14; Drissi H, 2002, EXP CELL RES, V274, P323, DOI 10.1006/excr.2002.5474; Yang K, 2012, BIOMATERIALS, V33, P6952, DOI 10.1016/j.biomaterials.2012.06.067; Arrabal PM, 2013, BIOL RES, V46, P421, DOI 10.4067/S0716-97602013000400013; Li MQ, 2013, HISTOL HISTOPATHOL, V28, P327; Cui JW, 2012, BIOMACROMOLECULES, V13, P2225, DOI 10.1021/bm300835r; Nagaoka H, 2008, BIOCHEM BIOPH RES CO, V377, P674, DOI 10.1016/j.bbrc.2008.10.036; Bosetti M, 2007, BIOMOL ENG, V24, P613, DOI 10.1016/j.bioeng.2007.08.019; Wright LM, 2005, BONE, V36, P840, DOI 10.1016/j.bone.2005.01.021; Takasu H, 2006, J CLIN INVEST, V116, P528, DOI 10.1172/JCI24742; Cottam E, 2009, MED ENG PHYS, V31, P221, DOI 10.1016/j.medengphy.2008.07.005; Sigurdsson TJ, 2001, INT J PERIODONT REST, V21, P461; Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c; Lohmann CH, 2000, J BONE MINER RES, V15, P1169, DOI 10.1359/jbmr.2000.15.6.1169; Ecarot B, 1999, ENDOCRINOLOGY, V140, P1192, DOI 10.1210/en.140.3.1192; Jung RE, 2003, CLIN ORAL IMPLAN RES, V14, P556, DOI 10.1034/j.1600-0501.2003.00921.x; Vallieres K, 2007, MACROMOL BIOSCI, V7, P738, DOI 10.1002/mabi.200600267; Chiapasco M, 2009, CLIN ORAL IMPLAN RES, V20, P113, DOI 10.1111/j.1600-0501.2009.01781.x; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Barthel TK, 2007, J STEROID BIOCHEM, V103, P381, DOI 10.1016/j.jsbmb.2006.12.054; Nystrom D, 2010, LANGMUIR, V26, P12748, DOI 10.1021/la1011567; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Yamaguchi M, 2012, INT J MOL MED, V29, P934, DOI 10.3892/ijmm.2012.900; Jia X, 2013, J AGR FOOD CHEM, V61, P2919, DOI 10.1021/jf3053059; Shiraishi A, 2002, CALCIFIED TISSUE INT, V71, P69, DOI 10.1007/s00223-001-2090-y; van Driel M, 2006, J CELL BIOCHEM, V99, P922, DOI 10.1002/jcb.20875; Avenell A, 2005, COCHRANE DB SYST REV, V20; Bosetti M., 2013, J BIOMED MAT RES A; Chen J, 2013, J TISSUE ENG REGEN M; COLE AA, 1987, J HISTOCHEM CYTOCHEM, V35, P203; Drzewiecki KE, 2014, LANGMUIR, V30, P11204, DOI 10.1021/la502418s; Ehnert S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-101; Fu BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061423; Han F., 2014, J BIOMED MAT RES B; HARRISON JR, 1989, ENDOCRINOLOGY, V125, P327; Hicok KC, 1998, J BONE MINER RES, V13, P205, DOI 10.1359/jbmr.1998.13.2.205; Inada M, 2008, BIOCHEM BIOPH RES CO, V372, P434, DOI 10.1016/j.bbrc.2008.05.041; Jang JW, 2003, POLYM-KOREA, V27, P226; Khan S.N., 2012, J SPINAL DISORD TECH, V27, P212; Li Y, 2008, J STEROID BIOCHEM, V112, P110, DOI 10.1016/j.jsbmb.2008.09.004; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Miyahara T, 2002, CALCIFIED TISSUE INT, V70, P488, DOI 10.1007/s00223-001-1039-5; Muzio G., 2014, J BIOMATER APPL; Nagai M, 2006, J BIOMATER APPL, V21, P33, DOI 10.1177/0885328206055316; Nawata H, 2005, J BONE MINER METAB, V23, P105, DOI 10.1007/s00774-004-0596-x; NODA M, 1990, P NATL ACAD SCI USA, V87, P9995, DOI 10.1073/pnas.87.24.9995; Oryan A, 2014, BIOFACTORS, V40, P459, DOI 10.1002/biof.1177; Reichert JC, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt316; Saito K., 2009, J BONE MINER METAB, V27, P643; Sakai S., 2007, BONE, V40, P293; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Ueno Y, 2003, J CELL BIOCHEM, V90, P267, DOI 10.1002/jcb.10623; Wang Z., 2014, J BIOMED MAT RES A; Yoon SJ, 2007, TISSUE ENG, V13, P1125, DOI 10.1089/ten.2006.0287	62	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	APR 1	2015	49						14	24		10.1016/j.msec.2014.12.064		11	Materials Science, Biomaterials	Materials Science	CC6YE	WOS:000350514100003		
J	Saito, T; Teraoka, K; Ota, K				Saito, Takao; Teraoka, Kay; Ota, Kazuyoshi			Arrayed three-dimensional structures designed to induce and maintain a cell pattern by a topographical effect on cell behavior	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Surface topography; 3-D structure; Groove; Cell behavior; Cellular microarray; Scaffold	IN-VITRO; OXIDIZED ALUMINUM; ACTIN-FILAMENT; DIFFERENTIATION; MONOLAYERS; ADHESION; SURFACES; PROLIFERATION; MICROARRAYS	We investigated the ability of the microscale topography of a three-dimensional (3-D) structure arrayed on the surface of a substrate to induce and maintain a cell pattern by controlling cell behavior. Arrayed 3-D structures having different topographical characteristics, i.e., geometry and dimension, were fabricated on the surface of glass substrates by masked sand blasting. Each 3-D structure was designed to have a unit composed of a planar island for cell growth and surrounding grooves exhibiting cell repellency. The principle of the cell repellency is based on the topographical control of cell attachment, spreading, growth, and differentiation by utilizing the spatially restricted microenvironment of the grooves. Grooves with a width of less than approximately 116 mu m and a depth of approximately 108 mu m formed narrow V-shapes with a dihedral angle of less than approximately 44.4 degrees. Cell culture experiments using osteoblast-like cells demonstrated that these narrow V-shaped grooves had sufficient cell repellency to form and maintain a cell pattern on the surface for at least 14 days. From the present study, arrayed 3-D structures designed to have narrow V-shaped grooves with optimal topographical characteristics for cell repellency are promising for the formation of stable cell patterns for creating novel cell microarray platforms without using conventional protein/cell-repellent chemicals. (C) 2015 Elsevier B.V. All rights reserved.	[Saito, Takao; Teraoka, Kay] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan; [Ota, Kazuyoshi] Otake Seisakusyo Co, Hashima, Gifu 5016338, Japan	Saito, T (reprint author), Natl Inst Adv Ind Sci & Technol, Moriyama Ku, 2266-98 Anagahora, Nagoya, Aichi 4638560, Japan.	t-saito@aist.go.jp					Angres B, 2005, EXPERT REV MOL DIAGN, V5, P769, DOI 10.1586/14737159.5-5.769; Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042; Mullins RD, 2013, CURR OPIN CELL BIOL, V25, P6, DOI 10.1016/j.ceb.2012.11.007; Hook AL, 2006, TRENDS BIOTECHNOL, V24, P471, DOI 10.1016/j.tibtech.2006.08.001; Saito T, 2010, MAT SCI ENG C-MATER, V30, P1, DOI 10.1016/j.msec.2009.06.010; Ito Y, 2005, BIOMATERIALS, V26, P211, DOI 10.1016/j.biomaterials.2004.02.019; Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154; Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Rorth P, 2011, DEV CELL, V20, P9, DOI 10.1016/j.devcel.2010.12.014; Fernandes TG, 2009, TRENDS BIOTECHNOL, V27, P342, DOI 10.1016/j.tibtech.2009.02.009; Malaval L, 1999, J CELL BIOCHEM, V74, P616; PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032; Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8; Aubin J. E., 1995, BONE, V17, p77S; Hamilton DW, 2007, BIOMATERIALS, V28, P2281, DOI 10.1016/j.biomaterials.2007.01.026; Hozumi A, 2009, LANGMUIR, V25, P6834, DOI 10.1021/la804127z; Jurisicova A, 1996, Mol Hum Reprod, V2, P93, DOI 10.1093/molehr/2.2.93; Miura M, 2006, COLLOID SURFACE B, V53, P245, DOI 10.1016/j.colsurfb.2006.10.006; Mousses S, 2002, CURR OPIN CHEM BIOL, V6, P97, DOI 10.1016/S1367-5931(01)00283-6; Paun IA, 2013, APPL SURF SCI, V278, P166, DOI 10.1016/j.apsusc.2013.03.106; Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8; Saito T, 2010, CHEM LETT, V39, P1048, DOI 10.1246/cl.2010.1048; Veiseh M, 2004, BIOMATERIALS, V25, P3315, DOI 10.1016/j.biomaterials.2003.10.014; Weber GF, 2006, DEV BIOL, V295, P714, DOI 10.1016/j.ydbio.2006.03.056; Zelman N.F.-, 1997, BONE, V20, P225	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	APR 1	2015	49						256	261		10.1016/j.msec.2015.01.021		6	Materials Science, Biomaterials	Materials Science	CC6YE	WOS:000350514100028		
J	Kato, S; Kato, Y; Shibata, H; Saitoh, Y; Miwa, N				Kato, Shinya; Kato, Yuko; Shibata, Hiroki; Saitoh, Yasukazu; Miwa, Nobuhiko			Repressive effects of oat extracts on intracellular lipid-droplet formation in adipocytes and a three-dimensional subcutaneous adipose tissue model	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Oat extracts; Preadipocytes OP9; Adipogenesis; Oil Red O stain; Three-dimensional subcutaneous adipose tissue model	OXIDATIVE-STRESS; STEM-CELLS; DIFFERENTIATION; ADIPOGENESIS; ANTIOXIDANT; PREADIPOCYTES; ACCUMULATION; OBESITY	We assessed the repression of lipid-droplet formation in mouse mesenchymal stromal preadipocytes OP9 by specified oat extracts (Hatomugi, coix lacryma-jobi var. ma-yuen) named "SPH" which were proteolytically and glucosyl-transferredly prepared from finely-milled oat whole-grain. Stimulation of OP9 preadipocytes with insulin-containing serum-replacement promoted differentiation to adipocytes, concurrently with an increase in the intracellular lipid droplets by 51.5%, which were repressed by SPH-bulk or SPH-water-extract at 840 ppm, to 33.5% or 46.9%, respectively, but not by SPH-ethanol-extract at the same dose, showing the hydrophilic property of the anti-adipogenetic ingredients. The intracellular lipid droplets were scanty for intact preadipocytes, small-sized but abundant for the SPH-unadministered adipocytes, and large-sized but few for SPH-bulk-administered adipocytes being coexistent with many lipid-droplet-lacking viable cells, suggesting "the all-or-none rule" for lipid-droplet generation in cell-to-cell. Hydrogen-peroxide-induced cell death in human epidermal keratinocytes HaCaT was prevented by SPH-bulk at 100 or 150 ppm by 5.6-8.1%, being consistent with higher viabilities of SPH-bulk-administered OP9 cells, together with repressions of both cell shrinkage and cell detachment from the culture substratum. In three-dimensional subcutaneous adipose tissue models reconstructed with HaCaT-keratinocytes and OP9-preadipocytes, lipid droplets were accumulated in dermal OP9-cell-parts, and repressed to 43.5% by SPH-bulk at 840 ppm concurrently with marked diminishment of huge aggregates of lipid droplets. Thus SPH-bulk suppresses adipogenesis-associated lipid-droplet accumulation during differentiation of OP9 preadipocytes together with lowered cytotoxicity to either HaCaT keratinocytes or the preadipocytes. (C) 2015 Elsevier B.V. All rights reserved.	[Kato, Shinya; Kato, Yuko; Saitoh, Yasukazu; Miwa, Nobuhiko] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Lab Cell Death Control BioTechnol, Shobara, Hiroshima 7270023, Japan; [Shibata, Hiroki] HABA Labs Inc, Tokyo 1000006, Japan	Miwa, N (reprint author), Butsuryo Coll Osaka, Fac Hlth Sci, Dept Radiol Technol, Nishi Ku, Otorikitamachi 3-33, Sakai, Osaka 5938328, Japan.	miwa@butsuryo.ac.jp			JCAAMS (Japanese Center for Anti-Aging MedSciences) [0708]	The present study was in part supported by a grant-in-aid to Anti-Aging Research (#0708) by JCAAMS (Japanese Center for Anti-Aging MedSciences).	Peng CH, 2013, J FUNCT FOODS, V5, P53, DOI 10.1016/j.jff.2012.08.003; Scioli MG, 2014, INT J MOL SCI, V15, P6517, DOI 10.3390/ijms15046517; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Xiao L, 2011, FREE RADICAL BIO MED, V51, P1376, DOI 10.1016/j.freeradbiomed.2011.05.026; Saitoh Y, 2010, FREE RADICAL RES, V44, P1072, DOI 10.3109/10715762.2010.499905; Chu YF, 2013, FOOD CHEM, V139, P426, DOI 10.1016/j.foodchem.2013.01.104; Bour S, 2011, ANTIOXID REDOX SIGN, V14, P403, DOI 10.1089/ars.2010.3350; Ishiyama M, 1996, BIOL PHARM BULL, V19, P1518; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chandalia M, 2012, J CLIN ENDOCR METAB, V97, P4663, DOI 10.1210/jc.2012-2018; Gregoire FM, 1998, PHYSIOL REV, V78, P783; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Puri N, 2012, J CELL BIOCHEM, V113, P1926, DOI 10.1002/jcb.24061; Kato S, 2012, J PHOTOCH PHOTOBIO B, V106, P24, DOI 10.1016/j.jphotobiol.2011.09.006; Lee OH, 2012, PHYTOTHER RES, V26, P403, DOI 10.1002/ptr.3568; GREENBERGER JS, 1979, IN VITRO CELL DEV B, V15, P823; HAUSMAN GJ, 1981, STAIN TECHNOL, V56, P149; Kato S, 2013, INT J HYPERTHER, V29, P30, DOI 10.3109/02656736.2012.750016; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Saitoh Y, 2012, MOL CELL BIOCHEM, V366, P191, DOI 10.1007/s11010-012-1297-8; Uskokovic A, 2013, J FUNCT FOODS, V5, P1966, DOI 10.1016/j.jff.2013.09.018; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Xiao L, 2010, BIOMATERIALS, V31, P5976, DOI 10.1016/j.biomaterials.2010.04.032	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	APR 1	2015	49						269	273		10.1016/j.msec.2015.01.015		5	Materials Science, Biomaterials	Materials Science	CC6YE	WOS:000350514100030		
J	Zuldesmi, M; Waki, A; Kuroda, K; Okido, M				Zuldesmi, Mansjur; Waki, Atsushi; Kuroda, Kensuke; Okido, Masazumi			Hydrothermal treatment of titanium alloys for the enhancement of osteoconductivity	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Titanium alloys; Hydrothermal; Hydrophilic; In vivo; Osteoconductivity	AQUEOUS-SOLUTIONS; TI ALLOYS; SURFACE; CORROSION; ADHESION; POWDERS; FILM	The surface wettability of implants is a crucial factor in their osteoconductivity because it influences the adsorption of cell-attached proteins onto the surface. In this study, a single-step hydrothermal surface treatment using distilled water at a temperature of 180 degrees C for 3 h was applied to titanium (Ti) and its alloys (Ti-6Al-4V, Ti-6Al-7Nb, Ti-29Nb-13Ta-4.6Zr, Ti-13Cr-1Fe-3Al; mass%) and compared with as-polished Ti implants and with implants produced by anodizing Ti in 0.1 M of H3PO4 with applied voltages from DV to 150 V at a scanning rate of 0.1 V s(-1). The surface-treated samples were stored in a five time phosphate buffered saline (x5 PBS(-)) solution to prevent increasing the water contact angle (WCA) with time. The surface characteristics were evaluated using scanning electron microscopy, X-ray diffraction, X-ray photoelectron spectroscopy, Auger electron spectroscopy, surface roughness, and contact angle measurement using a 2 mu L droplet of distilled water. The relationship between WCA and osteoconductivity at various surface modifications was examined using in vivo tests. The results showed that a superhydrophilic surface with a WCA <= 10 degrees and a high osteoconductivity (RB-I) of up to 50% in the cortical bone part, about four times higher than the as-polished Ti and Ti alloys, were provided by the combination of the hydrothermal surface treatment and storage in x5 of PBS(-). (C) 2015 Elsevier B.V. All rights reserved.	[Zuldesmi, Mansjur; Waki, Atsushi] Nagoya Univ, Grad Sch Engn, Dept Mat Sci & Engn, Nagoya, Aichi 4648601, Japan; [Zuldesmi, Mansjur] Monad State Univ UNIMA, Dept Mech Engn, Manado, Indonesia; [Kuroda, Kensuke; Okido, Masazumi] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648601, Japan	Zuldesmi, M (reprint author), Nagoya Univ, Grad Sch Engn, Dept Mat Sci & Engn, Nagoya, Aichi 4648601, Japan.	mzuldesmi@yahoo.com			Indonesian Government scholarship from the Directorate General of Higher Education (Dint); Project of Advanced Materials Development and Integration of Novel Structured Metallic and Inorganic Materials by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Japan;  [25289248];  [26630345]	This work was partially supported by an Indonesian Government scholarship from the Directorate General of Higher Education (Dint), Project of Advanced Materials Development and Integration of Novel Structured Metallic and Inorganic Materials by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Japan and a Grant-in-Aid for JSPS fellows (No. 25289248, 26630345).	Yamamoto D, 2011, MATER TRANS, V52, P1650, DOI 10.2320/matertrans.M2011049; de Jonge LT, 2008, PHARM RES-DORDR, V25, P2357, DOI 10.1007/s11095-008-9617-0; Akahori T, 2004, MATER TRANS, V45, P1540, DOI 10.2320/matertrans.45.1540; Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037; BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404; Tanaka Y, 2008, CORROS SCI, V50, P2111, DOI 10.1016/j.corsci.2008.06.002; Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R; SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257; Lopez MF, 2003, ELECTROCHIM ACTA, V48, P1395, DOI 10.1016/S0013-4686(03)00006-9; Yamamoto D, 2012, MATER TRANS, V53, P1956, DOI 10.2320/matertrans.M2012082; BAIER RE, 1968, SCIENCE, V162, P1360, DOI 10.1126/science.162.3860.1360; DEXTER SC, 1979, J COLLOID INTERF SCI, V70, P346, DOI 10.1016/0021-9797(79)90038-9; Att Wael, 2009, Biomaterials, V30, P5352, DOI 10.1016/j.biomaterials.2009.06.040; Chen HT, 2009, SURF COAT TECH, V204, P1126, DOI 10.1016/j.surfcoat.2009.06.043; DAWSON WJ, 1988, AM CERAM SOC BULL, V67, P1673; Kuroda K, 2006, MATER TRANS, V47, P1391, DOI 10.2320/matertrans.47.1391; Morant C, 2003, APPL SURF SCI, V220, P79, DOI 10.1016/S0169-4332(03)00746-3; Omori M., 2014, CLIN ORAL IMPL UNPUB; Semlitsch M., 1986, TITAN, V2, P721; Thair L, 2003, CORROS SCI, V45, P1951, DOI 10.1016/S0010-938X(03)00027-1; Xu HR, 2004, MATER LETT, V58, P1582, DOI 10.1016/j.matlet.2003.10.030; Yamamoto D., 2013, J BIOMATER NANOBIOTE, V4, P45, DOI DOI 10.4236/JBNB.2013.41007; Yamamoto D, 2012, MATER SCI FORUM, V706-709, P612, DOI 10.4028/www.scientific.net/MSF.706-709.612; Zuldesmi M., 2013, J BIOMATER NANOBIOTE, V4, P284	24	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	APR 1	2015	49						430	435		10.1016/j.msec.2015.01.031		6	Materials Science, Biomaterials	Materials Science	CC6YE	WOS:000350514100050		
J	Hirota, M; Hayakawa, T; Shima, T; Ametani, A; Tohnai, I				Hirota, Makoto; Hayakawa, Tohru; Shima, Takaki; Ametani, Akihiro; Tohnai, Iwai			High porous titanium scaffolds showed higher compatibility than lower porous beta-tricalcium phosphate scaffolds for regulating human osteoblast and osteoclast differentiation	MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS			English	Article						Scaffold; Titanium; Beta-tricalcium phosphate; Human mesenchymal stem cells; Osteoblast differentiation	MESENCHYMAL STEM-CELLS; BONE-FORMATION; FIBER-WEB; OSTEOGENIC DIFFERENTIATION; PORE-SIZE; IN-VIVO; HYDROXYAPATITE; POROSITY; INGROWTH; MESH	We compared osteoblast and osteoclast differentiation when using beta-tricalcium phosphate (beta TCP) and titanium scaffolds by investigating human mesenchymal stem cells (hMSCs) and osteoclast progenitor cell activities. hMSCs were cultured for 7, 14, and 21 days on titanium scaffolds with 60%, 73%, and 87% porosity and on beta TCP scaffolds with 60% and 75% porosity. Human osteoclast progenitor cells were cultured with osteoblast for 14 and 21 days on 87% titanium and 75% beta TCP scaffolds. Viable cell numbers with 60% and 73% titanium were higher than with 87% titanium and beta TCP scaffolds (P < 0.05). An 87% titanium scaffold resulted in the highest osteocalcin production with calcification on day 14 (P < 0.01) in titanium scaffolds. All titanium scaffolds resulted in higher osteocalcin production on days 7 and 14 compared to beta TCP scaffolds (P <0.01). Osteoblasts cultured on 87% titanium scaffolds suppressed osteoclast differentiation on day 7 but enhanced osteoclast differentiation on day 14 compared to 75% beta TCP scaffolds (P < 0.01). These findings concluded that high porosity titanium scaffolds could enhance progression of hMSC/osteoblast differentiation and regulated osteoclast differentiation cooperating with osteoblast differentiation for calcification as compared with lower porous beta TCP. (C) 2015 Elsevier B.V. All rights reserved.	[Hirota, Makoto; Tohnai, Iwai] Yokohama City Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kanazawa Ku, Yokohama, Kanagawa 236004, Japan; [Hayakawa, Tohru] Tsurumi Univ, Sch Dent Med, Dept Dent Engn, Tsurumi Ku, Yokohama, Kanagawa 2308501, Japan; [Shima, Takaki; Ametani, Akihiro] HI LEX Corp Inc, Med Device Dept, Takaraduka 6650845, Japan	Hirota, M (reprint author), Yokohama City Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kanazawa Ku, Yokohama, Kanagawa 236004, Japan.	mhirota@med.yokohama-cu.ac.jp					Amemiya T, 2012, J HARD TISSUE BIOL, V21, P103; Costa DO, 2013, BIOMATERIALS, V34, P7215, DOI 10.1016/j.biomaterials.2013.06.014; Holtorf HL, 2005, J BIOMED MATER RES A, V74A, P171, DOI 10.1002/jbm.a.30330; Lange T, 2009, BIOMATERIALS, V30, P5312, DOI 10.1016/j.biomaterials.2009.06.023; Gaasbeek RDA, 2005, BIOMATERIALS, V26, P6713, DOI 10.1016/j.biomaterials.2005.04.056; Sicchieri LG, 2012, J TISSUE ENG REGEN M, V6, P155, DOI 10.1002/term.422; Li JP, 2007, BIOMATERIALS, V28, P2810, DOI 10.1016/j.biomaterials.2007.02.020; Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031; Zerbo IR, 2004, CLIN ORAL IMPLAN RES, V15, P724, DOI 10.1111/j.1600-0501.2004.01055.x; Zerbo IR, 2005, BIOMATERIALS, V26, P1445, DOI 10.1016/j.biomaterials.2004.05.003; D'Lima DD, 1998, J ARTHROPLASTY, V13, P928, DOI 10.1016/S0883-5403(98)90201-7; Boanini E, 2008, BIOMATERIALS, V29, P790, DOI 10.1016/j.biomaterials.2007.10.040; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Hirota M, 2011, INT J ORAL MAX IMPL, V26, P245; Hirota M, 2010, INT J ORAL MAX IMPL, V25, P888; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Kurashina K, 2002, BIOMATERIALS, V23, P407, DOI 10.1016/S0142-9612(01)00119-3; Shi YC, 2007, BONE, V41, P87, DOI 10.1016/j.bone.2007.04.174; Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017; Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046; Vehof JWM, 2000, BIOMATERIALS, V21, P2003, DOI 10.1016/S0142-9612(00)00094-6; JANSEN JA, 1992, BIOMATERIALS, V13, P959, DOI 10.1016/0142-9612(92)90121-4; Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307; Lin LW, 2009, J BIOMED MATER RES A, V89A, P326, DOI 10.1002/jbm.a.31994; Makihira S, 2010, J MATER SCI-MATER M, V21, P647, DOI 10.1007/s10856-009-3891-1; Mayr-Wohlfart U, 2001, J BIOMED MATER RES, V57, P132, DOI 10.1002/1097-4636(200110)57:1<132::AID-JBM1152>3.0.CO;2-K; Mueller B., 2015, J BIOMATER IN PRESS; Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003; Pioletti DP, 2013, COMPUT METHOD BIOMEC, V16, P1050, DOI 10.1080/10255842.2013.780602; Vehof JWM, 2003, J BIOMED MATER RES A, V64A, P417, DOI 10.1002/jbm.a.10288	30	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0928-4931	1873-0191		MAT SCI ENG C-MATER	Mater. Sci. Eng. C-Mater. Biol. Appl.	APR 1	2015	49						623	631		10.1016/j.msec.2015.01.006		9	Materials Science, Biomaterials	Materials Science	CC6YE	WOS:000350514100072		
J	Chifan, I; Ioana, A; Kida, Y				Chifan, Ionut; Ioana, Adrian; Kida, Yoshikata			W*-Superrigidity for arbitrary actions of central quotients of braid groups	MATHEMATISCHE ANNALEN			English	Article							RELATIVELY HYPERBOLIC GROUPS; MAPPING CLASS GROUP; MEASURE SPACE DECOMPOSITION; NEGATIVELY CURVED GROUPS; PROPERTY T GROUPS; II1 FACTORS; STRUCTURAL THEORY; RIGID GROUPS; SUBGROUPS; INDEX	For any let be the quotient of the braid group through its center. We prove that any free ergodic probability measure preserving (pmp) action is virtually -superrigid in the following sense: if , for an arbitrary free ergodic pmp action , then the actions are virtually conjugate. Moreover, we prove that the same holds if is replaced with a finite index subgroup of the direct product , for some . The proof uses the dichotomy theorem for normalizers inside crossed products by free groups from Popa and Vaes (212, 141-198, 2014) in combination with the OE superrigidity theorem for actions of mapping class groups from Kida (131, 99-109, 2008). Similar techniques allow us to prove that if a group is hyperbolic relative to a finite family of proper, finitely generated, residually finite, infinite subgroups, then the factor has a unique Cartan subalgebra, up to unitary conjugacy, for any free ergodic pmp action . Gamma (X, mu).	[Chifan, Ionut] Univ Iowa, Dept Math, Iowa City, IA 52242 USA; [Ioana, Adrian] Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA; [Kida, Yoshikata] Kyoto Univ, Dept Math, Kyoto 6068502, Japan	Ioana, A (reprint author), Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA.	ionut-chifan@uiowa.edu; aioana@ucsd.edu; kida@math.kyoto-u.ac.jp			NSF [1301370]; NSF Grant DMS [1161047]; NSF Career Grant DMS [1253402]	I. C. was supported in part by NSF Grant #1301370.; A. I. was supported in part by NSF Grant DMS #1161047 and NSF Career Grant DMS #1253402.	Osin DV, 2006, INT J ALGEBR COMPUT, V16, P99, DOI 10.1142/S0218196706002901; PIMSNER M, 1986, ANN SCI ECOLE NORM S, V19, P57; Farb B, 1998, GEOM FUNCT ANAL, V8, P810, DOI 10.1007/s000390050075; CONNES A, 1976, ANN MATH, V104, P73, DOI 10.2307/1971057; Osin DV, 2007, INVENT MATH, V167, P295, DOI 10.1007/s00222-006-0012-3; Chifan I, 2013, ANN SCI ECOLE NORM S, V46, P1; Murray FJ, 1936, ANN MATH, V37, P116, DOI 10.2307/1968693; POWELL J, 1978, P AM MATH SOC, V68, P347, DOI 10.2307/2043120; Popa S, 2006, INVENT MATH, V165, P369, DOI 10.1007/s00222-006-0501-4; McCarthy JD, 2001, TOPOLOGY, V40, P401, DOI 10.1016/S0040-9383(99)00066-X; Popa S, 2006, ANN MATH, V163, P809; Ozawa N, 2010, ANN MATH, V172, P713; BIRMAN JS, 1973, ANN MATH, V97, P424, DOI 10.2307/1970830; Boutonnet R, 2013, ADV MATH, V244, P69, DOI 10.1016/j.aim.2013.05.012; Bowditch BH, 2012, INT J ALGEBR COMPUT, V22, DOI 10.1142/S0218196712500166; BOZEJKO M, 1993, P AM MATH SOC, V117, P1039, DOI 10.2307/2159531; Chifan I, 2013, DUKE MATH J, V162, P1923, DOI 10.1215/00127094-2331230; Chifan I, 2013, ADV MATH, V245, P208, DOI 10.1016/j.aim.2013.06.017; Dahmani F., ARXIV11117048; Farb B., 2011, PRINCETON MATH SERIE; Groves D, 2005, GEOM TOPOL, V9, P2319, DOI 10.2140/gt.2005.9.2319; Hain R., 1997, P S PURE MATH 2, V62, P97; Houdayer C, 2013, GROUP GEOM DYNAM, V7, P577, DOI 10.4171/GGD/198; Ioana A, 2011, J AM MATH SOC, V24, P1175; Ioana A, 2012, P 6 ECM KRA IN PRESS; Ioana A, 2012, GEOM FUNCT ANAL, V22, P699, DOI 10.1007/s00039-012-0178-3; Ioana A, 2013, ANN MATH, V178, P231, DOI 10.4007/annals.2013.178.1.4; Ioana A, 2011, DUKE MATH J, V157, P337, DOI 10.1215/00127094-2011-008; Ioana A, 2014, ANN SCI ECO IN PRESS; Ivanov Nikolai V., 2006, P S PURE MATH, V74, P71, DOI 10.1090/pspum/074/2264532; Ivanov N.V., 2002, HDB GEOMETRIC TOPOLO, P523; Jones V., 1982, OPERATOR THEORY ADV, V6, P89; Kharlampovich O., 1999, CRM P LECT NOTES, V17, P71; Kida Y, 2008, GEOMETRIAE DEDICATA, V131, P99, DOI 10.1007/s10711-007-9219-8; Kida Y, 2011, J TOPOL, V4, P687, DOI 10.1112/jtopol/jtr012; Osin D.V., 2006, MEMOIRS AM MATH SOC, V179; Peterson J., ARXIV10021745; Popa S, 2014, ACTA MATH-DJURSHOLM, V212, P141, DOI 10.1007/s11511-014-0110-9; Popa S., 2007, P INT C MATH MADR 20, VI, P445; Popa S, 2010, INVENT MATH, V182, P371, DOI 10.1007/s00222-010-0268-5; Popa S., J REINE ANGEW MATH; Putman A, 2010, P AM MATH SOC, V138, P753; SELA Z, 2001, PUBL MATH I HAUTES E, V93, P31, DOI 10.1007/s10240-001-8188-y; Vaes S, 2008, ANN SCI ECOLE NORM S, V41, P743; Vaes S, 2013, ARXIV13053225; Vaes S, 2013, MATH ANN, V355, P661, DOI 10.1007/s00208-012-0797-x; Vaes S., 2010, P INT C MATH HYD 201, V3, P1624	47	1	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5831	1432-1807		MATH ANN	Math. Ann.	APR	2015	361	3-4					563	582		10.1007/s00208-014-1077-8		20	Mathematics	Mathematics	CD6CI	WOS:000351176100001		
J	Munoz, R; Occhetta, G; Sola Conde, LE; Watanabe, K				Munoz, Roberto; Occhetta, Gianluca; Sola Conde, Luis E.; Watanabe, Kiwamu			Rational curves, Dynkin diagrams and Fano manifolds with nef tangent bundle	MATHEMATISCHE ANNALEN			English	Article							GREATER-THAN ONE; PROJECTIVE-MANIFOLDS; HOMOGENEOUS SPACES; VARIETIES	A Fano manifold with nef tangent bundle is of Flag-Type if it has the same kind of elementary contractions as a complete flag manifold. In this paper we present a method to associate a Dynkin diagram with any such , based on the numerical properties of its contractions. We then show that is the Dynkin diagram of a semisimple Lie group. As an application we prove that Campana-Peternell conjecture holds when is a Flag-Type manifold whose Dynkin diagram is , i.e. we show that is the variety of complete flags of linear subspaces in P-n.	[Munoz, Roberto] Univ Rey Juan Carlos, Dept Matemat Aplicada, ESCET, Madrid 28933, Spain; [Occhetta, Gianluca] Univ Trento, Dipartimento Matemat, I-38123 Trento, TN, Italy; [Sola Conde, Luis E.] Korea Inst Adv Study, Seoul 130722, South Korea; [Watanabe, Kiwamu] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan	Occhetta, G (reprint author), Univ Trento, Dipartimento Matemat, Via Sommarive 14, I-38123 Trento, TN, Italy.	roberto.munoz@urjc.es; gianluca.occhetta@unitn.it; lesolac@gmail.com; kwatanab@rimath.saitama-u.ac.jp	Sola Conde, Luis/I-5983-2014; Occhetta, Gianluca/H-5724-2012	Sola Conde, Luis/0000-0003-0522-6909; Occhetta, Gianluca/0000-0002-4651-3245	"Research in pairs" program of the Fondazione Bruno Kessler, at the Centro Internazionale per la Ricerca Matematica (Trento)	This project was conceived when the third and fourth author enjoyed a grant of the "Research in pairs" program of the Fondazione Bruno Kessler, at the Centro Internazionale per la Ricerca Matematica (Trento). We would like to express our gratitude to this institution for its support and hospitality. We would also like to thank J. Wisniewski for his interest in our project and his useful comments.	Munoz R, 2014, KYOTO J MATH, V54, P167, DOI 10.1215/21562261-2400310; MORI S, 1979, ANN MATH, V110, P593, DOI 10.2307/1971241; TSARANOV SV, 1990, EUR J COMBIN, V11, P189; Graber T, 2003, J AM MATH SOC, V16, P57, DOI 10.1090/S0894-0347-02-00402-2; CAMPANA F, 1991, MATH ANN, V289, P169, DOI 10.1007/BF01446566; CAMPANA F, 1993, MANUSCRIPTA MATH, V79, P225, DOI 10.1007/BF02568341; Casagrande C, 2008, COMPOS MATH, V144, P1429, DOI 10.1112/S0010437X08003679; Chierici E, 2006, INT J MATH, V17, P1195, DOI 10.1142/S0129167X06003850; Conde LES, 2004, P LOND MATH SOC, V89, P273, DOI 10.1112/S0024611504014856; Debarre O., 2001, HIGHER DIMENSIONAL A; Demailly J.-P., 1994, J ALGEBRAIC GEOM, V3, P295; Humphreys J. E., 1978, GRADUATE TEXTS MATH, V9; Hwang J.M., 2006, INT C MATH, VII, P613; Kac V. G., 1983, PROGR MATH, V44; KEMPF GR, 1976, ANN MATH, V103, P557, DOI 10.2307/1970952; Landsberg JM, 2003, COMMENT MATH HELV, V78, P65; Lau CH, 2009, J ALGEBRAIC GEOM, V18, P223; Mok N, 2002, T AM MATH SOC, V354, P2639, DOI 10.1090/S0002-9947-02-02953-7; Occhetta G, 2002, MATH Z, V241, P35, DOI 10.1007/s002090100405; Occhetta G., ARXIV14073658; Watanabe K, 2014, J ALGEBRA, V414, P105, DOI 10.1016/j.jalgebra.2014.05.026; Watanabe K, 2014, MATH Z, V276, P39, DOI 10.1007/s00209-013-1185-2; Yasutake K., ARXIV11045084V2	23	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5831	1432-1807		MATH ANN	Math. Ann.	APR	2015	361	3-4					583	609		10.1007/s00208-014-1083-x		27	Mathematics	Mathematics	CD6CI	WOS:000351176100002		
J	Miyamoto, Y				Miyamoto, Yasuhito			Nonradial maximizers for a H,non type problem and symmetry breaking bifurcations for a Liouville-Gel'fand problem with a vanishing coefficient	MATHEMATISCHE ANNALEN			English	Article							EXPONENTIAL NONLINEARITY; HENON EQUATION; DOMAINS; FIELD; BLOW	We study the radiality and nonradiality of the maximizers from a viewpoint of the bifurcation diagram of the Euler Lagrange equationand of the associated mean field equation. The analysis is based on exact solutions and explicit calculations.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Miyamoto, Y (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	miyayan@sepia.ocn.ne.jp			 [21740116]	This work was partially supported by Grant-in-Aid for Young Scientists (B) (Subject No. 21740116).	MOSER J, 1971, INDIANA U MATH J, V20, P1077, DOI 10.1512/iumj.1971.20.20101; HARTMAN P, 1953, AM J MATH, V75, P449, DOI 10.2307/2372496; BREZIS H, 1991, COMMUN PART DIFF EQ, V16, P1223, DOI 10.1080/03605309108820797; Smets D, 2002, COMMUN CONTEMP MATH, V4, P467, DOI 10.1142/S0219199702000725; JOSEPH DD, 1973, ARCH RATION MECH AN, V49, P241; SHERMAN J, 1950, ANN MATH STAT, V21, P124, DOI 10.1214/aoms/1177729893; Helffer B, 1999, COMMUN MATH PHYS, V202, P629, DOI 10.1007/s002200050599; Bonheure D., 2008, ADV DIFFERENTIAL EQU, V13, P105; Calanchi M, 2005, ADV NONLINEAR STUD, V5, P337; Chen CC, 2003, COMMUN PUR APPL MATH, V56, P1667, DOI 10.1002/cpa.10107; Chen G, 2000, INT J BIFURCAT CHAOS, V10, P1565, DOI 10.1142/S0218127400001006; Crandall Michael G., 1971, J FUNCT ANAL, V8, P321, DOI DOI 10.1016/0022-1236(71)90015-2; Dancer E., 1992, DIFFERENTIAL INTEGRA, V5, P903; Gazzini M, 2008, ANN I H POINCARE-AN, V25, P281, DOI 10.1016/j.anihpc.2006.09.003; Gelfand I.M., 1963, AM MATH SOC TRANSL 2, V29, P295; Golubitsky M, 1988, APPL MATH SCI, V2, P69; GURTIN ME, 1988, Q APPL MATH, V46, P301; HOLZMANN M, 1994, MATH ANN, V300, P221, DOI 10.1007/BF01450485; Kawohl B., 1985, LECT NOTES MATH, V1150; LI YY, 1994, INDIANA U MATH J, V43, P1255, DOI 10.1512/iumj.1994.43.43054; LIN SS, 1989, J DIFFER EQUATIONS, V80, P251, DOI 10.1016/0022-0396(89)90084-3; NAGASAKI K, 1994, MATH ANN, V299, P1, DOI 10.1007/BF01459770; Rabinowitz P.H., 1971, J FUNCT ANAL, V7, P487, DOI DOI 10.1016/0022-1236(71)90030-9; Sattinger D., 1971, INDIANA U MATH J, V21, P979; Secchi S, 2006, COMMUN CONTEMP MATH, V8, P823, DOI 10.1142/S0219199706002295; SUZUKI T, 1992, ANN I H POINCARE-AN, V9, P367; Suzuki T., 1994, GAKUTO INT SERIES, V3	27	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-5831	1432-1807		MATH ANN	Math. Ann.	APR	2015	361	3-4					787	809		10.1007/s00208-014-1089-4		23	Mathematics	Mathematics	CD6CI	WOS:000351176100008		
J	Yamamoto, JK; Kikuda, AT; Koike, K; Campanha, GAD; Leite, CBB; Endlen, A; Lopes, SD				Yamamoto, Jorge Kazuo; Kikuda, Antonio Tadashi; Koike, Katsuaki; da Cruz Campanha, Ginaldo Ademar; Baptista Leite, Claudio Benedito; Endlen, Arthur; Lopes, Santiago Diaz			Determination of volumetric uncertainty for geological bodies detected by boreholes	MEASUREMENT			English	Review						Geological model; Uncertainty; Monte Carlo; Volumetric uncertainty; Multiquadric equations		The volume of a mineralized body depends on the information available on borders between mineralization and host rocks. Sometimes, information is limited and a precise determination of the volume of ore body is not possible. This is the situation that a possible solution comes from stochastic simulation. Actually, simulation is carried out on an uncertainty zone in which the contact between ore and host rocks is located. Within the uncertainty zone different ore body shapes can be simulated and their volumes calculated. The frequency distribution of volumes and its statistics give us a good idea about volumetric uncertainty associated with an ore body. In order to avoid using an uncertain model for volumetric simulation, the initial model is resampled and post-processed for uncertainty reduction. This model with reduced uncertainty is then used for volumetric simulation. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamamoto, Jorge Kazuo; Kikuda, Antonio Tadashi; da Cruz Campanha, Ginaldo Ademar; Endlen, Arthur; Lopes, Santiago Diaz] Univ Sao Paulo, Inst Geosci, Sao Paulo, Brazil; [Koike, Katsuaki] Kyoto Univ, Grad Sch Engn, Kyoto, Japan; [Baptista Leite, Claudio Benedito] Univ Fed Sao Paulo, Sao Paulo, Brazil	Leite, CBB (reprint author), Univ Fed Sao Paulo, Sao Paulo, Brazil.	claudio.leite@unifesp.br	Campanha, G./J-9121-2012		Petrobras S.A. within CARMOD - Caracterizacao e modelagem geologica de reservatorios; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	The authors wish to thank Petrobras S.A. for supporting a research within CARMOD - Caracterizacao e modelagem geologica de reservatorios - and CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico for conceding research fellowships for two authors of this paper. We also want to acknowledge CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - for funding the postgraduate course of Santiago Diaz Lopez.	PAWLOWSKY V, 1993, MATH GEOL, V25, P125, DOI 10.1007/BF00893269; Wellmann F.J., 2010, TECTONOPHYSICS, V490, P141; Wellmann J.F., 2011, IAMG 2011 C MATH GEO, P745; Yamamoto JK, 2012, COMPUT GEOSCI-UK, V40, P146, DOI 10.1016/j.cageo.2011.09.005; Yamamoto JK, 2014, TECTONOPHYSICS, V633, P232, DOI 10.1016/j.tecto.2014.07.013; Yamamoto JK, 2013, GEOESTATISTICA CONCE; Yamamoto JK, 2000, MATH GEOL, V32, P489, DOI 10.1023/A:1007577916868	7	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0263-2241	1873-412X		MEASUREMENT	Measurement	APR	2015	66						45	53		10.1016/j.measurement.2015.01.023		9	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CD1HL	WOS:000350825500005		
J	Brewer, PJ; Panagoulia, D; Brown, RJC; Tromans, A; Reyes, A; Arce, M; Vospelova, A; Rozikova, M; Pratt, KW; Asakai, T; Jakobsen, PT; Camoes, MF; Oliveira, CS; Godinho, I; Spitzer, P; Sander, B; Mariassy, M; Vyskocil, L; Fisicaro, P; Stoica, D; Uysal, E				Brewer, P. J.; Panagoulia, D.; Brown, R. J. C.; Tromans, A.; Reyes, A.; Arce, M.; Vospelova, A.; Rozikova, M.; Pratt, K. W.; Asakai, T.; Jakobsen, P. T.; Camoes, M. F.; Oliveira, C. S.; Godinho, I.; Spitzer, P.; Sander, B.; Mariassy, M.; Vyskocil, L.; Fisicaro, P.; Stoica, D.; Uysal, E.			International comparison on Ag broken vertical bar AgCl electrodes for pH measurement	MEASUREMENT			English	Article						pH; Harned cell; Ag broken vertical bar AgCl electrode; Primary methods; Comparison	SILVER/SILVER CHLORIDE ELECTRODES; HARNED CELL MEASUREMENTS; AG/AGCL REFERENCE ELECTRODES; SILVER; PERFORMANCE; BUFFERS	The first practical comparison of the characteristics of Ag|AgCl electrodes prepared at different National Metrology Institutes (NMIs) has been carried out as a pilot study organised by the Consultative Committee for Amount of Substance (CCQM). Each NMI prepared at least three Ag|AgCl electrodes representative of those employed in their primary pH calibration facilities. The electrodes were sent to a coordinating laboratory where comparative measurements of their potential difference to a de facto reference, slope as a function of chloride ion concentration and electrochemical impedance were made. Electrodes from most NMIs were highly repeatable and consistent within the typical rejection criteria applied during production. An analysis of the electrode slopes in a phosphate buffer containing different concentrations of NaCl revealed the influence of variances in the Ag|AgCl electrodes between NMIs on the certified pH value of the buffer solution. The difference between NMIs is consistent with submitted values in CCQM-K9, although biases were smaller in the analysis here, suggesting the presence of other unknown contributions to the uncertainty such as cell design. The smaller biases observed in this work may also reflect improvements in the Ag|AgCl electrodes since CCQM-K9 was performed. Electrochemical impedance spectroscopy suggests a similar microstructure for electrodes prepared by most NMIs. (C) 2015 Elsevier Ltd. All rights reserved.	[Brewer, P. J.; Panagoulia, D.; Brown, R. J. C.] Natl Phys Lab, Analyt Sci Div, Teddington TW11 0LW, Middx, England; [Tromans, A.] Measurement Stand Lab New Zealand, Christchurch 8041, New Zealand; [Reyes, A.; Arce, M.] Ctr Nacl Metrol, Mpio El Marques 76246, Queretaro, Mexico; [Vospelova, A.; Rozikova, M.] Natl Czech Metrol Inst, Brno 63800, Czech Republic; [Pratt, K. W.] Inst Stand & Technol, Div Chem Sci, Gaithersburg, MD 20899 USA; [Asakai, T.] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan; [Jakobsen, P. T.] Danish Fundamental Metrol AS, DK-2800 Lyngby, Denmark; [Camoes, M. F.] Univ Lisbon, Fac Ciencias, Dept Quim & Bioquim, Ctr Ciencias Mol & Mat, P-1749016 Lisbon, Portugal; [Oliveira, C. S.; Godinho, I.] Inst Portugues Qualidade, P-2829513 Caparica, Portugal; [Spitzer, P.; Sander, B.] Phys Tech Bundesanstalt, D-38116 Braunschweig, Germany; [Mariassy, M.; Vyskocil, L.] Slovak Inst Metrol, SK-84255 Bratislava, Slovakia; [Fisicaro, P.; Stoica, D.] Dept Biomed & Inorgan Chem, Lab Natl Metrol & Essais, F-75724 Paris 15, France; [Uysal, E.] Natl Metrol Inst Turkey, TUBITAK UME, TR-41470 Gebze, Turkey	Brewer, PJ (reprint author), Natl Phys Lab, Analyt Sci Div, Hampton Rd, Teddington TW11 0LW, Middx, England.	paul.brewer@npl.co.uk			UK Department of Business Innovation and Skills National Measurement System's Chemistry & Biology Knowledge Base measurement programme	This work was funded by the UK Department of Business Innovation and Skills National Measurement System's Chemistry & Biology Knowledge Base measurement programme. We are grateful to Dipak Gohil for some very useful discussions. We gratefully acknowledge the contribution of the CCQM Working Group on Electrochemical Analysis.	Pratt KW, 2014, MAR CHEM, V162, P89, DOI 10.1016/j.marchem.2014.03.003; Buck RP, 2002, PURE APPL CHEM, V74, P2169, DOI 10.1351/pac200274112169; Bates R.G., 1973, DETERMINATION PH THE; BISHOP E, 1963, ANALYST, V88, P424, DOI 10.1039/an9638800424; Brewer PJ, 2012, ELECTROCHIM ACTA, V71, P252, DOI 10.1016/j.electacta.2012.03.164; Brewer PJ, 2011, SENSORS-BASEL, V11, P8072, DOI 10.3390/s110808072; Brewer PJ, 2009, SENSORS-BASEL, V9, P118, DOI 10.3390/s90100118; Brewer PJ, 2010, SENSORS-BASEL, V10, P2202, DOI 10.3390/s100302202; British Standards Institution, 1979, 25861979 BSI; Brown RJC, 2005, ACCREDIT QUAL ASSUR, V10, P352, DOI 10.1007/s00769-005-0014-7; Brown RJC, 2009, ACCREDIT QUAL ASSUR, V14, P139, DOI 10.1007/s00769-009-0487-x; Brown RJC, 2003, ACCREDIT QUAL ASSUR, V8, P505, DOI 10.1007/s00769-003-0689-6; Comer JEA, 1997, J AUTOM CHEM, V19, P213, DOI 10.1155/S1463924697000266; Galster H., 1991, PH MEASUREMENT; Guiomar Lito M.J., 2009, SOLUT CHEM, V38, P1471; Hamer WJ, 1939, J RES NAT BUR STAND, V23, P647, DOI 10.6028/jres.023.044; Harned HS, 1929, J AM CHEM SOC, V51, P416, DOI 10.1021/ja01377a011; JANZ GJ, 1968, ANN NY ACAD SCI, V148, P210, DOI 10.1111/j.1749-6632.1968.tb20350.x; Pfannenstiel E, 2002, INTECH, V49, P48; Sorensen SPL, 1909, BIOCHEM Z, V21, P131; Spitzer P, 2001, ACCREDIT QUAL ASSUR, V6, P55, DOI 10.1007/PL00010440; Spitzer P, 2011, J SOLID STATE ELECTR, V15, P69, DOI 10.1007/s10008-010-1106-9; Stoica D, 2011, ELECTROCHIM ACTA, V56, P10009, DOI 10.1016/j.electacta.2011.08.089; TANIGUCHI H, 1957, J ELECTROCHEM SOC, V104, P123, DOI 10.1149/1.2428506	24	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0263-2241	1873-412X		MEASUREMENT	Measurement	APR	2015	66						131	138		10.1016/j.measurement.2015.01.029		8	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CD1HL	WOS:000350825500015		
J	Fedchak, JA; Arai, K; Jousten, K; Setina, J; Yoshida, H				Fedchak, James A.; Arai, Kenta; Jousten, Karl; Setina, Janez; Yoshida, Hajime			Recommended practices for the use of spinning rotor gauges in inter-laboratory comparisons	MEASUREMENT			English	Article						Spinning rotor gauge; Key comparison; Vacuum standards; Vacuum gauge stability; Vacuum metrology; Long term stability		The spinning rotor gauge (SRG) is a common transfer standard in key comparisons (KCs) and other intercomparisons for pressures in the range of 1.0 x 10(-4) Pa to 1.0 Pa. To make absolute pressure measurements using a SRG, a calibration factor, known as the accommodation coefficient, must be determined. Comparisons which utilize SRGs require each participant to determine the accommodation coefficient. The accommodation coefficient of an SRG is known to have excellent long-term stability (<= 0.1% over 1 year; k = 1) in a laboratory environment where the rotor remains undisturbed and attached to a vacuum standard, but the long-term stability of SRGs used in comparisons is often worse than what is observed in the participants own laboratory. Recently, the Bureau International des Poids et Mesures Consultative Committee for Mass and Related Quantities Working Group on Low Pressures held a workshop to discuss the stability of the accommodation coefficient in inter-laboratory comparisons. Here we summarize the data presented during the workshop and the ensuing discussions and give a list of recommended practices derived from the workshop. Published by Elsevier Ltd.	[Fedchak, James A.] NIST, Gaithersburg, MD 20899 USA; [Arai, Kenta; Yoshida, Hajime] AIST, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan; [Jousten, Karl] Phys Tech Bundesanstalt, D-10587 Berlin, Germany; [Setina, Janez] Inst Met & Technol, SI-1000 Ljubljana, Slovenia	Fedchak, JA (reprint author), NIST, 100 Bur Dr, Gaithersburg, MD 20899 USA.	james.fedchak@nist.gov					Chang R.F., 2007, J VAC SCI TECHNOL A, V25, P1527; CHOI SH, 1990, J VAC SCI TECHNOL A, V8, P4079, DOI 10.1116/1.576443; Fedchak J. A., 2014, Metrologia, V51, DOI 10.1088/0026-1394/51/1A/07005; FREMEREY JK, 1982, VACUUM, V32, P685, DOI 10.1016/0042-207X(82)94048-9; FREMEREY JK, 1985, J VAC SCI TECHNOL A, V3, P1715, DOI 10.1116/1.573007; Jousten K., 2005, METROLOGIA TECH S42; Jousten K., 2008, HDB VACUUM TECHNOLOG, P716; Jousten K., 2005, METROLOGIA TECH S42; LINDENAU BE, 1995, VACUUM, V46, P835, DOI 10.1016/0042-207X(95)00051-8; Medina N, 2011, METROLOGIA, V48, DOI 10.1088/0026-1394/48/1A/07014; MESSER G, 1989, METROLOGIA, V26, P183, DOI 10.1088/0026-1394/26/3/004; Mohan P., 2008, METROLOGIA TECH S45; Olson D.A., 2010, METROLOGIA TECH S47; REDGRAVE FJ, 1988, VACUUM, V38, P839, DOI 10.1016/0042-207X(88)90475-7; Rohl P., 1988, VACUUM, V38, P509; Wuethrich C., DRAFT B IN PRESS; Yoshida H., 2011, METROLOGIA TECH	17	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0263-2241	1873-412X		MEASUREMENT	Measurement	APR	2015	66						176	183		10.1016/j.measurement.2015.02.012		8	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CD1HL	WOS:000350825500020		
J	Higuchi, C; Nakatsuka, A; Eguchi, J; Teshigawara, S; Kanzaki, M; Katayama, A; Yamaguchi, S; Takahashi, N; Murakami, K; Ogawa, D; Sasaki, S; Makino, H; Wada, J				Higuchi, Chigusa; Nakatsuka, Atsuko; Eguchi, Jun; Teshigawara, Sanae; Kanzaki, Motoko; Katayama, Akihiro; Yamaguchi, Satoshi; Takahashi, Naoto; Murakami, Kazutoshi; Ogawa, Daisuke; Sasaki, Sakiko; Makino, Hirofumi; Wada, Jun			Identification of Circulating miR-101, miR-375 and miR-802 as Biomarkers for Type 2 Diabetes	METABOLISM-CLINICAL AND EXPERIMENTAL			English	Article						miRNA; Liver; Adipose tissues; Serum; Diabetes	MICRORNAS; OVEREXPRESSION; EXPRESSION; MELLITUS; OBESITY; CANCER	Purpose. The unique circulating microRNAs (miRNAs) observed in patients with type 2 diabetes (T2D) are candidates as new biomarkers and therapeutic targets. In order to identify circulating miRNAs relevant to the disease process in case of type 2 diabetes, we performed the Illumina sequencing of miRNAs derived from the serum, liver and epididymal white adipose tissue (WAT) of diet-induced obese male C57BL/6J mice. Basic Procedures. We selected four miRNAs, miR-101, miR-335, miR-375, and miR-802, which are increased in the sera and tissues of obese mice, and measured the serum levels of miRNAs in T2D and subjects with normal glucose tolerance (NGT). Main Findings. The serum concentrations of miRNAs, log10miR-101, log(10)miR-375, and log(10)miR-802, were significantly increased in the T2D patients compared with NGT subjects (1.41 +/- 2.01 u.s. -0.57 +/- 1.05 (P = 1.36 x 10(-5)), 0.20 +/- 0.58 v.s. 0.038 +/- 1.00 (P = 3.06 x 10(-6)), and 2.45 +/- 1.27 u.s. 0.97 +/- 0.98 (P = 0.014), respectively). The log(10)miR-335 values did not demonstrate any significant differences between the T2D and NGT groups (-1.08 +/- 1.35 v.s. 0.38 +/- 1.21 (P = 0.25)). According to the stepwise regression analysis, the HbA1c was an independent predictor of miR-101. Regarding the serum miR-802 levels, eGFR, HbA1c and HDL-C values were identified as significant determinants. Principal Conclusions. The present findings demonstrated that the circulating miR-101, miR-375 and miR-802 levels are significantly increased in T2D patients versus NGT subjects and they may become the new biomarkers for type 2 diabetes. (C) 2015 Elsevier Inc. All rights reserved.	[Higuchi, Chigusa; Nakatsuka, Atsuko; Eguchi, Jun; Teshigawara, Sanae; Kanzaki, Motoko; Katayama, Akihiro; Yamaguchi, Satoshi; Takahashi, Naoto; Murakami, Kazutoshi; Makino, Hirofumi; Wada, Jun] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Kita Ku, Okayama 7008558, Japan; [Murakami, Kazutoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Kita Ku, Okayama 7008558, Japan; [Ogawa, Daisuke] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Diabet Nephropathy, Kita Ku, Okayama 7008558, Japan; [Sasaki, Sakiko] Okayama Southern Inst Hlth, Kita Ku, Okayama, Japan	Wada, J (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	junwada@md.okayama-u.ac.jp	Wada, Jun/B-2023-2011	Wada, Jun/0000-0003-1468-5170	JSPS [25126716, 25461354, 26293218, 26461361, 26461362]	This work was supported by JSPS Grant-in-Aid for Scientific Research, grant numbers (25126716, 25461354, 26293218: 26461361, and 26461362).	Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Nielsen LB, 2012, EXP DIABETES RES, DOI 10.1155/2012/896362; Karolina DS, 2012, J CLIN ENDOCR METAB, V97, pE2271, DOI 10.1210/jc.2012-1996; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Vickers KC, 2012, CURR OPIN LIPIDOL, V23, P91, DOI 10.1097/MOL.0b013e328350a425; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Nakahara O, 2012, ANN SURG ONCOL, V19, pS565, DOI 10.1245/s10434-011-2068-6; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Yang ZP, 2014, ACTA DIABETOL, V51, P823, DOI 10.1007/s00592-014-0617-8; Qing S, 2014, CELL PHYSIOL BIOCHEM, V34, P1733, DOI 10.1159/000366374; Sun K, 2014, MOL MED REP, V9, P967, DOI 10.3892/mmr.2013.1872; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Ortega FJ, 2014, DIABETES CARE, V37, P1375, DOI 10.2337/dc13-1847; Zhu L, 2014, CELL BIOCHEM BIOPHYS, V68, P283, DOI 10.1007/s12013-013-9708-3; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Boon RA, 2013, ARTERIOSCL THROM VAS, V33, P186, DOI 10.1161/ATVBAHA.112.300139; Chakraborty C, 2013, CURR DRUG TARGETS, V14, P1110; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Esguerra JLS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018613; Lahmy R, 2014, MOL BIOL REP; Li R., 2014, INT J ENDOCRINOL, V2014, DOI DOI 10.1155/2014/593956; Mao G, 2014, EXP THER MED, V8, P1901, DOI 10.3892/etm.2014.1996; Pescador N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077251; Rong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073272; Wang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086792	29	7	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0026-0495	1532-8600		METABOLISM	Metab.-Clin. Exp.	APR	2015	64	4					489	497		10.1016/j.metabol.2014.12.003		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CC8IZ	WOS:000350613000004		
J	Ramakrishnan, NK; Marosi, K; Nyakas, CJ; Kwizera, C; Elsinga, PH; Ishiwata, K; Luiten, PGM; Dierckx, RAJO; van Waarde, A				Ramakrishnan, Nisha K.; Marosi, Krisztina; Nyakas, Csaba J.; Kwizera, Chantal; Elsinga, Philip H.; Ishiwata, Kiichi; Luiten, Paul G. M.; Dierckx, Rudi A. J. O.; van Waarde, Aren			Altered Sigma-1 Receptor Expression in Two Animal Models of Cognitive Impairment	MOLECULAR IMAGING AND BIOLOGY			English	Article						Cholinergic lesion; microPET; Novel object recognition; Passive avoidance; REM sleep deprivation; [C-11]SA4503; Sigma-1 receptor	NUCLEUS BASALIS MAGNOCELLULARIS; SELECTIVE CHOLINERGIC LESION; UNFOLDED PROTEIN RESPONSE; EYE-MOVEMENT SLEEP; INDUCED CELL-DEATH; REM-SLEEP; RAT-BRAIN; DONEPEZIL; DEPRIVATION; MICE	Sigma-1 receptors are involved in learning and memory processes. We assessed sigma-1 receptor expression and memory function in two animal models of cognitive impairment. Male Wistar-Hannover rats were either lesioned by unilateral injection of N-methyl-D-aspartic acid in the nucleus basalis, or deprived of rapid eye movement sleep for 48 h, using the modified multiple platform method. Sigma-1 receptor expression was examined with the positron emission tomography radiotracer [C-11]SA4503, immunohistochemistry, and Western blotting. Cortical tracer uptake after 1 week was not significantly affected by lesioning. Immunohistochemistry revealed moderate increases of sigma-1 receptors at bregma level -2.8, in parietal cortex layer V of the lesioned hemisphere. Sleep deprivation lowered passive avoidance test scores and reduced [C-11]SA4503 accumulation and sigma-1 receptor expression in pons. Cholinergic lesioning causes an increase of sigma-1 receptor expression in a small cortical area which may be neuroprotective. Sleep deprivation decreases receptor expression in midbrain and pons.	[Ramakrishnan, Nisha K.; Kwizera, Chantal; Elsinga, Philip H.; Dierckx, Rudi A. J. O.; van Waarde, Aren] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, NL-9713 GZ Groningen, Netherlands; [Marosi, Krisztina; Nyakas, Csaba J.] Semmelweis Univ, Brain Physiol Res Unit, H-1123 Budapest, Hungary; [Nyakas, Csaba J.; Luiten, Paul G. M.] Univ Groningen, Res Grp Mol Neurobiol, NL-9747 AG Groningen, Netherlands; [Ishiwata, Kiichi] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Itabashi Ku, Tokyo 1730015, Japan	van Waarde, A (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	a.van.waarde@umcg.nl					van Waarde A, 2011, BEHAV BRAIN RES, V221, P543, DOI 10.1016/j.bbr.2009.12.043; Villard V, 2009, NEUROPSYCHOPHARMACOL, V34, P1552, DOI 10.1038/npp.2008.212; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Buckley AW, 2011, J CHILD ADOL PSYCHOP, V21, P353, DOI 10.1089/cap.2010.0121; Hanlon EC, 2011, P NATL ACAD SCI USA, V108, P15609, DOI 10.1073/pnas.1101338108; Ramakrishnan NK, 2013, J NUCL MED, V54, P1377, DOI 10.2967/jnumed.112.115931; Rothman SM, 2013, BRAIN RES, V1529, P200, DOI 10.1016/j.brainres.2013.07.010; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Killick R, 2012, J CLIN ENDOCR METAB, V97, P3876, DOI 10.1210/jc.2012-1845; Mavlyutov TA, 2013, NEUROSCIENCE, V240, P129, DOI 10.1016/j.neuroscience.2013.02.035; Kanbayashi T, 2002, PSYCHIAT CLIN NEUROS, V56, P307, DOI 10.1046/j.1440-1819.2002.01008.x; Kawamura K, 2003, NUCL MED BIOL, V30, P273, DOI 10.1016/S0969-8051(02)00439-0; Tufik S, 2009, AN ACAD BRAS CIENC, V81, P521, DOI 10.1590/S0001-37652009000300016; Banister SD, 2012, CURR PHARM DESIGN, V18, P884; GNADT JW, 1986, BRAIN RES, V384, P29, DOI 10.1016/0006-8993(86)91216-3; Meunier J, 2006, BRIT J PHARMACOL, V149, P998, DOI 10.1038/sj.bjp.0706927; Naidoo N, 2009, SLEEP MED REV, V13, P195, DOI 10.1016/j.smrv.2009.01.001; Ono Y, 2012, EUR J PHARMACOL, V696, P83, DOI 10.1016/j.ejphar.2012.09.037; Toyohara J, 2012, NUCL MED BIOL, V39, P1049, DOI 10.1016/j.nucmedbio.2012.03.002; Antonini V, 2011, J ALZHEIMERS DIS, V24, P569, DOI 10.3233/JAD-2011-101794; Antonini V, 2009, J NEUROCHEM, V109, P744, DOI 10.1111/j.1471-4159.2009.06000.x; Bliwise Donald L, 2004, Clin Cornerstone, V6 Suppl 1A, pS16, DOI 10.1016/S1098-3597(04)90014-2; Burghaus L, 2001, NEUROSCI LETT, V301, P111, DOI 10.1016/S0304-3940(01)01605-6; Chuah LYM, 2009, SLEEP, V32, P999; Chuah LYM, 2008, J NEUROSCI, V28, P11369, DOI 10.1523/JNEUROSCI.4045-08.2008; Dodds CM, 2011, HUM PSYCHOPHARM CLIN, V26, P578, DOI 10.1002/hup.1248; Hayashi T, 2011, HISTOCHEM CELL BIOL, V135, P627, DOI 10.1007/s00418-011-0811-5; Horan B, 2002, SYNAPSE, V46, P1, DOI 10.1002/syn.10107; Ivković Maja, 2004, Psychiatr Danub, V16, P15; LUITEN PGM, 1995, NEURODEGENERATION, V4, P307, DOI 10.1016/1055-8330(95)90020-9; Mardon K, 1999, LIFE SCI, V65, pPL281, DOI 10.1016/S0024-3205(99)00521-4; Maurice T, 1998, NEUROSCIENCE, V83, P413; Meyer DA, 2002, J BIOL CHEM, V277, P28725, DOI 10.1074/jbc.M202592200; MIYAI I, 1990, J NEURAL TRANSM-GEN, V82, P79, DOI 10.1007/BF01245165; Moraes WS, 2006, SLEEP, V29, P199; Naidoo N, 2014, AGING CELL, V13, P131, DOI 10.1111/acel.12158; Nissen C, 2006, NEUROPSYCHOPHARMACOL, V31, P1294, DOI 10.1038/sj.npp.1300906; PAUL IA, 1993, FASEB J, V7, P1171; Ramakrishnan NK, 2014, PSYCHOPHARMACOLOGY B, DOI [10.1007/s00213-014-3533-2, DOI 10.1007/S00213-014-3533-2]; ROSSNER S, 1994, BRAIN RES, V668, P85; Rybczynska AA, 2009, EUR J NUCL MED MOL I, V36, P1167, DOI 10.1007/s00259-009-1076-2; SalinPascual RJ, 1997, PSYCHOPHARMACOLOGY, V131, P216, DOI 10.1007/s002130050286; Senda T, 1998, PHARMACOL BIOCHEM BE, V59, P129, DOI 10.1016/S0091-3057(97)00385-7; Spira AP, 2013, JAMA NEUROL, V70, P1537, DOI 10.1001/jamaneurol.2013.4258; SU TP, 1991, EUR J BIOCHEM, V200, P633, DOI 10.1111/j.1432-1033.1991.tb16226.x; VERTES RP, 1984, PROG NEUROBIOL, V22, P241, DOI 10.1016/0301-0082(84)90020-0; Villard V, 2010, J PSYCHOPHARMACOL, V25, P1101; Wang HH, 2003, BRIT J PHARMACOL, V138, P941, DOI 10.1038/sj.bjp.0705117; Wang LX, 2012, MECH AGEING DEV, V133, P665, DOI 10.1016/j.mad.2012.09.005	49	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1536-1632	1860-2002		MOL IMAGING BIOL	Mol. Imaging. Biol.	APR	2015	17	2					231	238		10.1007/s11307-014-0780-x		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CD4YO	WOS:000351092900010		
J	Doan, ML; Nguyen, TT; Lin, ZP; Xu, L				Minh Luan Doan; Thanh Tung Nguyen; Lin, Zhiping; Xu, Li			Notes on minimal realizations of multidimensional systems	MULTIDIMENSIONAL SYSTEMS AND SIGNAL PROCESSING			English	Article						Multidimensional systems; State-space realization; Minimal realization; Roesser model; Symbolic approach; Grobner basis	STATE-SPACE REALIZATION; PASS DIGITAL-FILTERS; 2-D SYSTEMS; LINEAR-SYSTEMS; OBSERVABILITY; DISCRETE; DELAY; CONTROLLABILITY; POLYNOMIALS; ND	In this paper, we formalize two related but different notions for state-space realization of multidimensional () single-input-single-output discrete systems in Roesser model, namely the "absolutely minimal realization" and the "minimal realization". We then focus our study mainly on first-degree 2D and 3D causal systems. A necessary and sufficient condition for absolutely minimal realizations is given for first-degree 2D systems. It is then shown that first-degree 2D systems that do not admit absolutely minimal realizations always admit minimal realizations of order 3. A Grobner basis approach is also proposed which leads to a sufficient condition for the absolutely minimal realizations of some higher-degree 2D systems. We then present a symbolic method that gives simple necessary conditions for the existence of absolutely minimal realizations for first-degree 3D systems. A two-step approach to absolutely minimal realizations for first-degree 3D systems is then presented, followed by techniques for minimal realizations of first-degree 3D systems. Throughout the paper, several non-trivial examples are illustrated with the aim of helping the reader to apply the realization methods proposed in this paper.	[Minh Luan Doan; Thanh Tung Nguyen] Nanyang Technol Univ, Sch Phys & Math Sci, Singapore 639798, Singapore; [Lin, Zhiping] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Xu, Li] Akita Prefectural Univ, Dept Elect & Informat Syst, Akita, Japan	Xu, L (reprint author), Akita Prefectural Univ, Dept Elect & Informat Syst, Akita, Japan.	xuli@akita-pu.ac.jp			Nanyang Technological University under the Undergraduate Research Experience on Campus (URECA) program	We would like to thank the anonymous reviewers for constructive comments, which helped improve the quality and presentation of this paper. We wish to acknowledge the funding support for this project from Nanyang Technological University under the Undergraduate Research Experience on Campus (URECA) program.	Dymkov M, 2004, INT J CONTROL, V77, P847, DOI 10.1080/00207170410001726796; YOULA DC, 1979, IEEE T CIRCUITS SYST, V26, P105, DOI 10.1109/TCS.1979.1084614; Antoniou G. E., 1993, ELECTRON LETT, V29, P2004; ANTONIOU GE, 1988, IEEE T CIRCUITS SYST, V35, P1055, DOI 10.1109/31.1857; Antoniou GE, 2001, IEEE SIGNAL PROC LET, V8, P23, DOI 10.1109/97.889640; ANTONIOU GE, 1986, IEEE T CIRCUITS SYST, V33, P926, DOI 10.1109/TCS.1986.1086014; Ball JA, 2005, SIAM J CONTROL OPTIM, V44, P1474, DOI 10.1137/S0363012904443750; Beck C, 2004, IEEE T AUTOMAT CONTR, V49, P1815, DOI 10.1109/TAC.2004.835582; Beck C, 1997, P AMER CONTR CONF, P3130, DOI 10.1109/ACC.1997.612035; Belcastro C. M., 1994, THESIS U DREXEL US; Bose N. K., 2003, MULTIDIMENSIONAL SYS; Bose N. K., 1982, APPL MULTIDIMENSIONA; BOSE NK, 1976, P IEEE, V64, P185, DOI 10.1109/PROC.1976.10079; Buchberger B., 1985, MULTIDIMENSIONAL SYS; Cockburn J. C., 2000, P MTNS PERP FRANC SE; DAndrea R, 1997, P AMER CONTR CONF, P3557, DOI 10.1109/ACC.1997.609484; Decker W., 2012, SINGULAR 3 1 6 COMPU; EISING R, 1978, IEEE T AUTOMAT CONTR, V23, P793, DOI 10.1109/TAC.1978.1101861; El-Kasri B., 2013, MULTIDIMENSIONAL SYS, V24, P685; Fan H., 2009, J CONTROL THEORY APP, V7, P335; Galkowski K., 2001, LNCIS; Galkowski K, 2005, OPER THEOR, V160, P179; Galkowski K, 2001, INT J CONTROL, V74, P1279, DOI 10.1080/00207170110065901; GANAPATHY V, 1983, IEEE T ACOUST SPEECH, V31, P1577, DOI 10.1109/TASSP.1983.1164240; GIVONE DD, 1973, IEEE T COMPUT, VC 22, P673; GU GX, 1991, IEEE T CIRCUITS SYST, V38, P1228, DOI 10.1109/31.97545; Guiver J. P., 1985, MULTIDIMENSIONAL SYS, P52; JURY EI, 1978, P IEEE, V66, P1018, DOI 10.1109/PROC.1978.11079; Kailath T., 1980, LINEAR SYSTEMS; KANELLAKIS AJ, 1989, INT J SYST SCI, V20, P1213, DOI 10.1080/00207728908910206; KUNG SY, 1977, P IEEE, V65, P945; Lin Z., 2008, IEEE T CIRCUITS-I, V55, P445; Lin ZP, 2007, IEEE INT SYMP CIRC S, P597, DOI 10.1109/ISCAS.2007.378808; Lin ZP, 1999, MULTIDIM SYST SIGN P, V10, P379, DOI 10.1023/A:1008427830183; Lin ZP, 1998, MULTIDIM SYST SIGN P, V9, P149, DOI 10.1023/A:1008230204251; Lu W. S., 1992, 2 DIMENSIONAL DIGITA; Magni J-F., 2006, TECHNICAL REPORT; PARASKEVOPOULOS PN, 1993, INT J ELECTRON, V74, P491, DOI 10.1080/00207219308925853; REDDY MS, 1986, IEEE T ACOUST SPEECH, V34, P1011, DOI 10.1109/TASSP.1986.1164901; VAROUFAKIS SJ, 1987, IEEE T CIRCUITS SYST, V34, P289, DOI 10.1109/TCS.1987.1086131; Xu L, 2010, MULTIDIM SYST SIGN P, V21, P343, DOI 10.1007/s11045-010-0114-3; Xu L, 2012, IEEE T CIRCUITS-I, V59, P638, DOI 10.1109/TCSI.2011.2167262; Xu L, 2008, MULTIDIM SYST SIGN P, V19, P323, DOI 10.1007/s11045-008-0057-0; Xu L, 2011, MULTIDIM SYST SIGN P, V22, P97, DOI 10.1007/s11045-010-0140-1; ZAK SH, 1986, IEEE T CIRCUITS SYST, V33, P1241, DOI 10.1109/TCS.1986.1085872	45	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0923-6082	1573-0824		MULTIDIM SYST SIGN P	Multidimens. Syst. Signal Process.	APR	2015	26	2			SI		519	553		10.1007/s11045-014-0297-0		35	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CC7TI	WOS:000350570900010		
J	Elfwing, S; Uchibe, E; Doya, K				Elfwing, S.; Uchibe, E.; Doya, K.			Expected energy-based restricted Boltzmann machine for classification	NEURAL NETWORKS			English	Article						Classification; Restricted Boltzmann machine; Expected energy; Free energy	RECOGNITION; NETS; DEEP	In classification tasks, restricted Boltzmann machines (RBMs) have predominantly been used in the first stage, either as feature extractors or to provide initialization of neural networks. In this study, we propose a discriminative learning approach to provide a self-contained RBM method for classification, inspired by free-energy based function approximation (FE-RBM), originally proposed for reinforcement learning. For classification, the FE-RBM method computes the output for an input vector and a class vector by the negative free energy of an RBM. Learning is achieved by stochastic gradient-descent using a mean-squared error training objective. In an earlier study, we demonstrated that the performance and the robustness of FE-RBM function approximation can be improved by scaling the free energy by a constant that is related to the size of network. In this study, we propose that the learning performance of RBM function approximation can be further improved by computing the output by the negative expected energy (EE-RBM), instead of the negative free energy. To create a deep learning architecture, we stack several RBMs on top of each other. We also connect the class nodes to all hidden layers to try to improve the performance even further. We validate the classification performance of EE-RBM using the MNIST data set and the NORB data set, achieving competitive performance compared with other classifiers such as standard neural networks, deep belief networks, classification RBMs, and support vector machines. The purpose of using the NORB data set is to demonstrate that EE-RBM with binary input nodes can achieve high performance in the continuous input domain. (C) 2014 The Authors. Published by Elsevier Ltd.	[Elfwing, S.; Uchibe, E.; Doya, K.] Grad Univ, Okinawa Inst Sci & Technol, Okinawa 9040495, Japan	Elfwing, S (reprint author), Grad Univ, Okinawa Inst Sci & Technol, 1919-1 Tancha, Okinawa 9040495, Japan.	elfwing@oist.jp; uchibe@oist.jp; doya@oist.jp	Elfwing, Stefan/G-2940-2015; Doya, Kenji/B-5841-2015	Elfwing, Stefan/0000-0001-6689-1000; Doya, Kenji/0000-0002-2446-6820	 [23120007];  [26120727]	This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas: Prediction and Decision Making 23120007 and 26120727.	Ciresan DC, 2010, NEURAL COMPUT, V22, P3207, DOI 10.1162/NECO_a_00052; Sallans B, 2004, J MACH LEARN RES, V5, P1063; Decoste D, 2002, MACH LEARN, V46, P161, DOI 10.1023/A:1012454411458; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Larochelle H, 2012, J MACH LEARN RES, V13, P643; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hinton GE, 2007, PROG BRAIN RES, V165, P535, DOI 10.1016/S0079-6123(06)65034-6; Bengio Y., 2006, P ADV NEUR INF PROC, V19; Bengio Y., 2007, LARGE SCALE KERNEL M; Elfwing S., 2013, FRONTIERS NEUROROBOT, V7; Freund Y., 1992, ADV NEURAL INFORM PR, V4; Goodfellow I. J., 2013, P INT C MACH LEARN I; Goodfellow I. J., 2013, P ADV NEUR INF PROC, V26; Hinton G. E., 2010, 2010003 UTML TR DEP; Hinton G. E., 2012, ARXIV12070580CENE; Larochelle H., 2008, P INT C MACH LEARN I; LeCun Y., 2004, P CVPR2004; Nair V., 2008, P ADV NEUR INF PROC, V21; Ngiam J., 2011, P 28 INT C MACH LEAR, P1105; Raiko T., 2012, P INT C ART INT STAT, P924; Salakhutdinov R., 2009, JMLR W CP AISTATS 20, V5, P448; Schmah T., 2008, P ADV NEUR INF PROC, V21; Smolensky P., 1986, PARALLEL DISTRIBUTED, V1; Sutton R., 1998, REINFORCEMENT LEARNI	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0893-6080	1879-2782		NEURAL NETWORKS	Neural Netw.	APR	2015	64				SI		29	38		10.1016/j.neunet.2014.09.006		10	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CD2RL	WOS:000350926600005		
J	Kozawa, S; Sakumura, Y; Toriyama, M; Inagaki, N; Ikeda, K				Kozawa, Satoshi; Sakumura, Yuichi; Toriyama, Michinori; Inagaki, Naoyuki; Ikeda, Kazushi			Bayesian Cell Force Estimation Considering Force Directions	NEURAL PROCESSING LETTERS			English	Article						Traction force microscopy; Cellular force estimation; Inverse problem; Hierarchical Bayesian model	TRACTION FORCE; AXON GUIDANCE; GROWTH CONE; FLEXIBLE SUBSTRATA; NEURON MIGRATION; ACTIN-FILAMENTS; MOTILITY; STRESSES; BIOLOGY; FIELDS	Traction force microscopy is a useful technique for measuring mechanical forces generated by cells. In this method, fluorescent nano beads are embedded in the elastic substrate of cell culture, on which cells are cultured. Then, cellular forces are estimated from bead displacements, which represent the force-induced deformation of the substrate under the cell. Estimating the forces from the bead displacements is not easy when the bead density is low or the locations of cellular attachments are unknown. In this study, we propose a Bayesian algorithm by introducing a prior force direction that is based on cellular morphology. We apply the Bayesian framework to synthetic datasets in conditions under which the bead density is low and cellular attachment points are unknown. We demonstrate that the Bayesian algorithm improves accuracy in force estimation compared with the previous algorithms.	[Kozawa, Satoshi; Ikeda, Kazushi] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300192, Japan; [Sakumura, Yuichi] Aichi Prefectural Univ, Sch Informat Sci & Technol, Nagakute, Aichi 4801198, Japan; [Sakumura, Yuichi; Toriyama, Michinori; Inagaki, Naoyuki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	Ikeda, K (reprint author), Nara Inst Sci & Technol, Grad Sch Informat Sci, 8916-5 Takayama, Nara 6300192, Japan.	kazushi@is.naist.jp			JSPS [25330341, 25102010]	This work was supported by a JSPS Grant-in-Aid for Scientific Research (C) (25330341) and Scientific Research on Innovative Areas (25102010).	Bridgman PC, 2001, J NEUROSCI, V21, P6159; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Rieu JP, 2005, BIOPHYS J, V89, P3563, DOI 10.1529/biophysj.104.056333; Schwarz US, 2002, BIOPHYS J, V83, P1380; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595; Dembo M, 1999, BIOPHYS J, V76, P2307; Toriyama M, 2013, CURR BIOL, V23, P529, DOI 10.1016/j.cub.2013.02.017; Roy P, 2002, NAT CELL BIOL, V4, pE91, DOI 10.1038/ncb0402-e91; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Lin CH, 1996, NEURON, V16, P769, DOI 10.1016/S0896-6273(00)80097-5; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Stricker J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194104; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Yang ZC, 2006, J THEOR BIOL, V242, P607, DOI 10.1016/j.jtbi.2006.05.005; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Calandra T, 1997, CRIT REV IMMUNOL, V17, P77; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Dembo M, 1996, BIOPHYS J, V70, P2008; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Suter DM, 2001, J CELL BIOL, V155, P427, DOI 10.1083/jcb.200107063; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Kleeberger W, 2007, CANCER RES, V67, P9199, DOI 10.1158/0008-5472.CAN-07-0806; Beningo KA, 2002, TRENDS CELL BIOL, V12, P79, DOI 10.1016/S0962-8924(01)02205-X; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Landau L., 1970, COURSE THEORETICAL P, V2nd	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1370-4621	1573-773X		NEURAL PROCESS LETT	Neural Process. Lett.	APR	2015	41	2			SI		191	200		10.1007/s11063-013-9320-y		10	Computer Science, Artificial Intelligence	Computer Science	CD6CH	WOS:000351176000005		
J	Yamashita, S; Mori, A; Nishida, Y; Kurisaki, R; Tawara, N; Nishikami, T; Misumi, Y; Ueyama, H; Imamura, S; Higuchi, Y; Hashiguchi, A; Higuchi, I; Morishita, S; Yoshimura, J; Uchino, M; Takashima, H; Tsuji, S; Ando, Y				Yamashita, S.; Mori, A.; Nishida, Y.; Kurisaki, R.; Tawara, N.; Nishikami, T.; Misumi, Y.; Ueyama, H.; Imamura, S.; Higuchi, Y.; Hashiguchi, A.; Higuchi, I.; Morishita, S.; Yoshimura, J.; Uchino, M.; Takashima, H.; Tsuji, S.; Ando, Y.			Clinicopathological features of the first Asian family having vocal cord and pharyngeal weakness with distal myopathy due to a MATR3 mutation	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Letter							AMYOTROPHIC-LATERAL-SCLEROSIS; INCLUSION-BODY MYOSITIS; FRONTOTEMPORAL LOBAR DEGENERATION; TDP-43 ACCUMULATION; DEMENTIA; PROTEIN; COMMON		[Yamashita, S.; Mori, A.; Tawara, N.; Nishikami, T.; Misumi, Y.; Uchino, M.; Ando, Y.] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Japan; [Nishida, Y.; Ueyama, H.; Imamura, S.] Kumamoto Saishunsou Natl Hosp, Natl Hosp Org, Dept Neurol, Kumamoto, Japan; [Kurisaki, R.] Kumamoto Minami Natl Hosp, Natl Hosp Org, Dept Neurol, Kumamoto, Japan; [Higuchi, Y.; Hashiguchi, A.; Higuchi, I.; Takashima, H.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurol & Geriatr, Kagoshima 890, Japan; [Morishita, S.; Yoshimura, J.] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Tokyo, Japan; [Tsuji, S.] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo, Japan	Yamashita, S (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Japan.						Kusters B, 2009, ACTA NEUROPATHOL, V117, P209, DOI 10.1007/s00401-008-0471-2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Olive M, 2009, J NEUROPATH EXP NEUR, V68, P262, DOI 10.1097/NEN.0b013e3181996d8f; Senderek J, 2009, AM J HUM GENET, V84, P511, DOI 10.1016/j.ajhg.2009.03.006; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Salton M, 2010, CELL CYCLE, V9, P1568, DOI 10.4161/cc.9.8.11298; Salajegheh M, 2009, MUSCLE NERVE, V40, P19, DOI 10.1002/mus.21386; Udd B, 2012, NEUROMUSCULAR DISORD, V22, P5, DOI 10.1016/j.nmd.2011.10.003; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Weihl CC, 2010, CURR OPIN NEUROL, V23, P482, DOI 10.1097/WCO.0b013e32833d3897; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Tasca G, 2012, J NEUROL, V259, P1358, DOI 10.1007/s00415-011-6357-6; Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334; Feit H, 1998, AM J HUM GENET, V63, P1732, DOI 10.1086/302166; D'Agostino C, 2011, NEUROPATH APPL NEURO, V37, P315, DOI 10.1111/j.1365-2990.2010.01108.x; Dubourg O, 2011, Acta Myol, V30, P103; Nogalska A, 2009, ACTA NEUROPATHOL, V118, P407, DOI 10.1007/s00401-009-0564-6; Yamashita S, 2013, NEUROPATH APPL NEURO, V39, P406, DOI 10.1111/j.1365-2990.2012.01297.x	20	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	APR	2015	41	3					391	398		10.1111/nan.12179		8	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CD2LY	WOS:000350911100009		
J	Yamamoto, T; Uemura, K; Moriyama, K; Mitamura, K; Taga, A				Yamamoto, Tetsushi; Uemura, Kentaro; Moriyama, Kaho; Mitamura, Kuniko; Taga, Atsushi			Inhibitory effect of maple syrup on the cell growth and invasion of human colorectal cancer cells	ONCOLOGY REPORTS			English	Article						colon cancer; cell proliferation; cell invasion; AKT; phytomedicine	1ST-LINE TREATMENT; PHYTOCHEMICALS; FLUOROURACIL; BEVACIZUMAB; OXALIPLATIN; EXPRESSION; MIGRATION; COMPOUND; EFFICACY; LIGNANS	Maple syrup is a natural sweetener consumed by individuals of all ages throughout the world. Maple syrup contains not only carbohydrates such as sucrose but also various components such as organic acids, amino acids, vitamins and phenolic compounds. Recent studies have shown that these phenolic compounds in maple syrup may possess various activities such as decreasing the blood glucose level and an anticancer effect. In this study, we examined the effect of three types of maple syrup, classified by color, on the cell proliferation, migration and invasion of colorectal cancer (CRC) cells in order to investigate whether the maple syrup is suitable as a phytomedicine for cancer treatment. CRC cells that were administered maple syrup showed significantly lower growth rates than cells that were administered sucrose. In addition, administration of maple syrup to CRC cells caused inhibition of cell invasion, while there was no effect on cell migration. Administration of maple syrup clearly inhibited AKT phosphorylation, while there was no effect on ERK phosphorylation. These data suggest that maple syrup might inhibit cell proliferation and invasion through suppression of AKT activation and be suitable as a phytomedicine for CRC treatment, with fewer adverse effects than traditional chemotherapy.	[Yamamoto, Tetsushi; Uemura, Kentaro; Moriyama, Kaho; Mitamura, Kuniko; Taga, Atsushi] Kinki Univ, Fac Pharm, Pathol & Biomol Anal Lab, Higashiosaka, Osaka 5778502, Japan	Taga, A (reprint author), Kinki Univ, Sch Pharm, Pathol & Biomol Anal Lab, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	punk@phar.kindai.ac.jp			MEXT (Ministry of Education, Culture, Sports. Science and Technology); Maple Farms Japan; Japan Society for the Promotion of Science [24591019]	This study was supported by the MEXT (Ministry of Education, Culture, Sports. Science and Technology)-supported Program for the Strategic Research Foundation at Private Universities, 2014-2018, a grant from Maple Farms Japan, and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to T. Y. (C, No. 24591019).	Desai AG, 2008, CURR DRUG METAB, V9, P581, DOI 10.2174/138920008785821657; Zhai XY, 2014, J PHARMACOL SCI, V125, P132, DOI 10.1254/jphs.13263FP; de Gramont A, 2000, J CLIN ONCOL, V18, P2938; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Li Y, 2011, ONCOGENE, V30, P2633, DOI 10.1038/onc.2010.632; Li LY, 2010, J AGR FOOD CHEM, V58, P11673, DOI 10.1021/jf1033398; Van Cutsem E, 2009, ANN ONCOL, V20, P1842, DOI 10.1093/annonc/mdp233; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Apostolidis E, 2011, J FUNCT FOODS, V3, P100, DOI 10.1016/j.jff.2011.03.003; Zhao M, 2013, CANCER LETT, V337, P210, DOI 10.1016/j.canlet.2013.05.009; Kuo CL, 2014, ONCOL REP, V32, P355, DOI 10.3892/or.2014.3209; Gonzalez-Sarrias A, 2012, PHYTOTHER RES, V26, P995, DOI 10.1002/ptr.3677; Hochster HS, 2008, J CLIN ONCOL, V26, P3523, DOI 10.1200/JCO.2007.15.4138; Mazzio EA, 2009, PHYTOTHER RES, V23, P385, DOI 10.1002/ptr.2636; Li LY, 2011, J FUNCT FOODS, V3, P125, DOI 10.1016/j.jff.2011.02.004; Chen YQ, 2014, INT IMMUNOPHARMACOL, V21, P447, DOI 10.1016/j.intimp.2014.05.026; Li LY, 2011, J AGR FOOD CHEM, V59, P7708, DOI 10.1021/jf2011613; Gonzalez-Sarrias A, 2013, FOOD CHEM, V136, P636, DOI 10.1016/j.foodchem.2012.08.023; Perkins TD, 2009, ADV FOOD NUTR RES, V56, P101, DOI 10.1016/S1043-4526(08)00604-9; Ball DW, 2007, J CHEM EDUC, V84, pU1647; DAVISON RM, 1973, PLANTA, V109, P95, DOI 10.1007/BF00385455; Kang JS, 2014, PHYTOTHER RES, V28, P98, DOI 10.1002/ptr.4971; Legault J, 2010, J MED FOOD, V13, P460, DOI 10.1089/jmf.2009.0029; Nagai N, 2013, J OLEO SCI, V62, P737, DOI 10.5650/jos.62.737; Singh T, 2013, TOXICOL APPL PHARM, V273, P418, DOI 10.1016/j.taap.2013.09.021; Stuckel JG, 1996, FOOD RES INT, V29, P373, DOI 10.1016/0963-9969(96)00000-2; Taga A, 2012, J OLEO SCI, V61, P45, DOI 10.5650/jos.61.45; Taga A, 2012, CHROMATOGRAPHIA, V75, P1009, DOI 10.1007/s10337-012-2199-3; Tsai CM, 2012, EUR J PHARM SCI, V48, P494; Xu Q, 2014, BIOMED RES INT, V2014	31	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	APR	2015	33	4					1579	1584		10.3892/or.2015.3777		6	Oncology	Oncology	CD0RK	WOS:000350781400002		
J	Fujio, K; Watanabe, M; Ueki, H; Li, SA; Kinoshita, R; Ochiai, K; Futami, J; Watanabe, T; Nasu, Y; Kumon, H				Fujio, Kei; Watanabe, Masami; Ueki, Hideo; Li, Shun-Ai; Kinoshita, Rie; Ochiai, Kazuhiko; Futami, Junichiro; Watanabe, Toyohiko; Nasu, Yasutomo; Kumon, Hiromi			A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment	ONCOLOGY REPORTS			English	Article						prostate cancer; vaccine; prostatic acid phosphatase; cytokine; fusion protein	CYTOTOXIC T-LYMPHOCYTES; DENDRITIC CELLS; GROWTH-FACTOR; TUMOR-GROWTH; IMMUNOTHERAPY; INTERLEUKIN-2; ANTIGEN; INDUCTION; DIFFERENTIATION; REIC/DKK-3	Immunotherapy is one of the attractive treatment strategies for advanced prostate cancer. The US Food and Drug Administration (FDA) previously approved the therapeutic vaccine, sipuleucel-T, which is composed of autologous antigen-presenting cells cultured with a fusion protein [prostatic acid phosphatase (PAP) and granulocyte-macrophage colony-stimulating factor (GMCSF)]. Although sipuleucel-T has been shown to prolong the median survival of patients for 4.1 months, more robust therapeutic effects may be expected by modifying the vaccination protocol. In the present study, we aimed to develop and validate a novel vaccination strategy using multiple PAP-fused cytokines for prostate cancer treatment. Using a super gene expression (SGE) system that we previously established to amplify the production of a recombinant protein, significant amounts of PAP-fused cytokines [human GMCSF, interleukin-2 (IL2), IL4, IL7 and mouse GMCSF and IL4] were obtained. We examined the activity of the fusion proteins in vitro to validate their cytokine functions. A significant upregulation of dendritic cell differentiation from monocytes was achieved by PAP-GMCSF when used with the other PAP-fused cytokines. The PAP-fused human IL2 significantly increased the proliferation of lymphocytes, as determined by flow cytometry. We also investigated the in vivo therapeutic effects of multiple PAP-fused cytokines in a mouse prostate cancer model bearing prostate-specific antigen (PSA)- and PAP-expressing tumors. The simultaneous intraperitoneal administration of PAP-GMCSF, -IL2, -IL4 and -IL7 significantly prevented tumor induction and inhibited the tumor growth in the PAP-expressing tumors, yet not in the PSA-expressing tumors. The in vivo therapeutic effects with the multiple PAP-fused cytokines were superior to the effects of PAP-GMCSF alone. We thus demonstrated the advantages of the combined use of multiple PAP-fused cytokines including PAP-GMCSF, and propose a promising prostatic antigen-vaccination strategy to enhance the therapeutic effects.	[Fujio, Kei; Watanabe, Masami; Ueki, Hideo; Li, Shun-Ai; Watanabe, Toyohiko; Nasu, Yasutomo; Kumon, Hiromi] Okayama Univ, Dept Urol, Okayama 7008558, Japan; [Watanabe, Masami; Li, Shun-Ai; Nasu, Yasutomo] Okayama Univ, Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama 7008558, Japan; [Kinoshita, Rie; Futami, Junichiro] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Biotechnol, Okayama 7008558, Japan; [Ochiai, Kazuhiko] Nippon Vet & Life Sci Univ, Dept Vet Nursing & Technol, Sch Vet Sci, Musashino, Tokyo, Japan	Watanabe, M (reprint author), Okayama Univ, Okayama Univ Hosp, Ctr Innovat Clin Med, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	mwcorrespondence@gmail.com			Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKENHI: 24390368, 25462478, 25670683, 26293352]	This study was supported by scientific research grants (KAKENHI: 24390368, 25462478, 25670683 and 26293352) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We thank Ms. Fusaka Oonari (Okayama University) for her valuable assistance. Okayama University and Momotaro-Gene Inc. are applying for patents on the SGE systems. Okayama University and Dr M. Watanabe are applying for a patent regarding the cancer antigen-fused cytokines. Dr M. Watanabe, Dr Y. Nasu and Dr H. Kumon are the inventors of the patents and own stock in Momotaro-Gene Inc. Dr Kumon is the chief science officer of the company.	Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Machlenkin A, 2005, CANCER RES, V65, P6435, DOI 10.1158/0008-5472.CAN-05-0133; Saif JMS, 2014, EUR J IMMUNOL, V44, P994, DOI 10.1002/eji.201343863; Fong L, 1997, J IMMUNOL, V159, P3113; Fong L, 2001, J IMMUNOL, V167, P7150; CHAZEN GD, 1989, P NATL ACAD SCI USA, V86, P5923, DOI 10.1073/pnas.86.15.5923; Burch PA, 2000, CLIN CANCER RES, V6, P2175; McNeel DG, 2009, J CLIN ONCOL, V27, P4047, DOI 10.1200/JCO.2008.19.9968; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Zou GM, 2002, EUR CYTOKINE NETW, V13, P186; Drake CG, 2010, NAT REV IMMUNOL, V10, P580, DOI 10.1038/nri2817; Small EJ, 2000, J CLIN ONCOL, V18, P3894; Barata JT, 2006, EXP HEMATOL, V34, P1133, DOI 10.1016/j.exphem.2006.05.001; Bykovskaja SN, 1998, J LEUKOCYTE BIOL, V63, P620; CHARLEY B, 1985, IMMUNOL LETT, V10, P121, DOI 10.1016/0165-2478(85)90064-1; Chen J, 2009, INT J MOL MED, V24, P789, DOI 10.3892/ijmm_00000293; Civallero M, 2000, HISTOL HISTOPATHOL, V15, P1077; Di Lorenzo G, 2012, BJU INT, V110, pE99, DOI 10.1111/j.1464-410X.2011.10790.x; Iwamoto H, 2014, INT J CANCER, V134, P332, DOI 10.1002/ijc.28367; KITAMURA T, 1989, BLOOD, V73, P375; Klampfer L, 1999, CYTOKINE, V11, P849, DOI 10.1006/cyto.1999.0514; Kradin RL, 1996, PATHOBIOLOGY, V64, P180, DOI 10.1159/000164033; LU X, 1992, CELL, V70, P153, DOI 10.1016/0092-8674(92)90541-J; LYNCH DH, 1991, EUR J IMMUNOL, V21, P2977, DOI 10.1002/eji.1830211212; Mackensen Andreas, 1997, Cytokine and Growth Factor Reviews, V8, P119, DOI 10.1016/S1359-6101(96)00052-4; Marcais A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00450; Matera L, 2010, CANCER TREAT REV, V36, P131, DOI 10.1016/j.ctrv.2009.11.002; Matsueda S, 2005, CLIN CANCER RES, V11, P6933, DOI 10.1158/1078-0432.CCR-05-0682; Peshwa MV, 1998, PROSTATE, V36, P129, DOI 10.1002/(SICI)1097-0045(19980701)36:2<129::AID-PROS8>3.0.CO;2-D; Roos AK, 2005, PROSTATE, V62, P217, DOI 10.1002/pros.20135; Saha A, 2003, CANC THER, V1, P299; Sakaguchi M, 2009, J BIOL CHEM, V284, P14236, DOI 10.1074/jbc.M808002200; Sakaguchi M, 2014, MOL BIOTECHNOL, V56, P621, DOI 10.1007/s12033-014-9738-0; Watanabe M, 2014, ONCOL REP, V31, P1089, DOI 10.3892/or.2013.2958; Watanabe M, 2009, INT J ONCOL, V34, P657, DOI 10.3892/ijo_00000191; Watanabe M, 2014, ONCOL LETT, V7, P595, DOI 10.3892/ol.2013.1777	36	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	APR	2015	33	4					1585	1592		10.3892/or.2015.3770		8	Oncology	Oncology	CD0RK	WOS:000350781400003		
J	Nakata, H; Miyazaki, T; Iwasaki, T; Nakamura, A; Kidani, T; Sakayama, K; Masumoto, J; Miura, H				Nakata, Hiroshi; Miyazaki, Tatsuhiko; Iwasaki, Tomoyuki; Nakamura, Atsushi; Kidani, Teruki; Sakayama, Kenshi; Masumoto, Junya; Miura, Hiromasa			Development of tumor-specific caffeine-potentiated chemotherapy using a novel drug delivery system with Span 80 nano-vesicles	ONCOLOGY REPORTS			English	Article						Span 80 vesicles; drug delivery system; osteosarcoma; LM8; caffeine-potentiated chemotherapy	ENHANCED CYTOTOXICITY; SORBITAN MONOOLEATE; PROGNOSTIC-FACTORS; BONE-MARROW; OSTEOSARCOMA; IFOSFAMIDE; CANCER; DOXORUBICIN; NEPHROTOXICITY; CHILDREN	In recent years, chemotherapy with caffeine has manifested potently high efficacy against osteosarcoma, although adverse effects have been observed. Recently, we developed a novel drug delivery system (DDS) with nonionic vesicles prepared from Span 80 which have promising physicochemical properties as an attractive possible alternative to commonly used liposomes. Herein, we demonstrated that tumor-specific caffeine-potentiated chemotherapy for murine osteosarcoma administered by a novel DDS with Span 80 nano-vesicles showed significant antitumor effects as well as limited adverse effects. The osteosarcoma cell line, LM8, was transplanted into C3H/HeJ mice which then were administered therapeutic agents. Ifosfamide (IFO) was employed as well as caffeine as an enhancer. Span 80 vesicles containing IFO and/or caffeine were freshly prepared. On days 0, 2 and 4, different combinations of the agents were administered to mice: IFO alone (direct i.v.), IFO vesicles (IV), IV + caffeine, IV + caffeine vesicles (CV), PBS alone vesicles (PV), and PBS alone as negative control (PBS i.v.). Then, the mice were sacrificed on day 7. Antitumor effects of the reagents were also analyzed in vitro. Moreover, fertility examination was performed. In vitro, a combination of IV+CV showed significant induction of apoptosis in the early phase. Tumor volumes in the IV+CV group were significantly reduced compared with the other groups. Histological analyses showed that the IV and IV+CV groups had significantly lower viable tumor areas. The IFO direct i.v. group showed a certain grade of renal injury as well as marked suppression of spermato-genesis, while the IV or IV+CV group showed no marked changes. The fertility test revealed that the male mice with IV+CV administration had normal fertility, and no malformations were detected in their progeny. This DDS model is of potential importance for clinical application in the therapy of metastatic osteosarcoma.	[Nakata, Hiroshi; Nakamura, Atsushi; Kidani, Teruki; Miura, Hiromasa] Ehime Univ, Grad Sch Med, Dept Orthopaed Surg, Toon, Ehime, Japan; [Miyazaki, Tatsuhiko] Gifu Univ Hosp, Div Pathol, Gifu, Gifu 5011194, Japan; [Iwasaki, Tomoyuki] Ehime Univ, Integrated Ctr Sci, Div Med Biosci, Toon, Ehime, Japan; [Sakayama, Kenshi] Minami Matsuyama Hosp, Div Orthopaed Surg, Matsuyama, Ehime, Japan; [Masumoto, Junya] Ehime Univ, Grad Sch Med, Dept Analyt Pathol, Toon, Ehime, Japan	Miyazaki, T (reprint author), Gifu Univ Hosp, Div Pathol, Yanagido 1-1, Gifu, Gifu 5011194, Japan.	tats_m@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23592191, 25460496]	We would like to thank Professor Keiichi Kato (Ehime University Graduate School of Science and Engineering), Dr Yosuke Omokawa (Nanocareer Inc. Ltd.), and Dr Keita Hayashi (Nara National College of Technology) for their kind technical support and useful advice. We also deeply thank Professor Peter Walde (ETH, Zurich, Switzerland) for his helpful scientific discussion and advice. This study was supported by a Grant-in-Aid of Scientific Research for Basic Research (C) (nos. 23592191 and 25460496) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Hayashi K, 2013, COLLOID SURFACE B, V106, P258, DOI 10.1016/j.colsurfb.2012.12.022; Hayashi K, 2011, COLLOID SURFACE B, V87, P28, DOI 10.1016/j.colsurfb.2011.04.029; Omokawa Y, 2010, INT J PHARMACEUT, V389, P157, DOI 10.1016/j.ijpharm.2010.01.033; Kimura H, 2009, J ORTHOP SCI, V14, P556, DOI 10.1007/s00776-009-1372-5; Elbayoumi TA, 2007, EUR J PHARM SCI, V32, P159, DOI 10.1016/j.ejps.2007.05.113; Sultana S, 2013, J DRUG TARGET, V21, P107, DOI 10.3109/1061186X.2012.712130; Asai T, 1998, INT J CANCER, V76, P418, DOI 10.1002/(SICI)1097-0215(19980504)76:3<418::AID-IJC21>3.0.CO;2-5; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Maeng JH, 2010, BIOMATERIALS, V31, P4995, DOI 10.1016/j.biomaterials.2010.02.068; Wu PK, 2009, JPN J CLIN ONCOL, V39, P514, DOI 10.1093/jjco/hyp057; Longhi A, 2003, J PEDIAT HEMATOL ONC, V25, P292, DOI 10.1097/00043426-200304000-00005; Tsuchiya H, 1998, ANTICANCER RES, V18, P657; Oberlin O, 2009, J CLIN ONCOL, V27, P5350, DOI 10.1200/JCO.2008.17.5257; Ridola V, 2009, EUR J CANCER, V45, P814, DOI 10.1016/j.ejca.2009.01.002; HOTZ MA, 1994, CYTOMETRY, V15, P237, DOI 10.1002/cyto.990150309; Kato K, 2008, LANGMUIR, V24, P10762, DOI 10.1021/la801581f; LOTZ JP, 1995, CANCER, V75, P874, DOI 10.1002/1097-0142(19950201)75:3<874::AID-CNCR2820750320>3.0.CO;2-Q; Iwamoto T, 2013, BIOL PHARM BULL, V36, P715; Brochu Heidi, 2004, Current Drug Delivery, V1, P299, DOI 10.2174/1567201043334678; Eckes J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-337; Hayashi K, 2013, INT J BIOL SCI, V9, P142, DOI 10.7150/ijbs.5453; Hayashi K, 2009, J ORTHOP SCI, V14, P253, DOI 10.1007/s00776-009-1336-9; McCune JS, 2004, PEDIATR BLOOD CANCER, V42, P427, DOI 10.1002/pbc.20011; PATTERSON WP, 1989, CANCER, V63, P649, DOI 10.1002/1097-0142(19890215)63:4<649::AID-CNCR2820630408>3.0.CO;2-Z; SKINNER R, 1993, J CLIN ONCOL, V11, P173; SKINNER R, 1991, CANCER CHEMOTH PHARM, V28, P81, DOI 10.1007/BF00689694; Thomson B, 1999, BONE MARROW TRANSPL, V24, P527, DOI 10.1038/sj.bmt.1701939; Williams D, 2008, PEDIATR BLOOD CANCER, V50, P347, DOI 10.1002/pbc.21323; Yang C, 2014, BIOMED REP, V2, P335; Yonemoto T, 2009, ANTICANCER RES, V29, P763	30	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	APR	2015	33	4					1593	1598		10.3892/or.2015.3761		6	Oncology	Oncology	CD0RK	WOS:000350781400004		
J	Yoshimine, Y; Uto, H; Kumagai, K; Mawatari, S; Arima, S; Ibusuki, R; Mera, K; Nosaki, T; Kanmura, S; Numata, M; Tamai, T; Moriuchi, A; Tsubouchi, H; Ido, A				Yoshimine, Yozo; Uto, Hirofumi; Kumagai, Kotaro; Mawatari, Seiichi; Arima, Shiho; Ibusuki, Rie; Mera, Kumiko; Nosaki, Tsuyoshi; Kanmura, Shuji; Numata, Masatsugu; Tamai, Tsutomu; Moriuchi, Akihiro; Tsubouchi, Hirohito; Ido, Akio			Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis	ONCOLOGY REPORTS			English	Article						Sptlc3; MmpI3; Grip1; Cxcl14; nonalcoholic steatohepatitis; insulin secretion	FATTY LIVER-DISEASE; INDUCED INSULIN-RESISTANCE; NOVO CERAMIDE SYNTHESIS; ALPHA-FETOPROTEIN; GROWTH; CANCER; DIET; INFLAMMATION; INHIBITION; FIBROSIS	The molecular mechanisms underlying the progression of nonalcoholic steatohepatitis (NASH) have not been fully elucidated. The aim of this study was to identify factors involved in NASH progression by analysis of pathophysiological features and gene-expression profiles in livers of STAM mice, a model of NASH-associated hepatocarcinogenesis. C57BL/6N (B6N) mice were injected with streptozotocin to generate STAM mice. Four-week-old male STAM and B6N mice were fed a high-fat diet (HFD) (STAM-F, B6N-F) or a conventional diet (STAM-C, B6N-C) until they were 10, 14, or 18 weeks old. Blood glucose and nonalcoholic fatty liver disease (NAFLD) activity scores of STAM-F were higher than those of STAM-C during all observation periods. STAM-F mice had more severe hepatic fibrosis at 14 weeks, and exhibited higher levels of a-fetoprotein-positive hepatic tumor formation with multiplication than STAM-C mice at 18 weeks. At 14 weeks, cDNA microarray analysis revealed that the hepatic expression of eight mRNAs was >= 30-fold higher in STAM-F than B6N-F mice. The expression of another four genes was increased >= 5-fold in STAM-F than B6N-F mice, and >= 5-fold in B6N-F relative to B6N-C mice. Of the 12 genes, the difference in Sptlc3 mRNA expression was most pronounced, and gradually increased over time, as determined by quantitative RT-PCR in STAM-F mice. In addition, Sptlc3 mRNA expression in STAM-F mice was higher than that in db/db mice that received HFD and in B6N mice fed a choline-deficient L-amino acid (CDAA)-defined diet. In conclusion, a high-fat diet aggravated pathophysiological findings in the liver in NASH mouse models, and the hepatic expression of Sptlc3 mRNA was potentially associated with NASH progression.	[Yoshimine, Yozo; Uto, Hirofumi; Kumagai, Kotaro; Mawatari, Seiichi; Arima, Shiho; Ibusuki, Rie; Mera, Kumiko; Nosaki, Tsuyoshi; Kanmura, Shuji; Numata, Masatsugu; Tamai, Tsutomu; Ido, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, Kagoshima 8908520, Japan; [Moriuchi, Akihiro; Tsubouchi, Hirohito; Ido, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept HGF Tissue Repair & Regenerat Med, Kagoshima 8908520, Japan; [Tsubouchi, Hirohito] Kagoshima City Hosp, Kagoshima, Japan	Uto, H (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Digest & Lifestyle Dis, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	hirouto@m2.kufm.kagoshima-u.ac.jp					Andy SY, 2002, REV GASTROENTEROL DI, V2, P11; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Shimizu M, 2013, SEMIN IMMUNOPATHOL, V35, P191, DOI 10.1007/s00281-012-0336-6; Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1; Denda A, 2002, JPN J CANCER RES, V93, P125; Renehan A, 2010, LANCET, V375, P2201, DOI 10.1016/S0140-6736(10)60706-4; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI [10.1002/hep.22734, 10.1002/hep.227.34]; Lee YS, 2012, CANCER BIOL THER, V13, P92, DOI 10.4161/cbt.13.2.18870; Niwa Y, 1996, HEPATOLOGY, V23, P1384, DOI 10.1002/hep.510230614; Greenbaum CJ, 2002, DIABETES-METAB RES, V18, P192, DOI 10.1002/dmrr.291; Menaldino DS, 2003, PHARMACOL RES, V47, P373, DOI 10.1016/S1043-6618(03)00054-9; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Morss AS, 2007, J BIOL CHEM, V282, P14635, DOI 10.1074/jbc.M608565200; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Shin E, 2011, J HEPATO-BIL-PAN SCI, V18, P544, DOI 10.1007/s00534-010-0367-0; Bulum T, 2011, DIGEST DIS SCI, V56, P3655, DOI 10.1007/s10620-011-1807-7; Cinar R, 2014, HEPATOLOGY, V59, P143, DOI 10.1002/hep.26606; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Kurek K, 2014, BIOMED RES INT, DOI 10.1155/2014/980815; Lee YS, 2011, CELL PROLIFERAT, V44, P320, DOI 10.1111/j.1365-2184.2011.00761.x; Lyn-Cook LE, 2009, J ALZHEIMERS DIS, V16, P715, DOI 10.3233/JAD-2009-0984; Promrat K, 2011, HEPATOL RES, V41, P754, DOI 10.1111/j.1872-034X.2011.00815.x; Regnell Simon E, 2011, Rev Diabet Stud, V8, P454, DOI 10.1900/RDS.2011.8.454; Rosmorduc O, 2012, CLIN RES HEPATOL GAS, V36, P202, DOI 10.1016/j.clinre.2011.12.011; Satoh K, 2005, INT J CANCER, V115, P711, DOI 10.1002/ijc.20979; Yao M, 2013, HEPATOB PANCREAT DIS, V12, P171, DOI 10.1016/S1499-3872(13)60028-4	35	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	APR	2015	33	4					1657	1666		10.3892/or.2015.3745		10	Oncology	Oncology	CD0RK	WOS:000350781400012		
J	Ishibashi, Y; Miyoshi, H; Hiraoka, K; Arakawa, F; Haraguchi, T; Nakashima, S; Hashiguchi, T; Shoda, T; Hamada, T; Okawa, T; Higuchi, F; Shiba, N; Nagata, K; Ohshima, K				Ishibashi, Yukinao; Miyoshi, Hiroaki; Hiraoka, Koji; Arakawa, Fumiko; Haraguchi, Toshiaki; Nakashima, Shinji; Hashiguchi, Toshihiro; Shoda, Takanori; Hamada, Tetsuya; Okawa, Takahiro; Higuchi, Fujio; Shiba, Naoto; Nagata, Kensei; Ohshima, Koichi			Anaplastic lymphoma kinase protein expression, genetic abnormalities, and phosphorylation in soft tissue tumors: Phosphorylation is associated with recurrent metastasis	ONCOLOGY REPORTS			English	Article						anaplastic lymphoma kinase; soft tissue tumor; gene amplification; phosphorylation; metastasis	INFLAMMATORY MYOFIBROBLASTIC TUMOR; RECEPTOR TYROSINE KINASE; NON-HODGKINS-LYMPHOMA; CELL LUNG-CANCER; ACTIVATING MUTATIONS; THERAPEUTIC TARGET; ALK KINASE; NEUROBLASTOMA; IDENTIFICATION; INHIBITOR	Gene and protein abnormalities of anaplastic lymphoma kinase (ALK) play an important role in the pathogenesis of various cancers and serve as important therapeutic targets. We investigated ALK protein expression, phosphorylation, and genetic aberrations using fluorescence in situ hybridization (FISH) in 81 soft tissue tumor samples: inflammatory myofibroblastic tumor, n=1; alveolar soft part sarcoma, n=2; leiomyosarcoma, n=10; well-differentiated liposarcoma, n=7; pleomorphic liposarcoma, n=2; extraskeletal osteosarcoma, n=1; epithelioid sarcoma, n=1; synovial sarcoma, n=4; malignant peripheral nerve sheath tumor, n=4; undifferentiated pleomorphic sarcoma, n=19; rhabdomyosarcoma, n=6; myxofibrosarcoma, n=8; myxoid liposarcoma, n=11; fibrosarcoma, n=4; and desmoid-type fibromatosis, n=1. ALK protein expression, gene signal gain (without translocation), and phosphorylation were observed in 33/81 (40.7%), 55/81 (67.9%), and 30/81 (37.0%) tumor samples, respectively. ALK protein expression was statistically associated with phosphorylation, but not with gene signal gain. ALK phosphorylation-positive cases showed a statistically worse metastasis-free survival compared with phosphorylation-negative cases (P=0.0215). Particularly, metastasis of myxoid liposarcoma was associated with ALK phosphorylation (P=0.0019), but not with ALK protein expression or gene signal gain. However, the prognosis had no association with ALK protein expression, gene signal gain, or phosphorylation. ALK protein expression and phosphorylation play an important role in tumor biology and provide potential therapeutic targets for soft tissue tumors. Future research should focus on the oncogenic role and the efficacy of potential inhibitors of ALK.	[Ishibashi, Yukinao; Miyoshi, Hiroaki; Arakawa, Fumiko; Haraguchi, Toshiaki; Nakashima, Shinji; Hashiguchi, Toshihiro; Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 8300011, Japan; [Ishibashi, Yukinao; Hiraoka, Koji; Haraguchi, Toshiaki; Shoda, Takanori; Hamada, Tetsuya; Okawa, Takahiro; Higuchi, Fujio; Shiba, Naoto; Nagata, Kensei] Kurume Univ, Sch Med, Dept Orthoped Surg, Kurume, Fukuoka 8300011, Japan	Miyoshi, H (reprint author), Kurume Univ, Sch Med, Dept Pathol, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	miyoshi_hiroaki@med.kurume-u.ac.jp					MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Cessna MH, 2002, MODERN PATHOL, V15, P931, DOI 10.1097/01.MP.000002615.04130.1F; Coffin CM, 2007, AM J SURG PATHOL, V31, P509, DOI 10.1097/01.pas.0000213393.57322.c7; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Kasprzycka M, 2006, P NATL ACAD SCI USA, V103, P9964, DOI 10.1073/pnas.0603507103; Bai RY, 2000, BLOOD, V96, P4319; Pulford K, 1997, BLOOD, V89, P1394; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; van Gaal JC, 2012, J CLIN ONCOL, V30, P308, DOI 10.1200/JCO.2011.37.8588; Salido M, 2011, J THORAC ONCOL, V6, P21, DOI 10.1097/JTO.0b013e3181fb7cd6; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; De Brouwer BS, 2010, CLIN CANCER RES, V16, P4353; Duijkers FAM, 2011, CELL ONCOL, V34, P409, DOI 10.1007/s13402-011-0048-2; Fletcher CDM, 2013, WHO CLASSIFICATION T, P333; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Li XQ, 2004, HUM PATHOL, V35, P711, DOI 10.1016/j.humpath.2003.12.004; Wang YW, 2011, NEOPLASIA, V13, P704, DOI 10.1593/neo.11222; Yoshida A, 2013, MODERN PATHOL, V26, P772, DOI 10.1038/modpathol.2012.222; Zhang X, 2010, MOL CANCER, V13, P188	27	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	APR	2015	33	4					1667	1674		10.3892/or.2015.3806		8	Oncology	Oncology	CD0RK	WOS:000350781400013		
J	Inoue, T; Yorifuji, N; Iguchi, M; Fujiwara, K; Kakimoto, K; Nouda, S; Okada, T; Kawakami, K; Abe, Y; Takeuchi, T; Higuchi, K				Inoue, Takuya; Yorifuji, Naoki; Iguchi, Munetaka; Fujiwara, Kaori; Kakimoto, Kazuki; Nouda, Sadaharu; Okada, Toshihiko; Kawakami, Ken; Abe, Yosuke; Takeuchi, Toshihisa; Higuchi, Kazuhide			Geranylgeranylacetone suppresses colitis-related mouse colon carcinogenesis	ONCOLOGY REPORTS			English	Article						geranylgeranylacetone; dextran sulfate sodium; cancer; HSP70	INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; COLORECTAL-CANCER; KAPPA-B; EXPRESSION; HEAT-SHOCK-PROTEIN-70; CHEMOPREVENTION; PROTECTS; LESIONS; MICE	Geranylgeranylacetone (GGA), an isoprenoid compound, is an anti-ulcer drug developed in Japan. GGA protects a variety of cells and tissues against numerous stresses via induction of heat shock protein (HSP) 70, and it has recently been reported to protect mice from experimental ulcerative colitis (UC). However, it is unknown whether GGA exhibits a preventive effect on UC-associated neoplasia. In the present study, we evaluated the preventive effects of GGA on colitis-related carcinogenesis in the mouse colon. Mice were administered 1,2-dimethylhydrazine (DMH) subcutaneously three times within a week, followed by 2 cycles of dextran sulfate sodium (DSS) (each cycle, 3% DSS for 7 days and then distilled water for 14 days) and they were sacrificed 28 days after the completion of the 2 cycles. The mice were divided into the following groups according to the diet received during the experiment: group A, which received a standard diet and served as a disease control; group B, which received a diet mixed with 0.25% GGA; group C, which received a diet mixed with 0.5% GGA; group D, which received a diet mixed with 1.0% GGA; group E, which received a diet mixed with 2.0% GGA; and group F, which received a diet containing no agents, including DSS and served as a normal control. The incidence of neoplasia was assessed. The expression of inducible nitric oxide synthase (iNOS) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) was also determined. In addition, the expression of HSP70 in the colon tissues was determined by immunohistochemistry and western blot analysis. The mean number of tumors was 16.6, 11.0, 9.4, 5.8, 5.4 and 0 in groups A-F, respectively. GGA significantly suppressed the occurrence of neoplasia in a dose-dependent manner. GGA treatment enhanced the expression of HSP70 and suppressed the oxidative damage in the background mucosa (i.e. lesion-free colon). These results suggest that GGA could be useful in the prevention of UC-associated neoplasia.	[Inoue, Takuya; Yorifuji, Naoki; Iguchi, Munetaka; Fujiwara, Kaori; Kakimoto, Kazuki; Nouda, Sadaharu; Okada, Toshihiko; Kawakami, Ken; Abe, Yosuke; Takeuchi, Toshihisa; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Takatsuki, Osaka 5698686, Japan	Inoue, T (reprint author), Osaka Med Coll, Dept Internal Med 2, 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	ureuretakuwan@yahoo.co.jp					Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; Asano T, 2009, J PHARMACOL EXP THER, V330, P458, DOI 10.1124/jpet.109.152181; RIDDELL RH, 1983, HUM PATHOL, V14, P931, DOI 10.1016/S0046-8177(83)80175-0; Tao Y, 2009, CARCINOGENESIS, V30, P175, DOI 10.1093/carcin/bgn256; Lyakhovich A, 2010, ALIMENT PHARM THER, V31, P202, DOI 10.1111/j.1365-2036.2009.04195.x; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Wedemeyer J, 2005, LAB INVEST, V85, P388, DOI 10.1038/labinvest.3700232; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Inoue T, 2010, ONCOL REP, V24, P1487, DOI 10.3892/or_00001009; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Watanabe T, 2011, INFLAMM BOWEL DIS, V17, P802, DOI [10.1002/ibd.21365, 10.1002/ibd21365]; Chan JYH, 2004, CIRCULATION, V110, P3560, DOI 10.1161/01.CIR.0000143082.63063.33; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Forrest K, 2004, ALIMENT PHARM THERAP, V20, P1035, DOI 10.1111/j.1365-2036.2004.02270.x; Hauser GJ, 1996, AM J PHYSIOL-HEART C, V271, pH2529; Herfarth H, 2012, DIGEST DIS, V30, P55, DOI 10.1159/000341894; Hoshino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076306; Inoue T, 2007, J GASTROEN HEPATOL, V22, P1474, DOI 10.1111/j.1440-1746.2007.04866.x; Lopez A, 2013, DIGEST DIS, V31, P248, DOI 10.1159/000353806; Mizushima T., 2014, CURR OPIN PHARMACOL, V19, P1, DOI DOI 10.2174/138161210790945986; Namba T, PLOS ONE, V6; Nishida T, 2007, DIGEST DIS SCI, V52, P1890, DOI 10.1007/s10620-006-9661-8; Ohkawara T, 2005, SCAND J GASTROENTERO, V40, P1049, DOI 10.1080/00365520510023161; Ohkawara T, 2006, INT J MOL MED, V17, P229; Tardieu D, 2000, CARCINOGENESIS, V21, P973, DOI 10.1093/carcin/21.5.973; Umegaki E, 2014, INTERNAL MED, V53, P283, DOI 10.2169/internalmedicine.53.1572; Yanaka A, 2007, DIGESTION, V75, P148, DOI 10.1159/000106756	27	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	APR	2015	33	4					1769	1774		10.3892/or.2015.3794		6	Oncology	Oncology	CD0RK	WOS:000350781400026		
J	Tsukamoto, S; Shimada, K; Honoki, K; Kido, A; Akahane, M; Tanaka, Y; Konishi, N				Tsukamoto, Shinji; Shimada, Keiji; Honoki, Kanya; Kido, Akira; Akahane, Manabu; Tanaka, Yasuhito; Konishi, Noboru			Ubiquilin 2 enhances osteosarcoma progression through resistance to hypoxic stress	ONCOLOGY REPORTS			English	Article						ubiquilin 2; osteosarcoma; hypoxia; HIF-1 alpha; apoptosis	CHILDRENS ONCOLOGY GROUP; REFRACTORY SOLID TUMORS; GROWTH-FACTOR RECEPTOR; PHASE-I; PROTEIN; CANCER; ASSOCIATION; METASTASIS; EXPRESSION; APOPTOSIS	Ubiquilin 2 (UBQLN2), a member of the ubiquitin-like protein family (ubiquilins), maintains protein homeostasis. Although UBQLN2 has been implicated in the pathogenesis of neurodegenerative diseases, it is also associated with malignant tumors. Therefore, we examined whether UBQLN2 plays a role in human osteosarcoma. The human osteosarcoma cell line MG63 was transfected with UBQLN2 siRNA and cultured under hypoxic conditions. The rat osteosarcoma cell line COS1NR was inoculated into Fischer 344 rats, followed by injection of UBQLN2 siRNA with atelocollagen. An immunohistochemical analysis of UBQLN2 was performed using 34 cases of human high-grade osteosarcomas, and metastasis-free survival was estimated by the Kaplan-Meier method. Silencing of UBQLN2 by siRNA transfection under hypoxia led to activation of JNK and p38, resulting in induction of apoptosis in the osteosarcoma cell line MG63. Injection of UBQLN2 siRNA suppressed tumor growth in the rat osteosarcoma model, followed by apoptosis induction. The immunohistochemical examination revealed that high UBQLN2 expression was significantly associated with the unfavorable metastasis-free survival of osteosarcoma patients. UBQLN2 plays an important role in resistance to hypoxic stress and enhances tumor progression in osteosarcoma. UBQLN2 may be a new molecular target for chemotherapeutics and a useful clinicopathological marker in human osteosarcoma.	[Tsukamoto, Shinji; Honoki, Kanya; Kido, Akira; Tanaka, Yasuhito] Nara Med Univ, Dept Orthopaed Surg, Kashihara, Nara 6348521, Japan; [Tsukamoto, Shinji; Shimada, Keiji; Konishi, Noboru] Nara Med Univ, Dept Pathol, Kashihara, Nara 6348521, Japan; [Akahane, Manabu] Nara Med Univ, Dept Publ Hlth Hlth Management & Policy, Kashihara, Nara 6348521, Japan	Tsukamoto, S (reprint author), Nara Med Univ, Dept Orthopaed Surg, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	shinji104@mail.goo.ne.jp					Beverly LJ, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1119167109; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; BJORNSSON J, 1993, VIRCHOWS ARCH A, V423, P195, DOI 10.1007/BF01614770; Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005; Zhou QA, 2011, SURG ONCOL, V20, P13, DOI 10.1016/j.suronc.2009.09.002; Mizobuchi H, 2008, CLIN ORTHOP RELAT R, V466, P2052, DOI 10.1007/s11999-008-0328-y; Weigel B, 2014, PEDIATR BLOOD CANCER, V61, P452, DOI 10.1002/pbc.24605; Ebb D, 2012, J CLIN ONCOL, V30, P2545, DOI 10.1200/JCO.2011.37.4546; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Kubo T, 2008, CANCER, V112, P2119, DOI 10.1002/cncr.23437; Hockel M, 1996, CANCER RES, V56, P4509; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Lim PJ, 2009, J CELL BIOL, V187, P201, DOI 10.1083/jcb.200903024; Moroney J, 2012, CLIN CANCER RES, V18, P5796, DOI 10.1158/1078-0432.CCR-12-1158; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Bagatell R, 2007, CLIN CANCER RES, V13, P1783, DOI 10.1158/1078-0432.CCR-06-1892; Edge SB, 2010, AJCC CANC STAGING MA; Fletcher CDM, 2013, WHO CLASSIFICATION T, P275; HONOKI K, 1993, CANCER RES, V53, P5038; Honoki K, 1998, CANCER LETT, V127, P221, DOI 10.1016/S0304-3835(98)00048-2; Kunz Manfred, 2003, Mol Cancer, V2, P23, DOI 10.1186/1476-4598-2-23; Shimada K, 2006, HISTOL HISTOPATHOL, V21, P415; Skene JHP, 2001, NAT GENET, V28, P107, DOI 10.1038/88805	31	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	APR	2015	33	4					1799	1806		10.3892/or.2015.3788		8	Oncology	Oncology	CD0RK	WOS:000350781400030		
J	Imamura, Y; Mukohara, T; Shimono, Y; Funakoshi, Y; Chayahara, N; Toyoda, M; Kiyota, N; Takao, S; Kono, S; Nakatsura, T; Minami, H				Imamura, Yoshinori; Mukohara, Toru; Shimono, Yohei; Funakoshi, Yohei; Chayahara, Naoko; Toyoda, Masanori; Kiyota, Naomi; Takao, Shintaro; Kono, Seishi; Nakatsura, Tetsuya; Minami, Hironobu			Comparison of 2D-and 3D-culture models as drug-testing platforms in breast cancer	ONCOLOGY REPORTS			English	Article						breast cancer; 3D-culture; anti-apoptosis	CELL-CULTURE; HYPOXIA; 3D; EXPRESSION; RESISTANCE; DISCOVERY; CARCINOMA; PATHWAYS; ASSAYS; TUMORS	It is becoming recognized that screening of oncology drugs on a platform using two-dimensionally (2D)-cultured cell lines is unable to precisely select clinically active drugs; therefore three-dimensional (3D)-culture systems are emerging and show potential for better simulating the in vivo tumor microenvironment. The purpose of this study was to reveal the differential effects of chemotherapeutic drugs between 2D- and 3D-cultures and to explore their underlying mechanisms. We evaluated differences between 2D- and 3D-cultured breast cancer cell lines by assessing drug sensitivity, oxygen status and expression of Ki-67 and caspases. Three cell lines (BT-549, BT-474 and T-47D) developed dense multicellular spheroids (MCSs) in 3D-culture, and showed greater resistance to paclitaxel and doxorubicin compared to the 2D-cultured cells. An additional three cell lines (MCF-7, HCC-1954, and MDA-MB-231) developed only loose MCSs in 3D, and showed drug sensitivities similar to those found in the 2D-culture. Treatment with paclitaxel resulted in greater increases in cleaved-PARP expression in the 2D-culture compared with the 3D-culture, but only in cell lines forming dense 3D-MCSs, suggesting that MCS formation protected the cells from paclitaxel-induced apoptosis. Hypoxia was observed only in the dense 3D-MCSs. BT-549 had fewer cells positive for Ki-67 in 3D-than in 2D-culture, suggesting that the greater GO-dormant subpopulation was responsible for its drug resistance in the 3D-culture. BT-474 had a lower level of caspase-3 in the 3D-than in the 2D-culture, suggesting that the 3D-environment was anti-apoptotic. Finally, we compared staining for Ki-67 and caspases in the 2D- and 3D-primary-cultured cells originating from a patient-derived xenograft (PDX), fresh PDX tumor, and the patient's original tumor; 2D-cultured cells showed greater proportions of Ki-67-positive and caspase-3-positive cells, in agreement with the view that 3D-primary culture better represents characteristics of tumors in vivo. In conclusion, 3D-cultured cells forming dense MCSs may be better than 2D-cultured cells in simulating important tumor characteristics in vivo, namely hypoxia, dormancy, anti-apoptotic features and their resulting drug resistance.	[Imamura, Yoshinori; Mukohara, Toru; Shimono, Yohei; Funakoshi, Yohei; Chayahara, Naoko; Toyoda, Masanori; Kiyota, Naomi; Minami, Hironobu] Kobe Univ, Grad Sch Med, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo 657, Japan; [Shimono, Yohei] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 657, Japan; [Takao, Shintaro; Kono, Seishi] Kobe Univ, Grad Sch Med, Div Breast & Endocrine Surg, Dept Surg, Kobe, Hyogo 657, Japan; [Mukohara, Toru; Minami, Hironobu] Kobe Univ Hosp, Ctr Canc, Kobe, Hyogo 6500017, Japan; [Nakatsura, Tetsuya] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Canc Immunotherapy, Kashiwa, Chiba, Japan	Mukohara, T (reprint author), Kobe Univ Hosp, Ctr Canc, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	mukohara@med.kobe-u.ac.jp			Global Centers of Excellence Program; Takeda Science Foundation	We thank Ms. Megumi Izumi and staffs of Kobe University Hospital Advanced Tissue Staining Center (KATS) for their excellent technical support. This study was supported by the Global Centers of Excellence Program (H.M), Grant-in-Aid for Scientific Research (C) (T.M.), and by a Research Grant from the Takeda Science Foundation (T.M).	Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Li J, 2006, BIOCHEM BIOPH RES CO, V342, P1341, DOI 10.1016/j.bbrc.2006.02.094; Lovitt Carrie J, 2014, Biology (Basel), V3, P345, DOI 10.3390/biology3020345; Weigelt B, 2014, ADV DRUG DELIVER REV, V69, P42, DOI 10.1016/j.addr.2014.01.001; Gamelin E, 2008, J CLIN ONCOL, V26, P2099, DOI 10.1200/JCO.2007.13.3934; Lee JM, 2013, LAB INVEST, V93, P528, DOI 10.1038/labinvest.2013.41; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Fong ELS, 2014, MOL PHARMACEUT, V11, P2040, DOI 10.1021/mp500085p; [Anonymous], 2013, NAT BIOTECHNOL, V31, P85; Karlsson H, 2012, EXP CELL RES, V318, P1577, DOI 10.1016/j.yexcr.2012.03.026; Rimann M, 2012, CURR OPIN BIOTECH, V23, P803, DOI 10.1016/j.copbio.2012.01.011; Cottu P, 2012, BREAST CANCER RES TR, V133, P595, DOI 10.1007/s10549-011-1815-5; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Doublier S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-4; Flamant L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-191; Housman Genevieve, 2014, Cancers (Basel), V6, P1769, DOI 10.3390/cancers6031769; Nobutani K, 2014, GENES CELLS, V19, P141, DOI 10.1111/gtc.12122; Sullivan R, 2009, MOL CANCER THER, V8, P1702, DOI 10.1158/1535-7163.MCT-08-1090; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29	25	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	APR	2015	33	4					1837	1843		10.3892/or.2015.3767		7	Oncology	Oncology	CD0RK	WOS:000350781400035		
J	Maeda, Y; Kawano, Y; Wada, Y; Yatsuda, J; Motoshima, T; Murakami, Y; Kikuchi, K; Imamura, T; Eto, M				Maeda, Yoshihiro; Kawano, Yoshiaki; Wada, Yoshihiro; Yatsuda, Junji; Motoshima, Takanobu; Murakami, Yoji; Kikuchi, Ken; Imamura, Takahisa; Eto, Masatoshi			C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways	ONCOLOGY REPORTS			English	Article						renal cell carcinoma; C5a receptor; signal transduction; neoplasm invasiveness	MONOCYTE-LIKE CELLS; CHEMOTACTIC MIGRATION; SIGNALING PATHWAYS; CANCER METASTASIS; ANAPHYLATOXIN C5A; PROSTATE-CANCER; RECEPTOR; ACTIN; PHOSPHORYLATION; MACROPHAGES	The anaphylatoxin C5a is a chemoattractant for leukocyte migration via the C5a receptor (C5aR). We recently reported that C5aR was aberrantly expressed in a wide variety of human related cancers, while it also promotes cancer cell invasion by C5a stimulation. However, the biological significance of C5aR expression in renal cell carcinoma (RCC) has not yet been clarified. In the present study, we aimed to elucidate the biological role of C5aR in RCC progression. Clinical RCC specimens were analyzed for C5aR expression and its relationship with baseline demographic data and clinicopathological parameters was analyzed. Moreover, renal carcinoma Renca cells stably expressing C5aR were generated and used to assess the effects of C5a-C5aR axis activation on various cellular phenomena in culture. Immunohistochemistry revealed that 96.7% of the metastatic RCCs (mRCCs) showed C5aR expression, whereas only 50.5% of the non-metastatic RCCs expressed C5aR (P<0.001). Although C5a stimulation did not significantly alter anoikis of C5aR-expressing Renca cells, C5a elicited cell morphological change and scattering of those cells accompanied with dynamic actin rearrangement, which was not observed in the Renca cells harboring the empty vector only. Moreover, C5a triggered ERK and PI3K-dependent invasion of the C5aR-expressing renal carcinoma cells. These results are consistent with the idea that the C5a-C5aR axis plays a crucial role in renal carcinoma cell invasion, which may be one of the key steps for RCC metastasis. The present study provides proof-of-concept that the C5a-C5aR axis may be a useful therapeutic target for preventing RCC progression.	[Maeda, Yoshihiro; Kawano, Yoshiaki; Wada, Yoshihiro; Yatsuda, Junji; Motoshima, Takanobu; Murakami, Yoji; Eto, Masatoshi] Kumamoto Univ, Fac Life Sci, Dept Urol, Kumamoto, Kumamoto 8608556, Japan; [Kikuchi, Ken] Kumamoto Univ Hosp, Med Qual Management Ctr, Kumamoto 8600811, Japan; [Imamura, Takahisa] Kumamoto Univ, Fac Life Sci, Dept Mol Pathol, Kumamoto, Kumamoto 8608556, Japan	Kawano, Y (reprint author), Kumamoto Univ, Fac Life Sci, Dept Urol, 1-1-1 Honjo, Kumamoto, Kumamoto 8608556, Japan.	ykawano@kumamoto-u.ac.jp					Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Angelotti ML, 2012, STEM CELLS, V30, P1714, DOI 10.1002/stem.1130; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Kwan WH, 2013, J EXP MED, V210, P257, DOI 10.1084/jem.20121525; Bosmann M, 2011, FASEB J, V25, P4222, DOI 10.1096/fj.11-191205; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Tsai HR, 2004, EUR J PHARMACOL, V498, P45, DOI 10.1016/j.ejphar.2004.07.077; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Li K, 2012, IMMUNOBIOLOGY, V217, P65, DOI 10.1016/j.imbio.2011.07.033; Zisman A, 2002, J CLIN ONCOL, V20, P4559, DOI 10.1200/JCO.2002.05.111; Nitta H, 2013, CLIN CANCER RES, V19, P2004, DOI 10.1158/1078-0432.CCR-12-1204; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Figlin RA, 2013, INT J CANCER, V133, P788, DOI 10.1002/ijc.28023; Kawano Y, 2009, BRIT J CANCER, V100, P1165, DOI 10.1038/sj.bjc.6604976; Horiguchi A, 2003, J UROLOGY, V169, P710, DOI 10.1097/01.ju.0000038952.59355.b2; Chiou WF, 2004, INT IMMUNOPHARMACOL, V4, P1329, DOI 10.1016/j.intimp.2004.05.017; BANKS P, 1988, BIOCHEM J, V252, P765; Campbell L, 2009, CANCER, V115, P3457, DOI 10.1002/cncr.24389; Cao Q, 2012, AM J PHYSIOL-CELL PH, V302, pC1731, DOI 10.1152/ajpcell.00213.2011; Don MJ, 2007, BRIT J PHARMACOL, V151, P638, DOI 10.1038/sj.bjp.0707271; Eto M, 2008, CLIN CANCER RES, V14, P2833, DOI 10.1158/1078-0432.CCR-07-1742; MONK PN, 1991, J MOL ENDOCRINOL, V6, P241; Posern G, 2000, J CELL PHYSIOL, V183, P416, DOI 10.1002/(SICI)1097-4652(200006)183:3<416::AID-JCP15>3.0.CO;2-R; Shvarts O, 2006, UROLOGY, V68, P1132, DOI 10.1016/j.urology.2006.08.1073; Wada Y, 2012, INT J UROL, V19, P284, DOI 10.1111/j.1442-2042.2012.02962.x	28	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	APR	2015	33	4					1844	1850		10.3892/or.2015.3800		7	Oncology	Oncology	CD0RK	WOS:000350781400036		
J	Hirata, T; Zheng, QF; Chen, Z; Kinoshita, H; Okamoto, J; Kratz, J; Li, H; Lui, N; Do, H; Cheng, T; Tseng, HHK; Koizumi, K; Shimizu, K; Zhou, HM; Jablons, D; He, B				Hirata, Tomomi; Zheng, Qingfeng; Chen, Zhao; Kinoshita, Hiroyasu; Okamoto, Junichi; Kratz, Johannes; Li, Hui; Lui, Natalie; Hanh Do; Cheng, Tiffany; Tseng, Hsin-Hui Katty; Koizumi, Kiyoshi; Shimizu, Kazuo; Zhou, Hai-Meng; Jablons, David; He, Biao			Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma	ONCOLOGY REPORTS			English	Article						mesothelioma; marker; chemotherapy	LUNG-CANCER; EXTRAPLEURAL PNEUMONECTOMY; GENE-EXPRESSION; SURVIVAL; NEOADJUVANT; RB; VALIDATION; CISPLATIN; CELLS; LIMB	Malignant pleural mesothelioma (MPM) is a highly aggressive tumor that has a poor prognosis, limited treatment options, and a worldwide incidence that is expected to increase in the next decade. We evaluated Wnt7A expression in 50 surgically resected tumor specimens using quantitative PCR. The expression values, were assessed by clinicopathological factors and K-M and Cox's regression with OS. The mean level of Wnt7A expression had a significant correlation with International Mesothelioma Interest Group (IMIG) stage (P<0.034), gender, smoking history and ethnicity, respectively (P=0.020, P=0.014, P=0.039). In the univariate analysis, low Wnt7A expression was a significant negative factor for overall survival (P=0.043, HR=2.30). However, multivariate Cox's regression revealed no significant factors for overall survival (low Wnt7A: P=0.051, HR=2.283; non-epithelioid subtype: P=0.050, HR=2.898). In patients with epithelioid tumors, those with low Wnt7A expression had significantly worse prognosis (P=0.019, HR=2.98). In patients with epithelioid tumors, females had significantly better prognosis than males (P=0.035). In patients who did not have neoadjuvant chemotherapy, prognosis was significantly more favorable for patients with high Wnt7A expression than for those with low Wnt7A expression (P=0.031). Among the patients with low Wnt7A-expressing tumors, those who received neoadjuvant chemotherapy had better prognosis than those who did not (P=0.024). The results of our study suggest that Wnt7A expression is a putative prognostic factor and a predictor of chemosensitivity.	[Hirata, Tomomi; Zheng, Qingfeng; Chen, Zhao; Kinoshita, Hiroyasu; Okamoto, Junichi; Kratz, Johannes; Li, Hui; Lui, Natalie; Hanh Do; Cheng, Tiffany; Tseng, Hsin-Hui Katty; Jablons, David; He, Biao] Univ Calif San Francisco, Thorac Oncol Program, Dept Surg, San Francisco, CA 94115 USA; [Hirata, Tomomi; Kinoshita, Hiroyasu; Okamoto, Junichi; Koizumi, Kiyoshi; Shimizu, Kazuo] Nippon Med Sch, Div Thorac Surg, Dept Surg, Tokyo 1138602, Japan; [Zheng, Qingfeng] Peking Univ Canc Hosp & Inst, Thorac Surg 2, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100142, Peoples R China; [Chen, Zhao; Zhou, Hai-Meng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Jablons, David; He, Biao] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	He, B (reprint author), Univ Calif San Francisco, Thorac Oncol Program, Dept Surg, Helen Diller Family Comprehens Canc Ctr, 2340 Sutter St, San Francisco, CA 94115 USA.	biao.he@ucsfmedctr.org			NIH/NCI [R01CA125030]; Eileen D. Ludwig Endowed Fund for Thoracic Oncology Research; Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley and Oberman Foundation; Jeffrey and Karen Peterson Family Foundation; Paul and Michelle Zygielbaum Research Fund	The present study was supported by NIH/NCI R01CA125030, and the Eileen D. Ludwig Endowed Fund for Thoracic Oncology Research (to B.H); the Kazan, McClain, Abrams, Fernandez, Lyons, Greenwood, Harley and Oberman Foundation; the Jeffrey and Karen Peterson Family Foundation; and Paul and Michelle Zygielbaum Research Fund (to D.J).	Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Andujar P, 2010, LUNG CANCER, V67, P23, DOI 10.1016/j.lungcan.2009.03.018; Flores RM, 2007, J THORAC ONCOL, V2, P957, DOI 10.1097/JTO.0b013e31815608d9; Lopez-Rios F, 2006, CANCER RES, V66, P2970, DOI 10.1158/0008-5472/CAN-05-3907; Kumar-Singh S, 1998, J PATHOL, V186, P300, DOI 10.1002/(SICI)1096-9896(1998110)186:3<300::AID-PATH180>3.0.CO;2-Q; Metintas M, 2001, RESP MED, V95, P829, DOI 10.1053/rmed.2001.1178; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; Yang CT, 2000, J NATL CANCER I, V92, P636, DOI 10.1093/jnci/92.8.636; Tsao AS, 2009, CLIN LUNG CANCER, V10, P36, DOI 10.3816/CLC.2009.n.005; Krug LM, 2009, J CLIN ONCOL, V27, P3007, DOI 10.1200/JCO.2008.20.3943; Parr BA, 1998, NATURE, V395, P707, DOI 10.1038/27221; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Kirikoshi H, 2002, INT J ONCOL, V21, P895; Raz DJ, 2008, CLIN CANCER RES, V14, P5565, DOI 10.1158/1078-0432.CCR-08-0544; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Weder W, 2004, J CLIN ONCOL, V22, P3451, DOI 10.1200/JCO.2004.10.071; Pinton G, 2009, CANCER RES, V69, P4598, DOI 10.1158/0008-5472.CAN-08-4523; Edwards JG, 2006, LUNG CANCER, V54, P399, DOI 10.1016/j.lungcan.2006.08.012; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; Borasio P, 2008, EUR J CARDIO-THORAC, V33, P307, DOI 10.1016/j.ejcts.2007.09.044; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fennell DA, 2005, J CLIN ONCOL, V23, P184, DOI 10.1200/JCO.2005.07.050; Herndon JE, 1998, CHEST, V113, P723, DOI 10.1378/chest.113.3.723; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Baas P, 2003, CURR OPIN ONCOL, V15, P127, DOI 10.1097/00001622-200303000-00002; BECKLAKE MR, 1982, SCAND J WORK ENV HEA, V8, P105; Boersma C J, 1999, Mol Cell Biol Res Commun, V1, P117, DOI 10.1006/mcbr.1999.0115; Bui TD, 1997, GENE, V189, P25, DOI 10.1016/S0378-1119(96)00808-6; COTE RJ, 1991, CANCER RES, V51, P5410; Edwards JG, 2002, CLIN CANCER RES, V8, P1857; Flores EM, 2005, LUNG CANCER, V49, pS71; Gordon GJ, 2005, CLIN CANCER RES, V11, P4406, DOI 10.1158/1078-0432.CCR-04-2181; Li SF, 2001, J CLIN ENDOCR METAB, V86, P454, DOI 10.1210/jc.86.1.454; Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090; Miller C, 1998, NAT GENET, V20, P228; Modi S, 2000, ONCOGENE, V19, P4632, DOI 10.1038/sj.onc.1203815; Musk AW, 2004, LUNG CANCER-J IASLC, V45, pS21, DOI 10.1016/j.lungcan.2004.04.010; Neumann V, 2004, INT ARCH OCC ENV HEA, V77, P191, DOI 10.1007/s00420-003-0498-6; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; SHIMIZU E, 1994, ONCOGENE, V9, P2441; Timmreck L S, 2003, J Pediatr Adolesc Gynecol, V16, P217, DOI 10.1016/S1083-3188(03)00124-4; Wong L, 2002, LUNG CANCER-J IASLC, V38, P131, DOI 10.1016/S0169-5002(02)00178-2	42	2	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	APR	2015	33	4					2052	2060		10.3892/or.2015.3771		9	Oncology	Oncology	CD0RK	WOS:000350781400062		
J	Lou, CH; Yokoyama, S; Saiki, I; Hayakawa, Y				Lou, Chenghua; Yokoyama, Satoru; Saiki, Ikuo; Hayakawa, Yoshihiro			Selective anticancer activity of hirsutine against HER2-positive breast cancer cells by inducing DNA damage	ONCOLOGY REPORTS			English	Article						breast cancer; HER2; apoptosis; DNA damage	NF-KAPPA-B; HUMAN TUMOR-CELLS; CHEMOTHERAPEUTIC-AGENTS; SIGNALING PATHWAY; NATURAL-PRODUCTS; DRUG DISCOVERY; IKK-ALPHA; APOPTOSIS; ACTIVATION; REPAIR	Hirsutine is one of the major alkaloids isolated from plants of the Uncaria genus and is known for its cardio-protective, anti-hypertensive and anti-arrhythmic activities. We recently reported that hirsutine is an anti-metastatic phytochemical by targeting NF-kappa B activation in a murine breast cancer model. In the present study, we further examined the clinical utility of hirsutine against human breast cancer. Among six distinct human breast cancer cell lines, hirsutine showed strong cytotoxicity against HER2-positive/p53-mutated MDA-MB-453 and BT474 cell lines. Conversely, HER2-negative/p53 wild-type MCF-7 and ZR-75-1 cell lines showed resistance against hirsutine-induced cytotoxicity. Hirsutine induced apoptotic cell death in the MDA-MB-453 cells, but not in the MCF-7 cells, through activation of caspases. Furthermore, hirsutine induced the DNA damage response in the MDA-MB-453 cells, but not in the MCF-7 cells, as highlighted by the upregulation of gamma H2AX expression. Along with the induction of the DNA damage response, the suppression of HER2, NF-kappa B and Akt pathways and the activation of the p38 MAPK pathway in the MDA-MB-453 cells were observed. Considering that there was no difference between MDA-MB-453 and MCF-7 cells in regards to irinotecan-induced DNA damage response, our present results indicate the selective anticancer activity of hirsutine in HER2-positive breast cancer by inducing a DNA damage response.	[Lou, Chenghua; Yokoyama, Satoru; Saiki, Ikuo; Hayakawa, Yoshihiro] Toyama Univ, Div Pathogen Biochem, Dept Biosci, Inst Nat Med, Toyama, Toyama 9300194, Japan	Hayakawa, Y (reprint author), Toyama Univ, Div Pathogen Biochem, Dept Biosci, Inst Nat Med, Sugitani 2630, Toyama, Toyama 9300194, Japan.	haya@inm.u-toyama.ac.jp			Institute of Natural Medicine, University of Toyama; Campus Asian Program of the University of Toyama	This research was supported by a Grant-in-Aid for the 2012 and 2013 Cooperative Research Project I from the Institute of Natural Medicine, University of Toyama. C.L. is a graduate student supported by the Campus Asian Program of the University of Toyama.	Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; HORIE S, 1992, LIFE SCI, V50, P491, DOI 10.1016/0024-3205(92)90388-6; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Ivashkevich AN, 2011, MUTAT RES-FUND MOL M, V711, P49, DOI 10.1016/j.mrfmmm.2010.12.015; Anders C, 2014, BREAST CANCER RES TR, V146, P557, DOI 10.1007/s10549-014-3039-y; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Toulany M, 2010, RADIOTHER ONCOL, V94, P110, DOI 10.1016/j.radonc.2009.11.006; Kaltschmidt B, 2000, EUR J BIOCHEM, V267, P3828, DOI 10.1046/j.1432-1327.2000.01421.x; Hermanto U, 2001, ONCOGENE, V20, P7551, DOI 10.1038/sj.onc.1204964; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; CHEN AY, 1994, ANNU REV PHARMACOL, V34, P191; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Huang CY, 2009, BIOCHEM PHARMACOL, V77, P794, DOI 10.1016/j.bcp.2008.11.014; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Madson JG, 2009, AM J PATHOL, V174, P2357, DOI 10.2353/ajpath.2009.080638; Zhang WZ, 2013, CANCER CELL, V23, P647, DOI 10.1016/j.ccr.2013.03.012; Wu LX, 2011, EUR J PHARMACOL, V650, P290, DOI 10.1016/j.ejphar.2010.09.057; Cragg GM, 1997, J NAT PROD, V60, P52, DOI 10.1021/np9604893; Valdiglesias V, 2013, MUTAT RES-REV MUTAT, V753, P24, DOI 10.1016/j.mrrev.2013.02.001; Lu CG, 2008, FEBS LETT, V582, P2703, DOI 10.1016/j.febslet.2008.06.051; Lou CH, 2014, INT J ONCOL, V45, P2085, DOI 10.3892/ijo.2014.2624; Toulany M, 2008, MOL CANCER THER, V7, P1772, DOI 10.1158/1535-7163.MCT-07-2200; Henry MK, 2001, BLOOD, V98, P834, DOI 10.1182/blood.V98.3.834; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Zhu H, 2007, MOL CANCER THER, V6, P484, DOI 10.1158/1535-7163.MCT-06-0584; Ljungman M, 2010, ENVIRON MOL MUTAGEN, V51, P879, DOI 10.1002/em.20597; Volcic M, 2012, NUCLEIC ACIDS RES, V40, P181, DOI 10.1093/nar/gkr687; Toulany M, 2006, CLIN CANCER RES, V12, P4119, DOI 10.1158/1078-0432.CCR-05-2454; Boone JJM, 2009, MOL CANCER THER, V8, P3015, DOI 10.1158/1535-7163.MCT-09-0219; Bours V, 2000, TOXICOLOGY, V153, P27, DOI 10.1016/S0300-483X(00)00302-4; Cai B, 2013, CANCER LETT, V335, P343, DOI 10.1016/j.canlet.2013.02.046; Cai Y, 2007, CANCER BIOL THER, V6, P1794; Crowell JA, 2005, EUR J CANCER, V41, P1889, DOI 10.1016/j.ejca.2005.04.016; DeSantis C, 2013, CA-CANCER J CLIN, V64, P52, DOI DOI 10.3322/CAAC.21203; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Ikeda Masahiko, 2009, Gan To Kagaku Ryoho, V36, P773; Kudoh T, 2010, EXP CELL RES, V316, P2849, DOI 10.1016/j.yexcr.2010.06.025; Nottingham LK, 2014, ONCOGENE, V33, P1135, DOI 10.1038/onc.2013.49; Pommier Y, 1996, SEMIN ONCOL, V23, P3; Rudolf E, 2013, MUTAT RES-FUND MOL M, V741, P27, DOI 10.1016/j.mrfmmm.2013.02.002; Wasserman E, 2001, Clin Colorectal Cancer, V1, P149, DOI 10.3816/CCC.2001.n.015; Xiao GT, 2011, AM J CANCER RES, V1, P192	50	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	APR	2015	33	4					2072	2076		10.3892/or.2015.3796		5	Oncology	Oncology	CD0RK	WOS:000350781400064		
J	Wang, Q; Ma, DG; Ding, JQ; Wang, LX; Qiao, QQ; Jia, HP; Gnade, BE; Hoshikawa-Halbert, J				Wang, Qi; Ma, Dongge; Ding, Junqiao; Wang, Lixiang; Qiao, Qiquan; Jia, Huiping; Gnade, Bruce E.; Hoshikawa-Halbert, Jason			An efficient dual-emissive-layer white organic light emitting-diode: Insight into device working mechanism and origin of color-shift	ORGANIC ELECTRONICS			English	Article						White organic light-emitting diode; Phosphorescence; Color-shift; Charge transport	PHOSPHORESCENT IRIDIUM COMPLEXES; EXTERNAL QUANTUM EFFICIENCY; HIGHLY EFFICIENT; TRIPLET EXCITONS; TRADE-OFF; ROLL-OFF; BLUE; HYBRID; HOST; RED	By using a single host for both blue and orange phosphorescent dopants, a simple and efficient white organic light emitting-diode is reported. The dual-emissive-layer white device achieves a peak external quantum efficiency of 16.9 +/- 0.9% and power efficiency of 44.1 +/- 2.3 lm/W without out-coupling enhancement. Analysis of the device working mechanism determines that the blue dopant molecules can form a bridge to facilitate electron transport into the adjacent orange emitting-layer. The orange emission originates from both the direct electron trapping by the orange dopant and incomplete blue-orange energy transfer mechanisms. The origin of the voltage-dependent color shift of the device is quantitatively determined according to the working mechanism. Possible solution to reducing the color-shift is also provided based on the calculation and analytical results. (C) 2015 Elsevier B.V. All rights reserved.	[Wang, Qi; Ma, Dongge; Ding, Junqiao; Wang, Lixiang] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Qi; Qiao, Qiquan] S Dakota State Univ, Coll Engn, Dept Elect Engn & Comp Sci, Brookings, SD 57007 USA; [Jia, Huiping; Gnade, Bruce E.] Univ Texas Dallas, Erik Jonsson Sch Engn & Comp Sci, Dept Mat Sci & Engn, Richardson, TX 75083 USA; [Hoshikawa-Halbert, Jason] Kyoto Univ Katsura, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan	Ma, DG (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Polymer Phys & Chem, Changchun 130022, Jilin, Peoples R China.	mdg1014@ciac.jl.cn			National Natural Science Foundation of China [51333007, 91433201]; Ministry of Science and Technology of China (973 program) [2013CB834805]; Foundation of Jilin Research Council [2012ZDGG001, 20130206003GX]; Chinese Academy of Sciences [KGZD-EW-303-3]; CAS Instrument Project [YZ201103]; United States' NSF CAREER [ECCS-0950731]	The authors acknowledge the National Natural Science Foundation of China (51333007, 91433201), Ministry of Science and Technology of China (973 program No. 2013CB834805), the Foundation of Jilin Research Council (2012ZDGG001, 20130206003GX), Chinese Academy of Sciences (KGZD-EW-303-3), CAS Instrument Project (YZ201103), and United States' NSF CAREER (ECCS-0950731) for the support of this research.	Reineke S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.125328; Huang JS, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2357938; Yan BP, 2007, ADV MATER, V19, P3599, DOI 10.1002/adma.200602683; Wang Q, 2014, ADV FUNCT MATER, V24, P4746, DOI 10.1002/adfm.201400597; Wong WY, 2009, COORDIN CHEM REV, V253, P1709, DOI 10.1016/j.ccr.2009.01.013; Zhou GJ, 2011, CHEM-ASIAN J, V6, P1706, DOI 10.1002/asia.201000928; Lai SL, 2010, ORG ELECTRON, V11, P1511, DOI 10.1016/j.orgel.2010.06.011; Wang Q, 2014, ADV MATER, V26, P8107, DOI 10.1002/adma.201402947; Tao YT, 2010, ADV FUNCT MATER, V20, P2923, DOI 10.1002/adfm.201000669; Zhou GJ, 2010, J PHOTOCH PHOTOBIO C, V11, P133, DOI 10.1016/j.jphotochemrev.2011.01.001; Fleetham T, 2013, ADV MATER, V25, P2573, DOI 10.1002/adma.201204602; Hsiao CH, 2011, ORG ELECTRON, V12, P547, DOI 10.1016/j.orgel.2010.12.019; Ye J, 2012, ADV MATER, V24, P3410, DOI 10.1002/adma.201201124; Wong WY, 2009, J MATER CHEM, V19, P4457, DOI 10.1039/b819943d; D'Andrade BW, 2004, ADV MATER, V16, P624, DOI 10.1002/adma.200306670; Matsusue N, 2005, JPN J APPL PHYS 1, V44, P3691, DOI 10.1143/JJAP.44.3691; Chang YL, 2013, ADV FUNCT MATER, V23, P705, DOI 10.1002/adfm.201201858; Reineke S, 2009, NATURE, V459, P234, DOI 10.1038/nature08003; Wang Q, 2009, ADV FUNCT MATER, V19, P84, DOI 10.1002/adfm.200800918; Eom SH, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3120276; Wang Q, 2010, ORG ELECTRON, V11, P238, DOI 10.1016/j.orgel.2009.11.001; Huang WS, 2004, CHEM MATER, V16, P2480, DOI 10.1021/cm0498943; Noh S, 2009, J APPL PHYS, V105, DOI 10.1063/1.3072693; Wang Q, 2009, J APPL PHYS, V105, DOI 10.1063/1.3106051; Yang XL, 2014, J MATER CHEM C, V2, P1760, DOI 10.1039/c3tc31953a; Park YS, 2013, ADV FUNCT MATER, V23, P4914, DOI 10.1002/adfm.201300547; Wang Q, 2013, ADV FUNCT MATER, V23, P5420, DOI 10.1002/adfm.201300699; Shih PI, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2214141; Wang Q, 2010, CHEM SOC REV, V39, P2387, DOI 10.1039/b909057f; Gather MC, 2011, ADV MATER, V23, P233, DOI 10.1002/adma.201002636; Su SJ, 2008, ADV MATER, V20, P4189, DOI 10.1002/adma.200801375; Seo JH, 2010, ORG ELECTRON, V11, P1759, DOI 10.1016/j.orgel.2010.07.015; Cocchi M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3086900; Wang Q, 2009, ADV MATER, V21, P2397, DOI 10.1002/adma.200803312; D'Andrade BW, 2002, ADV MATER, V14, P147, DOI 10.1002/1521-4095(20020116)14:2<147::AID-ADMA147>3.0.CO;2-3; Tokito S, 2003, APPL PHYS LETT, V83, P2459, DOI 10.1063/1.1611620; Chen SM, 2011, ADV FUNCT MATER, V21, P3785, DOI 10.1002/adfm.201100895; Jou JH, 2010, J MATER CHEM, V20, P8411, DOI 10.1039/c0jm01163k; Lu KY, 2011, ADV MATER, V23, P4933, DOI 10.1002/adma.201102886; Sun YR, 2006, NATURE, V440, P908, DOI 10.1038/nature04645; Zou JH, 2011, ADV MATER, V23, P2976, DOI 10.1002/adma.201101130; Du BS, 2012, ADV FUNCT MATER, V22, P3491, DOI 10.1002/adfm.201200718; Schwartz G, 2009, ADV FUNCT MATER, V19, P1319, DOI 10.1002/adfm.200801503; Kalinowski J, 2007, ADV MATER, V19, P4000, DOI 10.1002/adma.200700655; Wu HB, 2009, ADV MATER, V21, P4181, DOI 10.1002/adma.200900638; Ying L, 2014, ADV MATER, V26, P2459, DOI 10.1002/adma.201304784; Zhang BH, 2013, J MATER CHEM C, V1, P4933, DOI 10.1039/c3tc30912f; Chen CH, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1923759; Ho CL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2883935; Kawamura Y, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1862777; Schwartz G., 2008, APPL PHYS LETT, V92; Seo CW, 2011, ORG ELECTRON, V12, P1459, DOI 10.1016/j.orgel.2011.05.026; Wang Q, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3097028; Yang XH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3541447	54	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1566-1199	1878-5530		ORG ELECTRON	Org. Electron.	APR	2015	19						157	162		10.1016/j.orgel.2015.01.027		6	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	CC8CI	WOS:000350595300018		
J	Morimoto, M; Saito, C; Muto, C; Akamatsu, Y; Chiba, T; Abe, T; Azuma, N; Suto, Y				Morimoto, M.; Saito, C.; Muto, C.; Akamatsu, Y.; Chiba, T.; Abe, T.; Azuma, N.; Suto, Y.			Impairment of Host Resistance to Helminthes with Age in Murine Small Intestine	PARASITE IMMUNOLOGY			English	Article						ageing; macrophages; nematode; small intestine; Th2 cytokine	ALTERNATIVELY ACTIVATED MACROPHAGES; EPITHELIAL-CELL FUNCTION; CD8(+) T-CELLS; NIPPOSTRONGYLUS-BRASILIENSIS; CYTOKINE PRODUCTION; ANTIBODY-RESPONSE; GENE-EXPRESSION; IFN-GAMMA; IN-VIVO; MICE	Age-associated alterations of Th2 immune responses against nematode parasites are largely unknown. We investigated primary and memory responses against two types of gastrointestinal nematode parasites, Heligmosomoides polygyrus (Hp) and Nippostrongylus brasiliensis (Nb), in aged mice. The small intestinal gene expression of Th2 cytokines was almost unchanged after primary (Nb and Hp) and secondary infection (Hp) in aged mice in contrast to strongly increased small intestinal gene expression of Th2 cytokines in young (3-month-old) mice. Mucus production decreased (Nb), and worm expulsion was impaired (Nb and Hp) compared with the young mice. Immunofluorescent staining revealed that after Hp infection, the number of alternatively activated macrophages, which are induced by Th2 cytokines, was lower in the aged mice. On the other hand, the number of CD4(+) T cells recruited to the worm cysts was normal compared with the young mice. These results suggest that migration of CD4(+) T cells to the host-parasite interface is not affected by ageing. Alterations in Th2 immune responses in aged mice might be due to inappropriate or insufficient activation of CD4(+) T cells in the submucosa.	[Morimoto, M.; Saito, C.; Muto, C.; Akamatsu, Y.; Chiba, T.; Abe, T.; Azuma, N.; Suto, Y.] Miyagi Univ, Sch Food Agr & Environm Sci, Sendai, Miyagi 9820215, Japan	Morimoto, M (reprint author), Miyagi Univ, Sch Food Agr & Environm Sci, Taihaku Ku, 2-2-1 Hatatate, Sendai, Miyagi 9820215, Japan.	morimoto@myu.ac.jp			Miyagi University Research Fund; Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University	This research was partly supported by the Miyagi University Research Fund and the Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University.	Ahluwalia N, 2001, MECH AGEING DEV, V122, P1269, DOI 10.1016/S0047-6374(01)00266-4; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1415; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Weyand CM, 1998, MECH AGEING DEV, V102, P131, DOI 10.1016/S0047-6374(97)00161-9; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Sugawara Y, 2011, J VET MED SCI, V73, P511, DOI 10.1292/jvms.10-0269; Finkelman FD, 2000, J IMMUNOL, V164, P2303; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; URBAN JF, 1991, P NATL ACAD SCI USA, V88, P5513, DOI 10.1073/pnas.88.13.5513; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Zanni F, 2003, EXP GERONTOL, V38, P981, DOI 10.1016/S0531-5565(03)00160-8; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Hesse M, 2001, J IMMUNOL, V167, P6533; UTSUYAMA M, 1992, MECH AGEING DEV, V63, P57, DOI 10.1016/0047-6374(92)90016-7; BELOSEVIC M, 1989, J IMMUNOL, V143, P266; Mirza N, 2011, AGING CELL, V10, P853, DOI 10.1111/j.1474-9726.2011.00730.x; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; CILLARI E, 1992, IMMUNOLOGY, V76, P362; Effros RB, 2000, MECH AGEING DEV, V121, P161; ERNST DN, 1990, J IMMUNOL, V145, P1295; ERSHLER WB, 1984, J CLIN IMMUNOL, V4, P445, DOI 10.1007/BF00916574; Fujino T, 1996, PARASITOL RES, V82, P577, DOI 10.1007/s004360050167; Haynes L, 2005, J EXP MED, V201, P845, DOI 10.1084/jem.20041933; KISHIMOTO S, 1978, J IMMUNOL, V121, P1773; KISHIMOTO S, 1982, CLIN IMMUNOL IMMUNOP, V25, P1, DOI 10.1016/0090-1229(82)90159-3; KURASHIMA C, 1995, INT IMMUNOL, V7, P97, DOI 10.1093/intimm/7.1.97; Kuroda E, 2002, J IMMUNOL, V168, P5477; Madden KB, 2004, J IMMUNOL, V172, P5616; Morimoto M, 2006, J IMMUNOL, V176, P491; Morimoto M, 2004, J IMMUNOL, V172, P2424; Notari L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084763; OGILVIE BM, 1968, J PARASITOL, V54, P1073, DOI 10.2307/3276966; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shea-Donohue T, 2001, J IMMUNOL, V167, P2234; vansPanhuys N, 2011, J IMMUNOL, V186, P2719; WALTERS CS, 1975, J IMMUNOL, V115, P1438; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077	42	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0141-9838	1365-3024		PARASITE IMMUNOL	Parasite Immunol.	APR	2015	37	4					171	179		10.1111/pim.12170		9	Immunology; Parasitology	Immunology; Parasitology	CD5UR	WOS:000351154100001		
J	Poulsen, CS; Skov, S; Yoshida, A; Skallerup, P; Maruyama, H; Thamsborg, SM; Nejsum, P				Poulsen, C. S.; Skov, S.; Yoshida, A.; Skallerup, P.; Maruyama, H.; Thamsborg, S. M.; Nejsum, P.			Differential serodiagnostics of Toxocara canis and Toxocara cati - is it possible?	PARASITE IMMUNOLOGY			English	Article						diagnosis; Toxocara canis; Toxocara cati; Western blot; zoonosis	VISCERAL LARVA MIGRANS; CLINICAL EXPRESSION; ANTIGEN; IMMUNODIAGNOSIS; EPIDEMIOLOGY; INFECTION; DIAGNOSIS; HUMANS; PIGS	One of the most common zoonotic helminth infections is caused by species in the genus Toxocara, particularly Toxocara canis and T.cati (Syn. T.mystax). However, their relative contribution to toxocarosis in humans remains largely unknown because causative larvae are seldom recovered and uncertainties regarding the validity of existing serological assays. In this study, we used sera from a pig model experimentally infected with T.canis and T.cati to evaluate whether a Western blot could discriminate between the two species. No proteins were observed that could be used as a diagnostic tool. In addition, a heterogenic protein pattern between individual hosts was found, which was most pronounced in the T.cati-infected pigs. There is therefore an urgent need to optimize and validate current methods or develop new species-specific serological methods in order to implement appropriate control measures.	[Poulsen, C. S.; Skov, S.; Skallerup, P.; Thamsborg, S. M.; Nejsum, P.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, DK-1870 Copenhagen C, Denmark; [Yoshida, A.; Maruyama, H.] Miyazaki Univ, Fac Med, Div Parasitol, Miyazaki, Japan	Nejsum, P (reprint author), Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth Sci, Dyrlaegevej 100, DK-1870 Copenhagen C, Denmark.	pn@sund.ku.dk			University of Copenhagen, Veterinary Parasitology Research Group; Japan Society for the Promotion of Science [S 2213]; Ministry of Health, Labour and Welfare [H25 Iryo-gijutsu shitei-012]; Oticon Foundation; PLAN Danmark	The authors would like to thank Claudia Bohm and Christina Strube, University of Veterinary Medicine Hannover, Germany, for providing eggs for the infection of pigs. Thanks to Helene Kringel, Lise-Lotte Christiansen, Nermina Vejzagic, Lars Andresen at the University of Copenhagen for help with ES production, protein measurement and western blot analysis. This work was funded by the University of Copenhagen, Veterinary Parasitology Research Group. Ayako Yoshida was supported by a grant from the Japan Society for the Promotion of Science (Young Researcher Overseas Visits Program for Accelerating Brain Circulation, S 2213) and a grant from Ministry of Health, Labour and Welfare (H25 Iryo-gijutsu shitei-012). The Oticon Foundation and PLAN Danmark are acknowledged for travel grants awarded to CSP.	Alcantara-Neves NM, 2008, EXP PARASITOL, V119, P349, DOI 10.1016/j.exppara.2008.03.006; Fisher M, 2003, TRENDS PARASITOL, V19, P167, DOI 10.1016/S1471-4922(03)00027-8; Othman AA, 2012, ACTA TROP, V124, P171, DOI 10.1016/j.actatropica.2012.08.003; Yamasaki H, 2000, J CLIN MICROBIOL, V38, P1409; Fillaux J, 2013, VET PARASITOL, V193, P327, DOI 10.1016/j.vetpar.2012.12.028; Rubinsky-Elefant G, 2010, ANN TROP MED PARASIT, V104, P3, DOI 10.1179/136485910X12607012373957; MAGNAVAL JF, 1991, PARASITOL RES, V77, P697, DOI 10.1007/BF00928685; MAGNAVAL JF, 1994, T ROY SOC TROP MED H, V88, P531, DOI 10.1016/0035-9203(94)90148-1; Gasser RB, 2013, VET PARASITOL, V193, P353, DOI 10.1016/j.vetpar.2012.12.031; Pawlowski Z, 2001, J HELMINTHOL, V75, P299; Roldan WH, 2009, MEM I OSWALDO CRUZ, V104, P411, DOI 10.1590/S0074-02762009000300003; BADLEY JE, 1987, J PARASITOL, V73, P593, DOI 10.2307/3282142; Boes J, 2000, PARASITOLOGY, V121, pS97, DOI 10.1017/S003118200000648X; HOGARTHS.RS, 1969, CLIN EXP IMMUNOL, V5, P619; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000400; KENNEDY MW, 1987, PARASITE IMMUNOL, V9, P407, DOI 10.1111/j.1365-3024.1987.tb00519.x; Magnaval Jean-Francois, 2001, Korean Journal of Parasitology, V39, P1; MEGHJI M, 1986, MOL BIOCHEM PARASIT, V18, P155, DOI 10.1016/0166-6851(86)90035-6; NAGAKURA K, 1990, J INFECT DIS, V162, P1418; NICHOLS RL, 1956, J PARASITOL, V42, P349, DOI 10.2307/3274518; Overgaauw PAM, 1997, CRIT REV MICROBIOL, V23, P215, DOI 10.3109/10408419709115137; RONEUS OTTO, 1966, ACTA VETERINARIA SCAND, V7, P1; SAVIGNY DHD, 1975, J PARASITOL, V61, P781; Skallerup P, 2014, PARASITOLOGY, V141, P777, DOI 10.1017/S0031182013002175; Smith H, 2006, TOXOCARA: THE ENIGMATIC PARASITE, P89; Taira K, 2003, PARASITOLOGY, V127, P593, DOI 10.1017/S0031182003004074	26	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0141-9838	1365-3024		PARASITE IMMUNOL	Parasite Immunol.	APR	2015	37	4					204	207		10.1111/pim.12181		4	Immunology; Parasitology	Immunology; Parasitology	CD5UR	WOS:000351154100004		
J	Ishisaka, M; Tsujii, S; Mizoguchi, T; Tsuruma, K; Shimazawa, M; Hara, H				Ishisaka, Mitsue; Tsujii, Saori; Mizoguchi, Takahiro; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki			The effects of valproate and olanzapine on the abnormal behavior of diacylglycerol kinase beta knockout mice	PHARMACOLOGICAL REPORTS			English	Article						Diacylglycerol kinase beta; Mania; Valproate; Olanzapine	GLYCOGEN-SYNTHASE KINASE-3; BIPOLAR-DISORDER; MOOD STABILIZERS; ANIMAL-MODEL; MOLECULAR-CLONING; MANIA; NEURONS; HIPPOCAMPUS; GENE; EXPRESSION	Background: Diacylglycerol kinase (DGK) is an enzyme that converts diacylglycerol to phosphatidic acid. Previously, we reported that DGK beta knockout (KO) mice showed mania-like behaviors such as hyperactivity, reduced anxiety, and cognitive impairment. Furthermore, lithium ameliorated the hyperactivity and reduced anxiety of DGK beta KO mice. In this study, we investigated the effects of the clinically active antimanic drugs valproate and olanzapine on the abnormal behaviors of DGK beta KO mice. Methods: Valproate (100 mg/kg/day) and olanzapine (1 mg/kg/day) were administered intraperitoneally. Following drugs treatments, behavioral tests were performed to investigate locomotor activity, anxiety levels, and cognitive function of the mice. Results: A single treatment of valproate and olanzapine did not ameliorate the hyperactivity or abnormal anxiety level of DGK beta KO mice. Chronic treatment with valproate and olanzapine significantly decreased locomotor activity and abnormal anxiety levels of DGK beta KO mice. Additionally, valproate also ameliorated cognitive function of DGK beta KO mice. Conclusion: These results suggest that the abnormal behaviors of DGK beta KO mice is responsive to antimanic drugs, and that DGK beta KO mice are useful as an animal model of mania. (C) 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.	[Ishisaka, Mitsue; Tsujii, Saori; Mizoguchi, Takahiro; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Mol Pharmacol, Gifu, Japan	Hara, H (reprint author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Mol Pharmacol, Gifu, Japan.	hidehara@gifu-pu.ac.jp					Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Ong JC, 2005, J PHARMACOL EXP THER, V315, P1163, DOI 10.1124/jpet.105.090845; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Machado-Vieira R, 2004, PROG NEURO-PSYCHOPH, V28, P209, DOI 10.1016/j.pnpbp.2003.10.015; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Li XH, 2002, BIPOLAR DISORD, V4, P137, DOI 10.1034/j.1399-5618.2002.40201.x; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Aubry JM, 2009, PSYCHOPHARMACOLOGY, V205, P419, DOI 10.1007/s00213-009-1551-2; Sutton LP, 2011, NEUROSCIENCE, V199, P116, DOI 10.1016/j.neuroscience.2011.09.056; Barbosa FJ, 2011, PHARMACOL REP, V63, P64; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Hozumi Yasukazu, 2012, Advances in Biological Regulation, V52, P315, DOI 10.1016/j.jbior.2012.03.003; Rezin GT, 2014, MOL NEUROBIOL, V49, P877, DOI 10.1007/s12035-013-8566-8; McOmish CE, 2012, NEUROPSYCHOPHARMACOL, V37, P2747, DOI 10.1038/npp.2012.139; Huang M, 2006, BRAIN RES, V1099, P44, DOI 10.1016/j.brainres.2006.04.081; Weber H, 2011, NEUROPSYCHOPHARMACOL, V36, P2076, DOI 10.1038/npp.2011.98; Craddock N, 1999, J MED GENET, V36, P585; Scotti MAL, 2011, PHYSIOL BEHAV, V103, P376, DOI 10.1016/j.physbeh.2011.03.005; Exton JH, 1997, PHYSIOL REV, V77, P303; Hozumi Y, 2008, EUR J NEUROSCI, V28, P2409, DOI 10.1111/j.1460-9568.2008.06547.x; Caricasole A, 2002, J BIOL CHEM, V277, P4790, DOI 10.1074/jbc.M110249200; Christakis DA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00546; El-Mallakh RS, 2006, PROG NEURO-PSYCHOPH, V30, P1261, DOI 10.1016/j.pnpbp.2006.04.003; Frey BN, 2006, LIFE SCI, V79, P281, DOI 10.1016/j.lfs.2006.01.002; GOTO K, 1993, P NATL ACAD SCI USA, V90, P7598, DOI 10.1073/pnas.90.16.7598; Hoertel N, 2013, EXPERT OPIN DRUG DIS, V8, P907, DOI 10.1517/17460441.2013.804057; Hozumi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-99; Ishisaka M, 2014, J PHARMACOL SCI, V124, P336, DOI 10.1254/jphs.13R07CR; Ishisaka M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037058; Kakefuda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013447; Moya PR, 2010, INT J NEUROPSYCHOPH, V13, P1127, DOI 10.1017/S1461145710000593; O'Brien WT, 2011, J CLIN INVEST, V121, P3756, DOI 10.1172/JCI45194; Salkovic-Petrisic M, 2006, J NEUROCHEM, V96, P1005, DOI 10.1111/j.1471-4159.2005.03637.x; Shirai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011602; Stertz L, 2013, REV BRAS PSIQUIATR, V36, P39; van Enkhuizen J, 2013, INT J NEUROPSYCHOPH, V16, P1021, DOI 10.1017/S1461145712001198	36	0	0	POLISH ACAD SCIENCES INST PHARMACOLOGY	KRAKOW	SMETNA 12, 31-343 KRAKOW, POLAND	1734-1140			PHARMACOL REP	Pharmacol. Rep.	APR	2015	67	2					275	280		10.1016/j.pharep.2014.10.009		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CC8IO	WOS:000350611900015		
J	Plucinski, KJ; Lakshminarayana, G				Plucinski, K. J.; Lakshminarayana, G.			Phototransparent properties in PMMA/SI(111) nanointerfaces	PHYSICA E-LOW-DIMENSIONAL SYSTEMS & NANOSTRUCTURES			English	Article						Nano-trapping levels; Polymer nanocomposites; Polymer nanointerfaces	LOW-TEMPERATURE ANOMALIES; NONLINEAR OPTICS; THIN-FILMS; NANOPARTICLES; NANOCRYSTALS; NANOCOMPOSITES; PHOTOPOLYMERS; CONDUCTIVITY; ABSORPTION; TRANSPORT	In this work, we report on the synthesis and non-linear optical studies of PMMA polymer films deposited on Si(111) wafers by using the spin-coating method. The transport features were measured using a four-probe method. The excitation was provided by 10 ns pulses of lambda=1.32 mu m YAG: Nd laser. The photoinduced laser light was polarized by a rotating Fresnel polarizer, and the output light powers were detected using a fast response photomultiplier. At low voltages, the photoinduced dependence of optical constants does not show an essential change with respect to the photoinduced power. The effect exists only on the nano-interfaces occurring on the borders. Drastic changes are observed only at higher voltages (about 6 V), which correlates with a drastic increase of the current. A novel mechanism describing low dc-elecric field for the trapping current by tunneling is proposed. (C) 2014 Elsevier B.V. All rights reserved.	[Plucinski, K. J.] Mil Univ Technol, Dept Elect, PL-00908 Warsaw, Poland; [Lakshminarayana, G.] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton MANA, Tsukuba, Ibaraki 3050044, Japan; [Lakshminarayana, G.] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	Plucinski, KJ (reprint author), Mil Univ Technol, Dept Elect, Kaliskiego 2, PL-00908 Warsaw, Poland.	kpluc2006@wp.pl					Kanda N, 2014, OPT LETT, V39, P3274, DOI 10.1364/OL.39.003274; Kityk IV, 2006, J PHYS CHEM B, V110, P8219, DOI [10.1021/jp0575254, 10.1016/jp0575254]; Kityk IV, 1997, POLYMER, V38, P4803, DOI 10.1016/S0032-3861(96)01084-1; Raj DR, 2015, OPT COMMUN, V340, P86, DOI 10.1016/j.optcom.2014.11.092; Ozga K, 2004, OPT COMMUN, V231, P437, DOI 10.1016/j.optcom.2003.12.037; Fuks-Janczarek I, 2008, J MATER SCI-MATER EL, V19, P434, DOI 10.1007/s10854-007-9356-8; Lee KH, 2015, CARBON, V83, P40, DOI 10.1016/j.carbon.2014.11.025; Califa R, 2014, OPT LETT, V39, P5905, DOI 10.1364/OL.39.005905; Ghaemi N, 2015, CHEM ENG J, V263, P101, DOI 10.1016/j.cej.2014.10.103; Ghavidel AK, 2015, OPT LASER TECHNOL, V67, P119, DOI 10.1016/j.optlastec.2014.10.003; Gruhn W, 2005, OPT APPL, V35, P329; Gruhn W, 2003, J APPL PHYS, V93, P2912, DOI 10.1063/1.1540228; Jung J, 2014, J POLYM SCI POL PHYS, V52, P1641, DOI 10.1002/polb.23612; Kamaniana N.V., 2013, OPT APPL, V43, P367; Kityk IV, 2004, J MOD OPTIC, V51, P1179, DOI 10.1080/09500340310001641913; Kityk IV, 2004, OPT MATER, V25, P33, DOI 10.1016/S0925-3467(03)00213-1; Li MK, 2015, MATER LETT, V141, P125, DOI 10.1016/j.matlet.2014.11.036; Mochizuki S, 2003, PHYSICA B, V340, P969, DOI 10.1016/j.physb.2003.09.271; Ozga K, 2008, PHYSICA B, V403, P2561, DOI 10.1016/j.physb.2008.01.027; Ozga K, 2011, MATER LETT, V65, P1734, DOI 10.1016/j.matlet.2011.03.003; Ozga K, 2006, PHYSICA E, V33, P315, DOI 10.1016/j.physe.2006.03.160; Reshak AH, 2010, PHYSICA E, V42, P1769, DOI 10.1016/j.physe.2010.01.045; Sahi S, 2015, J LUMIN, V159, P105, DOI 10.1016/j.jlumin.2014.11.004; Seno R, 2015, DYES PIGMENTS, V114, P166, DOI 10.1016/j.dyepig.2014.11.010; Tkaczyk S, 2004, J PHYS-CONDENS MAT, V16, P2231, DOI 10.1088/0953-8984/16/13/004; Tkaczyk SW, 2010, PHYSICA E, V42, P2124, DOI 10.1016/j.physe.2010.04.008; Tkaczyk SW, 2002, J PHYS D APPL PHYS, V35, P563, DOI 10.1088/0022-3727/35/6/311	27	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1386-9477	1873-1759		PHYSICA E	Physica E	APR	2015	68						140	142		10.1016/j.physe.2014.12.030		3	Nanoscience & Nanotechnology; Physics, Condensed Matter	Science & Technology - Other Topics; Physics	CD2QU	WOS:000350924900020		
J	Idzuchi, H; Fukuma, Y; Otani, Y				Idzuchi, Hiroshi; Fukuma, Yasuhiro; Otani, YoshiChika			Spin transport in non-magnetic nano-structures induced by non-local spin injection	PHYSICA E-LOW-DIMENSIONAL SYSTEMS & NANOSTRUCTURES			English	Review						Spintronics; Spin injection; Spin relaxation; Spin orbit interaction; Hanle curve analysis	ROOM-TEMPERATURE; CONDUCTION ELECTRONS; ELECTRICAL DETECTION; GIANT MAGNETORESISTANCE; METAL INTERFACE; RELAXATION; PRECESSION; SEMICONDUCTOR; ACCUMULATION; RESONANCE	We review our recent achievements on optimization of spin injection from ferromagnetic into nonmagnetic metals and characterization of spin transport properties in the non-magnetic nano-structures. We have realized the efficient spin injection by solving spin resistance mismatch problem in spin diffusion process across the interface between ferromagnetic and nonmagnetic metals. We analyzed temperature dependent spin relaxation length and time in Ag within the framework of the Elliot-Yafet mechanism based on spin-orbit interaction and momentum relaxation. The spin relaxation length in a light metal Mg is found comparable to that of Ag due to its peculiar electronic band structure in which so called spin-hotspots dramatically enhance spin relaxation. Spin relaxation properties in various metals are also quantitatively discussed. We employed commonly used Hanle effect measurements to characterize spin relaxation of spin current and reexamined both theoretically and experimentally the effect of spin absorption at the interface. The affected spatial profile of chemical potential due to the longitudinal and transverse spin absorption results in the broadened Hanle curve. All the Hanle curves both in metallic and semi-conductive materials including graphene fall into the universal scaling plot. Anatomy of spin injection properties of the junction and spin transport properties in non-magnetic metal is shown in tables. (C) 2014 The Authors. Published by Elsevier B.V.	[Idzuchi, Hiroshi; Otani, YoshiChika] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Idzuchi, Hiroshi; Fukuma, Yasuhiro; Otani, YoshiChika] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Fukuma, Yasuhiro] Kyushu Inst Technol, Frontier Res Acad Young Researchers, Iizuka, Fukuoka 8208502, Japan	Otani, Y (reprint author), Univ Tokyo, Inst Solid State Phys, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778581, Japan.	yotani@issp.u-tokyo.ac.jp	Wu, M. W./H-4632-2011; OTANI, Yoshichika/I-5884-2012; Fukuma, Yasuhiro/B-5988-2012	OTANI, Yoshichika/0000-0001-8008-1493; 			ABRIKOSOV AA, 1962, SOV PHYS JETP-USSR, V15, P752; Popinciuc M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.214427; Jain A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.106603; YAFET Y, 1963, SOLID STATE PHYS, V14, P1; Maassen T, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.115410; Chappert C, 2007, NAT MATER, V6, P813, DOI 10.1038/nmat2024; TORREY HC, 1956, PHYS REV, V104, P563, DOI 10.1103/PhysRev.104.563; Jedema FJ, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.085319; Erekhinsky M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3291047; Jedema FJ, 2002, NATURE, V416, P713, DOI 10.1038/416713a; Takahashi S, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.031009; Jedema FJ, 2002, APPL PHYS LETT, V81, P5162, DOI 10.1063/1.1532753; Lou XH, 2007, NAT PHYS, V3, P197, DOI 10.1038/nphys543; JOHNSON M, 1988, PHYS REV B, V37, P5326, DOI 10.1103/PhysRevB.37.5326; Idzuchi H, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824897; Schmidt G, 2000, PHYS REV B, V62, pR4790, DOI 10.1103/PhysRevB.62.R4790; Taniguchi T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.031302; Mihajlovic G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.237202; Kimura T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.156601; Dubois S, 1999, PHYS REV B, V60, P477, DOI 10.1103/PhysRevB.60.477; Ji Y, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2170138; Fabian J, 1998, PHYS REV LETT, V81, P5624, DOI 10.1103/PhysRevLett.81.5624; Takahashi YK, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3681804; Han W, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.167202; Yamaguchi T, 2012, J MAGN MAGN MATER, V324, P849, DOI 10.1016/j.jmmm.2011.09.031; Filip AT, 2000, PHYS REV B, V62, P9996, DOI 10.1103/PhysRevB.62.9996; Valenzuela SO, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196601; Fert A, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.184420; Tserkovnyak Y, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.224403; Fabian J, 2007, ACTA PHYS SLOVACA, V57, P565, DOI 10.2478/v10155-010-0086-8; Dash SP, 2009, NATURE, V462, P491, DOI 10.1038/nature08570; VALET T, 1993, PHYS REV B, V48, P7099, DOI 10.1103/PhysRevB.48.7099; Valenzuela SO, 2004, APPL PHYS LETT, V85, P5914, DOI 10.1063/1.1830685; Zwierzycki M, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.064420; Morota M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.174405; JOHNSON M, 1985, PHYS REV LETT, V55, P1790, DOI 10.1103/PhysRevLett.55.1790; Casanova F, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.184415; Ghosh A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.127202; Jedema FJ, 2001, NATURE, V410, P345, DOI 10.1038/35066533; Fabian J, 1999, J VAC SCI TECHNOL B, V17, P1708, DOI 10.1116/1.590813; Fabian J, 1999, PHYS REV LETT, V83, P1211, DOI 10.1103/PhysRevLett.83.1211; Tombros N, 2007, NATURE, V448, P571, DOI 10.1038/nature06037; JOHNSON M, 1988, PHYS REV B, V37, P5312, DOI 10.1103/PhysRevB.37.5312; Laczkowski P, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.063007; Bass J, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/18/183201; FEHER G, 1955, PHYS REV, V98, P337, DOI 10.1103/PhysRev.98.337; Liu LQ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.036601; Fukuma Y, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3460909; Idzuchi H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737001; VANSON PC, 1987, PHYS REV LETT, V58, P2271, DOI 10.1103/PhysRevLett.58.2271; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Liu YP, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4776699; Ilgaz D, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.076601; BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460; Liu LQ, 2012, SCIENCE, V336, P555, DOI 10.1126/science.1218197; BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472; Kimura T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014461; Wang L, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.093004; Bridoux G, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3635391; Valenzuela SO, 2006, NATURE, V442, P176, DOI 10.1038/nature04937; MESERVEY R, 1978, PHYS REV LETT, V41, P805, DOI 10.1103/PhysRevLett.41.805; Niimi Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.016805; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323; Yang T, 2008, NAT PHYS, V4, P851, DOI 10.1038/nphys1095; Kimura T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.037201; van Staa A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.214416; ELLIOTT RJ, 1954, PHYS REV, V96, P266, DOI 10.1103/PhysRev.96.266; Appelbaum I, 2007, NATURE, V447, P295, DOI 10.1038/nature05803; Dlubak B, 2012, NAT PHYS, V8, P557, DOI [10.1038/nphys2331, 10.1038/NPHYS2331]; Saitoh E, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2199473; Fukuma Y, 2011, NAT MATER, V10, P527, DOI [10.1038/nmat3046, 10.1038/NMAT3046]; Ashcroft N. W., 1976, SOLID STATE PHYS; Barnas J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.024426; Bass J., 1982, METALS ELECT TRANSPO; Bauer GEW, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.094421; BERGMANN G, 1982, Z PHYS B CON MAT, V48, P5, DOI 10.1007/BF02026422; BERGMANN G, 1984, PHYS REV B, V29, P6114, DOI 10.1103/PhysRevB.29.6114; Beuneu F., 1976, PHYS REV B, V13, P3424; Bid A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.035426; Bir G. L., 1975, SOV PHYS JETP, V42, P705; Costache MV, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.4722982; Dankert A, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4876060; DYAKONOV MI, 1971, SOV PHYS JETP-USSR, V33, P1053; DUGDALE JS, 1962, PROC R SOC LON SER-A, V270, P186, DOI 10.1098/rspa.1962.0211; Dyakonov M. I., 1972, SOV PHYS-SOLID STATE, V13, P3023; FREDKIN DR, 1972, PHYS REV LETT, V29, P1390, DOI 10.1103/PhysRevLett.29.1390; Garzon S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.176601; Gershenzon E., 1982, SOV PHYS JETP, V56, P1362; Gougam AB, 2000, J LOW TEMP PHYS, V118, P447, DOI 10.1023/A:1004658404535; Hershfield S, 1997, PHYS REV B, V56, P3296, DOI 10.1103/PhysRevB.56.3296; Huang BQ, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.241202; Idzuchi H, 2011, IEEE T MAGN, V47, P1545, DOI 10.1109/TMAG.2011.2108272; Idzuchi H, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.063002; Idzuchi H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00628; Idzuchi H., 2014, THESIS U TOKYO JAPAN; Idzuchi H, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.081308; Idzuchi H., ARXIV14112949; JACKEL LD, 1981, APPL PHYS LETT, V39, P268, DOI 10.1063/1.92668; Jaffres H, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.140408; Jedema F.J., 2002, THESIS U GRONINGEN H; Kardasz B, 2008, J APPL PHYS, V103, DOI 10.1063/1.2834399; Kimura T., 2008, PHYS REV LETT, V100; LUBZENS D, 1972, PHYS REV LETT, V29, P1387, DOI 10.1103/PhysRevLett.29.1387; MONOD P, 1979, PHYS REV B, V19, P911, DOI 10.1103/PhysRevB.19.911; MONOD P, 1982, J PHYS-PARIS, V43, P393, DOI 10.1051/jphys:01982004302039300; Mosendz O., 2010, PHYS REV LETT, V104; Neumann I, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4820586; Papaconstantopoulos D. A., 1986, HDB BAND STRUCTURE E; Pierre F., 2003, PHYS REV B, V68; Rashba EI, 2002, EUR PHYS J B, V29, P513, DOI 10.1140/epjb/e2002-00316-5; Rashba E. I., 2000, Physical Review B (Condensed Matter), V62, DOI 10.1103/PhysRevB.62.R16267; Sanchez JCR, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4800537; Rossiter P.L., 1993, ELECT MAGNETIC PRO 1, P257; Sasaki T, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3367748; SCHULTZ S, 1965, PHYS REV LETT, V15, P148, DOI 10.1103/PhysRevLett.15.148; Shanabarger M.R., 1970, THESIS U CALIFORNIA; Sun JZ, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3216851; Takahashi S, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.052409; Txoperena O, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4806987; VESCIAL F, 1964, PHYS REV A-GEN PHYS, V134, P1286; Villamor E, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.094417; Vogel A, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3109787; Wang L, 2011, J APPL PHYS, V109, DOI 10.1063/1.3556759; Wang XJ, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3182785; WHITE AE, 1984, PHYS REV B, V29, P3694, DOI 10.1103/PhysRevB.29.3694	125	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1386-9477	1873-1759		PHYSICA E	Physica E	APR	2015	68						239	263		10.1016/j.physe.2014.11.023		25	Nanoscience & Nanotechnology; Physics, Condensed Matter	Science & Technology - Other Topics; Physics	CD2QU	WOS:000350924900034		
J	Javadi, A; Shockravi, A; Rafieimanesh, A; Malek, A; Ando, S				Javadi, Ali; Shockravi, Abbas; Rafieimanesh, Atefeh; Malek, Ali; Ando, Shinji			Synthesis and structure-property relationships of novel thiazole-containing poly(amide imide)s with high refractive indices and low birefringences	POLYMER INTERNATIONAL			English	Article						copolymer; thiazole; high performance; high refractive index; low birefringence	CONTAINING AROMATIC DIAMINES; POLYIMIDES; DIANHYDRIDES; SULFUR; POLYAMIDES; ANHYDRIDE; THIOETHER; LINKAGES; POLYMER; REGION	The primary objective of this study was to investigate the structure-property relationships in high-performance polymers with high refractive indices and low birefringences. A series of novel poly(amide imide)s (PAIs) were synthesized from a thiazole-containing diimide-diacid monomer and various aromatic diamines. The influence of the pendant phenyl substituents on the optical properties of these PAIs was studied by comparison with the analogous polymers containing methyl groups. The PAIs exhibited excellent solubility and good thermal stability. The optical transmittances of the PAI films at 450nm were higher than 75%. The combination of the thiazole units, thioether linkages and pendant phenyl rings provided the PAIs with high average refractive indices of 1.7361-1.7536 and low birefringences of 0.0066-0.0097 at 632.8nm. (c) 2014 Society of Chemical Industry	[Javadi, Ali; Shockravi, Abbas; Rafieimanesh, Atefeh] Kharazmi Univ, Fac Chem, Tehran 1571914911, Iran; [Malek, Ali] Polish Acad Sci, Inst Phys Chem, PL-01224 Warsaw, Poland; [Ando, Shinji] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528552, Japan	Shockravi, A (reprint author), Kharazmi Univ, Fac Chem, Mofatteh Ave 49, Tehran 1571914911, Iran.	abbas_shockravi@yahoo.co.uk	ANDO, Shinji/D-6280-2011	ANDO, Shinji/0000-0002-3508-035X	Kharazmi University	This work was partially supported by Kharazmi University. The computations were carried out at the Computer Center of the Faculty of Chemistry, University of Warsaw.	Shockravi A, 2013, RSC ADV, V3, P6717, DOI 10.1039/c3ra22418j; Shockravi A, 2009, EUR POLYM J, V45, P1599, DOI 10.1016/j.eurpolymj.2009.01.014; Liu JG, 2008, MACROMOL CHEM PHYSIC, V209, P195, DOI 10.1002/macp.200700305; Shockravi A, 2009, DES MONOMERS POLYM, V12, P119, DOI 10.1163/156855509X412063; You NH, 2010, MACROMOLECULES, V43, P4613, DOI 10.1021/ma100448d; Liaw DJ, 2012, PROG POLYM SCI, V37, P907, DOI 10.1016/j.progpolymsci.2012.02.005; Okutsu R, 2008, CHEM MATER, V20, P4017, DOI 10.1021/cm800432p; Zhang G, 2013, POLYMER, V54, P601, DOI 10.1016/j.polymer.2012.12.008; Liu JG, 2007, MACROMOLECULES, V40, P7902, DOI 10.1021/ma0713714; Abouzari-Lotf E, 2011, POLYM DEGRAD STABIL, V96, P1022, DOI 10.1016/j.polymdegradstab.2011.01.004; You NH, 2009, POLYMER, V50, P789, DOI 10.1016/j.polymer.2008.12.001; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011; Shockravi A, 2011, POLYM J, V43, P816, DOI 10.1038/pj.2011.74; Ma H, 2002, ADV MATER, V14, P1339, DOI 10.1002/1521-4095(20021002)14:19<1339::AID-ADMA1339>3.0.CO;2-O; Ando S, 2002, JPN J APPL PHYS 2, V41, pL105, DOI 10.1143/JJAP.41.L105; WOODBRIDGE RG, 1949, J AM CHEM SOC, V71, P1744, DOI 10.1021/ja01173a057; Zhou M, 2002, OPT ENG, V41, P1631, DOI 10.1117/1.1481895; Javadi A, 2013, J POLYM SCI POL CHEM, V51, P3505, DOI 10.1002/pola.26752; Ando S, 2006, J PHOTOPOLYM SCI TEC, V19, P351, DOI 10.2494/photopolymer.19.351; Suzuki Y, 2008, POLYM J, V40, P414, DOI 10.1295/polymj.PJ2007233; Liu JG, 2007, POLYM J, V39, P543, DOI 10.1295/polymj.PJ2006232; Shockravi A, 2009, POLYM J, V41, P174, DOI 10.1295/polymj.PJ2008250; Ando S, 1997, POLYM J, V29, P69, DOI 10.1295/polymj.29.69; Garcia JM, 2010, PROG POLYM SCI, V35, P623, DOI 10.1016/j.progpolymsci.2009.09.002; Liu JG, 2009, J MATER CHEM, V19, P8907, DOI 10.1039/b909690f; Gao CY, 2000, J APPL POLYM SCI, V75, P1474, DOI 10.1002/(SICI)1097-4628(20000321)75:12<1474::AID-APP5>3.0.CO;2-1; Shockravi A, 2012, J APPL POLYM SCI, V125, P1521, DOI 10.1002/app.36363; BOESE D, 1992, J POLYM SCI POL PHYS, V30, P1321, DOI 10.1002/polb.1992.090301203; Zhang G, 2013, POLYM INT, V62, P1358, DOI 10.1002/pi.4431; Lin YZ, 2012, ADV MATER, V24, P3087, DOI 10.1002/adma.201200721; You NH, 2009, J POLYM SCI POL CHEM, V47, P4886, DOI 10.1002/pola.23538; You NH, 2008, MACROMOLECULES, V41, P6361, DOI 10.1021/ma800982x; Fukuzaki N, 2010, MACROMOLECULES, V43, P1836, DOI 10.1021/ma902013y; You NH, 2009, J POLYM SCI POL CHEM, V47, P4428, DOI 10.1002/pola.23497; Terui Y, 2005, J PHOTOPOLYM SCI TEC, V18, P337; Born M., 1999, PRINCIPLES OPTICS EL; Dean J A, 1998, LANGES HDB CHEM; Krogman KC, 2005, NANOTECHNOLOGY, V16, pS338, DOI 10.1088/0957-4484/16/7/005; Li Z, 2010, HIGH PERFORM POLYM, V22, P468, DOI 10.1177/0954008309104955; Okubo T, 1998, J MACROMOL SCI PURE, VA35, P1819, DOI 10.1080/10601329808000555; Seto R, 2010, POLYMER, V51, P4744, DOI 10.1016/j.polymer.2010.08.032; Terraza CA, 2008, J POLYM SCI POL CHEM, V46, P1510, DOI 10.1002/pola.22492	42	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0959-8103	1097-0126		POLYM INT	Polym. Int.	APR	2015	64	4					486	495		10.1002/pi.4815		10	Polymer Science	Polymer Science	CD6OR	WOS:000351209200004		
J	Tran, HN; Liem, PH				Hoai-Nam Tran; Liem, Peng Hong			Neutronic feasibility study of U-Th-Pa based high burnup fuel for pebble bed reactors	PROGRESS IN NUCLEAR ENERGY			English	Article						U-Th-Pa; Thorium fuel; High bumup; Pebble bed reactor	MINOR ACTINIDES; CORE; PLUTONIUM; OPTIMIZATION; PBMR-400; CYCLE	Neutronic feasibility study of U-Th-Pa based high burnup fuel for the pebble bed reactors has been carried out. An additional content of Pa-231 in a mixed U-233-Th-232 fuel pebble was optimized for simultaneously controlling long-term excess reactivity and attaining high fuel burnup. Because of a large thermal absorption cross section, Pa-231 has a potential to absorb thermal neutrons and act as a burnable absorber in the early stage of burnup. In the latter stage, Pa-231 is transmuted to U-233 and act as a fertile fuel. Parametric study was performed for heavy metal (HM) amount, U-233 enrichment and Pa-231 content. The objective is to attain a target burnup greater than 100 GWd/T with a low uranium enrichment and a small content of Pa-231. Six fuel compositions with the HM amount of 9-18 g per pebble, the U-233 enrichment of 8 and 10%, and the Pa-231 content of 3.2-5.5% were selected for discussion and comparison. The burnup levels of about 130-170 GWd/t are achieved for the six fuel compositions. The results of temperature coefficient show that negative reactivity feedback during burnup with the increase of temperature is assured, which is one of the important safety parameters. (C) 2014 Elsevier Ltd. All rights reserved.	[Hoai-Nam Tran] Duy Tan Univ, Inst Res & Dev, Da Nang, Vietnam; [Liem, Peng Hong] Nippon Adv Informat Serv NAIS Co Inc, Sci Computat Div, Ibaraki, Japan	Tran, HN (reprint author), Duy Tan Univ, Inst Res & Dev, K7-25 Quang Trung, Da Nang, Vietnam.	tranhoainam4@dtu.edu.vn			National Foundation for Science and Technology Development [103.04-2014.79]	The authors are grateful to Mr. V.K. Hoang of Institute for Nuclear Science and Technology for his assistance on MVP calculations. This work has been supported by National Foundation for Science and Technology Development via project No. 103.04-2014.79.	Acir A, 2012, ANN NUCL ENERGY, V48, P45, DOI 10.1016/j.anucene.2012.05.015; Acir A, 2015, PROG NUCL ENERG, V78, P380, DOI 10.1016/j.pnucene.2013.11.009; Liem PH, 2008, PROG NUCL ENERG, V50, P251, DOI 10.1016/j.pnucene.2007.11.007; Lung M, 1998, NUCL ENG DES, V180, P133, DOI 10.1016/S0029-5493(97)00296-3; Shibata K, 2002, J NUCL SCI TECHNOL, V39, P1125, DOI 10.3327/jnst.39.1125; Mazzini G, 2009, SCI TECHNOL NUCL INS, DOI 10.1155/2009/749736; [Anonymous], 2010, IAEATECDOC1645; Boer B, 2009, ANN NUCL ENERGY, V36, P1049, DOI 10.1016/j.anucene.2009.06.008; HANSEN U, 1972, NUCL SCI ENG, V47, P132; IAEA, 2000, IAEATECDOC1155; IAEA, 2005, IAEATECDOC1450; IAEA, 2003, IAEATECDOC1349; Imamura T, 2002, J NUCL SCI TECHNOL, V39, P226, DOI 10.3327/jnst.39.226; Liem PH, 1996, ANN NUCL ENERGY, V23, P207, DOI 10.1016/0306-4549(95)00018-1; Mulder E, 2008, NUCL ENG DES, V238, P2893, DOI 10.1016/j.nucengdes.2008.01.023; Nagaya Y, 2005, JAERI1348; Nikitin K, 1999, ANN NUCL ENERGY, V26, P1021; Shmelev A., 2000, P 2 ANN JNC INT FOR, P8795; Tran HN, 2009, NUCL ENG DES, V239, P2357, DOI 10.1016/j.nucengdes.2009.07.022; Tran HN, 2008, NUCL SCI ENG, V158, P264; Tran HN, 2012, PROG NUCL ENERG, V60, P47, DOI 10.1016/j.pnucene.2012.05.006; Tran HN, 2012, NUCL ENG DES, V253, P269, DOI 10.1016/j.nucengdes.2012.08.028; Tran HN, 2008, NUCL SCI ENG, V159, P83	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-1970			PROG NUCL ENERG	Prog. Nucl. Energy	APR	2015	80						17	23		10.1016/j.pnucene.2014.11.024		7	Nuclear Science & Technology	Nuclear Science & Technology	CD0QR	WOS:000350779500003		
J	Rawan, AF; Yoshioka, S; Abe, H; Acosta, TJ				Rawan, A. F.; Yoshioka, S.; Abe, H.; Acosta, T. J.			Insulin-Like Growth Factor-1 Regulates the Expression of Luteinizing Hormone Receptor and Steroid Production in Bovine Granulosa Cells	REPRODUCTION IN DOMESTIC ANIMALS			English	Article							FOLLICLE-STIMULATING-HORMONE; ESTROUS-CYCLE; FLUID FACTORS; INTRAFOLLICULAR INJECTION; DOMINANT FOLLICLES; GENE-EXPRESSION; CATTLE; SELECTION; DEVIATION; 3,5-MONOPHOSPHATE	Contents Luteinizing hormone LH plays important roles in follicular maturation and ovulation. The effects of LH are mediated by LH receptor (LHR) in the ovary. However, the factors that regulate the expression of LHR in bovine granulosa cells (GCs) are not well known. Insulin-like growth factor-1 (IGF-1) is known to play a key role in the acquisition and maintenance of functional dominance. To better understand the roles of LHR expression and IGF-1, we conducted three experiments to determine (i) mRNA expression of LHR in the GCs of developing follicles, (ii) the effects of IGF-1 on LHRmRNA expression in cultured GCs and (iii) the effects of IGF-1 on estradiol (E2), progesterone (P4) and androstenedione (A4) production by non-luteinized GCs. In experiment 1, small follicles (<6mm O) expressed lower levels of LHR than mid-sized follicles (6-8mm O) and large follicles (9mm O) expressed the highest levels of LHRmRNA (p<0.05). In experiment 2, IGF-1 (1 and 100ng/ml) increased (p<0.05) the expression of LHRmRNA in GCs from small and large follicles. In experiment 3, IGF-1 (0.1-100ng/ml) increased A4 and E2 in GCs from both small and large follicles but increased P4 only in large follicles. IGF-1 in combination with LH (0.1 and 1ng/ml) increased P4 and A4 in large follicles, and increased E2 and A4 in GCs of small follicles. These findings strongly support the concept that IGF-1 upregulates LHRmRNA expression as well as A4 and E2 production in GCs and that IGF-1 is required for determining which follicle becomes dominant and acquires ovulatory capacity.	[Rawan, A. F.; Yoshioka, S.; Abe, H.; Acosta, T. J.] Okayama Univ, Grad Sch Environm & Life Sci, Reprod Physiol Lab, Okayama 7008530, Japan	Acosta, TJ (reprint author), Obihiro Univ, Field Ctr Anim Sci & Agr, Farm Anim Dis Control Sect, Obihiro, Hokkaido 0808555, Japan.	tjacosta@obihiro.ac.jp					Luo WX, 2011, BIOL REPROD, V84, P369, DOI 10.1095/biolreprod.110.085274; Hillier SG, 2001, MOL CELL ENDOCRINOL, V179, P39, DOI 10.1016/S0303-7207(01)00469-5; SAVIO JD, 1988, J REPROD FERTIL, V83, P663; Sartori R, 2001, BIOL REPROD, V65, P1403, DOI 10.1095/biolreprod65.5.1403; Ginther OJ, 1996, BIOL REPROD, V55, P1187, DOI 10.1095/biolreprod55.6.1187; Beg MA, 2006, REPRODUCTION, V132, P365, DOI 10.1530/rep.1.01233; LANGHOUT DJ, 1991, J ANIM SCI, V69, P3321; Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190; Beg MA, 2001, BIOL REPROD, V64, P432, DOI 10.1095/biolreprod64.2.432; Nogueira MFG, 2007, MOL REPROD DEV, V74, P680, DOI 10.1002/mrd.20656; Baker J, 1996, MOL ENDOCRINOL, V10, P903, DOI 10.1210/me.10.7.903; Lopez H, 2005, BIOL REPROD, V72, P788, DOI 10.1095/biolrepond.104.035493; Bodensteiner KJ, 1996, THERIOGENOLOGY, V45, P499, DOI 10.1016/0093-691X(95)00386-M; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Beg MA, 2002, BIOL REPROD, V66, P120, DOI 10.1095/biolreprod66.1.120; Ginther OJ, 2001, BIOL REPROD, V64, P197, DOI 10.1095/biolreprod64.1.197; Ginther OJ, 2003, BIOL REPROD, V68, P524, DOI 10.1095/biolreprod.102.008474; Ginther OJ, 2004, BIOL REPROD, V70, P1063, DOI 10.1095/biolreprod.103.024844; Ginther OJ, 2004, BIOL REPROD, V70, P99, DOI 10.1095/biolreprod.103.021949; Hirakawa T, 1999, ENDOCRINOLOGY, V140, P4965, DOI 10.1210/en.140.11.4965; Hornick JE, 2013, REPRODUCTION, V145, P19, DOI 10.1530/REP-12-0233; McGee E, 1997, ENDOCRINOLOGY, V138, P2417, DOI 10.1210/en.138.6.2417; Merkus HG, 2009, PARTICLE SIZE MEASUR, P39; Sakumoto R, 2006, DOMEST ANIM ENDOCRIN, V31, P246, DOI 10.1016/j.domaniend.2005.11.001; Spicer LJ, 2000, DOMEST ANIM ENDOCRIN, V18, P265, DOI 10.1016/S0739-7240(99)00084-3; SPICER LJ, 1995, DOMEST ANIM ENDOCRIN, V12, P223, DOI 10.1016/0739-7240(95)00021-6; Tanikawa M, 2005, PROSTAG OTH LIPID M, V78, P279, DOI 10.1016/j.prostaglandins.2005.09.003; Uenoyama Y, 1997, BIOL REPROD, V57, P723, DOI 10.1095/biolreprod57.4.723; XU ZZ, 1995, BIOL REPROD, V53, P951, DOI 10.1095/biolreprod53.4.951	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0936-6768	1439-0531		REPROD DOMEST ANIM	Reprod. Domest. Anim.	APR	2015	50	2					283	291		10.1111/rda.12486		9	Agriculture, Dairy & Animal Science; Reproductive Biology; Veterinary Sciences	Agriculture; Reproductive Biology; Veterinary Sciences	CD5SW	WOS:000351149300017		
J	Ueda, K; Yonemoto, N; Bailey, DB				Ueda, Kimiko; Yonemoto, Naohiro; Bailey, Donald B., Jr.			Psychometric validation of the Family Outcomes Survey-Revised in Japan	RESEARCH IN DEVELOPMENTAL DISABILITIES			English	Article						Early intervention; Psychometric validation; Family Outcomes Survey-Revised; Japan	EARLY INTERVENTION; CHILDREN; DISABILITIES; SERVICES; FIT	According to a revision of Japan's Basic Law for Persons with Disabilities in 2011, Article 17 stipulated the government's obligation to provide early intervention to children with disabilities. However, the concept of family outcomes in early intervention has not really been considered in Japan yet. This article describes the development and validation of the Japanese version of the Family Outcomes Survey Revised (FOS-R). Our goal was to determine whether this survey for assessing how families of children with disabilities are affected by early intervention would be appropriate for use in early intervention in Japan. Both the Japanese version of the FOS-R and an anonymous, self-administered questionnaire about background factors were given to 394 mothers of children who were either currently using or had in the past year used early intervention at an early intervention facility or medical institution. Survey responses were obtained from 335 mothers (response rate of 85.0%). The total number of subjects in the analysis was 301 mothers who answered the Japanese version of the FOS-R completely. To assess content validity, another survey was given to 115 experts involved in supporting children with disabilities and their families. The family outcomes indicator items as well as the helpfulness indicators items showed good psychometric properties. Although the components of the FOS-R worked better as individual subscales than as a single scale, we confirmed that a total score was also psychometrically valid. We also confirmed both content validity and external validity. The Japanese version of the FOS-R appears to be a valid tool for assessing the benefits experienced by families as a result of services received, but further research is needed to determine the nature of practices most likely to lead to positive family outcomes. (C) 2015 Elsevier Ltd. All rights reserved.	[Ueda, Kimiko] Osaka Med Ctr, Izumi, Osaka 5941101, Japan; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Kodaira, Tokyo 1878553, Japan; [Bailey, Donald B., Jr.] RTI Int, Res Triangle Pk, NC 27709 USA	Ueda, K (reprint author), Osaka Med Ctr, 840 Murodo Cho, Izumi, Osaka 5941101, Japan.	kimi-h-u@mch.pref.osaka.jp; nyonemoto@gmail.com; dbailey@rti.org			Japan Society for the Promotion of Science (JSPS); Japanese Ministry of Health Labour Sciences Research Grant, Comprehensive Reserach on Disaiity Health an Welfare [H23-SHINTAI/TITEKI-IPPAN-007]; KAKENHI [24600033]	This work was supported by the Japan Society for the Promotion of Science (JSPS), KAKENHI grant number 24600033 and a Japanese Ministry of Health Labour Sciences Research Grant, Comprehensive Reserach on Disaiity Health an Welfare (H23-SHINTAI/TITEKI-IPPAN-007).	Samuel PS, 2012, J INTELL DISABIL RES, V56, P1, DOI 10.1111/j.1365-2788.2011.01486.x; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037//0033-2909.88.3.588; Dunst CJ, 2007, MENT RETARD DEV D R, V13, P370, DOI 10.1002/mrdd.20176; Kenny DA, 2003, STRUCT EQU MODELING, V10, P333, DOI 10.1207/S15328007SEM1003_1; Epley PH, 2011, J EARLY INTERVENTION, V33, P201, DOI 10.1177/1053815111425929; Bailey DB, 2005, PEDIATRICS, V116, P1346, DOI 10.1542/peds.2004-1239; Bailey DB, 2006, J EARLY INTERVENTION, V28, P227, DOI 10.1177/105381510602800401; Bailey DB, 2008, INFANT YOUNG CHILD, V21, P194; Bailey DB, 2011, J EARLY INTERVENTION, V33, P6, DOI 10.1177/1053815111399441; King G., 1997, CHILD CARE HLTH DEV, V97, P509; Kodama K., 1998, BRAIN DEV, V30, P197; Koroloff N., 1990, J MENT HEALTH ADMIN, V17, P13; Poon K. K., 2012, INFANTS YOUNG CHILDR, V25, P1; Poon KK, 2014, RES DEV DISABIL, V35, P1534, DOI 10.1016/j.ridd.2014.03.047; Sloper P, 2006, CHILD CARE HLTH DEV, V32, P147, DOI 10.1111/j.1365-2214.2006.00592.x; Ueda K, 2013, RES DEV DISABIL, V34, P3596, DOI 10.1016/j.ridd.2013.07.024	16	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0891-4222			RES DEV DISABIL	Res. Dev. Disabil.	APR	2015	39						55	66		10.1016/j.ridd.2015.01.003		12	Education, Special; Rehabilitation	Education & Educational Research; Rehabilitation	CD3ZO	WOS:000351022600006		
J	Shibayama, S; Baba, Y; Walsh, JP				Shibayama, Sotaro; Baba, Yasunori; Walsh, John P.			Organizational design of University laboratories: Task allocation and lab performance in Japanese bioscience laboratories	RESEARCH POLICY			English	Article						Laboratory; Task allocation; Organizational design; Scientific productivity; Biology	SCIENTIFIC PRODUCTIVITY; ACADEMIC SCIENTISTS; INNOVATION; SCIENCE; WORK	A university laboratory is a fundamental unit of scientific production, but optimizing its organizational design is a formidable task for lab heads, who play potentially conflicting roles of manager, educator, and researcher. Drawing on cross-sectional data from a questionnaire survey and bibliometric data on Japanese biology professors, this study investigates task allocation inside laboratories. Results show a general pattern that lab heads play managerial roles and members (e.g., students) are engaged in labor-intensive tasks (e.g., experiment), while revealing a substantial variation among laboratories. Further examining how this variation is related to lab-level scientific productivity, this study finds that productive task allocation differs by context. In particular, results suggest that significant task overlap across status hierarchies is more productive for basic research, and that rigidly separated task allocation is more productive in applied research. However, optimal task allocation, with regard to scientific productivity, might conflict with other goals of academic organizations, particularly training of future scientists. The paper concludes with a discussion of the policy implications of these findings. (C) 2014 Elsevier B.V. All rights reserved.	[Shibayama, Sotaro; Baba, Yasunori] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Shibayama, Sotaro] Univ Tokyo, Dept Technol Management Innovat, Bunky Ku, Tokyo 1138656, Japan; [Walsh, John P.] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA; [Walsh, John P.] Natl Grad Inst Policy Studies, Minato Ku, Tokyo 1060032, Japan	Shibayama, S (reprint author), Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	shibayama@00.alumni.u-tokyo.ac.jp			Konosuke Matsushita Memorial Foundation; Japan Society for the Promotion of Science [23810004]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [20330077]	We acknowledge financial support from the Konosuke Matsushita Memorial Foundation, Grant-in-Aid for Research Activity Start-up of the Japan Society for the Promotion of Science (#23810004), and Grant-in-Aid for Scientific Research (B) Program (#20330077) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. We acknowledge the U.S. National Science Foundation and the Patent Board for offering us the journal classification data. We appreciate thorough and encouraging comments from three anonymous referees. We acknowledge Ms. Aya Sasaki for technical support.	Agarwal R., 2012, MANAGE SCI, V59, P950; Amabile T. M., 1996, CREATIVITY CONTEXT U; Andrews R., 1979, SCI PRODUCTIVITY EFF; Owen-Smith J, 2001, AM SOCIOL REV, V66, P427, DOI 10.2307/3088887; Teasley SD, 2002, IEEE T SOFTWARE ENG, V28, P671, DOI 10.1109/TSE.2002.1019481; Delamont S, 2001, SOC STUD SCI, V31, P87, DOI 10.1177/030631201031001005; LINDSEY D, 1980, SOC STUD SCI, V10, P145, DOI 10.1177/030631278001000202; HACKMAN JR, 1976, ORGAN BEHAV HUM PERF, V16, P250, DOI 10.1016/0030-5073(76)90016-7; Etzkowitz H, 2000, RES POLICY, V29, P109, DOI 10.1016/S0048-7333(99)00055-4; Ford CM, 1996, ACAD MANAGE REV, V21, P1112, DOI 10.2307/259166; ALLISON PD, 1990, AM SOCIOL REV, V55, P469, DOI 10.2307/2095801; WOODMAN RW, 1993, ACAD MANAGE REV, V18, P293, DOI 10.2307/258761; Heinze T, 2009, RES POLICY, V38, P610, DOI 10.1016/j.respol.2009.01.014; Sauermann H, 2010, MANAGE SCI, V56, P2134, DOI 10.1287/mnsc.1100.1241; Roach M, 2010, RES POLICY, V39, P422, DOI 10.1016/j.respol.2010.01.004; Sauermann H, 2013, ORGAN SCI, V24, P889, DOI 10.1287/orsc.1120.0769; Arimoto A, 2011, CHANG ACAD, V2, P281, DOI 10.1007/978-94-007-1140-2_14; BARBER B, 1958, AM J SOCIOL, V64, P128, DOI 10.1086/222420; Becher T., 1994, GRADUATE ED BRITAIN; Bertalanffy L. V., 1962, GEN SYSTEMS YB; Calvert J, 2004, MINERVA, V42, P251, DOI 10.1023/B:MINE.0000038307.58765.b4; Carayol N, 2006, INF ECON POLICY, V18, P55, DOI 10.1016/j.infoecopol.2005.09.002; Council N. R., 1998, TRENDS EARLY CAREERS; Cyert R., 1963, BEHAV THEORY FIRM; Delamont S, 1997, BRIT J SOCIOL EDUC, V18, P533, DOI 10.1080/0142569970180404; Drazin R., 1985, ADM SCI Q, V30, P514, DOI DOI 10.2307/2392695; FOX MF, 1992, SOCIOL EDUC, V65, P293, DOI 10.2307/2112772; HACKETT EJ, 1990, J HIGH EDUC, V61, P241, DOI 10.2307/1982130; Hollingsworth R, 2000, PRACTISING INTERDISC, P215; Kneller R., 2007, CHANGING GOVERNANCE; Knorr-Cetina K., 1999, EPISTEMIC CULTURES S; Latour B., 1979, LAB LIFE CONSTRUCTIO; LEVIN SG, 1989, RES HIGH EDUC, V30, P531, DOI 10.1007/BF00992202; LONG JS, 1981, AM SOCIOL REV, V46, P422, DOI 10.2307/2095262; Merton R. K., 1973, SOCIOLOGY SCI; Merton R. K., 1968, SOCIAL THEORY SOCIAL, P156; Merton RK, 2004, TRAVELS AND ADVENTURES OF SERENDIPITY: A STUDY IN SOCIOLOGICAL SEMANTICS AND THE SOCIOLOGY OF SCIENCE, P1; NARIN F, 1976, J AM SOC INFORM SCI, V27, P25; NELSON RR, 1959, J POLIT ECON, V67, P297, DOI 10.1086/258177; Nightingale P, 1998, RES POLICY, V27, P689, DOI 10.1016/S0048-7333(98)00078-X; OECD, 2013, FP7ADHOC200713 OECD, VFP7-Adhoc-2007-13; Pelz D. C., 1966, SCI ORG; Salonius A., 2008, WORKING LAB SOCIAL O; Seymore S. B., 2009, NC L REV, V88, P185; Shibayama S, 2011, SCIENTOMETRICS, V88, P43, DOI 10.1007/s11192-011-0392-z; Shibayama S, 2012, AM SOCIOL REV, V77, P804, DOI 10.1177/0003122412452874; Shimizu H., 2012, SCHUMP C BRISB AUSTR; Simon Herbert A., 1957, ADM BEHAV STUDY DECI; Stapleton D. H., 2004, CONTRIBUTIONS HIST R; Stephan P. E., 1996, J ECON LIT, V34, P1199; Stokes D.E., 1997, PASTEURS QUADRANT BA; Traweek S, 1988, BEAMTIMES LIFETIMES; Tunzelmann N. V., 2003, EFFECTS SIZE RES PER; VanAndel P., 1992, CREATIVITY INNOVATIO, V1, P20; Weesie J., 1999, STATA TECH B, V52, P34; Whitley R., 1984, INTELLECTUAL SOCIAL; Zuckermann H., 1977, SCI ELITE NOBEL LAUR	57	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0048-7333	1873-7625		RES POLICY	Res. Policy	APR	2015	44	3					610	622		10.1016/j.respol.2014.12.003		13	Management; Planning & Development	Business & Economics; Public Administration	CD1MA	WOS:000350837800005		
J	Lee, YN; Walsh, JP; Wang, J				Lee, You-Na; Walsh, John P.; Wang, Jian			Creativity in scientific teams: Unpacking novelty and impact	RESEARCH POLICY			English	Article						Team science; Creativity; Interdisciplinarity; Division of labor; Size	WORK GROUP DIVERSITY; RESEARCH COLLABORATION; STATISTICAL PROPERTIES; SOCIAL-PSYCHOLOGY; ACADEMIC SCIENCE; AUTHORED PAPERS; GROUP-SIZE; PERFORMANCE; ORGANIZATIONS; KNOWLEDGE	The increasing dominance of team science highlights the importance of understanding the effects of team composition on the creativity of research results. In this paper, we analyze the effect of team size, and field and task variety on creativity. Furthermore, we unpack two facets of creativity in science: novelty and impact. We find that increasing team size has an inverted-U shaped relation with novelty. We also find that the size-novelty relationship is largely due to the relation between size and team field or task variety, consistent with the information processing perspective. On the other hand, team size has a continually increasing relation with the likelihood of a high-impact paper. Furthermore, variety does not have a direct effect on impact, net of novelty. This study develops our understanding of team science and highlights the need for a governance approach to scientific work. We also advance the creativity literature by providing an ex ante objective bibliometric measure that distinguishes novelty from impact, and illustrate the distinct team-level drivers of each. We conclude with a discussion of the policy implications of our findings. (C) 2014 Elsevier B.V. All rights reserved.	[Lee, You-Na; Walsh, John P.] Georgia Inst Technol, Atlanta, GA 30332 USA; [Walsh, John P.] Natl Grad Inst Policy Studies GRIPS, Tokyo, Japan; [Wang, Jian] Univ Leuven, Leuven, Belgium; [Wang, Jian] Inst Res Informat & Qual Assurance iFQ, Bonn, Germany	Walsh, JP (reprint author), Georgia Inst Technol, Sch Publ Policy, 685 Cherry St, Atlanta, GA 30332 USA.	jpwalsh@gatech.edu	Wang, Jian/E-6080-2011	Wang, Jian/0000-0003-0520-737X	German Federal Ministry of Education and Research (BMBF) [01PQ08004A]; Hitotsubashi University; Japan's National Institute for Science and Technology Policy; Georgia Tech Ivan Allen College research grant; NSF [1262418]	We would to thank the Competence Center for Bibliometrics for the German Science System (KB) for providing access to their Web of Science database for constructing the novelty measure. The novelty measure is constructed from a database derived from the 1980 to 2012 Science Citation Index Expanded (SCI-E), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI), Conference Proceedings Citation Index-Science (CPCI-S), and Conference Proceedings Citation Index-Social Science & Humanities (CPCI-SSH) prepared by Thomson Reuters Inc. (TR (R)), Philadelphia, PA, USA: (C)Copyright Thomson Reuters 2013. KB is funded by the German Federal Ministry of Education and Research (BMBF, project number: 01PQ08004A). The survey data were collected with funding from Hitotsubashi University and Japan's National Institute for Science and Technology Policy. J.P. Walsh was also partially supported by Georgia Tech Ivan Allen College research grant and NSF grant (#1262418). Earlier versions of this paper were presented at 4S Annual Meeting, San Diego; Workshop on the Organization, Economics and Policy of Scientific Research, Turin; Barcelona GSE Summer Forum; SciTS Conference, Austin; and ETH Zurich. We would like to thank the conference participants, and the anonymous reviewers, for helpful comments on the paper.	AMABILE TM, 1982, J PERS SOC PSYCHOL, V43, P997, DOI 10.1037/0022-3514.43.5.997; AMABILE TM, 1983, J PERS SOC PSYCHOL, V45, P357, DOI 10.1037//0022-3514.45.2.357; Andrews F. M., 1976, SCI ORG PRODUCTIVE C, Vsecond, P337; Hargadon AB, 2006, ORGAN SCI, V17, P484, DOI 10.1287/orsc.1060.0200; Pieterse AN, 2013, ACAD MANAGE J, V56, P782, DOI 10.5465/amj.2010.0992; Dahlin KB, 2005, RES POLICY, V34, P717, DOI 10.1016/j.respol.205.03.009; Hicks D, 2011, MINERVA, V49, P137, DOI 10.1007/s11024-011-9170-6; ETZKOWITZ H, 1983, MINERVA, V21, P198; Fleming L, 2007, ADMIN SCI QUART, V52, P443; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Harvey S, 2013, ADMIN SCI QUART, V58, P346, DOI 10.1177/0001839213498591; Stewart GL, 2006, J MANAGE, V32, P29, DOI 10.1177/0149206305277792; ZUCKERMAN H, 1967, AM SOCIOL REV, V32, P391, DOI 10.2307/2091086; Tang L, 2010, SCIENTOMETRICS, V84, P763, DOI 10.1007/s11192-010-0196-6; [Anonymous], 1985, ADM SCI Q, DOI DOI 10.2307/2392692; Melin G, 2000, RES POLICY, V29, P31, DOI 10.1016/S0048-7333(99)00031-1; Fiore SM, 2008, SMALL GR RES, V39, P251, DOI 10.1177/104649W8317797; Hong L, 2004, P NATL ACAD SCI USA, V101, P16385, DOI 10.1073/pnas.0403723101; COLE S, 1967, AM SOCIOL REV, V32, P377, DOI 10.2307/2091085; Baer M, 2012, ACAD MANAGE J, V55, P1102, DOI 10.5465/amj.2009.0470; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Singh J, 2005, MANAGE SCI, V51, P756, DOI 10.1287/mnsc.1040.0349; Hulsheger UR, 2009, J APPL PSYCHOL, V94, P1128, DOI 10.1037/a0015978; Cummings JN, 2005, SOC STUD SCI, V35, P703, DOI 10.1177/03061270505535; Singh J, 2010, MANAGE SCI, V56, P41, DOI 10.1287/mnsc.1090.1072; Stokols D, 2008, AM J PREV MED, V35, pS77, DOI 10.1016/j.amepre.2008.05.002; Cohen SG, 1997, J MANAGE, V23, P239, DOI 10.1177/014920639702300303; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; BARLEY SR, 1994, WORK OCCUPATION, V21, P85, DOI 10.1177/0730888494021001004; Ford CM, 1996, ACAD MANAGE REV, V21, P1112, DOI 10.2307/259166; WOODMAN RW, 1993, ACAD MANAGE REV, V18, P293, DOI 10.2307/258761; ALDRICH HE, 1976, ANNU REV SOCIOL, V2, P79, DOI 10.1146/annurev.so.02.080176.000455; Schoenmakers W, 2010, RES POLICY, V39, P1051, DOI 10.1016/j.respol.2010.05.013; Falk-Krzesinski HJ, 2010, CTS-CLIN TRANSL SCI, V3, P263, DOI 10.1111/j.1752-8062.2010.00223.x; Merton RK, 1940, SOC FORCES, V18, P560, DOI 10.2307/2570634; Taylor A, 2006, ACAD MANAGE J, V49, P723; Rafols I, 2010, SCIENTOMETRICS, V82, P263, DOI 10.1007/s11192-009-0041-y; Heinze T, 2009, RES POLICY, V38, P610, DOI 10.1016/j.respol.2009.01.014; Jones BF, 2009, REV ECON STUD, V76, P283, DOI 10.1111/j.1467-937X.2008.00531.x; Carayol N, 2004, RES POLICY, V33, P1081, DOI 10.1016/j.respol.2004.03.004; Uzzi B, 2013, SCIENCE, V342, P468, DOI 10.1126/science.1240474; Fleming L, 2001, MANAGE SCI, V47, P117, DOI 10.1287/mnsc.47.1.117.10671; Lavie D, 2012, ORGAN SCI, V23, P704, DOI 10.1287/orsc.1110.0656; Cummings JN, 2013, PSYCHOL SCI, V24, P880, DOI 10.1177/0956797612463082; Harrison DA, 2007, ACAD MANAGE REV, V32, P1199; Amason AC, 1997, J MANAGE, V23, P495, DOI 10.1177/014920639702300401; van Knippenberg D, 2004, J APPL PSYCHOL, V89, P1008, DOI 10.1037/0021-9010.89.6.1008; Pelled LH, 1999, ADMIN SCI QUART, V44, P1, DOI 10.2307/2667029; Uzzi B, 2005, AM J SOCIOL, V111, P447, DOI 10.1086/432782; Jehn KA, 1999, ADMIN SCI QUART, V44, P741, DOI 10.2307/2667054; Yong K, 2014, SMALL GR RES, V45, P266, DOI 10.1177/1046496414530789; Simonton DK, 2003, PSYCHOL BULL, V129, P475, DOI 10.1037/0033-2909.129.4.475; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Skilton PF, 2010, ACAD MANAGE REV, V35, P118; Harvey S, 2014, ACAD MANAGE REV, V39, P324, DOI 10.5465/amr.2012.0224; ANCONA DG, 1992, ADMIN SCI QUART, V37, P634, DOI 10.2307/2393475; Adams JD, 2005, RES POLICY, V34, P259, DOI 10.1016/j.respol.2005.01.014; Milliken FJ, 1996, ACAD MANAGE REV, V21, P402, DOI 10.2307/258667; Antonelli C, 2011, IND CORP CHANGE, V20, P201, DOI 10.1093/icc/dtq072; Association of University Technology Managers, 2007, AUTM US LIC ACT SURV; Aube C, 2011, GROUP DYN-THEOR RES, V15, P357, DOI 10.1037/a0025400; Bentley RA, 2007, SCIENCE, V317, P1496; BLAU PM, 1970, AM SOCIOL REV, V35, P201, DOI 10.2307/2093199; BLAU PM, 1966, AM SOCIOL REV, V31, P179, DOI 10.2307/2090903; Brown C., 2013, FERMILAB SCI WORK, V18, P42; CHILD J, 1973, ADMIN SCI QUART, V18, P168, DOI 10.2307/2392061; Clark K.B., 1987, BROOKINGS PAPERS EC, V3, P729; COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553; Contractor N. S., 2013, PHILOS T R SOC A, V371, P1; CULLEN JB, 1986, ACAD MANAGE J, V29, P203, DOI 10.2307/256186; De Bellis N, 2009, BIBLIOMETRICS CITATI; de Solla Price D. J., 1986, LITTLE SCI BIG SCI; EVERS FT, 1976, ADMIN SCI QUART, V21, P326, DOI 10.2307/2392049; FLEISHMAN JA, 1980, J PERS SOC PSYCHOL, V38, P629, DOI 10.1037/0022-3514.38.4.629; Franzoni C., 2010, EXPLORATORY ATTITUDE; GARFIELD E, 1973, NATURE, V242, P485, DOI 10.1038/242485a0; HACKETT EJ, 1990, J HIGH EDUC, V61, P241, DOI 10.2307/1982130; Hare AP, 1952, AM SOCIOL REV, V17, P261, DOI 10.2307/2088071; Hemlin S, 2013, ROUT STUD INNOV ORG, V29, P1; Hicks DM, 1996, SCI TECHNOL HUM VAL, V21, P379, DOI 10.1177/016224399602100401; Hollingsworth J. R., 2006, INNOVATION SCI I CHA, P423; Hollingsworth R., 2004, CREATING TRADITION B; Hong W, 2008, SOC STUD SCI, V38, P543, DOI 10.1177/0306312706092456; Hudson J, 1996, J ECON PERSPECT, V10, P153; Jordan C.B., 2006, INNOVATION SCI I CHA; Kalton G, 1983, INTRO SURVEY SAMPLIN; Katz J. S., 2000, SCI PUBL POLICY, V27, P23, DOI 10.3152/147154300781782156; Katz JS, 1999, RES POLICY, V28, P501, DOI 10.1016/S0048-7333(99)00010-4; Kiesler C. A., 1969, GROUP PRESSURE CONFO; KIMBERLY JR, 1976, ADMIN SCI QUART, V21, P571, DOI 10.2307/2391717; Lariviere V, 2010, J AM SOC INF SCI TEC, V61, P126, DOI 10.1002/asi.21226; Latour B., 1979, LAB LIFE; Lee E., 1989, ANAL COMPLEX SURVEY; MANNERS GE, 1975, ACAD MANAGE J, V18, P715, DOI 10.2307/255374; MARTIN BR, 1983, RES POLICY, V12, P61, DOI 10.1016/0048-7333(83)90005-7; Merton RK, 1973, SOCIOLOGY SCI THEORE; MEYER MW, 1972, AM SOCIOL REV, V37, P434, DOI 10.2307/2093182; Moed H. F., 2005, CITATION ANAL RES EV; Mueller J. S., 2011, PSYCHOL SCI; National Academy of Sciences National Academy of Engineering and Institute of Medicine. Committee on Facilitating Interdisciplinary Research, 2004, FAC INT RES; National Research Council, 1995, RES DOCT PROGR US CO; Nelson R., 1982, EVOLUTIONARY THEORY; Nemet GF, 2012, RES POLICY, V41, P190, DOI 10.1016/j.respol.2011.08.009; NEWMAN JM, 1993, J APPL PSYCHOL, V78, P518; Nooteboom B., 2008, HDB INTERORGANIZATIO, P607; NRC, 2014, CAPT CHANG SCI TECHN; Obstfeld D, 2005, ADMIN SCI QUART, V50, P100; Page S., 2007, THE DIFFERENCE; Pelz D.C., 1976, SCI ORG; Pfeffer J., 1978, EXTERNAL CONTROL ORG; Rogers JD, 2010, RES EVALUAT, V19, P281, DOI 10.3152/095820210X12827366906409; Schumpeter Joseph A., 1939, BUSINESS CYCLES THEO; Shibayama S., 2013, SOCIAL ORG LIFE SCI; Shrum W., 2007, STRUCTURES SCI COLLA; Simonton D. K., 2004, CREATIVITY SCI CHANC; Simonton D.K., 1999, ORIGINS GENIUS DARWI; Smith A, 1776, WEALTH NATIONS; Steele TW, 2000, J AM SOC INFORM SCI, V51, P476, DOI 10.1002/(SICI)1097-4571(2000)51:5<476::AID-ASI8>3.3.CO;2-7; Stephan Paula, 2012, EC SHAPES SCI; Swatez G. M., 1966, THESIS U CALIFORNIA; Traweek S, 1988, BEAMTIMES LIFETIMES; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Valderas JM, 2007, SCIENCE, V317, P1496; van Raan AFJ, 2006, J AM SOC INF SCI TEC, V57, P408, DOI 10.1002/asi.20284; van Raan AFJ, 2006, J AM SOC INF SCI TEC, V57, P1919, DOI 10.1002/asi.20389; Vogel AL, 2013, AM J PREV MED, V45, P787, DOI 10.1016/j.amepre.2013.09.001; Walsh J. P., 2013, AM SOC ASS ANN M NEW; Wang J, 2014, J INFORMETR, V8, P329, DOI 10.1016/j.joi.2014.01.006; West BT, 2008, STATA J, V8, P520; Whitley R., 1984, INTELLECTUAL SOCIAL; Williams KY, 1998, RES ORGAN BEHAV, V20, P77; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Yen De Ven A. H., 1976, AM SOCIOL REV, V41, P322; Zhu MX, 2013, SOC NETWORKS, V35, P251, DOI 10.1016/j.socnet.2013.03.001	134	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0048-7333	1873-7625		RES POLICY	Res. Policy	APR	2015	44	3					684	697		10.1016/j.respol.2014.10.007		14	Management; Planning & Development	Business & Economics; Public Administration	CD1MA	WOS:000350837800010		
J	Nishitani, I; Matsumura, T; Ozawa, M; Yorozu, A; Takahashi, M				Nishitani, Ippei; Matsumura, Tetsuya; Ozawa, Mayumi; Yorozu, Ayanori; Takahashi, Masaki			Human-centered X-Y-T space path planning for mobile robot in dynamic environments	ROBOTICS AND AUTONOMOUS SYSTEMS			English	Article						Mobile robot; Robot navigation; Dynamic environments; X-Y-T space path planning	OBSTACLE AVOIDANCE; NAVIGATION	An autonomous mobile robot in a human's living space should be able to realize not only collision-free motion, but also human-centered motion, i.e., motion giving priority to a moving human according to the situation. In this study, we propose a real-time obstacle avoidance method for an autonomous mobile robot that considers the robot's dynamic constraints, personal space, and the human's directional area using grid-based X-Y-T space path planning. The proposed method generates collision-free motion in which the robot can give way to humans. The relative position, velocity and avoidance motion with respect to the robot varies from person to person. To show the effectiveness of the proposed method to human-like motion, we verify the robot's motion under several assumed scenarios by changing the initial state of both the robot and the human. Moreover, we verify the robot's motion with respect to a simulated human based on the human-like behavior approach. Through these simulations, we confirm that the proposed method is able to generate safe human-centered motion under several assumed scenarios. Additionally, the effectiveness of the proposed method in practice is confirmed by experiments in which the human's position and velocity are estimated using a laser range finder. (C) 2015 Elsevier B.V. All rights reserved.	[Nishitani, Ippei; Matsumura, Tetsuya; Ozawa, Mayumi; Yorozu, Ayanori] Keio Univ, Sch Sci Open & Environm Syst, Grad Sch Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Takahashi, Masaki] Keio Univ, Dept Syst Design Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Nishitani, I (reprint author), Keio Univ, Sch Sci Open & Environm Syst, Grad Sch Sci & Technol, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	ippeinishitani@a3.keio.jp; matsumura.te28@gmail.com; mayumi65oz@gmail.com; ayanoriyorozu@a5.keio.jp; takahashi@sd.keio.ac.jp					Minguez J, 2004, IEEE T ROBOTIC AUTOM, V20, P45, DOI 10.1109/TRA.2003.820849; Lam CP, 2011, IEEE T ROBOT, V27, P99, DOI 10.1109/TRO.2010.2076851; Kruse T, 2013, ROBOT AUTON SYST, V61, P1726, DOI 10.1016/j.robot.2013.05.007; Takahashi M, 2010, ROBOT AUTON SYST, V58, P889, DOI 10.1016/j.robot.2010.03.010; Large F, 2005, AUTON ROBOT, V19, P159, DOI 10.1007/s10514-005-0610-8; Fiorini P, 1998, INT J ROBOT RES, V17, P760, DOI 10.1177/027836499801700706; BORENSTEIN J, 1991, IEEE T ROBOTIC AUTOM, V7, P278, DOI 10.1109/70.88137; Fox D., 1997, IEEE ROBOTICS AUTOMA, V4, P22; Fraichard T, 2007, IEEE INT CONF ROBOT, P1140, DOI 10.1109/ROBOT.2007.363138; Fraichard T., 2004, P IEEE INT C INT ROB, P388; Guzzi J, 2013, IEEE INT CONF ROBOT, P423, DOI 10.1109/ICRA.2013.6630610; Howard TM, 2014, IEEE ROBOT AUTOM MAG, V21, P64, DOI 10.1109/MRA.2013.2294914; Jerome G., 2013, P IEEE RSJ INT C INT, P2622; Kakinuma K., 2011, IEEE INT C ROB BIOM, P998; KHATIB O, 1986, INT J ROBOT RES, V5, P90, DOI 10.1177/027836498600500106; Kirby R., 2009, P 18 IEEE INT S ROB, P607; Liu C.H., 2008, J INFRASTRUCTURE P D, V64, P513; Nak Y., 1998, P IEEE INT C ROB AUT, P1615; Nishitani I, 2014, APPL MECH MATER, V490-491, P1163, DOI 10.4028/www.scientific.net/AMM.490-491.1163; Ohki T, 2012, ADV ROBOTICS, V26, P1623, DOI 10.1080/01691864.2012.694648; Pacchierotti E., 2005, P 2005 IEEE INT WORK, P164; Pacchierotti E, 2006, P 15 IEEE INT S ROB, P315; Phillips M., 2011, P IEEE INT C ROB AUT, P5628; Sakahara H, 2008, 2008 IEEE/SICE INTERNATIONAL SYMPOSIUM ON SYSTEM INTEGRATION, P60, DOI 10.1109/SI.2008.4770427; Shiller Z, 2011, IEEE INT C INT ROBOT, P3539, DOI 10.1109/IROS.2011.6048288; Takahashi M, 2009, ICINCO 2009: PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON INFORMATICS IN CONTROL, AUTOMATION AND ROBOTICS, VOL 2, P449; Tokuse N, 2008, 2008 IEEE/SICE INTERNATIONAL SYMPOSIUM ON SYSTEM INTEGRATION, P12, DOI 10.1109/SI.2008.4770419; Tsubouchi T., 1994, J ROBOTICS SOC JAPAN, V12, P1029; Yorozu A., 2014, P INT C INF CONTR AU, P127	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8890	1872-793X		ROBOT AUTON SYST	Robot. Auton. Syst.	APR	2015	66						18	26		10.1016/j.robot.2014.12.018		9	Automation & Control Systems; Computer Science, Artificial Intelligence; Robotics	Automation & Control Systems; Computer Science; Robotics	CD2TI	WOS:000350931500002		
J	Takano, W; Hamano, S; Nakamura, Y				Takano, Wataru; Hamano, Seiya; Nakamura, Yoshihiko			Correlated space formation for human whole-body motion primitives and descriptive word labels	ROBOTICS AND AUTONOMOUS SYSTEMS			English	Article						Motion primitive; Word label; Canonical correlation analysis	LATENT SEMANTIC ANALYSIS; ORGANIZATION; RECOGNITION; FEATURES; MODEL	The motion capture technology has been improved, and widely used for motion analysis and synthesis in various fields, such as robotics, animation, rehabilitation, and sports engineering. A massive amount of captured human data has already been collected. These prerecorded motion data should be reused in order to make the motion analysis and synthesis more efficient. The retrieval of a specified motion data is a fundamental technique for the reuse. Imitation learning frameworks have been developed in robotics, where motion primitive data is encoded into parameters in stochastic models or dynamical systems. We have also been making research on encoding motion primitive data into Hidden Markov Models, which are referred to as "motion symbol", and aiming at integrating the motion symbols with language. The relations between motions and words in natural language will be versatile and powerful to provide a useful interface for reusing motion data. In this paper, we construct a space of motion symbols for human whole body movements and a space of word labels assigned to those movements. Through canonical correlation analysis, these spaces are reconstructed such that a strong correlation is formed between movements and word labels. These spaces lead to a method for searching for movement data from a query of word labels. We tested our proposed approach on captured human whole body motion data, and its validity was demonstrated. Our approach serves as a fundamental technique for extracting the necessary movements from a database and reusing them. (C) 2015 The Authors. Published by Elsevier B.V.	[Takano, Wataru; Hamano, Seiya; Nakamura, Yoshihiko] Univ Tokyo, Mechanoinformat, Bunkyo Ku, Tokyo 1138656, Japan	Takano, W (reprint author), Univ Tokyo, Mechanoinformat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	takano@ynl.t.u-tokyo.ac.jp; hamano@ynl.t.u-tokyo.ac.jp; nakamura@ynl.t.u-tokyo.ac.jp			PREST "Information Environment and Humans"; Japan Science and Technology Agency; Japan Society for the Promotion of Science [26700021]	This research was supported by PREST "Information Environment and Humans", Japan Science and Technology Agency, and Grant-in-Aid for Young Scientists (A) (26700021), Japan Society for the Promotion of Science.	Inamura T, 2004, INT J ROBOT RES, V23, P363, DOI 10.1177/0278364904042199; DEERWESTER S, 1990, J AM SOC INFORM SCI, V41, P391, DOI 10.1002/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9; Hofmann T, 2001, MACH LEARN, V42, P177, DOI 10.1023/A:1007617005950; Tani J, 2003, IEEE T SYST MAN CY A, V33, P481, DOI 10.1109/TSMCA.2003.809171; Breazeal C, 2002, TRENDS COGN SCI, V6, P481, DOI 10.1016/S1364-6613(02)02016-8; Billard AG, 2006, ROBOT AUTON SYST, V54, P370, DOI 10.1016/j.robot.2006.01.007; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Argall BD, 2009, ROBOT AUTON SYST, V57, P469, DOI 10.1016/j.robot.2008.10.024; TAKANE Y, 1977, PSYCHOMETRIKA, V42, P7, DOI 10.1007/BF02293745; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Hotelling H., 1936, RELATION 2 SETS VARI; Ijspeert A. J., 2003, NEURAL INFORM PROCES, V15, P1547; Inamura T., 2003, P IEEE INT C HUM ROB, plb; Kadone H, 2005, P 2005 IEEE RSJ INT, P2900; Okada M., 2002, Proceedings 2002 IEEE International Conference on Robotics and Automation (Cat. No.02CH37292), DOI 10.1109/ROBOT.2002.1014741; Saussure F. D., 1966, COURSE GEN LINGUISTI; Takano W, 2010, P IEEE RAS-EMBS INT, P52; Takano W, 2007, IEEE INT CONF ROBOT, P3092, DOI 10.1109/ROBOT.2007.363942	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8890	1872-793X		ROBOT AUTON SYST	Robot. Auton. Syst.	APR	2015	66						35	43		10.1016/j.robot.2014.11.020		9	Automation & Control Systems; Computer Science, Artificial Intelligence; Robotics	Automation & Control Systems; Computer Science; Robotics	CD2TI	WOS:000350931500004		
J	Takano, W; Nakamura, Y				Takano, Wataru; Nakamura, Yoshihiko			Symbolically structured database for human whole body motions based on association between motion symbols and motion words	ROBOTICS AND AUTONOMOUS SYSTEMS			English	Article						Motion database; Motion recognition/generation; Hidden Markov Model; Motion symbol; Motion words	IMITATION; ROBOT; RECOGNITION; MODELS	Motion capture systems have been commonly used to enable humanoid robots or CG characters to perform human-like motions. However, prerecorded motion capture data cannot be reused efficiently because picking a specific motion from a large database and modifying the motion data to fit the desired motion patterns are difficult tasks. We have developed an imitative learning framework based on the symbolization of motion patterns using Hidden Markov Models (HMMs), where each HMM (hereafter referred to as "motion symbol") abstracts the dynamics of a motion pattern and allows motion recognition and generation. This paper describes a symbolically structured motion database that consists of original motion data, motion symbols, and motion words. Each motion data is labeled with motion symbols and motion words. Moreover, a network is formed between two layers of motion symbols and motion words based on their probability association. This network makes it possible to associate motion symbols with motion words and to search for motion datasets using motion symbols. The motion symbols can also generate motion data. Therefore, the developed framework can provide the desired motion data when only the motion words are input into the database. (C) 2015 The Authors. Published by Elsevier B.V.	[Takano, Wataru; Nakamura, Yoshihiko] Univ Tokyo, Mechanoinformat, Bunkyo Ku, Tokyo 1138656, Japan	Takano, W (reprint author), Univ Tokyo, Mechanoinformat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	takano@ynl.t.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [19024024]; Japan Society for the Promotion of Science [26700021]	This research was supported by "The i-Explosion Project" of the Grant-in-Aid for Scientific Research on Priority Areas (19024024), the Ministry of Education, Culture, Sports, Science and Technology, and Grant-in-Aid for Young Scientists (A) (26700021), Japan Society for the Promotion of Science. We would like to thank Atsushi Shiozawa, Toshio Murata, and Sumio Ito of Bandai Namco Corporation for letting us use their motion capture dataset.	Aarno D, 2008, ROBOT AUTON SYST, V56, P692, DOI 10.1016/j.robot.2007.11.005; Schaal S, 1999, TRENDS COGN SCI, V3, P233, DOI 10.1016/S1364-6613(99)01327-3; Inamura T, 2004, INT J ROBOT RES, V23, P363, DOI 10.1177/0278364904042199; Sugita Y, 2005, ADAPT BEHAV, V13, P33, DOI 10.1177/105971230501300102; Rose C, 1998, IEEE COMPUT GRAPH, V18, P32, DOI 10.1109/38.708559; Riley M, 2003, IEEE INT CONF ROBOT, P2368, DOI 10.1109/ROBOT.2003.1241947; Tani J, 2003, IEEE T SYST MAN CY A, V33, P481, DOI 10.1109/TSMCA.2003.809171; Billard AG, 2006, ROBOT AUTON SYST, V54, P370, DOI 10.1016/j.robot.2006.01.007; Arikan O, 2003, ACM T GRAPHIC, V22, P402, DOI 10.1145/882262.882284; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Arikan O, 2002, ACM T GRAPHIC, V21, P483; Pullen K, 2002, ACM T GRAPHIC, V21, P501; Hart P.E., 1968, IEEE Transactions on Systems Science and Cybernetics, VSSC-4, DOI 10.1109/TSSC.1968.300136; TAKANE Y, 1977, PSYCHOMETRIKA, V42, P7, DOI 10.1007/BF02293745; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Arie H, 2012, ROBOT AUTON SYST, V60, P729, DOI 10.1016/j.robot.2011.11.005; Asfour T, 2006, P IEEE RAS INT C HUM, P40; Bowden R., 2000, IEEE WORKSH HUM MOLD; Brown P. F., 1993, Computational Linguistics, V19; Ijspeert A. J., 2003, NEURAL INFORM PROCES, V15, P1547; Inamura T, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P334, DOI 10.1109/IROS.2008.4651194; Inamura T., 2003, P IEEE RAS INT C HUM, p1b; Kovar L., 2002, ACM T GRAPH, V21; Lee JH, 2002, ACM T GRAPHIC, V21, P491; Li Y, 2002, ACM T GRAPHIC, V21, P465; Nakaoka S, 2003, IEEE INT CONF ROBOT, P3905; Ogata T, 2007, P IEEE RSJ INT C INT, P1858; Okada M., 2002, Proceedings 2002 IEEE International Conference on Robotics and Automation (Cat. No.02CH37292), DOI 10.1109/ROBOT.2002.1014741; Pollard N., 2002, P IEEE INT C ROB AUT, V2, P1390, DOI 10.1109/ROBOT.2002.1014737; Sidenbladh H, 2002, LECT NOTES COMPUT SC, V2350, P784; Takano W., 2006, P IEEE RAS INT C HUM, P425; Witkin A., 1995, P SIGGRAPH 95, P105, DOI DOI 10.1145/218380.218422	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8890	1872-793X		ROBOT AUTON SYST	Robot. Auton. Syst.	APR	2015	66						75	85		10.1016/j.robot.2014.12.008		11	Automation & Control Systems; Computer Science, Artificial Intelligence; Robotics	Automation & Control Systems; Computer Science; Robotics	CD2TI	WOS:000350931500008		
J	Bonnet, V; Coste, CA; Lapierre, L; Cadic, J; Fraisse, P; Zapata, R; Venture, G; Geny, C				Bonnet, V.; Coste, C. Azevedo; Lapierre, L.; Cadic, J.; Fraisse, P.; Zapata, R.; Venture, G.; Geny, C.			Towards an affordable mobile analysis platform for pathological walking assessment	ROBOTICS AND AUTONOMOUS SYSTEMS			English	Article						Rehabilitation; Mobile robot for clinical assessment; Gait analysis; Mobile robot navigation; Kinect sensor	PARKINSONS-DISEASE; HEALTHY-SUBJECTS; GAIT; TRACKING; DEPTH; FEATURES; CAMERA; KINECT; LASER	This paper proposes an affordable mobile platform for pathological gait analysis. Gait spatio-temporal parameters are of great importance in clinical evaluation but often require expensive equipment and are limited to a small and controlled environment. The proposed system uses state-of-the art robotic tools, in contrast to their original use, for the development of a robust low-cost diagnostic decision-making tool. The mobile system, which is driven by a Kinect sensor, is able to (1) follow a patient at a constant distance on his own defined path, and (2) to estimate the gait spatio-temporal parameters. The Robust Tracking-Learning-Detection algorithm estimates the positions of the targets attached to the trunk and heels of the patient. Real-condition experimental validation including the corridor, occlusion cases, and illumination changes was performed. A gold standard stereophotogrammetric system was also used and showed good tracking of the patient and an accuracy in the stride length estimate of 2%. Finally, preliminary results showed an RMS error that was below 100 in the 3D lower-limb joint angle estimates during walking on a treadmill. (C) 2014 Elsevier B.V. All rights reserved.	[Bonnet, V.; Geny, C.] Univ Montpellier I, M2H EUROMOV, Montpellier, France; [Coste, C. Azevedo; Lapierre, L.; Cadic, J.; Fraisse, P.; Zapata, R.] Univ Montpellier 2, CNRS, LIRMM, Montpellier, France; [Coste, C. Azevedo] INRIA LIRMM, DEMAR, Montpellier, France; [Venture, G.] Tokyo Univ Agr & Technol, Dept Mech Syst Engn, Fuchu, Tokyo 183, Japan; [Geny, C.] CHU Montpellier, Dept Neurol, Montpellier, France; [Geny, C.] CHU Montpellier, Internal Med & Gerontol Serv, Montpellier, France	Bonnet, V (reprint author), Univ Montpellier I, M2H EUROMOV, Montpellier, France.	bonnet.vincent@gmail.com	Venture, Gentiane/E-7060-2013		Novartis laboratories; Japan Society for Promotion of Science [PE13559]	Novartis laboratories has partially financially supported this work. The Japan Society for Promotion of Science has partially supported this work (No. PE13559). The authors would like to thank Dr. Noritaka Kawashima from the National Rehabilitation Center for Persons with Disabilities of Tokorozawa (Japan) for his help during some of the data collection.	Alvarez D., 2006, P IEEE EMBS C NEW YO; Benedetti MG, 2013, GAIT POSTURE, V38, P934, DOI 10.1016/j.gaitpost.2013.04.022; Chiu SL, 2012, J BIOMECH, V45, P275, DOI 10.1016/j.jbiomech.2011.10.028; Lee SJ, 2012, AM J PHYS MED REHAB, V91, P2, DOI 10.1097/PHM.0b013e31823c7507; Sabatini AM, 2005, IEEE T BIO-MED ENG, V52, P486, DOI 10.1109/TBME.2004.840727; Morris TR, 2012, PARKINSONISM RELAT D, V18, P572, DOI 10.1016/j.parkreldis.2012.03.001; Herrera CD, 2012, IEEE T PATTERN ANAL, V34, P2058, DOI 10.1109/TPAMI.2012.125; Reinbolt JA, 2011, PROC IUTAM, V2, P186, DOI 10.1016/j.piutam.2011.04.019; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Motai Y, 2012, SIGNAL PROCESS-IMAGE, V27, P83, DOI 10.1016/j.image.2011.06.005; Shotton J, 2013, COMMUN ACM, V56, P116, DOI 10.1145/2398356.2398381; Kobilarov M, 2006, IEEE INT CONF ROBOT, P557; Azevedo-Coste C., 2014, SENSORS, V14, P6819; Baker R., 2013, HDB CLIN GAIT ANAL; Biswas J., 2012, P IEEE INT C ROB AUT; Bonnet V, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-29; CAPPOZZO A, 1984, HUM MOVEMENT SCI, V3, P27, DOI 10.1016/0167-9457(84)90004-6; Chen WM, 2012, ADV MATER RES-SWITZ, V542-543, P779, DOI 10.4028/www.scientific.net/AMR.542-543.779; Cosgun A., 2013, P IEEE INT C ROB AUT; de Boor C., 1978, PRACTICAL GUIDE SPLI; Delval A, 2008, GAIT POSTURE, V28, P495, DOI 10.1016/j.gaitpost.2008.03.003; Doisy G., 2012, ADAPTIVE PERSON FOLL; Enright Paul L, 2003, Respir Care, V48, P783; Gonzalez R. C., 2009, DIGITAL IMAGE PROCES; Hoshino F., 2011, IEEE SICE INT S SYST, P212; Jia Z., 2008, COMPUTER VISION IMAG, V109, P1, DOI 10.1016/j.cviu.2006.12.001; Kalal Z., 2010, IEEE T PATTERN ANAL, V6; Khoshelham K, 2012, SENSORS-BASEL, V12, P1437, DOI 10.3390/s120201437; Kose A., 2012, J NEUROENG REHABIL, V9; Lapierre L., 2010, INT J ROBUST NONLIN, V16, P485; Lapierre L., 2003, MANEUVERING CONTROL; Luber M, 2011, IEEE INT C INT ROBOT, P3844, DOI 10.1109/IROS.2011.6048836; Lucas B., 1981, P INT JOINT C ART IN, V81, P674; Martinez-Otzeta JM, 2009, LECT NOTES ARTIF INT, V5928, P33, DOI 10.1007/978-3-642-10817-4_4; Mazza C., 2011, GAIT POSTURE, V35, P138; Meat H. Wei, 2012, P TENCON IEEE REG 10; Moore S.T., 2013, J NEUROENG REHABIL, V10; Morris M, 2005, MOVEMENT DISORD, V20, P40, DOI 10.1002/mds.20278; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; Ojeda L, 2013, J BIOMECH, V46, P2316, DOI 10.1016/j.jbiomech.2013.06.002; Papadourakis V, 2010, COMPUT VIS IMAGE UND, V114, P835, DOI 10.1016/j.cviu.2010.02.003; Powell M.J.D., 1978, NUMERICAL ANAL; Salih Y, 2011, PATTERN RECOGN, V44, P2711, DOI 10.1016/j.patcog.2011.03.027; Sonoura Takafumi, 2008, Computer Vision; Stone E.E., 2011, INT C IEEE EMBS BOST; Viola P., 2001, INT C COMP VIS PATT; Yoshimi T., 2006, P IEEE RSJ INT C INT, P5286; Zhang H., 2011, P IEEE RSJ INT C INT, P2044	48	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-8890	1872-793X		ROBOT AUTON SYST	Robot. Auton. Syst.	APR	2015	66						116	128		10.1016/j.robot.2014.12.002		13	Automation & Control Systems; Computer Science, Artificial Intelligence; Robotics	Automation & Control Systems; Computer Science; Robotics	CD2TI	WOS:000350931500011		
J	Manh, HD; Kido, T; Tai, PT; Okamoto, R; Honma, S; Liang, SX; Anh, LT; Maruzeni, S; Nghi, TN; Nishijo, M; Nakagawa, H; Nhu, DD; Tung, DV; Hung, NN; Son, LK				Ho Dung Manh; Kido, Teruhiko; Pham The Tai; Okamoto, Rie; Honma, Seijiro; Liang, Sun Xian; Le Thai Anh; Maruzeni, Shoko; Tran Ngoc Nghi; Nishijo, Muneko; Nakagawa, Hideaki; Dang Duc Nhu; Dao Van Tung; Nguyen Ngoc Hung; Le Ke Son			Levels of polychlorinated dibenzodioxins and polychlorinated dibenzofurans in breast milk samples from three dioxin-contaminated hotspots of Vietnam	SCIENCE OF THE TOTAL ENVIRONMENT			English	Article						Agent Orange; Dioxins; Breast milk; Vietnamese primiparae; Hotspots	INFANTS DAILY INTAKE; AGENT-ORANGE; SOUTHERN VIETNAM; P-DIOXINS; HOT-SPOT; RESIDENTS; EXPOSURE; PCDD/FS; PCBS; MOTHERS	We determined polychlorinated dibenzodioxin (PCDD) and polychlorinated dibenzofuran (PCDF) levels in breast milk of 143 primiparae living around the three most dioxin-contaminated areas of Vietnam. The women sampled lived in the vicinity of former U.S. air bases at Bien Hoa (n = 51), Phu Cat (n = 23), and Da Nang (n = 69), which are known as dioxin hotspots. Breast milk samples from Bien Hoa City, where residents live very close to the air base, showed high levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), with 18% of the samples containing >5 pg TCDD/g lipid. However, Phu Cat residents lived far from the air base and their samples showed lower TCDD levels, with none containing >5 pg TCDD/g lipid. In Da Nang, TCDD levels in mothers from Thanh Khe (close to the air base, n = 43) were significantly higher than those in mothers from Son Tra (far from the air base, n = 26), but not other PCDD and PCDF (PCDD/F) congeners. Although TCDD levels in Bien Hoa were the highest among these hotspots, levels of other PCDD/F congeners as well as the geometric mean concentration of total PCDD/F level in Bien Hoa (9.3 pg toxic equivalents [TEQ]/g lipid) were significantly lower than the level observed in Phu Cat (14.1 pg TEQ/g lipid), Thanh Khe (14.3 pg TEQ/g lipid), and Son Tra (13.9 pg TEQ/g lipid). Our findings indicated that residents living close to former U.S. air bases were exposed to elevated levels of TCDD, but not of other PCDD/F congeners. (C) 2014 Elsevier B.V. All rights reserved.	[Ho Dung Manh; Liang, Sun Xian; Le Thai Anh] Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Kanazawa, Ishikawa, Japan; [Ho Dung Manh] Lac Hong Univ, Fac Chem & Environm Engn, Bien Hoa, Dong Nai, Vietnam; [Okamoto, Rie; Honma, Seijiro] Kanazawa Univ, Fac Hlth Sci, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Pham The Tai] Vietnam Mil Med Univ, Biomed & Pharmaceut Res Ctr, Hanoi, Vietnam; [Maruzeni, Shoko; Tran Ngoc Nghi; Nishijo, Muneko; Nakagawa, Hideaki] Kanazawa Med Univ, Dept Publ Hlth, Uchinada, Ishikawa 92002, Japan; [Dang Duc Nhu] Vietnam Natl Univ, Sch Med & Pharm, Hanoi, Vietnam; [Dao Van Tung; Nguyen Ngoc Hung] Hanoi Med Univ, Hanoi, Vietnam; [Le Ke Son] Environm Adm, Minist Nat Resources & Environm, Hanoi, Vietnam	Kido, T (reprint author), Kanazawa Univ, Fac Hlth Sci, Inst Med Pharmaceut & Hlth Sci, 5-11-80 Kodatsuno, Kanazawa, Ishikawa, Japan.	kido@mhs.mp.kanazawa-u.ac.jp			Japan Society for the Promotion of Science [19209021]	The study was supported by a Grant-in-Aid for Scientific Research (A) from the Japan Society for the Promotion of Science, no. 19209021. The authors declare that we have no actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations.	Anh NTN, 2014, J EXPO SCI ENV EPID, V24, P489, DOI 10.1038/jes.2013.73; Stellman JM, 2003, NATURE, V422, P681, DOI 10.1038/nature01537; Wittsiepe J, 2007, CHEMOSPHERE, V67, pS286, DOI 10.1016/j.chemosphere.2006.05.118; Hue NTM, 2014, SCI TOTAL ENVIRON, V491, P212, DOI 10.1016/j.scitotenv.2014.02.054; Hoang TT, 2014, CHEMOSPHERE, V114, P268, DOI 10.1016/j.chemosphere.2014.05.010; Milbrath MO, 2009, ENVIRON HEALTH PERSP, V117, P417, DOI 10.1289/ehp.11781; BAUGHMAN R, 1973, Environmental Health Perspectives, V5, P27, DOI 10.2307/3428110; Dwemychuk L. W., 2002, CHEMOSPHERE, V47, P117; Dwemychuk L.W., 2005, CHEMOSPHERE, V60, P998; Dwernychuk L.W., 2006, ORGANOHALOGEN COMPOU, V68, P312; Environmental Protection Agency U.S., 2009, REV INT SOIL LEV DIO; Focant JF, 2002, CHEMOSPHERE, V48, P763, DOI 10.1016/S0045-6535(02)00140-6; Kido T., 2013, EUR J ENDOCRINOL, V170, P131; Lemieux PM, 2000, ENVIRON SCI TECHNOL, V34, P377, DOI 10.1021/es990465t; Manh HD, 2013, ENVIRON HEALTH PREV, V18, P221, DOI 10.1007/s12199-012-0310-x; Minh N. H., 2009, INTERDISCIPLINARY ST, P21; Nishijo M, 2014, MOL PSYCHIATR, V19, P1220, DOI 10.1038/mp.2014.18; Tai PT, 2013, OCCUP ENVIRON MED, V70, P656, DOI 10.1136/oemed-2012-101021; Office of the National Steering Committee 33 and Hatfield Consultants, 2011, ENV HUM HLTH ASS DIO; OLIE K, 1977, Chemosphere, V6, P455, DOI 10.1016/0045-6535(77)90035-2; R Core Team, 2013, R LANG ENV STAT COMP; SCHECTER A, 1991, CHEMOSPHERE, V23, P1903, DOI 10.1016/0045-6535(91)90037-E; Schecter A, 2001, J OCCUP ENVIRON MED, V43, P435, DOI 10.1097/00043764-200105000-00002; SCHECTER A, 1995, AM J PUBLIC HEALTH, V85, P516, DOI 10.2105/AJPH.85.4.516; Schecter A, 2003, J OCCUP ENVIRON MED, V45, P781, DOI 10.1097/01.jom.0000085786.50835.71; Suzuki H, 2014, INT J MOL SCI, V15, P7485, DOI 10.3390/ijms15057485; Tai PT, 2011, ENVIRON SCI TECHNOL, V45, P6625, DOI 10.1021/es201666d; Takekuma M, 2004, CHEMOSPHERE, V54, P127, DOI 10.1016/S0045-6535(03)00670-2; Tawara K, 2011, CHEMOSPHERE, V84, P979, DOI 10.1016/j.chemosphere.2011.05.041; Tran THT, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21105; Ulaszewska MM, 2011, CHEMOSPHERE, V83, P774, DOI 10.1016/j.chemosphere.2011.02.066; Van den Berg M., 2005, TOXICOL SCI, V2006, P223, DOI DOI 10.1093/T0XSCI/KF1055; Weiss J, 2003, ACTA PAEDIATR, V92, P467; Young AL, 2008, ENVIRON SCI POLLUT R, V15, P113, DOI 10.1065/espr2007.10.453; Young AL, 2009, HIST USE DISPOSITION	35	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0048-9697	1879-1026		SCI TOTAL ENVIRON	Sci. Total Environ.	APR 1	2015	511						416	422		10.1016/j.scitotenv.2014.12.083		7	Environmental Sciences	Environmental Sciences & Ecology	CC6YC	WOS:000350513900043		
J	Harui, T; Komeda, J				Harui, Takeshi; Komeda, Jiryo			Numerical semigroups of genus seven and double coverings of curves of genus three	SEMIGROUP FORUM			English	Article						Weierstrass semigroups; Numerical semigroups; Double coverings; Plane quartics		The authors determine all possible numerical semigroups at ramification points of double coverings of curves when the covered curve is of genus three and the covering curve is of genus seven, and prove that all of such numerical semigroups are actually of double covering type.	[Harui, Takeshi] Kogakuin Univ, Acad Support Ctr, Hachioji, Tokyo 1920015, Japan; [Komeda, Jiryo] Kanagawa Inst Technol, Ctr Basic Educ & Integrated Learning, Dept Math, Atsugi, Kanagawa 2430292, Japan	Komeda, J (reprint author), Kanagawa Inst Technol, Ctr Basic Educ & Integrated Learning, Dept Math, Atsugi, Kanagawa 2430292, Japan.	takeshi@cwo.zaq.ne.jp; komeda@gen.kanagawa-it.ac.jp					Oliveira G, 2008, SEMIGROUP FORUM, V77, P152, DOI 10.1007/s00233-007-9038-0; Oliveira G, 2010, J PURE APPL ALGEBRA, V214, P1955, DOI 10.1016/j.jpaa.2009.12.032; Komeda J, 2011, SEMIGROUP FORUM, V83, P479, DOI 10.1007/s00233-011-9331-9; GARCIA A, 1986, MANUSCRIPTA MATH, V55, P419, DOI 10.1007/BF01186655; Harui T., SEMIGROUP F IN PRESS; Harui T., PREPRINT; Komeda J., 2004, SERDICA MATH J, V30, P43; Komeda J., 2008, SERDICA MATH J, V34, P771; Komeda J., 2009, RES REP KANAGAWA I B, V33, P37	9	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0037-1912	1432-2137		SEMIGROUP FORUM	Semigr. Forum	APR	2015	90	2					491	502		10.1007/s00233-014-9621-0		12	Mathematics	Mathematics	CD2AL	WOS:000350875800010		
J	Kobayashi, Y; Nakasuji, Y; Takahasi, SE; Tsukada, M				Kobayashi, Yuji; Nakasuji, Yasuo; Takahasi, Sin-Ei; Tsukada, Makoto			Continuous semigroup structures on , cancellative semigroups and bands	SEMIGROUP FORUM			English	Article						Topological semigroup; Topological group; Ordered semigroup; Archimedean semigroup; Cancellation condition; Band (idempotent semigroup)		Up to isomorphism there is only one continuous group operation on , as Acz,l (Bull Soc Math Fr 76: 59-64, 1949) showed in 1949. In this paper we show that there are exactly three distinct continuous (weakly) cancellative semigroup structures on modulo isomorphism. On the other hand, there are many continuous non-cancellative semigroup structures on . We classify all ordered continuous bands (idempotent semigroups) on . There are exactly eight (five) distinct ordered continuous band structures on modulo isomorphism (and anti-isomorphism).	[Kobayashi, Yuji; Nakasuji, Yasuo; Takahasi, Sin-Ei; Tsukada, Makoto] Toho Univ, Dept Informat Sci, Funabashi, Chiba 2748510, Japan; [Nakasuji, Yasuo] Open Univ Japan, Chiba 2618586, Japan	Tsukada, M (reprint author), Toho Univ, Dept Informat Sci, Funabashi, Chiba 2748510, Japan.	tsukada@is.sci.toho-u.ac.jp					Aczel J., 1949, B SOC MATH FRANCE, V76, P59; Clifford A.H., 1958, T AM MATH SOC, V88, P80, DOI 10.2307/1993238; Clifford A.H., 1959, T AM MATH SOC, V91, P193, DOI 10.2307/1993117; Craigen R., 1989, AEQUATIONES MATH, V37, P306; Fuchs L., 1963, PARTIALLY ORDERED AL; Holder O, 1901, BERICHTE VERHANDL MP, V53, P1; Ricci RG, 2006, SEMIGROUP FORUM, V72, P419, DOI 10.1007/s00233-005-0529-6	7	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0037-1912	1432-2137		SEMIGROUP FORUM	Semigr. Forum	APR	2015	90	2					518	531		10.1007/s00233-014-9624-x		14	Mathematics	Mathematics	CD2AL	WOS:000350875800012		
J	Yamamura, E				Yamamura, Eiji			Effects of Siblings and Birth Order on Income Redistribution Preferences: Evidence Based on Japanese General Social Survey	SOCIAL INDICATORS RESEARCH			English	Article						Inequality aversion; Redistribution; Family structure; Birth order; Siblings	FAMILY-SIZE; CHILDRENS EDUCATION; UNITED-STATES; QUALITY; OUTCOMES; INEQUALITY; QUANTITY; EARNINGS; CULTURE; INVESTMENT	Experiences in childhood are hypothesized to influence preference formation for redistribution in adulthood. For example, eldest male children who suffer loss because of parental redistribution are less likely to endorse government-mandated redistributions as an adult. In contrast, younger children enjoy benefits from parental redistributions as a result of having a large number of older siblings. Younger children are therefore more likely to prefer redistribution. The Japanese General Social Survey was used to determine how individual preferences for income redistribution are affected by number of siblings and birth order. The important findings were as follows. (1) The first-born child was less likely to prefer income redistribution when the child was male. However, such a tendency was not observed when the child was female. (2) The larger the number of elder brothers, the more likely an individual preferred income redistribution. However, the number of elder sisters did not affect the preference. (3) The number of younger siblings did not affect the preference for redistribution regardless of the sibling's sex.	Seinan Gakuin Univ, Dept Econ, Fukuoka 8148511, Japan	Yamamura, E (reprint author), Seinan Gakuin Univ, Dept Econ, 6-2-92 Sawara Ku, Fukuoka 8148511, Japan.	yamaei@seinan-gu.ac.jp					Akerlof GA, 2000, Q J ECON, V115, P715, DOI 10.1162/003355300554881; Alger I, 2010, AM ECON REV, V100, P1725, DOI 10.1257/aer.100.4.1725; Alesina A, 2005, J PUBLIC ECON, V89, P897, DOI 10.1016/j.jpubeco.2004.05.009; Oettinger GS, 2000, SOUTHERN ECON J, V66, P631, DOI 10.2307/1061429; HANUSHEK EA, 1992, J POLIT ECON, V100, P84, DOI 10.1086/261808; Benjamin DJ, 2010, AM ECON REV, V100, P1913, DOI 10.1257/aer.100.4.1913; Alesina A, 2004, J PUBLIC ECON, V88, P2009, DOI 10.1016/j.jpubeco.2003.07.006; Buckles KS, 2012, J HUM RESOUR, V47, P613; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Price J, 2008, J HUM RESOUR, V43, P240; Bjorklund A, 2007, J POPUL ECON, V20, P183, DOI 10.1007/s00148-006-0094-7; Luttmer EFF, 2001, J POLIT ECON, V109, P500, DOI 10.1086/321019; Stutzer A, 2004, J ECON BEHAV ORGAN, V54, P89, DOI 10.1016/j.jebo.2003.04.003; Klor EF, 2010, J PUBLIC ECON, V94, P269, DOI 10.1016/j.jpubeco.2009.12.003; BECKER GS, 1973, J POLIT ECON, V81, pS279, DOI 10.1086/260166; Luttmer EFP, 2011, AM ECON J-ECON POLIC, V3, P157, DOI 10.1257/pol.3.1.157; Kantarevic J, 2006, J HUM RESOUR, V41, P755; Mazumder B, 2008, J POPUL ECON, V21, P685, DOI 10.1007/s00148-006-0127-2; Fehr E, 2011, ECON J, V121, pF396, DOI 10.1111/j.1468-0297.2011.02478.x; Corneo G, 2002, J PUBLIC ECON, V83, P83, DOI 10.1016/S0047-2727(00)00172-9; Kawaguchi D, 2009, J POPUL ECON, V22, P115, DOI 10.1007/s00148-007-0175-2; BECKER GS, 1976, J POLIT ECON, V84, pS143, DOI 10.1086/260536; Fehr E, 2006, AM ECON REV, V96, P1912, DOI 10.1257/aer.96.5.1912; Lee JM, 2008, J POPUL ECON, V21, P855, DOI 10.1007/s00148-006-0124-5; Garg A, 1998, J POPUL ECON, V11, P471, DOI 10.1007/s001480050080; Ravallion M, 2000, J PUBLIC ECON, V76, P87, DOI 10.1016/S0047-2727(99)00064-X; Becker G. S., 1960, U NATL BUREAU C SERI, V11; BECKER GS, 1974, J POLIT ECON, V82, P1063, DOI 10.1086/260265; Berman J., 1986, J LABOR ECON, V4, P121; Black SE, 2005, Q J ECON, V120, P669, DOI 10.1093/qje/120.2.669; Caceres-Delpiano J, 2006, J HUM RESOUR, V41, P738; Chamarbagwala R, 2011, J POPUL ECON, V24, P935, DOI 10.1007/s00148-010-0314-z; Chang W-C., 2010, POVERTY PUBLIC POLIC, V2; Cho H, 2011, ECON LETT, V110, P200, DOI 10.1016/j.econlet.2010.11.044; Dammert AC, 2010, J POPUL ECON, V23, P199, DOI 10.1007/s00148-008-0237-0; Dayioglu M, 2009, OXFORD B ECON STAT, V71, P399, DOI 10.1111/j.1468-0084.2008.00540.x; Derin-Gure P, 2010, ECON LETT, V107, P208, DOI 10.1016/j.econlet.2010.01.026; Edmonds EV, 2006, J POPUL ECON, V19, P795, DOI 10.1007/s00148-005-0013-3; Eugster B, 2011, ECON J, V121, pF413, DOI 10.1111/j.1468-0297.2011.02479.x; Fernandez R, 2004, Q J ECON, V119, P1249, DOI 10.1162/0033553042476224; Greene W.H., 1997, ECONOMETRIC ANAL; Kawashima T., 1963, LAW JAPAN LEGAL ORDE; KESSLER D, 1991, J LABOR ECON, V9, P413, DOI 10.1086/298275; Lampi E, 2012, APPL ECON LETT, V19, P759, DOI 10.1080/13504851.2011.603683; Lampi E, 2010, J ECON PSYCHOL, V31, P131, DOI 10.1016/j.joep.2009.11.009; Luttmer EFP, 2005, Q J ECON, V120, P963, DOI 10.1162/003355305774268255; Makepeace G, 2008, J POPUL ECON, V21, P877, DOI 10.1007/s00148-006-0123-6; Ohtake F, 2004, JPN ECON REV, V55, P333, DOI 10.1111/j.1468-5876.2004.00318.x; Rainer H, 2008, ECON LETT, V99, P449, DOI 10.1016/j.econlet.2007.09.011; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; YAMAGISHI T, 1988, SOC PSYCHOL QUART, V51, P265, DOI 10.2307/2786924; YAMAGISHI T, 1988, J EXP SOC PSYCHOL, V24, P530, DOI 10.1016/0022-1031(88)90051-0; Yamamura E, 2012, EUR J POLIT ECON, V28, P498, DOI 10.1016/j.ejpoleco.2012.05.010	53	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0303-8300	1573-0921		SOC INDIC RES	Soc. Indic. Res.	APR	2015	121	2					589	606		10.1007/s11205-014-0649-z		18	Social Sciences, Interdisciplinary; Sociology	Social Sciences - Other Topics; Sociology	CC9NG	WOS:000350696900014		
J	Her, JL; Kohama, Y; Matsuda, YH; Kindo, K; Yang, WH; Chareev, DA; Mitrofanova, ES; Volkova, OS; Vasiliev, AN; Lin, JY				Her, J. L.; Kohama, Y.; Matsuda, Y. H.; Kindo, K.; Yang, W-H; Chareev, D. A.; Mitrofanova, E. S.; Volkova, O. S.; Vasiliev, A. N.; Lin, J-Y			Anisotropy in the upper critical field of FeSe and FeSe0.33Te0.67 single crystals	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						superconductivity phase diagrams; transition temperature variations; phase diagrams; pnictides and chalcogenides	CRITICAL MAGNETIC-FIELD; SUPERCONDUCTIVITY; TEMPERATURE; DEPENDENCE	The electric resistivity of single crystalline Fe-based superconductors FeSe and FeSe0.33Te0.67 was measured in pulsed magnetic fields up to 55 T. Te-doped iron selenide, FeSe0.33Te0.67, shows rather isotropic behavior in both magnetoresistance (MR) and upper critical fields (H-c2(perpendicular to)(0)/H-c2(parallel to)(0) = 48 T/42 T similar to 1.14), when an external magnetic field is applied parallel and perpendicular to the crystallographic c-axis. These isotropic behaviors are frequently observed in an iron-based superconductor, and the isotropy in H-c2 can likely be described by the Pauli effect. In contrast, our measurements elucidate that the undoped iron selenide, FeSe, exhibits a clear anisotropy in both MR and H-c2 (H-c2(perpendicular to)(0)/H-c2(parallel to)(0) = 27 T/15 T similar to 1.8). This behavior occurs because the clean in-plane conduction (RRR = 35) allows to form a closed electron orbit within the two-dimensional Fermi sheets only for the magnetic field parallel to the c-axis, which results in an appearance of an intrinsic (orbital-effect limited) upper critical field for the undoped FeSe. Doping of Te breaks the clean in-plane conduction and leads to a crossover from an orbital limit dominating behavior to a Pauli limit dominating one.	[Her, J. L.] Chang Gung Univ, Div Nat Sci, Ctr Gen Educ, Taoyuan 333, Taiwan; [Kohama, Y.; Matsuda, Y. H.; Kindo, K.] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Yang, W-H; Lin, J-Y] Natl Chiao Tung Univ, Inst Phys, Hsinchu 30010, Taiwan; [Chareev, D. A.] Russian Acad Sci, Inst Expt Mineral, Chernogolovka 142432, Russia; [Mitrofanova, E. S.; Volkova, O. S.; Vasiliev, A. N.] Moscow MV Lomonosov State Univ, Dept Low Temp Phys & Superconduct, Fac Phys, Moscow 119991, Russia; [Volkova, O. S.; Vasiliev, A. N.] Ural Fed Univ, Theoret Phys & Appl Math Dept, Ekaterinburg 620002, Russia; [Vasiliev, A. N.] Natl Univ Sci & Technol MISiS, Moscow 119049, Russia; [Lin, J-Y] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA	Her, JL (reprint author), Chang Gung Univ, Div Nat Sci, Ctr Gen Educ, Taoyuan 333, Taiwan.	her@mail.cgu.edu.tw	Volkova, Olga/A-4072-2008; Chareev, Dmitriy/B-8504-2009; Vasiliev, Alexander/A-7562-2008; Mitrofanova, Ekaterina/E-2942-2015		National Science Council of Taiwan [NSC101-2112-M-182-001-MY3, NSC-101-2112-M-009-017-MY2]; MOE ATU program at NCTU; Russian Foundation for Basic Research [14-02-92002]; Civilian Research and Development Foundation [FSAX-14-60108-0]; RF [MK-7138.2013.2]; JSPS [25800187]; Ministry of Education and Science of the Russian Federation in the framework of Increase Competitiveness Program of NUST "MISiS" [K2-2014-036]	This work was supported by National Science Council of Taiwan under Grant Nos. NSC101-2112-M-182-001-MY3, NSC-101-2112-M-009-017-MY2, the MOE ATU program at NCTU, Russian Foundation for Basic Research under Grant 14-02-92002, and Civilian Research and Development Foundation under Grant FSAX-14-60108-0. JYL would like to thank ALS for support. OSV acknowledges support of RF President Grant MK-7138.2013.2. YK was supported by JSPS Grant-in-Aid Young Scientists (B) 25800187. This work was supported in part from the Ministry of Education and Science of the Russian Federation in the framework of Increase Competitiveness Program of NUST "MISiS" (No. K2-2014-036).	Klein T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184506; Gurevich A, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.184515; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Fang MG, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.020509; Khim S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.104502; Nicholson A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.217002; Chareev D, 2013, CRYSTENGCOMM, V15, P1989, DOI 10.1039/c2ce26857d; SCHOSSMANN M, 1989, PHYS REV B, V39, P4210, DOI 10.1103/PhysRevB.39.4210; Zhang JL, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.174506; Lei HC, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.094515; Lin JY, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.220507; Vedeneev SI, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.134512; Rotter M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.107006; Chen XH, 2008, NATURE, V453, P761, DOI 10.1038/nature07045; Chen GF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.247002; Yuan HQ, 2009, NATURE, V457, P565, DOI 10.1038/nature07676; Kano M, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.084719; Finnemore DK, 2001, PHYS REV LETT, V86, P2420, DOI 10.1103/PhysRevLett.86.2420; Hsu FC, 2008, P NATL ACAD SCI USA, V105, P14262, DOI 10.1073/pnas.0807325105; Luo CW, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.257006; Baily SA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.117004; Wilke RHT, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.217003; Wang XC, 2008, SOLID STATE COMMUN, V148, P538, DOI 10.1016/j.ssc.2008.09.057; Gasparov VA, 2011, JETP LETT+, V93, P667, DOI 10.1134/S0021364011110038; Ishida S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.184514; Kida T, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.113701; Patnaik S, SUPERCOND SCI TECHNO, V14, P315; WERTHAME.NR, 1966, PHYS REV, V147, P295, DOI 10.1103/PhysRev.147.295; Zhang J L, 2012, ARXIV12012548V1CONDM	29	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	APR	2015	28	4							045013	10.1088/0953-2048/28/4/045013		6	Physics, Applied; Physics, Condensed Matter	Physics	CD4LY	WOS:000351055500019		
J	Inoue, K; Takeuchi, N; Narama, T; Yamanashi, Y; Yoshikawa, N				Inoue, Kenta; Takeuchi, Naoki; Narama, Tatsuya; Yamanashi, Yuki; Yoshikawa, Nobuyuki			Design and demonstration of adiabatic quantum-flux-parametron logic circuits with superconductor magnetic shields	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						quantum-flux-parametron; adiabatic logic; cell library; superconductor shield	JOSEPHSON; TECHNOLOGY	Adiabatic quantum-flux-parametron (AQFP) logic is an energy-efficient superconductor logic with zero static power and very small dynamic power due to adiabatic switching operations. In order to build large-scale digital circuits, we built AQFP logic cells using superconductor magnetic shields, which are necessary in order to avoid unwanted magnetic couplings between the cells and excitation currents. In preliminary experimental tests, we confirmed that the unwanted coupling became negligibly small thanks to the superconductor shields. As a demonstration, we designed a four-to-one multiplexor and a 16-junction full adder using the shielded logic cells. In both circuits, we confirmed correct logic operations with wide operation margins of excitation currents. These results indicate that large-scale AQFP digital circuits can be realized using the shielded logic cells.	[Inoue, Kenta; Narama, Tatsuya; Yamanashi, Yuki; Yoshikawa, Nobuyuki] Yokohama Natl Univ, Dept Elect & Comp Engn, Yokohama, Kanagawa 2408501, Japan; [Yamanashi, Yuki; Yoshikawa, Nobuyuki] Yokohama Natl Univ, Inst Adv Sci, Yokohama, Kanagawa 2408501, Japan; [Takeuchi, Naoki] Natl Inst Informat & Commun Technol, Adv ICT Res Inst, Nishi Ku, Kobe, Hyogo 6512492, Japan; [Takeuchi, Naoki] Japan Soc Promot Sci, Tokyo, Japan	Inoue, K (reprint author), Yokohama Natl Univ, Dept Elect & Comp Engn, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	takeuchi-naoki-kx@ynu.jp	Takeuchi, Naoki/A-8229-2015; Yamanashi, Yuki/N-1458-2014; YOSHIKAWA, Nobuyuki/M-9117-2014	Takeuchi, Naoki/0000-0003-0396-5222; Yamanashi, Yuki/0000-0003-4840-7611; YOSHIKAWA, Nobuyuki/0000-0001-6191-6715	Japan Society for the Promotion of Science (JSPS) [26220904]	The present study was supported by a Grant-in-Aid for Scientific Research (S) (No. 26220904) from the Japan Society for the Promotion of Science (JSPS). The circuits were fabricated in the Clean Room for Analog-digital superconductiVITY (CRAVITY) of National Institute of Advanced Industrial Science and Technology (AIST) with standard process 2 (STP2). The AIST-STP2 is based on the Nb circuit fabrication process developed at the International Superconductivity Technology Center (ISTEC). We would like to thank C J Fourie for improving the 3D inductance extractor, InductEx, which was used during layout design of the circuits.	Takeuchi N, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4817974; Takeuchi N, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4790276; Takeuchi N, 2014, J APPL PHYS, V115, DOI 10.1063/1.4868336; Tanaka M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.053102; Mukhanov OA, 2011, IEEE T APPL SUPERCON, V21, P760, DOI 10.1109/TASC.2010.2096792; Takeuchi N, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/3/035010; Fourie CJ, 2011, SUPERCOND SCI TECH, V24, DOI 10.1088/0953-2048/24/12/125015; Herr QP, 2011, J APPL PHYS, V109, DOI 10.1063/1.3585849; Yorozu S, 2002, PHYSICA C, V378, P1471, DOI 10.1016/S0921-4534(02)01759-8; WHITELEY SR, 1991, IEEE T MAGN, V27, P2902, DOI 10.1109/20.133816; NAGASAWA S, 1995, IEEE T APPL SUPERCON, V5, P2447, DOI 10.1109/77.403086; Takeuchi N, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2232336; Service RF, 2012, SCIENCE, V335, P394, DOI 10.1126/science.335.6067.394; Herr AY, 2013, J APPL PHYS, V113, DOI 10.1063/1.4776713; Likharev KK, 1991, IEEE T APPL SUPERCON, V1, P3, DOI 10.1109/77.80745; Ball P, 2012, NATURE, V492, P174, DOI 10.1038/492174a; Fujimaki A, 2008, IEICE T ELECTRON, VE91C, P342, DOI 10.1093/ietele/e91-c.3.342; Hosoya M, 1991, IEEE T APPL SUPERCON, V1, P77, DOI 10.1109/77.84613; Inoue K, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2236133; Kirichenko A. F., 2015, IEEE T APPL SUPERCON, V25; Takeuchi N, 2014, SCI REP-UK, V4, DOI 10.1038/srep06354; Tanaka M, 2014, IEICE T ELECTRON, VE97C, P166, DOI 10.1587/transele.E97.C.166; Zhirnov V, 2014, ICT ENERGY CONCEPTS, DOI [10.5772/57346, DOI 10.5772/57346]	23	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	APR	2015	28	4							045020	10.1088/0953-2048/28/4/045020		7	Physics, Applied; Physics, Condensed Matter	Physics	CD4LY	WOS:000351055500026		
J	Kawamura, Y; Matsumura, Y; Yamazaki, Y; Kaneko, S; Kokubo, N; Okuma, S				Kawamura, Y.; Matsumura, Y.; Yamazaki, Y.; Kaneko, S.; Kokubo, N.; Okuma, S.			Unusual current-voltage characteristics and dynamic correlation of rotating vortex-lattice rings	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						vortex-lattice rings; dynamic ordering; Corbino disk	SUPERCONDUCTING FILM; MODE-LOCKING; TRANSITION; MOTION	We report the unusual dc current-voltage (I-V) characteristics for the vortex-lattice rings rotated by a dc current I superimposed with ac currents of different amplitudes I-rf in a Corbino disk of an amorphous MoxGe1-x film. As Irf is increased from zero, the I-V curve in the large I region shows a trend to decrease. This is in contrast to the usual behavior of vortex flow in which ac-induced depinning leads to an increase in the flow voltage. We attribute the finding to the I-rf-induced growth in the transverse dynamic correlation of the rotating lattice rings.	[Kawamura, Y.; Matsumura, Y.; Yamazaki, Y.; Kaneko, S.; Okuma, S.] Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan; [Kokubo, N.] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan	Kawamura, Y (reprint author), Tokyo Inst Technol, Dept Phys, Meguro Ku, 2-12-1 Ohokayama, Tokyo 1528551, Japan.	sokuma@o.cc.titech.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Global Center of Excellence Program by MEXT, Japan through the 'Nanoscience and Quantum Physics' Project of the Tokyo Institute of Technology	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. YK acknowledges the financial support from the Global Center of Excellence Program by MEXT, Japan through the 'Nanoscience and Quantum Physics' Project of the Tokyo Institute of Technology.	Rycroft SFWR, 1999, PHYS REV B, V60, pR757, DOI 10.1103/PhysRevB.60.R757; Okuma S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.012503; Charalambous D, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.104514; Charalambous D, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.054506; Crabtree GW, 2003, NAT MATER, V2, P435, DOI 10.1038/nmat927; Eskildsen MR, 2011, FRONT PHYS-BEIJING, V6, P398, DOI 10.1007/s11467-011-0214-z; FIORY AT, 1971, PHYS REV LETT, V27, P501, DOI 10.1103/PhysRevLett.27.501; Furukawa A, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.064511; HIGGINS MJ, 1993, PHYS REV LETT, V70, P3784, DOI 10.1103/PhysRevLett.70.3784; Kokubo N, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.184512; Kokubo N, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.177005; Kolton AB, 2001, PHYS REV LETT, V86, P4112, DOI 10.1103/PhysRevLett.86.4112; KOSHELEV AE, 1994, PHYS REV LETT, V73, P3580, DOI 10.1103/PhysRevLett.73.3580; Li DP, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.214529; Lin NS, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.197003; Lin NS, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.134504; Lin NS, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.144511; Lopez D, 1999, PHYS REV LETT, V82, P1277, DOI 10.1103/PhysRevLett.82.1277; Matsukawa H, 2007, J PHYS CONF SER, V89, DOI 10.1088/1742-6596/89/1/012007; Miguel MC, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.245501; Miguel MC, 2003, NAT MATER, V2, P477, DOI 10.1038/nmat909; Misko VR, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.174507; Nakai N, 2009, PHYSICA C, V469, P1106, DOI 10.1016/j.physc.2009.05.208; Okuma S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.064520; Okuma S, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.212505; Okuma S, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/12/123021; Okuma S, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.114718; Okuma S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.172503; Okuma S, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.220501; Olson CJ, 1998, PHYS REV LETT, V81, P3757, DOI 10.1103/PhysRevLett.81.3757; Paltiel Y, 2000, PHYS REV LETT, V85, P3712, DOI 10.1103/PhysRevLett.85.3712; Pautrat A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.087002; Daroca DP, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.184520; Daroca DP, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.012508; Reichhardt C, 2000, PHYS REV B, V61, P11914; Rosen YJ, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.174511; SCHMID A, 1973, J LOW TEMP PHYS, V11, P667, DOI 10.1007/BF00654452; Silhanek AV, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2920078; Tkachenko DV, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051401; Togawa Y, 2000, PHYS REV LETT, V85, P3716, DOI 10.1103/PhysRevLett.85.3716; Valenzuela SO, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.247003; Van Look L, 1999, PHYS REV B, V60, pR6998, DOI 10.1103/PhysRevB.60.R6998; YARON U, 1994, PHYS REV LETT, V73, P2748, DOI 10.1103/PhysRevLett.73.2748; YARON U, 1995, NATURE, V376, P753, DOI 10.1038/376753a0	44	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	APR	2015	28	4							045002	10.1088/0953-2048/28/4/045002		7	Physics, Applied; Physics, Condensed Matter	Physics	CD4LY	WOS:000351055500008		
J	Kodama, M; Okamoto, K; Koga, Y; Yamamoto, T; Watanabe, H				Kodama, Motomune; Okamoto, Kazutaka; Koga, Yasunori; Yamamoto, Tsutomu; Watanabe, Hiroyuki			Analysis for formation of current path in the superconducting joint between Nb-Ti wires with the solder matrix replacement method	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						superconducting joint; current decay; Nb-Ti; Pb-Bi; resistance; persistent current	MULTIFILAMENTARY WIRES	We investigated a mechanism for formation of a current path in a superconducting joint between Nb-Ti wires with the solder matrix replacement method, where Pb-Bi connects Nb-Ti filaments. Superconducting joints were formed in the following steps. Firstly, the ends of wires were soaked in molten tin. Secondly, the ends of wires were soaked in molten Pb-Bi. Thirdly, the two ends of wires were set into the container filled with molten Pb-Bi and the Pb-Bi was solidified. One factor in the current path is the interface between Nb-Ti and Pb-Bi, where there was an intermediate layer composed of Nb3Sn and Ti-S. The intermediate layer appeared to be formed in the first step; niobium in Nb-Ti reacted with tin, and leftover titanium reacted with sulfur which may be contained as an impurity in the copper matrix of the wires. Another factor is the microstructure of Pb-Bi, which consisted of a superconducting epsilon phase and a bismuth phase. The specific surface area of the bismuth particles, which was affected by the composition and solidification rate of Pb-Bi in the third step, was positively correlated with the critical current density of Pb-Bi. This is because the bismuth particles are dominant flux pinning centers, as shown by Campbell. The present superconducting joints had excellent properties; the resistances were lower than 10(-13) Omega.	[Kodama, Motomune; Okamoto, Kazutaka] Hitachi Ltd, Hitachi Res Lab, Hitachi, Ibaraki 3191292, Japan; [Koga, Yasunori; Yamamoto, Tsutomu; Watanabe, Hiroyuki] Hitachi Ltd, Hitachi Works, Power Syst Co, Hitachi, Ibaraki 3170073, Japan	Kodama, M (reprint author), Hitachi Ltd, Hitachi Res Lab, 7-1-1 Omika Cho, Hitachi, Ibaraki 3191292, Japan.	motomune.kodama.yf@hitachi.com					Cheng JS, 2012, IEEE T APPL SUPERCON, V22, DOI 10.1109/TASC.2012.2185795; Swenson CA, 1999, IEEE T APPL SUPERCON, V9, P185, DOI 10.1109/77.783267; Barz H E, 1972, SCIENCE, V25, P884; CAMPBELL AM, 1968, PHILOS MAG, V18, P313; Hafstrom J W, 1997, IEEE T MAGN, VMAG-13, P94; Hansen M, 1968, CONSTITUTION BINARY; IWASA Y, 1976, CRYOGENICS, V16, P217, DOI 10.1016/0011-2275(76)90263-0; LEUPOLD MJ, 1976, CRYOGENICS, V16, P215, DOI 10.1016/0011-2275(76)90262-9; Liu JH, 2013, CRYOGENICS, V58, P62, DOI 10.1016/j.cryogenics.2013.09.011; Mizumaki S, 1997, IEEE T APPL SUPERCON, V7, P805, DOI 10.1109/77.614625; PHILLIP S, 1995, J LOW TEMP PHYS, V101, P581, DOI 10.1007/BF00753357; Shimohata K, 1995, J CRYO SUPER SOC JPN, V44, P70; Thorton R, 1988, US Patent, Patent No. 4744506; YETTER WE, 1982, PHILOS MAG B, V46, P523, DOI 10.1080/01418638208224026	14	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	APR	2015	28	4							045019	10.1088/0953-2048/28/4/045019		8	Physics, Applied; Physics, Condensed Matter	Physics	CD4LY	WOS:000351055500025		
J	Osamura, K; Machiya, S; Harjo, S; Nakamoto, T; Cheggour, N; Nijhuis, A				Osamura, Kozo; Machiya, Shutaro; Harjo, Stefanus; Nakamoto, Tatsushi; Cheggour, Najib; Nijhuis, Arend			Local strain exerted on Nb3Sn filaments in an ITER strand	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						superconductor; Nb3Sn; residual strain; ITER; neutron diffraction; diffraction elastic modulus; micromechanics	DEPENDENCE; CONDUCTORS	As part of an international project to benchmark facilities for measuring the strain dependence of critical current in International Thermonuclear Experimental Reactor (ITER) Nb3Sn strands, direct measurement of local strain exerted on Nb3Sn filaments was attempted at cryogenic temperature by means of a pulsed neutron technique. The lattice axial strain increased linearly with a slope close to unity against applied strain, while the thermal axial strain was -0.22% at 8.5 K. As a result, the force-free strain was evaluated to be 0.22-0.23%. This key parameter should provide an accurate estimate of the peak location of critical current versus applied strain. The lattice transverse strain decreased linearly as a function of applied strain with a slope of 0.33-0.34. The lattice strains of the Nb and Cu components were also measured and their behavior was analyzed by computing diffraction elastic moduli based on micromechanics theories. The stress-strain curve calculated according to the rule of mixtures described quite well the macroscopic curve measured for the present ITER Nb3Sn strand.	[Osamura, Kozo] Res Inst Appl Sci, Sakyo Ku, Kyoto 6068202, Japan; [Machiya, Shutaro] Daido Univ, Dept Mech Engn, Minami Ku, Nagoya, Aichi 4578530, Japan; [Harjo, Stefanus] Japan Atom Energy Agcy, J PARC Ctr, Tokai, Ibaraki 3191195, Japan; [Nakamoto, Tatsushi] High Energy Accelerator Org, KEK, Cryogen Sci Ctr, Tsukuba, Ibaraki 3050801, Japan; [Cheggour, Najib] NIST, Electromagnet Div, Boulder, CO 80305 USA; [Cheggour, Najib] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Nijhuis, Arend] Univ Twente, Energy Mat & Syst, NL-7500 AE Enschede, Netherlands	Osamura, K (reprint author), Res Inst Appl Sci, Sakyo Ku, Tanaka Ohi Cho 49, Kyoto 6068202, Japan.	kozo_osamura@rias.or.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [26420669]	Author expresses his hearty thanks to Dr C Scheuerlein, CERN for his valuable suggestions. This work was supported in part by a grant-in-aid of the Ministry of Education, Culture, Sports, Science and Technology, Japan (26420669). The neutron diffraction experiments were performed at TAKUMI of S-PARC/MLF as the general research subject (Proposal No. 2013B0098). Bronze-route Nb<INF>3</INF>Sn strand was provided by the ITER International Organization.	ten Haken B, 1999, J APPL PHYS, V85, P3247, DOI 10.1063/1.369667; Arbelaez D, 2009, SUPERCOND SCI TECH, V22, DOI 10.1088/0953-2048/22/2/025005; Cheggour N, 2012, IEEE T APPL SUPERCON, V22, DOI 10.1109/TASC.2011.2177433; Cheggour N, 2015, INT BENCHMARKI UNPUB; DeWit R, 1997, J APPL CRYSTALLOGR, V30, P510, DOI 10.1107/S0021889896012812; EKIN JW, 1980, CRYOGENICS, V20, P611, DOI 10.1016/0011-2275(80)90191-5; Harjo S., 2011, MATER SCI FORUM, V681, P443, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/MSF.681.443; Jin XZ, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4810010; KELLER KR, 1966, PHYS LETT, V21, P263, DOI 10.1016/0031-9163(66)90805-5; Lu XF, 2008, SUPERCOND SCI TECH, V21, DOI 10.1088/0953-2048/21/10/105016; Markiewicz WD, 2004, CRYOGENICS, V44, P895, DOI 10.1016/j.cryogenics.2004.06.004; Moller H, 1939, KWI EISENFORSCH, V21, P261; Osamura K, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/9/094001; Osamura K, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/5/054010; REHWALD W, 1972, PHYS REV B, V6, P363, DOI 10.1103/PhysRevB.6.363; Voigt W., 1928, LEHRBUCH KRISTALLPHY, P962	16	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	APR	2015	28	4							045016	10.1088/0953-2048/28/4/045016		9	Physics, Applied; Physics, Condensed Matter	Physics	CD4LY	WOS:000351055500022		
J	Sun, Y; Taen, T; Yamada, T; Tsuchiya, Y; Pyon, S; Tamegai, T				Sun, Yue; Taen, Toshihiro; Yamada, Tatsuhiro; Tsuchiya, Yuji; Pyon, Sunseng; Tamegai, Tsuyoshi			Evolution of superconducting and transport properties in annealed FeTe1-xSex (0.1 <= x <= 0.4) multiband superconductors	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						iron-based superconductors; FeTe1-xSex; critical current density; upper critical field; Hall effect	HIGH-FIELD SUPERCONDUCTORS; ORDER	We investigated the superconducting and transport properties in FeTe1-xSex (0.1 <= x <= 0.4) single crystals prepared by O-2-annealing. The sharp superconducting transition width observed in the magnetization measurement and the small residual resistivity prove the high quality of the crystals. All the crystals manifest large, homogeneous, and isotropic critical current density J(c) with a self-field value over 10(5) A cm(-2) at 2 K. The large and field-robust critical current densities prove that the superconductivity in FeTe1-xSex (0.1 <= x <= 0.4) is in bulk nature. The values of anisotropy parameter close to T-c for crystals with different Se doping levels all reside in the range of 2-3. Hall coefficients R-H remain positive and at an almost constant value at high temperatures, followed by a sudden decrease before reaching T-c, which indicates that the electron-type charge carriers become dominant at low temperatures. Furthermore, the characteristic temperature for the sudden decrease in R-H gradually increases with Se doping.	[Sun, Yue; Taen, Toshihiro; Yamada, Tatsuhiro; Tsuchiya, Yuji; Pyon, Sunseng; Tamegai, Tsuyoshi] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan	Sun, Y (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	sunyue.seu@gmail.com	悦, 孙/B-1373-2013	悦, 孙/0000-0002-5189-5460	Japan Society for the Promotion of Science	YS gratefully appreciates the support from Japan Society for the Promotion of Science. ICP analyses were performed at Chemical Analysis section in Materials Analysis Station of NIMS.	Zhang LJ, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.012506; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Noji T, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.054708; Biswas PK, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.092510; Gurevich A, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124501; Rodriguez EE, 2010, J AM CHEM SOC, V132, P10006, DOI 10.1021/ja104004t; Bao W, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.247001; Chen F, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.014526; Liu Y, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.134504; Kontani H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.157001; Liu Y, 2011, SUPERCOND SCI TECH, V24, DOI 10.1088/0953-2048/24/3/035012; Dong CH, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.224506; Sun Y, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.043101; CLOGSTON AM, 1962, PHYS REV LETT, V9, P266, DOI 10.1103/PhysRevLett.9.266; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Yasugaki M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.212502; BEAN CP, 1964, REV MOD PHYS, V36, P31, DOI 10.1103/RevModPhys.36.31; Sun Y, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.144512; Miao H, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.094506; Liu TJ, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.174509; Sun Y, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/1/015015; Soibel A, 2000, NATURE, V406, P282, DOI 10.1038/35018532; Stewart GR, 2011, REV MOD PHYS, V83, P1589, DOI 10.1103/RevModPhys.83.1589; Bendele M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.212504; Subedi A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134514; Taen T, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.092502; Xia Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.037002; CHANDRASEKHAR BS, 1962, APPL PHYS LETT, V1, P7, DOI 10.1063/1.1777362; Diaconu A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.104502; Eom MJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.024536; GORKOV LP, 1964, SOV PHYS JETP-USSR, V18, P1031; Hu J, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/8/084011; Kawasaki Y, 2012, SOLID STATE COMMUN, V152, P1135, DOI 10.1016/j.ssc.2012.04.002; Liu TJ, 2010, NAT MATER, V9, P716, DOI [10.1038/nmat2800, 10.1038/NMAT2800]; Pimenov A, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/013032; Sales BC, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.094521; Sun Y, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.115002; Sun Y, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.093705; Sun Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04585; Tanatar MA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.094507; Tsukada I, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054515; Werthamer N R, 1966, PHYS REV, V147, P295; Zeng B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1115; Zhou W, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.064704	44	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	APR	2015	28	4							044002	10.1088/0953-2048/28/4/044002		7	Physics, Applied; Physics, Condensed Matter	Physics	CD4LY	WOS:000351055500005		
J	Ito, S; Tsukiyama, I; Ando, M; Katakami, M; Hamanaka, R; Kosaka, K; Matsubara, A; Nishimura, M; Tanaka, H; Asai, N; Yokoe, N; Takahashi, A; Baba, K; Matsuura, K; Yamaguchi, E; Kubo, A				Ito, Sumiyo; Tsukiyama, Ikuto; Ando, Masahiko; Katakami, Masayo; Hamanaka, Rie; Kosaka, Kenshi; Matsubara, Ayako; Nishimura, Masaki; Tanaka, Hiroyuki; Asai, Nobuhiro; Yokoe, Norihito; Takahashi, Ayumu; Baba, Kenji; Matsuura, Katsuhiko; Yamaguchi, Etsuro; Kubo, Akihito			Therapeutic and preventive antiemetic effect of aprepitant in Japanese patients with thoracic malignancies who truly need it	SUPPORTIVE CARE IN CANCER			English	Article						Aprepitant; Neurokinin-1 receptor antagonist; Chemotherapy-induced nausea and vomiting; Therapeutic effect; Prophylactic effect; Quality of life	CHEMOTHERAPY-INDUCED NAUSEA; HIGH-DOSE CISPLATIN; MODERATELY EMETOGENIC CHEMOTHERAPY; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; COST-EFFECTIVENESS; INDUCED EMESIS; RISK-FACTORS; ANTAGONIST APREPITANT; CANCER-PATIENTS	Neurokinin-1 (NK-1) receptor antagonist is recommended for chemotherapy-induced nausea and vomiting (CINV) in highly emetogenic chemotherapy (HEC) and has recently been introduced to oncology practice in Japan. However, whether all patients undergoing HEC truly need NK-1 receptor antagonist remains unknown, and increasing medical costs due to uniform use of NK-1 receptor antagonist are a concern. This study was conducted to examine the prevalence of patients who needed aprepitant at the time of its introduction in Japan, and therapeutic and preventive effects of aprepitant on HEC or moderately emetogenic chemotherapy (MEC). Eligible patients with thoracic malignancies who were to undergo HEC or MEC received 5-hydroxytryptamine receptor antagonists and dexamethasone to prevent CINV. Aprepitant was administered to treat CINV occurring in the first course, or to prevent CINV in the second course. Frequency of vomiting, degree of nausea, and quality of life with respect to CINV were assessed. In total, 96 patients were enrolled. Aprepitant was not administered in 57 and 88 % of patients who received HEC and MEC, respectively. In patients treated with aprepitant (n = 18), therapeutic use of aprepitant after occurrence of CINV (n = 9) decreased average scores in numerical rating scale for nausea from 7.44 to 5.44 (p = 0.10), and average frequency of vomiting per day from 2.11 to 0.11 (p = 0.03). Prophylactic use of aprepitant in the second course (n = 18) increased the proportion of patients with no significant nausea from 6 % (first course) to 50 % (second course; p = 0.007), and those with no vomiting from 33 to 89 % (p = 0.002). Aprepitant use also significantly improved quality of life with respect to CINV in the second course. More than half of patients receiving HEC and 88 % of patients receiving MEC did not use aprepitant. Aprepitant showed significant therapeutic and preventive effects on CINV in patients who truly needed it.	[Ito, Sumiyo; Tsukiyama, Ikuto; Katakami, Masayo; Matsuura, Katsuhiko] Aichi Med Univ Hosp, Dept Pharm, Nagoya, Aichi, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Hamanaka, Rie; Kosaka, Kenshi; Matsubara, Ayako; Nishimura, Masaki; Tanaka, Hiroyuki; Asai, Nobuhiro; Yokoe, Norihito; Takahashi, Ayumu; Baba, Kenji; Yamaguchi, Etsuro; Kubo, Akihito] Aichi Med Univ, Dept Resp Med & Allergol, Sch Med, Nagakute, Aichi 4801195, Japan	Kubo, A (reprint author), Aichi Med Univ, Dept Resp Med & Allergol, Sch Med, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	kuboa@aichi-med-u.ac.jp					Akazawa M, 2008, JPN J PHARM HLTH CAR, V34, P742; Annemans L, 2008, SUPPORT CARE CANCER, V16, P905, DOI 10.1007/s00520-007-0349-1; Hesketh P, 1996, J CLIN ONCOL, V14, P2242; Yeo W, 2009, BREAST CANCER RES TR, V113, P529, DOI 10.1007/s10549-008-9957-9; Poli-Bigelli S, 2003, CANCER, V97, P3090, DOI 10.1002/cncr.11433; Roscoe JA, 2004, CANCER, V101, P2701, DOI 10.1002/cncr.20718; Takahashi T, 2011, CANCER CHEMOTH PHARM, V68, P653, DOI 10.1007/s00280-010-1519-2; Hesketh PJ, 2003, J CLIN ONCOL, V21, P4112, DOI 10.1200/JCO.2003.01.095; Rapoport BL, 2010, SUPPORT CARE CANCER, V18, P423, DOI 10.1007/s00520-009-0680-9; Roila F, 2006, ANN ONCOL, V17, P20, DOI 10.1093/annonc/mdj078; Martin AR, 2003, SUPPORT CARE CANCER, V11, P522, DOI 10.1007/s00520-003-0482-4; Warr DG, 2011, SUPPORT CARE CANCER, V19, P807, DOI 10.1007/s00520-010-0899-5; dos Santos LV, 2012, JNCI-J NATL CANCER I, V104, P1280, DOI 10.1093/jnci/djs335; Hesketh PJ, 2010, SUPPORT CARE CANCER, V18, P1171, DOI 10.1007/s00520-009-0737-9; Navari RM, 2009, EXPERT OPIN PHARMACO, V10, P629, DOI [10.1517/14656560902731894 , 10.1517/14656560902731894]; Gomez DR, 2013, CANCER-AM CANCER SOC, V119, P1428, DOI 10.1002/cncr.27899; Schmoll HJ, 2006, ANN ONCOL, V17, P1000, DOI 10.1093/annonc/mdl019; Osoba D, 1997, J CLIN ONCOL, V15, P116; Warr DG, 2005, J CLIN ONCOL, V23, P2822; Baker Paul D, 2005, Gastroenterol Nurs, V28, P469, DOI 10.1097/00001610-200511000-00003; Basch E, 2011, J CONTRACEPT FERTIL, V29, P1; Bayo J, 2012, CLIN TRANSL ONCOL, V14, P413, DOI 10.1007/s12094-012-0818-y; DUBOIS A, 1992, EUR J CANCER, V28A, P450, DOI 10.1016/S0959-8049(05)80075-9; Hesketh PJ, 2008, NEW ENGL J MED, V358, P2482, DOI 10.1056/NEJMra0706547; Higa Gerald M, 2006, J Oncol Pharm Pract, V12, P201, DOI 10.1177/1078155206072080; Lordick F, 2007, EUR J CANCER, V43, P299, DOI 10.1016/j.ejca.2006.09.019; Moore S, 2007, VALUE HEALTH, V10, P23, DOI 10.1111/j.1524-4733.2006.00141.x; National Comprehensive Cancer Network, 2013, NCCN CLIN PRACT GUID; Nomura H, 2008, JPN J CANC CHEMOTHER, V35, P941; ROILA F, 1987, J CLIN ONCOL, V5, P141; Takahashi T, 2010, CANCER SCI, V101, P2455, DOI 10.1111/j.1349-7006.2010.01689.x; Wood JM, 2011, CANC NURS, V34, P14	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	APR	2015	23	4					905	912		10.1007/s00520-014-2430-x		8	Oncology; Health Care Sciences & Services; Rehabilitation	Oncology; Health Care Sciences & Services; Rehabilitation	CC6RY	WOS:000350496500004		
J	Takekiyo, T; Dozono, K; Mitsuishi, T; Murayama, Y; Maeda, A; Nakano, N; Kubota, A; Tokunaga, M; Takeuchi, S; Takatsuka, Y; Utsunomiya, A				Takekiyo, Takahiro; Dozono, Koichiro; Mitsuishi, Takayuki; Murayama, Yoshihiro; Maeda, Ayako; Nakano, Nobuaki; Kubota, Ayumu; Tokunaga, Masahito; Takeuchi, Shogo; Takatsuka, Yoshifusa; Utsunomiya, Atae			Effect of exercise therapy on muscle mass and physical functioning in patients undergoing allogeneic hematopoietic stem cell transplantation	SUPPORTIVE CARE IN CANCER			English	Article						Allogeneic hematopoietic stem cell transplantation; Exercise therapy; Muscle mass; Physical functioning	BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; LOWER-LIMB MUSCLES; SKELETAL-MUSCLE; CANCER SURVIVORS; RANDOMIZED-TRIAL; BODY-COMPOSITION; BED REST; PROGRAM; WALKING	Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is associated with transplant-related toxicities, which may have a profound impact on a patient's physical functioning and body composition. In order to analyze the effect of exercise therapy on muscle mass and physical functioning in patients receiving allo-HSCT, we measured muscle mass and physical functioning before and after allo-HSCT. Eighty-six patients who had undergone allo-HSCT between February 2010 and September 2013 at Imamura Bun-in Hospital participated in this study. Physical therapists performed exercise therapy with patients 5 days a week, starting 2 weeks before allo-HSCT. Body composition, 6-min walk test (6MWT) scores, and handgrip strength were evaluated 2 weeks before allo-HSCT and 6 weeks after allo-HSCT. Thirty-five patients were available for evaluation 2 weeks before and 6 weeks after allo-HSCT. The 6MWT (p = 0.005) and handgrip strength (p < 0.001) significantly decreased after allo-HSCT. Although upper extremity muscle mass (p = 0.001) and trunk muscle mass (p < 0.001) significantly decreased after allo-HSCT, lower extremity muscle mass remained unchanged. In this study, it is suggested that exercise therapy may be effective for maintaining lower extremity muscle mass in patients undergoing allo-HSCT.	[Takekiyo, Takahiro; Dozono, Koichiro; Mitsuishi, Takayuki; Murayama, Yoshihiro; Maeda, Ayako] Imamura Bun In Hosp, Dept Rehabil Med, Kagoshima 8900064, Japan; [Nakano, Nobuaki; Kubota, Ayumu; Tokunaga, Masahito; Takeuchi, Shogo; Takatsuka, Yoshifusa; Utsunomiya, Atae] Imamura Bun In Hosp, Dept Hematol, Kagoshima 8900064, Japan	Takekiyo, T (reprint author), Imamura Bun In Hosp, Dept Rehabil Med, 11-23 Kamoikeshinmachi, Kagoshima 8900064, Japan.	soutakekiyo@yahoo.co.jp					Dimeo F, 1996, BONE MARROW TRANSPL, V18, P1157; FOBAIR P, 1986, J CLIN ONCOL, V4, P805; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Wilson RW, 2005, BONE MARROW TRANSPL, V35, P721, DOI 10.1038/sj.bmt.1704815; WINTER DA, 1987, ELECTROEN CLIN NEURO, V67, P402, DOI 10.1016/0013-4694(87)90003-4; Hacker ED, 2011, CANCER NURS, V34, P238, DOI 10.1097/NCC.0b013e3181fb3686; Wiskemann J, 2011, BLOOD, V117, P2604, DOI 10.1182/blood-2010-09-306308; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Morishita S, 2013, SUPPORT CARE CANCER, V21, P2161, DOI 10.1007/s00520-013-1778-7; Pietrobelli A, 2004, EUR J CLIN NUTR, V58, P1479, DOI 10.1038/sj.ejcn.1601993; Jarden M, 2009, BONE MARROW TRANSPL, V43, P725, DOI 10.1038/bmt.2009.27; Mello M, 2003, BONE MARROW TRANSPL, V32, P723, DOI 10.1038/sj.bmt.1704227; Baumann FT, 2010, BONE MARROW TRANSPL, V45, P355, DOI 10.1038/bmt.2009.163; Baumann FT, 2011, EUR J HAEMATOL, V87, P148, DOI 10.1111/j.1600-0609.2011.01640.x; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Defor TE, 2007, BIOL BLOOD MARROW TR, V13, P948, DOI 10.1016/j.bbmt.2007.04.008; Morishita S, 2012, SUPPORT CARE CANCER, V20, P3161, DOI 10.1007/s00520-012-1460-5; Minetto MA, 2011, J ENDOCRINOL INVEST, V34, P370; FERRANDO AA, 1995, AVIAT SPACE ENVIR MD, V66, P976; Morishita S, 2013, EUR J CANCER CARE, V22, P289, DOI 10.1111/ecc.12027; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Janssen I, 2000, J APPL PHYSIOL, V89, P465; Hung YC, 2013, SUPPORT CARE CANCER, V21, P1579, DOI 10.1007/s00520-012-1698-y; DECKER WA, 1989, TRANSPLANT P, V21, P3068; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Flowers MED, 1999, HEMATOL ONCOL CLIN N, V13, P1091, DOI 10.1016/S0889-8588(05)70111-8; Hides JA, 2011, EUR SPINE J, V20, P808, DOI 10.1007/s00586-010-1491-x; ATKINSON K, 1990, BONE MARROW TRANSPL, V5, P69; Belavy DL, 2009, EUR J APPL PHYSIOL, V107, P489, DOI 10.1007/s00421-009-1136-0; Carlson LE, 2006, BONE MARROW TRANSPL, V37, P945, DOI 10.1038/sj.bmt.1705343; Coleman EA, 2003, CANCER NURS, V26, P410, DOI 10.1097/00002820-200310000-00012; CUNNINGHAM BA, 1986, JPEN-PARENTER ENTER, V10, P558, DOI 10.1177/0148607186010006558; ERICSON MO, 1986, SCAND J REHABIL MED, V18, P159; Hayes S, 2003, BONE MARROW TRANSPL, V31, P331, DOI 10.1038/sj.bmt.1703867; HODGSON JA, 1983, J PHYSIOL-LONDON, V337, P553; Ikeda S, 2003, ARCH PHYS MED REHAB, V84, P419, DOI 10.1053/apmr.2003.50025; KELLERMAN J, 1977, AM J PSYCHIAT, V134, P563; Kern DS, 2001, J APPL PHYSIOL, V91, P2224; Knols RH, 2011, BONE MARROW TRANSPL, V46, P1245, DOI 10.1038/bmt.2010.288; Lorenzo Antonino D, 2003, Curr Opin Clin Nutr Metab Care, V6, P551, DOI 10.1097/00075197-200309000-00008	41	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	APR	2015	23	4					985	992		10.1007/s00520-014-2425-7		8	Oncology; Health Care Sciences & Services; Rehabilitation	Oncology; Health Care Sciences & Services; Rehabilitation	CC6RY	WOS:000350496500013		
J	Iihara, N; Nishio, T; Goda, T; Anzai, H; Kagawa, M; Houchi, H; Kirino, Y				Iihara, Naomi; Nishio, Takayuki; Goda, Tetsuko; Anzai, Hideaki; Kagawa, Masatoshi; Houchi, Hitoshi; Kirino, Yutaka			Effect of endurance for adverse drug reactions on the preference for aggressive treatments in cancer patients	SUPPORTIVE CARE IN CANCER			English	Article						Chemotherapy; Drug-related side effects and adverse reactions; Patient preference; Decision making	STAGE BREAST-CANCER; QUALITY-OF-LIFE; ADJUVANT CHEMOTHERAPY; THERAPY; WORTHWHILE	Cancer patients receiving chemotherapy will sometimes conceal their discomfort, but an excessive endurance for adverse drug reactions (ADRs) can lead to a poorer prognosis. The aim of this study was to clarify the association between ADR endurance and a preference of cancer patients for aggressive treatments. A cross-sectional study was undertaken of inpatients under 75 years of age receiving injectable systemic chemotherapy or oral chronic medications at hospitals in Japan. Subjects were asked to respond to a validated questionnaire to assess the extent of their ADR endurance and whether they would choose a novel, more aggressive therapy if their life expectancy was estimated at 2 years. Study participants were separated into the chemotherapy group (n = 36) and the non-chemotherapy group (n = 78). In the chemotherapy group, patients who had moderate ADR endurance scores were more likely to choose the new therapy (0-33, 34-67, and 68-100 points: 0.0, 54.5, and 27.3 %; chi (2) test, p = 0.15). Additionally, every patient on long-term chemotherapy (a parts per thousand yen3 years) had high ADR endurance scores but did not choose the new, riskier treatment. In the non-chemotherapy group, the proportion of those choosing the new therapy was linearly associated with higher ADR endurance scores (25.9, 38.2, and 64.7 %; p = 0.04). Cancer patients may prefer aggressive therapies, even when self-estimations of ADR endurance are not very high, especially if they have been receiving chemotherapy for a short period of time. These patients should be observed with great caution.	[Iihara, Naomi; Nishio, Takayuki; Kirino, Yutaka] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa 7692193, Japan; [Nishio, Takayuki] Sanuki City Hosp, Dept Pharm, Sanuki, Kagawa, Japan; [Goda, Tetsuko; Anzai, Hideaki] Takamatsu Red Cross Hosp, Dept Pharm, Takamatsu, Kagawa 7600017, Japan; [Kagawa, Masatoshi] Sakaide City Hosp, Dept Pharm, Sakaide, Kagawa 7620031, Japan; [Houchi, Hitoshi] Kagawa Univ Hosp, Dept Pharm, Kita, Kagawa 7610793, Japan	Iihara, N (reprint author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, 1314-1 Shido, Sanuki, Kagawa 7692193, Japan.	iiharan@kph.bunri-u.ac.jp			Pfizer Health Research Foundation	This work was supported by a research grant from the Pfizer Health Research Foundation. The funding source had no role in the collection or analysis of the study data.	Kuchuk I, 2013, BREAST CANCER RES TR, V142, P101, DOI 10.1007/s10549-013-2727-3; Lindley C, 1998, J CLIN ONCOL, V16, P1380; Sun CC, 2005, SUPPORT CARE CANCER, V13, P219, DOI 10.1007/s00520-004-0710-6; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Zafar SY, 2009, SUPPORT CARE CANCER, V17, P117, DOI 10.1007/s00520-008-0505-2; Ravdin PM, 1998, J CLIN ONCOL, V16, P515; Sahm S, 2005, SUPPORT CARE CANCER, V13, P206, DOI 10.1007/s00520-004-0725-z; Beusterien K, 2014, ONCOLOGIST, V19, P127, DOI 10.1634/theoncologist.2013-0359; Duric V, 2001, LANCET ONCOL, V2, P691, DOI 10.1016/S1470-2045(01)00559-9; Fayers PM, 2000, QUALITY LIFE ASSESSM; Iihara N, 2014, J CLIN PHARM THER, V39, P45, DOI 10.1111/jcpt.12100; Jansen SJT, 2004, J CLIN ONCOL, V22, P3181, DOI 10.1200/JCO.2004.06.109; Jansen SJT, 2001, BRIT J CANCER, V84, P1577, DOI 10.1054/bjoc.2001.1836; Luthy C, 2011, SUPPORT CARE CANCER, V19, P363, DOI 10.1007/s00520-010-0826-9; Martin MY, 2014, SUPPORT CARE CANCER, V22, P233, DOI 10.1007/s00520-013-1958-5; National Cancer Institute. Cancer Therapy Evaluation Program, 2006, COMM TERM CRIT ADV E; Simes RJ, 2001, J NATL CANC I MONOGR, V30, P146; SLEVIN ML, 1990, BRIT MED J, V300, P1458; Stiggelbout AM, 2001, J CLIN ONCOL, V19, P220; Zimmermann C, 2000, BREAST CANCER RES TR, V60, P9, DOI 10.1023/A:1006342316373	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	APR	2015	23	4					1091	1097		10.1007/s00520-014-2439-1		7	Oncology; Health Care Sciences & Services; Rehabilitation	Oncology; Health Care Sciences & Services; Rehabilitation	CC6RY	WOS:000350496500026		
J	Kosaka, Y; Rai, Y; Masuda, N; Takano, T; Saeki, T; Nakamura, S; Shimazaki, R; Ito, Y; Tokuda, Y; Tamura, K				Kosaka, Yoshimasa; Rai, Yoshiaki; Masuda, Norikazu; Takano, Toshimi; Saeki, Toshiaki; Nakamura, Seigo; Shimazaki, Ryutaro; Ito, Yoshinori; Tokuda, Yutaka; Tamura, Kazuo			Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy	SUPPORTIVE CARE IN CANCER			English	Article						Adjuvant therapy; Breast cancer; Febrile neutropenia; Granulocyte colony-stimulating factor (G-CSF); Pegfilgrastim; Docetaxel/cyclophosphamide therapy	DOCETAXEL PLUS CYCLOPHOSPHAMIDE; COLONY-STIMULATING FACTOR; ADJUVANT CHEMOTHERAPY; DOSE-INTENSITY; SOLID TUMORS; RECOMMENDATIONS; MULTICENTER; DOXORUBICIN; LYMPHOMA; THERAPY	Pegfilgrastim is a pegylated form of filgrastim, a recombinant protein of granulocyte colony-stimulating factor, that is used to reduce the risk of febrile neutropenia (FN). Here, we report the results of a phase III trial of pegfilgrastim in breast cancer patients receiving docetaxel and cyclophosphamide (TC) chemotherapy. We conducted a double-blind, placebo-controlled, randomized trial to determine the efficacy of pegfilgrastim in reducing the risk of FN in early-stage breast cancer patients. A total of 351 women (177 in the pegfilgrastim group and 174 in the placebo group) between 20 and 69 years of age with stage I-III invasive breast carcinoma who were to receive TC chemotherapy (docetaxel 75 mg/m(2) and cyclophosphamide 600 mg/m(2) every 3 weeks) as either neoadjuvant or adjuvant therapy were enrolled; 346 of these patients were treated with either pegfilgrastim (n = 173) or placebo (n = 173). The incidence of FN was significantly lower in the pegfilgrastim group than in the placebo group (1.2 vs. 68.8 %, respectively; P < 0.001). In addition, patients in the pegfilgrastim group required less hospitalization and antibiotics for FN. Most adverse events were consistent with those expected for breast cancer subjects receiving TC chemotherapy. Pegfilgrastim is safe and significantly reduces the incidence of FN in breast cancer patients.	[Kosaka, Yoshimasa] Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 228, Japan; [Rai, Yoshiaki] Hakuaikai Sagara Hosp, Dept Breast Surg, Kagoshima, Japan; [Masuda, Norikazu] Natl Hosp Org Osaka Natl Hosp, Dept Surg, Breast Oncol, Osaka, Japan; [Takano, Toshimi] Toranomon Gen Hosp, Dept Med Oncol, Tokyo, Japan; [Saeki, Toshiaki] Saitama Med Univ, Dept Breast Oncol, Int Med Ctr, Hidaka, Japan; [Nakamura, Seigo] Showa Univ Hosp, Dept Breast Surg Oncol, Tokyo, Japan; [Shimazaki, Ryutaro] Kyowa Hakko Kirin Co Ltd, R&D Div, Tokyo, Japan; [Ito, Yoshinori] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Med Oncol, Tokyo, Japan; [Tokuda, Yutaka] Tokai Univ Hosp, Dept Breast & Endocrine Surg, Isehara, Kanagawa, Japan; [Tamura, Kazuo] Fukuoka Univ Hosp, Div Med Oncol Hematol & Infect Dis, Fukuoka, Japan	Kosaka, Y (reprint author), Kitasato Univ, Sch Med, Dept Surg, Sagamihara, Kanagawa 228, Japan.	y-kosaka@med.kitasato-u.ac.jp			Kyowa Hakko Kirin Co., Ltd.	This study was funded by Kyowa Hakko Kirin Co., Ltd.	Vogel CL, 2005, J CLIN ONCOL, V23, P1178, DOI 10.1200/JCO.2005.09.102; Younis T, 2012, SUPPORT CARE CANCER, V20, P2523, DOI 10.1007/s00520-011-1375-6; Bosly A, 2008, ANN HEMATOL, V87, P277, DOI 10.1007/s00277-007-0399-y; Gandara DR, 2009, J CLIN ONCOL, V27, P3540, DOI 10.1200/JCO.2008.20.8793; Masaoka T, 2004, CLIN INFECT DIS, V39, pS49, DOI 10.1086/383054; Jones SE, 2006, J CLIN ONCOL, V24, P5381, DOI 10.1200/JCO.2006.06.5391; Takabatake D, 2009, JPN J CLIN ONCOL, V39, P478, DOI 10.1093/jjco/hyp050; Aapro MS, 2011, EUR J CANCER, V47, P8, DOI 10.1016/j.ejca.2010.10.013; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Lyman GH, 2004, J CLIN ONCOL, V22, P4302, DOI 10.1200/JCO.2004.03.213; Chan A, 2011, SUPPORT CARE CANCER, V19, P497, DOI 10.1007/s00520-010-0843-8; Martin M, 2006, ANN ONCOL, V17, P1205, DOI 10.1093/annonc/mdl135; Blackwell S, 1994, FILGRASTIM R METHUG, P103; Han HS, 2011, EUR J CANCER, V47, P2537, DOI 10.1016/j.ejca.2011.06.027; Japan Society of Clinical Oncology Clinical Practice Guideline, JAP SOC CLIN ONC CLI; Kawabata Hidetaka, 2010, Gan To Kagaku Ryoho, V37, P835; Masuda N, 2011, EUR J CANCER, V47, pS380; National Comprehensive Cancer Network, 2014, CLIN PRACT GUID ONC; Soong D, 2009, J CLIN ONCOL, V27, pE101, DOI 10.1200/JCO.2009.23.0508; Trent JC, 2003, CLIN CANCER RES, V9, P2426; Vandenberg T, 2010, Curr Oncol, V17, P2	21	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-4355	1433-7339		SUPPORT CARE CANCER	Support. Care Cancer	APR	2015	23	4					1137	1143		10.1007/s00520-014-2597-1		7	Oncology; Health Care Sciences & Services; Rehabilitation	Oncology; Health Care Sciences & Services; Rehabilitation	CC6RY	WOS:000350496500033		
J	Fujimoto, Y; Saito, S				Fujimoto, Yoshitaka; Saito, Susumu			Electronic structures and stabilities of bilayer graphene doped with boron and nitrogen	SURFACE SCIENCE			English	Article						Density-functional theory; Bilayer graphene; Chemical doping	SCANNING-TUNNELING-MICROSCOPY; MONOLAYER GRAPHENE; ENERGETICS; GAS	First-principles electronic-structure calculations have been performed to investigate energetics and electronic properties of boron (B) and nitrogen (N) defects in bilayer graphene. It is found that the formation energies for N-doped AB-stacked bilayers vary depending on dopant sites, whereas those for B-doped ones show almost site-independent behavior. From results of energy-band structure, B-doped and N-doped bilayer graphenes exhibit p-type and n-type electronic properties, respectively, with carriers on both two layers. It is also found that the boron and the nitrogen defects are observable in scanning tunneling microscopy (STM) images, while AA- and AB-stacking patterns of doped bilayer graphene exhibit similar STM images. (C) 2014 Elsevier B.V. All rights reserved.	[Fujimoto, Yoshitaka; Saito, Susumu] Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan; [Saito, Susumu] Tokyo Inst Technol, Int Res Ctr Nanosci & Quantum Phys, Meguro Ku, Tokyo 1528551, Japan; [Saito, Susumu] Tokyo Inst Technol, Mat Res Ctr Element Strategy, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Fujimoto, Y (reprint author), Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan.	fujimoto@stat.phys.titech.ac.jp			MEXT Elements Strategy Initiative to Form Core Research Center through the Tokodai Institute for Element Strategy; JSPS KAKENHI Grant [26390062]; MEXT [25107005]	This work was partly supported by the MEXT Elements Strategy Initiative to Form Core Research Center through the Tokodai Institute for Element Strategy, and JSPS KAKENHI Grant No. 26390062 and MEXT Grant No. 25107005. Computations were done at the Institute for Solid State Physics, the University of Tokyo and at the Global Scientific Information and Computing Center of the Tokyo Institute of Technology.	Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Fujimoto Y, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.205309; Omata Y, 2005, PHYSICA E, V29, P454, DOI 10.1016/j.physe.2005.06.009; Sakai Y, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.115424; Wang Y, 2010, ACS NANO, V4, P1790, DOI 10.1021/nn100315s; Yu YJ, 2009, NANO LETT, V9, P3430, DOI 10.1021/nl901572a; Fujimoto Y, 2011, J PHYS CONF SER, V302, DOI 10.1088/1742-6596/302/1/012006; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Lin JH, 2013, NANO LETT, V13, P3262, DOI 10.1021/nl4013979; Alam MS, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.080213; TERSOFF J, 1985, PHYS REV B, V31, P805, DOI 10.1103/PhysRevB.31.805; Zhang YB, 2009, NATURE, V459, P820, DOI 10.1038/nature08105; Liu Z, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.015501; Williams JR, 2007, SCIENCE, V317, P638, DOI 10.1126/science.1144657; Cho YJ, 2011, J PHYS CHEM C, V115, P9451, DOI 10.1021/jp201485j; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Kim H, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4889747; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Ziambaras E, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.155425; Fujimoto Y, 2011, PHYSICA E, V43, P677, DOI 10.1016/j.physe.2010.07.027; CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Fujimoto Y, 2014, J CERAM SOC JPN, V122, P346; Zhao LY, 2013, NANO LETT, V13, P4659, DOI 10.1021/nl401781d; Yamauchi J, 1996, PHYS REV B, V54, P5586, DOI 10.1103/PhysRevB.54.5586; Zhao LY, 2011, SCIENCE, V333, P999, DOI 10.1126/science.1208759; Jeong HM, 2011, NANO LETT, V11, P2472, DOI 10.1021/nl2009058; Wei DC, 2009, NANO LETT, V9, P1752, DOI 10.1021/nl803279t; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Kim Y, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075445; Fujimoto Y, 2001, MATER TRANS, V42, P2247, DOI 10.2320/matertrans.42.2247; Young AF, 2009, NAT PHYS, V5, P222, DOI 10.1038/NPHYS1198; Castro E.V., 2009, PHYS REV LETT, V99, P16802; Dai JY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3272008; Fujimoto Y, 2003, JPN J APPL PHYS 1, V42, P5267, DOI 10.1143/JJAP.42.5267; Fujimoto Y, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.245446; Fujimoto Y, 2014, J APPL PHYS, V115, DOI 10.1063/1.4871465; Guillaume SO, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.035444; Hou ZF, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.165439; Kang HS, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.233411; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Menezes MG, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.245414; Okada H, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.195324	43	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-6028	1879-2758		SURF SCI	Surf. Sci.	APR	2015	634				SI		57	61		10.1016/j.susc.2014.11.013		5	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CC1HO	WOS:000350092000010		
J	Al Balushi, ZY; Miyagi, T; Lin, YC; Wang, K; Calderin, L; Bhimanapati, G; Redwing, JM; Robinson, JA				Al Balushi, Zakaria Y.; Miyagi, Takahira; Lin, Yu-Chuan; Wang, Ke; Calderin, Lazaro; Bhimanapati, Ganesh; Redwing, Joan M.; Robinson, Joshua A.			The impact of graphene properties on GaN and AlN nucleation	SURFACE SCIENCE			English	Article						Graphene; GaN; AlN; Nucleation; Metalorganic chemical vapor deposition; Epitaxy	LIGHT-EMITTING-DIODES; EPITAXIAL GRAPHENE; RAMAN-SPECTROSCOPY; ALGAN/GAN HEMTS; GALLIUM-NITRIDE; GRAPHITE; CARBON; FILMS; GROWTH; LAYER	The use of graphene as a template layer for the heteroepitaxy of III-nitrides (GaN and AlN) has gained interest due to the hexagonal arrangement of the sp(2) hybridized carbon atoms being similar to the (0001) c-plane of wurtzite GaN. In this study, the nucleation of GaN and AlN by metalorganic chemical vapor deposition on quasi-free standing epitaxial graphene (EG) was investigated. We observed that the nucleation of AlN and GaN was preferential along the periodic (1 (1) over bar 0n) EG coated step edges and at defects sites on the (0001) terraces due to the enhanced chemical reactivity at those regions. The density of nuclei on the (0001) terraces of EG increased with the incorporation of nitrogen defects into the graphene lattice via NH3 exposure as was evident from surface chemical analysis by XPS. Raman spectral mapping showed that GaN selectively nucleates on regions of few-layered EG as opposed to regions of multi-layered EG. HR-TEM also revealed that the EG underlayers were highly defective in the region of GaN nucleation, however, the GaN nuclei were single crystalline, c-axis oriented and were free of threading dislocations. In contrast, polycrystalline islands of AlN were found to nucleate on EG without producing disorder in the underlying EG. (C) 2014 Elsevier B.V. All rights reserved.	[Al Balushi, Zakaria Y.; Miyagi, Takahira; Lin, Yu-Chuan; Bhimanapati, Ganesh; Redwing, Joan M.; Robinson, Joshua A.] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Wang, Ke; Calderin, Lazaro; Redwing, Joan M.; Robinson, Joshua A.] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA; [Al Balushi, Zakaria Y.; Miyagi, Takahira; Lin, Yu-Chuan; Calderin, Lazaro; Bhimanapati, Ganesh; Redwing, Joan M.; Robinson, Joshua A.] Penn State Univ, Ctr Twodimens & Layered Mat, University Pk, PA 16802 USA; [Miyagi, Takahira] Asahi Glass Co Ltd, Res Ctr, Kanagawa Ku, Yokohama, Kanagawa 2218755, Japan	Redwing, JM (reprint author), Penn State Univ, N-210 Millennium Sci Complex, University Pk, PA 16802 USA.	jmr31@psu.edu; jrobinson@psu.edu			Asahi Glass Co., Ltd, Japan; National Science Foundation [DMR-1006763]	This material is based upon work supported by Asahi Glass Co., Ltd, Japan. This study was also partially supported by the National Science Foundation under grant number DMR-1006763 (JMR). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. We would like to also acknowledge Dr. Ian Manning from Dow Corning Compound Semiconductor Solutions for providing vicinal SiC substrates for this study and Mr. Joshua J. Maier (Materials Characterization Laboratory, The Pennsylvania State University) for FIB-TEM sample preparation.	Alaskar Y, 2014, ADV FUNCT MATER, V24, P6629, DOI 10.1002/adfm.201400960; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Bertoti I, 2011, DIAM RELAT MATER, V20, P965, DOI 10.1016/j.diamond.2011.05.011; Liu L, 2008, NANO LETT, V8, P1965, DOI 10.1021/nl0808684; Mishra UK, 2002, P IEEE, V90, P1022, DOI 10.1109/JPROC.2002.1021567; Nakamura S, 2013, P IEEE, V101, P2211, DOI 10.1109/JPROC.2013.2274929; Wu QZ, 2013, CHEM COMMUN, V49, P677, DOI 10.1039/c2cc36747e; Chung K, 2010, SCIENCE, V330, P655, DOI 10.1126/science.1195403; Nakamura S, 1996, JPN J APPL PHYS 2, V35, pL74, DOI 10.1143/JJAP.35.L74; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Ferrari AC, 2013, NAT NANOTECHNOL, V8, P235, DOI 10.1038/nnano.2013.46; Binari SC, 1997, ELECTRON LETT, V33, P242, DOI 10.1049/el:19970122; Boukhvalov DW, 2009, J PHYS CHEM C, V113, P14176, DOI 10.1021/jp905702e; Chan KT, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235430; Robinson JA, 2011, NANO LETT, V11, P3875, DOI 10.1021/nl2019855; Riedl C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.246804; Lin YC, 2014, ACS NANO, V8, P3715, DOI 10.1021/nn5003858; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Reich S, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.035412; Ortmann F, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.205101; Cancado LG, 2011, NANO LETT, V11, P3190, DOI 10.1021/nl201432g; Speck F, 2010, PHYS STATUS SOLIDI C, V7, P398, DOI 10.1002/pssc.200982496; Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f; Chung K, 2012, NPG ASIA MATER, V4, DOI 10.1038/am.2012.45; Clark S.J., 2005, 1 PRINCIPLES METHODS; Gupta P, 2013, J CRYST GROWTH, V372, P105, DOI 10.1016/j.jcrysgro.2013.03.020; Jae-Kyung C., 2012, NANOTECHNOLOGY, V23; Kim J., 2014, NAT COMMUN, V5; Kneissl M, 2011, SEMICOND SCI TECH, V26, DOI 10.1088/0268-1242/26/1/014036; Leszczynski M, 1996, APPL PHYS LETT, V69, P73, DOI 10.1063/1.118123; Lin Y.-C., 2011, NANO LETT, V12, P414; Lv R., 2012, SCI REP, V2; Motoyuki T., 1997, JPN J APPL PHYS, V36, pL1062; NAKAMURA S, 1994, APPL PHYS LETT, V64, P1687, DOI 10.1063/1.111832; Neeraj N., 2013, APPL PHYS EXPRESS, V6; Xuan Y, 2008, APPL PHYS LETT, V92	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-6028	1879-2758		SURF SCI	Surf. Sci.	APR	2015	634				SI		81	88		10.1016/j.susc.2014.11.020		8	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	CC1HO	WOS:000350092000014		
J	Morino, M; Risio, M; Bach, S; Beets-Tan, R; Bujko, K; Panis, Y; Quirke, P; Rembacken, B; Rullier, E; Saito, Y; Young-Fadok, T; Allaix, ME				Morino, Mario; Risio, Mauro; Bach, Simon; Beets-Tan, Regina; Bujko, Krzysztof; Panis, Yves; Quirke, Philip; Rembacken, Bjorn; Rullier, Eric; Saito, Yutaka; Young-Fadok, Tonia; Allaix, Marco Ettore			Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Early rectal cancer; Local excision; Neoadjuvant chemoradiation; Laparoscopy; Total mesorectal excision	LYMPH-NODE METASTASIS; TOTAL MESORECTAL EXCISION; QUALITY-OF-LIFE; INVASIVE COLORECTAL-CANCER; RANDOMIZED CONTROLLED-TRIAL; ENDOLUMINAL LOCOREGIONAL RESECTION; LOW ANTERIOR RESECTION; SHORT-TERM OUTCOMES; LOCAL EXCISION; PREOPERATIVE RADIOTHERAPY	The last 30 years have witnessed a significant increase in the diagnosis of early-stage rectal cancer and the development of new strategies to reduce the treatment-related morbidity. Currently, there is no consensus on the definition of early rectal cancer (ERC), and the best management of ERC has not been yet defined. The European Association for Endoscopic Surgery in collaboration with the European Society of Coloproctology developed this consensus conference to provide recommendations on ERC diagnosis, staging and treatment based on the available evidence. A multidisciplinary group of experts selected on their clinical and scientific expertise was invited to critically review the literature and to formulate evidence-based recommendations by the Delphi method. Recommendations were discussed at the plenary session of the 14th World Congress of Endoscopic Surgery, Paris, 26 June 2014, and then posted on the EAES website for open discussion. Tumour biopsy has a low accuracy. Digital rectal examination plays a key role in the pre-operative work-up. Magnification chromoendoscopy, endoscopic ultrasound and magnetic resonance imaging are complementary staging modalities. Endoscopic submucosal dissection and transanal endoscopic microsurgery are the two established approaches for local excision (LE) of selected ERC. The role of all organ-sparing approaches including neoadjuvant therapies followed by LE should be formally assessed by randomized controlled trials. Rectal resection and total mesorectal excision is indicated in the presence of unfavourable features at the pathological evaluation of the LE specimen. The laparoscopic approach has better short-term outcomes and similar oncologic results when compared with open surgery. The management of ERC should always be based on a multidisciplinary approach, aiming to increase the rate of organ-preserving procedures without jeopardizing survival.	[Morino, Mario; Allaix, Marco Ettore] Univ Torino, Dept Surg Sci, I-10126 Turin, Italy; [Risio, Mauro] IRCCS, Dept Pathol, Candiolo Canc Inst FPO, Candiolo, Italy; [Bach, Simon] Univ Birmingham, Acad Dept Surg, Birmingham, W Midlands, England; [Beets-Tan, Regina] Maastricht Univ, Med & Oncol Ctr, Dept Radiol, NL-6200 MD Maastricht, Netherlands; [Bujko, Krzysztof] M Sklodowska Curie Mem Canc Ctr, Dept Radiotherapy, Warsaw, Poland; [Panis, Yves] Univ Paris 07, Colorectal Dept Beaujon Hosp, Paris, France; [Quirke, Philip] Univ Leeds, Pathol & Tumour Biol, Leeds, W Yorkshire, England; [Rembacken, Bjorn] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Rullier, Eric] St Andre Hosp, Dept Surg, Bordeaux, France; [Saito, Yutaka] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan; [Young-Fadok, Tonia] Mayo Clin, Coll Med, Dept Surg, Div Colon & Rectal Surg, Phoenix, AZ USA	Morino, M (reprint author), Univ Torino, Dept Surg Sci, Corso AM Dogliotti 14, I-10126 Turin, Italy.	mario.morino@unito.it; meallaix@gmail.com		Morino, Mario/0000-0003-4540-1409	Yorkshire Cancer Research	Drs. Mario Morino, Mauro Risio, Simon Bach, Regina Beets-Tan, Krzysztof Bujko, Yves Panis, Bjorn Rembacken, Eric Rullier, Yutaka Saito, Tonia Young-Fadok and Marco Ettore Allaix have no conflicts of interest or financial ties to disclose. Dr. Philip Quirke is funded by Yorkshire Cancer Research.	Absar M S, 2004, Tech Coloproctol, V8 Suppl 2, ps257, DOI 10.1007/s10151-004-0172-3; Allaix ME, 2013, J GASTROINTEST SURG, V17, P586, DOI 10.1007/s11605-012-2060-x; Brown G, 2004, BRIT J CANCER, V91, P23, DOI 10.1038/sj.bjc.6601871; Tominaga K, 2005, DIS COLON RECTUM, V48, P92, DOI 10.1007/S10350-004-0751-4; Garcia-Aguilar J, 2012, ANN SURG ONCOL, V19, P384, DOI 10.1245/s10434-011-1933-7; Uraoka T, 2011, DIGEST ENDOSC, V23, P112, DOI 10.1111/j.1443-1661.2011.01118.x; Saito Y, 2010, SURG ENDOSC, V24, P343, DOI 10.1007/s00464-009-0562-8; ISLER JT, 1987, DIS COLON RECTUM, V30, P435, DOI 10.1007/BF02556492; Brown G, 2003, RADIOLOGY, V227, P371, DOI 10.1148/radiol.2272011747; Cataldo PA, 2005, DIS COLON RECTUM, V48, P1366, DOI 10.1007/s10350-005-0031-y; Mamidanna R, 2012, DIS COLON RECTUM, V55, P788, DOI 10.1097/DCR.0b013e3182585a35; KUDO S, 1994, J CLIN PATHOL, V47, P880, DOI 10.1136/jcp.47.10.880; Kang SB, 2010, LANCET ONCOL, V11, P637, DOI 10.1016/S1470-2045(10)70131-5; Yasuda K, 2007, DIS COLON RECTUM, V50, P1370, DOI 10.1007/s10350-007-0263-0; Morino M, 2011, SURG ENDOSC, V25, P3683, DOI 10.1007/s00464-011-1777-z; Morino M, 2013, SURG ENDOSC, V27, P3315, DOI 10.1007/s00464-013-2911-x; Leong KJ, 2014, BRIT J SURG, V101, P1299, DOI 10.1002/bjs.9571; Doornebosch PG, 2007, COLORECTAL DIS, V9, P553, DOI 10.1111/j.1463-1318.2006.01186.x; Tateishi Y, 2010, MODERN PATHOL, V23, P1068, DOI 10.1038/modpathol.2010.88; Sohn DK, 2007, J CLIN PATHOL, V60, P912, DOI 10.1136/jcp.2006.043539; Marijnen CAM, 2002, J CLIN ONCOL, V20, P817, DOI 10.1200/JCO.20.3.817; Hewett DG, 2012, GASTROENTEROLOGY, V143, P599, DOI 10.1053/j.gastro.2012.05.006; [Anonymous], 2003, GASTROINTEST ENDOSC, V58, pS3; Kaneko I, 2007, DIS COLON RECTUM, V50, P13, DOI 10.1007/s10350-006-0745-5; Wallner C, 2008, J CLIN ONCOL, V26, P4466, DOI 10.1200/JCO.2008.17.3062; Gopaul D, 2004, DIS COLON RECTUM, V47, P1780, DOI 10.1007/s10350-004-0678-9; KODAMA Y, 1983, CANCER, V51, P320, DOI 10.1002/1097-0142(19830115)51:2<320::AID-CNCR2820510226>3.0.CO;2-#; Rutten H, 2007, EUR J CANCER, V43, P2295, DOI 10.1016/j.ejca.2007.07.009; Morino M, 2013, SURG ENDOSC, V27, P181, DOI 10.1007/s00464-012-2418-x; Puli S, 2009, ANN SURG ONCOL, V16, P254, DOI 10.1245/s10434-008-0231-5; Lee WY, 2007, SURG ENDOSC, V21, P975, DOI 10.1007/s00464-006-9170-z; Kawaguti FS, 2014, SURG ENDOSC, V28, P1173, DOI 10.1007/s00464-013-3302-z; Allaix ME, 2011, BRIT J SURG, V98, P1635, DOI 10.1002/bjs.7584; Albert MR, 2013, DIS COLON RECTUM, V56, P301, DOI 10.1097/DCR.0b013e31827ca313; Ramwell A, 2009, COLORECTAL DIS, V11, P964, DOI 10.1111/j.1463-1318.2008.01719.x; Gornicki A, 2014, EJSO-EUR J SURG ONC, V40, P723, DOI 10.1016/j.ejso.2013.11.010; Quirke P, 2011, VIRCHOWS ARCH, V458, P1, DOI 10.1007/s00428-010-0977-6; Kobayashi N, 2007, ENDOSCOPY, V39, P701, DOI 10.1055/s-2007-966587; Ashraf S, 2012, COLORECTAL DIS, V14, P821, DOI 10.1111/j.1463-1318.2011.02830.x; Morino M, 2009, SURG ENDOSC, V23, P1233, DOI 10.1007/s00464-008-0136-1; Kudo SE, 2008, GASTROINTEST ENDOSC, V68, pS3, DOI 10.1016/j.gie.2008.07.052; Levic K, 2013, TECH COLOPROCTOL, V17, P397, DOI 10.1007/s10151-012-0950-2; Christoforidis D, 2009, ANN SURG, V249, P776, DOI 10.1097/SLA.0b013e3181a3e54b; Pettersson D, 2010, BRIT J SURG, V97, P580, DOI 10.1002/bjs.6914; de Graaf EJR, 2011, COLORECTAL DIS, V13, P762, DOI 10.1111/j.1463-1318.2010.02269.x; Bretagnol F, 2007, DIS COLON RECTUM, V50, P523, DOI 10.1007/s70350-006-0819-4; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Suzuki A, 2009, AM J SURG PATHOL, V33, P1601, DOI 10.1097/PAS.0b013e3181ae29d6; Green BL, 2013, BRIT J SURG, V100, P75, DOI 10.1002/bjs.8945; Hayashi N, 2013, GASTROINTEST ENDOSC, V78, P625, DOI 10.1016/j.gie.2013.04.185; Floyd ND, 2006, DIS COLON RECTUM, V49, P164, DOI 10.1007/s10350-005-0269-4; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Chakravarti A, 1999, ANN SURG, V230, P49, DOI 10.1097/00000658-199907000-00008; Suppiah A, 2008, COLORECTAL DIS, V10, P314, DOI 10.1111/j.1463-1318.2007.01448.x; Taylor FGM, 2011, ANN SURG, V253, P711, DOI 10.1097/SLA.0b013e31820b8d52; van der Pas MHGM, 2013, LANCET ONCOL, V14, P210, DOI 10.1016/S1470-2045(13)70016-0; Borschitz T, 2008, ANN SURG ONCOL, V15, P712, DOI 10.1245/s10434-007-9732-x; Bujko K, 2013, RADIOTHER ONCOL, V106, P198, DOI 10.1016/j.radonc.2012.12.005; Saito Y, 2010, GASTROINTEST ENDOSC, V72, P1217, DOI 10.1016/j.gie.2010.08.004; Sebag-Montefiore D, 2009, LANCET, V373, P811, DOI 10.1016/S0140-6736(09)60484-0; Kitajima K, 2004, J GASTROENTEROL, V39, P534, DOI 10.1007/s00535-004-1339-4; Lezoche E, 2014, SURG ENDOSC, V28, P227, DOI 10.1007/s00464-013-3166-2; Nascimbeni R, 2002, DIS COLON RECTUM, V45, P200, DOI 10.1007/s10350-004-6147-7; Rullier E, 2013, DIS COLON RECTUM, V56, P560, DOI 10.1097/DCR.0b013e31827c4a8c; Greenberg JA, 2008, DIS COLON RECTUM, V51, P1185, DOI 10.1007/s10350-008-9231-6; Coco C, 2013, SURG ENDOSC, V27, P2860, DOI 10.1007/s00464-013-2842-6; Kim EK, 2012, GASTROINTEST ENDOSC, V75, P407; Wu Y, 2011, HEPATO-GASTROENTEROL, V58, P364; Bosch SL, 2013, ENDOSCOPY, V45, P827, DOI 10.1055/s-0033-1344238; Rullier E, 2005, ANN SURG, V241, P465, DOI 10.1097/01.sla.0000154551.06768.e1; Friel CM, 2002, DIS COLON RECTUM, V45, P875, DOI 10.1097/01.DCR.0000019509.23787.70; Moore JS, 2008, DIS COLON RECTUM, V51, P1026, DOI 10.1007/s10350-008-9337-x; Mamidanna R, 2012, COLORECTAL DIS, V14, P1175, DOI 10.1111/j.1463-1318.2011.02859.x; Kennedy ML, 2002, DIS COLON RECTUM, V45, P601, DOI 10.1007/s10350-004-6252-7; Barendse RM, 2013, SURG ENDOSC, V27, P3591, DOI 10.1007/s00464-013-2931-6; Smith KJE, 2011, DIS COLON RECTUM, V54, P35, DOI 10.1007/DCR.0b013e3181fb0e7a; Kudo SE, 1996, GASTROINTEST ENDOSC, V44, P8, DOI 10.1016/S0016-5107(96)70222-5; Arezzo A, 2013, SURG ENDOSC, V27, P1485, DOI 10.1007/s00464-012-2649-x; Saraste D, 2013, EUR J CANCER, V49, P1104, DOI 10.1016/j.ejca.2012.10.005; Lambregts DMJ, 2011, ANN SURG, V253, P539, DOI 10.1097/SLA.0b013e31820b01f1; O'Neill BDP, 2007, LANCET ONCOL, V8, P625, DOI 10.1016/S1470-2045(07)70202-4; Han KS, 2008, GASTROINTEST ENDOSC, V67, P97, DOI 10.1016/j.gie.2007.05.057; Gavagan JA, 2004, AM J SURG, V187, P630, DOI 10.1016/j.amjsurg.2004.01.004; Marusch F, 2011, ENDOSCOPY, V43, P425, DOI 10.1055/s-0030-1256111; Beets-Tan RGH, 2013, EUR RADIOL, V23, P2522, DOI 10.1007/s00330-013-2864-4; Lezoche E, 2012, BRIT J SURG, V99, P1211, DOI 10.1002/bjs.8821; Lee W, 2003, SURG ENDOSC, V17, P1283, DOI 10.1007/s00464-002-8814-x; Russell AH, 2000, INT J RADIAT ONCOL, V46, P313, DOI 10.1016/S0360-3016(99)00440-X; Baatrup G, 2009, SURG ENDOSC, V23, P2680, DOI 10.1007/s00464-008-0281-6; Morris E, 2008, GUT, V57, P1690, DOI 10.1136/gut.2007.137877; Bach SP, 2009, BRIT J SURG, V96, P280, DOI 10.1002/bjs.6456; Kiriyama S, 2012, ENDOSCOPY, V44, P1024, DOI 10.1055/s-0032-1310259; Borschitz T, 2006, DIS COLON RECTUM, V49, P1492, DOI 10.1007/s10350-006-0587-1; Nakajima T, 2013, SURG ENDOSC, V27, P3262, DOI 10.1007/s00464-013-2903-x; Brush J, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15350; Herman RM, 2001, INT J COLORECTAL DIS, V16, P370, DOI 10.1007/s003840100325; Park SU, 2012, ENDOSCOPY, V44, P1031, DOI 10.1055/s-0032-1310015; HASE K, 1995, DIS COLON RECTUM, V38, P19, DOI 10.1007/BF02053852; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Marks JH, 2009, SURG ENDOSC, V23, P1081, DOI 10.1007/s00464-009-0326-5; Lezoche G, 2008, SURG ENDOSC, V22, P352, DOI 10.1007/s00464-007-9596-y; Rembacken BJ, 2000, LANCET, V355, P1211, DOI 10.1016/S0140-6736(00)02086-9; Choi PW, 2008, WORLD J SURG, V32, P2089, DOI 10.1007/s00268-008-9628-3; Puppa G, 2012, HISTOPATHOLOGY, V61, P562, DOI 10.1111/j.1365-2559.2012.04270.x; ADLOFF M, 1989, AM J SURG, V157, P299, DOI 10.1016/0002-9610(89)90555-2; Borschitz T, 2007, DIS COLON RECTUM, V50, P292, DOI 10.1007/s10350-006-0816-7; Bentrem DJ, 2005, ANN SURG, V242, P472, DOI 10.1097/01.sla.0000183355.94322.db; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Smith NJ, 2008, BRIT J SURG, V95, P229, DOI 10.1002/bjs.5917; Beets-Tan RGH, 2001, LANCET, V357, P497, DOI 10.1016/S0140-6736(00)04040-X; Ueno H, 2010, AM J CLIN PATHOL, V134, P312, DOI 10.1309/AJCPMQ7I5ZTTZSOM; Lambert R, 2009, GASTROINTEST ENDOSC, V70, P1182, DOI 10.1016/j.gie.2009.09.015; Engelen SME, 2013, EUR J CANCER, V49, P2311, DOI 10.1016/j.ejca.2013.03.006; Perez RO, 2011, DIS COLON RECTUM, V54, P545, DOI 10.1007/DCR.0b013e3182083b84; Katagiri A, 2008, ALIMENT PHARM THER, V27, P1269, DOI 10.1111/j.1365-2036.2008.03650.x; Uraoka T, 2006, GUT, V55, P1592, DOI 10.1136/gut.2005.087452; Garcia-Aguilar J, 2002, DIS COLON RECTUM, V45, P10, DOI 10.1007/s10350-004-6106-3; Hoerske C, 2010, BRIT J SURG, V97, P1295, DOI 10.1002/bjs.7105; Clark AJ, 2004, BRIT J SURG, V91, P1345, DOI 10.1002/bjs.4601; Monson JRT, 2013, DIS COLON RECTUM, V56, P535, DOI 10.1097/DCR.0b013e31828cb66c; Sakuragi M, 2003, DIS COLON RECTUM, V46, P1626, DOI 10.1097/01.DCR.0000100821.53077.DD; Hendren SK, 2005, ANN SURG, V242, P212, DOI 10.1097/01.sla.0000171229.43954.ce; Patel UB, 2012, ANN SURG ONCOL, V19, P2842, DOI 10.1245/s10434-012-2309-3; Matsuda T, 2008, AM J GASTROENTEROL, V103, P2700, DOI 10.1111/j.1572-0241.2008.02190.x; Jin ZM, 2010, WORLD J SURG, V34, P1128, DOI 10.1007/s00268-010-0475-7; KIKUCHI R, 1995, DIS COLON RECTUM, V38, P1286, DOI 10.1007/BF02049154; Ptok H, 2006, EJSO, V32, P420, DOI 10.1016/j.ejso.2006.01.014; Fu KI, 2004, ENDOSCOPY, V36, P1089, DOI 10.1055/s-2004-826039; Ueno H, 2004, GASTROENTEROLOGY, V127, P385, DOI 10.1053/S0016-5085(04)00717-6; Juul T, 2014, DIS COLON RECTUM, V57, P585, DOI 10.1097/DCR.0000000000000116; COVERLIZZA S, 1989, CANCER, V64, P1937, DOI 10.1002/1097-0142(19891101)64:9<1937::AID-CNCR2820640929>3.0.CO;2-X; Heintz A, 1998, SURG ENDOSC-ULTRAS, V12, P1145, DOI 10.1007/s004649900802; Gondal G, 2005, ENDOSCOPY, V37, P1193, DOI 10.1055/s-921031; Suzuki T, 2003, DIS COLON RECTUM, V46, P203, DOI 10.1097/01.DCR.0000044728.97664.CB; Hahnloser D, 2005, DIS COLON RECTUM, V48, P429, DOI 10.1007/s10350-004-0900-9; Kreis ME, 1996, DIS COLON RECTUM, V39, P1116, DOI 10.1007/BF02081411; POLLETT WG, 1983, ANN SURG, V198, P159, DOI 10.1097/00000658-198308000-00008; Yamamoto S, 2004, HEPATO-GASTROENTEROL, V51, P998; Kennedy RH, 2014, J CLIN ONCOL, V32, P1804, DOI 10.1200/JCO.2013.54.3694; Schoellhammer HF, 2008, AM J SURG, V196, P904, DOI 10.1016/j.amjsurg.2008.08.005; Langer C, 2003, INT J COLORECTAL DIS, V18, P222, DOI 10.1007/s00384-002-0441-4; Marks JH, 2014, DIS COLON RECTUM, V57, P1176, DOI 10.1097/DCR.0000000000000208; Peng J, 2011, COLORECTAL DIS, V13, pe14, DOI 10.1111/j.1463-1318.2010.02424.x; Moss A, 2011, GASTROENTEROLOGY, V140, P1909, DOI 10.1053/j.gastro.2011.02.062; Doornebosch PG, 2008, INT J COLORECTAL DIS, V23, P709, DOI 10.1007/s00384-008-0442-z; Arezzo A, 2014, SURG ENDOSC, V28, P427, DOI 10.1007/s00464-013-3238-3; Baatrup G, 2009, EJSO-EUR J SURG ONC, V35, P1169, DOI 10.1016/j.ejso.2009.02.004; Banerjee AK, 1996, BRIT J SURG, V83, P211, DOI 10.1046/j.1365-2168.1996.02082.x; BARILLARI P, 1990, ACTA CHIR SCAND, V156, P163; BARON PL, 1995, DIS COLON RECTUM, V38, P177, DOI 10.1007/BF02052447; Bhangu A, 2013, ANN SURG, V258, P563, DOI 10.1097/SLA.0b013e3182a4e85a; Bleday R, 1997, DIS COLON RECTUM, V40, P388, DOI 10.1007/BF02258381; Bokkerink GMJ, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-34; Casadesus D, 2009, WORLD J GASTROENTERO, V15, P3844; Chen HS, 2000, DIS COLON RECTUM, V43, P1093, DOI 10.1007/BF02236556; Cooper HS, 1998, HUM PATHOL, V29, P15, DOI 10.1016/S0046-8177(98)90385-9; Emura F, 2007, J GASTROEN HEPATOL, V22, P1722, DOI 10.1111/j.1440-1746.2007.04975.x; Axon A, 2005, ENDOSCOPY, V37, P570, DOI 10.1055/s-2005-861352; Eyvazzadeh DJ, 2014, DIS COLON RECTUM, V57, P438, DOI 10.1097/DCR.0000000000000063; Finlayson E, 2012, DIS COLON RECTUM, V55, P1229, DOI 10.1097/DCR.0b013e318267bfe3; Fujii T, 1998, ENDOSCOPY, V30, P437, DOI 10.1055/s-2007-1001304; Gagliardi G, 2013, COLORECTAL DIS, V15, pE659, DOI 10.1111/codi.12387; Gao JD, 2003, WORLD J GASTROENTERO, V9, P871; Glasgow SC, 2012, J GASTROINTEST SURG, V16, P1019, DOI 10.1007/s11605-012-1827-4; HAGGITT R C, 1985, Gastroenterology, V89, P328; Haji A, 2014, DIS COLON RECTUM, V57, P378, DOI 10.1097/DCR.0b013e3182a0e39c; Ho P, 2003, INT J COLORECTAL DIS, V18, P230, DOI 10.1007/s00384-002-0042-3; Ikematsu H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-33; Kato S, 2006, WORLD J GASTROENTERO, V12, P1416; Kiriyama S, 2011, J GASTROEN HEPATOL, V26, P1028, DOI 10.1111/j.1440-1746.2011.06684.x; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Lee TG, 2014, SURG ENDOSC, V28, P271, DOI 10.1007/s00464-013-3184-0; Marusch F, 2002, ENDOSCOPY, V34, P385, DOI 10.1055/s-2002-25292; Mellgren A, 2000, DIS COLON RECTUM, V43, P1064, DOI 10.1007/BF02236551; NELSON RL, 1982, DIS COLON RECTUM, V25, P305, DOI 10.1007/BF02553602; Neri E, 2002, RADIOLOGY, V223, P615, DOI 10.1148/radiol.2233010928; Oh-e H, 2001, DIS COLON RECTUM, V44, P1129, DOI 10.1007/BF02234633; Petrelli NJ, 1999, J SURG ONCOL, V71, P46, DOI 10.1002/(SICI)1096-9098(199905)71:1<46::AID-JSO9>3.0.CO;2-T; Piscatelli N, 2005, ARCH SURG-CHICAGO, V140, P932, DOI 10.1001/archsurg.140.10.932; RAFAELSEN SR, 1994, ACTA RADIOL, V35, P300; Ricciardi R, 2010, DIS COLON RECTUM, V53, P874, DOI 10.1007/DCR.0b013e3181cf6f58; Rimonda R, 2013, SURG ENDOSC, V27, P3762, DOI 10.1007/s00464-013-2962-z; Siegel R, 2011, SURG ENDOSC, V25, P2423, DOI 10.1007/s00464-011-1805-z; Takahashi K, 2000, DIS COLON RECTUM, V43, pS40, DOI 10.1007/BF02237225; TANAKA S, 1995, DIS COLON RECTUM, V38, P959, DOI 10.1007/BF02049732; Thumbe V, 2007, Tech Coloproctol, V11, P111, DOI 10.1007/s10151-007-0339-9; Tominaga K, 2009, WORLD J GASTROENTERO, V15, P2351, DOI 10.3748/wjg.15.2351; van de Velde CJH, 2014, EUR J CANCER, V50, DOI 10.1016/j.ejca.2013.06.048; Vennix S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005200.pub3; Wolberink SVRC, 2009, DIS COLON RECTUM, V52, P928, DOI 10.1007/DCR.0b013e318194f923	190	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	APR	2015	29	4					755	773		10.1007/s00464-015-4067-3		19	Surgery	Surgery	CD2AT	WOS:000350876600001		
J	Ikematsu, H; Matsuda, T; Osera, S; Imajoh, M; Kadota, T; Morimoto, H; Sakamoto, T; Oono, Y; Kaneko, K; Saito, Y				Ikematsu, Hiroaki; Matsuda, Takahisa; Osera, Shozo; Imajoh, Maomi; Kadota, Tomohiro; Morimoto, Hiroyuki; Sakamoto, Taku; Oono, Yasuhiro; Kaneko, Kazuhiro; Saito, Yutaka			Usefulness of narrow-band imaging with dual-focus magnification for differential diagnosis of small colorectal polyps	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Dual focus; Colorectal polyp; Narrow-band imaging (NBI)	CONVENTIONAL COLONOSCOPY; CHROMOENDOSCOPY; NEOPLASIA; CANCER; TUMORS; FLAT; POPULATION; VALIDATION; ACCURACY; PATTERN	Many authors have already reported the usefulness of narrow-band imaging (NBI) for the differential diagnosis of non-neoplastic and neoplastic colorectal lesions. However, it is not clear whether magnification is required for differential diagnosis. The aim of this prospective study was to clarify the clinical usefulness of a newly developed NBI system with a dual focus function (dual-focus NBI) compared with conventional white-light imaging (WLI) and NBI without magnification for distinguishing between non-neoplastic and neoplastic lesions. Thirty-seven consecutive patients who underwent screening colonoscopy with the novel system between July and December 2013 were analyzed. Patients with polyps > 10 mm and those with polyps previously evaluated by histologic examination or colonoscopy were excluded. Lesions were diagnosed in real time with WLI, NBI without magnification, and dual-focus NBI, and then excised endoscopically. Each diagnosis was compared to that in the final histopathology reports. The primary endpoint was the diagnostic accuracy and the confidence level assigned to each modality by the endoscopists. The secondary endpoint was the differentiation ability according to the size of the lesion (a parts per thousand currency sign5 and 6-10 mm). In all, 100 lesions including 76 adenomatous polyps and 24 hyperplastic polyps were analyzed in 37 patients. The overall diagnostic accuracy, sensitivity, and specificity for differentiating adenomatous from hyperplastic polyps were 87.0, 89.5, and 79.2 % for WLI, 93.0, 94.7, and 87.5 % for NBI without magnification, and 94.0, 96.1, and 87.5 % for dual-focus NBI, respectively. The level of confidence was significantly different between dual-focus NBI and WLI and NBI without magnification for diminutive (a parts per thousand currency sign5 mm) lesions (p < 0.001 and p < 0.01). Dual-focus NBI is especially useful for differential diagnosis of diminutive colorectal lesions.	[Ikematsu, Hiroaki; Osera, Shozo; Imajoh, Maomi; Kadota, Tomohiro; Morimoto, Hiroyuki; Oono, Yasuhiro; Kaneko, Kazuhiro] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol & Endoscopy, Kashiwa, Chiba 2778577, Japan; [Matsuda, Takahisa; Sakamoto, Taku; Saito, Yutaka] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan	Ikematsu, H (reprint author), Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol & Endoscopy, Kashiwanoha 6-5-1, Kashiwa, Chiba 2778577, Japan.	hikemats@east.ncc.go.jp					KUDO S, 1994, J CLIN PATHOL, V47, P880, DOI 10.1136/jcp.47.10.880; Hewett DG, 2012, GASTROENTEROLOGY, V143, P599, DOI 10.1053/j.gastro.2012.05.006; [Anonymous], 2003, GASTROINTEST ENDOSC, V58, pS3; Hirata M, 2007, GASTROINTEST ENDOSC, V65, P988, DOI 10.1016/j.gie.2006.07.046; Konishi K, 2003, GASTROINTEST ENDOSC, V57, P48, DOI 10.1067/mge.2003.31; Ignjatovic A, 2009, LANCET ONCOL, V10, P1171, DOI 10.1016/S1470-2045(09)70329-8; Adler A, 2009, GASTROENTEROLOGY, V136, P410, DOI 10.1053/j.gastro.2008.10.022; Hassan Cesare, 2010, Clin Gastroenterol Hepatol, V8, P865, DOI 10.1016/j.cgh.2010.05.018; Axelrad AM, 1996, GASTROENTEROLOGY, V110, P1253, DOI 10.1053/gast.1996.v110.pm8613016; Kudo S, 2000, WORLD J SURG, V24, P1081; Higashi R, 2010, GASTROINTEST ENDOSC, V72, P127, DOI 10.1016/j.gie.2010.01.054; Su MY, 2006, AM J GASTROENTEROL, V101, P2711, DOI 10.1111/j.1572-0241.2006.00932.x; Chiu HM, 2007, GUT, V56, P373, DOI 10.1136/gut.2006.099614; Saitoh Y, 2001, GASTROENTEROLOGY, V120, P1657, DOI 10.1053/gast.2001.24886; Sano Y, 2009, GASTROINTEST ENDOSC, V69, P278, DOI 10.1016/j.gie.2008.04.066; Ikematsu H, 2012, J GASTROENTEROL, V47, P1099, DOI 10.1007/s00535-012-0575-2; Wada Y, 2009, GASTROINTEST ENDOSC, V70, P522, DOI 10.1016/j.gie.2009.01.040; Aronchick CA, 1999, AM J GASTROENTEROL, V94, P2667; CHAPUIS PH, 1982, DIS COLON RECTUM, V25, P669, DOI 10.1007/BF02629538; Emura F, 2007, J GASTROEN HEPATOL, V22, P1722, DOI 10.1111/j.1440-1746.2007.04975.x; Goda K, 2014, DIGEST ENDOSC, V26, P1, DOI 10.1111/den.12220; Hamilton SR, 2010, WHO CLASSIFICATION T, P132; Ikematsu H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-33; Kaltenbach T, 2008, GUT, V57, P1406, DOI 10.1136/gut.2007.137984; Kato S, 2006, WORLD J GASTROENTERO, V12, P1416; Kiesslich R, 2001, ENDOSCOPY, V33, P1001, DOI 10.1055/s-2001-18932; Matsuda T, 2009, WORLD J GASTROENTERO, V15, P2708, DOI 10.3748/wjg.15.2708; NEALE AV, 1987, DIS COLON RECTUM, V30, P247, DOI 10.1007/BF02556164; Rex DK, 2009, GASTROENTEROLOGY, V134, P1174; Sakamoto T, 2013, COLORECTAL DIS, V15, P295; Singh R, 2013, DIGEST ENDOSC, V25, P16, DOI 10.1111/den.12075; Soetikno R, 2006, GASTROENTEROLOGY, V130, P566, DOI 10.1053/j.gastro.2005.12.006; Tsuda S, 2002, GUT, V51, P550, DOI 10.1136/gut.51.4.550	33	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	APR	2015	29	4					844	850		10.1007/s00464-014-3736-y		7	Surgery	Surgery	CD2AT	WOS:000350876600010		
J	Kanehira, E; Tanida, T; Kamei, A; Nakagi, M; Iwasaki, M; Shimizu, H				Kanehira, Eiji; Tanida, Takashi; Kamei, Aya; Nakagi, Masafumi; Iwasaki, Mitsuharu; Shimizu, Hirofumi			Transanal endoscopic microsurgery for surgical repair of rectovesical fistula following radical prostatectomy	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Rectovesical fistula; Rectourethral fistula; Transanal endoscopic microsurgery; Endoluminal surgery	GRACILIS MUSCLE TRANSPOSITION; RECTO-URINARY FISTULAS; RECTOURETHRAL FISTULA; CLOSURE; EXPERIENCE; CLIP	Rectovesical fistula is a rare complication following prostatectomy, associated with significant symptoms such as urinary drainage from anus or faecaluria. While several surgical procedures have been described to treat this condition, none of them has been accepted as the universal standard. Transanal endoscopic microsurgery (TEM) is a well-established endoluminal procedure for local excision of rectal tumors. But its application to the repair of rectovesical fistula has been almost unknown. We performed TEM as a surgical repair for refractory rectovesical fistula developing after radical prostatectomy in 10 patients. Under the magnified three-dimensional view, through the stereoscope, the fistula and the surrounding rectal mucosa were precisely resected. The defect and the muscle layer of the rectum were closed by hand-sew technique in four layers. Fistula was completely closed in 7 patients, who eventually underwent enterostomy closure, while in the other 3 patients the fistula recurred. In the three recurrent cases, the fistula was associated with wide, tough scar tissue due to previous irradiation, HIFU, or repeated surgical repair attempts. Rectovesical fistulas associated with wide, tough scar tissue due to multi-time attempt of surgical repair or any type of energy ablation should not be indicated for repair by TEM. However, for simple fistulas without tough, fibrotic surroundings, TEM can be indicated as a minimally invasive surgical option with very low morbidity, without any incision in healthy tissue for approach.	[Kanehira, Eiji; Tanida, Takashi; Kamei, Aya; Nakagi, Masafumi] Med Topia Soka, Dept Surg, Soka, Saitama 3400028, Japan; [Iwasaki, Mitsuharu; Shimizu, Hirofumi] Med Topia Soka, Dept Urol, Soka, Saitama 3400028, Japan	Kanehira, E (reprint author), Med Topia Soka, Dept Surg, 1-11-18 Yatsuka, Soka, Saitama 3400028, Japan.	kanehira@mtopia.jp					Voelzke BB, 2013, J UROLOGY, V189, P966, DOI 10.1016/j.juro.2012.08.238; Wilbert DM, 1996, J UROLOGY, V155, P256, DOI 10.1016/S0022-5347(01)66612-6; Zmora O, 2003, ANN SURG, V237, P483, DOI 10.1097/00000658-200304000-00008; Zmora O, 2006, DIS COLON RECTUM, V49, P1316, DOI 10.1007/s10350-006-0585-3; Hechenbleikner EM, 2013, DIS COLON RECTUM, V56, P374, DOI 10.1097/DCR.0b013e318274dc87; Hadley DA, 2012, BJU INT, V109, P1095, DOI 10.1111/j.1464-410X.2011.10472.x; Arezzo A, 2014, MINIM INVASIV THER, V23, P21, DOI 10.3109/13645706.2013.833117; Buckley JC, 2011, CURR OPIN UROL, V21, P461, DOI 10.1097/MOU.0b013e32834b7e1b; Buess G, 1988, Surg Endosc, V2, P71, DOI 10.1007/BF00704356; Kanehira E, 2014, MINIM INVASIV THER, V23, P5, DOI 10.3109/13645706.2013.868814; Lirici MM, 2014, MINIM INVASIV THER, V23, P1, DOI 10.3109/13645706.2013.871294; Mangiavillano Benedetto, 2010, J Gastrointest Oncol, V1, P122, DOI 10.3978/j.issn.2078-6891.2010.020; Mori H, 2012, WORLD J GASTROENTERO, V18, P3177, DOI 10.3748/wjg.v18.i24.3177; Nfonsam VN, 2013, RES REP UROL, V30, P47; Renschler TD, 2003, J UROLOGY, V170, P1222, DOI 10.1097/01.ju.0000082013.58783.17; Schurr MO, 2008, MINIM INVASIV THER, V17, P262, DOI 10.1080/13645700802275114; Thomas C, 2009, J UROLOGY, V183, P608; Weiland T, 2012, MINIM INVASIV THER, V21, P249, DOI 10.3109/13645706.2012.694367	18	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	APR	2015	29	4					851	855		10.1007/s00464-014-3737-x		5	Surgery	Surgery	CD2AT	WOS:000350876600011		
J	Hidaka, E; Ishida, F; Mukai, S; Nakahara, K; Takayanagi, D; Maeda, C; Takehara, Y; Tanaka, J; Kudo, S				Hidaka, Eiji; Ishida, Fumio; Mukai, Shumpei; Nakahara, Kenta; Takayanagi, Daisuke; Maeda, Chiyo; Takehara, Yusuke; Tanaka, Jun-ichi; Kudo, Shin-ei			Efficacy of transanal tube for prevention of anastomotic leakage following laparoscopic low anterior resection for rectal cancers: a retrospective cohort study in a single institution	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Transanal tube; Anastomotic leakage; Laparoscopic low anterior resection; Rectal cancer; Double-stapling technique	RISK-FACTORS; DEFUNCTIONING STOMA; SURGERY; METAANALYSIS; DRAINAGE; EXCISION; THERAPY	Anastomotic leakage is one of the most serious complications following laparoscopic low anterior resection (LAR) for rectal cancers. The purpose of this study was to investigate whether transanal tube placement can reduce anastomotic leakage following laparoscopic LAR. Retrospective assessment was performed on 205 patients with rectal cancers who underwent laparoscopic LAR. A transanal tube was placed after anastomosis in 96 patients (group A). Another 109 patients were operated on without a transanal tube (group B). Clinicopathological and operative variables, the frequencies of anastomotic leakage and re-operation after leakage were investigated. Patient age, gender, body mass index, tumor size, Dukes' stage, intra-operative blood loss, and the rate of left colic artery preservation were comparable between the two groups. Tumor location was lower and operative time was significantly longer in group A than group B (p < 0.001). Overall rate of leakage was 9.3 % (19/205). The frequency of leakage was 4.2 % (4/96) in group A and was 13.8 % (15/109) in group B. The rate of leakage was significantly lower in group A (p < 0.05). Furthermore, the re-operation rate for symptomatic anastomotic leakage was 0 % (0/4) in group A, while in contrast it was 73.3 % (10/15) in group B. The rate of re-operation was lower in group A than group B (p < 0.05) and all cases with symptomatic leakage in group A were cured by conservative treatment. Transanal tube placement was effective for prevention of anastomotic leakage following laparoscopic LAR and avoiding re-operation after symptomatic leakage.	[Hidaka, Eiji; Ishida, Fumio; Mukai, Shumpei; Nakahara, Kenta; Takayanagi, Daisuke; Maeda, Chiyo; Takehara, Yusuke; Tanaka, Jun-ichi; Kudo, Shin-ei] Showa Univ, Ctr Digest Dis, North Yokohama Hosp, Tsuzuki Ku, Yokohama, Kanagawa 2248503, Japan	Hidaka, E (reprint author), Showa Univ, Ctr Digest Dis, North Yokohama Hosp, Tsuzuki Ku, 35-1 Chigasaki Chuo, Yokohama, Kanagawa 2248503, Japan.	ehidaka@med.showa-u.ac.jp					Vignali A, 1997, J AM COLL SURGEONS, V185, P105, DOI 10.1016/S1072-7515(01)00891-2; Baek SJ, 2013, WORLD J GASTROENTERO, V19, P5309, DOI 10.3748/wjg.v19.i32.5309; Kulu Y, 2013, SURGERY, V153, P753, DOI 10.1016/j.surg.2013.02.007; Yamamoto S, 2012, SURG LAPARO ENDO PER, V22, P239, DOI 10.1097/SLE.0b013e31824fbb56; Srinivasamurthy D, 2013, TECH COLOPROCTOL, V17, P275, DOI 10.1007/s10151-012-0911-9; Matthiessen P, 2007, ANN SURG, V246, P207, DOI 10.1097/SLA.0b013e3180603024; Hinoi T, 2013, WORLD J SURG, V37, P2935, DOI 10.1007/s00268-013-2194-3; Xiao L, 2011, WORLD J SURG, V35, P1367, DOI 10.1007/s00268-011-1053-3; Zhao WT, 2013, WORLD J SURG, V37, P227, DOI 10.1007/s00268-012-1812-9; Shiomi A, 2011, INT J COLORECTAL DIS, V26, P79, DOI 10.1007/s00384-010-1036-0; Maggiori L, 2011, COLORECTAL DIS, V13, P632, DOI 10.1111/j.1463-1318.2010.02252.x; Snijders HS, 2012, EJSO-EUR J SURG ONC, V38, P1013, DOI 10.1016/j.ejso.2012.07.111; Lange MM, 2013, ANN SURG ONCOL, V20, P1806, DOI 10.1245/s10434-012-2832-2; Huser N, 2008, ANN SURG, V248, P52, DOI [10.1097/SLA.0b013e318176bf65, 10.1097/SLA.0b013e18176bf65]; Milsom JW, 2009, DIS COLON RECTUM, V52, P1215, DOI [10.1007/DCR0b013e3181a73e81, 10.1007/DCR.0b013e3181a73e81]; Lee WS, 2008, WORLD J SURG, V32, P1124, DOI 10.1007/s00268-007-9451-2; Van Koperen PJ, 2008, COLORECTAL DIS, V10, P943, DOI 10.1111/j.1463-1318.2008.01485.x; Peng JJ, 2010, AM J SURG, V199, P753, DOI 10.1016/j.amjsurg.2009.03.026; Bertelsen CA, 2010, COLORECTAL DIS, V12, P37, DOI 10.1111/j.1463-1318.2008.01711.x; Kayano H, 2011, SURG ENDOSC, V25, P2972, DOI 10.1007/s00464-011-1655-8; Park JS, 2013, ANN SURG, V257, P665, DOI 10.1097/SLA.0b013e31827b8ed9; Eberl T, 2008, AM J SURG, V196, P592, DOI 10.1016/j.amjsurg.2007.10.023; Asoglu O, 2013, WORLD J SURG, V37, P883, DOI 10.1007/s00268-013-1927-7; Chopra SS, 2009, SURGERY, V145, P182, DOI 10.1016/j.surg.2008.09.012; Glitsch A, 2008, ENDOSCOPY, V40, P192, DOI 10.1055/s-2007-995384; Guenaga KF, 2008, ACTA CIR BRAS, V23, P294, DOI 10.1590/S0102-86502008000300014; Lam HD, 2011, SURG ENDOSC, V25, P454, DOI 10.1007/s00464-010-1191-y; Okuda J, 2011, Asian J Endosc Surg, V4, P68, DOI 10.1111/j.1758-5910.2011.00071.x; Seo Seok In, 2013, Ann Coloproctol, V29, P66, DOI 10.3393/ac.2013.29.2.66; Sirois-Giguere E, 2013, DIS COLON RECTUM, V56, P586, DOI 10.1097/DCR.0b013e31827687a4	30	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	APR	2015	29	4					863	867		10.1007/s00464-014-3740-2		5	Surgery	Surgery	CD2AT	WOS:000350876600013		
J	Kagawa, H; Kinugasa, Y; Shiomi, A; Yamaguchi, T; Tsukamoto, S; Tomioka, H; Yamakawa, Y; Sato, S				Kagawa, Hiroyasu; Kinugasa, Yusuke; Shiomi, Akio; Yamaguchi, Tomohiro; Tsukamoto, Syunsuke; Tomioka, Hiroyuki; Yamakawa, Yushi; Sato, Sumito			Robotic-assisted lateral lymph node dissection for lower rectal cancer: short-term outcomes in 50 consecutive patients	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Robotic surgery; Rectal cancer; Lateral lymph node	TOTAL MESORECTAL EXCISION; LOW ANTERIOR RESECTION; OPEN SURGERY; COLORECTAL-CANCER; COLON-CANCER; LAPAROSCOPIC SURGERY; RANDOMIZED-TRIAL; CLASICC TRIAL; RADIOTHERAPY; DYSFUNCTION	The goal of this study was to evaluate the short-term outcomes of robotic-assisted lateral lymph node dissection for patients with advanced lower rectal cancer. Between 2012 and 2013, 50 consecutive patients underwent robotic-assisted lateral lymph node dissection for rectal cancer in Shizuoka Cancer Center Hospital. Perioperative outcomes including operative time, operative blood loss, length of stay, postoperative complications, and histopathological data were collected prospectively. Median patient age was 62 years (range 36-74 years). Operative procedures included low anterior resections (n = 27), intersphincteric resections (n = 16), and abdominoperineal resections (n = 7). Bilateral lymph node dissection was performed in 44 patients. The median operative time was 476 min (range 320-683 min), and the median time required for lateral lymph node dissection was 165 min (range 85-257 min). The median blood loss was 27 mL (range 5-690 mL). There were no cases of open surgery or laparoscopic conversion. The median duration of postoperative hospital stay was 8 days (range 6-13 days). Clavien-Dindo classification Grade III-IV complications occurred in only one patient (2.0 %). There were no cases of anastomotic leak. There was no perioperative mortality. The median number of harvested lateral lymph nodes was 19 (range 5-47). Robotic-assisted lateral lymph node dissection is a safe, feasible, and useful approach for patients with advanced lower rectal cancer.	[Kagawa, Hiroyasu; Kinugasa, Yusuke; Shiomi, Akio; Yamaguchi, Tomohiro; Tsukamoto, Syunsuke; Tomioka, Hiroyuki; Yamakawa, Yushi; Sato, Sumito] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Nagaizumi, Shizuoka 4118777, Japan	Kagawa, H (reprint author), Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	h.kagawa@scchr.jp; y.kinugasa@scchr.jp					Lacy AM, 2008, ANN SURG, V248, P1, DOI 10.1097/SLA.0b013e31816a9d65; Fujita S, 2012, LANCET ONCOL, V13, P616, DOI 10.1016/S1470-2045(12)70158-4; Pigazzi A, 2006, SURG ENDOSC, V20, P1521, DOI 10.1007/s00464-005-0855-5; Corcione F, 2005, SURG ENDOSC, V19, P117, DOI 10.1007/s00464-004-9004-9; Baik SH, 2009, ANN SURG ONCOL, V16, P1480, DOI 10.1245/s10434-009-0435-3; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Sugihara K, 2006, DIS COLON RECTUM, V49, P1663, DOI 10.1007/s10350-006-0714-z; Lange MM, 2009, EUR J CANCER, V45, P1578, DOI 10.1016/j.ejca.2008.12.014; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Patriti A, 2009, JSLS-J SOC LAPAROEND, V13, P176; Peeters KCMJ, 2005, J CLIN ONCOL, V23, P6199, DOI 10.1200/JCO.2005.14.779; Delaney CP, 2003, DIS COLON RECTUM, V46, P1633, DOI 10.1097/01.DCR.0000098941.42470.D9; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Jayne DG, 2010, BRIT J SURG, V97, P1638, DOI 10.1002/bjs.7160; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Bruheim K, 2010, INT J RADIAT ONCOL, V76, P1005, DOI 10.1016/j.ijrobp.2009.03.010; MORIYA Y, 1995, EUR J CANCER, V31A, P1229, DOI 10.1016/0959-8049(95)00164-E; Buunen M, 2009, LANCET ONCOL, V10, P44, DOI DOI 10.1016/S1470-2045(08)70310-3; Guckenberger M, 2006, INT J COLORECTAL DIS, V21, P209, DOI 10.1007/s00384-005-0765-y; HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019; Kim JY, 2012, ANN SURG ONCOL, V19, P93; Liang JT, 2011, ANN SURG ONCOL, V18, P153, DOI 10.1245/s10434-010-1238-2; MORIYA Y, 1989, DIS COLON RECTUM, V32, P307, DOI 10.1007/BF02553486; Park Ju-A, 2012, J Korean Soc Coloproctol, V28, P265, DOI 10.3393/jksc.2012.28.5.265; Park JS, 2011, SURG ENDOSC, V25, P3322, DOI 10.1007/s00464-011-1719-9; Popescu I, 2010, Acta Chir Iugosl, V57, P29; Trial SRC, 1997, NEW ENGL J MED, V336, P980; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	APR	2015	29	4					995	1000		10.1007/s00464-014-3760-y		6	Surgery	Surgery	CD2AT	WOS:000350876600032		
J	Matsuda, T; Iwasaki, T; Mitsutsuji, M; Hirata, K; Maekawa, Y; Tanaka, T; Shimada, E; Kakeji, Y				Matsuda, Takeru; Iwasaki, Takeshi; Mitsutsuji, Masaaki; Hirata, Kenro; Maekawa, Yoko; Tanaka, Tomoko; Shimada, Etsuji; Kakeji, Yoshihiro			Cranial-to-caudal approach for radical lymph node dissection along the surgical trunk in laparoscopic right hemicolectomy	SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES			English	Article						Colon cancer; Right hemicolectomy; Laparoscopy; Cranial approach	COLON	Complete mesocolic excision with central vascular ligation is considered to contribute to superior oncological outcomes after colon cancer surgery [1]. For advanced right-sided colon cancer, this surgery sometimes requires lymph node (LN) dissection along the superior mesenteric vein (SMV), with division of the middle colic vessels, or their right branches, at origin [2]. Here, we present cranially approached radical LN dissection along the surgical trunk during laparoscopic right hemicolectomy. The omental bursa is first opened wide, and the gastrocolic trunk of Henle is exposed, using the right gastroepiploic vessels and the accessory right colic vein (ARCV) as landmarks. After division of ARCV, SMV and middle colic vein (MCV) are identified. After dividing MCV at its root, LN dissection along SMV is conducted in a cranial-to-caudal manner. Concurrently, the middle colic artery, or its right branch, is exposed and divided at origin. The transverse colon is then raised ventrally, and LN dissection along SMV using a cranial-to-caudal approach is again performed. The ileocolic and right colic vessels are divided at origin. The ascending and transverse mesocolon, including the pedicles, are then separated from the retroperitoneal tissues, pancreatic head, and duodenum, using a medial approach. The key characteristics in this procedure consist of easy access to pancreas, early division of ARCV and middle colic vessels at origin, and easy dissection along SMV. We performed a laparoscopic colectomy using this approach for 18 patients with right-sided colon cancer. The mean operative time and blood loss were 288 min and 83 ml, respectively. The mean number of harvested LNs was 24. There were 6 cases with positive LN metastasis. There were no recurrent cases at a median follow-up period of 24 months. We consider this approach to be safe and useful for radical LN dissection along SMV for right-sided colon cancers.	[Matsuda, Takeru; Iwasaki, Takeshi; Mitsutsuji, Masaaki; Hirata, Kenro; Maekawa, Yoko; Tanaka, Tomoko; Shimada, Etsuji] Natl Hosp Org Kobe Med Ctr, Dept Surg, Suma Ku, Kobe, Hyogo 6540155, Japan; [Kakeji, Yoshihiro] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo 657, Japan	Matsuda, T (reprint author), Natl Hosp Org Kobe Med Ctr, Dept Surg, Suma Ku, 3-1-1 Nishi Ochiai, Kobe, Hyogo 6540155, Japan.	takerumatsuda@nifty.com					West NP, 2010, J CLIN ONCOL, V28, P272, DOI 10.1200/JCO.2009.24.1448; Park IJ, 2009, ANN SURG ONCOL, V16, P1501, DOI 10.1245/s10434-009-0368-x	2	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-2794	1432-2218		SURG ENDOSC	Surg. Endosc.	APR	2015	29	4					1001	1001		10.1007/s00464-014-3761-x		1	Surgery	Surgery	CD2AT	WOS:000350876600033		
J	Blanke, A; Machida, R; Szucsich, NU; Wilde, F; Misof, B				Blanke, Alexander; Machida, Ryuichiro; Szucsich, Nikolaus Urban; Wilde, Fabian; Misof, Bernhard			Mandibles with two joints evolved much earlier in the history of insects: dicondyly is a synapomorphy of bristletails, silverfish and winged insects	SYSTEMATIC ENTOMOLOGY			English	Article							PHYLOGENETIC-RELATIONSHIPS; HEXAPODS; MANTOPHASMATODEA; EPHEMEROPTERA; ARCHAEOGNATHA; MICROSCOPY; MORPHOLOGY; CHARACTERS; ZYGENTOMA; EVOLUTION	The evolution of two-jointed mandibles is considered to be a major step during the evolution of early insects enabling the exploration of new types of food. Two-jointed-or dicondylic-mandibles are believed to be a groundplan characteristic for winged insects and silverfish. Jumping bristletails are thought to possess mandibles with one joint and are the sistergroup of winged insects+silverfish. However, our knowledge of the cephalic morphology of bristletails is limited to data from a few species and thus fragmentary. We investigated the cephalic morphology of both families of bristletails, Meinertellidae and Machilidae. We focused on skeletal elements and the musculature and compared them with the corresponding structures found in silverfish and winged insects. Bristletails show a previously unknown coupling structure between the maxillary palps and the mandibles and an additional anterior articulation of the mandibles in the region of the anterior tentorial pits. The articulation can be homologised with the anterior articulation in silverfish and winged insects. Together with a description of the functional morphology of the mandible system of bristletails and a discussion of the homology of mandibular articulations and related characters, we provide conclusive evidence that bristletails are, in fact, dicondylic insects.	[Blanke, Alexander; Misof, Bernhard] Zentrum Mol Biodiversitatsforsch, Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Blanke, Alexander; Machida, Ryuichiro] Univ Tsukuba, Sugadaira Montane Res Ctr, Ueda, Nagano 3862204, Japan; [Szucsich, Nikolaus Urban] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Wilde, Fabian] Zentrum Mat & Kstenforsch GmbH, Helmholtz Zentrum Geesthacht, Geesthacht, Germany	Blanke, A (reprint author), Univ Tsukuba, Sugadaira Montane Res Ctr, 1278-294 Sugadaira Kogen, Ueda, Nagano 3862204, Japan.	blanke@uni-bonn.de			Alexander Koenig Gesellschaft (AKG); Japanese Society for the Promotion of Science (JSPS) [P14071]; DESY; PSI; JSPS [21570089, 25440201]	Steven Yanoviak collected M. cundinamarcensis, which is highly appreciated, and Karl Kjer and Benjamin Wipfler helped to collect Trigoniophthalmus alternatus. Felix Beckmann (DESY), Marco Stampanoni, Peter Modregger and Rajmund Mokso (all PSI) provided excellent support at the synchrotron facilities. The scanning was done under proposals no. I-20080169, I-20090211 and I-20100029 (all DESY), as well as 20100137 and 20110069 (all PSI), which we gratefully acknowledge. Susanne Dungelhoef helped in the preparation of the figures. Many members of the ZFMK provided support in the laboratory and field. The Alexander Koenig Gesellschaft (AKG) provided financial support to AB for the collection of specimens. AB was supported by a fellowship of the Japanese Society for the Promotion of Science (JSPS fellowship P14071). SR-mu CT was financed by DESY and PSI. RM received a grant-in-aid from the JSPS (Scientific Research C: 21570089; 25440201).	Kjer KM, 2004, SYST BIOL, V53, P506, DOI 10.1080/10635150490445922; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Beutel Rolf G., 2006, Arthropod Systematics & Phylogeny, V64, P3; Terry MD, 2005, CLADISTICS, V21, P240, DOI 10.1111/j.1096-0031.2005.00062.x; Dell'Ampio E, 2014, MOL BIOL EVOL, V31, P239, DOI 10.1093/molbev/mst196; Pohl H, 2010, MICROSC RES TECHNIQ, V73, P1073, DOI 10.1002/jemt.20835; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Koch M, 2001, ANN SOC ENTOMOL FR, V37, P129; Kjer Karl M., 2006, Arthropod Systematics & Phylogeny, V64, P35; Blanke A, 2012, CLADISTICS, V28, P560, DOI 10.1111/j.1096-0031.2012.00405.x; Bitsch C, 2004, ZOOL SCR, V33, P511, DOI 10.1111/j.0300-3256.2004.00162.x; Bitsch C, 2000, ZOOL SCR, V29, P131, DOI 10.1046/j.1463-6409.2000.00036.x; Beutel RG, 2001, J ZOOL SYST EVOL RES, V39, P177, DOI 10.1046/j.1439-0469.2001.00155.x; Beckmann F., 2008, P SOC PHOTO-OPT INS, V7078; BITSCH J, 1994, ANN SOC ENTOMOL FR, V30, P103; Bitsch J., 1963, ANN SCI NAT ZOOL, V12, P585; Blanke A, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-16; Chaudonneret J., 1950, ANN SCI NAT ZOOL, V11, P145; Grimaldi David, 2005, pi; Hennig W., 1969, STAMMESGESCHICHTE IN; Klass K. -D., 2007, Denisia, P413; Klass KD, 2007, ZOOL ANZ, V246, P205, DOI 10.1016/j.jcz.2007.06.001; KLASS K.-D., 2009, P ARTHROPODAN EMBRYO, V43, P3; Koch M., 2003, ENTOMOLOGISCHE ABHAN, V62, P122; Kristensen N. P., 1991, INSECTS AUSTR, VI, P125; Kristensen Niels P., 1995, Zoologische Beitraege, V36, P83; Ogurreck M, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/18/182002; Stampanoni M., 2010, 6 INT C MED APPL SYN, V1266; Staniczek AH, 2000, ZOOL ANZ, V239, P147; Staniczek AH., 2001, THESIS EBERHARD KARL; STURM H, 1992, PAN-PAC ENTOMOL, V68, P174; STURM H, 1983, Caldasia, V13, P787; STURM H, 1993, ENTOMOL GEN, V18, P55; STURM H., 2001, HDB ZOOLOGY, VIV/37; vonsLieven A. F., 2000, ZOOL ANZ, V239, P139; vonsReumont B. M., 2009, BMC EVOLUTIONARY BIO, V9, P119; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI 10.1006/clad.2000.0147	38	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6970	1365-3113		SYST ENTOMOL	Syst. Entomol.	APR	2015	40	2					357	364		10.1111/syen.12107		8	Evolutionary Biology; Entomology	Evolutionary Biology; Entomology	CD3ML	WOS:000350982700004		
J	Schutze, MK; Aketarawong, N; Amornsak, W; Armstrong, KF; Augustinos, AA; Barr, N; Bo, W; Bourtzis, K; Boykin, LM; Caceres, C; Cameron, SL; Chapman, TA; Chinvinijkul, S; Chomic, A; De Meyer, M; Drosopoulou, E; Englezou, A; Ekesi, S; Gariou-Papalexiou, A; Geib, SM; Hailstones, D; Hasanuzzaman, M; Haymer, D; Hee, AKW; Hendrichs, J; Jessup, A; Ji, QG; Khamis, FM; Krosch, MN; Leblanc, L; Mahmood, K; Malacrida, AR; Mavragani-Tsipidou, P; Mwatawala, M; Nishida, R; Ono, H; Reyes, J; Rubinoff, D; San Jose, M; Shelly, TE; Srikachar, S; Tan, KH; Thanaphum, S; Haq, I; Vijaysegaran, S; Wee, SL; Yesmin, F; Zacharopoulou, A; Clarke, AR				Schutze, Mark K.; Aketarawong, Nidchaya; Amornsak, Weerawan; Armstrong, Karen F.; Augustinos, Antonis A.; Barr, Norman; Bo, Wang; Bourtzis, Kostas; Boykin, Laura M.; Caceres, Carlos; Cameron, Stephen L.; Chapman, Toni A.; Chinvinijkul, Suksom; Chomic, Anastasija; De Meyer, Marc; Drosopoulou, Ellena; Englezou, Anna; Ekesi, Sunday; Gariou-Papalexiou, Angeliki; Geib, Scott M.; Hailstones, Deborah; Hasanuzzaman, Mohammed; Haymer, David; Hee, Alvin K. W.; Hendrichs, Jorge; Jessup, Andrew; Ji, Qinge; Khamis, Fathiya M.; Krosch, Matthew N.; Leblanc, Luc; Mahmood, Khalid; Malacrida, Anna R.; Mavragani-Tsipidou, Pinelopi; Mwatawala, Maulid; Nishida, Ritsuo; Ono, Hajime; Reyes, Jesus; Rubinoff, Daniel; San Jose, Michael; Shelly, Todd E.; Srikachar, Sunyanee; Tan, Keng H.; Thanaphum, Sujinda; Haq, Ihsan; Vijaysegaran, Shanmugam; Wee, Suk L.; Yesmin, Farzana; Zacharopoulou, Antigone; Clarke, Anthony R.			Synonymization of key pest species within the Bactrocera dorsalis species complex (Diptera: Tephritidae): taxonomic changes based on a review of 20 years of integrative morphological, molecular, cytogenetic, behavioural and chemoecological data	SYSTEMATIC ENTOMOLOGY			English	Article							ORIENTAL FRUIT-FLY; FLIES DIPTERA; PHILIPPINENSIS DIPTERA; AEDEAGAL LENGTH; METHYL EUGENOL; WING-SHAPE; MATING COMPATIBILITY; POPULATION-STRUCTURE; CARAMBOLAE DIPTERA; MITOCHONDRIAL-DNA	Bactrocera papayaeDrew & Hancock, Bactrocera philippinensisDrew & Hancock, Bactrocera carambolaeDrew & Hancock, and Bactrocera invadensDrew, Tsuruta & White are four horticultural pest tephritid fruit fly species that are highly similar, morphologically and genetically, to the destructive pest, the Oriental fruit fly, Bactrocera dorsalis (Hendel) (Diptera: Tephritidae). This similarity has rendered the discovery of reliable diagnostic characters problematic, which, in view of the economic importance of these taxa and the international trade implications, has resulted in ongoing difficulties for many areas of plant protection and food security. Consequently, a major international collaborative and integrated multidisciplinary research effort was initiated in 2009 to build upon existing literature with the specific aim of resolving biological species limits among B. papayae, B. philippinensis, B. carambolae, B.invadens and B.dorsalis to overcome constraints to pest management and international trade. Bactrocera philippinensis has recently been synonymized with B. papayae as a result of this initiative and this review corroborates that finding; however, the other names remain in use. While consistent characters have been found to reliably distinguish B. carambolae from B. dorsalis, B. invadens and B. papayae, no such characters have been found to differentiate the latter three putative species. We conclude that B. carambolae is a valid species and that the remaining taxa, B. dorsalis, B. invadens and B. papayae, represent the same species. Thus, we consider B. dorsalis (Hendel) as the senior synonym of B.papayaeDrew and Hancock syn.n. and B. invadensDrew, Tsuruta & White syn.n. A redescription of B. dorsalis is provided. Given the agricultural importance of B. dorsalis, this taxonomic decision will have significant global plant biosecurity implications, affecting pest management, quarantine, international trade, postharvest treatment and basic research. Throughout the paper, we emphasize the value of independent and multidisciplinary tools in delimiting species, particularly in complicated cases involving morphologically cryptic taxa.	[Schutze, Mark K.; Cameron, Stephen L.; Vijaysegaran, Shanmugam; Clarke, Anthony R.] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia; [Schutze, Mark K.; Chapman, Toni A.; Englezou, Anna; Hailstones, Deborah; Krosch, Matthew N.; Clarke, Anthony R.] Plant Biosecur Cooperat Res Ctr, Canberra, ACT, Australia; [Aketarawong, Nidchaya] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok 10400, Thailand; [Amornsak, Weerawan] Kasetsart Univ, Dept Entomol, Fac Agr, Bangkok, Thailand; [Armstrong, Karen F.; Chomic, Anastasija] Lincoln Univ, Bioprotect Res Ctr, Christchurch, New Zealand; [Augustinos, Antonis A.; Bo, Wang; Bourtzis, Kostas; Caceres, Carlos; Hendrichs, Jorge; Reyes, Jesus; Haq, Ihsan] FAO IAEA Div Nucl Tech Food & Agr, Vienna, Austria; [Augustinos, Antonis A.; Bo, Wang; Bourtzis, Kostas; Caceres, Carlos; Hendrichs, Jorge; Reyes, Jesus; Haq, Ihsan] FAO IAEA Div Nucl Tech Food & Agr, Seibersdorf, Austria; [Augustinos, Antonis A.] Univ Patras, Dept Environm & Nat Resources Management, Agrinion, Greece; [Barr, Norman] USDA APHIS, Ctr Plant Hlth Sci & Technol, Mission Lab, Edinburg, TX USA; [Bo, Wang; Ji, Qinge] Fujian Agr & Forestry Univ, Fuzhou, Peoples R China; [Boykin, Laura M.] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Perth, WA 6009, Australia; [Boykin, Laura M.] Univ Western Australia, Sch Chem & Biochem, Perth, WA 6009, Australia; [Chapman, Toni A.; Englezou, Anna; Hailstones, Deborah] NSW Dept Primary Ind, Elizabeth Macarthur Agr Inst, Menangle, Australia; [Chinvinijkul, Suksom] Minist Agr & Cooperat, Dept Agr Extens, Bangkok, Thailand; [De Meyer, Marc] Royal Museum Cent Africa, Invertebrates Sect, Tervuren, Belgium; [Drosopoulou, Ellena; Mavragani-Tsipidou, Pinelopi] Aristotle Univ Thessaloniki, Fac Sci, Sch Biol, Dept Genet Dev & Mol Biol, GR-54006 Thessaloniki, Greece; [Ekesi, Sunday; Khamis, Fathiya M.] ICIPE, Nairobi, Kenya; [Gariou-Papalexiou, Angeliki; Zacharopoulou, Antigone] Univ Patras, Dept Biol, Patras, Greece; [Geib, Scott M.] ARS, Trop Crop & Commod Protect Res Unit, Pacific Basin Agr Res Ctr, USDA, Hilo, HI USA; [Hasanuzzaman, Mohammed; Yesmin, Farzana] Bangladesh Atom Energy Commiss, Inst Food & Radiat Biol, Atom Energy Res Estab, Dhaka, Bangladesh; [Haymer, David] Univ Hawaii, Dept Cell & Mol Biol, Honolulu, HI 96822 USA; [Hee, Alvin K. W.] Univ Putra Malaysia, Fac Sci, Dept Biol, Serdang 43400, Malaysia; [Jessup, Andrew] NSW Dept Primary Ind, Cent Coast Primary Ind Ctr, Gosford, Australia; [Krosch, Matthew N.] Univ Queensland, Sustainable Minerals Inst, Ctr Water Minerals Ind, St Lucia, Qld, Australia; [Leblanc, Luc; Rubinoff, Daniel; San Jose, Michael] Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA; [Mahmood, Khalid] Pakistan Museum Nat Hist, Islamabad, Pakistan; [Malacrida, Anna R.] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Mwatawala, Maulid] Sokoine Univ Agr, Dept Crop Sci & Prod, Morogoro, Tanzania; [Nishida, Ritsuo; Ono, Hajime] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Shelly, Todd E.] USDA APHIS, Honolulu, HI USA; [Srikachar, Sunyanee] Minist Agr & Cooperat, Dept Agr, Bangkok, Thailand; [Tan, Keng H.] Tan Hak Heng, George Town, Malaysia; [Thanaphum, Sujinda] Mahidol Univ, Fac Sci, Dept Biotechnol, Fruit Fly Mol Genet Lab, Bangkok 10400, Thailand; [Haq, Ihsan] Natl Agr Res Ctr, Islamabad, Pakistan; [Wee, Suk L.] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Bangi 43600, Malaysia	Schutze, MK (reprint author), Queensland Univ Technol, Sch Earth Environm & Biol Sci, GPO Box 2434, Brisbane, Qld 4001, Australia.	m.schutze@qut.edu.au	Cameron, Stephen/A-3742-2008; 	Cameron, Stephen/0000-0002-6694-4130; Clarke, Anthony/0000-0002-8165-3032; Jessup, Andrew/0000-0002-0479-7489	CRC National Plant Biosecurity and Plant Biosecurity CRC projects [CRC20115, CRC20183, PBCRC3024, PBCRC3066]; Australian Government's Cooperative Research Centres Program; Australian Research Council [FT120100746]; United States Department of Agriculture through Farm Bill funding [3.0251]; Tertiary Education Commission of New Zealand; UN-FAO/IAEA via the Coordinated Research Project 'Resolution of cryptic species complexes of tephritid pests to overcome constraints to SIT application and international trade'	M.K.S., A.R.C., K.F.A., T.A.C., A.C., A.E., D.H. and M.N.K. were supported entirely or in part through CRC National Plant Biosecurity and Plant Biosecurity CRC projects CRC20115, CRC20183, PBCRC3024 and PBCRC3066. These authors acknowledge the support of the Australian Government's Cooperative Research Centres Program. S.L.C. was supported by an Australian Research Council Future Fellowship (FT120100746). L.L. and M.S.J. were supported through a Cooperative Agreement from the United States Department of Agriculture through Farm Bill funding (project 3.0251) administered by the College of Tropical Agriculture and Human Resources of the University of Hawaii. K.F.A. and L.M.B. were supported by the Tertiary Education Commission of New Zealand. The authors sincerely acknowledge support provided by the UN-FAO/IAEA via the Coordinated Research Project 'Resolution of cryptic species complexes of tephritid pests to overcome constraints to SIT application and international trade'. We thank Bruce Halliday of the CSIRO for nomenclatural advice. The authors thank the numerous anonymous reviewers for improving the manuscript.	Aketarawong N., 2014, BMC GENET, V15, P40; Schutze MK, 2015, SYST ENTOMOL, V40, P472, DOI 10.1111/syen.12114; Boykin LM, 2014, J APPL ENTOMOL, V138, P235, DOI 10.1111/jen.12047; Schutze MK, 2013, J ECON ENTOMOL, V106, P695, DOI 10.1603/EC12409; Drew RAI, 2005, AFR ENTOMOL, V13, P149; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; McInnis DO, 1999, ANN ENTOMOL SOC AM, V92, P758; Iwaizumi R, 1997, ANN ENTOMOL SOC AM, V90, P664; Naeole CKM, 2003, MOL ECOL NOTES, V3, P662, DOI 10.1046/j.1471.8286.2003.00545.x; Schutze MK, 2012, B ENTOMOL RES, V102, P103, DOI 10.1017/S0007485311000423; Tan KH, 2011, CHEMOECOLOGY, V21, P25, DOI 10.1007/s00049-010-0063-1; Aketarawong N, 2007, MOL ECOL, V16, P3522, DOI 10.1111/j.1365-294X.2007.03409; White I. M., 2006, African Entomology Memoir, P1; SHELLY TE, 1994, ANN ENTOMOL SOC AM, V87, P375; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Iwahashi O, 1999, ANN ENTOMOL SOC AM, V92, P639; Wee SL, 2002, CHEMOECOLOGY, V12, P193, DOI 10.1007/PL00012668; Drew RAI, 2008, BIOL J LINN SOC, V93, P217; NISHIDA R, 1988, EXPERIENTIA, V44, P534, DOI 10.1007/BF01958941; Zacharopoulou A, 2011, GENETICA, V139, P79, DOI 10.1007/s10709-010-9495-3; David KJ, 2011, ZOOTAXA, P1; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Baimai V, 1998, ZOOL STUD, V37, P75; Wee SL, 2007, CHEMOECOLOGY, V17, P81, DOI 10.1007/s00049-006-0363-7; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Tan KH, 2013, APPL ENTOMOL ZOOL, V48, P275, DOI 10.1007/s13355-013-0183-5; Krosch MN, 2013, SYST ENTOMOL, V38, P2, DOI 10.1111/j.1365-3113.2012.00643.x; Muraji M, 2002, APPL ENTOMOL ZOOL, V37, P437, DOI 10.1303/aez.2002.437; Khamis FM, 2009, MOL ECOL, V18, P4798, DOI 10.1111/j.1365-294X.2009.04391.x; Bo W, 2014, J ECON ENTOMOL, V107, P623, DOI 10.1603/EC13514; Clarke AR, 2001, RAFFLES B ZOOL, V49, P207; Iwahashi O, 2001, APPL ENTOMOL ZOOL, V36, P289, DOI 10.1303/aez.2001.289; Krosch MN, 2012, MOL PHYLOGENET EVOL, V64, P513, DOI 10.1016/j.ympev.2012.05.006; De Meyer M, 2010, B ENTOMOL RES, V100, P35, DOI 10.1017/S0007485309006713; Armstrong Karen F., 2000, P703; Augustinos A.A., BMC GENETIC IN PRESS; Baimai V, 1999, ZOOL STUD, V38, P110; Bezzi M., 1913, Memoirs of the Indian Museum, V3; Bezzi M., 1916, Bulletin of Entomological Research London, V7; Clarke A.R., TRAPPING TE IN PRESS; Drew RAI, 1997, ACIAR PROC, P46; Drew R.A.I., 1994, B ENTOMOLOGICAL R S2, pi; Drew RAI, 1982, EC FRUIT FLIES S PAC, P1; Drew RAI, 2007, RAFFLES B ZOOL, V55, P1; DREW R A I, 1989, Memoirs of the Queensland Museum, V26, P1; Drew Romig M, 2013, TROPICAL FRUIT FLIES; Dyck VA, 2005, STERILE INSECT TECHN; Fabricius J. C., 1805, SYSTEMA ANTLIATORUM; Fabricius J.C., 1794, ENTOMOLOGIA SYSTEMAT, V4; FAO/IAEA/USDA, 2003, MAN PROD QUAL CONTR; FLETCHER MT, 1995, CHEM REV, V95, P789, DOI 10.1021/cr00036a001; Frey JE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-106; HARDY D E, 1973, Pacific Insects Monograph, V31, P1; HARDY DE, 1969, P HAWAII ENTOMOL SOC, V20, P395; Hardy D.E., 1977, CATALOG DIPTERA ORIE, VIII, P44; HARDY D. ELMO, 1956, BERNICE P BISHOP MUS INSECTS OF MICRONESIA, V14, P1; Hardy D.E., 1974, Pacific Insects Monogr, V32, P1; Hendel F. H., 1915, Ann Mus Hungar Budapest, V13; Hendel F., 1912, ENTOMOLOGICA S, V1, P13; Hering E. M., 1956, Verhandlungen der Naturforschenden Gesellschaft in Basel, V67, P62; Hill MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090121; Iwahashi Osamu, 2000, P591; Iwahashi O, 1999, ANN ENTOMOL SOC AM, V92, P182; Khamis FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044862; Leblanc Luc, 2013, Proceedings of the Hawaiian Entomological Society, V45, P51; Lin X.F., 2011, ACTA ZOOTAXONOMICA S, V36, P896; Lux Slawomir A., 2003, Insect Science and its Application, V23, P355; Mahmood Khalid, 2004, Pakistan Journal of Zoology, V36, P219; Mahmood Khalid, 1999, Pakistan Journal of Zoology, V31, P315; Mahmood K., 2005, PAKISTAN J ZOOLO 7 S, P1; Medina F.I.S., 1998, 5 INT S FRUIT FLIES, P155; Norrbom A.L., 1998, FRUIT FLY EXPERT IDE, V9, P65; PERKINS MV, 1990, J CHEM ECOL, V16, P2475, DOI 10.1007/BF01017470; Ranganath H.R., 1995, RAFFLES B ZOOL, V47, P221; RANGANATH HR, 1995, RAFFLES B ZOOL, V43, P235; San Jose M., 2013, Annals of the Entomological Society of America, V106, P684, DOI 10.1603/AN13017; Schutze MK, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-130; Shelly T, 1996, FLA ENTOMOL, V79, P481, DOI 10.2307/3496059; Shiraki T., 1968, US NATL MUSEUM B, V263, P1; SHIRAKI TOKUICHI, 1933, MEM FAC SCI AND AGRIC TAIHOKU IMP UNIV, V8, P1; Tan K.H., 2012, J INSECT SCI, V20; Tan Keng-Hong, 2000, P647; Tan K.H., TRAPPING TE IN PRESS; Tan KH, 1996, FRUIT FLY PESTS, P147; Tseng Yi-Hsiung, 1992, Journal of Taiwan Museum, V45, P15; van Sauers-Muller A., 2008, P CARIBBEAN FOOD CRO, V44, P135; VANSAUERSMULLER A, 1991, FLA ENTOMOL, V74, P432, DOI 10.2307/3494837; Van Sauers-Muller A, 2005, NEOTROP ENTOMOL, V34, P203, DOI 10.1590/S1519-566X2005000200008; YONG HS, 1995, B ENTOMOL RES, V85, P431	91	16	17	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0307-6970	1365-3113		SYST ENTOMOL	Syst. Entomol.	APR	2015	40	2					456	471		10.1111/syen.12113		16	Evolutionary Biology; Entomology	Evolutionary Biology; Entomology	CD3ML	WOS:000350982700010		
J	Yamamoto, Y; Takahashi, Y; Imai, K; Miyakawa, K; Ikeda, H; Ueda, Y; Yamaguchi, T; Nasu, H; Ohtani, H; Shigematsu, H; Kagawa, Y; Inoue, Y				Yamamoto, Yoshiaki; Takahashi, Yukitoshi; Imai, Katsumi; Miyakawa, Kou; Ikeda, Hiroko; Ueda, Yuki; Yamaguchi, Tokito; Nasu, Hirosato; Ohtani, Hideyuki; Shigematsu, Hideo; Kagawa, Yoshiyuki; Inoue, Yushi			Individualized Phenytoin Therapy for Japanese Pediatric Patients With Epilepsy Based on CYP2C9 and CYP2C19 Genotypes	THERAPEUTIC DRUG MONITORING			English	Article						individualized therapy; children; epilepsy; pharmacogenomic testing; therapeutic drug monitoring	ADVERSE DRUG-REACTIONS; GENETIC-POLYMORPHISM; ANTIEPILEPTIC DRUGS; POPULATION PHARMACOKINETICS; SODIUM VALPROATE; CARBAMAZEPINE; METABOLISM; INTOXICATION; MONOTHERAPY; CLEARANCE	Background: The aims of this study were to identify the target dose of phenytoin (PHT) and to compare the treatment continuation rate between patients receiving conventional therapy and patients receiving individualized therapy based on genotyping of the CYP2C9*3, CYP2C19*2, and CYP2C19*3 alleles. The operational definition for the target dose of PHT used in this study was the dose that yielded a steady-state PHT concentration within the range of 15-20 mcg/mL without dose-related adverse effects. Methods: We investigated 394 samples from 170 Japanese pediatric patients aged 9 months to 15 years to identify factors that influenced the target dose of PHT. We also analyzed the clinical records of 156 patients who commenced PHT therapy at our hospital and retrospectively assessed the time to treatment failure within 1 year after starting PHT therapy. During the study period, 17 patients underwent genotyping at the start of PHT therapy. If the patients had the CYP2C9*3, CYP2C19*2, or CYP2C19*3 alleles, the initial dose of PHT was reduced by 10%-50% according to previous reports. The other 139 patients received conventional PHT therapy. Results: According to multiple regression analysis, the body weight, concomitant use of sulthiame, and the CYP2C9*3, CYP2C19*2, and CYP2C19*3 alleles influenced the target dose of PHT. Our model explained 74% of the interindividual variability of the target dose of PHT. The total withdrawal rate in the individualized therapy group and the conventional therapy group was 23.5% and 33.1%, respectively. The adjusted hazard ratio for withdrawal of PHT therapy in the individualized therapy group was 0.37 (95% confidence interval; 0.12-1.10, P = 0.074). Conclusions: These findings suggest that genotyping can help to estimate the optimum target dose of PHT and may contribute to avoid intoxication and concentration-dependent adverse effects.	[Yamamoto, Yoshiaki; Takahashi, Yukitoshi; Imai, Katsumi; Miyakawa, Kou; Ikeda, Hiroko; Ueda, Yuki; Yamaguchi, Tokito; Nasu, Hirosato; Ohtani, Hideyuki; Shigematsu, Hideo; Inoue, Yushi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Dept Clin Res, Shizuoka 4208688, Japan; [Yamamoto, Yoshiaki; Takahashi, Yukitoshi; Kagawa, Yoshiyuki] Univ Shizuoka, Dept Clin Pharmaceut, Grad Sch Pharmaceut Sci, Shizuoka 4228526, Japan	Yamamoto, Y (reprint author), Shizuoka Inst Epilepsy & Neurol Disorders, NHO Natl Epilepsy Ctr, Dept Clin Res, 886 Urushiyama, Shizuoka 4208688, Japan.	yamamoty-3@hosp.go.jp					Tate SK, 2005, P NATL ACAD SCI USA, V102, P5507, DOI 10.1073/pnas.0407346102; Odani A, 1997, CLIN PHARMACOL THER, V62, P287, DOI 10.1016/S0009-9236(97)90031-X; Bajpai M, 1996, DRUG METAB DISPOS, V24, P1401; van der Weide J, 2001, PHARMACOGENETICS, V11, P287, DOI 10.1097/00008571-200106000-00002; deSilva M, 1996, LANCET, V347, P709, DOI 10.1016/S0140-6736(96)90074-4; Guerreiro MM, 1997, EPILEPSY RES, V27, P205, DOI 10.1016/S0920-1211(97)00025-9; Hung CC, 2004, THER DRUG MONIT, V26, P534, DOI 10.1097/00007691-200410000-00012; Ninomiya H, 2000, THER DRUG MONIT, V22, P230, DOI 10.1097/00007691-200004000-00016; Brandolese R, 2001, CLIN PHARMACOL THER, V70, P391, DOI 10.1067/mcp.2001.118868; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Kidd RS, 2001, PHARMACOGENETICS, V11, P803, DOI 10.1097/00008571-200112000-00008; CALLAGHAN N, 1985, J NEUROL NEUROSUR PS, V48, P639, DOI 10.1136/jnnp.48.7.639; CHAN E, 1990, EUR J CLIN PHARMACOL, V39, P177, DOI 10.1007/BF00280055; Chaudhry AS, 2010, J PHARMACOL EXP THER, V332, P599, DOI 10.1124/jpet.109.161026; GRASELA TH, 1983, CLIN PHARMACOKINET, V8, P355, DOI 10.2165/00003088-198308040-00006; Hashimoto Y, 1996, BIOL PHARM BULL, V19, P1103; Lee AY, 2004, EUR J CLIN PHARMACOL, V60, P155, DOI 10.1007/s00228-004-0753-0; Lee FXL, 2013, THER DRUG MONIT, V35, P54, DOI 10.1097/FTD.0b013e3182763739; Lin CJ, 2008, PHARMACOTHERAPY, V28, P35, DOI 10.1592/phco.28.1.35; Mamiya K, 1998, EPILEPSIA, V39, P1317, DOI 10.1111/j.1528-1157.1998.tb01330.x; Odani A, 1996, BIOL PHARM BULL, V19, P444; Perucca E, 2005, THER DRUG MONIT, V27, P714, DOI 10.1097/01.ftd.0000179847.37965.4e; Ramasamy K, 2007, NEUROL INDIA, V55, P408; Roopa BS, 2008, PHARMACOEPIDEM DR S, V17, P807, DOI 10.1002/pds.1540; Saito Y., 2007, Current Pharmacogenomics, V5, P49, DOI 10.2174/157016007780077202; SCHMIDT D, 1984, NEUROLOGY, V34, P1252; SHAKIR RA, 1981, EPILEPSIA, V22, P27, DOI 10.1111/j.1528-1157.1981.tb04330.x; Soga Y, 2004, LIFE SCI, V74, P827, DOI 10.1016/j.lfs.2003.07.018; Taguchi Masato, 2005, Drug Metab Pharmacokinet, V20, P107, DOI 10.2133/dmpk.20.107; Yamamoto Y, 2011, YAKUGAKU ZASSHI, V131, P809	31	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0163-4356	1536-3694		THER DRUG MONIT	Ther. Drug Monit.	APR	2015	37	2					229	235				7	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	Medical Laboratory Technology; Pharmacology & Pharmacy; Toxicology	CD3SW	WOS:000351002200012		
J	Ogata, K; Shimizu, T; Masumoto, H; Oguma, T; Sugiyama, N; Kunitada, S				Ogata, Koichiro; Shimizu, Takako; Masumoto, Hiroshi; Oguma, Toshihiro; Sugiyama, Nobutoshi; Kunitada, Satoshi			Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Novel Factor Xa Inhibitor DY-807f in Healthy Volunteers	THROMBOSIS RESEARCH			English	Article						DY-807f; Factor Xa inhibitor; Venous thromboembolism; Atrial fibrillation	EDOXABAN; THROMBIN	Introduction: Since Vitamin K antagonists are associated with various limitations such as narrow therapeutic window, slow onset and offset of effect, and numerous interactions with food and drugs, new oral anticoagulants targeted to inhibit thrombin or factor Xa (FXa) have been developed. DY-807f is a highly selective, reversible and orally bioavailable FXa inhibitor. Objectives: This article describes a first-in-human study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending oral doses of the novel direct FXa inhibitor DY-807f in healthy males. Methods: a placebo-controlled, single-blinded, randomized, single ascending dose study with 84 subjects (10, 30, 60, 120, 240, and 360 mg). Effects of food and formulation (tablet vs solution) on bioavailability of 60 mg were also assessed as a crossover design. Results: DY-807f doses were safe and well-tolerated with no dose-dependent increase in adverse events up to 360 mg. Pharmacokinetics profiles were consistent across doses with rapid absorption, biphasic elimination, and terminal elimination half-life of 10.5 to 12.4 hours. Coagulation parameters (Activated Partial Thromboplastin Time (aPTT) and Prothrombin Time (PT)) were linearly correlated with plasma DY-807 (free base of DY-807f) concentrations (correlation coefficient: 0.786 for aPTT, 0.945 for PT). Conclusions: Single doses of DY-807f are safe and well-tolerated up to 360 mg with predictable pharmacokinetic and pharmacodynamic profiles. (C) 2015 Elsevier Ltd. All rights reserved.	[Ogata, Koichiro; Shimizu, Takako; Oguma, Toshihiro; Sugiyama, Nobutoshi] Daiichi Sankyo Co Ltd, Shinagawa Ku, Tokyo 1408710, Japan; [Masumoto, Hiroshi] Daiichi Sankyo Co Ltd, Chuo Ku, Tokyo 1038426, Japan; [Kunitada, Satoshi] Daiichi Sankyo RD Novare Co Ltd, Edogawa Ku, Tokyo 1348630, Japan	Ogata, K (reprint author), Daiichi Sankyo Co Ltd, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	ogata.koichiro.fv@daiichisankyo.co.jp			Daiichi Sankyo Co., Ltd.	This study was funded by Daiichi Sankyo Co., Ltd. The authors would like to thank Emanuel Engmann and Diane Kleinermans (Covance Clinical Research Unit, Leeds, UK) for their trial support.	du Breuil AL, 2007, AM FAM PHYSICIAN, V75, P1031; Stangier J, 2007, BRIT J CLIN PHARMACO, V64, P292, DOI 10.1111/j.1365-2125.2007.02899.x; Ogata K, 2010, J CLIN PHARMACOL, V50, P743, DOI 10.1177/0091270009351883; Fuji T, 2010, J THROMB HAEMOST, V8, P2458, DOI 10.1111/j.1538-7836.2010.04021.x; Connolly SJ, 2007, CIRCULATION, V116, P449, DOI 10.1161/CIRCULATIONAHA.107.695163; Kubitza D, 2005, CLIN PHARMACOL THER, V78, P412, DOI 10.1016/j.clpt.2005.06.011; Ansell J, 2007, J THROMB HAEMOST, V5, P60, DOI 10.1111/j.1538-7836.2007.02473.x; Eikelboom JW, 2007, CIRCULATION, V116, P131, DOI 10.1161/CIRCULATIONAHA.107.712349; FDA CDER, 2002, GUID IND; Forest C, 2013, BR J CLIN PHARM, V75, P476	10	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	APR	2015	135	4					594	601		10.1016/j.thromres.2014.12.028		8	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CD4WJ	WOS:000351086000005		
J	Ikeda, M; Arai, S; Mukai, S; Takezawa, Y; Terasawa, F; Okumura, N				Ikeda, Minami; Arai, Shinpei; Mukai, Saki; Takezawa, Yuka; Terasawa, Fumiko; Okumura, Nobuo			Novel heterozygous dysfibrinogenemia, Sumida (A alpha C472S), showed markedly impaired lateral aggregation of protofibrils and mildly lower functional fibrinogen levels	THROMBOSIS RESEARCH			English	Article						Fibrinogen; Dysfibrinogenemia; Lateral aggregation of protofibrils; Fibrin fiber; Clot lysis	A-ALPHA-CHAIN; C-DOMAINS; FRAMESHIFT MUTATION; CLOT DEGRADABILITY; DUSART-SYNDROME; BINDING SITES; CROSS-LINKING; POLYMERIZATION; TRUNCATION; VARIANT	Introduction: We encountered a 6-year-old girl with systemic lupus erythematosus. Although no bleeding or thrombotic tendency was detected, routine coagulation screening tests revealed slightly lower plasma fibrinogen levels, as determined by functional and antigenic measurements (functional/antigenic ratio=0.857), suggesting hypodysfibrinogenemia. Materials and methods: DNA sequence and functional analyses were performed on purified plasma fibrinogen, and recombinant variant fibrinogen was synthesized in Chinese hamster ovary cells based on the results obtained. Results: DNA sequencing revealed a heterozygous A alpha C472S substitution (mature protein residue number) in the alpha C-domain. A alpha C472S fibrinogen indicated the presence of additional disulfide-bonded molecules, and markedly impaired lateral aggregation of protofibrils in spite of slightly lower functional plasma fibrinogen levels. Scanning electron microscopic observations showed a thin fiber fibrin clot, and t-PA and plasminogen-mediated clot lysis was similar to that of a normal control. Recombinant variant fibrinogen-producing cells demonstrated that destruction of the A alpha 442C-472C disulfide bond did not prevent the synthesis or secretion of fibrinogen, whereas the variant A alpha chain of the secreted protein was degraded faster than that of the normal control. Conclusion: Our results suggest that A alpha C472S fibrinogen may cause dysfibrinogenemia, but not hypofibrinogenemia. The destruction and steric hindrance of the alpha C-domain of variant fibrinogen led to the impaired lateral aggregation of protofibrils and t-PA and plasminogen-mediated fibrinolysis, as well as several previously reported variants located in the alpha C-domain, and demonstrated the presence of disulfide-bonded molecules. (C) 2015 Elsevier Ltd. All rights reserved.	[Ikeda, Minami; Terasawa, Fumiko; Okumura, Nobuo] Shinshu Univ, Dept Clin Lab Invest, Grad Sch Med, Matsumoto, Nagano 3908621, Japan; [Ikeda, Minami; Arai, Shinpei; Mukai, Saki; Takezawa, Yuka] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano, Japan; [Arai, Shinpei] Shinshu Univ, Dept Lab Med, Grad Sch Med, Matsumoto, Nagano 3908621, Japan; [Mukai, Saki; Terasawa, Fumiko; Okumura, Nobuo] Shinshu Univ, Dept Hlth & Med Sci, Grad Sch Med, Matsumoto, Nagano 3908621, Japan	Okumura, N (reprint author), Shinshu Univ, Lab Clin Chem & Immunol, Dept Biomed Lab Sci, Sch Hlth Sci, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	nobuoku@shinshu-u.ac.jp					Marchi R, 2006, THROMB RES, V118, P637, DOI 10.1016/j.thromres.2005.10.016; Ikeda M, 2014, THROMB RES, V134, P518, DOI 10.1016/j.thromres.2014.06.002; Okumura N, 1997, J BIOL CHEM, V272, P29596, DOI 10.1074/jbc.272.47.29596; Collen A, 2001, BLOOD, V97, P973, DOI 10.1182/blood.V97.4.973; Okumura N, 1996, THROMB HAEMOSTASIS, V75, P887; DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195; Collet JP, 2005, BLOOD, V106, P3824, DOI 10.1182/blood-2005-05-2150; Kobayashi T, 2014, THROMB RES, V133, P101, DOI 10.1016/j.thromres.2013.10.033; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; KOOPMAN J, 1992, BLOOD, V80, P1972; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Kamijyo Y, 2009, BLOOD COAGUL FIBRIN, V20, P726, DOI 10.1097/MBC.0b013e328332aa09; FURLAN M, 1994, J BIOL CHEM, V269, P33129; Brennan SO, 2006, THROMB HAEMOSTASIS, V96, P88; COLLET JP, 1993, BLOOD, V82, P2462; Dempfle CE, 2009, THROMB HAEMOSTASIS, V102, P29, DOI 10.1160/TH08-09-0559; Doolittle RF, 1979, CHEM PHYSL HUMAN PLA, P77; GORKUN OV, 1994, BIOCHEMISTRY-US, V33, P6986, DOI 10.1021/bi00188a031; Groupe d Etude sur 1 Hemostase et la Thrombose, BAS DONN VAR FIBR; Hanss M, 2008, J THROMB HAEMOST, V6, P1422, DOI 10.1111/j.1538-7836.2008.03013.x; HOLM B, 1985, THROMB RES, V37, P165, DOI 10.1016/0049-3848(85)90043-X; Homer VM, 2003, J THROMB HAEMOST, V1, P1245, DOI 10.1046/j.1538-7836.2003.00224.x; Ikeda M, 2014, J JPN SOC LAB HEMATO, V15, P163; LIJNEN HR, 1984, THROMB HAEMOSTASIS, V51, P108; Marchi R, 2004, BLOOD COAGUL FIBRIN, V15, P285, DOI 10.1097/01.mbc.0000114429.81125.33; Marchi R, 2000, THROMB RES, V99, P187, DOI 10.1016/S0049-3848(00)00235-8; Margaglione M, 2001, THROMB HAEMOSTASIS, V86, P1483; Zhang JZ, 1996, J BIOL CHEM, V271, P30083; Ridgway HJ, 1996, BRIT J HAEMATOL, V93, P177, DOI 10.1046/j.1365-2141.1996.4681007.x; Sugo T, 1998, BLOOD, V91, P3282; Tarumi T, 2000, BLOOD, V96, P1191; Tsurupa G, 2001, BIOCHEMISTRY-US, V40, P801, DOI 10.1021/bi001789t; WADA Y, 1994, BLOOD, V84, P3709; WEISEL JW, 1993, J MOL BIOL, V232, P285, DOI 10.1006/jmbi.1993.1382	34	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	APR	2015	135	4					710	717		10.1016/j.thromres.2015.01.013		8	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CD4WJ	WOS:000351086000024		
J	Ishibashi, Y; Matsui, T; Fukami, K; Ueda, S; Okuda, S; Yamagishi, S				Ishibashi, Yuji; Matsui, Takanori; Fukami, Kei; Ueda, Seiji; Okuda, Seiya; Yamagishi, Sho-ichi			Rivaroxaban inhibits oxidative and inflammatory reactions in advanced glycation end product-exposed tubular cells by blocking thrombin/protease-activated receptor-2 system	THROMBOSIS RESEARCH			English	Letter							DIABETIC-NEPHROPATHY; ATRIAL-FIBRILLATION; EXPRESSION; MELLITUS		[Ishibashi, Yuji; Matsui, Takanori; Yamagishi, Sho-ichi] Kurume Univ, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Sch Med, Kurume, Fukuoka 8300011, Japan; [Fukami, Kei; Ueda, Seiji; Okuda, Seiya] Kurume Univ, Dept Med, Sch Med, Kurume, Fukuoka 8300011, Japan	Yamagishi, S (reprint author), Kurume Univ, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Sch Med, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	shoichi@med.kurume-u.ac.jp					Morii T, 2003, J DIABETES COMPLICAT, V17, P11, DOI 10.1016/S1056-8727(02)00176-9; Chow FY, 2007, DIABETOLOGIA, V50, P471, DOI 10.1007/s00125-006-0497-8; Kato T, 2008, J CARDIOVASC ELECTR, V19, P415, DOI 10.1111/j.1540-8167.2007.01037.x; TAFT JL, 1994, DIABETES, V43, P1046, DOI 10.2337/diabetes.43.8.1046; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; ZIYADEH FN, 1991, KIDNEY INT, V39, P464, DOI 10.1038/ki.1991.57; Daroux M, 2010, DIABETES METAB, V36, P1, DOI 10.1016/j.diabet.2009.06.005; Kubitza D, 2013, J CLIN PHARMACOL, V53, P249, DOI 10.1002/jcph.5; Fatemi O, 2014, AM J CARDIOL, V114, P1217, DOI 10.1016/j.amjcard.2014.07.045; Forbes JM, 2012, AMINO ACIDS, V42, P1185, DOI 10.1007/s00726-010-0771-4; Grandaliano G, 2003, J AM SOC NEPHROL, V14, P2072, DOI 10.1097/01.ASN.0000080315.37254.A1; Ishibashi Y, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-60; Ojima A, 2013, AM J PATHOL, V182, P132, DOI 10.1016/j.ajpath.2012.09.016; Raposeiras-Roubin S, 2012, INT J CARDIOL, V157, P397, DOI 10.1016/j.ijcard.2011.05.072; Reinecke H, 2014, KIDNEY INT; Tsiachris D, 2014, CURR VASC PHARM; Vesey DA, 2005, KIDNEY INT, V67, P1315, DOI 10.1111/j.1523-1755.2005.00209.x	17	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	APR	2015	135	4					770	773		10.1016/j.thromres.2015.01.023		4	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CD4WJ	WOS:000351086000033		
J	Nguyen, TN; Miyata, K				Thao-Ngoc Nguyen; Miyata, Kazunori			Multi-scale region perpendicular local binary pattern: an effective feature for interest region description	VISUAL COMPUTER			English	Article						Local binary pattern; Perpendicular; Intensity order; Multi-support regions; Interest regions; Image matching; Feature descriptor	SCALE; DETECTORS	This paper proposes the perpendicular local binary pattern (PLBP) for efficiently describing textures in an interest region. Its novelty is two-fold: (1) the candidate generation scheme provides a set of patterns for each pixel, instead of conventionally assigning one pattern per pixel, and (2) an adaptive threshold based on the image contrast of a region is used. These modifications successfully enhance the robustness of PLBP to Gaussian noise as well as in near-uniform regions. We introduce the novel multi-scale region PLBP descriptor, which adopts the PLBP as its core feature. It defines multiple support regions from an interest point, sequentially performs ring-shaped and intensity order-based segmentations on each region, and pools PLBPs to corresponding segments. These steps are controlled easily by a set of parameters, thus offering high flexibility. Experimental results on challenging benchmarks, including three datasets of image matching and two datasets of object recognition, demonstrate the effectiveness of the proposed descriptor in handling common photometric and geometric transformations. It significantly improves the robustness, compared with current state-of-the-art descriptors, while maintaining a reasonable operational cost.	[Thao-Ngoc Nguyen; Miyata, Kazunori] Japan Adv Inst Sci & Technol, Sch Knowledge Sci, Nomi, Ishikawa 9231292, Japan	Nguyen, TN (reprint author), Japan Adv Inst Sci & Technol, Sch Knowledge Sci, Nomi, Ishikawa 9231292, Japan.	thao.nguyen@jaist.ac.jp; miyata@jaist.ac.jp					Anbarjafari G., 2013, EURASIP J IMAGE VIDE, V2013, P1; [Anonymous], 2004, P IEEE C COMP VIS PA, DOI DOI 10.1109/CVPR.2004.1315206; Gupta R, 2010, PROC CVPR IEEE, P334, DOI 10.1109/CVPR.2010.5540195; Heikkila M, 2009, PATTERN RECOGN, V42, P425, DOI 10.1016/j.patcog.2008.08.014; Lazebnik S, 2005, IEEE T PATTERN ANAL, V27, P1265, DOI 10.1109/TPAMI.2005.151; Wang ZH, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV), P603; Liao SC, 2010, PROC CVPR IEEE, P1301, DOI 10.1109/CVPR.2010.5539817; Fan B, 2012, IEEE T PATTERN ANAL, V34, P2031, DOI 10.1109/TPAMI.2011.277; Tan XY, 2010, IEEE T IMAGE PROCESS, V19, P1635, DOI 10.1109/TIP.2010.2042645; Mikolajczyk K, 2002, LECT NOTES COMPUT SC, V2350, P128; Mikolajczyk K, 2004, INT J COMPUT VISION, V60, P63, DOI 10.1023/B:VISI.0000027790.02288.f2; Brown M, 2007, INT J COMPUT VISION, V74, P59, DOI 10.1007/s11263-006-0002-3; Mortensen EN, 2005, PROC CVPR IEEE, P184; Tola E, 2010, IEEE T PATTERN ANAL, V32, P815, DOI 10.1109/TPAMI.2009.77; Song TC, 2013, IEEE SIGNAL PROC LET, V20, P59, DOI 10.1109/LSP.2012.2229273; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Tuytelaars T, 2004, INT J COMPUT VISION, V59, P61, DOI 10.1023/B:VISI.0000020671.28016.e8; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Chan CH, 2012, IEEE T INF FOREN SEC, V7, P602, DOI 10.1109/TIFS.2011.2175920; Cordes K, 2013, LECT NOTES COMPUT SC, V8047, P327, DOI 10.1007/978-3-642-40261-6_39; GUPTA R, 2008, P EUR C COMP VIS, V5303, P265; Heikkila M, 2006, IEEE T PATTERN ANAL, V28, P657, DOI 10.1109/TPAMI.2006.68; Lindeberg T, 1998, INT J COMPUT VISION, V30, P79, DOI 10.1023/A:1008045108935; Matas J., 2002, BMVC, V1, P384, DOI DOI 10.1016/J.IMAVIS.2004.02.006; Mattivi R., 2010, STUDIES COMPUTATIONA, V332, P69; Michelson A., 1995, DOVER BOOKS ASTRONOM; Nister D, 2006, IEEE COMP SOC C COMP, V2, P2161, DOI DOI 10.1109/CVPR.2006.264; Russell B. C., 2013, ACM T GRAPH, V32; Shi W., 2013, WSEAS T SIGNAL PROCE, V9, P31; Takala V, 2005, LECT NOTES COMPUT SC, V3540, P882; Tang F., 2009, P IEEE C COMP VIS PA, P2631; Winder S. A. J., 2007, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2007.382971; Zambanini S, 2013, LECT NOTES COMPUT SC, V7944, P11	35	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0178-2789	1432-2315		VISUAL COMPUT	Visual Comput.	APR	2015	31	4					391	406		10.1007/s00371-014-0934-5		16	Computer Science, Software Engineering	Computer Science	CD2IW	WOS:000350901600003		
J	Nishiyama, T				Nishiyama, Takahiro			General plane or spherical electromagnetic waves with electric and magnetic fields parallel to each other	WAVE MOTION			English	Article						Maxwell's equations; Electromagnetic waves; Electric field parallel to magnetic field; Beltrami flow; Force-free field	ND-YAG LASER; HYDROMAGNETIC-STABILITY; CAVITY	General plane-wave and spherical-wave solutions are found for Maxwell's equations with electric and magnetic fields parallel to each other everywhere in a uniform isotropic sourceless medium. For deriving them, Beltrami's and Chang-Carovillano-Low's results about a Beltrami flow (or a force-free field) with a non-constant proportionality factor are applied to Uehara-Kawai-Shimoda's equations. It is proved that other wave solutions, such as a cylindrical-wave solution, cannot be as general as the plane-wave or spherical-wave solution. (C) 2014 Elsevier B.V. All rights reserved.	Yamaguchi Univ, Dept Appl Sci, Ube, Yamaguchi 7558611, Japan	Nishiyama, T (reprint author), Yamaguchi Univ, Dept Appl Sci, Ube, Yamaguchi 7558611, Japan.	t-nishi@yamaguchi-u.ac.jp					ADAMS CS, 1993, OPT LETT, V18, P420, DOI 10.1364/OL.18.000420; EVTUHOV V, 1965, APPL OPTICS, V4, P142; Arnold V.I., 1998, TOPOL METHOD NONL AN, P71; Beltrami E., 1889, INT J FUSION ENERGY, V22, p[121, 53]; Bjorgum O., 1952, ARBOK NATURV REKKE 2, V13, P1; CHU C, 1987, PHYS REV LETT, V58, P424, DOI 10.1103/PhysRevLett.58.424; CHU C, 1982, PHYS REV LETT, V48, P837, DOI 10.1103/PhysRevLett.48.837; DEJONG DJ, 1977, OPT COMMUN, V22, P138, DOI 10.1016/0030-4018(77)90005-0; Eisenhart L.P., 1947, INTRO DIFFERENTIAL G, P100; Harrington R.F., 1961, TIME HARMONIC ELECTR, P47; KASTLER A, 1970, CR ACAD SCI B PHYS, V271, P999; Kihm HW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1430; Ko CM, 1996, ASTROPHYS SPACE SCI, V245, P117, DOI 10.1007/BF00637807; LOW BC, 1988, SOL PHYS, V115, P269, DOI 10.1007/BF00148728; LOW BC, 1988, ASTROPHYS J, V330, P992, DOI 10.1086/166528; Metcalf H J, 1999, LASER COOLING TRAPPI; SHIMODA K, 1990, AM J PHYS, V58, P394, DOI 10.1119/1.16482; Sokolnikoff I.S., 1964, TENSOR ANAL, P79; UEHARA K, 1989, J PHYS SOC JPN, V58, P3570, DOI 10.1143/JPSJ.58.3570; WALLMEROTH K, 1990, OPT LETT, V15, P903, DOI 10.1364/OL.15.000903; Yabe H., 1981, ELECT COMMUN JAPAN 1, V64, P43; Zaghloul H., 1993, ESSAYS FORMAL ASPECT, P207; ZAGHLOUL H, 1989, AM J PHYS, V57, P183, DOI 10.1119/1.16149	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2125	1878-433X		WAVE MOTION	Wave Motion	APR	2015	54						58	65		10.1016/j.wavemoti.2014.11.011		8	Acoustics; Mechanics; Physics, Multidisciplinary	Acoustics; Mechanics; Physics	CD2QJ	WOS:000350923800005		
J	Tsukuma, H; Kubokawa, T				Tsukuma, Hisayuki; Kubokawa, Tatsuya			Minimaxity in estimation of restricted and non-restricted scale parameter matrices	ANNALS OF THE INSTITUTE OF STATISTICAL MATHEMATICS			English	Article						Bayesian inference; Equivariance; Least favorable prior; Minimax estimation; Restricted parameter space; Statistical decision theory	RISK EQUIVARIANT ESTIMATOR; MODELS	In estimation of the normal covariance matrix, finding a least favorable sequence of prior distributions has been an open question for a long time. This paper addresses the classical problem and accomplishes the specification of such a sequence, which establishes minimaxity of the best equivariant estimator. This result is extended to the estimation of scale parameter matrix in an elliptically contoured distribution model. The methodology based on a least favorable sequence of prior distributions is applied to both restricted and non-restricted cases of parameters, and we give some examples which show minimaxity of the best equivariant estimators under restrictions of scale parameter matrix.	[Tsukuma, Hisayuki] Toho Univ, Fac Med, Ota Ku, Tokyo 1438540, Japan; [Kubokawa, Tatsuya] Univ Tokyo, Fac Econ, Bunkyo Ku, Tokyo 1130033, Japan	Tsukuma, H (reprint author), Toho Univ, Fac Med, Ota Ku, 5-21-16 Omori Nishi, Tokyo 1438540, Japan.	tsukuma@med.toho-u.ac.jp; tatsuya@e.u-tokyo.ac.jp			 [23500361];  [21540114];  [23243039]	The authors are deeply grateful to the two reviewers for their helpful comments and suggestions on this paper. The first author acknowledges support in part from Grant-in-Aid for Scientific Research (23500361), Japan. The second author acknowledges support from Grant-in-Aid for Scientific Research (21540114 and 23243039), Japan.	Kubokawa T, 2013, J MULTIVARIATE ANAL, V116, P382, DOI 10.1016/j.jmva.2013.01.001; Marchand E, 2005, ANN I STAT MATH, V57, P129, DOI 10.1007/BF02506883; Pourahmadi M, 1999, BIOMETRIKA, V86, P677, DOI 10.1093/biomet/86.3.677; Berger J. O., 1985, STAT DECISION THEORY; BONDAR JV, 1981, Z WAHRSCHEINLICHKEIT, V57, P103, DOI 10.1007/BF00533716; CALVIN JA, 1991, ANN STAT, V19, P850, DOI 10.1214/aos/1176348124; EATON ML, 1987, ANN STAT, V15, P1639, DOI 10.1214/aos/1176350615; Girshick M. A., 1951, P 2 BERK S MATH STAT, P53; James W., 1961, P 4 BERK S MATH STAT, V1, P361; KIEFER J, 1957, ANN MATH STAT, V28, P573, DOI 10.1214/aoms/1177706874; KRISHNAMOORTHY K, 1989, CAN J STAT, V17, P91, DOI 10.2307/3314766; Kubokawa T., 2004, J JAPAN STAT SOC, V34, P229; Marchand E, 2005, J STAT PLAN INFER, V134, P90, DOI 10.1016/j.jspi.2004.04.001; Marchand E, 2012, BERNOULLI, V18, P635, DOI 10.3150/10-BEJ336; Muirhead R. J., 1985, MULTIVARIATE ANAL, P431; Robertson T., 1988, ORDER RESTRICTED STA; Rockafellar R T, 1970, CONVEX ANAL; Selliah J. B., 1964, 10 STANF U DEP STAT, V10; Stein C, 1956, 6 STANF U DEP STAT, V6; Strawderman WE, 2000, J AM STAT ASSOC, V95, P1364, DOI 10.2307/2669789; Tsukuma H., 2012, DISCUSSION PAPER SER; Tsukuma H, 2011, J MULTIVARIATE ANAL, V102, P164, DOI 10.1016/j.jmva.2010.08.011	22	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0020-3157	1572-9052		ANN I STAT MATH	Ann. Inst. Stat. Math.	APR	2015	67	2					261	285		10.1007/s10463-014-0449-x		25	Statistics & Probability	Mathematics	CC3GS	WOS:000350235400003		
J	Terada, Y				Terada, Yoshikazu			Strong consistency of factorial -means clustering	ANNALS OF THE INSTITUTE OF STATISTICAL MATHEMATICS			English	Article						Subspace clustering; K-means	K-MEANS	Factorial -means (FKM) clustering is a method for clustering objects in a low-dimensional subspace. The advantage of this method is that the partition of objects and the low-dimensional subspace reflecting the cluster structure are obtained, simultaneously. In some cases that reduced -means (RKM) clustering does not work well, FKM clustering can discover the cluster structure underlying a lower dimensional subspace. Conditions that ensure the almost sure convergence of the estimator of FKM clustering as the sample size increases unboundedly are derived. The result is proved for a more general model including FKM clustering. Moreover, it is also shown that there exist some cases in which RKM clustering becomes equivalent to FKM clustering as the sample size goes to infinity.	Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5600043, Japan	Terada, Y (reprint author), Osaka Univ, Grad Sch Engn Sci, 1-3 Machikaneyama, Toyonaka, Osaka 5600043, Japan.	terada@sigmath.es.osaka-u.ac.jp			 [24 . 2466]	The author wishes to express his thanks to Dr. Michio Yamamoto for his helpful comments and discussions related to Example 2. The author gratefully acknowledges the helpful comments and suggestions of the two anonymous reviewers. Moreover, the author also thank Professor Yutaka Kano for his supervision of this research. This work was supported by Grant-in-Aid for JSPS Fellows Number 24 . 2466.	Akama Y, 2010, DISCRETE COMPUT GEOM, V44, P589, DOI 10.1007/s00454-009-9236-5; Timmerman ME, 2010, COMPUT STAT DATA AN, V54, P1858, DOI 10.1016/j.csda.2010.02.009; Vichi M, 2001, COMPUT STAT DATA AN, V37, P49, DOI 10.1016/S0167-9473(00)00064-5; POLLARD D, 1981, ANN STAT, V9, P135, DOI 10.1214/aos/1176345339; Arabie P., 1994, ADV METHODS MARKETIN, P160; CHANG WC, 1983, J R STAT SOC C-APPL, V32, P267; De Soete G., 1994, NEW APPROACHES CLASS, P212; DEHARDT J, 1971, ANN MATH STAT, V42, P2050, DOI 10.1214/aoms/1177693073; Devroye L., 1996, PROBABILISTIC THEORY; Peskir G., 2000, LECT NOTES SERIES, V66; Pfanzagl J., 1994, PARAMETRIC STAT THEO; POLLARD D, 1982, IEEE T INFORM THEORY, V28, P199, DOI 10.1109/TIT.1982.1056481; Terada Y., 2014, SCANDINAVIA IN PRESS	13	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0020-3157	1572-9052		ANN I STAT MATH	Ann. Inst. Stat. Math.	APR	2015	67	2					335	357		10.1007/s10463-014-0454-0		23	Statistics & Probability	Mathematics	CC3GS	WOS:000350235400006		
J	Toyota, H; Sudo, K; Kojima, K; Yanase, N; Nagao, T; Takahashi, RH; Iobe, H; Kuwabara, T; Kakiuchi, T; Mizuguchi, J				Toyota, H.; Sudo, K.; Kojima, K.; Yanase, N.; Nagao, T.; Takahashi, R. H.; Iobe, H.; Kuwabara, T.; Kakiuchi, T.; Mizuguchi, J.			Thy28 protects against anti-CD3-mediated thymic cell death in vivo	APOPTOSIS			English	Article						Thy28; Thymic cell death; Apoptosis; Thymic hyperplasia; Experimental autoimmune encephalomyelitis	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CD3/T-CELL RECEPTOR COMPLEX; MAP KINASES; T-CELLS; SIGNAL-TRANSDUCTION; IFN-GAMMA; APOPTOSIS; PATHOGENESIS; INFLAMMATION; HYPERPLASIA	Apoptotic cell death plays a pivotal role in the development and/or maintenance of several tissues including thymus. Deregulated thymic cell death is associated with autoimmune diseases including experimental autoimmune encephalomyelitis (EAE), a prototype murine model for analysis of human multiple sclerosis. Because Thy28 expression is modulated during thymocyte development, we tested whether Thy28 affects induction of EAE as effectively as antigen-induced thymocyte deletion using Thy28 transgenic (TG) mice. Thy28 TG mice showed partial resistance to anti-CD3 monoclonal antibody (mAb)-induced thymic cell death in vivo, as assessed by annexin V-expression and loss of mitochondrial membrane potential. The resistance to anti-CD3 mAb-induced cell death in Thy28 TG mice appeared to correlate with a decreased c-Jun N-terminal kinase phosphorylation and reduced down-regulation of Bcl-xL. Moreover, thymic hyperplasia was detected in Thy28 TG mice, although thymocyte development was unaltered. Development of peripheral lymphoid tissues including spleen and lymph nodes was also unaltered. Thy28 TG spleen T cells showed an increased production of IFN-gamma, but not IL-17, in response to both anti-CD3 and anti-CD28 mAbs. Finally, Thy28 TG mice displayed accelerated induction of EAE as assessed by disease incidence, clinical score, and pathology following immunization with myelin oligodendrocyte glycoprotein compared with control WT mice. These findings suggest that modulation of Thy28 expression plays a crucial role in the determination of thymic cell fate, which may contribute to the development of EAE through proinflammatory cytokine production.	[Toyota, H.; Yanase, N.; Mizuguchi, J.] Tokyo Med Univ, Dept Immunol, Shinjuku Ku, Tokyo 1608402, Japan; [Toyota, H.; Yanase, N.; Mizuguchi, J.] Tokyo Med Univ, Intractable Immunol Res Ctr, Shinjuku Ku, Tokyo 1608402, Japan; [Sudo, K.; Kojima, K.] Tokyo Med Univ, Anim Res Ctr, Shinjuku Ku, Tokyo 1608402, Japan; [Nagao, T.; Takahashi, R. H.; Iobe, H.] Tokyo Med Univ, Dept Anat Pathol, Shinjuku Ku, Tokyo 1600023, Japan; [Kuwabara, T.; Kakiuchi, T.] Toho Univ, Sch Med, Dept Immunol, Ota Ku, Tokyo 1438540, Japan; [Kakiuchi, T.] Toho Univ, Sch Med, Dept Adv & Integrated Anal Infect Dis, Ota Ku, Tokyo 1438540, Japan	Toyota, H (reprint author), Tokyo Med Univ, Dept Immunol, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	yuzz-t@tokyo-med.ac.jp; mizu@tokyo-med.ac.jp			Intractable Immune System Disease Center of Tokyo Medical University - Ministry of Education, Culture, Sports, Science, and Technology of Japan	We thank Dr. K. Miyake (Department of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan) for pCAGGS vector. This work was supported by a Grant from the Intractable Immune System Disease Center of Tokyo Medical University, which is supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. We also thank Zenji Sakamoto for his support.	Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Reed JC, 1998, ONCOGENE, V17, P3225; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; SHI YF, 1989, NATURE, V339, P625, DOI 10.1038/339625a0; Lleo A, 2008, J AUTOIMMUN, V31, P257, DOI 10.1016/j.jaut.2008.04.009; Zinkel S, 2006, CELL DEATH DIFFER, V13, P1351, DOI 10.1038/sj.cdd.4401987; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Ercolini AM, 2006, J IMMUNOL, V176, P3293; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Toyota H, 2003, CANCER LETT, V189, P221, DOI 10.1016/S0304-3835(02)00552-9; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Baccala R, 2005, IMMUNOL REV, V204, P9, DOI 10.1111/j.0105-2896.2005.00252.x; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; Petermann F, 2011, FEBS LETT, V585, P3747, DOI 10.1016/j.febslet.2011.03.064; Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2; Bassiri H, 2001, J IMMUNOL, V166, P5945; Cao YL, 2010, IMMUNOL LETT, V132, P38, DOI 10.1016/j.imlet.2010.05.006; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Furuhata M, 2009, EXP CELL RES, V315, P3467, DOI 10.1016/j.yexcr.2009.09.007; Gatzka M, 2007, AUTOIMMUNITY, V40, P442, DOI 10.1080/08916930701464962; Jiang XZ, 2003, APOPTOSIS, V8, P509, DOI 10.1023/A:1025594409056; Jiang XZ, 2003, TISSUE CELL, V35, P471, DOI 10.1016/S0040-8166(03)00073-9; MCCONKEY DJ, 1989, J IMMUNOL, V143, P1801; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Miyaji H, 2002, GENE, V297, P189, DOI 10.1016/S0378-1119(02)00886-7; Patel VA, 2009, AUTOIMMUNITY, V42, P317, DOI 10.1080/08916930902832124; Roger J, 2001, J IMMUNOL, V167, P6; Sherer Y, 1997, INT J ONCOL, V10, P939; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; Sohn SJ, 2003, CURR OPIN IMMUNOL, V15, P209, DOI 10.1016/S0952-7915(03)00004-9; Susin SA, 1998, BBA-BIOENERGETICS, V1366, P151, DOI 10.1016/S0005-2728(98)00110-8; Takada E, 2006, EXP CELL RES, V312, P3728, DOI 10.1016/j.yexcr.2006.06.036; Toyota H, 2012, CELL MOL BIOL LETT, V17, P36, DOI 10.2478/s11658-011-0034-8; Volkmann A, 1996, J IMMUNOL, V156, P136; vonBoehmer H, 1997, IMMUNOL TODAY, V18, P260, DOI 10.1016/S0167-5699(97)80018-7	41	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1360-8185	1573-675X		APOPTOSIS	Apoptosis	APR	2015	20	4					444	454		10.1007/s10495-014-1082-0		11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CC9EA	WOS:000350669500003		
J	Huang, YK; Inohara, T				Huang, Yuankan; Inohara, Takehiro			Group-separations based on the repeated prisoners' dilemma games	APPLIED MATHEMATICS AND COMPUTATION			English	Article						Subgame perfect equilibrium; Trigger strategy; Group-separation; complete graph	EVOLUTIONARY GAMES; COOPERATION; NETWORKS; RECIPROCITY; PROMOTES	We model group-separations in an n-player set. In the n-player set, every two players play an infinitely repeated two-player prisoners' dilemma game. Each player takes a mixed strategy to play the game and trigger strategy is used to punish the deviator. Let all players share a common discount factor delta. We find that with the variation of delta, the n-player set is separated into several subsets such that (1) for any two players in any two different subsets, their strategy profile is not a subgame perfect equilibrium and (2) each subset cannot be separated into several subsets that satisfy (1). Such subsets are called groups and the separation is called group-separation. We aim to specify the intervals (of delta) such that group-separations emerge. Particularly, we focus on the relationship between the interval and the form of each group-separation. (C) 2015 Elsevier Inc. All rights reserved.	[Huang, Yuankan; Inohara, Takehiro] Tokyo Inst Technol, Dept Value & Decis Sci, Grad Sch Decis Sci & Technol, Meguro Ku, Tokyo 1528552, Japan	Huang, YK (reprint author), Tokyo Inst Technol, Dept Value & Decis Sci, Grad Sch Decis Sci & Technol, Meguro Ku, 2-12-1 O Okayama, Tokyo 1528552, Japan.	huangyk@valdes.titech.ac.jp; inohara@valdes.titech.ac.jp					Jackson MO, 1996, J ECON THEORY, V71, P44, DOI 10.1006/jeth.1996.0108; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Pacheco JM, 2006, J THEOR BIOL, V243, P437, DOI 10.1016/j.jtbi.2006.06.027; Szolnoki A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0735; Wang Z, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052813; Wang Z, 2014, J THEOR BIOL, V349, P50, DOI 10.1016/j.jtbi.2014.01.037; Dutta B, 1997, J ECON THEORY, V76, P322, DOI 10.1006/jeth.1997.2306; Xia CY, 2013, CHAOS SOLITON FRACT, V51, P22, DOI 10.1016/j.chaos.2013.03.002; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Ma ZQ, 2011, INT J MOD PHYS C, V22, P1257, DOI 10.1142/S0129183111016877; Aumann R., 1988, THE SHAPLEY VALUE, P175; Chartrand G., 2012, 1 COURSE GRAPH THEOR; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; Jin Q, 2014, SCI REP-UK, V4, DOI 10.1038/srep04095; Maruta T, 2012, GAME ECON BEHAV, V74, P269, DOI 10.1016/j.geb.2011.05.006; Myerson R. B., 1977, Mathematics of Operations Research, V2, DOI 10.1287/moor.2.3.225; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Perc M., J R SOC INTERFACE, V10; Rubinstein A., 1994, COURSE GAME THEORY; VANDAMME E, 1989, J ECON THEORY, V47, P206, DOI 10.1016/0022-0531(89)90111-7; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Wang Z, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/3/033041; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0096-3003	1873-5649		APPL MATH COMPUT	Appl. Math. Comput.	APR 1	2015	256						267	275		10.1016/j.amc.2015.01.040		9	Mathematics, Applied	Mathematics	CB9UR	WOS:000349979300025		
J	Chang, LL; Sun, GQ; Wangb, Z; Jin, Z				Chang, Lili; Sun, Gui-Quan; Wang, Zhen; Jin, Zhen			Rich dynamics in a spatial predator-prey model with delay	APPLIED MATHEMATICS AND COMPUTATION			English	Article						Pattern formation; Reaction-diffusion equation; Predator-prey system; Spatiotemporal model; Discrete time delay	PATTERN-FORMATION; DIFFUSION; STABILITY; SYSTEM	In this paper, we study the spatiotemporal dynamics of a diffusive Holling-Tanner predator-prey model with discrete time delay. Via analytically and numerically analysis, we unveil six types of patterns with and without time delay. Among them, of particular novel is the observation of linear pattern (consisting of a series of parallel lines), whose formation is closely related with the temporal Hopf bifurcation threshold. Moreover, we also find that larger time delay or diffusion of predator may induce the extinction of both prey and predator. Theoretical analysis and numerical simulations validate the well-known conclusion: diffusion is usually beneficial for stabilizing pattern formation, yet discrete time delay plays a destabilizing role in the generation of pattern. (C) 2015 Elsevier Inc. All rights reserved.	[Chang, Lili; Sun, Gui-Quan; Jin, Zhen] Shanxi Univ, Complex Syst Res Ctr, Taiyuan 030006, Shanxi, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Dept Phys, Kowloon Tong, Hong Kong, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Ctr Nonlinear Studies, Kowloon Tong, Hong Kong, Peoples R China; [Wang, Zhen] Hong Kong Baptist Univ, Inst Computat & Theoret Studies, Beijing Hong Kong Singapore Joint Ctr Nonlinear &, Kowloon Tong, Hong Kong, Peoples R China; [Wang, Zhen] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan	Wangb, Z (reprint author), Hong Kong Baptist Univ, Dept Phys, Kowloon Tong, Hong Kong, Peoples R China.	changll@amss.ac.cn; gquansun@126.com; nkzhenwang@163.com; jinzhn@263.net	Wang, Zhen/H-5017-2011; jin, zhen/B-6563-2015	jin, zhen/0000-0002-9763-707X	National Natural Science Foundation of China [11301490, 11331009, 11171314, 11147015]; Natural Science Foundation of Shan'Xi Province [2012021002-1]	This research is supported by the National Natural Science Foundation of China under Grants 11301490, 11331009, 11171314 and 11147015, Natural Science Foundation of Shan'Xi Province Grant No. 2012021002-1.	TANNER JT, 1975, ECOLOGY, V56, P855, DOI 10.2307/1936296; SEGEL LA, 1972, J THEOR BIOL, V37, P545, DOI 10.1016/0022-5193(72)90090-2; Woolley TE, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046216; MAY RM, 1972, SCIENCE, V177, P900, DOI 10.1126/science.177.4052.900; Saez ES, 1999, SIAM J APPL MATH, V59, P1867; Wang YX, 2013, APPL ANAL, V92, P2168, DOI 10.1080/00036811.2012.724402; Faria T, 2001, J MATH ANAL APPL, V254, P433, DOI 10.1006/jmaa.2000.7182; Sun GQ, 2008, ECOL MODEL, V219, P248, DOI 10.1016/j.ecolmodel.2008.08.009; LEVIN SA, 1976, NATURE, V259, P659, DOI 10.1038/259659a0; OUYANG Q, 1991, NATURE, V352, P610, DOI 10.1038/352610a0; Sengupta A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.031914; Gurney WSC, 1998, ECOLOGY, V79, P2516; HSU SB, 1995, SIAM J APPL MATH, V55, P763, DOI 10.1137/S0036139993253201; Yan SL, 2013, APPL MATH COMPUT, V224, P524, DOI 10.1016/j.amc.2013.08.045; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; [Anonymous], 2007, APPL MATH COMPUT; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Banerjee M, 2014, CHAOS SOLITON FRACT, V67, P73, DOI 10.1016/j.chaos.2014.06.012; Biktashev VN, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.134101; Dufiet V, 1996, PHYS REV E, V53, P4883, DOI 10.1103/PhysRevE.53.4883; Choudhury B. S., 2013, INT J ECOL ECON STAT, V31, P19; Choudhury B.S., 2014, COMPUT APPL MATH; Engelhardt R., 1994, MODELLING PATTERN FO; Forys U, 2004, J BIOL SYST, V12, P1; Ghosh P, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016222; Hadeler KP, 2007, DISCRETE CONT DYN-B, V8, P95; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; Kunag Y., 1993, DELAY DIFFERENTIAL E; Lai YM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.118102; May R.M., 1978, STABILITY AND COMPLE; Murray J. D., 1993, MATHEMATICAL BIOLOGY; Piotrowska MJ, 2005, MATH COMPUT MODEL, V42, P123, DOI 10.1016/j.mcm.2004.05.010; Saunoriene L, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.056213; Sen S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046212; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Varea V., 1997, PHYS REV E, V56, P1250; Wang MX, 2008, IMA J APPL MATH, V73, P815, DOI 10.1093/imamat/hxn016; WOLLKIND DJ, 1988, B MATH BIOL, V50, P379	38	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0096-3003	1873-5649		APPL MATH COMPUT	Appl. Math. Comput.	APR 1	2015	256						540	550		10.1016/j.amc.2015.01.052		11	Mathematics, Applied	Mathematics	CB9UR	WOS:000349979300048		
J	Gani, MO; Ogawa, T				Gani, M. Osman; Ogawa, Toshiyuki			Instability of periodic traveling wave solutions in a modified FitzHugh-Nagumo model for excitable media	APPLIED MATHEMATICS AND COMPUTATION			English	Article						Periodic traveling wave; Modified FitzHugh-Nagumo model; Eckhaus instability; Excitable media; Essential spectrum	PARTIAL-DIFFERENTIAL-EQUATIONS; SPIRAL BREAKUP; NUMERICAL CONTINUATION; SEMIARID ENVIRONMENTS; CYCLIC POPULATIONS; TRAIN SOLUTIONS; PROPAGATION; BIFURCATIONS; RESTITUTION; TRANSITION	We introduce a two-variable system of reaction-diffusion equations for excitable media. We numerically investigate the existence and stability of periodic traveling wave solutions in a two-dimensional parameter plane. Our results based on the method of continuation show a stability change of Eckhaus type. There are two families of periodic traveling waves: fast and slow. The fast family is stable in the case of standard FitzHugh-Nagumo excitable system. However, we observe that the fast family becomes unstable in our model. Consequently, it bifurcates to an oscillating wave. We explain this phenomenon by numerically calculating the essential spectra of the periodic traveling wave solutions. Moreover, we study the stability of the periodic traveling wave solutions for the Aliev-Panfilov excitable system and compare its results with the proposed model. We show that the stability boundary of our model agrees qualitatively with that of the Aliev-Panfilov model, whereas it is different in the FitzHugh-Nagumo model. In addition, our results based on the stability boundary of the models show oscillating periodic traveling waves, except for the FitzHugh-Nagumo model. (C) 2015 Elsevier Inc. All rights reserved.	[Gani, M. Osman] Meiji Univ, Meiji Inst Adv Study Math Sci, Nakano Ku, Tokyo 1648525, Japan; [Gani, M. Osman; Ogawa, Toshiyuki] Meiji Univ, Grad Sch Adv Math Sci, Nakano Ku, Tokyo 1648525, Japan	Gani, MO (reprint author), Meiji Univ, Meiji Inst Adv Study Math Sci, Nakano Ku, 4-21-1 Nakano, Tokyo 1648525, Japan.	osmanganiju@gmail.com			Global Center of Excellence (GCOE) program "Formation and Development of Mathematical Sciences Based on Modeling and Analysis'', Meiji University, Japan	This work is supported by the Global Center of Excellence (GCOE) program "Formation and Development of Mathematical Sciences Based on Modeling and Analysis'', Meiji University, Japan. First of all, we would like to thank the author of the WAVETRAIN [19]. We thank Professor Daishin Ueyama (Meiji University) and Professor Hirokazu Ninomiya (Meiji University) for very fruitful discussions. M.O. Gani thank Dr. Ijioma (Meiji University) for helpful discussion. The authors also thank the anonymous reviewers for their valuable comments and suggestions to improve the quality of the paper.	Bierman SM, 2006, AM NAT, V167, P583, DOI 10.1086/501076; Panfilov AV, 1998, CHAOS, V8, P57, DOI 10.1063/1.166287; KARMA A, 1993, PHYS REV LETT, V71, P1103, DOI 10.1103/PhysRevLett.71.1103; Aliev RR, 1996, CHAOS SOLITON FRACT, V7, P293, DOI 10.1016/0960-0779(95)00089-5; Sherratt JA, 2012, APPL MATH COMPUT, V218, P4684, DOI 10.1016/j.amc.2011.11.005; STEINBERG V, 1989, PHYSICA D, V37, P359, DOI 10.1016/0167-2789(89)90143-7; Rademacher JDM, 2007, PHYSICA D, V229, P166, DOI 10.1016/j.physd.2007.03.016; van Hecke M, 2003, PHYSICA D, V174, P134, DOI 10.1016/S0167-2789(02)00687-5; Smith MJ, 2007, PHYSICA D, V236, P90, DOI 10.1016/j.physd.2007.07.013; Sherratt JA, 2008, J R SOC INTERFACE, V5, P483, DOI 10.1098/rsif.2007.1327; KOPELL N, 1973, STUD APPL MATH, V52, P291; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; MERON E, 1992, PHYS REP, V218, P1, DOI 10.1016/0370-1573(92)90098-K; Sherratt JA, 2013, SIAM J APPL MATH, V73, P1347, DOI 10.1137/120899510; PANFILOV A, 1993, PHYS LETT A, V176, P295, DOI 10.1016/0375-9601(93)90921-L; van Saarloos W, 2003, PHYS REP, V386, P29, DOI 10.1016/j.physrep.2003.08.001; Sherratt JA, 2013, ECOL COMPLEX, V14, P8, DOI 10.1016/j.ecocom.2012.12.002; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Sherratt JA, 2007, THEOR POPUL BIOL, V71, P1, DOI 10.1016/j.tpb.2006.07.009; CHAMPNEYS AR, 1994, INT J BIFURCAT CHAOS, V4, P785, DOI 10.1142/S0218127494000587; [Anonymous], 2007, NONLINEARITY; FITZHUGH R, 1961, BIOPHYS J, V1, P445; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500; Bordiougov G, 2006, PHYSICA D, V215, P25, DOI 10.1016/j.physd.2006.01.005; [Anonymous], 2010, PHYSICA D; Bar M., 2004, NEW J PHYS, V6, P1; Bauer S, 2007, CHAOS, V17, DOI 10.1063/1.2715668; Bordyugov G, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016205; Champneys AR, 1996, INT J BIFURCAT CHAOS, V6, P867, DOI 10.1142/S0218127496000485; Doedel EJ, 1986, AUTO SOFTWARE CONTIN; Doelman A., 2005, DYNAMICS MODULATED W; Echebarria B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.040902; Epstein I. R., 1996, J PHYS CHEM-US, V100, P13132; Grindrod P., 1996, THEORY APPL REACTION; MAGINU K, 1980, J MATH BIOL, V10, P133; MAGINU K, 1978, J MATH BIOL, V6, P49, DOI 10.1007/BF02478516; Maree AFM, 1997, PHYS REV LETT, V78, P1819, DOI 10.1103/PhysRevLett.78.1819; NOBLE D, 1962, J PHYSIOL-LONDON, V160, P317; Panfilov AV, 2002, CHAOS, V12, P800, DOI 10.1063/1.1493095; Pinnell J, 2007, CRITICAL CARE PAIN, V7, P85, DOI 10.1093/bjaceaccp/mkm013; Ranta E., 1997, GEOCHIM COSMOCHIM AC, V61, P3503; Sakaguchi H., 2008, J PHYS SOC JPN, V77, P1; Sandstede B., 2002, HDB DYNAMICAL SYSTEM, VII, P983, DOI 10.1016/S1874-575X(02)80039-X; Sherratt JA, 2013, ADV COMPUT MATH, V39, P175, DOI 10.1007/s10444-012-9273-0; Vanag V. K., 2008, J NONLINEAR SCI, V18; Zemlin CW, 2001, PHYS REV E, V63	46	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0096-3003	1873-5649		APPL MATH COMPUT	Appl. Math. Comput.	APR 1	2015	256						968	984		10.1016/j.amc.2015.01.109		17	Mathematics, Applied	Mathematics	CB9UR	WOS:000349979300081		
J	Kato, N; Sasaki, T; Mukai, Y				Kato, Noritaka; Sasaki, Takanori; Mukai, Yuri			Partially induced transition from horizontal to vertical orientation of helical peptides at the air-water interface and the structure of their monolayers transferred on the solid substrates	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						Amphiphilic peptide; alpha-Helix; Air-water interface; Langmuir-Blodgett film	LANGMUIR-BLODGETT MONOLAYERS; DIBLOCK COPOLYPEPTIDES; MEMBRANE-PROTEINS; MOLECULAR-CONFORMATION; AIR/WATER INTERFACE; TRANSMEMBRANE HELIX; IN-SITU; SURFACE; POLARIZATION; MICROSCOPY	To apply the Langmuir-Blodgett (LB) technique as a platform for investigating the fundamental properties of amphiphilic peptides (APs), we have investigated the structure of LB films using the APs. To vertically orient the helical APs like transmembrane proteins in the membrane, the primary structure of the APs was designed to have two domains: a hydrophilic domain (three amino acids) and a hydrophobic domain (ca. 20 amino adds). However, we are still far from having full control of their orientation. This study reports the contribution of the subphase temperature to the change in the orientation of helical APs. When the surface pressure-area isotherm of AP was observed at the subphase temperature at 41.5 degrees C, the isotherm exhibited a plateau, implying that a phase transition of the monolayer at the air-water interface occurred. Circular dichroism (CD) spectra of the monolayers transferred on the solid substrates revealed that the orientation of the helices changed at the pressure, where the plateau of the isotherm was observed. This change was not observed at 21.5 degrees C, i.e., the horizontal alignment of helixes was maintained. Atomic force microscopy (AFM) was used to systematically investigate the surface structure of the monolayers transferred at different surface pressures. A structural model of the monolayer that did not contradict with the results obtained by the three different techniques (the isotherm, CD spectroscopy, and AFM) was derived, and it was concluded that the horizontally oriented helices partially changed their orientation to vertical upon compression in the plateau region of the isotherm. (C) 2014 Elsevier B.V. All rights reserved.	[Kato, Noritaka; Sasaki, Takanori; Mukai, Yuri] Meiji Univ, Grad Sch Sci & Engn, Kawasaki, Kanagawa 2148571, Japan; [Kato, Noritaka; Mukai, Yuri] Meiji Univ, Sch Sci & Engn, Kawasaki, Kanagawa 2148571, Japan; [Sasaki, Takanori] Meiji Univ, Sch Interdisciplinary Math Sci, Tokyo 1648525, Japan	Kato, N (reprint author), Meiji Univ, Grad Sch Sci & Engn, Kawasaki, Kanagawa 2148571, Japan.	nkato@meiji.ac.jp			Institute of Science and Technology, Meiji University	Financial support from The Institute of Science and Technology, Meiji University is gratefully acknowledged. The authors also acknowledge significant experimental support from T. lizuka, T. Dan, and T. Tanaka.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; JACQUEMAIN D, 1992, ANGEW CHEM INT EDIT, V31, P130, DOI 10.1002/anie.199201301; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbtl338; Alessandrini A, 2005, MEAS SCI TECHNOL, V16, pR65, DOI 10.1088/0957-0233/16/6/R01; Gillgren H, 2002, LANGMUIR, V18, P462, DOI 10.1021/la011143h; WU Y, 1990, BIOPHYS J, V57, P797; Rath A, 2009, BIOCHEMISTRY-US, V48, P3036, DOI 10.1021/bi900184j; White SH, 2004, PROTEIN SCI, V13, P1948, DOI 10.1110/ps.04712004; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; White SH, 2001, J BIOL CHEM, V276, P32395, DOI 10.1074/jbc.R100008200; Wallin E, 1998, PROTEIN SCI, V7, P1029; Florsheimer M, 1999, LANGMUIR, V15, P5437, DOI 10.1021/la9815603; Boncheva M, 1997, BIOPHYS J, V73, P1056; Bordag N, 2010, CHEM PHYS LIPIDS, V163, P1, DOI 10.1016/j.chemphyslip.2009.07.009; Cornut I, 1996, BIOPHYS J, V70, P305; Dutta P, 2000, COLLOID SURFACE A, V171, P59, DOI 10.1016/S0927-7757(99)00543-9; FLORSHEIMER M, 1994, BER BUNSEN PHYS CHEM, V98, P521; Gaines Jr G.L., 1966, INSOLUBLE MONOLAYERS; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Hosokawa H, 1997, CHEM LETT, P745, DOI 10.1246/cl.1997.745; Kato N, 2001, J CHEM PHYS, V115, P1473, DOI 10.1063/1.1380375; Kishihara K, 1998, CHEM LETT, P951, DOI 10.1246/cl.1998.951; Liu LP, 1997, BIOCHEMISTRY-US, V36, P5476, DOI 10.1021/bi970030n; Lowik DWPM, 2004, CHEM SOC REV, V33, P234, DOI 10.1039/b212638a; Merzlyakov M, 2006, LANGMUIR, V22, P1247, DOI 10.1021/la051933h; Meunier J, 2000, COLLOID SURFACE A, V171, P33, DOI 10.1016/S0927-7757(99)00555-5; Nguyen LTT, 2010, LANGMUIR, V26, P11018, DOI 10.1021/la1002622; Nguyen LTT, 2010, LANGMUIR, V26, P6515, DOI 10.1021/la904007m; Nguyen LTT, 2010, SOFT MATTER, V6, P2774, DOI 10.1039/c001163k; Petsko G.A., 2009, PROTEIN STRUCTURE FU; Rees D.C., 2003, ADV PROTEIN CHEM, V63; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Selinsky B.S., 2003, METHODS MOL BIOL, V228; Tanida H, 2004, SPECTROCHIM ACTA B, V59, P1071, DOI 10.1016/j.sab.2004.05.019; Togashi K, 2012, J NANOSCI NANOTECHNO, V12, P568, DOI 10.1166/jnn.2012.5387; Togashi K., 2012, E J SURF SCI NANOTEC, V10, P379; Toyotama A, 1997, CHEM LETT, P443, DOI 10.1246/cl.1997.443; Ulman A., 1991, INTRO ULTRATHIN ORGA; Ulman A., 1991, INTRO ULTRATHIN ORGA; Yano Y, 2002, BIOCHEMISTRY-US, V41, P3073, DOI 10.1021/bi011161y; Yano Y, 2010, J PHYS CHEM B, V114, P1925, DOI 10.1021/jp910185w; Yano YF, 2009, LANGMUIR, V25, P32, DOI 10.1021/la803235x; Ye SX, 2004, LANGMUIR, V20, P5897, DOI 10.1021/la0363884; Yokoi H, 2004, CHEM LETT, V33, P426, DOI 10.1246/cl.2004.426; Yokoi H, 2003, PROG POLYM SCI, V28, P341, DOI 10.1016/S0079-6700(02)00081-3	47	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	0006-3002		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	APR	2015	1848	4					967	975		10.1016/j.bbamem.2014.12.022		9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CC6ZZ	WOS:000350518800009		
J	Clark, DS; Karube, I; Sode, K; Bulow, L; Bruggemann, O; Lowe, CR; Poulsen, PB; Langer, RS				Clark, Douglas S.; Karube, Isao; Sode, Koji; Bulow, Leif; Brueggemann, Oliver; Lowe, Christopher R.; Poulsen, Poul Borge; Langer, Robert S.			Klaus Mosbach Tribute	BIOTECHNOLOGY AND BIOENGINEERING			English	Editorial Material									[Clark, Douglas S.] Univ Calif Berkeley, Coll Chem, Berkeley, CA 94720 USA; [Karube, Isao] Tokyo Univ Technol, Tokyo, Japan; [Sode, Koji] Tokyo Univ Agr & Technol, Grad Sch Engn, Dept Biotechnol & Life Sci, Tokyo, Japan; [Bulow, Leif] Lund Univ, Pure & Appl Biochem, Lund, Sweden; [Brueggemann, Oliver] Johannes Kepler Univ Linz, Inst Polymer Chem ICP, Leonding, Austria; [Lowe, Christopher R.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 1QT, England; [Poulsen, Poul Borge] C5 Ligno Technol Lund AB, Copenhagen Area, Capital Region, Denmark; [Langer, Robert S.] MIT, Cambridge, MA 02139 USA	Clark, DS (reprint author), Univ Calif Berkeley, Coll Chem, Berkeley, CA 94720 USA.		Sode, Koji/F-6914-2013					0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-3592	1097-0290		BIOTECHNOL BIOENG	Biotechnol. Bioeng.	APR	2015	112	4					645	647		10.1002/bit.25507		3	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CC6KO	WOS:000350474000002		
J	Toya, Y; Shiraki, T; Shimizu, H				Toya, Yoshihiro; Shiraki, Takanori; Shimizu, Hiroshi			SSDesign: Computational Metabolic Pathway Design Based on Flux Variability Using Elementary Flux Modes	BIOTECHNOLOGY AND BIOENGINEERING			English	Article						elementary flux mode; metabolic pathway design; growth-associated production; non-growth-associated production	MINIMAL CUT SETS; IN-SILICO DESIGN; ESCHERICHIA-COLI; KNOCKOUT STRATEGIES; ENHANCED PRODUCTION; ACID PRODUCTION; NETWORKS; OPTIMIZATION; CELL	Metabolic pathway modification based on the stoichiometric model has been an effective approach for enhancing microbial bio-production. The network of optimal pathways for growth-associated and non-growth-associated production can be designed from the flux variability (solution space). The present study introduces a new computational method (solution space design [SSDesign]) that visually designs the gene knockout solution space. The smallest reaction sets that satisfy the mass balances of intermediates are called elementary flux nodes (EFMs). Because some of the EFMs necessarily occupy the outer boundary nodes of the flux solution space, the proposed SSDesign determines the area over which EFMs should be removed from the solution space of the parent strain, and explores the gene knockouts that will eliminate these undesirable EFMs. To evaluate the performance of SSDesign, the model was applied to growth-associated and non-growth-associated succinate production in Escherichia coli. In the growth-associated case, the deletion mutants that promoted succinate production at maximum biomass yield were predicted, and a candidate of ptsG pykA,F pflA has been experimentally confirmed as a succinate producer. Simply by changing the parameters, the gene knockout combinations yielding high growth yield were successfully predicted by SSDesign. In the non-growth-associated case, strong candidates for succinate production were the deletion mutants pntAB sfcA pykA,F and sfcA maeB pykA,F zwf. According to the solution spaces, these strains allow high growth yield and inevitably produce succinate at zero biomass yield, since their metabolic pathways cannot sustain steady-state without discarding succinate from the cell. Biotechnol. Bioeng. 2015;112: 759-768. (c) 2014 Wiley Periodicals, Inc.	[Toya, Yoshihiro; Shiraki, Takanori; Shimizu, Hiroshi] Osaka Univ, Dept Bioinformat Engn, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan; [Toya, Yoshihiro; Shiraki, Takanori; Shimizu, Hiroshi] Japan Sci & Technol Agcy JST, ALCA, Adv Low Carbon Technol Res & Dev Program, Tokyo, Japan	Shimizu, H (reprint author), Osaka Univ, Dept Bioinformat Engn, Grad Sch Informat Sci & Technol, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	shimizu@ist.osaka-u.ac.jp					Klamt S, 2004, BIOINFORMATICS, V20, P226, DOI 10.1093/bioinformatics/btg395; Papin JA, 2004, TRENDS BIOTECHNOL, V22, P400, DOI 10.1016/j.tibtech.2004.06.010; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Zomorrodi AR, 2012, METAB ENG, V14, P672, DOI 10.1016/j.ymben.2012.09.005; Kim J, 2011, APPL MICROBIOL BIOT, V91, P143, DOI 10.1007/s00253-011-3275-6; de Figueiredo LF, 2009, BIOINFORMATICS, V25, P3158, DOI 10.1093/bioinformatics/btp564; Terzer M, 2008, BIOINFORMATICS, V24, P2229, DOI 10.1093/bioinformatics/btn401; Klamt S, 2006, BIOSYSTEMS, V83, P233, DOI 10.1016/j.biosystems.2005.04.009; von Kamp A, 2006, BIOINFORMATICS, V22, P1930, DOI 10.1093/bioinformatics/btl267; Chubukov V, 2014, APPL ENVIRON MICROB, V80, P2901, DOI 10.1128/AEM.00061-14; Fong SS, 2005, BIOTECHNOL BIOENG, V91, P643, DOI 10.1002/bit.20542; Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Poblete-Castro I, 2013, METAB ENG, V15, P113, DOI 10.1016/j.ymben.2012.10.004; Trinh CT, 2008, APPL ENVIRON MICROB, V74, P3634, DOI 10.1128/AEM.02708-07; Neuner A, 2011, BIOTECHNOL J, V6, P318, DOI 10.1002/biot.201000307; Lee SJ, 2005, APPL ENVIRON MICROB, V71, P7880, DOI 10.1128/AEM.71.12.7880-7887.2005; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Ballerstein K, 2012, BIOINFORMATICS, V28, P381, DOI 10.1093/bioinformatics/btr674; Knuf C, 2013, APPL ENVIRON MICROB, V79, P6050, DOI 10.1128/AEM.01445-13; Unrean P, 2010, METAB ENG, V12, P112, DOI 10.1016/j.ymben.2009.11.002; Trinh CT, 2011, APPL ENVIRON MICROB, V77, P4894, DOI 10.1128/AEM.00382-11; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Edwards JS, 2002, ENVIRON MICROBIOL, V4, P133, DOI 10.1046/j.1462-2920.2002.00282.x; Feist AM, 2010, METAB ENG, V12, P173, DOI 10.1016/j.ymben.2009.10.003; Chan SHJ, 2011, BIOINFORMATICS, V27, P2256, DOI 10.1093/bioinformatics/btr367; Melzer G, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-120; NUNHEIME.TD, 1970, APPL MICROBIOL, V20, P215; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Ohno S, 2014, BIOINFORMATICS, V30, P981, DOI 10.1093/bioinformatics/btt672; Tashiro Y, 2007, J BIOSCI BIOENG, V104, P1; Tokuyama K, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-64	31	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0006-3592	1097-0290		BIOTECHNOL BIOENG	Biotechnol. Bioeng.	APR	2015	112	4					759	768		10.1002/bit.25498		10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CC6KO	WOS:000350474000016		
J	Saito, M; Grynpas, MD; Burr, DB; Allen, MR; Smith, SY; Doyle, N; Amizuka, N; Hasegawa, T; Kida, Y; Marumo, K; Saito, H				Saito, Mitsuru; Grynpas, Marc D.; Burr, David B.; Allen, Matthew R.; Smith, Susan Y.; Doyle, Nancy; Amizuka, Norio; Hasegawa, Tomoka; Kida, Yoshikuni; Marumo, Keishi; Saito, Hitoshi			Treatment with eldecalcitol positively affects mineralization, microdamage, and collagen crosslinks in primate bone	BONE			English	Article						Vitamin D; Bone quality; Bone mineralization; Bone microdamage; Bone microarchitecture; Collagen crosslinks	VITAMIN-D ANALOG; OVARIECTOMIZED CYNOMOLGUS MONKEYS; GLYCATION-INDUCED-PENTOSIDINE; BIOMECHANICAL PROPERTIES; NONENZYMATIC GLYCATION; CANCELLOUS BONE; CORTICAL BONE; MECHANICAL-PROPERTIES; 1-YEAR TREATMENT; TRABECULAR BONE	Eldecalcitol (ELD), an active form of vitamin D analog approved for the treatment of osteoporosis in Japan, increases lumbar spine bone mineral density (BMD), suppresses bone turnover markers, and reduces fracture risk in patients with osteoporosis. We have previously reported that treatment with ELD for 6 months improved the mechanical properties of the lumbar spine in ovariectomized (OVX) cynomolgus monkeys. ELD treatment increased lumbar BMD, suppressed bone turnover markers, and reduced histomorphometric parameters of both bone formation and resorption in vertebral trabecular bone. In this study, we elucidated the effects of ELD on bone quality (namely, mineralization, microarchitecture, microdamage, and bone collagen crosslinks) in OVX cynomolgus monkeys in comparison with OVX-vehicle control monkeys. Density fractionation of bone powder prepared from lumbar vertebrae revealed that ELD treatment shifted the distribution profile of bone mineralization to a higher density, and backscattered electron microscopic imaging showed improved trabecular bone connectivity in the ELD-treated groups. Higher doses of ELD more significantly reduced the amount of microdamage compared to OVX-vehicle controls. The fractionated bone powder samples were divided according to their density, and analyzed for collagen crosslinks. Enzymatic crosslinks were higher in both the high-density (>= 2.0 mg/mL) and low-density (<2.0 mg/mL) fractions from the ELD-treated groups than in the corresponding fractions in the OVX-vehicle control groups. On the other hand, non-enzymatic crosslinks were lower in both the high- and low-density fractions. These observations indicated that ELD treatment stimulated the enzymatic reaction of collagen crosslinks and bone mineralization, but prevented non-enzymatic reaction of collagen crosslinks and accumulation of bone microdamage. Bone anti-resorptive agents such as bisphosphonates slow down bone remodeling so that bone mineralization, bone microdamage, and non-enzymatic collagen crosslinks all increase. Bone anabolic agents such as parathyroid hormone decrease bone mineralization and bone microdamage by stimulating bone remodeling. ELD did not fit into either category. Histological analysis indicated that the ELD treatment strongly suppressed bone resorption by reducing the number of osteoclasts, while also stimulating focal bone formation without prior bone resorption (bone minimodeling). These bidirectional activities of ELD may account for its unique effects on bone quality. (C) 2014 The Authors. Published by Elsevier Inc.	[Saito, Mitsuru; Kida, Yoshikuni; Marumo, Keishi] Jikei Univ, Sch Med, Dept Orthoped Surg, Minato Ku, Tokyo 1058461, Japan; [Grynpas, Marc D.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Burr, David B.; Allen, Matthew R.] Indiana Univ Sch Med, Dept Orthopaed Surg, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Smith, Susan Y.; Doyle, Nancy] Charles River Labs Preclin Serv Montreal, Musculoskeletal Res, Senneville, PQ, Canada; [Amizuka, Norio; Hasegawa, Tomoka] Hokkaido Univ, Grad Sch Dent Med, Div Oral Hlth Sci, Sapporo, Hokkaido, Japan; [Saito, Hitoshi] Chugai Pharmaceut Co Ltd, Dept Med Sci, Tokyo, Japan	Saito, M (reprint author), Jikei Univ, Sch Med, Dept Orthoped Surg, Minato Ku, 3-25-8 Nishishinbashi, Tokyo 1058461, Japan.	xlink67@gol.com			Chugai Pharmaceutical Co., Ltd.	This study was partly supported by a research grant from Chugai Pharmaceutical Co., Ltd. We thank all the members assigned to this project at Charles River Laboratories. The authors also wish to thank Dr. Keith Condon for the histological measurements used for microdamage analysis.	Allen MR, 2006, BONE, V39, P872, DOI 10.1016/j.bone.2006.04.028; Saito H, 2013, J STEROID BIOCHEM, V136, P178, DOI 10.1016/j.jsbmb.2012.10.004; Ito M, 2011, BONE, V49, P328, DOI 10.1016/j.bone.2011.05.002; Jerome CP, 2001, BONE, V29, P1, DOI 10.1016/S8756-3282(01)00477-X; de Freitas PHL, 2011, BONE, V49, P335, DOI 10.1016/j.bone.2011.05.022; Paschalis EP, 2004, J BONE MINER RES, V19, P2000, DOI 10.1359/JBMR.040820; Saito M, 2014, CURR OSTEOPOROS REP, V12, P181, DOI 10.1007/s11914-014-0202-7; Manolagas SC, 2007, MOL ENDOCRINOL, V21, P2605, DOI 10.1210/me.2007-0259; Tang SY, 2007, BONE, V40, P1144, DOI 10.1016/j.bone.2006.12.056; Saito M, 2010, BONE, V46, P1170, DOI 10.1016/j.bone.2009.12.008; Nagaoka H, 2008, BIOCHEM BIOPH RES CO, V377, P674, DOI 10.1016/j.bbrc.2008.10.036; Matsumoto T, 2011, BONE, V49, P605, DOI 10.1016/j.bone.2011.07.011; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; Saito M, 1997, ANAL BIOCHEM, V253, P26, DOI 10.1006/abio.1997.2350; Mashiba T, 2000, J BONE MINER RES, V15, P613, DOI 10.1359/jbmr.2000.15.4.613; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Mori H, 2008, BONE, V43, P840, DOI 10.1016/j.bone.2008.07.242; Saito M, 2008, OSTEOPOROSIS INT, V19, P1343, DOI 10.1007/s00198-008-0585-3; Harada S, 2012, J BONE MINER RES, V27, P461, DOI 10.1002/jbmr.555; Sakai S, 2012, BONE, V50, P1054, DOI 10.1016/j.bone.2012.02.005; Saito M, 2010, OSTEOPOROSIS INT, V21, P655, DOI 10.1007/s00198-009-0980-4; Saito M, 2006, OSTEOPOROSIS INT, V17, P1514, DOI 10.1007/s00198-006-0155-5; Nojiri H, 2011, J BONE MINER RES, V26, P2682, DOI 10.1002/jbmr.489; Kikuta J, 2013, P NATL ACAD SCI USA, V110, P7009, DOI [10.1073/pnas.1218799110, 10.1073/1218799110]; Banse X, 2002, J BONE MINER RES, V17, P1621, DOI 10.1359/jbmr.2002.17.9.1621; Bracci PM, 1998, BIOMETRICS, V54, P337, DOI 10.2307/2534021; GRYNPAS MD, 1988, J BONE MINER RES, V3, P159; Hagino H, 2013, J BONE MINER METAB, V31, P183, DOI 10.1007/s00774-012-0397-6; Itoh F, 2002, J BONE MINER RES, V17, P534, DOI 10.1359/jbmr.2002.17.3.534; Karim L, 2013, OSTEOPOROSIS INT, V24, P2441, DOI 10.1007/s00198-013-2319-4; Lundon K, 1997, CALCIFIED TISSUE INT, V60, P54, DOI 10.1007/s002239900186; Matsumoto Toshio, 2014, Bonekey Rep, V3, P513, DOI 10.1038/bonekey.2014.8; Nagaoka H, 2014, J ORTHOP RES, V32, P1030, DOI 10.1002/jor.22642; OXLUND H, 1995, BONE, V17, pS365, DOI 10.1016/8756-3282(95)00328-B; Saito M, 2011, OSTEOPOROSIS INT, V22, P2373, DOI 10.1007/s00198-010-1454-4; Saito M, 2006, OSTEOPOROSIS INT, V17, P986, DOI 10.1007/s00198-006-0087-0; Saito M, 2006, CALCIFIED TISSUE INT, V79, P160, DOI 10.1007/s00223-006-0035-1; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Smith SY, 2009, AM J PRIMATOL, V71, P752, DOI 10.1002/ajp.20715; Smith SY, 2003, BONE, V32, P45, DOI 10.1016/S8756-3282(02)00923-7; Smith SY, 2013, BONE, V57, P116, DOI 10.1016/j.bone.2013.06.005; Sodek KL, 2000, BONE, V26, P189, DOI 10.1016/S8756-3282(99)00251-3; Tang SY, 2009, OSTEOPOROSIS INT, V20, P887, DOI 10.1007/s00198-008-0754-4; Uchiyama Y, 2002, BONE, V30, P582, DOI 10.1016/S8756-3282(02)00682-8; Yamauchi M, 2002, COLLAGEN BIOCH OVERV	46	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	APR	2015	73						8	15		10.1016/j.bone.2014.11.025		8	Endocrinology & Metabolism	Endocrinology & Metabolism	CC7FJ	WOS:000350532800002		
J	Lezot, F; Chesneau, J; Navet, B; Gobin, B; Amiaud, J; Choi, YW; Yagita, H; Castaneda, B; Berdal, A; Mueller, CG; Redini, F; Heymann, D				Lezot, Frederic; Chesneau, Julie; Navet, Benjamin; Gobin, Berengere; Amiaud, Jerome; Choi, YongWon; Yagita, Hideo; Castaneda, Beatriz; Berdal, Ariane; Mueller, Christopher G.; Redini, Francoise; Heymann, Dominique			Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: Mouse strain disparities and synergic effect with zoledronic acid	BONE			English	Article						Bone resorption; RANKL; Zoledronic acid; Skeleton growth; Side effect	HUMAN OSTEOSARCOMA CELLS; JUVENILE PAGETS-DISEASE; FACTOR-KAPPA-B; BONE TURNOVER MARKERS; RECEPTOR ACTIVATOR; OSTEOGENESIS IMPERFECTA; DENOSUMAB TREATMENT; IDIOPATHIC HYPERPHOSPHATASIA; EWING SARCOMA; IN-VITRO	High doses of bone resorption inhibitors are currently under evaluation in pediatric oncology. Previous works have evidenced transient arrest in long bone and skull bone growth and tooth eruption blockage when mice were treated with zoledronic acid (ZOL). The question of potential similar effects with a RANKL-blocking antibody (IK22.5) was raised. Sensitivity disparities in these inhibitors between mouse strains and synergic effects of zoledronic acid and a RANKL-blocking antibody were subsidiary questions. In order to answer these questions, newborn C57BL/6J and CD1 mice were injected every two or three days (4 injections in total so 7 or 10 days of treatment length) with high doses of a RANKL-blocking antibody. The consequences on the tibia, craniofacial bones and teeth were analyzed by mu CT and histology at the end of the treatment and one, two and three months later. The results obtained showed that RANKL-blocking antibody injections induced a transient arrest of tibia and skull bone growth and an irreversible blockage of tooth eruption in C57BL/6J mice. In CD1 mice, tooth eruption defects were also present but only at much higher doses. Similar mouse strain differences were obtained with zoledronic acid. Finally, a synergic effect of the two inhibitors was evidenced. In conclusion as previously observed for bisphosphonates (ZOL), a RANKL-blocking antibody induced a transient arrest in long bone and skull bone growth and a blockage of tooth eruption with however disparities between mouse strains with regard to this last effect. A synergic effect of both bone resorption inhibitors was also demonstrated. (C) 2014 Elsevier Inc. All rights reserved.	[Lezot, Frederic; Chesneau, Julie; Navet, Benjamin; Gobin, Berengere; Amiaud, Jerome; Redini, Francoise; Heymann, Dominique] INSERM, UMR957, Equipe Ligue Natl Canc 2012, F-44035 Nantes 1, France; [Lezot, Frederic; Chesneau, Julie; Navet, Benjamin; Gobin, Berengere; Amiaud, Jerome; Redini, Francoise; Heymann, Dominique] Univ Nantes, Fac Med, Lab Physiopathol Resorpt Osseuse & Therapie Tumeu, F-44035 Nantes, France; [Choi, YongWon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Yagita, Hideo] Juntendo Univ, Dept Immunol, Sch Med, Tokyo 1138421, Japan; [Castaneda, Beatriz; Berdal, Ariane] Ctr Rech Cordeliers, INSERM, UMR 1138, Equipe 5, F-75006 Paris, France; [Castaneda, Beatriz] Univ Antioquia, Fac Odontol, Dept Basic Studies, Medellin 1226, Colombia; [Mueller, Christopher G.] Univ Strasbourg, CNRS, UPR 9021, IBMC,Lab Immunol & Chim Therapeut, F-67084 Strasbourg, France	Lezot, F (reprint author), Fac Med, INSERM, UMR957, 1 Rue Gaston Veil, F-44035 Nantes 1, France.	frederic.lezot@univ-nantes.fr	REDINI, Francoise/K-7981-2015; Lezot, Frederic/K-8075-2015		French Association for Cancer Research (ARC) [ECL2010R00778]; Liddy Shriver Sarcoma Initiative; French National Cancer Institute [INCa-6001]	The authors wish to thank G. Hamery, and P. Monmousseau from the Therapeutic Experimental Unit (Nantes, France) for their technical assistance. The project received financial support from the French Association for Cancer Research (ARC, Project # ECL2010R00778), the Liddy Shriver Sarcoma Initiative (grant) and the French National Cancer Institute (Funding INCa-6001).	Acil Y, 2012, J CRANIO MAXILL SURG, V40, pE229, DOI 10.1016/j.jcms.2011.10.024; Akiyama Taishin, 2012, World J Orthop, V3, P142, DOI 10.5312/wjo.v3.i9.142; Zwolak P, 2013, ANTICANCER RES, V33, P2981; Goldsby RE, 2013, EUR J CANCER, V49, P2384, DOI 10.1016/j.ejca.2013.03.018; Ward LM, 2013, LANCET, V382, P1388, DOI 10.1016/S0140-6736(13)61531-7; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; Saki F, 2013, J BONE MINER RES, V28, P1501, DOI 10.1002/jbmr.1868; Semler O, 2012, J MUSCULOSKEL NEURON, V12, P183; Cundy T, 2004, J BONE MINER RES, V19, P703, DOI 10.1359/JBMR.040127; Koto K, 2010, ONCOL REP, V24, P233, DOI 10.3892/or_00000851; Russell RGG, 2011, BONE, V49, P2, DOI 10.1016/j.bone.2011.04.022; Benassi MS, 2007, CANCER LETT, V250, P194, DOI 10.1016/j.canlet.2006.10.004; Russell RGG, 2006, ANN NY ACAD SCI, V1068, P367, DOI 10.1196/annals.1346.041; Moriceau G, 2010, CANCER RES, V70, P10329, DOI 10.1158/0008-5472.CAN-10-0578; Barbaroux JBO, 2008, J IMMUNOL, V181, P1103; Hanada R, 2009, NATURE, V462, P505, DOI 10.1038/nature08596; Chawla S, 2013, LANCET ONCOL, V14, P901, DOI 10.1016/S1470-2045(13)70277-8; Eriksen EF, 2013, ACTA OBSTET GYN SCAN, V92, P620, DOI 10.1111/j.1600-0412.2012.01473.x; Sousa T, 2014, J PEDIATR ORTHOPED, V34, P118, DOI 10.1097/BPO.0b013e3182a006a0; Mori K, 2007, J PATHOL, V211, P555, DOI 10.1002/path.2140; Mori K, 2009, HISTOL HISTOPATHOL, V24, P235; Hanada R, 2011, J MOL MED, V89, P647, DOI 10.1007/s00109-011-0749-z; Reid IR, 2012, NAT REV RHEUMATOL, V8, P90, DOI 10.1038/nrrheum.2011.181; Demir E, 2000, J PEDIATR ENDOCR MET, V13, P217; Polyzos SA, 2010, J BONE MINER METAB, V28, P706, DOI 10.1007/s00774-010-0198-8; Duheron V, 2011, P NATL ACAD SCI USA, V108, P5342, DOI 10.1073/pnas.1013054108; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Elias LSA, 2010, ORAL SURG ORAL MED O, V110, P624, DOI 10.1016/j.tripleo.2010.06.014; O'Day K, 2009, EXPERT REV ANTICANC, V9, P511, DOI [10.1586/era.09.7, 10.1586/ERA.09.7]; Mori K, 2007, ONCOL REP, V18, P1365; Barros ER, 2012, J PEDIATR ENDOCR MET, V25, P485, DOI 10.1515/jpem-2012-0016; Hess E, 2012, J IMMUNOL, V188, P1245, DOI 10.4049/jimmunol.1101513; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Leibbrandt A, 2010, ADV EXP MED BIOL, V658, P77, DOI 10.1007/978-1-4419-1050-9_9; Castaneda B, 2011, J CELL PHYSIOL, V226, P74, DOI 10.1002/jcp.22305; Bishop N, 2013, LANCET, V382, P1424, DOI 10.1016/S0140-6736(13)61091-0; Sugiyama M, 2012, INT IMMUNOL, V24, P369, DOI 10.1093/intimm/dxs002; Boyce AM, 2012, J BONE MINER RES, V27, P1462, DOI 10.1002/jbmr.1603; Kong YY, 1999, NATURE, V397, P315; Odri GA, 2010, CANCER RES, V70, P7610, DOI 10.1158/0008-5472.CAN-09-4272; Bargman R, 2012, PEDIATR RES, V72, P495, DOI 10.1038/pr.2012.118; Battaglia S, 2011, J BONE MINER RES, V26, P2439, DOI 10.1002/jbmr.453; Castaneda B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080054; Chang J, 2012, ONCOL LETT, V4, P299, DOI 10.3892/ol.2012.723; Demirsoy U, 2013, J PEDIAT HEMATOL ONC; Dos Santos MP, 2014, ONCOL REP, V31, P955, DOI 10.3892/or.2013.2907; Federman N, 2013, PAEDIAT DRUGS; Grasemann C, 2013, J CLIN ENDOCR METAB, V98, P3121, DOI 10.1210/jc.2013-1143; Gutierrez H, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120150; Hanada R, 2010, BIOL CHEM, V391, P1365, DOI 10.1515/BC.2010.149; Hanley DA, 2012, INT J CLIN PRACT, V66, P1139, DOI 10.1111/ijcp.12022; Heymann D, 2005, BONE, V37, P74, DOI 10.1016/j.bone.2005.02.020; Iguchi T, 2007, INT J ONCOL, V31, P285; Karras NA, 2013, J CLIN ONCOL, V31, pE200, DOI 10.1200/JCO.2012.46.4255; Kubista B, 2006, J ORTHOP RES, V24, P1145, DOI 10.1002/jor.20129; Labrinidis A, 2009, CLIN CANCER RES, V15, P3451, DOI 10.1158/1078-0432.CCR-08-1616; Lange T, 2013, EUR SPINE J, V22, P1417, DOI 10.1007/s00586-013-2715-7; Lee JC, 2011, J CRANIOFAC SURG, V22, P699, DOI 10.1097/SCS.0b013e3182077fbd; Lezot F, 2014, BONE, V68, P146, DOI 10.1016/j.bone.2014.08.018; Li ZX, 2012, J ORTHOP RES, V30, P824, DOI 10.1002/jor.21579; Morii T, 2010, ANTICANCER RES, V30, P3565; Mueller CG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00261; Ory B, 2008, J CELL MOL MED, V12, P928, DOI [10.1111/j.1582-4934.2008.00141.x, 10.1111/j.1582-4934.2007.00141.x]; Ryu K, 2010, ANTICANCER RES, V30, P2713; Siddiqui Tariq, 2010, Clin Adv Hematol Oncol, V8, P499; Silverman SL, 2011, ANN NY ACAD SCI, V1218, P33, DOI 10.1111/j.1749-6632.2010.05769.x; Tells SH, 2013, J STEROID BIOCH MOL; Wittrant Y, 2006, INT J ONCOL, V28, P261; Yamaguchi T, 2006, NAT MED, V12, P1358, DOI 10.1038/nm1206-1358; Zhou ZC, 2005, CANCER, V104, P1713, DOI 10.1002/cncr.21383	70	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	APR	2015	73						51	59		10.1016/j.bone.2014.12.011		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CC7FJ	WOS:000350532800007		
J	Mori, T; Ishii, S; Greendale, GA; Cauley, JA; Ruppert, K; Crandall, CJ; Karlamangla, AS				Mori, Takahiro; Ishii, Shinya; Greendale, Gail A.; Cauley, Jane A.; Ruppert, Kristine; Crandall, Carolyn J.; Karlamangla, Arun S.			Parity, lactation, bone strength, and 16-year fracture risk in adult women: Findings from the Study of Women's Health Across the Nation (SWAN)	BONE			English	Article						Parity; Lactation; Fracture; Bone strength; Bone mineral density; Composite strength indices	FEMORAL-NECK STRENGTH; PREDICTS HIP FRACTURE; MINERAL DENSITY; OSTEOPOROTIC FRACTURES; POSTMENOPAUSAL WOMEN; MENOPAUSAL TRANSITION; REPRODUCTIVE HISTORY; MULTIETHNIC COHORT; PHYSICAL-ACTIVITY; MATERNAL RECALL	Our objective was to examine the associations of lifetime parity and accumulated length of lactation with bone strength in women prior to the menopause transition and fracture risk during and after the transition. Participants were 2239 pre- or early pen-menopausal women from the Study of Women's Health Across the Nation (SWAN), ages 42-53 years at baseline, who had no childbirths after age 42. Bone mineral density (BMD) was measured in the femoral neck and the lumbar spine at the baseline SWAN visit using dual-energy x-ray absorptiometry, and the composite indices of femoral neck strength relative to load (in three failure modes: compression, bending, and impact) were calculated from femoral neck BMD, femoral neck size, and body size. Data on fractures after age 42 were collected for a median follow-up of 15.7 years (interquartile range, 11.4-18.5 years). In multiple linear regressions adjusted for covariates, lifetime parity was associated positively with femoral neck strength relative to load (0.024 standard deviation (SD) increment in impact strength index per childbirth, p = 0.049), but accumulated length of lactation was associated negatively with lumbar spine BMD (0.018 SD decrement per every additional 6 months of lactation, p = 0.040). In Cox proportional hazards regressions adjusted for covariates, neither parity nor lactation was associated with fracture hazard after age 42. In conclusion, parity and lactation have little impact on peak bone strength prior to menopause, and do not affect fracture risk after age 42 over 16-year follow-up. (C) 2015 Elsevier Inc. All rights reserved.	[Mori, Takahiro] Kameda Med Ctr, Dept Med, Div Gen Internal Med, Chiba 2968602, Japan; [Ishii, Shinya] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan; [Greendale, Gail A.; Karlamangla, Arun S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Geriatr, Los Angeles, CA 90095 USA; [Cauley, Jane A.; Ruppert, Kristine] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Crandall, Carolyn J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90024 USA	Mori, T (reprint author), Kameda Med Ctr, Dept Med, Div Gen Internal Med, 929 Higashi Cho, Chiba 2968602, Japan.	takahiromori@outlook.com	Cauley, Jane A/N-4836-2015	Cauley, Jane A/0000-0003-0752-4408	National Institutes of Health (NIH), DHHS, through National Institute on Aging (NIA); National Institute of Nursing Research (NINR); NIH Office of Research on Women's Health (ORWH) [U01NR004061, U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495]; NIA [AG026463]; VA Special Fellowship Program in Advanced Geriatrics; VA Greater Los Angeles Geriatric Research Education and Clinical Center	The Study of Women's Health Across the Nation (SWAN) has grant support from the National Institutes of Health (NIH), DHHS, through the National Institute on Aging (NIA), the National Institute of Nursing Research (NINR) and the NIH Office of Research on Women's Health (ORWH) (Grants U01NR004061; U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495). The Hip Strength Through the Menopausal Transition has grant support from the NIA (AG026463). Takahiro Mori was supported by the VA Special Fellowship Program in Advanced Geriatrics and the VA Greater Los Angeles Geriatric Research Education and Clinical Center. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIA, NINR, ORWH, VA or the NIH.	ALDERMAN BW, 1986, AM J EPIDEMIOL, V124, P262; Riis BJ, 1996, BONE, V19, P9, DOI 10.1016/8756-3282(96)00102-0; Greendale GA, 2012, J BONE MINER RES, V27, P111, DOI 10.1002/jbmr.534; Moller UK, 2012, OSTEOPOROSIS INT, V23, P1213, DOI 10.1007/s00198-011-1654-6; Mori T, 2014, OSTEOPOROSIS INT, V25, P265, DOI 10.1007/s00198-013-2429-z; FELSON DT, 1993, J BONE MINER RES, V8, P567; Kalkwarf HJ, 2002, ENDOCRINE, V17, P49, DOI 10.1385/ENDO:17:1:49; Leslie WD, 2009, OSTEOPOROSIS INT, V20, P1767, DOI 10.1007/s00198-009-0874-5; Nehring I, 2011, AM J CLIN NUTR, V94, P1225, DOI 10.3945/ajcn.111.015289; Faulkner KG, 2006, OSTEOPOROSIS INT, V17, P593, DOI 10.1007/s00198-005-0019-4; Karlamangla AS, 2004, OSTEOPOROSIS INT, V15, P62, DOI 10.1007/s00198-003-1513-1; Kojima N, 2002, MATURITAS, V41, P203, DOI 10.1016/S0378-5122(01)00296-1; Wiklund PK, 2012, OSTEOPOROSIS INT, V23, P1939, DOI 10.1007/s00198-011-1790-z; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Cauley JA, 2012, MENOPAUSE, V19, P1200, DOI 10.1097/gme.0b013e31825ae17e; Ishii S, 2012, J CLIN ENDOCR METAB, V97, P3593, DOI 10.1210/jc.2012-1997; Tomeo CA, 1999, EPIDEMIOLOGY, V10, P774, DOI 10.1097/00001648-199911000-00022; FAULKNER KG, 1993, J BONE MINER RES, V8, P1211; Horton NJ, 2001, AM STAT, V55, P244, DOI 10.1198/000313001317098266; Karlsson MK, 2005, BJOG-INT J OBSTET GY, V112, P851, DOI 10.1111/j.1471-0528.2005.00571.x; Dursun N, 2006, OSTEOPOROSIS INT, V17, P651, DOI 10.1007/s00198-005-0029-2; Mackey DC, 2007, JAMA-J AM MED ASSOC, V298, P2381, DOI 10.1001/jama.298.20.2381; Gunderson EP, 2009, OBSTET GYN CLIN N AM, V36, P317, DOI 10.1016/j.ogc.2009.04.001; Bjornerem A, 2011, J BONE MINER RES, V26, P2843, DOI 10.1002/jbmr.496; Alonso CG, 2000, OSTEOPOROSIS INT, V11, P714; Beck TJ, 2009, J BONE MINER RES, V24, P1369, DOI [10.1359/jbmr.090307, 10.1359/JBMR.090307]; Ishii S, 2012, OSTEOPOROSIS INT, V23, P1381, DOI 10.1007/s00198-011-1723-x; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Li RW, 2005, NUTR REV, V63, P103, DOI 10.1301/nr.2005.apr.103-110; Ishii S, 2012, J CLIN ENDOCR METAB, V97, P190, DOI 10.1210/jc.2011-1883; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Chung M, 2007, EVID TECHNOL ASSES F, V153, P1; Dufour AB, 2012, OSTEOPOROSIS INT, V23, P513, DOI 10.1007/s00198-011-1569-2; Finkelstein JS, 2008, J CLIN ENDOCR METAB, V93, P861, DOI 10.1210/jc.2007-1876; HOFFMAN S, 1993, OSTEOPOROSIS INT, V3, P171, DOI 10.1007/BF01623672; Haitian DF, 1991, APPL STAT, P13; Ishii S, 2014, J BONE MINER RES, V29, P2561, DOI 10.1002/jbmr.2303; JOHNELL O, 1995, J BONE MINER RES, V10, P1802; KENT GN, 1990, J BONE MINER RES, V5, P361; Laskey MA, 2011, BONE, V48, P755, DOI 10.1016/j.bone.2010.11.016; LISSNER L, 1991, CALCIFIED TISSUE INT, V48, P319, DOI 10.1007/BF02556151; Marshall D, 1996, BRIT MED J, V312, P1254; ONeill TW, 1997, OSTEOPOROSIS INT, V7, P72, DOI 10.1007/BF01623464; SEELEY DG, 1991, ANN INTERN MED, V115, P837; Sowers MR, 2000, MENOPAUSE BIOL PATHO, P175, DOI 10.1016/B978-012453790-3/50012-3; Specker B, 2005, OSTEOPOROSIS INT, V16, P1969, DOI 10.1007/s00198-005-1978-1; Tsvetov G, 2014, MATURITAS, V77, P249, DOI 10.1016/j.maturitas.2013.11.003	47	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	APR	2015	73						160	166		10.1016/j.bone.2014.12.013		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CC7FJ	WOS:000350532800020		
J	Ikeda, T; Kuraguchi, J; Kogashiwa, Y; Yokoi, H; Satomi, T; Kohno, N				Ikeda, Tetsuya; Kuraguchi, Jun; Kogashiwa, Yasunao; Yokoi, Hidenori; Satomi, Takafumi; Kohno, Naoyuki			Successful treatment of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) patients with sitafloxacin: New strategies for the treatment of BRONJ	BONE			English	Article						Bisphosphonates; Osteonecrosis of the jaw; Sitafloxacin; Surgical treatment; Sequestrectomy	SURGEONS POSITION PAPER; RISK-FACTORS; AMERICAN ASSOCIATION; AVASCULAR NECROSIS; CANCER-PATIENTS; UPDATE; IDENTIFICATION; PAMIDRONATE; MANAGEMENT; VARIANT	BRONJ has become a well-known, occasionally severe side effect of bisphosphonate therapy, as well as a clinical problem. Although treatment recommendations exist, no standard therapy has yet been established for BRONJ. Also, these recommendations identify several limitations that prevent clinicians from confidently diagnosing BRONJ. The aim of the present study was to establish a treatment approach in which all patients with exposed, infected bone or intraoral/extraoral fistulas were treated with sitafloxacin (STFX). We examined 20 BRONJ patients, fourteen with cancer and six with osteoporosis. We used the current updated definition of BRONJ (12), except that we included patients who had shown symptoms for a minimum of only one month, rather than two months. Thus half of our patients had infection with no exposed, necrotic bone in the oral cavity. We purposely excluded all patients exhibiting no signs of infection (current Stages 0 and 1). In addition, each potentially causative organism was isolated from pus collected from an intraoral or extraoral fistula in ten patients on their first visit to our department. 90% of the patients had received a course of treatment with common antibiotics. STFX was administered to all patients. We then re-evaluated the lesion every other week, to determine whether epithelialization was present. We recommended surgical treatment for cases without epithelialization within 4 weeks after the onset of administration of STFX even if bone was not exposed at the lesion. 19 of our 20 cases of Stages 2-3 BRONJ responded to 2-10 weeks of STFX treatment by entering either a remission or healed phase. While surgery was done on thirteen cases, seven others reached such phases without surgery. Every patient had at least one bacterial species that showed resistance to common antibiotics. All species in all patients were susceptible to STFX. Our results indicate that STFX, with or without minor surgery, gives a high probability of controlling infection in BRONJ patients with persistent infection after use of common antibiotics, leading to remission and/or complete healing in 95% of patients. (C) 2014 The Authors. Published by Elsevier Inc.	[Ikeda, Tetsuya; Kuraguchi, Jun; Kogashiwa, Yasunao; Yokoi, Hidenori; Satomi, Takafumi; Kohno, Naoyuki] Kyorin Univ, Sch Med, Dept Otorhinolaryngol, Oral Surg, Tokyo, Japan	Ikeda, T (reprint author), Shinkawa 6-20-2, Mitaka, Tokyo, Japan.	t-ikeda@ks.kyorin-u.ac.jp					Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws. American Association of Oral and Maxillofacial Surgeons, 2007, J ORAL MAXILLOFAC SU, V65, P369, DOI DOI 10.1016/J.JOMS.2006.11.003; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Lazarovici TS, 2009, J ORAL MAXIL SURG, V67, P850, DOI 10.1016/j.joms.2008.11.015; Migliorati CA, 2005, J AM DENT ASSOC, V136, P1658; Major P, 2001, J CLIN ONCOL, V19, P558; Tarassoff P, 2003, J ORAL MAXIL SURG, V61, P1238, DOI 10.1053/S0278-2391(03)00883-8; Yoneda T, 2010, J BONE MINER METAB, V28, P365, DOI 10.1007/s00774-010-0162-7; Junquera L, 2008, J ORAL MAXIL SURG, V66, P1516, DOI 10.1016/j.joms.2008.02.012; Saia G, 2010, J ORAL MAXIL SURG, V68, P797, DOI 10.1016/j.joms.2009.10.026; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Van den Wyngaert T, 2009, ANN ONCOL, V20, P331, DOI 10.1093/annonc/mdn630; Mawardi H, 2009, J ORAL MAXIL SURG, V67, P593, DOI 10.1016/j.joms.2008.09.031; Ruggiero SL, 2009, J ORAL MAXIL SURG, V67, P2, DOI 10.1016/j.joms.2009.01.009; Fedele S, 2010, AM J MED, V123, P1060, DOI 10.1016/j.amjmed.2010.04.033; Diel IJ, 2007, CRIT REV ONCOL HEMAT, V64, P198, DOI 10.1016/j.critrevonc.2007.07.005; Wang EP, 2007, J ORAL MAXIL SURG, V65, P1328, DOI 10.1016/j.joms.2007.03.006; Yarom N, 2007, OSTEOPOROSIS INT, V18, P1363, DOI 10.1007/s00198-007-0384-2; Durie BGM, 2005, NEW ENGL J MED, V353, P99; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Bamias A, 2005, J CLIN ONCOL, V23, P8580, DOI 10.1200/JCO.2005.02.8670; Ruggiero SL, 2006, ORAL SURG ORAL MED O, V102, P433, DOI 10.1016/j.tripleo.2006.06.004; Reid IR, 2007, BONE, V41, P318, DOI 10.1016/j.bone.2007.04.196; APPELBAUM PC, 1984, J CLIN MICROBIOL, V19, P588; Cheng A, 2005, AUST DENT J, V50, pS4, DOI 10.1111/j.1834-7819.2005.tb00384.x; Clinical and Laboratory Standards Institute, 2007, M11A7 CLSI; Clinical and Laboratory Standards Institute, 2009, M7A CLSI; Herrod NW, 2006, J AM DENT ASSOC, V137, P441; Kalmar JR, 2012, ORAL DIS, V18, P724, DOI 10.1111/j.1601-0825.2012.01936.x; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Ruggiero Salvatore, 2006, J Oncol Pract, V2, P7, DOI 10.1200/JOP.2.1.7; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Ruggiero SL, 2009, AUST ENDOD J, V35, P119, DOI 10.1111/j.1747-4477.2009.00213.x; SCHRECKENBERGER PC, 1988, J CLIN MICROBIOL, V26, P225	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	APR	2015	73						217	222		10.1016/j.bone.2014.12.021		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CC7FJ	WOS:000350532800027		
J	Aoyama, E; Kubota, S; Khattab, HM; Nishida, T; Takigawa, M				Aoyama, Eriko; Kubota, Satoshi; Khattab, Hany Mohamed; Nishida, Takashi; Takigawa, Masaharu			CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG	BONE			English	Article						CCN2 family protein 2 (CCN2); Osteoclast; Receptor activator of nuclear factor-kappa B ligand (RANK); RANK ligand (RANKL); Osteoprotegerin (OPG)	TISSUE-GROWTH-FACTOR; NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; RECEPTOR ACTIVATOR; OSTEOPROTEGERIN LIGAND; FACTOR CTGF/CCN2; FACTOR CTGF; C-FOS; CHONDROCYTES; EXPRESSION	CCN family protein 2/connective tissue growth factor (CCN2/CTGF) is a multi-potent factor for mesenchymal cells such as chondrocytes, osteoblasts, osteoclasts, and endothelial cells. CCN2 is also known as a modulator of other cytokines and receptors via direct molecular interactions with them. We screened additional factors binding to CCN2 and found receptor activator of NF-kappa B (RANK) as one of them. RANK is also known as TNF-related activation-induced cytokine (TRANCE) receptor, and its signaling plays a critical role in osteoclastogenesis. Notable affinity between CCN2 and RANK was confirmed by using surface plasmon resonance (SPR) analysis. In fact, CCN2 enhanced the RANK-mediated signaling, such as occurs in NF-kappa B, p38 and JNK pathways, in pre-osteoclastic RAW264.7 cells; whereas CCN2 had no influence on RANK RANK ligand (RANKL) binding. Moreover, CCN2 also significantly bound to osteoprotegerin (OPG), which is a decoy receptor of RANKL. Of note, OPG markedly inhibited the binding between CCN2 and RANK; and CCN2 canceled the inhibitory effect of OPG on osteoclast differentiation. These findings suggest CCN2 as a candidate of the fourth factor in the RANK/RANKL/OPG system for osteodastogenesis, which regulates OPG and RANK via direct interaction. (C) 2014 Elsevier Inc. All rights reserved.	[Aoyama, Eriko; Kubota, Satoshi; Khattab, Hany Mohamed; Takigawa, Masaharu] Okayama Univ, Sch Dent, Adv Res Ctr Oral & Craniofacial Sci, Okayama 7008525, Japan; [Kubota, Satoshi; Nishida, Takashi; Takigawa, Masaharu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Okayama 7008525, Japan	Takigawa, M (reprint author), Okayama Univ, Sch Dent, Adv Res Ctr Oral & Craniofacial Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008525, Japan.	takigawa@md.okayama-u.ac.jp			JSPS KAKENHI [25861755, 19109008, 24390415, 26462810, 25462886, 266708]	We thank Dr. Takako Hattori and Dr. Harumi Kawald for their helpful suggestions and Ms. Eni Yashiro and Yoshiko Miyake for their secretarial assistance. This study was supported in part by the programs JSPS KAKENHI Grants-in-aid for Young Scientists (B), No. 25861755 (to EA) and JSPS KAKENHI Grants-in-aid for Scientific Research (S), No. 19109008 (to MT) and (B), No. 24390415 (to MT) and (C), No. 26462810 (to TN), and (C), No. 25462886 (to SK), and by JSPS KAKENHI Challenging Exploratory Research, No. 266708 (to MT).	Abd El Kader Tarek, 2014, Bone, V59, P180, DOI 10.1016/j.bone.2013.11.010; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Liu CZ, 2010, J IMMUNOL, V184, P6910, DOI 10.4049/jimmunol.0904033; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Aoyama E, 2012, FEBS LETT, V586, P4270, DOI 10.1016/j.febslet.2012.10.038; Zhang SQ, 2009, ARCH BIOCHEM BIOPHYS, V487, P49, DOI 10.1016/j.abb.2009.04.008; Kawata K, 2012, J CELL SCI, V125, P2965, DOI 10.1242/jcs.101956; Wahab NA, 2005, J AM SOC NEPHROL, V16, P340, DOI 10.1681/ASN.2003100905; Xing LP, 2002, J BONE MINER RES, V17, P1200, DOI 10.1359/jbmr.2002.17.7.1200; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Nishida T, 2011, ENDOCRINOLOGY, V152, P4232, DOI 10.1210/en.2011-0234; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Wagner EF, 2003, ANN RHEUM DIS, V62, P83; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; Kubota S, 2007, INT REV CYTOL, V257, P1, DOI 10.1016/S0074-7696(07)57001-4; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Takigawa M, 2013, J CELL COMMUN SIGNAL, V7, P191, DOI 10.1007/s12079-013-0204-8; Aoyama E, 2009, BIOCHEM J, V420, P413, DOI 10.1042/BJ20081991; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Ball DK, 2003, J ENDOCRINOL, V176, pR1, DOI 10.1677/joe.0.176R001; Hakozaki A, 2010, J IMMUNOL, V184, P2442, DOI 10.4049/jimmunol.0901188; Hoshijima M, 2012, FEBS J, V279, P3584, DOI 10.1111/j.1742-4658.2012.08717.x; Kanazawa K, 2005, J BONE MINER RES, V20, P2053, DOI 10.1359/JBMR.050706; Kawaki H, 2010, BIOCHIMIE, V92, P1010, DOI 10.1016/j.biochi.2010.04.021; Kawasaki M, 2011, LUPUS, V20, P1231, DOI 10.1177/0961203311409963; Naidu VGM, 2013, CHEM-BIOL INTERACT, V203, P467, DOI 10.1016/j.cbi.2012.12.016; Nishida T, 2011, J BONE MINER RES, V26, P351, DOI 10.1002/jbmr.222; Nozawa K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2863; Perbal B, 2005, CCN PROTEINS: A NEW FAMILY OF CELL GROWTH AND DIFFERENTIATION REGULATORS, P1, DOI 10.1142/9781860946899_0001; Shimo T, 2006, J BONE MINER RES, V21, P1045, DOI 10.1359/JBMR.060416; Shimo T, 2008, ANTICANCER RES, V28, P2343; Tomita N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059226; Velasco CR, 2011, GLYCOBIOLOGY, V21, P781, DOI 10.1093/glycob/cwr002; Vitovski S, 2007, J BIOL CHEM, V282, P31601; Wright H L, 2009, Curr Rev Musculoskelet Med, V2, P56, DOI 10.1007/s12178-009-9046-7	46	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	APR	2015	73						242	248		10.1016/j.bone.2014.12.058		7	Endocrinology & Metabolism	Endocrinology & Metabolism	CC7FJ	WOS:000350532800030		
J	Hu, GR				Hu, Guorong			MAXIMAL HARDY SPACES ASSOCIATED TO NONNEGATIVE SELF-ADJOINT OPERATORS	BULLETIN OF THE AUSTRALIAN MATHEMATICAL SOCIETY			English	Article						Hardy spaces; metric measure spaces; self-adjoint operators; Gaussian heat kernel bounds; maximal functions	REVERSE HOLDER INEQUALITY; DIRICHLET SPACES; HP-SPACES; BMO; VARIABLES	Let (X, d, mu) be a metric measure space satisfying the doubling, reverse doubling and noncollapsing conditions. Let L be a nonnegative self-adjoint operator on L-2(X, d mu) satisfying a pointwise Gaussian upper bound estimate and Holder continuity for its heat kernel. In this paper, we introduce the Hardy spaces H-L(p)(X), 0 < p <= 1, associated to L in terms of grand maximal functions and show that these spaces are equivalently characterised by radial and nontangential maximal functions.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan	Hu, GR (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.	hugr@ms.u-tokyo.ac.jp		Hu, Guorong/0000-0001-7362-148X	Program of Leading Graduate Schools, MEXT, Japan	This work is supported by the Program of Leading Graduate Schools, MEXT, Japan.	Dziubanski J, 1999, REV MAT IBEROAM, V15, P279; STEIN EM, 1960, ACTA MATH-DJURSHOLM, V103, P25, DOI 10.1007/BF02546524; Hofmann S, 2009, MATH ANN, V344, P37, DOI 10.1007/s00208-008-0295-3; Duong XT, 2005, J AM MATH SOC, V18, P943, DOI 10.1090/S0894-0347-05-00496-0; Dziubanski J, 2005, MATH Z, V249, P329, DOI 10.1007/s00209-004-0701-9; Duong XT, 2005, COMMUN PUR APPL MATH, V58, P1375, DOI 10.1002/cpa.20080; FEFFERMA.C, 1972, ACTA MATH-UPPSALA, V129, P137, DOI 10.1007/BF02392215; Auscher P, 2008, J GEOM ANAL, V18, P192, DOI 10.1007/s12220-007-9003-x; Auscher P., 2004, BOUNDEDNESS BA UNPUB; Coulhon T, 2012, J FOURIER ANAL APPL, V18, P995, DOI 10.1007/s00041-012-9232-7; Dekel S., ARXIV14090424; Dziubanski J, 2011, POTENTIAL ANAL, V35, P39, DOI 10.1007/s11118-010-9202-0; Folland G, 1982, HARDY SPACES HOMOGEN; Hofmann S., 2011, MEM AM MATH SOC, V214; Jiang RJ, 2011, REV MAT COMPLUT, V24, P251, DOI 10.1007/s13163-010-0041-8; Kerkyacharian G, 2015, T AM MATH SOC, V367, P121; Stein E., 1993, HARMONIC ANAL REAL V; Zienkiewicz J., 2002, BANACH CTR PUBL, V56, P45	18	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0004-9727	1755-1633		B AUST MATH SOC	Bull. Aust. Math. Soc.	APR	2015	91	2					286	302		10.1017/S0004972714001105		17	Mathematics	Mathematics	CC2XN	WOS:000350208500014		
J	Zhao, P; Wang, Y; Huang, ZL; Mao, YW; Takashi, G				Zhao, Pei; Wang, Ying; Huang, Zhi Liang; Mao, Yang Wu; Takashi, Goto			Influence of laser power on orientation, microstructure and electrical performance of YBa2Cu3O7-x film prepared on (001) SrTiO3 single crystal substrate by spray atomizing and coprecipitating laser chemical vapor deposition	CERAMICS INTERNATIONAL			English	Article						YBa2Cu3O7-x film; Laser chemical vapor deposition; SrTiO3 single crystal	COATED CONDUCTOR DEVELOPMENT; MULTIPLE-STAGE CVD; THIN-FILMS; MULTISTAGE CVD; TEMPERATURE; GROWTH; JAPAN	YBa2Cu3O7-x film was prepared on (001) SrTiO3 single crystal substrate by spray atomizing and coprecipitating laser chemical vapor deposition. At laser power of 101-116 W (corresponding deposition temperature was 893-942 K), a-axis-oriented YBa2Cu3O7-x film was prepared, which showed an epitaxial growth mode of YBa2Cu3O7-x [100]|| SrTiO3 [001] (YBa2Cu3O7-x [001]||SrTiO3 [100]). The a-axis-oriented YBa2Cu3O7-x film had critical temperature of 75-82 K, with critical current density from 0 to 0.4 MA cm(-2). At laser power of 167-181 W (corresponding deposition temperature was 1093-1154 K), c-axis-oriented YBa2Cu3O7-x film was obtained, whose epitaxial growth mode was YBa2Cu3O7-x [001]||SrTiO3 [001] (YBa2Cu3O7-x [100]||SrTiO3 [100]). A c-axis-oriented YBa2Cu3O7-x film prepared at a deposition rate of 14 mu m h(-1) showed a high critical temperature of 91 K and critical current density of 2.8 MA cm(-2). (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Zhao, Pei; Wang, Ying; Huang, Zhi Liang; Mao, Yang Wu] Wuhan Inst Technol, Sch Mat Sci & Engn, Wuhan 430074, Peoples R China; [Takashi, Goto] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Zhao, P (reprint author), Wuhan Inst Technol, Sch Mat Sci & Engn, Wuhan 430074, Peoples R China.	zhaopei410@163.com			National Natural Science Foundation of China [51302199, 51374155]	This work was supported by the National Natural Science Foundation of China (Grant nos. 51302199 and 51374155).	Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Weijers HW, 2010, IEEE T APPL SUPERCON, V20, P576, DOI 10.1109/TASC.2010.2043080; Shiohara Y, 2013, PHYSICA C, V484, P1, DOI 10.1016/j.physc.2012.03.058; CHAR K, 1987, APPL PHYS LETT, V51, P1370, DOI 10.1063/1.98682; HE YL, 1990, J APPL PHYS, V67, P7460, DOI 10.1063/1.345831; Izumi T, 2009, PHYSICA C, V469, P1322, DOI 10.1016/j.physc.2009.05.021; Kashima N, 2005, IEEE T APPL SUPERCON, V15, P2763, DOI 10.1109/TASC.2005.847773; Kashima N, 2004, PHYSICA C, V412, P944, DOI 10.1016/j.physc.2004.01.111; Kashima N, 2007, PHYSICA C, V463, P488, DOI 10.1016/j.physc.2007.01.038; KWO J, 1987, PHYS REV B, V36, P4039, DOI 10.1103/PhysRevB.36.4039; Ma YW, 2000, JPN J APPL PHYS 2, V39, pL726, DOI 10.1143/JJAP.39.L726; Ma YW, 2001, JPN J APPL PHYS 1, V40, P6339, DOI 10.1143/JJAP.40.6339; RAMESH R, 1990, APPL PHYS LETT, V57, P1064, DOI 10.1063/1.104282; Shiohara Y, 2007, IEEE T APPL SUPERCON, V17, P3227, DOI 10.1109/TASC.2007.899376; SIMON RW, 1988, APPL PHYS LETT, V53, P2677, DOI 10.1063/1.100543; Stadel O, 2009, IEEE T APPL SUPERCON, V19, P3160, DOI 10.1109/TASC.2009.2018736; Teranishi R, 2006, SUPERCOND SCI TECH, V19, pS4, DOI 10.1088/0953-2048/19/3/002; Watanabe T, 2007, IEEE T APPL SUPERCON, V17, P3386, DOI 10.1109/TASC.2007.899370; ZHAO J, 1991, APPL PHYS LETT, V59, P1254, DOI 10.1063/1.105468; Zhao J., 1990, APPL PHYS LETT, V58, P89; Zhao P, 2011, APPL SURF SCI, V257, P4317, DOI 10.1016/j.apsusc.2010.12.047; Zhao P, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/12/125010; Zulkifli Z, 2008, PHYSICA C, V468, P1518, DOI 10.1016/j.physc.2008.05.227	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	APR	2015	41	3	A				3624	3630		10.1016/j.ceramint.2014.11.027		7	Materials Science, Ceramics	Materials Science	CC2QE	WOS:000350188900038		
J	Itoh, T; Uchida, T; Matsubara, I; Izu, N; Shin, W; Miyazaki, H; Tanjo, H; Kanda, K				Itoh, Toshio; Uchida, Toshio; Matsubara, Ichiro; Izu, Noriya; Shin, Woosuck; Miyazaki, Hiroshi; Tanjo, Hiromasa; Kanda, Keisen			Preparation of gamma-alumina large grain particles with large specific surface area via polyol synthesis	CERAMICS INTERNATIONAL			English	Article						Polyol synthesis; Gamma-alumina; Poly(vinylpyrrolidone) (PVP); Secondary particle size; Specific surface area	CATALYTIC-ACTIVITY; GEL; PRECIPITATION; GAMMA-AL2O3; MORPHOLOGY; PT/GAMMA-AL2O3; REDUCTION; POWDER	We developed the polyol synthesis of gamma-alumina particles that allows for control of their particle size from the nanometer level to the micrometer level. The developed polyol synthesis utilized a reflux reaction of ethylene glycol solution with aluminum nitrate hexahydrate and poly(vinylpyrrolidone) (PVP). Two important process parameters - the molecular weight of PVP and refiuxing temperature - were investigated to control the size of the alumina particles. Further, two growth models for amorphous alumina particles in polyol synthesis were suggested. gamma-Alumina with secondary particle size ranging from 142 nm to 1.0 mu m with a specific surface area ranging from 81 to 32 m(2)/g was obtained. The a-alumina prepared by high-temperature annealing of over 1200 degrees C had secondary particle sizes ranging from 246 to 330 nm, but with specific surface areas of only 5.4-11 m(2)/g. Therefore, it is proved that the polyol synthesis is able to control secondary particle size of gamma-alumina upon maintaining a large specific surface area. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Itoh, Toshio; Uchida, Toshio; Matsubara, Ichiro; Izu, Noriya; Shin, Woosuck] Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan; [Miyazaki, Hiroshi; Tanjo, Hiromasa; Kanda, Keisen] New Cosmos Elect Co Ltd, Yodogawa Ku, Osaka 5320036, Japan	Itoh, T (reprint author), Natl Inst Adv Ind Sci & Technol, Moriyama Ku, Nagoya, Aichi 4638560, Japan.	itoh-toshio@aist.go.jp	Izu, Noriya/C-5674-2014	Izu, Noriya/0000-0001-5063-1415			Abello MC, 2001, APPL CATAL A-GEN, V207, P421, DOI 10.1016/S0926-860X(00)00680-3; Adraider Y, 2012, J EUR CERAM SOC, V32, P4229, DOI 10.1016/j.jeurceramsoc.2012.07.012; Izu N, 2008, B CHEM SOC JPN, V81, P761, DOI 10.1246/bcsj.81.761; Yu Y, 2013, J CATAL, V304, P135, DOI 10.1016/j.jcat.2013.04.009; Zamorategui A, 2012, J CERAM SOC JPN, V120, P290, DOI 10.2109/jcersj2.120.290; Vaarkamp M, 1996, J CATAL, V163, P294, DOI 10.1006/jcat.1996.0330; Skrabalak SE, 2008, NANO LETT, V8, P2077, DOI 10.1021/nl800910d; Macedo MIF, 2004, J SOL-GEL SCI TECHN, V30, P135, DOI 10.1023/B:JSST.0000039497.46154.8f; Parida KM, 2009, MATER CHEM PHYS, V113, P244, DOI 10.1016/j.matchemphys.2008.07.076; Miyazaki A, 2001, J CATAL, V204, P364, DOI 10.1006/jcat.2001.3418; Juszczyk W, 1998, APPL CATAL A-GEN, V166, P311, DOI 10.1016/S0926-860X(97)00265-2; Jiang D, 2008, J AM CERAM SOC, V91, P151, DOI 10.1111/j.1551-2916.2007.02086.x; Ordonez S, 2002, APPL CATAL B-ENVIRON, V38, P139, DOI 10.1016/S0926-3373(02)00036-X; Zhang ZR, 2002, J AM CHEM SOC, V124, P12294, DOI 10.1021/ja0208299; Yu Q, 2010, APPL CATAL B-ENVIRON, V96, P350, DOI 10.1016/j.apcatb.2010.02.032; Dhonge BP, 2010, SURF COAT TECH, V205, P1838, DOI 10.1016/j.surfcoat.2010.08.026; Bora B, 2012, CURR APPL PHYS, V12, P880, DOI 10.1016/j.cap.2011.12.001; El Kady FYA, 2011, TRANSIT METAL CHEM, V36, P237, DOI 10.1007/s11243-011-9461-7; Fu L, 2003, J AM CERAM SOC, V86, P1635; Gomaa MM, 2009, MATER CHEM PHYS, V113, P790, DOI 10.1016/j.matchemphys.2008.08.058; HALL WH, 1949, P PHYS SOC LOND A, V62, P741, DOI 10.1088/0370-1298/62/11/110; Jin XH, 2010, J AM CERAM SOC, V93, P1232, DOI 10.1111/j.1551-2916.2009.03544.x; Martin JC, 2009, CHEM ENG J, V150, P8, DOI 10.1016/j.cej.2008.11.050; Matsouka V, 2008, APPL CATAL B-ENVIRON, V84, P715, DOI 10.1016/j.apcatb.2008.06.004; Oh JH, 2009, CATAL LETT, V130, P403, DOI 10.1007/s10562-009-0021-0; Pai RV, 2012, J SOL-GEL SCI TECHN, V61, P192, DOI 10.1007/s10971-011-2613-6; Shojaie-Bahaabad M, 2008, MATER LETT, V62, P3364, DOI 10.1016/j.matlet.2008.03.012; Villanueva R, 2011, J AM CERAM SOC, V94, P237, DOI 10.1111/j.1551-2916.2010.04021.x; Wang JA, 1999, J PHYS CHEM B, V103, P299, DOI 10.1021/jp983130r; Wang SY, 2008, MATER LETT, V62, P3552, DOI 10.1016/j.matlet.2008.03.048; Witharana S, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0851-3	31	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	APR	2015	41	3	A				3631	3638		10.1016/j.ceramint.2014.11.028		8	Materials Science, Ceramics	Materials Science	CC2QE	WOS:000350188900039		
J	Beck, M; Hattori, K; Kaschta, J; Kakimoto, K; Roosen, A				Beck, M.; Hattori, K.; Kaschta, J.; Kakimoto, K.; Roosen, A.			Lamination and sintering behavior of tape cast, transparent Mg-Al-spinel ceramics	CERAMICS INTERNATIONAL			English	Article						Tape casting; Spinel; Laminated ceramics; Translucent ceramics	STRUCTURAL APPLICATIONS; MGAL2O4 SPINEL; CONSEQUENCES; TRANSMISSION; FABRICATION; PHYSICS; SPS	High purity Mg-Al-spinel powders were processed to form slurries for tape casting. The dried green tapes were cut and laminated via thermo-compression under uniaxial and isostatic pressure conditions. Finally the laminates were sintered pressurelessly in air. The influence of the transformation temperature of the green tape's binder plasticizer system and of lamination parameters on density and microstructure of the sintered laminates was analyzed. UV-VIS transmission spectroscopy was performed to measure the transparency of the fired laminates. The interrelation between the lamination parameters, sintering behavior and properties of the sintered product is discussed. Isostatic thermal lamination resulted in higher sintered densities than uniaxial lamination. For both techniques an increase in lamination pressure or temperature led to higher relative densities after sintering. The laminates exhibited total forward transmission values of up to 67% at a wavelength of 700 nm. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.	[Beck, M.; Roosen, A.] Univ Erlangen Nurnberg, Dept Mat Sci Glass & Ceram, D-91054 Erlangen, Germany; [Kaschta, J.] Univ Erlangen Nurnberg, Dept Mat Sci, D-91054 Erlangen, Germany; [Hattori, K.; Kakimoto, K.] Nagoya Inst Technol, Inst Ceram Res & Educ, Nagoya, Aichi, Japan	Beck, M (reprint author), Univ Erlangen Nurnberg, Dept Mat Sci Glass & Ceram, D-91054 Erlangen, Germany.	Michael.Beck@ww.uni-erlangen.de					Krell A, 2009, OPT MATER, V31, P1144, DOI 10.1016/j.optmat.2008.12.009; Kupp ER, 2010, J MATER RES, V25, P476, DOI 10.1557/JMR.2010.0069; Morita K, 2008, SCRIPTA MATER, V58, P1114, DOI 10.1016/j.scriptamat.2008.02.008; Piwonski MA, 1999, J EUR CERAM SOC, V19, P263, DOI 10.1016/S0955-2219(98)00196-4; Lee SH, 2009, J AM CERAM SOC, V92, P1456, DOI 10.1111/j.1551-2916.2009.03029.x; Ikesue A, 1996, J AM CERAM SOC, V79, P1927, DOI 10.1111/j.1151-2916.1996.tb08015.x; Krell A, 2009, J EUR CERAM SOC, V29, P275, DOI 10.1016/j.jeurceramsoc.2008.03.024; Krell A, 2009, J EUR CERAM SOC, V29, P207, DOI 10.1016/j.jeurceramsoc.2008.03.025; Krell A, 2010, J AM CERAM SOC, V93, P2656, DOI 10.1111/j.1551-2916.2010.03814.x; Morita K, 2010, SCRIPTA MATER, V63, P565, DOI 10.1016/j.scriptamat.2010.06.012; Wei GC, 2009, J EUR CERAM SOC, V29, P237, DOI 10.1016/j.jeurceramsoc.2008.03.018; Frage N, 2007, J MATER SCI, V42, P3273, DOI 10.1007/s10853-007-1672-0; Hellebrand H., 1996, PROCESSING CERAMIC 1, V17, P190; Krell A, 2007, CFI-CERAM FORUM INT, V84, pE50; Krell A, 2007, CFI-CERAM FORUM INT, V84, pE41; Mouzon J, 2009, J EUR CERAM SOC, V29, P311, DOI 10.1016/j.jeurceramsoc.2008.03.022; Roosen A, 2012, CERAMICS SCIENCE AND TECHNOLOGY, P39; Schindler K, 2009, J EUR CERAM SOC, V29, P899, DOI 10.1016/j.jeurceramsoc.2008.07.041; Schwarzl F.R., 1990, POLYMERMECHANIK; Strassburger E, 2009, J EUR CERAM SOC, V29, P267, DOI 10.1016/j.jeurceramsoc.2008.03.049; Yamashita I, 2011, J CERAM SOC JPN, V119, P133, DOI 10.2109/jcersj2.119.133	21	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	APR	2015	41	3	A				3853	3859		10.1016/j.ceramint.2014.11.063		7	Materials Science, Ceramics	Materials Science	CC2QE	WOS:000350188900067		
J	Saito, T; Toriu, M				Saito, Takayuki; Toriu, Masahiko			Effects of a bubble and the surrounding liquid motions on the instantaneous mass transfer across the gas-liquid interface	CHEMICAL ENGINEERING JOURNAL			English	Article						Mass transfer; CO2 bubble; Zigzag motion; Bubble wake; Enhancement mechanism	CARBON-DIOXIDE BUBBLES; TRANSFER COEFFICIENT; DECAYING TURBULENCE; DISSOLUTION RATE; RISING BUBBLES; PHASE MOTION; LIFT SYSTEM; PURE WATER; RISE; DYNAMICS	To understand the mass transfer mechanism from a bubble to the surrounding liquid, one must consider the relation between the mass transfer, gravity-center and surface motions of the bubble. Bubbles in chemical and bio-reactors usually exhibit a zigzag motion. Simultaneously, such bubbles accompany periodic surface oscillation. Knowledge about the correlation between the mass-transfer mechanism and bubble motion is as yet incomplete. In this study, we used experimental results from highly precise measurements of bubble volume to clarify the instantaneous mass-transfer coefficients of a zigzagging CO2 bubble. We visualized the zigzagging motion and surface oscillation 3-dimensionally and simultaneously, using two high-speed cameras and mirrors. We also visualized the CO2 dissolution (mass transfer) process from the bubble to the surrounding liquid using the LIF/HPTS method. To obtain the precise instantaneous mass transfer coefficient and bubble motions, single bubbles were visualized in three sections: the linear-ascent, the first-inversion, and the second-inversion of the zigzag motion. The instantaneous mass-transfer coefficients in an interval of 6 ms in these sections were calculated from the bubble-volume shrinkage with ms time-resolution. The instantaneous mass-transfer coefficients increased in acceleration areas i.e., in the linear-ascent and second-inversion sections. Interestingly, in the latter, the gravity-center velocity of the bubble reached terminal velocity and was constant, but the velocity of the bubble hemisphere was accelerated due to the zigzag motion. This partial acceleration of the bubble hemisphere led to a high renewal rate of the liquid on the bubble interface. The effect of the partial acceleration on the instantaneous mass transfer was significant for bubbles categorized into zigzag motion. (C) 2014 Elsevier B.V. All rights reserved.	[Saito, Takayuki] Shizuoka Univ, Res Inst Green Sci & Technol, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan; [Toriu, Masahiko] Shizuoka Univ, Grad Sch Engn, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan	Saito, T (reprint author), Shizuoka Univ, Res Inst Green Sci & Technol, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.	ttsaito@ipc.shizuoka.ac.jp			Japan Society for the Promotion of Science (JSPS); JSPS	The present study was promoted and financially supported by Category "A" of Grants-in-Aid for Scientific Research, from the Japan Society for the Promotion of Science (JSPS). We thank the JSPS for its financial support.	Magnaudet J, 2000, ANNU REV FLUID MECH, V32, P659, DOI 10.1146/annurev.fluid.32.1.659; AKITA K, 1973, IND ENG CHEM PROC DD, V12, P76, DOI 10.1021/i260045a015; Ferreira A, 2012, CHEM ENG J, V180, P216, DOI 10.1016/j.cej.2011.09.117; BAIRD MHI, 1962, CHEM ENG SCI, V17, P87, DOI 10.1016/0009-2509(62)80020-7; Brucker C, 1999, PHYS FLUIDS, V11, P1781, DOI 10.1063/1.870043; Coppeta J, 1998, EXP FLUIDS, V25, P1, DOI 10.1007/s003480050202; de Vries AWG, 2002, INT J MULTIPHAS FLOW, V28, P1823, DOI 10.1016/S0301-9322(02)00036-8; DUINEVELD PC, 1995, J FLUID MECH, V292, P325, DOI 10.1017/S0022112095001546; Saito T, 2010, CHEM ENG J, V158, P39, DOI 10.1016/j.cej.2008.07.021; Tsuchiya K, 2001, CHEM ENG SCI, V56, P6411, DOI 10.1016/S0009-2509(01)00278-0; SAFFMAN PG, 1956, J FLUID MECH, V1, P249, DOI 10.1017/S0022112056000159; Takemura F, 1998, CHEM ENG SCI, V53, P2691, DOI 10.1016/S0009-2509(98)00094-3; Khinast JG, 2003, CHEM ENG SCI, V58, P3961, DOI 10.1016/S0009-2509(03)00311-7; MOORE DW, 1965, J FLUID MECH, V23, P749, DOI 10.1017/S0022112065001660; Someya S, 2005, INT J HEAT MASS TRAN, V48, P2508, DOI 10.1016/j.ijheatmasstransfer.2004.12.042; AKITA K, 1974, IND ENG CHEM PROC DD, V13, P84, DOI 10.1021/i260049a016; Terasaka K, 2004, J CHEM ENG JPN, V37, P921, DOI 10.1252/jcej.37.921; Saito T, 2000, ENVIRON SCI TECHNOL, V34, P4140, DOI 10.1021/es990155a; Petitti M, 2013, CHEM ENG J, V228, P1182, DOI 10.1016/j.cej.2013.05.047; Takemura F, 2000, CHEM ENG SCI, V55, P3907, DOI 10.1016/S0009-2509(00)00022-1; LEONARD JH, 1963, CHEM ENG SCI, V18, P133, DOI 10.1016/0009-2509(63)80022-6; MOTARJEMI M, 1978, CHEM ENG SCI, V33, P1415, DOI 10.1016/0009-2509(78)85190-2; Takemura F, 1999, J FLUID MECH, V378, P319, DOI 10.1017/S0022112098003358; Lunde K, 1998, APPL SCI RES, V58, P387; CALDERBANK PH, 1964, CHEM ENG SCI, V19, P485, DOI 10.1016/0009-2509(64)85075-2; Clift R, 1978, BUBBLES DROPS PARTIC; Fan L.S., 1990, BUTTERWORTH HEINEMAN; KOMORI S, 1993, J FLUID MECH, V249, P161, DOI 10.1017/S0022112093001120; Lunde K., 1997, ASME FLUIDS ENG DIV; Miyamoto Y., 2005, JPN SOC MECH ENG B, V71, P1307; Nagami Y, 2013, PARTICUOLOGY, V11, P158, DOI 10.1016/j.partic.2012.06.012; Nagami Y, 2014, FLOW TURBUL COMBUST, V92, P147, DOI 10.1007/s10494-013-9510-8; Saito T, 2001, ENERG FUEL, V15, P285, DOI 10.1021/ef0002501; Saito T, 2004, EXP THERM FLUID SCI, V28, P479, DOI 10.1016/j.expthermflusci.2003.07.005; Sanada T, 2007, CHEM ENG SCI, V62, P7264, DOI 10.1016/j.ces.2007.08.037; Shirota M, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2899836; The Intergovernmental Panel on Climate Change, 2007, IPCC REP, P282; Tsuchiya K, 2003, CAN J CHEM ENG, V81, P647	38	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1385-8947	1873-3212		CHEM ENG J	Chem. Eng. J.	APR 1	2015	265						164	175		10.1016/j.cej.2014.12.039		12	Engineering, Environmental; Engineering, Chemical	Engineering	CC2NY	WOS:000350183100019		
J	Awual, MR; Hasan, MM; Shahat, A; Naushad, M; Shiwaku, H; Yaita, T				Awual, Md. Rabiul; Hasan, Md. Munjur; Shahat, Ahmed; Naushad, Mu.; Shiwaku, Hideaki; Yaita, Tsuyoshi			Investigation of ligand immobilized nano-composite adsorbent for efficient cerium(III) detection and recovery	CHEMICAL ENGINEERING JOURNAL			English	Article						Nano-composite adsorbent; Ce(III) ions; Detection and recovery; Sensitivity and selectivity; High kinetics and sorption	CONJUGATE ADSORBENT; WASTE-WATER; MESOPOROUS ADSORBENT; COPPER(II) IONS; PALLADIUM(II) DETECTION; SELENIUM(IV) DETECTION; LANTHANIDE SORPTION; MEMBRANE SENSOR; CESIUM REMOVAL; LEAD(II) IONS	In this study, the organic ligand of 4-dodecyl-6-((4-(hexyloxy)phenyl)diazenyl) benzene-1,3-diol (DPDB) and mesoporous silica have been used to prepare the nano-composite adsorbent. The nano-composite adsorbent was fabricated by indirect immobilization of DPDB onto the mesoporous silica. The adsorbent was applied as an efficient material for the detection and recovery of Ce(III) ions in aqueous solutions. The adsorbent was exhibited fast and specific capturing of Ce(III) ions observable to the naked eye and based on the stable complex formation between DPDB and Ce(III) ions. Several experimental parameters such as solution pH, color optimization with initial concentrations, contact time, foreign ions effect and regeneration studies were systematically performed. The experimental data clarified that the Ce(III) was detected and adsorbed by the adsorbent at pH 2.50. The limit of detection for Ce(III) ions by the adsorbent was 0.12 lig/L and the sorption capacity was 150.37 mu g/g at optimum conditions. The co-existing ions did not affect the Ce(III) detection and sorption and sorption uptake on the adsorbent reached equilibrium with rapid kinetic performances. The adsorbed Ce(III) was completely eluted with 0.30 M HNO3 and the adsorbent was regenerated into the initial form at the same time. In addition, the adsorbent was reused for several cycles without significant deterioration in its original functionality. Therefore, the proposed adsorbent allowed the sensitive, selective, easy to use, cost-effective, high efficiency, fast kinetics and stable capturing of Ce(III) ions even in the presence of diverse competing ions. In addition, there was no more secondary sludge produced in this operation and considered the adsorbent as the potential candidate in better replacement technology for capturing Ce(III) ions in a wide range of practical operations. (C) 2014 Elsevier B.V. All rights reserved.	[Awual, Md. Rabiul; Shiwaku, Hideaki; Yaita, Tsuyoshi] Japan Atom Energy Agcy SPring 8, Quantum Beam Sci Ctr, Actinide Coordinat Chem Grp, Mikazuki, Hyogo 6795148, Japan; [Hasan, Md. Munjur] Shaheed Ziaur Rahman Med Coll, Bogra 5800, Bangladesh; [Shahat, Ahmed] Suez Univ, Dept Chem, Fac Sci, Suez, Egypt; [Naushad, Mu.] King Saud Univ, Dept Chem, Coll Sci, Riyadh 11451, Saudi Arabia	Awual, MR (reprint author), Japan Atom Energy Agcy SPring 8, Quantum Beam Sci Ctr, Actinide Coordinat Chem Grp, Mikazuki, Hyogo 6795148, Japan.	awual75@yahoo.com		Shahat ahmed, ahmed/0000-0001-9198-9712	Japan Society for the Promotion of Science [24860070]; King Saud University, Deanship of Scientific Research, College of Science Research Center	This research was partially supported by the Grant-in-Aid for Research Activity Start-up (24860070) from the Japan Society for the Promotion of Science. The authors also greatly acknowledge Christopher Paul Taylor for his selfless English language editing. The authors also wish to thank the anonymous reviewers and editor for their helpful suggestions and enlightening comments. Mu. Naushad acknowledges the King Saud University, Deanship of Scientific Research, College of Science Research Center for the support.	Akhond M, 2004, SENSOR ACTUAT B-CHEM, V99, P410, DOI 10.1016/j.snb.2003.12.008; Awual MR, 2013, CHEM ENG J, V221, P322, DOI 10.1016/j.cej.2013.02.016; Zamani HA, 2007, SENSOR ACTUAT B-CHEM, V120, P545, DOI 10.1016/j.snb.2006.03.013; Wang LS, 2013, CHEM ENG J, V215, P162, DOI 10.1016/j.cej.2012.09.126; Awual MR, 2014, SENSOR ACTUAT B-CHEM, V203, P854, DOI 10.1016/j.snb.2014.07.063; Amin AS, 1997, TALANTA, V44, P311, DOI 10.1016/S0039-9140(96)02011-5; Awual MR, 2015, CHEM ENG J, V259, P611, DOI 10.1016/j.cej.2014.08.028; Awual MR, 2013, CHEM ENG J, V222, P67, DOI 10.1016/j.cej.2013.02.042; Awual MR, 2014, J IND ENG CHEM, V20, P2332, DOI 10.1016/j.jiec.2013.10.009; Palmieri MC, 2002, HYDROMETALLURGY, V67, P31, DOI 10.1016/S0304-386X(02)00133-0; Mai HX, 2006, J AM CHEM SOC, V128, P6426, DOI 10.1021/ja060212h; Fryxell GE, 2004, J MATER CHEM, V14, P3356, DOI 10.1039/b408181a; Awual MR, 2013, CHEM ENG J, V225, P558, DOI 10.1016/j.cej.2013.04.015; Awual MR, 2014, J HAZARD MATER, V278, P227, DOI 10.1016/j.jhazmat.2014.06.011; Awual MR, 2014, SENSOR ACTUAT B-CHEM, V202, P395, DOI 10.1016/j.snb.2014.05.103; Awual MR, 2015, SENSOR ACTUAT B-CHEM, V209, P194, DOI 10.1016/j.snb.2014.11.010; Awual MR, 2013, J HAZARD MATER, V252, P313, DOI 10.1016/j.jhazmat.2013.03.020; Awual MR, 2013, CHEM ENG J, V228, P327, DOI 10.1016/j.cej.2013.05.010; Gupta VK, 2006, ANAL CHIM ACTA, V575, P198, DOI 10.1016/j.aca.2006.05.090; Afkhami A, 2012, SENSOR ACTUAT B-CHEM, V174, P237, DOI 10.1016/j.snb.2012.07.116; Awual MR, 2014, MICROPOR MESOPOR MAT, V196, P261, DOI 10.1016/j.micromeso.2014.05.021; Hubscher-Bruder V, 2010, INORG CHEM, V49, P1363, DOI 10.1021/ic9010899; Raju CSK, 2007, J HAZARD MATER, V145, P315, DOI 10.1016/j.jhazmat.2006.11.024; Awual MR, 2013, CHEM ENG J, V222, P172, DOI 10.1016/j.cej.2013.02.058; Awwad NS, 2010, COLLOID SURFACE B, V81, P593, DOI 10.1016/j.colsurfb.2010.08.002; Awual MR, 2014, SENSOR ACTUAT B-CHEM, V191, P9, DOI 10.1016/j.snb.2013.09.076; Awual MR, 2014, SENSOR ACTUAT B-CHEM, V203, P71, DOI 10.1016/j.snb.2014.06.088; Awual MR, 2014, MICROPOR MESOPOR MAT, V197, P331, DOI 10.1016/j.micromeso.2014.07.005; Awual MR, 2015, SENSOR ACTUAT B-CHEM, V206, P692, DOI 10.1016/j.snb.2014.09.086; Awual MR, 2014, CHEM ENG J, V236, P100, DOI 10.1016/j.cej.2013.09.083; Awual MR, 2014, CHEM ENG J, V242, P127, DOI 10.1016/j.cej.2013.12.072; Awual MR, 2013, SENSOR ACTUAT B-CHEM, V183, P332, DOI 10.1016/j.snb.2013.04.009; Awual MR, 2014, SENSOR ACTUAT B-CHEM, V196, P457, DOI 10.1016/j.snb.2014.02.055; El-Hefny NE, 2011, INT J MINER PROCESS, V101, P58, DOI 10.1016/j.minpro.2011.07.013; HAMAJIMA Y, 1985, J RADIOANAL NUCL CH, V89, P315, DOI 10.1007/BF02040595; Kusaka E, 1998, COLLOID SURFACE A, V139, P155, DOI 10.1016/S0927-7757(98)00249-0; Kusumocahyo SP, 2004, J MEMBRANE SCI, V244, P251, DOI 10.1016/j.memsci.2004.07.013; Li JM, 2010, J RARE EARTH, V28, P387, DOI 10.1016/S1002-0721(09)60117-4; Liao WP, 2002, TALANTA, V56, P613, DOI 10.1016/S0039-9140(01)00627-0; Oehme F.W., 1979, TOXICITY HEAVY METAL, P971; Rodriguez-Abreu C, 2009, MICROPOR MESOPOR MAT, V119, P338, DOI 10.1016/j.micromeso.2008.11.003; Saleh MB, 2006, SENSOR ACTUAT B-CHEM, V119, P275, DOI 10.1016/j.snb.2005.12.031; Singh AK, 2010, ANAL CHIM ACTA, V675, P170, DOI 10.1016/j.aca.2010.07.023	43	11	11	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1385-8947	1873-3212		CHEM ENG J	Chem. Eng. J.	APR 1	2015	265						210	218		10.1016/j.cej.2014.12.052		9	Engineering, Environmental; Engineering, Chemical	Engineering	CC2NY	WOS:000350183100024		
J	Hayashi, N; Naumkin, PI				Hayashi, Nakao; Naumkin, Pavel I.			Large Time Asymptotics for the Reduced Ostrovsky Equation	COMMUNICATIONS IN MATHEMATICAL PHYSICS			English	Article							SHORT-PULSE EQUATION; SCHRODINGER-EQUATIONS; GLOBAL EXISTENCE; GORDON EQUATIONS; WELL-POSEDNESS; WAVE BREAKING; SCATTERING; SPACE	We consider the Cauchy problem for the reduced Ostrovsky equation with real valued initial data . We introduce the factorization for the free evolution group to prove the global existence of solutions. Also, we show that the large time asymptotics of solutions has a logarithmic correction in the phase comparing with the corresponding linear case.	[Hayashi, Nakao] Osaka Univ, Grad Sch Sci, Dept Math, Tokyonaka, Osaka 5600043, Japan; [Naumkin, Pavel I.] UNAM Campus Morelia, Ctr Ciencias Matemat, Morelia 58089, Michoacan, Mexico	Hayashi, N (reprint author), Osaka Univ, Grad Sch Sci, Dept Math, Tokyonaka, Osaka 5600043, Japan.	nhayashi@math.sci.osaka-u.ac.jp; pavelni@matmor.unam.mx			JSPS KAKENHI [24654034, 25220702]; CONACYT; PAPIIT [IN100113]	We would like to thank an unknown referee for useful suggestions. The work of N.H. is supported by JSPS KAKENHI Grant Numbers 24654034, 25220702. The work of P.I.N. is partially supported by CONACYT and PAPIIT project IN100113.	Liu Y, 2010, SIAM J MATH ANAL, V42, P1967, DOI 10.1137/09075799X; Schafer T, 2004, PHYSICA D, V196, P90, DOI 10.1016/j.physd.2004.04.007; HAYASHI N, 1988, ANN I H POINCARE-PHY, V48, P17; KLAINERMAN S, 1985, COMMUN PUR APPL MATH, V38, P631, DOI 10.1002/cpa.3160380512; Hayashi N, 2008, Z ANGEW MATH PHYS, V59, P1002, DOI 10.1007/s00033-007-7008-8; Hayashi N, 1999, T AM MATH SOC, V351, P109, DOI 10.1090/S0002-9947-99-02285-0; Boyd JP, 2005, EUR J APPL MATH, V16, P65, DOI 10.1017/S0956792504005625; Delort J.M., 2001, ANN SCI ECOLE NORM S, V34, P1, DOI 10.1016/S0012-9593(00)01059-4; Hayashi N, 2014, J MATH PHYS, V55, DOI 10.1063/1.4874107; Hayashi N, 2013, J DIFFER EQUATIONS, V255, P2505, DOI 10.1016/j.jde.2013.07.001; Hayashi N., 1998, INT MATH RES NOTICES, V8, P395; HAYASHI N, 1993, COMMUN PART DIFF EQ, V18, P1109, DOI 10.1080/03605309308820965; Hunter J., 1990, LECT APPL MATH, V26, P301; Liu Y, 2009, DYNAM PART DIFFER EQ, V6, P291; Niizato T, 2014, NONLINEAR ANAL-THEOR, V111, P15, DOI 10.1016/j.na.2014.08.008; OSTROVSKY LA, 1978, OKEANOLOGIYA+, V18, P181; Pelinovsky D, 2010, COMMUN PART DIFF EQ, V35, P613, DOI 10.1080/03605300903509104; Stefanov A, 2010, J DIFFER EQUATIONS, V249, P2600, DOI 10.1016/j.jde.2010.05.015	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0010-3616	1432-0916		COMMUN MATH PHYS	Commun. Math. Phys.	APR	2015	335	2					713	738		10.1007/s00220-014-2222-7		26	Physics, Mathematical	Physics	CC5AE	WOS:000350367700006		
J	Takahashi, KZ				Takahashi, Kazuaki Z.			An improvement of truncation method by a novel reaction field: Accurate computation for estimating methanol liquid-vapor interfacial systems	COMPUTATIONAL MATERIALS SCIENCE			English	Article						Molecular dynamics simulation; Long-range interaction; Truncation method; Linear-combination-based isotropic periodic sum; Methanol; Liquid-vapor interface	MOLECULAR-DYNAMICS SIMULATIONS; ISOTROPIC PERIODIC SUM; RANGE ELECTROSTATIC INTERACTIONS; PARTICLE MESH EWALD; LENNARD-JONES FLUIDS; SIMPLE POINT-CHARGE; SOLVATED POLYPEPTIDES; BOUNDARY-CONDITIONS; COMPUTER-SIMULATIONS; LIPID-BILAYERS	Molecular dynamics (MD) simulations of the methanol liquid-vapor interfacial systems were carried out for assessing the accuracy of a novel reaction field and other conventional truncation methods. The results were compared with that of a Ewald sum. The novel reaction field achieved improved accuracy for estimating the surface thickness and electric potential profile. Furthermore, these two values were almost the same as the results from the Ewald sum. We conclude that the novel reaction field method provides an advanced accuracy in determining the liquid-vapor interfacial properties of polar molecules. (C) 2014 Elsevier B.V. All rights reserved.	Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Takahashi, KZ (reprint author), Keio Univ, Dept Mech Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	takahashi@mech.keio.ac.jp			Japan Society for the Promotion of Science (JSPS) [25820065]	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) Grant No. 25820065.	ALPER HE, 1989, J CHEM PHYS, V91, P1242, DOI 10.1063/1.457198; ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Wu XW, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3160730; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; SCHREIBER H, 1992, BIOCHEMISTRY-US, V31, P5856, DOI 10.1021/bi00140a022; Ojeda-May P, 2014, J CHEM THEORY COMPUT, V10, P134, DOI 10.1021/ct400724d; Takahashi K, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2775929; SMITH PE, 1994, J CHEM PHYS, V100, P3169, DOI 10.1063/1.466407; Lopez-Lemus J, 2002, MOL PHYS, V100, P2983, DOI 10.1080/00268970210121669; van der Spoel D, 1998, J CHEM PHYS, V108, P10220, DOI 10.1063/1.476482; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Takahashi KZ, 2013, ENTROPY-SWITZ, V15, P3249, DOI 10.3390/e15083339; Takahashi KZ, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3578473; Hunenberger PH, 1999, J CHEM PHYS, V110, P1856, DOI 10.1063/1.477873; Wu XW, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2992601; Venable RM, 2009, J PHYS CHEM B, V113, P5855, DOI 10.1021/jp900843x; SMIT B, 1992, J CHEM PHYS, V96, P8639, DOI 10.1063/1.462271; Norberg J, 2000, BIOPHYS J, V79, P1537; van der Spoel D, 2006, J CHEM THEORY COMPUT, V2, P1, DOI 10.1021/ct0502256; Yonetani Y, 2005, CHEM PHYS LETT, V406, P49, DOI 10.1016/j.cplett.2005.02.073; Takahashi KZ, 2012, J CHEM THEORY COMPUT, V8, P4503, DOI 10.1021/ct3003805; Feller SE, 1996, J PHYS CHEM-US, V100, P17011, DOI 10.1021/jp9614658; Trokhymchuk A, 1999, J CHEM PHYS, V111, P8510, DOI 10.1063/1.480192; NEUMANN M, 1980, MOL PHYS, V39, P437, DOI 10.1080/00268978000100361; NOSE S, 1984, J CHEM PHYS, V81, P511; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Mark P, 2002, J COMPUT CHEM, V23, P1211, DOI 10.1002/jcc.10117; Wu XW, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1836733; Matsumoto M, 2002, NATURE, V416, P409, DOI 10.1038/416409a; Cisneros GA, 2014, CHEM REV, V114, P779, DOI 10.1021/cr300461d; Klauda JB, 2007, J PHYS CHEM B, V111, P4393, DOI 10.1021/jp068767m; Patra M, 2003, BIOPHYS J, V84, P3636; Weber W, 2000, J PHYS CHEM B, V104, P3668, DOI 10.1021/jp9937757; SWOPE WC, 1982, J CHEM PHYS, V76, P637, DOI 10.1063/1.442716; Ojeda-May P, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4871871; Nakamura H, 2013, J CHEM THEORY COMPUT, V9, P1193, DOI 10.1021/ct300998z; Beck DAC, 2005, BIOCHEMISTRY-US, V44, P609, DOI 10.1021/bi0486381; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ewald P., 1921, ANN PHYS, V64, P253, DOI DOI 10.1002/ANDP.19213690304; GUENOT J, 1993, J COMPUT CHEM, V14, P295, DOI 10.1002/jcc.540140306; Hunenberger PH, 1999, BIOPHYS CHEM, V78, P69, DOI 10.1016/S0301-4622(99)00007-1; Kia A, 2008, J COMPUT PHYS, V227, P8551, DOI 10.1016/j.jcp.2008.06.016; KITCHEN DB, 1990, J COMPUT CHEM, V11, P1169, DOI 10.1002/jcc.540111009; LONCHARICH RJ, 1989, PROTEINS, V6, P32, DOI 10.1002/prot.340060104; Luty BA, 1996, J PHYS CHEM-US, V100, P2581, DOI 10.1021/jp9518623; Mazars M, 2011, PHYS REP, V500, P43, DOI 10.1016/j.physrep.2010.11.004; Monticelli L, 2006, J PHYS-CONDENS MAT, V18, pS329, DOI 10.1088/0953-8984/18/14/S15; Nozawa T., MOL SIMULATION UNPUB; Oda K, 1996, MOL SIMULAT, V16, P167, DOI 10.1080/08927029608024070; Ohto T., 2014, J PHYS CONDENS MATT, V26; Patra M, 2004, J PHYS CHEM B, V108, P4485, DOI 10.1021/jp031281a; Piana S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039918; Reif MM, 2009, J PHYS CHEM B, V113, P3112, DOI 10.1021/jp807421a; ROBERTS JE, 1995, J PHYS CHEM-US, V99, P1322, DOI 10.1021/j100004a037; ROBERTS JE, 1994, J CHEM PHYS, V101, P5024, DOI 10.1063/1.467425; SAITO M, 1994, J CHEM PHYS, V101, P4055, DOI 10.1063/1.468411; SAITO M, 1992, MOL SIMULAT, V8, P321, DOI 10.1080/08927029208022487; SCHREIBER H, 1992, J MOL BIOL, V228, P909, DOI 10.1016/0022-2836(92)90874-J; SCHREIBER H, 1992, CHEM PHYS, V168, P75, DOI 10.1016/0301-0104(92)80111-8; Takahashi K, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3462241; Takahashi K, 2012, MOL SIMULAT, V38, P397, DOI 10.1080/08927022.2010.547857; Takahashi K. Z., COMPUTAT MAT S UNPUB; Takahashi KZ, 2014, MOL SIMULAT, P1; Takahashi KZ, 2014, J COMPUT CHEM, V35, P865, DOI 10.1002/jcc.23562; TASAKI K, 1993, J COMPUT CHEM, V14, P278, DOI 10.1002/jcc.540140304; Walser R, 2000, J CHEM PHYS, V112, P10450, DOI 10.1063/1.481680; Yokota R, 2013, COMPUT PHYS COMMUN, V184, P445, DOI 10.1016/j.cpc.2012.09.011; Yonetani Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2198208	68	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0256	1879-0801		COMP MATER SCI	Comput. Mater. Sci.	APR 1	2015	100		B		SI		191	194		10.1016/j.commatsci.2014.11.019		4	Materials Science, Multidisciplinary	Materials Science	CC4ZQ	WOS:000350366000012		
J	Ono, S; Noguchi, Y; Sahara, R; Kawazoe, Y; Ohno, K				Ono, Shota; Noguchi, Yoshifumi; Sahara, Ryoji; Kawazoe, Yoshiyuki; Ohno, Kaoru			TOMBO: All-electron mixed-basis approach to condensed matter physics	COMPUTER PHYSICS COMMUNICATIONS			English	Article						Density functional theory; All-electron calculations; Mixed-basis method	TOTAL-ENERGY CALCULATIONS; ALKALI-METAL CLUSTERS; MOLECULAR-DYNAMICS; AB-INITIO; COPPER CLUSTERS; ATOMS; ACCELERATION; EQUATIONS; INSERTION; ACCURATE	TOMBO is a computer code for calculating the electronic structure of systems that consist both of core and valence electrons and nuclei, based on density-functional theory. It is based on an all-electron mixed-basis approach, in which the Kohn-Sham (KS) wave function is expressed by a linear combination of plane-waves and atomic-orbitals. This approach can describe both spatially localized and extended orbitals, which enables us to perform all-electron calculations with high accuracy from isolated clusters to periodic crystals. The present paper describes a theory of the all-electron mixed-basis approach, as well as input variables and benchmark tests in TOMBO. The algorithm for accelerating the computational time that is needed to solve the KS equation is also presented. (C) 2014 Elsevier B.V. All rights reserved.	[Ono, Shota; Ohno, Kaoru] Yokohama Natl Univ, Grad Sch Engn, Dept Phys, Yokohama, Kanagawa 2408501, Japan; [Noguchi, Yoshifumi] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Sahara, Ryoji] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Kawazoe, Yoshiyuki] Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Kawazoe, Yoshiyuki] Russian Acad Sci, Siberian Branch, Inst Thermophys, Novosibirsk 630090, Russia	Ono, S (reprint author), Yokohama Natl Univ, Grad Sch Engn, Dept Phys, Yokohama, Kanagawa 2408501, Japan.	shota-o@ynu.ac.jp; ohno@ynu.ac.jp			JSPS [25289218]; Russian Megagrant Project [14.B25.31.0030]	We thank Y. Maruyama, S. Ishii, T. Morisato, A. A. Farajian, K. Shiga, T. Sawada, Y. Kodama, R. Kuwahara, M. Nagaoka, Y. Tadokoro, M. Ikeoka, H. Adachi, M. Sluiter, and S. G. Louie for the helpful discussions and contributions to the earlier version of TOMBO. We also thank A. Hasegawa for providing us the Herman-Skillman code for the logarithmic radial mesh. This study was supported by a Grant-in-Aid for Scientific Research B (No. 25289218) from JSPS. One of the authors (Y.K.) thanks the Russian Megagrant Project No. 14.B25.31.0030 "New energy technologies and energy carriers" for supporting the present research.	Bae YC, 1999, MATER T JIM, V40, P1205; Bae YC, 2001, MATER TRANS, V42, P432, DOI 10.2320/matertrans.42.432; Kodama Y, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/6/064217; WIJERS CMJ, 1995, PHYS REV B, V52, P7767, DOI 10.1103/PhysRevB.52.7767; Sawada T, 2004, SCI TECHNOL ADV MAT, V5, P609, DOI 10.1016/j.stam.2004.02.020; Farajian AA, 1999, J CHEM PHYS, V111, P2164, DOI 10.1063/1.479487; Ohtsuki T, 1998, PHYS REV LETT, V81, P967, DOI 10.1103/PhysRevLett.81.967; Bahramy MS, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045111; PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244; Ishii S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.155104; PAYNE MC, 1988, PHYS REV B, V37, P8138, DOI 10.1103/PhysRevB.37.8138; Sawada T, 2005, CHEM PHYS LETT, V405, P234, DOI 10.1016/j.cplett.2005.02.027; Shiga K, 1999, J MATER RES, V14, P980, DOI 10.1557/JMR.1999.0130; Noguchi Y, 2005, MATER TRANS, V46, P1103, DOI 10.2320/matertrans.46.1103; Kodama Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2227024; Ohno K, 2004, SCI TECHNOL ADV MAT, V5, P603, DOI 10.1016/j.stam.2004.02.018; CAR R, 1985, PHYS REV LETT, V55, P2471, DOI 10.1103/PhysRevLett.55.2471; PAYNE MC, 1992, REV MOD PHYS, V64, P1045, DOI 10.1103/RevModPhys.64.1045; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Marini A, 2002, PHYS REV LETT, V88, DOI 10.1103/PHysRevLett.88.016403; Noguchi Y, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2970927; TETER MP, 1989, PHYS REV B, V40, P12255, DOI 10.1103/PhysRevB.40.12255; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; Noguchi Y, 2004, SCI TECHNOL ADV MAT, V5, P663, DOI 10.1016/j.stam.2004.03.013; LOUIE SG, 1979, PHYS REV B, V19, P1774, DOI 10.1103/PhysRevB.19.1774; Ishii S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.195412; Sklyadneva IY, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.094302; Bae YC, 2002, MATER TRANS, V43, P482, DOI 10.2320/matertrans.43.482; Noguchi Y, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2069907; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Schwarz K, 2003, COMP MATER SCI, V28, P259, DOI 10.1016/S0927-0256(03)00112-5; Kodama Y, 2007, J PHYS-CONDENS MAT, V19, DOI [10.1088/0953-8984/19/36/365242, 10.1080/0953-8984/19/36/365242]; Hartwigsen C, 1998, PHYS REV B, V58, P3641, DOI 10.1103/PhysRevB.58.3641; Kikuchi E, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195410; Lamago D, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.144307; Ishii S, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.245109; PULAY P, 1980, CHEM PHYS LETT, V73, P393, DOI 10.1016/0009-2614(80)80396-4; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; LIU B, 1973, J CHEM PHYS, V59, P4557, DOI 10.1063/1.1680654; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Sawamura A, 1999, MATER T JIM, V40, P1186; HO KM, 1983, PHYS REV B, V28, P6687, DOI 10.1103/PhysRevB.28.6687; Sahara R, 2013, RSC ADV, V3, P12307, DOI 10.1039/c3ra40928g; Behrmann M., 2010, PHYS REV B, V86; De la Pena-Seaman O, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.014301; Harrison W. A., 1980, SOLID STATE THEORY; Herman F., 1963, ATOMIC STRUCTURE CAL; HO KM, 1992, J PHYS-CONDENS MAT, V4, P5189, DOI 10.1088/0953-8984/4/22/017; Ishii S, 2010, MATER TRANS, V51, P2150, DOI 10.2320/matertrans.M2010303; Kikuchi E, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075325; Kodama Y, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3291558; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Martin R. M., 2004, ELECT STRUCTURE BASI; MEYER B, FORTRAN90 PROGRAM MI; Noguchi Y, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4890730; Noguchi Y, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.045201; Noguchi Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2348879; Noguchi Y, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165411; Noguchi Y, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035132; Noguchi Y, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4732123; Ohno K, 2006, COMP MATER SCI, V36, P125, DOI 10.1016/j.commatsci.2005.01.017; Ohno K., 1999, SUPERCOMPUTING SYSTE, V4, P1; Ohno K, 2006, CHEMPHYSCHEM, V7, P1820, DOI 10.1002/cphc.200600144; Ohno K., 2006, J PHYS C SER, V29, P39, DOI 10.1088/1742-6596/29/1/006; Ohno K., 1999, SPRINGER SERIES SOLI, V129; Ohno K, 1997, PHYS REV B, V56, P1009, DOI 10.1103/PhysRevB.56.1009; Pachucki K, 2004, CHEM PHYS LETT, V389, P209, DOI 10.1016/j.cplett.2004.03.069; Press W., 1996, NUMERICAL RECIPES FO, V77; Sawada T., 2004, T MAT RES SOC JPN, V29, P3727; Schuwalow S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.035116; Shingh D., 1989, PHYS REV B, V40, P5428; Sklyadneva IY, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.085440; Ziman J. M., 1972, PRINCIPLES THEORY SO	73	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0010-4655	1879-2944		COMPUT PHYS COMMUN	Comput. Phys. Commun.	APR	2015	189						20	30		10.1016/j.cpc.2014.11.012		11	Computer Science, Interdisciplinary Applications; Physics, Mathematical	Computer Science; Physics	CC1FT	WOS:000350087300002		
J	Ueda, A; Saneoka, H				Ueda, Akihiro; Saneoka, Hirofumi			Characterization of the Ability to Form Biofilms by Plant-Associated Pseudomonas Species	CURRENT MICROBIOLOGY			English	Article							AERUGINOSA PAO1 BIOFILM; BACTERIAL BIOFILM; EXTRACELLULAR DNA; FLUORESCENS PF-5; EXOPOLYSACCHARIDE; POLYSACCHARIDES; RHIZOSPHERE; DISPERSION; SEQUENCE; GENOME	Successful colonization is the initial step for plant-bacteria interactions; therefore, the development of strategies to improve adherence to plant surfaces is critically important for environmental bacteria. Biofilm formation is thought to be one such strategy for bacteria to establish stable colonization on inert and living surfaces. Although biofilms play potential roles in enabling persistent bacterial colonization, little attention has been paid to biofilms formed by plant-associated bacteria. In this study, we characterized the biofilm-forming ability of 6 species of bacteria from the family Pseudomonadaceae: Pseudomonas protegens, Pseudomonas fluorescens, Pseudomonas putida, Pseudomonas stutzeri, Pseudomonas mendocina, and Pseudomonas syringae. These strains exhibit different degrees of biofilm formation depending on incubation time and nutrient availability. Distinct preferences for growth media were observed, as biofilms were formed by P. protegens with rich nutrients and by P. fluorescens and P. putida with poor nutrients. Likewise, P. stutzeri did not form biofilms with rich nutrients but did form biofilms under nutrient-poor conditions. These observations indicate that particular components in media may influence biofilm formation. P. putida, one of the strains with high biofilm-forming ability, showed the highest ability for initial attachment, which may be mediated by the hydrophobicity of its cell surface. P. mendocina also has high ability for initial attachment, and this strain produces cell surface-attached extracellular polysaccharides that promote cell aggregation. Thus, each strain possesses different properties that facilitate biofilm formation. Shedding light on bacterial strategies for colonization via biofilm formation would enable a better understanding of plant-bacteria interactions.	[Ueda, Akihiro; Saneoka, Hirofumi] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan	Ueda, A (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan.	akiueda@hiroshima-u.ac.jp			Takano Life Science Research Foundation; Institute for Fermentation, Osaka	We are grateful to Professors George A. O'Toole (P. protegens Pf-5, P. fluorescens Pf0-1), Juan Ruis Ramos (P. putida KT2440), Steven Lindow (P. syringae B728a) for kindly providing the strains. We are also grateful to NBRC (P. mendocina NBRC 14162) and Pasteur Institute (P. stutzeri A1501) for distributing the strains. This research was supported in part by the grants from Takano Life Science Research Foundation and the Institute for Fermentation, Osaka.	Lakshmanan V, 2012, PLANT PHYSIOL, V160, P1642, DOI 10.1104/pp.112.200386; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Davies DG, 2009, J BACTERIOL, V191, P1393, DOI 10.1128/JB.01214-08; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002; Jackson KD, 2004, J BACTERIOL, V186, P4466, DOI 10.1128/JB.186.14.4466-4475.2004; ROSS P, 1990, J BIOL CHEM, V265, P18933; Monds RD, 2007, MOL MICROBIOL, V63, P656, DOI 10.1111/j.1365-2958.2006.05539.x; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Beauregard PB, 2013, P NATL ACAD SCI USA, V110, pE1621, DOI 10.1073/pnas.1218984110; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Ueda A, 2009, MICROB BIOTECHNOL, V2, P62, DOI 10.1111/j.1751-7915.2008.00060.x; Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004; DEWANTI R, 1995, INT J FOOD MICROBIOL, V26, P147, DOI 10.1016/0168-1605(94)00103-D; Egamberdiyeva D, 2005, THESCIENTIFICWORLDJO, V5, P501, DOI 10.1100/tsw.2005.64; Goller C, 2006, J BACTERIOL, V188, P8022, DOI 10.1128/JB.01106-06; Huynh TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042874; Loper JE, 2007, PHYTOPATHOLOGY, V97, P233, DOI 10.1094/PHYTO-97-2-0233; OSMAN SF, 1986, J BACTERIOL, V166, P66; RICH JJ, 1992, APPL ENVIRON MICROB, V58, P1440; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Ueda A, 2010, ENV MICROBIOL REP, V2, P449, DOI 10.1111/j.1758-2229.2010.00171.x; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; Ueda A, 2008, APPL MICROBIOL BIOT, V79, P843, DOI 10.1007/s00253-008-1483-5	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0343-8651	1432-0991		CURR MICROBIOL	Curr. Microbiol.	APR	2015	70	4					506	513		10.1007/s00284-014-0749-7		8	Microbiology	Microbiology	CC3IR	WOS:000350241000007		
J	Lee, H; Yoshizawa, S; Kogure, K; Kim, HS; Yoon, J				Lee, Hyunsang; Yoshizawa, Susumu; Kogure, Kazuhiro; Kim, Hyun Soo; Yoon, Jaewoo			Pelagitalea pacifica gen. nov., sp nov., a New Marine Bacterium Isolated from Seawater	CURRENT MICROBIOLOGY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SPERM-WHALE CARCASSES; EMENDED DESCRIPTION; OCEANOSPIRILLUM-JANNASCHII; DEOXYRIBONUCLEIC-ACID; SEDIMENT ADJACENT; PURPLE BACTERIA; NEPTUNOMONAS; MARINOBACTERIUM; PROTEOBACTERIA	A strictly aerobic, Gram-negative, beige-pigmented, short-rod-shaped, non-motile and chemoheterotrophic bacteria, designated K2-48(T) was isolated from seawater collected in the Western North Pacific Ocean near Japan. Preliminary analysis based on the 16S rRNA gene sequence revealed that the novel isolate was affiliated with the family Oceanospirillaceae within the class Gammaproteobacteria and that it showed the highest sequence similarity (93.7 %) to Neptunomonas qingdaonensis P10-2-4(T). The strain could be differentiated phenotypically from recognized members of the family Oceanospirillaceae. The major fatty acids of strain K2-48(T) were identified as summed feature 3 (C16:1 omega 7c and/or iso-C15:0 2-OH) and C16:0 as defined by the MIDI system. The DNA G+C content was determined to be 43.2 mol%, the major respiratory quinone was identified as ubiquinone 9 and a polar lipid profile was present consisting of phosphatidylethanolamine, a phosphatidylglycerol and an unidentified phospolipid. On the basis of polyphasic taxonomic studies, it was concluded that strain K2-48(T) represents a novel genus sp. We propose the name Pelagitalea pacifica gen. nov., sp. nov. for this strain; its type strain is K2-48(T) (=KCCM 90119(T)).	[Lee, Hyunsang; Yoon, Jaewoo] Keimyung Univ, Coll Pharm, Taegu 704701, South Korea; [Yoshizawa, Susumu; Kogure, Kazuhiro] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Kim, Hyun Soo] Keimyung Univ, Dept Microbiol, Coll Nat Sci, Taegu 704701, South Korea	Yoon, J (reprint author), Keimyung Univ, Coll Pharm, 1095 Dalgubeoldaero, Taegu 704701, South Korea.	jwyoon@kmu.ac.kr			Institute for Fermentation, Osaka, Japan	We are grateful to the officers and crews of the R/V Mirai (Japan Agency for Marine-Earth Science and Technology [JAMSTEC]) for their assistance and support in sample collection. This work was supported by a research grant from the Institute for Fermentation, Osaka, Japan.	FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Gonzalez JM, 1997, INT J SYST BACTERIOL, V47, P369; MARMUR J, 1961, J MOL BIOL, V3, P208; Arahal DR, 2007, INT J SYST EVOL MICR, V57, P1000, DOI 10.1099/ijs.0.64524-0; Hedlund BP, 1999, APPL ENVIRON MICROB, V65, P251; DITTMER JC, 1964, J LIPID RES, V5, P126; COLLINS MD, 1981, J APPL BACTERIOL, V51, P129, DOI 10.1111/j.1365-2672.1981.tb00916.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697; Satomi M, 2002, INT J SYST EVOL MICR, V52, P739, DOI 10.1099/ijs.0.01427-0; Kersters K, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P3, DOI 10.1007/0-387-30745-1_1; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; Miyazaki M, 2008, INT J SYST EVOL MICR, V58, P2815, DOI 10.1099/ijs.0.65826-0; STACKEBRANDT E, 1988, INT J SYST BACTERIOL, V38, P321; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; BIANCHI A, 1995, MICROBIAL DIVERSITY AND ECOSYSTEM FUNCTION, P185; BOWDITCH RD, 1984, CURR MICROBIOL, V10, P221, DOI 10.1007/BF01627259; Chen MH, 2012, INT J SYST EVOL MICR, V62, P1104, DOI 10.1099/ijs.0.030379-0; Espinosa E, 2010, INT J SYST EVOL MICR, V60, P93, DOI 10.1099/ijs.0.008607-0; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Giovannoni S.J., 2000, MICROBIAL ECOLOGY OC, P47; Jung YT, 2012, INT J SYST EVOL MICR, V62, P2062, DOI 10.1099/ijs.0.036582-0; Kim JM, 2010, INT J SYST EVOL MICR, V60, P1828, DOI 10.1099/ijs.0.016246-0; Kim SJ, 2009, INT J SYST EVOL MICR, V59, P3030, DOI 10.1099/ijs.0.009134-0; Kimura M., 1983, NEUTRAL THEORY MOL E; Kumari P, 2014, INT J SYST EVOL MICR, V64, P487, DOI 10.1099/ijs.0.054809-0; Lee HW, 2012, INT J SYST EVOL MICR, V62, P2657, DOI 10.1099/ijs.0.037473-0; Liu A, 2013, INT J SYST EVOL MICR, V63, P1673, DOI 10.1099/ijs.0.041970-0; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159; MINNIKIN DE, 1984, J MICROBIOL METH, V2, P233, DOI 10.1016/0167-7012(84)90018-6; Miyazaki M, 2008, INT J SYST EVOL MICR, V58, P866, DOI 10.1099/ijs.0.65509-0; Pinhassi J, 2003, APPL ENVIRON MICROB, V69, P199, DOI 10.1128/AEM.69.1.199-211.2003; POT B, 1989, INT J SYST BACTERIOL, V39, P23; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sasser M., 1990, 101 MIDI; WOESE CR, 1985, SYST APPL MICROBIOL, V6, P25; Worliczek HL, 2007, SYST APPL MICROBIOL, V30, P355, DOI 10.1016/j.syapm.2007.03.004; Zhang XY, 2010, INT J SYST EVOL MICR, V60, P1958, DOI 10.1099/ijs.0.017756-0	38	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0343-8651	1432-0991		CURR MICROBIOL	Curr. Microbiol.	APR	2015	70	4					514	519		10.1007/s00284-014-0750-1		6	Microbiology	Microbiology	CC3IR	WOS:000350241000008		
J	Srisapoomi, T; Ichiyanagi, T; Nakajima, H; Aimi, T; Boonlue, S				Srisapoomi, Totsaporn; Ichiyanagi, Tsuyoshi; Nakajima, Hiromitsu; Aimi, Tadanori; Boonlue, Sophon			Biosynthesis of Integric Acid Isolated from the Wood-Decay Fungus Xylaria feejeensis 2FB-PPM08M	CURRENT MICROBIOLOGY			English	Article							MEVALONATE	The biosynthesis of integric acid, a secondary metabolite of the wood-decay fungus Xylaria feejeensis strain 2FB-PPM08M, has been studied. Labeling experiments using [1-C-13], [2-C-13] and [1,2-C-13(2)] acetate and l-methionine (methyl-C-13) were separately performed with fungal culture. The labeling patterns of these metabolites indicated the same origin, and determined that integric acid was formed through the condensation of a sesquiterpene and a polyketide. These experiments showed that side chain of compounds would be synthesized by the polyketide pathway, while the ring carbon indicated the biosynthesis of compounds via the mevalonate pathway.	[Srisapoomi, Totsaporn; Boonlue, Sophon] Khon Kaen Univ, Dept Microbiol, Fac Sci, Khon Kaen 40002, Thailand; [Ichiyanagi, Tsuyoshi; Nakajima, Hiromitsu; Aimi, Tadanori] Tottori Univ, Fac Agr, Minami Ku, Tottori 6808553, Japan	Boonlue, S (reprint author), Khon Kaen Univ, Dept Microbiol, Fac Sci, Khon Kaen 40002, Thailand.	vhonas@yahoo.com; bsopho@kku.ac.th					Wilson RJM, 2002, J MOL BIOL, V319, P257, DOI 10.1016/S0022-2836(02)00303-0; Simpson TJ, 1998, TOP CURR CHEM, V195, P1; Singh SB, 1999, TETRAHEDRON LETT, V40, P8775, DOI 10.1016/S0040-4039(99)01878-X; Furumoto T, 1999, J CHEM SOC PERK T 1, P131, DOI 10.1039/a808295b; Jux A, 2001, ANGEW CHEM INT EDIT, V40, P2091; Putra SR, 1998, FEMS MICROBIOL LETT, V164, P169; ROGERS J D, 1985, Sydowia, V38, P255; Rohnmer M, 1999, NAT PROD REP, V16, P565; Romminger S, 2012, J BRAZIL CHEM SOC, V23, P1783; Singh SB, 2000, BIOORG MED CHEM LETT, V10, P235, DOI 10.1016/S0960-894X(99)00666-6; Srisapoomi T, 2014, CHIANG MAI J SCI, V42, pxx; Waalboer DCJ, 2009, J ORG CHEM, V74, P8878, DOI 10.1021/jo901845r	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0343-8651	1432-0991		CURR MICROBIOL	Curr. Microbiol.	APR	2015	70	4					550	555		10.1007/s00284-014-0759-5		6	Microbiology	Microbiology	CC3IR	WOS:000350241000013		
J	Kikko, T; Usuki, T; Ishizaki, D; Kai, Y; Fujioka, Y				Kikko, Takeshi; Usuki, Takahiro; Ishizaki, Daisuke; Kai, Yoshiaki; Fujioka, Yasuhiro			Relationship of egg and hatchling size to incubation temperature in the multiple-spawning fish Gnathopogon caerulescens (Honmoroko)	ENVIRONMENTAL BIOLOGY OF FISHES			English	Article						Egg size; Seasonal change; Hatchling size; Incubation temperature; Gnathopogon caerulescens	PLECOGLOSSUS-ALTIVELIS; WATER TEMPERATURE; RHINOGOBIUS GOBY; PACIFIC SALMON; CLUTCH SIZE; LAKE BIWA; LARVAE; SURVIVAL; NUMBER; EMBRYOS	Egg size affects larval size, growth rate, survival and fecundity with maternal fitness being maximized by a trade-off between egg size and fecundity. Production of a small number of large eggs maximizes female fitness under poor food conditions, as does a large number of small eggs under rich food conditions. Gnathopogon caerulescens (Honmoroko) spawns over a wide range of water temperature from spring to summer. Thus, we determined whether or not egg size varied with water temperature and how egg size influenced hatchling size at different water temperature. Changes in egg size strongly correlated with seasonal changes in water temperature around the lake, regardless of time and area. An experiment using eggs from the lake indicated that hatchling size has a significant positive relationship with egg size in water temperatures of 24 A degrees C. On the other hand, a lower incubation temperature, similar to that likely to be encountered at the beginning of the spawning season, resulted in a smaller hatchling size, eggs requiring a longer time to hatch. At the beginning of the spawning season, therefore, egg size may have a lesser impact on hatching size in the natural environment of Honmoroko because of the relatively lower temperatures. Although fish larvae below a certain threshold of effective body size are generally not expected to have a high early survival rate due to, for example, a lower competitive ability or a high susceptibility to predation, seasonal egg size variation in Honmoroko may be adaptive so as to enhance the likehood of early survival by establishing an effective body size under changing water temperature conditions.	[Kikko, Takeshi; Usuki, Takahiro; Ishizaki, Daisuke] Shiga Prefectural Fisheries Expt Stn, Hikone, Shiga 5220057, Japan; [Kai, Yoshiaki] Kyoto Univ, Field Sci Educ & Res Ctr, Maizuru Fisheries Res Stn, Maizuru, Kyoto 6250086, Japan; [Fujioka, Yasuhiro] Lake Biwa Museum, Kusatsu, Shiga 5250001, Japan	Kikko, T (reprint author), Shiga Prefectural Fisheries Expt Stn, 2138-3 Hassaka, Hikone, Shiga 5220057, Japan.	kikkou-takeshi@pref.shiga.lg.jp					Akimoto K, 2009, LIMNOLOGY, V10, P105; Regnier T, 2013, ECOL FRESHW FISH, V22, P169, DOI 10.1111/eff.12018; BLAXTER JHS, 1986, T AM FISH SOC, V115, P98; SHRODE JB, 1977, PHYSIOL ZOOL, V50, P1; Fujioka Y, 2006, FISHERIES SCI, V72, P1034, DOI 10.1111/j.1444-2906.2006.01253.x; Kikko Takeshi, 2014, Japanese Journal of Ichthyology, V61, P1; Heins DC, 2004, ECOL FRESHW FISH, V13, P258, DOI 10.1111/j.1600-0633.2004.00064.x; Tamada K, 2005, ENVIRON BIOL FISH, V73, P379, DOI 10.1007/s10641-005-2230-8; Fujioka Y, 2013, NIPPON SUISAN GAKK, V79, P31; FLEMING IA, 1990, ECOLOGY, V71, P1, DOI 10.2307/1940241; BEACHAM TD, 1987, CAN J FISH AQUAT SCI, V44, P244, DOI 10.1139/f87-034; Laurel BJ, 2011, FISH B-NOAA, V109, P282; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; BEACHAM TD, 1990, T AM FISH SOC, V119, P927, DOI 10.1577/1548-8659(1990)119<0927:TESADO>2.3.CO;2; BAGENAL TB, 1971, J FISH BIOL, V3, P207, DOI 10.1111/j.1095-8649.1971.tb03665.x; CANINO MF, 1994, J EXP MAR BIOL ECOL, V175, P1, DOI 10.1016/0022-0981(94)90173-2; Chapman RM, 1962, J FISH RES BOARD CAN, V19, P1047; Coleman RM, 1998, COPEIA, P209, DOI 10.2307/1447721; FOLKVORD A, 1986, FISH B-NOAA, V84, P859; Fujioka Y, 2010, RED DATA BOOK SHIGA, P475; Goto A, 2001, EVOLUTIONARY BIOL EG; Hirai K-i., 1970, J. Limnol., V31, P1; Hunter J. R., 1980, FISH B US, V77, P641; IGUCHI K, 1994, COPEIA, P184; Iguchi K, 2012, ICHTHYOL RES, V59, P20, DOI 10.1007/s10228-011-0251-1; Ijima S, 1996, B SHIGA PREF FISH EX, P63; IMAI C, 1987, NIPPON SUISAN GAKK, V53, P2169; Jaworski A, 2002, J FISH BIOL, V60, P785, DOI 10.1006/jfbi.2002.1873; Kikko T, 2015, J FISH BIOL IN PRESS; Kikko Takeshi, 2012, Japanese Journal of Ichthyology, V59, P84; Kikko T, 2015, NIPPON SUIS IN PRESS; Knustsen GM, 1985, T AM FISH SOC, V11, P507; KOMADA N, 1977, COPEIA, P573; Laurel BJ, 2008, J PLANKTON RES, V30, P1051, DOI 10.1093/plankt/fbn057; Maki I, 1968, JPN J ECOL, V16, P254; MARSH E, 1984, COPEIA, P291, DOI 10.2307/1445184; Maruyama A, 2003, ENVIRON BIOL FISH, V67, P223, DOI 10.1023/A:1025870628640; Moore MV, 1996, ARCH HYDROBIOL, V135, P289; Morita K, 2003, SEX BEHAV ECOLOGY AQ, P48; Nakamura M., 1969, CYPRINID FISHES JAPA; Nakamura M, 1949, NIPPON SUISAN GAKK, V15, P88; Okamoto I, 1969, JPN J LIMNOL, V30, P108; Saegusa J, 2010, B SHIGA PREF FISH EX, P28; Saegusa J, 2011, B SHIGA PREF FISH EX, P22; SEHGAL HS, 1991, AQUACULTURE, V97, P269, DOI 10.1016/0044-8486(91)90269-D; SHIROTA A, 1970, BULL JAP SOC SCI FISH, V36, P353; Sund T, 2005, AQUAC RES, V36, P1133, DOI 10.1111/j.1365-2109.2005.01336.x; Suzuki T, 2007, ENVIRON BIOL FISH, V82, P353; TANASICHUK RW, 1987, CAN J FISH AQUAT SCI, V44, P1485, DOI 10.1139/f87-178; TSUKAMOTO K, 1975, B JPN SOC SCI FISH, V41, P167; Tsuruta Y., 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V108, P111; WARE DM, 1977, J FISH RES BOARD CAN, V34, P2308; Yamamoto T, 2006, LIMNOLOGY, V7, P75, DOI 10.1007/s10201-006-0172-2; Yoshida Takehito, 2001, Aquatic Ecology, V35, P19, DOI 10.1023/A:1011498202050; Zenitani Hiromu, 1995, Bulletin of the National Research Institute of Fisheries Science, V7, P411; Zuur A., 2009, MIXED EFFECTS MODELS	56	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0378-1909	1573-5133		ENVIRON BIOL FISH	Environ. Biol. Fishes	APR	2015	98	4					1151	1161		10.1007/s10641-014-0348-2		11	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	CC7RY	WOS:000350567300017		
J	Ashida, H; Suzuki, N; Tanabe, T; Suzuki, N; Aonuma, Y				Ashida, Hiroshi; Suzuki, Nobuaki; Tanabe, Toshiyuki; Suzuki, Nobuhiro; Aonuma, Yoshimasa			Reproductive condition, batch fecundity, and spawning fraction of large Pacific bluefin tuna Thunnus orientalis landed at Ishigaki Island, Okinawa, Japan	ENVIRONMENTAL BIOLOGY OF FISHES			English	Article						Atresia; Germinal epithelium; Ovary; Spawning omission; Testis	SCOMBER-JAPONICUS; CHUB MACKEREL; KATSUWONUS-PELAMIS; MEDITERRANEAN SEA; SKIPJACK TUNA; THYNNUS L.; FREQUENCY; ATLANTIC; WESTERN; OCEAN	In order to illustrate the reproductive activity of Pacific bluefin tuna (Thunnus orientalis) around the Yaeyama archipelago, an area known to be the species' major spawning ground, gonadal condition of large individuals obtained by longline fishing was assessed during the commercial fishery season between late April and early July in 2008 and 2009. Almost all of the specimens landed at Ishigaki Island during these two seasons were larger than 200 cm in fork length (FL), and, while the sex ratio was nearly 1:1 in total, a significant bias existed towards males when only individuals with FL values greater than 230 cm were considered. All females were sexually mature and sperm was observed in the testes of all males throughout the fishing season. Average spawning intervals (fraction) and average batch fecundity (mean +/- SD) were estimated at 3.29 days (0.30) and 15.4 +/- 10.2 million oocytes, respectively. Ovarian and testicular maturation phase based on histological assessment did not show any significant changes over the two-year study period, while commencement of spawning varied from year to year. We determined that spawning activity of Pacific bluefin tuna around the Yaeyama archipelago persisted throughout the fishing season, and likely varied due to the annual fluctuations in environmental conditions at the spawning ground.	[Ashida, Hiroshi; Suzuki, Nobuaki] Tokai Univ, Grad Sch Biosci, Shimizu, Shizuoka 4248610, Japan; [Ashida, Hiroshi; Tanabe, Toshiyuki] Fisheries Res Agcy, Natl Res Inst Far Seas Fisheries, Shimizu, Shizuoka 4248633, Japan; [Suzuki, Nobuaki; Aonuma, Yoshimasa] Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, Res Ctr Subtrop Fisheries, Ishigaki, Okinawa 9070451, Japan	Ashida, H (reprint author), Tokai Univ, Grad Sch Biosci, 3-20-1 Orido, Shimizu, Shizuoka 4248610, Japan.	hashida@affrc.go.jp			Japan Fisheries Agency	We thank the staff of the Yaeyama Fisheries Cooperative Association and the long-line fishermen for their cooperation regarding fish measurement and sampling. We also thank O. Abe and H. Nakano (National Research Institute of Far Seas Fisheries) for their helpful advice regarding our study. This research was made possible by a grant from the Japan Fisheries Agency.	Rideout RM, 2005, FISH FISH, V6, P50, DOI 10.1111/j.1467-2679.2005.00174.x; Medina A, 2007, MAR ECOL PROG SER, V337, P221, DOI 10.3354/meps337221; Farley JH, 1998, FISH B-NOAA, V96, P223; Boustany AM, 2010, PROG OCEANOGR, V86, P94, DOI 10.1016/j.pocean.2010.04.015; Kimura S, 2010, PROG OCEANOGR, V86, P39, DOI 10.1016/j.pocean.2010.04.018; Corriero A, 2003, J FISH BIOL, V63, P108, DOI 10.1046/j.1095-8649.2003.00132.x; Chapman EW, 2011, CAN J FISH AQUAT SCI, V68, P1934, DOI 10.1139/F2011-109; Chen KS, 2006, FISHERIES SCI, V72, P985, DOI 10.1111/j.1444-2906.2006.01247.x; Goldstein J, 2007, MAR BIOL, V151, P2063, DOI 10.1007/s00227-007-0638-8; Abascal FJ, 2004, FISH B-NOAA, V102, P407; HUNTER JR, 1985, FISH B-NOAA, V83, P119; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; HUNTER JR, 1986, FISH B-NOAA, V84, P895; Schaefer KM, 1996, FISH B-NOAA, V94, P98; Heinisch G, 2008, MAR BIOL, V154, P623, DOI 10.1007/s00227-008-0955-6; Itoh T, 2009, NIPPON SUISAN GAKK, V75, P412; Ashida H, 2008, NIPPON SUISAN GAKK, V74, P902; Ashida H, 2010, FISHERIES SCI, V76, P785, DOI 10.1007/s12562-010-0282-y; Ashida H, 2007, NIPPON SUISAN GAKK, V73, P436; Bayliff W. H., 1994, FAO FISH TECH PAP, V336, P244; DICKERSON TL, 1992, CAL COOP OCEAN FISH, V33, P130; Farley JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060577; GRIER HJ, 1981, AM ZOOL, V21, P345; Hunter J. R., 1980, FISH B US, V77, P641; Hunter J.R., 1985, NOAA Technical Report NMFS, V36, P67; Hunter J.R., 1985, NOAA Technical Report NMFS, V36, P79; Knapp JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098233; MASUMA S, 2006, B FISH RES AGEN S, V4, P157; Masuma Shukei, 2003, Bulletin of Fisheries Research Agency, V6, P9; Miyashita M, 2000, SUISAN ZOSHOKU, V48, P475; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P23, DOI 10.2960/J.v33.a2; Murua H, 2003, J NW ATL FISH SCI, V33, P33; Nakadate M, 2011, AQUACULTURE, V310, P325, DOI 10.1016/j.aquaculture.2010.11.007; NIKAIDO H, 1991, B NAT RES I FAR SEAS, V28, P47; Nishikawa Y, 1985, B FAR SEAS FISH RES, V12, P1; Okiyama M., 1974, Bulletin Japan Sea reg Fish Res Lab, VNo. 25, P89; ORANGE CRAIGJ., 1963, CALIF FISH AND GAME, V49, P307; Rideout RM, 2000, J FISH BIOL, V57, P1429, DOI 10.1006/jfbi.2000.1405; Russell L.D., 1993, SERTOLI CELL, P703; Schaefer Kurt M., 2005, Inter-American Tropical Tuna Commission Bulletin, V23, P1; Schaefer KM, 1998, INT AM TROP TUNA COM, V21, P201; Shimose T, 2009, FISH RES, V100, P134, DOI 10.1016/j.fishres.2009.06.016; Shiraishi T, 2009, FISHERIES SCI, V75, P649, DOI 10.1007/s12562-009-0094-0; Tan T.-H., 1975, Acta oceanogr taiwan, VNo. 5,1975, P179; UEYANAGI S, 1969, Bulletin Far Seas Fisheries Research Laboratory (Shimizu), V2, P177; WOODHEAD A. D., 1965, INT COMM NORTHWEST ATLANTIC FISH SPEC PUBLICATION, V6, P691; Yabe H, 1966, REP NANKAI REG FISH, V23, P95; Yamada T, 1998, FISH RES, V38, P83, DOI 10.1016/S0165-7836(98)00113-1; Zupa R, 2009, J FISH BIOL, V75, P1221, DOI 10.1111/j.1095-8649.2009.02355.x	49	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0378-1909	1573-5133		ENVIRON BIOL FISH	Environ. Biol. Fishes	APR	2015	98	4					1173	1183		10.1007/s10641-014-0350-8		11	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	CC7RY	WOS:000350567300019		
J	Harnkarnsujarit, N; Kawai, K; Suzuki, T				Harnkarnsujarit, Nathdanai; Kawai, Kiyoshi; Suzuki, Toru			Effects of Freezing Temperature and Water Activity on Microstructure, Color, and Protein Conformation of Freeze-Dried Bluefin Tuna (Thunnus orientalis)	FOOD AND BIOPROCESS TECHNOLOGY			English	Article						Freezing; Microstructure; Tuna; Browning; Protein; Water activity	DIFFERENTIAL SCANNING CALORIMETRY; SECONDARY STRUCTURE; GLASS-TRANSITION; FTIR CHARACTERIZATION; IR SPECTROSCOPY; AMIDE-I; FISH; STATE; STABILITY; STORAGE	Freeze-drying of muscle foods including bluefin tuna (Thunnus orientalis) effectively restricted microbial growth and prolonged shelf life; however, microstructures and protein conformation changes possibly take place which contribute to functional and quality loss. This study aimed to investigate the effects of freezing and water sorption on microstructure, color, and conformation changes of protein in freeze-dried tuna. Tuna were frozen at various freezing temperatures prior to freeze-drying and stored at different a (w) at 25 A degrees C. X-ray computed tomography revealed microstructures of freeze-dried solids and reflected ice formation in parallel to the muscle fiber. Higher temperature freezing gave a slower nucleation and subsequent larger ice crystals formed, which enhanced aggregation of muscle fiber resulting in a thicker size but less integrity of fibrous structures. Water sorption induced structural changes of solids stored at above T (g) in concurrent with the acceleration of browning which attributed to the increased molecular mobility. Attenuated total reflectance Fourier transform infrared spectroscopy indicated that freeze-dried tuna undergoing all freezing temperatures revealed a significant frequency shift and broadening of amide I band mainly associated with stretching vibrations of the C = O bond as a (w) increased. The increased intermolecular interaction via hydrogen bonding was found in high a (w) systems. The results indicated that a faster freezing increased protein stability in freeze-dried tuna but accelerated browning induced by water sorption which increased molecular mobility of solids above T (g).	[Harnkarnsujarit, Nathdanai] Kasetsart Univ, Fac Agroind, Dept Packaging & Mat Technol, Bangkok 10900, Thailand; [Harnkarnsujarit, Nathdanai; Suzuki, Toru] Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Minato Ku, Tokyo, Japan; [Kawai, Kiyoshi] Hiroshima Univ, Grad Sch Biosphere Sci, Dept Biofunct Sci & Technol, Hiroshima, Japan	Harnkarnsujarit, N (reprint author), Tokyo Univ Marine Sci & Technol, Dept Food Sci & Technol, Minato Ku, 4-5-7 Konan, Tokyo, Japan.	nathdanai.h@ku.ac.th	SUZUKI, Toru/O-1972-2014		Ministry of Education, Culture, Sports, Science and Technology of Japan	The authors gratefully acknowledge the Ministry of Education, Culture, Sports, Science and Technology of Japan on the project title of "MEXT Revitalization Project for the Creation of Fisheries Research and Education Center in Sanriku" for the financial support.	Acevedo N, 2006, J FOOD ENG, V77, P1108, DOI 10.1016/j.jfoodeng.2005.08.045; Acevedo NC, 2008, J FOOD ENG, V85, P222, DOI 10.1016/j.jfoodeng.2007.06.037; AGUILIERA JM, 1993, BIOTECHNOL PROGR, V9, P651, DOI 10.1021/bp00024a013; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; NELSON KA, 1992, ACS SYM SER, V500, P93; Rao QC, 2012, FOOD CHEM, V132, P373, DOI 10.1016/j.foodchem.2011.10.107; Lai MC, 1999, J PHARM SCI, V88, P489, DOI 10.1021/js980374e; JACKSON M, 1991, CAN J CHEM, V69, P1639, DOI 10.1139/v91-240; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Fu K, 1999, J CONTROL RELEASE, V58, P357, DOI 10.1016/S0168-3659(98)00192-8; Torii H, 1998, J RAMAN SPECTROSC, V29, P537, DOI 10.1002/(SICI)1097-4555(199806)29:6<537::AID-JRS272>3.0.CO;2-X; Zamora R, 2005, CRIT REV FOOD SCI, V45, P49, DOI 10.1080/10408690590900117; Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Orlien V, 2003, J AGR FOOD CHEM, V51, P211, DOI 10.1021/jf020355x; PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105; Pikal MJ, 2008, J PHARM SCI-US, V97, P5122, DOI 10.1002/jps.21386; Zhou P, 2008, J AGR FOOD CHEM, V56, P4534, DOI 10.1021/jf073216u; COSTANTINO HR, 1994, PHARMACEUT RES, V11, P21, DOI 10.1023/A:1018981208076; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Chu HL, 2001, AQUAT TOXICOL, V55, P171, DOI 10.1016/S0166-445X(01)00177-1; Das M, 2002, INT J FOOD SCI TECH, V37, P223, DOI 10.1046/j.1365-2621.2002.00560.x; D'Cruz NM, 2005, J FOOD SCI, V70, pE64; DOUSSEAU F, 1990, BIOCHEMISTRY-US, V29, P8771, DOI 10.1021/bi00489a038; GEORGE P, 1952, BIOCHEM J, V51, P103; GRIEBENOW K, 1995, P NATL ACAD SCI USA, V92, P10969, DOI 10.1073/pnas.92.24.10969; Harnkarnsujarit N., 2012, J FOOD SCI, V77, P313; Hashimoto T, 2004, FISHERIES SCI, V70, P1144, DOI 10.1111/j.1444-2906.2004.00916.x; Rahman MS, 2009, FOOD CHEM, V114, P1257, DOI 10.1016/j.foodchem.2008.11.002; Careche M, 1999, J AGR FOOD CHEM, V47, P952, DOI 10.1021/jf9809481; Roos YH, 2009, MODERN BIOPOLYMER SCIENCE: BRIDGING THE DIVIDE BETWEEN FUNDAMENTAL TREATISE AND INDUSTRIAL APPLICATION, P261, DOI 10.1016/B978-0-12-374195-0.00008-2; Roos YH, 1997, J THERM ANAL, V48, P535, DOI 10.1007/BF01979500; Saltmarch M., 1982, Diabetes, V31, P29; Shah AKMA, 2009, J FOOD SCI, V74, pS309, DOI 10.1111/j.1750-3841.2009.01271.x; Tahergorabi R, 2011, WOODHEAD PUBL FOOD S, P116; White KL, 1999, J FOOD SCI, V64, P1010, DOI 10.1111/j.1365-2621.1999.tb12270.x; Zhu SC, 2013, FOOD BIOPROCESS TECH, V6, P3068, DOI 10.1007/s11947-012-0991-6	37	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1935-5130	1935-5149		FOOD BIOPROCESS TECH	Food Bioprocess Technol.	APR	2015	8	4					916	925		10.1007/s11947-014-1460-1		10	Food Science & Technology	Food Science & Technology	CC6WL	WOS:000350509600019		
J	Asanuma, T; Nakatani, S				Asanuma, Toshihiko; Nakatani, Satoshi			Myocardial ischaemia and post-systolic shortening	HEART			English	Review							DOBUTAMINE STRESS ECHOCARDIOGRAPHY; CORONARY-ARTERY-DISEASE; SPECKLE TRACKING ECHOCARDIOGRAPHY; STRAIN-RATE; WALL-MOTION; MEMORY; CONTRACTION; RELAXATION	The assessment of regional wall motion is useful to identify myocardial ischaemia because wall motion abnormalities occur relatively upstream in the ischaemic cascade. Echocardiography is widely used for this, but the subjectivity of visual observation may hamper accurate evaluation. The analysis of myocardial velocity and strain by tissue Doppler and speckle tracking echocardiography has allowed the quantitative assessment of regional wall motion and facilitated the detection of subtle myocardial deformation that is difficult to identify by conventional methods, such as post-systolic shortening (PSS). PSS is defined as myocardial shortening that occurs after end-systole (or aortic valve closure), and it is observed in the myocardium with regional contractile dysfunction. In experimental and clinical studies, it has been reported that the assessment of PSS is superior to that of conventional parameters such as wall thickening or peak systolic strain in detecting acute ischaemia and diagnosing coronary artery disease. Moreover, it has recently been found that PSS remains after recovery from brief ischaemia despite the rapid recovery of peak systolic strain. The assessment of PSS allows after-the-fact recognition of myocardial ischaemic insults and is expected to be used for ischaemic memory imaging. In this review, the usefulness of the assessment of PSS for the diagnosis of acute ischaemia and ischaemic memory is demonstrated, and issues that need to be resolved for the widespread use of this assessment in the echocardiographic laboratory are discussed.	[Asanuma, Toshihiko] Osaka Univ, Grad Sch Med, Dept Adv Cardiovasc Therapeut, Suita, Osaka 5650871, Japan; [Nakatani, Satoshi] Osaka Univ, Grad Sch Med, Dept Hlth Sci, Div Funct Diagnost, Suita, Osaka 5650871, Japan	Asanuma, T (reprint author), Osaka Univ, Grad Sch Med, Dept Adv Cardiovasc Therapeut, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	toshi@sahs.med.osaka-u.ac.jp					AKAISHI M, 1988, CARDIOVASC RES, V22, P889, DOI 10.1093/cvr/22.12.889; Ingul CB, 2007, J AM COLL CARDIOL, V49, P1651, DOI 10.1016/j.jacc.2007.01.059; Celutkiene J, 2004, EUR HEART J, V25, P932, DOI 10.1016/j.ehj.2004.04.005; Weidemann F, 2006, ULTRASOUND MED BIOL, V32, P53, DOI 10.1016/j.ultrasmedbio.2005.09.003; Sengupta PP, 2009, JACC-CARDIOVASC IMAG, V2, P212, DOI 10.1016/j.jcmg.2008.12.005; Takigiku K, 2012, CIRC J, V76, P2623, DOI 10.1253/circj.CJ-12-0264; Voigt JU, 2003, CIRCULATION, V107, P2120, DOI 10.1161/01.CIR.0000065249.69988.AA; Pislaru C, 2002, J AM COLL CARDIOL, V40, P1487, DOI 10.1016/S0735-1097(02)02171-4; Sicari R, 2008, EUR J ECHOCARDIOGR, V9, P415, DOI 10.1093/ejechocard/jen175; Asanuma T, 2012, JACC-CARDIOVASC IMAG, V5, P1, DOI 10.1016/j.jcmg.2011.09.019; Dilsizian V, 2005, CIRCULATION, V112, P2169, DOI 10.1061/CIRCULATIONHA.104.530428; Smedsrud MK, 2012, J AM COLL CARDIOL, V60, P1086, DOI 10.1016/j.jacc.2012.06.022; Ishii K, 2009, J AM COLL CARDIOL, V54, P1589, DOI 10.1016/j.jacc.2009.06.030; Voigt JV, 2003, J AM SOC ECHOCARDIOG, V16, P415, DOI 10.1016/S0894-7317(03)00111-1; Ishii K, 2009, J AM COLL CARDIOL, V53, P698, DOI 10.1016/j.jacc.2008.09.057; Asanuma T, 2009, JACC-CARDIOVASC IMAG, V2, P1253, DOI 10.1016/j.jcmg.2009.07.008; Pislaru C, 2001, J AM COLL CARDIOL, V37, P1141, DOI 10.1016/S0735-1097(01)01113-5; Skulstad H, 2002, CIRCULATION, V106, P718, DOI 10.1161/01.CIR.0000024102.55150.B6; Kukulski T, 2003, J AM COLL CARDIOL, V41, P810, DOI 10.1016/S0735-1097(02)02934-0; Belohlavek M, 2001, J AM SOC ECHOCARDIOG, V14, P360, DOI 10.1067/mje.2001.110786; Claus P, 2007, ULTRASOUND MED BIOL, V33, P1963, DOI 10.1016/j.ultrasmedbio.2007.06.003; Derumeaux G, 1998, CIRCULATION, V97, P1970; Jamal F, 2001, J AM SOC ECHOCARDIOG, V14, P874, DOI 10.1067/mje.2001.112037; Kawai Y, 2001, J AM COLL CARDIOL, V38, P1888, DOI 10.1016/S0735-1097(01)01634-5; Kurosawa K, 2013, J ECHOCARDIOGR, V11, P50; Masuda K, 2008, JACC-CARDIOVASC IMAG, V1, P210, DOI 10.1016/j.jcmg.2007.12.002; NESTO RW, 1987, AM J CARDIOL, V59, pC23, DOI 10.1016/0002-9149(87)90192-5; Okuda K, 2006, J AM SOC ECHOCARDIOG, V19, P781, DOI 10.1016/j.echo.2006.10.016; Onishi T, 2010, J AM SOC ECHOCARDIOG, V23, P1103, DOI 10.1016/j.echo.2010.06.031; Sakurai D, 2014, INT J CARDIOVAS IMAG, V30, P739, DOI 10.1007/s10554-014-0388-x	30	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1355-6037	1468-201X		HEART	Heart	APR 1	2015	101	7					509	516		10.1136/heartjnl-2013-305403		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CC4VK	WOS:000350352200006		
J	Thanasegaran, S; Ito, S; Nishio, N; Uddin, MN; Sun, Y; Isobe, K				Thanasegaran, Suganya; Ito, Sachiko; Nishio, Naomi; Uddin, Mohammad Nizam; Sun, Yang; Isobe, Ken-ichi			Recruitment of Gr1(+)CD11b(+)F4/80(+) Population in the Bone Marrow and Spleen by Irradiation-Induced Pulmonary Damage	INFLAMMATION			English	Article						macrophages; radiation; inflammation	SUPPRESSOR-CELLS; INFLAMMATORY RESPONSE; STEM-CELLS; MACROPHAGE; SEPSIS; LUNG; MICE; MOBILIZATION; NEUTROPHIL; MONOCYTES	Radiation-induced lung injury is a kind of sterile inflammation, which may lead to morbidity and mortality. The mechanism by which ionizing radiation activate the immune system is not well understood. In the present study, we have investigated the immunological responses induced by local irradiation-induced damage in mouse lung. The left lungs of C57BL/6 mice were irradiated at a high dose of 100 Gy. The histology of the lungs and spleen showed evidences of alveolar inflammation and congestion at 2 weeks after X-ray treatment. Also, prominent increase in cells expressing the cell surface markers, Gr(+)CD11b(+)F4/80(+) and Ly6C(+) Ly6G(+) were observed 2 weeks after X-ray treatment (100 Gy). Gr1(+)CD11b(+)F4/80(+) cell depletion by clodronate treatment reversed the histological effects and also failed to recruit Gr(+)CD11b(+) cells or F4/80(+) cells caused by irradiation. The origin of recruited Gr1(+)CD11b(+) cells was found to be a mixed resident and recruited phenotype.	[Thanasegaran, Suganya; Ito, Sachiko; Nishio, Naomi; Uddin, Mohammad Nizam; Sun, Yang; Isobe, Ken-ichi] Nagoya Univ, Grad Sch Med, Dept Immunol, Showa Ku, Nagoya, Aichi 4668550, Japan	Isobe, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Immunol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kisobe@med.nagoya-u.ac.jp					Serafini N, 2012, J IMMUNOL, V189, P3689, DOI 10.4049/jimmunol.1102969; Cheng Z, 2011, J MOL CELL BIOL, V3, P91, DOI 10.1093/jmcb/mjq044; Ishii H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-87; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666; Delano MJ, 2011, J IMMUNOL, V187, P911, DOI 10.4049/jimmunol.1100588; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Zhang R, 2011, CLIN EXP IMMUNOL, V164, P417, DOI 10.1111/j.1365-2249.2011.04374.x; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Richards PJ, 1999, RHEUMATOLOGY, V38, P818, DOI 10.1093/rheumatology/38.9.818; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Brudecki L, 2012, INFECT IMMUN, V80, P2026, DOI 10.1128/IAI.00239-12; Cakarova L, 2009, AM J RESP CRIT CARE, V180, P521, DOI 10.1164/rccm.200812-1837OC; TRAVIS EL, 1980, INT J RADIAT ONCOL, V6, P345; Sturrock A, 2012, AM J PHYSIOL-LUNG C, V302, pL343, DOI 10.1152/ajplung.00276.2011; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P93, DOI 10.1189/jlb.0809549; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Ornellas DS, 2011, RESP PHYSIOL NEUROBI, V178, P304, DOI 10.1016/j.resp.2011.06.029; Craciun F.L., 2012, J IMMUNOL, V185, P6930; Deshane J, 2011, MUCOSAL IMMUNOL, V4, P503, DOI 10.1038/mi.2011.16; Goedegebuure P, 2011, CURR CANCER DRUG TAR, V11, P734; Hara M., 2012, BIODISCOVERY, V2, P1, DOI [10.7750/BioDiscovery.2012.2.1, DOI 10.7750/BIODISCOVERY.2012.2.1]; Ito S., 2013, PLOS ONE, V4, DOI [10.1371/journal.pone.00769434;8(10):e76943, DOI 10.1371/JOURNAL.PONE.00769434;8(10):E76943]; Kudo K, 2007, TOHOKU J EXP MED, V212, P143, DOI 10.1620/tjem.212.143; Lech M, 2012, MEDIAT INFLAMM, V2012, DOI [10.1155/2012/951390, DOI 10.1155/2012/951390]; Lee J.C., 2008, CANCER BIOL THER, V8, P1; MAH K, 1987, INT J RADIAT ONCOL, V13, P179; Murray PJ, NAT REV IMMUNOL, V11, P723; Roc K.L., 2010, ANNU REV IMMUNOL, V28, P321; Stahl M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081382; Zhang C, 2012, INFECT IMMUN, V80, P3634, DOI 10.1128/IAI.00668-12	37	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0360-3997	1573-2576		INFLAMMATION	Inflammation	APR	2015	38	2					465	475		10.1007/s10753-014-9952-8		11	Cell Biology; Immunology	Cell Biology; Immunology	CC7NC	WOS:000350553800001		
J	Wang, XT; Tanino, Y; Sato, S; Nikaido, T; Misa, K; Fukuhara, N; Fukuhara, A; Saito, J; Yokouchi, H; Ishida, T; Fujita, T; Munakata, M				Wang, Xintao; Tanino, Yoshinori; Sato, Suguru; Nikaido, Takefumi; Misa, Kenichi; Fukuhara, Naoko; Fukuhara, Atsuro; Saito, Junpei; Yokouchi, Hiroshi; Ishida, Takashi; Fujita, Teizo; Munakata, Mitsuru			Secretoglobin 3A2 Attenuates Lipopolysaccharide-Induced Inflammation Through Inhibition of ERK and JNK Pathways in Bronchial Epithelial Cells	INFLAMMATION			English	Article						secretoglobin gene family 3A2; lipopolysaccharide; airway inflammation; bronchial epithelial cells; mitogen activated protein kinase	UTEROGLOBIN-RELATED PROTEIN-1; NEUTROPHIL MIGRATION; LUNG INFLAMMATION; GENE-EXPRESSION; TRANSCRIPTION; ENDOTOXIN; FIBROSIS; ASTHMA; MOUSE; UGRP1	Secretoglobin (SCGB) 3A2, previously known as uteroglobin-related protein 1, is a secreted protein highly expressed in the epithelial cells of the airways. It has been demonstrated that SCGB3A2 is involved in allergic airway inflammation such as bronchial asthma. However, the role of SCGB3A2 in lipopolysaccharide (LPS)-induced airway inflammation has yet to be reported. The goal of this study was therefore to clarify the role of SCGB3A2 in LPS-induced airway inflammation. We stimulated BEAS-2B, human bronchial epithelial cells, with LPS and analyzed messenger RNA (mRNA) expression of tumor necrosis factor (TNF)-alpha and CXCL8 with or without pre-incubation of SCGB3A2. The mRNA expression of TNF-alpha and CXCL8 was clearly upregulated 3 h after LPS stimulation, and pre-incubation of SCGB3A2 significantly inhibited the upregulation of the mRNA expression. The pre-incubation of SCGB3A2 also inhibited LPS-induced phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), but not p38 mitogen-activated protein kinase in BEAS-2B cells. Furthermore, PD98059, a specific inhibitor for ERK, as well as SP600125, a specific inhibitor for JNK, inhibited LPS-induced mRNA upregulation of inflammatory mediators. These results demonstrate the novel biological activity of SCGB3A2, which is that it attenuates LPS-induced inflammation in bronchial epithelial cells through inhibition of ERK and JNK activation.	[Wang, Xintao; Tanino, Yoshinori; Sato, Suguru; Nikaido, Takefumi; Misa, Kenichi; Fukuhara, Naoko; Fukuhara, Atsuro; Saito, Junpei; Yokouchi, Hiroshi; Ishida, Takashi; Munakata, Mitsuru] Fukushima Med Univ, Sch Med, Dept Pulm Med, Fukushima, Fukushima 9601295, Japan; [Fujita, Teizo] Fukushima Med Univ, Sch Med, Dept Immunol, Fukushima, Fukushima 9601295, Japan	Tanino, Y (reprint author), Fukushima Med Univ, Sch Med, Dept Pulm Med, 1 Hikarigaoka, Fukushima, Fukushima 9601295, Japan.	ytanino@fmu.ac.jp			Diffuse Lung Diseases Research Group from Ministry of Health, Labour and Welfare, Japan	This study was partly supported by a grant to the Diffuse Lung Diseases Research Group from the Ministry of Health, Labour and Welfare, Japan.	Srisodsai A, 2004, J BIOL CHEM, V279, P54358, DOI 10.1074/jbc.M405331200; Chiba Y, 2006, AM J RESP CRIT CARE, V173, P958, DOI 10.1164/rccm.200503-456OC; Arsalane K, 2000, AM J RESP CRIT CARE, V161, P1624; Cai Y, 2014, AM J PHYSIOL-LUNG C, V306, pL10, DOI 10.1152/ajplung.00037.2013; Koay MA, 2002, AM J RESP CELL MOL, V26, P572; Hippenstiel S, 2000, BLOOD, V95, P3044; Skerrett SJ, 2004, AM J PHYSIOL-LUNG C, V287, pL143, DOI 10.1152/ajplung.00030.2004; Tanino Y, 2010, J IMMUNOL, V184, P2677, DOI 10.4049/jimmunol.0903274; Tanino Y, 2012, AM J RESP CELL MOL, V47, P196, DOI 10.1165/rcmb.2011-0294OC; Reynolds SD, 2002, AM J RESP CRIT CARE, V166, P1498, DOI 10.1164/rrcm.200204-285OC; Niimi T, 2001, MOL ENDOCRINOL, V15, P2021, DOI 10.1210/me.15.11.2021; Shi L, 2002, AM J PHYSIOL-CELL PH, V282, pC1205, DOI 10.1152/ajpcell.00511.2001; Kurotani R, 2011, J BIOL CHEM, V286, P19682, DOI 10.1074/jbc.M111.239046; Bin LH, 2003, J IMMUNOL, V171, P924; de Burbure C, 2007, CHEST, V131, P172, DOI 10.1378/chest.06-0835; HAY JG, 1995, AM J PHYSIOL-LUNG C, V268, pL565; Hayashida S, 2000, AM J PHYSIOL-LUNG C, V279, pL452; Inoue Keiichi, 2008, Allergol Int, V57, P57, DOI 10.2332/allergolint.O-07-493; Li J, 2002, AM J PHYSIOL-LUNG C, V283, pL690, DOI 10.1152/ajplung.00060.2002; Miele L, 2000, ANN NY ACAD SCI, V923, P128; Niimi T, 2002, AM J HUM GENET, V70, P718, DOI 10.1086/339272	21	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0360-3997	1573-2576		INFLAMMATION	Inflammation	APR	2015	38	2					828	834		10.1007/s10753-014-9992-0		7	Cell Biology; Immunology	Cell Biology; Immunology	CC7NC	WOS:000350553800040		
J	Heinbockel, L; Palacios-Chaves, L; Alexander, C; Rietschel, E; Behrends, J; Correa, W; Fukuoka, S; Gutsmann, T; Ulmer, AJ; Brandenburg, K				Heinbockel, Lena; Palacios-Chaves, Leyre; Alexander, Christian; Rietschel, Ernst; Behrends, Jochen; Correa, Wilmar; Fukuoka, Satoshi; Gutsmann, Thomas; Ulmer, Artur J.; Brandenburg, Klaus			Mechanism of Hb gamma-35-induced an increase in the activation of the human immune system by endotoxins	INNATE IMMUNITY			English	Article						Peptides; endotoxin; sepsis; aggregate structure; immune stimulation; lipopolysaccharide	HOST-DEFENSE PEPTIDES; BIOPHYSICAL CHARACTERIZATION; BACTERIAL-ENDOTOXIN; LIPID-A; LIPOPOLYSACCHARIDE RECOGNITION; ANTIMICROBIAL PEPTIDES; BIOLOGICAL-ACTIVITIES; SECONDARY STRUCTURE; ENDOTHELIAL-CELLS; FREE HEMOGLOBIN	Endotoxins (LPS) are highly potent immune stimulatory molecules and are mainly known for triggering Gram-negative sepsis. However, besides their toxic effects, this stimulatory function may be advantageous, for example when used as an adjuvant during vaccination. Thus, there is always a narrow range between the useful wake-up of the immune system and its overwhelming reaction, which can lead to diseases like sepsis. This raises the question of which conformational properties are responsible for making the LPS aggregates more or less potent. As described previously, the size, type and form of LPS aggregates play a major role in their immune stimulatory activity. In this study we investigate the role of these parameters. On the one hand, we use a peptide (Pep19-2.5; Aspidasept) that causes a change of the LPS aggregate structure into a less toxic state; on the other hand, we use a potent immune stimulating peptide (Hb-35), leading to higher toxicity. We have found opposing effects on LPS aggregate conformations allowing a better understanding of the processes of immune stimulation.	[Heinbockel, Lena; Palacios-Chaves, Leyre; Alexander, Christian; Correa, Wilmar; Gutsmann, Thomas; Ulmer, Artur J.; Brandenburg, Klaus] Res Ctr Borstel, Div Biophys, Borstel, Germany; [Palacios-Chaves, Leyre] Inst Agrobiotecnol CSIC UPNA Gobierno Navarra, Pamplona, Spain; [Rietschel, Ernst] Charite, Berlin Inst Hlth, Berlin, Germany; [Behrends, Jochen] Res Ctr Borstel, Div Fluorescence Cytometry, Borstel, Germany; [Fukuoka, Satoshi] Natl Inst Adv Ind Sci & Technol, Takamatsu, Kagawa, Japan	Heinbockel, L (reprint author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Div Biophysiscs, Pk Allee 10, D-23845 Borstel, Germany.	lheinbockel@fz-borstel.de			Else-Kroner-Fresenius Stiftung [2011_A140]; Clinique la Prairie; Department of Education of the Government of Navarra (Spain)	Research at the laboratories of the authors is supported by the Else-Kroner-Fresenius Stiftung (project 2011_A140), the Clinique la Prairie, and the Department of Education of the Government of Navarra (Spain) for the Post-doctoral Fellowship within the "Anabasi + d Program (2010-2011), Outgoing model''.	Andra J, 2006, J ENDOTOXIN RES, V12, P261, DOI 10.1179/096805106X118852; Andrda J, 2004, BIOCHEM PHARMACOL, V68, P1297, DOI 10.1016/j.bcp.2004.05.054; Gutsmann T, 2010, ANTIMICROB AGENTS CH, V54, P3817, DOI 10.1128/AAC.00534-10; Andra J, 2004, ANTIMICROB AGENTS CH, V48, P1593, DOI 10.1128/AAC.48.5.1593-1599.2004; Seydel U, 2000, EUR J BIOCHEM, V267, P3032; YOSHIDA M, 1995, J LAB CLIN MED, V126, P151; Kaconis Y, 2011, BIOPHYS J, V100, P2652, DOI 10.1016/j.bpj.2011.04.041; MIYAZAWA T, 1958, J CHEM PHYS, V29, P611, DOI 10.1063/1.1744547; Howe J, 2007, BIOPHYS J, V92, P2796, DOI 10.1529/biophysj.106.095711; Andra J, 2005, BIOCHEM J, V385, P135, DOI 10.1042/BJ20041270; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; KACA W, 1994, J BIOL CHEM, V269, P25078; Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006; ROTH RI, 1994, BLOOD, V83, P2860; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Brandenburg K, 2001, BIOL CHEM, V382, P1215, DOI 10.1515/BC.2001.152; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; RIETSCHEL ET, 1992, SCI AM, V267, P54; SWEADNER KJ, 1977, APPL ENVIRON MICROB, V34, P382; Heinbockel L, 2013, ANTIMICROB AGENTS CH, V57, P1480, DOI 10.1128/AAC.02066-12; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Brandenburg K, 2010, SUBCELL BIOCHEM, V53, P53, DOI 10.1007/978-90-481-9078-2_3; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Blunck R, 2001, J IMMUNOL, V166, P1009; Brandenburg K, 2003, J BIOL CHEM, V278, P47660, DOI 10.1074/jbc.M304743200; Brandenburg K, 2002, THERMOCHIM ACTA, V382, P189, DOI 10.1016/S0040-6031(01)00731-6; Brandenburg K, 2002, EUR J BIOCHEM, V269, P5972, DOI 10.1046/j.1432-1033.2002.03333.x; Brandenburg K, 2005, BIOPHYS J, V88, P1845, DOI 10.1529/biophysj.104.047944; Brandenburg K, 2011, APPL MICROBIOL BIOT, V90, P799, DOI 10.1007/s00253-011-3185-7; Brandenburg K, 1999, J STRUCT BIOL, V128, P175, DOI 10.1006/jsbi.1999.4186; Carrillo EH, 2002, J TRAUMA, V52, P449, DOI 10.1097/00005373-200203000-00006; Clark RJ, 1986, SPECTROSCOPY BIOL SY; Domingues MM, 2012, PEPTIDE SCI, V98, P338; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Howe J, 2008, INNATE IMMUN, V14, P39, DOI 10.1177/1753425907087257; Howe J, 2007, MED CHEM, V3, P13, DOI 10.2174/157340607779317625; Jurgens G, 2001, EUR J BIOCHEM, V268, P4233, DOI 10.1046/j.1432-1327.2001.02338.x; Jurgens G, 2002, J ENDOTOXIN RES, V8, P115, DOI 10.1179/096805102125000263; KENNEDY DF, 1991, BIOCHEMISTRY-US, V30, P6541, DOI 10.1021/bi00240a026; KOTANI S, 1985, INFECT IMMUN, V49, P225; LEVITT M, 1977, J MOL BIOL, V114, P181, DOI 10.1016/0022-2836(77)90207-8; LUDERITZ O, 1966, ANN NY ACAD SCI, V133, P349, DOI 10.1111/j.1749-6632.1966.tb52376.x; Pike AF, 2013, BBA-MOL BASIS DIS, V1832, P2044, DOI 10.1016/j.bbadis.2013.07.016; Richter W, 2011, INNATE IMMUN-LONDON, V17, P427, DOI 10.1177/1753425910372434; Roth R I, 1994, Prog Clin Biol Res, V388, P161; Roth RI, 1996, THROMB HAEMOSTASIS, V76, P258; Schromm AB, 2007, J BIOL CHEM, V282, P11030, DOI 10.1074/jbc.M700287200; Schuerholz T, 2013, CRIT CARE, V17, DOI 10.1186/cc11920; Schuerholz T, 2012, CRIT CARE, V16, DOI 10.1186/cc11220; Steinstraesser L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039373; Su DH, 1999, CRIT CARE MED, V27, P771, DOI 10.1097/00003246-199904000-00034; Wellinghausen N, 1996, J IMMUNOL, V157, P3139	58	3	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-4259	1753-4267		INNATE IMMUN-LONDON	Innate Immun.	APR	2015	21	3					305	313		10.1177/1753425914535957		9	Biochemistry & Molecular Biology; Immunology; Medicine, Research & Experimental; Microbiology	Biochemistry & Molecular Biology; Immunology; Research & Experimental Medicine; Microbiology	CC3IQ	WOS:000350240900007		
J	Semboshi, S; Tsuda, H; Kaneno, Y; Iwase, A; Takasugi, T				Semboshi, Satoshi; Tsuda, Hiroyuki; Kaneno, Yasuyuki; Iwase, Akihiro; Takasugi, Takayuki			Thermal conductivity of Ni3V-Ni3Al pseudo-binary alloys	INTERMETALLICS			English	Article						Intermetallics; Thermal properties; Microstructure; Physical properties	V TYPE STRUCTURES; PACKED NI3X X; INTERMETALLIC ALLOYS; MECHANICAL-PROPERTIES; PHASE-EQUILIBRIA; AL; TI; STABILITY; SYSTEMS	The effect of changes in the composition and microstructure of the Ni3V-Ni3Al pseudo-binary alloys on their thermal conductivity has been investigated. For Ni3V and Ni3Al-based single-phase alloys, the thermal conductivity shows a maximum value at the stoichiometric compositions, and it decreases as the V (or Al) content of the Ni3Al (or Ni3V) alloy increases, following the Nordheim rule. For Ni3V-Ni3Al two-phase alloys, the thermal conductivity of the constituent Ni3Al phase exhibits a smaller value than that of the Ni3V phase. Eventually, the thermal conductivity of the two-phase alloys decreases as the Al content increases because of the increase in the volume fraction of the Ni3Al phase with low conductivity. As the temperature increases from 293 K to 1073 K, the conductivity increases for all of the alloys but not for stoichiometric Ni3V. However, the dependence of the thermal conductivity on the alloy composition between 293 K and 1073 K is similar. Hence, it is confirmed that the thermal conductivity of the Ni3V-Ni3Al pseudo-binary alloys is controlled by the composition and volume fraction of the constituent phase. (C) 2014 Elsevier Ltd. All rights reserved.	[Semboshi, Satoshi] Tohoku Univ, Kansai Ctr, Inst Mat Res, Naka Ku, Sakai, Osaka 5998531, Japan; [Semboshi, Satoshi; Tsuda, Hiroyuki; Kaneno, Yasuyuki; Iwase, Akihiro; Takasugi, Takayuki] Osaka Prefecture Univ, Dept Mat Sci, Naka Ku, Sakai, Osaka 5998531, Japan	Semboshi, S (reprint author), Tohoku Univ, Kansai Ctr, Inst Mat Res, Naka Ku, Gakuen Cho 1-1, Sakai, Osaka 5998531, Japan.	semboshi@imr.tohoku.ac.jp			Japan Society for the Promotion of Science (JSPS) [26420663]	The authors are grateful to Prof. N. Masahashi of the Institute for Materials Research (IMR) at Tohoku University for useful discussions and comments. The authors also thank Mr. E. Aoyagi and Dr. T. Ashino of the IMR for their technical assistance. Financial support provided by the Japan Society for the Promotion of Science (JSPS) as a Grant-in-Aid for Scientific Research (C) (No. 26420663) is gratefully acknowledged.	PARKER WJ, 1961, J APPL PHYS, V32, P1679, DOI 10.1063/1.1728417; TERADA Y, 1995, INTERMETALLICS, V3, P347, DOI 10.1016/0966-9795(95)94253-B; Shibuya S, 2006, ACTA MATER, V54, P861, DOI 10.1016/j.actamat.2005.10.016; Liu CT, 1997, INTERMETALLICS, V5, P579, DOI 10.1016/S0966-9795(97)00045-9; Nunomura Y, 2006, ACTA MATER, V54, P851, DOI 10.1016/j.actama.2005.10.014; LIU CT, 1995, MATER CHEM PHYS, V42, P77, DOI 10.1016/0254-0584(95)01546-9; MOOIJ JH, 1973, PHYS STATUS SOLIDI A, V17, P521, DOI 10.1002/pssa.2210170217; Kobayashi S, 2012, INTERMETALLICS, V23, P68, DOI 10.1016/j.intermet.2011.12.008; Zheng X, 2007, ACTA MATER, V55, P5177, DOI 10.1016/j.actamat.2007.05.037; Min S, 2007, THERMOCHIM ACTA, V455, P46, DOI 10.1016/j.tca.2006.11.026; Yamaguchi M, 2000, ACTA MATER, V48, P307, DOI 10.1016/S1359-6454(99)00301-8; LANDAUER R, 1952, J APPL PHYS, V23, P779, DOI 10.1063/1.1702301; MISHIMA Y, 1991, MAT SCI ENG A-STRUCT, V146, P123, DOI 10.1016/0921-5093(91)90272-O; Caillard D, 2001, MAT SCI ENG A-STRUCT, V319, P74, DOI 10.1016/S0921-5093(00)02017-7; HITCHCOC.AH, 1971, PHYS LETT A, VA 35, P80; Hong TM, 1989, P MAT RES SOC MRS S, V133, P429; MAZDIYASNI S, 1989, SCRIPTA METALL MATER, V23, P327, DOI 10.1016/0036-9748(89)90376-1; MIYAKE J, 1992, ACTA METALL MATER, V40, P733, DOI 10.1016/0956-7151(92)90015-7; Moronaga T, 2012, MAT SCI ENG A-STRUCT, V539, P30, DOI 10.1016/j.msea.2011.12.106; Poduri R, 1998, ACTA MATER, V46, P1719, DOI 10.1016/S1359-6454(97)00335-2; SHIRAI Y, 1995, INTERMETALLICS, V3, P381, DOI 10.1016/0966-9795(95)94256-E; Suzuki A, 2004, INTERMETALLICS, V12, P969, DOI 10.1016/j.intermet.2004.02.028; Takasugi T, 2009, MATER RES SOC SYMP P, V1128, P351; Terada Y, 1997, MAT SCI ENG A-STRUCT, V240, P907, DOI 10.1016/S0921-5093(97)00682-5; Terada Y, 2001, MAT SCI ENG A-STRUCT, V311, P232, DOI 10.1016/S0921-5093(01)01231-X; YOO MH, 1993, ACTA METALL MATER, V41, P987, DOI 10.1016/0956-7151(93)90148-L	26	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0966-9795	1879-0216		INTERMETALLICS	Intermetallics	APR	2015	59						1	7		10.1016/j.intermet.2014.12.006		7	Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Chemistry; Materials Science; Metallurgy & Metallurgical Engineering	CC2OZ	WOS:000350185800001		
J	Zhang, MX; Li, JW; Kong, FL; Liu, J				Zhang, Mingxiao; Li, Jiawei; Kong, Fanli; Liu, Jian			Magnetic properties and magnetocaloric effect of FeCrNbYB metallic glasses with high glass-forming ability	INTERMETALLICS			English	Article						Metallic glasses; Glass forming ability; Magnetic properties; Thermal properties	ROOM-TEMPERATURE; CURIE-TEMPERATURE; ALLOY RIBBONS; NB; REFRIGERATION; CR; SI; TRANSITIONS	The influences of Cr addition on the Curie temperature (T-C), glass-forming ability (GFA), and magnetocaloric effect were investigated in FeCrNbYB metallic glasses. It was found that the addition of Cr element slightly decreases the GFA and saturation magnetization, whereas effectively modulates T-C. By the method of copper mold casting, bulk metallic glasses (BMGs) with critical diameters up to 5 mm can be obtained in Fe68-xCrxNb4Y6B22 (x = 2-6) alloys. The resulting metallic glasses exhibit T-C of 271-367 K and excellent magnetocaloric properties, including magnetic entropy change of 0.76-1.05 J/kg K, and refrigerant capacity of 83-93 J/kg under a low field change of 1.5 T. In addition, they exhibit a wide supercooled liquid region of 116-135 K. The successful synthesis of the FeCrNbYB BMGs with near room-temperature magnetocaloric properties is encouraging for the future development of Fe-based BMGs as a new magnetic refrigerant in magnetic cooling system. (C) 2014 Elsevier Ltd. All rights reserved.	[Zhang, Mingxiao; Li, Jiawei; Liu, Jian] Chinese Acad Sci, Ningbo Inst Mat Technol & Engn, Key Lab Magnet Mat & Devices, Ningbo 315201, Zhejiang, Peoples R China; [Zhang, Mingxiao; Li, Jiawei; Liu, Jian] Chinese Acad Sci, Ningbo Inst Mat Technol & Engn, Zhejiang Prov Key Lab Magnet Mat & Applicat Techn, Ningbo 315201, Zhejiang, Peoples R China; [Kong, Fanli] Josai Int Univ, Int Inst Green Mat, Togane 2838555, Japan	Zhang, MX (reprint author), Chinese Acad Sci, Ningbo Inst Mat Technol & Engn, Key Lab Magnet Mat & Devices, Ningbo 315201, Zhejiang, Peoples R China.	mxzhang@nimte.ac.cn; liujian@nimte.ac.cn	Liu, Jian/A-2309-2010		China Postdoctoral Science Foundation [2013M541553]; National Natural Science Foundation of China [51371184]; Zhejiang Provincial Natural Science Foundation of China [LR14E010001]	This work was supported by the China Postdoctoral Science Foundation (Grant No. 2013M541553), National Natural Science Foundation of China (Grant No. 51371184), and Zhejiang Provincial Natural Science Foundation of China (Grant No. LR14E010001).	Alvarez P, 2010, INTERMETALLICS, V18, P2464, DOI 10.1016/j.intermet.2010.07.018; Alvarez-Alonso P, 2013, J MAGN MAGN MATER, V347, P75, DOI 10.1016/j.jmmm.2013.07.048; Franco V, 2012, ANNU REV MATER RES, V42, P305, DOI 10.1146/annurev-matsci-062910-100356; Smith A, 2012, ADV ENERGY MATER, V2, P1288, DOI 10.1002/aenm.201200167; Bitoh T, 2003, MATER TRANS, V44, P2020, DOI 10.2320/matertrans.44.2020; Huang XM, 2009, SCRIPTA MATER, V60, P152, DOI 10.1016/j.scriptamat.2008.09.022; Makino A, 2008, J MAGN MAGN MATER, V320, P2499, DOI 10.1016/j.jmmm.2008.04.063; Zhang HY, 2013, J MAGN MAGN MATER, V347, P131, DOI 10.1016/j.jmmm.2013.07.020; Lin CY, 2007, J PHYS D APPL PHYS, V40, P310, DOI 10.1088/0022-3727/40/2/004; Lee S, 2009, INTERMETALLICS, V17, P218, DOI 10.1016/j.intermet.2008.07.021; Gschneidner KA, 2000, ANNU REV MATER SCI, V30, P387, DOI 10.1146/annurev.matsci.30.1.387; Franco V, 2006, J APPL PHYS, V100, DOI 10.1063/1.2358311; TURNBULL D, 1969, CONTEMP PHYS, V10, P473, DOI 10.1080/00107516908204405; Franco V, 2010, INT J REFRIG, V33, P465, DOI 10.1016/j.ijrefrig.2009.12.019; Trexler MM, 2010, PROG MATER SCI, V55, P759, DOI 10.1016/j.pmatsci.2010.04.002; Waske A, 2012, J APPL PHYS, V112, DOI 10.1063/1.4770468; Caballero-Flores R, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3427439; Pecharsky VK, 2006, INT J REFRIG, V29, P1239, DOI 10.1016/j.ijrefrig.2006.03.020; Mizushima T, 1999, J APPL PHYS, V85, P4418, DOI 10.1063/1.369803; Law JY, 2010, J ALLOY COMPD, V508, P14, DOI 10.1016/j.jallcom.2010.08.049; Zhukova V, 2006, J MAGN MAGN MATER, V300, P16, DOI 10.1016/j.jmmm.2005.10.024; Lu ZP, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.115505; Caballero-Flores R, 2010, J APPL PHYS, V108, DOI 10.1063/1.3489990; CHIEN CL, 1979, PHYS REV B, V19, P81, DOI 10.1103/PhysRevB.19.81; De Boer F. R., 1989, COHESION METALS, P217; Fang YK, 2009, J APPL PHYS, V105, DOI 10.1063/1.3054369; Franco V, 2007, J APPL PHYS, V101, DOI 10.1063/1.2709409; Franco V, 2012, SCRIPTA MATER, V67, P594, DOI 10.1016/j.scriptamat.2012.05.004; HASHIMOTO T, 1981, CRYOGENICS, V21, P647, DOI 10.1016/0011-2275(81)90254-X; Kim KS, 2006, J MAGN MAGN MATER, V304, pE642, DOI 10.1016/j.jmmm.2006.02.156; Lee S, 2008, MATER TRANS, V49, P506, DOI 10.2320/matertrans.MBW200732; Min SG, 2007, MAT SCI ENG A-STRUCT, V449, P423, DOI 10.1016/j.msea.2006.02.357; Mishra D, 2010, MATER SCI ENG B-ADV, V175, P253, DOI 10.1016/j.mseb.2010.07.038; Schwarz B, 2011, J MAGN MAGN MATER, V323, P1782, DOI 10.1016/j.jmmm.2011.02.004; Stoica MH, 2002, MATER TRANS, V43, P1966, DOI 10.2320/matertrans.43.1966; Yapp R, 2000, J MAGN MAGN MATER, V215, P300, DOI 10.1016/S0304-8853(00)00139-6; Zhang MX, 2013, J APPL PHYS, V113, DOI 10.1063/1.4800837	37	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0966-9795	1879-0216		INTERMETALLICS	Intermetallics	APR	2015	59						18	22		10.1016/j.intermet.2014.12.005		5	Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Chemistry; Materials Science; Metallurgy & Metallurgical Engineering	CC2OZ	WOS:000350185800003		
J	Nagase, T; Rack, PD; Noh, JH; Egami, T				Nagase, Takeshi; Rack, Philip D.; Noh, Joo Hyon; Egami, Takeshi			In-situ TEM observation of structural changes in nano-crystalline CoCrCuFeNi multicomponent high-entropy alloy (HEA) under fast electron irradiation by high voltage electron microscopy (HVEM)	INTERMETALLICS			English	Article						High-entropy alloys; Irradiation effects; In situ; Microstructure	ORDER-DISORDER TRANSFORMATION; NI PHASE-DIAGRAM; HF-NB ALLOY; CO-CU-FE; METALLIC GLASSES; STABILITY; SYSTEM; AMORPHIZATION; TRANSITION; CHROMIUM	The structural changes induced in a CoCrCuFeNi multicomponent nano-crystalline high-entropy alloy (HEA) under fast electron irradiation were investigated by in-situ transmission electron microscopy (TEM) using a high voltage electron microscope (HVEM). A fine-grained face centered cubic (fcc) single phase was obtained in the sputtered specimens. The fcc solid solution showed high phase stability against irradiation over a wide temperature range from 298 to 773 K, and remained as the main constituent phase even when the samples were irradiated up to 40 displacement per atom (dpa). Moreover, the irradiation did not seem to induce grain coarsening. This is the first report on the irradiation damage in 5-component HEA under MeV electron irradiation. (C) 2014 Elsevier Ltd. All rights reserved.	[Nagase, Takeshi] Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, Ibaraki, Osaka 5670047, Japan; [Nagase, Takeshi] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan; [Rack, Philip D.; Egami, Takeshi] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; [Rack, Philip D.; Noh, Joo Hyon; Egami, Takeshi] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA; [Egami, Takeshi] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA	Nagase, T (reprint author), Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, 7-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.	t-nagase@uhvem.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Joint Institute for Advanced Materials at the University of Tennessee; Oak Ridge National Laboratory; Department of Energy [DE-AC07-05ID14517]	This work was supported in part by the Grants for Excellent Graduate Schools from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. PDR and JHN acknowledge support from the Joint Institute for Advanced Materials at the University of Tennessee and the Oak Ridge National Laboratory. TE acknowledges support from the Department of Energy through the NEUP program, DE-AC07-05ID14517.	ADAM J, 1952, PHILOS MAG, V43, P1216; Anada S, 2013, J ALLOY COMPD, V579, P646, DOI 10.1016/j.jallcom.2013.06.122; Anada S, 2014, ACTA MATER, V71, P195, DOI 10.1016/j.actamat.2014.03.023; Okamoto H, 2003, J PHASE EQUILIB, V24, P377, DOI 10.1361/105497103770330460; Ong SP, 2008, CHEM MATER, V20, P1798, DOI 10.1021/cm702327g; Yeh JW, 2004, ADV ENG MATER, V6, P299, DOI 10.1002/adem.200300567; SINKLER W, 1993, SCRIPTA METALL MATER, V28, P863, DOI 10.1016/0956-716X(93)90367-2; Nagase T, 2013, INTERMETALLICS, V38, P70, DOI 10.1016/j.intermet.2013.02.009; Turchi PEA, 2006, CALPHAD, V30, P70, DOI 10.1016/j.calphad.2005.10.003; Jain A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.045115; Yang CW, 1996, J PHASE EQUILIB, V17, P522, DOI 10.1007/BF02665999; Palumbo M, 2006, CALPHAD, V30, P171, DOI 10.1016/j.calphad.2005.10.007; Jain A, 2011, COMP MATER SCI, V50, P2295, DOI 10.1016/j.commatsci.2011.02.023; SCHULSON EM, 1979, J NUCL MATER, V83, P239, DOI 10.1016/0022-3115(79)90610-X; Nagase T, 2012, J NON-CRYST SOLIDS, V358, P502, DOI 10.1016/j.jnoncrysol.2011.11.010; Nagase T, 2012, INTERMETALLICS, V26, P122, DOI 10.1016/j.intermet.2012.02.015; Zhang Y, 2008, ADV ENG MATER, V10, P534, DOI 10.1002/adem.200700240; Egami T, 2014, METALL MATER TRANS A, V45A, P180, DOI 10.1007/s11661-013-1994-2; Amara SE, 1999, Z METALLKD, V90, P116; MCKINLEY WA, 1948, PHYS REV, V74, P1759, DOI 10.1103/PhysRev.74.1759; Cantor B, 2004, MAT SCI ENG A-STRUCT, V375, P213, DOI 10.1016/j.msea.2003.10.257; BANERJEE S, 1984, PHYS STATUS SOLIDI A, V81, P145, DOI 10.1002/pssa.2210810114; BANERJEE S, 1984, ACTA METALL MATER, V32, P299, DOI 10.1016/0001-6160(84)90103-2; Bein S, 2000, J ALLOY COMPD, V313, P133, DOI 10.1016/S0925-8388(00)01198-1; Carpenter GJC, 1978, J NUCL MATER, V23, P180; Chakrabarti DJ, 1990, BINARY ALLOY PHASE D, V2; Chen SL, 2006, J PHASE EQUILIB DIFF, V27, P121, DOI 10.1361/154770306X97137; Corbett J. W., 1966, ELECT RAD DAMAGE SEM; Decker D, 1968, PHYS STATUS SOLIDI, V30, P219; DIXON CE, 1953, PHILOS MAG, V44, P449; Haschimoto U, 1937, NIPPON KINZOKU GAKKA, V1, P177; HOWE LM, 1974, J NUCL MATER, V50, P139, DOI 10.1016/0022-3115(74)90151-2; Kiritani M, 1977, P 5 INT C HIGH VOLT, V501; KOCZAK MJ, 1971, ACTA METALL MATER, V19, P303, DOI 10.1016/0001-6160(71)90096-4; Leonov MP, 1986, PHYS CHEM, V290, P886; Miettinen J, 2005, CALPHAD, V29, P40, DOI 10.1016/j.calphad.2005.02.002; Mori H, 1997, PHYS TECHNOL, P120; Nagase T, 2011, INTERMETALLICS, V19, P1313, DOI 10.1016/j.intermet.2011.04.013; Nagase T, UNPUB; Nagase T, 2013, J SOC MAT SCI JPN, V62, P185; Nagase T., 2013, PROGR ADV STRUCTURAL, P137; Nagase T, 2007, MATER TRANS, V48, P1651, DOI 10.2320/matertrans.MJ200701; Nagase T, 2003, SCRIPTA MATER, V48, P1237, DOI 10.1016/S1359-6462(03)00056-3; Nishizawa T, 1990, BINARY ALLOY PHASE D, V2; OEN OS, 1988, NUCL INSTRUM METH B, V33, P744, DOI 10.1016/0168-583X(88)90672-6; Okamoto H, 1997, J PHASE EQUILIB, V18, P221, DOI 10.1007/BF02665713; Ranganathan S, 2003, CURR SCI INDIA, V85, P1404; Rar A, 2005, MEAS SCI TECHNOL, V16, P46, DOI 10.1088/0957-0233/16/1/007; REUTER KB, 1989, METALL TRANS A, V20, P719, DOI 10.1007/BF02667589; REUTER KB, 1989, METALL TRANS A, V20, P711, DOI 10.1007/BF02667588; TOMISKA J, 1985, BER BUNSEN PHYS CHEM, V89, P1104; URBAN K, 1979, PHYS STATUS SOLIDI A, V56, P157, DOI 10.1002/pssa.2210560116; Urban K., 1980, ELECT MICROSC, V4, P188; Ustinovshikov YI, 2006, INORG MATER+, V42, P354, DOI 10.1134/S0020168506040042	54	5	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0966-9795	1879-0216		INTERMETALLICS	Intermetallics	APR	2015	59						32	42		10.1016/j.intermet.2014.12.007		11	Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Chemistry; Materials Science; Metallurgy & Metallurgical Engineering	CC2OZ	WOS:000350185800005		
J	Furukawa, M; Morishita, M; Yokoyama, S				Furukawa, Masao; Morishita, Mimpei; Yokoyama, Shuichi			Feasibility study of electromagnetic driven dream pipe	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article						Dream pipe; Forced oscillation; Electromagnetic drive; Enhanced heat transfer	HIGH-FREQUENCY OSCILLATIONS; HEAT-TRANSFER; LONGITUDINAL DISPERSION; PIEZOELECTRIC FAN; FLOW; TUBES; TRANSPORT	Dream pipes, a kind of forced oscillatory heat pipes, necessarily require some driving mechanisms for oscillations of enclosed working fluids. Commonly fitted up are mechanical shakers but not suited for practical use because of becoming quite large in volume. Proposed in this study is an innovative type of dream pipe with an electromagnetically actuated oscillating disk. The driving principle basically follows Lorentz force generated upon electric wires set on the disk, in the radial direction of which a periodically varying magnetic field is formed by applying the three-phase alternating current. Feasibilities of this new device are theoretically examined by analyses from both thermal and electrical points of view. Heat transfer analysis is first made to determine the required driving force, from which the tidal displacement of the fluids is derived to show a resulted possible oscillation amplitude. Joule heat minimization analysis is then made to specify a suitable couple of the applied direct and alternating current voltages. Such specified voltages may go down to a lowest level by selecting the driving frequency to become an intrinsic one. The specific power, defined as the power to heat ratio, is introduced as a performance index of that device. Numerical results show that less specific power than 0.10 is possible in most of supposed design cases and that the required magnetic flux density is far smaller than 0.5 T. It is thus concluded that the electromagnetic driven dream pipe is realizable. A 400 W m class dream pipe of electromagnetic drive is then design-specified as a demonstrative example. (C) 2014 Elsevier Ltd. All rights reserved.	[Furukawa, Masao; Morishita, Mimpei; Yokoyama, Shuichi] Kogakuin Univ, Dept Elect Syst Engn, Shinjuku Ku, Tokyo 1638677, Japan	Furukawa, M (reprint author), Kogakuin Univ, Dept Elect Syst Engn, Shinjuku Ku, 1-24-2 Nishi Shinjuku, Tokyo 1638677, Japan.	au40740@ns.kogakuin.ac.jp					Ahmadian M.T., 2006, 8 BIENN ASME C ENG S; Akachi H., 1993, SAE AEROSPACE APPL T, Patent No. 5219020; Akachi H., 1993, US Patent, Patent No. 5219020; Akachi H., 1990, US Patent, Patent No. [4921041, 4,921,041]; Huang CH, 2012, INT J HEAT MASS TRAN, V55, P5289, DOI 10.1016/j.ijheatmasstransfer.2012.05.037; [Anonymous], 1994, SAE Aerospace Applied Thermodynamics Manual, AIR1168/6, P32, Patent No. 2012029954; Park JH, 2002, JSME INT J C-MECH SY, V45, P502, DOI 10.1299/jsmec.45.502; Vasiliev LL, 2005, APPL THERM ENG, V25, P1, DOI 10.1016/j.applthermaleng.2003.12.004; Liu SF, 2009, INT J HEAT MASS TRAN, V52, P2565, DOI 10.1016/j.ijheatmasstransfer.2009.01.013; WATSON EJ, 1983, J FLUID MECH, V133, P233, DOI 10.1017/S0022112083001883; CHATWIN PC, 1975, J FLUID MECH, V71, P513, DOI 10.1017/S0022112075002716; JAEGER MJ, 1983, PHYS FLUIDS, V26, P1380, DOI 10.1063/1.864323; Yeom T, 2012, INT J HEAT MASS TRAN, V55, P7398, DOI 10.1016/j.ijheatmasstransfer.2012.07.019; Burt W., 2003, SPACECRAFT THERMAL C, V2, P135; Eastman A, 2012, INT J HEAT MASS TRAN, V55, P2461, DOI 10.1016/j.ijheatmasstransfer.2012.01.014; Fukuda T., 2012, IEEJ JOINT TECH M MD, P17; Furukawa M., 2011, ASME J HEAT TRANSFER, V133, P1; Furukawa M, 2003, J HEAT TRANS-T ASME, V125, P1183, DOI 10.1115/1.1597615; Goodman T. R., 1964, ADV HEAT TRANSFER, V1, P51, DOI 10.1016/S0065-2717(08)70097-2; Hassami M.A., 2011, J ENHANC HEAT TRANSF, V18, P295; Hishida M, 2009, INT J HEAT MASS TRAN, V52, P5634, DOI 10.1016/j.ijheatmasstransfer.2009.05.018; Katsuta M., 1991, P 3 ASME JSME JOINT, V3, P69; Kaviany M., 1990, ASME J HEAT TRANSFER, V112, P56; Kdvidny M., 1990, ASME J HEAT TRANSFER, V112, P49; Khandekar S., 2010, FRONT HEAT PIPES, V1, P1; Kurzweg O.H., 1985, ASME J HEAT TRANSFER, V107, P459; KURZWEG UH, 1986, INT J HEAT MASS TRAN, V29, P1969, DOI 10.1016/0017-9310(86)90016-5; KURZWEG UH, 1984, PHYS FLUIDS, V27, P2624, DOI 10.1063/1.864563; NISHIO S, 1995, INT J HEAT MASS TRAN, V38, P2457, DOI 10.1016/0017-9310(94)00372-3; OZAWA M, 1991, INT J HEAT MASS TRAN, V34, P3083; Patel R., 2006, 8 BIENN ASME C ENG S; Rocha LAO, 2001, J HEAT TRANS-T ASME, V123, P233, DOI 10.1115/1.1337654; Schmit L.A., 1956, 56287 WADC ASTIA MIT; Takahashi I., 1995, HEAT TRANSFER JPN RE, V23, P525; Yokoyama S., 2012, Japanese Patent Application, Patent No. [2012-029954, 4590993]; Zhang J.G., 1991, AIAA J THERMOPHYSICS, V5, P401; ZHANG JG, 1991, AIP CONF PROC, V217, P728	37	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310	1879-2189		INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	APR	2015	83						212	221		10.1016/j.ijheatmasstransfer.2014.11.072		10	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	CC1CY	WOS:000350080000021		
J	Fiedler, T; Borovinsek, M; Hokamoto, K; Vesenjak, M				Fiedler, T.; Borovinsek, M.; Hokamoto, K.; Vesenjak, M.			High-performance thermal capacitors made by explosion forming	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article						Thermal capacitor; Cellular metal; Phase change material; Experimental analysis; Finite element method	ENERGY STORAGE TECHNOLOGIES; PHASE-CHANGE MATERIALS; HEAT SINK; CONDUCTIVITY; COMPOSITES; MATRIX	This paper addresses the thermal testing of UniPore-paraffin composites for use as thermal capacitors. UniPore is a relatively new porous material with unidirectional pores formed by the explosive fusion of multiple thin copper pipes filled with paraffin. The current study investigates the suitability of this composite for transient thermal energy storage. The application demands both high thermal diffusivity and a large specific energy storage capacity. These requirements are met by the highly conductive copper and the phase change material paraffin, respectively. Combined experimental and numerical analyses are conducted towards the determination of temperature stabilization performance. Furthermore, key geometric criteria for the design of optimum UniPore structures as thermal capacitors are identified. (C) 2014 Elsevier Ltd. All rights reserved.	[Fiedler, T.] Univ Newcastle, Sch Engn, Callaghan, NSW 2287, Australia; [Borovinsek, M.; Vesenjak, M.] Univ Maribor, Fac Mech Engn, Maribor 2000, Slovenia; [Hokamoto, K.] Kumamoto Univ, Inst Pulsed Power Sci, Chuo Ku, Kumamoto 8608555, Japan	Fiedler, T (reprint author), Univ Newcastle, Sch Engn, Callaghan, NSW 2287, Australia.	Thomas.Fiedler@newcastle.edu.au			Kumamoto University, Japan; European Regional Development Fund; Operational Programme for Strengthening Regional Development Potentials [3330-13-500032]; Australian Research Council (ARC) [094698]	The authors would like to acknowledge the support of Mr A. Sato and Mr R. Tsunoda (Kumamoto University, Japan). The research work was also produced within the framework of the operation entitled "Centre of Open innovation and ResEarchUM (CORE@UM)". The operation is co-funded by the European Regional Development Fund and conducted within the framework of the Operational Programme for Strengthening Regional Development Potentials for the period 2007-2013, development priority 1: "Competitiveness of companies and research excellence", priority axis 1.1: "Encouraging competitive potential of enterprises and research excellence", contact No. 3330-13-500032. One of the authors (T. Fiedler) further acknowledges financial support by the Australian Research Council (ARC) in framework of the Discovery Project DPI 094698.	Powell KM, 2012, CHEM ENG SCI, V71, P138, DOI 10.1016/j.ces.2011.12.009; Hokamoto K, 2014, MATER LETT, V137, P323, DOI 10.1016/j.matlet.2014.09.039; Wang Q, 2012, INT J REFRIG, V35, P7, DOI 10.1016/j.ijrefrig.2011.09.001; Pomianowski M, 2013, ENERG BUILDINGS, V67, P56, DOI 10.1016/j.enbuild.2013.08.006; Solorzano E, 2008, INT J HEAT MASS TRAN, V51, P6259, DOI 10.1016/j.ijheatmasstransfer.2007.11.062; Tian Y, 2011, ENERGY, V36, P5539, DOI 10.1016/j.energy.2011.07.019; Chan CW, 2013, APPL THERM ENG, V50, P1257, DOI 10.1016/j.applthermaleng.2012.06.041; Jankowski NR, 2014, APPL ENERG, V113, P1525, DOI 10.1016/j.apenergy.2013.08.026; Ukrainczyk N, 2010, CHEM BIOCHEM ENG Q, V24, P129; Hosseinizadeh SF, 2011, APPL THERM ENG, V31, P3827, DOI 10.1016/j.applthermaleng.2011.07.031; Mesalhy O, 2005, ENERG CONVERS MANAGE, V46, P847, DOI 10.1016/j.enconman.2004.06.010; Fiedler T, 2013, APPL THERM ENG, V58, P314, DOI 10.1016/j.applthermaleng.2013.04.022; Gibson L. J., 1997, CELLULAR SOLIDS STRU; Vesenjak M., 2008, DEFECT DIFFUS FORUM, V273-276, P669; Vesenjak M., MAT DESIGN UNPUB; Weast R., 1981, CRC HDB CHEM PHYS	16	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310	1879-2189		INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	APR	2015	83						366	371		10.1016/j.ijheatmasstransfer.2014.12.025		6	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	CC1CY	WOS:000350080000037		
J	Li, K; Matsumoto, S; Imaishi, N; Hu, WR				Li, Kai; Matsumoto, Satoshi; Imaishi, Nobuyuki; Hu, Wen-Rui			Marangoni flow in floating half zone of molten tin	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article						Marangoni flow; Flow instabilities; Deformed half zone; Buoyancy	THERMOCAPILLARY LIQUID BRIDGES; PRANDTL NUMBER FLUID; NUMERICAL-SIMULATION; LINEAR-STABILITY; CONVECTION; INSTABILITIES	Gravity affects the stability of Marangoni flow in floating half zone of low-Pr fluids through two different factors, i.e., the buoyancy and the static deformation of the free surface shape. In the present study, influence of these two factors are evaluated by unsteady three-dimensional (3D) simulations for a realistic model of floating half zone of molten tin (Pr = 0.009) with an aspect ratio As = 2.0 under a ramped temperature difference (1.19 K/rnin) between the top and bottom ends of two iron supporting rods. The corresponding first critical conditions for the onset of 3D asymmetric non-oscillatory flows and the second critical conditions for the onset of 3D oscillatory flows are determined. Simulation results indicate that the fee surface deformation is the most influential factor for the critical conditions of the flow transitions. Buoyancy is less influential to the flow transitions. However, buoyancy causes multiple step transitions between different 3D asymmetric non-oscillatory flow modes. (C) 2014 Elsevier Ltd. All rights reserved.	[Li, Kai; Hu, Wen-Rui] Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Beijing 100190, Peoples R China; [Matsumoto, Satoshi] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Tsukuba, Ibaraki, Japan; [Imaishi, Nobuyuki] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan	Li, K (reprint author), Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Beijing 100190, Peoples R China.	likai@imech.ac.cn; imaishi@cm.kyushu-u.ac.jp			National Natural Science Foundation of China [11032011, 11472282]; Japan Society for Promotion of Science (KAKENHI) [17360087]	This research was supported by the National Natural Science Foundation of China (11032011, 11472282) and the Japan Society for Promotion of Science (KAKENHI 17360087).	SMITH MK, 1983, J FLUID MECH, V132, P119, DOI 10.1017/S0022112083001512; CHEN JC, 1995, J CRYST GROWTH, V154, P98, DOI 10.1016/0022-0248(95)00095-X; Croell A., 1989, MAT RES B, V24, P995; Croell A., 1994, J CRYST GROWTH, V137, P95; Han JH, 1996, J CRYST GROWTH, V169, P129, DOI 10.1016/0022-0248(96)00263-1; Hibiya T, 1999, ADV SPACE RES, V24, P1225, DOI 10.1016/S0273-1177(99)00724-3; Hibiya T, 2008, ADV SPACE RES, V41, P2107, DOI 10.1016/j.asr.2007.04.106; Imaishi N, 2001, J CRYST GROWTH, V230, P164, DOI 10.1016/S0022-0248(01)01332-X; Kuhlmann HC, 2002, ADV SPACE RES, V29, P639, DOI 10.1016/S0273-1177(01)00665-2; Lappa M, 2003, INT J NUMER METHOD H, V13, P309, DOI 10.1108/09615530310464526; Lappa M., 2005, COMPUT FLUIDS, V34, P643; Levenstam M, 2001, PHYS FLUIDS, V13, P807, DOI 10.1063/1.1337063; Levenstam M, 1996, J CRYST GROWTH, V158, P224, DOI 10.1016/0022-0248(95)00466-1; Li K, 2007, J CRYST GROWTH, V307, P155, DOI 10.1016/j.jcrysgro.2007.03.064; Li K, 2008, INT J HEAT FLUID FL, V29, P1190, DOI 10.1016/j.ijheatfluidflow.2008.02.011; Li K, 2005, J CRYST GROWTH, V280, P620, DOI 10.1016/j.jcrysgro.2005.03.087; Matsumoto S., 2004, THERMAL SCI ENG, V12, P21; Matsumoto S., 2005, JAXARR04027E, P112; Nienhuser C, 2002, J FLUID MECH, V458, P35, DOI 10.1017/S0022112001007650; RUPP R, 1989, J CRYST GROWTH, V97, P34, DOI 10.1016/0022-0248(89)90244-3; Shevtsova V, 2005, J CRYST GROWTH, V280, P632, DOI 10.1016/j.jcrysgro.2005.03.092; Takagi K, 2001, J CRYST GROWTH, V233, P399, DOI 10.1016/S0022-0248(01)01538-X; VELTEN R, 1991, PHYS FLUIDS A-FLUID, V3, P267, DOI 10.1063/1.858135; Wanschura M, 1997, PHYS REV E, V55, P7036, DOI 10.1103/PhysRevE.55.7036; WANSCHURA M, 1995, PHYS FLUIDS, V7, P912, DOI 10.1063/1.868567; Yang YK, 2001, J CRYST GROWTH, V222, P135, DOI 10.1016/S0022-0248(00)00936-2; Yasuhiro S, 2004, J CRYST GROWTH, V266, P152, DOI 10.1016/j.jcrysgro.2004.02.040; Yasuhiro S, 2004, J CRYST GROWTH, V262, P631, DOI 10.1016/j.jcrysgro.2003.10.042	28	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310	1879-2189		INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	APR	2015	83						575	585		10.1016/j.ijheatmasstransfer.2014.12.016		11	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	CC1CY	WOS:000350080000056		
J	Aoki, J; Hayashi, K; Tomiyama, A				Aoki, Jiro; Hayashi, Kosuke; Tomiyama, Akio			Mass transfer from single carbon dioxide bubbles in contaminated water in a vertical pipe	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article						Bubble; Mass transfer; Carbon dioxide (CO2); Surfactant	SOLUBLE SURFACTANTS; TAYLOR BUBBLE; DIFFUSION; INTERFACE; VELOCITY; FLOW	Mass transfer from single carbon dioxide bubbles rising through contaminated water in a vertical pipe of 12.5 mm diameter was measured to investigate effects of surfactant. The bubble diameter was widely varied to cover various bubble shapes such as spheroidal, wobbling, cap and Taylor bubbles. The gas and liquid phases were 99.9% purity carbon dioxide and a surfactant solution made of purified water and Triton X-100. Comparison of mass transfer rates between contaminated and clean bubbles made clear that the surfactant decreases the mass transfer rates of small bubbles. The Sherwood numbers of small bubbles in the extreme cases, i.e. zero and the highest surfactant concentrations, are well correlated in terms of the bubble Reynolds number, Schmidt number and the ratio, 2, of the bubble diameter to pipe diameter. The Sherwood numbers at intermediate surfactant concentrations, however, are not well correlated using available correlations. The mass transfer rates of Taylor bubbles also decrease with increasing the surfactant concentration. They however increase with the diameter ratio and approach those of clean Taylor bubbles as 2 increases. The main cause of this tendency was revealed by interface tracking simulations, i.e. the surfactant adsorbs only in the bubble tail region and the nose-to-side region is almost clean at high A. (C) 2014 Elsevier Ltd. All rights reserved.	[Aoki, Jiro; Hayashi, Kosuke; Tomiyama, Akio] Kobe Univ, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan	Tomiyama, A (reprint author), Kobe Univ, Grad Sch Engn, Nada Ku, Kobe, Hyogo 6578501, Japan.	tomiyama@mech.kobe-u.ac.jp			Japan Society for Promotion Science (JSPS) [24360070]	The authors would like to express their thanks to Prof. Shigeo Hosokawa and Mr. Shogo Hosoda for their assistance in this work and the financial support by the Japan Society for Promotion Science (JSPS) (Grants-in-aid for scientific research (B), No. 24360070).	Asgharpour M, 2010, BIOCHEM ENG J, V49, P351, DOI 10.1016/j.bej.2010.01.010; Hayashi K, 2012, INT J MULTIPHAS FLOW, V39, P78, DOI 10.1016/j.ijmultiphaseflow.2011.11.001; DAVIES RM, 1950, PROC R SOC LON SER-A, V200, P375, DOI 10.1098/rspa.1950.0023; FRUMKIN A, 1947, ZH FIZ KHIM+, V21, P1183; Sardeing R, 2006, CHEM ENG SCI, V61, P6249, DOI 10.1016/j.ces.2006.05.051; Tsuchiya K, 2001, CHEM ENG SCI, V56, P6411, DOI 10.1016/S0009-2509(01)00278-0; Hayashi K, 2014, INT J MULTIPHAS FLOW, V58, P236, DOI 10.1016/j.ijmultiphaseflow.2013.09.009; Rosso D, 2006, CHEM ENG SCI, V61, P5500, DOI 10.1016/j.ces.2006.04.018; Kurimoto R, 2013, INT J MULTIPHAS FLOW, V49, P8, DOI 10.1016/j.ijmultiphaseflow.2012.08.001; Muradoglu M, 2008, J COMPUT PHYS, V227, P2238, DOI 10.1016/j.jcp.2007.10.003; Alves SS, 2005, CHEM ENG SCI, V60, P1, DOI 10.1016/j.ces.2004.07.053; Hosoda S, 2014, INT J HEAT MASS TRAN, V69, P215, DOI 10.1016/j.ijheatmasstransfer.2013.10.031; Cuenot B, 1997, J FLUID MECH, V339, P25, DOI 10.1017/S0022112097005053; Vazquez G, 2000, CHEM ENG J, V78, P13, DOI 10.1016/S1385-8947(99)00174-6; Takemura F, 1999, J FLUID MECH, V378, P319, DOI 10.1017/S0022112098003358; BRACKBILL JU, 1992, J COMPUT PHYS, V100, P335, DOI 10.1016/0021-9991(92)90240-Y; HIMMELBLAU DM, 1964, CHEM REV, V64, P527, DOI 10.1021/cr60231a002; Clift R, 1978, BUBBLES DROPS PARTIC; Hosokawa S., 2005, P 6 WORLD C EXP HEAT; Kang M., 2000, J SCI COMPUT, V15, P323, DOI DOI 10.1023/A:1011178417620; Koide K., 1976, CHEM ENG SCI, V31, P471, DOI 10.1016/0009-2509(76)87048-0; Landau LD, 1987, FLUID MECH; Levich V. G., 1962, PHYSICOCHEMICAL HYDR; Liberzon D, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2192781; lvarez A E, 2000, T ICHEME, V78, P1; Martin M, 2009, CHEM ENG J, V155, P272, DOI 10.1016/j.cej.2009.08.009; STONE HA, 1990, PHYS FLUIDS A-FLUID, V2, P111, DOI 10.1063/1.857686; SUSSMAN M, 1994, J COMPUT PHYS, V114, P146, DOI 10.1006/jcph.1994.1155; Takagi S., 2003, T JSME B, V69, P2192; Tomiyama A., 2009, P 5 EUR JAP 2 PHAS F; Xu JJ, 2003, J SCI COMPUT, V19, P573, DOI 10.1023/A:1025336916176	31	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310	1879-2189		INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	APR	2015	83						652	658		10.1016/j.ijheatmasstransfer.2014.12.062		7	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	CC1CY	WOS:000350080000064		
J	Watanabe, T; Sakai, Y; Nagata, K; Terashima, O; Kubo, T				Watanabe, Tomoaki; Sakai, Yasuhiko; Nagata, Kouji; Terashima, Osamu; Kubo, Takashi			Conditional statistics in a planar liquid jet with a second-order chemical reaction	INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER			English	Article						Turbulent transfer; Chemical reaction; Jet; Conditional moment closure; Mixing	SCALAR DISSIPATION RATE; DIRECT NUMERICAL-SIMULATION; TURBULENT CHANNEL FLOW; MOMENT CLOSURE; MIXING LAYER; PASSIVE SCALAR; FLAMES; COMBUSTION; DIFFUSION; VARIANCE	Conditional statistics, conditioned on mixture fraction, are experimentally investigated in a planar liquid jet with a second-order isothermal chemical reaction A + B --> R. Reactants A and B are contained in the jet and ambient flows, respectively, and are supplied into the test section under the non-premixed condition. Streamwise velocity, mixture fraction and concentrations of all reactive species are simultaneously measured by using an I-type hot-film probe and an optical fibre probe based on light absorption spectrometry. The cross-streamwise profiles of conditional mean concentrations and conditional mean reaction rate show that the conditional mean concentrations and the conditional mean reaction rate near the jet exit change with the cross-streamwise position, whereas they are independent of the cross-streamwise position in the downstream regions. On the jet centreline, the conditional mean reaction rate has a peak value on the condition that the conditional mean concentration of product R has a peak value. A comparison between the conditional mean reaction rate and the covariance of conditional concentration fluctuations shows that the covariance of conditional concentration fluctuations is so small that a first moment closure model for the conditional mean reaction rate is valid. The conditional mean streamwise velocity is almost linear to the mixture fraction for small mixture fraction fluctuations. The conditional scalar dissipation rate is calculated from the budget of the conditional moment closure equation. The results show that the conditional scalar dissipation rate has a single peak value in the upstream region, whereas in the downstream region, it has two peaks for the large and small mixture fraction values. The conventional mean scalar dissipation rate is calculated from the probability density function of the mixture fraction and the conditional scalar dissipation rate. The conventional mean scalar dissipation rate on the jet centreline decreases in the downstream direction as (x*)(-2.9) (where x* is the distance from the virtual origin), which is almost the same as that expected from scaling arguments. (C) 2014 Elsevier Ltd. All rights reserved.	[Watanabe, Tomoaki; Sakai, Yasuhiko; Nagata, Kouji; Terashima, Osamu] Nagoya Univ, Dept Mech Sci & Engn, Nagoya, Aichi 4648603, Japan; [Watanabe, Tomoaki] Japan Soc Promot Sci, Tokyo, Japan; [Kubo, Takashi] Meijo Univ, Dept Mech Engn, Nagoya, Aichi 4688502, Japan	Watanabe, T (reprint author), Nagoya Univ, Dept Mech Sci & Engn, Nagoya, Aichi 4648603, Japan.	watanabe.tomoaki@c.nagoya-u.jp			JSPS KAKENHI [25002531]; MEXT KAKENHI [25289030, 25289031, 25630052]	This work was supported by JSPS KAKENHI Grant No. 25002531 and MEXT KAKENHI Grant Nos. 25289030, 25289031 and 25630052.	Pierce CD, 1998, PHYS FLUIDS, V10, P3041, DOI 10.1063/1.869832; Klimenko AY, 1999, PROG ENERG COMBUST, V25, P595, DOI 10.1016/S0360-1285(99)00006-4; MCMURTRY PA, 1986, AIAA J, V24, P962, DOI 10.2514/3.9371; Watanabe T, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4898208; Mi J, 2003, EXP FLUIDS, V34, P687, DOI 10.1007/S00348-003-0603-3; Zhdanov V, 2011, INT J HEAT MASS TRAN, V54, P3245, DOI 10.1016/j.ijheatmasstransfer.2011.04.006; Barlow RS, 1996, COMBUST FLAME, V104, P288, DOI 10.1016/0010-2180(95)00123-9; PETERS N, 1983, AIAA J, V21, P423, DOI 10.2514/3.8089; BATCHELOR GK, 1959, J FLUID MECH, V5, P113, DOI 10.1017/S002211205900009X; Fabregat A, 2010, INT J HEAT MASS TRAN, V53, P4248, DOI 10.1016/j.ijheatmasstransfer.2010.05.051; POPE SB, 1985, PROG ENERG COMBUST, V11, P119, DOI 10.1016/0360-1285(85)90002-4; Su LK, 2010, J FLUID MECH, V643, P59, DOI 10.1017/S0022112009991856; TOOR HL, 1969, IND ENG CHEM FUND, V8, P655, DOI 10.1021/i160032a009; Karpetis AN, 2002, P COMBUST INST, V29, P1929, DOI 10.1016/S1540-7489(02)80234-6; Veynante D, 2002, PROG ENERG COMBUST, V28, P193, DOI 10.1016/S0360-1285(01)00017-X; Bilger RW, 2004, FLOW TURBUL COMBUST, V72, P93, DOI 10.1023/B:APPL.0000044404.24369.f1; Barlow RS, 2000, COMBUST FLAME, V120, P549, DOI 10.1016/S0010-2180(99)00126-1; Bilger R. W., 1976, PROG ENERG COMBUST, V1, P87, DOI DOI 10.1016/0360-1285(76)90022-8; BILGER RW, 1993, PHYS FLUIDS A-FLUID, V5, P436, DOI 10.1063/1.858867; BILGER RW, 1991, J FLUID MECH, V233, P211, DOI 10.1017/S0022112091000460; BOURNE JR, 1985, CHEM ENG COMMUN, V37, P293, DOI 10.1080/00986448508911287; Brethouwer G, 2001, FLOW TURBUL COMBUST, V66, P209, DOI 10.1023/A:1012217219924; Brown RJ, 1998, ATMOS ENVIRON, V32, P629, DOI 10.1016/S1352-2310(97)00295-1; Chornyi A. D., 2010, Journal of Engineering Physics and Thermophysics, V83, DOI 10.1007/s10891-010-0372-9; Combest DP, 2011, IND ENG CHEM RES, V50, P8817, DOI 10.1021/ie200055s; Cook AW, 1999, PHYS FLUIDS, V11, P746, DOI 10.1063/1.869945; de Bruyn Kops SM, 2001, PHYS FLUIDS, V13, P1450, DOI 10.1063/1.1359185; DUTTA A, 1989, AICHE J, V35, P2013, DOI 10.1002/aic.690351212; Fairweather M, 2004, COMBUST FLAME, V138, P3, DOI 10.1016/j.combustflame.2004.03.001; Feng H, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2718580; FOX RO, 1995, PHYS FLUIDS, V7, P1082, DOI 10.1063/1.868550; HILL JC, 1976, ANNU REV FLUID MECH, V8, P135, DOI 10.1146/annurev.fl.08.010176.001031; KAILASNATH P, 1993, PHYS FLUIDS A-FLUID, V5, P3207, DOI 10.1063/1.858677; Kim SH, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2221352; Klimenko A. Yu., 1990, Fluid Dynamics, V25, DOI 10.1007/BF01049811; KOMORI S, 1993, AICHE J, V39, P1611, DOI 10.1002/aic.690391005; KOMORI S, 1994, J CHEM ENG JPN, V27, P742, DOI 10.1252/jcej.27.742; LI JD, 1994, PHYS FLUIDS, V6, P605, DOI 10.1063/1.868356; LI JD, 1993, PHYS FLUIDS A-FLUID, V5, P3255, DOI 10.1063/1.858682; MASRI AR, 1992, COMBUST FLAME, V89, P167, DOI 10.1016/0010-2180(92)90026-L; MEHTA RV, 1987, AICHE J, V33, P1089, DOI 10.1002/aic.690330705; MILLER RS, 1994, COMBUST SCI TECHNOL, V99, P1, DOI 10.1080/00102209408935423; NAKAMURA I, 1987, J FLUID MECH, V178, P379, DOI 10.1017/S0022112087001277; PATTERSON GK, 1981, CHEM ENG COMMUN, V8, P25, DOI 10.1080/00986448108912575; Pouransari Z, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3622774; Roomina MR, 2001, COMBUST FLAME, V125, P1176, DOI 10.1016/S0010-2180(01)00237-1; Sakai Y., 1997, P 11 S TURB SHEAR FL, P18; Su LK, 1999, EXP FLUIDS, V27, P507, DOI 10.1007/s003480050375; Swaminathan N, 1999, PHYS FLUIDS, V11, P2679, DOI 10.1063/1.870129; TOOR HL, 1993, AICHE J, V39, P1603, DOI 10.1002/aic.690391004; Vervisch L, 1998, ANNU REV FLUID MECH, V30, P655, DOI 10.1146/annurev.fluid.30.1.655; WANG DM, 1993, CHEM ENG SCI, V48, P3907, DOI 10.1016/0009-2509(93)80369-2; Watanabe T, 2012, EXP FLUIDS, V53, P1369, DOI 10.1007/s00348-012-1365-6; Watanabe T, 2014, J FLUID MECH, V754, P98, DOI 10.1017/jfm.2014.387; Watanabe T, 2014, J FLUID MECH, V758, P754, DOI 10.1017/jfm.2014.559; Watanabe T, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4896298; Watanabe T, 2014, AICHE J, V60, P3969, DOI 10.1002/aic.14610; Watanabe T, 2013, PHYS SCRIPTA, VT155, DOI 10.1088/0031-8949/2013/T155/014039; Watanabe T., 2013, INT J MODEL SIMUL SC, V4	59	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0017-9310	1879-2189		INT J HEAT MASS TRAN	Int. J. Heat Mass Transf.	APR	2015	83						768	780		10.1016/j.ijheatmasstransfer.2014.12.008		13	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	CC1CY	WOS:000350080000075		
J	Pajarinen, J; Tamaki, Y; Antonios, JK; Lin, TH; Sato, T; Yao, ZY; Takagi, M; Konttinen, YT; Goodman, SB				Pajarinen, Jukka; Tamaki, Yasunobu; Antonios, Joseph K.; Lin, Tzu-Hua; Sato, Taishi; Yao, Zhenyu; Takagi, Michiaki; Konttinen, Yrjo T.; Goodman, Stuart B.			Modulation of mouse macrophage polarization in vitro using IL-4 delivery by osmotic pumps	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A			English	Article						total joint replacement; inflammation; osteolysis; macrophage polarization; interleukin-4; osmotic pumps	JOINT REPLACEMENT; WEAR PARTICLES; OSTEOLYSIS; ACTIVATION; INTERLEUKIN-4; PLASTICITY; RESPONSES; MODEL	Modulation of macrophage polarization is emerging as promising means to mitigate wear particle-induced inflammation and periprosthetic osteolysis. As a model for continuous local drug delivery, we used miniature osmotic pumps to deliver IL-4 in order to modulate macrophage polarization in vitro from nonactivated M0 and inflammatory M1 phenotypes towards a tissue regenerative M2 phenotype. Pumps delivered IL-4 into vials containing mouse bone marrow macrophage (mBMM) media. This conditioned media (CM) was collected at seven day intervals up to four weeks (week 1 to week 4 samples). IL-4 concentration in the CM was determined by ELISA and its biological activity was assayed by exposing M0 and M1 mBMMs to week 1 or week 4 CM. The IL-4 concentration in the CM approximated the mathematically calculated amount, and its biological activity was well retained, as both M0 and M1 macrophages exposed to either the week 1 or week 4 CM assumed M2-like phenotype as determined by qRT-PCR, ELISA, and immunocytochemistry. The results show that IL-4 can be delivered using osmotic pumps and that IL-4 delivered can modulate macrophage phenotype. Results build a foundation for in vivo studies using our previously validated animal models and provide possible strategies to locally mitigate wear particle-induced macrophage activation and periprosthetic osteolysis. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1339-1345, 2015.	[Pajarinen, Jukka; Antonios, Joseph K.; Lin, Tzu-Hua; Sato, Taishi; Yao, Zhenyu; Goodman, Stuart B.] Stanford Univ, Sch Med, Dept Orthopaed Surg, Orthopaed Res Labs, Stanford, CA 94305 USA; [Tamaki, Yasunobu; Takagi, Michiaki] Yamagata Univ, Sch Med, Dept Orthopaed Surg, Yamagata 99023, Japan; [Konttinen, Yrjo T.] Univ Helsinki, Inst Clin Med, Dept Med, Helsinki, Finland; [Konttinen, Yrjo T.] Univ Helsinki, Cent Hosp, Helsinki, Finland	Goodman, SB (reprint author), Stanford Univ, Sch Med, Dept Orthopaed Surg, Orthopaed Res Labs, Stanford, CA 94305 USA.	goodbone@stanford.edu			NIH [2R01AR055650-05, 1R01AR063717]; Ellenburg Chair in Surgery at Stanford University; Stanford Medical Scholars Program; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation	Contract grant sponsor: NIH; Contract grant number: 2R01AR055650-05, 1R01AR063717; Contract grant sponsors: Ellenburg Chair in Surgery at Stanford University; the Stanford Medical Scholars Program, Sigrid Juselius Foundation, Jane and Aatos Erkko Foundation	Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Im GI, 2001, J BIOMED MATER RES, V58, P531; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599; Schwarz EM, 2003, J ORTHOPAED RES, V21, P1049, DOI 10.1016/S0736-0266(03)00093-7; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Gibon E, 2012, J ORTHOP RES, V30, P547, DOI 10.1002/jor.21548; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Trindade MCD, 1999, J ORTHOPAED RES, V17, P797, DOI 10.1002/jor.1100170602; Rao AJ, 2012, ACTA BIOMATER, V8, P2815, DOI 10.1016/j.actbio.2012.03.042; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132532; Pajarinen J, 2013, ACTA BIOMATER, V9, P9229, DOI 10.1016/j.actbio.2013.06.027; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Ma T, 2008, BIOMATERIALS, V29, P3738, DOI 10.1016/j.biomaterials.2008.05.031; Gallo J, 2013, INNATE IMMUN-LONDON, V19, P213, DOI 10.1177/1753425912451779; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Antonios JK, 2013, CELL MOL IMMUNOL, V10, P471, DOI 10.1038/cmi.2013.39; Goodman SB, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0962; Goodman Stuart B, 2013, Instr Course Lect, V62, P201; Rao AJ, 2013, J BIOMED MATER RES A, V101, P1925, DOI 10.1002/jbm.a.34486; Wang Y, 2013, J SURG RES, V180, pE73, DOI 10.1016/j.jss.2012.04.016; Weischenfeldt J, 2008, CSH PROTOCOLS, V2008	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1549-3296	1552-4965		J BIOMED MATER RES A	J. Biomed. Mater. Res. Part A	APR	2015	103	4					1339	1345		10.1002/jbm.a.35278		7	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CC5JQ	WOS:000350395300006		
J	Matsuzawa, A; Matsusaki, M; Akashi, M				Matsuzawa, Atsushi; Matsusaki, Michiya; Akashi, Mitsuru			Construction of three-dimensional liver tissue models by cell accumulation technique and maintaining their metabolic functions for long-term culture without medium change	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A			English	Article						hepatocyte; cell accumulation technique; three-dimensional liver tissue model; long-term culture; nonmedium change	RAT HEPATOCYTES; IN-VITRO; GENE-EXPRESSION; 3D COCULTURE; OXYGEN; MANIPULATION; FIBROBLASTS; NANOFILMS; SCAFFOLDS; MEMBRANE	Three-dimensional (3D) hepatocyte cultures have attracted much attention to obtain high biological functions of hepatocyte for pharmaceutical drug assessment. However, maintaining the high functions for over one month is still a key challenge although many approaches have been reported. In this study, we demonstrate for the first time simple and rapid construction of 3D-hepatocyte constructs by our cell accumulation technique and their high biological functions for one month, without any medium change. The human hepatocyte carcinoma (HepG2) cells were coated with approximate to 7 nm-sized extracellular matrix (ECM) films consisting of fibronectin (FN) and gelatin (G), and then incubated in cell culture insert to construct 3D-tissue constructs for 24 h. The thickness of obtained 3D-HepG2 constructs was easily controlled by altering seeding cell number and the maximum is over 100 m. When a large volume of culture media was employed, the 3D-constructs showed higher mRNA expression of albumin and some cytochrome P450 (CYP) enzymes as compared to general two-dimensional (2D) culture. Surprisingly, their high cell viabilities (over 80%) and high mRNA expressions were successfully maintained without medium change for at least 27 days. These results demonstrate novel easy and rapid technique to construct 3D-human liver tissue models which can maintain their high functions and viability for 1 month without medium change. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1554-1564, 2015.	[Matsuzawa, Atsushi; Matsusaki, Michiya; Akashi, Mitsuru] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Matsuzawa, Atsushi] Mitsubishi Paper Mills Co Ltd, Imaging Media Div, Kyoto R&D Lab, Kyoto 6178666, Japan	Akashi, M (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	akashi@chem.eng.osaka-u.ac.jp			Next Generation World-Leading Researchers (NEXT Program) [LR026]; Japan Society for the Promotion of Science (JSPS) [A232250040]; SENTAN-JST program [13A1204]	Contract grant sponsor: Next Generation World-Leading Researchers (NEXT Program); contract grant number: LR026; Contract grant sponsor: Japan Society for the Promotion of Science (JSPS); contract grant number: A232250040; Contract grant sponsor: SENTAN-JST program; contract grant number: 13A1204	Corcoran J, 2012, ENVIRON SCI TECHNOL, V46, P6306, DOI 10.1021/es3005305; Tuleuova N, 2010, BIOMATERIALS, V31, P9221, DOI 10.1016/j.biomaterials.2010.08.050; Rajagopalan P, 2006, TISSUE ENG, V12, P1553, DOI 10.1089/ten.2006.12.1553; Evenou F, 2011, BIOTECHNOL PROGR, V27, P1146, DOI 10.1002/btpr.626; LeCluyse EL, 2001, EUR J PHARM SCI, V13, P343, DOI 10.1016/S0928-0987(01)00135-X; Calvert P, 2007, SCIENCE, V318, P208, DOI 10.1126/science.1144212; Matsuzawa A, 2013, LANGMUIR, V29, P7362, DOI 10.1021/la303459v; ROTEM A, 1992, BIOTECHNOL BIOENG, V40, P1286, DOI 10.1002/bit.260401020; Tuschl G, 2009, CHEM-BIOL INTERACT, V181, P124, DOI 10.1016/j.cbi.2009.05.015; Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; Matsusaki M, 2012, B CHEM SOC JPN, V85, P401, DOI 10.1246/bcsj.20110194; Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; KOIDE N, 1989, BIOCHEM BIOPH RES CO, V161, P385, DOI 10.1016/0006-291X(89)91609-4; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; ROTEM A, 1994, BIOTECHNOL BIOENG, V43, P654, DOI 10.1002/bit.260430715; Hirode M, 2009, J TOXICOL SCI, V34, P281; Kim K, 2012, BIOMATERIALS, V33, P1406, DOI 10.1016/j.biomaterials.2011.10.084; Kidambi S, 2009, P NATL ACAD SCI USA, V106, P15714, DOI 10.1073/pnas.0906820106; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Underhill GH, 2007, BIOMATERIALS, V28, P256, DOI 10.1016/j.biomaterials.2006.08.043; GUILLOUZO A, 1985, XENOBIOTICA, V15, P635; Matsusaki M, 2007, ANGEW CHEM INT EDIT, V46, P4689, DOI 10.1002/anie.20070108; Nagamoto Y, 2012, BIOMATERIALS, V33, P4526, DOI 10.1016/j.biomaterials.2012.03.011; Nishiguchi A, 2011, ADV MATER, V23, P3506, DOI 10.1002/adma.201101787; Kadowaki K, 2010, LANGMUIR, V26, P5670, DOI 10.1021/la903738n; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Matsusaki M, 2012, J BIOMAT SCI-POLYM E, V23, P63, DOI 10.1163/092050610X541953; Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061; Sasagawa T, 2010, BIOMATERIALS, V31, P1646, DOI 10.1016/j.biomaterials.2009.11.036; Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481; Chetprayoon P, 2012, ACTA BIOMATER, V9, P4698; Evenou F, 2010, TISSUE ENG PART C-ME, V16, P311, DOI 10.1089/ten.TEC.2009.0042; Hosoya H, 2012, BIOCHEM BIOPH RES CO, V419, P32, DOI 10.1016/j.bbrc.2012.01.117; Hynes R.O., 1990, FIBRONECTINS; Kadowaki K, 2010, BIOCHEM BIOPH RES CO, V402, P153, DOI 10.1016/j.bbrc.2010.10.007; Kaihara S, 2000, J PEDIATR SURG, V35, P1287, DOI 10.1053/jpsu.2000.9298; Matsusaki M, 2013, ADV HEALTHC MATER, V4, P533; Matsusaki M, 2012, ADV HLTH MAT, V2, P534; Matsusaki M, 2011, ANGEW CHEM INT EDIT, V50, P7557, DOI 10.1002/anie.201008204; Nishikawaa M, 2008, J BIOTECHNOL, V133, P253, DOI 10.1016/j.jbiotec.2007.08.041; Wen YA, 2009, TOXICOL IN VITRO, V23, P744, DOI 10.1016/j.tiv.2009.02.009; Yamasaki C, 2006, J HEPATOL, V44, P749, DOI 10.1016/j.jhep.2005.10.028; Yu HM, 2007, LAB CHIP, V7, P726, DOI 10.1039/b618793e	45	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1549-3296	1552-4965		J BIOMED MATER RES A	J. Biomed. Mater. Res. Part A	APR	2015	103	4					1554	1564		10.1002/jbm.a.35292		11	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	CC5JQ	WOS:000350395300025		
J	Chen, ZZ; Fan, Y; Wang, LS				Chen, Zhi-Zhong; Fan, Ying; Wang, Lusheng			Faster exact computation of rSPR distance	JOURNAL OF COMBINATORIAL OPTIMIZATION			English	Article						Phylogenetic tree; rSPR distance; Fixed-parameter algorithm	EVOLUTIONARY TREES; PHYLOGENETIC TREES; AGREEMENT FORESTS; GENE-TRANSFER; APPROXIMATION; ALGORITHMS; COMPLEXITY; NETWORKS; TOOL; FPT	Due to hybridization events in evolution, studying two different genes of a set of species may yield two related but different phylogenetic trees for the set of species. In this case, we want to measure the dissimilarity of the two trees. The rooted subtree prune and regraft (rSPR) distance of the two trees has been used for this purpose, and many algorithms and software tools have been developed for computing the rSPR distance of two given phylogenetic trees. The previously fastest exact algorithm for this problem runs in time, where and are the number of leaves and the rSPR distance of the input trees, respectively. In this paper, we present a faster exact algorithm which runs in time. Our experiments show that the new algorithm is significantly faster than the newest version (namely, v1.1.1) of the previously best software (namely, rSPR) for RSPR distance.	[Chen, Zhi-Zhong] Tokyo Denki Univ, Div Informat Syst Design, Hiki, Saitama 3590394, Japan; [Fan, Ying; Wang, Lusheng] City Univ Hong Kong, Dept Comp Sci, Kowloon, Hong Kong, Peoples R China	Chen, ZZ (reprint author), Tokyo Denki Univ, Div Informat Syst Design, Hiki, Saitama 3590394, Japan.	zzchen@mail.dendai.ac.jp; yingying1988@gmail.com; cswangl@cityu.edu.hk			Ministry of Education, Science, Sports and Culture of Japan [24500023]; Research Grants Council of the Hong Kong Special Administrative Region, China [CityU 121608]	Zhi-Zhong Chen was supported in part by the Grant-in-Aid for Scientific Research of the Ministry of Education, Science, Sports and Culture of Japan, under Grant No. 24500023. Lusheng Wang was fully supported by a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China [Project No. CityU 121608].	Bonet ML, 2006, J COMPUT BIOL, V13, P1419, DOI 10.1089/cmb.2006.13.1419; Rodrigues EM, 2007, THEOR COMPUT SCI, V374, P91, DOI 10.1016/j.tcs.2006.12.011; Beiko RG, 2006, BMC EVOL BIOL, V6, P159; Bordewich M., 2008, J DISCRETE ALGORITHM, V6, P458, DOI 10.1016/j.jda.2007.10.002; Bordewich M., 2004, ANN COMB, V8, P409; Chen ZZ, 2013, J COMPUT BIOL, V20, P38, DOI 10.1089/cmb.2012.0240; Chen ZZ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-155; Gasieniec L, 1999, J COMB OPTIM, V3, P183, DOI 10.1023/A:1009833626004; Goloboff P. A., 2007, CLADISTICS, V24, P591; Barker NP, 2001, ANN MO BOT GARD, V88, P373; Hein J, 1996, DISCRETE APPL MATH, V71, P153, DOI 10.1016/S0166-218X(96)00062-5; Hill T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-42; Ma B, 2011, J COMB OPTIM, V21, P409, DOI 10.1007/s10878-009-9261-6; Ma B, 1999, J COMB OPTIM, V3, P213, DOI 10.1023/A:1009837726913; MacLeod D, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-27; Than C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-322; Whidden C, 2009, LECT N BIOINFORMAT, V5724, P390, DOI 10.1007/978-3-642-04241-6_32; Whidden C, 2010, LECT NOTES COMPUT SC, V6049, P141, DOI 10.1007/978-3-642-13193-6_13; Wu YF, 2009, BIOINFORMATICS, V25, P190, DOI 10.1093/bioinformatics/btn606	19	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1382-6905	1573-2886		J COMB OPTIM	J. Comb. Optim.	APR	2015	29	3			SI		605	635		10.1007/s10878-013-9695-8		31	Computer Science, Interdisciplinary Applications; Mathematics, Applied	Computer Science; Mathematics	CC9JL	WOS:000350685800006		
J	Ishikawa, G; Kitagawa, Y; Yukuno, W				Ishikawa, Goo; Kitagawa, Yumiko; Yukuno, Wataru			Duality of Singular Paths for (2,3,5)-Distributions	JOURNAL OF DYNAMICAL AND CONTROL SYSTEMS			English	Article						Singular control; Cartan prolongation; Cone structure	DISTRIBUTIONS	We show a duality which arises from distributions of Cartan type, having growth (2, 3, 5), from the viewpoint of geometric control theory. In fact, we consider the space of singular (or abnormal) paths on a given five-dimensional space endowed with a Cartan distribution, which form another five-dimensional space with a cone structure. We regard the cone structure as a control system and show that the space of singular paths of the cone structure is naturally identified with the original space. Moreover, we observe an asymmetry on this duality in terms of singular paths.	[Ishikawa, Goo; Yukuno, Wataru] Hokkaido Univ, Dept Math, Sapporo, Hokkaido 0600810, Japan; [Kitagawa, Yumiko] Oita Natl Coll Technol, Oita 8700152, Japan	Ishikawa, G (reprint author), Hokkaido Univ, Dept Math, Sapporo, Hokkaido 0600810, Japan.	ishikawa@math.sci.hokudai.ac.jp; kitagawa@oita-ct.ac.jp; yukuwata@math.sci.hokudai.ac.jp			KAKENHI [22340030, 23654058]	This work was supported by KAKENHI no. 22340030 and no. 23654058.	Agrachev A, 2006, P RIMS S DEV CART GE, V1502, P204; Agrachev A. A., 2004, ENCY MATH SCI, V87; Agrachev AA, 2004, NONLINEAR OPTIMAL CO, P1; BRYANT RL, 1993, INVENT MATH, V114, P435, DOI 10.1007/BF01232676; Zelenko I, 2006, J DYN CONTROL SYST, V12, P247, DOI 10.1007/S10450-006-0383-1; Bonnard B., 2003, SINGULAR TRAJECTORIE; Bryant RL, 1998, COMMUNICATION   0619; Cartan E., 1910, ANN SCI ECOLE NORM, V27, P109; Doubrov B, ARXIVMATHDG12107334V; Doubrov B, 2009, J LOND MATH SOC, V80, P545, DOI 10.1112/jlms/jdp044; Doubrov B, 2011, DIFFER GEOM APPL, V29, P255, DOI 10.1016/j.difgeo.2010.12.004; HSU L, 1992, J DIFFER GEOM, V36, P551; Ishikawa G, 2012, HOKKAIDO U PREPRINT, V1020; Ishikawa G, 2011, J SINGUL, V3, P126; Kitagawa Y, 2005, THESIS NARA WOMENS U; Liu W., 1995, MEMOIRS AM MATH SOC, V118-564; Montgomery R., 2002, MATH SURVEYS MONOGRA, V91; Nurowski P, 2005, J GEOM PHYS, V55, P19, DOI 10.1016/j.geomphys.2004.11.006; Pontryagin L. S., 1964, MATH THEORY OPTIMAL; Tanaka N., 1985, HOKKAIDO MATH J, V14, P277; Yatsui T, 1988, HOKKAIDO MATH J, V17, P333; Zelenko I., 1999, Journal of Dynamical and Control Systems, V5, DOI 10.1023/A:1021766616913; Zhitomirskii M, 2006, RIMS KOKYUROKU, V1502, P16	23	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1079-2724	1573-8698		J DYN CONTROL SYST	J. Dyn. Control Syst.	APR	2015	21	2					155	171		10.1007/s10883-014-9216-9		17	Automation & Control Systems; Mathematics, Applied	Automation & Control Systems; Mathematics	CC3IJ	WOS:000350240100001		
J	Nagai, T; Fujiwara, N; Kitta, M; Asahi, M; Yamazaki, S; Siroma, Z; Ioroi, T				Nagai, Tsukasa; Fujiwara, Naoko; Kitta, Mitsunori; Asahi, Masafumi; Yamazaki, Shin-ichi; Siroma, Zyun; Ioroi, Tsutomu			Oxygen Reduction Activity on a Nanosized Perovskite-Type Oxide Prepared by Polyvinyl Pyrrolidone Method	JOURNAL OF FUEL CELL SCIENCE AND TECHNOLOGY			English	Article							CARBON; CATALYSTS; ELECTRODE	A nanosized perovskite-type oxide supported on carbon black (perovskite/C) was prepared by the polyvinyl pyrrolidone (PVP) addition method and subsequent mechanical milling with carbon black. Transmission electron microscope (TEM) observation and scanning transmission electron microscope (STEM)-energy dispersive X-ray (EDX) mapping clearly revealed that the oxide prepared by the PVP method was small (ca. 20 nm) and highly dispersed on the carbon support. The oxygen reduction reaction (ORR) activity on the perovskite/C catalyst was investigated with rotating ring-disk electrode (RRDE) measurement in an alkaline solution at 25 degrees C. The prepared perovskite/C catalyst showed enhanced activity compared to catalysts obtained by the conventional solid state reaction and citrate process; i.e., a positive shift of the onset potential and increased ORR current at a disk electrode. The present catalyst was also associated with decreased ring current.	[Nagai, Tsukasa; Fujiwara, Naoko; Kitta, Mitsunori; Asahi, Masafumi; Yamazaki, Shin-ichi; Siroma, Zyun; Ioroi, Tsutomu] Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Ikeda, Osaka 5638577, Japan	Nagai, T (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, 1-8-31,Midorigaoka, Ikeda, Osaka 5638577, Japan.	tsukasa-nagai@aist.go.jp; n-fujiwara@aist.go.jp; m-kitta@aist.go.jp; m.asahi@aist.go.jp; s-yamazaki@aist.go.jp; siroma.z@aist.go.jp; ioroi-t@aist.go.jp					Spendelow JS, 2007, PHYS CHEM CHEM PHYS, V9, P2654, DOI 10.1039/b703315j; Thiele D, 2008, J POWER SOURCES, V183, P590, DOI 10.1016/j.jpowsour.2008.05.042; Haider MA, 2011, SOLID STATE IONICS, V196, P65, DOI 10.1016/j.ssi.2011.06.013; Hayashi M, 1998, ELECTROCHEM SOLID ST, V1, P268; Yuasa M, 2011, J ELECTROCHEM SOC, V158, pA411, DOI 10.1149/1.3551499; Slanac DA, 2012, J PHYS CHEM C, V116, P11032, DOI 10.1021/jp3012816; Asazawa K, 2007, ANGEW CHEM INT EDIT, V46, P8024, DOI 10.1002/anie.200701334; Tulloch J, 2009, J POWER SOURCES, V188, P359, DOI 10.1016/j.jpowsour.2008.12.024; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; Suntivich J, 2011, NAT CHEM, V3, P546, DOI 10.1038/nchem.1069; Bursell M, 2002, ELECTROCHIM ACTA, V47, P1651, DOI 10.1016/S0013-4686(02)00002-6; Paulus UA, 2001, J ELECTROANAL CHEM, V495, P134, DOI 10.1016/S0022-0728(00)00407-1; Poux T, 2012, CATAL TODAY, V189, P83, DOI 10.1016/j.cattod.2012.04.046; SHIMIZU Y, 1990, J ELECTROCHEM SOC, V137, P3430, DOI 10.1149/1.2086234; Fujiwara N., 2013, 80 M EL SOC JAP KAT, p3A21; Kinoshita K., 1988, CARBON ELECTROCHEMIC; MEADOWCR.DB, 1970, NATURE, V226, P847, DOI 10.1038/226847a0; Nagai T., 2014, J ASIAN CERAM SOC, V2, P329; Savy M., 1968, ELECTROCHIM ACTA, V3, P1359; Song C., 2008, PEM FUEL CELL ELECTR, P89, DOI DOI 10.1007/978-1-84800-936-3_2	20	1	1	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	1550-624X	1551-6989		J FUEL CELL SCI TECH	J. Fuel Cell Sci. Technol.	APR	2015	12	2							021007	10.1115/1.4029424		5	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	CC6RR	WOS:000350495700007		
J	Malek, MF; Mamat, MH; Musa, MZ; Soga, T; Rahman, SA; Alrokayan, SAH; Khan, HA; Rusop, M				Malek, M. F.; Mamat, M. H.; Musa, M. Z.; Soga, T.; Rahman, S. A.; Alrokayan, Salman A. H.; Khan, Haseeb A.; Rusop, M.			Metamorphosis of strain/stress on optical band gap energy of ZAO thin films via manipulation of thermal annealing process	JOURNAL OF LUMINESCENCE			English	Article						ZAO; Strain; Stress; Optical band gap energy	SOL-GEL METHOD; ZINC-OXIDE FILMS; CHEMICAL-VAPOR-DEPOSITION; SPRAY-PYROLYSIS; ZNO FILMS; ULTRAVIOLET EMISSION; PHYSICAL-PROPERTIES; ROOM-TEMPERATURE; SUBSTRATE; TRANSPARENT	We report on the growth of Al-doped ZnO (ZAO) thin films prepared by the sol-gel technique associated with dip-coating onto Corning 7740 glass substrates. The influence of varying thermal annealing (T-a) temperature on crystallisation behaviour, optical and electrical properties of ZAO films has been systematically investigated. All films are polycrystalline with a hexagonal wurtzite structure with a preferential orientation according to the direction < 0 0 2 >. The metamorphosis of strain/stress effects in ZAO thin films has been investigated using X-ray diffraction. The as growth films have a large compressive stress of 0.55 GPa, which relaxed to 025 GPa as the Ta was increased to 500 degrees C. Optical parameters such as optical transmittance, absorption coefficient, refractive index and optical band gap energy have been studied and discussed with respect to T-a. All films exhibit a transmittance above 80-90% along the visible-NIR range up to 1500 nm and a sharp absorption onset below 400 nm corresponding to the fundamental absorption edge of ZnO. Experimental results show that the tensile stress in the films reveals an incline pattern with the optical band gap energy, while the compressive stress shows opposite relation. (C) 2014 Elsevier B.V. All rights reserved.	[Malek, M. F.; Mamat, M. H.; Musa, M. Z.; Rusop, M.] Univ Teknol MARA UiTM, Fac Elect Engn, NANOelecTron Ctr NET, Shah Alam 40450, Selangor, Malaysia; [Malek, M. F.; Rusop, M.] Univ Teknol MARA UiTM, Inst Sci, NANOsciTech Ctr, Shah Alam 40450, Selangor, Malaysia; [Musa, M. Z.] Univ Teknol MARA UiTM, Fac Elect Engn, Permatang Pauh 13500, Pulau Pinang, Malaysia; [Soga, T.] Nagoya Inst Technol NITech, Dept Frontier Mat, Nagoya, Aichi 4668555, Japan; [Rahman, S. A.] Univ Malaya, Fac Sci, Dept Phys, Low Dimens Mat Res Ctr, Kuala Lumpur 50603, Malaysia; [Alrokayan, Salman A. H.; Khan, Haseeb A.] King Saud Univ, Coll Sci, Dept Biochem, Riyadh 11451, Saudi Arabia	Malek, MF (reprint author), Univ Teknol MARA UiTM, Fac Elect Engn, NANOelecTron Ctr NET, Shah Alam 40450, Selangor, Malaysia.	firz_solarzelle@yahoo.com	Rahman, Saadah/A-8561-2010; Mamat, Mohamad Hafiz/P-9026-2015	Rahman, Saadah/0000-0002-5738-5920; Mamat, Mohamad Hafiz/0000-0002-6640-2366	MyBrain15 programme under the Ministry of Education (MOE); Research Management Institute (RMI), Universiti Teknologi MARA (UiTM), Malaysia;  [600-RMI/LRGS 5/3 (3/2013)];  [600-RMI/DANA 5/3/PSI (165/2013)];  [600-RMI/RACE 16/6/2 (9/2013)]	This work was supported by Grant nos. 600-RMI/LRGS 5/3 (3/2013), 600-RMI/DANA 5/3/PSI (165/2013), and 600-RMI/RACE 16/6/2 (9/2013) and by the MyBrain15 programme under the Ministry of Education (MOE). The authors would like to thank the Research Management Institute (RMI), Universiti Teknologi MARA (UiTM), Malaysia for their support. The authors thank Mr. Salifairus Mohammad Jafar (UiTM Science Officer), Mrs. Nurul Wahida (UiTM Asst. Science Officer), Mr. Mohd Azlan Jaafar (UiTM assistant engineer) and Mr. Suhaimi Ahmad (UiTM assistant engineer) for their kind support of this research.	Al-Salman HS, 2013, J ALLOY COMPD, V547, P132, DOI 10.1016/j.jallcom.2012.08.119; Angus Macleod H., 2001, THIN FILM OPTICAL FI; Hrkac V, 2013, J APPL CRYSTALLOGR, V46, P396, DOI 10.1107/S0021889812051333; Wang MR, 2006, MATER CHEM PHYS, V97, P219, DOI 10.1016/j.matcheinphys.2005.07.072; Dhara S, 2011, FUNCT MATER LETT, V4, P25, DOI 10.1142/S1793604711001658; Shan FK, 2005, J CRYST GROWTH, V277, P284, DOI [10.1016/j.jcrysgro.2005.01.016, 10.1016/j.jcyrgro.2004.01.016]; JOU JH, 1992, J APPL PHYS, V71, P4333, DOI 10.1063/1.350815; Pauporte T, 2000, ELECTROCHIM ACTA, V45, P3345, DOI 10.1016/S0013-4686(00)00405-9; Hur TB, 2006, J APPL PHYS, V99, DOI 10.1063/1.2183391; Peiro AM, 2006, J MATER CHEM, V16, P2088, DOI 10.1039/b602084d; Li HX, 2005, J CRYST GROWTH, V275, pE943, DOI 10.1016/j.jcrysgro.2004.11.098; Lee SY, 2005, THIN SOLID FILMS, V484, P184, DOI 10.1016/j.tsf.2005.03.007; Rodriguez-Baez J, 2006, MATER LETT, V60, P1594, DOI 10.1016/j.matlet.2005.11.077; Malek MF, 2014, J ALLOY COMPD, V610, P575, DOI 10.1016/j.jallcom.2014.05.036; Shirazi M, 2014, J ALLOY COMPD, V602, P108, DOI 10.1016/j.jallcom.2014.03.029; Lupan O, 2010, APPL SURF SCI, V256, P1895, DOI 10.1016/j.apsusc.2009.10.032; Fang DY, 2014, CERAM INT, V40, P5873, DOI 10.1016/j.ceramint.2013.11.030; Kim YS, 2007, APPL SURF SCI, V253, P4911, DOI 10.1016/j.apsusc.2006.10.068; Ohashi N, 2002, APPL PHYS LETT, V80, P2869, DOI 10.1063/1.1470703; Keskenler EF, 2013, J ALLOY COMPD, V550, P129, DOI 10.1016/j.jallcom.2012.09.131; Lee JH, 2003, J CRYST GROWTH, V247, P119, DOI 10.1016/S0022-0248(02)01907-3; Srikant V, 1997, J APPL PHYS, V81, P6357, DOI 10.1063/1.364393; Musat V, 2004, SURF COAT TECH, V180, P659, DOI 10.1016/j.surfcoat.2003.10.112; Murali KR, 2007, J PHYS CHEM SOLIDS, V68, P2293, DOI 10.1016/j.jpcs.2007.06.006; Ohyama M, 1998, J AM CERAM SOC, V81, P1622; Malek MF, 2014, J ALLOY COMPD, V582, P12, DOI 10.1016/j.jallcom.2013.07.202; Lee JH, 2004, MAT SCI ENG B-SOLID, V106, P242, DOI 10.1016/j.mseb.2003.09.040; Saito N, 2002, ADV MATER, V14, P418, DOI 10.1002/1521-4095(20020318)14:6<418::AID-ADMA418>3.0.CO;2-K; Kang HS, 2008, THIN SOLID FILMS, V516, P3147, DOI 10.1016/j.tsf.2007.08.084; Gedamu D, 2014, ADV MATER, V26, P1541, DOI 10.1002/adma.201304363; Dutta M, 2008, APPL SURF SCI, V254, P2743, DOI 10.1016/j.apsusc.2007.10.009; Malek MF, 2013, THIN SOLID FILMS, V527, P102, DOI 10.1016/j.tsf.2012.11.095; Ghosh R, 2004, J APPL PHYS, V96, P2689, DOI 10.1063/1.1769598; Mamat MH, 2011, SENSOR ACTUAT A-PHYS, V171, P241, DOI 10.1016/j.sna.2011.07.002; Lin Y, 2005, THIN SOLID FILMS, V492, P101, DOI 10.1016/j.tsf.2005.06.060; Rao TP, 2010, PHYSICA B, V405, P2226, DOI 10.1016/j.physb.2010.02.016; Wang YG, 2003, J APPL PHYS, V94, P1597, DOI 10.1063/1.1592007; Mridha S, 2007, MATER RES BULL, V42, P875, DOI 10.1016/j.materresbull.2006.08.019; TAUC J, 1966, PHYS STATUS SOLIDI, V15, P627, DOI 10.1002/pssb.19660150224; Ilican S, 2007, J OPTOELECTRON ADV M, V9, P1414; Kim YS, 2005, THIN SOLID FILMS, V491, P153, DOI 10.1016/j.tsf.2005.06.013; Rostan PJ, 2006, SOL ENERG MAT SOL C, V90, P1345, DOI 10.1016/j.solmat.2005.11.010; Wei XQ, 2007, MATER CHEM PHYS, V101, P285, DOI 10.1016/j.matchemphys.2006.05.005; Fu ZX, 2002, THIN SOLID FILMS, V402, P302, DOI 10.1016/S0040-6090(01)01363-3; Rao TP, 2009, APPL SURF SCI, V255, P4579, DOI 10.1016/j.apsusc.2008.11.079; Malek MF, 2013, APPL SURF SCI, V275, P75, DOI 10.1016/j.apsusc.2013.01.119; Alam MJ, 2001, J VAC SCI TECHNOL A, V19, P1642, DOI 10.1116/1.1340659; BURSTEIN E, 1954, PHYS REV, V93, P632, DOI 10.1103/PhysRev.93.632; BERGER PR, 1988, APPL PHYS LETT, V53, P684, DOI 10.1063/1.99850; Brinker C.J., 1975, SOL GEL SCI PHYS CHE, P803; Bux S. A. B. S. A., 2005, SOLID STATE SCI TECH, V13, P251; Cimpoiasu A, 1996, SMART MATER STRUCT, V5, P744, DOI 10.1088/0964-1726/5/6/003; Cullity B. D., 1978, ELEMENTS XRAY DIFFRA; Cullity B.D., 2001, ELEMENTS XRAY DIFFRA; DAVIS EA, 1970, PHILOS MAG, V22, P903, DOI 10.1080/14786437008221061; Ezema FI, 2010, DIG J NANOMATER BIOS, V5, P981; Fang DY, 2014, J ALLOY COMPD, V589, P346, DOI 10.1016/j.jallcom.2013.11.061; Gupta V, 1996, J APPL PHYS, V80, P1063, DOI 10.1063/1.362842; Jayakrishnan R, 2003, THIN SOLID FILMS, V440, P19, DOI 10.1016/S0040-6090(03)00811-3; Kumar R, 2008, APPL SURF SCI, V254, P6509, DOI 10.1016/j.apsusc.2008.04.012; Mishra YK, 2014, KONA POWDER PART J, V31, P92; NATSUME Y, 2002, MATER CHEM PHYS, V78, P170; Pandey V, 2005, J OPTOELECTRON ADV M, V7, P2641; Pankove J.I., 1971, OPTICAL PROCESSES SE, P22; Ping X. J., 2010, CHINESE PHYS LETT, V27; Rusop M., 2006, MAT SCI ENG B, V127, P151; Sahdan MZ, 2010, PHYS STATUS SOLIDI C, V7, DOI 10.1002/pssc.200983722; Sang N.D., 2012, COMMUN PHYS, V22, P65; Suwanboon S., 2008, NARESUAN U J, V6, P173; Tanunchai S., 2005, CHIANG MAI J SCI, V32, P453; Wu H.Z., 2005, J APPL PHYS, V97; Wypych G., 1999, HDB FILLERS, P172; Xue SW, 2008, J ALLOY COMPD, V448, P21, DOI 10.1016/j.jallcom.2006.10.076; Yim J.H., 2003, MAT RES SOC S P, V766; Zamfirescu M, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.161205	75	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-2313	1872-7883		J LUMIN	J. Lumines.	APR	2015	160						165	175		10.1016/j.jlumin.2014.12.003		11	Optics	Optics	CC1FR	WOS:000350087100025		
J	El-Khouly, ME; El-Kemary, MA; Fukuzumi, S				El-Khouly, Mohamed E.; El-Kemary, Maged A.; Fukuzumi, Shunichi			Photoinduced electron transfer from silyl end-capped sexithiophene to benzoquinone derivatives studied by laser photolysis	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY			English	Article						Sexithiophene; Benzoquinone; Electron transfer; Laser photolysis	ARTIFICIAL PHOTOSYNTHETIC SYSTEMS; ORGANIC PHOTOVOLTAIC CELLS; REACTION CENTERS; OLIGOTHIOPHENE; FULLERENE; ACCEPTOR; OXYGEN; DONOR; SUBPHTHALOCYANINE; PHTHALOCYANINES	Photoinduced electron transfer from the electron-donating bis(dimethyl-n-octylsilyl)sexithiophene, (DSi6T), to the electron-accepting benzoquinone derivatives, BQs, in polar benzonitrile has been investigated with laser photolysis method. The employed benzoquinone derivatives include 1,4-benzoquinone (BQ), 2,5-dichloro-1,4-benzoquinone (Cl(2)BQ), 2,6-dimethyl-1,4-benzoquinone (Me(2)BQ), tetrafluoro-1,4-benzoquinone (F(4)BQ) and 2-methyl-1,4-benzoquinone (MeBQ). The electrochemical measurements showed pronounced effect of the substituted groups on the reduction potentials of BQs, and consequently on the driving forces of the electron transfer of the DSi6T/BQs mixture systems. Such effect of the driving forces for electron-transfer reactions of DSi6T/BQs mixture systems have been examined by utilizing the femtosecond and nanosecond laser flash photolysis, in addition the complementary steady state absorption and fluorescence techniques. Upon excitation of DSi6T with 440 nm laser light, the electron-transfer reactions from the triplet excited state of DSi6T to BQs were confirmed by observing the transient absorption bands of DSi6T radical cation in the visible region. The excellent electron donating properties of DSi6T suggests its potential to be a photoactive unit in the bulk heterojunction solar cells. (C) 2015 Elsevier B.V. All rights reserved.	[El-Khouly, Mohamed E.; El-Kemary, Maged A.] Kafrelsheikh Univ, Fac Sci, Dept Chem, Kafi El Sheikh 33516, Egypt; [Fukuzumi, Shunichi] Osaka Univ, Japan Sci & Technol Agcy JST, AICA, Grad Sch Engn,Dept Mat & Life Sci, Suita, Osaka 5650871, Japan	El-Khouly, ME (reprint author), Kafrelsheikh Univ, Fac Sci, Dept Chem, Kafi El Sheikh 33516, Egypt.	mohamedelkhouly@yahoo.com; fukuzumi@chem.eng.osaka-u.ac.jp	Fukuzumi, Shunichi /E-4728-2010		Ministry of Education, Culture, Sports, Science and Technology, Japan [20108010]	This work was supported by the Grant-in-Aid (no. 20108010) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Amao Y, 2002, J MOL CATAL B-ENZYM, V17, P9, DOI 10.1016/S1381-1177(01)00075-3; Fukuzumi S, 2010, COORDIN CHEM REV, V254, P372, DOI 10.1016/j.ccr.2009.10.020; Kong JA, 2010, SOL ENERG MAT SOL C, V94, P2057, DOI 10.1016/j.solmat.2010.06.016; Videlot C, 2000, SOL ENERG MAT SOL C, V63, P69, DOI 10.1016/S0927-0248(00)00021-0; Kanematsu M, 2011, CHEM-EUR J, V17, P12372, DOI 10.1002/chem.201100493; El-Khouly ME, 2011, J PORPHYR PHTHALOCYA, V15, P111, DOI 10.1142/S1088424611003070; REHM D, 1969, BERICH BUNSEN GESELL, V73, P834; KAVARNOS GJ, 1986, CHEM REV, V86, P401, DOI 10.1021/cr00072a005; FEHER G, 1989, NATURE, V339, P111, DOI 10.1038/339111a0; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; El-Khouly ME, 2010, CHEM-EUR J, V16, P6193, DOI 10.1002/chem.201000045; El-Khouly ME, 2014, CHEMPHYSCHEM, V15, P30, DOI 10.1002/cphc.201300715; El-Khouly ME, 2012, CHEM-EUR J, V18, P13844, DOI 10.1002/chem.201202265; El-Khouly ME, 2009, J AM CHEM SOC, V131, P6370, DOI 10.1021/ja901588f; Gust D, 2009, ACCOUNTS CHEM RES, V42, P1890, DOI 10.1021/ar900209b; Fukuzumi S, 2008, PHYS CHEM CHEM PHYS, V10, P2283, DOI 10.1039/b801198m; Amao Y, 2000, POLYM ADVAN TECHNOL, V11, P705, DOI 10.1002/1099-1581(200008/12)11:8/12<705::AID-PAT23>3.0.CO;2-L; Ma ZF, 2014, ENERG ENVIRON SCI, V7, P361, DOI 10.1039/c3ee42989j; Fu BY, 2012, CHEM MATER, V24, P4123, DOI 10.1021/cm3021929; Sakai J, 2008, ORG ELECTRON, V9, P582, DOI 10.1016/j.orgel.2008.03.008; Rosokha SV, 2008, ACCOUNTS CHEM RES, V41, P641, DOI 10.1021/ar700256a; Hoganson CW, 1997, SCIENCE, V277, P1953, DOI 10.1126/science.277.5334.1953; El-Khouly ME, 2004, J PHOTOCH PHOTOBIO C, V5, P79, DOI 10.1016/j.jphotochemrev.2004.01.003; El-Khouly ME, 2002, PHYS CHEM CHEM PHYS, V4, P3322, DOI 10.1039/b201922c; OKAMURA MY, 1992, ANNU REV BIOCHEM, V61, P861; El-Khouly ME, 2012, CHEM-EUR J, V18, P5239, DOI 10.1002/chem.201103074; Mishra A, 2009, CHEM REV, V109, P1141, DOI 10.1021/cr8004229; Babcock GT, 1999, P NATL ACAD SCI USA, V96, P12971, DOI 10.1073/pnas.96.23.12971; Balzani V., 2001, ELECT TRANSFER CHEM, V1-5; Blankenship R.E., 1995, ANOXYGENIC PHOTOSYNT; Calvo R, 2000, J AM CHEM SOC, V122, P7327, DOI 10.1021/ja000399r; Choi JH, 2009, SYNTHETIC MET, V159, P1589, DOI 10.1016/j.synthmet.2009.04.022; Choi J, 2013, UEEE INT SYM PERS IN, P1; El-Khouly M, 2001, J PHOTOCH PHOTOBIO A, V141, P1, DOI 10.1016/S1010-6030(01)00430-0; El-Khouly ME, 2012, J PHYS CHEM C, V116, P19709, DOI 10.1021/jp3066103; El-Khouly M.E., 2000, J PORPHYR PHTHALOCYA, V4, P591, DOI 10.1002/1099-1409(200009/10)4:6<591::AID-JPP221>3.0.CO;2-3; El-Khouly ME, 2000, J PORPHYR PHTHALOCYA, V4, P713, DOI 10.1002/1099-1409(200012)4:8<713::AID-JPP282>3.0.CO;2-E; Fichou D., 1999, HDB OLIGO POLYTHIOPH; Fox M. A., 1988, PHOTOINDUCED ELECT T; Isaacson R.A., 1996, REACTION CTR PHOTOSY, P353; Liu P, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2392823; MALMSTROM BG, 1993, ACCOUNTS CHEM RES, V26, P332, DOI 10.1021/ar00030a006; Mullen K, 1998, ELECT MAT OLIGOMER A; Murov S.I., 1985, HDB PHOTOCHEMISTRY; Nojiri T, 1997, J PHYS CHEM A, V101, P7943, DOI 10.1021/jp9714734; NOMA N, 1995, ADV MATER, V7, P647, DOI 10.1002/adma.19950070709; Trumpower B.I., 1986, FUNCTIONS QUINONES E	47	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1010-6030			J PHOTOCH PHOTOBIO A	J. Photochem. Photobiol. A-Chem.	APR 1	2015	302						11	16		10.1016/j.jphotochem.2015.01.003		6	Chemistry, Physical	Chemistry	CD0RI	WOS:000350781200002		
J	Truong, MA; Fukuta, S; Koganezawa, T; Shoji, Y; Ueda, M; Higashihara, T				Minh Anh Truong; Fukuta, Seijiro; Koganezawa, Tomoyuki; Shoji, Yu; Ueda, Mitsuru; Higashihara, Tomoya			Synthesis, Characterization, and Application to Polymer Solar Cells of Polythiophene Derivatives with Ester- or Ketone-Substituted Phenyl Side Groups	JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY			English	Article						conducting polymers; conjugated polymers; high-performance polymers; high V-oc value; low HOMO level; polymer solar cells; polythiophene; Stille coupling	ACCEPTOR COPOLYMER SEMICONDUCTORS; EFFECT CARRIER MOBILITY; PHOTOVOLTAIC PROPERTIES; CONJUGATED POLYMERS; OPTICAL-PROPERTIES; TRANSISTORS; ELECTROCHEMISTRY; NETWORK	Four polythiophene derivatives including regiorandom polymers P1, P2, and P3 and a regioregular polymer P4, containing a phenyl side chain with electron-withdrawing carbonyl groups such as an ester and a ketone at the 3-position of the thiophene ring, were synthesized by Stille coupling reaction. Bulk-heterojunction polymer solar cells (PSCs) based on these polymers as p-type semiconductors and [6,6]-phenyl-C-61-butyric acid methyl ester (PCBM) were fabricated, and their photovoltaic performances were evaluated for the first time. The PSC devices based on the regioregular polymer P4:PCBM=1:2 (w/w) exhibited a high-open-circuit voltage (V-oc) of 0.943 V because of the low-lying highest occupied molecular orbit energy level of P4. The short - stacking distance (0.355 nm) in the parallel direction to the substrate and face-on rich orientation were observed by the grazing incidence wide-angle X-ray scattering experiment, which might reflect higher J(sc) and FF values of the P4:[6,6]-phenyl-C-71-butyric acid methyl ester (PC71BM) PSC device than others. (c) 2015 Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym. Chem. 2015, 53, 875-887	[Minh Anh Truong] Tokyo Univ Agr & Technol, Dept Organ & Polymer Mat Chem, Koganei, Tokyo 1848588, Japan; [Fukuta, Seijiro; Ueda, Mitsuru; Higashihara, Tomoya] Yamagata Univ, Grad Sch Sci & Engn, Dept Polymer Sci & Engn, Yonezawa, Yamagata 9928510, Japan; [Koganezawa, Tomoyuki] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Shoji, Yu] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan; [Higashihara, Tomoya] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Higashihara, T (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Dept Polymer Sci & Engn, 4-3-16 Jonan, Yonezawa, Yamagata 9928510, Japan.	thigashihara@yz.yamagata-u.ac.jp			Mitsubishi Chemical Group Science and Technology Research Center, Inc.; Japan Science and Technology Agency (JST), PRESTO program [JY 220176]	This work received financial support from the Mitsubishi Chemical Group Science and Technology Research Center, Inc. This work was partly supported by the Japan Science and Technology Agency (JST), PRESTO program (JY 220176). GIWAXS experiments were performed at the BL19B2 of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI; Proposal No. 2012B1728). The authors thank Itaru Osaka (RIKEN) for operating the GIWAXS experiments.	YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Kang I, 2013, ADV MATER, V25, P524, DOI 10.1002/adma.201202867; Lewis NS, 2007, SCIENCE, V315, P798, DOI 10.1126/science.1137014; Yuan MC, 2010, MACROMOLECULES, V43, P6936, DOI 10.1021/ma101523a; Hou JH, 2006, J AM CHEM SOC, V128, P4911, DOI 10.1021/ja060141m; Coffin RC, 2009, NAT CHEM, V1, P657, DOI [10.1038/nchem.403, 10.1038/NCHEM.403]; Yang XN, 2005, NANO LETT, V5, P579, DOI 10.1021/nl048120i; Osaka I, 2009, J AM CHEM SOC, V131, P2521, DOI 10.1021/ja801475h; Kim DH, 2009, J AM CHEM SOC, V131, P6124, DOI 10.1021/ja8095569; Li G, 2005, NAT MATER, V4, P864, DOI 10.1038/nmat1500; Bijleveld JC, 2009, J AM CHEM SOC, V131, P16616, DOI 10.1021/ja907506r; Zhang MJ, 2014, ADV MATER, V26, P5880, DOI 10.1002/adma.201401494; Xin H, 2009, J MATER CHEM, V19, P5303, DOI 10.1039/b900073a; BREDAS JL, 1983, J AM CHEM SOC, V105, P6555, DOI 10.1021/ja00360a004; Service RF, 2011, SCIENCE, V332, P293, DOI 10.1126/science.332.6027.293; Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727; Huo LJ, 2009, MACROMOLECULES, V42, P4377, DOI 10.1021/ma900841q; Park SH, 2009, NAT PHOTONICS, V3, P297, DOI 10.1038/NPHOTON.2009.69; Wu PT, 2008, MACROMOLECULES, V41, P7021, DOI 10.1021/ma801348b; CHEN TA, 1995, J AM CHEM SOC, V117, P233, DOI 10.1021/ja00106a027; Hou JH, 2009, MACROMOLECULES, V42, P9217, DOI 10.1021/ma902197a; Zhao JH, 1998, APPL PHYS LETT, V73, P1991, DOI 10.1063/1.122345; Guo XG, 2009, J AM CHEM SOC, V131, P7206, DOI 10.1021/ja810050y; Burkhart B, 2012, MACROMOLECULES, V45, P3740, DOI 10.1021/ma300263a; Duan CH, 2012, J MATER CHEM, V22, P10416, DOI 10.1039/c2jm30470h; Forrest SR, 2004, NATURE, V428, P911, DOI 10.1038/nature02498; Shah A, 1999, SCIENCE, V285, P692, DOI 10.1126/science.285.5428.692; Yiu AT, 2012, J AM CHEM SOC, V134, P2180, DOI 10.1021/ja2089662; Zhu Y, 2006, MACROMOLECULES, V39, P8712, DOI 10.1021/ma061861g; Cheng YJ, 2009, CHEM REV, V109, P5868, DOI 10.1021/cr900182s; He YJ, 2010, ADV FUNCT MATER, V20, P3383, DOI 10.1002/adfm.201001122; Huo L., 2010, ANGEW CHEM INT EDIT, V49, P500; Noriega Rodrigo, 2013, Nat Mater, V12, P1038, DOI [10.1038/nmat3722, 10.1038/NMAT3722]; Oshimizu K., 2011, MACROMOLECULES, V44, P719	34	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-624X	1099-0518		J POLYM SCI POL CHEM	J. Polym. Sci. Pol. Chem.	APR 1	2015	53	7					875	887		10.1002/pola.27513		13	Polymer Science	Polymer Science	CC3VJ	WOS:000350278400006		
J	Fujioka, T				Fujioka, Terutaka			Elastic-Route Estimation of Strain Range in Notched Components Under Thermal Loading Without Performing Stress Linearization	JOURNAL OF PRESSURE VESSEL TECHNOLOGY-TRANSACTIONS OF THE ASME			English	Article								In this paper, a simplified method is proposed for estimating the strain range produced in notched components under thermal loading for the purpose of assessing fatigue, creep, and creep-fatigue life consumptions. The proposed method is based on the previously proposed stress redistribution locus (SRL) and elastic follow-up factor, which are combined with a new method for evaluating the primary-plus-secondary stress limit. The proposed method does not require the linearization of stresses and was validated by performing elastic-plastic finite element analysis (FEA) of notched components subjected to cyclic thermal loading.	Toyo Univ, Dept Mech Engn, Fac Sci & Engn, Kawagoe, Saitama 3508585, Japan	Fujioka, T (reprint author), Toyo Univ, Dept Mech Engn, Fac Sci & Engn, 2100 Kujirai, Kawagoe, Saitama 3508585, Japan.	fujioka@toyo.jp					Asada S., 2008, T JAPAN SOC MECH E A, V74, P1485; Asada Seiji, 2010, Journal of Environment and Engineering, V6, DOI 10.1299/jee.6.753; Asada S., 2002, PVP AM SOC MECH ENG, V439, P17; ASME, 2004, BOIL PRESS VESS COD; Fujioka T., 2007, T JPN SOC MECH ENG A, V73, P1045; Fujioka T., 2008, T JPN SOC MECH ENG A, V74, P224; Hayashi M., 1998, ASME PRESSURE VESSEL, V360, P227; IIDA K, 1987, NUCL ENG DES, V98, P305, DOI 10.1016/0029-5493(87)90008-2; Kasahara N., 2001, JSME P CREEP, V7, P625; Kroenke W. C., 1974, PRESS VESS PIP C, P107; Nakagawa Y., 1995, 3 JSME ASME JOINT IN, V1, P255; Teramae T., 2008, T JSME A, V74, P592; The Japan Atomic Power Company, 1999, DEM FAST BREED REACT; The Japan Society of Mechanical Engineers (JSME), 2008, SNC12008 JSME	14	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0094-9930	1528-8978		J PRESS VESS-T ASME	J. Press. Vessel Technol.-Trans. ASME	APR	2015	137	2							021205	10.1115/1.4027418		6	Engineering, Mechanical	Engineering	CC6FM	WOS:000350460400005		
J	Li, YS; Hasegawa, K; Sakai, M; Matsuura, S; Miura, N				Li, Yinsheng; Hasegawa, Kunio; Sakai, Michiya; Matsuura, Shinichi; Miura, Naoki			Experimental Investigation of Failure Estimation Method for Circumferentially Cracked Pipes Subjected to Combined Bending and Torsion Moments	JOURNAL OF PRESSURE VESSEL TECHNOLOGY-TRANSACTIONS OF THE ASME			English	Article						failure estimation method; plastic collapse of pipe; failure experiment; combined bending and torsion moments; circumferential surface crack; fitness-for-service		When a crack is detected in a nuclear piping system during in-service inspections, failure estimation method provided in codes such as ASME Boiler and Pressure Vessel Code Section XI or JSME Rules on Fitness-for-Service for Nuclear Power Plants can be applied to evaluate the structural integrity of the cracked pipe. In the current codes, the failure estimation method for circumferentially cracked pipes is applicable for both bending moment and axial force due to pressure. Torsion moment is not considered. Recently, two failure estimation methods for circumferentially cracked pipes subjected to combined bending and torsion moments were proposed based on analytical investigations on the limit load for cracked pipes. In this study, experimental investigation was conducted to confirm the applicability of the failure estimation method for cracked pipes subjected to bending and torsion moments. Experiments were carried out on 8-in. diameter Schedule 80 stainless steel pipes containing a circumferential surface crack. Based on the experimental results, the proposed failure estimation methods were confirmed to be applicable to cracked pipes subjected to combined bending and torsion moments.	[Li, Yinsheng] Japan Nucl Energy Safety Org, Tokai, Ibaraki 3191195, Japan; [Hasegawa, Kunio] Japan Nucl Energy Safety Org, Hitachi Naka, Ibaraki 3120016, Japan; [Sakai, Michiya; Matsuura, Shinichi] Cent Res Inst Elect Power Ind, Abiko, Chiba 2701194, Japan; [Miura, Naoki] Cent Res Inst Elect Power Ind, Yokosuka, Kanagawa 2400196, Japan	Li, YS (reprint author), Japan Atom Energy Agcy, Tokai, Ibaraki, Japan.	li.yinsheng@jaea.go.jp; kunioh@kzh.biglobe.ne.jp; m-sakai@criepi.denken.or.jp; matsuura@criepi.denken.or.jp; miura@criepi.denken.or.jp					[Anonymous], 2010, ASME BOIL PRESS VESS; ASME, 2012, ASME BOIL PRESS VESS; Bezensek B, 2012, J PRESS VESS-T ASME, V134, DOI 10.1115/1.4005875; Hoang PH, 2012, J PRESS VESS-T ASME, V134, DOI 10.1115/1.4006559; Iwamatsu F., 2011, ASME 2011 PRESS VESS; JSME, 2012, SNA12012 JSME; Kanninen M. F., 1976, NP192 EPRI; Li Y., 2010, ASME 2010 PRESS VESS; Li Y., 2010, T JAPAN SOC MECH E A, V76, P164; Li YS, 2013, J PRESS VESS-T ASME, V135, DOI 10.1115/1.4023735; Li YS, 2012, J PRESS VESS-T ASME, V134, DOI 10.1115/1.4007032; Machida H., 2011, ASME 2011 PRESS VESS; Miura N., 2012, ASME 2012 PRESS VESS; Miura N., 2011, 19 INT C NUCL ENG OS; The Japan Society of Mechanical Engineers (JSME), 2008, SNC12008 JSME	15	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0094-9930	1528-8978		J PRESS VESS-T ASME	J. Press. Vessel Technol.-Trans. ASME	APR	2015	137	2							021202	10.1115/1.4027640		7	Engineering, Mechanical	Engineering	CC6FM	WOS:000350460400002		
J	Maruyama, K; Nakamura, J; Yoshimi, K				Maruyama, K.; Nakamura, J.; Yoshimi, K.			Prediction of Long-Term Creep Rupture Life of Grade 122 Steel by Multiregion Analysis	JOURNAL OF PRESSURE VESSEL TECHNOLOGY-TRANSACTIONS OF THE ASME			English	Article								Conventional time-temperature-parameter (TTP) methods often overestimate long-term rupture life of creep strength enhanced ferritic steels. Decrease in activation energy Q for rupture life in long-term creep is the cause of the overestimation, since the TTP methods cannot deal with the change in Q. Creep rupture data of a heat of Gr. 122 steel (up to 26,200 h) were divided into several data sets so that Q was unique in each divided data set. Then a TTP method was applied to each divided data set for rupture life prediction. This is the procedure of multiregion analysis of creep rupture data. The predicted rupture lives have been reported in literature. Long-term rupture lives (up to 51,400 h) of the same heat of the steel have been published in 2013. The multiregion analysis of creep rupture life can predict properly the long-term lives reported. Stress and temperature dependences of rupture life show similar behavior among different heats. Therefore, database on results of the multiregion analyses of various heats of the steel is helpful for rupture life estimation of another heat.	[Maruyama, K.; Nakamura, J.; Yoshimi, K.] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Maruyama, K (reprint author), Tohoku Univ, Grad Sch Engn, Aoba Ku, 6-6-02 Aramaki Aoba, Sendai, Miyagi 9808579, Japan.	maruyama@material.tohoku.ac.jp			Advanced Low Carbon Technology Research and Development Program; Japan Science and Technology Agency; Ministry of Education, Science, Sports, and Culture, Japan [23360296]	A part of the present study was carried out as a research activity supported by Advanced Low Carbon Technology Research and Development Program. Financial support from Japan Science and Technology Agency is gratefully acknowledged. The other part of the present study was supported by the Ministry of Education, Science, Sports, and Culture, Japan (Grant No. 23360296).	Maruyama K, 2007, INT J PRES VES PIP, V84, P171, DOI 10.1016/j.ijpvp.2006.09.015; Bendick W, 2009, CREEP & FRACTURE IN HIGH TEMPERATURE COMPONENTS: DESIGN & LIFE ASSESSMENT ISSUES, PROCEEDINGS, P56; Danielsen H. K., 2006, Energy Materials, V1, DOI 10.1179/174892306X99732; Kimura K., 2005, PVP200571039 ASME; Kimura K., 2005, ACTIVITY REPORT WGI, P74; Kimura K., 2006, PVP2006ICPVT1193294; Kimura K., 2004, PVP20042566 ASME; Kimura K., 2012, PVP201278323 ASME; Maruyama K, 2010, INT J PRES VES PIP, V87, P276, DOI 10.1016/j.ijpvp.2010.03.012; Maruyama K, 2001, ISIJ INT, V41, P641, DOI 10.2355/isijinternational.41.641; Maruyama K., 2014, P 7 C ADV MAT TECHN; Maruyama K, 2008, WOODHEAD PUBL MATER, P350, DOI 10.1533/9781845694012.2.350; Maruyama K, 2007, J PRESS VESS-T ASME, V129, P449, DOI 10.1115/1.2748825; MARUYAMA K, 1994, TETSU TO HAGANE, V80, P336; Masuyama F., 1995, ASME CODE APPROVAL N, P98; Masuyama F., 2010, P HIGH TEMP DEF ASS; National Institute for Materials Science, 2006, DAT SHEETS EL TEMP P, V51; National Institute for Materials Science, 2013, DAT SHEET EL TEMP PR	18	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0094-9930	1528-8978		J PRESS VESS-T ASME	J. Press. Vessel Technol.-Trans. ASME	APR	2015	137	2							021403	10.1115/1.4028203		5	Engineering, Mechanical	Engineering	CC6FM	WOS:000350460400013		
J	Qian, SX; Frith, J; Kasahara, N				Qian, Shaoxiang; Frith, James; Kasahara, Naoto			Classification of Flow Patterns in Angled T-Junctions for the Evaluation of High Cycle Thermal Fatigue	JOURNAL OF PRESSURE VESSEL TECHNOLOGY-TRANSACTIONS OF THE ASME			English	Article						piping; T-junction; Y-junction; thermal striping; high cycle thermal fatigue; flow pattern; momentum ratio; computational fluid dynamics (CFD)	MIXING TEE; AREA	Temperature fluctuations caused by the mixing of hot and cold streams at tee junctions may lead to high cycle thermal fatigue (HCTF) failure. It is necessary to evaluate the integrity of structures where the HCTF may occur. Therefore, the Japan Society of Mechanical Engineers (JSME) published "Guideline for Evaluation of High Cycle Thermal Fatigue of a Pipe (JSME S017)," in 2003, which provides the procedures and methods for evaluating the integrity of structures with the potential for HCTF. In JSME S017, one of the important procedures of thermal fatigue evaluation is to classify the flow patterns at tee junctions, because the degree of thermal fatigue damage is closely related to the flow pattern downstream of the mixing junction. The conventional characteristic equations for classifying flow patterns are only applicable to 90-deg tee junctions (T-junctions). However, angled tee junctions other than 90 deg (Y-junctions) are also used in chemical plants and refineries for reducing the pressure drop in the mixing zone and for weakening the force of the impingement of the branch pipe stream against the main pipe. The aim of this paper is to develop general characteristic equations applicable to both T-and Y-junctions. In this paper, general characteristic equations have been proposed based on the momentum ratio for all angles of tee junctions. Further, the validity of the proposed characteristic equations and their applicability to all angles of tee junctions have been confirmed using computational fluid dynamics (CFD) simulations. The results have also highlighted that the angle of the branch pipe has a significant effect on increasing the velocity ratio range for less damaging deflecting jet flow pattern, which is an important finding that could be used to extend the current design options for piping systems where HCTF may be a concern. In addition, categorization 3 is recommended as a more proper method for classifying flow patterns at tee junctions when evaluating the potential for thermal fatigue.	[Qian, Shaoxiang; Frith, James] JGC Corp, Div Engn, Ctr Technol, Nishi Ku, Yokohama, Kanagawa 2206001, Japan; [Kasahara, Naoto] Univ Tokyo, Sch Engn, Nucl Engn & Management, Bunkyo Ku, Tokyo 1138656, Japan	Qian, SX (reprint author), JGC Corp, Div Engn, Ctr Technol, Nishi Ku, 2-3-1 Minato Mirai, Yokohama, Kanagawa 2206001, Japan.	qian.shaoxiang@jgc.com; frith.james@jgc.com; kasahara@n.t.u-tokyo.ac.jp			Japanese government	The CFD simulations were carried out using the modified general-purpose multiphysics CFD software FrontFlow/Red (FFR). FFR was developed based on the project of "Frontier Simulation Software for Industrial Science (FSIS)" granted by the Japanese government. Its source program is open and available from the website.	Kamide H, 2009, NUCL ENG DES, V239, P58, DOI 10.1016/j.nucengdes.2008.09.005; Lee JI, 2009, NUCL ENG DES, V239, P833, DOI 10.1016/j.nucengdes.2008.06.014; Hu LW, 2006, INT J HEAT FLUID FL, V27, P54, DOI 10.1016/j.ijheatfluidflow.2005.08.001; De Chant LJ, 2005, APPL MATH COMPUT, V161, P463, DOI 10.1016/j.amc.2003.12.109; Faidy C., 2000, INT C FAT REACT COMP; Gelineau O., 2001, T 16 INT C STRUCT ME, P1; Hosseini SM, 2008, INT J HEAT MASS TRAN, V51, P2444, DOI 10.1016/j.ijheatmasstransfer.2007.08.024; JNES (Japan Nuclear Energy Safety Organization), 2003, TROUBL NUCL POW PLAN; Maegawa M., 2006, 19 S MAINT EQ JAP PE, P12; Oka K, 2005, J FLUID ENG-T ASME, V127, P110, DOI 10.1115/1.1852475; Qian S., 2011, PVP201157292 ASME; The Japan Society of Mechanical Engineers (JSME), 2003, GUID EV HIGH CYCL TH, pS017; Wakamatsu M., 2003, ICONE11 TOK JAP ICON	13	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0094-9930	1528-8978		J PRESS VESS-T ASME	J. Press. Vessel Technol.-Trans. ASME	APR	2015	137	2							021301	10.1115/1.4027903		7	Engineering, Mechanical	Engineering	CC6FM	WOS:000350460400009		
J	Nishitani, K; Kaneko, S; Komatsu, S; Fujii, H				Nishitani, Kimitaka; Kaneko, Shinji; Komatsu, Satoru; Fujii, Hidemichi			How does a firm's management of greenhouse gas emissions influence its economic performance? Analyzing effects through demand and productivity in Japanese manufacturing firms (vol 42, pg 355, 2014)	JOURNAL OF PRODUCTIVITY ANALYSIS			English	Correction									[Nishitani, Kimitaka] Kobe Univ, Res Inst Econ & Business Adm, Nada Ku, Kobe, Hyogo 6578501, Japan; [Kaneko, Shinji] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Higashihiroshima 7398529, Japan; [Komatsu, Satoru] Nagasaki Univ, Sch Global Humanities & Social Sci, Nagasaki 8528521, Japan; [Fujii, Hidemichi] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 8528521, Japan	Nishitani, K (reprint author), Kobe Univ, Res Inst Econ & Business Adm, Nada Ku, 2-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	kimitakan@rieb.kobe-u.ac.jp	Fujii, Hidemichi/E-8261-2014	Fujii, Hidemichi/0000-0002-3043-1122			Nishitani K, 2014, J PROD ANAL, V42, P355, DOI 10.1007/s11123-014-0388-9; Nishitani K, 2011, J CLEAN PROD, V19, P1956, DOI 10.1016/j.jclepro.2011.06.021	2	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0895-562X	1573-0441		J PROD ANAL	J. Prod. Anal.	APR	2015	43	2					231	231		10.1007/s11123-015-0432-4		1	Business; Economics; Social Sciences, Mathematical Methods	Business & Economics; Mathematical Methods In Social Sciences	CC9AQ	WOS:000350660200010		
J	Ashiya, M				Ashiya, Masahiro			Lock! Risk-Free Arbitrage in the Japanese Racetrack Betting Market	JOURNAL OF SPORTS ECONOMICS			English	Article						arbitrage; pari-mutuel; market efficiency; betting; wagering	STRATEGIES; EFFICIENCY	This article finds that arbitrage was possible in 2 of the 175 Japanese thoroughbred races even after taking account of (a) the size of the minimum betting unit and (b) the negative effect of arbitrage on the odds. The guaranteed profits in these two races were 5,120 yen (about US$64) and 340 yen.	Kobe Univ, Fac Econ, Kobe, Hyogo 6578501, Japan	Ashiya, M (reprint author), Kobe Univ, Fac Econ, 2-1 Rokko Dai, Kobe, Hyogo 6578501, Japan.	ashiya@econ.kobe-u.ac.jp			Japan Society for the Promotion of Science Kakenhi [24530197]	The author disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by Japan Society for the Promotion of Science Kakenhi [Grant No. 24530197].	SHIN HS, 1993, ECON J, V103, P1141, DOI 10.2307/2234240; Edelman D. C., 2004, EUROPEAN J FINANCE, V10, P370, DOI 10.1080/1351847042000199042; Franck E., 2012, ECONOMICA, V80, P300; Gramm M, 2012, APPL ECON, V44, P1813, DOI 10.1080/00036846.2011.554378; HAUSCH DB, 1990, J BUS, V63, P61, DOI 10.1086/296483; HAUSCH DB, 1990, INTERFACES, V20, P41, DOI 10.1287/inte.20.3.41; Marshall B. R., 2009, Q REV EC FINANCE, V49, P917, DOI DOI 10.1016/J.QREF.2009.04.006; Mori S., 2009, ARXIV09113249V1; POPE PF, 1989, ECONOMICA, V56, P323, DOI 10.2307/2554281; ROSENBLOOM ES, 1992, INTERFACES, V22, P15, DOI 10.1287/inte.22.2.15; Vlastakis N, 2009, J FORECASTING, V28, P426, DOI 10.1002/for.1085; THALER RH, 1988, J ECON PERSPECT, V2, P161	12	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1527-0025	1552-7794		J SPORT ECON	J. Sport. Econ.	APR	2015	16	3					322	330		10.1177/1527002513493630		9	Economics; Hospitality, Leisure, Sport & Tourism	Business & Economics; Social Sciences - Other Topics	CC7OP	WOS:000350558100006		
J	Hosokawa, T; Somaya, K; Miyatake, M; Yoshimoto, S				Hosokawa, Takako; Somaya, Kei; Miyatake, Masaaki; Yoshimoto, Shigeka			Static Characteristics of Aerostatic Thrust Bearings With Multiple Porous Inlet Ports	JOURNAL OF TRIBOLOGY-TRANSACTIONS OF THE ASME			English	Article						aerostatic thrust bearing; porous inlet ports; mesh superposition method; static characteristics	LUBRICATED JOURNAL BEARINGS; SLIP; STIFFNESS; VELOCITY	Aerostatic porous bearings have been applied successfully to various precision devices, such as precision machine tools and precision measuring equipment, to achieve higher accuracy of motion. Recently, large aerostatic porous thrust bearings have been used as essential components in a lithography machine for large liquid crystal display (LCD) glasses. Conventional aerostatic porous bearings are made of porous material that covers the whole of the bearing surface area, requiring a large piece of such material for large bearings. However, making large pieces of porous material requires the use of a large electric furnace, which is a very expensive part of the bearing's manufacturing cost. To overcome this problem, this paper proposes an aerostatic thrust bearing with multiple porous inlet ports. The proposed bearing has a number of small porous inlet ports on the bearing surface, thereby avoiding the need for large electric furnaces. The static characteristics of the proposed bearings are investigated numerically and experimentally. The results show that the proposed aerostatic thrust bearing is potentially very useful for the manufacture of large aerostatic thrust bearings, where it would have advantages over conventional aerostatic porous thrust bearings.	[Hosokawa, Takako; Somaya, Kei; Miyatake, Masaaki; Yoshimoto, Shigeka] Tokyo Univ Sci, Dept Mech Engn, Katsushika Ku, Tokyo 1258585, Japan	Miyatake, M (reprint author), Tokyo Univ Sci, Dept Mech Engn, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	4513646@ed.tus.ac.jp; somaya@rs.kagu.tus.ac.jp; m-miyatake@rs.tus.ac.jp; yosimoto@rs.kagu.tus.ac.jp					Yoshimoto S, 2003, P I MECH ENG J-J ENG, V217, P125, DOI 10.1243/13506500360603552; GARGIULO EP, 1979, J LUBRIC TECH-T ASME, V101, P458; GARGIULO EP, 1979, J LUBRIC TECH-T ASME, V101, P466; Kawashima I., 1990, T JSPE, V56, P87; Luong TS, 2004, TRIBOL INT, V37, P825, DOI 10.1016/j.triboint.2004.05.004; MAJUMDER MC, 1988, WEAR, V124, P261, DOI 10.1016/0043-1648(88)90217-7; MORI H, 1973, J LUBRIC TECH-T ASME, V95, P195; RAMAN KV, 1979, WEAR, V52, P71, DOI 10.1016/0043-1648(79)90197-2; RAO NS, 1980, WEAR, V61, P375, DOI 10.1016/0043-1648(80)90299-9; Sawada K., 2003, FANUC TECH REV, V16, P1; Shingh K. C., 1982, WEAR, V77, P229; SINGH KC, 1984, J TRIBOL-T ASME, V106, P156; SINGH KC, 1984, J TRIBOL-T ASME, V106, P322; Sneck H. J., 1964, ASLE T, V7, P288; SNECK HJ, 1965, ASLE TRANS, V8, P339; Sun D. C., 1975, ASME, V97, P44; Yoshimoto S, 2001, J TRIBOL-T ASME, V123, P501, DOI 10.1115/1.1308027	17	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0742-4787	1528-8897		J TRIBOL-T ASME	J. Tribol.-Trans. ASME	APR	2015	137	2							021702	10.1115/1.4028999		8	Engineering, Mechanical	Engineering	CC6FU	WOS:000350461400018		
J	Ohta, H; Kato, T; Kato, S; Tajimi, H				Ohta, Hiroyuki; Kato, Taiki; Kato, Soichiro; Tajimi, Hideyuki			Carriage Drift in Linear-Guideway Type Roller Bearings	JOURNAL OF TRIBOLOGY-TRANSACTIONS OF THE ASME			English	Article						linear-guideway; roller bearing; carriage drift; roller skew; antiskewing brace; multibody analysis	BALL PASSAGE VIBRATIONS	This study deals with carriage drift (which is the differences of the carriage displacements or angular displacements at a certain position on a rail during a forward and return process) in linear-guideway type roller bearings. First, the displacements and angular displacements of the carriage of the "nonrecirculating" linear roller and ball bearings under a reciprocating operation were measured. The experimental results showed that carriage drift (in the horizontal, vertical, yaw, and pitch directions) occurred in the roller bearing and not in the ball bearing. Next, in relationship to roller skew, the generating mechanism of carriage drift in roller bearings was examined by a multibody analysis (MBA), then the generating mechanism of carriage drift was explained. Finally, to reduce carriage drift by restricting the roller skew, an antiskewing brace (ASB) was developed.	[Ohta, Hiroyuki] Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata 9402188, Japan; [Kato, Taiki] Nagaoka Univ Technol, Dept Mech Engn, Grad Sch, Nagaoka, Niigata 9402188, Japan; [Kato, Soichiro] NSK Ltd, Linear Technol Ctr, LG Technol Dept, Fujisawa, Kanagawa 2520811, Japan; [Tajimi, Hideyuki] NSK Ltd, Linear Technol Ctr, Res Dept, Fujisawa, Kanagawa 2520811, Japan	Ohta, H (reprint author), Nagaoka Univ Technol, Dept Mech Engn, 1603-1 Kamitomioka, Nagaoka, Niigata 9402188, Japan.	ohta@mech.nagaokaut.ac.jp					Ohta H, 1999, J TRIBOL-T ASME, V121, P678, DOI 10.1115/1.2834123; Ohta H, 2000, J SOUND VIB, V235, P847, DOI 10.1006/jsvi.2000.2950; FunctionBay K. K., 2012, RECURDYN SOLVER THEO, P122; Harris T. A., 1999, ROLLING BEARING ANAL, P106; Kasai S., 1989, NSK TECH J, V649, P27; Kasai S., 1987, NSK TECHNICAL J, V647, P39; Kasai S., 1989, NSK TECH J, V650, P47; Kato S., 2000, MOTION CONTROL, V9, P27; Matsumoto J., 2004, MOTION CONTROL, V16, P29; Ohta H, 2007, J TRIBOL-T ASME, V129, P188, DOI 10.1115/1.2401215; Ohta H, 2005, J TRIBOL-T ASME, V127, P257, DOI 10.1115/1.1828436; Ohta H, 2003, J TRIBOL-T ASME, V125, P480, DOI 10.1115/1.1537264; Sawamoto T., 1965, J JPN SOC LUBR ENG, V10, P34; Schneider M., 1991, STATISHES DYNAMISCHE; Shimizu S., 1990, J JPN SOC PRECIS ENG, V56, P1445	15	0	0	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0742-4787	1528-8897		J TRIBOL-T ASME	J. Tribol.-Trans. ASME	APR	2015	137	2							024505	10.1115/1.4029641		7	Engineering, Mechanical	Engineering	CC6FU	WOS:000350461400027		
J	Watanabe, KP; Kawai, YK; Nakayama, SMM; Ikenaka, Y; Mizukawa, H; Takaesu, N; Ito, M; Ikushiro, SI; Sakaki, T; Ishizuka, M				Watanabe, K. P.; Kawai, Y. K.; Nakayama, S. M. M.; Ikenaka, Y.; Mizukawa, H.; Takaesu, N.; Ito, M.; Ikushiro, S. -I.; Sakaki, T.; Ishizuka, M.			Partial cloning of CYP2C23a genes and hepatic protein expression in eight representative avian species	JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS			English	Article							CYTOCHROME-P450; WARFARIN; SITES; RAT	Large interspecies differences in avian xenobiotic metabolism have been revealed by microsome-based studies, but specific enzyme isoforms in different bird species have not yet been compared. We have previously shown that CYP2C23 genes are the most induced CYP isoforms in chicken liver. In this study, we collected partial CYP2C23a gene sequences from eight avian species (ostrich, blue-eared pheasant, snowy owl, great-horned owl, Chilean flamingo, peregrin falcon, Humboldt penguin, and black-crowned night heron) selected to cover the whole avian lineage: Paleognathae, Galloanserae, and Neoaves. Genetic analysis showed that CYP2C23 genes of Galloanserae species (chicken and blue-eared pheasant) had unique characteristics. We found some duplicated genes (CYP2C23a and CYP2C23b) and two missing amino acid residues in Galloanserae compared to the other two lineages. The genes have lower homology than in other avian lineages, which suggests Galloanserae-specific rapid evolutionary changes. These genetic features suggested that the Galloanserae are not the most representative avian species, considering that the Neoaves comprise more than 95% of birds. Moreover, we succeeded in synthesizing an antipeptide polyclonal antibody against the region of CYP2C23 protein conserved in avians. However, comparative quantitation of CYP2C23 proteins in livers from six species showed that expression levels of these proteins differed no more than fourfold. Further study is needed to clarify the function of avian CYP2C23 proteins.	[Watanabe, K. P.; Kawai, Y. K.; Nakayama, S. M. M.; Ikenaka, Y.; Mizukawa, H.; Ishizuka, M.] Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Sapporo, Hokkaido 0600818, Japan; [Takaesu, N.; Ito, M.] Maruyama Zoo, Sapporo, Hokkaido, Japan; [Ikushiro, S. -I.; Sakaki, T.] Toyama Prefectural Univ, Fac Engn, Dept Biotechnol, Imizu, Toyama, Japan	Ishizuka, M (reprint author), Hokkaido Univ, Grad Sch Vet Med, Dept Environm Vet Sci, Toxicol Lab,Kita Ku, N18,W9, Sapporo, Hokkaido 0600818, Japan.	ishizum@vetmed.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24248056, 24405004, 26304043]	This study was partly supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan awarded to M. Ishizuka (Nos.24248056 and 24405004) and Y. Ikenaka (No. 26304043). One of the authors (K. P. Watanabe) is a research fellow at the Japan Society for the Promotion of Science (No. 2300186400). The authors would like to thank Enago (www.enago.jp) for the language review.	Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/01.fpc.0000054151.92680.31; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Watanabe KP, 2010, COMP BIOCHEM PHYS C, V152, P114, DOI 10.1016/j.cbpc.2010.03.006; Darwish WS, 2010, J VET MED SCI, V72, P1237, DOI 10.1292/jvms.10-0019; GOTOH O, 1992, J BIOL CHEM, V267, P83; Ikushiro S, 2004, BBA-GEN SUBJECTS, V1672, P86, DOI 10.1016/j.bbagen.2004.02.012; KAMINSKY LS, 1993, MOL PHARMACOL, V43, P234; Ridderstrom M, 2001, J MED CHEM, V44, P4072, DOI 10.1021/jm0109107; Watanabe KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075689	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0140-7783	1365-2885		J VET PHARMACOL THER	J. Vet. Pharmacol. Ther.	APR	2015	38	2					190	195		10.1111/jvp.12159		6	Pharmacology & Pharmacy; Veterinary Sciences	Pharmacology & Pharmacy; Veterinary Sciences	CC8TQ	WOS:000350641500012		
J	Suzuki, M; Kogure, T; Sakuda, S; Nagasawa, H				Suzuki, Michio; Kogure, Toshihiro; Sakuda, Shohei; Nagasawa, Hiromichi			Identification of Ligament Intra-Crystalline Peptide (LICP) from the Hinge Ligament of the Bivalve, Pinctada Fucata	MARINE BIOTECHNOLOGY			English	Article						Aragonite; Biomineralization; Intra-crystalline peptide; Ligament; Pinctada fucata	MOLECULAR-WEIGHT MOLECULES; MATRIX; CALCIFICATION; MOLLUSCAN; ARAGONITE; PROTEIN; CHITIN; EXOSKELETON; MECHANISM; CRAYFISH	The hinge ligament of the bivalve is an important hard tissue that functions to open and close the shells. The ligament contains a fibrous structure consisting of aragonite crystals surrounded by dense organic matrices. Although many matrix proteins have been identified from various shell microstructures in previous works, ligament-specific matrix proteins have not yet been reported. In this study, in order to reveal the formation mechanism of the fibrous aragonite crystals in the ligament of Pinctada fucata, we identified a novel, small acidic peptide, named ligament intra-crystalline peptide (LICP), from the aragonite crystal of the ligament that had been pre-treated with sodium hypochlorite to remove the inter-crystalline organic matrices. LICP consists of 10 amino acid residues with N-terminal pyroglutamic acid. The result of cDNA cloning showed that the cDNA encodes another putative 10-residue peptide at the C-terminal end of LICP. LICP showed inhibitory activity on calcium carbonate precipitation, while the synthetic 10-residue peptide from the C-terminal sequence of proLICP did not. We also noted that the TEM and SEM observations of aragonite crystals formed by the in vitro crystallization experiment showed that LICP inhibited the growth of aragonite crystal to stop elongation in the c-axis direction. These results suggested that LICP has a role of regulating the formation of the aragonite crystals in the ligament.	[Suzuki, Michio; Sakuda, Shohei; Nagasawa, Hiromichi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Kogure, Toshihiro] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Nagasawa, Hiromichi] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	Suzuki, M (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amichiwo@mail.ecc.u-tokyo.ac.jp	Kogure, Toshihiro/N-1932-2014; Kogure, Toshihiro/K-7857-2015		Japan Society for the Promotion of Science (JSPS) [22228006, 22248037, 25850078]	We are grateful to Dr. H. Aoki of the Fisheries Research Institute, Mie Prefecture, Japan, for the kind gift of live pearl oysters. This work was supported by Grants-in-Aid for Scientific Research (22228006, 22248037, and 25850078) from the Japan Society for the Promotion of Science (JSPS).	Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Sato A, 2011, NAT CHEM BIOL, V7, P197, DOI [10.1038/nchembio.532, 10.1038/NCHEMBIO.532]; Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319; TRUEMAN ER, 1950, Q J MICROSC SCI, V91, P225; ONO K, 1990, J BIOMECH, V23, P307, DOI 10.1016/0021-9290(90)90058-B; Inoue H, 2001, BIOSCI BIOTECH BIOCH, V65, P1840, DOI 10.1271/bbb.65.1840; KAHLER GA, 1976, J COMP PHYSIOL, V109, P209; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Inoue H, 2003, COMP BIOCHEM PHYS B, V136, P755, DOI 10.1016/S1096-4959(03)00210-0; Xie AJ, 2007, MATER CHEM PHYS, V101, P87, DOI 10.1016/j.matchemphys.2006.02.019; Rousseau M, 2008, J BIOMED MATER RES A, V85A, P487, DOI 10.1002/jbm.a.31553; Bedouet L, 2006, COMP BIOCHEM PHYS B, V144, P532, DOI 10.1016/j.cbpb.2006.05.012; BEVELAND.G, 1969, CALC TISS RES, V4, P101, DOI 10.1007/BF02279112; HARE PE, 1963, SCIENCE, V139, P216, DOI 10.1126/science.139.3551.216; HUNT S, 1987, COMP BIOCHEM PHYS B, V88, P1107, DOI 10.1016/0305-0491(87)90013-7; KAHLER GA, 1976, BIOL BULL, V151, P161, DOI 10.2307/1540712; KELLY RE, 1967, SCIENCE, V155, P208, DOI 10.1126/science.155.3759.208; KIKUCHI Y, 1987, EUR J BIOCHEM, V164, P397, DOI 10.1111/j.1432-1033.1987.tb11071.x; Kim W, 2005, CRYST GROWTH DES, V5, P513; Lowenstam H. A., 1989, BIOMINERALIZATION; Mann S., 2002, BIOMINERALIZATION; MARSH M, 1978, CALC TISS RES, V25, P45, DOI 10.1007/BF02010750; MARSH ME, 1981, J ULTRA MOL STRUCT R, V76, P57, DOI 10.1016/S0022-5320(81)80050-0; MARSH ME, 1980, SCIENCE, V208, P1262, DOI 10.1126/science.208.4449.1262; Nagasawa H, 2013, BIOSCI BIOTECH BIOCH, V77, P1991, DOI 10.1271/bbb.130464; PETERS W, 1972, COMP BIOCHEM PHYSIOL, V41, P541, DOI 10.1016/0305-0491(72)90117-4; STENZEL HB, 1962, SCIENCE, V136, P1121, DOI 10.1126/science.136.3522.1121-a; Suzuki M, 2013, CAN J ZOOL, V91, P349, DOI 10.1139/cjz-2012-0333; TRUEMAN ER, 1953, Q J MICROSC SCI, V94, P193; TRUEMAN ER, 1951, Q J MICROSC SCI, V92, P129; TRUEMAN ER, 1950, NATURE, V165, P397, DOI 10.1038/165397c0	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-2228	1436-2236		MAR BIOTECHNOL	Mar. Biotechnol.	APR	2015	17	2					153	161		10.1007/s10126-014-9603-y		9	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	CC7NO	WOS:000350555000004		
J	Matsuda, R; Ozgur, R; Higashi, Y; Takechi, K; Takano, H; Takio, S				Matsuda, Ryuya; Ozgur, Rengin; Higashi, Yuya; Takechi, Katsuaki; Takano, Hiroyoshi; Takio, Susumu			Preferential Expression of a Bromoperoxidase in Sporophytes of a Red Alga, Pyropia yezoensis	MARINE BIOTECHNOLOGY			English	Article						Bromoform; Sporophyte; Allelochemical; Vanadium; Pyropia yezoensis	VANADIUM-DEPENDENT BROMOPEROXIDASE; PORPHYRA-YEZOENSIS; CORALLINA-OFFICINALIS; MOLECULAR-CLONING; MARINE ALGA; CELL-WALLS; RHODOPHYTA; MACROALGAE; ORGANOHALOGENS; MORPHOGENESIS	A 2,158 bp cDNA (PyBPO1) encoding a bromoperoxidase (BPO) of 625 amino acids was isolated from Pyropia yezoensis. Phylogenetic analysis using amino acid sequences of BPOs suggested that P. yezoensis and cyanobacteria were grouped in the same clade and separated from brown algae. Genomic Southern blot analysis suggested that PyBPO1 existed as a single copy per haploid genome. RT-PCR revealed that PyBPO1 was actively expressed in filamentous sporophytes but repressed in leafy gametophytes under normal growth conditions. High expression levels of PyBPO1 in sporophytes were observed when sporophytes were grown under gametophyte conditions, suggesting that preferential expression of PyBPO1 occurs during the sporophyte phase. BPO activity of cell-free extracts from sporophytes and gametophytes was examined by activity staining on native PAGE gel using o-dianisidine. One activity band was detected in sporophyte sample, but not in gametophyte sample. In addition, we found that bromide and iodide were effective substrate, but chloride was not. BPO activity was observed-likely in chloroplasts-when sporophyte cells were incubated with o-dianisidine and hydrogen peroxide. Cellular BPO staining showed the same halogen preference identified by in-gel BPO staining. Based on GS-MS analysis, bromoform was detected in medium containing sporophytes. Bromoform was not detected under dark culture conditions but was detected in the culture exposed to low light intensity (5 mu mol m(-2) s(-1)) and increased under a moderate light intensity (30 mu mol m(-2) s(-1)).	[Matsuda, Ryuya; Ozgur, Rengin; Higashi, Yuya; Takechi, Katsuaki; Takano, Hiroyoshi] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan; [Takio, Susumu] Kumamoto Univ, Ctr Marine Environm Studies, Kumamoto 8608555, Japan	Takio, S (reprint author), Kumamoto Univ, Ctr Marine Environm Studies, Kumamoto 8608555, Japan.	stakio@gpo.kumamoto-u.ac.jp		Takano, Hiroyoshi/0000-0003-4720-5057	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	We would like to thank Dr. Naotsune Saga of Hokkaido University, Japan, for providing the gametophyte and sporophytes of P. yezoensis. This work was supported by Grants-in-Aid for Scientific Research on Priority Areas (to S.T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and from the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN, to H.T.).	Gribble GW, 2003, CHEMOSPHERE, V52, P289, DOI 10.1016/S0045-6535(03)00207-8; Winter JM, 2009, J BIOL CHEM, V284, P18577, DOI 10.1074/jbc.R109.001602; Ohshiro T, 2004, PROTEIN SCI, V13, P1566, DOI 10.1110/ps.03496004; Isupov MN, 2000, J MOL BIOL, V299, P1035, DOI 10.1006/jmbi.2000.3806; Kuwano K, 1996, PLANT SCI, V116, P117, DOI 10.1016/0168-9452(96)04380-4; Carter JN, 2002, J INORG BIOCHEM, V91, P59, DOI 10.1016/S0162-0134(02)00400-2; THEILER R, 1978, SCIENCE, V202, P1094, DOI 10.1126/science.202.4372.1094; MUKAI LS, 1981, J PHYCOL, V17, P192, DOI 10.1111/j.0022-3646.1981.00192.x; Matsuo Y, 2005, SCIENCE, V307, P1598, DOI 10.1126/science.1105486; Ritter A, 2010, PROTEOMICS, V10, P2074, DOI 10.1002/pmic.200900004; Laturnus F, 1996, MAR ENVIRON RES, V41, P169, DOI 10.1016/0141-1136(95)00017-8; Butler A, 2004, NAT PROD REP, V21, P180, DOI 10.1039/b302337k; Kwon MJ, 2006, LIFE SCI, V79, P1956, DOI 10.1016/j.lfs.2006.06.031; Ohsawa N, 2001, PHYTOCHEMISTRY, V58, P683, DOI 10.1016/S0031-9422(01)00259-X; Nikaido I, 2000, DNA RES, V7, P223, DOI 10.1093/dnares/7.3.223; Asamizu E, 2003, J PHYCOL, V39, P923; Weinberger F, 2007, J EXP BOT, V58, P4365, DOI 10.1093/jxb/erm303; Johnson TL, 2011, J PHYCOL, V47, P792, DOI 10.1111/j.1529-8817.2011.01007.x; Colin C, 2003, J BIOL CHEM, V278, P23545, DOI 10.1074/jbc.M300247200; Laturnus F, 2001, ENVIRON SCI POLLUT R, V8, P103, DOI 10.1007/BF02987302; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Cabrita MT, 2010, MAR DRUGS, V8, P2301, DOI 10.3390/md8082301; Blouin NA, 2011, TRENDS PLANT SCI, V16, P29, DOI 10.1016/j.tplants.2010.10.004; Paul NA, 2006, MAR ECOL PROG SER, V306, P87, DOI 10.3354/meps306087; Baharum H, 2013, PHYTOCHEMISTRY, V92, P49, DOI 10.1016/j.phytochem.2013.04.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Shin ES, 2011, INT J MOL MED, V28, P809, DOI 10.3892/ijmm.2011.729; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564; APT KE, 1993, PLANT MOL BIOL, V21, P27, DOI 10.1007/BF00039615; Beissner RS, 1981, BIOCHEMISTRY-US, V20, P3727; Colin C, 2005, J BIOL INORG CHEM, V10, P155; Collen J, 2013, P NATL ACAD SCI USA, V110, P5247, DOI 10.1073/pnas.1221259110; Crepineau F, 2000, PLANT MOL BIOL, V43, P503, DOI 10.1023/A:1006489920808; EVERETT RR, 1990, J BIOL CHEM, V265, P4908; Fukui Y, 2014, MICROB ECOL, V68, P556, DOI 10.1007/s00248-014-0423-4; GRETZ MR, 1984, PHYTOCHEMISTRY, V23, P2513, DOI 10.1016/S0031-9422(00)84087-X; Gupta V, 2011, AQUACULTURE, V318, P389, DOI 10.1016/j.aquaculture.2011.06.009; HOFSTEN AV, 1977, BOT MAR, V20, P267; Hofsen AV, 1980, Z PFLANZENPHYSIOL, V96, P115; Latham H, 2008, BIOSCI HORIZON, V1, P104, DOI 10.1093/biohorizons/hzn016; Manley SL, 2002, BIOGEOCHEMISTRY, V60, P163, DOI 10.1023/A:1019859922489; Manley SL, 1979, PLANT PHYSIOL, V64, P1322; Marshall RA, 1999, LIMNOL OCEANOGR, V44, P1348; Nakamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057122; NIGHTINGALE PD, 1995, LIMNOL OCEANOGR, V40, P680; Nozaki Y., 2001, ENCY OCEAN SCI, P840; Saga N, 2012, PORPHYRA YEZOENSIS F, P1; Sandy M, 2011, CHEM COMMUN, V47, P12086, DOI 10.1039/c1cc15605e; Shimonishi M, 1998, FEBS LETT, V428, P105, DOI 10.1016/S0014-5793(98)00500-6; Suzuki N, 1998, J PLANT PHYSL, V152, P31; Uji T, 2012, MOL BIOL REP, V39, P7973, DOI 10.1007/s11033-012-1643-7; Uji T, 2013, MAR BIOTECHNOL, V15, P188, DOI 10.1007/s10126-012-9475-y; Wischang D, 2012, BIOORG CHEM, V44, P25, DOI 10.1016/j.bioorg.2012.05.003; YAMADA H, 1985, AGR BIOL CHEM TOKYO, V49, P2961; YOSHIZAWA Y, 1995, BIOSCI BIOTECH BIOCH, V59, P1933; Yotsukura N, 2012, J APPL PHYCOL, V24, P163, DOI 10.1007/s10811-011-9664-5	56	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1436-2228	1436-2236		MAR BIOTECHNOL	Mar. Biotechnol.	APR	2015	17	2					199	210		10.1007/s10126-014-9608-6		12	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	CC7NO	WOS:000350555000009		
J	Liesenfeld, DB; Rattray, NJW; van der Hooft, JJJ; Daskalaki, E; Weber, RJM; Payne, T; Putri, SP				Liesenfeld, David B.; Rattray, Nicholas J. W.; van der Hooft, Justin J. J.; Daskalaki, Evangelia; Weber, Ralf J. M.; Payne, Thomas; Putri, Sastia P.			Activity update from the early career members network	METABOLOMICS			English	News Item									[Liesenfeld, David B.] German Canc Res Ctr, Heidelberg, Germany; [Rattray, Nicholas J. W.] Univ Manchester MIB, Manchester, Lancs, England; [van der Hooft, Justin J. J.] Univ Glasgow, Glasgow, Lanark, Scotland; [Daskalaki, Evangelia] Univ Strathclyde, Glasgow, Lanark, Scotland; [Weber, Ralf J. M.] Univ Birmingham, Birmingham, W Midlands, England; [Payne, Thomas] Univ London Imperial Coll Sci Technol & Med, London, England; [Putri, Sastia P.] Osaka Univ, Osaka, Japan	Putri, SP (reprint author), Osaka Univ, Osaka, Japan.	sastia_putri@bio.eng.osaka-u.ac.jp					Putri S., 2014, METABOLOMICS, V10, P1	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1573-3882	1573-3890		METABOLOMICS	Metabolomics	APR	2015	11	2					247	248		10.1007/s11306-015-0779-6		2	Endocrinology & Metabolism	Endocrinology & Metabolism	CC7TC	WOS:000350570300001		
J	Kusano, M; Baxter, I; Fukushima, A; Oikawa, A; Okazaki, Y; Nakabayashi, R; Bouvrette, DJ; Achard, F; Jakubowski, AR; Ballam, JM; Phillips, JR; Culler, AH; Saito, K; Harrigan, GG				Kusano, Miyako; Baxter, Ivan; Fukushima, Atsushi; Oikawa, Akira; Okazaki, Yozo; Nakabayashi, Ryo; Bouvrette, Denise J.; Achard, Frederic; Jakubowski, Andrew R.; Ballam, Joan M.; Phillips, Jonathan R.; Culler, Angela H.; Saito, Kazuki; Harrigan, George G.			Assessing metabolomic and chemical diversity of a soybean lineage representing 35 years of breeding	METABOLOMICS			English	Article						Soybean (Glycine max) breeding; Food safety; Metabolomics; Ionomics	GENETIC DIVERSITY; ACCUMULATION; ENVIRONMENT; IMPROVEMENT; GERMPLASM; CROPS; SEEDS; RICE	Information on crop genotype- and phenotype-metabolite associations can be of value to trait development as well as to food security and safety. The unique study presented here assessed seed metabolomic and ionomic diversity in a soybean lineage representing similar to 35 years of breeding (launch years 1972-2008) and increasing yield potential. Selected varieties included six conventional and three genetically modified (GM) glyphosate-tolerant lines. A metabolomics approach utilizing capillary electrophoresis (CE)-time-of-flight-mass spectrometry (TOF-MS), gas chromatography (GC)-TOF-MS and liquid chromatography (LC)-quadrupole (q)-TOFMS resulted in measurement of a total of 732 annotated peaks. Ionomics through inductively-coupled plasma (ICP)-MS profiled twenty mineral elements. Orthogonal partial least squares-discriminant analysis (OPLS-DA) of the seed data successfully differentiated newer higher-yielding soybean from earlier lower-yielding accessions at both field sites. This result reflected genetic fingerprinting data that demonstrated a similar distinction between the newer and older soybean. Correlation analysis also revealed associations between yield data and specific metabolites. There were no clear metabolic differences between the conventional and GM lines. Overall, observations of metabolic and genetic differences between older and newer soybean varieties provided novel and significant information on the impact of varietal development on biochemical variability. Proposed applications of omics in food and feed safety assessments will need to consider that GM is not a major source of metabolite variability and that trait development in crops will, of necessity, be associated with biochemical variation.	[Kusano, Miyako; Fukushima, Atsushi; Oikawa, Akira; Okazaki, Yozo; Nakabayashi, Ryo; Saito, Kazuki] RIKEN Ctr Sustainable Resource Sci, Tsunumi Ku, Yokohama, Kanagawa 23000405, Japan; [Baxter, Ivan] ARS, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, USDA, St Louis, MO 63132 USA; [Bouvrette, Denise J.; Achard, Frederic; Jakubowski, Andrew R.; Ballam, Joan M.; Phillips, Jonathan R.; Culler, Angela H.; Harrigan, George G.] Monsanto Co, St Louis, MO 63167 USA; [Saito, Kazuki] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan	Baxter, I (reprint author), ARS, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, USDA, St Louis, MO 63132 USA.	ivan.baxter@ars.usda.gov; kazuki.saito@riken.jp; george.g.harrigan@monsanto.com	Saito, Kazuki/D-2670-2009; Baxter, Ivan/A-1052-2009	Baxter, Ivan/0000-0001-6680-1722	Japan Advanced Plant Science Network	We are very grateful for the agronomic support provided by Matt Culler of Monsanto. Genetic fingerprint analyses were conducted within the Molecular Breeding Technology group at Monsanto. The excellent logistical support provided by James McCarter and his sample management team was also critical to the success of this experiment. We are indebted to Nordine Cheikh for his support and encouragement and to Mark Leibman and John Vicini for helpful comments on the manuscript. We also thank Tomoko Nishizawa, Makoto Kobayashi, Ryosuke Sasaki, and Koji Takano (RIKEN) for their technical assistance in the study. This research was also supported by the Japan Advanced Plant Science Network.	Kusano M, 2007, J CHROMATOGR B, V855, P71, DOI 10.1016/j.jchromb.2007.05.002; Specht JE, 1999, CROP SCI, V39, P1560; Redestig H, 2009, ANAL CHEM, V81, P7974, DOI 10.1021/ac901143w; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Harrigan GG, 2010, NAT BIOTECHNOL, V28, P402, DOI 10.1038/nbt0510-402; Ricroch AE, 2013, NEW BIOTECHNOL, V30, P349, DOI 10.1016/j.nbt.2012.12.001; Rischer H, 2006, TRENDS BIOTECHNOL, V24, P102, DOI 10.1016/j.tibtech.2006.01.009; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Kimbara J, 2013, PLANT CELL PHYSIOL, V54, P1535, DOI 10.1093/pcp/pct100; [Anonymous], 2004, J BIOL BIOTECHNOL; Baxter I, 2012, SCIENCE, V336, P1661, DOI 10.1126/science.1219992; Ricroch AE, 2011, PLANT PHYSIOL, V155, P1752, DOI 10.1104/pp.111.173609; Rotundo JL, 2009, FIELD CROP RES, V110, P147, DOI 10.1016/j.fcr.2008.07.012; Berman K. H., 2011, JOURNAL OF AGRICULTU, V59, P11643; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Davies H., 2010, Food Control, V21, P1601; Gutierrez-Gonzalez JJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-105; Harrigan GG, 2013, J AGR FOOD CHEM, V61, P10807, DOI 10.1021/jf4032102; Hothorn LA, 2006, REGUL TOXICOL PHARM, V44, P125, DOI 10.1016/j.yttph.2005.10.001; Kusano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016989; Kusano M, 2012, J PLANT BIOCHEM BIOT, V21, pS24, DOI 10.1007/s13562-012-0131-4; Meksem K., 2001, Journal of Biomedicine and Biotechnology, V1, P38, DOI 10.1155/S1110724301000110; Mikel MA, 2010, CROP SCI, V50, P1219, DOI 10.2135/cropsci2009.08.0456; Okazaki Y., 2013, METABOLOMICS S1, V9, P121, DOI [10.1007/s11306-011-0318-z, DOI 10.1007/S11306-011-0318-Z]; Redestig H, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-176; Redestig H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-214; Sansone S.A., 2007, NAT BIOTECHNOL, V25, P846, DOI 10.1038/nbt0807-846b; Team R. D. C., 2004, R LANG ENV STAT COMP; Thompson JA, 1998, CROP SCI, V38, P1362; VedrinaDragojevic I, 1997, J PLANT PHYSIOL, V150, P437; Ziegler G., 2013, PLANT GENOME, V6, P1, DOI DOI 10.3835/PLANTGENOME2012.07.0012	32	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1573-3882	1573-3890		METABOLOMICS	Metabolomics	APR	2015	11	2					261	270		10.1007/s11306-014-0702-6		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CC7TC	WOS:000350570300003		
J	Yokoyama, Y; Itoh, S; Murakami, Y; Narita, I; Wang, GY; Liaw, PK				Yokoyama, Yoshihiko; Itoh, Shun; Murakami, Yoshihiro; Narita, Issei; Wang, Gongyao; Liaw, Peter K.			Microsegregation in and Phase Stability of As-Cast Ti-Zr-Hf-Ni-Pd-Pt High-Entropy Alloys	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							MULTICOMPONENT ALLOYS; MICROSTRUCTURE; ALUMINUM; BEHAVIOR; ELEMENTS; DESIGN; GLASS	Microsegregation in as-cast Ti-Zr-Hf-Ni-Pd-Pt high-entropy alloys (HEAs) was examined by scanning electron microscopy and transmission electron microscopy. The structure of the microsegregated HEAs was composed of dendrite grains and grain boundaries. Since Hf, Zr, and Pt show both high melting temperatures and large negative mixing enthalpy, microsegregation on a micrometer scale occurred easily, similar to the spontaneous inoculation during solidification of copper-mold casts. In contrast, the grain boundaries were identified as being Ti- and Ni-enriched regions. Macroscopic X-ray data showed the combination of a distinct body-centered-cubic structure and broad halo peaks (amorphous structure). Microstructure analysis revealed that heteroamorphous and nanocrystalline regions are observed when the Ti group:Ni group molar ratio was 50/50. This unique microsegregated structure resulted in an ultimate compression strength of more than 2 GPa. (C) The Minerals, Metals & Materials Society and ASM International 2014	[Yokoyama, Yoshihiko; Itoh, Shun; Murakami, Yoshihiro; Narita, Issei] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Wang, Gongyao; Liaw, Peter K.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA	Yokoyama, Y (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	yy@imr.tohoku.ac.jp			JSPS KAKENHI [23560857]	This research was funded in part by a JSPS KAKENHI Grant-in-Aid for Scientific Research (C) Project No. 23560857.	Senkov ON, 2010, INTERMETALLICS, V18, P1758, DOI 10.1016/j.intermet.2010.05.014; Yeh JW, 2004, ADV ENG MATER, V6, P299, DOI 10.1002/adem.200300567; Senkov ON, 2011, J ALLOY COMPD, V509, P6043, DOI 10.1016/j.jallcom.2011.02.171; Tong CJ, 2005, METALL MATER TRANS A, V36A, P881, DOI 10.1007/s11661-005-0283-0; Martinez LM, 2001, NATURE, V410, P663, DOI 10.1038/35070517; Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6; Yeh JW, 2006, ANN CHIM-SCI MAT, V31, P633, DOI 10.3166/acsm.31.633-648; Senkov ON, 2014, ACTA MATER, V68, P214, DOI 10.1016/j.actamat.2014.01.029; Takeuchi A, 2011, INTERMETALLICS, V19, P1546, DOI 10.1016/j.intermet.2011.05.030; Senkov ON, 2011, INTERMETALLICS, V19, P698, DOI 10.1016/j.intermet.2011.01.004; Zhang Y, 2012, JOM-US, V64, P830, DOI 10.1007/s11837-012-0366-5; Kao YF, 2009, J ALLOY COMPD, V488, P57, DOI 10.1016/j.jallcom.2009.08.090; Takeuchi A, 2013, MATER TRANS, V54, P776, DOI 10.2320/matertrans.M2012370; Tang Z, 2013, JOM-US, V65, P1848, DOI 10.1007/s11837-013-0776-z; EGAMI T, 1984, J NON-CRYST SOLIDS, V64, P113, DOI 10.1016/0022-3093(84)90210-2; Hemphill MA, 2012, ACTA MATER, V60, P5723, DOI 10.1016/j.actamat.2012.06.046; Zhang Y, 2008, ADV ENG MATER, V10, P534, DOI 10.1002/adem.200700240; Cantor B, 2004, MAT SCI ENG A-STRUCT, V375, P213, DOI 10.1016/j.msea.2003.10.257; de Boer F.R., COHESION METALS; Yeh J.W., 2011, CHANGSH M; Zhang YM, 2014, J MANUF PROCESS, V16, P1, DOI 10.1016/j.jmapro.2013.12.004; Zhang Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01455	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	APR	2015	46A	4					1474	1480		10.1007/s11661-014-2622-5		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CC4DL	WOS:000350300900009		
J	Park, N; Watanabe, I; Terada, D; Yokoyama, Y; Liaw, PK; Tsuji, N				Park, Nokeun; Watanabe, Ikuto; Terada, Daisuke; Yokoyama, Yoshihiko; Liaw, Peter K.; Tsuji, Nobuhiro			Recrystallization Behavior of CoCrCuFeNi High-Entropy Alloy	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							MULTICOMPONENT ALLOYS; PHASE-STABILITY; MICROSTRUCTURE; ENTHALPY; ELEMENTS	We investigated the recrystallization behavior of a cold-rolled CoCrCuFeNi high-entropy alloy (HEA). Two different face-centered cubic phases having different chemical compositions and lattice constants in the as-cast specimen have different chemical compositions: One phase was the Cu-lean matrix and the other was the Cu-rich second phase. The second phase remained even after a heat treatment at 1373 K (1100 A degrees C) and Cu enriched more in the Cu-rich second phase. The calculated mixing enthalpies of both Cu-lean and Cu-rich phases in the as-cast and heat-treated specimens explained that Cu partitioning during the heat treatment decreased the mixing enthalpy in both phases. In the specimens 90 pct cold rolled and annealed at 923 K, 973 K, and 1073 K (650 A degrees C, 700 A degrees C, and 800 A degrees C), recrystallization proceeded with increasing the annealing temperature, and ultrafine recrystallized grains with grain sizes around 1 mu m could be obtained. The microhardness tended to decrease with increasing the fraction recrystallized, but it was found that the microhardness values of partially recrystallized specimens were much higher than those expected by a simple rule of mixture between the initial and cold-rolled specimens. The reason for the higher hardness was discussed based on the ultrafine grain size, sluggish diffusion expected in HEAs, and two-phase structure in the CoCrCuFeNi alloy. (C) The Minerals, Metals & Materials Society and ASM International 2014	[Park, Nokeun] Kyoto Univ, Dept Mat Sci & Engn, Sakyo Ku, Kyoto 6068501, Japan; [Park, Nokeun] Max Planck Inst Iron Res, Dept Microstruct Phys & Alloy Design, Dusseldorf, Germany; [Watanabe, Ikuto; Terada, Daisuke; Tsuji, Nobuhiro] Kyoto Univ, Dept Mat Sci & Engn, Kyoto 6068501, Japan; [Terada, Daisuke] Chiba Inst Technol, Dept Mech Sci & Engn, Narashino, Chiba 2750016, Japan; [Terada, Daisuke] Kyoto Univ, Elements Strategy Initiat Struct Mat ESISM, Sakyo Ku, Kyoto 6068501, Japan; [Yokoyama, Yoshihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Liaw, Peter K.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA; [Tsuji, Nobuhiro] Kyoto Univ, Elements Strategy Initiat Struct Mat ESISM, Kyoto 6068501, Japan	Park, N (reprint author), Kyoto Univ, Dept Mat Sci & Engn, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	nobuhiro-tsuji@mtl.kyoto-u.ac.jp	Tsuji, Nobuhiro/F-7951-2010; Park, Nokeun/A-8366-2013	Tsuji, Nobuhiro/0000-0002-2132-1327; Park, Nokeun/0000-0002-7863-1457	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [24246114, 2201, 26630365, 22102002]; Elements Strategy Initiative for Structural Materials (ESISM) through the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [22102002]; Japan Society for Promotion of Science (JSPS)	This study was financially supported by the Grant-in-Aid for Scientific Research on Innovative Area, "Bulk Nanostructured Metals" (Area No. 2201), the Grant-in-Aid for Scientific Research (A) (No. 24246114), the Grant-in-Aid for Challenging Exploratory Research (No. 26630365), and the Elements Strategy Initiative for Structural Materials (ESISM), all through the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (Contact No. 22102002). N.P. was supported also by the Japan Society for Promotion of Science (JSPS) as a JSPS postdoctoral fellow. All the support is gratefully appreciated.	Yeh JW, 2004, ADV ENG MATER, V6, P299, DOI 10.1002/adem.200300567; Tong CJ, 2005, METALL MATER TRANS A, V36A, P881, DOI 10.1007/s11661-005-0283-0; Otto F, 2013, ACTA MATER, V61, P2628, DOI 10.1016/j.actamat.2013.01.042; Zhang KB, 2012, INTERMETALLICS, V22, P24, DOI 10.1016/j.intermet.2011.10.010; Tsai KY, 2013, ACTA MATER, V61, P4887, DOI 10.1016/j.actamat.2013.04.058; Liu WH, 2013, SCRIPTA MATER, V68, P526, DOI 10.1016/j.scriptamat.2012.12.002; Takeuchi A, 2000, MATER T JIM, V41, P1372; Zhang Y, 2008, ADV ENG MATER, V10, P534, DOI 10.1002/adem.200700240; Yeh JW, 2013, JOM-US, V65, P1759, DOI 10.1007/s11837-013-0761-6; Otto F, 2013, ACTA MATER, V61, P5743, DOI 10.1016/j.actamat.2013.06.018; Cantor B, 2004, MAT SCI ENG A-STRUCT, V375, P213, DOI 10.1016/j.msea.2003.10.257; Gao MC, 2013, JOM-US, V65, P1749, DOI 10.1007/s11837-013-0788-8; Bhattacharjee PP, 2014, J ALLOY COMPD, V587, P544, DOI 10.1016/j.jallcom.2013.10.237; Yao MJ, 2014, SCRIPTA MATER, V72-73, P5, DOI 10.1016/j.scriptamat.2013.09.030; Yokoyama Y, 2002, MATER TRANS, V43, P2316, DOI 10.2320/matertrans.43.2316; Zhang YM, 2014, J MANUF PROCESS, V16, P1, DOI 10.1016/j.jmapro.2013.12.004	16	6	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	APR	2015	46A	4					1481	1487		10.1007/s11661-014-2594-5		7	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CC4DL	WOS:000350300900010		
J	Liu, ZQ; Miyamoto, G; Yang, ZG; Zhang, C; Furuhara, T				Liu, Zhen-Qing; Miyamoto, Goro; Yang, Zhi-Gang; Zhang, Chi; Furuhara, Tadashi			Carbon Enrichment in Austenite During Bainite Transformation in Fe-3Mn-C Alloy	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							C-X ALLOYS; INCOMPLETE TRANSFORMATION; ATOM-PROBE; FERRITE; STEEL	Carbon enrichment in austenite after the cessation of bainite transformations in an Fe-3Mn-0.08C alloy was measured by FE-EPMA. The carbon content in austenite is lower than paraequilibrium composition, and undercoolings from paraequilibrium model vary from 400 to 1000 J/mol, while carbon contents are higher than those predicted by negligible partitioning local equilibrium model. On the other hand, it was found that undercoolings from T (0) composition are nearly the constant, 400 J/mol, at the temperatures investigated. (C) The Minerals, Metals & Materials Society and ASM International 2015	[Liu, Zhen-Qing; Yang, Zhi-Gang; Zhang, Chi] Tsinghua Univ, Sch Mat Sci & Engn, Key Lab Adv Mat, Minist Educ, Beijing 100084, Peoples R China; [Liu, Zhen-Qing] Tohoku Univ, Dept Met, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Miyamoto, Goro; Furuhara, Tadashi] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Liu, ZQ (reprint author), Tsinghua Univ, Sch Mat Sci & Engn, Key Lab Adv Mat, Minist Educ, Beijing 100084, Peoples R China.	zhqliu@yeah.net	Miyamoto, Goro/G-2802-2010; Furuhara, Tadashi/B-2149-2010		China Scholarship Council; "Creation of Innovative Functions of Intelligent Materials on the Basis of Element Strategy" by CREST Basic Research Program; Ministry of Education, Culture, Sports, Science, and Technology [23360316]; National Natural Science Foundation of China [51471094, 51171087]	Financial support provided by China Scholarship Council through Joint-Supervising PhD Program is gratefully acknowledged. A part of this research was supported by" Creation of Innovative Functions of Intelligent Materials on the Basis of Element Strategy" by CREST Basic Research Program. T.F. greatly acknowledged the financial support provided by the Ministry of Education, Culture, Sports, Science, and Technology through a Grant-in-Aid for Scientific Research (B) No. 23360316 (2011-2013). Z.-G. Y. and Z.-Q. L. greatly acknowledged the financial support provided by the National Natural Science Foundation of China (Grant No. 51471094 and No. 51171087).	BHADESHIA HKDH, 1980, ACTA METALL MATER, V28, P1265, DOI 10.1016/0001-6160(80)90082-6; Chen H, 2013, ACTA MATER, V61, P5458, DOI 10.1016/j.actamat.2013.05.034; Hillert M, 2004, METALL MATER TRANS A, V35A, P3693, DOI 10.1007/s11661-004-0275-5; Peet M, 2004, SCRIPTA MATER, V50, P1277, DOI 10.1016/j.scriptamat.2004.02.024; BHADESHIA HKDH, 1982, ACTA METALL MATER, V30, P775, DOI 10.1016/0001-6160(82)90075-X; Caballero FG, 2009, ACTA MATER, V57, P8, DOI 10.1016/j.actamat.2008.08.041; Liu ZQ, 2013, ACTA MATER, V61, P3120, DOI 10.1016/j.actamat.2013.02.003; Hutchinson CR, 2006, METALL MATER TRANS A, V37A, P1711, DOI 10.1007/s11661-006-0114-y; Aaronson HI, 2006, METALL MATER TRANS A, V37A, P1731, DOI 10.1007/s11661-006-0116-9; SELF PG, 1981, ULTRAMICROSCOPY, V6, P29, DOI 10.1016/S0304-3991(81)80175-1; Chen H, 2014, ACTA MATER, V72, P1, DOI 10.1016/j.actamat.2014.03.034; Bhadeshia H. K. D. H., 2001, BAINITE STEELS; Garcia-Mateo C, 2003, ISIJ INT, V43, P1238, DOI 10.2355/isijinternational.43.1238; REYNOLDS WT, 1990, METALL TRANS A, V21, P1479, DOI 10.1007/BF02672563; Hillert M, 2012, METALL MATER TRANS A, V43A, P4487, DOI 10.1007/s11661-012-1263-9; Hillert M, 2002, SCRIPTA MATER, V47, P175, DOI 10.1016/S1359-6462(02)00125-2; Takayama N., 2012, THESIS TOHOKU U SEND	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	APR	2015	46A	4					1544	1549		10.1007/s11661-015-2744-4		6	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CC4DL	WOS:000350300900015		
J	Okayasu, M; Takeuchi, S; Yamamoto, M; Ohfuji, H; Ochi, T				Okayasu, Mitsuhiro; Takeuchi, Shuhei; Yamamoto, Masaki; Ohfuji, Hiroaki; Ochi, Toshihiro			Precise Analysis of Microstructural Effects on Mechanical Properties of Cast ADC12 Aluminum Alloy	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							ULTIMATE TENSILE-STRENGTH; NANOCRYSTALLINE MATERIALS; GRAIN-REFINEMENT; DIE-CASTINGS; COOLING RATE; A356/357; BEHAVIOR; HARDNESS; DEFECTS	The effects of microstructural characteristics (secondary dendrite arm spacing, SDAS) and Si- and Fe-based eutectic structures on the mechanical properties and failure behavior of an Al-Si-Cu alloy are investigated. Cast Al alloy samples are produced using a special continuous-casting technique with which it is easy to control both the sizes of microstructures and the direction of crystal orientation. Dendrite cells appear to grow in the casting direction. There are linear correlations between SDAS and tensile properties (ultimate tensile strength sigma (UTS), 0.2 pct proof strength sigma (0.2), and fracture strain epsilon (f)). These linear correlations, however, break down, especially for sigma (UTS) vs SDAS and epsilon (f) vs SDAS, as the eutectic structures become more than 3 mu m in diameter, when the strength and ductility (sigma (UTS) and epsilon (f)) decrease significantly. For eutectic structures larger than 3 mu m, failure is dominated by the brittle eutectic phases, for which SDAS is no longer strongly correlated with sigma (UTS) and epsilon (f). In contrast, a linear correlation is obtained between sigma (0.2) and SDAS, even for eutectic structures larger than 3 mu m, and the eutectic structure does not have a strong effect on yield behavior. This is because failure in the eutectic phases occurs just before final fracture. In situ failure observation during tensile testing is performed using microstructural and lattice characteristics. From the experimental results obtained, models of failure during tensile loading are proposed. (C) The Minerals, Metals & Materials Society and ASM International 2015	[Okayasu, Mitsuhiro; Takeuchi, Shuhei; Yamamoto, Masaki] Ehime Univ, Dept Mat Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Ohfuji, Hiroaki] Ehime Univ, Geodynam Res Ctr, Matsuyama, Ehime 7908577, Japan; [Ochi, Toshihiro] Ochi Foundry Inc, Saijo, Ehime 7910522, Japan	Okayasu, M (reprint author), Ehime Univ, Dept Mat Sci & Engn, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	mitsuhiro.okayasu@utoronto.ca			Japanese Government (Ministry of Education, Science, Sports and Culture); Light Metal Educational Foundation Inc.	This work was supported by a grant (Grant-in-Aid for Scientific Research (C), 2014) from the Japanese Government (Ministry of Education, Science, Sports and Culture) and the Light Metal Educational Foundation Inc.	Aziz Ahamed AKM, 2008, MATER TRANS, V49, P1621, DOI 10.2320/matertrans.F-MRA2008814; Jana S, 2010, ACTA MATER, V58, P989, DOI 10.1016/j.actamat.2009.10.015; Wang QG, 2010, ACTA MATER, V58, P3006, DOI 10.1016/j.actamat.2010.01.032; Irfan MA, 2012, MAT SCI ENG A-STRUCT, V535, P108, DOI 10.1016/j.msea.2011.12.049; Lumley RN, 2013, METALL MATER TRANS A, V44A, P1074, DOI 10.1007/s11661-012-1443-7; INOUE A, 1992, MATER T JIM, V33, P937; Okayasu M, 2014, MAT SCI ENG A-STRUCT, V592, P189, DOI 10.1016/j.msea.2013.10.098; Youssef KM, 2006, SCRIPTA MATER, V54, P251, DOI 10.1016/j.scriptamat.2005.09.028; Zhao HD, 2009, J MATER PROCESS TECH, V209, P4537, DOI 10.1016/j.jmatprotec.2008.10.028; Benzerga AA, 2001, ACTA MATER, V49, P3071, DOI 10.1016/S1359-6454(01)00195-1; Wang QG, 2003, METALL MATER TRANS A, V34A, P2901, DOI 10.1007/s11661-003-0190-1; Ceschini L, 2009, MATER DESIGN, V30, P4525, DOI 10.1016/j.matdes.2009.05.012; Brooks I, 2008, MAT SCI ENG A-STRUCT, V491, P412, DOI 10.1016/j.msea.2008.02.015; Eskin DG, 2004, PROG MATER SCI, V49, P629, DOI 10.1016/S0079-6425(03)00037-9; Carlton CE, 2007, ACTA MATER, V55, P3749, DOI 10.1016/j.actamat.2007.02.021; Wang QG, 2004, METALL MATER TRANS A, V35A, P2707, DOI 10.1007/s11661-004-0216-3; Okayasu M, 2012, MAT SCI ENG A-STRUCT, V543, P185, DOI 10.1016/j.msea.2012.02.073; Hu XW, 2012, J ALLOY COMPD, V538, P21, DOI 10.1016/j.jallcom.2012.05.089; CAHOON JR, 1971, METALL TRANS, V2, P1979; Okayasu M, 2012, J MATER SCI, V47, P241, DOI 10.1007/s10853-011-5791-2; Wang QG, 1998, MAT SCI ENG A-STRUCT, V241, P72, DOI 10.1016/S0921-5093(97)00476-0; Horita Z, 2000, METALL MATER TRANS A, V31, P691, DOI 10.1007/s11661-000-0011-8; Kabir M.S., 2014, INT J ENG ADV TECHNO, V3, P115; Kawaguchi Y., 1997, Journal of Japan Institute of Light Metals, V47, DOI 10.2464/jilm.47.3; Kobayashi M, 2012, INT J CAST METAL RES, V25, P31, DOI 10.1179/1743133611Y.0000000012; KOVACS I, 1980, ACTA METALL MATER, V28, P1621, DOI 10.1016/0001-6160(80)90015-2; Kuwazuru O., 2008, J SOLID MECH MAT ENG, V2, P1220, DOI 10.1299/jmmp.2.1220; Ohno A., 1987, SOLIDIFICATION, Vfirst, P113; Okayasu M., 1998, J JPN FOUNDRY ENG SO, V70, P266; Ran G, 2006, J ALLOY COMPD, V421, P80, DOI 10.1016/j.jallcom.2005.11.019; Seah KHW, 1998, J MATER SCI, V33, P23, DOI 10.1023/A:1004321007806; Sengupta S, 2002, J MATER SCI, V37, P1747, DOI 10.1023/A:1014969000741; Shen YL, 2001, MAT SCI ENG A-STRUCT, V297, P44, DOI 10.1016/S0921-5093(00)01256-9; Tiryakioglu M, 2009, METALL MATER TRANS A, V40A, P1000, DOI 10.1007/s11661-008-9762-4; Vandyoussefi M, 2002, ACTA MATER, V50, P1693, DOI 10.1016/S1359-6454(02)00015-0; Wang Q. G., 2001, J LIGHT METALS, V1, P85, DOI 10.1016/S1471-5317(00)00009-2; Wang QG, 2003, METALL MATER TRANS A, V34A, P2887, DOI 10.1007/s11661-003-0189-7; Xin H., 2013, J WUHAN UNIV TECHNOL, V28, P202; Zhang LY, 2008, J MATER PROCESS TECH, V207, P107, DOI 10.1016/j.jmatprotec.2007.12.059	39	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	APR	2015	46A	4					1597	1609		10.1007/s11661-015-2747-1		13	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CC4DL	WOS:000350300900022		
J	Su, YH; Morooka, S; Ohnuma, M; Suzuki, J; Tomota, Y				Su, Yuhua; Morooka, Satoshi; Ohnuma, Masato; Suzuki, Junichi; Tomota, Yo			Quantitative Analysis of Cementite Spheroidization in Pearlite by Small-Angle Neutron Scattering	METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND MATERIALS SCIENCE			English	Article							BEHAVIOR; SILICON; STEELS	Small-angle neutron scattering (SANS) was used to investigate the spheroidization of cementite in pearlite upon annealing. Globally averaged information on the shape and size of cementite particles was collected by using the SANS profile analysis of 0.8 mass pct C pearlitic steel (0.8C) samples annealed at 973 K (700 A degrees C) for 3.6 to 86.4 ks. The change in the total area of the ferrite-cementite interface or aspect ratio determined by ex situ SANS exhibits excellent correspondence with scanning electron microscopy observations. Then, in situ SANS data were collected during isothermal annealing of the 0.8C steel and the commercially available 0.45C carbon steel (JIS-S45C). The shape change of the cementite plate was monitored, and the spheroidization rate of the 0.8C steel was found to be faster than that of the 0.45C steel. (C) The Minerals, Metals & Materials Society and ASM International 2015	[Su, Yuhua; Tomota, Yo] Ibaraki Univ, Grad Sch Sci & Engn, Hitachi, Ibaraki 3168511, Japan; [Morooka, Satoshi] Tokyo Metropolitan Univ, Fac Syst Design, Dept Aerosp Engn, Hino, Tokyo 1910065, Japan; [Ohnuma, Masato] Hokkaido Univ, Grad Sch Engn, Lab Quantum Beam Syst Engn Fac, Sapporo, Hokkaido 0608628, Japan; [Suzuki, Junichi] Comprehens Res Org Sci & Soc, Neutron R&D Div, Tokai, Ibaraki 3191106, Japan	Su, YH (reprint author), Japan Atom Energy Agcy, Neutron Sci Sect, MLF Div, J PARC Ctr, 2-4 Shirane Shirakata, Naka, Ibaraki 3191195, Japan.	yuhua.su@j-parc.jp			Ministry of Education, Culture, Sports, Science, and Technology [21246106]	The authors would like to thank Prof. Y. Adachi of Kagoshima University for his valuable advice and guidance in preparing the 0.8C steel sample, and Dr. T. Shiraga of JFE Steel Corporation for supplying the S45C steel rods and fruitful discussion. This study was financially supported by a Grant-in-Aid for Scientific Research (A) #21246106 of the Ministry of Education, Culture, Sports, Science, and Technology. The authors would like to thank Enago (www.enago.co.jp) for the English language review.	Kim B, 2013, ACTA MATER, V61, P6983, DOI 10.1016/j.actamat.2013.08.012; TIAN YL, 1987, METALL TRANS A, V18, P1403, DOI 10.1007/BF02646654; Tomota Y, 2003, MATER SCI TECH-LOND, V19, P1715, DOI 10.1179/026708303225008310; Jang JH, 2009, COMP MATER SCI, V44, P1319, DOI 10.1016/j.commatsci.2008.08.022; Pedersen JS, 1997, ADV COLLOID INTERFAC, V70, P171, DOI 10.1016/S0001-8686(97)00312-6; Miyamoto G, 2007, ACTA MATER, V55, P5027, DOI 10.1016/j.actamat.2007.05.023; Ohnuma M, 2008, SCRIPTA MATER, V58, P142, DOI 10.1016/j.scriptamat.2007.09.026; Adachi Y, 2008, ACTA MATER, V56, P5995, DOI 10.1016/j.actamat.2008.08.017; Ohnuma M, 2009, ACTA MATER, V57, P5571, DOI 10.1016/j.actamat.2009.07.054; Buckley CE, 1999, J ALLOY COMPD, V293, P231, DOI 10.1016/S0925-8388(99)00425-9; Caballero FG, 2005, MATER TRANS, V46, P581, DOI 10.2320/matertrans.46.581; CHATTOPADHYAY S, 1977, METALLOGRAPHY, V10, P89, DOI 10.1016/0026-0800(77)90044-1; Ciccariello S., 2000, EPL-EUROPHYS LETT, V5, P601; Feigin L, 1987, STRUCTURE ANAL SMALL; Guinier A., 1955, SMALL ANGLE SCATTERI; Inoue T., 1975, TETSU TO HAGANE, V61, P808; KANETSUKI Y, 1992, TETSU TO HAGANE, V78, P477; Koo M, 2009, SCRIPTA MATER, V61, P797, DOI 10.1016/j.scriptamat.2009.06.032; Maii K., 1997, SCRIPTA MATER, V37, P1753; Muller G., 2006, NUCL MAT, V309, P114; Nam WJ, 1999, ISIJ INT, V39, P1181, DOI 10.2355/isijinternational.39.1181; Park ES, 2011, J ALLOY COMPD, V509, pS52, DOI 10.1016/j.jallcom.2011.01.094; Pellisier G. E., 1942, T AM SOC MET, V29, P1049; ROOSZ A, 1981, METALLOGRAPHY, V14, P129, DOI 10.1016/0026-0800(81)90037-9; Sato T., 1951, TETSU TO HAGANE, V37, P92; Sato T., 1950, TETSU TO HAGANE, V36, P543; Sato T., 1952, TETSU TO HAGANE, V38, P464; Wang YT, 2010, ACTA MATER, V58, P4849, DOI 10.1016/j.actamat.2010.05.023; Wignal G.D., 1987, J APPL CRYSTALLOGR, V20, P30; Yamashita T, 1999, TETSU TO HAGANE, V85, P486; Yasuhara Hisao, 2010, Tetsu-to-Hagane, V96, DOI 10.2355/tetsutohagane.96.545	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5623	1543-1940		METALL MATER TRANS A	Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.	APR	2015	46A	4					1731	1740		10.1007/s11661-014-2737-8		10	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CC4DL	WOS:000350300900033		
J	Miyamoto, M; Nakatani, T; Fujioka, Y; Yogo, K				Miyamoto, Manabu; Nakatani, Takenao; Fujioka, Yuichi; Yogo, Katsunori			Verified synthesis of pure silica CHA-type zeolite in fluoride media	MICROPOROUS AND MESOPOROUS MATERIALS			English	Article						Pure silica CHA; Hydrothermal synthesis; Fluoride medium	FAU-TYPE ZEOLITE; INTERZEOLITE CONVERSION; 5-COORDINATE SILICON; CO2/CH4 SEPARATION; SI/AL RATIO; ALL-SILICA; MEMBRANE; METHANOL; SAPO-34; SSZ-13	Among the increasingly popular zeolites with eight-membered ring channels, CHA-type zeolites are considered to have great potential for various applications such as catalysis and separation. While CHA-type aluminosilicates with Si/AI ratios below 100 can be synthesized in both hydroxide and fluoride media, to date, pure silica CHA-type zeolites can only be prepared in a fluoride medium, with a low H2O/SiO2 of 3. Herein, we investigated the effect of various synthesis conditions on the formation of pure silica CHA-type zeolites. Single phase crystalline pure silica CHA was synthesized within a very narrow range of H2O/SiO2 ratio, and small deviations in the water content from this range led to the formation of STT-type zeolites. High N,N,N-trimethy1-1-adamant ammonium fluoride/SiO2 ratios allowed the formation of pure silica CHA, with no by-products, in the synthesis gel, with a high H2O/SiO2 ratio of 8. Additionally, synthesis conditions, in particular the H2O/SiO2 ratio, significantly influenced the specific surface and pore volume of CHA. (C) 2014 Elsevier Inc. All rights reserved.	[Miyamoto, Manabu; Fujioka, Yuichi; Yogo, Katsunori] Res Inst Innovat Technol Earth RITE, Kyoto 6190292, Japan; [Nakatani, Takenao; Yogo, Katsunori] Nara Inst Sci & Technol, Nara 6300192, Japan	Yogo, K (reprint author), Res Inst Innovat Technol Earth RITE, 9-2 Kizugawadai, Kyoto 6190292, Japan.	yogo@rite.or.jp		Miyamoto, Manabu/0000-0001-5352-6872	Ministry of Economy, Trade and Industry (METI), Japan	This work was financially supported by the Ministry of Economy, Trade and Industry (METI), Japan.	Villaescusa LA, 2003, J MATER CHEM, V13, P1978, DOI 10.1039/b300728f; Palomino M, 2012, CHEM COMMUN, V48, P215, DOI 10.1039/c1cc16320e; Ikeda T, 2004, ANGEW CHEM INT EDIT, V43, P4892, DOI 10.1002/anie.200460168; van den Bergh J, 2008, J MEMBRANE SCI, V316, P35, DOI 10.1016/j.memsci.2007.12.051; Wagner P, 2000, J AM CHEM SOC, V122, P263, DOI 10.1021/ja990722u; Eilertsen EA, 2008, STUD SURF SCI CATAL, V174, P265; Krishna R, 2012, SEP PURIF TECHNOL, V87, P120, DOI 10.1016/j.seppur.2011.11.031; Carreon MA, 2008, J AM CHEM SOC, V130, P5412, DOI 10.1021/ja801294f; Palomino M, 2010, LANGMUIR, V26, P1910, DOI 10.1021/la9026656; Zhu QJ, 2009, TOP CATAL, V52, P1272, DOI 10.1007/s11244-009-9272-7; Wilson S, 1999, MICROPOR MESOPOR MAT, V29, P117, DOI 10.1016/S1387-1811(98)00325-4; Sastre G, 2005, CHEM MATER, V17, P545, DOI 10.1021/cm049912g; Castaneda R, 2003, J AM CHEM SOC, V125, P7820, DOI 10.1021/ja035534p; Arstad B, 2001, J AM CHEM SOC, V123, P8137, DOI 10.1021/ja010668t; Morigami Y, 2001, SEP PURIF TECHNOL, V25, P251, DOI 10.1016/S1383-5866(01)00109-5; Kalipcilar H, 2002, CHEM MATER, V14, P3458, DOI 10.1021/cm020248i; Hudson MR, 2012, J AM CHEM SOC, V134, P1970, DOI 10.1021/ja210580b; Camblor MA, 1999, TOP CATAL, V9, P59, DOI 10.1023/A:1019154304344; Corma A, 2001, ANGEW CHEM INT EDIT, V40, P2277, DOI 10.1002/1521-3773(20010618)40:12<2277::AID-ANIE2277>3.0.CO;2-O; Blackwell CS, 2003, ANGEW CHEM INT EDIT, V42, P1737, DOI 10.1002/anie.200250076; Kwak JH, 2010, J CATAL, V275, P187, DOI 10.1016/j.jcat.2010.07.031; Corma A, 2002, NATURE, V418, P514, DOI 10.1038/nature00924; Camblor MA, 1998, ANGEW CHEM INT EDIT, V37, P2122, DOI 10.1002/(SICI)1521-3773(19980817)37:15<2122::AID-ANIE2122>3.0.CO;2-6; Zhu QJ, 2008, MICROPOR MESOPOR MAT, V112, P153, DOI 10.1016/j.micromeso.2007.09.026; Miyamoto M, 2012, J MATER CHEM, V22, P20186, DOI 10.1039/c2jm34597h; Burton AW, 2005, CURR OPIN COLLOID IN, V10, P211, DOI 10.1016/j.cocis.2005.08.005; ZONES SI, 1991, J CHEM SOC FARADAY T, V87, P3709, DOI 10.1039/ft9918703709; Koller H, 1999, J AM CHEM SOC, V121, P3368, DOI 10.1021/ja9840549; BARRER RM, 1981, ZEOLITES, V1, P130, DOI 10.1016/S0144-2449(81)80001-2; Itakura M, 2011, MICROPOR MESOPOR MAT, V144, P91, DOI 10.1016/j.micromeso.2011.03.041; Yamanaka N, 2012, MICROPOR MESOPOR MAT, V158, P141, DOI 10.1016/j.micromeso.2012.03.030; Cejka J, 2010, ZEOLITES CATALYSIS S; Corma A, 2003, NAT MATER, V2, P493, DOI 10.1038/nmat921; Diaz-Cabanas MJ, 1998, CHEM COMMUN, P1881, DOI 10.1039/a804800b; Eilertsen EA, 2012, MICROPOR MESOPOR MAT, V153, P94, DOI 10.1016/j.micromeso.2011.12.026; Goto I, 2012, MICROPOR MESOPOR MAT, V158, P117, DOI 10.1016/j.micromeso.2012.03.032; Kim E, 2014, MICROPOR MESOPOR MAT, V184, P47, DOI 10.1016/j.micromeso.2013.09.027; Koller H, 1997, ANGEW CHEM INT EDIT, V36, P2823, DOI 10.1002/anie.199728231; Zones SI, 1996, J AM CHEM SOC, V118, P7558, DOI 10.1021/ja954246t	39	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1387-1811	1873-3093		MICROPOR MESOPOR MAT	Microporous Mesoporous Mat.	APR	2015	206						67	74		10.1016/j.micromeso.2014.12.012		8	Chemistry, Applied; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CC2RB	WOS:000350191200009		
J	Hara, N; Yoshimune, M; Negishi, H; Haraya, K; Hara, S; Yamaguchi, T				Hara, Nobuo; Yoshimune, Mild; Negishi, Hideyuki; Haraya, Kenji; Hara, Shigeki; Yamaguchi, Takeo			ZIF-8 membranes prepared at miscible and immiscible liquid-liquid interfaces	MICROPOROUS AND MESOPOROUS MATERIALS			English	Article						Gas separation membrane; Propylene/propane separation; Zeolitic-imidazolate framework-8; Counter diffusion method; Liquid liquid interface	ZEOLITIC-IMIDAZOLATE FRAMEWORK; IN-SITU SYNTHESIS; GAS SEPARATION; PROPYLENE/PROPANE SEPARATION; HYDROGEN SEPARATION; ROOM-TEMPERATURE; FILMS	ZIF-8 membranes are currently attracting attention for the separation of propylene/propane based on the molecular sieve effect. We have recently reported the preparation of ZIF-8 membranes using the counterdiffusion method, which is advantageous in reducing defects in the selective layer. In the present study, ZIF-8 membranes were prepared at the interface of miscible and immiscible pairs of solvents such as water/methanol and water/1-octanol, respectively. ZIF-8 membranes prepared from the immiscible pair of water and 1-octanol showed a propylene permeance of 5.2 x 10(-9) mol m(-2) s(-1) Pa-1 and a propylene/propane permselectivity of 7.2 at 25 C. As for the ZIF-8 membrane prepared by the initial reaction using the immiscible pair of water/l-octanol and the successive reaction using the miscible pair of water/methanol mixture, the average propylene permeance and average propylene/propane permselectivity increased to 1.2 x 10(-8) MO1 IT1-2 S-1 Pa-1 and 20 at 25 degrees C, respectively. The successive reactions in water/1-octanol and water/methanol mixtures successfully decreased the defects in the ZIF-8 selective layer, resulting in high propylene permeance and high permselectivity for propylene/propane. The structure and gas permeation properties were also thoroughly characterized. 2014 Elsevier Inc. All rights reserved.	[Hara, Nobuo; Yoshimune, Mild; Negishi, Hideyuki; Haraya, Kenji; Hara, Shigeki] Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki 3058565, Japan; [Yamaguchi, Takeo] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Hara, N (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	n-hara@aist.go.jp	Yamaguchi, Takeo/H-1607-2011	Yamaguchi, Takeo/0000-0001-9043-4408	JSPS KAKENHI [25820385]; Cooperative Research Program of "Network Joint Research Center for Materials and Devices	This work was supported by JSPS KAKENHI Grant No. 25820385 and the Cooperative Research Program of "Network Joint Research Center for Materials and Devices." We thank NOR Corporation for supplying the porous a-alumina capillary substrate.	Kwon HT, 2013, CHEM COMMUN, V49, P3854, DOI 10.1039/c3cc41039k; Lee HR, 2011, AICHE J, V57, P2755, DOI 10.1002/aic.12501; Shah M, 2013, MICROPOR MESOPOR MAT, V165, P63, DOI 10.1016/j.micromeso.2012.07.046; Bux H, 2011, CHEM MATER, V23, P2262, DOI 10.1021/cm200555s; Pan YC, 2012, J MEMBRANE SCI, V390, P93, DOI 10.1016/j.memsci.2011.11.024; Xu GS, 2011, J MEMBRANE SCI, V385, P187, DOI 10.1016/j.memsci.2011.09.040; Bux H, 2009, J AM CHEM SOC, V131, P16000, DOI 10.1021/ja907359t; Brown AJ, 2014, SCIENCE, V345, P72, DOI 10.1126/science.1251181; Venna SR, 2010, J AM CHEM SOC, V132, P76, DOI 10.1021/ja909263x; Cravillon J, 2009, CHEM MATER, V21, P1410, DOI 10.1021/cm900166h; Tanaka S, 2012, CHEM LETT, V41, P1337, DOI 10.1246/cl.2012.1337; Yoshimune M, 2007, CARBON, V45, P553, DOI 10.1016/j.carbon.2006.10.017; Park KS, 2006, P NATL ACAD SCI USA, V103, P10186, DOI 10.1073/pnas.0602439103; Pan YC, 2012, J MEMBRANE SCI, V421, P292, DOI 10.1016/j.memsci.2012.07.028; Cacho-Bailo F, 2014, J MEMBRANE SCI, V464, P119, DOI 10.1016/j.memsci.2014.03.070; Kwon HT, 2013, J AM CHEM SOC, V135, P10763, DOI 10.1021/ja403849c; Zhang C, 2012, J PHYS CHEM LETT, V3, P2130, DOI 10.1021/jz300855a; Yao JF, 2014, CHEM SOC REV, V43, P4470, DOI 10.1039/c3cs60480b; Liu DF, 2014, J MEMBRANE SCI, V451, P85, DOI 10.1016/j.memsci.2013.09.029; Tao K, 2013, CHEM ENG J, V220, P1, DOI 10.1016/j.cej.2013.01.051; Ge L, 2012, J PHYS CHEM C, V116, P13264, DOI 10.1021/jp3035105; Li LX, 2013, MICROPOR MESOPOR MAT, V168, P15, DOI 10.1016/j.micromeso.2012.09.029; Hara N, 2014, J MEMBRANE SCI, V450, P215, DOI 10.1016/j.memsci.2013.09.012; McCarthy MC, 2010, LANGMUIR, V26, P14636, DOI 10.1021/la102409e; Baker RW, 2002, IND ENG CHEM RES, V41, P1393, DOI 10.1021/ie0108088; Hara N, 2014, J CHEM ENG JPN, V47, P770, DOI 10.1252/jcej.14we340; Mauhar SM, 2004, CHEM PAP-CHEM ZVESTI, V58, P386	27	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1387-1811	1873-3093		MICROPOR MESOPOR MAT	Microporous Mesoporous Mat.	APR	2015	206						75	80		10.1016/j.micromeso.2014.12.018		6	Chemistry, Applied; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CC2RB	WOS:000350191200010		
J	Matsunaga, Y; Yamazaki, H; Imai, H; Yokoi, T; Tatsumi, T; Kondo, JN				Matsunaga, Yuichi; Yamazaki, Hiroshi; Imai, Hiroyuki; Yokoi, Toshiyuki; Tatsumi, Takashi; Kondo, Junko N.			Hexamethyleneimine and pivalonitrile as location probe molecules of Lewis acid sites on MWW-type zeolites	MICROPOROUS AND MESOPOROUS MATERIALS			English	Article						Zeolites; Location of acid sites; IR spectroscopy; Probe molecules	M-XYLENE TRANSFORMATION; H-MCM-22 ZEOLITE; CATALYTIC-PROPERTIES; DELAMINATED ZEOLITE; PORE SYSTEMS; MCM-22; PRECURSORS; SURFACE; ITQ-2; ACCESSIBILITY	Locations of Lewis acid sites (LASs) on three MWW-type zeolites, the conventional Al-containing MWW zeolite (Al-MWW), acid-treated Al-containing MWW zeolite (Al-MWW-AT) and interlayer-expanded Al-containing MWW zeolite (Al-IEZ-MWW), were clarified by IR method using hexamethyleneimine (HMI), pivalonitrile (PN) and CO as probe molecules. No significant difference was found for Bronsted acid sites (BASs) in the strength and positions, while the locations of LASs were distinguished. LASs existed only on the external surfaces of Al-MWW, and in the expanded interlayer micropores (12-membered ring, 12-MR) of Al-IEZ-MWW. The simple acid treatment with nitric acid was found to generate LASs in the interlayer 10-MR micropores of Al-MWW-AT. The reactivity of the three zeolites depending on the positions of the active LASs was further confirmed in the Meerwein-Ponndorf-Verley (MPV) reduction of different ketones in size; 4-methylcyclohexanone and 2-butanone. Al-IEZ-MWW was superior for the reduction of 4-methylcyclohexanone over LASs in the interlayer 12-MR micropores, and Al-MWW-AT also showed fair reactivity for the reduction of smaller 2-butanone over LASs in the interlayer 10-MR micropores. (C) 2014 Elsevier Inc. All rights reserved.	[Matsunaga, Yuichi; Yamazaki, Hiroshi; Yokoi, Toshiyuki; Tatsumi, Takashi; Kondo, Junko N.] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Imai, Hiroyuki] Univ Kitakyushu, Fac Environm Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 8080135, Japan	Kondo, JN (reprint author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	jnomura@res.titech.ac.jp	Yokoi, Toshiyuki/E-8047-2014; Kondo, Junko /E-8648-2014	Yokoi, Toshiyuki/0000-0002-3315-3172; 			LEONOWICZ ME, 1994, SCIENCE, V264, P1910, DOI 10.1126/science.264.5167.1910; Tsapatsis M, 2008, ANGEW CHEM INT EDIT, V47, P4262, DOI 10.1002/anie.200705755; Corma A, 2000, J CATAL, V191, P218, DOI 10.1006/jcat.1999.2774; Laforge S, 2004, MICROPOR MESOPOR MAT, V67, P235, DOI 10.1016/j.micromeso.2003.11.008; [Anonymous], 1996, HYDROCARBON PROCESSI, P40; Sadowska K, 2013, J PHYS CHEM C, V117, P9237, DOI 10.1021/jp400400t; Gil B, 2014, DALTON T, V43, P10501, DOI 10.1039/c4dt00130c; Lavalley JC, 1996, CATAL TODAY, V27, P377, DOI 10.1016/0920-5861(95)00161-1; Roth WJ, 2013, CATAL TODAY, V204, P8, DOI 10.1016/j.cattod.2012.07.040; Wu P, 2008, J AM CHEM SOC, V130, P8178, DOI 10.1021/ja0758739; Ayrault P, 2004, J PHYS CHEM B, V108, P13755, DOI 10.1021/jp048242z; Inagaki S, 2011, MICROPOR MESOPOR MAT, V142, P354, DOI 10.1016/j.micromeso.2010.12.022; Corma A, 2000, MICROPOR MESOPOR MAT, V38, P301, DOI 10.1016/S1387-1811(00)00149-9; Roth WJ, 1995, STUD SURF SCI CATAL, V94, P301; Onida B, 2003, J CATAL, V214, P191, DOI 10.1016/S0021-9517(02)00090-8; Onida B, 1999, MICROPOR MESOPOR MAT, V30, P119, DOI 10.1016/S1387-1811(99)00033-5; Corma A, 1998, NATURE, V396, P353, DOI 10.1038/24592; Maheshwari S, 2008, J AM CHEM SOC, V130, P1507, DOI 10.1021/ja077711i; Bevilacqua M, 2008, J PHYS CHEM C, V112, P9023, DOI 10.1021/jp801072h; Yokoi T, 2014, DALTON T, V43, P10584, DOI 10.1039/c4dt00352g; Wang Y, 2009, J PHYS CHEM C, V113, P18753, DOI 10.1021/jp904436c; Juttu GG, 2000, MICROPOR MESOPOR MAT, V40, P9, DOI 10.1016/S1387-1811(00)00233-X; Thibault-Starzyk F, 1998, TOP CATAL, V6, P111; Chlubna P, 2012, CATAL TODAY, V179, P35, DOI 10.1016/j.cattod.2011.06.035; Lawton S, 1998, MICROPOR MESOPOR MAT, V23, P109, DOI 10.1016/S1387-1811(98)00057-2; [Anonymous], 1996, DATA GEORGIA GULF CU; Emis C.A., 1993, J CATAL, V141, P347; Fan WB, 2009, J CATAL, V266, P268, DOI 10.1016/j.jcat.2009.06.017; Inagaki S, 2009, CHEM COMMUN, P2583, DOI 10.1039/b823524d; Laforge S, 2004, APPL CATAL A-GEN, V268, P33, DOI 10.1016/j.apcata.2004.03.027; Laforge S, 2003, J CATAL, V220, P92, DOI 10.1016/S0021-9517(03)00240-9; Laforge S, 2005, APPL CATAL A-GEN, V279, P79, DOI 10.1016/j.apcata.2004.10.015; Madzzone D.N., 1997, HYDROCARBON ASIA, V7, P56; Maerz B.R., 1996, DEWITT 1996 PETROCHE; Nuntasri D, 2003, J CATAL, V213, P272, DOI 10.1016/S0021-9517(02)00052-0; Onida B, 2002, J PHYS CHEM B, V106, P1684, DOI 10.1021/jp0122068	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1387-1811	1873-3093		MICROPOR MESOPOR MAT	Microporous Mesoporous Mat.	APR	2015	206						86	94		10.1016/j.micromeso.2014.12.014		9	Chemistry, Applied; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CC2RB	WOS:000350191200012		
J	Muraza, O; Abdul-lateef, A; Tago, T; Nandiyanto, ABD; Konno, H; Nakasaka, Y; Yamani, ZH; Masuda, T				Muraza, Oki; Abdul-lateef, Adedigba; Tago, Teruoki; Nandiyanto, Asep B. D.; Konno, Hiroki; Nakasaka, Yuta; Yamani, Zain H.; Masuda, Takao			Microwave-assisted hydrothermal synthesis of submicron ZSM-22 zeolites and their applications in light olefin production	MICROPOROUS AND MESOPOROUS MATERIALS			English	Article						ZSM-22 (TON); Microwave-assisted synthesis; Surface-modification; Cracking of n-hexane; On-purpose propylene	CHEMICAL LIQUID DEPOSITION; PORE MOUTH CATALYSIS; N-HEXANE CRACKING; HYDROCRACKING; PT/H-ZSM-22; MEMBRANES; PHASE; RATIO; SIZE	There is an increased demand for facile and rapid synthesis of one-dimensional pore zeolites with controlled crystal size in the nanometer range. Here, we report for the first time, the rapid synthesis of ZSM-22 (TON) by using microwave-assisted hydrothermal synthesis (MAHyS) to control nucleation and growth. ZSM-22 crystals were synthesized rapidly in 24 h (instead of 72 h in conventional synthesis). Effect of synthesis time under microwave irradiation on the crystallinity of TON zeolites from 8 to 24 h was investigated. The conventional hydrothermal synthesis was used for comparison. Under microwave-assisted synthesis, uniform crystal size with lower crystal aspect-ratio (length/width) was obtained and high agglomeration was prevented. Surface modification was applied by deposition of silica on the external surface of ZSM-22 using catalytic cracking of diphenyl silane. The protonated H-ZSM-22 prepared by the MAHyS and the surface-modified TON zeolites were applied in catalytic cracking of n-hexane. The modified MAHyS zeolites showed superior selectivity to propylene and lower selectivity to aromatics. Stability against deactivation was clearly observed over surface-modified ZSM-22 zeolites. The physico-chemical properties of modified zeolite-catalysts were characterized by using XRD, FE-SEM, N-2 adsorption-desorption, Al-27 MAS NMR and NH3-TPD. (C) 2014 Elsevier Inc. All rights reserved.	[Muraza, Oki; Abdul-lateef, Adedigba; Yamani, Zain H.] King Fahd Univ Petr & Minerals, Ctr Res Excellence Nanotechnol, Dhahran 31261, Saudi Arabia; [Muraza, Oki; Abdul-lateef, Adedigba; Yamani, Zain H.] King Fahd Univ Petr & Minerals, Dept Chem Engn, Dhahran 31261, Saudi Arabia; [Tago, Teruoki; Konno, Hiroki; Nakasaka, Yuta; Masuda, Takao] Hokkaido Univ, Fac Engn, Div Chem Proc Engn, Kita Ku, Sapporo, Hokkaido 060, Japan; [Nandiyanto, Asep B. D.] Univ Pendidikan Indonesia, Fak Pendidikan Matemat & Ilmu Pengetahuan Alam, Dept Kimia, Bandung 40154, Indonesia	Muraza, O (reprint author), King Fahd Univ Petr & Minerals, Ctr Res Excellence Nanotechnol, Dhahran 31261, Saudi Arabia.	omuraza@kfupm.edu.sa; tago@eng.hokudai.ac.jp	Muraza, Oki/B-6765-2015; TAGO, Teruoki/A-8040-2012	Muraza, Oki/0000-0002-8348-8085; TAGO, Teruoki/0000-0003-2445-0949	(KACST) through the Science & Technology Unit in Center of Research Excellence in Nanotechnology at (KFUPM), National Science, Technology and Innovation Plan. [10-NAN1391-04]; New Energy and Industrial Technology Development Organization (NEDO)	The authors would like to thank Saori Furukawa and Dr. A. Hakeem for part of FE-SEM experiments. The authors would like to acknowledge the funding provided by King Abdulaziz City for Science and Technology (KACST) through the Science & Technology Unit in Center of Research Excellence in Nanotechnology at King Fahd University of Petroleum & Minerals (KFUPM) for supporting this work through project No.10-NAN1391-04 as part of the National Science, Technology and Innovation Plan. We thank the New Energy and Industrial Technology Development Organization (NEDO) for the funding at Hokkaido University.	KOKOTAILO GT, 1985, ZEOLITES, V5, P349, DOI 10.1016/0144-2449(85)90122-8; Dedecek J, 2012, CATAL REV, V54, P135, DOI 10.1080/01614940.2012.632662; Hayasaka K, 2007, CHEM-EUR J, V13, P10070, DOI 10.1002/chem.200700967; Kamimura Y, 2012, MICROPOR MESOPOR MAT, V163, P282, DOI 10.1016/j.micromeso.2012.07.014; Tago T, 2011, APPL CATAL A-GEN, V403, P183, DOI 10.1016/j.apcata.2011.06.029; Zhu ZR, 2007, MICROPOR MESOPOR MAT, V101, P169, DOI 10.1016/j.micromeso.2006.12.016; Hu YY, 2009, MICROPOR MESOPOR MAT, V119, P306, DOI 10.1016/j.micromeso.2008.11.005; MARTENS JA, 1991, APPL CATAL, V76, P95, DOI 10.1016/0166-9834(91)80007-J; Konno H, 2012, J JPN PETROL INST, V55, P267, DOI 10.1627/jpi.55.267; Muraza O, 2013, CHEM ENG J, V226, P367, DOI 10.1016/j.cej.2013.04.072; Muraza O, 2008, CHEM ENG J, V135, pS117, DOI 10.1016/j.cej.2007.07.003; Jolly S, 1997, APPL CATAL A-GEN, V156, P71, DOI 10.1016/S0926-860X(96)00407-3; Li G, 2011, SOLID STATE SCI, V13, P662, DOI 10.1016/j.solidstatesciences.2010.12.040; Corma A, 2000, MICROPOR MESOPOR MAT, V35-6, P21, DOI 10.1016/S1387-1811(99)00205-X; ERNST S, 1989, APPL CATAL, V48, P137, DOI 10.1016/S0166-9834(00)80271-7; Choudhury IR, 2012, J CATAL, V290, P165, DOI 10.1016/j.jcat.2012.03.015; Arroyo JAM, 2000, APPL CATAL A-GEN, V192, P9, DOI 10.1016/S0926-860X(99)00331-2; Tompsett GA, 2006, CHEMPHYSCHEM, V7, P296, DOI 10.1002/cphc.200500449; Souverijns W, 1998, J CATAL, V174, P177, DOI 10.1006/jcat.1998.1959; Baerlocher C., 2007, ATLAS ZEOLITE FRAMEW, P3, DOI 10.1016/B978-044453064-6/50187-0; Baerlocher C., 2007, ELSEVIER SCI; Breck D.W., 1974, ZEOLITE MOL SIEVES S; Corma A, 1997, CURR OPIN SOLID ST M, V2, P63, DOI 10.1016/S1359-0286(97)80107-6; Gobin O., 2010, J PHYS CHEM C, V115, P1171; Narasimhan CSL, 2003, J CATAL, V220, P399, DOI 10.1016/S0021-9517(03)00281-1; Rees L.V.C., 1992, ZEOLITES, V12, P767, DOI 10.1016/0144-2449(92)90130-H; Reitmeier SJ, 2009, ANGEW CHEM INT EDIT, V48, P533, DOI 10.1002/anie.200803869; Tago T, 2009, J CHEM ENG JPN, V42, pS162; Tago T, 2012, J JPN PETROL INST, V55, P149; Thoma SG, 2001, MICROPOR MESOPOR MAT, V50, P33, DOI 10.1016/S1387-1811(01)00432-2; Valyocsik E.W., 1984, Google Patents, Patent No. 02208931987; Valyocsik E.W., 1990, Google Patents, Patent No. 19930254751993; Zhu ZR, 2006, J MOL CATAL A-CHEM, V248, P152, DOI 10.1016/j.molcata.2005.10.023	33	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1387-1811	1873-3093		MICROPOR MESOPOR MAT	Microporous Mesoporous Mat.	APR	2015	206						136	143		10.1016/j.micromeso.2014.12.025		8	Chemistry, Applied; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Chemistry; Science & Technology - Other Topics; Materials Science	CC2RB	WOS:000350191200018		
J	Diaz, CG; Ryan-Weber, EV; Cooke, J; Koyama, Y; Ouchi, M				Diaz, C. Gonzalo; Ryan-Weber, Emma V.; Cooke, Jeff; Koyama, Yusei; Ouchi, Masami			Large-scale environment of z similar to 5.7 CIV absorption systems -II. Spectroscopy of Lyman alpha emitters	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						galaxies: distances and redshifts; galaxies: high redshift; intergalactic medium; early universe	SUBARU DEEP FIELD; STAR-FORMATION HISTORY; LY-ALPHA; INTERGALACTIC MEDIUM; BREAK GALAXIES; GALACTIC WINDS; 1ST GALAXIES; C IV; COSMIC REIONIZATION; LUMINOSITY FUNCTION	The flow of baryons to and from a galaxy, which is fundamental for galaxy formation and evolution, can be studied with galaxy-metal absorption system pairs. Our search for galaxies around C IV absorption systems at z similar to 5.7 showed an excess of photometric Lyman alpha emitter (LAE) candidates in the fields J1030+0524 and J1137+3549. Here, we present spectroscopic follow-up of 33 LAEs in both fields. In the first field, three out of the five LAEs within 10h(-1) projected comoving Mpc from the C IV system are within +/- 500 km s(-1) from the absorption at z(CIV) = 5.7242 +/- 0.0001. The closest candidate (LAE 103027+052419) is robustly confirmed at 212.8(-0.4)(+14) h(-1) physical kpc from the C IV system. In the second field, the LAE sample is selected at a lower redshift (Delta z similar to 0.04) than the C IV absorption system as a result of the filter transmission and, thus, do not trace its environment. The observed properties of LAE 103027+052419 indicate that it is near the high-mass end of the LAE distribution, probably having a large HI column density and large-scale outflows. Therefore, our results suggest that the C IV system is likely produced by a star-forming galaxy which has been injecting metals into the intergalactic medium since z > 6. Thus, the C IV system is either produced by LAE 103027+052419, implying that outflows can enrich larger volumes at z > 6 than at z similar to 3.5, or an undetected dwarf galaxy. In either case, C IV systems like this one trace the ionized intergalactic medium at the end of cosmic hydrogen reionization and may trace the sources of the ionizing flux density.	[Diaz, C. Gonzalo; Ryan-Weber, Emma V.; Cooke, Jeff] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Koyama, Yusei] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Koyama, Yusei] Japan Aerosp Explorat Agcy, Inst Space Astron Sci, Sagamihara, Kanagawa 2525210, Japan; [Ouchi, Masami] Univ Tokyo, Inst Cosm Ray Res, Kashiwa, Chiba 2778582, Japan; [Ouchi, Masami] Univ Tokyo, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan	Diaz, CG (reprint author), Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia.	gdiaz@swin.edu.au			Victorian Government through the Victorian International Research Scholarship programme; Australian Research Council [DP1095600, FF130101219]; Japan Society for the Promotion of Science (JSPS); JSPS KAKENHI [26800107]; World Premier International Research Center Initiative (WPI Initiative); MEXT, Japan; KAKENHI [23244025]	We are extremely grateful to Kym-Vy Tran whose data contribution obtained in 2014 February has significantly enriched the scientific output of this work. Many thanks to Neil Crighton, Valentina D'Odorico and Thibault Garel for their comments and the interesting conversations that we had over this work. CGD acknowledges the support from the Victorian Government through the Victorian International Research Scholarship programme. ERW acknowledges the support of Australian Research Council grant DP1095600. JC acknowledges the support of Australian Research Council grant FF130101219. YK acknowledges the support from the Japan Society for the Promotion of Science (JSPS) through JSPS research fellowships for young scientists. YK also acknowledges the support by JSPS KAKENHI Number 26800107. MO acknowledges the supports from World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan, and KAKENHI (23244025) Grant-in-Aid for Scientific Research (A) through Japan Society for the Promotion of Science (JSPS).	Fan XH, 2006, ASTRON J, V132, P117, DOI 10.1086/504836; Oppenheimer BD, 2006, MON NOT R ASTRON SOC, V373, P1265, DOI 10.1111/j.1365-2966.2006.10989.x; Hu EM, 2010, ASTROPHYS J, V725, P394, DOI 10.1088/0004-637X/725/1/394; Bouche N, 2012, MON NOT R ASTRON SOC, V426, P801, DOI 10.1111/j.1365-2966.2012.21114.x; Bromm V, 2011, ANNU REV ASTRON ASTR, V49, P373, DOI 10.1146/annurev-astro-081710-102608; Hansen M, 2006, MON NOT R ASTRON SOC, V367, P979, DOI 10.1111/j.1365-2966.2005.09870.x; Adelberger KL, 2005, ASTROPHYS J, V629, P636, DOI 10.1086/431753; Steidel CC, 2010, ASTROPHYS J, V717, P289, DOI 10.1088/0004-637X/717/1/289; Becker GD, 2013, MON NOT R ASTRON SOC, V430, P2067, DOI 10.1093/mnras/stt031; Verhamme A, 2008, ASTRON ASTROPHYS, V491, P89, DOI 10.1051/0004-6361:200809648; Ferrara A, 2013, MON NOT R ASTRON SOC, V431, P2826, DOI 10.1093/mnras/stt381; Brook CB, 2012, MON NOT R ASTRON SOC, V419, P771, DOI 10.1111/j.1365-2966.2011.19740.x; McLinden EM, 2014, MON NOT R ASTRON SOC, V439, P446, DOI 10.1093/mnras/stu023; Osterbrock DE, 1996, PUBL ASTRON SOC PAC, V108, P277, DOI 10.1086/133722; Ahn SH, 2003, MON NOT R ASTRON SOC, V340, P863, DOI 10.1046/j.1365-8711.2003.06353.x; Tescari E, 2011, MON NOT R ASTRON SOC, V411, P826, DOI 10.1111/j.1365-2966.2010.17761.x; Martin CL, 2010, ASTROPHYS J, V721, P174, DOI 10.1088/0004-637X/721/1/174; Madau P, 1998, ASTROPHYS J, V498, P106, DOI 10.1086/305523; Vanzella E, 2009, ASTROPHYS J, V695, P1163, DOI 10.1088/0004-637X/695/2/1163; Ryan-Weber EV, 2009, MON NOT R ASTRON SOC, V395, P1476, DOI [10.1111/j.1365-2966.2009.14618.X, 10.1111/j.1365-2966.2009.14618.x]; Adelberger KL, 2003, ASTROPHYS J, V584, P45, DOI 10.1086/345660; Oppenheimer BD, 2009, MON NOT R ASTRON SOC, V396, P729, DOI 10.1111/j.1365-2966.2009.14771.x; Pallottini A, 2014, MON NOT R ASTRON SOC, V440, P2498, DOI 10.1093/mnras/stu451; Madau P, 2001, ASTROPHYS J, V555, P92, DOI 10.1086/321474; Fontanot F, 2014, MON NOT R ASTRON SOC, V438, P2097, DOI 10.1093/mnras/stt2332; Kashikawa N, 2006, ASTROPHYS J, V648, P7, DOI 10.1086/504966; Shapley AE, 2003, ASTROPHYS J, V588, P65, DOI 10.1086/373922; Dijkstra M, 2012, MON NOT R ASTRON SOC, V424, P1672, DOI 10.1111/j.1365-2966.2012.21131.x; Oppenheimer BD, 2008, MON NOT R ASTRON SOC, V387, P577, DOI 10.1111/j.1365-2966.2008.13280.x; Rupke DS, 2005, ASTROPHYS J SUPPL S, V160, P115, DOI 10.1086/432889; Dijkstra M, 2010, MON NOT R ASTRON SOC, V408, P352, DOI 10.1111/j.1365-2966.2010.17112.x; Ando M, 2006, ASTROPHYS J, V645, pL9, DOI 10.1086/505652; Shimasaku K, 2006, PUBL ASTRON SOC JPN, V58, P313; Yoshida N, 2003, ASTROPHYS J, V592, P645, DOI 10.1086/375810; Hopkins PF, 2012, MON NOT R ASTRON SOC, V421, P3522, DOI 10.1111/j.1365-2966.2012.20593.x; Ouchi M, 2010, ASTROPHYS J, V723, P869, DOI 10.1088/0004-637X/723/1/869; Orsi A, 2012, MON NOT R ASTRON SOC, V425, P87, DOI 10.1111/j.1365-2966.2012.21396.x; Greif TH, 2010, ASTROPHYS J, V716, P510, DOI 10.1088/0004-637X/716/1/510; Jensen H, 2013, MON NOT R ASTRON SOC, V428, P1366, DOI 10.1093/mnras/sts116; Verhamme A, 2006, ASTRON ASTROPHYS, V460, P397, DOI 10.1051/0004-6361:20065554; Bouwens RJ, 2007, ASTROPHYS J, V670, P928, DOI 10.1086/521811; Becker GD, 2009, ASTROPHYS J, V698, P1010, DOI 10.1088/0004-637X/698/2/1010; Weiner BJ, 2009, ASTROPHYS J, V692, P187, DOI 10.1088/0004-637X/692/1/187; Hu EM, 2004, ASTRON J, V127, P563, DOI 10.1086/381302; Barkana R., 2001, Physics Reports, V349, DOI 10.1016/S0370-1573(01)00019-9; Behrens C., 2014, ASTRON ASTROPHYS, V563, P77; Cai ZY, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/65; Cassata P, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201014410; Cen RY, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/11; Chonis TS, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/99; Coil AL, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/46; Cooper M. C., 2012, ASTROPHYSICS SOURCE; D'Odorico V, 2013, MON NOT R ASTRON SOC, V435, P1198, DOI 10.1093/mnras/stt1365; Diaz CG, 2014, MON NOT R ASTRON SOC, V442, P946, DOI 10.1093/mnras/stu914; Dressler A., 2014, ARXIV14120655; Dressler A, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/71; Finkelstein SL, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/140; Finkelstein SL, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/93; Gao L, 2007, MON NOT R ASTRON SOC, V378, P449, DOI 10.1111/j.1365-2966.2007.11814.x; Garel T, 2012, MON NOT R ASTRON SOC, V422, P310, DOI 10.1111/j.1365-2966.2012.20607.x; Gonzalez V, 2011, ASTROPHYS J LETT, V735, DOI 10.1088/2041-8205/735/2/L34; Hashimoto T, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/140; Jeeson-Daniel A, 2012, MON NOT R ASTRON SOC, V424, P2193, DOI 10.1111/j.1365-2966.2012.21378.x; Jones T, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/51; Karman W., 2014, ASTRON ASTROPHYS, V565, P5; Kashikawa N, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/119; Loeb A., 2010, DID 1 STARS GALAXIES; Ly C, 2007, ASTROPHYS J, V657, P738, DOI 10.1086/510828; Malhotra S, 2002, ASTROPHYS J, V565, pL71, DOI 10.1086/338980; Martin CL, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/2/127; Martin CL, 2005, ASTROPHYS J, V621, P227, DOI 10.1086/427277; McLinden EM, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/136; McLure RJ, 2011, MON NOT R ASTRON SOC, V418, P2074, DOI 10.1111/j.1365-2966.2011.19626.x; Murray N, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/66; Newman JA, 2013, ASTROPHYS J SUPPL S, V208, DOI 10.1088/0067-0049/208/1/5; Ouchi M, 2005, ASTROPHYS J, V620, pL1, DOI 10.1086/428499; Ouchi M, 2008, ASTROPHYS J SUPPL S, V176, P301, DOI 10.1086/527673; Porciani C, 2005, ASTROPHYS J, V625, pL43, DOI 10.1086/430779; Rhoads JE, 2003, ASTRON J, V125, P1006, DOI 10.1086/346272; Shen SJ, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/50; Shibuya T, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/74; Simcoe RA, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/21; Stanway ER, 2007, MON NOT R ASTRON SOC, V376, P727, DOI 10.1111/j.1365-2966.2007.11469.x; Verhamme A., 2014, ARXIV14042958; Wang JX, 2004, ASTROPHYS J, V608, pL21, DOI 10.1086/422311; Zheng Z, 2010, ASTROPHYS J, V716, P574, DOI 10.1088/0004-637X/716/1/574; Zheng ZY, 2014, MON NOT R ASTRON SOC, V439, P1101, DOI 10.1093/mnras/stu054; Zheng ZY, 2010, ASTROPHYS J, V718, P52, DOI 10.1088/0004-637X/718/1/52	88	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	APR 1	2015	448	2					1240	1270		10.1093/mnras/stu2738		31	Astronomy & Astrophysics	Astronomy & Astrophysics	CC3UB	WOS:000350274500015		
J	Adams, SM; Martini, P; Croxall, KV; Overzier, RA; Silverman, JD				Adams, Scott M.; Martini, Paul; Croxall, Kevin V.; Overzier, Roderik A.; Silverman, John D.			Discovery of an overdensity of Lyman alpha emitters around a z similar to 4 QSO with the Large Binocular Telescope	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						galaxies: clusters: general; galaxies: high-redshift; quasars: general; quasars: individual: SDSSJ 114514.18+394715.9; large-scale structure of Universe	DIGITAL SKY SURVEY; HIGH-REDSHIFT GALAXIES; SUBARU-DEEP-FIELD; BREAK GALAXIES; RADIO GALAXIES; DATA RELEASE; STAR-FORMATION; QUASARS; PROTOCLUSTER; EVOLUTION	Measurements of QSO clustering in the SDSS show that z > 4 QSOs are some of the most highly biased objects in the Universe. Their large correlation lengths of r(0) similar to 20 h(-1) Mpc are comparable to the most massive clusters of galaxies in the Universe today and suggest that these QSOs may mark the locations of massive cluster progenitors at high redshift. We report the discovery of an overdensity of Lyman-break galaxies (LBGs) around QSO SDSSJ 114514.18+394715.9 as part of our survey to identify LBGs around luminous z similar to 4 QSOs. In this field three of the eight LBGs with secure redshifts are consistent with the redshift of the QSO. We find that the likelihood that this is merely an apparent overdensity due to the chance selection of field galaxies is only 0.02 per cent, based on comparisons to simulations and our modelled selection efficiency. Overall, our survey finds 4 of the 15 LBGs with secure redshifts are consistent with the redshifts of their respective QSOs, which is consistent with luminous QSOs residing in larger haloes.	[Adams, Scott M.; Martini, Paul; Croxall, Kevin V.] Ohio State Univ, Dept Astron, Columbus, OH 43210 USA; [Martini, Paul] Ohio State Univ, Ctr Cosmol & AstroParticle Phys CCAPP, Columbus, OH 43210 USA; [Overzier, Roderik A.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Overzier, Roderik A.] Observ Nacl, BR-20921400 Rio De Janeiro, RJ, Brazil; [Silverman, John D.] Univ Tokyo, Todai Inst Adv Study, Kavli IPMU, WPI, Kashiwa, Chiba 2778583, Japan	Adams, SM (reprint author), Ohio State Univ, Dept Astron, 140 W 18th Ave, Columbus, OH 43210 USA.	sadams@astronomy.ohio-state.edu			NSF [AST-9987045, AST-1108693]; NSF Telescope System Instrumentation Program; Ohio Board of Regents; Ohio State University Office of Research	We thank the anonymous referee for helpful comments and thank Joe Antognini, Dale Mudd, and Ben Shappee for valuable discussions. This paper uses data taken with the MODS spectrographs built with funding from NSF grant AST-9987045 and the NSF Telescope System Instrumentation Program, with additional funds from the Ohio Board of Regents and the Ohio State University Office of Research. This work was based on observations made with the LBT. The LBT is an international collaboration among institutions in the United States, Italy, and Germany. The LBT Corporation partners are: the University of Arizona on behalf of the Arizona university system; the Istituto Nazionale di Astrofisica, Italy; the LBT Beteiligungsgesellschaft, Germany, representing the Max Planck Society, the Astrophysical Institute Potsdam, and Heidelberg University; the Ohio State University; and the Research Corporation, on behalf of the University of Notre Dame, the University of Minnesota, and the University of Virginia. This paper made use of the modsIDL spectral data reduction pipeline developed in part with funds provided by NSF Grant AST-1108693. The Millennium Simulation data bases used in this paper and the web application providing online access to them were constructed as part of the activities of the German Astrophysical Virtual Observatory.	Aihara H, 2011, ASTROPHYS J SUPPL S, V193, DOI 10.1088/0067-0049/193/2/29; Priddey RS, 2008, MON NOT R ASTRON SOC, V383, P289, DOI 10.1111/j.l365-2966.2007.12536.x; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Bertin E, 2002, ASTR SOC P, V281, P228; Martini P, 2001, ASTROPHYS J, V547, P12, DOI 10.1086/318331; Hewett PC, 2010, MON NOT R ASTRON SOC, V405, P2302, DOI 10.1111/j.1365-2966.2010.16648.x; Husband K, 2013, MON NOT R ASTRON SOC, V432, P2869, DOI 10.1093/mnras/stt642; Vestergaard M, 2006, ASTROPHYS J, V641, P689, DOI 10.1086/500572; Pettini M, 2001, ASTROPHYS J, V554, P981, DOI 10.1086/321403; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Henriques BMB, 2012, MON NOT R ASTRON SOC, V421, P2904, DOI 10.1111/j.1365-2966.2012.20521.x; Tapken C, 2007, ASTRON ASTROPHYS, V467, P63, DOI 10.1051/0004-6361:20065825; Rigby EE, 2014, MON NOT R ASTRON SOC, V437, P1882, DOI 10.1093/mnras/stt2019; Capak PL, 2011, NATURE, V470, P233, DOI 10.1038/nature09681; Shankar F, 2010, ASTROPHYS J, V718, P231, DOI 10.1088/0004-637X/718/1/231; White M, 2008, MON NOT R ASTRON SOC, V390, P1179, DOI 10.1111/j.1365-2966.2008.13817.x; Kashikawa N, 2006, ASTROPHYS J, V648, P7, DOI 10.1086/504966; Shapley AE, 2003, ASTROPHYS J, V588, P65, DOI 10.1086/373922; Hatch NA, 2011, MON NOT R ASTRON SOC, V410, P1537, DOI 10.1111/j.1365-2966.2010.17538.x; Overzier R, 2013, MON NOT R ASTRON SOC, V428, P778, DOI 10.1093/mnras/sts076; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Yoshida M, 2006, ASTROPHYS J, V653, P988, DOI 10.1086/508621; Simpson C, 2014, MON NOT R ASTRON SOC, V442, P3454, DOI 10.1093/mnras/stu1116; Fanidakis N, 2013, MON NOT R ASTRON SOC, V436, P315, DOI 10.1093/mnras/stt1567; Venemans BP, 2007, ASTRON ASTROPHYS, V461, P823, DOI 10.1051/0004-6361:20053941; Schneider DP, 2010, ASTRON J, V139, P2360, DOI 10.1088/0004-6256/139/6/2360; Utsumi Y, 2010, ASTROPHYS J, V721, P1680, DOI 10.1088/0004-637X/721/2/1680; Guo Q, 2011, MON NOT R ASTRON SOC, V413, P101, DOI 10.1111/j.1365-2966.2010.18114.x; Overzier RA, 2009, MON NOT R ASTRON SOC, V394, P577, DOI 10.1111/j.1365-2966.2008.14264.x; Eisenhardt PRM, 2008, ASTROPHYS J, V684, P905, DOI 10.1086/590105; Banados E, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/178; Bertin E., 2006, ASP C SER, V351, P112; Brodwin M, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/138; Chiang YK, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/127; Ciardullo R, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/83; Drouart G, 2014, ASTRON ASTROPHYS, V566, DOI 10.1051/0004-6361/201323310; GASKELL CM, 1982, ASTROPHYS J, V263, P79, DOI 10.1086/160481; Hayashi M, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/15; Intema HT, 2006, ASTRON ASTROPHYS, V456, P433, DOI 10.1051/0004-6361:20064812; Kashikawa N, 2007, ASTROPHYS J, V663, P765, DOI 10.1086/518410; Kelson DD, 1997, ASTROPHYS J, V478, pL13, DOI 10.1086/310545; Kim S, 2009, ASTROPHYS J, V695, P809, DOI 10.1088/0004-637X/695/2/809; MADAU P, 1995, ASTROPHYS J, V441, P18, DOI 10.1086/175332; Miley GK, 2004, NATURE, V427, P47, DOI 10.1038/nature02125; Overzier RA, 2003, ASTRON ASTROPHYS, V405, P53, DOI 10.1051/0004-6361:20030527; Pogge RW, 2010, PROC SPIE, V7735, DOI 10.1117/12.857215; Rhoads JE, 2003, ASTRON J, V125, P1006, DOI 10.1086/346272; Richards GT, 2002, ASTRON J, V124, P1, DOI 10.1086/341167; Roettgering H. J. A., 1994, A AS, V108, P79; Shen Y, 2007, ASTRON J, V133, P2222, DOI 10.1086/513517; Shen Y, 2011, ASTROPHYS J SUPPL S, V194, DOI 10.1088/0067-0049/194/2/45; Stern D, 1999, PUBL ASTRON SOC PAC, V111, P1475, DOI 10.1086/316471; Toshikawa J, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/137; Trainor RF, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/39; van Dokkum PG, 2001, PUBL ASTRON SOC PAC, V113, P1420, DOI 10.1086/323894; Venemans BP, 2002, ASTROPHYS J, V569, pL11, DOI 10.1086/340563; Wylezalek D, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/79	58	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	APR 1	2015	448	2					1335	1344		10.1093/mnras/stv065		10	Astronomy & Astrophysics	Astronomy & Astrophysics	CC3UB	WOS:000350274500021		
J	Sivaraman, B; Radhika, N; Das, A; Gopakumar, G; Majumdar, L; Chakrabarti, SK; Subramanian, KP; Sekhar, BNR; Hada, M				Sivaraman, B.; Radhika, N.; Das, A.; Gopakumar, G.; Majumdar, L.; Chakrabarti, S. K.; Subramanian, K. P.; Sekhar, B. N. Raja; Hada, M.			Infrared spectra and chemical abundance of methyl propionate in icy astrochemical conditions	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						astrochemistry; methods: laboratory: molecular; ISM: abundances; ISM: molecules; infrared: general	APPROXIMATION; DENSITY; MOLECULES; BEHAVIOR; ACETATE; PHASE	We carried out an experiment in order to obtain the infrared (IR) spectra of methyl propionate (CH3CH2COOCH3) in astrochemical conditions and present the IR spectra for future identification of this molecule in the interstellar medium (ISM). The experimental IR spectrum is compared with the theoretical spectrum, and an attempt was made to assign the observed peak positions to their corresponding molecular vibrations in condensed phase. Moreover, our calculations suggest that methyl propionate must be synthesized efficiently within the complex chemical network of the ISM and therefore be present in cold dust grains, awaiting identification.	[Sivaraman, B.; Subramanian, K. P.] Phys Res Lab, Space & Atmospher Sci Div, Ahmadabad 380009, Gujarat, India; [Radhika, N.; Gopakumar, G.; Hada, M.] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Das, A.; Majumdar, L.; Chakrabarti, S. K.] Indian Ctr Space Phys, Kolkata 700084, India; [Gopakumar, G.; Hada, M.] JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Chakrabarti, S. K.] SN Bose Natl Ctr Basic Sci, Kolkata 700098, India; [Sekhar, B. N. Raja] BARC, Atom & Mol Phys Div, BARC Spect Lab, Indus 1, Bombay, Maharashtra, India; [Sekhar, B. N. Raja] RRCAT, Indore 452013, Madhya Pradesh, India	Sivaraman, B (reprint author), Phys Res Lab, Space & Atmospher Sci Div, Ahmadabad 380009, Gujarat, India.	bhala@prl.res.in			ISRO Respond [ISRO/RES/2/372/11-12]; DST [SB/S2HEP-021/2013]; MOES; INSPIRE grant [IFA-11 CH -11]	BS would like to acknowledge Professor N. J. Mason, the Open University, UK and R. Mukherjee, PRL, Ahmedabad, India for their valuable discussions and comments in improving the quality of this manuscript. GG and MH would like to thank JST, CREST entitled 'Creation of Innovative Functions of Intelligent Materials in the basis of the Element Strategy'. AD and SKC want to thank ISRO Respond (grant no. ISRO/RES/2/372/11-12) and DST (grant no. SB/S2HEP-021/2013) project for their financial supports. LM wants to thank MOES for funding during this work. BS also thank INSPIRE grant (IFA-11 CH -11).	Blagojevic V, 2003, MON NOT R ASTRON SOC, V339, pL7, DOI 10.1046/j.1365-8711.2003.06351.x; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Majumdar L, 2013, NEW ASTRON, V20, P15, DOI 10.1016/j.newast.2012.09.002; Allouche AR, 2011, J COMPUT CHEM, V32, P174, DOI 10.1002/jcc.21600; Woon DE, 2009, ASTROPHYS J SUPPL S, V185, P273, DOI 10.1088/0067-0049/185/2/273; Das A, 2013, MON NOT R ASTRON SOC, V433, P3152, DOI 10.1093/mnras/stt958; Sivaraman B, 2014, CHEM PHYS LETT, V609, P167, DOI 10.1016/j.cplett.2014.06.043; WOON DE, 1993, J CHEM PHYS, V98, P1358, DOI 10.1063/1.464303; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Moller C, 1934, PHYS REV, V46, P0618, DOI 10.1103/PhysRev.46.618; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Clary D. C., 1994, APJ, V422, P7; Frisch M.J., 2009, GAUSSIAN 09; Hesse S, 2009, PHYS CHEM CHEM PHYS, V11, P11157, DOI 10.1039/b915419a; Karton A, 2014, CHEM PHYS, V436, P22, DOI 10.1016/j.chemphys.2014.03.010; Lide D. R., 2001, CRC HDB CHEM PHYS; Majumdar L, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/73; MORAVIE RM, 1974, CHEM PHYS LETT, V26, P210, DOI 10.1016/0009-2614(74)85398-4; Sivaraman B, 2013, SPECTROCHIM ACTA A, V105, P238, DOI 10.1016/j.saa.2012.12.039; Sivaraman B, 2012, CHEM PHYS LETT, V554, P57, DOI 10.1016/j.cplett.2012.10.005; STRIETER FJ, 1962, ACTA CRYSTALLOGR, V15, P1233, DOI 10.1107/S0365110X62003278; SU T, 1982, J CHEM PHYS, V76, P5183, DOI 10.1063/1.442828; Tercero B, 2013, ASTROPHYS J LETT, V770, DOI 10.1088/2041-8205/770/1/L13; VENKATESWARLU P, 1955, J CHEM PHYS, V23, P1200, DOI 10.1063/1.1742240; Woodall J, 2007, ASTRON ASTROPHYS, V466, P1197, DOI 10.1051/0004-6361:20064981	26	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	APR 1	2015	448	2					1372	1377		10.1093/mnras/stu2602		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CC3UB	WOS:000350274500024		
J	Machida, MN; Nakamura, T				Machida, Masahiro N.; Nakamura, Teppei			Accretion phase of star formation in clouds with different metallicities	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						accretion, accretion discs; binaries: general; stars: formation; stars: protostars; cosmology: theory; early Universe	1ST HYDROSTATIC CORE; INITIAL MASS FUNCTION; RADIATION MAGNETOHYDRODYNAMIC SIMULATIONS; PROTOSTELLAR DISK FORMATION; ROTATING MAGNETIZED CLOUDS; POPULATION III STARS; PRIMORDIAL STAR; FORMING CLOUDS; GRAVITATIONAL-INSTABILITY; STELLAR DENSITIES	The main accretion phase of star formation is investigated in clouds with different metallicities in the range 0 <= Z <= Z(circle dot), resolving the protostellar radius. Starting from a near-equilibrium prestellar cloud, we calculate the cloud evolution up to similar to 100 yr after the first protostar forms. Star formation differs considerably between clouds with lower (Z <= 10(-4) Z(circle dot)) and higher (Z > 10(-4) Z(circle dot)) metallicities. Fragmentation frequently occurs and many protostars appear without a stable circumstellar disc in lower-metallicity clouds. In these clouds, although protostars mutually interact and some are ejected from the cloud centre, many remain as a small stellar cluster. In contrast, higher-metallicity clouds produce a single protostar surrounded by a nearly stable rotation-supported disc. In these clouds, although fragmentation occasionally occurs in the disc, the fragments migrate inwards and finally fall on to the central protostar. The difference in cloud evolution is due to different thermal evolutions and mass accretion rates. The thermal evolution of the cloud determines the emergence and lifetime of the first core. The first core develops prior to the formation of a protostar in higher-metallicity clouds, whereas no (obvious) first core appears in lower-metallicity clouds. The first core evolves into a circumstellar disc with a spiral pattern, which effectively transfers the angular momentum outwards and suppresses frequent fragmentation. In lower-metallicity clouds, the higher mass accretion rate increases the disc surface density within a very short time, rendering the disc unstable to self-gravity and inducing vigorous fragmentation.	[Machida, Masahiro N.; Nakamura, Teppei] Kyushu Univ, Fac Sci, Dept Earth & Planetary Sci, Higashi Ku, Fukuoka 812, Japan	Machida, MN (reprint author), Kyushu Univ, Fac Sci, Dept Earth & Planetary Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 812, Japan.	machida.masahiro.018@m.kyushu-u.ac.jp			Cyberscience Center Tohoku University through the HPCI System Research Project [hp140065]; JSPS KAKENHI [25400232, 26103707]	The authors thank K. Omukai and K. Doi for providing the one-zone thermal evolution calculation code. The authors also thank T. Hosokawa for providing the mass-radius relation of protostars calculated by his stellar evolution code. We have benefited greatly from discussions with H. Susa. We are very grateful to an anonymous reviewer for a number of very useful suggestions and comments. This research used computational resources of the HPCI system provided by NEC SX-9 at Cybermedia Center Osaka University and Cyberscience Center Tohoku University through the HPCI System Research Project (Project ID: hp140065). This work was supported by JSPS KAKENHI Grant Numbers 25400232, 26103707.	Andre P, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014666; Mellon RR, 2009, ASTROPHYS J, V698, P922, DOI 10.1088/0004-637X/698/1/922; Alves JF, 2001, NATURE, V409, P159, DOI 10.1038/35051509; Clark PC, 2011, SCIENCE, V331, P1040, DOI 10.1126/science.1198027; Nakano T, 2002, ASTROPHYS J, V573, P199, DOI 10.1086/340587; Krumholz MR, 2010, ASTROPHYS J, V713, P1120, DOI 10.1088/0004-637X/713/2/1120; Mellon RR, 2008, ASTROPHYS J, V681, P1356, DOI 10.1086/587542; Larson RB, 2003, REP PROG PHYS, V66, P1651, DOI 10.1088/0034-4885/66/10/R03; Greif TH, 2012, MON NOT R ASTRON SOC, V424, P399, DOI 10.1111/j.1365-2966.2012.21212.x; Omukai K, 2003, ASTROPHYS J, V589, P677, DOI 10.1086/374810; Stacy A, 2012, MON NOT R ASTRON SOC, V422, P290, DOI 10.1111/j.1365-2966.2012.20605.x; Truelove JK, 1997, ASTROPHYS J, V489, pL179, DOI 10.1086/310975; Bromm V, 2001, MON NOT R ASTRON SOC, V328, P969, DOI 10.1046/j.1365-8711.2001.04915.x; Clark PC, 2008, ASTROPHYS J, V672, P757, DOI 10.1086/524187; Offner SSR, 2009, ASTROPHYS J, V703, P131, DOI 10.1088/0004-637X/703/1/131; BATE MR, 1995, MON NOT R ASTRON SOC, V277, P362; Hosokawa T, 2009, ASTROPHYS J, V691, P823, DOI 10.1088/0004-637X/691/1/823; Tsuribe T, 1999, ASTROPHYS J, V523, pL155, DOI 10.1086/312267; Machida MN, 2006, ASTROPHYS J, V647, pL1, DOI 10.1086/507326; Yanny B, 2009, ASTRON J, V137, P4377, DOI 10.1088/0004-6256/137/5/4377; Smith RJ, 2011, MON NOT R ASTRON SOC, V414, P3633, DOI 10.1111/j.1365-2966.2011.18659.x; Krumholz MR, 2004, ASTROPHYS J, V611, P399, DOI 10.1086/421935; Hubber DA, 2013, MON NOT R ASTRON SOC, V430, P3261, DOI 10.1093/mnras/stt128; Omukai K, 2005, ASTROPHYS J, V626, P627, DOI 10.1086/429955; Inutsuka S, 2010, ASTROPHYS J LETT, V718, pL58, DOI 10.1088/2041-8205/718/2/L58; Safranek-Shrader C, 2014, MON NOT R ASTRON SOC, V438, P1669, DOI 10.1093/mnras/stt2307; Motte F, 1998, ASTRON ASTROPHYS, V336, P150; Yoshida N, 2006, ASTROPHYS J, V652, P6, DOI 10.1086/507978; Smith B, 2008, MON NOT R ASTRON SOC, V385, P1443, DOI 10.1111/J.1365-2966.2008.12922.x; Tsukamoto Y, 2011, MON NOT R ASTRON SOC, V416, P591, DOI 10.1111/j.1365-2966.2011.19081.x; Suda T, 2004, ASTROPHYS J, V611, P476, DOI 10.1086/422135; Bergin EA, 2007, ANNU REV ASTRON ASTR, V45, P339, DOI 10.1146/annurev.astro.45.071206.100404; WHITWORTH A, 1985, MON NOT R ASTRON SOC, V214, P1; Machida MN, 2010, ASTROPHYS J, V724, P1006, DOI 10.1088/0004-637X/724/2/1006; Masunaga H, 2000, ASTROPHYS J, V531, P350, DOI 10.1086/308439; Bate MR, 2009, MON NOT R ASTRON SOC, V392, P1363, DOI 10.1111/j.1365-2966.2008.14165.x; Machida MN, 2008, ASTROPHYS J, V685, P690, DOI 10.1086/591074; Caselli P, 2002, ASTROPHYS J, V572, P238, DOI 10.1086/340195; Stamatellos D, 2009, MON NOT R ASTRON SOC, V392, P413, DOI 10.1111/j.1365-2966.2008.14069.x; Vorobyov EI, 2006, ASTROPHYS J, V650, P956, DOI 10.1086/507320; Komiya Y, 2010, ASTROPHYS J, V717, P542, DOI 10.1088/0004-637X/717/1/542; Jappsen AK, 2009, ASTROPHYS J, V696, P1065, DOI 10.1088/0004-637X/696/2/1065; Stamatellos D, 2012, MON NOT R ASTRON SOC, V427, P1182, DOI 10.1111/j.1365-2966.2012.22038.x; Stamatellos D, 2009, MON NOT R ASTRON SOC, V400, P1563, DOI 10.1111/j.1365-2966.2009.15564.x; GOODMAN AA, 1993, ASTROPHYS J, V406, P528, DOI 10.1086/172465; Machida MN, 2007, ASTROPHYS J, V670, P1198, DOI 10.1086/521779; Machida MN, 2005, MON NOT R ASTRON SOC, V362, P382, DOI 10.1111/j.1365-2966.2005.09327.x; Vorobyov EI, 2010, ASTROPHYS J, V719, P1896, DOI 10.1088/0004-637X/719/2/1896; Bromm V, 2002, ASTROPHYS J, V564, P23, DOI 10.1086/323947; Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Greif TH, 2013, MON NOT R ASTRON SOC, V434, P3408, DOI 10.1093/mnras/stt1251; Omukai K, 2001, ASTROPHYS J, V561, pL55, DOI 10.1086/324410; Omukai K, 1998, ASTROPHYS J, V508, P141, DOI 10.1086/306395; Bate MR, 2014, MON NOT R ASTRON SOC, V437, P77, DOI 10.1093/mnras/stt1865; Bate MR, 2011, MON NOT R ASTRON SOC, V417, P2036, DOI 10.1111/j.1365-2966.2011.19386.x; Bate MR, 1998, ASTROPHYS J, V508, pL95, DOI 10.1086/311719; Belloche A, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201015733; BONNOR WB, 1956, MON NOT R ASTRON SOC, V116, P351; Chen XP, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/89; Chen XP, 2010, ASTROPHYS J, V715, P1344, DOI 10.1088/0004-637X/715/2/1344; Clark PC, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/110; Crutcher R. M., 1991, APJ, V520, P706; Dopcke G, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/103; Dopcke G, 2011, ASTROPHYS J LETT, V729, DOI 10.1088/2041-8205/729/1/L3; Dunham MM, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/1/1; Ebert R., 1955, Zeitschrift fur Astrophysik, V36; Enoch ML, 2010, ASTROPHYS J LETT, V722, pL33, DOI 10.1088/2041-8205/722/1/L33; Greif TH, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/75; Hennebelle P, 2008, ASTRON ASTROPHYS, V477, P25, DOI 10.1051/0004-6361:20078310; Hirano N, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/50; Hirano S, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/2/60; Hosokawa T, 2009, ASTROPHYS J, V703, P1810, DOI 10.1088/0004-637X/703/2/1810; HUNTER C, 1977, ASTROPHYS J, V218, P834, DOI 10.1086/155739; Inutsuka S., 2012, PROG THEOR EXP PHYS, V2012; Tsuribe T, 1999, ASTROPHYS J, V526, P307, DOI 10.1086/307983; Jappsen AK, 2007, ASTROPHYS J, V660, P1332, DOI 10.1086/513085; Johnson J. L., 2014, ARXIV14114189; LARSON RB, 1969, MON NOT R ASTRON SOC, V145, P271; Lomax O, 2014, MON NOT R ASTRON SOC, V439, P3039, DOI 10.1093/mnras/stu177; Machida MN, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/42; Machida MN, 2011, MON NOT R ASTRON SOC, V413, P2767, DOI 10.1111/j.1365-2966.2011.18349.x; Machida MN, 2008, ASTROPHYS J LETT, V682, pL1, DOI 10.1086/590109; Machida MN, 2009, MON NOT R ASTRON SOC, V399, P1255, DOI 10.1111/j.1365-2966.2009.15394.x; Machida MN, 2008, ASTROPHYS J, V676, P1088, DOI 10.1086/528364; Machida MN, 2012, MON NOT R ASTRON SOC, V421, P588, DOI 10.1111/j.1365-2966.2011.20336.x; Machida MN, 2009, ASTROPHYS J, V705, P64, DOI 10.1088/0004-637X/705/1/64; Machida MN, 2008, ASTROPHYS J, V677, P813, DOI 10.1086/533434; Machida MN, 2013, MON NOT R ASTRON SOC, V435, P3283, DOI 10.1093/mnras/stt1524; Machida MN, 2004, MON NOT R ASTRON SOC, V348, pL1, DOI 10.1111/j.1365-2966.2004.07402.x; Machida MN, 2008, ASTROPHYS J, V677, P327, DOI 10.1086/529133; Machida MN, 2005, MON NOT R ASTRON SOC, V362, P369, DOI [10.1111/j.1365-2966.2005.09297.x, 10.1111/j.1365-2966.2005.09297]; Maki H, 2004, ASTROPHYS J, V609, P467, DOI 10.1086/421103; Maki H, 2007, PUBL ASTRON SOC JPN, V59, P787; Matsumoto T, 2003, ASTROPHYS J, V595, P913, DOI 10.1086/377367; Omukai K, 2000, ASTROPHYS J, V534, P809, DOI 10.1086/308776; Omukai K, 2010, ASTROPHYS J, V722, P1793, DOI 10.1088/0004-637X/722/2/1793; Pezzuto S, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201219501; Pineda JE, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/201; Saigo K, 2006, ASTROPHYS J, V645, P381, DOI 10.1086/504028; Saigo K, 2000, ASTROPHYS J, V531, P971, DOI 10.1086/308493; SHU FH, 1977, ASTROPHYS J, V214, P488, DOI 10.1086/155274; Smith BD, 2007, ASTROPHYS J, V661, pL5, DOI 10.1086/518692; Smith RJ, 2012, MON NOT R ASTRON SOC, V424, P457, DOI 10.1111/j.1365-2966.2012.21211.x; Stacy A, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/73; Tanaka KEI, 2014, MON NOT R ASTRON SOC, V439, P1884, DOI 10.1093/mnras/stu069; Tomida K, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/6; Tomisaka K, 2002, ASTROPHYS J, V575, P306, DOI 10.1086/341133; TOOMRE A, 1964, ASTROPHYS J, V139, P1217, DOI 10.1086/147861; Tsitali AE, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321204; Tsukamoto Y, 2013, MON NOT R ASTRON SOC, V436, P1667, DOI 10.1093/mnras/stt1684; Walch S, 2012, MON NOT R ASTRON SOC, V419, P760, DOI 10.1111/j.1365-2966.2011.19741.x; Walch S, 2009, MON NOT R ASTRON SOC, V400, P13, DOI 10.1111/j.1365-2966.2009.15293.x	112	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	APR 1	2015	448	2					1405	1429		10.1093/mnras/stu2633		25	Astronomy & Astrophysics	Astronomy & Astrophysics	CC3UB	WOS:000350274500029		
J	Hony, S; Gouliermis, DA; Galliano, F; Galametz, M; Cormier, D; Chen, CHR; Dib, S; Hughes, A; Klessen, RS; Roman-Duval, J; Smith, L; Bernard, JP; Bot, C; Carlson, L; Gordon, K; Indebetouw, R; Lebouteiller, V; Lee, MY; Madden, SC; Meixner, M; Oliveira, J; Rubio, M; Sauvage, M; Wu, R				Hony, S.; Gouliermis, D. A.; Galliano, F.; Galametz, M.; Cormier, D.; Chen, C. -H. R.; Dib, S.; Hughes, A.; Klessen, R. S.; Roman-Duval, J.; Smith, L.; Bernard, J. -P.; Bot, C.; Carlson, L.; Gordon, K.; Indebetouw, R.; Lebouteiller, V.; Lee, M. -Y.; Madden, S. C.; Meixner, M.; Oliveira, J.; Rubio, M.; Sauvage, M.; Wu, R.			Star formation rates from young-star counts and the structure of the ISM across the NGC 346/N66 complex in the SMC	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						stars: pre-main-sequence; ISM: individual objects: NGC 346; ISM: structure; Magellanic Clouds	SMALL-MAGELLANIC-CLOUD; FORMING REGION NGC-346; KENNICUTT-SCHMIDT LAW; GALAXY EVOLUTION; MOLECULAR CLOUDS; STELLAR OBJECTS; LOW METALLICITY; MASSIVE STARS; N 66; SUBMILLIMETER EXCESS	The rate at which interstellar gas is converted into stars, and its dependence on environment, is one of the pillars on which our understanding of the visible Universe is build. We present a comparison of the surface density of young stars (Sigma(star)) and dust surface density (Sigma(dust)) across NGC 346 (N66) in 115 independent pixels of 6 x 6 pc(2). We find a correlation between Sigma(star) and Sigma(dust) with a considerable scatter. A power-law fit to the data yields a steep relation with an exponent of 2.6 +/- 0.2. We convert Sigma(dust) to gas surface density (Sigma(gas)) and Sigma(star) to star formation rate (SFR) surface densities (Sigma(SFR)), using simple assumptions for the gas-to-dust mass ratio and the duration of star formation. The derived total SFR (4 +/- 1x10(-3) M-circle dot yr(-1)) is consistent with SFR estimated from the Ha emission integrated over the Ha nebula. On small scales the Sigma(SFR) derived using H alpha systematically underestimates the count-based Sigma(SFR), by up to a factor of 10. This is due to ionizing photons escaping the area, where the stars are counted. We find that individual 36 pc(2) pixels fall systematically above integrated disc galaxies in the Schmidt-Kennicutt diagram by on average a factor of similar to 7. The NGC 346 average SFR over a larger area (90 pc radius) lies closer to the relation but remains high by a factor of similar to 3. The fraction of the total mass (gas plus young stars) locked in young stars is systematically high (similar to 10 per cent) within the central 15 pc and systematically lower outside (2 per cent), which we interpret as variations in star formation efficiency. The inner 15 pc is dominated by young stars belonging to a centrally condensed cluster, while the outer parts are dominated by a dispersed population. Therefore, the observed trend could reflect a change of star formation efficiency between clustered and non-clustered star formation.	[Hony, S.; Gouliermis, D. A.; Cormier, D.; Klessen, R. S.] Heidelberg Univ, Inst Theoret Astrophys, Zentrum Astron, D-69120 Heidelberg, Germany; [Gouliermis, D. A.; Hughes, A.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Galliano, F.; Lebouteiller, V.; Lee, M. -Y.; Madden, S. C.; Sauvage, M.] Univ Paris Diderot, Lab AIM, CEA, IRFU,Serv Astrophys, F-91191 Gif Sur Yvette, France; [Galametz, M.] European So Observ, D-85748 Garching, Germany; [Chen, C. -H. R.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Dib, S.] Niels Bohr Inst, Niels Bohr Int Acad, DK-2100 Copenhagen, Denmark; [Dib, S.] Univ Copenhagen, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark; [Hughes, A.; Bernard, J. -P.] IRAP, CNRS, F-31028 Toulouse 4, France; [Hughes, A.; Bernard, J. -P.] Univ Toulouse, UPS OMP, IRAP, F-31028 Toulouse 4, France; [Klessen, R. S.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Klessen, R. S.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Roman-Duval, J.; Smith, L.; Gordon, K.; Meixner, M.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Smith, L.] European Space Agcy, Baltimore, MD 21218 USA; [Bot, C.] Univ Strasbourg, Observ Astron Strasbourg, CNRS, UMR 7550, F-67000 Strasbourg, France; [Carlson, L.; Indebetouw, R.] Univ Virginia, Dept Astron, Charlottesville, VA 22903 USA; [Gordon, K.] Univ Ghent, Sterrenkundig Observ, B-9000 Ghent, Belgium; [Indebetouw, R.] Natl Radio Astron Observ, Charlottesville, VA 22904 USA; [Meixner, M.] Johns Hopkins Univ, Dept Phys & Astron, Bloomberg Ctr 366, Baltimore, MD 21218 USA; [Oliveira, J.] Keele Univ, Sch Phys & Geog Sci, Lennard Jones Labs, Keele ST5 5BG, Staffs, England; [Rubio, M.] Univ Chile, Dept Astron, Santiago, Chile; [Wu, R.] Univ Tokyo, Grad Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan	Hony, S (reprint author), Heidelberg Univ, Inst Theoret Astrophys, Zentrum Astron, Albert Ueberle Str 2, D-69120 Heidelberg, Germany.	sacha.hony@free.fr	Gouliermis, Dimitrios/A-1827-2008	Gouliermis, Dimitrios/0000-0002-2763-0075	NASA [NAS 5-26555]; Deutsche Forschungsgemeinschaft (DFG) [SFB881, SPP 1573, SCHI 536/5-1, SCHI 536/7-1]; European Research Council under the European Community via ERC [339177]; German Research Foundation [GO 1659/3-1]; Marie-Curie Intra European Fellowship under European Community [627008]; Centre National d'Etudes Spatiales (CNES); DIM ACAV of the Region Ile de France	Herschel is an ESA space observatory with science instruments provided by European-led Principal Investigator consortia and with important participation from NASA. This work is based in part on observations made with the NASA/ESA Hubble Space Telescope, obtained from the data archive at the Space Telescope Science Institute (STScI). STScI is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS 5-26555. This work is also based in part on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA. This publication is based in part on data acquired with the Atacama Pathfinder Experiment (APEX). APEX is a collaboration between the Max-Planck-Institut fur Radioastronomie, the European Southern Observatory and the Onsala Space Observatory. We thank Sean Points and Roger Leighton for kindly making available the MCELS H alpha data. SH and RSK acknowledge support from the Deutsche Forschungsgemeinschaft (DFG) in the collaborative research project SFB881 'The Milky Way System (subprojects B1, B2 and B5) as well as in the priority programme SPP 1573 'Physics of the Interstellar Medium'. RSK furthermore acknowledges support from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013) via the ERC Advanced Grant STARLIGHT (project number 339177). DAG kindly acknowledges financial support by the German Research Foundation through grant GO 1659/3-1. SD is supported by a Marie-Curie Intra European Fellowship under the European Community's Seventh Framework Programme FP7/2007-2013 grant agreement no. 627008 AH acknowledges support from the Centre National d'Etudes Spatiales (CNES) and funding from the Deutsche Forschungsgemeinschaft (DFG) via grants SCHI 536/5-1 and SCHI 536/7-1 as part of the priority programme SPP 1573 'ISM-SPP: Physics of the Interstellar Medium'. MYL acknowledges supports from the DIM ACAV of the Region Ile de France.	Clark PC, 2014, MON NOT R ASTRON SOC, V444, P2396, DOI 10.1093/mnras/stu1589; Saintonge A, 2011, MON NOT R ASTRON SOC, V415, P61, DOI 10.1111/j.1365-2966.2011.18823.x; Zubko V, 2004, ASTROPHYS J SUPPL S, V152, P211, DOI 10.1086/382351; Gouliermis DA, 2014, MON NOT R ASTRON SOC, V439, P3775, DOI 10.1093/mnras/stu228; Harries TJ, 2003, MON NOT R ASTRON SOC, V339, P157, DOI 10.1046/j.1365-8711.2003.06169.x; Dale DA, 2001, ASTROPHYS J, V549, P215, DOI 10.1086/319077; Kruijssen JMD, 2014, MON NOT R ASTRON SOC, V439, P3239, DOI 10.1093/mnras/stu098; Haser SM, 1998, ASTRON ASTROPHYS, V330, P285; Dale JE, 2014, MON NOT R ASTRON SOC, V442, P694, DOI 10.1093/mnras/stu816; Krumholz MR, 2007, ASTROPHYS J, V654, P304, DOI 10.1086/509101; Bernard JP, 2008, ASTRON J, V136, P919, DOI 10.1088/0004-6256/136/3/919; Galametz M, 2013, MON NOT R ASTRON SOC, V431, P1596, DOI 10.1093/mnras/stt280; Lada CJ, 2010, ASTROPHYS J, V724, P687, DOI 10.1088/0004-637X/724/1/687; Mokiem MR, 2006, ASTRON ASTROPHYS, V456, P1131, DOI [10.1051/0004-6361:20064995, 10.1051/0004-6361:50064995]; MATHIS JS, 1983, ASTRON ASTROPHYS, V128, P212; Dib S, 2011, MON NOT R ASTRON SOC, V415, P3439, DOI 10.1111/j.1365-2966.2011.18966.x; Mauch T, 2003, MON NOT R ASTRON SOC, V342, P1117, DOI 10.1046/j.1365-8711.2003.06605.x; Longmore SN, 2013, MON NOT R ASTRON SOC, V429, P987, DOI 10.1093/mnras/sts376; Evans NJ, 2009, ASTROPHYS J SUPPL S, V181, P321, DOI 10.1088/0067-0049/181/2/321; Zubko VG, 1996, MON NOT R ASTRON SOC, V282, P1321; Heiderman A, 2010, ASTROPHYS J, V723, P1019, DOI 10.1088/0004-637X/723/2/1019; Onodera S, 2010, ASTROPHYS J LETT, V722, pL127, DOI 10.1088/2041-8205/722/2/L127; Kim S, 2003, ASTROPHYS J SUPPL S, V148, P473, DOI 10.1086/376980; Rogers H, 2013, MON NOT R ASTRON SOC, V431, P1337, DOI 10.1093/mnras/stt255; Lebouteiller V, 2008, ASTROPHYS J, V680, P398, DOI 10.1086/587503; Rieke GH, 2009, ASTROPHYS J, V692, P556, DOI 10.1088/0004-637X/692/1/556; Gouliermis DA, 2006, ASTROPHYS J SUPPL S, V166, P549, DOI 10.1086/507273; LADA CJ, 1984, ASTROPHYS J, V285, P141, DOI 10.1086/162485; Draine BT, 2007, ASTROPHYS J, V657, P810, DOI 10.1086/511055; MASSEY P, 1989, ASTRON J, V98, P1305, DOI 10.1086/115217; Bolatto AD, 2013, ANNU REV ASTRON ASTR, V51, P207, DOI 10.1146/annurev-astro-082812-140944; Calzetti D, 2007, ASTROPHYS J, V666, P870, DOI 10.1086/520082; Naze Y, 2002, ASTROPHYS J, V580, P225, DOI 10.1086/343079; Bonanos AZ, 2010, ASTRON J, V140, P416, DOI 10.1088/0004-6256/140/2/416; Williams MJ, 2010, MON NOT R ASTRON SOC, V409, P1330, DOI 10.1111/j.1365-2966.2010.17406.x; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Wu JW, 2010, ASTROPHYS J SUPPL S, V188, P313, DOI 10.1088/0067-0049/188/2/313; Chen CHR, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/2/162; Chen CHR, 2010, ASTROPHYS J, V721, P1206, DOI 10.1088/0004-637X/721/2/1206; Cignoni M, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/2/31; Dib S, 2011, ASTROPHYS J LETT, V737, DOI 10.1088/2041-8205/737/1/L20; Dickel JR, 2010, ASTRON J, V140, P1511, DOI 10.1088/0004-6256/140/5/1511; Elmegreen BG, 2000, ASTROPHYS J, V530, P277, DOI 10.1086/308361; Federrath C, 2013, MON NOT R ASTRON SOC, V436, P3167, DOI 10.1093/mnras/stt1799; Galliano F, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201117952; Goodman AA, 2004, ASTR SOC P, V323, P171; Gordon KD, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/2/85; Gordon KD, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/4/102; Gouliermis DA, 2012, SPACE SCI REV, V169, P1, DOI 10.1007/s11214-012-9868-2; Gutermuth RA, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/84; Hao CN, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/124; Hony S, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014628; Hopkins PF, 2013, MON NOT R ASTRON SOC, V428, P1950, DOI 10.1093/mnras/sts147; Indebetouw R, 2008, ASTRON J, V136, P1442, DOI 10.1088/0004-6256/136/4/1442; Israel FP, 2011, ASTRON ASTROPHYS, V531, DOI 10.1051/0004-6361/201016336; Jeffries RD, 2012, ASTROPHYSICS SPACE, P163, DOI 10.1007/978-3-642-22113-2_23; Kennicutt RC, 2008, ASTR SOC P, V390, P149; Kiseleva LG, 1998, MON NOT R ASTRON SOC, V301, P759, DOI 10.1046/j.1365-8711.1998.02043.x; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Kruijssen JMD, 2012, MON NOT R ASTRON SOC, V426, P3008, DOI 10.1111/j.1365-2966.2012.21923.x; Leroy AK, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/2/19; Li YM, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/180; Markwardt CB, 2009, ASTR SOC P, V411, P251; Meixner M, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/3/62; Murphy EJ, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/67; Nota A, 2006, ASTROPHYS J, V640, pL29, DOI 10.1086/503301; Ade PAR, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201116473; Preibisch T, 2012, RES ASTRON ASTROPHYS, V12, P1, DOI 10.1088/1674-4527/12/1/001; Rathborne JM, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/140; Reid WA, 2006, MON NOT R ASTRON SOC, V367, P1379, DOI 10.1111/j.1365-2966.2006.10017.x; Relano M, 2012, MON NOT R ASTRON SOC, V423, P2933, DOI 10.1111/j.1365-2966.2012.21107.x; Rubio M, 2000, ASTRON ASTROPHYS, V359, P1139; Sabbi E, 2008, ASTRON J, V135, P173, DOI 10.1088/0004-6256/135/1/173; Sandstrom Karin M, 2010, Astrophysical Journal, V715, DOI 10.1088/0004-637X/715/2/701; SAUVAGE M, 1990, ASTRON ASTROPHYS, V237, P296; Scalo J. M., 1986, Fundamentals of Cosmic Physics, V11; Schuller F., 2010, BOA BOLOMETER DATA A, V4th; Sewillo M, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/1/15; Simon JD, 2007, ASTROPHYS J, V669, P327, DOI 10.1086/521544; Smith C., 2000, ASP C SER, V221, P83; Smith LJ, 2012, ASTR SOC P, V465, P416; Vutisalchavakul N, 2013, ASTROPHYS J, V765, DOI 10.1088/0004-637X/765/2/129	82	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-8711	1365-2966		MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	APR 1	2015	448	2					1847	1862		10.1093/mnras/stv107		16	Astronomy & Astrophysics	Astronomy & Astrophysics	CC3UB	WOS:000350274500062		
J	Larcher, L; Hara-Nishimura, I; Sternberg, L				Larcher, Leticia; Hara-Nishimura, Ikuko; Sternberg, Leonel			Effects of stomatal density and leaf water content on the O-18 enrichment of leaf water	NEW PHYTOLOGIST			English	Article						Arabidopsis; leaf water; leaf water content; oxygen isotope ratios; stomatal density	HYDROGEN-ISOTOPE COMPOSITION; TREE-RING CELLULOSE; ATMOSPHERIC CO2; DRY-MATTER; OXYGEN; RATIOS; LEAVES; PLANTS; TRANSPIRATION; FRACTIONATION	Leaf water isotopic composition is imprinted in several biomarkers of interest and it is imperative that we understand the isotopic enrichment of leaf water. Here, we test the effect of stomatal density and leaf water content on the oxygen isotopic composition of leaf water in transgenic Arabidopsis plants expressing different stomatal densities, and several other species showing a range of stomatal density. We grew Arabidopsis plants hydroponically and collected other species in the field. Stomatal density and leaf water content were determined for each plant. We measured transpiration and extracted leaf water for isotopic determination. Using these measurements and the current leaf water isotope model, we calculated several of the parameters related to leaf water isotopic enrichment. High stomatal density promoted leaf water isotope enrichment. No conclusion, however, can be drawn regarding the effect of leaf water content on leaf water isotope enrichment. Factors such as transpiration might mask the effect of stomatal density on leaf water isotopic enrichment. We propose a method by which stomatal density can be incorporated in the current Peclet model of leaf water isotope enrichment. These findings have important applications in the use of plant-based metabolic proxies in paleoclimate studies.	[Larcher, Leticia] Univ Fed Parana, Programa Pos Grad Ecol & Conservacao, BR-80060000 Curitiba, Parana, Brazil; [Hara-Nishimura, Ikuko] Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto 6068502, Japan; [Sternberg, Leonel] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA	Sternberg, L (reprint author), Univ Miami, Dept Biol, 1301 Mem Dr, Coral Gables, FL 33124 USA.	leo@bio.miami.edu	Larcher, Leticia/L-3141-2014	Larcher, Leticia/0000-0001-9439-7544	CAPES-PDSE [013809/2013-0]	We would like to acknowledge CAPES-PDSE for the doctoral fellowship granted to L.L. (013809/2013-0).	Jahren AH, 2003, GEOLOGY, V31, P463, DOI 10.1130/0091-7613(2003)031<0463:HEFTME>2.0.CO;2; Cuntz M, 2007, PLANT CELL ENVIRON, V30, P892, DOI 10.1111/j.1365-3040.2007.01676.x; DONGMANN G, 1974, RADIAT ENVIRON BIOPH, V11, P41, DOI 10.1007/BF01323099; Kahmen A, 2009, NEW PHYTOL, V184, P619, DOI 10.1111/j.1469-8137.2009.03008.x; Vendramini PF, 2007, RAPID COMMUN MASS SP, V21, P164, DOI 10.1002/rcm.2826; Richter SL, 2008, GEOCHIM COSMOCHIM AC, V72, P2744, DOI 10.1016/j.gca.2008.01.031; FLANAGAN LB, 1991, PLANT PHYSIOL, V96, P588, DOI 10.1104/pp.96.2.588; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; Tanaka Y, 2013, NEW PHYTOL, V198, P757, DOI 10.1111/nph.12186; Cernusak LA, 2002, PLANT CELL ENVIRON, V25, P893, DOI 10.1046/j.1365-3040.2002.00875.x; Ellsworth PV, 2013, PLANT CELL ENVIRON, V36, P138, DOI 10.1111/j.1365-3040.2012.02562.x; Sternberg LDLO, 2009, NEW PHYTOL, V181, P553, DOI 10.1111/j.1469-8137.2008.02661.x; Cernusak LA, 2005, TREE PHYSIOL, V25, P129; BENDER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P363, DOI 10.1029/94GB00724; LEANEY FW, 1985, PLANTA, V164, P215, DOI 10.1007/BF00396084; Franks PJ, 2009, P NATL ACAD SCI USA, V106, P10343, DOI 10.1073/pnas.0904209106; Gessler A, 2013, NEW PHYTOL, V200, P144, DOI 10.1111/nph.12359; Ferrio JP, 2012, PLANT CELL ENVIRON, V35, P611, DOI 10.1111/j.1365-3040.2011.02440.x; Kahmen A, 2008, PLANT CELL ENVIRON, V31, P738, DOI 10.1111/j.1365-3040.2008.01784.x; Beerling DJ, 2002, NEW PHYTOL, V153, P387, DOI 10.1046/j.0028-646X.2001.00335.x; Farquhar GD, 2005, FUNCT PLANT BIOL, V32, P293, DOI 10.1071/FP04232; Song X, 2013, PLANT CELL ENVIRON, V36, P1338, DOI 10.1111/pce.12063; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Roden JS, 2000, GEOCHIM COSMOCHIM AC, V64, P21, DOI 10.1016/S0016-7037(99)00195-7; Doria G, 2011, AM J SCI, V311, P63, DOI 10.2475/01.2011.03; GUY RD, 1993, PLANT PHYSIOL, V101, P37; Barkan E, 2007, RAPID COMMUN MASS SP, V21, P2999, DOI 10.1002/rcm.3180; Barbour MM, 2003, PLANT CELL ENVIRON, V27, P107; DOLE M, 1954, GEOCHIM COSMOCHIM AC, V6, P65, DOI 10.1016/0016-7037(54)90016-2; Farquhar G. D., 1993, Stable isotopes and plant carbon-water relations., P47; FARRIS F, 1978, RADIAT ENVIRON BIOPH, V15, P167, DOI 10.1007/BF01323264; MAJOUBE M, 1971, J CHIM PHYS PCB, V68, P1423; Rosado BHP, 2013, AN ACAD BRAS CIENC, V85, P1035, DOI 10.1590/S0001-37652013005000051; Sternberg LDL, 2014, FUNCT PLANT BIOL, V41, P648, DOI 10.1071/FP13235; WOODWARD FI, 1995, NEW PHYTOL, V131, P311, DOI 10.1111/j.1469-8137.1995.tb03067.x; YAKIR D, 1989, GEOCHIM COSMOCHIM AC, V53, P2769, DOI 10.1016/0016-7037(89)90147-6	36	2	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0028-646X	1469-8137		NEW PHYTOL	New Phytol.	APR	2015	206	1					141	151		10.1111/nph.13154		11	Plant Sciences	Plant Sciences	CC4TT	WOS:000350347500017		
J	Takezawa, D; Watanabe, N; Ghosh, TK; Saruhashi, M; Suzuki, A; Ishiyama, K; Somemiya, S; Kobayashi, M; Sakata, Y				Takezawa, Daisuke; Watanabe, Naoki; Ghosh, Totan Kumar; Saruhashi, Masashi; Suzuki, Atsushi; Ishiyama, Kanako; Somemiya, Shinnosuke; Kobayashi, Masatomo; Sakata, Yoichi			Epoxycarotenoid-mediated synthesis of abscisic acid in Physcomitrella patens implicating conserved mechanisms for acclimation to hyperosmosis in embryophytes	NEW PHYTOLOGIST			English	Article						abscisic acid (ABA); dehydration tolerance; osmotic acclimation; Physcomitrella patens; zeaxanthin epoxidase	INDUCED FREEZING TOLERANCE; RESPONSIVE GENE-EXPRESSION; PLANT COLD-ACCLIMATION; STRESS-RELATED GENES; ARABIDOPSIS-THALIANA; LOW-TEMPERATURE; DESICCATION TOLERANCE; ZEAXANTHIN EPOXIDASE; ABA BIOSYNTHESIS; MOSS	Plants acclimate to environmental stress signals such as cold, drought and hypersalinity, and provoke internal protective mechanisms. Abscisic acid (ABA), a carotenoid-derived phytohormone, which increases in response to the stress signals above, has been suggested to play a key role in the acclimation process in angiosperms, but the role of ABA in basal land plants such as mosses, including its biosynthetic pathways, has not been clarified. Targeted gene disruption of PpABA1, encoding zeaxanthin epoxidase in the moss Physcomitrella patens was conducted to determine the role of endogenous ABA in acclimation processes in mosses. The generated ppaba1 plants were found to accumulate only a small amount of endogenous ABA. The ppaba1 plants showed reduced osmotic acclimation capacity in correlation with reduced dehydration tolerance and accumulation of late embryogenesis abundant proteins. By contrast, cold-induced freezing tolerance was less affected in ppaba1, indicating that endogenous ABA does not play a major role in the regulation of cold acclimation in the moss. Our results suggest that the mechanisms for osmotic acclimation mediated by carotenoid-derived synthesis of ABA are conserved in embryophytes and that acquisition of the mechanisms played a crucial role in terrestrial adaptation and colonization by land plant ancestors.	[Takezawa, Daisuke; Ghosh, Totan Kumar; Saruhashi, Masashi; Suzuki, Atsushi] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, Saitama 3388570, Japan; [Takezawa, Daisuke] Saitama Univ, Inst Environm Sci & Technol, Sakura Ku, Saitama 3388570, Japan; [Watanabe, Naoki; Somemiya, Shinnosuke; Sakata, Yoichi] Tokyo Univ Agr, Dept BioSci, Setagaya Ku, Tokyo 1568502, Japan; [Ishiyama, Kanako; Kobayashi, Masatomo] RIKEN BioResource Ctr, Expt Plant Div, Tsukuba, Ibaraki 3050074, Japan	Sakata, Y (reprint author), Tokyo Univ Agr, Dept BioSci, Setagaya Ku, 1-1-1 Sakuragaoka, Tokyo 1568502, Japan.	sakata@nodai.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [26291054, 23119504, 25119705, 24570058, 16780235]; Sumitomo Foundation [110493]	We thank R. Quatrano for Em-GUS and Tuan-hua David Ho for Ubi-LUC. We thank Shoko Kageyama for her technical assistance with RNA gel blot experiments. This study was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan to D.T. (nos. 26291054, 23119504 and 25119705) and to Y.S. (nos. 24570058 and 16780235) and by Grant for Basic Science Research Projects from The Sumitomo Foundation to Y.S. (no. 110493).	Xiong LM, 2002, J BIOL CHEM, V277, P8588, DOI 10.1074/jbc.M109275200; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.2307/3870648; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; KOSTER KL, 1992, PLANT PHYSIOL, V98, P108, DOI 10.1104/pp.98.1.108; Agrawal GK, 2001, PLANT PHYSIOL, V125, P1248, DOI 10.1104/pp.125.3.1248; GILMOUR SJ, 1988, PLANT PHYSIOL, V87, P745, DOI 10.1104/pp.87.3.745; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI 10.1016/S1360-1385(01)02187-2; HAJELA RK, 1990, PLANT PHYSIOL, V93, P1246, DOI 10.1104/pp.93.3.1246; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Minami A, 2005, PLANTA, V220, P414, DOI 10.1007/s00425-004-1361-z; Gusta LV, 2005, J PLANT GROWTH REGUL, V24, P308, DOI 10.1007/s00344-005-0079-x; North HM, 2007, PLANT J, V50, P810, DOI 10.1111/j.1365-313X.2007.03094.x; Bhyan SB, 2012, J PLANT PHYSIOL, V169, P137, DOI 10.1016/j.jplph.2011.08.004; Schwartz SH, 1997, PLANT PHYSIOL, V114, P161, DOI 10.1104/pp.114.1.161; Uemura M, 2003, PLANT PHYSIOL, V131, P1800, DOI 10.1104/pp.102.013227; Sakata Y, 2014, PROG BOT, V75, P57, DOI 10.1007/978-3-642-38797-5_2; Proust H, 2011, DEVELOPMENT, V138, P1531, DOI 10.1242/dev.058495; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Richardt S, 2010, PLANT MOL BIOL, V72, P27, DOI 10.1007/s11103-009-9550-6; Nagao M, 2005, J PLANT PHYSIOL, V162, P169, DOI 10.1016/j.jplph.2004.06.012; Marin E, 1996, EMBO J, V15, P2331; MARCOTTE WR, 1989, PLANT CELL, V1, P969, DOI 10.2307/3868997; Khandelwal A, 2010, SCIENCE, V327, P546, DOI 10.1126/science.1183672; Iuchi S, 2000, PLANT PHYSIOL, V123, P553, DOI 10.1104/pp.123.2.553; KNIGHT CD, 1995, PLANT CELL, V7, P499; Komatsu K, 2009, PLANT MOL BIOL, V70, P327, DOI 10.1007/s11103-009-9476-z; CHEN HH, 1983, PLANT PHYSIOL, V71, P362, DOI 10.1104/pp.71.2.362; Milborrow BV, 2001, J EXP BOT, V52, P1145, DOI 10.1093/jexbot/52.359.1145; Cuming AC, 2007, NEW PHYTOL, V176, P275, DOI 10.1111/j.1469-8137.2007.02187.x; Nishiyama T, 2000, DNA RES, V7, P9, DOI 10.1093/dnares/7.1.9; KOORNNEEF M, 1982, THEOR APPL GENET, V61, P385, DOI 10.1007/BF00272861; ASHTON NW, 1979, PLANTA, V144, P427, DOI 10.1007/BF00380118; Chinnusamy V, 2008, TRENDS PLANT SCI, V12, P1360; GILMOUR SJ, 1991, PLANT MOL BIOL, V17, P1233, DOI 10.1007/BF00028738; HUDSON MA, 1965, PLANTA, V66, P135, DOI 10.1007/BF00521348; Inomata M, 2004, PHYTOCHEMISTRY, V65, P2667, DOI 10.1016/j.phytochem.2004.08.025; Komatsu K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3219; Koster KL, 2010, PLANT GROWTH REGUL, V62, P293, DOI 10.1007/s10725-010-9490-9; LALK I, 1985, PHYSIOL PLANTARUM, V63, P287, DOI 10.1111/j.1399-3054.1985.tb04267.x; Levitt J., 1980, RESPONSES PLANTS ENV; MANTYLA E, 1995, PLANT PHYSIOL, V107, P141; Marella HH, 2006, PLANT J, V46, P1032, DOI 10.1111/j.1365-313X.2006.02764.x; Minami A, 2006, COLD HARDINESS IN PLANTS: MOLECULAR GENETICS, CELL BIOLOGY AND PHYSIOLOGY, P138; Minami A, 2003, J PLANT PHYSIOL, V160, P475, DOI 10.1078/0176-1617-00888; Nagao M, 2006, PHYTOCHEMISTRY, V67, P702, DOI 10.1016/j.phytochem.2006.01.031; RUTTEN D, 1992, OECOLOGIA, V91, P260, DOI 10.1007/BF00317794; Sakai A, 1987, FROST SURVIVAL PLANT; SMOLENSKASYM G, 1995, PLANT GROWTH REGUL, V17, P61; Takezawa D, 2011, J PLANT RES, V124, P4371; WERNER O, 1991, PLANTA, V186, P99, DOI 10.1007/BF00201503; YEMM EW, 1954, BIOCHEM J, V57, P508	51	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0028-646X	1469-8137		NEW PHYTOL	New Phytol.	APR	2015	206	1					209	219		10.1111/nph.13231		11	Plant Sciences	Plant Sciences	CC4TT	WOS:000350347500023		
J	Ichikawa-Seki, M; Aita, J; Masatani, T; Suzuki, M; Nitta, Y; Tamayose, G; Iso, T; Suganuma, K; Fujiwara, T; Matsuyama, K; Niikura, T; Yokoyama, N; Suzuki, H; Yamakawa, K; Inokuma, H; Itagaki, T; Zakimi, S; Nishikawa, Y				Ichikawa-Seki, Madoka; Aita, Junya; Masatani, Tatsunori; Suzuki, Moemi; Nitta, Yoshiki; Tamayose, Genta; Iso, Takehiro; Suganuma, Keisuke; Fujiwara, Takashi; Matsuyama, Keita; Niikura, Tadamasa; Yokoyama, Naoaki; Suzuki, Hiroshi; Yamakawa, Kazuhiro; Inokuma, Hisashi; Itagaki, Tadashi; Zakimi, Satoshi; Nishikawa, Yoshifumi			Molecular characterization of Cryptosporidium parvum from two different Japanese prefectures, Okinawa and Hokkaido	PARASITOLOGY INTERNATIONAL			English	Article						Cryptosporidium parvum; Immunochromatography test; SSUrRNA; GP60; Japan	PRE-WEANED CALVES; DEER-LIKE GENOTYPE; SUBGENOTYPE ANALYSIS; ENTERIC PATHOGENS; GENETIC DIVERSITY; SEQUENCE-ANALYSIS; UNITED-STATES; DAIRY CALVES; CATTLE; HUMANS	Infectious diarrhea is the most frequent cause of morbidity and mortality in neonatal calves. Cryptosporidium parvum is one of the main pathogens associated with calf diarrhea. Although diarrhea is a symptom of infection with various pathogens, investigations to detect the types of pathogens have never been performed in Japan. This study investigated the prevalence of four major diarrhea-causing pathogens in calves: C. parvum, rotavirus, coronavirus, and enterotoxigenic Escherichia colt (E. coli K99). Commercial immunochromatography testing of all four pathogens and molecular analysis of C. parvum with diarrhea in calves from southernmost Okinawa and northernmost Hokkaido, Japan, were conducted. The frequencies of C. parvum, rotavirus, coronavirus, and E. coli (K99) in Okinawa were 50%, 28%, 23%, and 4.7%, respectively. Watery fecal stools were significantly correlated with C. parvum (p < 0.05). In oocyst calculations for C. parvum, no significant difference was observed between the single-infection cases and the mixed-infection cases with rotavirus. Interestingly, molecular analyses targeting small subunit ribosomal RNA as well as glycoprotein 60 (GP60) genes revealed that the C. parvum nucleotide sequences from the two prefectures were identical, indicating that C. parvum with a uniform characteristic is distributed throughout Japan. GP60 subtyping analysis identified C. parvum from Okinawa and Hokkaido as belonging to the IIaA15G2R1 subtype, a known zoonotic subtype. Hence, control of cryptosporidiosis is important not only for pre-weaned calves, but also for human health. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Ichikawa-Seki, Madoka; Aita, Junya; Iso, Takehiro; Itagaki, Tadashi] Iwate Univ, Fac Agr, Lab Vet Parasitol, Morioka, Iwate 0208550, Japan; [Masatani, Tatsunori] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima 8900065, Japan; [Suzuki, Moemi; Nitta, Yoshiki; Zakimi, Satoshi] Yaeyama Livestock Hyg Serv Ctr, Ishigaki, Okinawa 9070243, Japan; [Tamayose, Genta] Tamayose Vet Hosp, Ishigaki, Okinawa 9070002, Japan; [Ichikawa-Seki, Madoka; Masatani, Tatsunori; Suganuma, Keisuke; Yokoyama, Naoaki; Suzuki, Hiroshi; Nishikawa, Yoshifumi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; [Fujiwara, Takashi] Tokachi Agr Mutual Aid Assoc, Honbetsu Vet Clin Ctr, Honbetsu 0893324, Japan; [Matsuyama, Keita; Niikura, Tadamasa] Tokachi Agr Mutual Aid Assoc, Hokubu Vet Clin Ctr, Asyoro 0893708, Japan; [Yamakawa, Kazuhiro] Yubetsu Herd Management Serv, Yubetsu, Hokkaido 0930731, Japan; [Inokuma, Hisashi] Obihiro Univ Agr & Vet Med, Dept Vet Clin Sci, Obihiro, Hokkaido 0808555, Japan	Nishikawa, Y (reprint author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Inada Cho, Obihiro, Hokkaido 0808555, Japan.	nisikawa@obihiro.ac.jp			Adaptable and Seamless Technology Transfer Program through target driven R & D (A-STEP) from the Japan Science and Technology Agency [AS242Z03137P]; National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine [*25-joint-10]	The authors would like to thank Noboru Inoue (Obihiro University of Agriculture and Veterinary Medicine) for his useful advices about this study. This study was supported in part by a Joint Research Grant from the National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine (*25-joint-10) and the Adaptable and Seamless Technology Transfer Program through target driven R & D (A-STEP) from the Japan Science and Technology Agency (AS242Z03137P).	Amer S, 2009, PARASITOL RES, V104, P745, DOI 10.1007/s00436-008-1250-7; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P3386; Wu ZL, 2003, APPL ENVIRON MICROB, V69, P4720, DOI 10.1128/AEM.69.8.4720-4726.2003; Chalmers RM, 2011, PARASITOL RES, V108, P1321, DOI 10.1007/s00436-010-2199-x; Wielinga PR, 2008, INT J PARASITOL, V38, P809, DOI 10.1016/j.ijpara.2007.10.014; Xiao LH, 2007, PARASITOL RES, V100, P701, DOI 10.1007/s00436-006-0337-2; Silverlas C, 2010, VET PARASITOL, V169, P289, DOI 10.1016/j.vetpar.2010.01.003; Feng YY, 2007, VET PARASITOL, V144, P1, DOI 10.1016/j.vetpar.2006.10.001; Abe M, 2009, VIRUS RES, V144, P250, DOI 10.1016/j.virusres.2009.05.005; Murakoshi F, 2013, J VET MED SCI, V75, P837, DOI 10.1292/jvms.12-0435; Pangasa A, 2010, ELECTROPHORESIS, V31, P1637, DOI 10.1002/elps.200900706; Silverlas C, 2013, INT J PARASITOL, V43, P155, DOI 10.1016/j.ijpara.2012.10.009; Brook EJ, 2009, VET J, V179, P378, DOI 10.1016/j.tvjl.2007.10.023; Abe N, 2006, PARASITOL RES, V99, P303, DOI 10.1007/s00436-006-0140-0; Plutzer J, 2009, VET PARASITOL, V165, P187, DOI 10.1016/j.vetpar.2009.07.003; Strong WB, 2000, INFECT IMMUN, V68, P4117, DOI 10.1128/IAI.68.7.4117-4134.2000; Bendali F, 1999, VET RES, V30, P509; Imre K, 2011, VET PARASITOL, V181, P321, DOI 10.1016/j.vetpar.2011.04.042; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; Rzezutka A, 2013, VET PARASITOL, V196, P301, DOI 10.1016/j.vetpar.2013.03.009; Cho YI, 2012, J VET DIAGN INVEST, V24, P559, DOI 10.1177/1040638712440997; Del Coco VF, 2014, RES VET SCI, V96, P311, DOI 10.1016/j.rvsc.2013.12.010; Feltus DC, 2006, J CLIN MICROBIOL, V44, P4303, DOI 10.1128/JCM.01067-06; Herges GR, 2012, APPL ENVIRON MICROB, V78, P8096, DOI 10.1128/AEM.02105-12; Izzo MM, 2011, AUST VET J, V89, P167, DOI 10.1111/j.1751-0813.2011.00692.x; Karanis P, 2010, VET PARASITOL, V169, P387, DOI 10.1016/j.vetpar.2010.01.014; Murakoshi F, 2012, VET PARASITOL, V187, P123, DOI 10.1016/j.vetpar.2011.12.011; Okada N, 2002, VET MICROBIOL, V84, P297, DOI 10.1016/S0378-1135(01)00445-X; Peng MM, 2001, J EUKARYOT MICROBIOL, p28S; Rieux A, 2013, VET PARASITOL, V197, P7, DOI 10.1016/j.vetpar.2013.05.001; Slapeta J, 2013, INT J PARASITOL, V44, P957; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Uga S, 2000, VET PARASITOL, V94, P27, DOI 10.1016/S0304-4017(00)00338-1; Uhde FL, 2008, VET REC, V163, P362; Waldron LS, 2011, APPL ENVIRON MICROB, V77, P7757, DOI 10.1128/AEM.00615-11; Widmer G, 2010, APPL ENVIRON MICROB, V76, P6639, DOI 10.1128/AEM.01268-10	37	2	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1383-5769			PARASITOL INT	Parasitol. Int.	APR	2015	64	2					161	166		10.1016/j.parint.2014.11.007		6	Parasitology	Parasitology	CC1FW	WOS:000350087600009		
J	Galay, RL; Umemiya-Shirafuji, R; Mochizuld, M; Fujisald, K; Tanaka, T				Galay, Remil Linggatong; Umemiya-Shirafuji, Rika; Mochizuld, Masami; Fujisald, Kozo; Tanaka, Tetsuya			Iron metabolism in hard ticks (Acari: Ixodidae): The antidote to their toxic diet	PARASITOLOGY INTERNATIONAL			English	Review						Ticks; Iron; Heme; Iron-binding proteins; Ferritin; Hematophagy	DERMACENTOR-VARIABILIS ACARI; HEME-BINDING PROTEIN; BOOPHILUS-MICROPLUS; CATTLE-TICK; HAEMAPHYSALIS-LONGICORNIS; MOLECULAR CHARACTERIZATION; DROSOPHILA-MELANOGASTER; OXIDATIVE STRESS; AEDES-AEGYPTI; FUNCTIONAL-CHARACTERIZATION	Ticks are notorious parasitic arthropods, known for their completely host-blood-dependent lifestyle. Hard ticks (Acari: Ixodidae) feed on their hosts for several days and can ingest blood more than a hundred times their unfed weight. Their blood-feeding habit facilitates the transmission of various pathogens. It is remarkable how hard ticks cope with the toxic nature of their blood meal, which contains several molecules that can promote oxidative stress including iron. While it is required in several physiological processes, high amounts of iron can be dangerous because iron can also participate in the formation of free radicals that may cause cellular damage and death. Here we review the current knowledge on heme and inorganic iron metabolism in hard ticks and compare it with that in vertebrates and other arthropods. We briefly discuss the studies on heme transport, storage and detoxification, and the transport and storage of inorganic iron, with emphasis on the functions of tick ferritins. This review points out other aspects of tick iron metabolism that warrant further investigation, as compared to mammals and other arthropods. Further understanding of this physiological process may help in formulating new control strategies for tick infestation and the spread of tick-borne diseases. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Galay, Remil Linggatong; Mochizuld, Masami; Tanaka, Tetsuya] Yamaguchi Univ, United Grad Sch Vet Sci, Dept Pathol & Prevent Vet Sci, Yamaguchi 7538515, Japan; [Galay, Remil Linggatong; Mochizuld, Masami; Tanaka, Tetsuya] Kagoshima Univ, Joint Fac Vet Med, Infect Dis Lab, Kagoshima 8900065, Japan; [Umemiya-Shirafuji, Rika] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; [Fujisald, Kozo] Natl Agr & Food Res Org, Tsukuba, Ibaraki 3050856, Japan	Tanaka, T (reprint author), Kagoshima Univ, Joint Fac Vet Med, Infect Dis Lab, 1-21-24 Korimoto, Kagoshima 8900065, Japan.	tetsuya@ms.kagoshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [25292173, 26660229]; National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine [26-joint-6]; Morinaga Foundation; Japanese Government Ministry of Education, Culture, Sports, Science, and Technology Scholarship (Monbukagakusho: MEXT)	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 25292173 and 26660229, a cooperative research grant (26-joint-6) from the National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, and the Morinaga Foundation. RL Galay is supported by the Japanese Government Ministry of Education, Culture, Sports, Science, and Technology Scholarship (Monbukagakusho: MEXT) for doctoral fellowship.	ACKERMAN S, 1981, J PARASITOL, V67, P737, DOI 10.2307/3280459; AGBEDE RIS, 1985, INT J PARASITOL, V15, P147, DOI 10.1016/0020-7519(85)90080-3; AGYEI AD, 1995, INT J PARASITOL, V25, P55, DOI 10.1016/0020-7519(94)00114-4; Alim MA, 2010, JPN J VET PARASITOL, V8, P79; Anderson JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-552; Maya-Monteiro CM, 2000, J BIOL CHEM, V275, P36584, DOI 10.1074/jbc.M007344200; Miyoshi T, 2004, INSECT BIOCHEM MOLEC, V34, P799, DOI 10.1016/j.ibmb.2004.04.004; Motobu M, 2007, FEBS J, V274, P3299, DOI 10.1111/j.1742-4658.2007.05852.x; Lang ML, 2012, P NATL ACAD SCI USA, V109, P13337, DOI 10.1073/pnas.1208703109; Sojka D, 2013, TRENDS PARASITOL, V29, P276, DOI 10.1016/j.pt.2013.04.002; Winzerling JJ, 2006, INSECT BIOCHEM MOLEC, V36, P310, DOI 10.1016/j.ibmb.2006.01.006; Yoshiga T, 1999, EUR J BIOCHEM, V260, P414, DOI 10.1046/j.1432-1327.1999.00173.x; FUJISAKI K, 1978, NATL I ANIM HEALTH Q, V18, P27; Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Gkouvatsos K, 2012, BBA-GEN SUBJECTS, V1820, P188, DOI 10.1016/j.bbagen.2011.10.013; Tang XN, 2013, FASEB J, V27, P288, DOI 10.1096/fj.12-213595; Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Donohue KV, 2008, INSECT MOL BIOL, V17, P197, DOI 10.1111/j.1365-2583.2008.00794.x; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Pereira LOR, 2007, BIOCHEMISTRY-US, V46, P6822, DOI 10.1021/bi700011d; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; De Zoysa M, 2007, FISH SHELLFISH IMMUN, V23, P624, DOI 10.1016/j.fsi.2007.01.013; Galay RL, 2013, J EXP BIOL, V216, P1905, DOI 10.1242/jeb.081240; Lara FA, 2005, J EXP BIOL, V208, P3093, DOI 10.1242/jeb.01749; Ong ST, 2006, IMMUNOBIOLOGY, V211, P295, DOI 10.1016/j.imbio.2006.02.004; Hajdusek O, 2010, VACCINE, V28, P2993, DOI 10.1016/j.vaccine.2010.02.008; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; ATAMNA H, 1995, J BIOL CHEM, V270, P24876; Boldbaatar D, 2010, J INSECT PHYSIOL, V56, P1587, DOI 10.1016/j.jinsphys.2010.05.019; Hatta T, 2006, INT J PARASITOL, V36, P1123, DOI 10.1016/j.ijpara.2006.05.010; Pascoa V, 2002, INSECT BIOCHEM MOLEC, V32, P517, DOI 10.1016/S0965-1748(01)00130-8; Chmelar J, 2012, J PROTEOMICS, V75, P3842, DOI 10.1016/j.jprot.2012.04.026; Dunkov B, 2006, INSECT BIOCHEM MOLEC, V36, P300, DOI 10.1016/j.ibmb.2006.01.007; Yoshiga T, 1997, P NATL ACAD SCI USA, V94, P12337, DOI 10.1073/pnas.94.23.12337; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Paiva-Silva GO, 2006, P NATL ACAD SCI USA, V103, P8030, DOI 10.1073/pnas.0602224103; Missirlis F, 2006, P NATL ACAD SCI USA, V103, P5893, DOI 10.1073/pnas.0601471103; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Horn M, 2009, CHEM BIOL, V16, P1053, DOI 10.1016/j.chembiol.2009.09.009; Mandilaras K, 2013, NUTRIENTS, V5, P1622, DOI 10.3390/nu5051622; Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P1, DOI 10.1016/j.ibmb.2003.09.002; Arosio P, 2009, BBA-GEN SUBJECTS, V1790, P589, DOI 10.1016/j.bbagen.2008.09.004; Mulenga A, 2004, INSECT MOL BIOL, V13, P423, DOI 10.1111/j.0962-1075.2004.00502.x; Paiva-Silva GO, 2002, INSECT BIOCHEM MOLEC, V32, P1533, DOI 10.1016/S0965-1748(02)00074-7; Lind MI, 2006, J BIOL CHEM, V281, P18707, DOI 10.1074/jbc.M603354200; Hajdusek O, 2009, P NATL ACAD SCI USA, V106, P1033, DOI 10.1073/pnas.0807961106; Meyron-Holtz EG, 2011, J NEURAL TRANSM, V118, P337, DOI 10.1007/s00702-011-0582-0; Kongsuwan K, 2010, J INSECT PHYSIOL, V56, P212, DOI 10.1016/j.jinsphys.2009.10.003; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Wickramasekara S, 2008, EMERG INFECT DIS, V14, P1273, DOI 10.3201/eid1408.080227; AZIZ N, 1987, P NATL ACAD SCI USA, V84, P8478, DOI 10.1073/pnas.84.23.8478; Balashov Y., 1972, ENTOMOL SOC AM, V8, P161; Bettedi L, 2011, J EXP BIOL, V214, P971, DOI 10.1242/jeb.051664; Boldbaatar D, 2006, INSECT BIOCHEM MOLEC, V36, P25, DOI 10.1016/j.ibmb.2005.10.003; Braz GRC, 2002, INSECT BIOCHEM MOLEC, V32, P361, DOI 10.1016/S0965-1748(01)00163-1; Braz GRC, 1999, CURR BIOL, V9, P703, DOI 10.1016/S0960-9822(99)80312-1; Citelli M, 2007, MOL BIOCHEM PARASIT, V151, P81, DOI 10.1016/j.molbiopara.2006.10.008; de la Fuente J, 2003, EXP APPL ACAROL, V29, P437; Donohue KV, 2009, J INSECT PHYSIOL, V55, P287, DOI [10.1016/j.jinsphys.2009.01.002, 10.1016/j.jinphys.2009.01.002]; Dunkov Boris C, 2002, J Insect Sci, V2, P7; Dupejova J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-4; Fontaine A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-187; Francischetti IMB, 2010, FRONT BIOSCI, V14, P2051; Franta Z, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-119; Friesen KJ, 2009, J INSECT PHYSIOL, V55, P936, DOI 10.1016/j.jinsphys.2009.06.007; Galay RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0482-x; Galay RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090661; Geiser DL, 2012, INSECT SCI, V20, P601; Geiser DL, 2011, BIOCHIM BIOPHYS ACTA, V1829, P437; Geiser DL, 2003, EUR J BIOCHEM, V270, P3667, DOI 10.1046/j.1432-1033.2003.03709.x; Gudderra NP, 2001, INSECT BIOCHEM MOLEC, V31, P299, DOI 10.1016/S0965-1748(00)00122-3; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Jonjegan F, 2004, PARASITOLOGY, V129, pS3; Kaufman WR, 2007, J INSECT PHYSIOL, V53, P264, DOI 10.1016/j.jinsphys.2006.10.004; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Kim BY, 2008, COMP BIOCHEM PHYS B, V150, P161, DOI 10.1016/j.cbpb.2008.02.009; Kopacek P, 2003, INSECT BIOCHEM MOLEC, V33, P103, DOI 10.1016/S0965-1748(02)00181-9; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Lara FA, 2003, J EXP BIOL, V206, P1707, DOI 10.1242/jeb.00334; Liyou N, 1996, INSECT BIOCHEM MOLEC, V26, P147, DOI 10.1016/0965-1748(95)00073-9; Logullo C, 2002, INSECT BIOCHEM MOLEC, V32, P1805, DOI 10.1016/S0965-1748(02)00162-5; Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252; Magalhaes T, 2008, EXP PARASITOL, V120, P364, DOI 10.1016/j.exppara.2008.09.003; Mori H, 2014, TICKS TICK-BORNE DIS, V5, P121, DOI 10.1016/j.ttbdis.2013.09.004; NICHOL H, 1990, TISSUE CELL, V22, P767, DOI 10.1016/0040-8166(90)90042-8; Oliveira MF, 2007, COMP BIOCHEM PHYS C, V146, P168, DOI 10.1016/j.cbpc.2006.12.007; Papanikolaou G, 2005, TOXICOL APPL PHARM, V1800, P824; Pham DQD, 1999, EUR J BIOCHEM, V266, P236, DOI 10.1046/j.1432-1327.1999.00849.x; ROSELLDAVIS R, 1989, EXP APPL ACAROL, V7, P95, DOI 10.1007/BF01200456; Schussler P, 1996, EUR J BIOCHEM, V241, P64, DOI 10.1111/j.1432-1033.1996.0064t.x; Silva JR, 2007, INSECT BIOCHEM MOLEC, V37, P523, DOI 10.1016/j.ibmb.2007.01.001; Silva-Gomes S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00096; Symeonidis A, 2012, BOOK IRON MICROBIAL; Tamowski BI, 1989, EXP APPL ACAROL, V6, P263; Toh SQ, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-108; Tsuji N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000062; VONDARL M, 1994, EUR J BIOCHEM, V222, P353; Wanasundara PKJPD, 2005, BAILEYS IND OIL FAT, V6, P431; Wang D, 2009, COMP BIOCHEM PHYS B, V152, P20, DOI 10.1016/j.cbpb.2008.09.082; Xu G, 2004, ANN ENTOMOL SOC AM, V97, P567, DOI 10.1603/0013-8746(2004)097[0567:FGCSAC]2.0.CO;2; Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009	105	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1383-5769			PARASITOL INT	Parasitol. Int.	APR	2015	64	2					182	189		10.1016/j.parint.2014.12.005		8	Parasitology	Parasitology	CC1FW	WOS:000350087600012		
J	Iguchi, A; Matsuu, A; Matsuyama, K; Hikasa, Y				Iguchi, Aiko; Matsuu, Aya; Matsuyama, Kazuyoshi; Hikasa, Yoshiaki			The efficacy of artemisinin, artemether, and lumefantrine against Babesia gibsoni in vitro	PARASITOLOGY INTERNATIONAL			English	Article						Babesia gibsoni; Artemisinin; Artemether; Lumefantrine	CYTOCHROME-B GENE; ATOVAQUONE; ARTESUNATE; DIHYDROARTEMISININ; PHARMACOKINETICS; FALCIPARUM; INFECTION; PROGUANIL; MALARIA; VIVO	Artemisinin has many derivatives, and it is effective against Plasmodium spp. However, only a limited number of reports have confirmed the efficacy of artemisinin derivatives against Babesia spp. In this study, whether artemisinin and artemether could inhibit the growth of Babesia gibsoni was evaluated in vitro. In addition, the interaction between artemether and lumefantrine was evaluated. These drugs inhibited the growth of B. gibsoni, but artemisinin and artemether showed lower sensitivity against atovaquone-resistant B. gibsoni than against wild-type B. gibsoni. The interaction between artemether and lumefantrine showed synergism against B. gibsoni. Although further study is needed, the combination of artemisinin derivatives could be useful for babesiosis. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Iguchi, Aiko] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; [Matsuu, Aya] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Res Ctr, Kagoshima 8900065, Japan; [Iguchi, Aiko; Matsuyama, Kazuyoshi; Hikasa, Yoshiaki] Tottori Univ, Fac Agr, Joint Dept Vet Med, Lab Vet Internal Med, Tottori 6808553, Japan	Iguchi, A (reprint author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, 2-11 Inada Cho Nishi, Obihiro, Hokkaido 0808555, Japan.	iguchi@obihiro.ac.jp; matsuu@vet.kagoshima-u.ac.jp; hikasa@muses.tottori-u.ac.jp					Goo YK, 2010, PARASITOL INT, V59, P481, DOI 10.1016/j.parint.2010.06.004; Lefevre G, 2002, BRIT J CLIN PHARMACO, V54, P485, DOI 10.1046/j.1365-2125.2002.01696.x; Meshnick SR, 1996, MICROBIOL REV, V60, P301; Homer MJ, 2000, CLIN MICROBIOL REV, V13, P451, DOI 10.1128/CMR.13.3.451-469.2000; Matsuu A, 2004, VET PARASITOL, V124, P9, DOI 10.1016/j.vetpar.2004.07.005; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; Baggish AL, 2002, ANTIMICROB AGENTS CH, V46, P1163, DOI 10.1128/AAC.46.5.1163-1173.2002; Ezzet F, 1998, BRIT J CLIN PHARMACO, V46, P553, DOI 10.1046/j.1365-2125.1998.00830.x; Iguchi A, 2012, VET PARASITOL, V185, P145, DOI 10.1016/j.vetpar.2011.09.031; Iguchi A, 2013, VET PARASITOL, V197, P527, DOI 10.1016/j.vetpar.2013.06.006; Iguchi A, 2014, J VET MED SCI, V76, P1291, DOI 10.1292/jvms.14-0139; Matsuu A, 2008, VET PARASITOL, V157, P1, DOI 10.1016/j.vetpar.2008.07.023; Matsuu A, 2006, AM J TROP MED HYG, V74, P593; Nagai A, 2003, ANTIMICROB AGENTS CH, V47, P800, DOI 10.1128/AAC.47.2.800-803.2003; Noeten F, 2000, LANCET, V356, P297; Sakuma M, 2012, J VET MED SCI, V74, P1341, DOI 10.1292/jvms.12-0140; Smithuis F, 2006, LANCET, V367, P2075, DOI 10.1016/S0140-6736(06)68931-9; Wang J, 2010, PLANT SIGNAL BEHAV, V5, P1	18	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1383-5769			PARASITOL INT	Parasitol. Int.	APR	2015	64	2					190	193		10.1016/j.parint.2014.12.006		4	Parasitology	Parasitology	CC1FW	WOS:000350087600013		
J	Zhou, Y; Zhang, L; Gui, JD; Dong, F; Cheng, SH; Mei, X; Zhang, LY; Li, YQ; Su, XG; Baldermann, S; Watanabe, N; Yang, ZY				Zhou, Ying; Zhang, Ling; Gui, Jiadong; Dong, Fang; Cheng, Sihua; Mei, Xin; Zhang, Linyun; Li, Yongqing; Su, Xinguo; Baldermann, Susanne; Watanabe, Naoharu; Yang, Ziyin			Molecular Cloning and Characterization of a Short-Chain Dehydrogenase Showing Activity with Volatile Compounds Isolated from Camellia sinensis	PLANT MOLECULAR BIOLOGY REPORTER			English	Article						Camellia sinensis; 1-Phenylethanol; Phenylpropanoids; Short chain dehydrogenase; Volatile compound	ALCOHOL-DEHYDROGENASE; PHENYLACETALDEHYDE REDUCTASE; PLANT VOLATILES; L-PHENYLALANINE; LEAF HERBIVORY; FLORAL SCENT; STRAIN EBN1; EXPRESSION; GENE; 2-PHENYLETHANOL	Camellia sinensis synthesizes and emits a large variety of volatile phenylpropanoids and benzenoids (VPB). To investigate the enzymes involved in the formation of these VPB compounds, a new C. sinensis short-chain dehydrogenase/reductase (CsSDR) was isolated, cloned, sequenced, and functionally characterized. The complete open reading frame of CsSDR contains 996 nucleotides with a calculated protein molecular mass of 34.5 kDa. The CsSDR recombinant protein produced in Escherichia coli exhibited dehydrogenase-reductase activity towards several major VPB compounds in C. sinensis flowers with a strong preference for NADP/NADPH co-factors, and showed affinity for (R)/(S)-1-phenylethanol (1PE), phenylacetaldehyde, benzaldehyde, and benzyl alcohol, and no affinity for acetophenone (AP) and 2-phenylethanol. CsSDR showed the highest catalytic efficiency towards (R)/(S)-1PE. Furthermore, the transient expression analysis in Nicotiana benthamiana plants validated that CsSDR could convert 1PE to AP in plants. CsSDR transcript level was not significantly affected by floral development and some jasmonic acid-related environmental stress, and CsSDR transcript accumulation was detected in most floral tissues such as receptacle and anther, which were main storage locations of VPB compounds. Our results indicate that CsSDR is expressed in C. sinensis flowers and is likely to contribute to a number of floral VPB compounds including the 1PE derivative AP.	[Zhou, Ying; Zhang, Ling; Gui, Jiadong; Mei, Xin; Li, Yongqing; Yang, Ziyin] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resource Conservat & Sustainable Ut, Guangzhou 510650, Guangdong, Peoples R China; [Gui, Jiadong; Yang, Ziyin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Dong, Fang; Su, Xinguo] Guangdong Food & Drug Vocat Coll, Guangzhou 510520, Guangdong, Peoples R China; [Cheng, Sihua; Zhang, Linyun] South China Agr Univ, Coll Hort Sci, Guangzhou 510642, Guangdong, Peoples R China; [Baldermann, Susanne] Univ Potsdam, Inst Nutr Sci, D-14558 Nuthetal, Germany; [Watanabe, Naoharu] Shizuoka Univ, Grad Sch Sci & Technol, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan	Yang, ZY (reprint author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resource Conservat & Sustainable Ut, Xingke Rd 723, Guangzhou 510650, Guangdong, Peoples R China.	zyyang@scbg.ac.cn	Baldermann, Susanne/C-4292-2014	Baldermann, Susanne/0000-0002-1501-4320	100 Talents Programme of the Chinese Academy of Sciences [Y321011001, 201209]; National Natural Science Foundation for Young Scholar of China [30900997]; Foundation of Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences	This work was supported by the "100 Talents Programme of the Chinese Academy of Sciences" (Y321011001 and 201209), the National Natural Science Foundation for Young Scholar of China (30900997), and the Foundation of Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences.	Dong F, 2011, J AGR FOOD CHEM, V59, P13131, DOI 10.1021/jf203396a; Maffei ME, 2011, NAT PROD REP, V28, P1359, DOI 10.1039/c1np00021g; Finsterbusch A, 1999, PLANTA, V209, P478, DOI 10.1007/s004250050751; Arimura GI, 2008, PLANT PHYSIOL, V146, P965, DOI 10.1104/pp.107.111088; Negre-Zakharov F, 2009, PLANT-DERIVED NATURAL PRODUCTS: SYNTHESIS, FUNCTION, AND APPLICATION, P405, DOI 10.1007/978-0-387-85498-4_19; Tieman DM, 2007, PHYTOCHEMISTRY, V68, P2660, DOI 10.1016/j.phytochem.2007.06.005; Sakai M, 2007, BIOSCI BIOTECH BIOCH, V71, P2408, DOI 10.1271/bbb.70090; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Abokitse K, 2003, APPL MICROBIOL BIOT, V62, P380, DOI 10.1007/s00253-003-1310-y; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Hoffken HW, 2006, BIOCHEMISTRY-US, V45, P82, DOI 10.1021/bi051596b; Pennacchio A, 2008, APPL ENVIRON MICROB, V74, P3949, DOI 10.1128/AEM.00217-08; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Schiestl FP, 2010, ECOL LETT, V13, P643, DOI 10.1111/j.1461-0248.2010.01451.x; Wu JQ, 2007, PLANT CELL, V19, P1096, DOI 10.1105/tpc.106.049353; Liu ZZ, 2003, PLANTA, V216, P824, DOI 10.1007/s00425-002-0934-y; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Tieman D, 2006, P NATL ACAD SCI USA, V103, P8287, DOI 10.1073/pnas.0602469103; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Okamoto S, 2011, FEBS J, V278, P2892, DOI 10.1111/j.1742-4658.2011.08211.x; Kessler D, 2010, CURR BIOL, V20, P237, DOI 10.1016/j.cub.2009.11.071; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kniemeyer O, 2001, ARCH MICROBIOL, V176, P129, DOI 10.1007/s002030100303; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Manriquez D, 2006, PLANT MOL BIOL, V61, P675, DOI 10.1007/s11103-006-0040-9; Theis N, 2009, AM J BOT, V96, P897, DOI 10.3732/ajb.0800300; Brosche M, 1999, PLANT PHYSIOL, V121, P479, DOI 10.1104/pp.121.2.479; de Kraker JW, 2001, PLANT PHYSIOL, V125, P1930, DOI 10.1104/pp.125.4.1930; Dong F, 2012, J PLANT PHYSIOL, V169, P217, DOI 10.1016/j.jplph.2011.12.003; Effmert U, 2008, PLANT PHYSIOL, V146, P1996, DOI 10.1104/pp.107.112326; Itoh N, 1997, APPL ENVIRON MICROB, V63, P3783; Joshi R, 2011, NAT PROD COMMUN, V6, P1155; Kallberg Y, 2006, FEBS J, V273, P1177, DOI 10.1111/j.1742-4658.2006.05153.x; Moummou H, 2012, J PLANT PHYSIOL, V169, P1435, DOI 10.1016/j.jplph.2012.06.007	37	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0735-9640	1572-9818		PLANT MOL BIOL REP	Plant Mol. Biol. Rep.	APR	2015	33	2					253	263		10.1007/s11105-014-0751-z		11	Biochemical Research Methods; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	CC9CK	WOS:000350665000007		
J	Katsurada, M				Katsurada, Masanori			Complete asymptotic expansions associated with Epstein zeta-functions II	RAMANUJAN JOURNAL			English	Article						Epstein zeta-function; Mellin-Barnes integral; Asymptotic expansion; Weighted mean value; Riemann-Liouville transform	EISENSTEIN SERIES; POWER-SERIES; FORMULA; VARIABLES; RAMANUJAN; INTEGRALS; SHINTANI; BARNES	Let be a positive-definite quadratic form with a complex parameter in the upper half-plane. The Epstein zeta-function attached to is initially defined by (1.3) below. We have established in the preceding paper Katsurada (Ramanujan J 14:249-275, 2007) complete asymptotic expansions of as , and those of its weighted mean value (with respect to ) in the form of a Laplace-Mellin transform (1.4). The present paper proceeds further with our previous study to show that similar asymptotic series still exist for a more general Epstein zeta-function defined by (1.2) below (Theorem 1), and also for the Riemann-Liouville transform (1.5) of (Theorem 2). Prior to the proofs of these asymptotic expansions, the meromorphic continuation of over the whole -plane is prepared by means of Mellin-Barnes integral transforms (Proposition 1 in Sect. 3). This procedure differs slightly from other previously known methods of analytic continuation, and provides the meromorphic continuation of in the form of a double infinite series [see (2.9) and (3.9) with (3.8)], which is most appropriate for deriving the asymptotic expansions in question. The use of Mellin-Barnes type integrals such as in (3.3) is crucial in all aspects of the proofs; several transformation and connection formulae for hypergeometric functions are especially applied with manipulation of these integrals.	Keio Univ, Dept Math, Kouhoku Ku, Yokohama, Kanagawa 2238521, Japan	Katsurada, M (reprint author), Keio Univ, Dept Math, Kouhoku Ku, Hiyoshi Campus,4-1-1 Hiyoshi, Yokohama, Kanagawa 2238521, Japan.	katsurad@z3.keio.jp			JSPS [16540038]	The author was supported by the Grant-in-Aid for Scientific Research (No. 16540038) from JSPS.	Apostol T. M., 1951, PAC J MATH, V1, P161; Berndt B., 1992, CRM P LECT NOTES, V1, P1; Berndt B. C., 2006, NUMBER THEORY SPIRIT; SELBERG A, 1967, J REINE ANGEW MATH, V227, P86; CHOWLA S, 1949, P NATL ACAD SCI USA, V35, P371, DOI 10.1073/pnas.35.7.371; Eldelyi A., 1953, HIGHER TRANSCENDENTA, V1; Eldelyi A., 1953, HIGHER TRANSCENDENTA, VII; GOLDSTEI.LJ, 1974, ISRAEL J MATH, V17, P283, DOI 10.1007/BF02756878; Ivic A., 1985, RIEMANN ZETA FUNCTIO; Katsurada M., 2012, KOKYUROKU RIMS, V1806, P99; Katsurada M., 1997, COLLECT MATH, V48, P137; Katsurada M, 1999, ACTA ARITH, V90, P79; Katsurada M, 1998, P JPN ACAD A-MATH, V74, P167; Katsurada M, 2005, COLLECT MATH, V56, P57; Katsurada M, 2001, ACTA ARITH, V97, P157, DOI 10.4064/aa97-2-4; Katsurada M, 2012, ACTA ARITH, V152, P109, DOI 10.4064/aa152-2-1; Katsurada M, 2009, INT J NUMBER THEORY, V5, P1061, DOI 10.1142/S1793042109002559; Katsurada M., 1998, LIET MAT RINK, V38, P98; Katsurada M, 1996, P JPN ACAD A-MATH, V72, P61; Katsurada M, 2007, RAMANUJAN J, V14, P249, DOI 10.1007/s11139-007-9027-7; Katsurada M, 2011, AIP CONF PROC, V1385, P58, DOI 10.1063/1.3630041; Katsurada M., 1997, PUBL I MATH, V62, P13; Katsurada M, 2003, ACTA ARITH, V107, P269, DOI 10.4064/aa107-3-5; Kohnen W., 1993, MEM FS KYUSHU U A, V47, P103, DOI 10.2206/kyushumfs.47.103; Lerch M., ACTA MATH, V11, P19; Matsumoto K, 2003, NAGOYA MATH J, V172, P59; Noda T., 2003, KOKYUROKU RIMS, V1319, P29; Ramanujan S., 1916, T CAMBRIDGE PHILOS S, V22, P159; Siegel C.L., 1980, ADV ANAL NUMBER THEO; Slater L.J., 1960, CONFLUENT HYPERGEOME; Stark H.M., 1967, ACTA ARITH, V14, P35; TERRAS AA, 1971, NAGOYA MATH J, V44, P89; Whittaker E.T., 1927, COURSE MODERN ANAL	33	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1382-4090	1572-9303		RAMANUJAN J	Ramanujan J.	APR	2015	36	3					403	437		10.1007/s11139-014-9583-6		35	Mathematics	Mathematics	CC9DF	WOS:000350667300004		
J	Nakamura, K; Honda, K; Akahoshi, K; Ihara, E; Matsuzaka, H; Sumida, Y; Yoshimura, D; Akiho, H; Motomura, Y; Iwasa, T; Komori, K; Chijiiwa, Y; Harada, N; Ochiai, T; Oya, M; Oda, Y; Takayanagi, R				Nakamura, Kazuhiko; Honda, Kuniomi; Akahoshi, Kazuya; Ihara, Eikichi; Matsuzaka, Hiroshi; Sumida, Yorinobu; Yoshimura, Daisuke; Akiho, Hirotada; Motomura, Yasuaki; Iwasa, Tsutomu; Komori, Keishi; Chijiiwa, Yoshiharu; Harada, Naohiko; Ochiai, Toshiaki; Oya, Masafumi; Oda, Yoshinao; Takayanagi, Ryoichi			Suitability of the expanded indication criteria for the treatment of early gastric cancer by endoscopic submucosal dissection: Japanese multicenter large-scale retrospective analysis of short- and long-term outcomes	SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY			English	Article						endoscopic submucosal dissection; gastric cancer; indication; outcome	RESECTION; EMR; ABSOLUTE	Objective. The criteria for endoscopic resection for early gastric cancer include absolute and expanded indications. Consensus already exists for the absolute indications. However, the suitability of the expanded indications must be validated by long-term outcome analyses since such lesions have only recently become resectable with the development of endoscopic submucosal dissection. The aim of this study is to clarify the suitability of the expanded indications for the treatment of early gastric cancer with endoscopic submucosal dissection. Materials and methods. The medical records of 1161 patients with early gastric cancers (1332 lesions) treated by endoscopic submucosal dissection and meeting the criteria for absolute or expanded indications without additional treatment with gastrectomy were divided into absolute indication group or expanded indication group. Results. Complete resection rates were 96.4% and 93.4% in absolute and expanded indication groups, respectively, with no significant differences between the groups. Delayed bleeding rates were significantly higher in the expanded indication group, whereas all cases were successfully managed conservatively. The 5-year overall survival and recurrence-free rates were 93.7%/99.77% and 90.49%/98.90% in the absolute and the expanded indication groups, respectively, with no significant differences between the groups for either measure. Multivariate analyses revealed that affected horizontal margin and tumor location were independent predictive factors for recurrence. Conclusion. The expanded indication group showed excellent post-endoscopic submucosal dissection short-term and long-term outcomes compared with the absolute indications group, demonstrating that expanded indications are suitable for endoscopic submucosal dissection for early gastric cancer.	[Nakamura, Kazuhiko; Ihara, Eikichi; Iwasa, Tsutomu; Komori, Keishi; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan; [Honda, Kuniomi; Akiho, Hirotada] Kitakyushu Municipal Med Ctr, Dept Gastroenterol, Kitakyushu, Fukuoka, Japan; [Akahoshi, Kazuya; Motomura, Yasuaki] Aso Iizuka Hosp, Dept Gastroenterol, Iizuka, Fukuoka, Japan; [Matsuzaka, Hiroshi; Chijiiwa, Yoshiharu] Hara Sanshin Hosp, Dept Gastroenterol, Fukuoka, Japan; [Sumida, Yorinobu; Harada, Naohiko] Natl Hosp Org Kyushu Med Ctr, Dept Gastroenterol, Fukuoka, Japan; [Yoshimura, Daisuke; Ochiai, Toshiaki] Saiseikai Fukuoka Gen Hosp, Dept Internal Med, Fukuoka, Japan; [Oya, Masafumi] Aso Iizuka Hosp, Dept Pathol, Iizuka, Fukuoka, Japan; [Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Pathol Sci, Fukuoka 812, Japan	Nakamura, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	knakamur@intmed3.med.kyushu-u.ac.jp			Eisai Co., Ltd.; AstraZeneca; Daiichi Sankyo Co., Ltd.; Takeda Pharmaceutical Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; Johnson and Johnson	K Nakamura received research grants from Eisai Co., Ltd., AstraZeneca, Daiichi Sankyo Co., Ltd., Takeda Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., and Johnson and Johnson. E Ihara received research grants from Eisai Co., Ltd., Daiichi Sankyo Co., Ltd., and Otsuka Pharmaceutical Co., Ltd.	Choi MK, 2013, SURG ENDOSC, V27, P4250, DOI 10.1007/s00464-013-3030-4; Gotoda T, 2007, GASTRIC CANCER, V10, P1, DOI 10.1007/s10120-006-0408-1; Yamaguchi N, 2009, DIGESTION, V80, P173, DOI 10.1159/000215388; Ahn JY, 2011, GASTROINTEST ENDOSC, V74, P485, DOI 10.1016/j.gie.2011.04.038; SANO T, 1993, CANCER, V72, P3174, DOI 10.1002/1097-0142(19931201)72:11<3174::AID-CNCR2820721107>3.0.CO;2-H; Kamada K, 2012, DIGESTION, V85, P111, DOI 10.1159/000334681; Oka S, 2006, GASTROINTEST ENDOSC, V64, P877, DOI 10.1016/j.gie.2006.03.932; Lian JJ, 2012, GASTROINTEST ENDOSC, V76, P763, DOI 10.1016/j.gie.2012.06.014; Gotoda T, 2006, J GASTROENTEROL, V41, P929, DOI 10.1007/s00535-006-1954-3; Choi KS, 2011, GASTROINTEST ENDOSC, V73, P942, DOI 10.1016/j.gie.2010.12.032; Lee H, 2011, SURG ENDOSC, V25, P1985, DOI 10.1007/s00464-010-1499-7; Goto O, 2009, ENDOSCOPY, V41, P118, DOI 10.1055/s-0028-1119452; Park CH, 2013, DIGEST LIVER DIS, V45, P651, DOI 10.1016/j.dld.2013.01.014; Akahoshi K, 2011, DIGEST ENDOSC, V23, P24, DOI 10.1111/j.1443-1661.2010.01037.x; Abe S, 2013, ENDOSCOPY, V45, P703, DOI 10.1055/s-0033-1344396; Okada K, 2012, ENDOSCOPY, V44, P122, DOI 10.1055/s-0031-1291486; Gotoda T, 2000, GASTRIC CANCER, V3, P219, DOI 10.1007/PL00011720; Itaba S, 2011, DIGEST ENDOSC, V23, P69, DOI 10.1111/j.1443-1661.2010.01066.x; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Oda Ichiro, 2006, Gastric Cancer, V9, P262, DOI 10.1007/s10120-006-0389-0; Oka S, 2014, SURG ENDOSC, V28, P639, DOI 10.1007/s00464-013-3222-y	22	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0036-5521	1502-7708		SCAND J GASTROENTERO	Scand. J. Gastroenterol.	APR	2015	50	4					413	422		10.3109/00365521.2014.940377		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CC4QF	WOS:000350337300006		
J	Han, Y; Ekici, E; Kremo, H; Altintas, O				Han, You; Ekici, Eylem; Kremo, Haris; Altintas, Onur			A survey of MAC issues for TV white space access	AD HOC NETWORKS			English	Article						TV white space; Cognitive radio; Medium access control; Survey; Open research issues	COGNITIVE RADIO NETWORKS; COEXISTENCE; MECHANISMS; PROTOCOLS	The opening of TV white space (TVWS) bands for cognitive access is one of the first tangible steps to solve spectrum scarcity problem in current wireless networks. However, this has also raised many new challenges to efficiently use the TVWS spectrum. One of the primary challenges is the design of efficient Medium Access Control (MAC) protocols that conform to various rules imposed to protect primary users as well as accommodate spatio-temporal variations of the TVWS spectrum. This article presents MAC-related challenges related to cognitive access to TVWS, discusses potential approaches to overcoming these challenges, and investigates open research issues. It also reviews regulatory activities in several countries and worldwide standardization efforts for TVWS access. (C) 2014 Elsevier B.V. All rights reserved.	[Han, You; Ekici, Eylem] Ohio State Univ, Dept Elect & Comp Engn, Columbus, OH 43210 USA; [Kremo, Haris; Altintas, Onur] Toyota InfoTechnol Ctr Co Ltd, Tokyo, Japan	Han, Y (reprint author), Ohio State Univ, Dept Elect & Comp Engn, Columbus, OH 43210 USA.	han.639@osu.edu; ekici.2@osu.edu; hkremo@jp.toyota-itc.com; onur@jp.toyota-itc.com					Akter L, 2009, COMPUT COMMUN, V32, P1923, DOI 10.1016/j.comcom.2009.06.009; Ali S., 2009, WIR COMM NETW C 2009, P1, DOI DOI 10.1109/WCNC.2009.4917655; Willkomm D, 2010, IEEE WIREL COMMUN, V17, P16, DOI 10.1109/MWC.2010.5547917; Etkin R, 2007, IEEE J SEL AREA COMM, V25, P517, DOI [10.1109/JSAC.2007.070402, 10.1109/JSAC.2007.070402.]; Chang CY, 2009, J PARALLEL DISTR COM, V69, P824, DOI 10.1016/j.jpdc.2009.07.006; Yucek T, 2009, IEEE COMMUN SURV TUT, V11, P116, DOI 10.1109/SURV.2009.090109; Mo JH, 2008, IEEE T MOBILE COMPUT, V7, P50, DOI 10.1109/TMC.2007.1075; Song Y, 2012, IEEE T MOBILE COMPUT, V11, P1127, DOI 10.1109/TMC.2011.140; Baykas T, 2012, IEEE WIREL COMMUN, V19, P10, DOI 10.1109/MWC.2012.6155872; Cormio C, 2009, AD HOC NETW, V7, P1315, DOI 10.1016/j.adhoc.2009.01.002; Chiasserini CF, 2003, IEEE T WIREL COMMUN, V2, P964, DOI 10.1109/TWC.2003.817417; Choi YJ, 2011, IEEE T VEH TECHNOL, V60, P3853, DOI 10.1109/TVT.2011.2164426; Lee WY, 2012, IEEE T MOBILE COMPUT, V11, P529, DOI 10.1109/TMC.2011.69; Akyildiz IF, 2008, IEEE COMMUN MAG, V46, P40, DOI 10.1109/MCOM.2008.4481339; Parzy M, 2011, IEEE INT SYMP DYNAM, P389, DOI 10.1109/DYSPAN.2011.5936228; Su H, 2008, IEEE J SEL AREA COMM, V26, P118, DOI 10.1109/JSAC.2008.080111; Southwell R, 2012, 2012 PROCEEDINGS IEEE INFOCOM, P37, DOI 10.1109/INFCOM.2012.6195776; Bolivar N., 2010, 2010 6 ADV INT C TEL, P30, DOI 10.1109/AICT.2010.72; Canberk B., 2010, IEEE 21 INT S PERS I, P533, DOI DOI 10.1109/PIMRC.2010.5671959; Cendrillon R., 2004, IEEE INT C COMM ICC, V1, P1; Chiasserini C.F., 2001, IEEE VTS 53 VEH TECH, V3, P2187; Dai Y., 2012, INT ICST C COGN RAD, P303; Delahaye C.M.P., 2011, EUROPEAN TELECOMMUNI, V60, P38; European Conference of Postal and Telecommunications Administrations, 2011, 159 ECC, P470; Gebert J, 2012, 2012 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE WORKSHOPS (WCNCW), P410, DOI 10.1109/WCNCW.2012.6215532; Guo T., 2012, 2012 IEEE VEH TECHN, P1, DOI DOI 10.1109/VTCFA11.2012.6399317; Hou F, 2011, IEEE T VEH TECHNOL, V60, P1728, DOI 10.1109/TVT.2011.2119384; Jing XP, 2005, 2005 1st IEEE International Symposium on New Frontiers in Dynamic Spectrum Access Networks, Conference Record, P243; Kalil Mohamed A, 2010, 2010 Proceedings of the 7th International Symposium on Wireless Communication Systems (ISWCS 2010), DOI 10.1109/ISWCS.2010.5624253; Liang Q, 2012, 2012 IEEE GLOB COMM, P5608, DOI DOI 10.1109/GL0C0M.2012.6504014; Liang YC, 2011, IEEE T VEH TECHNOL, V60, P3386, DOI 10.1109/TVT.2011.2158673; Lim S., 2011, 2011 INT C ICT CONV, P465; lwamura M., 2010, IEEE COMMUN MAG, V48, P60; Malanchini I., 2009, GLOBECOM 2009 IEEE N, P1, DOI 10.1109/GLOCOM.2009.5425335; Marias GF, 2005, 2005 1st IEEE International Symposium on New Frontiers in Dynamic Spectrum Access Networks, Conference Record, P684; Nie N., 2005, DYSPAN2005, P269; Radunovic B., 2012, P 8 INT C EM NETW EX, P205; Rajbanshi R., 2006, 1 INT C COGN RAD OR, V2006, P1, DOI DOI 10.1109/CR0WNC0M.2006.363452; Rhee W., 1998, IEEE VEH TECHN C VTC, V2, P768; Sikora A., 2005, P IEEE INSTR MEAS TE, V3, DOI DOI 10.1109/IMTC.2005.1604479; Sum C.-S., 2012, 2012 18 IEEE INT C N, P326; Vidal JR, 2013, AD HOC NETW, V11, P1858, DOI 10.1016/j.adhoc.2013.04.010; Villardi G. P., 2012, IEEE Wireless Communications, V19, DOI 10.1109/MWC.2012.6393520; Villardi GP, 2011, IEEE WIREL COMMUN, V18, P32, DOI 10.1109/MWC.2011.5999762; Wang F., 2008, 27 C COMP COMM INFOC; Xing G., 2010, 18 IEEE INT C NETW P, P305; Yaginuma N., 2012, 2012 IEEE INT C COMM, P428; Yau K-L, 2009, 4 INT C COGN RAD OR, p; Yoon S.-U., 2010, IEEE INT C COMM ICC, P1, DOI DOI 10.1109/ICC.2010.5502725; Zhang Xinyu, 2011, P 12 ACM INT S MOB A, P6; Zhang YK, 2009, IFPT'6: PROGRESS ON POST-GENOME TECHNOLOGIES, PROCEEDINGS, P1; Zhao Q, 2007, SYSTEMS COMPUTERS, P767; Zou C, 2008, COMPUT NETW, V52, P864, DOI 10.1016/j.comnet.2007.11.008	53	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-8705	1570-8713		AD HOC NETW	Ad Hoc Netw.	APR	2015	27						195	218		10.1016/j.adhoc.2014.11.009		24	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	CB6JD	WOS:000349732400012		
J	Sakimoto, Y; Sakata, S				Sakimoto, Yuya; Sakata, Shogo			Change in hippocampal theta activity during behavioral inhibition for a stimulus having an overlapping element	BEHAVIOURAL BRAIN RESEARCH			English	Article						Simultaneous feature-positive task; Serial feature-positive task; Simple discrimination task; Hippocampal theta activity	DECISION-MAKING; RATS; OSCILLATIONS; DECLINE; RHYTHM; FREQUENCY; AMPLITUDE; MOVEMENT; ATROPINE; URETHANE	It is believed that a decline in hippocampal theta power is induced by response inhibition for a conflict stimulus having an overlapping element. This study used a simultaneous feature positive (simul FP: A-, AX+) task and a serial FP (A-, X -> A+) task. In these tasks, the compound and single stimuli have an overlapping element, and rats are required to exhibit response inhibition for the single stimulus A. We examined hippocampal theta activity during simul FP (A-, AX+), serial FP (A-, X -> A+), and simple discrimination (SD; A-, X+) tasks and revealed that the transient decrease in hippocampal theta power occurred during response inhibition for the single stimulus A in simul FP tasks, which provides evidence that a transient decline in hippocampal theta power is induced by behavioral inhibition of conflict stimuli having an overlapping element. Thus, we concluded that the transient decline in hippocampal theta power was induced by behavioral inhibition for the conflict stimulus having an overlapping element. (C) 2014 Elsevier B.V. All rights reserved.	[Sakimoto, Yuya] Yamaguchi Univ, Grad Sch Med, Yamaguchi, Japan; [Sakata, Shogo] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Hiroshima, Japan	Sakata, S (reprint author), Hiroshima Univ, Grad Sch Integrated Arts & Sci, Dept Behav Sci, 1-7-1 Kagamiyama, Higashihiroshima, Hiroshima 7398521, Japan.	ysaki@yamaguchi-u.ac.jp; ssakata@hiroshima-u.ac.jp			Japan Society for Promotion of Science (JSPS) [16530471, 16203038, 21300125, 25280051, 26119519]; Hiroshima University Research Grant	This work was supported by Grants-in-Aid for Scientific Research (16530471, 16203038, 21300125, 25280051, 26119519) from the Japan Society for Promotion of Science (JSPS) and a Hiroshima University Research Grant. We would like to thank Kozue Takeda for her excellent assistance with the experiment.	Schmidt B, 2013, J NEUROSCI, V33, P6212, DOI 10.1523/JNEUROSCI.2915-12.2013; Montgomery SM, 2009, J NEUROSCI, V29, P1381, DOI 10.1523/JNEUROSCI.4339-08.2009; VANDERWOLF CH, 1975, J COMP PHYSIOL PSYCH, V88, P300, DOI 10.1037/h0076211; Belchior H, 2014, HIPPOCAMPUS, V24, P693, DOI 10.1002/hipo.22260; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Sakimoto Y, 2013, EXP BRAIN RES, V225, P177, DOI 10.1007/s00221-012-3359-2; WHISHAW IQ, 1973, BEHAV BIOL, V8, P461, DOI 10.1016/S0091-6773(73)80041-0; KRAMIS R, 1975, EXP NEUROL, V49, P58, DOI 10.1016/0014-4886(75)90195-8; Bland BH, 2007, BEHAV BRAIN RES, V179, P299, DOI 10.1016/j.bbr.2007.02.002; Buzsaki G, 1986, HIPPOCAMPUS; Campolattaro MM, 2006, BEHAV NEUROSCI, V120, P970, DOI 10.1037/0735-7044.120.4.970; FOX SE, 1986, EXP BRAIN RES, V62, P495; GRASTYAN E, 1959, ELECTROEN CLIN NEURO, V11, P409, DOI 10.1016/0013-4694(59)90040-9; Gray J. A., 2000, NEUROPSYCHOLOGY ANXI; Kasicki S, 2009, ACTA NEUROBIOL EXP, V69, P119; MITCHELL SJ, 1980, BRAIN RES, V189, P49, DOI 10.1016/0006-8993(80)90006-2; O'Keefe J., 2008, HIPPOCAMPUS BOOK, P475; Olvera Cortes E, 2002, BRAIN RES B, V58, P261; Paxinos G., 1997, RAT BRAIN STEREOTAXI; Sakimoto Y, 2014, BEHAV BRAIN RES, V275, P183, DOI 10.1016/j.bbr.2014.08.063; Sakimoto Y, 2013, BEHAV BRAIN RES, V237, P1, DOI 10.1016/j.bbr.2012.09.013; Sakimoto Y, 2013, BEHAV BRAIN RES, V257, P111, DOI 10.1016/j.bbr.2013.09.020; Sakimoto Y, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00159; Sakimoto Y, 2013, BEHAV BRAIN RES, V246, P132, DOI 10.1016/j.bbr.2013.02.012; Sakimoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070756; Sato N, 1999, PSYCHOBIOLOGY, V27, P331; Sinnamon HM, 2006, NEUROSCIENCE, V140, P779, DOI 10.1016/j.neuroscience.2006.02.058; Sinnamon HM, 2005, BEHAV BRAIN RES, V160, P236, DOI 10.1016/j.bbr.2004.12.006; VANDERWO.CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Wyble BP, 2004, HIPPOCAMPUS, V14, P662, DOI 10.1002/hipo.20012	31	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	APR	2015	282						111	116		10.1016/j.bbr.2014.12.041		6	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	CC2PB	WOS:000350186000014		
J	Hosomi, A; Suzuki, T				Hosomi, Akira; Suzuki, Tadashi			Cytoplasmic peptide:N-glycanase cleaves N-glycans on a carboxypeptidase Y mutant during ERAD in Saccharomyces cerevisiae	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						peptide:N-glycanase; ER-associated degradation; carboxypeptidase Y; Saccharomyces cerevisiae; Endoproteolysis	RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; YEAST; PROTEIN; IDENTIFICATION; GLYCOSYLATION; PROTEASOME; PATHWAY; NGLY1	Background: Endoplasmic reticulum (ER)-associated degradation (ERAD) is a pathway by which misfolded or improperly assembled proteins in the ER are directed to degradation. The cytoplasmic peptide:N-glycanase (PNGase) is a deglycosylating enzyme that cleaves N-glycans from misfolded glycoproteins during the ERAD process. The mutant form of yeast carboxypeptidase Y (CPY*) is an ERAD model substrate that has been extensively studied in yeast. While a delay in the degradation of CPY* in yeast cells lacking the cytoplasmic PNGase (Png1 in yeast) was evident, the in vivo action of PNGase on CPY* has not been detected. Methods: We constructed new BRAD substrates derived from CPY*, bearing epitope tags at both N- and C-termini and examined the degradation intermediates observed in yeast cells with compromised proteasome activity. Results: The occurrence of the PNGase-mediated deglycosylation of intact CPY* and its degradation intermediates was evident. A major endoproteolytic reaction on CPY* appears to occur between amino acid 400 and 404. Conclusions: The findings reported herein clearly indicate that PNGase indeed releases N-glycans from CPY* during the ERAD process in vivo. General Significance: This report implies that the PNGase-mediated deglycosylation during the ERAD process may occur more abundantly than currently envisaged. (C) 2014 Elsevier B.V. All rights reserved.	[Hosomi, Akira; Suzuki, Tadashi] RIKEN, Max Planck Inst Joint Res Ctr, Glycometabolome Team, Global Res Cluster, Wako, Saitama 3510198, Japan	Suzuki, T (reprint author), RIKEN, Max Planck Inst Joint Res Ctr, Glycometabolome Team, Global Res Cluster, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp	Hosomi, Akira/O-1538-2015		Ministry of Education, Science, Sports and Culture of Japan [23770162, 25440058, 25291030]	We thank the members of the Glycometabolome Team (RIKEN) for fruitful discussions. Special thanks go to Mr. Tanim J. Hossain and Dr. Hiroto Hirayama (Glycometabolome Team) for critical reading of the manuscript. We thank Ms. Tsugiyo Matsuda and Yae Tsuchiya (RIKEN) for technical support. We thank Dr. Hironori Kato (Miyazaki Univ.) for valuable technical advice and Dr. Davis Ng (NUS Singapore) for providing us with a CPY*-HA construct used in this study. The work was supported in part by a Grant-in-Aid for Young Scientists (B) (23770162) (to AH); a Grant-in-Aid for Scientific Research (C) (25440058) (to AH); and a Grant-in-Aid for Scientific Research (B) (25291030) (to TS) from the Ministry of Education, Science, Sports and Culture of Japan.	Need AC, 2012, J MED GENET, V49, P353, DOI 10.1136/jmedgenet-2012-100819; Lass A, 2007, ARCH BIOCHEM BIOPHYS, V462, P62, DOI 10.1016/j.abb.2007.04.010; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; WINTHER JR, 1991, EUR J BIOCHEM, V197, P681, DOI 10.1111/j.1432-1033.1991.tb15959.x; Habibi-Babadi N, 2010, J NEUROSCI, V30, P1766, DOI 10.1523/JNEUROSCI.4962-08.2010; Masahara-Negishi Y, 2012, BBA-GEN SUBJECTS, V1820, P1457, DOI 10.1016/j.bbagen.2012.05.009; WOLF DH, 1975, J BACTERIOL, V123, P1150; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V304, P326, DOI 10.1016/S0006-291X(03)00600-4; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Wolf DH, 2005, CURR TOP MICROBIOL, V300, P41; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Bernasconi K., 2011, CURR OPIN CELL BIOL, V23, P176; Diepold A, 2007, PLANT J, V52, P94, DOI 10.1111/j.1365-313X.2007.03215.x; Enns GM, 2014, GENET MED, V16, P751, DOI 10.1038/gim.2014.22; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Funakoshi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010545; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Hirashima K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj011; Hosomi A, 2010, J BIOL CHEM, V285, P24324, DOI 10.1074/jbc.M109.095919; Maerz S, 2010, J BIOL CHEM, V285, P2326, DOI 10.1074/jbc.M109.045302; Petris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023712; Rose M.D., 1990, METHODS YEAST GENETI; [Anonymous], 1991, METHOD ENZYMOL; Tanabe K, 2006, METHOD ENZYMOL, V415, P46, DOI 10.1016/S0076-6879(06)15004-1; Tzelepis G, 2014, BIOCHEM BIOPH RES CO, V449, P256, DOI 10.1016/j.bbrc.2014.05.017	29	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	APR	2015	1850	4					612	619		10.1016/j.bbagen.2014.12.008		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CC2RG	WOS:000350191700004		
J	Miyamoto, L; Yagi, Y; Hatano, A; Kawazoe, K; Ishizawa, K; Minakuchi, K; Tomita, S; Tsuchiya, K				Miyamoto, Licht; Yagi, Yuko; Hatano, Aya; Kawazoe, Kazuyoshi; Ishizawa, Keisuke; Minakuchi, Kazuo; Tomita, Shuhei; Tsuchiya, Koichiro			Spontaneously hyperactive MEK-Erk pathway mediates paradoxical facilitation of cell proliferation in mild hypoxia	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Mild hypoxia; Cell proliferation; MAP kinase cascade; Eric; Caco2 cells; Cell reprogramming	INDUCIBLE FACTOR-I; 5'-AMP-ACTIVATED PROTEIN-KINASE; TISSUE OXYGEN-TENSION; C-MYC; HUMAN CANCER; MAP KINASE; ACTIVATION; ASTROCYTES; IDENTIFICATION; SPECIFICITY	Background: Oxygen is important for common eukaryotic cells to generate ATP. Pathophysiological conditions such as ischemic diseases cause tissue hypoxia. In addition, oxygen availability in deep tissues is supposed to be far lower than surrounding atmosphere even in healthy animals, and the oxygen partial pressures in most normal tissues are estimated to be around 40-50 mmHg, so-called mild hypoxia. Recent studies have demonstrated that mild hypoxia has distinct effects on living cells from severe hypoxia. For instance, mild hypoxia was reported to promote cell reprogramming. Although severe hypoxia is known to inhibit cell proliferation, mild hypoxia has been paradoxically demonstrated to increase cell proliferation. However, it has not been clarified by which molecular mechanisms mild hypoxia evokes the discontinuous increment of cell proliferation. Methods: We established experimental conditions showing the opposite influences of mild and severe hypoxia on cell proliferation using undifferentiated Caco(2) human colon carcinoma cells in order to clarify the underlying molecular mechanism. Results: The basal activity of Erk, which is a typical mediator of mitogenic signals, is spontaneously increased specifically in cells exposed to mild hypoxia, and inhibition of MEK, an upstream kinase of the Erk, completely inhibited the mild hypoxia-induced enhancement of cell proliferation. Conclusions: Spontaneous hyperactivation of the MEK-Erk pathway by mild hypoxia should be the plausible molecular mechanism of the paradoxical promotion of cell proliferation. General Significance: Our findings will provide clues to the molecular basis of mild hypoxia-evoked phenomena such as cell reprogramming. (C) 2014 Elsevier B.V. All rights reserved.	[Miyamoto, Licht] Univ Tokushima, Grad Sch, Lab Pharmacol & Physiol Sci, Frontier Lab Pharmaceut Sci,Inst Hlth Biosci, Tokushima 7708505, Japan; [Miyamoto, Licht; Yagi, Yuko; Hatano, Aya; Ishizawa, Keisuke; Tsuchiya, Koichiro] Univ Tokushima, Grad Sch, Dept Med Pharmacol, Inst Hlth Biosci, Tokushima 7708505, Japan; [Yagi, Yuko; Kawazoe, Kazuyoshi; Minakuchi, Kazuo] Univ Tokushima, Grad Sch, Dept Clin Pharm, Inst Hlth Biosci, Tokushima 7708505, Japan; [Tomita, Shuhei] Tottori Univ, Fac Med, Div Mol Pharmacol, Yonago, Tottori 6838503, Japan	Miyamoto, L (reprint author), Univ Tokushima, Grad Sch, Dept Med Pharmacol, Inst Hlth Biosci, 1-78-1 Sho Machi, Tokushima 7708505, Japan.	licht.ph@gmail.com; tsuchiya@tokushima-u.ac.jp			Regional Cluster Program, Japan	We thank Kayoko Miyoshi for secretarial assistance and Drs. Toshiaki Tamaki, Kazuhiko Tsutsumi and Satoko Nakanishi for helpful advice. This work was partly supported by a grant from the Regional Cluster Program, Japan.	Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Hopfl G, 2004, AM J PHYSIOL-REG I, V286, pR608, DOI 10.1152/ajpregu.00538.2003; BOS JL, 1989, CANCER RES, V49, P4682; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Miyamoto L, 2012, J BIOL CHEM, V287, P40441, DOI 10.1074/jbc.M112.384545; Miyamoto L, 2007, J APPL PHYSIOL, V102, P1007, DOI 10.1152/japplphysiol.01034.2006; Li Q, 2009, BIOCHIMIE, V91, P1307, DOI 10.1016/j.biochi.2009.07.001; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Braun RD, 2001, AM J PHYSIOL-HEART C, V280, pH2533; WANG GL, 1995, J BIOL CHEM, V270, P1230; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Park SY, 2002, MOL BRAIN RES, V107, P9, DOI 10.1016/S0169-328X(02)00421-7; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Dang CV, 1999, MOL CELL BIOL, V19, P1; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; WANG GL, 1993, J BIOL CHEM, V268, P21513; Das M, 2001, J BIOL CHEM, V276, P15631, DOI 10.1074/jbc.M010690200; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Cheng M, 1999, J BIOL CHEM, V274, P6553, DOI 10.1074/jbc.274.10.6553; Copin JC, 2001, FASEB J, V15, P525, DOI 10.1096/fj.00-0330com; Liu J, 2006, J NEUROSCI, V26, P4329, DOI 10.1523/JNEUROSCI.0382-06.2006; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; Miyamoto L, 2012, J TOXICOL SCI, V37, P1059; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ochi J, 1986, Nihon Shokakibyo Gakkai Zasshi, V83, P180; PAYNE DM, 1991, EMBO J, V10, P885; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447; Shigenaga A, 2012, CHEMBIOCHEM, V13, P968, DOI 10.1002/cbic.201200141; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; ZHANG JD, 1995, STRUCTURE, V3, P299, DOI 10.1016/S0969-2126(01)00160-5	35	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	APR	2015	1850	4					640	646		10.1016/j.bbagen.2014.12.006		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CC2RG	WOS:000350191700007		
J	Okada, M; Corzo, G; Romero-Perez, GA; Coronas, F; Matsuda, H; Possani, LD				Okada, Masayoshi; Corzo, Gerardo; Romero-Perez, Gustavo A.; Coronas, Fredy; Matsuda, Hiroko; Possani, Lourival D.			A pore forming peptide from spider Lachesana sp venom induced neuronal depolarization and pain	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Arachnoid venom; Depolarization; Inwardly rectifying K+ channel (Kir2.1); Pain; Pore-forming peptide; Thermal hyperalgesia	INWARD RECTIFIER; POTASSIUM CHANNEL; K+ CHANNEL; ANTIMICROBIAL PEPTIDES; FUNCTIONAL EXPRESSION; SCORPION TOXIN; KIR2.1; CONDUCTANCE; DIVERSITY; CTENIDAE	Background: Arachnoid venoms contain numerous peptides with ion channel modifying and cytolytic activities. Methods: We developed a green fluorescent protein (GFP)-based assay that can monitor the changes in currents through overexpressed inwardly rectifying K+ channels (Kir2.1), in which GFP expression was increased by blockade of Kir2.1 current. Using this assay, we screened venom of many spider species. A peptide causing GFP decreasing effect was purified and sequenced. Electrophysiological and pain-inducing effects of the peptide were analyzed with whole-cell patch-clamp recordings and hot-plate test, respectively. Results: Among venoms we screened, soluble venom from Lachesana sp. decreased the GFP expression. Purification and sequencing of the peptide showed that the peptide is identical to a pore-forming peptide purified from Lachesana tarabaevi venom. Whole cell patch-clamp recordings revealed that the peptide had no effect on Kir2.1 current. Instead, it induced a current that was attributable to the pore-formation of the peptide. The peptide was selectively incorporated into hyperpolarized, i.e., Kir2.1 expressing, cells and for this reason the peptide decreased GFP expression in our Kir2.1 assay. The pore-formation positively shifted the reversal potential and induced burst firings in the hippocampal neurons in a synaptic current-independent way. The application of the Lachesana sp. peptide induced pain-related behavior in mice. Conclusions: The peptide, which was found in Lachesana sp. venom, formed pores and thereby depolarized neurons and induced pain. General significance: Our data suggested an additional physiological role of the pore-forming peptides. (C) 2014 Elsevier B.V. All rights reserved.	[Okada, Masayoshi; Romero-Perez, Gustavo A.; Matsuda, Hiroko] Kansai Med Univ, Dept Pysiol, Hirakata, Osaka 5731010, Japan; [Corzo, Gerardo; Coronas, Fredy; Possani, Lourival D.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62210, Morelos, Mexico	Okada, M (reprint author), 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan.	mokada-tky@umin.ac.jp	Romero, Pepa/C-9037-2009; Romero-Perez, Gustavo/O-4430-2015; 	Romero, Pepa/0000-0003-3301-8269; Romero-Perez, Gustavo/0000-0003-2448-9704; Corzo, Gerardo/0000-0002-9513-1622	Strategic International Research Cooperative Program between JST; CONACyT	This work was supported by Strategic International Research Cooperative Program between JST and CONACyT.	STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; Kuzmenkov AI, 2013, BBA-BIOMEMBRANES, V1828, P724, DOI 10.1016/j.bbamem.2012.10.014; Vassilevski AA, 2008, BIOCHEM J, V411, P687, DOI 10.1042/bj20071123; Rowe AH, 2013, SCIENCE, V342, P441, DOI 10.1126/science.1236451; Vassilevski AA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1505, DOI 10.1134/S0006297909130069; Kuhn-Nentwig L, 2002, J BIOL CHEM, V277, P11208, DOI 10.1074/jbc.M111099200; Estrada G, 2007, BBA-GEN SUBJECTS, V1770, P1161, DOI 10.1016/j.bbagen.2007.04.006; Kozlov SA, 2006, J BIOL CHEM, V281, P20983, DOI 10.1074/jbc.M602168200; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Lewis LM, 2009, MOL PHARMACOL, V76, P1094, DOI 10.1124/mol.109.059840; Casewell NR, 2013, TRENDS ECOL EVOL, V28, P219, DOI 10.1016/j.tree.2012.10.020; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Haeberli S, 2000, TOXICON, V38, P373, DOI 10.1016/S0041-0101(99)00167-1; Corzo G, 2002, J BIOL CHEM, V277, P23627, DOI 10.1074/jbc.M200511200; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Dunlop J, 2008, NAT REV DRUG DISCOV, V7, P358, DOI 10.1038/nrd2552; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Garcia F, 2013, J ANTIBIOT, V66, P3, DOI 10.1038/ja.2012.87; DANIEL S, 1991, J PHARMACOL METHOD, V25, P185, DOI 10.1016/0160-5402(91)90009-T; Freudenberg H., 1971, SYNTHESIS-STUTTGART, V232, P537; Malmberg A.B., 1999, CURR PROTOC NEUROSCI, V41, P891; Okada M, 2013, BRAIN RES, V1528, P8, DOI 10.1016/j.brainres.2013.07.008; Okada M, 2008, NEUROSCIENCE, V156, P289, DOI 10.1016/j.neuroscience.2008.07.038; Quintero-Hernandez V, 2013, TOXICON, V76, P328, DOI 10.1016/j.toxicon.2013.07.012; SAKMANN B, 1984, J PHYSIOL-LONDON, V347, P641; TAGLIALATELA M, 1995, EMBO J, V14, P5532; TANG WM, 1995, MOL BIOL CELL, V6, P1231; Valdez-Cruz NA, 2004, EUR J BIOCHEM, V271, P4753, DOI 10.1111/j.1432-1033.2004.04439.x; Yan Lizhen, 1998, Journal of Biological Chemistry, V273, P2059, DOI 10.1074/jbc.273.4.2059; Zaks-Makhina E, 2004, MOL PHARMACOL, V65, P214, DOI 10.1124/mol.65.1.214	34	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	APR	2015	1850	4					657	666		10.1016/j.bbagen.2014.11.022		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CC2RG	WOS:000350191700009		
J	Cho, G; Bragiel, AM; Wang, D; Pieczonka, TD; Skowronski, MT; Shono, M; Nielsen, S; Ishikawa, Y				Cho, Gota; Bragiel, Aneta M.; Wang, Di; Pieczonka, Tomasz D.; Skowronski, Mariusz T.; Shono, Masayuki; Nielsen, Soren; Ishikawa, Yasuko			Activation of muscarinic receptors in rat parotid acinar cells induces AQP5 trafficking to nuclei and apical plasma membrane	BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS			English	Article						Aquaporin-5; Trafficking; Nuclei; Apical plasma membrane; Parotid glands; Acinar cells	AQUAPORIN-5 WATER CHANNEL; LIPID RAFTS; PROTEOMIC ANALYSIS; EPITHELIAL-CELLS; FLUID SECRETION; GLAND; SALIVA; TRANSLOCATION; EXOSOMES; IDENTIFICATION	Background: The subcellular distribution of aquaporin-5 (AQP5) in rat parotid acinar cells in response to muscarinic acetylcholine receptor (mAChR) activation remains unclear. Methods: Immunoconfocal and immunoelectron microscopy were used to visualize the distribution of AQP5 in parotid acinar cells. Western blotting was used to analyze AQP5 levels in membranes. To clarify the characteristics of membrane domains associated with AQP5, detergent solubility and sucrose-density flotation experiments were performed. Results: Under control conditions, AQP5 was diffusely distributed on the apical plasma membrane (APM) and apical plasmalemmal region and throughout the cytoplasm. Upon mAChR activation, AQP5 was predominantly located in the nucleus, APM and lateral plasma membrane (LPM). Subsequently, localization of AQP5 in the nucleus, APM and LPM was decreased. Prolonged atropine treatment inhibited mAChR agonist-induced translocation of AQP5 to the nucleus, APM and LPM. AQP5 levels were enhanced in isolated nuclei and nuclear membranes prepared from parotid tissues incubated with mAChR agonist mAChR agonist induced AQP5 levels in both soluble and insoluble nuclear fractions solubilized with Triton X-100 or Lubrol WX Small amounts of AQP5 in nuclei were detected using low-density sucrose gradient When AQP5 was present in the nuclear membrane, nuclear size decreased. Conclusion: The activation of mAChR induced AQP5 translocation to the nucleus, APM and LPM, and AQP5 may trigger water transport across the nuclear membrane and plasma membrane in rat parotid acinar cells. General significance: AQP5 translocates to the nuclear membrane and may trigger the movement of water, inducing shrinkage of the nucleus and the start of nuclear functions. (C) 2015 Elsevier B.V. All rights reserved.	[Cho, Gota] Univ Tokushima, Dept Dent Anesthesiol, Grad Sch, Inst Hlth Biosci, Tokushima 7708504, Japan; [Bragiel, Aneta M.; Wang, Di; Pieczonka, Tomasz D.; Ishikawa, Yasuko] Univ Tokushima, Dept Med Pharmacol, Grad Sch, Inst Hlth Biosci, Tokushima 7708504, Japan; [Skowronski, Mariusz T.; Nielsen, Soren] Aalborg Univ, Inst Med & Hlth Technol, DK-9220 Aalborg, Denmark; [Shono, Masayuki] Univ Tokushima, Support Ctr Adv Med Sci, Grad Sch, Inst Hlth Biosci, Tokushima 7708504, Japan	Ishikawa, Y (reprint author), Univ Tokushima, Dept Med Pharmacol, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708504, Japan.	yisikawa@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23592738]; Iwadare Scholarship Foundation	This work was supported by a Grant-in-Aid for Scientific Research and for Knowledge Cluster Initiative from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant number 23592738). Cevimeline was kindly provided by the Daiichi-Sankyo Pharmaceutical Co. (Tokyo, Japan). We are also grateful to the Iwadare Scholarship Foundation.	Adam RM, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-30; Albi E, 1996, CELL BIOL INT, V20, P407, DOI 10.1006/cbir.1996.0051; Ambudkar IS, 2014, CELL CALCIUM, V55, P297, DOI 10.1016/j.ceca.2014.02.009; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; Ishikawa Y, 1999, BIOCHEM BIOPH RES CO, V265, P94, DOI 10.1006/bbrc.1999.1630; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Pan Y, 2009, BBA-GEN SUBJECTS, V1790, P49, DOI 10.1016/j.bbagen.2008.08.009; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Mobius W, 2002, J HISTOCHEM CYTOCHEM, V50, P43; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; Nielsen S, 2007, J INTERN MED, V261, P53, DOI 10.1111/j.1365-2796.2006.01760.x; Ogawa Y, 2011, BIOL PHARM BULL, V34, P13, DOI 10.1248/bpb.34.13; Ishikawa Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1303, DOI 10.1152/ajpcell.00211.2005; Cao XW, 2012, CELL RES, V22, P793, DOI 10.1038/cr.2012.64; Ishibashi K, 2011, AM J PHYSIOL-REG I, V300, pR566, DOI 10.1152/ajpregu.90464.2008; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Slimane TA, 2003, MOL BIOL CELL, V14, P611, DOI 10.1091/mbc.E02-08-0528; Ishikawa Y, 1998, BIOCHEM BIOPH RES CO, V245, P835, DOI 10.1006/bbrc.1998.8395; Denzer K, 2000, J CELL SCI, V113, P3365; RAINA S, 1995, J BIOL CHEM, V270, P1908; Yan WH, 2009, PROTEOM CLIN APPL, V3, P116, DOI 10.1002/prca.200800140; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; Proctor GB, 2007, AUTON NEUROSCI-BASIC, V133, P3, DOI 10.1016/j.autneu.2006.10.006; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Sidhaye V, 2005, J BIOL CHEM, V280, P3590, DOI 10.1074/jbc.M411038200; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Ishikawa Y, 2006, BBA-BIOMEMBRANES, V1758, P1053, DOI 10.1016/j.bbamem.2006.03.026; Mobius W, 2003, TRAFFIC, V4, P222; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Kusumi A, 2005, BBA-MOL CELL RES, V1746, P234, DOI 10.1016/j.bbamcr.2005.10.001; Pani B, 2013, J CELL SCI, V126, P667, DOI 10.1242/jcs.118943; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Roussa E, 2011, CELL TISSUE RES, V343, P263, DOI 10.1007/s00441-010-1089-y; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Parvin MN, 2005, AM J PHYSIOL-GASTR L, V288, pG1283, DOI 10.1152/ajpgi.00030.2004; Roper K, 2000, NAT CELL BIOL, V2, P582; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Collaco AM, 2013, AM J PHYSIOL-GASTR L, V305, pG258, DOI 10.1152/ajpgi.00485.2012; Inoue R, 2013, J DERMATOL SCI, V70, P26, DOI 10.1016/j.jdermsci.2013.01.013; Kim JH, 2009, J PHARMACOL EXP THER, V330, P403, DOI 10.1124/jpet.109.153023; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Day RE, 2014, BBA-GEN SUBJECTS, V1840, P1492, DOI 10.1016/j.bbagen.2013.09.033; Bkaily G, 2012, CAN J PHYSIOL PHARM, V90, P953, DOI [10.1139/y2012-077, 10.1139/Y2012-077]; Chamberlain LH, 2004, FEBS LETT, V559, P1, DOI 10.1016/S0014-5793(04)00050-X; Czogalla A, 2014, BBA-MOL CELL BIOL L, V1841, P1049, DOI 10.1016/j.bbalip.2013.12.012; Delacour D, 2006, CELL MOL LIFE SCI, V63, P2491, DOI 10.1007/s00018-006-6210-8; Finan JD, 2009, ANN BIOMED ENG, V37, P477, DOI 10.1007/s10439-008-9618-5; Finan JD, 2011, BIOCHEM BIOPH RES CO, V408, P230, DOI 10.1016/j.bbrc.2011.03.131; Gilchrist J. S., 1993, J BIOL CHEM, V268, P4291; Gresz V., 2015, ORAL DIS, V21, P114; Hoetzl S, 2007, J NEUROCHEM, V103, P3, DOI 10.1111/j.1471-4159.2007.04721.x; ISHIDA H, 1973, EXP CELL RES, V78, P31, DOI 10.1016/0014-4827(73)90034-7; Ishikawa Y, 2000, FEBS LETT, V477, P253, DOI 10.1016/S0014-5793(00)01763-4; Ledeen R, 2007, J NEUROCHEM, V103, P126, DOI 10.1111/j.1471-4159.2007.04722.x; Ledeen RW, 2006, BBA-MOL CELL BIOL L, V1761, P588, DOI 10.1016/j.bbalip.2006.04.010; Masuda W, 2011, ARCH BIOCHEM BIOPHYS, V513, P131, DOI 10.1016/j.abb.2011.07.006; Matsuki M, 2005, J Membr Biol, V203, P119, DOI 10.1007/s00232-005-0736-9; Mattaj I.W., 2004, NAT REV MOL CELL BIO, V5, P65; Sidhaye VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038717; Susa T, 2013, ACTA HISTOCHEM CYTOC, V46, P187, DOI 10.1267/ahc.13037; Tada J, 1999, BIOCHEM BIOPH RES CO, V266, P443, DOI 10.1006/bbrc.1999.1828; Tempera I, 2008, BIOCHEM BIOPH RES CO, V368, P495, DOI 10.1016/j.bbrc.2007.12.196; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Waugh Mark G., 2009, V462, P403, DOI 10.1007/978-1-60327-115-8_26; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Wu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053342	70	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4165	1872-8006		BBA-GEN SUBJECTS	Biochim. Biophys. Acta-Gen. Subj.	APR	2015	1850	4					784	793		10.1016/j.bbagen.2015.01.009		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CC2RG	WOS:000350191700022		
J	Kawahara, K; Hohjoh, H; Inazumi, T; Tsuchiya, S; Sugimoto, Y				Kawahara, Kohichi; Hohjoh, Hirofumi; Inazumi, Tomoaki; Tsuchiya, Soken; Sugimoto, Yukihiko			Prostaglandin E-2-induced inflammation: Relevance of prostaglandin E receptors	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Review						Prostanoid; Mast cell; Irritant contact dermatitis; Helper T cell; Multiple sclerosis	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MAST-CELL ACTIVATION; CD4 T-CELLS; PROSTANOID RECEPTORS; CONTACT HYPERSENSITIVITY; PHOSPHATIDYLINOSITOL 3-KINASE; INTERNATIONAL UNION; SIGNALING PATHWAYS; ADAPTIVE IMMUNITY; HISTAMINE-RELEASE	Prostaglandin E-2 (PGE(2)) is one of the most typical lipid mediators produced from arachidonic acid (AA) by cyclooxygenase (COX) as the rate-limiting enzyme, and acts on four kinds of receptor subtypes (EP1-EP4) to elicit its diverse actions including pyrexia, pain sensation, and inflammation. Recently, the molecular mechanisms underlying the PGE(2) actions mediated by each EP subtype have been elucidated by studies using mice deficient in each EP subtype as well as several compounds highly selective to each EP subtype, and their findings now enable us to discuss how PGE(2) initiates and exacerbates inflammation at the molecular level. Here, we review the recent advances in PGE(2) receptor research by focusing on the activation of mast cells via the EP3 receptor and the control of helper T cells via the EP2/4 receptor, which are the molecular mechanisms involved in PGE(2)-induced inflammation that had been unknown for many years. We also discuss the roles of PGE(2) in acute inflammation and inflammatory disorders, and the usefulness of anti-inflammatory therapies that target EP receptors. This article is part of a Special Issue entitled "Oxygenated metabolism of PUFA: analysis and biological relevance". (C) 2014 Elsevier B.V. All rights reserved.	[Kawahara, Kohichi; Hohjoh, Hirofumi; Inazumi, Tomoaki; Tsuchiya, Soken; Sugimoto, Yukihiko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Biochem, Kumamoto 8620973, Japan; [Inazumi, Tomoaki; Tsuchiya, Soken; Sugimoto, Yukihiko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama 3320012, Japan	Sugimoto, Y (reprint author), Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Biochem, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	ysugi@kumamoto-u.ac.jp					Komiyama Y, 2006, J IMMUNOL, V177, P566; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Gorbachev AV, 2001, CRIT REV IMMUNOL, V21, P451; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Bjorgo E, 2010, MOL CELL BIOL, V30, P1660, DOI 10.1128/MCB.00696-09; GOODWIN JS, 1983, J CLIN IMMUNOL, V3, P295, DOI 10.1007/BF00915791; Yokomizo T, 2001, ARCH BIOCHEM BIOPHYS, V385, P231, DOI 10.1006/abbi.2000.2168; Chizzolini C, 2008, BLOOD, V112, P3696, DOI 10.1182/blood-2008-05-155408; Lassmann H, 2004, TRENDS IMMUNOL, V25, P132, DOI 10.1016/j.it.2004.01.007; Kuehn HS, 2010, J CELL SCI, V123, P2576, DOI 10.1242/jcs.071043; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; Zaslona Z, 2014, J ALLERGY CLIN IMMUN, V133, P379, DOI 10.1016/j.jaci.2013.07.037; Goulet JL, 2004, J IMMUNOL, V173, P1321; Li XL, 2012, J CLIN INVEST, V122, P963, DOI 10.1172/JCI59097; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; RAO TS, 1993, INFLAMMATION, V17, P723, DOI 10.1007/BF00920477; Esaki Y, 2010, P NATL ACAD SCI USA, V107, P12233, DOI 10.1073/pnas.0915112107; Chun KS, 2009, CARCINOGENESIS, V30, P1620, DOI 10.1093/carcin/bgp168; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Helliwell RJA, 2004, PROSTAG LEUKOTR ESS, V70, P101, DOI 10.1016/j.plefa.2003.04.002; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Morimoto K, 2014, J IMMUNOL, V192, P1130, DOI 10.4049/jimmunol.1300290; Wang XS, 2006, ALLERGY, V61, P503, DOI 10.1111/j.1398-9995.2006.01043.x; Feng CL, 2006, BLOOD, V107, P3243, DOI 10.1182/blood-2005-07-2772; Stables MJ, 2011, PROG LIPID RES, V50, P35, DOI 10.1016/j.plipres.2010.07.005; Narumiya S, 1999, PHYSIOL REV, V79, P1193; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; BETZ M, 1991, J IMMUNOL, V146, P108; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Brooke EC, 2013, BRIT J DERMATOL, V169, P645; Chan CL, 2000, BRIT J PHARMACOL, V129, P589, DOI 10.1038/sj.bjp.0703072; Chen HY, 2009, PROSTAG LEUKOTR ESS, V80, P195, DOI 10.1016/j.plefa.2009.01.006; GOLD KN, 1994, ARTHRITIS RHEUM, V37, P925, DOI 10.1002/art.1780370623; HASLER F, 1983, J IMMUNOL, V131, P768; HILKENS CMU, 1995, EUR J IMMUNOL, V25, P59, DOI 10.1002/eji.1830250112; Hirata T, 2012, ADV IMMUNOL, V116, P143, DOI 10.1016/B978-0-12-394300-2.00005-3; Meyer T, 2007, BRIT J DERMATOL, V157, P1, DOI 10.1111/j.1365-2133.2007.08264.x; MONCADA S, 1973, NATURE, V246, P217, DOI 10.1038/246217a0; Nishida K, 2011, J IMMUNOL, V187, P932, DOI 10.4049/jimmunol.1100360; Niwa H, 2009, CLIN IMMUNOL, V132, P184, DOI 10.1016/j.clim.2009.04.012; Pennino D, 2010, J IMMUNOL, V184, P4880, DOI 10.4049/jimmunol.0901767; Perretti M, 2000, MICROCIRCULATION, V7, P147, DOI 10.1038/sj.mn.7300108; Smith W. L., 2002, BIOCH LIPIDS LIPOPRO, P341; Smith W.L., 2000, ANNU REV BIOCHEM, V69, P149; WILLIAMS TJ, 1973, NATURE, V246, P215, DOI 10.1038/246215a0; Yao CC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2684	63	8	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	APR	2015	1851	4			SI		414	421		10.1016/j.bbalip.2014.07.008		8	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CC2PJ	WOS:000350186800010		
J	Imai, Y				Imai, Yumiko			Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Review						Omega-3 PUFA; Protectins; Influenza virus infection	DEPENDENT RNA EXPORT; MESSENGER-RNA; LIPID MEDIATORS; INFLAMMATION-RESOLUTION; NEUROPROTECTIN D1; REPLICATION; TAP; REVEALS; LIPOXIN; PATHWAY	Influenza A viruses are the causative agents of seasonal and pandemic infections. Influenza strains have recently emerged that show resistance to anti-viral drugs. Moreover, therapies in critically ill patients with severe influenza are limited, with the current anti-viral drugs showing disappointing results even in the absence of obvious viral resistance. Given the high mortality associated with avian H5N1 or H7N9 infections and the risk of pandemic potentials, effective drugs are needed for the treatment of severe influenza. A virus-host interaction is a multidimensional host response, in which not only genes and protein but also metabolites are up- or down-regulated, and cellular pathways and networks implicated in the viral pathogenesis are perturbed. Thus, it seems an attractive strategy to overcome influenza by targeting host metabolites and/or metabolic pathways involved in viral pathogenesis. Using lipidomics and lipid libraries screening, potectin D1 isomer (PDX) derived from the 15-lipoxygenase product 17S-H(p)DHA and/or 17HDHA precursor, has recently been identified, which suppresses influenza virus replication by inhibiting the nuclear export of viral mRNA rather than regulating resolution of inflammation. Contribution of the protectins to control influenza virus replication and their therapeutic potentials are reviewed here. This article is part of a Special Issue entitled "Oxygenated metabolism of PUFA: analysis and biological relevance". (C) 2015 Elsevier B.V. All rights reserved.	Akita Univ, Grad Sch Med, Dept Biol Informat & Expt Therapeut, Akita 0108543, Japan	Imai, Y (reprint author), Akita Univ, Grad Sch Med, Dept Biol Informat & Expt Therapeut, Akita 0108543, Japan.	imai@med.alcita-u.ac.jp			Funding Program for Next Generation World-Leading Researchers (NEXT Program, JSPS); Global COE Program	I thank Dr. Charlie Serhan (Harvard University - Brigham & Women's Hospital in USA) for helpful discussions, and Dr. Makoto Arita (RIKEN Center for Integrative Medical Sciences in Japan) and Dr. Trond Vidar Hansen (University of Oslo in Norway) for sharing synthetic PD1. YI is supported by Funding Program for Next Generation World-Leading Researchers (NEXT Program, JSPS), grants-in-aid for Specially Promoted Research and for Scientific Research, and the Global COE Program.	Lin SH, 2010, TALANTA, V83, P262, DOI 10.1016/j.talanta.2010.09.019; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Chiang N, 2005, PROSTAG LEUKOTR ESS, V73, P163, DOI 10.1016/j.plefa.2005.05.003; Duffield JS, 2006, J IMMUNOL, V177, P5902; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Rajasagi NK, 2013, INVEST OPHTH VIS SCI, V54, P6269, DOI 10.1167/iovs.13-12152; Serhan CN, 2006, J IMMUNOL, V176, P1848; Shirey KA, 2014, MUCOSAL IMMUNOL, V7, P549, DOI 10.1038/mi.2013.71; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Sun DX, 1996, J BIOL CHEM, V271, P24055; Cilloniz C, 2010, J VIROL, V84, P7613, DOI 10.1128/JVI.00553-10; Rajasagi NK, 2011, J IMMUNOL, V186, P1735, DOI 10.4049/jimmunol.1003456; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; Levy BD, 2007, FASEB J, V21, P3877, DOI 10.1096/fj.07-8653com; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Chanez P, 2002, AM J RESP CELL MOL, V27, P655, DOI 10.1165/rcmb.F253; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Russell CD, 2014, IMMUNOLOGY, V141, P166, DOI 10.1111/imm.12206; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Kumar A, 2011, J ANTIMICROB CHEMOTH, V66, P959, DOI 10.1093/jac/dkr090; Levy BD, 2007, J IMMUNOL, V178, P496; Josset L, 2013, VIRUS RES, V178, P151, DOI 10.1016/j.virusres.2013.02.011; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Clark NM, 2011, SEMIN RESP CRIT CARE, V32, P373, DOI 10.1055/s-0031-1283278; Arya V, 2010, CLIN PHARMACOL THER, V88, P587, DOI 10.1038/clpt.2010.187; Beigel H, 2005, NEW ENGL J MED, V353, P1374; Braun IC, 1999, EMBO J, V18, P1953, DOI 10.1093/emboj/18.7.1953; Ho DN, 2002, P NATL ACAD SCI USA, V99, P1888, DOI 10.1073/pnas.042698599; Isobe Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00270; Kumar S, 2010, PEDIATR INFECT DIS J, V29, P591, DOI 10.1097/INF.0b013e3181d73e32; Liker E, 2000, EMBO J, V19, P5587, DOI 10.1093/emboj/19.21.5587; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Ritter JB, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-61; Rodriguez-Navarro S, 2011, CURR OPIN CELL BIOL, V23, P302, DOI 10.1016/j.ceb.2010.12.002; Serhan C.N., 2014, BIOCHIM BIOPHYS AC S, P00161; Shankaran S, 2012, CURR INFECT DIS REP, V14, P155, DOI 10.1007/s11908-012-0236-x; Stewart M, 2010, TRENDS BIOCHEM SCI, V35, P609, DOI 10.1016/j.tibs.2010.07.001; World Health Organization (WHO), 2014, BACKGR SUMM HUM INF; Yatherajam G, 2011, J VIROL, V85, P1429, DOI 10.1128/JVI.02108-10	52	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	APR	2015	1851	4			SI		496	502		10.1016/j.bbalip.2015.01.006		7	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	CC2PJ	WOS:000350186800017		
J	Katsumi, N; Yonebayashi, K; Fujitake, N; Okazaki, M				Katsumi, Naoya; Yonebayashi, Koyo; Fujitake, Nobuhide; Okazaki, Masanori			Relationship between stable carbon and nitrogen isotope ratios of humic acids extracted from Andisols and non-Andisols	CATENA			English	Article						Andisol; Non-Andisol; Humic acid; Stable carbon isotope ratio; Stable nitrogen isotope ratio	SOIL ORGANIC-MATTER; VOLCANIC ASH SOILS; DELTA-C-13 VALUES; FUNCTIONAL-GROUPS; ELEMENTAL COMPOSITION; C-13; VEGETATION; SUBSTANCES; FRACTIONS; DYNAMICS	To relate the isotopic composition of soil humic acids (HAs) to their source plants and their degree of humification (as indicated by the degree of darkening), as well as to soil type, we determined the stable isotope ratios for carbon (delta C-13) and nitrogen (delta N-15) of HAs extracted from 26 virgin soil samples (14 Andisols and 12 non-Andisols) and from leaf samples from ten C-3 plants and seven C-4 plants. The high absorption coefficients (estimated at 600 nm for 1% solutions), low hydrogen and nitrogen contents, low H/C ratios, low alkyl C and O-alkyl C contents, high O/H and C/N ratios, high aryl C contents, and high aromaticity of the Andisol HAs indicated a high degree of humification. The delta C-13 and delta N-15 values of the non-Andisol HAs increased along with the progression of humification of C-3 plant-derived HAs. A significant correlation was observed between the delta N-15 and delta C-13 values of the non-Andisol HAs, but not for the Andisol HAs. Most of the Andisol HA delta C-13 values were higher than the highest non-Andisol HA delta C-13 value, and delta C-13 values were distributed between the delta C-13 values for the C-3 and C-4 plants. The contributions of C-4 plant-derived carbon to total Andisol HA carbon (CRC4) are usually calculated on the assumption that the delta C-13 values are not substantially altered during the decomposition of plant materials and the formation of soil organic matter. However, if C-13 enrichment occurs during organic matter decomposition, CRC4 will be overestimated. Therefore, we suggest a new method to calculate CRC4 values of Andisol HAs with a correction for isotopic fractionation associated with microbial degradation; the corrected CRC4 values ranged from -5% to 58% and were approximately 22% lower than the uncorrected values. (C) 2015 Elsevier B.V. All rights reserved.	[Katsumi, Naoya; Yonebayashi, Koyo; Okazaki, Masanori] Ishikawa Prefectural Univ, Fac Bioresources & Environm Sci, Nonoichi, Ishikawa 9218836, Japan; [Fujitake, Nobuhide] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan	Yonebayashi, K (reprint author), Ishikawa Prefectural Univ, Fac Bioresources & Environm Sci, Nonoichi, Ishikawa 9218836, Japan.	ky-yone@ishikawa-pu.ac.jp			Japan Society for the Promotion of Science [C-20580064]	This study was financially supported by a Grant-in-Aid for Scientific Research (C-20580064, 2008-2010) from the Japan Society for the Promotion of Science. We are grateful to T. Nishi for technical assistance.	Watanabe A, 2008, ANAL CHIM ACTA, V618, P110, DOI 10.1016/j.aca.2008.04.045; Akamatsu F, 2004, ECOL RES, V19, P655, DOI 10.1111/j.1440-1703.2004.00680.x; NADELHOFFER KF, 1988, SOIL SCI SOC AM J, V52, P1633; Boutton TW, 1998, GEODERMA, V82, P5, DOI 10.1016/S0016-7061(97)00095-5; Miyamoto T, 2004, APPL ENVIRON MICROB, V70, P6580, DOI 10.1128/AEM.70.11.6580-6586.2004; Yanagi Y, 2003, SOIL SCI PLANT NUTR, V49, P201; Hiradate S, 2004, GEODERMA, V119, P133, DOI 10.1016/S0016-7061(03)00257-X; Marin-Spiotta E, 2009, GLOBAL CHANGE BIOL, V15, P1584, DOI 10.1111/j.1365-2486.2008.01805.x; YONEBAYASHI K, 1988, SOIL SCI PLANT NUTR, V34, P571; Peri PL, 2012, GLOBAL CHANGE BIOL, V18, P311, DOI 10.1111/j.1365-2486.2011.02494.x; Fujitake N, 1999, SOIL SCI PLANT NUTR, V45, P359; Inagaki Y, 2004, FOREST ECOL MANAG, V202, P107, DOI 10.1016/j.foreco.2004.07.029; Rivas Y, 2012, AUSTRAL ECOL, V37, P153, DOI 10.1111/j.1442-9993.2011.02258.x; Shindo H, 2005, SOIL SCI, V170, P175, DOI 10.1097/00010694-200503000-00003; Tiunov AV, 2007, BIOL BULL+, V34, P395, DOI 10.1134/S1062359007040127; Watanabe A, 2006, SOIL SCI PLANT NUTR, V52, P145, DOI 10.1111/j.1747-0765.2006.00029.x; Abe T, 2004, SOIL SCI, V169, P35, DOI 10.1097/01.ss.0000112016.97541.28; Wang G, 2008, BIOGEOSCIENCES, V5, P1325; Balieiro FD, 2012, CATENA, V99, P97, DOI 10.1016/j.catena.2012.06.004; Connin SL, 2001, SOIL BIOL BIOCHEM, V33, P41, DOI 10.1016/S0038-0717(00)00113-9; Fujitake N, 1999, SOIL SCI PLANT NUTR, V45, P349; Iimura Y., 2013, SOIL BIOL BIOCHEM, V57, P60; Iimura Y., 2010, GEODERMA, V159, P122; Ikeya K, 2004, ORG GEOCHEM, V35, P583, DOI 10.1016/j.oggeochem.2003.12.004; Khan NA, 2006, SOIL SCI PLANT NUTR, V52, P349, DOI 10.1111/j.1747-0765.2006.00044.x; Kogel-Knabner I., 1991, SOIL SCI SOC AM J, V55, P241; Kumada K., 1987, CHEM SOIL ORGANIC MA; KUWATSUKA S, 1978, SOIL SCI PLANT NUTR, V24, P337; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Pardo LH, 2007, FOREST ECOL MANAG, V251, P217, DOI 10.1016/j.foreco.2007.06.047; Sase T., 1996, EARTH SCI, V50, P466; SCHWARTZ D, 1986, GEODERMA, V39, P97, DOI 10.1016/0016-7061(86)90069-8; Shoji S, 1993, DEV SOIL SCI, V21; Stevenson F.J., 1994, HUMUS CHEM GENESIS C; TATE KR, 1990, SOIL SCI PLANT NUTR, V36, P611; Van Krevelen D., 1950, FUEL, V29, P269; VON FISCHER JC, 1995, BIOTROPICA, V27, P138, DOI 10.2307/2388989; Yonebayashi K., 1997, CURRENT SOIL SCI, P43; Yonebayashi K., 1989, Pedorojisuto = Pedologist, V33, P37; YONEBAYASHI K, 1994, HUMIC SUBSTANCES IN THE GLOBAL ENVIRONMENT AND IMPLICATIONS ON HUMAN HEALTH, P181; Yoneyama T, 2001, SOIL SCI PLANT NUTR, V47, P17	41	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0341-8162	1872-6887		CATENA	Catena	APR	2015	127						214	221		10.1016/j.catena.2015.01.005		8	Geosciences, Multidisciplinary; Soil Science; Water Resources	Geology; Agriculture; Water Resources	CB8KF	WOS:000349877800023		
J	Arakawa, T; Kuwabara, T; Malikov, F				Arakawa, T.; Kuwabara, T.; Malikov, F.			Localization of Affine W-Algebras	COMMUNICATIONS IN MATHEMATICAL PHYSICS			English	Article							CHIRAL DIFFERENTIAL-OPERATORS; RATIONAL CHEREDNIK ALGEBRAS; REPRESENTATION-THEORY; QUANTUM REDUCTION; G-MODULES	We introduce the notion of an asymptotic algebra of chiral differential operators. We then construct, via a chiral Hamiltonian reduction, one such algebra over a resolution of the intersection of the Slodowy slice with the nilpotent cone. We compute the space of global sections of this algebra, thereby proving a localization theorem for affine W-algebras at the critical level.	[Arakawa, T.] Kyoto Univ, Rims, Kyoto 6068502, Japan; [Kuwabara, T.] Natl Res Univ Higher Sch Econ, Dept Math, Moscow 101000, Russia; [Kuwabara, T.] Natl Res Univ Higher Sch Econ, Int Lab Representat Theory & Math Phys, Moscow 101000, Russia; [Malikov, F.] Univ So Calif, Dept Math, Los Angeles, CA 90089 USA	Arakawa, T (reprint author), Kyoto Univ, Rims, Kyoto 6068502, Japan.	arakawa@kurims.kyoto-u.ac.jp; toshiro.kuwa@gmail.com; fmalikov@usc.edu			JSPS [20340007, 23654006]; Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) [2011-0027952]; NSF	T. Arakawa is partially supported by the JSPS Grant-in-Aid for Scientific Research (B) No. 20340007 and the JSPS Grant-in-Aid for challenging Exploratory Research No. 23654006.; T. Kuwabara was partially supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST)(2011-0027952).; F. Malikov is partially supported by an NSF grant.	BERSHADSKY M, 1991, COMMUN MATH PHYS, V139, P71, DOI 10.1007/BF02102729; Kashiwara M, 2008, DUKE MATH J, V144, P525, DOI 10.1215/00127094-2008-043; POLYAKOV AM, 1990, INT J MOD PHYS A, V5, P833, DOI 10.1142/S0217751X90000386; Gorbounov V, 2004, INVENT MATH, V155, P605, DOI 10.1007/s00222-003-0333-4; Bellamy G, 2012, PAC J MATH, V260, P89, DOI 10.2140/pjm.2012.260.89; Arakawa T, 2012, MATH Z, V270, P559, DOI 10.1007/s00209-010-0812-4; De Sole A, 2006, JAP J MATH, V1, P137, DOI 10.1007/s11537-006-0505-2; KRONHEIMER PB, 1989, J DIFFER GEOM, V29, P665; Kac VG, 2004, ADV MATH, V185, P400, DOI 10.1016/j.aim.2003.12.005; KOSTANT B, 1987, ANN PHYS-NEW YORK, V176, P49, DOI 10.1016/0003-4916(87)90178-3; Losev I, 2010, J AM MATH SOC, V23, P35; Bressler P, 2007, COMPOS MATH, V143, P1127, DOI 10.1112/S0010437X07002710; Mustata M, 2001, INVENT MATH, V145, P397, DOI 10.1007/s002220100152; Arakawa T, 2012, ADV MATH, V229, P2908, DOI 10.1016/j.aim.2011.11.002; Arakawa T., ARXIV10041554; Arakawa T, 2012, CONTEMP MATH, V565, P1, DOI 10.1090/conm/565/11184; Arakawa T, 2011, SEL MATH-NEW SER, V17, P1, DOI 10.1007/s00029-010-0040-0; BEILINSON A, 1981, CR ACAD SCI I-MATH, V292, P15; Beilinson A., 1993, ADV SOVIET MATH, V16, P1; Beilinson A., INTRO ALGEBRAI UNPUB; Brieskorn E., 1971, ACT C INT MATH NIC 1, V2, P279; BRYLINSKI JL, 1981, INVENT MATH, V64, P387, DOI 10.1007/BF01389272; Dodd C., ARXIVMATH09112210; Drinfeld V., 2004, AM MATH SOC C PUBLIC, V51; Feigin B, 1984, USP MAT NAUK, V39, P155; Feigin Boris, 1992, ADV SER MATH PHYS, V16, P197; Frenkel E, 2010, PROG MATH, V279, P101, DOI 10.1007/978-0-8176-4831-2_5; Fu B., 2006, ANN MATH BLAISE PASC, V13, P209; Gan W.L., 2004, INT MATH RES NOT IMR, V2, P243; Ginzburg V., 2009, REPRESENT THEOR, V13, P236; Gorbounov V., 2001, INT J MATH MATH SCI, V26, P83, DOI 10.1155/S0161171201020051; Kac V, 2003, COMMUN MATH PHYS, V241, P307, DOI 10.1007/s00220-003-0926-1; Kac V. G., 1997, U LECT SERIES, V10; Kapranov M, 1998, J REINE ANGEW MATH, V505, P73; Kuwabara T, 2013, PUBL RES I MATH SCI, V49, P87, DOI 10.4171/PRIMS/97; Li HS, 2004, COMMUN CONTEMP MATH, V6, P61, DOI 10.1142/S0219199704001264; Malikov F, 1999, COMMUN MATH PHYS, V204, P439, DOI 10.1007/s002200050653; Premet A., 2002, ADV MATH, V170, P397; SLODOWY P, 1980, LECT NOTES MATH, V815; Vaisman I., 1994, PROGR MATH, V118	40	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0010-3616	1432-0916		COMMUN MATH PHYS	Commun. Math. Phys.	APR	2015	335	1					143	182		10.1007/s00220-014-2183-x		40	Physics, Mathematical	Physics	CC0MT	WOS:000350030600006		
J	Ito, T				Ito, Tetsuya			Reading the Dual Garside Length of Braids from Homological and Quantum Representations	COMMUNICATIONS IN MATHEMATICAL PHYSICS			English	Article								We show that Lawrence's representation and linear representations of the braid groups from generic highest weight representations of detect the dual Garside length of braids in a simple and natural way. That is, by expressing a representation as a matrix over a Laurent polynomial ring using a certain natural basis, the span of the variable is equal to a constant multiple of the dual Garside length.	Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan	Ito, T (reprint author), Kyoto Univ, Math Sci Res Inst, Kyoto 6068502, Japan.	tetitoh@kurims.kyoto-u.ac.jp			JSPS	This research was supported by JSPS Research Fellowships for Young Scientists and JSPS Postdoctoral Fellowships for Research Abroad. The author would like to thank Toshitake Kohno for stimulating discussions.	Bigelow S, 2002, J KNOT THEOR RAMIF, V11, P493, DOI 10.1142/S0218216502001779; Krammer D, 2002, ANN MATH, V155, P131, DOI 10.2307/3062152; Birman J, 1998, ADV MATH, V139, P322, DOI 10.1006/aima.1998.1761; Bigelow S., 2004, P CASSON FEST GEOM T, V7, P493; Bigelow S., 2000, J AM MATH SOC, V14, P471; Drinfeld V. G., 1990, LENINGRAD MATH J, V1, P1419; Ito T., GEOM TOPOL IN PRESS; Jackson C, 2011, ADV MATH, V228, P1689, DOI 10.1016/j.aim.2011.06.027; Kassel C., 1995, QUANTUM GROUPS GRADU, V155; KOHNO T, 1987, ANN I FOURIER, V37, P139; Kohno T., 2012, CONFIGURATION SPACES, P355; Krammer D, 2000, INVENT MATH, V142, P451, DOI 10.1007/s002220000088; LAWRENCE RJ, 1990, COMMUN MATH PHYS, V135, P141, DOI 10.1007/BF02097660; Paoluzzi L., 2002, ALGEBR GEOM TOPOL, V2, P499, DOI 10.2140/agt.2002.2.499; Zheng H, 2005, J KNOT THEOR RAMIF, V14, P467, DOI 10.1142/S0218216505003877	15	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0010-3616	1432-0916		COMMUN MATH PHYS	Commun. Math. Phys.	APR	2015	335	1					345	367		10.1007/s00220-014-2249-9		23	Physics, Mathematical	Physics	CC0MT	WOS:000350030600011		
J	Kim, TY; Iliescu, T; Fried, E				Kim, Tae-Yeon; Iliescu, Traian; Fried, Eliot			B-spline based finite-element method for the stationary quasi-geostrophic equations of the ocean	COMPUTER METHODS IN APPLIED MECHANICS AND ENGINEERING			English	Article						Conforming finite-element method; Fourth-order partial-differential equation; Geophysical fluid dynamics	STREAMFUNCTION FORMULATION; BOUNDARY-CONDITIONS; INTERFACE PROBLEMS; NITSCHES METHOD; DISCRETIZATION; MECHANICS; MODEL	We present a B-spline based conforming finite-element method of the streamfunction formulation of the stationary one-layer quasi-geostrophic equations for the study of the large scale wind-driven ocean circulation. The method encompasses standard simplifications of these equations, in particular the linear Stommel and Stommel-Munk models. A variational form of the method is developed and its consistency is established. In this formulation Dirichlet boundary conditions are enforced only weakly and stabilization is achieved via Nitsche's method. Stability parameters are evaluated by solving a local generalized eigenvalue problem on the Dirichlet boundary and by monitoring the condition number of the resulting linear systems. Comparisons of the results from our simulations with previously published results and convergence studies lead us to conclude that our finite-element discretization is accurate. (C) 2015 Published by Elsevier B.V.	[Kim, Tae-Yeon] Khalifa Univ Sci Technol & Res, Abu Dhabi 127788, U Arab Emirates; [Iliescu, Traian] Virginia Tech, Dept Math, Blacksburg, VA 24061 USA; [Fried, Eliot] Okinawa Inst Sci & Technol, Math Soft Matter Unit, Onna Son, Okinawa 9040495, Japan	Fried, E (reprint author), Okinawa Inst Sci & Technol, Math Soft Matter Unit, Onna Son, Okinawa 9040495, Japan.	taeyeon.kim@kustar.ac.ae; iliescu@vt.edu; eliot.fried@oist.jp			National Science Foundation [DMS-1025314]; U.S. Department of Energy [DE-FG-02-10ER25876/DE-SC0004604]	We thank Dr. Embar Anand of ABAQUS for his helpful advice on the implementation of the code. T.I. thanks the National Science Foundation for the partial support of this work under grant DMS-1025314. E.F. acknowledges the support of the U.S. Department of Energy under grant DE-FG-02-10ER25876/DE-SC0004604.	Hansbo A, 2002, COMPUT METHOD APPL M, V191, P5537, DOI 10.1016/S0045-7825(02)00524-8; FIX GJ, 1975, SIAM J APPL MATH, V29, P371, DOI 10.1137/0129031; Hughes TJR, 2005, COMPUT METHOD APPL M, V194, P4135, DOI 10.1016/j.cma.2004.10.008; Ma L, 2008, J COMPUT PHYS, V227, P5816, DOI 10.1016/j.jcp.2008.02.019; Burman E, 2012, APPL NUMER MATH, V62, P328, DOI 10.1016/j.apnum.2011.01.008; Embar A, 2013, BIOMECH MODEL MECHAN, V12, P597, DOI 10.1007/s10237-012-0428-1; MYERS PG, 1995, J ATMOS OCEAN TECH, V12, P511, DOI 10.1175/1520-0426(1995)012<0511:ADBFEO>2.0.CO;2; Kim TY, 2012, INT J SOLIDS STRUCT, V49, P771, DOI 10.1016/j.ijsolstr.2011.11.018; Fernandez-Mendez S, 2004, COMPUT METHOD APPL M, V193, P1257, DOI 10.1016/j.cma.2003.12.019; Kim TY, 2007, J COMPUT PHYS, V223, P551, DOI 10.1016/j.jcp.2006.09.022; Cascon JM, 2003, COMPUT METHOD APPL M, V192, P5305, DOI 10.1016/j.cma.2003.09.002; CUMMINS PF, 1992, J MAR RES, V50, P545, DOI 10.1357/002224092784797548; Embar A, 2010, INT J NUMER METH ENG, V83, P877, DOI 10.1002/nme.2863; Foster EL, 2013, COMPUT METHOD APPL M, V261, P105, DOI 10.1016/j.cma.2013.04.008; Kim TY, 2009, FINITE ELEM ANAL DES, V45, P485, DOI 10.1016/j.finel.2009.02.004; Ghil M, 2008, PHYSICA D, V237, P2111, DOI 10.1016/j.physd.2008.03.036; Feng F, 2006, J COMPUT PHYS, V220, P394, DOI 10.1016/j.jcp.2006.05.023; Dolbow J, 2009, INT J NUMER METH ENG, V78, P229, DOI 10.1002/nme.2486; Kim TY, 2012, INT J SOLIDS STRUCT, V49, P3942, DOI 10.1016/j.ijsolstr.2012.08.023; BAKER GA, 1977, MATH COMPUT, V31, P45, DOI 10.2307/2005779; Beckers J. M., 2011, INTRO GEOPHYS FLUID; Dijkstra H.A., 2005, NONLINEAR PHYS OCEAN; Fairag F., 2004, ARXIVMATH0406070; Fairag F, 1998, COMPUT MATH APPL, V36, P117, DOI 10.1016/S0898-1221(98)00123-0; Foster EL, 2013, COMPUT MATH APPL, V66, P1261, DOI 10.1016/j.camwa.2013.07.025; Gunzburger M. D., 1989, FINITE ELEMENT METHO; Hollig K., 2003, FINITE ELEMENT METHO; Majda A., 2003, INTRO PDES WAVE ATMO; Majda A., 2006, NONLINEAR DYNAMICS S; McWilliams J., 2006, FUNDAMENTALS GEOPHYS; Nitsche J., 1970, ABH MATH SEM HAMBURG, V36, P9; Pedlosky J., 1992, GEOPHYS FLUID DYNAMI; Piegl L, 1997, NURBS BOOK; Vallis G.K., 2006, ATMOSPHERE OCEAN FLU	34	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0045-7825	1879-2138		COMPUT METHOD APPL M	Comput. Meth. Appl. Mech. Eng.	APR 1	2015	286						168	191		10.1016/j.cma.2014.12.024		24	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications; Mechanics	Engineering; Mathematics; Mechanics	CB8DB	WOS:000349857700009		
J	Yabe, D; Kuwata, H; Kaneko, M; Ito, C; Nishikino, R; Murorani, K; Kurose, T; Seino, Y				Yabe, D.; Kuwata, H.; Kaneko, M.; Ito, C.; Nishikino, R.; Murorani, K.; Kurose, T.; Seino, Y.			Use of the Japanese health insurance claims database to assess the risk of acute pancreatitis in patients with diabetes: comparison of DPP-4 inhibitors with other oral antidiabetic drugs	DIABETES OBESITY & METABOLISM			English	Article						acute pancreatitis; claims database; dipeptidyl peptidase-4 inhibitor	DIPEPTIDYL PEPTIDASE-4 INHIBITORS; INCRETIN-BASED THERAPIES; CLINICAL-USE; SAFETY; SITAGLIPTIN; EXENATIDE; EFFICACY	This study was initiated to evaluate the association of acute pancreatitis (AP) with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors among patients with diabetes in Japan. A retrospective cohort study of a large medical and pharmacy claims database was performed to compare the incidence of AP among those receiving DPP-4 inhibitors and those receiving other oral antidiabetic drugs. The incidence of all AP and hospitalizations for AP was similar between the two groups. Previous exposure to DPP-4 inhibitors did not affect occurrence of AP in patients on other oral antidiabetic drugs. The Kaplan-Meier curve for time to AP was similar between the two groups, and was not affected by previous exposure to DPP-4 inhibitors. The Cox proportional hazard models showed the incidence of AP was not significantly higher in those receiving DPP-4 inhibitors. Despite numerous, important limitations related to claims database-based analyses, our results indicate that there is no increased risk of AP with use of DPP-4 inhibitors among patients with diabetes in Japan.	[Yabe, D.; Kuwata, H.; Kurose, T.; Seino, Y.] Kansai Elect Power Hosp, Ctr Diabet Endocrinol & Metab, Osaka 5530003, Japan; [Yabe, D.] Kansai Elect Power Hosp, Ctr Metab & Clin Nutr, Osaka 5530003, Japan; [Yabe, D.] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Mol & Metab Med, Kobe, Hyogo 657, Japan; [Kaneko, M.; Ito, C.; Nishikino, R.] Japan Med Data Ctr Co Ltd, Tokyo, Japan; [Murorani, K.] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan	Yabe, D (reprint author), Kansai Elect Power Hosp, Ctr Diabet Endocrinol & Metab, 2-1-7 Fukushima Ku, Osaka 5530003, Japan.	ydaisuke-kyoto@umin.ac.jp; seino.yutaka@e2.kepco.co.jp	Yabe, Daisuke/J-6682-2014	Yabe, Daisuke/0000-0002-5334-7687	Japan Society for Science Promotion; Japan Association for Diabetes Education and Care; Japan Vascular Disease Research Foundation	The authors thank Michiko Yamane of Kansai Electric Power Hospital for secretarial assistance. D. Y. received Grant-in-Aid for Young Scientists (B) funding from the Japan Society for Science Promotion and grants for young researchers from the Japan Association for Diabetes Education and Care. Y. S. received grants from the Japan Vascular Disease Research Foundation.	Dore DD, 2009, CURR MED RES OPIN, V25, P1019, DOI 10.1185/03007990902820519 ; Seino Y, 2013, J DIABETES INVEST, V4, P108, DOI 10.1111/jdi.12065; Kim YG, 2013, DIABETOLOGIA, V56, P696, DOI 10.1007/s00125-012-2827-3; Egan AG, 2014, NEW ENGL J MED, V370, P794, DOI 10.1056/NEJMp1314078; Garg R, 2010, DIABETES CARE, V33, P2349, DOI 10.2337/dc10-0482; Noel RA, 2009, DIABETES CARE, V32, P834, DOI 10.2337/dc08-1755; Nauck MA, 2013, DIABETES CARE, V36, P2126, DOI 10.2337/dc12-2504; Deacon CF, 2013, EXPERT OPIN PHARMACO, V14, P2047, DOI 10.1517/14656566.2013.824966; Butler PC, 2013, DIABETES CARE, V36, P2118, DOI 10.2337/dc12-2713; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Takada T, 2009, JPN GUIDELINES 2010, P22	11	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1462-8902	1463-1326		DIABETES OBES METAB	Diabetes Obes. Metab.	APR	2015	17	4					430	434		10.1111/dom.12381		5	Endocrinology & Metabolism	Endocrinology & Metabolism	CD3HR	WOS:000350969500015		
J	Kaburagi, E; Yamada, M; Fujiyama, H				Kaburagi, Emi; Yamada, Mina; Fujiyama, Hideyasu			Sodium, but not potassium, enhances root to leaf nitrate translocation in Swiss chard (Beta vulgaris var. cicla L.)	ENVIRONMENTAL AND EXPERIMENTAL BOTANY			English	Article						K+; Na+; NO3- uptake; Salinity; Swiss chard; Xylem sap	AMINO-ACIDS; NITROGEN ASSIMILATION; PLASMA-MEMBRANE; SALT TOLERANCE; HIGHER-PLANTS; SALINITY; STRESS; SEEDLINGS; COTRANSPORTERS; MECHANISMS	Salinity is known to reduce NO3- uptake in many plants. Our previous study found that the increasing NaCl concentrations in media enhanced NO3- uptake in leaves. Here, we investigated whether nitrate (NO3-) uptake by Swiss chard (Beta vulgaris var. cicla L.) was affected more by Na+ than by K+, and elucidated which NO3- uptake processes were related to the application of these ions in the culture medium. Plants were grown hydroponically and subjected to 5 mM or 50 mM of either K or Na treatments for 7 days: K5 (K 5, Na 0), K50 (K 50, Na 0), Na5 (K 0, Na 5), and Na50 (K 0, Na 50). The leaf NO3- concentration was significantly enhanced in the Na treatments compared with the K treatments. The ratio of leaf to root NO3- concentrations in K5 and Na5 were 0.46 and 1.59, respectively, which indicates that NO3- is translocated to the leaves in the Na treatments. The NO3- concentration in the xylem sap, collected 6 h after the start of the treatments, was significantly higher in Na50 than in the other treatments. These are the opposite of the results for Arabidopsis, which accumulates NO3- in its roots to increase its salinity tolerance. Our results suggest that Na but not K enhances NO3- uptake and transport to the leaves in Swiss chard and that its function may relate to xylem translocation of NO3-. (C) 2014 Elsevier B.V. All rights reserved.	[Kaburagi, Emi] Tottori Univ, United Grad Sch Agr Sci, Tottori 6808553, Japan; [Yamada, Mina; Fujiyama, Hideyasu] Tottori Univ, Fac Agr, Tottori 6808553, Japan	Fujiyama, H (reprint author), Tottori Univ, Fac Agr, 4-101 Koyama Minami, Tottori 6808553, Japan.	fujiyama@muses.tottori-u.ac.jp			Japan Society for the Promotion of Science through its Global Center of Excellence for Dryland Science program	We thank the Japan Society for the Promotion of Science for supporting this study through its Global Center of Excellence for Dryland Science program.	Di Martino C, 2003, NEW PHYTOL, V158, P455, DOI 10.1046/j.1469-8137.2003.00770.x; Wang YH, 2001, PLANT PHYSIOL, V127, P345, DOI 10.1104/pp.127.1.345; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; MAGNE C, 1992, ANAL BIOCHEM, V200, P115, DOI 10.1016/0003-2697(92)90285-F; Abd-El Baki GK, 2000, PLANT CELL ENVIRON, V23, P515, DOI 10.1046/j.1365-3040.2000.00568.x; Britto DT, 2013, ANN BOT-LONDON, V112, P957, DOI 10.1093/aob/mct157; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Colmenero-Flores JM, 2007, PLANT J, V50, P278, DOI 10.1111/j.1365-313X.2007.03048.x; Teakle NL, 2010, PLANT CELL ENVIRON, V33, P566, DOI 10.1111/j.1365-3040.2009.02060.x; Li JY, 2010, PLANT CELL, V22, P1633, DOI 10.1105/tpc.110.075242; Roberts SK, 2006, NEW PHYTOL, V169, P647, DOI 10.1111/j.1469-8137.2005.01639.x; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; Debouba M, 2006, J PLANT PHYSIOL, V163, P1247, DOI 10.1016/j.jplph.2005.09.012; Flores P, 2004, CAN J BOT, V82, P207, DOI [10.1139/B03-152, 10.1139/b03-152]; Song J, 2006, NEW PHYTOL, V171, P357, DOI 10.1111/j.1469-8137.2006.01748.x; BLOMZANDSTRA G, 1983, J PLANT NUTR, V6, P611, DOI 10.1080/01904168309363129; CASADESUS J, 1995, PHYSIOL PLANTARUM, V93, P279, DOI 10.1034/j.1399-3054.1995.930211.x; Cerezo M, 1997, PLANT SCI, V126, P105, DOI 10.1016/S0168-9452(97)00095-2; Gilbert GA, 1998, J EXP BOT, V49, P107, DOI 10.1093/jexbot/49.318.107; HAAS M, 1994, AM J PHYSIOL-CELL PH, V267, pC869; Ivashikina NV, 1998, PLANT SCI, V131, P25, DOI 10.1016/S0168-9452(97)00235-5; Kaburagi E, 2014, SOIL SCI PLANT NUTR, V60, P651, DOI 10.1080/00380768.2014.938595; Kong XQ, 2011, PLANT MOL BIOL, V75, P567, DOI 10.1007/s11103-011-9744-6; Liu LiYun, 2013, Australian Journal of Crop Science, V7, P1046; MEHARG AA, 1995, J MEMBRANE BIOL, V145, P49; Mistrik I, 1996, PLANT PHYSIOL BIOCH, V34, P629; Peuke AD, 1996, J EXP BOT, V47, P377, DOI 10.1093/jxb/47.3.377; Yamada M., 2014, J PLANT NUM IN PRESS; Yuan JF, 2010, J ARID LAND, V2, P190, DOI 10.3724/SP.J.1227.2010.00190	30	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0098-8472	1873-7307		ENVIRON EXP BOT	Environ. Exp. Bot.	APR	2015	112						27	32		10.1016/j.envexpbot.2014.11.007		6	Plant Sciences; Environmental Sciences	Plant Sciences; Environmental Sciences & Ecology	CB6HG	WOS:000349727500003		
J	Nahar, K; Hasanuzzaman, M; Alam, MM; Fujita, M				Nahar, Kamrun; Hasanuzzaman, Mirza; Alam, Md. Mahabub; Fujita, Masayuki			Exogenous glutathione confers high temperature stress tolerance in mung bean (Vigna radiata L.) by modulating antioxidant defense and methylglyoxal detoxification system	ENVIRONMENTAL AND EXPERIMENTAL BOTANY			English	Article						Abiotic stress tolerance; Glutathione; High temperature; Methylglyoxal; Oxidative stress	OXIDATIVE STRESS; HYDROGEN-PEROXIDE; REACTIVE OXYGEN; HEAT-STRESS; MONODEHYDROASCORBATE REDUCTASE; TRANSGENIC ARABIDOPSIS; LIPOXYGENASE ACTIVITY; SPINACH-CHLOROPLASTS; ASCORBATE PEROXIDASE; SUPEROXIDE-DISMUTASE	The present study investigates the role of exogenous glutathione (GSH) in conferring high temperature stress (HT, 42 degrees C) tolerance in mung bean (Vigna radiata L. cv. Binamoog-1) seedlings by modulating the antioxidant defense and methylglyoxal (MG) detoxification systems. Six-day-old seedlings were exposed to HT stress with or without exogenous GSH (0.5 mM for 24 has pretreatment) for 24 and 48 h. Heat stress at any duration significantly increased lipid peroxidation (MDA), H2O2, MG, and Proline (Pro) content, generation rate of O-2(center dot-) and lipoxygenase (LOX) activity; decreased leaf chlorophyll (chl) and leaf relative water content (RWC), and the level of ascorbate (AsA); increased endogenous GSH and GSSG (glutathione disulfide); decreased the GSH/GSSG ratio. For both treatment durations, activities of ascorbate peroxidase (APX), glutathione reductase (GR), glutathione-S-transferase (GST) increased; the activities of monodehydroascorbate reductase (MDHAR), dehydroascorbate reductase (DHAR), glutathione peroxidase (GPX), catalase (CAT) and glyoxalase I (Gly I) decreased; the activity of glyoxalase II (Gly II) increased at 48 h. Mung bean seedlings pretreated with exogenous GSH under HT improved chl and leaf RWC; increased APX (only after 24 h), MDHAR, DHAR, GR, GPX, GST (increased only after 24 h), CAT, Gly I and Gly II activities; improved endogenous GSH content and the GSH/GSSG ratio; lowered GSSG content. Glutathione supplementation with drought stress significantly decreased MDA, H2O2 and MG content, O-2(center dot-) generation rate and LOX activity. Pretreatment with GSH resulted in better physiological performance, improved antioxidant and glyoxalase systems, and reduced MG and oxidative stress under 24 h of HT stress, compared with that of 48 h. The results suggest that exogenous GSH enhances mung bean seedling tolerance of short-term HT stress by modulating the antioxidant and glyoxalase systems and by improving physiological adaptation. (C) 2014 Elsevier B.V. All rights reserved.	[Nahar, Kamrun; Alam, Md. Mahabub; Fujita, Masayuki] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Lab Plant Stress Responses, Miki, Kagawa 7610795, Japan; [Nahar, Kamrun] Sher E Bangla Agr Univ, Fac Agr, Dept Agr Bot, Dhaka 1207, Bangladesh; [Hasanuzzaman, Mirza] Sher E Bangla Agr Univ, Fac Agr, Dept Agron, Dhaka 1207, Bangladesh	Fujita, M (reprint author), Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Lab Plant Stress Responses, Miki, Kagawa 7610795, Japan.	knahar84@yahoo.com; mhzsauag@yahoo.com; fujita@ag.kagawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	The first author is grateful to the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan for financial supports. We acknowledge Dr. Md. Motiar Rohman, Senior Scientific Officer, Bangladesh Agricultural Research Institute for his cordial cooperation and helping in measurement of enzymatic activities and other biochemical parameters. We thankfully acknowledge Dennis Murphy, Ehime University, Japan for critical review and English language correction of the manuscript.	Addinsoft, 2010, XLSTAT 2010 DAT AN S; Ahmed C. B., 2011, Amino Acids, V40, P565, DOI 10.1007/s00726-010-0677-1; Alam M. M., 2013, Australian Journal of Crop Science, V7, P1053; Ali Q., 2011, THESIS U AGR FAISALA; Alla MMN, 2014, PESTIC BIOCHEM PHYS, V112, P56, DOI 10.1016/j.pestbp.2014.04.012; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Kuhn H, 2002, FREE RADICAL BIO MED, V33, P154, DOI 10.1016/S0891-5849(02)00855-9; Yang HY, 2010, AQUAT TOXICOL, V100, P282, DOI 10.1016/j.aquatox.2010.07.026; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; Wang H, 2009, BIOCHEM PHARMACOL, V77, P1709, DOI 10.1016/j.bcp.2009.02.024; Lyles GA, 1996, INT J BIOCHEM CELL B, V28, P259, DOI 10.1016/1357-2725(95)00130-1; Huang CH, 2005, J EXP BOT, V56, P3041, DOI 10.1093/jxb/eri301; Singla-Pareek SL, 2006, PLANT PHYSIOL, V140, P613, DOI 10.1104/pp.105.073734; He YL, 2005, CROP SCI, V45, P988, DOI 10.2135/cropsci2003.0678; Hossain MZ, 2006, BIOL PLANTARUM, V50, P210, DOI 10.1007/s10535-006-0009-1; Tateishi Y, 2005, PHYSIOL PLANTARUM, V125, P224, DOI 10.1111/j.1399-3054.2005.00553.x; Eltayeb AE, 2007, PLANTA, V225, P1255, DOI 10.1007/s00425-006-0417-7; BARRS HD, 1962, AUST J BIOL SCI, V15, P413; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Shao HB, 2005, COLLOID SURFACE B, V42, P187, DOI 10.1016/j.colsurfb.2005.02.007; Szalai G, 2009, J PLANT GROWTH REGUL, V28, P66, DOI 10.1007/s00344-008-9075-2; [Anonymous], 1999, MOL RESPONSES COLD D; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Al-Taweel K, 2007, PLANT PHYSIOL, V145, P258, DOI 10.1104/pp.107.101733; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Yadav SK, 2005, FEBS LETT, V579, P6265, DOI 10.1016/j.febslet.2005.10.006; Foyer CH, 2003, PHYSIOL PLANTARUM, V119, P355, DOI 10.1034/j.1399-3054.2003.00223.x; Havaux M, 1998, TRENDS PLANT SCI, V3, P147; PRINCIPATO GB, 1987, BIOCHIM BIOPHYS ACTA, V911, P349, DOI 10.1016/0167-4838(87)90076-8; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Chen Z, 2003, P NATL ACAD SCI USA, V100, P3525, DOI 10.1073/pnas.0635176100; MACRI F, 1994, BBA-LIPID LIPID MET, V1215, P109, DOI 10.1016/0005-2760(94)90098-1; RICHARD JP, 1993, BIOCHEM SOC T, V21, P549; Yu CW, 2003, FUNCT PLANT BIOL, V30, P955, DOI 10.1071/FP03091; Wild R, 2012, ANAL BIOANAL CHEM, V403, P2577, DOI 10.1007/s00216-012-6086-4; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Chen JH, 2012, PLANT PHYSIOL, V158, P340, DOI 10.1104/pp.111.181875; Yadav SK, 2005, BIOCHEM BIOPH RES CO, V337, P61, DOI 10.1016/j.bbrc.2005.08.263; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Shahid MA, 2014, TURK J BOT, V38, P914, DOI 10.3906/bot-1312-13; Gaber A, 2006, PHYSIOL PLANTARUM, V128, P251, DOI 10.1111/j.1399-3054.2006.00730.x; RHODES D, 1993, ANNU REV PLANT PHYS, V44, P357, DOI 10.1146/annurev.pp.44.060193.002041; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Chaplen FWR, 1998, CYTOTECHNOLOGY, V26, P173, DOI 10.1023/A:1007953628840; Paradiso A, 2008, PLANT CELL PHYSIOL, V49, P362, DOI 10.1093/pcp/pcn013; Kaushal Neeru, 2011, Physiology and Molecular Biology of Plants, V17, P203, DOI 10.1007/s12298-011-0078-2; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; Desai KM, 2010, CAN J PHYSIOL PHARM, V88, P273, DOI 10.1139/Y10-001; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Martins AMTBS, 2001, FEBS LETT, V499, P41, DOI 10.1016/S0014-5793(01)02519-4; Yadav Sudesh Kumar, 2008, Drug Metabolism and Drug Interactions, V23, P51; CASAZZA JP, 1984, J BIOL CHEM, V259, P231; Turoczy Z, 2011, PLANT MOL BIOL, V75, P399, DOI 10.1007/s11103-011-9735-7; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Su J, 2004, PLANT SCI, V166, P941, DOI 10.1016/j.plantsci.2003.12.004; Yin H, 2008, PLANT GROWTH REGUL, V54, P45, DOI 10.1007/s10725-007-9227-6; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P385; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Ali MB, 2005, PLANT PHYSIOL BIOCH, V43, P213, DOI 10.1016/j.plaphy.2005.01.007; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Apostolova P., 2011, OXIDATIVE STRESS PLA, P52; Babu NR, 2008, AUST J CROP SCI, V2, P40; Banu M.N.A., 2010, BIOSCI BIOTECH BIOCH, V10, P2043; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; Cansev A., 2012, PLANT ARCH, V12, P521; Chaitanya KV, 2001, BIOL PLANTARUM, V44, P379, DOI 10.1023/A:1012446811036; Rao A. S. V. Chalapathi, 2008, P111, DOI 10.1007/978-3-540-76326-0_6; DODERER A, 1992, BIOCHIM BIOPHYS ACTA, V1120, P97, DOI 10.1016/0167-4838(92)90429-H; Ella A.C., 2003, ECOTOX ENVIRON SAFE, V55, P162; EPA, 2011, STUD GUID GLOB CLIM; Field C. B., 2012, SPECIAL REPORT WORKI; Fragkostefanakis S., 2014, PLANT CELL ENV; Hasanuzzaman M., 2012, Australian Journal of Crop Science, V6, P1314; Hasanuzzaman M, 2014, BIOMED RES INT, V2014, P1; Howarth C.J., 2005, ABIOTIC STRESSES PLA, P277; Karuppanapandian T, 2011, AUST J CROP SCI, V5, P709; Kattab H., 2007, Australian Journal of Basic and Applied Sciences, V1, P323; Kesici M, 2013, NOT BOT HORTI AGROBO, V41, P244; Kocsy Gabor, 2002, Acta Biologica Szegediensis, V46, P71; Li YingLi, 2010, Frontiers of Agriculture in China, V4, P84; Mahmood Q, 2010, ASCORBATE-GLUTATHIONE PATHWAY AND STRESS TOLERANCE IN PLANTS, P209, DOI 10.1007/978-90-481-9404-9_7; Melchiorre M, 2009, PLANT GROWTH REGUL, V57, P57, DOI 10.1007/s10725-008-9322-3; Molassiotis A, 2006, ENVIRON EXP BOT, V56, P54, DOI 10.1016/j.envexpbot.2005.01.002; Noctor G., 2002, J EXP BOT, V53, P283; Pang Cai-Hong, 2008, V69, P231, DOI 10.1007/978-3-540-72954-9_9; Pang CH, 2010, ASCORBATE-GLUTATHIONE PATHWAY AND STRESS TOLERANCE IN PLANTS, P91, DOI 10.1007/978-90-481-9404-9_3; Rivero RM, 2004, J HORTIC SCI BIOTECH, V79, P560; Rosales MA, 2007, J HORTIC SCI BIOTECH, V82, P739; Saha S. R., 2010, Bangladesh Journal of Agricultural Research, V35, P525; Salama K. H. A., 2009, INT J AGRIC BIOL, V11, P639; SANCHEZCASAS P, 1994, PLANT PHYSIOL, V106, P1675; Savicka M, 2010, EKOLOGIYA, V56, P26; Sharma P., 2012, J BOT, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/217037]; Kumar B, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P263, DOI 10.1007/978-90-481-3112-9_13; Wang F, 2011, BIOL TRACE ELEM RES, V144, P1275, DOI 10.1007/s12011-011-9121-y; Wang Y. J., 2006, Journal of Applied Horticulture (Lucknow), V8, P87; Wu JC, 2011, ACTA HORTIC, V887, P221; Xu WF, 2008, PEDOSPHERE, V18, P486, DOI 10.1016/S1002-0160(08)60039-9; Yadav Sudesh Kumar, 2005, Physiology and Molecular Biology of Plants, V11, P1; Zrobek-sokolnik A., 2012, ENV ADAPTATIONS STRE, P113	106	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0098-8472	1873-7307		ENVIRON EXP BOT	Environ. Exp. Bot.	APR	2015	112						44	54		10.1016/j.envexpbot.2014.12.001		11	Plant Sciences; Environmental Sciences	Plant Sciences; Environmental Sciences & Ecology	CB6HG	WOS:000349727500005		
J	Loeb, S; Bruinsma, SM; Nicholson, J; Briganti, A; Pickles, T; Kakehi, Y; Carlsson, SV; Roobol, MJ				Loeb, Stacy; Bruinsma, Sophie M.; Nicholson, Joseph; Briganti, Alberto; Pickles, Tom; Kakehi, Yoshiyuki; Carlsson, Sigrid V.; Roobol, Monique J.			Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification	EUROPEAN UROLOGY			English	Review						Prostate cancer; Active surveillance; PSA; Risk stratification; Genetic markers; Treatment; Nomogram	BASE-LINE; EXPECTANT MANAGEMENT; ANTIGEN KINETICS; FOLLOW-UP; BIOPSY RECLASSIFICATION; PATIENT SELECTION; MEN; PROGRESSION; COHORT; INTERVENTION	Context: Active surveillance (AS) is an important strategy to reduce prostate cancer overtreatment. However, the optimal criteria for eligibility and predictors of progression while on AS are debated. Objective: To review primary data on markers, genetic factors, and risk stratification for patient selection and predictors of progression during AS. Evidence acquisition: Electronic searches were conducted in PubMed, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) from inception to April 2014 for original articles on biomarkers and risk stratification for AS. Evidence synthesis: Patient factors associated with AS outcomes in some studies include age, race, and family history. Multiple studies provide consistent evidence that a lower percentage of free prostate-specific antigen (PSA), a higher Prostate Health Index (PHI), a higher PSA density (PSAD), and greater biopsy core involvement at baseline predict a greater risk of progression. During follow-up, serial measurements of PHI and PSAD, as well as repeat biopsy results, predict later biopsy progression. While some studies have suggested a univariate relationship between urinary prostate cancer antigen 3 (PCA3) and transmembrane protease, serine 2-v-ets avian erythroblastosis virus E26 oncogene homolog gene fusion (TMPRSS2:ERG) with adverse biopsy features, these markers have not been consistently shown to independently predict AS outcomes. No conclusive data support the use of genetic tests in AS. Limitations of these studies include heterogeneous definitions of progression and limited follow-up. Conclusions: There is a growing body of literature on patient characteristics, biopsy features, and biomarkers with potential utility in AS. More data are needed on practical applications such as combining these tests into multivariable clinical algorithms and long-term outcomes to further improve AS in the future. Patient summary: Several PSA-based tests (free PSA, PHI, PSAD) and the extent of cancer on biopsy can help to stratify the risk of progression during active surveillance. Investigation of several other markers is under way. (C) 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.	[Loeb, Stacy] NYU, Dept Urol, New York, NY USA; [Loeb, Stacy] Manhattan Vet Affairs Hosp, New York, NY USA; [Bruinsma, Sophie M.; Roobol, Monique J.] Erasmus MC, Dept Urol, NL-3015 CN Rotterdam, Netherlands; [Nicholson, Joseph] NYU, Hlth Sci Lib, New York, NY USA; [Briganti, Alberto] Univ Milan, Osped San Raffaele, IRCCS, Div Oncol,Unit Urol,Urol Res Inst, I-20127 Milan, Italy; [Pickles, Tom] BC Canc Agcy, Vancouver Ctr, Radiat Therapy Program, Vancouver, BC, Canada; [Pickles, Tom] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Kakehi, Yoshiyuki] Kagawa Univ, Dept Urol, Fac Med, Miki, Kagawa, Japan; [Carlsson, Sigrid V.] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Urol, Gothenburg, Sweden; [Carlsson, Sigrid V.] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA	Roobol, MJ (reprint author), Erasmus MC, Dept Urol, Wytemaweg 80,Room 1706, NL-3015 CN Rotterdam, Netherlands.	m.roobol@erasmusmc.nl			National Institutes of Health [K07CA178258]; AFA Insurance; Movember; Dutch Cancer Society	S. Loeb is supported by the National Institutes of Health (award number K07CA178258). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. S. Carlsson is supported by a grant from AFA Insurance. S. M. Bruinsma is supported by a grant from Movember. M.J. Roobol is supported by a grant from the Dutch Cancer Society. The sponsors had a role in the collection of the data and the preparation of the manuscript.	Abern MR, 2013, PROSTATE CANCER P D, V16, P84, DOI 10.1038/pcan.2012.38; Klotz L, 2013, CURR OPIN ENDOCRINOL, V20, P204, DOI 10.1097/MED.0b013e328360332a; Goh CL, 2013, BJU INT, V112, P666, DOI 10.1111/j.1464-410X.2012.11648.x; van den Bergh RCN, 2014, EUR UROL, V65, P1023, DOI 10.1016/j.eururo.2014.01.027; Zhang LY, 2006, J UROLOGY, V176, P1392, DOI 10.1016/j.juro.2006.06.103; Makarov DV, 2009, CLIN CANCER RES, V15, P7316, DOI 10.1158/1078-0432.CCR-09-1263; Cohn JA, 2014, BJU INT, V114, P75, DOI 10.1111/bju.12463; Bul M, 2013, EUR UROL, V63, P597, DOI 10.1016/j.eururo.2012.11.005; Eggener SE, 2009, J UROLOGY, V181, P1635, DOI 10.1016/j.juro.2008.11.109; van As NJ, 2008, EUR UROL, V54, P1297, DOI 10.1016/j.eururo.2008.02.039; Shappley WV, 2009, J CLIN ONCOL, V27, P4980, DOI 10.1200/JCO.2008.21.2613; Dall'Era MA, 2008, CANCER, V112, P2664, DOI 10.1002/cncr.23502; Roobol MJ, 2009, EUR UROL, V56, P584, DOI 10.1016/j.eururo.2009.07.018; Tosoian JJ, 2010, J UROLOGY, V183, P534, DOI 10.1016/j.juro.2009.10.003; Soloway MS, 2008, BJU INT, V101, P165, DOI 10.1111/j.1464-410X.2007.07190.x; Porten SP, 2011, J CLIN ONCOL, V29, P2795, DOI 10.1200/JCO.2010.33.0134; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; van den Bergh RCN, 2010, BJU INT, V105, P956, DOI 10.1111/j.1464-410X.2009.08887.x; Patel HD, 2014, J UROLOGY, V191, P629, DOI 10.1016/j.juro.2013.09.029; van den Bergh RCN, 2009, BJU INT, V103, P1472, DOI 10.1111/j.1464-410X.2008.08281.x; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Loeb S, 2005, J UROLOGY, V173, P63, DOI 10.1097/01.ju.0000145883.01068.5f; Iremashvili V, 2012, J UROLOGY, V187, P1594, DOI 10.1016/j.juro.2011.12.082; Cornu JN, 2013, PROSTATE, V73, P242, DOI 10.1002/pros.22563; Tseng KS, 2010, J UROLOGY, V183, P1779, DOI 10.1016/j.juro.2010.01.001; Cary KC, 2014, EUR UROL, V66, P337, DOI 10.1016/j.eururo.2013.08.060; Ng MK, 2009, BJU INT, V103, P872, DOI 10.1111/j.1464-410X.2008.08116.x; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Whitson JM, 2011, J UROLOGY, V185, P1656, DOI 10.1016/j.juro.2010.12.042; Lin DW, 2013, CLIN CANCER RES, V19, P2442, DOI 10.1158/1078-0432.CCR-12-3283; Soloway MS, 2010, EUR UROL, V58, P831, DOI 10.1016/j.eururo.2010.08.027; Iremashvili V, 2013, BJU INT, V112, P39, DOI 10.1111/bju.12112; Adamy A, 2011, J UROLOGY, V185, P477, DOI 10.1016/j.juro.2010.09.095; Tosoian JJ, 2012, J UROLOGY, V188, P1131, DOI 10.1016/j.juro.2012.06.009; Isharwal S, 2010, BJU INT, V105, P329, DOI 10.1111/j.1464-410X.2009.08791.x; Iremashvili V, 2013, BJU INT, V111, P396, DOI 10.1111/j.1464-410X.2012.11295.x; Ross AE, 2010, J CLIN ONCOL, V28, P2810, DOI 10.1200/JCO.2009.25.7311; Bul M, 2012, EUR UROL, V61, P370, DOI 10.1016/j.eururo.2011.06.027; Loblaw A, 2010, J UROLOGY, V184, P1942, DOI 10.1016/j.juro.2010.06.101; Barayan GA, 2014, BJU INT, V114, pE99, DOI 10.1111/bju.12754; Berg KD, 2014, EUR UROL, V66, P851, DOI 10.1016/j.eururo.2014.02.058; Burton AJ, 2012, CANCER EPIDEM BIOMAR, V21, P1877, DOI 10.1158/1055-9965.EPI-12-0411; Cullen J, 2011, J UROLOGY, V185, pe64; Fleshner NE, 2011, EUR UROL SUPPL, V10, P51; Fromont G, 2011, EUR UROL SUPPL, V10, P315; Hirama H, 2014, J CANCER RES CLIN, V140, P257, DOI 10.1007/s00432-013-1566-2; Iremashvili V, 2013, BJU INT, V111, P574, DOI 10.1111/j.1464-410X.2012.11127.x; Jhavar S, 2009, PROSTATE CANCER P D, V12, P143, DOI 10.1038/pcan.2008.47; Kakehi Y, 2008, JPN J CLIN ONCOL, V38, P122, DOI 10.1093/jjco/hym161; Khatami Ali, 2007, Int J Cancer, V120, P170; Klotz L., 2004, J UROL 2, V172, pS51; Klotz Laurence, 2004, J Urol, V172, pS48, DOI 10.1097/01.ju.0000141712.79986.77; Komisarenko M, 2014, J UROLOGY, V191, pE720; Krakowsky Y, 2010, J UROLOGY, V184, P131, DOI 10.1016/j.juro.2010.03.041; Lees K, 2012, CURR OPIN UROL, V22, P210, DOI 10.1097/MOU.0b013e328351dc47; Mukerji GM, 2010, BJU INT, V106, P3; Pujara AC, 2010, J UROL S4, V183, pe831; San Francisco Ignacio F, 2011, J Urol, V185, P471, DOI 10.1016/j.juro.2010.09.115; Smith A, 2009, J UROLOGY, V181, P608; Sternberg I, 2014, J CLIN ONCOL S4, V32; Sundi D, 2014, J UROLOGY, V191, pE598; Umbehr MH, 2014, BJU INT, V113, P561, DOI 10.1111/bju.12131; VALERI A, 2010, EUR UROL SUPPL, V9, P196; Venkitaraman R, 2008, BJU INT, V101, P161, DOI 10.1111/j.1464-410X.2007.07175.x; Venkitaraman R, 2007, J UROLOGY, V178, P833, DOI 10.1016/j.juro.2007.05.038; Venkitaraman R, 2008, INT J BIOL MARKER, V23, P192; Vickers A, 2012, ACTIVE SURVEILLANCE; Welty C, 2014, J CLIN ONCOL S4, V32; Yee DS, 2010, J UROLOGY, V183, pe57	69	10	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0302-2838	1873-7560		EUR UROL	Eur. Urol.	APR	2015	67	4					619	626		10.1016/j.eururo.2014.10.010		8	Urology & Nephrology	Urology & Nephrology	CB8VY	WOS:000349910900014		
J	Ploussard, G; Xylinas, E; Lotan, Y; Novara, G; Margulis, V; Roupret, M; Matsumoto, K; Karakiewicz, PI; Montorsi, F; Remzi, M; Seitz, C; Scherr, DS; Kapoor, A; Fairey, AS; Rendon, R; Izawa, J; Black, PC; Lacombe, L; Shariat, SF; Kassouf, W				Ploussard, Guillaume; Xylinas, Evanguelos; Lotan, Yair; Novara, Giacomo; Margulis, Vitaly; Roupret, Morgan; Matsumoto, Kazumasa; Karakiewicz, Pierre I.; Montorsi, Francesco; Remzi, Mezut; Seitz, Christian; Scherr, Douglas S.; Kapoor, Anil; Fairey, Adrian S.; Rendon, Ricardo; Izawa, Jonathan; Black, Peter C.; Lacombe, Louis; Shariat, Shahrokh F.; Kassouf, Wassim			Conditional Survival After Radical Nephroureterectomy for Upper Tract Carcinoma	EUROPEAN UROLOGY			English	Article						Upper urinary tract carcinoma; Radical nephroureterectomy; Outcomes; Recurrence; Survival; Bladder cancer	UPPER URINARY-TRACT; UROTHELIAL CARCINOMA; CANCER-PATIENTS; TERM SURVIVORS; BLADDER; RECURRENCE; PROGNOSIS; GENDER; PROBABILITY; CYSTECTOMY	Background: Conditional survival (CS) provides better estimates of the survival probability at each follow-up time, and its usefulness has been proven in several solid malignancies. Objective: To assess the changes in 5-yr CS rates after radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) and to determine how well-established prognostic factors evolve over time. Design, setting, and participants: We analysed data from 3544 patients treated with RNU at 15 international academic centres between 1989 and 2012. Intervention: RNU. Outcomes measurements and statistical analysis: Conditional intravesical recurrencefree (IVRFS), cancer-specific survival (CSS), and overall survival (OS) estimates were calculated using the Kaplan-Meier method. A multivariable Cox regression model was used to calculate proportional hazard ratios for the prediction of mortality. Results and limitations: The 5-yr bladder cancer recurrence-free survival, CSS, and OS rates were 54.9%, 72.2%, and 62.6%, respectively. Given a 1-, 2-, 3-, and 4-yr survivorship, the 5-yr conditional OS rates improved to 65.2%, 69.3%, 71.5%, and 73.0%, respectively. The 5-yr CS improvement was primarily noted among surviving patients with advancedstage disease. The impact of pathologic parameters on CS estimates decreased over time for both CSS and OS, whereas the impact of age and gender increased with survivorship. No survival benefit was noted regarding the adjuvant chemotherapy status. Findings were confirmed upon multivariable analyses. Tumour location, the presence of carcinoma in situ, and the type of bladder cuff excision were continuously predictive for IVRFS whatever the survivorship. A limitation is the retrospective design. Conclusions: CS analysis demonstrates that the patient risk profile evolves during the post-RNU follow-up. The probability of survival markedly increases over time in patients having high-stage disease. The impact of prognostic pathologic features decreases over time and can disappear for long-term CS. Patient summary: In this study, we found that the risk of intravesical recurrence, cancer-specific survival, and overall mortality evolves over the follow-up after surgery. Taking into account the survivorship provides better estimates of the survival probability at each follow-up time. (C) 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.	[Ploussard, Guillaume; Kassouf, Wassim] McGill Univ, Dept Surg, Montreal, PQ H3G 1A4, Canada; [Ploussard, Guillaume] Univ Paris 07, St Louis Hosp, Dept Urol, AP HP, Paris, France; [Xylinas, Evanguelos; Shariat, Shahrokh F.] New York Presbyterian Hosp, Dept Urol, Weill Cornell Med Coll, New York, NY USA; [Xylinas, Evanguelos] Paris Descartes Univ, Cochin Hosp, AP HP, Dept Urol, Paris, France; [Lotan, Yair; Margulis, Vitaly] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Novara, Giacomo] Univ Padua, Dept Surg Oncol & Gastroenterol, Urol Clin, Padua, Italy; [Roupret, Morgan] Univ Paris 06, Acad Dept Urol, La Pitie Salpetriere Hosp, AP HP,Fac Med Pierre & Marie Curie, Paris, France; [Matsumoto, Kazumasa] Kitasato Univ, Sch Med, Dept Urol, Minami Ku, Sagamihara, Kanagawa 228, Japan; [Karakiewicz, Pierre I.] Univ Montreal, Ctr Hlth, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ, Canada; [Montorsi, Francesco] Univ Vita Salute San Raffaele, Dept Urol, Milan, Italy; [Remzi, Mezut; Seitz, Christian; Shariat, Shahrokh F.] Med Univ Vienna, Dept Urol, Vienna, Austria; [Scherr, Douglas S.] Weill Cornell Med Coll, Dept Urol, New York, NY USA; [Kapoor, Anil] McMaster Univ, St Joseph Hosp, Dept Urol, Hamilton, ON, Canada; [Fairey, Adrian S.] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Rendon, Ricardo] Dalhousie Univ, Dept Surg, Halifax, NS B3H 4H2, Canada; [Izawa, Jonathan] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; [Black, Peter C.] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Lacombe, Louis] Univ Laval, Dept Surg, Quebec City, PQ, Canada	Kassouf, W (reprint author), McGill Univ, Dept Surg, Div Urol, Ctr Hlth, 1650 Cedar Ave,Room L8-315, Montreal, PQ H3G 1A4, Canada.	wassim.kassouf@muhc.mcgill.ca					Xylinas E, 2014, EUR UROL, V65, P650, DOI 10.1016/j.eururo.2013.09.003; Janssen-Heijnen MLG, 2010, J CLIN ONCOL, V28, P2520, DOI 10.1200/JCO.2009.25.9697; Zigeuner RE, 2006, BJU INT, V98, P1181, DOI 10.1111/j.1464-410X.2006.06519.x; Messer JC, 2014, UROLOGY, V83, P863, DOI 10.1016/j.urology.2013.10.060; Ploussard G, 2014, EUR UROL, V66, P361, DOI 10.1016/j.eururo.2013.09.050; Roupret M, 2013, EUR UROL, V63, P1059, DOI 10.1016/j.eururo.2013.03.032; HENSON DE, 1994, SEMIN SURG ONCOL, V10, P2, DOI 10.1002/ssu.2980100103; Fajkovic H, 2013, WORLD J UROL, V31, P5, DOI 10.1007/s00345-012-0939-5; Sun M, 2012, EUR J CANCER, V48, P1503, DOI 10.1016/j.ejca.2011.11.024; Hagiwara M, 2013, J UROLOGY, V189, P2062, DOI 10.1016/j.juro.2013.01.024; Harshman LC, 2012, LANCET ONCOL, V13, P927, DOI 10.1016/S1470-2045(12)70285-1; Rink M, 2013, BJU INT, V112, P623, DOI 10.1111/bju.12014; Roupret M, 2013, J UROLOGY, V189, P1662, DOI 10.1016/j.juro.2012.10.057; Ouzzane A, 2011, EUR UROL, V60, P1258, DOI 10.1016/j.eururo.2011.05.049; Stephenson AJ, 2005, J CLIN ONCOL, V23, P7005, DOI 10.1200/JCO.2005.01.867; Hellenthal NJ, 2009, J UROLOGY, V182, P900, DOI 10.1016/j.juro.2009.05.011; Bianchi M, 2013, BJU INT, V111, P283; Bryant H, 2012, CURR ONCOL, V19, P222, DOI 10.3747/co.19.1148; Ito Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-304; Janssen-Heijnen MLG, 2007, ANN ONCOL, V18, P1408, DOI 10.1093/annonc/mdm127; Ku JH, 2013, BRIT J CANCER, V109, P1130, DOI 10.1038/bjc.2013.462; Liu JY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0640-6; Merrill RM, 2010, ONCOLOGIST, V15, P873, DOI 10.1634/theoncologist.2009-0211; Polley MYC, 2011, J CLIN ONCOL, V29, P4175, DOI 10.1200/JCO.2010.32.4343; Yu XQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-460; Zabor EC, 2013, CANCER, V119, P3389	26	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0302-2838	1873-7560		EUR UROL	Eur. Urol.	APR	2015	67	4					803	812		10.1016/j.eururo.2014.08.003		10	Urology & Nephrology	Urology & Nephrology	CB8VY	WOS:000349910900042		
J	Saka, H; Ueda, Y; Nishihara, K; Ilegbusi, OJ; Iguchi, M				Saka, Hisanori; Ueda, Yoshiaki; Nishihara, Kazuyoshi; Ilegbusi, Olusegun J.; Iguchi, Manabu			Transition phenomena and velocity distribution in constant-deceleration pipe flow	EXPERIMENTAL THERMAL AND FLUID SCIENCE			English	Article						Unsteady flow; Pipe flow; Constant-deceleration flow; Turbulence transition	TURBULENCE; IDENTIFICATION; LAMINAR; REST	The critical Reynolds number for transition to turbulence in a constant-acceleration pipe flow is well known to be significantly higher than the value for steady pipe flow. This is a consequence of the significant suppression of amplification of disturbances entering the pipe by the acceleration in spite of the increase of inertial force due to increase in instantaneous Reynolds number. In contrast, relatively little is known of the transition phenomena in a constant-deceleration pipe flow. Such a flow system is investigated by an experimental method in which the cross-sectional mean velocity is initially kept constant and subsequently decreased linearly to zero. The characteristics of the transition phenomena will be determined by two factors deceleration and viscosity. Deceleration will amplify the disturbances, while a decrease in the instantaneous Reynolds number is expected to suppress the amplification of the disturbances due to viscosity. The study uses hot-wire experiments to clarify which of the two effects predominates in constant-deceleration pipe flow. (C) 2014 Elsevier Inc. All rights reserved.	[Saka, Hisanori; Ueda, Yoshiaki; Iguchi, Manabu] Osaka Electrocommun Univ, Grad Sch Engn, Neyagawa, Osaka 5728530, Japan; [Nishihara, Kazuyoshi] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Ilegbusi, Olusegun J.] Univ Cent Florida, Dept Mech & Aerosp Engn, Orlando, FL 32816 USA	Ilegbusi, OJ (reprint author), Univ Cent Florida, Dept Mech & Aerosp Engn, Orlando, FL 32816 USA.						MERKLI P, 1975, J FLUID MECH, V68, P567, DOI 10.1017/S0022112075001826; FARGIE D, 1971, PROC R SOC LON SER-A, V321, P461, DOI 10.1098/rspa.1971.0043; HINO M, 1976, J FLUID MECH, V75, P193, DOI 10.1017/S0022112076000177; Greenblatt D, 2003, J FLUID ENG-T ASME, V125, P1072, DOI 10.1115/1.1624423; Iguchi M, 2010, J FLUID ENG-T ASME, V132, DOI 10.1115/1.4002519; JSME, 1979, JSME HYDR LOS PIP DU; Koppel T, 2006, J FLUID ENG-T ASME, V128, P680, DOI 10.1115/1.2201640; Kurokawa J., 1988, T JPN SOC MECH ENG-B, V54B-498, P302; Kurokawa J., 1985, T JPN SOC MECH ENG-B, V51B-467, P2076; Lefebvre P. J., 1989, Transactions of the ASME. Journal of Fluids Engineering, V111; LEFEBVRE PJ, 1991, J FLUID ENG-T ASME, V113, P223, DOI 10.1115/1.2909484; MOSS EA, 1989, EXP FLUIDS, V7, P271; MOSS EA, 1983, ISRAEL J TECHNOL, V21, P221; Nakahata Y., 2008, J JSEM, V8-3, P232; Nishihara K., 2008, J JSEM, V8-3, P213; OHMI M, 1982, B JSME, V25, P165; Szymanski P., 1932, J MATH PURES APPLI 9, V11, P67; WYGNANSK.IJ, 1973, J FLUID MECH, V59, P281, DOI 10.1017/S0022112073001576	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0894-1777	1879-2286		EXP THERM FLUID SCI	Exp. Therm. Fluid Sci.	APR	2015	62						175	182		10.1016/j.expthermflusci.2014.12.010		8	Thermodynamics; Engineering, Mechanical; Physics, Fluids & Plasmas	Thermodynamics; Engineering; Physics	CC1AT	WOS:000350074100018		
J	Parga, ML; Pons, M; Andraka, S; Rendin, L; Mituhasi, T; Hall, M; Pacheco, L; Segura, A; Osmond, M; Vogel, N				Parga, Maria L.; Pons, Maite; Andraka, Sandra; Rendon, Liliana; Mituhasi, Takahisa; Hall, Martin; Pacheco, Lucas; Segura, Alvaro; Osmond, Michael; Vogel, Nick			Hooking locations in sea turtles incidentally captured by artisanal longline fisheries in the Eastern Pacific Ocean	FISHERIES RESEARCH			English	Article						Hook type; Hook size; Bait; Olive ridley; Surface longline	CIRCLE HOOKS; PELAGIC LONGLINES; BY-CATCH; BYCATCH; REDUCE; CONSERVATION; MITIGATION; MANAGEMENT; MORTALITY; SWORDFISH	Bycatch by longline fisheries, especially by artisanal small-scale fisheries, is one of the main conservation problems for some sea turtle populations around the world. Since 2004, a network of professionals under the "Eastern Pacific Regional Sea Turtle Bycatch Program" have been working with artisanal longline fishers in the Eastern Pacific Ocean (EPO) to reduce sea turtle bycatch and related mortality. Trials assessing circle hooks of different sizes and shapes, and different baits, have been conducted to determine the effectiveness in the reduction of sea turtle bycatch and changes in hooking location. In this paper, information from 1823 olive ridley sea turtles incidentally captured in the EPO were analyzed to assess how hook type (J, tuna hooks or circle hooks), hook size, bait type (squid or fish), turtle size and target species (tunas, sharks or mahi-mahi) affect hooking location on sea turtles. This were modeled with a Classification and Regression Tree using hooking location as a multinomial variable response (for 6 categories of hooking locations); and also as a binomial response (swallowed vs. non-swallowed) using a Generalized Linear Mixed Model (GLMM). Hook type and size, plus bait type, were the most important factors affecting hooking location, while turtle size and target species did not have any significant effect. J-hooks and tuna hooks had a much greater probability of being swallowed than circle hooks. In addition, as the hook size increased, the likelihood of swallowing it decreased. The use of fish bait in combination with larger circle hooks tended to produce higher proportions of external hookings. An increase in external or lower mandible hookings is preferred since these locations are assumed to be less dangerous for the animal's post-release survival, and because hooks and attached gear are easier to remove by well-trained fishermen. (C) 2014 Elsevier B.V. All rights reserved.	[Parga, Maria L.] SUBMON, Barcelona 08024, Spain; [Pons, Maite] Ctr Invest & Conservac Marina CICMAR, Canelones 15008, Uruguay; [Andraka, Sandra] WWF, Latin Amer & Caribbean Program, San Jose, Costa Rica; [Rendon, Liliana] Escuela Pesca Pacifico Oriental WWF, Manta, Ecuador; [Mituhasi, Takahisa] Overseas Fishery Cooperat Fdn Japan, Minato Ku, Tokyo 1070052, Japan; [Hall, Martin; Vogel, Nick] IATTC, La Jolla, CA 92037 USA; [Pacheco, Lucas] WWF, Panama Off, Clayton 081607168, Panama; [Segura, Alvaro] WWF, Costa Rica Off, San Jose, Costa Rica; [Osmond, Michael] WWF US, Mountain View, CA USA	Andraka, S (reprint author), WWF, Latin Amer & Caribbean Program, 400 M Pl Sol,POB 629-2350, San Jose, Costa Rica.	mariluz@submon.org; pons.maite@cicmar.org; sandrakag@gmail.com; lilianarendonm@hotmail.com; mituhasi@fish.kagoshima-u.ac.jp; mhall@iattc.org; lucasrovira@yahoo.es; alvaro.segurah@gmail.com; michael.osmond@wwfus.org; nvogel@iattc.org			Overseas Fishery Cooperation Foundation-Japan; MUSTAD; Walton Family Foundation; NOAA NMFS personnel-Jeffrey Seminoff, Charlie Bergmann, Chris Boggs; Western Pacific Regional Fishery Management Council-Kitty Simonds	The authors would like to thank all the observers for their efforts helping produce the database. Thank you also to all the fishers from the region that have cooperated with us and trusted us, fisheries organizations and country fisheries agencies from Mexico, Guatemala, El Salvador, Nicaragua, Costar Rica, Panama, Colombia, Ecuador and Peru. The authors would also like to acknowledge the long list of organizations that have supported this project with funds, technical advice, or in many other ways, which includes: WWF Latin American Program (Mexico, Central America, Colombia and Peru), WWF National Offices (WWF Netherlands and WWF US) and WWF International, particularly to Robin Davies, Carol Phua, Carlos Drews, Moises Mug, Samuel Amoros, Michael Valqui, and other fisheries staff; other key collaborators and member of the team-Manuel Parrales, Erick Villagren, Sara Perez, Celina de Paz and Salvador Siu; Fauna and Flora International Nicaragua Program-Velkiss Gadea, Alejandro Cotto and Jose Urteaga; the Western Pacific Regional Fishery Management Council-Kitty Simonds; NOAA NMFS personnel-Jeffrey Seminoff, Charlie Bergmann, Chris Boggs and many others; the Inter-American Tropical Tuna Commission staff; the State Department USA-US-AID; the Overseas Fishery Cooperation Foundation-Japan; MUSTAD; the Walton Family Foundation, and other donors and foundations that trusted and supported our work. A very special thank you to the Nationale Postkode Loterij for supporting all the analysis carried out for this work.	Andraka S, 2013, BIOL CONSERV, V160, P214, DOI 10.1016/j.biocon.2013.01.019; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Lucchetti A, 2010, REV FISH BIOL FISHER, V20, P141, DOI 10.1007/s11160-009-9126-1; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Casale P, 2007, AQUAT CONSERV, V17, P686, DOI 10.1002/aqc.841; DAYTON PK, 1995, AQUAT CONSERV, V5, P205, DOI 10.1002/aqc.3270050305; Watson JW, 2005, CAN J FISH AQUAT SCI, V62, P965, DOI 10.1139/F05-004; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Deflorio M, 2005, FISHERIES SCI, V71, P1010, DOI 10.1111/j.1444-2906.2005.01058.x; Parga ML, 2012, B MAR SCI, V88, P731, DOI 10.5343/bms.2011.1063; Gilman E, 2007, BIOL CONSERV, V139, P19, DOI 10.1016/j.biocon.2007.06.002; Gilman EL, 2011, MAR POLICY, V35, P590, DOI 10.1016/j.marpol.2011.01.021; Soykan Candan U., 2008, Endangered Species Research, V5, P91, DOI 10.3354/esr00175; Baez JC, 2007, MAR ECOL PROG SER, V338, P249, DOI 10.3354/meps338249; Bolten A., 2003, EXPT EVALUATE GEAR M; Brazner JC, 2008, FISH RES, V91, P310, DOI 10.1016/j.fishres.2007.12.023; Breiman L., 1984, CLASSIFICATION REGRE; Caminas Juan A., 2003, P88; Casale Paolo, 2003, Marine Turtle Newsletter, V101, P28; Crawley M. J., 2007, R BOOK; De la Serna J.M., 2006, DOCCRS2006163 IEO; Epperly SP, 2012, B MAR SCI, V88, P513, DOI 10.5343/bms.2011.1083; FAO, 2004, 738 FAO UN; Gilman E., 2006, FISH FISH, V7, P1; Guglielmi P., 2000, RAPPORTO MINISTERO P; Hall Martin, 2012, P136; Largacha E., 2005, WORKING ECUADORIAN F; Mangel JC, 2011, MAR ECOL PROG SER, V433, P261, DOI 10.3354/meps09152; McCulloch CE, 2001, GEN LINEAR MIXED MOD; Minami H., 2006, WCPFCSC22006EB; Mituhasi T., 2011, HOOKS USED ARTISANAL; Nelder J., 1989, GEN LINEAR MODELS; Pacheco L., 2013, ASPECTOS OPERATIVOS; Piovano S, 2009, AQUAT CONSERV, V19, P779, DOI 10.1002/aqc.1021; Read AJ, 2007, BIOL CONSERV, V135, P155, DOI 10.1016/j.biocon.2006.10.030; Ryder C.E., 2006, NMFSFOPR29 NOAA US D; Sales G, 2010, AQUAT CONSERV, V20, P428, DOI 10.1002/aqc.1106; Serafy JE, 2012, B MAR SCI, V88, P371, DOI 10.5343/bms.2012.1038; Shiode D, 2005, FISHERIES SCI, V71, P1182, DOI 10.1111/j.1444-2906.2005.01080.x; Stokes Lesley W., 2011, Endangered Species Research, V14, P1, DOI 10.3354/esr00339; Stokes LW, 2012, B MAR SCI, V88, P703, DOI 10.5343/bms.2011.1074; Swimmer Y, 2005, MAR ECOL PROG SER, V295, P273, DOI 10.3354/meps295273; Swimmer Y., 2012, CONVENED VIA WEBINAR; Swimmer Y., 2013, AQUAT CONSERV MAR FR; Swimmer Y, 2010, AQUAT CONSERV, V20, P445, DOI 10.1002/aqc.1108; Wallace B.P., 2010, CONSERV LETT, V3, P1; Wang JH, 2007, ANIM CONSERV, V10, P176, DOI 10.1111/j.1469-1795.2006.00085.x; Watson J. W., 2004, EXPT W ATLANTIC NE D; Yokota K, 2012, B MAR SCI, V88, P623, DOI 10.5343/bms.2011.1066; Zug GR, 2006, MAR ECOL-EVOL PERSP, V27, P263, DOI 10.1111/j.1439-0485.2006.00109.x	50	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-7836	1872-6763		FISH RES	Fish Res.	APR	2015	164						231	237		10.1016/j.fishres.2014.11.012		7	Fisheries	Fisheries	CB6LA	WOS:000349737300028		
J	Chen, X; Yuan, LJ; Lu, WJ; Li, YY; Liu, P; Nie, K				Chen, Xi; Yuan, Linjiang; Lu, Wenjuan; Li, Yuyou; Liu, Pei; Nie, Kun			Cultivation of aerobic granular sludge in a conventional, continuous flow, completely mixed activated sludge system	FRONTIERS OF ENVIRONMENTAL SCIENCE & ENGINEERING			English	Article						aerobic granular sludge; completely mixed activated sludge system (CMAS); continuous flow; shear force; filamentous bacteria; polymerase chain reaction-denaturing gradient gel electrophoresis (PCR-DGGE)	HYDRODYNAMIC SHEAR FORCE; WASTE-WATER TREATMENT; BACTERIAL COMMUNITY; SETTLING TIME; REACTOR; POPULATIONS	Aerobic granules were formed in a conventional, continuous flow, completely mixed activated sludge system (CMAS). The reactor was inoculated with seed sludge containing few filaments and fed with synthetic municipal wastewater. The settling time of the sludge and the average dissolved oxygen (DO) of the reactor were 2 h and 4.2 mg center dot L-1, respectively. The reactor was agitated by a stirrer, with a speed of 250 r center dot min(-1), to ensure good mixing. The granular sludge had good settleability, and the sludge volume index (SVI) was between 50 and 90 mL center dot g(-1). The laser particle analyzer showed the diameter of the granules to be between 0.18 and 1.25 mm. A scanning electron microscope (SEM) investigation revealed the predominance of sphere-like and rod-like bacteria, and only few filaments grew in the granules. The microbial community structure of the granules was also analyzed by polymerase chain reaction-denaturing gradient gel electrophoresis (PCR-DGGE). Sequencing analysis indicated the dominant species were alpha, beta, and gamma-Proteobacteria, Bacteroidetes, and Firmicutes. The data from the study suggested that aerobic granules could form, if provided with sufficient number of filaments and high shear force. It was also observed that a high height-to-diameter ratio of the reactor and short settling time were not essential for the formation of aerobic granular sludge.	[Chen, Xi; Yuan, Linjiang; Lu, Wenjuan; Li, Yuyou; Liu, Pei; Nie, Kun] Xian Univ Architecture & Technol, Sch Environm & Municipal Engn, Xian 710055, Peoples R China; [Li, Yuyou] Tohoku Univ, Grad Sch Environm Studies, Dept Environm Sci, Sendai, Miyagi 9808579, Japan	Yuan, LJ (reprint author), Xian Univ Architecture & Technol, Sch Environm & Municipal Engn, Xian 710055, Peoples R China.	Xi_Chen2011@126.com; yuanlinjiang@xauat.edu.cn			National Natural Science Foundation of China [50878180]	This research was supported by the National Natural Science Foundation of China (Grant No. 50878180).	Wu J, 2009, WATER RES, V43, P3029, DOI 10.1016/j.watres.2009.04.026; Xia SQ, 2010, BIOCHEM ENG J, V49, P370, DOI 10.1016/j.bej.2010.01.013; Qin L, 2004, BIOCHEM ENG J, V21, P47, DOI 10.1016/j.bej.2004.03.005; Militon C, 2010, FEMS MICROBIOL ECOL, V74, P669, DOI 10.1111/j.1574-6941.2010.00982.x; Perez JAS, 2006, CHEM ENG J, V124, P1, DOI 10.1016/j.cej.2006.07.002; McSwain BS, 2004, WATER SCI TECHNOL, V50, P195; Brakstad OG, 2005, MICROB ECOL, V49, P94, DOI 10.1007/s00248-003-0225-6; Rosman NH, 2013, BIORESOURCE TECHNOL, V129, P620, DOI 10.1016/j.biortech.2012.12.113; Othman I, 2013, BIORESOURCE TECHNOL, V133, P630, DOI 10.1016/j.biortech.2013.01.149; Liu Y, 2002, WATER RES, V36, P1653, DOI 10.1016/S0043-1354(01)00379-7; MISHIMA K, 1991, WATER SCI TECHNOL, V23, P981; Song ZW, 2010, J ENVIRON SCI-CHINA, V22, P1312, DOI 10.1016/S1001-0742(09)60256-4; Guo F, 2011, BIORESOURCE TECHNOL, V102, P6421, DOI 10.1016/j.biortech.2011.03.046; Beun JJ, 2002, WATER RES, V36, P702, DOI 10.1016/S0043-1354(01)00250-0; Peng DC, 1999, WATER RES, V33, P890; Lee DJ, 2010, BIOTECHNOL ADV, V28, P919, DOI 10.1016/j.biotechadv.2010.08.007; Abdullah N, 2013, BIORESOURCE TECHNOL, V127, P181, DOI 10.1016/j.biortech.2012.09.047; APHA, 1998, STANDARD METHODS EXA; Bin Zhang, 2011, Water Res, V45, P6207, DOI 10.1016/j.watres.2011.09.026; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P7444, DOI 10.1016/j.biortech.2008.02.028; De Sanctis M, 2010, BIORESOURCE TECHNOL, V101, P2152, DOI 10.1016/j.biortech.2009.11.018; Gao DW, 2011, CRIT REV BIOTECHNOL, V31, P137, DOI 10.3109/07388551.2010.497961; Li AJ, 2011, SEP PURIF TECHNOL, V80, P276, DOI 10.1016/j.seppur.2011.05.006; Tay JH, 2001, J APPL MICROBIOL, V91, P168, DOI 10.1046/j.1365-2672.2001.01374.x; McCabe W.L., 1993, UNIT OPERATIONS CHEM; Molina-Munoz M, 2009, SCI TOTAL ENVIRON, V407, P3994, DOI 10.1016/j.scitotenv.2009.03.024; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695; Puigagut J, 2007, WATER RES, V41, P3168, DOI 10.1016/j.watres.2007.04.016; Rushton JH, 1996, UNIT OPERATIONS PROC; Zhu L, 2013, CHEM ENG J, V217, P442, DOI 10.1016/j.cej.2012.11.132	30	0	0	HIGHER EDUCATION PRESS	BEIJING	SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA	2095-2201	2095-221X		FRONT ENV SCI ENG	Front. Env. Sci. Eng.	APR	2015	9	2					324	333		10.1007/s11783-014-0627-3		10	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CB8VI	WOS:000349909300017		
J	Solga, AC; Pong, WW; Walker, J; Wylie, T; Magrini, V; Apicelli, AJ; Griffith, M; Griffith, OL; Kohsaka, S; Wu, GF; Brody, DL; Mardis, ER; Gutmann, DH				Solga, Anne C.; Pong, Winnie W.; Walker, Jason; Wylie, Todd; Magrini, Vincent; Apicelli, Anthony J.; Griffith, Malachi; Griffith, Obi L.; Kohsaka, Shinichi; Wu, Gregory F.; Brody, David L.; Mardis, Elaine R.; Gutmann, David H.			RNA-Sequencing Reveals Oligodendrocyte and Neuronal Transcripts in Microglia Relevant to Central Nervous System Disease	GLIA			English	Article						laser-capture microdissection; fluorescence-activated cell sorting; macrophage	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRANSLATIONAL PROFILING APPROACH; CONTROLLED CORTICAL IMPACT; PERCOLL DENSITY GRADIENTS; RAT ALVEOLAR MACROPHAGES; TRAUMATIC BRAIN-INJURY; AMYLOID-BETA-PROTEIN; CNS CELL-TYPES; PERITONEAL-MACROPHAGES; FUNCTIONAL-PROPERTIES	Expression profiling of distinct central nervous system (CNS) cell populations has been employed to facilitate disease classification and to provide insights into the molecular basis of brain pathology. One important cell type implicated in a wide variety of CNS disease states is the resident brain macrophage (microglia). In these studies, microglia are often isolated from dissociated brain tissue by flow sorting procedures [fluorescence-activated cell sorting (FACS)] or from postnatal glial cultures by mechanic isolation. Given the highly dynamic and state-dependent functions of these cells, the use of FACS or short-term culture methods may not accurately capture the biology of brain microglia. In the current study, we performed RNA-sequencing using Cx3cr1(+/GFP) labeled microglia isolated from the brainstem of 6-week-old mice to compare the transcriptomes of FACS-sorted versus laser capture microdissection (LCM). While both isolation techniques resulted in a large number of shared (common) transcripts, we identified transcripts unique to FACS-isolated and LCM-captured microglia. In particular, approximate to 50% of these LCM-isolated microglial transcripts represented genes typically associated with neurons and glia. While these transcripts clearly localized to microglia using complementary methods, they were not translated into protein. Following the induction of murine experimental autoimmune encephalomyelitis, increased oligodendrocyte and neuronal transcripts were detected in microglia, while only the myelin basic protein oligodendrocyte transcript was increased in microglia after traumatic brain injury. Collectively, these findings have implications for the design and interpretation of microglia transcriptome-based investigations. GLIA 2015;63:531-548	[Solga, Anne C.; Pong, Winnie W.; Apicelli, Anthony J.; Wu, Gregory F.; Brody, David L.; Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Walker, Jason; Wylie, Todd; Magrini, Vincent; Griffith, Malachi; Griffith, Obi L.; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Kohsaka, Shinichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neurochem, Kodaira, Tokyo 1870031, Japan	Gutmann, DH (reprint author), Dept Neurol, Box 8111,660 South Euclid Ave, St Louis, MO 63110 USA.	gutmannd@neuro.wustl.edu	Griffith, Malachi/P-1285-2014	Pong, Winnie/0000-0001-8254-3305; Griffith, Malachi/0000-0002-6388-446X	NCI Cancer Center Support Grant [P30 CA91842]; National Institutes of Health [RC4 NS072916]; W.M. Keck Foundation	Grant sponsor: NCI Cancer Center Support Grant (to The Siteman Cancer Center); Grant number: #P30 CA91842; Grant sponsor: National Institutes of Health; Grant number: RC4 NS072916 (to DHG); Grant sponsor: W.M. Keck Foundation (to WWP).	PENFOLD PL, 1991, VISUAL NEUROSCI, V7, P383; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Jack C, 2005, J NEUROSCI RES, V81, P363, DOI 10.1002/jnr.20482; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Graeber MB, 2002, GLIA, V40, P252, DOI 10.1002/glia.10147; Roggendorf W, 1996, ACTA NEUROPATHOL, V92, P288; Cabanski CR, 2014, J MOL DIAGN, V16, P440, DOI 10.1016/j.jmoldx.2014.03.004; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Wang LH, 1996, J NEUROSCI, V16, P6197; Dheen ST, 2007, CURR MED CHEM, V14, P1189; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Parkhurst CN, 2010, CURR OPIN NEUROBIOL, V20, P595, DOI 10.1016/j.conb.2010.07.002; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Pong WW, 2013, ANN NEUROL, V73, P303, DOI 10.1002/ana.23813; Jiang Y, 2012, J NEUROTRAUM, V29, P2332, DOI 10.1089/neu.2012.2362; Kaindl AM, 2012, ANN NEUROL, V72, P536, DOI 10.1002/ana.23626; Sasaki A, 1997, ACTA NEUROPATHOL, V94, P316; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Liang KJ, 2009, INVEST OPHTH VIS SCI, V50, P4444, DOI 10.1167/iovs.08-3357; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Simmons GW, 2011, J NEUROPATH EXP NEUR, V70, P51, DOI 10.1097/NEN.0b013e3182032d37; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; MORIMURA T, 1990, ACTA NEUROPATHOL, V80, P287; Boddeke EWGH, 1999, EUR J PHARMACOL, V374, P309, DOI 10.1016/S0014-2999(99)00307-6; CHANDLER DB, 1986, J LEUKOCYTE BIOL, V39, P371; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; DAVIS JB, 1992, BIOCHEM BIOPH RES CO, V189, P1096, DOI 10.1016/0006-291X(92)92317-Q; Gitik M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-24; HASSAN NF, 1991, J LEUKOCYTE BIOL, V50, P86; Hernandez-Ontiveros Diana G, 2013, Front Neurol, V4, P30, DOI 10.3389/fneur.2013.00030; Hirasawa T, 2005, J NEUROSCI RES, V81, P357, DOI 10.1002/jnr.20480; Hurley SD, 1999, GLIA, V25, P304, DOI 10.1002/(SICI)1098-1136(19990201)25:3<304::AID-GLIA10>3.0.CO;2-W; Khodosevich K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001151; Klein RS, 2004, J CELL BIOCHEM, V92, P213, DOI 10.1002/jcb.20052; Lemarchant S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-133; Lewis C.A., 2012, NEUROL RES INT, V2012, DOI DOI 10.1155/2012/803701; MATSUMOTO Y, 1992, J NEUROIMMUNOL, V37, P23, DOI 10.1016/0165-5728(92)90152-B; Miranda KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096094; OHMANN HB, 1986, J LEUKOCYTE BIOL, V39, P167; Ohtaki Hirokazu, 2013, Acta Neurochir Suppl, V118, P49, DOI 10.1007/978-3-7091-1434-6_8; ONEILL SJ, 1984, INFECT IMMUN, V46, P282; Petersohn D, 1996, EUR J BIOCHEM, V239, P827, DOI 10.1111/j.1432-1033.1996.0827u.x; PLASMAN N, 1993, RES IMMUNOL, V144, P151, DOI 10.1016/0923-2494(93)80070-F; Pong WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077571; Racke M. K., 2001, CURR PROTOC NEUROSCI; RASMUSSEN SE, 1983, ACTA PATH MICRO IM C, V91, P299; RINNER WA, 1995, GLIA, V14, P257, DOI 10.1002/glia.440140403; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Szabo M, 2013, NEUROSCIENCE, V241, P280, DOI 10.1016/j.neuroscience.2013.03.033; Tariq MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr547; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Waller R, 2012, J NEUROSCI METH, V208, P108, DOI 10.1016/j.jneumeth.2012.04.014; Windak R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073294	67	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	APR	2015	63	4					531	548		10.1002/glia.22754		18	Neurosciences	Neurosciences & Neurology	CB9SX	WOS:000349973900002		
J	Tanaka, T; Murakami, K; Bando, Y; Yoshida, S				Tanaka, Tatsuhide; Murakami, Koichi; Bando, Yoshio; Yoshida, Shigetaka			Interferon Regulatory Factor 7 Participates in the M1-Like Microglial Polarization Switch	GLIA			English	Article						microglia; M1; M2; polarization; IRF7	CENTRAL-NERVOUS-SYSTEM; CRITICAL TRANSCRIPTION FACTOR; MACROPHAGE ACTIVATION; IN-VIVO; POSITIVE FEEDBACK; ADULT MICROGLIA; SPINAL-CORD; PHENOTYPE; RESPONSES; INJURY	Microglia are generally considered the immune cells of the central nervous system. Recent studies have demonstrated that under specific polarization conditions, microglia develop into two different phenotypes, termed M1-like and M2-like microglia. However, the phenotypic characteristics of M1-like- and M2-like-polarized microglia and the mechanisms that regulate polarization are largely unknown. In this study, we characterized lipopolysaccharide-treated M1-like and IL-4-treated M2-like microglia and investigated the mechanisms that regulate phenotypic switching. The addition of M2-like microglial conditioned medium (CM) to primary neurons resulted in an increase in neurite length when compared with neurons treated with M1-like microglial CM, possibly because of the enhanced secretion of neurotrophic factors by M2-like microglia. M1-like microglia were morphologically characterized by larger soma, whereas M2-like microglia were characterized by long processes. M2-like microglia exhibited greater phagocytic capacity than M1-like microglia. These features switched in response to polarization cues. We found that expression of interferon regulatory factor 7 (IRF7) increased during the M2-like to M1-like switch in microglia in vitro and in vivo. Knockdown of IRF7 using siRNA suppressed the expression of M1 marker mRNA and reduced phosphorylation of STAT1. Our findings suggest that IRF7 signaling may play an important role in microglial polarization switching. GLIA 2015;63:595-610	[Tanaka, Tatsuhide; Murakami, Koichi; Bando, Yoshio; Yoshida, Shigetaka] Asahikawa Med Univ, Dept Funct Anat & Neurosci, Asahikawa, Hokkaido, Japan	Tanaka, T (reprint author), Asahikawa Med Univ, Dept Funct Anat & Neurosci, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido, Japan.	ttanaka@asahikawa-med.ac.jp			Uehara Memorial Foundation	Grant sponsor: Grant-in-Aid for Young Scientists (B), Uehara Memorial Foundation.	STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Tanaka T, 2009, J BIOL CHEM, V284, P21626, DOI 10.1074/jbc.M109.005603; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Biber K, 2014, GLIA, V62, P841, DOI 10.1002/glia.22654; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Wergeland S, 2012, APMIS, V120, P648, DOI 10.1111/j.1600-0463.2012.02882.x; Shimizu E, 2008, J IMMUNOL, V181, P6503; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Melief J, 2012, GLIA, V60, P1506, DOI 10.1002/glia.22370; Lucin KM, 2013, NEURON, V79, P873, DOI 10.1016/j.neuron.2013.06.046; Fujita H, 1996, GLIA, V18, P269, DOI 10.1002/(SICI)1098-1136(199612)18:4<269::AID-GLIA2>3.0.CO;2-T; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Beutner C, 2013, GLIA, V61, P1429, DOI 10.1002/glia.22524; Schmid CD, 2009, J NEUROCHEM, V109, P117, DOI 10.1111/j.1471-4159.2009.05984.x; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Tanaka T, 2013, J NEUROCHEM, V127, P259, DOI 10.1111/jnc.12289; Ajmone-Cat MA, 2013, GLIA, V61, P1698, DOI 10.1002/glia.22550; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Masuda T, 2012, CELL REPORTS, V1, P334, DOI 10.1016/j.celrep.2012.02.014; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Khorooshi R, 2010, J IMMUNOL, V185, P1258, DOI 10.4049/jimmunol.0901753; Kloss CUA, 2001, EXP NEUROL, V168, P32, DOI 10.1006/exnr.2000.7575; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Fu RY, 2014, MOL NEUROBIOL, V49, P1422, DOI 10.1007/s12035-013-8620-6; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hosmane S, 2012, J NEUROSCI, V32, P7745, DOI 10.1523/JNEUROSCI.0203-12.2012; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murakami K, 2013, NEUROSCIENCE, V236, P1, DOI 10.1016/j.neuroscience.2012.12.073; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Takaoka A, 2008, CANCER SCI, V99, P467, DOI 10.1111/j.1349-7006.2007.00720.x; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Ellert-Miklaszewska A, 2013, GLIA, V61, P1178, DOI 10.1002/glia.22510; Horiuchi M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-227; Owens T, 2014, GLIA, V62, P339, DOI 10.1002/glia.22608; Przanowski P, 2014, J MOL MED, V92, P239, DOI 10.1007/s00109-013-1090-5; Salem M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-181; Zhou XL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-210	54	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	APR	2015	63	4					595	610		10.1002/glia.22770		16	Neurosciences	Neurosciences & Neurology	CB9SX	WOS:000349973900005		
J	Koblmuller, S; Albertson, RC; Genner, MJ; Sefc, KM; Takahashi, T				Koblmueller, Stephan; Albertson, R. Craig; Genner, Martin J.; Sefc, Kristina M.; Takahashi, Tetsumi			Preface: Advances in cichlid research: behavior, ecology, and evolutionary biology	HYDROBIOLOGIA			English	Editorial Material							ADAPTIVE RADIATION; SYMPATRIC SPECIATION; LAKE MALAWI; FISH; HYBRIDIZATION; MODEL		[Koblmueller, Stephan; Sefc, Kristina M.] Karl Franzens Univ Graz, Dept Zool, A-8010 Graz, Austria; [Albertson, R. Craig] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Genner, Martin J.] Univ Bristol, Sch Biol Sci, Bristol BS8 1TQ, Avon, England; [Takahashi, Tetsumi] Natl Inst Genet, Ecol Genet Lab, Mishima, Shizuoka 4118540, Japan	Koblmuller, S (reprint author), Karl Franzens Univ Graz, Dept Zool, Univ Pl 2, A-8010 Graz, Austria.	stephan.koblmueller@uni-graz.at		Sefc, Kristina/0000-0001-8108-8339			Turner GF, 2001, MOL ECOL, V10, P793, DOI 10.1046/j.1365-294x.2001.01200.x; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Salzburger W, 2009, MOL ECOL, V18, P169, DOI 10.1111/j.1365-294X.2008.03981.x; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Koblmuller S, 2008, HYDROBIOLOGIA, V615, P5, DOI 10.1007/s10750-008-9552-4; Salzburger W, 2014, ANNU REV ECOL EVOL S, V45, P519, DOI 10.1146/annurev-ecolsys-120213-091804; Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Danley PD, 2001, MOL ECOL, V10, P1075, DOI 10.1046/j.1365-294X.2001.01283.x; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; LIEM KF, 1973, SYST ZOOL, V22, P425, DOI 10.2307/2412950; Joyce DA, 2011, CURR BIOL, V21, pR108, DOI 10.1016/j.cub.2010.11.029; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0; Boulenger G. A, 1899, P ZOOL SOC LOND, V1899, P98; Boulenger G. A, 1898, P ZOOL SOC LOND, V1898, P132; Boulenger G. A, 1999, T ZOOLOGICAL SOC LON, V15, P1; Gillardin C, 2011, PARASITOL RES, V110, P305; Joyce DA, 2005, NATURE, V435, P90, DOI 10.1038/nature03489; Keenleyside MHA, 1991, CICHLID FISHES BEHAV; Lopez-Fernandez H, 2013, EVOLUTION, V67, P1321, DOI 10.1111/evo.12038; Maan ME, 2013, SEMIN CELL DEV BIOL, V24, P516, DOI 10.1016/j.semcdb.2013.05.003; Takahashi T., 2011, INT J EVOLUTIONARY B, V2011	24	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0018-8158	1573-5117		HYDROBIOLOGIA	Hydrobiologia	APR	2015	748	1					1	5		10.1007/s10750-015-2196-2		5	Marine & Freshwater Biology	Marine & Freshwater Biology	CB9QV	WOS:000349968000001		
J	Maruyama, A; Shinohara, K; Sakurai, M; Ohtsuka, T; Rusuwa, B				Maruyama, Atsushi; Shinohara, Kohei; Sakurai, Michito; Ohtsuka, Taisuke; Rusuwa, Bosco			Microhabitat variations in diatom composition and stable isotope ratios of the epilithic algae in Lake Malawi	HYDROBIOLOGIA			English	Article						Attached algae; delta C-13; Gut content; Niche; Periphyton; Slope; Stable carbon isotope; Rock slope	CICHLID FISHES; PERIPHYTON; CARBON; NITROGEN; AFRICA; SEGREGATION; TISSUE; DIET	Microhabitat-level spatial variations in diatom and isotope compositions of epilithic periphyton in the littoral zones of Lake Malawi were examined using periphyton samples collected from seven regions of the lake. Discriminant analysis revealed a clear difference in diatom composition among the slopes of the rocks from which the samples were collected. This difference may be associated with interspecific variation in the adhesive power of diatoms. The slope of the rocks also strongly affected the stable carbon isotope ratios of periphyton, together with subsidiary effects of algae size class, sampling site, depth, and some of their interaction terms. The effect of slope can be explained by the decrease in photosynthetic activity along the slope, which originates from the decline in sunlight. Thus, the diatom composition and carbon isotope ratios may be good indicators of microhabitat and have the potential to be powerful tools for quantitative measurement of microhabitat utilization of epilithic algae-feeding consumers of this lake, including territorial cichlids.	[Maruyama, Atsushi; Shinohara, Kohei; Sakurai, Michito] Ryukoku Univ, Fac Sci & Technol, Otsu, Shiga 5202194, Japan; [Ohtsuka, Taisuke] Lake Biwa Museum, Kusatsu, Shiga 5250001, Japan; [Rusuwa, Bosco] Univ Malawi, Chancellor Coll, Dept Biol Sci, Zomba, Malawi	Maruyama, A (reprint author), Ryukoku Univ, Fac Sci & Technol, 1-5 Seta Oe, Otsu, Shiga 5202194, Japan.	maruyama@rins.ryukoku.ac.jp			Joint Research Centre for Science and Technology of Ryukoku University; JSPS KAKENHI [25840144]	We are grateful to Mr R. Zatha, Mr Y. Kazembe, Mr B. Matundu, Mr A. Nyoni, and Mr A. Mangawa at the University of Malawi for their support during sample collection. We also thank Ms Y. Nonomatsu, Ms M. Umemoto, Mr Y. Nakamura, and Ms E. Ishizumi for their assistance with laboratory analyses. Our thanks go to Dr M. Yuma, Dr M. Genner, and anonymous reviewers for their constructive criticism. This study was conducted in accordance with the prevailing laws of the Republic of Malawi. Financial support was provided by the Joint Research Centre for Science and Technology of Ryukoku University and by JSPS KAKENHI Grant Number 25840144.	Abe S., 2000, DIATOM, V16, P37; Turner GF, 2001, MOL ECOL, V10, P793, DOI 10.1046/j.1365-294x.2001.01200.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; RIBBINK AJ, 1983, S AFR J ZOOL, V18, P149; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Rutz C, 2010, SCIENCE, V329, P1523, DOI 10.1126/science.1192053; Bearhop S, 2004, J ANIM ECOL, V73, P1007; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Hill WR, 2006, LIMNOL OCEANOGR, V51, P2360; Maruyama A, 2001, CAN J FISH AQUAT SCI, V58, P2125, DOI 10.1139/cjfas-58-11-2125; MARKS JC, 1993, CAN J FISH AQUAT SCI, V50, P1270, DOI 10.1139/f93-144; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; BEAUCHAMP RSA, 1953, J ECOL, V41, P226, DOI 10.2307/2257037; Bootsma HA, 1996, ECOLOGY, V77, P1286, DOI 10.2307/2265598; Cocquyt C., 1994, Advances in Limnology, V44, P161; DeNiro MJ, 1981, GEOCHIMICA COSMOCHIM, V45; Dixit SS, 2000, T GEOBIOL, V15, P279; Genner MJ, 1999, ECOL LETT, V2, P185; Genner MJ, 1999, OECOLOGIA, V121, P283, DOI 10.1007/s004420050930; Higgins MJ, 2003, J PHYCOL, V39, P1181, DOI 10.1111/j.0022-3646.2003.03-027.x; Higgins SN, 2003, J GREAT LAKES RES, V29, P181; Hubbell S.P., 2001, UNIFIED NEUTRAL THEO, V32; KLEE R, 1992, ARCH PROTISTENKD, V142, P179; Klee R., 1995, ARCH PROTISTENKD, V146, P293; Krammer K., 1988, SUSSWASSERFLORA MITT, V2/2, P1; Lange-Bertalot H., 2001, DIATOMS EUROPE, V2, P1; MacLeod NA, 1998, CAN J FISH AQUAT SCI, V55, P1919, DOI 10.1139/cjfas-55-8-1919; MARSH AC, 1985, BIOL J LINN SOC, V25, P331, DOI 10.1111/j.1095-8312.1985.tb00399.x; May R.M., 1973, STABILITY COMPLEXITY; Muller O., 1910, BOT JB SYSTEMATIK PF, V45, P69; Muller O, 1904, BOT JB SYSTEMATIK PF, V34, P255; Muller O., 1903, BOT JB, V34, P9; Muller O., 1905, BOT JB SYSTEMATIK PF, V34, P138; REINTHAL PN, 1990, ENVIRON BIOL FISH, V27, P215, DOI 10.1007/BF00001674; SCHMIDT A., 1874, ATLAS DIATOMACEEN KU; Shinohara K, 2014, PHYCOL RES, V62, P9, DOI 10.1111/pre.12036; Stoermer E. F., 1999, DIATOMS APPL ENV EAR	38	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0018-8158	1573-5117		HYDROBIOLOGIA	Hydrobiologia	APR	2015	748	1					161	169		10.1007/s10750-014-1977-3		9	Marine & Freshwater Biology	Marine & Freshwater Biology	CB9QV	WOS:000349968000012		
J	Sekine, T; Kimura, T; Kobayashi, T; Mashimo, T				Sekine, Toshimori; Kimura, Tomoaki; Kobayashi, Takamichi; Mashimo, Tsutomu			Dynamic water loss of antigorite by impact process	ICARUS			English	Article						Impact processes; Terrestrial planets	SERPENTINE; MINERALS; DEHYDROXYLATION; DECOMPOSITION; TEMPERATURE; PRESSURE; MANTLE; VAPOR; CO2	Impact-induced dehydration of serpentine in primitive meteorites is believed to be a mechanism to provide water in terrestrial planets. Primitive meteorites show a wide range of porosity and it is necessary to know the effect of porosity on the dehydration. In this work we report the dynamic dehydration reaction in powdered samples of antigorite by shock recovery experiments, in which recovered samples were investigated using techniques of X-ray diffractions, electron microscopy, and thermal analyses of shock recovered samples. The present experimental results indicate that the dehydration reaction is weakly pressure-dependent below a peak shock pressure of similar to 21 GPa and becomes violent at pressures of 21-60 GPa. The kinetics was found to be dependent on not only peak shock pressure but also the initial porosity and sample amount. We discuss the heterogeneous dehydration reactions based on the phases identified in the recovered samples, more than previously thought. (C) 2014 Elsevier Inc. All rights reserved.	[Sekine, Toshimori; Kimura, Tomoaki] Hiroshima Univ, Dept Earth & Planetary Syst Sci, Hiroshima 7398526, Japan; [Kobayashi, Takamichi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Mashimo, Tsutomu] Kumamoto Univ, Inst Pulsed Power Sci, Kumamoto 8608555, Japan	Sekine, T (reprint author), Hiroshima Univ, Dept Earth & Planetary Syst Sci, Hiroshima 7398526, Japan.	toshimori-sekine@hiroshima-u.ac.jp			X-ray Free Electron Priority Strategy Program (MEXT)	We thank M. Maeda, N-BIRD Hiroshima University for TEM observations. Shock experiments were carried out at NIMS and KU as collaboration researches. This study was supported in part by X-ray Free Electron Priority Strategy Program (MEXT). We thank two anonymous reviewers for their comments to improve our manuscript.	Abe Y., 1986, J GEOPHYS RES, VE91, P291; Ahrens T. J., 1972, Moon, V4, DOI 10.1007/BF00562927; Akai J., 1994, P NIPR S ANT MET, V7, P101; Gualtieri AF, 2012, AM MINERAL, V97, P666, DOI 10.2138/am.2012.3952; Holland G, 2009, SCIENCE, V326, P1522, DOI 10.1126/science.1179518; Ohno S, 2014, NAT GEOSCI, V7, P279, DOI 10.1038/ngeo2095; Kraus RG, 2010, EARTH PLANET SC LETT, V289, P162, DOI 10.1016/j.epsl.2009.11.002; Albarede F, 2013, ICARUS, V222, P44, DOI 10.1016/j.icarus.2012.10.026; Tomeoka K, 2003, NATURE, V423, P60, DOI 10.1038/nature01567; Britt DT, 2003, METEORIT PLANET SCI, V38, P1161; Prescher C, 2011, METEORIT PLANET SCI, V46, P1619, DOI 10.1111/j.1945-5100.2011.01249.x; Agrinier P, 2001, GEOCHIM COSMOCHIM AC, V65, P2615, DOI 10.1016/S0016-7037(01)00617-2; Bell MS, 2010, GEOL SOC AM SPEC PAP, V465, P593, DOI 10.1130/2010.2465(28); Tomioka N, 2007, METEORIT PLANET SCI, V42, P19; Furukawa Y, 2011, GEOCHIM COSMOCHIM AC, V75, P6461, DOI 10.1016/j.gca.2011.08.029; Arrhenius G., 1974, SEA, P839; Boslough M.B., 1980, P LUNAR PLANET SCI, V11, P2145; BOSLOUGH MB, 1982, EARTH PLANET SC LETT, V61, P166, DOI 10.1016/0012-821X(82)90049-8; BRINDLEY GW, 1967, AM MINERAL, V52, P1697; Irifune T, 1996, SCIENCE, V272, P1468, DOI 10.1126/science.272.5267.1468; LANGE MA, 1985, GEOCHIM COSMOCHIM AC, V49, P1715, DOI 10.1016/0016-7037(85)90142-5; LANGE MA, 1986, EARTH PLANET SC LETT, V77, P409, DOI 10.1016/0012-821X(86)90150-0; Marsh S.P., 1980, LASL HUGONIOT DATA; Martinez L.A., 1995, J GEOPHYS RES, V100, P15465; Ohno S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033796; Ohno S, 2014, J PHYS CONF SER, V500, DOI 10.1088/1742-6596/500/6/062001; Perillat J.P., 2005, EARTH PLANET SC LETT, V236, P899; Scambelluri E.H., 1995, GEOLOGY, V23, P459; Sekine T, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008439; Sekine T, 1997, EUR J SOL STATE INOR, V34, P823; Skala R, 2002, GEOL SOC AM SPEC PAP, V356, P571; TYBURCZY JA, 1991, J GEOPHYS RES-SOL EA, V96, P18011, DOI 10.1029/91JB01573; Tyburczy J.A., 1986, EARTH PLANET SC LETT, V80, P2012; Tyburczy J.A., 1988, P LUNAR PLANET SCI C, V18, P435; Umehara S., 1985, MINERAL J, V12, P299; Viti C, 2010, AM MINERAL, V95, P631, DOI 10.2138/am.2010.3366; Zhang FP, 2007, GEOCHIM COSMOCHIM AC, V71, P4125, DOI 10.1016/j.gca.2007.06.037; Zhang YJ, 2014, AM MINERAL, V99, P2374, DOI 10.2138/am-2014-5021; Zhang YJ, 2014, PHYS CHEM MINER, V41, P313, DOI 10.1007/s00269-013-0650-0	39	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0019-1035	1090-2643		ICARUS	Icarus	APR	2015	250						1	6		10.1016/j.icarus.2014.11.008		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CB8KJ	WOS:000349878200001		
J	Kadono, T; Suzuki, AI; Wada, K; Mitani, NK; Yamamoto, S; Arakawa, M; Sugita, S; Haruyama, J; Nakamura, AM				Kadono, T.; Suzuki, A. I.; Wada, K.; Mitani, N. K.; Yamamoto, S.; Arakawa, M.; Sugita, S.; Haruyama, J.; Nakamura, A. M.			Crater-ray formation by impact-induced ejecta particles	ICARUS			English	Article						Impact processes; Collisional physics; Cratering; Moon, surface	GRANULAR MATERIAL; MECHANISM; SPHERES	We performed impact experiments with granular targets to reveal the formation process of crater "rays", the non-uniform ejecta distributions around some fresh craters on the Moon and planets. We found mesh patterns, loosely woven with spaces like a net, as ejecta. A characteristic length of spaces between meshes was evaluated, and an angle, defined as the ratio of the characteristic length to the distance from the ejection point, was obtained as few degrees. These features are similar to the results of the analyses of the ray patterns around two lunar craters, Glushko and Kepler. Numerical simulations of granular material showed that clear mesh pattern appeared at lower coefficients of restitution between particles but was less clear at larger one, suggesting that the inelastic collisions between particles cause the clear mesh-pattern formation of impact ejecta. (C) 2014 Elsevier Inc. All rights reserved.	[Kadono, T.; Mitani, N. K.] Univ Occupat & Environm Hlth, Sch Med, Yahata, Kitakyusyu 8078555, Japan; [Suzuki, A. I.; Haruyama, J.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Wada, K.] Chiba Inst Technol, Planetary Explorat Res Ctr, Narashino, Chiba 2750016, Japan; [Yamamoto, S.] Natl Inst Environm Studies, Ctr Environm Measurement & Anal, Tsukuba, Ibaraki 3058506, Japan; [Arakawa, M.; Nakamura, A. M.] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan; [Sugita, S.] Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan	Kadono, T (reprint author), Univ Occupat & Environm Hlth, Sch Med, 1-1 Iseigaoka, Yahata, Kitakyusyu 8078555, Japan.	kadono@med.uoeh-u.ac.jp					ALLEN CC, 1977, PHYS EARTH PLANET IN, V15, P179, DOI 10.1016/0031-9201(77)90030-9; Andrews R. J., 1977, IMPACT EXPLOSION CRA, P1089; Wada K, 2006, ICARUS, V180, P528, DOI 10.1016/j.icarus.2005.10.002; GOLDHIRSCH I, 1993, PHYS REV LETT, V70, P1619, DOI 10.1103/PhysRevLett.70.1619; Labous L, 1997, PHYS REV E, V56, P5717, DOI 10.1103/PhysRevE.56.5717; Kudrolli A, 1997, PHYS REV LETT, V78, P1383, DOI 10.1103/PhysRevLett.78.1383; Hawke BR, 2004, ICARUS, V170, P1, DOI 10.1016/j.icarus.2004.02.013; Hermalyn B, 2010, ICARUS, V209, P866, DOI 10.1016/j.icarus.2010.05.025; Royer JR, 2009, NATURE, V459, P1110, DOI 10.1038/nature08115; FOERSTER SF, 1994, PHYS FLUIDS, V6, P1108, DOI 10.1063/1.868282; Barnouin-Jha OS, 1998, J GEOPHYS RES-PLANET, V103, P25739, DOI 10.1029/98JE02025; BarnouinJha OS, 1996, J GEOPHYS RES-PLANET, V101, P21099, DOI 10.1029/96JE01949; Barnouin-Jha OS, 1999, J GEOPHYS RES-PLANET, V104, P27105, DOI 10.1029/1999JE001026; Duran J., 2002, SABLES POUDRES GRAIN; Goldhirsch I, 2003, ANNU REV FLUID MECH, V35, P267, DOI 10.1146/annurev.fluid.35.101101.161114; Landau LD, 1987, FLUID MECH; MCNAMARA S, 1994, PHYS REV E, V50, pR28, DOI 10.1103/PhysRevE.50.R28; Melosh H.J., 1989, IMPACT CRATERING GEO; Mobius M. E., 2006, PHYS REV E, V74; Oberbeck V. R., 1971, Moon, V2, DOI 10.1007/BF00561880; Schmidt R. M., 1980, P LUNAR PLANET SCI C, V11, P2099; SCHULTZ PH, 1985, J GEOPHYS RES-SOLID, V90, P3701, DOI 10.1029/JB090iB05p03701; SCHULTZ PH, 1992, J GEOPHYS RES-PLANET, V97, P11623; Shuvalov V, 2012, METEORIT PLANET SCI, V47, P262, DOI [10.1111/J.1945-5100.2011.01324.x, 10.1111/j.1945-5100.2011.01324.x]; Suzuki AI, 2013, ICARUS, V225, P298, DOI 10.1016/j.icarus.2013.03.027	25	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0019-1035	1090-2643		ICARUS	Icarus	APR	2015	250						215	221		10.1016/j.icarus.2014.11.030		7	Astronomy & Astrophysics	Astronomy & Astrophysics	CB8KJ	WOS:000349878200018		
J	Nishino, MN; Saito, Y; Tsunakawa, H; Takahashi, F; Fujimoto, M; Harada, Y; Yokota, S; Matsushima, M; Shibuya, H; Shimizu, H				Nishino, Masaki N.; Saito, Yoshifumi; Tsunakawa, Hideo; Takahashi, Futoshi; Fujimoto, Masaki; Harada, Yuki; Yokota, Shoichiro; Matsushima, Masaki; Shibuya, Hidetoshi; Shimizu, Hisayoshi			Electrons on closed field lines of lunar crustal fields in the solar wind wake	ICARUS			English	Article						Moon; Solar wind; Magnetic fields	MAGNETIC-ANOMALIES; ONBOARD SELENE; MOON; CALIBRATION; SURFACE; KAGUYA; SHAPE; PACE	Plasma signature around crustal magnetic fields is one of the most important topics of the lunar plasma sciences. Although recent spacecraft measurements are revealing solar-wind interaction with the lunar crustal fields on the dayside, plasma signatures around crustal fields on the night side have not been fully studied yet. Here we show evidence of plasma trapping on the closed field lines of the lunar crustal fields in the solar-wind wake, using SELENE (Kaguya) plasma and magnetic field data obtained at 14-15 km altitude from the lunar surface. In contrast to expectation on plasma cavity formation at the strong crustal fields, electron flux is enhanced above Crisium Antipode (CA) anomaly which is one of the strongest lunar crustal fields. The enhanced electron fluxes above CA are characterised by (1) occasional bi-directional field-aligned beams in the lower energy range (<150 eV) and (2) a medium energy component (150-300 eV) that has a double loss-cone distribution representing bounce motion between the two footprints of the crustal magnetic fields. The low-energy electrons on the closed field lines may come from the lunar night side surface, while supply mechanism of medium-energy electrons on the closed field line remains to be solved. We also report that a density cavity in the wake is observed not above the strongest magnetic field but in its vicinity. (C) 2014 Elsevier Inc. All rights reserved.	[Nishino, Masaki N.] Nagoya Univ, Solar Terrestrial Environm Lab, Chikusa Ku, Aichi 4648601, Japan; [Saito, Yoshifumi; Fujimoto, Masaki; Yokota, Shoichiro] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Tsunakawa, Hideo; Matsushima, Masaki] Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; [Takahashi, Futoshi] Kyushu Univ, Fac Sci, Dept Earth & Planetary Sci, Higashi Ku, Fukuoka 8128581, Japan; [Harada, Yuki] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Shibuya, Hidetoshi] Kumamoto Univ, Kumamoto 8608555, Japan; [Shimizu, Hisayoshi] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	Nishino, MN (reprint author), Nagoya Univ, Solar Terrestrial Environm Lab, Chikusa Ku, Aichi 4648601, Japan.	mnishino@stelab.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [26400477]	The authors thank the principal investigators of Wind spacecraft for providing the solar wind data via CDAWeb. The authors also wish to express their grateful thanks to all the system members of the SELENE project. Prof. Kazuo Shiokawa is greatly acknowledged for fruitful discussion and suggestion. This work was supported by Grant-in-Aid for Scientific Research (C) No. 26400477 from Japan Society for the Promotion of Science (JSPS).	Saito Y, 2010, SPACE SCI REV, V154, P265, DOI 10.1007/s11214-010-9647-x; Wieser M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041721; Halekas JS, 2009, PLANET SPACE SCI, V57, P78, DOI 10.1016/j.pss.2008.11.009; DYAL P, 1974, REV GEOPHYS, V12, P568, DOI 10.1029/RG012i004p00568; Saito Y, 2012, EARTH PLANETS SPACE, V64, P83, DOI [10.5047/eps.2011.07.01, 10.5047/eps.2011.07.011]; Halekas JS, 2008, PLANET SPACE SCI, V56, P941, DOI 10.1016/j.pss.2008.01.008; Lue C, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046215; Takahashi F, 2009, EARTH PLANETS SPACE, V61, P1269; Tsunakawa H, 2010, SPACE SCI REV, V154, P219, DOI 10.1007/s11214-010-9652-0; Halekas JS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014428; Shue JH, 1997, J GEOPHYS RES-SPACE, V102, P9497, DOI 10.1029/97JA00196; Kurata M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024097; Purucker ME, 2008, ICARUS, V197, P19, DOI 10.1016/j.icarus.2008.03.016; Baumjohann W., 1997, BASIC SPACE PLASMA P; Borovsky J. E., 2008, J GEOPHYS RES, V113; Bosqued JM, 1996, GEOPHYS RES LETT, V23, P1259, DOI 10.1029/96GL00303; Deca J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.151102; DYAL P, 1972, NATURE, V236, P381, DOI 10.1038/236381a0; Halekas JS, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027684; Halekas J.S., 2008, J GEOPHYS RES, V113; Khazanov GV, 2011, ASTROPHYS SPACE SC L, V372, P541, DOI 10.1007/978-1-4419-6797-8; Nishino MN, 2012, PLANET SPACE SCI, V73, P161, DOI 10.1016/j.pss.2012.09.011; Richmond N. C., 2008, J GEOPHYS RES, V113; Saito Y, 2008, EARTH PLANETS SPACE, V60, P375; Schulz M., 1974, PARTICLE DIFFUSION R; Shimizu H, 2008, EARTH PLANETS SPACE, V60, P353; SLAVIN JA, 1981, J GEOPHYS RES-SPACE, V86, P1401, DOI 10.1029/JA086iA13p11401; Tsunakawa H, 2014, ICARUS, V228, P35, DOI 10.1016/j.icarus.2013.09.026	28	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0019-1035	1090-2643		ICARUS	Icarus	APR	2015	250						238	248		10.1016/j.icarus.2014.12.007		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CB8KJ	WOS:000349878200021		
J	Kamata, S; Sugita, S; Abe, Y; Ishihara, Y; Harada, Y; Morota, T; Namiki, N; Iwata, T; Hanada, H; Araki, H; Matsumoto, K; Tajika, E; Kuramoto, K; Nimmo, F				Kamata, Shunichi; Sugita, Seiji; Abe, Yutaka; Ishihara, Yoshiaki; Harada, Yuji; Morota, Tomokatsu; Namiki, Noriyuki; Iwata, Takahiro; Hanada, Hideo; Araki, Hiroshi; Matsumoto, Koji; Tajika, Eiichi; Kuramoto, Kiyoshi; Nimmo, Francis			The relative timing of Lunar Magma Ocean solidification and the Late Heavy Bombardment inferred from highly degraded impact basin structures	ICARUS			English	Article						Moon; Moon, interior; Impact processes; Thermal histories	PROCELLARUM KREEP TERRANE; TERRESTRIAL PLANETS; VISCOUS RELAXATION; INTERNAL STRUCTURE; CRUSTAL THICKNESS; THERMAL EVOLUTION; MANTLE CONVECTION; MOONS INTERIOR; MARE VOLCANISM; GRAVITY-FIELD	The solidification of the Lunar Magma Ocean (LMO) and formation of impact basins are important events that took place on the early Moon. The relative timing of these events, however, is poorly constrained. The aim of this study is to constrain the formation ages of old impact basins based on inferences of their thermal state. Most proposed basins formed before Pre-Nectarian (PN) 5 stage do not exhibit clear concentric features in either topography or gravity, suggesting substantial viscous lateral flow in the crust. Recent geodetic measurements reveal that the lunar crust is thinner than previously estimated, indicating that an extremely high crustal temperature is required for lateral flow to occur. In this study, we calculate lunar thermal evolution and viscoelastic deformation of basins and investigate the thermal state at the time of basin formation using recent crustal thickness models. We find that a Moho temperature >1300-1400 K at the time of basin formation is required for substantial viscous relaxation of topography to occur; the implied elastic thickness at the time of loading is <30 km. Such a high temperature can be maintained only for a short time (i.e., <50 Myr for most conditions) after solidification of the LMO or after mantle overturn if it took place; relaxed impact basins forming >= 150 Myr later than LMO solidification are unlikely. This result is in conflict with an intensive Late Heavy Bombardment (LHB) model, which assumes that most impact basins were formed at similar to 3.9 Ga, since it requires LMO solidification time much later than previous theoretical estimates. Either the LHB was moderate, or the majority of proposed early PN basins were not in fact formed by impacts. (C) 2014 Elsevier Inc. All rights reserved.	[Kamata, Shunichi; Nimmo, Francis] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Kamata, Shunichi] Hokkaido Univ, Dept Nat Hist Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Sugita, Seiji; Tajika, Eiichi] Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan; [Sugita, Seiji; Abe, Yutaka; Tajika, Eiichi] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Ishihara, Yoshiaki] Japan Aerosp Explorat Agcy, Lunar & Planetary Explorat Program Grp, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Harada, Yuji] China Univ Geosci, Sch Earth Sci, Planetary Sci Inst, Wuhan 430074, Hubei, Peoples R China; [Morota, Tomokatsu] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Namiki, Noriyuki; Araki, Hiroshi] Natl Astron Observ Japan, RISE Project Off, Mitaka, Tokyo 1818588, Japan; [Iwata, Takahiro] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, Sagamihara, Kanagawa 2525210, Japan; [Hanada, Hideo; Matsumoto, Koji] Natl Astron Observ Japan, RISE Project Off, Mizusawa Ku, Oshu, Iwate 0230861, Japan; [Kuramoto, Kiyoshi] Hokkaido Univ, Dept Cosmosci, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Kamata, S (reprint author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, 1156 High St, Santa Cruz, CA 95064 USA.	skamata@ucsc.edu			JSPS; JSPS KAKENHI [25120006, 26247092]; GRAIL Guest Scientist program [NNX12AL08G]	We thank P. McGovern and an anonymous reviewer for their careful reviews and constructive comments for improving this manuscript; M. Ohtake, Y. Karouji, S. Kobayashi, M. Hareyama, H. Nagaoka, Y. Sekine, Y. Cho, and J. Besserer for fruitful discussions; W. Bottke for his constructive comments; M. Wieczorek for making crustal thickness models available to the public. The GRAIL crustal thickness models we analyzed are available at www.ipgp.fr/wieczor/. Our spherical harmonic analyses were conducted using the software archive SHTOOLS (available at shtools.ipgp.fr). This work was supported by JSPS Grant-in-Aid for JSPS Fellows, JSPS KAKENHI Grant Nos. 25120006 and 26247092, and the GRAIL Guest Scientist program (NNX12AL08G).	Fassett CI, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003951; Shearer CK, 2006, REV MINERAL GEOCHEM, V60, P365, DOI 10.2138/rmg.2006.60.4; Melosh HJ, 2013, SCIENCE, V340, P1552, DOI [10.1126/science.1235768, 10.1126/science.1238663]; Mackwell SJ, 1998, J GEOPHYS RES-SOL EA, V103, P975, DOI 10.1029/97JB02671; Stoffler D, 2006, REV MINERAL GEOCHEM, V60, P519, DOI 10.2138/rmg.2006.60.05; SAGAN C, 1972, SCIENCE, V177, P52, DOI 10.1126/science.177.4043.52; Nakamura R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040765; Zuber MT, 2013, SCIENCE, V339, P668, DOI 10.1126/science.1231507; Hui HJ, 2013, NAT GEOSCI, V6, P177, DOI 10.1038/ngeo1735; Cohen BA, 2000, SCIENCE, V290, P1754, DOI 10.1126/science.290.5497.1754; Hartmann WK, 2003, METEORIT PLANET SCI, V38, P579; Bottke WF, 2012, NATURE, V485, P78, DOI 10.1038/nature10967; Morbidelli A, 2012, EARTH PLANET SC LETT, V355, P144, DOI 10.1016/j.epsl.2012.07.037; Laneuville M, 2013, J GEOPHYS RES-PLANET, V118, P1435, DOI 10.1002/jgre.20103; Spohn T, 2001, ICARUS, V149, P54, DOI 10.1006/icar.2000.6514; WARREN PH, 1985, ANNU REV EARTH PL SC, V13, P201, DOI 10.1146/annurev.ea.13.050185.001221; Wieczorek MA, 1999, ICARUS, V139, P246, DOI 10.1006/icar.1999.6102; MULLER PM, 1968, SCIENCE, V161, P680, DOI 10.1126/science.161.3842.680; Evans AJ, 2014, J GEOPHYS RES-PLANET, V119, P1061, DOI 10.1002/2013JE004494; Marchi S, 2012, EARTH PLANET SC LETT, V325, P27, DOI 10.1016/j.epsl.2012.01.021; PELTIER WR, 1974, REV GEOPHYS, V12, P649, DOI 10.1029/RG012i004p00649; VLAAR NJ, 1994, EARTH PLANET SC LETT, V121, P1, DOI 10.1016/0012-821X(94)90028-0; Nimmo F, 2001, J GEOPHYS RES-PLANET, V106, P5085, DOI 10.1029/2000JE001331; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Wieczorek MA, 2013, SCIENCE, V339, P671, DOI 10.1126/science.1231530; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Saal AE, 2008, NATURE, V454, P192, DOI 10.1038/nature07047; Sugano T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL022059; Elkins-Tanton LT, 2011, EARTH PLANET SC LETT, V304, P326, DOI 10.1016/j.epsl.2011.02.004; Nemchin A, 2009, NAT GEOSCI, V2, P133, DOI 10.1038/NGEO417; Wieczorek MA, 1998, J GEOPHYS RES-PLANET, V103, P1715, DOI 10.1029/97JE03136; Khan A, 2013, TECTONOPHYSICS, V609, P331, DOI 10.1016/j.tecto.2013.02.024; Jolliff BL, 2000, J GEOPHYS RES-PLANET, V105, P4197, DOI 10.1029/1999JE001103; TERA F, 1974, EARTH PLANET SC LETT, V22, P1, DOI 10.1016/0012-821X(74)90059-4; HESS PC, 1995, EARTH PLANET SC LETT, V134, P501, DOI 10.1016/0012-821X(95)00138-3; ZUBER MT, 1994, SCIENCE, V266, P1839, DOI 10.1126/science.266.5192.1839; Korotev RL, 1998, J GEOPHYS RES-PLANET, V103, P1691, DOI 10.1029/97JE03267; Warren PH, 2005, METEORIT PLANET SCI, V40, P477; Balcerski J.A., 2010, 41 P LUN PLAN SCI C; Besserer J., 2014, GEOPHYS RES LETT; CASSEN P, 1979, PHYS EARTH PLANET IN, V19, P183, DOI 10.1016/0031-9201(79)90082-7; Cook AC, 2000, J GEOPHYS RES-PLANET, V105, P12023, DOI 10.1029/1999JE001083; Crosby A, 2005, ICARUS, V173, P100, DOI 10.1016/j.icarus.2004.07.017; Dombard AJ, 2013, GEOPHYS RES LETT, V40, P28, DOI 10.1029/2012GL054310; Freed A.M., 2014, J GEOPHYS RES; FUKUYAMA H, 1985, EARTH PLANET SC LETT, V73, P407, DOI 10.1016/0012-821X(85)90088-3; Grimm RE, 2013, J GEOPHYS RES-PLANET, V118, DOI 10.1029/2012JE004114; Head JW, 2010, SCIENCE, V329, P1504, DOI 10.1126/science.1195050; Herzberg C, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000089; Ishihara Y, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039708; Ishihara Y., 2010, 41 P LUN PLAN SCI C; JOHANNES W, 1978, CONTRIB MINERAL PETR, V66, P295, DOI 10.1007/BF00373413; Kamata S, 2013, J GEOPHYS RES-PLANET, V118, P398, DOI 10.1002/jgre.20056; Kamata S, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003945; Karato SI, 2008, DEFORMATION OF EARTH MATERIALS: AN INTRODUCTION TO THE RHEOLOGY OF SOLID EARTH, P1, DOI 10.1017/CBO9780511804892; Konrad W, 1997, ADV SPACE RES-SERIES, V19, P1511, DOI 10.1016/S0273-1177(97)00364-5; Lawlis J., 1998, THESIS PENNSYLVANIA; Lemoine FGR, 1997, J GEOPHYS RES-PLANET, V102, P16339, DOI 10.1029/97JE01418; Lucey PG, 1998, J GEOPHYS RES-PLANET, V103, P3701, DOI 10.1029/97JE03146; McKenzie D, 2000, J GEOPHYS RES-SOL EA, V105, P11029, DOI 10.1029/1999JB900446; Meyer J, 2010, ICARUS, V208, P1, DOI 10.1016/j.icarus.2010.01.029; Mohit PS, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002654; Namiki N, 2009, SCIENCE, V323, P900, DOI 10.1126/science.1168029; Neumann GA, 1996, J GEOPHYS RES-PLANET, V101, P16841, DOI 10.1029/96JE01246; Rybacki E, 2000, J GEOPHYS RES-SOL EA, V105, P26017, DOI 10.1029/2000JB900223; Ryder G, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001583; Solomon S., 1977, P LUNAR PLANET SCI C, V8, P583; SOLOMON SC, 1982, J GEOPHYS RES, V87, P3975, DOI 10.1029/JB087iB05p03975; Stegman DR, 2003, NATURE, V421, P143, DOI 10.1038/nature01267; STEVENSON DJ, 1983, ICARUS, V54, P466, DOI 10.1016/0019-1035(83)90241-5; Stuart-Alexander D. E., 1970, Icarus, V12, DOI 10.1016/0019-1035(70)90013-8; Takeuchi H., 1972, METHODS COMPUTATIONA, V11, P217; THOMAS PJ, 1987, J GEOPHYS RES-SOLID, V92, pE749, DOI 10.1029/JB092iB04p0E749; Toksoz M.N., 1973, MOON, V7, P251, DOI 10.1007/BF00564634; Turcotte D. L., 2002, GEODYNAMICS; Wieczorek MA, 2000, J GEOPHYS RES-PLANET, V105, P20417, DOI 10.1029/1999JE001092; Wieczorek MA, 2001, GEOPHYS RES LETT, V28, P4023, DOI 10.1029/2001GL012918; Wilhelms D, 1987, 1348 US GEOL SURV; Wilhelms D.E., 1977, GEOLOGIC MAP E SIDE, P1; Zhong SJ, 2000, J GEOPHYS RES-PLANET, V105, P4153, DOI 10.1029/1999JE001075	80	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0019-1035	1090-2643		ICARUS	Icarus	APR	2015	250						492	503		10.1016/j.icarus.2014.12.025		12	Astronomy & Astrophysics	Astronomy & Astrophysics	CB8KJ	WOS:000349878200043		
J	Goda, T				Goda, Takashi			Constructing good higher order polynomial lattice rules with modulus of reduced degree	JOURNAL OF COMPLEXITY			English	Article						Quasi-Monte Carlo; Numerical integration; Higher order polynomial lattice rules; Weighted Sobolev spaces	ARBITRARY HIGH-ORDER; BY-COMPONENT CONSTRUCTION; FINITE-FIELDS; POINT SETS; ALGORITHMS; INTEGRATION; EFFICIENT; SPACES; NETS	In this paper we investigate multivariate integration in weighted unanchored Sobolev spaces of smoothness of arbitrarily high order. As quadrature points we employ higher order polynomial lattice point sets over F-2 which are randomly digitally shifted and then folded using the tent transformation. We first prove the existence of good higher order polynomial lattice rules which achieve the optimal rate of the mean square worst-case error, while reducing the required degree of modulus by half as compared to higher order polynomial lattice rules whose quadrature points are randomly digitally shifted but not folded using the tent transformation. Thus we are able to restrict the search space of generating vectors significantly. We then study the component-by-component construction as an explicit means of obtaining good higher order polynomial lattice rules. In a way analogous to Baldeaux et al. (2012), we show how to calculate the quality criterion efficiently and how to obtain the fast component-by-component construction using the fast Fourier transform. Our result generalizes the previous result shown by Cristea et al. (2007), in which the degree of smoothness is fixed at 2 and classical polynomial lattice rules are considered. (C) 2014 Elsevier Inc. All rights reserved.	Univ Tokyo, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	Goda, T (reprint author), Univ Tokyo, Grad Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	goda@frcer.t.u-tokyo.ac.jp			 [24-4020]	The author would like to thank two anonymous referees for their many helpful comments, which improved the presentation of this paper. This work was supported by Grant-in-Aid for JSPS Fellows No. 24-4020.	Sloan IH, 1998, J COMPLEXITY, V14, P1, DOI 10.1006/jcom.1997.0463; Dick J, 2007, SIAM J NUMER ANAL, V45, P2141, DOI 10.1137/060658916; Nuyens D, 2006, MATH COMPUT, V75, P903, DOI 10.1090/S0025-5718-06-01785-6; Baldeaux J, 2012, NUMER ALGORITHMS, V59, P403, DOI 10.1007/s11075-011-9497-y; Dick J, 2008, SIAM J NUMER ANAL, V46, P1519, DOI 10.1137/060666639; Baldeaux J, 2009, CONSTR APPROX, V30, P495, DOI 10.1007/s00365-009-9074-y; Baldeaux J, 2011, J COMPLEXITY, V27, P281, DOI 10.1016/j.jco.2010.06.002; Cristea LL, 2007, NUMER MATH, V105, P413, DOI 10.1007/s00211-006-0046-x; Dick J., 2010, DIGITLA NETS SEQUENC; Dick J, 2007, J COMPLEXITY, V23, P436, DOI 10.1016/j.jco.2007.02.001; Goda T., PREPRINT; Goda T., 2014, FDN COMPUT MATH; Goda T., 2014, NUMER ALGORITHMS; Hickernell FJ, 2002, MONTE CARLO AND QUASI-MONTE CARLO METHODS 2000, P274; Kritzer P, 2012, J NUMBER THEORY, V132, P2510, DOI 10.1016/j.jnt.2012.05.006; LARCHER G, 1993, ACTA ARITH, V63, P1; Niederreiter H., 1992, CBMS NSF SERIES APPL, V63; NIEDERREITER H, 1992, CZECH MATH J, V42, P143; Nuyens D, 2006, Monte Carlo and Quasi-Monte Carlo Methods 2004, P373, DOI 10.1007/3-540-31186-6_22; Nuyens D., PREPRINT; Sharygin I.F., 1963, ZH VYCH MAT MAT FIZ, V3, P370; Sloan I. H., 1994, LATTICE METHODS MULT	22	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0885-064X	1090-2708		J COMPLEXITY	J. Complex.	APR	2015	31	2					237	259		10.1016/j.jco.2014.09.005		23	Computer Science, Theory & Methods; Mathematics, Applied	Computer Science; Mathematics	CC1AM	WOS:000350073300005		
J	Iwagami, M; Yasunaga, H; Noiri, E; Horiguchi, H; Fushimi, K; Matsubara, T; Yahagi, N; Nangaku, M; Doi, K				Iwagami, Masao; Yasunaga, Hideo; Noiri, Eisei; Horiguchi, Hiromasa; Fushimi, Kiyohide; Matsubara, Takehiro; Yahagi, Naoki; Nangaku, Masaomi; Doi, Kent			Choice of renal replacement therapy modality in intensive care units: Data from a Japanese Nationwide Administrative Claim Database	JOURNAL OF CRITICAL CARE			English	Article						Acute kidney injury; Continuous renal replacement therapy; Intensive care unit; Intermittent renal replacement therapy	ACUTE KIDNEY INJURY; CRITICALLY-ILL PATIENTS; RANDOMIZED CLINICAL-TRIAL; INTERMITTENT HEMODIALYSIS; CONTINUOUS HEMOFILTRATION; INTERNATIONAL SURVEY; DIALYSIS MODALITY; CYTOKINE REMOVAL; SEPTIC PATIENTS; FAILURE	Purpose: This study was undertaken to assess recent trends of the choice of renal replacement therapy (RRT) modalities in Japanese intensive care units (ICUs). Materials and methods: Data were extracted from the Japanese Diagnosis Procedure Combination database for 2011. We identified adult patients without end-stage renal disease who had been admitted to ICUs for 3 days or longer and started continuous RRT (CRRT) or intermittent RRT (IRRT). Logistic regression was used to analyze which factors affected the modality choice. We further evaluated in-hospital mortality according to the choice of RRT. Results: Of 7353 eligible patients, 5854 (79.6%) initially received CRRT. The choice of CRRT was independently associated with sex (female), diagnosis of sepsis, hospital type (academic) and volume, vasoactive agents, mechanical ventilation, colloid administration, blood transfusion, intra-aortic balloon pumping, and venoarterial extracorporeal membrane oxygenation. Particularly, the number of vasoactive drugs was strongly associated with the CRRT choice. Overall in-hospital mortality in the CRRT group was higher than that in the IRRT group (50.0% vs 31.1%) and was increased when IRRT was switched to CRRT (59.1%). Conclusions: Continuous RRT is apparently preferred in actual ICU practice, especially for hemodynamically unstable patients, and subsequent RRT modality switch is associated with mortality. (C) 2014 Elsevier Inc. All rights reserved.	[Iwagami, Masao; Noiri, Eisei; Nangaku, Masaomi; Doi, Kent] Tokyo Univ Hosp, Dept Hemodialysis & Apheresis, Tokyo 113, Japan; [Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Noiri, Eisei] Tokyo Univ Hosp, Dept Nephrol & Endocrinol, Tokyo 113, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Clin Res Ctr, Dept Clin Data Management & Res, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Informat & Policy, Tokyo, Japan; [Matsubara, Takehiro; Yahagi, Naoki] Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Tokyo 113, Japan	Doi, K (reprint author), Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kdoi-tky@umin.ac.jp		Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation Grant) [H22-Policy-031]; Ministry of Education, Culture, Sports, Science and Technology, Japan [22390131]; Council for Science and Technology Policy, Japan (Funding Program for World-Leading Innovative R&D on Science and Technology, FIRST program Grant) [0301002001001]; Tokyo Society of Medical Sciences	This study was funded by grants from the Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation Grant No. H22-Policy-031), Ministry of Education, Culture, Sports, Science and Technology, Japan (Scientific Research B, No. 22390131), Council for Science and Technology Policy, Japan (Funding Program for World-Leading Innovative R&D on Science and Technology, FIRST program Grant No. 0301002001001), and the Tokyo Society of Medical Sciences. The funders had no role in the execution of this study or interpretation of results. The authors have no conflicts of interest to declare.	Overberger P, 2007, CLIN J AM SOC NEPHRO, V2, P623, DOI 10.2215/CJN.00780207; Cho KC, 2006, J AM SOC NEPHROL, V17, P3132, DOI 10.1681/ASN.2006030268; Ricci Z, 2011, CURR OPIN CRIT CARE, V17, P556, DOI 10.1097/MCC.0b013e32834cd360; Lins RL, 2009, NEPHROL DIAL TRANSPL, V24, P512, DOI 10.1093/ndt/gfn560; De Vriese AS, 1999, J AM SOC NEPHROL, V10, P846; Schneider AG, 2013, INTENS CARE MED, V39, P987, DOI 10.1007/s00134-013-2864-5; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; Pannu N, 2008, JAMA-J AM MED ASSOC, V299, P793, DOI 10.1001/jama.299.7.793; Vinsonneau C, 2006, LANCET, V368, P379, DOI 10.1016/S0140-6736(06)69111-3; Gatward JJ, 2008, ANAESTHESIA, V63, P959, DOI 10.1111/j.1365-2044.2008.05514.x; Legrand M, 2013, INTENS CARE MED, V39, P101, DOI 10.1007/s00134-012-2706-x; Schortgen F, 2000, AM J RESP CRIT CARE, V162, P197; Uchino S, 2006, CURR OPIN CRIT CARE, V12, P538, DOI 10.1097/01.ccx.0000247448.94252.5a; Uchino S, 2001, INTENS CARE MED, V27, P1037, DOI 10.1007/s001340100953; John S, 2001, NEPHROL DIAL TRANSPL, V16, P320, DOI 10.1093/ndt/16.2.320; Heering P, 1997, INTENS CARE MED, V23, P288, DOI 10.1007/s001340050330; Ricci Z, 2006, NEPHROL DIAL TRANSPL, V21, P690, DOI 10.1093/ndt/gfi296; Uchino S, 2007, INT J ARTIF ORGANS, V30, P281; Kellum JA, 2002, INTENS CARE MED, V28, P29, DOI 10.1007/s00134-001-1159-4; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Ghahramani N, 2008, NEPHROLOGY, V13, P570, DOI 10.1111/j.1440-1797.2008.00966.x; Guerin C, 2002, INTENS CARE MED, V28, P1411, DOI 10.1007/s00134-002-1433-0; Prowle JR, 2010, NAT REV NEPHROL, V6, P521, DOI 10.1038/nrneph.2010.100; Rabindranath K, 2007, COCHRANE DB SYST REV, V18; RENAL Study Investigators, 2008, CRIT CARE RESUSC, V10, P225; Ronco C, 2007, CLIN J AM SOC NEPHRO, V2, P597, DOI 10.2215/CJN.00430107; Ronco C, 1998, NEPHROL DIAL TRANSPL, V13, P79, DOI 10.1093/ndt/13.suppl_6.79; Schefold JC, 2014, CRIT CARE, V18, DOI 10.1186/cc13188; Swartz RD, 1999, AM J KIDNEY DIS, V34, P424, DOI 10.1016/S0272-6386(99)70068-5	29	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	APR	2015	30	2					381	385		10.1016/j.jcrc.2014.11.003		5	Critical Care Medicine	General & Internal Medicine	CB8WV	WOS:000349913800029		
J	Koley, P; Sakurai, M; Aono, M				Koley, Pradyot; Sakurai, Makoto; Aono, Masakazu			Tunable morphology from 2D to 3D in the formation of hierarchical architectures from a self-assembling dipeptide: thermal-induced morphological transition to 1D nanostructures	JOURNAL OF MATERIALS SCIENCE			English	Article							BIOMATERIALS; FABRICATION; STABILITY; CHEMISTRY; PEPTIDES; SURFACES; COMPLEX; DESIGN	Construction of complex three-dimensional (3D) architectures through hierarchical self-assembly of peptide molecules has become an attractive approach of fabricating multifunctional advanced materials due to their various potential applications in bionanotechnology. This paper describes the tunable formation of flower-like 3D hierarchical architectures of intricate morphology from a simple self-assembling dipeptide phenylalanine-tyrosine with a facile preparative method by applying a range of voltages through a drop of peptide solution. The fine-tuning of voltages and their application time enable to produce morphological changes of the microstructures from 2D to 3D and also control their formation. The morphology has been characterized by the gradual change in the height-to-diameter ratio of the microstructures with change in the applied voltages. Moreover, these microstructures show significant thermal stability over a wide range of temperatures, whereas adequately high temperature promotes the morphological transformation of the microstructures into different types of ultrathin 1D nanostructures such as nanowires, nanofibrils, etc. Furthermore, we have suggested a possible growth model for the fabrication of unique hierarchical architectures through diffusion-limited aggregation mechanism.	[Koley, Pradyot; Sakurai, Makoto; Aono, Masakazu] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan	Koley, P (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	koley.pradyot@nims.go.jp; sakurai.makoto@nims.go.jp			World Premier International Center (WPI) Initiative on Materials Nanoarchitectonics, MEXT, Japan; JPSP KAKENHI [24241047]	This work was supported in part by the World Premier International Center (WPI) Initiative on Materials Nanoarchitectonics, MEXT, Japan, and in part by JPSP KAKENHI (24241047).	Abramovich LA, 2014, CHEM SOC REV, V43, P6881; Abramovich LA, 2006, LANGMUIR, V22, P1313; Noorduin WL, 2013, SCIENCE, V340, P832, DOI 10.1126/science.1234621; Wiersma DS, 2013, NAT PHOTONICS, V7, P188, DOI [10.1038/nphoton.2013.29, 10.1038/NPHOTON.2013.29]; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; Palmer LC, 2008, ACCOUNTS CHEM RES, V41, P1674, DOI 10.1021/ar8000926; Su Y, 2010, J MATER CHEM, V20, P6734, DOI 10.1039/c0jm00110d; Williams RJ, 2009, NAT NANOTECHNOL, V4, P19, DOI [10.1038/nnano.2008.378, 10.1038/NNANO.2008.378]; Koley P, 2012, SOFT MATTER, V8, P5364, DOI 10.1039/c2sm25205h; Ge J, 2012, NAT NANOTECHNOL, V7, P428, DOI [10.1038/nnano.2012.80, 10.1038/NNANO.2012.80]; Ding Y, 2013, LANGMUIR, V29, P13299, DOI 10.1021/la4029639; Scheffel A, 2011, P NATL ACAD SCI USA, V108, P3175, DOI 10.1073/pnas.1012842108; Adams DJ, 2011, MACROMOL BIOSCI, V11, P160, DOI 10.1002/mabi.201000316; Yan XH, 2010, CHEM SOC REV, V39, P1877, DOI 10.1039/b915765b; Wang WP, 2009, SOFT MATTER, V5, P4893, DOI 10.1039/b919782f; Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Jeon TY, 2014, ADV MATER, V26, P1422, DOI 10.1002/adma.201304317; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Zelzer M, 2010, CHEM SOC REV, V39, P3351, DOI 10.1039/c0cs00035c; Gazit E, 2010, NAT CHEM, V2, P1010, DOI 10.1038/nchem.912; Yuran S, 2012, ACS NANO, V6, P9559, DOI 10.1021/nn302983e; Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h; Kwak J, 2013, LANGMUIR, V29, P4477, DOI 10.1021/la4003252; Lehn JM, 2013, ANGEW CHEM INT EDIT, V52, P2836, DOI 10.1002/anie.201208397; de la Rica R, 2010, CHEM SOC REV, V39, P3499, DOI 10.1039/b917574c; Kiyonaka S, 2004, NAT MATER, V3, P58, DOI 10.1038/nmat1034; Mason TO, 2014, ACS NANO, V8, P1243, DOI 10.1021/nn404237f; Wang AD, 2014, SOFT MATTER, V10, P3362, DOI 10.1039/c3sm53214c; Qin SY, 2012, LANGMUIR, V28, P2083, DOI 10.1021/la203518w; Mart RJ, 2006, SOFT MATTER, V2, P822, DOI 10.1039/b607706d; Koley P, 2011, ADV FUNCT MATER, V21, P4126, DOI 10.1002/adfm.201101465; Chu KH, 2010, NAT MATER, V9, P413, DOI 10.1038/nmat2726; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Ryu J, 2010, BIOTECHNOL BIOENG, V105, P221, DOI 10.1002/bit.22544; Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339; Nakanishi T, 2010, CHEM COMMUN, V46, P3425, DOI 10.1039/c001723j; Demirel G, 2011, LANGMUIR, V27, P12533, DOI 10.1021/la202750n; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; MATSUMURA M, 1988, NATURE, V334, P406, DOI 10.1038/334406a0; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Ball P, 1999, SELF MADE TAPESTRY; Hadjichristidis N, 2011, COMPLEX MACROMOLECULAR ARCHITECTURES: SYNTHESIS, CHARACTERIZATION, AND SELF-ASSEMBLY, P1, DOI 10.1002/9780470825150; Handelman A, 2012, PHYS CHEM CHEM PHYS, V14, P6391, DOI 10.1039/c2cp40157f; Jayawarna V., 2012, SUPRAMOL CHEM, V7, P3525; Koley P, 2012, SMALL, V8, P984, DOI 10.1002/smll.201101685; Koley P, 2014, J MATER SCI, V49, P2000, DOI 10.1007/s10853-013-7887-3; Marshall KE, 2012, PLOS ONE, V7; Panciera M, 2014, CHEM-EUR J, V20, P10260, DOI 10.1002/chem.201403319; Saito Y., 1996, STAT PHYS CRYSTAL GR; Sakurai M, 2014, CHEM COMMUN, V50, P12556, DOI 10.1039/c4cc05820h; Semin S, 2014, SMALL, DOI [10.1002/smll.201401602, DOI 10.1002/SMLL.201401602]; Surmacz-Chwedoruk W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086320; Tirrell D.A., 1994, HIERARCHICAL STRUCTU	54	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-2461	1573-4803		J MATER SCI	J. Mater. Sci.	APR	2015	50	8					3139	3148		10.1007/s10853-015-8875-6		10	Materials Science, Multidisciplinary	Materials Science	CB9RL	WOS:000349969800015		
J	Miyazaki, H; Ando, J; Nose, A; Suzuki, H; Ota, T				Miyazaki, Hidetoshi; Ando, Jun; Nose, Atsushi; Suzuki, Hisao; Ota, Toshitaka			Effects of a B2O3 additive on the sintering properties of WO3 ceramics	MATERIALS RESEARCH BULLETIN			English	Article						Ceramics; Microstructure; Electron microscopy; Dielectric properties	DIELECTRIC-PROPERTIES; TUNGSTEN TRIOXIDE; CUO	WO3 ceramics were sintered at various temperatures with a B2O3 additive, and WO3 sintering was observed at temperatures above the heat-treatment temperature of 900 degrees C. For the WO3 ceramic with B2O3 (heat-treated for 20 h), a dense microstructure with crystal facets was formed, while the numbers of pores decreased. The dielectric constant of the sintered WO3 ceramic with B2O3 additive was twice as large as that without B2O3. (C) 2015 Elsevier Ltd. All rights reserved.	[Miyazaki, Hidetoshi; Ando, Jun; Nose, Atsushi] Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan; [Suzuki, Hisao] Shizuoka Univ, Grad Sch Sci & Technol, Hamamatsu, Shizuoka 4328561, Japan; [Ota, Toshitaka] Nagoya Inst Technol, Ceram Res Lab, Tajimi, Gifu 5070071, Japan	Miyazaki, H (reprint author), Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, 1060 Nishikawatsu, Matsue, Shimane 6908504, Japan.	miya@riko.shimane-u.ac.jp					Ahn CW, 2006, J AM CERAM SOC, V89, P921, DOI 10.1111/j.1551-2916.2005.00823.x; Souza AG, 1999, J MATER SCI, V34, P1031, DOI 10.1023/A:1004544011638; Hirose T, 2006, PHYS STATUS SOLIDI A, V203, P608, DOI 10.1002/pssa.200521407; Huang CL, 2002, JPN J APPL PHYS 1, V41, P758, DOI 10.1143/JJAP.41.758; Maitra S, 2002, CERAM INT, V28, P819, DOI 10.1016/S0272-8842(02)00048-2; Miyazaki H, 2011, J CERAM SOC JPN, V119, P650, DOI 10.2109/jcersj2.119.650; Nose A, 2014, J CERAM SOC JPN, V122, P25, DOI 10.2109/jcersj2.122.25; PFEIFER J, 1994, J SOLID STATE CHEM, V111, P349, DOI 10.1006/jssc.1994.1238; Soshnikov L. E., 1995, Physics of the Solid State, V37	9	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0025-5408	1873-4227		MATER RES BULL	Mater. Res. Bull.	APR	2015	64						233	235		10.1016/j.materresbull.2014.12.076		3	Materials Science, Multidisciplinary	Materials Science	CB8KQ	WOS:000349878900038		
J	Taguchi, H; Kido, H; Kato, M; Hirota, K				Taguchi, Hideki; Kido, Hiroyasu; Kato, Masaki; Hirota, Ken			The crystal structure and electrical properties of K2NiF4-type (Ca2-xSmx)MnO4	MATERIALS RESEARCH BULLETIN			English	Article						Oxides; Sol-gel chemistry; X-ray diffraction; Crystal structure; Electrical properties	EFFECTIVE IONIC-RADII; CA2-XSMXMNO4; TRANSITION; MAGNETISM	K2NiF4-type (Ca2-xSmx)MnO4 (0.02 <= x <= 03) was synthesized using a polymerized complex route. The crystal structure changed from tetragonal to orthorhombic at x= 0.3. A variation in the lattice parameters was explained by the Mn-O(2) distance, the Mn-O(2)-Mn angle, and the (Ca,Sm)-(Ca,Sm) distance. The samples were n-type semiconductors, and the minimum values of electrical resistivity (rho) and an energy gap (E-g) at x=0.1 were accounted by electron transfer through an Mn-O(2) -Mn path and overlap between the Mnt(2g) and Op(pi) orbitals. In the sample (x= 0.3), the log rho-1000/T curve consisted of two different lines that intersected at ca. 325 K, and a peak was observed at ca. 315 K in the magnetic susceptibility-temperature curve. These results indicated the presence of a charge-ordering (CO) transition at 315-325K. (C) 2015 Elsevier Ltd. All rights reserved.	[Taguchi, Hideki] Okayama Univ, Grad Sch Nat Sci & Technol Sci, Kita Ku, Okayama 7008530, Japan; [Kido, Hiroyasu] Osaka Municipal Tech Res Inst, Jyoto Ku, Osaka 5368553, Japan; [Kato, Masaki; Hirota, Ken] Doshisha Univ, Fac Sci & Engn, Dept Mol Chem & Biochem, Kyotanabe 6100321, Japan	Taguchi, H (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol Sci, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	htaguchi@cc.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was financially supported by "Advanced Study for Integrated Particle Science and Technology", Strategic Development of Research Infrastructure for Private Universities, the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Alam S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205134; Castro-Couceiro A, 2005, SOLID STATE SCI, V7, P905, DOI 10.1016/j.solidstatesciences.2005.03.001; DAOUDI A, 1972, J SOLID STATE CHEM, V5, P57, DOI 10.1016/0022-4596(72)90009-6; Dekker A. J., 1957, SOLID STATE PHYS; Fawcett ID, 1998, CHEM MATER, V10, P3643, DOI 10.1021/cm980380b; Issaoui F, 2012, J SUPERCOND NOV MAGN, V25, P1169, DOI 10.1007/s10948-011-1386-z; LAUBITZ MJ, 1969, CAN J PHYS, V47, P2633; LINES ME, 1967, PHYS REV, V164, P736, DOI 10.1103/PhysRev.164.736; lzumi F., 2007, SOLID STATE PHENOM, V130, P15; MACCHESN.JB, 1967, PHYS REV, V164, P779, DOI 10.1103/PhysRev.164.779; Mihut AI, 1998, J PHYS-CONDENS MAT, V10, pL727, DOI 10.1088/0953-8984/10/45/001; Mott N F, 1974, METAL INSULATOR TRAN; Muller O, 1974, MAJOR TERNARY STRUCT; Nagai T, 2008, J ALLOY COMPD, V453, P247, DOI 10.1016/j.jallcom.2006.11.100; OLLIVIER G, 1975, PHYS STATUS SOLIDI A, V30, P383, DOI 10.1002/pssa.2210300140; Pechini M., 1967, U.S. Patent, Patent No. [330,697, 330697]; SAITO H, 1994, PHYSICA C, V235, P753, DOI 10.1016/0921-4534(94)91601-2; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SHANNON RD, 1969, ACTA CRYSTALL B-STRU, VB 25, P925, DOI 10.1107/S0567740869003220; Taguchi H, 2013, SOLID STATE SCI, V25, P22, DOI 10.1016/j.solidstatesciences.2013.07.017; Taguchi H, 1996, J SOLID STATE CHEM, V122, P297, DOI 10.1006/jssc.1996.0116; Taguchi H, 2001, PHYSICA B, V304, P38, DOI 10.1016/S0921-4526(01)00338-6; Takahashi J, 2006, J ALLOY COMPD, V408, P598, DOI 10.1016/j.jallcom.2004.12.150; TAKAHASHI J, 1993, J ALLOY COMPD, V192, P96, DOI 10.1016/0925-8388(93)90197-U; Tlili MT, 2011, J ALLOY COMPD, V509, P6447, DOI 10.1016/j.jallcom.2011.03.088; Yamashita T, 1996, PHYS REV B, V53, P14470, DOI 10.1103/PhysRevB.53.14470	26	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0025-5408	1873-4227		MATER RES BULL	Mater. Res. Bull.	APR	2015	64						318	322		10.1016/j.materresbull.2015.01.022		5	Materials Science, Multidisciplinary	Materials Science	CB8KQ	WOS:000349878900053		
J	Fujihara, K; Narita, K; Suzuki, Y; Takei, Y; Suda, M; Tagawa, M; Ujita, K; Sakai, Y; Narumoto, J; Near, J; Fukuda, M				Fujihara, Kazuyuki; Narita, Kosuke; Suzuki, Yusuke; Takei, Yuichi; Suda, Masashi; Tagawa, Minami; Ujita, Koichi; Sakai, Yuki; Narumoto, Jin; Near, Jamie; Fukuda, Masato			Relationship of gamma-aminobutyric acid and glutamate plus glutamine concentrations in the perigenual anterior cingulate cortex with performance of Cambridge Gambling Task	NEUROIMAGE			English	Article						Cambridge gambling task; Decision making; Magnetic resonance spectroscopy; gamma-Aminobutyric acid; Glutamate plus glutamine; Anterior cingulate cortex	IMPAIRED DECISION-MAKING; MAGNETIC-RESONANCE SPECTROSCOPY; PREFRONTAL CORTEX; IN-VIVO; BIPOLAR DISORDER; SCHIZOPHRENIA; DYSFUNCTION; QUANTITATION; ANTICIPATION; INDIVIDUALS	The anterior cingulate cortex (ACC), consisting of the perigenual ACC (pgACC) and mid-ACC (i.e., affective and cognitive areas, respectively), plays a significant role in the performance of gambling tasks, which are used to measure decision-making behavior under conditions of risk. Although recent neuroimaging studies have suggested that the gamma-aminobutyric acid (GABA) concentration in the pgACC is associated with decision-making behavior, knowledge regarding the relationship of GABA concentrations in subdivisions of the ACC with gambling task performance is still limited. The aim of our magnetic resonance spectroscopy study is to investigate in 20 healthy males the relationship of concentrations of GABA and glutamate + glutamine (Glx) in the pgACC, mid-ACC, and occipital cortex (OC) with multiple indexes of decision-making behavior under conditions of risk, using the Cambridge Gambling Task (CGT). The GABA/creatine (Cr) ratio in the pgACC negatively correlated with delay aversion score, which corresponds to the impulsivity index. The Glx/Cr ratio in the pgACC negatively correlated with risk adjustment score, which is reported to reflect the ability to change the amount of the bet depending on the probability of winning or losing. The scores of CGT did not significantly correlate with the GABA/Cr or Glx/Cr ratio in the mid-ACC or OC. Results of this study suggest that in the pgACC, but not in the mid-ACC or OC, GABA and Glx concentrations play a distinct role in regulating impulsiveness and risk probability during decision-making behavior under conditions of risk, respectively. (C) 2015 Elsevier Inc. All rights reserved.	[Fujihara, Kazuyuki; Narita, Kosuke; Suzuki, Yusuke; Takei, Yuichi; Suda, Masashi; Tagawa, Minami; Fukuda, Masato] Gunma Univ, Grad Sch Med, Dept Psychiat & Neurosci, Maebashi, Gumma 3718511, Japan; [Ujita, Koichi] Gunma Univ, Grad Sch Med, Dept Diagnost Radiol & Nucl Med, Maebashi, Gumma 3718511, Japan; [Sakai, Yuki; Narumoto, Jin] Kyoto Prefectural Univ Med, Dept Psychiat, Grad Sch Med, Kyoto, Japan; [Near, Jamie] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Near, Jamie] McGill Univ, Dept Psychiat, Montreal, PQ, Canada	Narita, K (reprint author), Gunma Univ, Grad Sch Med, Dept Psychiat & Neurosci, 3-39-22 Showa Machi, Maebashi, Gumma 3718511, Japan.	knarita.med.gunma.u@gmail.com			Ministry of Education, Culture, Sports, Science and Technology [23118001, 23118003]; Japan Society for the Promotion of Science [23390286, 23591695, 22659209, 256705094]; Health and Labour Sciences Research Grants for Comprehensive Research on Disability, Health and Welfare [H23-Seishin-Ippan-002]; Research on Applying Health Technology from the Ministry of Health, Labour and Welfare [H25-Seishin-Jitsuyouka-Ippan-002, H25-Jitsuyouka-Shitei-002]; Intramural Research Grants for Neurological and Psychiatric Disorders from the National Center for Neurology and Psychiatry [23-10, 24-1]	This work was supported by Grants-in-Aid for Scientific Research on Innovative Areas (Adolescent Mind and Self-Regulation; Nos. 23118001 and 23118003) from the Ministry of Education, Culture, Sports, Science and Technology; a Grant-in-Aid for Scientific Research (B) (No. 23390286); a Grant-in-Aid for Scientific Research (C) (No. 23591695); Grants-in-Aid for Challenging Exploratory Research (Nos. 22659209 and 256705094) from the Japan Society for the Promotion of Science, Health and Labour Sciences Research Grants for Comprehensive Research on Disability, Health and Welfare (No. H23-Seishin-Ippan-002) and Research on Applying Health Technology (Nos. H25-Seishin-Jitsuyouka-Ippan-002 and H25-Jitsuyouka-Shitei-002) from the Ministry of Health, Labour and Welfare; and Intramural Research Grants for Neurological and Psychiatric Disorders (Nos. 23-10 and 24-1) from the National Center for Neurology and Psychiatry.	Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Rudorf S, 2012, J NEUROSCI, V32, P16683, DOI 10.1523/JNEUROSCI.4235-11.2012; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Boy F, 2011, BIOL PSYCHIAT, V70, P866, DOI 10.1016/j.biopsych.2011.05.030; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; McIntyre RS, 2007, J AFFECT DISORDERS, V102, P27, DOI 10.1016/j.jad.2006.12.005; Larquet M, 2010, SCHIZOPHR RES, V116, P266, DOI 10.1016/j.schres.2009.11.010; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Anton RF, 1996, ARCH GEN PSYCHIAT, V53, P225; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Adinoff B, 2003, AM J PSYCHIAT, V160, P1892, DOI 10.1176/appi.ajp.160.10.1892; Cavedini P, 2002, BIOL PSYCHIAT, V51, P334, DOI 10.1016/S0006-3223(01)01227-6; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Shurman B, 2005, SCHIZOPHR RES, V72, P215, DOI 10.1016/j.schres.2004.03.020; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; DeVito EE, 2008, BIOL PSYCHIAT, V64, P636, DOI 10.1016/j.biopsych.2008.04.017; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; Le Berre AP, 2014, EUR PSYCHIAT, V29, P125, DOI 10.1016/j.eurpsy.2012.10.002; Kegeles LS, 2012, ARCH GEN PSYCHIAT, V69, P449, DOI 10.1001/archgenpsychiatry.2011.1519; Grant JE, 2011, PSYCHIAT RES, V189, P115, DOI 10.1016/j.psychres.2011.05.034; Ersche KD, 2005, PSYCHOPHARMACOLOGY, V180, P612, DOI 10.1007/s00213-005-2205-7; Deakin J, 2004, J INT NEUROPSYCH SOC, V10, P590, DOI 10.1017/S1355617704104104; Fukui H, 2005, NEUROIMAGE, V24, P253, DOI 10.1016/j.neuroimage.2004.08.028; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Frye MA, 2007, NEUROPSYCHOPHARMACOL, V32, P2490, DOI 10.1038/sj.npp.1301387; Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012; Li XR, 2010, HUM BRAIN MAPP, V31, P410, DOI 10.1002/hbm.20875; Jocham G, 2012, NAT NEUROSCI, V15, P960, DOI 10.1038/nn.3140; Chandler RA, 2009, BIOL PSYCHIAT, V66, P840, DOI 10.1016/j.biopsych.2009.05.011; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; Adler A, 2013, J NEUROSCI, V33, P4854, DOI 10.1523/JNEUROSCI.4791-12.2013; Woolrich Mark W, 2009, Neuroimage, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Epperson CN, 2006, PSYCHOPHARMACOLOGY, V186, P425, DOI 10.1007/s00213-006-0313-7; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Rahman S, 1999, BRAIN, V122, P1469, DOI 10.1093/brain/122.8.1469; Bauer J, 2013, NEUROPSYCHOPHARMACOL, V38, P1401, DOI 10.1038/npp.2013.45; Engelmann JB, 2009, BRAIN RES, V1290, P28, DOI 10.1016/j.brainres.2009.06.078; First MB, 1997, STRUCTURED CLIN INTE; First MB, 1996, STRUCTURED CLIN INTE; Hollingshead A. B., 1957, 2 FACTOR INDEX SOCIA; Linke J, 2013, BIOL PSYCHIAT, V74, P908, DOI 10.1016/j.biopsych.2013.04.010; Morris RC, 1987, COGNITIVE NEUROCHEMI, P21; Near J, 2013, NMR BIOMED, V26, P1353, DOI 10.1002/nbm.2960; Nelson HE, 1982, NATL ADULT READING T; Quetscher C., 2014, BRAIN STRUCT FUNCT; R Development Core Team, 2011, R LANG ENV STAT COMP; Silveri M.M., 2013, BIOL PSYCHIAT, V15, P296; Studer B., 2013, CEREB CORTEX, V25, P1; Studer B., 2012, FRONT NEUROSCI, V6, pe46; Vanhamme L, 2001, NMR BIOMED, V14, P233, DOI 10.1002/nbm.695; Yildiz A, 2014, HUM BRAIN MAPP, V35, P5040, DOI 10.1002/hbm.22530	59	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	APR 1	2015	109						102	108		10.1016/j.neuroimage.2015.01.014		7	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CB9SB	WOS:000349971600010		
J	Matsuzaki, N; Schwarzlose, RF; Nishida, M; Ofen, N; Asano, E				Matsuzaki, Naoyuki; Schwarzlose, Rebecca F.; Nishida, Masaaki; Ofen, Noa; Asano, Eishi			Upright face-preferential high-gamma responses in lower-order visual areas: Evidence from intracranial recordings in children	NEUROIMAGE			English	Article						High-frequency oscillations (HFOs); Ripples; Intracranial recording; Category-specific responses; Pediatric epilepsy surgery; ECoG	HUMAN CEREBRAL-CORTEX; ELECTRICAL-STIMULATION; DEVELOPMENTAL-CHANGES; EPILEPSY SURGERY; FOCAL EPILEPSY; EYE TRACKING; OSCILLATIONS; PERCEPTION; MRI; ELECTROCORTICOGRAPHY	Behavioral studies demonstrate that a face presented in the upright orientation attracts attention more rapidly than an inverted face. Saccades toward an upright face take place in 100-140 ms following presentation. The present study using electrocorticography determined whether upright face-preferential neural activation, as reflected by augmentation of high-gamma activity at 80-150 Hz, involved the lower-order visual cortex within the first 100 ms post-stimulus presentation. Sampled lower-order visual areas were verified by the induction of phosphenes upon electrical stimulation. These areas resided in the lateral-occipital, lingual, and cuneus gyri along the calcarine sulcus, roughly corresponding to V1 and V2. Measurement of high-gamma augmentation during central (circular) and peripheral (annular) checkerboard reversal pattern stimulation indicated that central-field stimuli were processed by the more polar surface whereas peripheral-field stimuli by the more anterior medial surface. Upright face stimuli, compared to inverted ones, elicited up to 23% larger augmentation of high-gamma activity in the lower-order visual regions at 40-90 ms. Upright face-preferential high-gamma augmentation was more highly correlated with high-gamma augmentation for central than peripheral stimuli. Our observations are consistent with the hypothesis that lower-order visual regions, especially those for the central field, are involved in visual cues for rapid detection of upright face stimuli. (C) 2015 Elsevier Inc. All rights reserved.	[Matsuzaki, Naoyuki; Nishida, Masaaki; Ofen, Noa; Asano, Eishi] Wayne State Univ, Childrens Hosp Michigan, Detroit Med Ctr, Dept Pediat, Detroit, MI 48201 USA; [Asano, Eishi] Wayne State Univ, Childrens Hosp Michigan, Detroit Med Ctr, Dept Neurol, Detroit, MI 48201 USA; [Schwarzlose, Rebecca F.; Ofen, Noa] Wayne State Univ, Inst Gerontol, Detroit, MI 48201 USA; [Nishida, Masaaki] Hanyu Gen Hosp, Dept Anesthesiol, Hanyu City, Saitama 3488505, Japan; [Schwarzlose, Rebecca F.] Cell Press, Trends Cognit Sci, Cambridge, MA 02139 USA	Asano, E (reprint author), Wayne State Univ, Childrens Hosp Michigan, Div Pediat Neurol, 3901 Beaubien St, Detroit, MI 48201 USA.	eishi@pet.wayne.edu			NIH [NS64033]; Children's Hospital of Michigan Foundation	This work was supported by NIH grant NS64033 (to E. Asano) as well as the intramural grant from Children's Hospital of Michigan Foundation (to E. Asano). We are grateful to Harry T. Chugani, MD, Sandeep Sood, MD, Csaba Juhasz, MD, PhD, Robert Rothermel, PhD, Yutaka Nonoda, MD, Nicole Goellnitz, RN, MSN, CPNP, and Carol Pawlak, REEG/EPT at Children's Hospital of Michigan, Wayne State University for the collaboration and assistance in performing the studies described above.	Valenza E, 1996, J EXP PSYCHOL HUMAN, V22, P892, DOI 10.1037/0096-1523.22.4.892; Parvizi J, 2012, J NEUROSCI, V32, P14915, DOI 10.1523/JNEUROSCI.2609-12.2012; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Summerfield C, 2006, CEREB CORTEX, V16, P500, DOI 10.1093/cercor/bhi129; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Levy I, 2001, NAT NEUROSCI, V4, P533; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/j.neuron.2004.11.018; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Alkonyi B, 2009, EPILEPSY RES, V87, P77, DOI 10.1016/j.eplepsyres.2009.08.002; Miller KJ, 2007, J NEUROSCI METH, V162, P303, DOI 10.1016/j.jneumeth.2007.01.019; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Yoshor D, 2007, CEREB CORTEX, V17, P2293, DOI 10.1093/cercor/bhl138; Ball T, 2009, NEUROIMAGE, V46, P708, DOI 10.1016/j.neuroimage.2009.02.028; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Asano E, 2009, BRAIN, V132, P1038, DOI 10.1093/brain/awp025; Scherf KS, 2007, DEVELOPMENTAL SCI, V10, pF15, DOI 10.1111/j.1467-7687.2007.00595.x; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Murphey DK, 2009, P NATL ACAD SCI USA, V106, P5389, DOI 10.1073/pnas.0804998106; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037//0033-295X.105.3.482; Jacobs J, 2009, BRAIN, V132, P1022, DOI 10.1093/brain/awn351; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; SCHNEIDER W, 1993, NATURE, V365, P150, DOI 10.1038/365150a0; Fukuda M, 2008, BRAIN, V131, P1793, DOI 10.1093/brain/awn100; Dalal SS, 2008, J NEUROSCI METH, V174, P106, DOI 10.1016/j.jneumeth.2008.06.028; Fletcher-Watson S, 2008, PERCEPTION, V37, P571, DOI 10.1068/p5705; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Asano E, 2009, NEUROIMAGE, V45, P477, DOI 10.1016/j.neuroimage.2008.12.003; Birmingham E, 2013, CHILD DEV, V84, P1407, DOI 10.1111/cdev.12039; Brown EC, 2008, NEUROIMAGE, V41, P1120, DOI 10.1016/j.neuroimage.2008.03.011; Crouzet S. M., 2010, J VIS, V10, P161, DOI 10.1167/10.4.1610/4/16; Crouzet SM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00342; Ekman P., 1976, PICTURES FACIAL AFFE; Engell AD, 2010, J NEUROSCI, V30, P8780, DOI 10.1523/JNEUROSCI.1575-10.2010; Golarai G., 2010, FRONT HUM NEUROSCI; Hochberg J., 1967, PSYCHON SCI, V9, P619; HORTON JC, 1991, BRAIN, V114, P1703, DOI 10.1093/brain/114.4.1703; Kim SE, 2013, CLIN NEUROPHYSIOL, V124, P2248, DOI 10.1016/j.clinph.2013.04.341; Kojima K, 2013, CLIN NEUROPHYSIOL, V124, P2368, DOI 10.1016/j.clinph.2013.05.030; Kojima K, 2013, CLIN NEUROPHYSIOL, V124, P857, DOI 10.1016/j.clinph.2012.09.031; Kojima K, 2013, CLIN NEUROPHYSIOL, V124, P1737, DOI 10.1016/j.clinph.2013.01.030; Korzeniewska A, 2011, NEUROIMAGE, V56, P2218, DOI 10.1016/j.neuroimage.2011.03.030; Kumar G, 2012, EPILEPSY BEHAV, V24, P264, DOI 10.1016/j.yebeh.2012.03.027; Matsuzaki N, 2012, NEUROIMAGE, V59, P1639, DOI 10.1016/j.neuroimage.2011.09.014; Mendola JD, 2013, J COGNITIVE NEUROSCI, V25, P62, DOI 10.1162/jocn_a_00296; Miller KJ, 2009, IEEE ENG MED BIO, P6465, DOI 10.1109/IEMBS.2009.5333546; Muzik O., 2007, INT J BIOMED IMAGING; Nagasawa T, 2011, NEUROIMAGE, V58, P1101, DOI 10.1016/j.neuroimage.2011.07.043; Papp N, 1977, Biomed Sci Instrum, V13, P135; Pieters TA, 2013, J NEUROSURG, V118, P1086, DOI 10.3171/2013.2.JNS121450; Quinn PC, 1998, J EXP CHILD PSYCHOL, V69, P151, DOI 10.1006/jecp.1998.2443; Quinn PC, 2009, CHILD DEV, V80, P151, DOI 10.1111/j.1467-8624.2008.01251.x; Uematsu M, 2013, NEUROIMAGE, V83, P224, DOI 10.1016/j.neuroimage.2013.06.046; Vaidya AR, 2014, COGNITION, V133, P443, DOI 10.1016/j.cognition.2014.07.004; Vidal J.R., 2010, FRONT HUM NEUROSCI, V2010; Wellmer J, 2002, EPILEPSIA, V43, P1543, DOI 10.1046/j.1528-1157.2002.30002.x; Woods D.L., 2003, ARCH NEUROBEHAVIORAL, V46; Wu HC, 2011, CLIN NEUROPHYSIOL, V122, P1929, DOI 10.1016/j.clinph.2011.03.011; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Zijlmans M, 2009, J NEUROL NEUROSUR PS, V80, P686, DOI 10.1136/jnnp.2008.154310	65	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	APR 1	2015	109						249	259		10.1016/j.neuroimage.2015.01.015		11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CB9SB	WOS:000349971600023		
J	Toyomura, A; Fujii, T; Kuriki, S				Toyomura, Akira; Fujii, Tetsunoshin; Kuriki, Shinya			Effect of an 8-week practice of externally triggered speech on basal ganglia activity of stuttering and fluent speakers	NEUROIMAGE			English	Article						Stuttering; Externally triggered speech; Self-paced speech; Basal ganglia; fMRI; Brain	DEEP BRAIN-STIMULATION; EVENT-RELATED FMRI; PARKINSONS-DISEASE; ACTIVATION PATTERNS; ALE METAANALYSIS; MOVEMENTS; NETWORK; ADULTS; ABNORMALITIES; CHILDREN	The neural mechanisms underlying stuttering are not well understood. It is known that stuttering appears when persons who stutter speak in a self-paced manner, but speech fluency is temporarily increased when they speak in unison with external trigger such as a metronome. This phenomenon is very similar to the behavioral improvement by external pacing in patients with Parkinson's disease. Recent imaging studies have also suggested that the basal ganglia are involved in the etiology of stuttering. In addition, previous studies have shown that the basal ganglia are involved in self-paced movement. Then, the present study focused on the basal ganglia and explored whether long-term speech-practice using external triggers can induce modification of the basal ganglia activity of stuttering speakers. Our study of functional magnetic resonance imaging revealed that stuttering speakers possessed significantly lower activity in the basal ganglia than fluent speakers before practice, especially when their speech was self-paced. After an 8-week speech practice of externally triggered speech using a metronome, the significant difference in activity between the two groups disappeared. The cerebellar vermis of stuttering speakers showed significantly decreased activity during the self-paced speech in the second compared to the first experiment. The speech fluency and naturalness of the stuttering speakers were also improved. These results suggest that stuttering is associated with defective motor control during self-paced speech, and that the basal ganglia and the cerebellum are involved in an improvement of speech fluency of stuttering by the use of external trigger. (C) 2015 Elsevier Inc. All rights reserved.	[Toyomura, Akira; Kuriki, Shinya] Tokyo Denki Univ, Adv Technol Res Ctr, Chiba 2701382, Japan; [Toyomura, Akira] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gunma 3718514, Japan; [Toyomura, Akira] Hokkaido Univ, Res & Educ Ctr Brain Sci, Sapporo, Hokkaido 0608638, Japan; [Fujii, Tetsunoshin] Hokkaido Univ, Dept Psychol, Sapporo, Hokkaido 0600810, Japan	Toyomura, A (reprint author), Gunma Univ, Grad Sch Hlth Sci, 3-39-22 Showa Machi, Maebashi, Gunma 3718514, Japan.	toyomura@rcat.dendai.ac.jp			JSPS KAKENHI [24680025, 24650138, 21700232]; Mitsubishi Foundation; Strategic Research Project for Private University from the Ministry of Education. [07H012]	The authors would like to thank Ms. Michiko Shimada, Mr. Takayuki Minami and other members of the Hokkaido Stuttering Genyukai Association for their support of this study. We are also grateful to Dr. Tohru Yamaguchi, Mr. Shuhei Bannae and Mr. Yojiro So for providing technical assistance. This study was supported by JSPS KAKENHI Grant Numbers 24680025, 24650138 and 21700232, the Mitsubishi Foundation, and Strategic Research Project (07H012) for Private University from the Ministry of Education.	Allert N, 2010, J NEURAL TRANSM, V117, P617, DOI 10.1007/s00702-010-0380-0; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; ANDREWS G, 1982, J SPEECH HEAR RES, V25, P208; Andrews G., 1964, SYNDROME STUTTERING; Beal DS, 2010, NEUROIMAGE, V52, P1645, DOI 10.1016/j.neuroimage.2010.04.277; Bhatnagar S, 2010, CURR NEUROL NEUROSCI, V10, P491, DOI 10.1007/s11910-010-0146-y; Fox PT, 1996, NATURE, V382, P158, DOI 10.1038/382158a0; Turner RS, 2010, CURR OPIN NEUROBIOL, V20, P704, DOI 10.1016/j.conb.2010.08.022; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; De Nil LF, 2003, J FLUENCY DISORD, V28, P357, DOI 10.1016/j.jfludis.2003.07.002; Chang SE, 2009, NEUROIMAGE, V46, P201, DOI 10.1016/j.neuroimage.2009.01.066; Beal DS, 2013, CORTEX, V49, P2151, DOI 10.1016/j.cortex.2012.08.013; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Ingham RJ, 2009, J SPEECH LANG HEAR R, V52, P1286, DOI 10.1044/1092-4388(2009/08-0181); Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; Kikuchi Y, 2011, NEUROIMAGE, V55, P891, DOI 10.1016/j.neuroimage.2010.12.083; Neumann K, 2005, J FLUENCY DISORD, V30, P23, DOI 10.1016/j.jfludis.2004.12.002; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Chang SE, 2013, BRAIN, V136, P3709, DOI 10.1093/brain/awt275; Taniwaki T, 2006, NEUROIMAGE, V31, P745, DOI 10.1016/j.neuroimage.2005.12.032; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; Nozaradan S, 2012, J NEUROSCI, V32, P17572, DOI 10.1523/JNEUROSCI.3203-12.2012; Lewis MM, 2007, NEUROSCIENCE, V147, P224, DOI 10.1016/j.neuroscience.2007.04.006; Beal DS, 2011, NEUROIMAGE, V54, P2994, DOI 10.1016/j.neuroimage.2010.11.026; Burghaus L, 2006, J NEURAL TRANSM, V113, P625, DOI 10.1007/s00702-005-0341-1; Kobayashi K, 2001, NEUROREPORT, V12, P353, DOI 10.1097/00001756-200102120-00034; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; Kell CA, 2009, BRAIN, V132, P2747, DOI 10.1093/brain/awp185; Neumann K, 2003, J FLUENCY DISORD, V28, P381, DOI 10.1016/j.jfludis.2003.07.003; Howe TE, 2003, CLIN REHABIL, V17, P363, DOI 10.1191/0269215503cr621oa; Lim I, 2005, CLIN REHABIL, V19, P695, DOI 10.1191/0269215505cr906oa; Nagy A, 2006, EUR J NEUROSCI, V24, P917, DOI 10.1111/j.1460-9568.2006.04942.x; Burock MA, 2000, HUM BRAIN MAPP, V11, P249, DOI 10.1002/1097-0193(200012)11:4<249::AID-HBM20>3.0.CO;2-5; Toyomura A, 2011, NEUROIMAGE, V57, P1507, DOI 10.1016/j.neuroimage.2011.05.039; MARTIN RR, 1984, J SPEECH HEAR DISORD, V49, P53; Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Civier O, 2013, BRAIN LANG, V126, P263, DOI 10.1016/j.bandl.2013.05.016; Belyk M, 2015, EUR J NEUROSCI, V41, P275, DOI 10.1111/ejn.12765; Bloodstein O., 2007, HDB STUTTERING; BRADY JP, 1969, BEHAV RES THER, V7, P197, DOI 10.1016/0005-7967(69)90033-3; Budde KS, 2014, BRAIN LANG, V139, P99, DOI 10.1016/j.bandl.2014.10.002; Cai SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041830; DeLong M R, 1984, Hum Neurobiol, V2, P235; De Nil LF, 2008, BRAIN LANG, V107, P114, DOI 10.1016/j.bandl.2008.07.003; Donaldson I., 2012, MARSDENS BOOK MOVEME; Etchell AC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00467; Francois-Brosseau FE, 2009, EUR J NEUROSCI, V29, P1277, DOI 10.1111/j.1460-9568.2009.06671.x; Guitar B, 2005, STUTTERING INTEGRATE, V3th; Horita H, 2008, EUR J NEUROSCI, V28, P2519, DOI 10.1111/j.1460-9568.2008.06535.x; Hove MJ, 2013, NEUROIMAGE, V67, P313, DOI 10.1016/j.neuroimage.2012.11.032; Jiang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039747; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Lu C, 2009, NEUROSCIENCE, V161, P1008, DOI 10.1016/j.neuroscience.2009.04.020; Lu CM, 2010, CORTEX, V46, P49, DOI 10.1016/j.cortex.2009.02.017; Nebel A, 2009, J NEURAL TRANSM, V116, P167, DOI 10.1007/s00702-008-0173-x; Onslow M, 2003, LIDCOMBE PROGRAM OF EARLY STUTTERING INTERVENTION: CLINICIANS GUIDE, P3; Riley G. D., 2009, STUTTERING SEVERITY; Seger Carol A, 2011, Front Syst Neurosci, V5, P66, DOI 10.3389/fnsys.2011.00066; Smits-Bandstra S, 2007, J FLUENCY DISORD, V32, P251, DOI 10.1016/j.jfludis.2007.06.001; Tani T, 2010, J FLUENCY DISORD, V35, P141, DOI 10.1016/j.jfludis.2010.03.001; Toft M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-44; Toyomura A, 2012, NEUROSCI LETT, V516, P39, DOI 10.1016/j.neulet.2012.03.049; Tsuboi T, 2014, J NEUROL NEUROSURG P; Van Riper C, 1982, NATURE STUTTERING; Walker HC, 2009, J SPEECH LANG HEAR R, V52, P1652, DOI 10.1044/1092-4388(2009/08-0089); Weber-Fox C, 2013, J FLUENCY DISORD, V38, P206, DOI 10.1016/j.jfludis.2013.01.001; Yairi E., 2005, EARLY CHILDHOOD STUT	71	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	APR 1	2015	109						458	468		10.1016/j.neuroimage.2015.01.024		11	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CB9SB	WOS:000349971600041		
J	Fukushima, M; Yamashita, O; Knosche, TR; Sato, MA				Fukushima, Makoto; Yamashita, Okito; Knoesche, Thomas R.; Sato, Masa-aki			MEG source reconstruction based on identification of directed source interactions on whole-brain anatomical networks (vol 105, pg 408, 2015)	NEUROIMAGE			English	Correction									[Fukushima, Makoto] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300101, Japan; [Fukushima, Makoto; Yamashita, Okito; Sato, Masa-aki] ATR, Neural Informat Anal Labs, Kyoto 6190288, Japan; [Yamashita, Okito] Brain Funct Imaging Technol Grp, CiNet, Osaka, Japan; [Knoesche, Thomas R.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany	Yamashita, O (reprint author), ATR, Neural Informat Anal Labs, 2-2-2 Hikaridai Seika Cho, Kyoto 6190288, Japan.	oyamashi@atr.jp					Fukushima M, 2015, NEUROIMAGE, V105, P408, DOI 10.1016/j.neuroimage.2014.09.066	1	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	APR 1	2015	109						529	529		10.1016/j.neuroimage.2015.01.020		1	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	CB9SB	WOS:000349971600047		
J	Ohta, T; Urayama, K; Tada, Y; Furue, T; Imai, S; Matsubara, K; Ono, H; Sakano, T; Jinno, K; Yoshida, Y; Miyata, T; Fujimura, Y				Ohta, Toshiyuki; Urayama, Kohtaro; Tada, Yoshihiro; Furue, Takeki; Imai, Sayaka; Matsubara, Keita; Ono, Hiroaki; Sakano, Takashi; Jinno, Kazuhiko; Yoshida, Yoko; Miyata, Toshiyuki; Fujimura, Yoshihiro			Eculizumab in the treatment of atypical hemolytic uremic syndrome in an infant leads to cessation of peritoneal dialysis and improvement of severe hypertension	PEDIATRIC NEPHROLOGY			English	Article						Plasmapheresis-resistant; Meningococcal infection; Prophylactic antibiotics; Vaccination; Pathological findings; Atypical hemolytic uremic syndrome; Anti-C5 therapy		Severe hypertension (HTN) and acute kidney injury frequently associated with atypical hemolytic uremic syndrome (aHUS) were refractory to various therapies in the pre-eculizumab era. Here we report the case of a 4-month-old boy who developed aHUS presenting with undetectable C3 protein, no predisposing mutations in complement factors, and no antibodies against factor H. Repeated plasma infusions and nine sessions of plasmapheresis were ineffective. The patient initially required continuous hemodiafiltration and thereafter peritoneal dialysis. Despite vigorous antihypertensive treatment and improved fluid overload with dialysis, HTN persisted. His low C3 level (< 20 mg/dl) suggested unrestricted complement activation. Therefore, based on the suspicion of unrestricted complement cascade in the pathogenesis, treatment with eculizumab, a human anti-C5 monoclonal antibody, was initiated with the aim of controlling disease activity. Eculizumab therapy resulted in the control of severe HTN and cessation of peritoneal dialysis. This infant with HTN and acute kidney injury associated with aHUS was treated successfully with eculizumab.	[Ohta, Toshiyuki; Furue, Takeki] Hiroshima Prefectural Hosp, Dept Pediat Nephrol, Minami Ku, Hiroshima, Hiroshima 7348530, Japan; [Urayama, Kohtaro; Imai, Sayaka; Matsubara, Keita; Ono, Hiroaki; Sakano, Takashi; Jinno, Kazuhiko] Hiroshima Prefectural Hosp, Dept Pediat, Minami Ku, Hiroshima, Hiroshima 7348530, Japan; [Tada, Yoshihiro] Hiroshima Prefectural Hosp, Dept Crit Care, Minami Ku, Hiroshima, Hiroshima 7348530, Japan; [Yoshida, Yoko; Fujimura, Yoshihiro] Nara Med Univ, Dept Blood Transfus Med, Kashihara, Nara 634, Japan; [Miyata, Toshiyuki] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka, Japan	Ohta, T (reprint author), Hiroshima Prefectural Hosp, Dept Pediat Nephrol, Minami Ku, 1-5-54 Ujina Kanda, Hiroshima, Hiroshima 7348530, Japan.	t-ohta@hph.pref.hiroshima.jp					Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Dorresteijn EM, 2012, PEDIATR NEPHROL, V27, P1193, DOI 10.1007/s00467-012-2130-z; Lapeyraque AL, 2011, PEDIATR NEPHROL, V26, P621, DOI 10.1007/s00467-010-1719-3; Ariceta G, 2012, AM J KIDNEY DIS, V59, P707, DOI 10.1053/j.ajkd.2011.11.027; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Ishikura K, 2013, NEPHROL DIAL TRANSPL, V28, P2345, DOI 10.1093/ndt/gfs611; Ram S, 2010, CLIN MICROBIOL REV, V23, P740, DOI 10.1128/CMR.00048-09; Vilalta R, 2012, PEDIATR NEPHROL, V27, P2323, DOI 10.1007/s00467-012-2276-8; Waters AM, 2011, PEDIATR NEPHROL, V26, P41, DOI 10.1007/s00467-010-1556-4; Ariceta G, 2009, PEDIATR NEPHROL, V24, P687, DOI 10.1007/s00467-008-0964-1; Bouts A, 2011, PEDIATR NEPHROL, V26, P1918; Fakhouri F, 2013, J AM SOC NEPHROL, V24, p49A; Garjau Maria, 2012, Clin Kidney J, V5, P31, DOI 10.1093/ndtplus/sfr157; Kim Jon Jin, 2012, Clin Kidney J, V5, P34, DOI 10.1093/ndtplus/sfr174; Laszik Z, 1996, RENAL BIOPSY INTERPR, P283; Nurnberger J, 2009, NEW ENGL J MED, V360, P542, DOI 10.1056/NEJMc0808527; Taylor CM, 2009, BRIT J HAEMATOL, V148, P37	18	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0931-041X	1432-198X		PEDIATR NEPHROL	Pediatr. Nephrol.	APR	2015	30	4					603	608		10.1007/s00467-014-2975-4		6	Pediatrics; Urology & Nephrology	Pediatrics; Urology & Nephrology	CB9SO	WOS:000349972900009		
J	Fujinaga, S; Sakuraya, K; Yamada, A; Urushihara, Y; Ohtomo, Y; Shimizu, T				Fujinaga, Shuichiro; Sakuraya, Koji; Yamada, Akifumi; Urushihara, Yasuko; Ohtomo, Yoshiyuki; Shimizu, Toshiaki			Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome	PEDIATRIC NEPHROLOGY			English	Article							LONG-TERM CYCLOSPORINE; RISK-FACTORS; SINGLE INFUSION; THERAPY; MAINTENANCE	Recent randomized studies indicate that mycophenolate mofetil (MMF) is inferior to cyclosporine (CsA) in preventing relapses of nephrotic syndrome (NS). During the last decade, rituximab (RTX) has emerged as a rescue therapy in patients with complicated, frequently relapsing, or steroid-dependent NS. After introducing RTX in our single center, we analyzed 26 patients with steroid-dependent NS who had relapses while receiving long-term CsA and who were subsequently switched to MMF. MMF was adjusted to maintain a targeted predose mycophenolic acid (MPA) level of 2-5 mu g/ml. Moreover, for patients who required MMF and high-dose prednisolone (PSL) to maintain remission, a single infusion of RTX (375 mg/m(2)) was added. The primary endpoint was the probability of achieving PSL-free remission for > 1 year. At a mean follow-up of 28.8 +/- 9.9 months, 11 of 26 patients (42 %) required RTX treatment, and 22 of those patients (85 %) achieved PSL-free sustained remission. The mean predose MPA levels for patients who achieved PSL-free sustained remission were significantly higher compared with those for patients who did not (3.1 mu g/ml vs. 1.7 mu g/ml, p < 0.05). After RTX introduction, most patients were able to switch from CsA to MMF and achieve sustained PSL-free remission.	[Fujinaga, Shuichiro; Sakuraya, Koji; Yamada, Akifumi; Urushihara, Yasuko] Saitama Childrens Med Ctr, Div Nephrol, Iwatsuki Ku, Saitama, Saitama, Japan; [Ohtomo, Yoshiyuki] Juntendo Nerima Hosp, Dept Pediat, Tokyo, Japan; [Shimizu, Toshiaki] Juntendo Univ, Dept Pediat, Sch Med, Urayasu, Japan	Fujinaga, S (reprint author), Saitama Childrens Med Ctr, Div Nephrol, Iwatsuki Ku, 2100 Magome, Saitama, Saitama, Japan.	f_shuich@d2.dion.ne.jp					Ishikura K, 2012, CLIN J AM SOC NEPHRO, V7, P1576, DOI 10.2215/CJN.00110112; Sellier-Leclerc AL, 2013, PEDIATR NEPHROL, V28, P1875, DOI 10.1007/s00467-013-2485-9; Chaumais MC, 2009, PEDIATR NEPHROL, V24, P1753, DOI 10.1007/s00467-009-1195-9; Fujinaga S, 2010, PEDIATR NEPHROL, V25, P539, DOI 10.1007/s00467-009-1377-5; Tellier S, 2013, PEDIATR NEPHROL, V28, P911, DOI 10.1007/s00467-012-2406-3; Gellermann J, 2013, J AM SOC NEPHROL, V24, P1689, DOI 10.1681/ASN.2012121200; Iijima K, 2002, KIDNEY INT, V61, P1801, DOI 10.1046/j.1523-1755.2002.00303.x; Ito S, 2011, PEDIATR NEPHROL, V26, P1823, DOI 10.1007/s00467-011-1886-x; Boyer O, 2013, NAT REV NEPHROL, V9, P562, DOI 10.1038/nrneph.2013.153; Dorresteijn EM, 2008, PEDIATR NEPHROL, V23, P2013, DOI 10.1007/s00467-008-0899-6; Fujinaga S, 2006, ARCH DIS CHILD, V91, P666, DOI 10.1136/adc.2005.080960; Fujinaga S, 2014, PEDIATR NEPHROL, V29, P491, DOI 10.1007/s00467-013-2674-6; Fujinaga S, 2009, CLIN NEPHROL, V72, P268; Fujinaga S, 2007, PEDIATR NEPHROL, V22, P71, DOI 10.1007/s00467-006-0294-0; Ishikura K, 2010, NEPHROL DIAL TRANSPL, V25, P3956, DOI 10.1093/ndt/gfq318; Kemper MJ, 2004, NEPHROL DIAL TRANSPL, V19, P1136, DOI 10.1093/ndt/gfh066; Trujillo JE, 2014, CLIN TRANSL ALLERGY, V28, P4	17	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0931-041X	1432-198X		PEDIATR NEPHROL	Pediatr. Nephrol.	APR	2015	30	4					687	691		10.1007/s00467-014-3034-x		5	Pediatrics; Urology & Nephrology	Pediatrics; Urology & Nephrology	CB9SO	WOS:000349972900019		
J	Chen, ZQ; Fukushima, M				Chen, Zhen-Qing; Fukushima, Masatoshi			One-point reflection	STOCHASTIC PROCESSES AND THEIR APPLICATIONS			English	Article						Boundary theory; One-point reflection; Excursion law; Local time; Dirichlet form; Brownian motion with darning; Conformal invariance; Harmonic functions	MARKOV-PROCESSES; BOUNDARY-CONDITIONS; BROWNIAN-MOTION; WEAK DUALITY; EXTENSIONS; DIFFUSIONS; EXCURSIONS	We examine symmetric extensions of symmetric Markov processes with one boundary point. Relationship among various normalizations of local times, entrance laws and excursion laws is studied. Dirichlet form characterization of elastic one-point reflection of symmetric Markov processes is derived. We give a direct construction of Walsh's Brownian motion as a one-point reflection together with its Dirichlet form characterization. This yields directly the analytic characterization of harmonic and subharmonic functions for Walsh's Brownian motion, recently obtained by Fitzsimmons and Kuter (2014) using a different method. We further study as a one-point reflection two-dimensional Brownian motion with darning (BMD). (C) 2014 Elsevier B.V. All rights reserved.	[Chen, Zhen-Qing] Univ Washington, Dept Math, Seattle, WA 98195 USA; [Fukushima, Masatoshi] Osaka Univ, Branch Math Sci, Toyonaka, Osaka 5600043, Japan	Chen, ZQ (reprint author), Univ Washington, Dept Math, Seattle, WA 98195 USA.	zqchen@uw.edu; fuku2@mx5.canvas.ne.jp			NSF [DMS-1206276]	We thank the referee for helpful comments, especially for the current proof of Theorem 3.1 which significantly simplifies our original proof. The first author's research was partially supported by NSF Grant DMS-1206276.	BARLOW M, 1989, LECT NOTES MATH, V1372, P275; Yano K, 2014, OSAKA J MATH, V51, P375; Bogdan K, 2003, PROBAB THEORY REL, V127, P89, DOI 10.1007/s00440-003-0275-1; Baxter J.R., 1984, CONT MATH, V26, P33; Blumental R.M., 2007, MARKOV PROCESSES POT; Blumenthal R. M., 1992, EXCURSIONS MARKOV PR; Burdzy K, 2006, MATH Z, V252, P103, DOI 10.1007/s00209-005-0849-y; Chen ZQ, 2007, J FUNCT ANAL, V252, P710, DOI 10.1016/j.jfa.2007.06.005; Chen ZQ, 2012, J MATH SOC JPN, V64, P1181, DOI 10.2969/jmsj/06441181; Chen ZQ, 2007, ABEL SYMP, V2, P153; Chen ZQ, 2008, PROBAB THEORY REL, V141, P61, DOI 10.1007/s00440-007-0080-3; Chen ZQ, 2006, ILLINOIS J MATH, V50, P269; Chen ZQ, 2009, P AM MATH SOC, V137, P3497; Chen Z.-Q., 2012, LECT NOTES TALKS GIV; Chen Z.-Q., 2012, SYMMETRIC MARKOV PRO; Chen Z.-Q., 2015, T AM MATH S IN PRESS; Drenning S., ARXIV11124123; Fitzsimmons P. J., 1996, ITOS STOCHASTIC CALC, P31; Fitzsimmons PJ, 2014, STOCH PROC APPL, V124, P2228, DOI 10.1016/j.spa.2014.02.005; FITZSIMMONS PJ, 2008, J THEOR PROBAB, V21, P246; Fitzsimmons PJ, 2006, ILLINOIS J MATH, V50, P413; Fukushima M., 2014, P MATH STAT IN PRESS, V100; Fukushima M., 2010, STOCHASTIC PROCESS A, V82, P590; Fukushima M, 2005, ANN I H POINCARE-PR, V41, P419, DOI 10.1016/j.anihpb.2004.10.004; Fukushima M, 2014, J MATH SOC JPN, V66, P289, DOI 10.2969/jmsj/06610289; Fukushima M., 2011, DIRICHLET FORMS SYMM; Getoor R. K., 1990, EXCESSIVE MEASURES; Ikeda N., 1989, STOCHASTIC DIFFERENT; Ito K., 1963, ILLINOIS J MATH, V7, P181; Ito K., 1970, P 6 BERK S MATH STAT, V3, P225; Lawler GF, 2006, ILLINOIS J MATH, V50, P701; MAISONNEUVE B, 1975, ANN PROBAB, V3, P399, DOI 10.1214/aop/1176996348; Meyer P.A., 1971, LECT NOTES MATH, V191, P177; Revuz D., 1999, CONTINUOUS MARTINGAL; Rogers L.C.G., 1983, PROBAB THEORY REL, V63, P237; SALISBURY TS, 1986, PROBAB THEORY REL, V73, P351, DOI 10.1007/BF00776238; Walsh J. B., 1978, ASTERISQUE, p[52, 37]; Watanabe S., 1979, BANACH CTR PUBLICATI, V5, P255	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-4149	1879-209X		STOCH PROC APPL	Stoch. Process. Their Appl.	APR	2015	125	4					1368	1393		10.1016/j.spa.2014.11.002		26	Statistics & Probability	Mathematics	CC1CI	WOS:000350078400008		
J	Asai, S; Limbeck, A				Asai, Shiho; Limbeck, Andreas			LA-ICP-MS of rare earth elements concentrated in cation-exchange resin particles for origin attribution of uranium ore concentrate	TALANTA			English	Article						Rare earth elements; Chondrite-normalized REE plot; Uranium ore concentrate; Cation-exchange resin; LA-ICP-MS; Nuclear forensics	PLASMA-MASS SPECTROMETRY	Rare earth elements (REE) concentrated on cation-exchange resin particles were measured with laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) to obtain chondrite-normalized REE plots. The sensitivity of REE increased in ascending order of the atomic number, according to the sensitivity trend in pneumatic nebulization ICP-MS (PN-ICP-MS). The signal intensities of REE were nearly proportional to the concentrations of REE in the immersion solution used for particle-preparation. Minimum measurable concentration calculated from the net signals of REE was approximately 1 ng/g corresponding to 0.1 ng in the particle-preparation solution. In LA analysis, formation of oxide and hydroxide of the light REE and Ba which causes spectral interferences in the heavy REE measurement was effectively attenuated due to the solvent-free measurement capability, compared to conventional PN-ICP-MS. To evaluate the applicability of the proposed method, the REE-adsorbed particles prepared by immersing them in a U-bearing solution (commercially available U standard solution) were measured with LA-ICP-MS. Aside from the LA analysis, each concentration of REE in the same U standard solution was determined with conventional PN-ICP-MS after separating REE by cation-exchange chromatography. The concentrations of REE were ranging from 0.04 (Pr) to 1.08 (Dy) mu g/g-U. The chondrite-normalized plot obtained through LA-ICP-MS analysis of the U standard sample exhibited close agreement with that obtained through the PN-ICP-MS of the REE-separated solution within the uncertainties. (C) 2014 Elsevier B.V. All rights reserved.	[Asai, Shiho] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan; [Limbeck, Andreas] Vienna Univ Technol, A-1060 Vienna, Austria	Asai, S (reprint author), Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan.	asai.shiho@jaea.go.jp					Gaboardi M, 2009, J ANAL ATOM SPECTROM, V24, P1188, DOI 10.1039/b900876d; Vorapalawut N, 2012, TALANTA, V97, P574, DOI 10.1016/j.talanta.2012.04.040; Varga Z, 2009, ANAL CHEM, V81, P8327, DOI 10.1021/ac901100e; Kristo MJ, 2013, NUCL INSTRUM METH B, V294, P656, DOI 10.1016/j.nimb.2012.07.047; Baker J, 2002, GEOCHIM COSMOCHIM AC, V66, P3635, DOI 10.1016/S0016-7037(02)00921-3; Varga Z, 2010, RADIOCHIM ACTA, V98, P771, DOI 10.1524/ract.2010.1777; Varga Z, 2010, TALANTA, V80, P1744, DOI 10.1016/j.talanta.2009.10.018; Krajko J, 2014, TALANTA, V129, P499, DOI 10.1016/j.talanta.2014.06.022; Gao Y, 2012, TALANTA, V92, P78, DOI 10.1016/j.talanta.2012.01.043; Gonzalezm C.H., 2005, TALANTA, V68, P47; Johnstone S., 2014, GEOCHIM COSMOCHIM AC, V109, P143; Palme H., 1988, REV MODERN ASTRONOMY, P28; Pourmand A., 2012, CHEM GEOL, V291, P28; Quemet A, 2012, TALANTA, V99, P207, DOI 10.1016/j.talanta.2012.05.041; Roudil D, 2012, PROCEDIA CHEM, V7, P709, DOI 10.1016/j.proche.2012.10.108; STRELOW FWE, 1965, ANAL CHEM, V37, P106, DOI 10.1021/ac60220a027; Vallandon M., 1998, P GOLDSCHM C TOUL FR, P1711	17	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-9140	1873-3573		TALANTA	Talanta	APR 1	2015	135						41	49		10.1016/j.talanta.2014.12.009		9	Chemistry, Analytical	Chemistry	CB6IM	WOS:000349730700007		
J	Zakaria, MR; Norrrahim, MNF; Hirata, S; Hassan, MA				Zakaria, Mohd Rafein; Norrrahim, Mohd Nor Faiz; Hirata, Satoshi; Hassan, Mohd Ali			Hydrothermal and wet disk milling pretreatment for high conversion of biosugars from oil palm mesocarp fiber	BIORESOURCE TECHNOLOGY			English	Article						Oil palm mesocarp fiber; Hydrothermal pretreatment; Hot compressed water; Wet disk milling pretreatment of biomass; Enzymatic hydrolysis	PHYSICOCHEMICAL PROPERTY CHANGES; ENHANCED ENZYMATIC-HYDROLYSIS; EMPTY FRUIT BUNCHES; SUPERHEATED STEAM; LIGNOCELLULOSIC BIOMASS; SULFURIC-ACID; RICE STRAW; SACCHARIFICATION; COMBINATION; YIELD	Eco-friendly pretreatment methods for lignocellulosic biomass are being developed as alternatives to chemical based methods. Superheated steam (SHS), hot compressed water (HCW) and wet disk milling (WDM) were used individually and with combination to partially remove hemicellulose and alter the lignin composition of recalcitrant structure of oil palm mesocarp fiber (OPMF). The efficiency of the pretreatment methods was evaluated based on the chemical compositions altered, SEM analysis, power consumption and degree of enzymatic digestibility. Hemicellulose removal (94.8%) was more pronounced under HCW compared to SHS, due to maximal contact of water and production of acetic acid which enhanced further degradation of hemicellulose. Subsequent treatment with WDM resulted in defibrillation of OPMF and expansion of the specific surface area thus increasing the conversion of cellulose to glucose. The highest glucose yield was 98.1% (g/g-substrate) when pretreated with HCW (200 degrees C, 20 min) and WDM which only consumed 9.6 MJ/kg of OPMF. (C) 2015 Elsevier Ltd. All rights reserved.	[Zakaria, Mohd Rafein; Hirata, Satoshi] Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, Hiroshima 7390046, Japan; [Zakaria, Mohd Rafein; Norrrahim, Mohd Nor Faiz; Hassan, Mohd Ali] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Bioproc Technol, Upm Serdang 43400, Selangor, Malaysia; [Hassan, Mohd Ali] Univ Putra Malaysia, Fac Engn, Dept Proc & Food Engn, Upm Serdang 43400, Selangor, Malaysia	Zakaria, MR (reprint author), Natl Inst Adv Ind Sci & Technol, Biomass Refinery Res Ctr, 3-11-32 Kagamiyama, Hiroshima 7390046, Japan.	rafein-zakaria@aist.go.jp			Science and Technology Research Partnership for Sustainable Development (SATREPS); Japan International Cooperation Agency (JICA); Japan Science and Technology Agency (JST)	This work is partly supported by the Science and Technology Research Partnership for Sustainable Development (SATREPS), organized by Japan Science and Technology Agency (JST) and Japan International Cooperation Agency (JICA). We are grateful to Seri Ulu Langat Palm Oil Mill for providing the raw materials. Special thanks to Ms. Yuuki Nishimoto for the technical assistance.	Teramoto Y, 2008, BIOTECHNOL BIOENG, V99, P75, DOI 10.1002/bit.21522; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Barakat A, 2014, APPL ENERG, V113, P97, DOI 10.1016/j.apenergy.2013.07.015; Yu QA, 2011, APPL ENERG, V88, P2472, DOI 10.1016/j.apenergy.2011.01.031; Xiao X, 2014, BIORESOURCE TECHNOL, V159, P41, DOI 10.1016/j.biortech.2014.02.096; Lee SH, 2010, BIORESOURCE TECHNOL, V101, P7218, DOI 10.1016/j.biortech.2010.04.069; Zakaria MR, 2014, APPL BIOCHEM BIOTECH, V173, P1778, DOI 10.1007/s12010-014-0964-5; Hideno A, 2009, BIORESOURCE TECHNOL, V100, P2706, DOI 10.1016/j.biortech.2008.12.057; Nazir MS, 2013, BIORESOURCES, V8, P2161; Yunos NSHM, 2012, BIORESOURCES, V7, P5983; Hideno A, 2012, BIORESOURCE TECHNOL, V104, P743, DOI 10.1016/j.biortech.2011.11.014; Zhang J, 2013, BIOENERG RES, V6, P35, DOI 10.1007/s12155-012-9226-y; Zakaria MR, 2015, BIORESOURCE TECHNOL, V176, P142, DOI 10.1016/j.biortech.2014.11.027; Miura T, 2012, BIORESOURCE TECHNOL, V126, P182, DOI 10.1016/j.biortech.2012.09.030; Nordin NIAA, 2013, MOLECULES, V18, P9132, DOI 10.3390/molecules18089132; Zakaria MR, 2014, BIORESOURCE TECHNOL, V169, P236, DOI 10.1016/j.biortech.2014.06.095; Bahrin EK, 2012, BIORESOURCES, V7, P1784; Bakar NKA, 2012, BIORESOURCES, V7, P3627; Barros RDRO, 2013, BIORESOURCE TECHNOL, V136, P288; Chang FX, 2012, WOOD SCI TECHNOL, V46, P393, DOI 10.1007/s00226-011-0416-0; Gao MT, 2012, BIOCHEM ENG J, V68, P152, DOI 10.1016/j.bej.2012.07.023; Inoue H, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-2; Mahmud NAN, 2013, BIORESOURCES, V8, P1320; Pu YQ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-15; Silva A. S. da, 2010, Bioresource Technology, V101, P7402; Sun Y., 2012, BIORESOURCE TECHNOL, V83, P1; Vancov T, 2012, APPL ENERG, V92, P421, DOI 10.1016/j.apenergy.2011.11.053; Weiqi Wei, 2013, Bioresour Technol, V128, P725, DOI 10.1016/j.biortech.2012.08.130; Yoshizaki T, 2013, J CLEAN PROD, V44, P1, DOI 10.1016/j.jclepro.2012.12.007; Zahari MAKM, 2014, J CLEAN PROD, V65, P252, DOI 10.1016/j.jclepro.2013.10.007	30	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0960-8524	1873-2976		BIORESOURCE TECHNOL	Bioresour. Technol.	APR	2015	181						263	269		10.1016/j.biortech.2015.01.072		7	Agricultural Engineering; Biotechnology & Applied Microbiology; Energy & Fuels	Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels	CB6ES	WOS:000349720300036		
J	Futamura, R; Ozeki, S; Iiyama, T				Futamura, Ryusuke; Ozeki, Sumio; Iiyama, Taku			An X-ray investigation of the adsorption of methane, water, and their mixtures in carbon micropores	CARBON			English	Article							METAL-ORGANIC FRAMEWORK; ACTIVATED CARBON; HYDROPHOBIC NANOSPACES; NEUTRON-DIFFRACTION; CONFINED WATER; GAS-STORAGE; PORE SIZES; HYDRATE; SCATTERING; NANOPORES	The adsorption of methane and water, and their coexisting state in carbon micropores were investigated by X-ray scattering measurements. The mechanisms of single-component adsorption of water and methane in the carbon micropores proceeded by cluster formation and micropore filling, respectively. The X-ray scattering of the coexisting state reveals that a mesoscopic phase separation occurred in the carbon micropores at 111 K because of the weak interaction between water and methane. At this low temperature, water molecules could not reform hydrogen bonds even with further adsorption of methane molecules. The X-ray scattering measurements provided detailed information on the coexisting state and can be used to study the temperature dependence of the phase behavior of the methane water system during methane hydration formation in nanospaces. (C) 2015 Elsevier Ltd. All rights reserved.	[Futamura, Ryusuke; Iiyama, Taku] Shinshu Univ, Ctr Energy & Environm Sci, Nagano 3808553, Japan; [Ozeki, Sumio; Iiyama, Taku] Shinshu Univ, Fac Sci, Dept Chem, Matsumoto, Nagano 3908621, Japan	Iiyama, T (reprint author), Shinshu Univ, Fac Sci, Dept Chem, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	tiiyama@shinshu-u.ac.jp			JSPS [24550017]	This research was supported by JSPS Grants-in-Aid for Scientific Research Number 24550017.	Ma SQ, 2008, J AM CHEM SOC, V130, P1012, DOI 10.1021/ja0771639; Uchida T, 2002, J PHYS CHEM B, V106, P820, DOI 10.1021/jp012823w; Perrin A, 2004, CARBON, V42, P1249, DOI 10.1016/j.carbon.2004.01.039; Uchida T, 1999, J PHYS CHEM B, V103, P3659, DOI 10.1021/jp984559l; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; KANEKO K, 1992, CARBON, V30, P1075, DOI 10.1016/0008-6223(92)90139-N; Li H, 1999, NATURE, V402, P276; Radhakrishnan R, 1999, J CHEM PHYS, V111, P9058, DOI 10.1063/1.480261; Radhakrishnan R, 2000, J CHEM PHYS, V112, P11048, DOI 10.1063/1.481745; DEBYE P, 1957, J APPL PHYS, V28, P679, DOI 10.1063/1.1722830; Kirchner MT, 2004, J AM CHEM SOC, V126, P9407, DOI 10.1021/ja049247c; Liu J, 2011, CARBON, V49, P3731, DOI 10.1016/j.carbon.2011.05.005; Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a; Celzard A, 2006, FUEL, V85, P957, DOI 10.1016/j.fuel.2005.10.019; Iiyama T, 1997, J PHYS CHEM B, V101, P3037, DOI 10.1021/jp962408h; DEBYE P, 1949, J APPL PHYS, V20, P518, DOI 10.1063/1.1698419; Fukano M, 2013, J PHYS CHEM C, V117, P5752, DOI 10.1021/jp311896q; CRACKNELL RF, 1993, J PHYS CHEM-US, V97, P494, DOI 10.1021/j100104a036; Najibi H, 2008, FUEL, V87, P7, DOI 10.1016/j.fuel.2007.03.044; Gogotsi Y, 2003, NAT MATER, V2, P591, DOI 10.1038/nmat957; KVENVOLDEN KA, 1988, CHEM GEOL, V71, P41, DOI 10.1016/0009-2541(88)90104-0; TAN ZM, 1990, J PHYS CHEM-US, V94, P6061, DOI 10.1021/j100378a079; Zhou YP, 2005, CARBON, V43, P2007, DOI 10.1016/j.carbon.2005.03.017; Liu DZ, 2007, P NATL ACAD SCI USA, V104, P9570, DOI 10.1073/pnas.0701352104; Jahnert S, 2008, PHYS CHEM CHEM PHYS, V10, P6039, DOI 10.1039/b809438c; Billemont P, 2011, LANGMUIR, V27, P1015, DOI 10.1021/la103107t; Tanaka A, 2010, J AM CHEM SOC, V132, P2112, DOI 10.1021/ja9087874; Iiyama T, 2004, COLLOID SURFACE A, V241, P207, DOI 10.1016/j.colsurfa.2004.04.008; Ohba T, 2005, NANO LETT, V5, P227, DOI 10.1021/nl048327b; JACKSON CL, 1990, J CHEM PHYS, V93, P9002, DOI 10.1063/1.459240; Kvenvolden KA, 2002, TERRA NOVA, V14, P302, DOI 10.1046/j.1365-3121.2002.00414.x; BEAUME R, 1984, SURF SCI, V137, pL117; BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020; Bomchil G, PHILOS T R SOC B; Futamura R, 2012, PHYS CHEM CHEM PHYS, V14, P981, DOI 10.1039/c1cp22954k; Futamura R, 2012, CHEM LETT, V41, P159, DOI 10.1246/cl.2012.159; Gregg SJ, 1982, ADSORPTION SURFACE A; Iiyama T, ADSORPT SCI TECHNOL; Iiyama T, 1997, CHEM PHYS LETT, V274, P152, DOI 10.1016/S0009-2614(97)00664-7; Liu DZ, 2008, J PHYS CHEM B, V112, P4309, DOI 10.1021/jp710331k; Miyawaki J, 1998, J PHYS CHEM B, V102, P2187, DOI 10.1021/jp980034h; Morishige K, J CHEM PHYS; Ohba T, 2004, J PHYS CHEM B, V108, P14964, DOI 10.1021/jp048323v; QUINN DF, 1992, CARBON, V30, P1097, DOI 10.1016/0008-6223(92)90141-I; RodrIguez-Reinoso F, J PHYS CHEM B; Sloan E.D., 1998, CLATHRATE HYDRATES N; VORA P, 1979, PHYS REV LETT, V43, P704, DOI 10.1103/PhysRevLett.43.704; Yamaguchi T, 2006, J MOL LIQ, V129, P57, DOI 10.1016/j.molliq.2006.08.003; Zhou L, 2002, AICHE J, V48, P2412, DOI 10.1002/aic.690481030; Zhou L, 2001, CARBON, V39, P773, DOI 10.1016/S0008-6223(01)00025-2	50	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0008-6223	1873-3891		CARBON	Carbon	APR	2015	85						8	15		10.1016/j.carbon.2014.12.043		8	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CB6GE	WOS:000349724700002		
J	Hu, C; Liu, ACY; Weyland, M; Madani, SH; Pendleton, P; Rodriguez-Reinoso, F; Kaneko, K; Biggs, MJ				Hu, Cheng; Liu, Amelia C. Y.; Weyland, Matthew; Madani, S. Hadi; Pendleton, Philip; Rodriguez-Reinoso, Francisco; Kaneko, Katsumi; Biggs, Mark J.			A multi-method study of the transformation of the carbonaceous skeleton of a polymer-based nanoporous carbon along the activation pathway	CARBON			English	Article							HIGHLY POROUS CHARS; KINETICALLY CONTROLLED CONDITIONS; TRANSMISSION ELECTRON-MICROSCOPE; ENERGY-LOSS SPECTROSCOPY; MEDIUM-RANGE ORDER; COAL CHAR; FLUCTUATION MICROSCOPY; HEAT-TREATMENT; MICROSTRUCTURAL CHANGES; CRYSTALLINE-STRUCTURE	The change in the carbonaceous skeleton of nanoporous carbons during their activation has received limited attention, unlike its counterpart process in the presence of an inert atmosphere. Here we adopt a multi-method approach to elucidate this change in a poly(furfuryl alcohol)-derived carbon activated using cyclic application of oxygen saturation at 250 degrees C before its removal (with carbon) at 800 degrees C in argon. The methods used include helium pycnometry, synchrotron-based X-ray diffraction (XRD) and associated radial distribution function (RDF) analysis, transmission electron microscopy (TEM) and, uniquely, electron energyloss spectroscopy spectrum-imaging (EELS-SI), electron nanodiffraction and fluctuation electron microscopy (FEM). Helium pycnometry indicates the solid skeleton of the carbon densifies during activation from 78% to 93% of graphite. RDF analysis, EELS-SI, and FEM all suggest this densification comes through an in-plane growth of sp(2) carbon out to the medium range without commensurate increase in order normal to the plane. This process could be termed 'graphenization'. The exact way in which this process occurs is not clear, but TEM images of the carbon before and after activation suggest it may come through removal of the more reactive carbon, breaking constraining cross-links and creating space that allows the remaining carbon material to migrate in an annealing-like process. (C) 2014 Elsevier Ltd. All rights reserved.	[Hu, Cheng; Biggs, Mark J.] Univ Adelaide, Sch Chem Engn, Adelaide, SA 5005, Australia; [Liu, Amelia C. Y.] Monash Univ, Sch Phys, Clayton, Vic 3800, Australia; [Liu, Amelia C. Y.; Weyland, Matthew] Monash Univ, Monash Ctr Elect Microscopy, Clayton, Vic 3800, Australia; [Weyland, Matthew] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia; [Madani, S. Hadi; Pendleton, Philip] Univ S Australia, Ian Wark Res Inst, Adelaide, SA 5095, Australia; [Pendleton, Philip] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia; [Rodriguez-Reinoso, Francisco] Univ Alicante, Dept Quim Inorgan, Lab Mat Avanzados, E-03080 Alicante, Spain; [Kaneko, Katsumi] Shinshu Univ, Ctr Energy & Environm Sci, Nagano 3808553, Japan; [Biggs, Mark J.] Univ Loughborough, Sch Sci, Loughborough LE11 3TU, Leics, England	Biggs, MJ (reprint author), Univ Loughborough, Sch Sci, Loughborough LE11 3TU, Leics, England.	m.biggs@lboro.ac.uk	Laboratory, Advanced Materials/I-7298-2015; 	Rodriguez-Reinoso, Francisco/0000-0002-4212-9860	China Scholarship Council (CSC); University of Adelaide; Australian Research Council Discovery Program [DP110101293]; Monash Centre for Electron Microscopy (MCEM), Monash University; Australian Research Council [LE0454166]; University of South Australia	C.H. acknowledges a joint scholarship provided by China Scholarship Council (CSC) and the University of Adelaide. The support of the Australian Research Council Discovery Program (DP110101293) is also gratefully acknowledged. ACYL gratefully acknowledges the support of the Science Faculty and the Monash Centre for Electron Microscopy (MCEM), Monash University. The electron microscopy was performed in the MCEM. The FEI Titan<SUP>3</SUP> 80-300 FEGTEM was funded by the Australian Research Council (LE0454166). S.H.M. acknowledges the award of a President's Scholarship from the University of South Australia. The authors thank Tim Petersen for many illuminating discussions. The XRD experiments were undertaken on the powder diffraction beam line at the Australian Synchrotron, Victoria, Australia.	Pikunic J, 2003, LANGMUIR, V19, P8565, DOI 10.1021/la034595y; Guo JJ, 2012, SMALL, V8, P3283, DOI 10.1002/smll.201200894; Farmahini AH, 2013, J PHYS CHEM C, V117, P14081, DOI 10.1021/jp403929r; GRUBER T, 1994, CARBON, V32, P1377, DOI 10.1016/0008-6223(94)90125-2; MARIWALA RK, 1994, IND ENG CHEM RES, V33, P607, DOI 10.1021/ie00027a018; Shim HS, 2000, CARBON, V38, P29, DOI 10.1016/S0008-6223(99)00096-2; Qajar A, 2013, CARBON, V60, P538, DOI 10.1016/j.carbon.2013.04.001; Zhao G, 2009, ULTRAMICROSCOPY, V109, P177, DOI 10.1016/j.ultramic.2008.10.006; Feng B, 2003, ENERG FUEL, V17, P744, DOI 10.1021/ef0202541; DAVIS KA, 1995, COMBUST FLAME, V100, P31, DOI 10.1016/0010-2180(94)00062-W; Zobelli A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.245402; Laffont L, 2004, CARBON, V42, P2485, DOI 10.1016/j.carbon.2004.04.043; BERGER SD, 1988, PHIL MAG LETT, V57, P285, DOI 10.1080/09500838808214715; Biscoe J, 1942, J APPL PHYS, V13, P364, DOI 10.1063/1.1714879; Daniels H, 2007, PHILOS MAG, V87, P4073, DOI 10.1080/14786430701394041; Sharma A, 1999, FUEL, V78, P1203, DOI 10.1016/S0016-2361(99)00046-0; Yazyev OV, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195420; Petkov V, 1999, PHILOS MAG B, V79, P1519, DOI 10.1080/13642819908218319; OBERLIN A, 1984, CARBON, V22, P521, DOI 10.1016/0008-6223(84)90086-1; O'Malley B, 1998, PHYS REV B, V57, P14148, DOI 10.1103/PhysRevB.57.14148; Russell NV, 1999, FUEL, V78, P803, DOI 10.1016/S0016-2361(98)00210-5; Bandosz TJ, 2003, CHEM PHYS CARBON, V28, P41; RUIKE M, 1994, J PHYS CHEM-US, V98, P9594, DOI 10.1021/j100089a038; Sharma A, 2002, ENERG FUEL, V16, P54, DOI 10.1021/ef0101513; Pastor-Villegas J, 1998, CARBON, V36, P1251, DOI 10.1016/S0008-6223(97)00200-5; KANTOROVICH II, 1994, COMBUST FLAME, V97, P79, DOI 10.1016/0010-2180(94)90117-1; SHI H, 1993, J APPL CRYSTALLOGR, V26, P827, DOI 10.1107/S0021889893003784; Treacy MMJ, 2005, REP PROG PHYS, V68, P2899, DOI 10.1088/0034-4885/68/12/R06; ISHIGURO T, 1991, COMBUST FLAME, V85, P1, DOI 10.1016/0010-2180(91)90173-9; Lu LM, 2002, FUEL, V81, P1215, DOI 10.1016/S0016-2361(02)00035-2; Suenaga K, 2010, NATURE, V468, P1088, DOI 10.1038/nature09664; Smith MA, 2004, CARBON, V42, P2041, DOI 10.1016/j.carbon.2004.04.009; Haverkamp RG, 2009, J SYNCHROTRON RADIAT, V16, P849, DOI 10.1107/S0909049509036723; Neimark AV, 2009, CARBON, V47, P1617, DOI 10.1016/j.carbon.2009.01.050; Emmerich FG, 1995, CARBON, V33, P1709, DOI 10.1016/0008-6223(95)00127-8; Bergamaschi A, 2009, NUCL INSTRUM METH A, V604, P136, DOI 10.1016/j.nima.2009.01.092; Hu C, 2014, CARBON, V78, P113, DOI 10.1016/j.carbon.2014.06.054; Chen XD, 2004, APPL PHYS LETT, V84, P2823, DOI 10.1063/1.1713048; Burket CL, 2006, CARBON, V44, P2957, DOI 10.1016/j.carbon.2006.05.029; Burian A, 1998, CARBON, V36, P1613, DOI 10.1016/S0008-6223(98)00131-6; Dahn JR, 1997, CARBON, V35, P825, DOI 10.1016/S0008-6223(97)00037-7; Feng B, 2002, CARBON, V40, P481, DOI 10.1016/S0008-6223(01)00137-3; Banhart F., 2010, ACS NANO, V5, P26, DOI DOI 10.1021/NN102598M; Burket CL, 2008, CARBON, V46, P501, DOI 10.1016/j.carbon.2007.12.016; Castro-Marcano F, 2012, ENERG FUEL, V26, P4336, DOI 10.1021/ef300364e; Dmowski W, 2011, J PHYS CHEM C, V116, P2946; Egami T, 2012, PERGAMON MATER SER, V16, P1; Egerton RF, 2011, ELECT ENERGY LOSS SP; FAN GY, 1987, ULTRAMICROSCOPY, V21, P125, DOI 10.1016/0304-3991(87)90079-9; FRANKLIN RE, 1951, PROC R SOC LON SER-A, V209, P196, DOI 10.1098/rspa.1951.0197; Furuta T, 1989, TANSO, V140, P241; Gregg SJ, 1982, ADSORPTION SURFACE A; Harris PJF, 2008, J PHYS CONDENS MATTE, V20; Hawelek L, 2008, DIAM RELAT MATER, V17, P1633, DOI 10.1016/j.diamond.2008.01.035; Hebert C, 2006, ULTRAMICROSCOPY, V106, P1139, DOI 10.1016/j.ultramic.2006.04.030; HURT RH, 1995, FUEL, V74, P1297, DOI 10.1016/0016-2361(95)00100-J; HURT RH, 1988, CARBON, V26, P433, DOI 10.1016/0008-6223(88)90142-X; Jeanne-Rose V, 2003, J MICROSC-OXFORD, V210, P53, DOI 10.1046/j.1365-2818.2003.01170.x; Johnson J.L., 1981, CHEM COAL UTILIZATIO, pP1491; Johnson JL, 1975, P NATL M AM CHEM SOC, V20, P85; KANTOROVICH II, 1994, COMBUST FLAME, V97, P61, DOI 10.1016/0010-2180(94)90116-3; Kantorovich II, 1997, COMBUST FLAME, V109, P521, DOI 10.1016/S0010-2180(97)00098-9; LEVENDIS YA, 1989, CARBON, V27, P265, DOI 10.1016/0008-6223(89)90133-4; Liu ACY, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205402; Marsh H, 1982, INT S TOYOH JAP, P81; Marsh H, 2006, ACTIVATED CARBON, P1; MARSH H, 1984, CARBON, V22, P413, DOI 10.1016/0008-6223(84)90014-9; MASTERS KJ, 1984, CARBON, V22, P595, DOI 10.1016/0008-6223(84)90095-2; NODA T, 1964, CARBON, V2, P127, DOI 10.1016/0008-6223(64)90052-1; NODA T, 1962, NATURE, V196, P772, DOI 10.1038/196772a0; OBERLIN A, 1983, J MICROSC-OXFORD, V132, P353; Palotas AB, 1996, ENERG FUEL, V10, P254, DOI 10.1021/ef950168j; Per Z, 2005, J PHYS CONDENS MATT, V17, P3509; Pikunic J, 2001, STUDIES SURFACE SCI, P647, DOI DOI 10.1016/S0167-2991(01)82174-1; Qiu X., 2004, J APPL CRYSTALLOGR, V37, P678, DOI DOI 10.1107/S0021889804011744; Rouquerol J., 2007, STUD SURF SCI CATAL, V160, P49, DOI DOI 10.1016/S0167-2991(07)80008-5; ROUZAUD JN, 1991, NATO ADV SCI I E-APP, V192, P257; Scherdel C, 2012, CARBON, V50, P3074, DOI 10.1016/j.carbon.2012.02.093; Sedghi S, CONTROL SPATIA UNPUB; SHA XZ, 1990, FUEL, V69, P1564, DOI 10.1016/0016-2361(90)90208-8; Song CW, 2008, SEP PURIF TECHNOL, V58, P412, DOI 10.1016/j.seppur.2007.05.019; Temleitner L, 2012, MATER RES BULL, V47, P4409, DOI 10.1016/j.materresbull.2012.09.040; Tran KN, 2008, ENERG FUEL, V22, P1902, DOI 10.1021/ef700732p; Urbonaite S, 2007, CARBON, V45, P2047, DOI 10.1016/j.carbon.2007.05.022; Voyles PM, 2002, ULTRAMICROSCOPY, V93, P147, DOI 10.1016/S0304-3991(02)00155-9; Zhang ZL, 2011, CARBON, V49, P5049, DOI 10.1016/j.carbon.2011.07.023	86	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0008-6223	1873-3891		CARBON	Carbon	APR	2015	85						119	134		10.1016/j.carbon.2014.12.051		16	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CB6GE	WOS:000349724700014		
J	Hu, C; Sedghi, S; Silvestre-Albero, A; Andersson, GG; Sharma, A; Pendleton, P; Rodriguez-Reinoso, F; Kaneko, K; Biggs, MJ				Hu, Cheng; Sedghi, Saeid; Silvestre-Albero, Ana; Andersson, Gunther G.; Sharma, Anirudh; Pendleton, Phillip; Rodriguez-Reinoso, Francisco; Kaneko, Katsumi; Biggs, Mark J.			Raman spectroscopy study of the transformation of the carbonaceous skeleton of a polymer-based nanoporous carbon along the thermal annealing pathway	CARBON			English	Article							ENERGY-LOSS SPECTROSCOPY; AMORPHOUS-CARBON; ACTIVATED CARBON; X-RAY; DISORDERED CARBONS; GRAPHENE; GRAPHITE; SPECTRA; GRAPHITIZATION; DEFECTS	We report a multi-wavelength Raman spectroscopy study of the structural changes along the thermal annealing pathway of a poly(furfuryl alcohol) (PFA) derived nanoporous carbon (NPC). The Raman spectra were deconvoluted utilizing G, D, D', A and TPA bands. The appropriateness of these deconvolutions was confirmed via recovery of the correct dispersive behaviours of these bands. It is proposed that the I-D/I-G ratio is composed of two parts: one associated with the extent of graphitic crystallites (the Tuinstra- Koenig relationship), and a second related to the inter-defect distance. This model was used to successfully determine the variation of the in-plane size and intra-plane defect density along the annealing pathway. It is proposed that the NPC skeleton evolves along the annealing pathway in two stages: below 1600 degrees C it was dominated by a reduction of in-plane defects with a minor crystallite growth, and above this temperature growth of the crystallites accelerates as the in-plane defect density approaches zero. A significant amount of transpolyacetylene (TPA)-like structures was found to be remaining even at 2400 degrees C. These may be responsible for resistance to further graphitization of the PFA-based carbon at higher temperatures. (C) 2015 Elsevier Ltd. All rights reserved.	[Hu, Cheng; Sedghi, Saeid; Biggs, Mark J.] Univ Adelaide, Sch Chem Engn, Adelaide, SA 5005, Australia; [Silvestre-Albero, Ana; Rodriguez-Reinoso, Francisco] Univ Alicante, Dept Quim Inorgan, Lab Mat Avanzados, E-03080 Alicante, Spain; [Andersson, Gunther G.; Sharma, Anirudh] Flinders Univ S Australia, Flinders Ctr NanoScale Sci & Technol, Adelaide, SA 5001, Australia; [Pendleton, Phillip] Univ S Australia, Ian Wark Res Inst, Adelaide, SA 5095, Australia; [Pendleton, Phillip] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia; [Kaneko, Katsumi] Shinshu Univ, Res Ctr Exot Nano Carbons, Nagano 3808553, Japan; [Biggs, Mark J.] Univ Loughborough, Sch Sci, Loughborough LE11 3TU, Leics, England	Biggs, MJ (reprint author), Univ Loughborough, Sch Sci, Loughborough LE11 3TU, Leics, England.	m.biggs@lboro.ac.uk	Laboratory, Advanced Materials/I-7298-2015; 	Rodriguez-Reinoso, Francisco/0000-0002-4212-9860	China Scholarship Council (CSC); University of Adelaide; International Postgraduate Research Scholarship (IPRS) from the University of Adelaide; Australian Research Council's Discovery Program [DP110101293]; Linkage Infrastructure, Equipment and Facilities Program [LE130100119]	C.H. acknowledges a joint scholarship provided by China Scholarship Council (CSC) and the University of Adelaide. S.S. acknowledges the award of International Postgraduate Research Scholarship (IPRS) from the University of Adelaide. The support of the Australian Research Council's Discovery Program (DP110101293) and Linkage Infrastructure, Equipment and Facilities Program (LE130100119) is also gratefully acknowledged.	Eckmann A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.035426; Balandin AA, 2011, NAT MATER, V10, P569, DOI [10.1038/nmat3064, 10.1038/NMAT3064]; Biniak S, 2001, CHEM PHYS CARBON, V27, P125; Pimenta MA, 2007, PHYS CHEM CHEM PHYS, V9, P1276, DOI 10.1039/b613962k; Sadezky A, 2005, CARBON, V43, P1731, DOI 10.1016/j.carbon.2005.02.018; Farmahini AH, 2013, J PHYS CHEM C, V117, P14081, DOI 10.1021/jp403929r; Harris PJF, 2013, J MATER SCI, V48, P565, DOI 10.1007/s10853-012-6788-1; GRUBER T, 1994, CARBON, V32, P1377, DOI 10.1016/0008-6223(94)90125-2; VIDANO RP, 1981, SOLID STATE COMMUN, V39, P341, DOI 10.1016/0038-1098(81)90686-4; Lucchese MM, 2010, CARBON, V48, P1592, DOI 10.1016/j.carbon.2009.12.057; Saito R, 2002, PHYSICA B, V323, P100, DOI 10.1016/S0921-4526(02)00992-4; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; Biscoe J, 1942, J APPL PHYS, V13, P364, DOI 10.1063/1.1714879; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Hang SJ, 2014, CARBON, V72, P233, DOI 10.1016/j.carbon.2014.01.071; DOYLE TE, 1995, PHYS REV B, V51, P196, DOI 10.1103/PhysRevB.51.196; TSU R, 1978, SOLID STATE COMMUN, V27, P507, DOI 10.1016/0038-1098(78)90382-4; Petkov V, 1999, PHILOS MAG B, V79, P1519, DOI 10.1080/13642819908218319; OBERLIN A, 1984, CARBON, V22, P521, DOI 10.1016/0008-6223(84)90086-1; Eckmann A, 2012, NANO LETT, V12, P3925, DOI 10.1021/nl300901a; Bandosz TJ, 2003, CHEM PHYS CARBON, V28, P41; Bogdanov K, 2014, CARBON, V73, P78, DOI 10.1016/j.carbon.2014.02.041; Ferrari AC, 2013, NAT NANOTECHNOL, V8, P235, DOI 10.1038/nnano.2013.46; Hawelek L, 2007, PHILOS MAG, V87, P4973, DOI 10.1080/14786430701594038; JAWHARI T, 1995, CARBON, V33, P1561, DOI 10.1016/0008-6223(95)00117-V; YOSHIKAWA M, 1988, J APPL PHYS, V64, P6464, DOI 10.1063/1.342063; Shimodaira N, 2002, J APPL PHYS, V92, P902, DOI 10.1063/1.1487434; Ferrari AC, 2000, PHYS REV B, V62, P11089, DOI 10.1103/PhysRevB.62.11089; Smith MA, 2004, CARBON, V42, P2041, DOI 10.1016/j.carbon.2004.04.009; WANG Y, 1990, CHEM MATER, V2, P557, DOI 10.1021/cm00011a018; CUESTA A, 1994, CARBON, V32, P1523, DOI 10.1016/0008-6223(94)90148-1; Hu C, 2014, CARBON, V78, P113, DOI 10.1016/j.carbon.2014.06.054; Loudon R, 2001, ADV PHYS, V50, P813, DOI 10.1080/00018730110101395; Cancado LG, 2011, NANO LETT, V11, P3190, DOI 10.1021/nl201432g; Burket CL, 2006, CARBON, V44, P2957, DOI 10.1016/j.carbon.2006.05.029; Harris PJF, 2005, CRIT REV SOLID STATE, V30, P235, DOI 10.1080/10408430500406265; Lehtinen O, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.153401; Banhart F., 2010, ACS NANO, V5, P26, DOI DOI 10.1021/NN102598M; Bevington P. R., 2003, DATA REDUCTION ERROR; Burian A, 2001, PHILOS MAG B, V81, P525, DOI 10.1080/13642810110044988; Burket CL, 2008, CARBON, V46, P501, DOI 10.1016/j.carbon.2007.12.016; Cancado LG, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196057; Cancado LG, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.064304; Casiraghi C, PHYS REV B; Dallas TEJ, 1996, THESIS TEXAS TU; Dmowski W, 2011, J PHYS CHEM C, V116, P2946; Dresselhaus MS, PHILOS T R SOC A; El-Barbary AA, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.144107; Ferrari AC, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.075414; Ferrari AC, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.121405; Franklin RE, 1957, P R SOC A, V1097, P196; Guo J, 2012, SMALL, V8, P3283; Harris PJF, 2008, J PHYS CONDENS MATTE, V20; Hawelek L, 2008, DIAM RELAT MATER, V17, P1633, DOI 10.1016/j.diamond.2008.01.035; Jorio A, 2009, PHYS STATUS SOLIDI B, V246, P2689, DOI 10.1002/pssb.200982314; Kim C, 2003, J MATER SCI, V38, P2987, DOI 10.1023/A:1024429828872; Li L, PHYS REV B; Marsh H, 2006, ACTIVATED CARBON, P1; OBERLIN A, 1980, CARBON, V18, P347, DOI 10.1016/0008-6223(80)90006-8; Osipov VY, 2011, DIAM RELAT MATER, V20, P205, DOI 10.1016/j.diamond.2010.12.006; Powles RC, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.075430; RAO AM, 1992, J MATER RES, V7, P1788, DOI 10.1557/JMR.1992.1788; SAITO R, 2001, PHYS REV LETT, V88, P7401, DOI 10.1103/PhysRevLett.88.027401; Seber G. A. F., 2003, NONLINEAR REGRESSION; Valeri P., 2011, J PHYS CONDENS MATT, V23; Vazquez-Santos M.B., 2011, J PHYS CHEM C, V116, P257; Wang ZX, 1998, J APPL PHYS, V84, P227, DOI 10.1063/1.368022; Zhang ZL, 2011, CARBON, V49, P5049, DOI 10.1016/j.carbon.2011.07.023	68	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0008-6223	1873-3891		CARBON	Carbon	APR	2015	85						147	158		10.1016/j.carbon.2014.12.098		12	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CB6GE	WOS:000349724700016		
J	Wang, SW; Kaneko, K				Wang, Shuwen; Kaneko, Katsurni			CO2-pressure swing activation for efficient production of highly porous carbons	CARBON			English	Article							PARTICLES; POROSITY	In this work, we describe a new type of activation method of carbon materials using pressure swing of CO2. The porosity development markedly depends on the pressure swinging frequency. The porous carbon obtained from pressure-swing activation shows an additional porosity development without pitting corrosion on the surface, which occurs on CO2 activation without pressure-swing. This phenomenon is ascribed to the enhancement of Knudsen diffusion and/or configurational diffusion of CO2 which is caused by an exterior stimulus from the pressure swing. (C) 2015 Elsevier Ltd. All rights reserved.	[Wang, Shuwen; Kaneko, Katsurni] Shinshu Univ, Ctr Energy & Environm Sci, Wakasato, Nagano 3808553, Japan	Wang, SW (reprint author), Shinshu Univ, Ctr Energy & Environm Sci, Wakasato, Nagano 3808553, Japan.	kkaneko@shinshu-u.ac.jp			Concert-Japan: Efficient Energy Storage and Distribution, JST;  [24241038]	S.W. is supported by Concert-Japan: Efficient Energy Storage and Distribution, JST. This work is partially supported by Grant-in-Aid for Scientific Research (A) (24241038).	KANEKO K, 1992, CARBON, V30, P1075, DOI 10.1016/0008-6223(92)90139-N; Py X, 2003, CARBON, V41, P1533, DOI 10.1016/S0008-6223(03)00092-7; Fujimori T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3162; MALONE DM, 1978, CHEM ENG SCI, V33, P1429, DOI 10.1016/0009-2509(78)85192-6; Robau-Sanchez A, 2003, CARBON, V41, P693, DOI 10.1016/S0008-6223(02)00383-4; Thomas JM, 1997, PRINCIPLES PRACTICE, P291	6	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0008-6223	1873-3891		CARBON	Carbon	APR	2015	85						245	248		10.1016/j.carbon.2015.01.004		4	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CB6GE	WOS:000349724700027		
J	Hayashida, K; Matsuoka, Y				Hayashida, Kenichi; Matsuoka, Yoriko			Electromagnetic interference shielding properties of polymer-grafted carbon nanotube composites with high electrical resistance	CARBON			English	Article							SANDWICH STRUCTURES; LOW PERCOLATION; ASPECT-RATIO; CONDUCTIVITY; LIGHTWEIGHT; ABSORPTION; NANOCOMPOSITES; FABRICATION; FILMS	Poly(methyl methacrylate) (PMMA)-grafted multiwalled CNTs were prepared, and then dispersed into additional PMMA matrix, yielding highly insulated PMMA-CNT composites. The volume resistivity of PMMA-CNT was as high as 1.3 x 10(15) Omega cm even at 7.3 wt% of the CNT. The individual CNTs electrically-isolated by the grafted PMMA chains in PMMA-CNT transmitted electromagnetic (EM) waves in the frequency range of 0.001-1 GHz, whereas the percolated CNTs in a conventional composite prepared by blending PMMA with the pristine CNTs strongly shielded the EM waves. This result suggests that the intrinsic conductivity of the CNT itself in PMMA-CNT does not contribute to the EM interference (EMI) shielding in the frequency range of 0.001-1 GHz. On the other hand, PMMA-CNT exhibited EMI shielding at the higher frequency range than 1 GHz because the dielectric loss of the CNT itself was rapidly increased over 1 GHz. At 110 GHz, PMMA-CNT with 7.3 wt% of the CNT had EMI SE of as high as 29 dB (0.57 mm thickness), though is slightly lower than that of the percolated conventional composite (35 dB). Thus, it is demonstrated that the highly insulated PMMA-CNT has the good EMI shielding at extremely high frequency range (30-300 GHz). (C) 2015 Elsevier Ltd. All rights reserved.	[Hayashida, Kenichi] Toyota Cent Res & Dev Labs Inc, Mat & Proc Dept 2, Nagakute, Aichi 4801192, Japan; [Matsuoka, Yoriko] Toyota Cent Res & Dev Labs Inc, Mat Anal & Evaluat Dept, Nagakute, Aichi 4801192, Japan	Hayashida, K (reprint author), Toyota Cent Res & Dev Labs Inc, Mat & Proc Dept 2, Nagakute, Aichi 4801192, Japan.	e1440@mosk.tytlabs.co.jp					Liu XM, 2014, CARBON, V68, P501, DOI 10.1016/j.carbon.2013.11.027; Liu ZF, 2007, CARBON, V45, P821, DOI 10.1016/j.carbon.2006.11.020; Connor MT, 1998, PHYS REV B, V57, P2286, DOI 10.1103/PhysRevB.57.2286; Yang YL, 2005, NANO LETT, V5, P2131, DOI 10.1021/nl051375r; Qin F, 2012, J APPL PHYS, V111, DOI 10.1063/1.3688435; Maiti S, 2014, RSC ADV, V4, P7979, DOI 10.1039/c3ra46480f; Yang YL, 2005, J NANOSCI NANOTECHNO, V5, P927, DOI 10.1166/jnn.2005.115; Kilbride BE, 2002, J APPL PHYS, V92, P4024, DOI 10.1063/1.1506397; Ren FJ, 2014, RSC ADV, V4, P14419, DOI 10.1039/c3ra46989a; Paton KR, 2008, CARBON, V46, P1935, DOI 10.1016/j.carbon.2008.08.001; Coleman JN, 2006, CARBON, V44, P1624, DOI 10.1016/j.carbon.2006.02.038; Kim HM, 2004, APPL PHYS LETT, V84, P589, DOI 10.1063/1.1641167; Li J, 2007, ADV FUNCT MATER, V17, P3207, DOI 10.1002/adfm.200700065; Wen B, 2014, ADV MATER, V26, P3484, DOI 10.1002/adma.201400108; Zhang CS, 2007, COMPOS SCI TECHNOL, V67, P2973, DOI 10.1016/j.compscitech.2007.05.011; Song WL, 2014, CARBON, V66, P67, DOI 10.1016/j.carbon.2013.08.043; Yan DX, 2012, J MATER CHEM, V22, P18772, DOI 10.1039/c2jm32692b; Li N, 2006, NANO LETT, V6, P1141, DOI 10.1021/nl0602589; [Anonymous], 2010, PROG POLYM SCI, DOI DOI 10.1016/J.PROGPOLYMSCI.2009.09.003; Shen B, 2014, ADV FUNCT MATER, V24, P4542, DOI 10.1002/adfm.201400079; Chung DDL, 2012, CARBON, V50, P3342, DOI 10.1016/j.carbon.2012.01.031; Thomassin JM, 2010, POLYMER, V51, P115, DOI 10.1016/j.polymer.2009.11.012; Chung DDL, 2001, CARBON, V39, P279, DOI 10.1016/S0008-6223(00)00184-6; Wang HS, 2012, J MATER CHEM, V22, P21232, DOI 10.1039/c2jm35129c; Al-Saleh MH, 2009, CARBON, V47, P1738, DOI 10.1016/j.carbon.2009.02.030; Wang LL, 2009, CARBON, V47, P1905, DOI 10.1016/j.carbon.2009.03.033; Mahmoodi M, 2012, CARBON, V50, P1455, DOI 10.1016/j.carbon.2011.11.004; Moniruzzaman M, 2006, MACROMOLECULES, V39, P5194, DOI 10.1021/ma060733p; Ameli A, 2014, ACS APPL MATER INTER, V6, P11091, DOI 10.1021/am500445g; Al-Saleh MH, 2013, CARBON, V60, P146, DOI 10.1016/j.carbon.2013.04.008; Hayashida K, 2012, ADV FUNCT MATER, V22, P2338, DOI 10.1002/adfm.201103089; Theilmann P, 2013, ORG ELECTRON, V14, P1531, DOI 10.1016/j.orgel.2013.02.029; ENGEN GF, 1979, IEEE T MICROW THEORY, V27, P987, DOI 10.1109/TMTT.1979.1129778; Park KY, 2006, COMPOS SCI TECHNOL, V66, P576, DOI 10.1016/j.compscitech.2005.05.034; Thomassin JM, 2013, MAT SCI ENG R, V74, P211, DOI 10.1016/j.mser.2013.06.001; Born M., 1970, PRINCIPLES OPTICS EL; Byrne MT, ADV MAT; CATRYSSE JA, 1993, IEEE T ELECTROMAGN C, V35, P440, DOI 10.1109/15.247857; Hayashida K, RSC ADV; Hayashida K, CARBON; Kwon S, 2014, CARBON, V68, P118, DOI 10.1016/j.carbon.2013.10.070; Lestriez B, POLYMER; Mdarhri A, J APPL PHYS; Villacorta BS, 2013, COMPOS SCI TECHNOL, V89, P158, DOI 10.1016/j.compscitech.2013.10.003; Zhao TK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05619; Zhou Z, NANOSCALE	46	4	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0008-6223	1873-3891		CARBON	Carbon	APR	2015	85						363	371		10.1016/j.carbon.2015.01.006		9	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	CB6GE	WOS:000349724700039		
J	Pham, SH; Kawara, Z; Yokomine, T; Kunugi, T				Pham, Son H.; Kawara, Zensaku; Yokomine, Takehiko; Kunugi, Tomoaki			Measurements of liquid film and droplets of annular two-phase flow on a rod-bundle geometry with spacer	INTERNATIONAL JOURNAL OF MULTIPHASE FLOW			English	Article						High speed camera; Liquid film; Droplet; Annular flow; Spacer; BWR rod-bundle	LASER-INDUCED FLUORESCENCE; THICKNESS; DESIGN; SIZE; ENTRAINMENT; VELOCITY; MODEL; GRIDS; CHF	Measurements have been conducted to simultaneously consider both liquid films and droplets of the annular flow on a 3 x 3 simulating BWR fuel rod-bundle test-section with spacers. The optical system of a high speed camera and a tele-microscope was used to record the backlight images at the gap between a corner rod and a side rod of the bundle at high time and space resolutions. The data obtained from the liquid film showed that the mean film thickness, wave height, power spectral density, and wave velocity at the corner rod are larger than those at the side rod, and that the influences of the spacer are different in the cases of low and high gas superficial velocities. Simultaneously, the data containing size and spatial distributions as well as the axial velocity distribution of liquid droplets were obtained. In the case of lower gas flow rates, the spacer generates not only a large number of small droplets but also big droplets whose size exceeds the maximum droplet diameter at upstream. At further downstream, the spatial distribution of the droplets indicates an asymmetry characteristic, which emphasizes the contribution of the droplet impingement mechanism to the entrainment phenomena. Moreover, a close-up observation at right up- and downstreams of the spacer was conducted to describe the interactions between the two-phase flow and this structure. By using these new experimental arrangements, the interaction mechanisms among the wavy liquid film, droplets and spacer were discussed. (C) 2014 Elsevier Ltd. All rights reserved.	[Pham, Son H.; Kawara, Zensaku; Yokomine, Takehiko; Kunugi, Tomoaki] Kyoto Univ, Dept Nucl Engn, Nishikyo Ku, Kyoto 6158540, Japan	Kunugi, T (reprint author), Kyoto Univ, Dept Nucl Engn, Nishikyo Ku, Kyoto 6158540, Japan.	phamhsv@gmail.com; kawara@nucleng.kyoto-u.ac.jp; yokomine@nucleng.kyoto-u.ac.jp; kunugi@nucleng.kyoto-u.ac.jp					Alekseenko S, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3151999; Barbosa JR, 2002, INT J MULTIPHAS FLOW, V28, P943, DOI 10.1016/S0301-9322(02)00003-4; Zhao YJ, 2013, INT J MULTIPHAS FLOW, V55, P111, DOI 10.1016/j.ijmultiphaseflow.2013.04.001; NISHIDA K, 1994, J NUCL SCI TECHNOL, V31, P213; Pham SH, 2014, INT J MULTIPHAS FLOW, V59, P135, DOI 10.1016/j.ijmultiphaseflow.2013.11.004; AZZOPARDI BJ, 1985, EXP FLUIDS, V3, P53, DOI 10.1007/BF00285271; Azzopardi BJ, 1997, INT J MULTIPHAS FLOW, V23, P1; Schubring D, 2010, INT J MULTIPHAS FLOW, V36, P385, DOI 10.1016/j.ijmultiphaseflow.2010.01.003; Kamei T, 1998, NUCL ENG DES, V184, P349, DOI 10.1016/S0029-5493(98)00208-8; Hurlburt ET, 1996, EXP FLUIDS, V21, P357, DOI 10.1007/BF00189056; Farias PSC, 2012, EXP FLUIDS, V52, P633, DOI 10.1007/s00348-011-1084-4; Hay KJ, 1998, EXP FLUIDS, V25, P226, DOI 10.1007/s003480050225; Damsohn M, 2011, NUCL ENG DES, V241, P2494, DOI 10.1016/j.nucengdes.2011.04.016; Yano T, 2001, NUCL ENG DES, V210, P21, DOI 10.1016/S0029-5493(01)00419-8; JAYANTI S, 1990, INT J MULTIPHAS FLOW, V16, P1097, DOI 10.1016/0301-9322(90)90108-U; Schubring D, 2010, INT J MULTIPHAS FLOW, V36, P815, DOI 10.1016/j.ijmultiphaseflow.2010.05.007; Yano T, 2000, NUCL ENG DES, V201, P177, DOI 10.1016/S0029-5493(00)00279-X; ISHII M, 1975, AICHE J, V21, P308, DOI 10.1002/aic.690210212; Azzopardi B. J., 1983, 11068 UKAEA AERER; AZZOPARDI BJ, 1986, NUCL ENG DES, V92, P121, DOI 10.1016/0029-5493(86)90240-2; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679; Cho HK, 2011, NUCL ENG DES, V241, P4649, DOI 10.1016/j.nucengdes.2011.03.042; Dominguez-Ontiveros EE, 2012, NUCL ENG DES, V253, P396, DOI 10.1016/j.nucengdes.2012.09.003; FORE LB, 1995, INT J MULTIPHAS FLOW, V21, P137, DOI 10.1016/0301-9322(94)00061-N; Feldhaus G, 2002, NUCL ENG DES, V213, P199, DOI 10.1016/S0029-5493(01)00508-8; Hazuku T, 2008, INT J MULTIPHAS FLOW, V34, P111, DOI 10.1016/j.ijmultiphaseflow.2007.10.008; Jayanti S, 2013, NUCL ENG DES, V261, P66, DOI 10.1016/j.nucengdes.2013.03.044; KRAEMER W, 1995, NUCL ENG DES, V154, P17, DOI 10.1016/0029-5493(95)92757-5; PARAS SV, 1991, INT J MULTIPHAS FLOW, V17, P439, DOI 10.1016/0301-9322(91)90041-Z; Shin BS, 2009, NUCL ENG DES, V239, P899, DOI 10.1016/j.nucengdes.2009.01.011; Yano T, 2001, NUCL ENG DES, V205, P295, DOI 10.1016/S0029-5493(00)00392-7	31	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0301-9322	1879-3533		INT J MULTIPHAS FLOW	Int. J. Multiph. Flow	APR	2015	70						35	57		10.1016/j.ijmultiphaseflow.2014.11.010		23	Mechanics	Mechanics	CB4BR	WOS:000349573700004		
J	Soma, T; Katayama, T; Tanimoto, J; Saito, Y; Matsushita, Y; Aoki, H; Nakai, D; Kitamura, G; Miura, M; Asakawa, T; Daikoku, M; Haneda, T; Hatayama, Y; Shirota, M; Inamura, T				Soma, Tatsuya; Katayama, Tomoyuki; Tanimoto, Junichi; Saito, Yasuhiro; Matsushita, Yohsuke; Aoki, Hideyuki; Nakai, Daichi; Kitamura, Genki; Miura, Masanari; Asakawa, Takukatsu; Daikoku, Masatoshi; Haneda, Toshiki; Hatayama, Yohsuke; Shirota, Minori; Inamura, Takao			Liquid film flow on a high speed rotary bell-cup atomizer	INTERNATIONAL JOURNAL OF MULTIPHASE FLOW			English	Article						Numerical simulation; High speed rotary bell-cup atomizer; Spray painting; Volume of fluid	ELECTROSTATIC COATING PROCESS; SPRAY TRANSFER PROCESSES; ROTATING-DISK; SURFACE; SIMULATION; PATTERNS; MODEL	In a high-speed rotary bell-cup atomizer, which is mainly used in the automotive industry, atomization is achieved by disintegration of a thin liquid film at the bell-cup edge. To obtain the hydrodynamic behavior of the liquid film as it passes over the bell cup, the liquid-film formation was simulated using the volume of fluid method under various conditions of the rotational speed, flow rate, liquid viscosity, and surface tension coefficient, based on industrial painting conditions. The liquid supplied from the liquid supply nozzle to the bell-cup surface flowed radially upon rotation of the bell cup and formed a film, which reached steady-state. We clarified the flow field depended on the rotational speed, flow rate, and liquid viscosity, and was independent of the surface tension coefficient. Based on these results, an equation for the liquid film thickness was proposed. In addition, the unsteady behavior of film with flow fluctuation in liquid supply was also investigated; the fluctuations persisted at the edge of the bell-cup atomizer. The proposed equation can be applied to this case regardless of the normalized amplitude of the fluctuation up to 50%. Thus, in this condition, unsteady film flow may be described in the proposed equation, which assumes a steady flow. (C) 2014 Elsevier Ltd. All rights reserved.	[Soma, Tatsuya; Katayama, Tomoyuki; Tanimoto, Junichi; Saito, Yasuhiro; Matsushita, Yohsuke; Aoki, Hideyuki] Tohoku Univ, Grad Sch Engn, Dept Chem Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Nakai, Daichi; Kitamura, Genki; Miura, Masanari; Asakawa, Takukatsu; Daikoku, Masatoshi] Hachinohe Inst Technol, Fac Engn, Dept Mech Engn, Hachinohe, Aomori 0318501, Japan; [Haneda, Toshiki; Hatayama, Yohsuke; Shirota, Minori; Inamura, Takao] Hirosaki Univ, Fac Sci & Technol, Dept Intelligent Machines & Syst Engn, Hirosaki, Aomori 0368561, Japan	Saito, Y (reprint author), Tohoku Univ, Grad Sch Engn, Dept Chem Engn, Aoba Ku, 6-6-07 Aoba, Sendai, Miyagi 9808579, Japan.	saito@tranpo.che.tohoku.ac.jp					Amsden A. A., 1970, Journal of Computational Physics, V6, DOI 10.1016/0021-9991(70)90029-X; HIRT CW, 1981, J COMPUT PHYS, V39, P201, DOI 10.1016/0021-9991(81)90145-5; Leshev I, 2003, CHEM ENG PROCESS, V42, P925, DOI 10.1016/S0255-2701(02)00191-5; Burns JR, 2003, CHEM ENG SCI, V58, P2245, DOI 10.1016/S0009-2509(03)00091-5; Nusselt W, 1916, Z VER DTSCH ING, V60, P541; Im KS, 2001, J FLUID ENG-T ASME, V123, P237, DOI 10.1115/1.1359210; BRACKBILL JU, 1992, J COMPUT PHYS, V100, P335, DOI 10.1016/0021-9991(92)90240-Y; de Caprariis B, 2012, CHEM ENG SCI, V76, P73, DOI 10.1016/j.ces.2012.03.043; Kazama S, 2003, JSAE REV, V24, P489, DOI 10.1016/S0389-4304(03)00075-4; Chakravarthy S., 1985, 850363 AIAA; CHARWAT AF, 1972, J FLUID MECH, V53, P227, DOI 10.1017/S0022112072000138; Colbert SA, 2005, POWDER TECHNOL, V151, P77, DOI 10.1016/j.powtec.2004.11.039; Colbert SA, 2006, J ELECTROSTAT, V64, P234, DOI 10.1016/j.elstat.2005.06.003; Daikoku M., 2012, 48 TOH BRANCH JSME A; Domnick J, 2005, PART PART SYST CHAR, V22, P141, DOI 10.1002/ppsc.200400968; Domnick J., 2006, EXTERNAL CHARGING 2, V23, P408; Ghiasy D, 2012, CHEM ENG PROCESS, V55, P1, DOI 10.1016/j.cep.2012.02.009; HINZE JO, 1950, J APPL MECH-T ASME, V17, P145; Im KS, 2004, J FLUID ENG-T ASME, V126, P449, DOI 10.1115/1.1758263; Leneweit G, 1999, EXP FLUIDS, V26, P75, DOI 10.1007/s003480050266; Ogasawara Shin, 2010, Journal of Fluid Science and Technology, V5, DOI 10.1299/jfst.5.464; Panneton B, 2002, APPL ENG AGRIC, V18, P435; Takatani K, 2007, ISIJ INT, V47, P545, DOI 10.2355/isijinternational.47.545; Tanasawa Y., 1978, P 1 INT C LIQ AT SPR, P165; Toljic N, 2012, J ELECTROSTAT, V70, P499, DOI 10.1016/j.elstat.2012.08.001; Toljic N, 2011, J ELECTROSTAT, V69, P189, DOI 10.1016/j.elstat.2011.03.008; Ubbink O., 1997, NUMERICAL PREDICTION; Viti V., 2008, ILASS AM 21 ANN C LI; WOOD RM, 1973, T I CHEM ENG-LOND, V51, P315; Yabe T., 2003, CIP METHOD; Yasumura K, 2011, KAGAKU KOGAKU RONBUN, V37, P296; Yasumura K, 2011, KAGAKU KOGAKU RONBUN, V37, P251	32	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0301-9322	1879-3533		INT J MULTIPHAS FLOW	Int. J. Multiph. Flow	APR	2015	70						96	103		10.1016/j.ijmultiphaseflow.2014.11.013		8	Mechanics	Mechanics	CB4BR	WOS:000349573700008		
J	Hayashi, S				Hayashi, S.			Influence of traces of gaseous sulphur on carburisation rate of iron in CO-H-2 mixtures	IRONMAKING & STEELMAKING			English	Article						Traces of gaseous sulphur; Carburisation rate of iron; CO-H-2 mixtures; Hydrogen half substitute to CO gas; Blast furnace; Direct reduction	FURNACE SIMULATED CONDITION; H-2-CO GAS-MIXTURES; REACTION BEHAVIOR; CARBIDE; HYDROGEN; SINTER; H2S; ORE	The influence of traces of gaseous sulphur on the carburisation rate of a pure iron plate in CO-H-2-H2S gas mixtures was examined at 920-1200 degrees C to clarify the carburisation behaviour in the blast furnace utilising hydrogen or the direct reduction processes. The initial rates were analysed based on two chemical reactions for gas carburisation and the chemisorption equilibrium of sulphur atoms on the surface of iron. Traces of sulphur in gas mixtures significantly decreased the carburisation rate as the sulphur content increased. The carburisation was found to proceed to a small extent dependent on temperature and gas composition even under sulphur saturated chemisorption. The higher sulphur gas mixtures caused simultaneous reactions of carburisation and sulphurisation. When 50% of the CO was substituted by hydrogen, the rates were roughly twice as large as the condition without hydrogen, and approximately independent of the existence of sulphur. With rising temperature, the carburisation rates without sulphur tended to increase until around 1000 degrees C and decrease beyond 1100 degrees C, while the rates under sulphur saturated chemisorption increased gradually with rising temperature. The results are discussed relating to the carburisation behaviour inside the blast furnace utilising hydrogen or the direct reduction processes.	Nagoya Inst Technol, Grad Sch Mat Engn, Showa Ku, Nagoya, Aichi 4668555, Japan	Hayashi, S (reprint author), Nagoya Inst Technol, Grad Sch Mat Engn, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	hayashis@nitech.ac.jp					FRUEHAN RJ, 1973, METALL TRANS, V4, P2123, DOI 10.1007/BF02643276; WANG C, 1991, TETSU TO HAGANE, V77, P353; Ohno K, 2008, ISIJ INT, V48, P1368, DOI 10.2355/isijinternational.48.1368; Asano R, 2002, ISIJ INT, V42, P121, DOI 10.2355/isijinternational.42.121; Benique F. B., 2010, P 8 JAP BRAZ S FUK J, P118; Feinman J., 1999, DIRECT REDUCED IRON; Grabke HJ, 2001, ISIJ INT, V41, pS1, DOI 10.2355/isijinternational.41.Suppl_S1; Hayashi S, 2014, TETSU TO HAGANE, V100, P277, DOI 10.2355/tetsutohagane.100.277; Hayashi S., 2002, 7 EUR EL STEELM C P; Hayashi S, 1997, ISIJ INT, V37, P16, DOI 10.2355/isijinternational.37.16; Hayashi S., P 2011 CSM BEIJ CHIN; Hayashi S, 2000, IRONMAK STEELMAK, V27, P111, DOI 10.1179/030192300677408; Hayashi S., 1999, ISS IR C P CHIC IL U, P399; Hayashi S, 1997, ISIJ INT, V37, P345, DOI 10.2355/isijinternational.37.345; Hayashi S, 2000, TETSU TO HAGANE, V86, P285; Hayashi S., 2000, TETSU TO HAGANE, V86, P641; HAYASHI S, 1989, ISIJ INT, V29, P596, DOI 10.2355/isijinternational.29.596; Inayoshi A, 2010, TETSU TO HAGANE, V96, P586, DOI 10.2355/tetsutohagane.96.586; Matsuzaki S., 2010, CAMP ISIJ, V23, P874; Min S., 2009, CAMP ISIJ, V22, P775; Miwa T., 2010, J JPN I ENERGY, V89, P28; Mizoguchi H, 2011, TETSU TO HAGANE, V97, P597, DOI 10.2355/tetsutohagane.97.597; OLSSON RG, 1974, METALL TRANS, V5, P21; Shimomura Y., 1976, TETSU TO HAGANE, V62, P547; Zhang XH, 1997, TETSU TO HAGANE, V83, P299; Zhang X., 1997, CAMP ISIJ, V10, P988	26	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0301-9233	1743-2812		IRONMAK STEELMAK	Ironmak. Steelmak.	APR	2015	42	3					233	240		10.1179/1743281214Y.0000000202		8	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	CB4MZ	WOS:000349603200009		
J	Chuamchaitrakool, P; Widjaja, J; Yoshimura, H				Chuamchaitrakool, Porntip; Widjaja, Joewono; Yoshimura, Hiroyuki			Holographic particle sizing using Wigner-Ville distribution	OPTICS AND LASERS IN ENGINEERING			English	Article						In-line particle holography; Particle sizing; Wigner-Ville distribution	DIGITAL HOLOGRAPHY; SIZE MEASUREMENT; RECONSTRUCTION; MICROSCOPY; TARGET	A novel method for measuring size of small objects with high-aspect ratio from in-line holograms by using Wigner-Ville distribution (WVD) is proposed. The proposed method provides direct calculation of the particle size by using local spatial-frequency information at the half length of holograms being analyzed. Feasibility of this method is experimentally verified by analyzing in-line holograms of an optical fiber. (C) 2014 Elsevier Ltd. All rights reserved.	[Chuamchaitrakool, Porntip; Widjaja, Joewono] Suranaree Univ Technol, Sch Laser Technol & Photon, Nakhon, Ratchasima, Thailand; [Yoshimura, Hiroyuki] Chiba Univ, Dept Urban Environm Syst, Fac Engn, Chiba, Japan	Widjaja, J (reprint author), Suranaree Univ Technol, Sch Laser Technol & Photon, Nakhon, Ratchasima, Thailand.	widjaja@sut.ac.th			Thailand Research Fund through Royal Golden jubilee Ph.D. Program [PHD/0114/2554]	The financial support from the Thailand Research Fund through the Royal Golden jubilee Ph.D. Program (Grant no. PHD/0114/2554) is acknowledged.	Pitkaaho T, 2014, APPL OPTICS, V53, P3233, DOI 10.1364/AO.53.003233; Javidi B, 2005, OPT EXPRESS, V13, P4492, DOI 10.1364/OPEX.13.004492; WIDJAJA J, 1992, OPT COMMUN, V94, P313, DOI 10.1016/0030-4018(92)90568-C; TYLER GA, 1976, OPT ACTA, V23, P685; Yu X, 2014, OPT ENG, V53, DOI 10.1117/1.OE.53.11.112306; Widjaja J, 2013, OPT LASER ENG, V51, P311, DOI 10.1016/j.optlaseng.2012.09.009; Choi YS, 2009, APPL OPTICS, V48, P2983, DOI 10.1364/AO.48.002983; SCHNARS U, 1994, APPL OPTICS, V33, P179, DOI 10.1364/AO.33.000179; Lee SJ, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/6/064004; BOASHASH B, 1988, IEEE T ACOUST SPEECH, V36, P1518, DOI 10.1109/29.90380; Khanam T, 2011, CHEM ENG SCI, V66, P2699, DOI 10.1016/j.ces.2011.03.026; Carl D, 2004, APPL OPTICS, V43, P6536, DOI 10.1364/AO.43.006536; Pan G, 2003, APPL OPTICS, V42, P827, DOI 10.1364/AO.42.000827; Black DL, 1996, PROG ENERG COMBUST, V22, P267; Chuamchaitrakool P, 2014, PROC SPIE, V9234, DOI 10.1117/12.2054226; Darakis E, 2010, CHEM ENG SCI, V65, P1037, DOI 10.1016/j.ces.2009.09.057; Goodman J. W., 1996, INTRO FOURIER OPTICS; Hariharan P., 1996, OPTICAL HOLOGRAPHY P; Hlawatsch F., 1984, Digital Signal Processing - 84. Proceedings of the International Conference; MORRISON KE, 1995, AM MATH MON, V102, P716, DOI 10.2307/2974641; Murata K, 1970, P C ENG US HOL, P289; THOMPSON BJ, 1974, J PHYS E SCI INSTRUM, V7, P781, DOI 10.1088/0022-3735/7/10/001	22	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0143-8166	1873-0302		OPT LASER ENG	Opt. Lasers Eng.	APR	2015	67						186	190		10.1016/j.optlaseng.2014.11.016		5	Optics	Optics	CB4EO	WOS:000349581200022		
